{"meta":{"query_hash":"8352a2c221bc","filters":{"venue":"Alimentary Pharmacology & Therapeutics"},"cohort_total":774,"direct_labels_cover":2,"predictions_cover":774,"exported":774,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/8352a2c221bc","api":"https://metacan.xera.ac/api/v1/cohort?venue=Alimentary+Pharmacology+%26+Therapeutics"},"results":[{"id":"W1481405636","doi":"10.1111/j.1365-2036.2006.03226.x","title":"Predictors of inappropriate utilization of intravenous proton pump inhibitors","year":2006,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Proton-pump inhibitor; Evening; Medical prescription; Pantoprazole; Upper gastrointestinal bleeding; Gastrointestinal bleeding; Retrospective cohort study; Intravenous therapy; Internal medicine; Anesthesia; Endoscopy; Omeprazole; Pharmacology","score_opus":0.026793926347553298,"score_gpt":0.31052715448808393,"score_spread":0.28373322814053065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1481405636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99725103,0.00037773445,0.000037855185,0.00018654074,0.00042268462,0.001287744,0.000033200125,0.000036499758,0.00036670134],"genre_scores_gemma":[0.9984335,0.00018068241,0.00023827149,0.00060777436,0.0001577016,0.00006093246,0.00017199245,0.00002754881,0.00012162881],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987562,0.000086304644,0.0004714551,0.00020283334,0.00024020144,0.00024304369],"domain_scores_gemma":[0.9994072,0.000031709442,0.0002463148,0.00015265787,0.0001028992,0.000059217935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000111013745,0.00018299549,0.00033821794,0.00013290253,0.000039308852,0.0000021429305,0.00008148733,0.000101772755,0.00016685306],"category_scores_gemma":[1.5977123e-7,0.00015451075,0.000093420655,0.00019122752,0.00019442863,0.000059517166,0.000033908585,0.00012639581,0.0000060191583],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071127445,0.003090874,0.62871194,0.00019904526,0.0060912203,0.00008949733,0.00038665094,0.00005128994,0.35843673,0.000034731253,0.000081799575,0.0021149414],"study_design_scores_gemma":[0.0036698133,0.001762055,0.073867865,0.000023300385,0.005854917,0.000023148477,0.000034974826,0.00009921787,0.91408324,0.000117653326,0.00040556883,0.00005826344],"about_ca_topic_score_codex":0.00006902314,"about_ca_topic_score_gemma":0.0000013649129,"teacher_disagreement_score":0.5556465,"about_ca_system_score_codex":0.00007846056,"about_ca_system_score_gemma":0.00008031984,"threshold_uncertainty_score":0.6300765},"labels":[],"label_agreement":null},{"id":"W1482376759","doi":"10.1111/j.1365-2036.2011.04789.x","title":"Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole - results from the STARS II study","year":2011,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Abbott Laboratories","keywords":"Esomeprazole; Medicine; Internal medicine; Clinical trial; Gastroenterology","score_opus":0.07991019146012868,"score_gpt":0.34729297806688164,"score_spread":0.26738278660675296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1482376759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99197984,0.0003538344,0.0000028053068,0.0043373145,0.00018163517,0.002983127,0.00009318397,0.000018513345,0.0000497473],"genre_scores_gemma":[0.9968279,0.00017545845,0.00025040703,0.0024400072,0.00009539149,0.0000981153,0.000040844814,0.000019838053,0.000052037423],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979045,0.0006517974,0.00073066284,0.00030835843,0.00019514946,0.00020956858],"domain_scores_gemma":[0.9983862,0.0007054998,0.0003172153,0.0004034087,0.00009002466,0.000097646094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006484655,0.00022877347,0.00053288596,0.00003373918,0.00012250066,0.0000036132747,0.00017012909,0.00006291372,0.00014372992],"category_scores_gemma":[0.000003230505,0.00011075787,0.00010631525,0.00013337926,0.0011545677,0.000042229116,0.000079539954,0.00022382321,0.0000011886974],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77091706,0.004751234,0.1559032,0.000010149895,0.014585326,0.00005398276,0.04933018,0.000011161073,0.0021107234,0.000002845584,0.00006732983,0.0022568177],"study_design_scores_gemma":[0.6669396,0.06830359,0.19055755,0.0000721642,0.03703226,0.000025823929,0.028493902,0.00030882852,0.007238159,0.00015814054,0.00066966895,0.00020029525],"about_ca_topic_score_codex":0.001830701,"about_ca_topic_score_gemma":0.00025944618,"teacher_disagreement_score":0.10397744,"about_ca_system_score_codex":0.000024146346,"about_ca_system_score_gemma":0.00012131391,"threshold_uncertainty_score":0.4516575},"labels":[],"label_agreement":null},{"id":"W1482759447","doi":"10.1111/j.1365-2036.2011.04666.x","title":"The association of coeliac disease and microscopic colitis: a large population-based study","year":2011,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Microscopic Colitis","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"Health Research Board","keywords":"Microscopic colitis; Lymphocytic colitis; Medicine; Incidence (geometry); Colitis; Population; Collagenous colitis; Coeliac disease; Internal medicine; Ulcerative colitis; Cohort; Gastroenterology; Disease; Inflammatory bowel disease; Pathology; Environmental health","score_opus":0.025754828667320668,"score_gpt":0.3270370124568525,"score_spread":0.30128218378953187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1482759447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955938,0.0011584153,0.000009348401,0.0013232887,0.00046252375,0.0012833666,0.000081830265,0.000030080106,0.000057348378],"genre_scores_gemma":[0.99095327,0.00016894932,0.00009102744,0.008255302,0.000065686865,0.00007831937,0.000043979137,0.000018813591,0.00032468204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987729,0.00023504015,0.00031894288,0.00020260883,0.00017970013,0.00029076863],"domain_scores_gemma":[0.9992119,0.00021370541,0.00017626373,0.0001972934,0.00008939051,0.0001114692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003149658,0.00013725246,0.00022521018,0.000050746687,0.00018726394,0.00000851662,0.000094972944,0.000053949545,0.00032490888],"category_scores_gemma":[0.0000012000274,0.00011376723,0.000051030238,0.00009695273,0.000058074635,0.000037636306,0.000048188274,0.00014234683,0.0000058973874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007923283,0.0010131865,0.9850104,0.000033095883,0.0026602247,0.00001538488,0.0008062456,2.1694613e-7,0.009274878,0.00003944456,0.00020530437,0.00014932817],"study_design_scores_gemma":[0.004804758,0.00053992064,0.97579676,0.000018143983,0.007029408,0.000001584071,0.00031850432,0.00007923756,0.009504194,0.00007552341,0.0017381525,0.00009383047],"about_ca_topic_score_codex":0.0003164655,"about_ca_topic_score_gemma":0.00018564252,"teacher_disagreement_score":0.00921362,"about_ca_system_score_codex":0.00017709317,"about_ca_system_score_gemma":0.000115473784,"threshold_uncertainty_score":0.4639293},"labels":[],"label_agreement":null},{"id":"W1483462250","doi":"10.1111/j.1365-2036.2007.03399.x","title":"Systematic review and meta‐analysis: the incidence and prognosis of post‐infectious irritable bowel syndrome","year":2007,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":466,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Irritable bowel syndrome; Medicine; Internal medicine; Odds ratio; Gastroenterology; Incidence (geometry); Meta-analysis; Epidemiology; Anxiety; Psychiatry","score_opus":0.06787871587370563,"score_gpt":0.38191483047208974,"score_spread":0.3140361145983841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1483462250","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001819153,0.9934009,0.000010020155,0.0014131652,0.000052776715,0.0048222994,0.000056213154,0.000032754393,0.000030008643],"genre_scores_gemma":[0.0010635277,0.98188484,0.00013136023,0.016338583,0.000010918269,0.00040543408,0.000054151606,0.000034481483,0.000076714416],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9970795,0.00071675883,0.0011339566,0.00045533205,0.0002615307,0.0003529132],"domain_scores_gemma":[0.99775094,0.00089505495,0.0006956957,0.00036405973,0.00015705652,0.00013719054],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012217136,0.0005152207,0.0049139704,0.00027039796,0.00012303359,0.000014642997,0.00022624686,0.00015972368,0.00021874084],"category_scores_gemma":[0.000003868404,0.00030547107,0.00097576564,0.00067373674,0.00043291642,0.00007390642,0.0001368103,0.0005380937,0.0000072911344],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016004227,0.00020782145,0.00009151678,0.51313424,0.48608,0.00005076963,0.00004339269,2.096984e-7,0.0000032002065,0.0000042522092,0.000015658998,0.00035293042],"study_design_scores_gemma":[0.0002736957,0.00063970435,0.000043069733,0.016355447,0.97795266,0.0027024471,0.000060773775,0.0000053595886,0.0000035550822,0.000010349569,0.0017739384,0.00017900382],"about_ca_topic_score_codex":0.000110371206,"about_ca_topic_score_gemma":0.0000253144,"teacher_disagreement_score":0.49677882,"about_ca_system_score_codex":0.000049372993,"about_ca_system_score_gemma":0.00011914279,"threshold_uncertainty_score":0.99993974},"labels":[],"label_agreement":null},{"id":"W1486067581","doi":"10.1111/j.1365-2036.2011.04590.x","title":"Review article: the design of clinical trials in hepatic encephalopathy - an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement","year":2011,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":349,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Hepatic encephalopathy; Medicine; Cirrhosis; Encephalopathy; Intensive care medicine; Hyperammonemia; Clinical trial; Rifaximin; Internal medicine","score_opus":0.3161130313169462,"score_gpt":0.503374709272029,"score_spread":0.1872616779550828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1486067581","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007827383,0.98362285,0.00018557628,0.0003954043,0.00082118536,0.0067015085,0.00042014846,0.00001920605,0.00000674986],"genre_scores_gemma":[0.0010160536,0.98478884,0.0017143312,0.010809934,0.0002698704,0.00083661795,0.00051597843,0.000042157342,0.000006205409],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9924111,0.0036471314,0.0028967774,0.0004948584,0.00023609426,0.00031404043],"domain_scores_gemma":[0.99473226,0.0034051705,0.0012559359,0.00029000783,0.00015497326,0.000161625],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008101855,0.00041398796,0.0026721093,0.00009354603,0.000071314236,0.000011802811,0.0003027016,0.00019506637,0.0001772759],"category_scores_gemma":[0.0000068205036,0.00027197876,0.0008936078,0.00016786138,0.00033274243,0.000117746335,0.00004574686,0.00039525717,0.0000056481535],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004073828,0.0048371,0.0071429797,0.059796274,0.18010418,0.00013826427,0.00498715,0.00000457663,0.00051895995,0.00015279537,0.0010669166,0.73717695],"study_design_scores_gemma":[0.01286659,0.0017733275,0.0006023055,0.015039897,0.7452322,0.00015814061,0.0003418732,0.0013008764,0.000558163,0.0009175471,0.22041397,0.00079511234],"about_ca_topic_score_codex":0.00004331376,"about_ca_topic_score_gemma":0.0000030591327,"teacher_disagreement_score":0.7363819,"about_ca_system_score_codex":0.00007589246,"about_ca_system_score_gemma":0.0006627923,"threshold_uncertainty_score":0.99997324},"labels":[],"label_agreement":null},{"id":"W1486205675","doi":"10.1111/apt.13291","title":"Randomised clinical trial: a placebo‐controlled study of intravenous golimumab induction therapy for ulcerative colitis","year":2015,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"UCB Pharma; Janssen Research and Development; Relypsa; Genentech; Norgine; Mitsubishi Tanabe Pharma Corporation; Tillotts Pharma; Shire; Sanofi; Kyowa Hakko Kirin; Janssen Scientific Affairs; Ironwood Pharmaceuticals, Incorporated; Danone; Therakos; Novo Nordisk; Janssen Biotech; Teva Pharmaceutical Industries; Gilead Sciences; Astellas Pharma; Celltrion; Procter and Gamble; Celgene; BioClinica; Pfizer; Biogen; GlaxoSmithKline; Atlantic Healthcare; ActoGeniX; Amgen; IC Design Education Center; Orexigen Therapeutics; Eli Lilly and Company; Bristol-Myers Squibb; Dr. Falk Pharma; Abbott Laboratories","keywords":"Golimumab; Medicine; Placebo; Ulcerative colitis; Internal medicine; Clinical endpoint; Clinical trial; Gastroenterology; Surgery; Tumor necrosis factor alpha; Adalimumab","score_opus":0.07750055535918386,"score_gpt":0.3899949360759915,"score_spread":0.31249438071680763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1486205675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873848,0.0003343341,0.000103020524,0.00020489891,0.0019275926,0.009891559,0.000045798537,0.000023488665,0.00008450201],"genre_scores_gemma":[0.99272805,0.00038787123,0.00013241342,0.0037997235,0.0009923736,0.0016650972,0.00012078079,0.0000497007,0.00012398732],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99655527,0.0015792815,0.00088607374,0.00045833745,0.00018817067,0.00033284785],"domain_scores_gemma":[0.9985949,0.00019311308,0.0004295903,0.00030661636,0.00029850766,0.00017730887],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014798151,0.0002882932,0.000603881,0.00006922667,0.00010672918,0.0000140910815,0.00026532667,0.00021872621,0.00004626104],"category_scores_gemma":[0.000005894396,0.00025946944,0.00027529776,0.00006493565,0.00020303637,0.000010637251,0.0000608878,0.00016349138,0.000004087838],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9469202,0.0043785707,0.00053084653,0.0000067035435,0.015236531,0.0000180771,0.0011509567,0.00010343981,0.02881566,0.000006348964,0.0010556689,0.0017769621],"study_design_scores_gemma":[0.9510591,0.01559995,0.001876151,0.0000029884347,0.004294183,0.000006361989,0.0018222259,0.00021379814,0.022153018,0.000089332185,0.002581971,0.0003009413],"about_ca_topic_score_codex":0.000014978819,"about_ca_topic_score_gemma":0.000033853477,"teacher_disagreement_score":0.01122138,"about_ca_system_score_codex":0.00005264866,"about_ca_system_score_gemma":0.00038493145,"threshold_uncertainty_score":0.99998575},"labels":[],"label_agreement":null},{"id":"W1487387487","doi":"10.1111/j.1365-2036.2011.04936.x","title":"Non‐invasive algorithms for liver fibrosis: authors’ reply","year":2011,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"Gilead Sciences","keywords":"Transient elastography; Medicine; Algorithm; Cirrhosis; Liver biopsy; Fibrosis; Biopsy; Clinical Practice; Liver disease; Machine learning; Internal medicine; Artificial intelligence; Computer science; Family medicine","score_opus":0.09852500251365463,"score_gpt":0.34330030459667144,"score_spread":0.2447753020830168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1487387487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786315,0.0070612878,0.00017275198,0.0059698,0.0023614545,0.0040662843,0.0003356349,0.0002140871,0.0011872032],"genre_scores_gemma":[0.8931797,0.003549918,0.007871793,0.09249587,0.00065213686,0.001079083,0.00031470426,0.000088790905,0.0007679606],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985574,0.000057521313,0.0003041137,0.0004631753,0.00016412967,0.00045365197],"domain_scores_gemma":[0.9990724,0.00014102893,0.00011561438,0.0002829429,0.00012317295,0.00026486928],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011949608,0.00029206113,0.0003491414,0.00009350132,0.000161596,0.000009462046,0.00014907119,0.00010733898,0.0014800573],"category_scores_gemma":[2.0796728e-7,0.00025027455,0.0002674988,0.00010379025,0.0001410818,0.00010849738,0.000060837505,0.00014181434,0.00012828328],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015449565,0.031699162,0.352723,0.0009070755,0.21960674,0.0027818552,0.026263217,0.000009610387,0.18913743,0.00042020468,0.12452345,0.036478695],"study_design_scores_gemma":[0.0131089315,0.0049741487,0.09648262,0.00009309732,0.067970924,0.00008949807,0.000655576,0.00058952137,0.7874767,0.00033064015,0.027656084,0.00057226757],"about_ca_topic_score_codex":0.00013015822,"about_ca_topic_score_gemma":0.0000041872518,"teacher_disagreement_score":0.59833926,"about_ca_system_score_codex":0.00014339726,"about_ca_system_score_gemma":0.00013948302,"threshold_uncertainty_score":0.99999493},"labels":[],"label_agreement":null},{"id":"W1487789923","doi":"10.1111/j.1365-2036.2007.03554.x","title":"Putative hepatoprotective effects of coffee: authors' reply","year":2007,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Coffee research and impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stornoway Diamond (Canada)","funders":"","keywords":"Caffeine; Cirrhosis; Medicine; Oxidative stress; Liver injury; Polyphenol; Consumption (sociology); Food science; Physiology; Internal medicine; Antioxidant; Biochemistry; Biology","score_opus":0.0259718661206127,"score_gpt":0.3848109137741386,"score_spread":0.3588390476535259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1487789923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98873544,0.0025389881,0.0009767173,0.0041645397,0.0007109326,0.0017397711,0.000016711376,0.000076423676,0.0010404678],"genre_scores_gemma":[0.9789186,0.0005292275,0.00069683546,0.019192226,0.00022943287,0.000032475495,0.000025946476,0.000035152054,0.00034008932],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981095,0.0002341235,0.0003516612,0.00030095113,0.00037597129,0.0006277762],"domain_scores_gemma":[0.99835724,0.0007523802,0.00014362053,0.00022098403,0.00018468405,0.00034110498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000699354,0.00022253787,0.00040794368,0.00023376028,0.00009401976,0.000005379979,0.00013705691,0.00011019657,0.00030764722],"category_scores_gemma":[0.0000031907407,0.00019142443,0.0001366916,0.00037092494,0.00034300468,0.000093980685,0.00007927094,0.0005118168,0.00003517945],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035014458,0.0009022187,0.00886752,0.00017495122,0.009709632,0.0004798948,0.0016923725,0.0000015084897,0.9562274,0.000033053027,0.00086651114,0.017543465],"study_design_scores_gemma":[0.004184381,0.003303781,0.03216565,0.00004436565,0.0035079625,0.00008936838,0.00023344894,0.00007715226,0.95021856,0.00019416893,0.0058296565,0.00015153279],"about_ca_topic_score_codex":0.00013407212,"about_ca_topic_score_gemma":0.000004821372,"teacher_disagreement_score":0.02329813,"about_ca_system_score_codex":0.00021377888,"about_ca_system_score_gemma":0.00018221968,"threshold_uncertainty_score":0.7806062},"labels":[],"label_agreement":null},{"id":"W1490097030","doi":"10.1111/j.1365-2036.2008.03620.x","title":"Histological benefits of virological response to peginterferon alfa‐2a monotherapy in patients with hepatitis C and advanced fibrosis or compensated cirrhosis","year":2008,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network; University of Manitoba; University of Calgary","funders":"Gilead Sciences; Genentech; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Medicine; Fibrosis; Gastroenterology; Cirrhosis; Internal medicine; Hepatitis C; Peginterferon alfa-2a; Inflammation; Hepatitis C virus; Decompensation; Ribavirin; Immunology; Virus","score_opus":0.04773881451419614,"score_gpt":0.32793374046384804,"score_spread":0.2801949259496519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1490097030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946529,0.0004963349,0.000015125635,0.0032834334,0.00008907159,0.0013083701,0.00008213424,0.000044814147,0.000027769132],"genre_scores_gemma":[0.9844459,0.0025634025,0.00196343,0.0107288435,0.00002022818,0.00011013656,0.000047707344,0.000039860373,0.00008046683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976394,0.00050498283,0.00050322537,0.00049036037,0.00036497216,0.0004970338],"domain_scores_gemma":[0.99883634,0.00043145308,0.00011783368,0.00023806204,0.00014026553,0.00023607383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023278272,0.0002903387,0.00064318674,0.000291914,0.00008846789,0.000004684266,0.00018243438,0.00016886205,0.00079080026],"category_scores_gemma":[0.0000032212365,0.00021558872,0.000052535055,0.00037329333,0.00045513408,0.00009097195,0.00010557927,0.00034548197,0.000015355676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09869052,0.0012392311,0.8092673,0.00001615634,0.0010997234,0.00013325314,0.00097272394,0.00006708803,0.08014369,0.000001717802,0.000113134396,0.008255491],"study_design_scores_gemma":[0.013476288,0.01673731,0.94272363,0.000057468085,0.0005040901,0.000035795354,0.000032795462,0.00019689083,0.023467585,0.000002662859,0.0025168697,0.00024862954],"about_ca_topic_score_codex":0.00017862854,"about_ca_topic_score_gemma":0.00007639238,"teacher_disagreement_score":0.13345633,"about_ca_system_score_codex":0.00025410627,"about_ca_system_score_gemma":0.00008063949,"threshold_uncertainty_score":0.87914526},"labels":[],"label_agreement":null},{"id":"W1493700154","doi":"10.1111/j.1365-2036.2011.04911.x","title":"Randomised clinical trial: the efficacy of treatment, guided by a shorter duration of response, using peginterferon alfa‐2a plus ribavirin for hepatitis C virus other than genotypes 2 or 3","year":2011,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Jewish General Hospital; Abbotsford Veterinary Clinic; University of British Columbia; University Health Network; Toronto Liver Centre; McGill University; University of Calgary","funders":"","keywords":"Medicine; Ribavirin; Peginterferon alfa-2a; Internal medicine; Gastroenterology; Regimen; Randomized controlled trial; Hepatitis C virus; Hepatitis C; Surgery; Immunology; Virus","score_opus":0.3384986465073326,"score_gpt":0.4872978535277139,"score_spread":0.1487992070203813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1493700154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99211764,0.00049050176,0.0005120865,0.00073089986,0.00054627773,0.005235105,0.0002455068,0.000028364268,0.00009361207],"genre_scores_gemma":[0.99175614,0.0023039812,0.00117595,0.0034970033,0.0002591722,0.0003145561,0.00007304566,0.00008120871,0.0005389141],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962327,0.0015178772,0.001251027,0.00036580788,0.0002430178,0.00038958693],"domain_scores_gemma":[0.9969615,0.0018856744,0.0004419266,0.0004157079,0.00017827208,0.00011696712],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014731305,0.00028001843,0.00079172174,0.00013393801,0.00010772472,0.000007984797,0.0002635511,0.00018791083,0.0011970773],"category_scores_gemma":[0.000014829147,0.0001805607,0.00035678816,0.00015659643,0.00049598597,0.00008234767,0.000054747157,0.00019065237,0.000008728347],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.59857124,0.0014439989,0.0092726685,0.000022428008,0.009027707,0.000011720271,0.0015646839,0.000004295187,0.3755304,0.000002538632,0.0009876144,0.0035607046],"study_design_scores_gemma":[0.3320525,0.01762486,0.0033965076,0.000044836404,0.011593675,0.000017156215,0.00010686841,0.003818553,0.6150731,0.000017479098,0.016006274,0.000248182],"about_ca_topic_score_codex":0.002383216,"about_ca_topic_score_gemma":0.0003677036,"teacher_disagreement_score":0.26651874,"about_ca_system_score_codex":0.00030058445,"about_ca_system_score_gemma":0.0005094772,"threshold_uncertainty_score":0.999716},"labels":[],"label_agreement":null},{"id":"W1498340456","doi":"10.1111/j.1365-2036.2006.03236.x","title":"Meta‐analysis: <i>Helicobacter pylori</i> eradication treatment efficacy in children","year":2007,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Dalhousie University; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Helicobacter pylori; Clarithromycin; Amoxicillin; Metronidazole; Internal medicine; Randomized controlled trial; Proton-pump inhibitor; Placebo; Meta-analysis; Nitroimidazole; Antibiotics; Pathology; Alternative medicine; Microbiology","score_opus":0.14283431935826607,"score_gpt":0.40712420183277576,"score_spread":0.2642898824745097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1498340456","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0043621087,0.9893439,0.000011087248,0.001688957,0.00056068395,0.003586581,0.00020516518,0.00015859804,0.000082949155],"genre_scores_gemma":[0.00038955745,0.97887,0.00023557102,0.016389297,0.0005054596,0.0007383019,0.0024324325,0.00015185712,0.00028752687],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9945948,0.0008760184,0.0017544077,0.0012589708,0.00036800763,0.0011477642],"domain_scores_gemma":[0.9976557,0.00043151638,0.0006959538,0.0008195268,0.00010372096,0.00029359455],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00053197256,0.0013482359,0.0059354417,0.0016447562,0.00014389344,0.000020073281,0.00043092895,0.00079891604,0.0006412783],"category_scores_gemma":[2.9646114e-7,0.0010197549,0.0028418794,0.0017335775,0.00035808908,0.00010594359,0.00014735025,0.0012497178,0.00025473896],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000193538,0.0022519715,0.0058782734,0.00022088927,0.92786574,0.00011827894,0.00019698984,0.0000052899336,0.000018930383,0.0000011747824,0.00009290056,0.06315599],"study_design_scores_gemma":[0.002472102,0.000613314,0.0018475102,0.00007907142,0.64670855,0.00016478261,0.000007448624,0.0000030169992,0.00004650103,7.0726344e-7,0.34772113,0.00033586164],"about_ca_topic_score_codex":0.00013284654,"about_ca_topic_score_gemma":0.000051764695,"teacher_disagreement_score":0.34762824,"about_ca_system_score_codex":0.0010986234,"about_ca_system_score_gemma":0.0002605053,"threshold_uncertainty_score":0.99992687},"labels":[],"label_agreement":null},{"id":"W1504806404","doi":"10.1111/j.1365-2036.2011.04676.x","title":"The changing epidemiology of paediatric inflammatory bowel disease: authors’ reply","year":2011,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Inflammatory bowel disease; Epidemiology; Disease; Population; Crohn's disease; Inflammatory Bowel Diseases; Internal medicine; Gastroenterology; Demography; Pediatrics; Environmental health","score_opus":0.03169673032565581,"score_gpt":0.2984800860354765,"score_spread":0.2667833557098207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1504806404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98733073,0.009198486,0.0001247447,0.0008895501,0.0015900123,0.0005439832,0.00005152062,0.000040870902,0.00023009251],"genre_scores_gemma":[0.9793357,0.002840581,0.00029828493,0.01620077,0.000644737,0.00013737104,0.00009169167,0.000059595026,0.00039124244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973233,0.0008028062,0.00061040226,0.00044278847,0.00013427642,0.00068644964],"domain_scores_gemma":[0.99854827,0.00014499477,0.00036663996,0.00059679383,0.000105099956,0.00023822412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011788928,0.00029005812,0.00021037205,0.000105450184,0.00031057835,0.000003647585,0.0005773415,0.00015175041,0.00014039846],"category_scores_gemma":[0.0000054158318,0.00024027863,0.00022466443,0.0001158704,0.0005528662,0.000010571294,0.00030207,0.00020627472,0.000028201575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004613946,0.000477355,0.8923417,0.000107493404,0.008736569,0.00021023952,0.0011711397,0.00014219941,0.08484921,0.0009624543,0.0048486865,0.0015390286],"study_design_scores_gemma":[0.0034764907,0.00066172826,0.8029585,0.000023243634,0.008470558,0.000034711524,0.0008098062,0.0010248135,0.11923157,0.0021395683,0.06003019,0.0011388122],"about_ca_topic_score_codex":0.0000068885747,"about_ca_topic_score_gemma":0.000004913523,"teacher_disagreement_score":0.08938317,"about_ca_system_score_codex":0.000033093398,"about_ca_system_score_gemma":0.00017636963,"threshold_uncertainty_score":0.9798278},"labels":[],"label_agreement":null},{"id":"W1505738485","doi":"10.1111/j.1365-2036.2007.03410.x","title":"Randomized‐controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1‐week trial of acid suppression predict symptom response?","year":2007,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Dalhousie University","funders":"","keywords":"Esomeprazole; Medicine; Placebo; Epigastric pain; Internal medicine; Gastroenterology; Randomized controlled trial; Population","score_opus":0.02045984371495304,"score_gpt":0.2976143143004464,"score_spread":0.27715447058549336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1505738485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907918,0.0001562183,0.00051206653,0.0009052244,0.00084505236,0.006678753,0.000023909795,0.000031092914,0.000055893153],"genre_scores_gemma":[0.9972657,0.00006333988,0.00058112515,0.0015048181,0.00015931854,0.00020379908,0.00009001171,0.000028359998,0.00010352097],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9952754,0.001930558,0.0013789784,0.0003601841,0.0006107927,0.0004441072],"domain_scores_gemma":[0.99496615,0.003838066,0.0006660498,0.00022121352,0.00016396205,0.00014455798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005119092,0.0003217385,0.0015168249,0.000470159,0.00006294067,0.000004910896,0.00015094597,0.00014726786,0.0005901136],"category_scores_gemma":[0.00006618235,0.00018912405,0.00031055306,0.00037467646,0.00047214495,0.000103348444,0.000049396207,0.0003965004,0.0000014461887],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9408637,0.007593485,0.031146703,0.000048438713,0.0038375012,0.00003099467,0.00033460537,0.00006390882,0.015532336,0.0000025700876,0.000052479118,0.00049325306],"study_design_scores_gemma":[0.95384234,0.021757793,0.009201716,0.00011402787,0.006087173,0.00000911532,0.00033937735,0.00034077305,0.008067641,0.000041528045,0.000066083,0.00013240293],"about_ca_topic_score_codex":0.000028344864,"about_ca_topic_score_gemma":0.000013707301,"teacher_disagreement_score":0.021944987,"about_ca_system_score_codex":0.000101258396,"about_ca_system_score_gemma":0.00030138847,"threshold_uncertainty_score":0.77122545},"labels":[],"label_agreement":null},{"id":"W1506077210","doi":"10.1111/j.1365-2036.2010.04294.x","title":"Susceptibility loci reported in genome‐wide association studies are associated with Crohn’s disease in Canadian children","year":2010,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Children's Hospital; Children's Hospital of Eastern Ontario; McGill University Health Centre; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Institutes of Health Research","keywords":"Single-nucleotide polymorphism; Medicine; SNP; Genome-wide association study; Locus (genetics); Allele; Disease; Case-control study; Genetics; Genetic association; Gene; Genotype; Internal medicine; Biology","score_opus":0.014281026033570194,"score_gpt":0.2859916975654504,"score_spread":0.2717106715318802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1506077210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964859,0.0004810305,3.9055803e-7,0.0018004036,0.00028716278,0.0007317753,0.0001654919,0.000019945413,0.000027890334],"genre_scores_gemma":[0.9861964,0.00022101193,0.000017679917,0.012390527,0.00011664043,0.00009241603,0.0008172308,0.0000360934,0.00011199735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979537,0.00032496886,0.00039429293,0.0005069867,0.00017119205,0.0006488753],"domain_scores_gemma":[0.9988912,0.00007467446,0.00027355895,0.00032061635,0.00015608857,0.00028386447],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067400915,0.00026284947,0.00023970209,0.00013820393,0.000115540424,0.000015141879,0.00021613135,0.0002190007,0.000101452606],"category_scores_gemma":[0.000027057806,0.0002686271,0.000066799796,0.00017321596,0.0001557545,0.000014674318,0.00006818907,0.00039037477,0.0000071882787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004274281,0.00028459547,0.9728154,0.00000702168,0.0030291872,0.0006350183,0.00013514518,0.00019004746,0.022150183,8.6666404e-7,0.00030696156,0.000018152918],"study_design_scores_gemma":[0.0019615446,0.00005217992,0.9936424,0.0000074766735,0.0009886846,0.000001916463,0.000076798664,0.00004438295,0.0022752313,0.000030428424,0.00062370335,0.00029523578],"about_ca_topic_score_codex":0.005609629,"about_ca_topic_score_gemma":0.5859878,"teacher_disagreement_score":0.5803782,"about_ca_system_score_codex":0.00066380017,"about_ca_system_score_gemma":0.00058221375,"threshold_uncertainty_score":0.9999766},"labels":[],"label_agreement":null},{"id":"W1506441991","doi":"10.1111/j.1365-2036.2008.03626.x","title":"Review article: self‐report measures to evaluate constipation","year":2008,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"","keywords":"Constipation; Medicine; CINAHL; Psychometrics; Chronic constipation; MEDLINE; Physical therapy; Functional constipation; Clinical psychology; Internal medicine; Psychiatry; Psychological intervention","score_opus":0.13127065876989186,"score_gpt":0.4412007843922405,"score_spread":0.3099301256223486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1506441991","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013231137,0.9916242,0.000041258932,0.0032508038,0.0006728275,0.003695676,0.000026251171,0.00017410758,0.00038261167],"genre_scores_gemma":[0.000021019272,0.93132204,0.0010326463,0.06658335,0.00021326132,0.00032518632,0.00032167046,0.00006601137,0.00011479151],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967451,0.0005942613,0.001082689,0.00063265953,0.0004364023,0.00050889334],"domain_scores_gemma":[0.998325,0.00022929396,0.00038365414,0.00047459095,0.00025378846,0.00033368004],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052944367,0.00057837856,0.0017854249,0.00017668816,0.00013859656,0.000008867291,0.00022555797,0.00018533616,0.00069291686],"category_scores_gemma":[0.0000049836895,0.0004901115,0.0005216481,0.00045372243,0.0001692906,0.00006179741,0.0000900472,0.0006295396,0.000540822],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025346346,0.0018037994,0.00048221144,0.02857985,0.022960804,0.0014906026,0.00015119901,0.0000040385535,0.00012658295,0.000003730961,0.041230284,0.90291345],"study_design_scores_gemma":[0.00082292233,0.00056938117,0.000031300275,0.01089187,0.077142455,0.008021301,0.000007702025,0.000009379185,0.000032805572,0.000006581068,0.9021732,0.0002910853],"about_ca_topic_score_codex":0.00001805744,"about_ca_topic_score_gemma":0.0000036402143,"teacher_disagreement_score":0.90262234,"about_ca_system_score_codex":0.00030370158,"about_ca_system_score_gemma":0.00081520644,"threshold_uncertainty_score":0.999755},"labels":[],"label_agreement":null},{"id":"W1509007473","doi":"10.1111/j.1365-2036.2011.04689.x","title":"Single-drug treatments for chronic hepatitis B: summarising current information by network meta-analysis","year":2011,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions; American Association for the Study of Liver Diseases","keywords":"Entecavir; Telbivudine; Medicine; Adefovir; Lamivudine; HBeAg; Internal medicine; Hepatitis B; Virology; Drug; Chronic hepatitis; HBsAg; Hepatitis B virus; Pharmacology; Virus","score_opus":0.13389215833001392,"score_gpt":0.3574927298540475,"score_spread":0.2236005715240336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1509007473","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0051124156,0.29494756,0.002874155,0.6631698,0.010552431,0.012724549,0.0091654705,0.00067696616,0.00077662704],"genre_scores_gemma":[0.0028939215,0.025545675,0.0012325997,0.94284153,0.003695905,0.0016350866,0.020604013,0.00016073546,0.0013905235],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996118,0.0004074868,0.0011752476,0.00064820936,0.0005252537,0.0011258018],"domain_scores_gemma":[0.9978003,0.00041413115,0.00084278546,0.00053202646,0.00027884106,0.00013189964],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030267716,0.00093471556,0.0024902646,0.00041507982,0.00039455213,0.000049653252,0.00032879494,0.00051338127,0.0018894768],"category_scores_gemma":[5.082962e-7,0.0008143175,0.0019241668,0.0004769579,0.000244232,0.00033919772,0.00014896065,0.0012088793,0.00011628744],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082932274,0.00018396112,0.0028211465,0.00010799053,0.4812217,0.000020398937,0.0002491316,0.0000113957385,0.00010459421,5.2799595e-7,0.51318884,0.0020073755],"study_design_scores_gemma":[0.0010142073,0.00038477744,0.00007581023,0.000009515,0.49555707,0.000004898846,0.0000026914258,0.00014468929,0.0013179773,0.000025104362,0.5011458,0.00031746703],"about_ca_topic_score_codex":0.0020532333,"about_ca_topic_score_gemma":0.00057877996,"teacher_disagreement_score":0.2796717,"about_ca_system_score_codex":0.0012608655,"about_ca_system_score_gemma":0.00020126675,"threshold_uncertainty_score":0.9994308},"labels":[],"label_agreement":null},{"id":"W1512390910","doi":"10.1111/j.1365-2036.2008.03700.x","title":"Clinical trial design in adult reflux disease: a methodological workshop","year":2008,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Alberta","funders":"AstraZeneca; Pfizer","keywords":"Medicine; Generalizability theory; Comparability; Clinical trial; Voting; Delphi method; Medical physics; MEDLINE; GERD; Family medicine; Physical therapy; Disease; Psychology; Internal medicine; Reflux; Statistics","score_opus":0.5283827103637182,"score_gpt":0.5656200086467792,"score_spread":0.03723729828306099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1512390910","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011969359,0.98998356,0.0000964496,0.00041097443,0.0023876613,0.0056721983,0.000059601396,0.00011723249,0.000075383905],"genre_scores_gemma":[0.00020111814,0.97833765,0.0065585957,0.011446525,0.0012272182,0.00090969016,0.0005442769,0.00012979736,0.0006451246],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98999727,0.005476192,0.0019947367,0.0011855213,0.00044693862,0.0008993586],"domain_scores_gemma":[0.99458444,0.0035299507,0.0005719209,0.00061128184,0.00008209859,0.00062032865],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010324479,0.00096708006,0.003836292,0.00034237563,0.00012007547,0.000014117844,0.00045306172,0.00089369656,0.0006707111],"category_scores_gemma":[0.000011817056,0.0006962797,0.0014422862,0.00047949172,0.00045724792,0.00007090013,0.00018105523,0.0019044804,0.00027760048],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046312835,0.007886009,0.0010913409,0.0012516862,0.037025668,0.02055088,0.00005470024,0.0000030630774,0.0000022160398,0.000008541059,0.0023818964,0.88343114],"study_design_scores_gemma":[0.11767204,0.006666899,0.00040620763,0.0022892824,0.14591512,0.0007275598,0.000012676624,0.000042978154,0.000013819855,0.00008097018,0.72547233,0.0007000995],"about_ca_topic_score_codex":0.0000035246787,"about_ca_topic_score_gemma":5.771658e-7,"teacher_disagreement_score":0.8827311,"about_ca_system_score_codex":0.00045494837,"about_ca_system_score_gemma":0.00091019046,"threshold_uncertainty_score":0.99954885},"labels":[],"label_agreement":null},{"id":"W1515840786","doi":"10.1111/j.1365-2036.2007.03445.x","title":"Differences in the management of Crohn’s disease among experts and community providers, based on a national survey of sample case vignettes","year":2007,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Crohn's disease; Disease; Medical diagnosis; Health care; Family medicine; Variation (astronomy); Sample (material); Internal medicine; Pathology","score_opus":0.04633822760331807,"score_gpt":0.323974271924677,"score_spread":0.2776360443213589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1515840786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988698,0.00021177084,0.00005681433,0.00011355032,0.000058516558,0.00044477836,0.00018853317,0.000003225279,0.00005300608],"genre_scores_gemma":[0.995685,0.00006363049,0.00010982679,0.003899374,0.000017067803,0.00003540631,0.00017679029,0.000009280578,0.0000036373563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984747,0.00081069366,0.00024089676,0.00014857293,0.00016262665,0.00016251479],"domain_scores_gemma":[0.99924153,0.00034764304,0.00010713728,0.00018783403,0.0000630761,0.00005276199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010269659,0.00013034866,0.000106772866,0.000057975263,0.000108456145,0.000005757907,0.00019318698,0.000047049492,0.000023428829],"category_scores_gemma":[0.0000017487235,0.00010600115,0.000036352725,0.00006999943,0.00031200523,0.0000056798126,0.00006777454,0.00010557562,1.3738259e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031722537,0.001447519,0.9833607,0.00011950222,0.0013102931,0.0006445633,0.0006095888,0.0000981272,0.0087403,0.00002979603,0.00012602205,0.00034129815],"study_design_scores_gemma":[0.0011879094,0.00016540418,0.98938084,0.000013807394,0.0003810359,0.000004220847,0.00076699955,0.00042777363,0.0074920203,0.000047465048,0.000027184919,0.00010534404],"about_ca_topic_score_codex":0.00047536546,"about_ca_topic_score_gemma":0.0005951479,"teacher_disagreement_score":0.0060200994,"about_ca_system_score_codex":0.000018180799,"about_ca_system_score_gemma":0.00004640036,"threshold_uncertainty_score":0.43226016},"labels":[],"label_agreement":null},{"id":"W1517504372","doi":"10.1111/j.1365-2036.2007.03319.x","title":"Review article: possible beneficial effects of coffee on liver disease and function","year":2007,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Coffee research and impacts","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cirrhosis; Disease; Green coffee; Hepatocellular carcinoma; Liver function; Liver disease; Consumption (sociology); Mechanism (biology); Diabetes mellitus; Fatty liver; Health benefits; Traditional medicine; Environmental health; Internal medicine; Food science; Endocrinology","score_opus":0.09247934083368858,"score_gpt":0.4319447778491418,"score_spread":0.33946543701545323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1517504372","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012114698,0.99481523,0.000004097524,0.0004211017,0.00050613016,0.0028843672,0.000043576736,0.00003225614,0.00008175228],"genre_scores_gemma":[0.00023035813,0.97705686,0.000015983065,0.021894813,0.00040770593,0.000073808544,0.00015211145,0.000056191544,0.00011219659],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979078,0.0003558097,0.0005169432,0.00038331636,0.00034285182,0.00049325253],"domain_scores_gemma":[0.9982201,0.0006813096,0.00022916419,0.0002926673,0.000080777914,0.0004959942],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036435665,0.00041097536,0.0013253625,0.00025680993,0.00007790024,0.00000806787,0.00012195426,0.00017114154,0.00046356948],"category_scores_gemma":[0.0000029514629,0.000313433,0.00032263977,0.00033811957,0.00018874342,0.000059875165,0.000084167084,0.0005891817,0.000069406015],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008970335,0.00077988685,0.00005027732,0.096843325,0.009321942,0.00022286805,0.000015290841,7.124617e-8,0.00035356882,0.000009413083,0.0033285408,0.8881778],"study_design_scores_gemma":[0.0016809744,0.0025280947,0.0004315656,0.031299226,0.10877396,0.000065831286,0.0000017637269,0.000010974812,0.0007089999,0.000013945281,0.8542202,0.00026443196],"about_ca_topic_score_codex":0.000013683592,"about_ca_topic_score_gemma":0.0000014420972,"teacher_disagreement_score":0.88791335,"about_ca_system_score_codex":0.0001602968,"about_ca_system_score_gemma":0.0003696646,"threshold_uncertainty_score":0.99993175},"labels":[],"label_agreement":null},{"id":"W1519025828","doi":"10.1111/j.1365-2036.2007.03324.x","title":"Systematic review: the potential influence of mesalazine formulation on maintenance of remission in Crohn’s disease","year":2007,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"American College of Gastroenterology; Procter and Gamble","keywords":"Mesalazine; Medicine; Number needed to treat; Randomized controlled trial; Placebo; Odds ratio; Internal medicine; Gastroenterology; Crohn's disease; Confidence interval; Relative risk; Surgery; Inflammatory bowel disease; Disease; Pathology","score_opus":0.020153527392415802,"score_gpt":0.3478983052412526,"score_spread":0.32774477784883677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1519025828","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011095877,0.98533416,0.000010683475,0.00008792996,0.00020477748,0.0031341824,0.0001079011,0.0000064593273,0.000018013285],"genre_scores_gemma":[0.0066620978,0.98833364,0.00001650619,0.004278414,0.00007826034,0.00018485035,0.00033284625,0.00004718785,0.00006622287],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.996986,0.0007080363,0.00134789,0.00037574483,0.00028053657,0.00030179613],"domain_scores_gemma":[0.9979506,0.000095134405,0.0010896897,0.00063375407,0.0001375551,0.00009327837],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00079296954,0.0004018763,0.0010348213,0.00012272432,0.000047486643,0.0000036098393,0.00056379987,0.00021315677,0.00002441737],"category_scores_gemma":[0.0000064817837,0.00027167733,0.00043085247,0.00018357199,0.00016573629,0.000007751965,0.00013988289,0.00025927657,0.000006854781],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015653392,0.0008115082,0.00012580543,0.97185975,0.00836951,0.00047287717,0.000051438838,0.0006582631,0.0072039883,0.00004804973,0.00095667486,0.007876763],"study_design_scores_gemma":[0.0041916794,0.0006805121,0.0054166657,0.67102313,0.14363417,0.000096744196,0.000049727074,0.00025969755,0.0041350345,0.00010134387,0.16838878,0.002022526],"about_ca_topic_score_codex":0.0000041200797,"about_ca_topic_score_gemma":0.0000022867123,"teacher_disagreement_score":0.30083665,"about_ca_system_score_codex":0.00008574622,"about_ca_system_score_gemma":0.00024397207,"threshold_uncertainty_score":0.99997354},"labels":[],"label_agreement":null},{"id":"W1521687820","doi":"10.1111/j.1365-2036.2011.04920.x","title":"Carbon‐based compounds emerging as sparkling diamonds for IBS treatment? authors’ reply","year":2011,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Flatulence; Medicine; Irritable bowel syndrome; Placebo; Bloating; Confounding; Internal medicine; Loperamide; Abdominal pain; Gastroenterology; Diarrhea; Alternative medicine","score_opus":0.11005113298602744,"score_gpt":0.35967869864553603,"score_spread":0.2496275656595086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1521687820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98673064,0.00069693185,0.00027485628,0.006543579,0.000906955,0.0011059785,0.000021209586,0.00018573397,0.00353412],"genre_scores_gemma":[0.96738344,0.000068452675,0.004739023,0.026782382,0.00019585721,0.00015304837,0.00012463784,0.000058509617,0.0004946346],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99831015,0.000119878896,0.00039202877,0.00045650222,0.0001567415,0.0005647138],"domain_scores_gemma":[0.9990613,0.00019760859,0.00013555368,0.00029038073,0.000090496054,0.00022466337],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022242511,0.00033374006,0.0004044529,0.00014913682,0.00019413397,0.000009904329,0.00014765191,0.00009174677,0.0006265184],"category_scores_gemma":[0.0000011251014,0.0003126674,0.00022554376,0.00015448392,0.00021157459,0.00006691374,0.000030763695,0.00021454955,0.000021457809],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019924369,0.0082994625,0.65101707,0.00024751187,0.019911394,0.0004073455,0.00741046,0.00009185699,0.28533262,0.00012778456,0.0018399619,0.0053901207],"study_design_scores_gemma":[0.05163699,0.034933366,0.051216703,0.00021478935,0.07002054,0.0005234064,0.004120178,0.025968716,0.68759435,0.0026699887,0.06946766,0.0016332945],"about_ca_topic_score_codex":0.00045462244,"about_ca_topic_score_gemma":0.000034498837,"teacher_disagreement_score":0.5998004,"about_ca_system_score_codex":0.0001791034,"about_ca_system_score_gemma":0.00016360315,"threshold_uncertainty_score":0.9999325},"labels":[],"label_agreement":null},{"id":"W1523437341","doi":"10.1111/j.1365-2036.2006.03225.x","title":"The safety of endoscopic sphincterotomy in patients receiving antiplatelet agents – a case–control study","year":2006,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gallbladder and Bile Duct Disorders","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University","funders":"American Society for Gastrointestinal Endoscopy","keywords":"Medicine; Clopidogrel; Aspirin; Odds ratio; Coagulopathy; Confounding; Surgery; Internal medicine; Gastroenterology","score_opus":0.014631264654135076,"score_gpt":0.2991351230384822,"score_spread":0.28450385838434716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1523437341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952286,0.0004420118,0.0000042354277,0.00090254605,0.0005394005,0.0025714692,0.000030318848,0.000024638926,0.00025681208],"genre_scores_gemma":[0.9959988,0.0001562022,0.000026681191,0.003559031,0.000075699296,0.00006998164,0.000027067903,0.000025940008,0.00006056946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819386,0.0003233215,0.00057707843,0.00026817998,0.0002371441,0.00040041585],"domain_scores_gemma":[0.9992962,0.00020341958,0.0001531484,0.00023038556,0.00006867878,0.000048194703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034183246,0.00021646186,0.00035804184,0.00010579546,0.00015812718,0.000009452327,0.00015701618,0.00006731746,0.00023197249],"category_scores_gemma":[4.0644827e-7,0.00015958928,0.00008212271,0.00021178086,0.00013655549,0.00006688019,0.00005110887,0.00025904758,0.0000070009237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013059184,0.0026921507,0.9845227,0.00001731475,0.0033763861,0.00037366108,0.0004813981,0.000027829085,0.0041936673,0.0000016813847,0.00019415635,0.0028131206],"study_design_scores_gemma":[0.023266992,0.0012853452,0.96653825,0.000016887097,0.0038402507,0.000050022005,0.0007066519,0.00017276061,0.0029277937,0.000025091465,0.0010336972,0.00013623187],"about_ca_topic_score_codex":0.00036100193,"about_ca_topic_score_gemma":0.00025781002,"teacher_disagreement_score":0.021961074,"about_ca_system_score_codex":0.00009045388,"about_ca_system_score_gemma":0.000047365327,"threshold_uncertainty_score":0.6507862},"labels":[],"label_agreement":null},{"id":"W1525329652","doi":"10.1111/j.1365-2036.2007.03547.x","title":"The utilization of parenteral nutrition during the in‐patient management of inflammatory bowel disease in the United States: a national survey","year":2007,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Clinical Nutrition and Gastroenterology","field":"Nursing","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Agency for Healthcare Research and Quality","keywords":"Parenteral nutrition; Medicine; Inflammatory bowel disease; Odds ratio; Ulcerative colitis; National Health and Nutrition Examination Survey; Short bowel syndrome; Disease; Malnutrition; Internal medicine; Clinical nutrition; Intensive care medicine; Population; Environmental health","score_opus":0.0560372686172255,"score_gpt":0.369102360768789,"score_spread":0.3130650921515635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1525329652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858545,0.00033599857,0.00001700288,0.012513759,0.00044756828,0.0007495899,0.000068825786,0.00000788002,0.0000048954303],"genre_scores_gemma":[0.9796992,0.0010427211,0.000012011455,0.018892448,0.000032201733,0.000056314468,0.00025446364,0.000009253882,0.000001371636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976759,0.0009724862,0.00066727767,0.00014762551,0.00028093916,0.00025575468],"domain_scores_gemma":[0.9986552,0.0008567373,0.00022132315,0.0001372547,0.0000984505,0.000031052386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012404935,0.00011536778,0.00011672651,0.00015014772,0.00011458089,0.000008014296,0.00026696295,0.000039506984,0.000016103084],"category_scores_gemma":[0.0000013805737,0.00007475563,0.000059481692,0.0003092078,0.00029827756,0.000052371804,0.000054350636,0.00020726844,7.3083976e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020460904,0.004561385,0.9623351,0.00022891207,0.0013112321,0.000048277663,0.003480004,0.003148174,0.0025276577,0.00009512671,0.001046221,0.0007570176],"study_design_scores_gemma":[0.004098608,0.00026882775,0.9864119,0.000065617794,0.00029542024,0.0000028359848,0.0018013375,0.0022574265,0.0020048225,0.0004513437,0.0022728366,0.00006898917],"about_ca_topic_score_codex":0.00008852557,"about_ca_topic_score_gemma":0.00038669264,"teacher_disagreement_score":0.024076845,"about_ca_system_score_codex":0.000106524356,"about_ca_system_score_gemma":0.0000057246207,"threshold_uncertainty_score":0.30484462},"labels":[],"label_agreement":null},{"id":"W1525507473","doi":"10.1111/j.1365-2036.2011.04956.x","title":"Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease","year":2011,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"Canadian Institutes of Health Research; Canadian Association of Gastroenterology; Crohn's and Colitis Foundation; Crohn's and Colitis Foundation of Canada; Danone","keywords":"Medicine; Ulcerative colitis; Inflammatory bowel disease; Demographics; Internal medicine; Disease; Inflammatory Bowel Diseases; Adverse effect; Alternative medicine; Population; Crohn's disease; Physical therapy; Pathology","score_opus":0.13341852262500628,"score_gpt":0.40202528316261266,"score_spread":0.26860676053760635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1525507473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574155,0.0013098505,0.0000069401976,0.0017423562,0.0003205952,0.0007473306,0.000073027375,0.000015085591,0.000043290962],"genre_scores_gemma":[0.99052256,0.0038319323,0.00005018312,0.0052260924,0.0001651717,0.000042186686,0.00013417681,0.000014490432,0.000013188729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986588,0.00016943106,0.00044003667,0.0002909002,0.00022892401,0.00021196004],"domain_scores_gemma":[0.9991791,0.00024944902,0.00021603558,0.00011694637,0.0000743567,0.00016407733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024723788,0.00023219953,0.0003313682,0.00022719646,0.000061640916,0.0000024909807,0.000082998966,0.000016788954,0.00085997756],"category_scores_gemma":[0.0000020013686,0.00017553446,0.00003220152,0.00007917434,0.0003684172,0.00019632185,0.00008439292,0.00018817697,0.0000020139394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029150934,0.0004177886,0.9360509,0.000094517876,0.00273019,0.000075627075,0.005975004,0.0000013416567,0.04974959,0.00013064928,0.000068460104,0.0017908758],"study_design_scores_gemma":[0.005246252,0.00264298,0.974908,0.00020047759,0.002064887,0.000012087537,0.0007615018,0.00078077166,0.012937481,0.00017613647,0.00013873902,0.0001307176],"about_ca_topic_score_codex":0.0003448557,"about_ca_topic_score_gemma":0.000018843673,"teacher_disagreement_score":0.038857106,"about_ca_system_score_codex":0.000080457605,"about_ca_system_score_gemma":0.000035464003,"threshold_uncertainty_score":0.9416151},"labels":[],"label_agreement":null},{"id":"W1525581188","doi":"10.1111/j.1365-2036.2011.04950.x","title":"Long‐term maintenance treatment with omeprazole in children with healed erosive oesophagitis: a prospective study","year":2011,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Medicine; Omeprazole; Esophagitis; GERD; Gastroenterology; Internal medicine; Reflux; Prospective cohort study; Atresia; Esophageal disease; Reflux esophagitis; Surgery; Disease; Esophagus","score_opus":0.02933340948000143,"score_gpt":0.3075656274050917,"score_spread":0.2782322179250903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1525581188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941613,0.0005093084,0.000014843082,0.00013428328,0.00008670447,0.004727288,0.000037561782,0.000081830556,0.00024685386],"genre_scores_gemma":[0.99512774,0.00022434132,0.00041779308,0.0028252609,0.00006797145,0.00087061815,0.00007281392,0.000070305156,0.00032318252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799234,0.00013326241,0.00031004654,0.0006551576,0.00025536536,0.00065382745],"domain_scores_gemma":[0.9992078,0.000025577068,0.00014774743,0.0003284915,0.000083869825,0.00020650771],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000075406875,0.0004895385,0.0005812325,0.00016825524,0.00011571916,0.00001120244,0.00014150294,0.000069999485,0.0002958643],"category_scores_gemma":[5.3879713e-8,0.000314296,0.00006850321,0.00027729827,0.00024192444,0.00014465871,0.00004163916,0.00026250156,0.000042330088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043996125,0.011013356,0.95343703,0.000006350116,0.022979619,0.0031156638,0.0037719277,0.0000031591997,0.00041682957,0.0000023652553,0.0000043950677,0.0008497054],"study_design_scores_gemma":[0.034484845,0.028112464,0.91201174,0.000029484048,0.010364443,0.0005147748,0.00030553463,0.000004319914,0.013991628,0.000012923164,0.0000023159146,0.0001655276],"about_ca_topic_score_codex":0.00024593037,"about_ca_topic_score_gemma":0.00016147122,"teacher_disagreement_score":0.041425273,"about_ca_system_score_codex":0.000628985,"about_ca_system_score_gemma":0.00015257647,"threshold_uncertainty_score":0.9999309},"labels":[],"label_agreement":null},{"id":"W1528458425","doi":"10.1111/apt.13229","title":"Letter: what else can improve survival in cirrhotic patients with spontaneous bacterial peritonitis and associated septic shock? Authors’ reply","year":2015,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital; University of Alberta Hospital; University of Alberta","funders":"Taipei Tzu Chi Hospital; Buddhist Tzu Chi Medical Foundation","keywords":"Medicine; Septic shock; Spontaneous bacterial peritonitis; Hepatorenal syndrome; Cirrhosis; Intensive care medicine; Sepsis; Acute kidney injury; Shock (circulatory); Renal replacement therapy; Peritonitis; Mortality rate; Internal medicine","score_opus":0.018093139303863,"score_gpt":0.2629947420844698,"score_spread":0.24490160278060683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1528458425","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8607475,0.00041514018,4.4455328e-7,0.13262701,0.0038265407,0.0013836153,0.00090370234,0.000066398025,0.000029654762],"genre_scores_gemma":[0.25660563,0.00088191475,0.000025906053,0.7280805,0.0018964167,0.00008157991,0.012003448,0.00013499823,0.00028959516],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9970534,0.00054761715,0.0004843751,0.00070199434,0.0005441188,0.0006685185],"domain_scores_gemma":[0.998941,0.00018007022,0.00024363582,0.00026041502,0.00017272725,0.00020213528],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019698282,0.00057469914,0.0007566359,0.00022546873,0.00009442279,0.00008350271,0.00015924913,0.00052807544,0.00033219068],"category_scores_gemma":[2.0458876e-7,0.00052719895,0.0000931458,0.00014434023,0.00021225997,0.00025506807,0.0000454157,0.0013873493,0.000012111148],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051096424,0.00643587,0.29705843,0.0027704285,0.23182495,0.18628882,0.022288097,0.00001725832,0.029914916,0.0000016931081,0.16718827,0.00511486],"study_design_scores_gemma":[0.12932745,0.020229306,0.13368903,0.002465641,0.4237919,0.0021599603,0.001180808,0.00037653075,0.0063070655,0.00014469506,0.27442512,0.005902498],"about_ca_topic_score_codex":0.00035546903,"about_ca_topic_score_gemma":0.00019732838,"teacher_disagreement_score":0.60414183,"about_ca_system_score_codex":0.0005855399,"about_ca_system_score_gemma":0.00033527586,"threshold_uncertainty_score":0.99971795},"labels":[],"label_agreement":null},{"id":"W1529594729","doi":"10.1111/j.1365-2036.2011.04908.x","title":"Anti‐α actinin antibodies as new predictors of response to treatment in autoimmune hepatitis type 1","year":2011,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Medicine; Autoantibody; Internal medicine; Autoimmune hepatitis; Gastroenterology; Pathological; Antibody; Actinin; Cohort; Immunology; Disease; Cell","score_opus":0.059619789873332364,"score_gpt":0.3475703238835884,"score_spread":0.287950534010256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1529594729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99469227,0.0013052387,0.0000011527611,0.0022520556,0.0007029009,0.00064735045,0.000029324661,0.000040522507,0.00032918423],"genre_scores_gemma":[0.9887377,0.0031129508,0.00030289716,0.0068974113,0.00006372005,0.00001415896,0.00003626061,0.000025606261,0.00080929225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988278,0.00024415852,0.00031841482,0.00020440994,0.0001270073,0.00027819216],"domain_scores_gemma":[0.9993016,0.00010699104,0.00008823155,0.0002560371,0.000053989184,0.0001931547],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013635217,0.0001970509,0.00038700903,0.00018396013,0.000047226422,0.00000287348,0.00013501699,0.00007436425,0.0019023544],"category_scores_gemma":[0.0000012616628,0.00017070987,0.00008779837,0.00024397772,0.00010423321,0.00007816641,0.00007206847,0.00012459267,0.00006860815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01089267,0.0014125553,0.6465,0.00001243548,0.0045940722,0.00009920544,0.005467055,0.0000027151923,0.32919177,0.000004657826,0.0004761079,0.0013467642],"study_design_scores_gemma":[0.0032266313,0.00465078,0.752688,0.00003179179,0.0036242793,0.00001809393,0.00047374182,0.00001703192,0.22993359,0.000019041876,0.005194608,0.00012239738],"about_ca_topic_score_codex":0.0072277067,"about_ca_topic_score_gemma":0.000045664205,"teacher_disagreement_score":0.106188044,"about_ca_system_score_codex":0.00016862265,"about_ca_system_score_gemma":0.00041369162,"threshold_uncertainty_score":0.9993833},"labels":[],"label_agreement":null},{"id":"W1530534806","doi":"10.1111/apt.12491","title":"Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease","year":2013,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"UCB Pharma; F. Hoffmann-La Roche; AstraZeneca; Bristol-Myers Squibb; Abbott Laboratories","keywords":"Medicine; Thiopurine methyltransferase; Psoriasis; Inflammatory bowel disease; Skin cancer; Adverse effect; Dermatology; Rash; Incidence (geometry); Cancer; Internal medicine; Disease","score_opus":0.059805856885040067,"score_gpt":0.3472349550690884,"score_spread":0.2874290981840483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1530534806","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01768328,0.9786767,7.3947126e-7,0.00043717583,0.00047663497,0.0024138398,0.00024150276,0.000042495496,0.00002765094],"genre_scores_gemma":[0.0015654535,0.9924706,0.000026774811,0.0041167326,0.000025784684,0.0009519741,0.0007563085,0.000043201562,0.00004316892],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996676,0.0013294297,0.000992086,0.000507157,0.00004637196,0.00044891323],"domain_scores_gemma":[0.998378,0.0005006521,0.00056108757,0.00043392638,0.00006226303,0.00006410959],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018188865,0.00056849443,0.0015158403,0.00018129099,0.0001317743,0.000009648742,0.00044703198,0.00040283593,0.00083880854],"category_scores_gemma":[6.8374794e-7,0.0004334562,0.00032313843,0.00018483972,0.00056097476,0.00010103918,0.00016297627,0.0004384658,0.0002029589],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015688708,0.0016701224,0.004966492,0.009483814,0.02445289,0.00006744482,0.00017077758,7.232649e-7,0.00680213,0.000074726384,0.0028145039,0.9493395],"study_design_scores_gemma":[0.0028481907,0.00014298537,0.0039270855,0.006034467,0.026235297,0.00017274106,0.000026765263,0.0000020341583,0.0018011129,0.00004805588,0.95811224,0.000648998],"about_ca_topic_score_codex":0.000015687667,"about_ca_topic_score_gemma":9.641378e-7,"teacher_disagreement_score":0.95529777,"about_ca_system_score_codex":0.00006254706,"about_ca_system_score_gemma":0.00016772201,"threshold_uncertainty_score":0.9998117},"labels":[],"label_agreement":null},{"id":"W1533676538","doi":"10.1111/j.1365-2036.2010.04241.x","title":"Review article: the modern management of autoimmune hepatitis","year":2010,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Medicine; Autoimmune hepatitis; Azathioprine; Intensive care medicine; Liver transplantation; Disease; Cirrhosis; Tacrolimus; Hepatocellular carcinoma; Clinical trial; Hepatitis; Transplantation; Immunology; Internal medicine","score_opus":0.06442911325871993,"score_gpt":0.3954687555872063,"score_spread":0.33103964232848637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1533676538","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014572307,0.9945527,0.0000064455753,0.0013704344,0.0008086581,0.002606301,0.00009299599,0.00004072729,0.00037604698],"genre_scores_gemma":[0.000035092085,0.97653955,0.00013075536,0.022055464,0.00011893446,0.00023440538,0.0002535316,0.000061847495,0.00057038845],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978751,0.0004705104,0.00078490813,0.00029310115,0.00023864541,0.0003377649],"domain_scores_gemma":[0.99844235,0.00015466927,0.0004322437,0.00080161914,0.0000755349,0.00009360493],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000409227,0.00041025702,0.0014130952,0.00006002475,0.00012134161,0.0000071905392,0.00051593565,0.00017664928,0.0014834031],"category_scores_gemma":[1.2783714e-7,0.00026021496,0.0006536798,0.0002632595,0.00029234868,0.000049271093,0.00027041225,0.0008681763,0.000088709254],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035322886,0.00060790614,0.000044063694,0.03992502,0.0285618,0.000048587124,0.00004640623,9.3907396e-8,0.00008567757,0.00002611176,0.0021072149,0.9285118],"study_design_scores_gemma":[0.0005597214,0.00012912432,0.000112225534,0.013325856,0.1813729,0.0000781177,0.0000075346693,0.000028848423,0.000044489836,0.000032744123,0.80412626,0.00018219675],"about_ca_topic_score_codex":0.00005464976,"about_ca_topic_score_gemma":7.460346e-7,"teacher_disagreement_score":0.9283296,"about_ca_system_score_codex":0.00009458106,"about_ca_system_score_gemma":0.00016246705,"threshold_uncertainty_score":0.999985},"labels":[],"label_agreement":null},{"id":"W1535489029","doi":"10.1111/j.1365-2036.2011.04873.x","title":"Systematic review: the role of tacrolimus in the management of Crohn’s disease","year":2011,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Tacrolimus; Medicine; Adverse effect; Crohn's disease; Internal medicine; Randomized controlled trial; Cohort study; Meta-analysis; Cohort; Disease; Gastroenterology; Transplantation","score_opus":0.022085663603885218,"score_gpt":0.32250667805324845,"score_spread":0.30042101444936326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1535489029","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037298596,0.99450254,0.0000011053985,0.00006266097,0.00020191802,0.0044836253,0.00014708756,0.0000048960396,0.00022316648],"genre_scores_gemma":[0.0006985008,0.9928446,0.000013702137,0.0049552857,0.000069372974,0.0010943774,0.00021920436,0.000048239406,0.000056710014],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99660456,0.0014233158,0.0011000455,0.0003499738,0.00021368943,0.00030840348],"domain_scores_gemma":[0.99799436,0.00006592858,0.0008181852,0.0010034658,0.000056714147,0.00006134733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008046211,0.00042557175,0.0010052942,0.00006332912,0.000057684836,0.00000547624,0.001387073,0.00013903843,0.00006840238],"category_scores_gemma":[4.8191396e-7,0.00024500614,0.0005904501,0.00016210531,0.00026690995,0.000004205084,0.0002657732,0.00022774182,0.000015942243],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030508905,0.0007883022,0.00004506953,0.95531046,0.032028995,0.00035525314,0.0002041812,0.0000025482711,0.00009443934,0.00022980766,0.00071180385,0.009924048],"study_design_scores_gemma":[0.00086258637,0.00013879119,0.0003032753,0.10515081,0.22534531,0.000041115327,0.0002949402,0.000006075651,0.00020868609,0.00012183993,0.6668697,0.0006568463],"about_ca_topic_score_codex":0.0000063898315,"about_ca_topic_score_gemma":0.0000026034054,"teacher_disagreement_score":0.85015965,"about_ca_system_score_codex":0.00003292865,"about_ca_system_score_gemma":0.00013023466,"threshold_uncertainty_score":0.999106},"labels":[],"label_agreement":null},{"id":"W1537066184","doi":"10.1111/j.1365-2036.2007.03459.x","title":"Clinical trial: an efficacy evaluation of reduced bisacodyl given as part of a polyethylene glycol electrolyte solution preparation prior to colonoscopy","year":2007,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Celiac Association","keywords":"Bisacodyl; Medicine; Cathartic; Colonoscopy; Laxative; Gastroenterology; Internal medicine; Constipation","score_opus":0.12681003131011198,"score_gpt":0.4924609362372564,"score_spread":0.3656509049271444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1537066184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930117,0.0004555943,0.0004008827,0.0010725855,0.0014172836,0.0033997425,0.000007814484,0.00006588429,0.00016847168],"genre_scores_gemma":[0.9954936,0.00014016753,0.00086912676,0.0026340252,0.0006049732,0.00012089256,0.0000649326,0.00002660819,0.000045691082],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970797,0.00066603767,0.0009683667,0.0004077101,0.00055562874,0.00032258139],"domain_scores_gemma":[0.9983653,0.00029387997,0.00046126195,0.00027344484,0.00042267234,0.00018346387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003378267,0.00018748942,0.00046405374,0.00022743852,0.000091060094,0.0000054870643,0.000119305696,0.00021100654,0.00020371817],"category_scores_gemma":[0.000009742065,0.00019089133,0.00015785464,0.00040605452,0.00012639722,0.00011599258,0.000032942185,0.0002527235,0.000009480246],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3464852,0.0012629562,0.0003872634,0.000010402934,0.001619504,0.0000016156507,0.00057609734,0.000095763906,0.6236758,0.0000017897396,0.00013132312,0.025752256],"study_design_scores_gemma":[0.042393833,0.066960655,0.008254776,0.000032654232,0.009404708,0.000016225431,0.00010240589,0.0029139498,0.8684156,0.000029394649,0.0013222147,0.00015357311],"about_ca_topic_score_codex":0.00015326132,"about_ca_topic_score_gemma":0.00007611632,"teacher_disagreement_score":0.30409136,"about_ca_system_score_codex":0.0003086275,"about_ca_system_score_gemma":0.00048672117,"threshold_uncertainty_score":0.7784322},"labels":[],"label_agreement":null},{"id":"W1539389911","doi":"10.1111/j.1365-2036.2007.03500.x","title":"Clinical trial: knowledge of negative <i>Helicobacter pylori</i> status reduces subsequent dyspepsia‐related resource use","year":2007,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Helicobacter pylori; Confidence interval; Placebo; Internal medicine; Randomized controlled trial; Population; Relative risk; Health care; Gastroenterology; Environmental health; Alternative medicine; Pathology","score_opus":0.0885731619560179,"score_gpt":0.39959560091858193,"score_spread":0.31102243896256404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1539389911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873162,0.0018288837,0.000020169655,0.0045547984,0.0034356555,0.0018181056,0.000073710566,0.0001800483,0.0007724381],"genre_scores_gemma":[0.97231054,0.0025691641,0.0007764033,0.02258323,0.00064763334,0.000049189603,0.00015681243,0.000108601474,0.00079840585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945129,0.00096142705,0.002137267,0.000798145,0.00032631733,0.0012639236],"domain_scores_gemma":[0.9964341,0.0014317196,0.0007097535,0.00050402526,0.00042985182,0.000490539],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016661901,0.00058105413,0.0012222818,0.0003404478,0.00017497268,0.000014427731,0.0003153119,0.0005269864,0.00032807837],"category_scores_gemma":[0.000010917848,0.0005163966,0.00039590657,0.0005899973,0.001516285,0.00022564932,0.00025711863,0.0013650006,0.0000917648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20459388,0.009678976,0.41430122,0.00007980463,0.10578402,0.000493144,0.010899524,0.000011633729,0.23217964,0.000044486875,0.0074193124,0.014514336],"study_design_scores_gemma":[0.22964883,0.020110574,0.25316498,0.00021069648,0.048560657,0.00025899036,0.0025618377,0.000086015,0.2297213,0.00008619792,0.2144824,0.001107535],"about_ca_topic_score_codex":0.00008075826,"about_ca_topic_score_gemma":0.000037896585,"teacher_disagreement_score":0.20706308,"about_ca_system_score_codex":0.0003476191,"about_ca_system_score_gemma":0.00022305782,"threshold_uncertainty_score":0.99972874},"labels":[],"label_agreement":null},{"id":"W1540357441","doi":"10.1111/j.1365-2036.2010.04505.x","title":"Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation","year":2010,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Ribavirin; Medicine; Liver transplantation; Hepatitis C; Hepatocellular carcinoma; Pegylated interferon; Hepatitis C virus; Cirrhosis; Transplantation; Viral hepatitis; Liver disease; Internal medicine; Immunology; Gastroenterology; Viral load; Virus","score_opus":0.06247532865731669,"score_gpt":0.41166163441591813,"score_spread":0.34918630575860143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1540357441","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005369715,0.98950756,0.000007471846,0.00025994238,0.0009724598,0.008069755,0.0004638434,0.00005304233,0.00012893294],"genre_scores_gemma":[0.000108348824,0.98896885,0.00015430973,0.007893873,0.000246438,0.0015228259,0.0008363089,0.00013994834,0.00012908631],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99488777,0.0014485826,0.0017869553,0.00058449176,0.0007248121,0.0005673806],"domain_scores_gemma":[0.99775285,0.00041783054,0.0007447624,0.000650278,0.00022943145,0.0002048448],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00075695757,0.0007116889,0.0038143808,0.00037432136,0.00007120986,0.00001373583,0.00045564625,0.0005244576,0.0020572136],"category_scores_gemma":[0.0000013228065,0.0005406559,0.0009232996,0.0003677055,0.00030462988,0.00011679197,0.00006112455,0.0013987881,0.0002473033],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015965126,0.0005972605,0.00009049051,0.79742575,0.015050326,0.0006226356,0.00017553347,2.025391e-8,0.00019845706,0.0000023243158,0.00037748594,0.18530008],"study_design_scores_gemma":[0.0015781162,0.00096374995,0.00003079399,0.29580522,0.11711844,0.00043571458,0.0000033008112,0.000018019118,0.00071087695,0.000003139296,0.5827558,0.0005768099],"about_ca_topic_score_codex":0.00007878603,"about_ca_topic_score_gemma":0.000018795577,"teacher_disagreement_score":0.5823783,"about_ca_system_score_codex":0.00021598638,"about_ca_system_score_gemma":0.0004723689,"threshold_uncertainty_score":0.9997045},"labels":[],"label_agreement":null},{"id":"W1540925918","doi":"10.1111/j.1365-2036.2011.04623.x","title":"Night-time intra-oesophageal bile and acid exposure in GERD patients failing PPI therapy","year":2011,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; GERD; Bile acid; Disease; Gastroenterology; Proton-pump inhibitor; Internal medicine; Population; Reflux","score_opus":0.026245271637458895,"score_gpt":0.28102962206508664,"score_spread":0.25478435042762776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1540925918","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9659458,0.0042301686,0.0000014846069,0.02588131,0.0013267057,0.002016434,0.00017996758,0.000119144664,0.00029901342],"genre_scores_gemma":[0.45182753,0.0018561777,0.00031863476,0.5421982,0.0011465816,0.00015871348,0.0014440842,0.00015301412,0.00089708733],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99647516,0.00039205427,0.00073029194,0.00094210426,0.0004490212,0.0010113649],"domain_scores_gemma":[0.998816,0.00014575406,0.00029569105,0.00044018478,0.000103626386,0.00019875156],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017954274,0.00088861765,0.0010737246,0.00042676897,0.00014432208,0.000029041046,0.00030841475,0.00095601723,0.002075708],"category_scores_gemma":[3.1425458e-7,0.00073794846,0.000222616,0.0002068741,0.0002932266,0.00016930376,0.00013094896,0.0020359687,0.00020749656],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003424148,0.0067103878,0.6563409,0.0004489816,0.055590138,0.043759983,0.0044088364,0.00000251459,0.029972646,0.0000016716585,0.17050521,0.02883456],"study_design_scores_gemma":[0.14416556,0.03473661,0.18154009,0.0005424772,0.06321375,0.0020451818,0.00012983104,0.00021292869,0.26134795,0.0007668314,0.30713868,0.004160096],"about_ca_topic_score_codex":0.00002621936,"about_ca_topic_score_gemma":0.0000011273864,"teacher_disagreement_score":0.5163169,"about_ca_system_score_codex":0.00026271906,"about_ca_system_score_gemma":0.00013011837,"threshold_uncertainty_score":0.9995071},"labels":[],"label_agreement":null},{"id":"W1540991136","doi":"10.1111/j.1365-2036.2007.03413.x","title":"The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT‐1001 in coeliac disease subjects: a proof of concept study","year":2007,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":282,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Tolerability; Placebo; Gastroenterology; Internal medicine; Intestinal permeability; Coeliac disease; Adverse effect; Gluten; Inflammatory bowel disease; Lactulose; Immunology; Pharmacology; Disease; Pathology","score_opus":0.0154350204340273,"score_gpt":0.33386071760335784,"score_spread":0.31842569716933056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1540991136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753148,0.019933065,0.00003096265,0.00063417316,0.0003125392,0.0035181928,0.000045957277,0.000015108173,0.0001952001],"genre_scores_gemma":[0.9944334,0.0039631054,0.000020231144,0.001258091,0.000058111546,0.00007624602,0.000026149839,0.000029109893,0.00013553862],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976885,0.0003053539,0.00071498327,0.00031275421,0.0004822568,0.0004961853],"domain_scores_gemma":[0.99835056,0.0007625288,0.00026220974,0.00025134243,0.00012562521,0.00024772985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061241095,0.0002449552,0.0005076756,0.00022069523,0.00008163026,0.000003804728,0.00021136047,0.000037876485,0.00009918905],"category_scores_gemma":[0.000002539546,0.00019145572,0.00010993512,0.00038795505,0.00066972687,0.0000610999,0.00023346752,0.00018947334,7.7997055e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02277636,0.009599009,0.08346885,0.0012358429,0.0073407623,0.00037492346,0.0013463733,0.00013775646,0.84176546,0.000018640976,0.00018995604,0.03174606],"study_design_scores_gemma":[0.024470108,0.0033393437,0.096366905,0.00017814488,0.009890099,0.00000774098,0.0008356724,0.0010190815,0.86106324,0.000037694314,0.0025636007,0.00022839477],"about_ca_topic_score_codex":0.00007605682,"about_ca_topic_score_gemma":0.000047498695,"teacher_disagreement_score":0.031517666,"about_ca_system_score_codex":0.00015074125,"about_ca_system_score_gemma":0.00011138634,"threshold_uncertainty_score":0.78073376},"labels":[],"label_agreement":null},{"id":"W1546666727","doi":"10.1111/j.1365-2036.2010.04427.x","title":"Meta‐analysis: re‐treatment of genotype I hepatitis C nonresponders and relapsers after failing interferon and ribavirin combination therapy","year":2010,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Vertex Pharmaceuticals; Intarcia Therapeutics; Gilead Sciences; Valeant Pharmaceuticals International; Pfizer","keywords":"Ribavirin; Medicine; Internal medicine; Combination therapy; Gastroenterology; Pegylated interferon; Hepatitis C; Randomized controlled trial; Hepatitis C virus; Population; Alpha interferon; Immunology; Interferon; Virus","score_opus":0.21019218822837724,"score_gpt":0.44129993716211885,"score_spread":0.2311077489337416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1546666727","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034008157,0.96292496,0.000011936199,0.0005791973,0.00023509792,0.0020230643,0.00013960517,0.000030840456,0.000047114547],"genre_scores_gemma":[0.011290873,0.98572344,0.00033032618,0.0014448301,0.000070469054,0.00045342787,0.0003198725,0.000089068046,0.00027769723],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9968578,0.00091953896,0.00079707877,0.0006632997,0.0003469325,0.00041535363],"domain_scores_gemma":[0.9983461,0.0005445756,0.0003466056,0.00043175303,0.0001270046,0.00020397794],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048035668,0.0006060732,0.0028278488,0.00078247814,0.00009362801,0.000025466123,0.00015810067,0.0004786589,0.0010456264],"category_scores_gemma":[4.823399e-7,0.00046477615,0.00079151354,0.0004622174,0.0004538821,0.000106616804,0.00009579743,0.0006107377,0.0000131149045],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008337185,0.00061165367,0.0017187711,0.0008884782,0.6010417,0.00011236982,0.00076977344,4.184771e-7,0.00060774,0.0000037880388,0.000012684941,0.3933989],"study_design_scores_gemma":[0.0018502515,0.002225353,0.0001431412,0.000105080115,0.60481095,0.000021687172,0.000029346516,0.00006373545,0.0007663875,0.000010542949,0.3896927,0.00028081425],"about_ca_topic_score_codex":0.00045440588,"about_ca_topic_score_gemma":0.00025133902,"teacher_disagreement_score":0.3931181,"about_ca_system_score_codex":0.0002321395,"about_ca_system_score_gemma":0.00021113557,"threshold_uncertainty_score":0.99986756},"labels":[],"label_agreement":null},{"id":"W1549133315","doi":"10.1111/j.1365-2036.2011.04732.x","title":"Mesalazine (5‐aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea‐predominant irritable bowel syndrome","year":2011,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; Crohn's and Colitis Foundation of Canada; GlaxoSmithKline; Health Research Board; Canadian Association of Gastroenterology; Crohn's and Colitis Foundation","keywords":"Mesalazine; Irritable bowel syndrome; Medicine; Gastroenterology; Internal medicine; Bacteroidetes; Firmicutes; Bacteria; Inflammatory bowel disease; Biology; Disease","score_opus":0.04566964431680563,"score_gpt":0.2906705543857546,"score_spread":0.24500091006894897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1549133315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99264675,0.0002151841,0.000087779525,0.0033378575,0.0009079349,0.002253726,0.000089220885,0.00013906181,0.0003225094],"genre_scores_gemma":[0.9916085,0.00009289373,0.0017087511,0.005735574,0.00015199742,0.00030921705,0.00009982358,0.000074396936,0.00021882648],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99690634,0.00039346496,0.0006010117,0.0007344018,0.00032423568,0.0010405433],"domain_scores_gemma":[0.99889666,0.00011743535,0.000198628,0.0003860636,0.00007072852,0.00033049122],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045004082,0.0005321003,0.00072878844,0.00025717844,0.00013350934,0.000018501618,0.00032885378,0.00022597254,0.0018843911],"category_scores_gemma":[0.000003011565,0.0005060408,0.00018947829,0.0002706224,0.0004944516,0.0003012016,0.00018013245,0.00077131286,0.0001416931],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011017238,0.0035266094,0.042014882,0.00019627098,0.0020343293,0.0010326196,0.00078359526,0.0000044013223,0.93814605,0.00002168773,0.00017665897,0.0010456463],"study_design_scores_gemma":[0.013775708,0.004463897,0.2494496,0.00011651858,0.0044692354,0.0013467429,0.00032701835,0.0010642867,0.7239118,0.00012069884,0.00036128226,0.00059319485],"about_ca_topic_score_codex":0.00071039365,"about_ca_topic_score_gemma":0.000099207464,"teacher_disagreement_score":0.21423423,"about_ca_system_score_codex":0.00029319976,"about_ca_system_score_gemma":0.0002941804,"threshold_uncertainty_score":0.9997391},"labels":[],"label_agreement":null},{"id":"W1553892107","doi":"10.1111/j.1365-2036.2010.04284.x","title":"Meta‐analysis: proton pump inhibitor use and the risk of community‐acquired pneumonia","year":2010,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Systematics Association","keywords":"Medicine; Community-acquired pneumonia; Pneumonia; Observational study; Odds ratio; Meta-analysis; Internal medicine; MEDLINE; Subgroup analysis; Relative risk; Intensive care medicine; Confidence interval","score_opus":0.15164942643167334,"score_gpt":0.3962914887736182,"score_spread":0.24464206234194485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1553892107","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030348409,0.9638656,0.000002156389,0.00026535123,0.00028424937,0.004806273,0.00036807018,0.000040878916,0.000019055686],"genre_scores_gemma":[0.017785424,0.9773876,0.00015591584,0.0028627946,0.00011457961,0.0009936409,0.00042372808,0.00007686436,0.00019943385],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99485564,0.0031389943,0.00093737186,0.0003444576,0.00031976847,0.0004037717],"domain_scores_gemma":[0.9964303,0.0014850294,0.0009529988,0.00084383937,0.00011761282,0.00017021847],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009870082,0.0007088838,0.0041635726,0.0003275991,0.00031735233,0.000030349938,0.0003702891,0.00039952103,0.00023286714],"category_scores_gemma":[0.0000012100304,0.00037980068,0.0021688296,0.00048129514,0.00097046955,0.000102774626,0.00024318772,0.0014878806,0.000016132015],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027142247,0.00089103676,0.0013569419,0.0015918433,0.9786367,0.00006608811,0.00035436483,7.044758e-7,0.00008044134,0.000004530016,0.000009011579,0.016736927],"study_design_scores_gemma":[0.0032584434,0.00044957415,0.00022132318,0.00007412958,0.91451013,0.0000757926,0.00002313442,0.000009377091,0.0005473613,0.000022593276,0.08067359,0.0001345446],"about_ca_topic_score_codex":0.00020259425,"about_ca_topic_score_gemma":0.000015527814,"teacher_disagreement_score":0.08066458,"about_ca_system_score_codex":0.00006382864,"about_ca_system_score_gemma":0.00014006384,"threshold_uncertainty_score":0.9998654},"labels":[],"label_agreement":null},{"id":"W1554857574","doi":"10.1111/j.1365-2036.2008.03713.x","title":"Underutilization of gastroprotective strategies in aspirin users at increased risk of upper gastrointestinal complications","year":2008,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Aspirin; Medicine; Risk factor; Internal medicine; Concomitant; Risk assessment; Disease; Computer security","score_opus":0.03188984781053404,"score_gpt":0.3018310319450234,"score_spread":0.26994118413448936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1554857574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963435,0.000966542,0.0016753756,0.00015684923,0.000037021848,0.0005669544,0.00006135136,0.000025295292,0.0001670897],"genre_scores_gemma":[0.9966328,0.0011518316,0.0012004133,0.0008220381,0.00002514149,0.00003153625,0.000105954816,0.000019302763,0.000010951133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879366,0.00026684714,0.00034251172,0.0002056704,0.00019075944,0.00020055931],"domain_scores_gemma":[0.9993405,0.000094949355,0.00018983326,0.00019510684,0.00011330987,0.000066348024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013682898,0.0001562494,0.00033874367,0.0001380829,0.00008671957,0.000001499031,0.00009328351,0.00004723753,0.00020292126],"category_scores_gemma":[4.93208e-7,0.0001505581,0.00018736544,0.00021271012,0.00044798572,0.00007843199,0.000033699675,0.00016388386,0.000004721466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019263517,0.0007780044,0.72501963,0.000045490837,0.004199464,0.00003484608,0.00033231115,0.0009831291,0.2663255,0.000040830917,0.000016887629,0.00029753966],"study_design_scores_gemma":[0.005697283,0.0008459713,0.841388,0.000076246804,0.004294398,0.00042197725,0.0009319898,0.0010010594,0.14496382,0.00012617552,0.0001211221,0.00013198052],"about_ca_topic_score_codex":0.00022158511,"about_ca_topic_score_gemma":0.000017102222,"teacher_disagreement_score":0.121361695,"about_ca_system_score_codex":0.00010700457,"about_ca_system_score_gemma":0.0001631301,"threshold_uncertainty_score":0.6139581},"labels":[],"label_agreement":null},{"id":"W1554962003","doi":"10.1111/j.1365-2036.2011.04699.x","title":"A one-hour infusion of infliximab during maintenance therapy is safe and well tolerated: a prospective cohort study","year":2011,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Merck Canada; University of Alberta","keywords":"Medicine; Infliximab; Premedication; Ankylosing spondylitis; Prospective cohort study; Tolerability; Surgery; Infusion therapy; Anesthesia; Maintenance therapy; Internal medicine; Adverse effect; Disease; Chemotherapy","score_opus":0.018797442251377337,"score_gpt":0.2713998113262819,"score_spread":0.2526023690749045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1554962003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969684,0.00059051794,0.000007238965,0.000073061,0.00018551483,0.0015283503,0.000024612342,0.000020727515,0.00060161453],"genre_scores_gemma":[0.9940554,0.0015081964,0.00014857561,0.003832796,0.00008762497,0.00014933031,0.000017922037,0.000040701503,0.00015947748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851274,0.0001906527,0.00034596454,0.00047553715,0.00015474025,0.00032033262],"domain_scores_gemma":[0.9992723,0.000008956637,0.00018237093,0.000304917,0.00013648214,0.00009497319],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019367089,0.00025936353,0.00024981707,0.000065139364,0.000123414,0.000008018962,0.00021851374,0.00012179994,0.0003735462],"category_scores_gemma":[2.499535e-7,0.00025965215,0.00007034725,0.000083771454,0.00021866175,0.000014412752,0.00018126478,0.00014871154,0.000011071592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003100353,0.0009995963,0.5575724,0.000013067561,0.0039502624,0.000038172166,0.0017651181,0.0000026240882,0.43235987,0.000003620345,0.00005425065,0.00014066312],"study_design_scores_gemma":[0.0038842561,0.00069348805,0.58875895,0.0000063311686,0.00078360573,0.00000737322,0.00033965718,0.00001979335,0.40499756,0.000028896307,0.00028409073,0.00019603029],"about_ca_topic_score_codex":0.000053284497,"about_ca_topic_score_gemma":0.000018735269,"teacher_disagreement_score":0.03118651,"about_ca_system_score_codex":0.000035938912,"about_ca_system_score_gemma":0.00006925231,"threshold_uncertainty_score":0.9999856},"labels":[],"label_agreement":null},{"id":"W1555473009","doi":"10.1111/j.1365-2036.2010.04303.x","title":"Clinical trial: the effects of certolizumab pegol therapy on work productivity in patients with moderate‐to‐severe Crohn’s disease in the PRECiSE 2 study","year":2010,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Certolizumab pegol; Medicine; Placebo; Crohn's disease; Internal medicine; Work productivity; Physical therapy; Disease; Productivity; Adalimumab; Pathology","score_opus":0.01945636435486284,"score_gpt":0.32737700136264947,"score_spread":0.3079206370077866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1555473009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913365,0.00008734347,0.0000012364758,0.0009116153,0.0009285549,0.006695464,0.000017843899,0.000008621602,0.000012825338],"genre_scores_gemma":[0.9952675,0.000051133975,0.00001542319,0.0036166816,0.0002493641,0.0007082387,0.00003195248,0.00003750566,0.000022186801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968416,0.0015406288,0.00043452226,0.00054787315,0.0002937084,0.00034163243],"domain_scores_gemma":[0.9986647,0.00023496896,0.00016042736,0.00075950485,0.000077254575,0.000103161205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004546552,0.00029185542,0.0002592393,0.00006536511,0.000102777456,0.000018261502,0.00060740166,0.00010876329,0.000021091404],"category_scores_gemma":[0.000007161699,0.00017217985,0.00009732806,0.0001943183,0.00022348989,0.00001135624,0.00010427304,0.0004947646,0.000004513011],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27069163,0.011448242,0.7102269,0.000014438332,0.0011514623,0.00020334612,0.001022177,0.00017238501,0.0027087224,0.0000027493452,0.00017890737,0.0021790478],"study_design_scores_gemma":[0.046543814,0.0029842083,0.9467263,0.000010956166,0.00055786304,9.432335e-7,0.000051882762,0.000012075119,0.0025432012,0.00002103109,0.00032776353,0.00021995237],"about_ca_topic_score_codex":0.0000179684,"about_ca_topic_score_gemma":0.00011779086,"teacher_disagreement_score":0.23649941,"about_ca_system_score_codex":0.00002360047,"about_ca_system_score_gemma":0.00015691239,"threshold_uncertainty_score":0.70212907},"labels":[],"label_agreement":null},{"id":"W1562098600","doi":"10.1111/j.1365-2036.2008.03631.x","title":"Intravenous esomeprazole for prevention of peptic ulcer re‐bleeding: rationale/design of Peptic Ulcer Bleed study","year":2008,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Esomeprazole; Bleed; Peptic; Endoscopy; Placebo; Randomized controlled trial; Internal medicine; Gastroenterology; Surgery; Peptic ulcer","score_opus":0.12109789040763091,"score_gpt":0.36253293740459347,"score_spread":0.24143504699696255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1562098600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929349,0.0005681754,0.0009127111,0.0013087421,0.00035358404,0.0037824071,0.00002424216,0.000040124207,0.00007511059],"genre_scores_gemma":[0.99172556,0.00038536248,0.0055903583,0.0012668403,0.00018026971,0.0003786814,0.00007728902,0.000046799552,0.00034884075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980886,0.0001431073,0.0006972708,0.00036836846,0.0003466449,0.00035599864],"domain_scores_gemma":[0.9985349,0.00046847085,0.00037086275,0.00021149183,0.00030520957,0.00010905159],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035178408,0.0002868426,0.0005955003,0.00019550227,0.00014591755,0.000004800874,0.0001458654,0.000077792734,0.00048988144],"category_scores_gemma":[0.000002020411,0.00025922497,0.0001940639,0.00020100968,0.0002067983,0.000094012685,0.000041897394,0.00017032523,0.000012275083],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055362945,0.027681401,0.21332186,0.00029800175,0.027679909,0.00013322353,0.006302957,0.0014254038,0.7140756,0.000058204816,0.0025270754,0.0009600382],"study_design_scores_gemma":[0.047285713,0.06978023,0.18017544,0.00039522862,0.07650676,0.00065313024,0.005190116,0.005406239,0.612588,0.000539112,0.0006736758,0.00080634496],"about_ca_topic_score_codex":0.000033255357,"about_ca_topic_score_gemma":0.0000020880268,"teacher_disagreement_score":0.10148762,"about_ca_system_score_codex":0.00015489786,"about_ca_system_score_gemma":0.00015437705,"threshold_uncertainty_score":0.999986},"labels":[],"label_agreement":null},{"id":"W1566752131","doi":"10.1111/j.1365-2036.2011.04829.x","title":"Questions about mesalazine and the irritable bowel syndrome: authors’ reply","year":2011,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Irritable bowel syndrome; Mesalazine; Medicine; Internal medicine; Placebo; Gastroenterology; Alternative medicine; Inflammatory bowel disease; Disease","score_opus":0.038519017581523284,"score_gpt":0.29980906975406446,"score_spread":0.2612900521725412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1566752131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95340264,0.0052637956,0.00016448066,0.03566812,0.0007181123,0.0010356817,0.000018353852,0.00016384534,0.0035649794],"genre_scores_gemma":[0.93998396,0.00084683317,0.0021177295,0.055876788,0.000059520135,0.00006607684,0.000021301434,0.000027433982,0.0010003463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986469,0.00023122363,0.0003077485,0.00030168018,0.00014476816,0.0003676458],"domain_scores_gemma":[0.9992635,0.0001625309,0.000087662185,0.0002555969,0.000069052425,0.00016162367],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046394565,0.00020883631,0.00029306245,0.000070307215,0.00024055252,0.000011768945,0.00014644572,0.00006708883,0.0009820521],"category_scores_gemma":[0.0000017043124,0.0001503307,0.000090709065,0.00014064761,0.00083069317,0.00010096244,0.00008374594,0.00039983698,0.0000498986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03984354,0.0117162345,0.7256117,0.0006916185,0.05581481,0.0025316428,0.026785785,0.000042186693,0.083157234,0.015243146,0.028695703,0.00986642],"study_design_scores_gemma":[0.042071454,0.006145627,0.8132402,0.00024237004,0.054655604,0.010442973,0.0032866793,0.0027329342,0.011703015,0.013286151,0.041256037,0.0009370002],"about_ca_topic_score_codex":0.00037632012,"about_ca_topic_score_gemma":0.000018568899,"teacher_disagreement_score":0.08762848,"about_ca_system_score_codex":0.000038211016,"about_ca_system_score_gemma":0.000063918735,"threshold_uncertainty_score":0.99993116},"labels":[],"label_agreement":null},{"id":"W1570384443","doi":"10.1111/j.1365-2036.2006.03234.x","title":"Helicobacter pylori eradication in long‐term proton pump inhibitor users in primary care: a randomized‐controlled trial","year":2006,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McMaster University; Abbott Laboratories","keywords":"Proton-pump inhibitor; Medicine; Helicobacter pylori; Medical prescription; Heartburn; Placebo; Internal medicine; Gastroenterology; Quality of life (healthcare); Randomized controlled trial; Reflux; Pharmacology; Alternative medicine","score_opus":0.014835898872026522,"score_gpt":0.2932696392678956,"score_spread":0.2784337403958691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1570384443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96950626,0.002533243,0.000013590067,0.008427978,0.0018664625,0.01721809,0.000012704926,0.00010503444,0.00031665995],"genre_scores_gemma":[0.9713059,0.0015592733,0.00013604974,0.019378807,0.0009550802,0.0060064434,0.00041978387,0.00007578052,0.00016290377],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99536854,0.0011550802,0.0016010681,0.0006735727,0.00036047076,0.00084126805],"domain_scores_gemma":[0.99863726,0.00038286299,0.00041326095,0.00032074505,0.00012853964,0.00011733369],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009249566,0.0005509149,0.0020575793,0.0006425891,0.00009390961,0.0000206746,0.0002175749,0.0003589558,0.00012268232],"category_scores_gemma":[0.0000020511936,0.00046672422,0.00037236937,0.0004006712,0.00048369128,0.0002205204,0.000103163984,0.0008955884,0.000035531375],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73198277,0.0015996905,0.23615979,0.00008819118,0.0062945755,0.0001818146,0.0009338572,0.000022556396,0.022322508,0.000002640196,0.00006172852,0.00034990712],"study_design_scores_gemma":[0.91304344,0.0010995631,0.06871323,0.000095304385,0.007792201,0.00003808228,0.00006468828,0.00007051715,0.008425162,0.000018544866,0.0003608729,0.00027842002],"about_ca_topic_score_codex":0.00017127684,"about_ca_topic_score_gemma":0.00015315083,"teacher_disagreement_score":0.18106067,"about_ca_system_score_codex":0.0010648615,"about_ca_system_score_gemma":0.00021390454,"threshold_uncertainty_score":0.99977845},"labels":[],"label_agreement":null},{"id":"W1574415806","doi":"10.1111/j.1365-2036.2007.03409.x","title":"One‐week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks’ treatment with esomeprazole: a randomized, placebo‐controlled study","year":2007,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Dalhousie University","funders":"","keywords":"Esomeprazole; Medicine; Epigastric pain; Placebo; Internal medicine; Gastroenterology; Randomized controlled trial; Helicobacter pylori; Pathology","score_opus":0.028578323321511424,"score_gpt":0.31158552943403867,"score_spread":0.2830072061125272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1574415806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734158,0.00014553042,0.00026960648,0.0053179804,0.0004464832,0.020205136,0.000029970823,0.00014937055,0.000020151501],"genre_scores_gemma":[0.97852284,0.00005546775,0.0013314438,0.017426662,0.00016143796,0.0020556247,0.0000742861,0.00011532894,0.00025693723],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.992013,0.003906985,0.0012918515,0.0009419239,0.0006343203,0.0012119657],"domain_scores_gemma":[0.9963512,0.0019644445,0.0003795868,0.00045099048,0.00020522703,0.0006485521],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0041919737,0.000771381,0.0021649078,0.0010108561,0.00020192715,0.000022883449,0.00025671316,0.00019499882,0.00013630485],"category_scores_gemma":[0.000030797877,0.0004940023,0.00012763683,0.0010780517,0.000329264,0.00012880955,0.00013803112,0.00062398775,0.000024823268],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81785667,0.008513477,0.13026592,0.000009162342,0.02494258,0.00062022265,0.0058772475,0.00011172935,0.010566954,8.567237e-8,0.00010291551,0.0011330376],"study_design_scores_gemma":[0.8445537,0.10529293,0.027372632,0.00015091097,0.01585604,0.00002126142,0.001463208,0.00010878738,0.004540145,0.0000011121017,0.00030226997,0.00033697477],"about_ca_topic_score_codex":0.00008705518,"about_ca_topic_score_gemma":0.00017664739,"teacher_disagreement_score":0.102893285,"about_ca_system_score_codex":0.00081791956,"about_ca_system_score_gemma":0.00025330516,"threshold_uncertainty_score":0.99975115},"labels":[],"label_agreement":null},{"id":"W1580128246","doi":"10.1111/j.1365-2036.2011.04961.x","title":"Evolution of GERD over 5 years: author’s reply","year":2012,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nerd; Medicine; GERD; Reflux; Endoscopy; Disease; General surgery; Gastroenterology; Internal medicine","score_opus":0.036520263676797546,"score_gpt":0.3603211669520895,"score_spread":0.32380090327529193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1580128246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99609643,0.0017446245,0.000027792028,0.00039919966,0.00092501636,0.00033392257,0.000019917412,0.000044810025,0.00040828326],"genre_scores_gemma":[0.9897756,0.00008593143,0.000690106,0.008473578,0.0003204418,0.00001937627,0.000042680178,0.000025746518,0.0005665208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989116,0.00008596263,0.00025876067,0.00016408625,0.00020092119,0.00037862727],"domain_scores_gemma":[0.99945873,0.00004467302,0.0001122174,0.00019367809,0.000037153353,0.00015357164],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016400072,0.00015189977,0.00024283378,0.000096894364,0.000039534738,0.0000022684626,0.00007272997,0.00007601933,0.0010459295],"category_scores_gemma":[1.7751846e-7,0.00013636399,0.00010637077,0.0001238173,0.000109138404,0.0001199541,0.000042907017,0.0001565072,0.00009902586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003944162,0.0016756975,0.84562796,0.000026712103,0.007480025,0.00011012864,0.0005805953,0.0000027883048,0.14068572,0.00009239475,0.0017808855,0.0015426861],"study_design_scores_gemma":[0.0049496996,0.0009727575,0.86331844,0.000013328066,0.013198363,0.00014732112,0.00006794357,0.00006435584,0.10771822,0.000092709946,0.009344067,0.000112802954],"about_ca_topic_score_codex":0.000026841297,"about_ca_topic_score_gemma":2.445227e-7,"teacher_disagreement_score":0.032967504,"about_ca_system_score_codex":0.00020582834,"about_ca_system_score_gemma":0.000053583593,"threshold_uncertainty_score":0.99986726},"labels":[],"label_agreement":null},{"id":"W1581565933","doi":"10.1111/j.1365-2036.2010.04380.x","title":"Treatment of ulcerative colitis with adalimumab or infliximab: long‐term follow‐up of a single‐centre cohort","year":2010,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"","keywords":"Medicine; Infliximab; Ulcerative colitis; Adalimumab; Internal medicine; Calprotectin; Cohort; Cohort study; Randomized controlled trial; Maintenance therapy; Gastroenterology; Inflammatory bowel disease; Surgery; Disease; Chemotherapy","score_opus":0.016146118121175942,"score_gpt":0.28710511511472,"score_spread":0.27095899699354403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1581565933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99774307,0.00017639236,0.00002005203,0.00020647013,0.00052049576,0.0008851672,0.0002348767,0.000015634098,0.00019785033],"genre_scores_gemma":[0.9971125,0.0002667781,0.0002978038,0.0011611925,0.00016942598,0.000073860894,0.00028700609,0.00004654988,0.000584853],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99857366,0.00015791511,0.0003748125,0.00037301806,0.0001758864,0.00034469215],"domain_scores_gemma":[0.9990125,0.000037329493,0.0002604809,0.00037053527,0.00018789417,0.00013126318],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006694164,0.00031514984,0.00034582787,0.000057614587,0.0000718019,0.00000780355,0.00021359933,0.00016904986,0.0005258722],"category_scores_gemma":[3.9237534e-7,0.0002486596,0.00013416131,0.00008060413,0.00045903688,0.000010880657,0.0000602215,0.00009359429,0.0000047498565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013150261,0.0013031537,0.17675793,0.000034191824,0.008066251,0.00016844283,0.0005576018,0.000012905189,0.7989974,0.000014397569,0.00010639306,0.00083109323],"study_design_scores_gemma":[0.009316913,0.00264249,0.11831293,0.000010837455,0.0045524226,0.00004832455,0.00012926654,0.00002250104,0.86225516,0.0000059649733,0.0024144538,0.0002887425],"about_ca_topic_score_codex":0.000026359836,"about_ca_topic_score_gemma":0.00073601684,"teacher_disagreement_score":0.063257776,"about_ca_system_score_codex":0.000055868764,"about_ca_system_score_gemma":0.00027726972,"threshold_uncertainty_score":0.99999654},"labels":[],"label_agreement":null},{"id":"W1583019489","doi":"10.1111/apt.12488","title":"Meta-analysis: rectal indomethacin for the prevention of post-ERCP pancreatitis","year":2013,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gallbladder and Bile Duct Disorders","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université Laval; Jewish General Hospital; McGill University","funders":"Takeda Canada; Boston Scientific Corporation; AstraZeneca","keywords":"Medicine; Pancreatitis; Meta-analysis; Placebo; Internal medicine; Subgroup analysis; Endoscopic retrograde cholangiopancreatography; Gastroenterology; Randomized controlled trial; Acute pancreatitis; Relative risk; Population; Confidence interval","score_opus":0.2077836694335584,"score_gpt":0.4300665834541104,"score_spread":0.22228291402055203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1583019489","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018155194,0.9917457,0.00010307413,0.0011060034,0.00037940065,0.005954605,0.00042159896,0.00003297693,0.00007508801],"genre_scores_gemma":[0.00024388828,0.9885325,0.0005368484,0.0050127693,0.00017365438,0.0022874486,0.0014203342,0.00007331796,0.0017192342],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99717736,0.0006190083,0.001021352,0.00048949505,0.00029766906,0.00039513092],"domain_scores_gemma":[0.9974401,0.0010578027,0.00067630206,0.00049825374,0.00024118445,0.00008635743],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00059102295,0.00055566296,0.0037576642,0.00038964362,0.000113352624,0.000014640733,0.00038451148,0.00032935277,0.004611346],"category_scores_gemma":[7.9310036e-7,0.00031867975,0.004975195,0.0006443825,0.00022923965,0.00007307556,0.00007876777,0.00045941962,0.000030562922],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000947206,0.0004061143,0.000008117991,0.0017970717,0.88012356,0.000002937882,0.000110729365,0.0000015627165,0.00040697842,0.0000049822147,0.00066748384,0.11637574],"study_design_scores_gemma":[0.0007206667,0.0005508118,0.0000039551064,0.000037108184,0.6779638,0.000027185226,0.0001062557,0.000010659857,0.0005280296,0.000016627611,0.31985912,0.00017577689],"about_ca_topic_score_codex":0.00011677169,"about_ca_topic_score_gemma":0.000017862418,"teacher_disagreement_score":0.31919163,"about_ca_system_score_codex":0.000075322554,"about_ca_system_score_gemma":0.0002605822,"threshold_uncertainty_score":0.9999265},"labels":[],"label_agreement":null},{"id":"W1589299857","doi":"10.1111/j.1365-2036.2008.03651.x","title":"Mortality risks associated with Barrett’s oesophagus: authors' reply","year":2008,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Confounding; Socioeconomic status; Demography; Population; Mortality rate; Gerontology; Environmental health; Internal medicine","score_opus":0.1361149434304146,"score_gpt":0.4055067392774916,"score_spread":0.26939179584707695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1589299857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803052,0.011850805,0.000016492188,0.0055741686,0.00040707763,0.0010440412,0.000081184364,0.00020401232,0.0005170361],"genre_scores_gemma":[0.96158415,0.0013258704,0.00018206386,0.03523266,0.00024673913,0.00014390156,0.00023348018,0.00005574393,0.000995385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975624,0.0002974764,0.00034103254,0.00051242363,0.0005899014,0.0006967481],"domain_scores_gemma":[0.9987722,0.00014723043,0.00013703591,0.00037831336,0.00015003498,0.00041518925],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030580504,0.00033332373,0.00046305134,0.00011203981,0.00034095754,0.000009967605,0.0001767397,0.00012590799,0.0014955978],"category_scores_gemma":[8.411883e-7,0.0002581388,0.00013897558,0.00031477906,0.00048181036,0.00011969458,0.00006192057,0.0005771174,0.00008268823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018059544,0.001862232,0.9516699,0.00002169375,0.031784583,0.0050415057,0.00059906516,0.000019528667,0.0025286512,0.000011339447,0.004229431,0.00042614713],"study_design_scores_gemma":[0.013662051,0.0047991094,0.86210865,0.00004268612,0.015868938,0.0005429682,0.00011322482,0.00028032693,0.10004589,0.000091067595,0.0020344134,0.00041068104],"about_ca_topic_score_codex":0.00038944322,"about_ca_topic_score_gemma":0.000033029773,"teacher_disagreement_score":0.09751724,"about_ca_system_score_codex":0.0004778839,"about_ca_system_score_gemma":0.00038526917,"threshold_uncertainty_score":0.99998707},"labels":[],"label_agreement":null},{"id":"W1589772597","doi":"10.1111/j.1365-2036.2011.04841.x","title":"Aerobic exercise and caloric reduction should be the key lifestyle modifications in obese patients with GERD","year":2011,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"GlaxoSmithKline; AstraZeneca","keywords":"Medicine; Metabolic syndrome; GERD; Internal medicine; Waist; Gastroenterology; Obesity; Insulin resistance; Population; Weight loss; Disease; Coronary artery disease; Reflux; Physical therapy","score_opus":0.053539350439581204,"score_gpt":0.30362085908652464,"score_spread":0.25008150864694345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1589772597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8600334,0.001414757,0.0000021894512,0.13525678,0.0008037885,0.0022030128,0.00008123342,0.000057920275,0.00014694197],"genre_scores_gemma":[0.57722837,0.0020286408,0.00023991257,0.41707927,0.0005886643,0.0004428348,0.0012379182,0.000099703095,0.0010546795],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99809897,0.00018533724,0.00036183783,0.0005353927,0.0003157356,0.00050273305],"domain_scores_gemma":[0.999122,0.00007656546,0.0001941376,0.00040891086,0.00009595484,0.00010241949],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000098130724,0.0004575427,0.00046988652,0.00021950887,0.00017466988,0.000016392605,0.00019312206,0.000393377,0.00022001758],"category_scores_gemma":[1.6491408e-7,0.00029935586,0.000079256606,0.00022139156,0.00033163713,0.000107135944,0.00006443721,0.001384734,0.000031014868],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004575719,0.010446537,0.4461487,0.0006914023,0.045439474,0.005244418,0.010926709,0.00003550562,0.0027887914,0.0000133029935,0.46302056,0.010668874],"study_design_scores_gemma":[0.05986665,0.010009958,0.44812593,0.0008407564,0.20586564,0.0010583445,0.00043274285,0.00018868322,0.014627686,0.00050878205,0.25617257,0.0023022688],"about_ca_topic_score_codex":0.00010400222,"about_ca_topic_score_gemma":0.000005618431,"teacher_disagreement_score":0.282805,"about_ca_system_score_codex":0.00021016375,"about_ca_system_score_gemma":0.000099596764,"threshold_uncertainty_score":0.9999459},"labels":[],"label_agreement":null},{"id":"W1591664728","doi":"10.1111/j.1365-2036.2007.03332.x","title":"Review article: the diagnosis and management of Crohn’s disease in populations with high‐risk rates for tuberculosis","year":2007,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Diagnosis and treatment of tuberculosis","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Tuberculosis; Disease; Crohn's disease; Latent tuberculosis; Intensive care medicine; INTESTINAL TUBERCULOSIS; Radiological weapon; Ulcerative colitis; Internal medicine; Mycobacterium tuberculosis; Surgery; Pathology","score_opus":0.10798169127184215,"score_gpt":0.4370057633632497,"score_spread":0.32902407209140755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1591664728","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0059582405,0.9823884,0.0000034274517,0.0045027193,0.00017340899,0.006630202,0.0003090878,0.0000194847,0.000015071188],"genre_scores_gemma":[0.00077831955,0.9850589,0.00068361324,0.009056598,0.00006731222,0.003881219,0.00037882698,0.000067511835,0.000027678125],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979897,0.00022981179,0.00075373106,0.00045969043,0.00020383102,0.0003632402],"domain_scores_gemma":[0.99843013,0.00061380403,0.0003707105,0.00037665982,0.00006160964,0.00014707806],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039016514,0.000464722,0.0013137584,0.00016823993,0.00012335849,0.000012470236,0.00016356014,0.00010268786,0.00014806403],"category_scores_gemma":[5.7178823e-7,0.0002760603,0.00033651927,0.0004161289,0.00019652613,0.0000634681,0.000078116616,0.00024340626,0.0000055214323],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041469792,0.003351794,0.059121806,0.06211436,0.04728316,0.00022720208,0.000049391776,0.0000061192522,4.486752e-7,0.00016125092,0.0027273998,0.82454234],"study_design_scores_gemma":[0.0027855835,0.0005156565,0.034738686,0.034708854,0.3994247,0.000018684137,0.000026081787,0.0000147591845,0.000041186366,0.00006653379,0.52728045,0.0003788375],"about_ca_topic_score_codex":0.00012926996,"about_ca_topic_score_gemma":0.00003612087,"teacher_disagreement_score":0.82416356,"about_ca_system_score_codex":0.00015253974,"about_ca_system_score_gemma":0.000057791272,"threshold_uncertainty_score":0.9999692},"labels":[],"label_agreement":null},{"id":"W1595553499","doi":"10.1111/j.1365-2036.2011.04580.x","title":"An open-label, parallel, multiple-dose study comparing the pharmacokinetics and gastric acid suppression of rabeprazole extended-release with esomeprazole 40 mg and rabeprazole delayed-release 20 mg in healthy volunteers","year":2011,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre","funders":"Eisai","keywords":"Rabeprazole; Esomeprazole; Pharmacokinetics; Medicine; Gastric acid; Pharmacodynamics; Pharmacology; Internal medicine; Gastroenterology; Helicobacter pylori; Stomach","score_opus":0.061107948227029724,"score_gpt":0.3437143308585133,"score_spread":0.2826063826314835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1595553499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906913,0.0036263126,0.00007397252,0.0018762714,0.00033255012,0.0032241046,0.000054078177,0.00007353434,0.000047895344],"genre_scores_gemma":[0.9856849,0.0029700922,0.0013499922,0.0094612045,0.000074422074,0.0002743231,0.000076408345,0.00008993298,0.000018755374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959842,0.0008516223,0.0009426547,0.0009100741,0.0003618395,0.000949608],"domain_scores_gemma":[0.998147,0.0002176172,0.00039279196,0.0006009488,0.00018410453,0.00045755043],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071756466,0.0006399228,0.0010054419,0.00032249573,0.00036369657,0.000031481137,0.00061233435,0.00016246263,0.00009418679],"category_scores_gemma":[0.0000022681395,0.0004834456,0.000037975202,0.00046375705,0.0008860515,0.0004351815,0.00061901275,0.0010761303,0.000006321502],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04446046,0.009926338,0.7707791,0.00006295577,0.0069658426,0.0002678029,0.00654558,0.00015117392,0.15877107,0.000002235228,0.00021872098,0.0018487343],"study_design_scores_gemma":[0.123411484,0.033395153,0.76618177,0.00013698472,0.016343035,0.00054492726,0.008909976,0.028637217,0.02107698,0.000019403638,0.00053123076,0.00081185007],"about_ca_topic_score_codex":0.00085656863,"about_ca_topic_score_gemma":0.0006862885,"teacher_disagreement_score":0.13769409,"about_ca_system_score_codex":0.00011848468,"about_ca_system_score_gemma":0.00012804808,"threshold_uncertainty_score":0.9997617},"labels":[],"label_agreement":null},{"id":"W1595829166","doi":"10.1111/j.1365-2036.2010.04568.x","title":"Randomised clinical trial: improvement in health outcomes with certolizumab pegol in patients with active Crohn’s disease with prior loss of response to infliximab","year":2011,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"UCB Pharma","keywords":"Certolizumab pegol; Medicine; Infliximab; Crohn's disease; Internal medicine; Physical therapy; Work productivity; Disease; Productivity","score_opus":0.026831366868922315,"score_gpt":0.3329184131343723,"score_spread":0.30608704626545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1595829166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99431986,0.00004238869,0.000021787751,0.000793135,0.00014259211,0.004563106,0.00009317234,0.000011846502,0.000012131314],"genre_scores_gemma":[0.9938979,0.00004678433,0.00040129572,0.0050061652,0.00003038983,0.00045851796,0.000071260554,0.000054940705,0.0000327244],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9970263,0.00086001394,0.00078833645,0.0005708506,0.00026096255,0.00049353956],"domain_scores_gemma":[0.9986413,0.00009826885,0.00039833118,0.00042772756,0.00012222769,0.00031213547],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032092654,0.0003526372,0.00051593623,0.00015501441,0.00005385929,0.0000062344525,0.00028994674,0.000098952965,0.000058403304],"category_scores_gemma":[0.0000034868087,0.00025809312,0.00008940955,0.00014526807,0.00027607448,0.000018556575,0.00010703918,0.00020401545,0.000002617655],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6385423,0.0024784289,0.35527945,0.000025516565,0.00153327,0.0003719241,0.0004757313,0.000026656195,0.0006901093,9.803751e-7,0.0000083855675,0.00056725845],"study_design_scores_gemma":[0.27663112,0.0068457136,0.711425,0.000030639763,0.0005952008,0.0000021461276,0.00011800316,0.000007050675,0.003965593,0.0000033127903,0.00010739251,0.00026883296],"about_ca_topic_score_codex":0.00007530799,"about_ca_topic_score_gemma":0.00021610192,"teacher_disagreement_score":0.36191118,"about_ca_system_score_codex":0.00014412704,"about_ca_system_score_gemma":0.0007939049,"threshold_uncertainty_score":0.9999871},"labels":[],"label_agreement":null},{"id":"W1597600359","doi":"10.1111/j.1365-2036.2011.04749.x","title":"Use of tacrolimus in the treatment of autoimmune hepatitis: a single centre experience","year":2011,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions; Virginia Commonwealth University","keywords":"Medicine; Tacrolimus; Autoimmune hepatitis; Prednisone; Azathioprine; Gastroenterology; Internal medicine; Nausea; Vomiting; Liver function; Trough level; Hepatitis; Transplantation; Disease","score_opus":0.10398209279272984,"score_gpt":0.32422859956432165,"score_spread":0.2202465067715918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1597600359","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93258935,0.005912432,0.0000010415757,0.059380468,0.0006331406,0.0011499003,0.00024137014,0.000018524506,0.00007376328],"genre_scores_gemma":[0.37522405,0.012094811,0.00013547354,0.61088926,0.00039171777,0.00009558289,0.00059067743,0.000056193894,0.00052221504],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99811137,0.00044354046,0.0005485179,0.0002664345,0.00025229587,0.00037781722],"domain_scores_gemma":[0.9987428,0.00026051176,0.00033039274,0.0005483661,0.00008208767,0.000035801186],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000058021393,0.00034285698,0.0006565729,0.00013600381,0.0000490423,0.0000066997604,0.00030494208,0.0002775893,0.0009776945],"category_scores_gemma":[1.8147436e-7,0.00024076027,0.0002681174,0.00016639617,0.0004262538,0.000086435124,0.000047356174,0.00045239314,0.000007099739],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055623674,0.039151862,0.40700585,0.0009835609,0.060084563,0.0041815806,0.12827505,0.000010339609,0.1966061,0.000012254325,0.1489006,0.009225856],"study_design_scores_gemma":[0.006552517,0.006961287,0.06496789,0.00024783146,0.03389102,0.000082855404,0.0014234317,0.00009059083,0.08820774,0.000026663234,0.7970205,0.0005276575],"about_ca_topic_score_codex":0.002920068,"about_ca_topic_score_gemma":0.000017707607,"teacher_disagreement_score":0.6481199,"about_ca_system_score_codex":0.00018840097,"about_ca_system_score_gemma":0.000110019384,"threshold_uncertainty_score":0.99993557},"labels":[],"label_agreement":null},{"id":"W1599647953","doi":"10.1111/j.1365-2036.2007.03582.x","title":"Mortality rates in patients with Barrett’s oesophagus","year":2007,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Cancer Research UK; McMaster University; AstraZeneca","keywords":"Medicine; Standardized mortality ratio; Internal medicine; Barrett's oesophagus; Cohort study; Cohort; Population; Gastroenterology; Adenocarcinoma; Epidemiology; Retrospective cohort study; Surgery; Cancer","score_opus":0.033254645589014434,"score_gpt":0.37555023898592255,"score_spread":0.3422955933969081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1599647953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922969,0.005157277,0.00001062079,0.001006759,0.00023711978,0.0009577992,0.00002113487,0.00004133469,0.00027105428],"genre_scores_gemma":[0.9854344,0.00015603672,0.00019733218,0.013807805,0.00010992336,0.00003887214,0.00012979041,0.000028888475,0.000096918426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839634,0.00007835918,0.00026916683,0.00031262994,0.0003643895,0.00057909376],"domain_scores_gemma":[0.9993528,0.0000854389,0.000059362883,0.00019792504,0.000078774654,0.00022569991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028816197,0.00021421269,0.0002747081,0.00014287837,0.00007007642,0.000007335643,0.00010607288,0.00007206833,0.00071746676],"category_scores_gemma":[1.3184064e-7,0.00016220687,0.000052213196,0.00024952006,0.00017072029,0.00009170919,0.000038530565,0.00030943865,0.0000404896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032388829,0.0014622647,0.9883739,0.000019171404,0.004261486,0.0005528807,0.00013568207,0.0000042017996,0.00047283046,0.0000091949905,0.00011437356,0.0013551846],"study_design_scores_gemma":[0.011138589,0.0019248843,0.93566823,0.000012951491,0.0020398404,0.0000072395915,0.000045898887,0.000014452715,0.04878645,0.000035209523,0.00020008054,0.00012615531],"about_ca_topic_score_codex":0.00016404403,"about_ca_topic_score_gemma":0.00009996317,"teacher_disagreement_score":0.0527056,"about_ca_system_score_codex":0.000354637,"about_ca_system_score_gemma":0.00011443326,"threshold_uncertainty_score":0.7855758},"labels":[],"label_agreement":null},{"id":"W1600694123","doi":"10.1111/j.1365-2036.2011.04762.x","title":"Microscopic colitis and disease associations","year":2011,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Microscopic Colitis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Azathioprine; Transplantation; Population; Internal medicine; Incidence (geometry); Rheumatoid arthritis; Gastroenterology; Disease; Inflammatory bowel disease; Kidney transplantation; Organ transplantation; Lymphocytic colitis; Immunology; Microscopic colitis","score_opus":0.044109255166160176,"score_gpt":0.33190202742814495,"score_spread":0.2877927722619848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1600694123","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04940951,0.006296814,0.000014189598,0.93643284,0.0030525033,0.0018833885,0.0014392369,0.00018630543,0.0012852391],"genre_scores_gemma":[0.002710344,0.0022495592,0.0004083941,0.9828364,0.002733627,0.00013814057,0.0018346958,0.00011280904,0.006975994],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977629,0.00027646893,0.00043070212,0.00061189564,0.00024118507,0.0006768534],"domain_scores_gemma":[0.998765,0.00021332863,0.00021761798,0.00039621242,0.00009618992,0.00031166323],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011361638,0.00046347248,0.000636605,0.00017869673,0.00018354168,0.000027930822,0.00020161619,0.00058415375,0.00265914],"category_scores_gemma":[7.80941e-7,0.0004967021,0.00015447038,0.00010809654,0.00035556382,0.00006494326,0.0001567364,0.0015034447,0.00010179831],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015835639,0.0002340775,0.015134881,0.00027220132,0.010261177,0.0007251771,0.0003403483,2.8911723e-8,0.0059890947,0.000017031321,0.9663783,0.0004893488],"study_design_scores_gemma":[0.0024949093,0.00029771272,0.024979897,0.00008520427,0.031413816,0.00007864138,0.000011133265,0.000009867988,0.0023352539,0.0004919972,0.9373787,0.00042288334],"about_ca_topic_score_codex":0.00023803374,"about_ca_topic_score_gemma":0.000012985284,"teacher_disagreement_score":0.046699166,"about_ca_system_score_codex":0.00033423735,"about_ca_system_score_gemma":0.0004151415,"threshold_uncertainty_score":0.99974847},"labels":[],"label_agreement":null},{"id":"W1601475317","doi":"10.1111/j.1365-2036.2010.04407.x","title":"Review article: lymphatic system and associated adipose tissue in the development of inflammatory bowel disease","year":2010,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Lymphatic system; Immune system; Lymph; Inflammation; Adipose tissue; Medicine; Lymphangiogenesis; Immunology; Tissue fluid; Pathology; Internal medicine","score_opus":0.045437956075054284,"score_gpt":0.3664882579123304,"score_spread":0.3210503018372761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1601475317","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0058373907,0.9898038,8.751391e-7,0.0002508963,0.00041649723,0.003530369,0.000050949096,0.000040699033,0.00006851287],"genre_scores_gemma":[0.0020874904,0.99016523,0.00006584993,0.006669127,0.00011652962,0.0005835102,0.00022070341,0.000053508258,0.000038070364],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99653625,0.0009438471,0.0014200446,0.00037410727,0.00036116331,0.0003645582],"domain_scores_gemma":[0.998106,0.00051031035,0.00065271294,0.00041584502,0.00007408295,0.00024102141],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010226979,0.00047298157,0.0015546634,0.00015502685,0.000097106735,0.000012488097,0.00031073546,0.00021520336,0.000101374375],"category_scores_gemma":[0.0000033075505,0.00030804754,0.00020347007,0.00026758158,0.00018164655,0.0000583685,0.000088756315,0.0001337254,0.000037574973],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021114183,0.0020704474,0.003501283,0.36734807,0.018306501,0.0005870126,0.0015513039,1.8872949e-7,0.00021895336,0.00003623729,0.0011016252,0.60506725],"study_design_scores_gemma":[0.0033499545,0.0001606109,0.001578655,0.0959763,0.14992805,0.00024595484,0.00026945234,0.000024841469,0.000098103366,0.000005637506,0.7477871,0.0005753488],"about_ca_topic_score_codex":0.0000043545374,"about_ca_topic_score_gemma":0.0000060928865,"teacher_disagreement_score":0.74668545,"about_ca_system_score_codex":0.00032482404,"about_ca_system_score_gemma":0.0012756055,"threshold_uncertainty_score":0.9999372},"labels":[],"label_agreement":null},{"id":"W1601965618","doi":"10.1111/j.1365-2036.2011.04717.x","title":"Adalimumab sustains steroid‐free remission after 3 years of therapy for Crohn’s disease","year":2011,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Adalimumab; Crohn's disease; Disease; Crohn disease; Internal medicine; Gastroenterology","score_opus":0.024710548970656426,"score_gpt":0.28786546089751763,"score_spread":0.2631549119268612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1601965618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959672,0.0019664883,0.00012218072,0.00018556026,0.00046176623,0.0009224761,0.00027167588,0.000022006348,0.00008066577],"genre_scores_gemma":[0.9885829,0.0008844714,0.0006088094,0.00894253,0.00022881561,0.0002398787,0.00015219732,0.00006394424,0.0002964419],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986411,0.00014867133,0.00031372352,0.00038260274,0.00013607736,0.00037786542],"domain_scores_gemma":[0.9990051,0.000021217898,0.00014203033,0.00052239106,0.00011666982,0.00019258888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016220435,0.00023304464,0.00017054657,0.000061859406,0.000065318854,0.0000063595767,0.00042187827,0.00013234856,0.00036728158],"category_scores_gemma":[8.0903794e-7,0.00024076215,0.0001950465,0.000048686117,0.00020942366,0.000011545711,0.00015643089,0.000085101354,0.0000054643488],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05490711,0.0018497033,0.048942063,0.00013200755,0.0072138896,0.0005740292,0.0012113636,0.000021893837,0.87431484,0.000055651275,0.004607232,0.0061702128],"study_design_scores_gemma":[0.011370484,0.0010721469,0.46798804,0.000021892249,0.0033861257,0.000006931008,0.0002699374,0.00009543627,0.47498816,0.0008129163,0.039252512,0.00073540874],"about_ca_topic_score_codex":0.000008753099,"about_ca_topic_score_gemma":0.0000054187713,"teacher_disagreement_score":0.41904598,"about_ca_system_score_codex":0.000032650812,"about_ca_system_score_gemma":0.00017025374,"threshold_uncertainty_score":0.98179954},"labels":[],"label_agreement":null},{"id":"W1643534101","doi":"10.1111/j.1365-2036.2010.04401.x","title":"Extended spectrum beta‐lactamase‐producing bacteria and <i>Clostridium difficile</i> in patients with pouchitis","year":2010,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Pouchitis; Clostridium difficile; Medicine; Internal medicine; Antibiotics; Metronidazole; Refractory (planetary science); Gastroenterology; Ileitis; Dysbiosis; Aztreonam; Microbiology; Antibiotic resistance; Ulcerative colitis; Biology; Crohn's disease","score_opus":0.011539135788230593,"score_gpt":0.27718844564839135,"score_spread":0.2656493098601608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1643534101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895457,0.0002655919,0.0000016551612,0.007872282,0.00061451487,0.0011692034,0.00008591668,0.0000783363,0.00036679703],"genre_scores_gemma":[0.9935614,0.00041368097,0.00029093368,0.0048475815,0.00038895855,0.00004856121,0.00022760546,0.000080877435,0.00014043246],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973181,0.00012204917,0.00046594228,0.0007601873,0.0004601576,0.00087359274],"domain_scores_gemma":[0.9988623,0.00014093197,0.000121235884,0.00045538944,0.00009494039,0.00032520105],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025421724,0.00043679238,0.0005437175,0.00029030102,0.00017064778,0.000042456355,0.00020471917,0.00020030714,0.0013069917],"category_scores_gemma":[9.025318e-7,0.00037502268,0.00007921584,0.0003924845,0.0003718107,0.00014364236,0.00015643756,0.0011950921,0.0000326518],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003575777,0.002293392,0.20959029,0.000062225234,0.0021041422,0.0001748865,0.00026736653,0.0000021591236,0.7789954,0.000019993531,0.0002809776,0.0026334082],"study_design_scores_gemma":[0.010674543,0.0017489954,0.29741046,0.00003636652,0.0022393512,0.00008359331,0.000089693734,0.000056828278,0.6838155,0.000014509661,0.003424695,0.00040548036],"about_ca_topic_score_codex":0.00015012341,"about_ca_topic_score_gemma":0.00009594287,"teacher_disagreement_score":0.09517991,"about_ca_system_score_codex":0.00015499118,"about_ca_system_score_gemma":0.00020024936,"threshold_uncertainty_score":0.9998702},"labels":[],"label_agreement":null},{"id":"W1679076542","doi":"10.1111/j.1365-2036.2011.04921.x","title":"Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease","year":2012,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Inflammatory bowel disease; Incidence (geometry); Medicine; Ulcerative colitis; Disease; Epidemiology; Population; Clinical phenotype; Internal medicine; Gastroenterology; Pediatrics; Phenotype; Biology; Environmental health","score_opus":0.01156579620443135,"score_gpt":0.25876378350378737,"score_spread":0.24719798729935602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1679076542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92485785,0.018502358,0.0000013462296,0.05472179,0.0007445991,0.0008351754,0.0002974228,0.000021075752,0.000018386494],"genre_scores_gemma":[0.57143867,0.00686512,0.000019379646,0.41871145,0.0018320666,0.00020094811,0.0007320125,0.00008173251,0.00011858293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99723214,0.00053809816,0.00047512795,0.00076122826,0.00023343002,0.00075998815],"domain_scores_gemma":[0.9988314,0.00007003218,0.00019753372,0.0003741891,0.000053967615,0.00047290293],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019415186,0.00060238794,0.00034852102,0.00020623537,0.00008610947,0.000030831256,0.00031532996,0.0005186723,0.00008936744],"category_scores_gemma":[0.000001958123,0.00061941455,0.000092703565,0.00008176917,0.0004524559,0.000023451425,0.00030002987,0.0008513297,0.000012433733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001383149,0.0003241037,0.9660125,0.00040157774,0.0013322502,0.0020362316,0.00014961006,0.0000069761973,0.0017100594,0.000007378327,0.02637047,0.0002657406],"study_design_scores_gemma":[0.0035727476,0.00009831854,0.9624238,0.000059265658,0.005598868,0.0000074919835,0.000055905824,0.00024896432,0.0001403454,0.00016083894,0.026565583,0.001067844],"about_ca_topic_score_codex":0.00001808684,"about_ca_topic_score_gemma":0.000041052714,"teacher_disagreement_score":0.36398968,"about_ca_system_score_codex":0.00006278611,"about_ca_system_score_gemma":0.00036649423,"threshold_uncertainty_score":0.99962574},"labels":[],"label_agreement":null},{"id":"W1685269777","doi":"10.1111/j.1365-2036.2011.04894.x","title":"Sequential therapy – more studies are still required","year":2011,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"AstraZeneca","keywords":"Medicine; MEDLINE; Intensive care medicine","score_opus":0.18811073924173805,"score_gpt":0.418598922103132,"score_spread":0.23048818286139394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1685269777","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.059743237,0.047172986,0.0000072957278,0.8805711,0.009290313,0.0021496431,0.00036465673,0.00043587622,0.0002648889],"genre_scores_gemma":[0.0042630346,0.024907414,0.000328189,0.9528136,0.013631508,0.0002469705,0.0009633253,0.0003138641,0.0025320698],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99445117,0.00091363105,0.0011779286,0.001267749,0.0009876966,0.001201816],"domain_scores_gemma":[0.99701166,0.0004334879,0.0009390704,0.0010281611,0.00037619262,0.00021142745],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00054093613,0.0011961943,0.0019894459,0.0003579542,0.00022614459,0.00002738285,0.0007298016,0.0012174879,0.00219667],"category_scores_gemma":[9.695476e-7,0.0010901062,0.0006472771,0.00027587762,0.0011379016,0.00017218919,0.00028437065,0.0031408158,0.00022208704],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013625966,0.00055380753,0.0012372051,0.00045008535,0.08827923,0.002168847,0.0073182005,0.0000010169108,0.0053459937,0.0000018343845,0.8926418,0.0006393834],"study_design_scores_gemma":[0.0066046705,0.0011381117,0.00048825357,0.0002953204,0.025778797,0.00027188272,0.0011113472,0.000006631997,0.02074479,0.00018905033,0.9423354,0.0010357397],"about_ca_topic_score_codex":0.00025203955,"about_ca_topic_score_gemma":0.000022399518,"teacher_disagreement_score":0.07224252,"about_ca_system_score_codex":0.00056277675,"about_ca_system_score_gemma":0.00040977966,"threshold_uncertainty_score":0.999159},"labels":[],"label_agreement":null},{"id":"W1709638636","doi":"10.1111/apt.13286","title":"Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low <scp>FODMAP</scp> diet in children with the irritable bowel syndrome","year":2015,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":431,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Nursing Research; National Research Council Canada; National Institutes of Health; North American Society for Pediatric Gastroenterology, Hepatology and Nutrition; NASPGHAN Foundation; Mead Johnson Nutrition; U.S. Department of Agriculture","keywords":"Irritable bowel syndrome; Medicine; Gastroenterology; Internal medicine; Faecalibacterium prausnitzii; Abdominal pain; Crossover study; Microbiome; Gut flora; Placebo; Bioinformatics; Biology; Immunology; Pathology","score_opus":0.06440659171302482,"score_gpt":0.36481654650805,"score_spread":0.3004099547950252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1709638636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773259,0.00035919264,0.000026461843,0.017259205,0.00042237714,0.004392493,0.00006787955,0.000104668194,0.00004179666],"genre_scores_gemma":[0.9593113,0.00006106425,0.00051301235,0.039360587,0.000108577224,0.00018521001,0.00012233274,0.00007166372,0.0002662303],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99402547,0.002949328,0.001063148,0.00073806377,0.00040372225,0.00082027406],"domain_scores_gemma":[0.99518555,0.0031484696,0.00043674983,0.00046175762,0.00020060464,0.0005668687],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005568622,0.00045630662,0.0010458565,0.0002116693,0.0001393093,0.00003462702,0.0004275277,0.00025908227,0.000043893644],"category_scores_gemma":[0.00009141838,0.00030114094,0.00024934407,0.0006824146,0.00085604895,0.00011165843,0.00012730957,0.000918968,0.00005001441],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50298226,0.0039664404,0.47348818,0.00000826461,0.010957728,0.0002956709,0.00030636633,0.00004261508,0.0015660923,2.282539e-7,0.006326305,0.000059826616],"study_design_scores_gemma":[0.37624913,0.023695396,0.5898816,0.00014518913,0.006874598,0.00036329133,0.0011328228,0.00010078243,0.00018390696,0.000010743732,0.0011860182,0.00017649801],"about_ca_topic_score_codex":0.00008871221,"about_ca_topic_score_gemma":0.00013421211,"teacher_disagreement_score":0.12673312,"about_ca_system_score_codex":0.00021710813,"about_ca_system_score_gemma":0.00056654314,"threshold_uncertainty_score":0.9999441},"labels":[],"label_agreement":null},{"id":"W1718737649","doi":"10.1111/j.1365-2036.2010.04400.x","title":"The pharmacokinetics and safety of porfimer after repeated administration 30–45 days apart to patients undergoing photodynamic therapy","year":2010,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Quebec Rehabilitation Research Network","funders":"National Cancer Institute","keywords":"Medicine; Pharmacokinetics; Adverse effect; Surgery; Photodynamic therapy; Anesthesia; Pharmacology","score_opus":0.01662093804507745,"score_gpt":0.3352789096279698,"score_spread":0.31865797158289233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1718737649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908858,0.0010720677,0.000009531934,0.004990841,0.0007922372,0.0018601834,0.00007983007,0.000053199215,0.00025632587],"genre_scores_gemma":[0.97318494,0.011082693,0.00015414189,0.014982726,0.00013796921,0.00017245096,0.00006951563,0.000054544038,0.0001610244],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978471,0.00020511862,0.0005598414,0.0004229145,0.0004278875,0.0005371862],"domain_scores_gemma":[0.99853647,0.0004494556,0.00017540739,0.00037084022,0.00024384144,0.000224011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047682764,0.00033076608,0.00037387453,0.00012096108,0.00030055028,0.000023359496,0.0002354346,0.00013001032,0.00047038004],"category_scores_gemma":[0.000002401248,0.00024292314,0.00009595486,0.00024160554,0.0005161706,0.00008664777,0.0001412222,0.00060419075,0.000013226054],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010987491,0.000702186,0.024632983,0.000030319112,0.0062809894,0.000022014785,0.0007471926,0.000004034927,0.9486032,0.000012793232,0.00029765253,0.007679122],"study_design_scores_gemma":[0.014590825,0.0043840664,0.16264895,0.000052059946,0.0028713027,0.000049500646,0.00022212228,0.0006693835,0.77525085,0.00011367694,0.038624026,0.0005232534],"about_ca_topic_score_codex":0.00003388875,"about_ca_topic_score_gemma":0.000101286554,"teacher_disagreement_score":0.17335238,"about_ca_system_score_codex":0.000075317956,"about_ca_system_score_gemma":0.00016928127,"threshold_uncertainty_score":0.99061185},"labels":[],"label_agreement":null},{"id":"W1723503809","doi":"10.1111/j.1365-2036.2011.04592.x","title":"Gastric histology in children treated with proton pump inhibitors long term, with emphasis on enterochromaffin cell-like hyperplasia","year":2011,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Children's Hospital; University of British Columbia","funders":"University of British Columbia; Takeda Pharmaceuticals North America; AstraZeneca Canada; AstraZeneca","keywords":"Enterochromaffin cell; Medicine; Histology; Hyperplasia; Enterochromaffin-like cell; Internal medicine; Term (time); Gastroenterology; Stomach; Gastric mucosa; Serotonin","score_opus":0.019848107740789978,"score_gpt":0.26785594876025826,"score_spread":0.24800784101946827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1723503809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99657774,0.00022279249,0.000006434079,0.00012280935,0.000113840506,0.002400675,0.000018517238,0.00009438098,0.00044278224],"genre_scores_gemma":[0.99403536,0.000135015,0.00037230327,0.004494994,0.00006700539,0.00038147916,0.0001973251,0.00008123567,0.00023527644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979484,0.00017028094,0.0003539561,0.00061074016,0.00025346773,0.00066315476],"domain_scores_gemma":[0.9992497,0.00003296982,0.0001732454,0.0002923397,0.0000447645,0.00020695703],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006859558,0.0004981384,0.00052098196,0.00037709408,0.000099790406,0.0000075904827,0.00017134883,0.00014935016,0.0004357293],"category_scores_gemma":[6.5170816e-8,0.0003524662,0.00007808507,0.00032470733,0.0002457103,0.000104582345,0.00004009765,0.00039311775,0.000065636596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044050054,0.004142339,0.97325015,0.00002528032,0.0049761366,0.002646942,0.00033785647,0.0000036027059,0.008801417,4.3520183e-7,0.00002928652,0.001381539],"study_design_scores_gemma":[0.015369642,0.010533101,0.7466899,0.0000469255,0.0059977043,0.0012895605,0.00003061115,0.0000066475873,0.21982183,0.0000010614369,0.000035261837,0.00017776714],"about_ca_topic_score_codex":0.000102222904,"about_ca_topic_score_gemma":0.000016591997,"teacher_disagreement_score":0.22656026,"about_ca_system_score_codex":0.00034531092,"about_ca_system_score_gemma":0.00009625455,"threshold_uncertainty_score":0.9998927},"labels":[],"label_agreement":null},{"id":"W1728325376","doi":"10.1111/j.1365-2036.2008.03705.x","title":"Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alfa‐2a plus ribavirin","year":2008,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Centre for Disease Control; Royal Alexandra Hospital; Hamilton Health Sciences; University Health Network; Dalhousie University; Royal Victoria Hospital; Vancouver Hospital and Health Sciences Centre; University of Calgary; University of Alberta","funders":"","keywords":"Ribavirin; Medicine; Genotype; Clinical trial; Virology; Gastroenterology; Internal medicine; Peginterferon alfa-2a; Hepatitis C virus; Virus","score_opus":0.07746818897090328,"score_gpt":0.38252373505300064,"score_spread":0.30505554608209734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1728325376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947975,0.00020195926,0.000028087594,0.0010234305,0.00030258115,0.003232497,0.0000305505,0.00009141369,0.00029193584],"genre_scores_gemma":[0.9908357,0.0012003556,0.00027575952,0.006750769,0.00021671527,0.00019551758,0.00015343635,0.00007763046,0.00029411068],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99702686,0.0006056161,0.00062618597,0.0006462273,0.0004903933,0.0006047451],"domain_scores_gemma":[0.9987939,0.00018510796,0.00013013121,0.0003308607,0.00017914691,0.0003808513],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041788298,0.00036126497,0.0006441332,0.00031277182,0.00014112121,0.000014786838,0.00014187672,0.00022398832,0.00026141276],"category_scores_gemma":[0.0000022719234,0.00028255585,0.000060038918,0.00042381338,0.0003851054,0.0001720557,0.00010750405,0.0007212253,0.000058109363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.099862784,0.0016389723,0.8852762,0.000022150476,0.0024980227,0.00021537225,0.00050969777,0.000044455763,0.00089023286,6.0829814e-7,0.00042975068,0.0086117275],"study_design_scores_gemma":[0.12118173,0.033601902,0.83205247,0.00006902049,0.001990291,0.000027545679,0.000023224105,0.00018094711,0.002054514,0.0000015845818,0.008503259,0.00031352395],"about_ca_topic_score_codex":0.000571605,"about_ca_topic_score_gemma":0.00036806683,"teacher_disagreement_score":0.053223763,"about_ca_system_score_codex":0.0003905914,"about_ca_system_score_gemma":0.00027121132,"threshold_uncertainty_score":0.9999627},"labels":[],"label_agreement":null},{"id":"W1734005900","doi":"10.1111/j.1365-2036.2011.04763.x","title":"Mycophenolate mofetil for patients with autoimmune hepatitis and overlap syndromes","year":2011,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Mycophenolate; Mycophenolic acid; Medicine; Autoimmune hepatitis; Azathioprine; IMP dehydrogenase; Pharmacology; Discontinuation; Hepatitis; Immunology; Transplantation; Internal medicine; Disease","score_opus":0.026955274913903596,"score_gpt":0.2752207825338258,"score_spread":0.24826550761992222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1734005900","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8837468,0.0057185646,0.000013217825,0.10406085,0.0017909055,0.0032063697,0.0011263397,0.000136883,0.000200058],"genre_scores_gemma":[0.05715301,0.004521991,0.00055734813,0.9314775,0.00067836244,0.00024513688,0.0034107657,0.00017757645,0.0017783014],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981973,0.00013421147,0.00036221158,0.00048464315,0.0002511098,0.0005705061],"domain_scores_gemma":[0.99891806,0.00016543039,0.0002481065,0.00038787565,0.00017074538,0.000109757704],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006900739,0.00052520016,0.0007032496,0.00013712054,0.00021238356,0.00002047902,0.0002178997,0.0003680269,0.0011536251],"category_scores_gemma":[1.5063972e-7,0.00043097825,0.00016366525,0.00008306301,0.00030713086,0.00012898153,0.0001253727,0.0009362404,0.000022808419],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005894712,0.002325793,0.4259983,0.0014285143,0.088379875,0.0006590892,0.0009435064,5.188539e-7,0.0010098792,0.000008745489,0.47065336,0.0026977034],"study_design_scores_gemma":[0.018908551,0.0075138123,0.24797674,0.00025418392,0.082743436,0.00012306831,0.000052019506,0.00008855517,0.0006345112,0.00014336461,0.64050305,0.001058697],"about_ca_topic_score_codex":0.0003559823,"about_ca_topic_score_gemma":0.0000013672981,"teacher_disagreement_score":0.82741666,"about_ca_system_score_codex":0.00013601776,"about_ca_system_score_gemma":0.00014152563,"threshold_uncertainty_score":0.9998142},"labels":[],"label_agreement":null},{"id":"W1801429735","doi":"10.1111/j.1365-2036.2007.03402.x","title":"Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disorders","year":2007,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Reverse transcriptase; Primary biliary cirrhosis; Medicine; Autoimmune hepatitis; Cirrhosis; Liver disease; Immunology; Liver transplantation; Hepatitis; Autoimmune disease; Antibody; Polymerase chain reaction; Virology; Transplantation; Internal medicine; Biology","score_opus":0.015612525288886403,"score_gpt":0.2703018247547916,"score_spread":0.2546892994659052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1801429735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963944,0.0014115889,0.00002169712,0.00084675476,0.00021126126,0.0008198129,0.000054659497,0.000040331677,0.00019950407],"genre_scores_gemma":[0.9696732,0.00088462484,0.00018514734,0.02907103,0.000030232815,0.000010185479,0.0000519952,0.000035020068,0.000058521044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988373,0.00013236597,0.00020782618,0.0002777863,0.00017769462,0.00036702226],"domain_scores_gemma":[0.99948275,0.00008228565,0.000070765236,0.00020678056,0.000029847759,0.00012756734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018608638,0.00022678904,0.0002806478,0.00013566087,0.00009739001,0.0000059406575,0.00009124139,0.00009144836,0.00042857058],"category_scores_gemma":[1.0351527e-7,0.00019055804,0.00006467061,0.0001851881,0.00026498947,0.00017557491,0.000045740497,0.0003275687,0.000006610447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007136427,0.003251103,0.93125033,0.000078851815,0.0028410563,0.00003208206,0.00074125186,0.0000012691718,0.044901572,0.000002221255,0.00012478788,0.009639038],"study_design_scores_gemma":[0.009644362,0.0009771105,0.97497267,0.000030450867,0.004391527,0.0000041485127,0.00014163739,0.00003517349,0.004707874,0.000008788493,0.00487152,0.00021474247],"about_ca_topic_score_codex":0.00061116245,"about_ca_topic_score_gemma":0.00003406002,"teacher_disagreement_score":0.043722324,"about_ca_system_score_codex":0.00015184651,"about_ca_system_score_gemma":0.00006016891,"threshold_uncertainty_score":0.77707314},"labels":[],"label_agreement":null},{"id":"W1823493423","doi":"10.1111/j.1365-2036.2007.03303.x","title":"Systematic review: renal and other clinically relevant outcomes in hepatorenal syndrome trials","year":2007,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Hepatorenal syndrome; Medicine; Intensive care medicine; Randomized controlled trial; Randomization; Clinical endpoint; Internal medicine; Renal replacement therapy; Renal function; Clinical trial","score_opus":0.1580257182337732,"score_gpt":0.47877496213139303,"score_spread":0.32074924389761983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1823493423","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005174173,0.9922682,0.000006441588,0.00034632706,0.00048152547,0.0060658264,0.00022998548,0.00004610942,0.000038184633],"genre_scores_gemma":[0.000059915197,0.9657549,0.00009783011,0.03314341,0.000114243245,0.0003466474,0.00029189832,0.00007735216,0.00011375856],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99346197,0.0019802083,0.003230926,0.0005395113,0.00037100527,0.00041639805],"domain_scores_gemma":[0.9960424,0.0023563826,0.0010054181,0.00033596432,0.000044506996,0.00021534349],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003505742,0.0006026988,0.0059959157,0.00033133756,0.000049825794,0.000012553963,0.0002064166,0.00036994836,0.0002919207],"category_scores_gemma":[0.0000020424213,0.00040005494,0.00080304913,0.0002337676,0.00014143251,0.00006999125,0.00004129176,0.0006680798,0.000085432875],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003700487,0.00065680937,0.0013535506,0.8872736,0.102893226,0.0018837596,0.00012127284,4.981937e-8,0.000016078255,0.000008326281,0.00008346696,0.00533979],"study_design_scores_gemma":[0.0033634289,0.000539482,0.000075741904,0.35281423,0.6097314,0.001200464,0.000014889531,0.0000035026922,0.0000109741795,0.000017217933,0.031774078,0.00045457922],"about_ca_topic_score_codex":0.000021760377,"about_ca_topic_score_gemma":0.000004074656,"teacher_disagreement_score":0.5344594,"about_ca_system_score_codex":0.00016559513,"about_ca_system_score_gemma":0.00027655446,"threshold_uncertainty_score":0.99984515},"labels":[],"label_agreement":null},{"id":"W1840927757","doi":"10.1111/j.1365-2036.2007.03556.x","title":"Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change","year":2007,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":439,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Capsule endoscopy; Medicine; Endoscopy; Gastroenterology; Internal medicine; Capsule; Inflammatory Bowel Diseases; Stenosis; Inflammatory bowel disease","score_opus":0.0968124947504707,"score_gpt":0.3569835534092948,"score_spread":0.26017105865882406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1840927757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99579144,0.0008313953,0.00059325155,0.00081877114,0.0005895102,0.0012319379,0.000012051707,0.000054801825,0.000076826436],"genre_scores_gemma":[0.9584568,0.00011998563,0.035244405,0.0054474487,0.00033394917,0.00026327555,0.000054761855,0.000042475247,0.000036870544],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855524,0.000020637171,0.00048403352,0.00027484074,0.00017136984,0.0004938856],"domain_scores_gemma":[0.9992822,0.00013538418,0.0001814533,0.00013123204,0.00010894085,0.00016080309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003909487,0.00024090717,0.00031764127,0.00016697729,0.000112111615,0.0000048395023,0.00011167499,0.000076632066,0.000079515354],"category_scores_gemma":[4.1932236e-7,0.00022287112,0.00010714118,0.00009582706,0.00009451645,0.000052070543,0.00005993727,0.00015557831,0.000009395004],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012654081,0.0014772969,0.35253504,0.00019745107,0.0059828963,0.00009690569,0.0018508796,0.000003323656,0.62807107,0.00003825121,0.0000904421,0.008391006],"study_design_scores_gemma":[0.006695289,0.0010233511,0.13387328,0.00012970284,0.0042499234,0.00006174502,0.00037675697,0.00012635914,0.8487944,0.000016816912,0.0044630715,0.000189291],"about_ca_topic_score_codex":0.000031424886,"about_ca_topic_score_gemma":0.000033590735,"teacher_disagreement_score":0.22072332,"about_ca_system_score_codex":0.00022579184,"about_ca_system_score_gemma":0.00013084515,"threshold_uncertainty_score":0.908842},"labels":[],"label_agreement":null},{"id":"W1851453522","doi":"10.1111/apt.13402","title":"Review article: pharmacological aspects of anti-TNF biosimilars in inflammatory bowel diseases","year":2015,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"UCB Pharma; Genentech; Vlaamse regering; Hellenic Society of Gastroenterology; Norgine; Agentschap voor Innovatie door Wetenschap en Technologie; Fonds Wetenschappelijk Onderzoek; Celltrion; European Crohn's and Colitis Organisation; National Institute for Health and Care Research; Janssen Biotech; Teva Pharmaceutical Industries; Celgene; Pfizer; Biogen; Ablynx; Gilead Sciences; Amgen; ActoGeniX; Sanofi; Tillotts Pharma; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Ironwood Pharmaceuticals, Incorporated","keywords":"Biosimilar; Medicine; Infliximab; Adalimumab; Inflammatory bowel disease; Ulcerative colitis; Bioequivalence; Rheumatoid arthritis; Pharmacokinetics; Drug; Pharmacology; Crohn's disease; Pharmacodynamics; Ankylosing spondylitis; Internal medicine; Immunology; Tumor necrosis factor alpha; Disease","score_opus":0.08557301642064606,"score_gpt":0.4069166715807467,"score_spread":0.3213436551601006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1851453522","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022209225,0.993986,0.000001560567,0.0010984174,0.0019880831,0.0019322499,0.00045181785,0.00007989355,0.00023986674],"genre_scores_gemma":[0.00015129666,0.9760308,0.00007532741,0.023050018,0.0001264817,0.00017361887,0.0002445239,0.00007003,0.00007785216],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934002,0.0029639723,0.0017660869,0.0008323728,0.00013140621,0.0009059181],"domain_scores_gemma":[0.9977746,0.0007032743,0.0007912051,0.00044788368,0.00013423926,0.0001488238],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001124364,0.0008751964,0.003196184,0.0003316675,0.00008930987,0.000011171993,0.00094678876,0.0009838981,0.003103543],"category_scores_gemma":[0.000003511319,0.000661906,0.0007554326,0.0006331071,0.0010580639,0.000103469116,0.00040421326,0.0013959392,0.00018378362],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005128403,0.006029531,0.0009130871,0.043238495,0.068127304,0.0006048735,0.000104355946,0.0000029556882,0.017947853,0.00019922043,0.096916415,0.7654031],"study_design_scores_gemma":[0.0016075672,0.00032072628,0.00004823797,0.0051444992,0.06251662,0.00010174953,0.0000149016305,0.0000030901044,0.0030746837,0.00010359799,0.9264272,0.0006371501],"about_ca_topic_score_codex":0.000006261509,"about_ca_topic_score_gemma":0.0000020463904,"teacher_disagreement_score":0.82951075,"about_ca_system_score_codex":0.00025756483,"about_ca_system_score_gemma":0.0005639981,"threshold_uncertainty_score":0.99958324},"labels":[],"label_agreement":null},{"id":"W1866984045","doi":"10.1111/j.1365-2036.2010.04364.x","title":"The effects of paracetamol (acetaminophen) on hepatic tests in patients who chronically abuse alcohol – a randomized study","year":2010,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse","keywords":"Medicine; Acetaminophen; Placebo; Internal medicine; Gastroenterology; Alcohol abuse; Hepatitis C; Alcohol; Hepatitis; Hepatitis C virus; Randomized controlled trial; Antipyretic; Liver injury; Anesthesia; Analgesic; Immunology; Psychiatry; Virus; Pathology","score_opus":0.040077401220141355,"score_gpt":0.39511956547649957,"score_spread":0.3550421642563582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1866984045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839038,0.00034849448,0.0000043964624,0.00081429246,0.007029716,0.007462128,0.000020903204,0.00008281511,0.0003334108],"genre_scores_gemma":[0.9878865,0.0010292775,0.000034536788,0.009283288,0.00024815268,0.0012249957,0.000020073954,0.000063750296,0.00020941747],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99250764,0.0043870206,0.0011566689,0.0006272815,0.00043828133,0.0008831262],"domain_scores_gemma":[0.99185324,0.0066654906,0.0005835579,0.0005205815,0.0001596132,0.00021754343],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0028081804,0.00057826866,0.0010282836,0.0002501176,0.00058661087,0.00003085413,0.0007974702,0.00054776756,0.0002715486],"category_scores_gemma":[0.00002375401,0.000443658,0.00028345213,0.000441065,0.0009097333,0.00018440475,0.00013231466,0.0028450966,0.00009735319],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13583171,0.027606705,0.33752373,0.00029434773,0.023424631,0.00015444455,0.012058464,0.00042468452,0.43236142,0.00044459724,0.00050268753,0.029372578],"study_design_scores_gemma":[0.4271589,0.00580606,0.089264475,0.000082361534,0.012840717,0.000012659794,0.00026026287,0.004454007,0.4477354,0.0007167474,0.010489701,0.0011786956],"about_ca_topic_score_codex":0.000114616254,"about_ca_topic_score_gemma":0.00029288942,"teacher_disagreement_score":0.29132718,"about_ca_system_score_codex":0.00018131257,"about_ca_system_score_gemma":0.00013303352,"threshold_uncertainty_score":0.9998015},"labels":[],"label_agreement":null},{"id":"W1874038071","doi":"10.1111/j.1365-2036.2011.04830.x","title":"Meta-analysis: predictors of rebleeding after endoscopic treatment for bleeding peptic ulcer","year":2011,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"AstraZeneca","keywords":"Medicine; Internal medicine; Gastroenterology; Odds ratio; Endoscopy; Peptic ulcer; Peptic; Surgery","score_opus":0.2904840159729914,"score_gpt":0.41917742185531615,"score_spread":0.12869340588232475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1874038071","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00096665777,0.993741,0.000024541852,0.00020170213,0.0007240481,0.0037035956,0.0004539069,0.00007403124,0.00011051711],"genre_scores_gemma":[0.0036201454,0.98736715,0.0023614503,0.000975081,0.00043584505,0.0040436015,0.00047683614,0.00014824313,0.00057164725],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9964793,0.00019367547,0.001417375,0.00090293196,0.00028007827,0.0007266717],"domain_scores_gemma":[0.9974689,0.0007076283,0.00089589704,0.0004884656,0.00017582341,0.00026327732],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031927062,0.0010722945,0.0058926255,0.0007774669,0.000106432984,0.000017522854,0.0002620052,0.00030398925,0.0019877045],"category_scores_gemma":[5.0832307e-7,0.00072218257,0.005621735,0.0005444513,0.00019633396,0.00007985811,0.00008852616,0.00031209196,0.000028597065],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024162457,0.0016821373,0.0024835162,0.002847881,0.98670584,0.00006498734,0.00024841275,0.000002244646,0.000050853774,0.000011255797,0.0001178701,0.0055434066],"study_design_scores_gemma":[0.0016207044,0.0031876597,0.00005335074,0.0004980288,0.82880855,0.000056291432,0.000034703662,0.000010193482,0.00053228217,0.000007584463,0.16491286,0.00027777432],"about_ca_topic_score_codex":0.00006971982,"about_ca_topic_score_gemma":0.000005555603,"teacher_disagreement_score":0.164795,"about_ca_system_score_codex":0.00056644174,"about_ca_system_score_gemma":0.0002485777,"threshold_uncertainty_score":0.9995229},"labels":[],"label_agreement":null},{"id":"W1875330998","doi":"10.1111/j.1365-2036.2007.03455.x","title":"Medical management of mild to moderate Crohn’s disease: evidence‐based treatment algorithms for induction and maintenance of remission","year":2007,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Azathioprine; Budesonide; Maintenance therapy; Sulfasalazine; Mesalazine; Crohn's disease; Prednisone; Internal medicine; Randomized controlled trial; Thiopurine methyltransferase; Inflammatory bowel disease; Gastroenterology; Mercaptopurine; Disease; Surgery; Ulcerative colitis; Corticosteroid; Chemotherapy","score_opus":0.13390052484250173,"score_gpt":0.4303415760863589,"score_spread":0.2964410512438572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1875330998","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0066566705,0.9884252,0.0012181333,0.0002705335,0.0004859911,0.0026365903,0.00028765775,0.000010430846,0.000008794475],"genre_scores_gemma":[0.0007473004,0.9944976,0.00189924,0.0016389815,0.00020395985,0.00043204188,0.00037936083,0.000055743487,0.00014577247],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979979,0.00020681156,0.00065242726,0.0005584291,0.0002585194,0.00032591063],"domain_scores_gemma":[0.9988493,0.00006896355,0.00033411977,0.00033842446,0.00011244428,0.00029677147],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003941776,0.00040415174,0.000641531,0.000121424295,0.00006724165,0.00000530023,0.00026723227,0.00028661964,0.000047724403],"category_scores_gemma":[0.0000010027219,0.00033788488,0.00029581678,0.00009433634,0.00017981496,0.000006793449,0.0001253684,0.00009941676,0.000001340445],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005339036,0.00084887317,0.000069691494,0.011363569,0.014231627,0.00029561174,0.00003791629,0.000074025294,0.0027610736,0.000021415688,0.0007246804,0.9642325],"study_design_scores_gemma":[0.0044500693,0.001318656,0.00062094454,0.009322073,0.04954233,0.000018059121,0.000047180605,0.0006973154,0.018660264,0.000030757325,0.914362,0.00093034806],"about_ca_topic_score_codex":0.0000052902365,"about_ca_topic_score_gemma":0.0000017646607,"teacher_disagreement_score":0.96330214,"about_ca_system_score_codex":0.00011470194,"about_ca_system_score_gemma":0.0003659492,"threshold_uncertainty_score":0.9999073},"labels":[],"label_agreement":null},{"id":"W1879451449","doi":"10.1111/j.1365-2036.2011.04935.x","title":"PPI co‐therapy did not adversely affect outcomes in clopidogrel users","year":2011,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"GlaxoSmithKline","keywords":"Clopidogrel; Medicine; Discontinuation; Proton-pump inhibitor; Percutaneous coronary intervention; Confounding; Hazard ratio; Internal medicine; Confidence interval; Population; Intensive care medicine; Adverse effect; Aspirin; Myocardial infarction","score_opus":0.06489476994855954,"score_gpt":0.3417638286430503,"score_spread":0.2768690586944908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1879451449","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6536531,0.020855619,0.00001944942,0.31380948,0.00512275,0.0045085987,0.00047631495,0.0004710995,0.0010836052],"genre_scores_gemma":[0.0468996,0.02371759,0.00010445394,0.92406166,0.0020421832,0.0002466718,0.0012197086,0.00025878838,0.0014493618],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954456,0.00085499045,0.00077689445,0.0010392413,0.0007213066,0.0011619637],"domain_scores_gemma":[0.99826354,0.00032781303,0.00031207353,0.00081443624,0.00008175475,0.00020037453],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042237405,0.0010751383,0.0018913312,0.00051705894,0.00015321752,0.000023573903,0.00057589717,0.0012570948,0.0030109785],"category_scores_gemma":[3.379591e-7,0.0009480922,0.0014482872,0.00027431382,0.0005190469,0.00016126124,0.000080829195,0.0026255185,0.00033612503],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0085145775,0.0026369197,0.20278004,0.000416814,0.19772264,0.014316688,0.0011462517,0.000011549408,0.01202949,0.0000055060364,0.5501958,0.010223741],"study_design_scores_gemma":[0.015612492,0.0011853093,0.017923186,0.00009611131,0.018313466,0.00023747323,0.00007625157,0.000011105161,0.018895607,0.000025473963,0.9265656,0.001057935],"about_ca_topic_score_codex":0.00014904604,"about_ca_topic_score_gemma":0.0000070396336,"teacher_disagreement_score":0.61025214,"about_ca_system_score_codex":0.00030730892,"about_ca_system_score_gemma":0.00028429902,"threshold_uncertainty_score":0.99967545},"labels":[],"label_agreement":null},{"id":"W1891595854","doi":"10.1111/j.1365-2036.2010.04304.x","title":"Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn’s disease","year":2010,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Adalimumab; Medicine; Internal medicine; Placebo; Adverse effect; Crohn's disease; Randomized controlled trial; Hazard ratio; Clinical trial; Surgery; Disease; Confidence interval; Pathology; Alternative medicine","score_opus":0.024580916824419357,"score_gpt":0.3684814707838611,"score_spread":0.34390055395944175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1891595854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961145,0.0010879011,0.000027099448,0.0005944706,0.0011606676,0.0008053846,0.00017754703,0.000016101436,0.000016338217],"genre_scores_gemma":[0.9800032,0.003161309,0.00060918985,0.0149379745,0.0007990992,0.0000968051,0.0001504059,0.000051149244,0.00019088834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822885,0.00019014935,0.0006148047,0.0005080348,0.00012449543,0.0003336404],"domain_scores_gemma":[0.9988281,0.00013125222,0.00019698363,0.00039423726,0.00012961046,0.00031982287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005677842,0.00022251745,0.00026028248,0.000039603718,0.00007129767,0.000012172085,0.0002444996,0.00029000908,0.0001604076],"category_scores_gemma":[0.0000037519865,0.00022190197,0.0002753669,0.000028411367,0.00046026026,0.000010897926,0.0001466781,0.0002670958,0.0000030456765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03978668,0.002049118,0.61507595,0.00007292166,0.0056027826,0.00028896538,0.000118946584,0.0000129636455,0.30602258,0.00011355302,0.0027051102,0.02815046],"study_design_scores_gemma":[0.007222039,0.00062046404,0.9135867,0.0000072491675,0.0016308897,0.000004615953,0.00002405624,0.00016943572,0.01025125,0.00038327434,0.06576997,0.00033006803],"about_ca_topic_score_codex":0.000004237751,"about_ca_topic_score_gemma":0.000010528128,"teacher_disagreement_score":0.29851076,"about_ca_system_score_codex":0.000010200509,"about_ca_system_score_gemma":0.0001971078,"threshold_uncertainty_score":0.90488994},"labels":[],"label_agreement":null},{"id":"W1891870373","doi":"10.1111/apt.13387","title":"Randomised clinical study: discrepancies between patient‐reported outcomes and endoscopic appearance in moderate to severe ulcerative colitis","year":2015,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"UCB Pharma; Genentech; Norgine; Atlantic Healthcare; Astellas Pharma; Bristol-Myers Squibb; Shire; AbbVie; Celgene; Therakos; Teva Pharmaceutical Industries; Tillotts Pharma; Amgen; Vifor Pharma; Pfizer; Kyowa Hakko Kirin; ActoGeniX; GlaxoSmithKline","keywords":"Medicine; Ulcerative colitis; Internal medicine; Gastroenterology; Endoscopy; Inflammatory bowel disease; Quality of life (healthcare); Disease","score_opus":0.05064015960121283,"score_gpt":0.3645189036782965,"score_spread":0.31387874407708366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1891870373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99660367,0.00026092347,0.00003380221,0.0006318159,0.0004250216,0.0018912792,0.000058202564,0.000021666794,0.00007363778],"genre_scores_gemma":[0.9908258,0.000074756244,0.00014994998,0.008388604,0.00013937037,0.00023169571,0.00006282805,0.000030539806,0.00009650339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744403,0.00085569225,0.00063125626,0.0005300433,0.00017221815,0.00036678513],"domain_scores_gemma":[0.9991528,0.00006168414,0.00015034906,0.00026011595,0.0000997078,0.00027533545],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000513231,0.00027507433,0.0004174066,0.000060454575,0.000084744446,0.00002366007,0.00016685235,0.00011931328,0.000014676401],"category_scores_gemma":[0.000004571985,0.00025882758,0.00006946265,0.000087005865,0.00015790711,0.000015458472,0.00019666862,0.0001734042,0.000008040797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01123123,0.0004883213,0.97890407,0.000007938973,0.00397796,0.00020920862,0.0012978438,0.00014242447,0.0026983502,0.0000023001267,0.00022229341,0.00081808836],"study_design_scores_gemma":[0.043048088,0.0012423124,0.94368666,0.000011167778,0.0017094658,0.000007696984,0.0012797313,0.000098716046,0.0069719558,0.000064123094,0.0014689069,0.00041117542],"about_ca_topic_score_codex":0.000057618046,"about_ca_topic_score_gemma":0.0002109439,"teacher_disagreement_score":0.035217382,"about_ca_system_score_codex":0.00004651664,"about_ca_system_score_gemma":0.00018307017,"threshold_uncertainty_score":0.9999864},"labels":[],"label_agreement":null},{"id":"W1907039258","doi":"10.1111/apt.13408","title":"Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials","year":2015,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"UCB Pharma; Takeda Oncology; Tillotts Pharma; Genentech; Biogen; Celgene; National Institute for Health and Care Research; Teva Pharmaceutical Industries; Gilead Sciences; Wyeth Pharmaceuticals; Pfizer; ActoGeniX; Bristol-Myers Squibb","keywords":"Medicine; Ulcerative colitis; Mesalazine; Placebo; Internal medicine; Interim analysis; Clinical trial; Inflammatory bowel disease; Clinical endpoint; Interim; Endoscopy; Colonoscopy; Gastroenterology; Disease; Surgery; Pathology; Alternative medicine; Colorectal cancer","score_opus":0.2507047214101915,"score_gpt":0.4853118432067941,"score_spread":0.2346071217966026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1907039258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956237,0.00019221101,0.0013355325,0.00042017756,0.00079388154,0.0014739032,0.00012804706,0.000005685857,0.000026857126],"genre_scores_gemma":[0.9962401,0.00007894454,0.0013476397,0.0018381057,0.00009343221,0.00028593605,0.00008014055,0.000019600067,0.000016141805],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99662846,0.0013489635,0.0013054231,0.00028536897,0.00021027988,0.0002214937],"domain_scores_gemma":[0.9983591,0.00029102716,0.0007075215,0.00026593913,0.00023027784,0.00014612229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033661777,0.00018873038,0.00042629323,0.00004677496,0.00005252459,0.000005481876,0.00022671578,0.0001007223,0.000023386408],"category_scores_gemma":[0.00002084786,0.00014540988,0.00021615643,0.00005322489,0.00023785146,0.000008392299,0.00013572419,0.00012477973,4.9075544e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034346625,0.0037710543,0.42384428,0.00012692793,0.021995287,0.00005860121,0.0013757312,0.00051167235,0.48814088,0.000058324244,0.0010543183,0.024716306],"study_design_scores_gemma":[0.009397419,0.0008276449,0.7148768,0.00001995432,0.0043497463,0.000002147711,0.0006852825,0.0010638714,0.25769785,0.00006112822,0.010680659,0.00033754908],"about_ca_topic_score_codex":0.000008595455,"about_ca_topic_score_gemma":0.000068868074,"teacher_disagreement_score":0.29103246,"about_ca_system_score_codex":0.00007735049,"about_ca_system_score_gemma":0.00086142635,"threshold_uncertainty_score":0.5929643},"labels":[],"label_agreement":null},{"id":"W1911381531","doi":"10.1111/apt.13432","title":"Miravirsen dosing in chronic hepatitis C patients results in decreased micro<scp>RNA</scp>‐122 levels without affecting other micro<scp>RNA</scp>s in plasma","year":2015,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Cilag; Alnylam Pharmaceuticals; Gilead Sciences; Janssen Research and Development; Innogenetics; Novartis; MedImmune; Roche; AbbVie; Merck; Bristol-Myers Squibb","keywords":"Medicine; Dosing; Placebo; Internal medicine; Gastroenterology; Chronic hepatitis; RNA; microRNA; Immunology; Pharmacology; Virus; Pathology; Biology","score_opus":0.02910347638518196,"score_gpt":0.3047417585793402,"score_spread":0.27563828219415826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1911381531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946589,0.002820997,0.000021773696,0.00014243303,0.00055000413,0.0011948453,0.00021732673,0.000033375418,0.0003603408],"genre_scores_gemma":[0.99491197,0.00028603215,0.0007723596,0.002588587,0.00028046622,0.000085332074,0.0006568372,0.00011888603,0.00029950874],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961095,0.00083913316,0.000891758,0.00092343433,0.00027844647,0.0009577336],"domain_scores_gemma":[0.99855864,0.00022400223,0.0004304867,0.00042617787,0.00012419483,0.00023650567],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00073223613,0.0005483193,0.0004818949,0.00034583782,0.00009356837,0.00004446995,0.0004601406,0.0004467997,0.000021629203],"category_scores_gemma":[0.000021719025,0.0006242637,0.00012642234,0.0004110972,0.00020426106,0.000045452747,0.00024526002,0.00042002441,0.000040251278],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027524686,0.00090980483,0.14920233,0.000034345638,0.0006302998,0.000038685586,0.0009774044,0.0007096195,0.8454401,5.5594734e-7,0.00093391625,0.0008476926],"study_design_scores_gemma":[0.018326875,0.00057215814,0.05236104,0.00012110294,0.00045594922,0.000015816126,0.0002850319,0.0010403437,0.9141015,0.000028352082,0.012450176,0.00024167917],"about_ca_topic_score_codex":0.0010029468,"about_ca_topic_score_gemma":0.00206616,"teacher_disagreement_score":0.09684129,"about_ca_system_score_codex":0.00089765486,"about_ca_system_score_gemma":0.0004415612,"threshold_uncertainty_score":0.99962085},"labels":[],"label_agreement":null},{"id":"W1915321816","doi":"10.1111/j.1365-2036.2011.04660.x","title":"The changing epidemiology of paediatric inflammatory bowel disease","year":2011,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Medical Research Council","keywords":"Medicine; Incidence (geometry); Inflammatory bowel disease; Epidemiology; Disease; Crohn's disease; Population; Internal medicine; Pediatrics; Environmental health","score_opus":0.024310453099510694,"score_gpt":0.28729360568285683,"score_spread":0.26298315258334615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1915321816","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53649694,0.09298667,0.00017323368,0.34827536,0.015312604,0.0045250165,0.0013469594,0.00020627749,0.0006769521],"genre_scores_gemma":[0.025870182,0.009731969,0.00010198808,0.95255053,0.008093906,0.00036638076,0.0015035269,0.00021050934,0.0015710371],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954724,0.0014590039,0.000914916,0.00074765773,0.00023515604,0.0011708731],"domain_scores_gemma":[0.99751216,0.00034494573,0.00080770603,0.00097646314,0.00016002671,0.0001986687],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009443498,0.00065371534,0.0004540683,0.00020689734,0.0003567165,0.0000074027503,0.0011503604,0.00086711586,0.00018581687],"category_scores_gemma":[0.0000041617377,0.00054587075,0.000507666,0.000111806505,0.0008975263,0.000008581375,0.00053090503,0.0010629423,0.00006272805],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024394356,0.00023833639,0.09105922,0.0005017411,0.0219929,0.0013797407,0.00028666932,0.00009611955,0.00849367,0.000068773545,0.8728186,0.0006248035],"study_design_scores_gemma":[0.0016260424,0.0002764791,0.016491009,0.0000311339,0.0130262785,0.00002554215,0.00007373014,0.00013986627,0.006018014,0.00056835316,0.96066505,0.0010585261],"about_ca_topic_score_codex":0.000006391778,"about_ca_topic_score_gemma":0.000004113039,"teacher_disagreement_score":0.60427517,"about_ca_system_score_codex":0.00006657098,"about_ca_system_score_gemma":0.0004245716,"threshold_uncertainty_score":0.9996993},"labels":[],"label_agreement":null},{"id":"W1919353320","doi":"10.1111/j.1365-2036.2011.04910.x","title":"Development and assessment of the constipation‐related disability scale","year":2011,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"","keywords":"Medicine; Constipation; Scale (ratio); Physical therapy; Intensive care medicine; Internal medicine","score_opus":0.06251188885522244,"score_gpt":0.3373681292074343,"score_spread":0.2748562403522119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1919353320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954492,0.00012761295,0.00003550057,0.0018293179,0.00021100021,0.0004244383,0.000004849183,0.00002081786,0.0018972805],"genre_scores_gemma":[0.98709756,0.000028906848,0.00911012,0.0036855163,0.000007967545,0.00001564689,0.000008780533,0.0000072349376,0.0000382805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918133,0.000098911245,0.0002839925,0.00016433925,0.00012132266,0.00015012271],"domain_scores_gemma":[0.99960446,0.0000561256,0.00009062135,0.00014319032,0.000043250508,0.00006232749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001827064,0.000109341636,0.00016382792,0.00001786461,0.000092971735,0.0000017485322,0.00008107524,0.000042969565,0.00048960873],"category_scores_gemma":[2.7839238e-7,0.000079078134,0.000045489487,0.000088855915,0.00069691276,0.000036034897,0.00007198872,0.00018278294,0.000002497552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017448791,0.0009923138,0.97533196,0.000036678477,0.0012427213,0.0000019075862,0.0013095919,0.0000015589674,0.018068932,0.00008799923,0.000016783611,0.002735093],"study_design_scores_gemma":[0.0017222733,0.0002471069,0.95141906,0.000020844705,0.002334242,0.000043030057,0.00053524954,0.00022200582,0.04252334,0.00019865156,0.0006658666,0.000068348425],"about_ca_topic_score_codex":0.00003648244,"about_ca_topic_score_gemma":0.000022569679,"teacher_disagreement_score":0.024454407,"about_ca_system_score_codex":0.00005753561,"about_ca_system_score_gemma":0.0001145695,"threshold_uncertainty_score":0.5360872},"labels":[],"label_agreement":null},{"id":"W1919372113","doi":"10.1111/j.1365-2036.2011.04779.x","title":"Mycophenolate mofetil for patients with autoimmune hepatitis and overlap syndromes: authors’ reply","year":2011,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Medicine; Autoimmune hepatitis; Azathioprine; Prednisolone; Overlap syndrome; Budesonide; Primary biliary cirrhosis; Gastroenterology; Internal medicine; Liver transplantation; Cohort; Primary sclerosing cholangitis; Hepatitis; Cirrhosis; Corticosteroid; Transplantation; Disease","score_opus":0.03859837642730549,"score_gpt":0.2860804413167782,"score_spread":0.2474820648894727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1919372113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596107,0.0012717223,0.000034020675,0.0006444821,0.000544992,0.0011533153,0.000120094235,0.00007826816,0.00019206034],"genre_scores_gemma":[0.9781901,0.0011259856,0.0015212526,0.018374342,0.0000534192,0.000096387645,0.0001882071,0.00005187452,0.0003984092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988213,0.0000871862,0.00027157983,0.0003098338,0.00014908648,0.00036101742],"domain_scores_gemma":[0.9992454,0.0000738647,0.00012544688,0.00027209043,0.00012260764,0.00016058267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107662614,0.0002447117,0.00032801533,0.00007460682,0.0001997724,0.0000102140875,0.00012180366,0.00006708578,0.0008035687],"category_scores_gemma":[2.861929e-7,0.00019966876,0.00007906733,0.000097537944,0.00020072107,0.00015824611,0.000078668636,0.00019241533,0.00001274167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005440292,0.002185861,0.9694202,0.00013123626,0.013368611,0.000052263465,0.0020644572,4.8667005e-7,0.004135574,0.000052397954,0.00081294286,0.002335692],"study_design_scores_gemma":[0.011445333,0.0052719414,0.9578068,0.000055002558,0.014664932,0.000044930162,0.0002283267,0.00025786195,0.0031517635,0.00017193436,0.0065765143,0.00032461635],"about_ca_topic_score_codex":0.00040120305,"about_ca_topic_score_gemma":0.0000019617448,"teacher_disagreement_score":0.017770924,"about_ca_system_score_codex":0.00007474205,"about_ca_system_score_gemma":0.00007320148,"threshold_uncertainty_score":0.8798514},"labels":[],"label_agreement":null},{"id":"W1929941258","doi":"10.1111/j.1365-2036.2011.04962.x","title":"Meta‐analysis: the diagnostic accuracy of lactose breath hydrogen or lactose tolerance tests for predicting the North European lactase polymorphism C/T‐13910","year":2011,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Digestive system and related health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Montreal General Hospital","funders":"","keywords":"Lactose; Lactase; Medicine; Hydrogen breath test; Breath test; Genotype; Lactose intolerance; Internal medicine; Gastroenterology; Food science; Genetics; Biology","score_opus":0.13586597491236674,"score_gpt":0.3821014192045269,"score_spread":0.24623544429216015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1929941258","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031278492,0.9913804,0.000032730597,0.00031207732,0.00052473776,0.0031153222,0.0013031171,0.00003008596,0.00017367059],"genre_scores_gemma":[0.02292385,0.9694818,0.000039273167,0.004551543,0.0006027122,0.0005567459,0.0011163711,0.00014000793,0.00058764505],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9952409,0.0019859402,0.0011660783,0.000748293,0.00019948192,0.00065928337],"domain_scores_gemma":[0.9954335,0.0019262558,0.0014330681,0.0009064376,0.00014543779,0.00015531738],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010045761,0.000768642,0.0018102804,0.00013206438,0.00040802304,0.000024242965,0.0012665812,0.0003342368,0.00016310561],"category_scores_gemma":[0.000008558835,0.00038424338,0.0017452717,0.00049362873,0.00037851447,0.000012773398,0.00029274882,0.00054385024,0.000024355319],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039859416,0.0007407873,0.0006452154,0.0023407987,0.9700727,0.000043142787,0.0006918354,0.000081091894,0.0006758946,0.000011713505,0.0012397859,0.023058437],"study_design_scores_gemma":[0.00054491457,0.0004263063,0.000078974495,0.00012405038,0.55952466,0.000057754027,0.000035169964,0.000009705006,0.000728404,0.0000027385393,0.43813732,0.0003299749],"about_ca_topic_score_codex":0.00011368901,"about_ca_topic_score_gemma":0.00012036233,"teacher_disagreement_score":0.43689755,"about_ca_system_score_codex":0.000036570964,"about_ca_system_score_gemma":0.0004556219,"threshold_uncertainty_score":0.99986094},"labels":[],"label_agreement":null},{"id":"W1934005616","doi":"10.1111/j.1365-2036.2011.04636.x","title":"Evaluation of a daily practice composite score for the assessment of Crohn’s disease: the treatment impact of certolizumab pegol","year":2011,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Certolizumab pegol; Inflammatory bowel disease; Crohn's disease; Internal medicine; Placebo; Physical therapy; Quality of life (healthcare); Disease; Adalimumab; Alternative medicine","score_opus":0.07461764309195078,"score_gpt":0.40286611457377136,"score_spread":0.32824847148182057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1934005616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943939,0.0024086295,0.00019623952,0.00042743492,0.00022848592,0.00187604,0.0003089104,0.0000041731605,0.00015622795],"genre_scores_gemma":[0.9977838,0.00089949364,0.00032817095,0.0004647421,0.0000777379,0.0002954208,0.00011297564,0.000022585638,0.000015089249],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983389,0.0005974985,0.00035928396,0.00020660058,0.0003042442,0.0001935072],"domain_scores_gemma":[0.99836564,0.00015326373,0.0004429214,0.00043190696,0.0005477499,0.00005851055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000419695,0.0001896765,0.0001761193,0.000031898027,0.00011272744,0.000003978844,0.0003092296,0.00005849862,0.00014411024],"category_scores_gemma":[0.0000019012297,0.000114562026,0.00028218597,0.00005567564,0.00029711207,0.000011232142,0.000056404184,0.00005720109,5.6550505e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013875464,0.004393959,0.050752092,0.00008158276,0.046601385,0.00003691938,0.0021040568,0.0023045149,0.8731464,0.00010290248,0.00044731252,0.0061534108],"study_design_scores_gemma":[0.006899876,0.0022284053,0.6798812,0.000015350131,0.0544276,0.000022378295,0.0005027133,0.009453188,0.24526109,0.0001440336,0.00093315844,0.00023099473],"about_ca_topic_score_codex":0.000111447334,"about_ca_topic_score_gemma":0.000016932887,"teacher_disagreement_score":0.6291291,"about_ca_system_score_codex":0.00011680518,"about_ca_system_score_gemma":0.00064187276,"threshold_uncertainty_score":0.4671704},"labels":[],"label_agreement":null},{"id":"W1936469955","doi":"10.1111/j.1365-2036.2011.04641.x","title":"Rabeprazole extended-release 50 mg compared with esomeprazole 40 mg and rabeprazole delayed release 20 mg: authors’ reply","year":2011,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre","funders":"Eisai","keywords":"Rabeprazole; Pharmacodynamics; Medicine; Esomeprazole; Pharmacology; Pharmacokinetics; Internal medicine; Omeprazole","score_opus":0.03978799445244836,"score_gpt":0.3079945686704791,"score_spread":0.26820657421803074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1936469955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910867,0.0029355367,0.000113685295,0.0018220291,0.00061894546,0.0014820932,0.00012718697,0.00027922654,0.0015345704],"genre_scores_gemma":[0.96482736,0.0008668761,0.0032884248,0.02872411,0.00021999337,0.0001718357,0.00039045146,0.00013574315,0.0013752258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963636,0.0003058532,0.00071182335,0.0010307041,0.0004997508,0.0010882593],"domain_scores_gemma":[0.997752,0.00013442706,0.00034423202,0.00073006767,0.00016970071,0.0008695523],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031754977,0.0007573624,0.00086384965,0.00025653752,0.0003991937,0.00003303113,0.00030860546,0.00021824586,0.0014358055],"category_scores_gemma":[9.909544e-7,0.0006267443,0.00017836562,0.0003212708,0.0005675735,0.00031771188,0.00017699771,0.0007533022,0.00021448372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05498987,0.018438157,0.4616225,0.0003180981,0.07595104,0.015983675,0.0075187585,0.00007718474,0.3358091,0.00017988011,0.011132859,0.017978858],"study_design_scores_gemma":[0.09248362,0.016743237,0.44477844,0.00020143343,0.07925119,0.0034923616,0.00167022,0.004599118,0.3193111,0.0007387018,0.03472345,0.002007116],"about_ca_topic_score_codex":0.00023607,"about_ca_topic_score_gemma":0.000027816424,"teacher_disagreement_score":0.037493747,"about_ca_system_score_codex":0.00019518286,"about_ca_system_score_gemma":0.00022049643,"threshold_uncertainty_score":0.9996184},"labels":[],"label_agreement":null},{"id":"W1940939704","doi":"10.1111/j.1365-2036.2010.04305.x","title":"Cost‐utility analysis of proton pump inhibitors and other gastro‐protective agents for prevention of gastrointestinal complications in elderly patients taking nonselective nonsteroidal anti‐inflammatory agents","year":2010,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Capital District Health Authority; University of Alberta; Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Proton-pump inhibitor; Intensive care medicine; Nonsteroidal; Rabeprazole; Internal medicine","score_opus":0.05173611235530043,"score_gpt":0.3702493942348575,"score_spread":0.3185132818795571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1940939704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99472886,0.000015291083,0.000570687,0.000063928055,0.00009502979,0.0042735785,0.00020912304,0.000014921918,0.000028590752],"genre_scores_gemma":[0.99717253,0.0000043313307,0.0017888879,0.0003216471,0.000022196813,0.0005120368,0.00014609788,0.00002339107,0.000008885218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983955,0.00015162598,0.0005598445,0.00037280328,0.00020618258,0.00031405696],"domain_scores_gemma":[0.9988334,0.000101119134,0.00054574735,0.00018755779,0.0002320901,0.00010007081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002240555,0.00023218636,0.00048444708,0.00039936329,0.000083104875,0.000005443853,0.000098343495,0.00008005868,0.00009455469],"category_scores_gemma":[0.0000023704933,0.00022148639,0.00017119314,0.0003477476,0.00030417254,0.0000914314,0.00004508219,0.00026457556,9.575986e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076397334,0.0021194045,0.9329051,0.00006821151,0.005798936,0.0000054755023,0.0003927464,0.000015808559,0.05578634,0.000003013055,0.0000028876475,0.002138104],"study_design_scores_gemma":[0.005516237,0.0016080929,0.910207,0.000049598802,0.008047343,0.000009269049,0.000070964685,0.0016219709,0.07274717,0.000033319357,0.000017150298,0.00007193359],"about_ca_topic_score_codex":0.000050281757,"about_ca_topic_score_gemma":0.000051798437,"teacher_disagreement_score":0.022698153,"about_ca_system_score_codex":0.000079039,"about_ca_system_score_gemma":0.00006927082,"threshold_uncertainty_score":0.90319526},"labels":[],"label_agreement":null},{"id":"W1941012103","doi":"10.1111/apt.12852","title":"Editorial: ‘brain fog’ and coeliac disease – evidence for its existence","year":2014,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Coeliac disease; Gluten free; Internal medicine; Disease; Serology; Gluten; Cognition; Pediatrics; Pathology; Immunology; Psychiatry; Antibody","score_opus":0.07486988523451742,"score_gpt":0.4375092928538907,"score_spread":0.36263940761937324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1941012103","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022566794,0.029581526,0.00007393878,0.016309507,0.9494769,0.0034975775,0.0006591696,0.00011834934,0.00005737123],"genre_scores_gemma":[0.00033241304,0.029786132,0.00014435072,0.015298711,0.94958645,0.0009908349,0.0013256493,0.00012784678,0.0024076167],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960112,0.0003145266,0.0005145869,0.0010172615,0.0012409672,0.00090146],"domain_scores_gemma":[0.9941849,0.0035409743,0.00024147774,0.00051857345,0.0005569056,0.00095715484],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010161598,0.0005970703,0.0007712796,0.00021069164,0.00024637298,0.000074447365,0.00043217422,0.00047343833,0.00022714364],"category_scores_gemma":[0.00005155091,0.00056183565,0.00029198005,0.00013772392,0.0003381037,0.00017827649,0.00035877564,0.0008191484,0.000058510857],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066655097,0.00038328927,0.000042177744,0.0015955872,0.0077817272,0.00006115322,0.00004541276,0.0000013953473,0.004083314,0.000021643165,0.97783047,0.0014883112],"study_design_scores_gemma":[0.005169006,0.0013104391,0.000032552885,0.00037624,0.027993882,0.0000015671276,0.000023394567,0.00027626354,0.0007421367,0.0001493179,0.96346486,0.00046036462],"about_ca_topic_score_codex":0.000023960058,"about_ca_topic_score_gemma":0.0000048212614,"teacher_disagreement_score":0.020212155,"about_ca_system_score_codex":0.00028925308,"about_ca_system_score_gemma":0.00093589566,"threshold_uncertainty_score":0.9996833},"labels":[],"label_agreement":null},{"id":"W1951049318","doi":"10.1111/apt.13347","title":"Liver injury is associated with mortality in sickle cell disease","year":2015,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Allergy and Infectious Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Medicine; Internal medicine; Gastroenterology; Ferritin; Haemolysis; Liver function tests; Bilirubin; Liver function; Liver disease; Portal hypertension; Cirrhosis; Chronic liver disease; Fibrosis; Pathology; Immunology","score_opus":0.0374239328660533,"score_gpt":0.3167563842523916,"score_spread":0.27933245138633833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1951049318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912787,0.0028270835,0.000004203918,0.003789856,0.00033016046,0.00055699534,0.000047598896,0.00006785556,0.0010975451],"genre_scores_gemma":[0.9417567,0.0009783622,0.000037549387,0.056468554,0.00005629825,0.000025850664,0.000100908714,0.00003361508,0.00054211786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862725,0.00015796788,0.0002546342,0.0002954535,0.0002669249,0.00039776447],"domain_scores_gemma":[0.99924904,0.000041019342,0.000088197536,0.00019488011,0.00007872296,0.00034813152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021809583,0.00021960118,0.00029107527,0.00009063135,0.000053582287,0.0000071090976,0.00010784861,0.00013791253,0.000502893],"category_scores_gemma":[3.349948e-7,0.00017680871,0.00006572308,0.00027383852,0.0001950334,0.00008610693,0.00004879091,0.00038927686,0.00006756495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047950745,0.006376217,0.9401767,0.000077678655,0.010092197,0.0022467184,0.0043215742,0.00015698432,0.01580096,0.000011590013,0.014909922,0.0010343746],"study_design_scores_gemma":[0.09372447,0.009953151,0.52196544,0.00045424417,0.1034513,0.00011960617,0.006803553,0.018947462,0.15672955,0.0008704549,0.08369462,0.0032861365],"about_ca_topic_score_codex":0.00016807171,"about_ca_topic_score_gemma":0.000020862988,"teacher_disagreement_score":0.41821125,"about_ca_system_score_codex":0.00021594722,"about_ca_system_score_gemma":0.00029592996,"threshold_uncertainty_score":0.721005},"labels":[],"label_agreement":null},{"id":"W1963621196","doi":"10.1111/j.1365-2036.2009.04219.x","title":"The pharmacodynamics and pharmacokinetics of S‐tenatoprazole‐Na 30 mg, 60 mg and 90 mg vs. esomeprazole 40 mg in healthy male subjects","year":2010,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; University of Toronto; McMaster University; Population Health Research Institute","funders":"Eisai; Allergan; AstraZeneca Canada; Abbott Laboratories","keywords":"Esomeprazole; Pharmacodynamics; Medicine; Pharmacokinetics; Crossover study; Internal medicine; Gastroenterology; Pharmacology; Placebo","score_opus":0.013990705502871502,"score_gpt":0.32232385409147535,"score_spread":0.30833314858860383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963621196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886487,0.0041017383,0.000006827384,0.0042552073,0.0012967124,0.0012178369,0.000082581384,0.000052588268,0.00033776578],"genre_scores_gemma":[0.9717384,0.012052538,0.00043103338,0.015107893,0.00022046173,0.00008258118,0.0000716906,0.000076038734,0.00021939349],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9971951,0.00021891484,0.0007159157,0.000592067,0.0003835371,0.0008944611],"domain_scores_gemma":[0.9984253,0.00040267818,0.00029369505,0.00035701744,0.00011627366,0.0004050389],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005130615,0.00051260885,0.0006421987,0.00021767577,0.00029772043,0.000030025165,0.00028084437,0.00021171171,0.00036128084],"category_scores_gemma":[0.0000015224816,0.0004038056,0.00010675849,0.0002910286,0.0007325234,0.00015427067,0.00021532281,0.0010587837,0.00001964752],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049523995,0.0019566836,0.33963615,0.00021562593,0.005567889,0.0010885048,0.0009694554,0.000018336981,0.62881094,0.00009289995,0.00037839962,0.016312718],"study_design_scores_gemma":[0.09028849,0.0070837867,0.43922234,0.000113929025,0.023721324,0.0023892105,0.0007268049,0.025207052,0.38757497,0.0005839294,0.021877917,0.0012102425],"about_ca_topic_score_codex":0.0000684351,"about_ca_topic_score_gemma":0.00004691293,"teacher_disagreement_score":0.24123597,"about_ca_system_score_codex":0.00010598578,"about_ca_system_score_gemma":0.00016247507,"threshold_uncertainty_score":0.9998414},"labels":[],"label_agreement":null},{"id":"W1963849816","doi":"10.1111/j.1365-2036.2004.01876.x","title":"Osteoporosis and inflammatory bowel disease","year":2004,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Microscopic Colitis","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research; Crohn's and Colitis Foundation of Canada; Crohn's and Colitis Foundation","keywords":"Medicine; Bone mineral; Inflammatory bowel disease; Osteoporosis; Vitamin D and neurology; Population; Bone density; Bone disease; Internal medicine; Disease; vitamin D deficiency; Gastroenterology; Environmental health","score_opus":0.040563044838317144,"score_gpt":0.3723726240132815,"score_spread":0.33180957917496434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963849816","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013179164,0.99432045,0.0000014298654,0.00073419075,0.001047874,0.0021701627,0.00017554782,0.000107936394,0.00012448306],"genre_scores_gemma":[0.00006462058,0.9858547,0.0001694523,0.012036863,0.0004494583,0.00024192197,0.0003936313,0.000120415534,0.0006689314],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997791,0.00019432795,0.00066093705,0.00062109117,0.00021683733,0.0005158352],"domain_scores_gemma":[0.9986708,0.00013704713,0.00025882933,0.00042741862,0.000042930893,0.00046294148],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013658259,0.0006191271,0.0012701128,0.00021183808,0.00012611058,0.00002109673,0.0002092516,0.0003134744,0.001316165],"category_scores_gemma":[2.3076363e-7,0.0005592073,0.00035637635,0.00013062899,0.00035267012,0.000065846325,0.0002080104,0.0006556585,0.00013174888],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064423855,0.0015623987,0.002443194,0.12007786,0.065079294,0.0033341367,0.0009811386,0.0000012160294,0.0007521544,0.00013126727,0.0028237111,0.8021694],"study_design_scores_gemma":[0.0019091495,0.00019188477,0.00022289134,0.0044416785,0.09264807,0.000252496,0.000017645574,0.0000020348746,0.00006650953,0.000039974402,0.89979935,0.00040834578],"about_ca_topic_score_codex":0.000025455678,"about_ca_topic_score_gemma":0.000003004485,"teacher_disagreement_score":0.89697564,"about_ca_system_score_codex":0.00051579584,"about_ca_system_score_gemma":0.001018192,"threshold_uncertainty_score":0.99968594},"labels":[],"label_agreement":null},{"id":"W1963918477","doi":"10.1046/j.1365-2036.2000.00737.x","title":"The effects of omeprazole on healing and appearance of small gastric and duodenal lesions during dosing with diclofenac in healthy subjects","year":2000,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Omeprazole; Diclofenac; Medicine; Placebo; Gastroenterology; Duodenum; Lesion; Internal medicine; Anesthesia; Surgery; Pathology","score_opus":0.010528160196663139,"score_gpt":0.27371986400875037,"score_spread":0.26319170381208723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963918477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99077904,0.0076784045,0.0000027496967,0.00072552357,0.00013270402,0.00064328325,0.000002175259,0.000012570589,0.000023570621],"genre_scores_gemma":[0.99024904,0.007517315,0.00007917112,0.0020316783,0.000066317305,0.000023117169,0.0000019389784,0.000020090572,0.000011346403],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988839,0.00018282559,0.0002743731,0.00020246246,0.00014120698,0.0003152287],"domain_scores_gemma":[0.9992335,0.00041894818,0.000106885185,0.00012096791,0.000020501757,0.00009920427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026082885,0.00016129004,0.00031365262,0.00010839467,0.00015174977,0.0000039620672,0.000056731686,0.000058823407,0.0000085389365],"category_scores_gemma":[6.4732006e-7,0.00011207896,0.000026971982,0.00017625696,0.00025173163,0.000035157314,0.000020627478,0.00026662418,7.58811e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022192223,0.0007522742,0.2686423,0.0019180563,0.0019617775,0.00027822272,0.0025960258,0.00025010487,0.6770371,0.000022725912,0.000010204634,0.024338953],"study_design_scores_gemma":[0.018174188,0.0061217844,0.40721604,0.0011156022,0.0020058928,0.00024339683,0.000208914,0.0011009619,0.56336737,0.000021325308,0.00017246885,0.0002520491],"about_ca_topic_score_codex":0.00005950211,"about_ca_topic_score_gemma":0.000022557753,"teacher_disagreement_score":0.13857372,"about_ca_system_score_codex":0.000044155742,"about_ca_system_score_gemma":0.00005978337,"threshold_uncertainty_score":0.45704475},"labels":[],"label_agreement":null},{"id":"W1964759577","doi":"10.1111/j.1365-2036.2004.02239.x","title":"Review article: sleep and its relationship to gastro‐oesophageal reflux","year":2004,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital","funders":"","keywords":"GERD; Medicine; Reflux; Heartburn; Swallowing; Internal medicine; Gastroenterology; Sleep (system call); Saliva; Gastric emptying; Nocturnal; Obstructive sleep apnea; Apnea; Gastro-; Disease; Stomach; Surgery","score_opus":0.09159279093797568,"score_gpt":0.4229230013450678,"score_spread":0.3313302104070921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964759577","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00099527,0.99338967,0.00000449476,0.0011470405,0.0005216233,0.0036205729,0.00010919572,0.00010446495,0.00010766293],"genre_scores_gemma":[0.0025042596,0.96437836,0.00066882384,0.030597378,0.000287319,0.00042489878,0.00043220437,0.00012506224,0.00058169727],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99695164,0.00036641984,0.00089816516,0.00076987833,0.00030441323,0.00070946815],"domain_scores_gemma":[0.9984075,0.00022768838,0.00029587196,0.00040887462,0.00008852328,0.0005715306],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030263298,0.0007647198,0.0019223669,0.00024693468,0.00018739152,0.000018568033,0.000228252,0.00029810658,0.00060684653],"category_scores_gemma":[0.0000017689167,0.0006150999,0.00039437955,0.00047948858,0.00009430212,0.000104847604,0.00016008789,0.00083511404,0.0008998516],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033261557,0.0031541735,0.005507175,0.13075684,0.06655571,0.006493651,0.0003450012,0.000004005316,0.00014761761,0.00016705165,0.0035945491,0.78294164],"study_design_scores_gemma":[0.004434165,0.002183106,0.0011478339,0.028350886,0.23086227,0.0021125397,0.000006795503,0.000006262757,0.00018138859,0.000058410344,0.73012173,0.0005346341],"about_ca_topic_score_codex":0.0000026989612,"about_ca_topic_score_gemma":4.652982e-7,"teacher_disagreement_score":0.782407,"about_ca_system_score_codex":0.0005123805,"about_ca_system_score_gemma":0.0002889466,"threshold_uncertainty_score":0.99987805},"labels":[],"label_agreement":null},{"id":"W1964829068","doi":"10.1111/j.1365-2036.2005.02490.x","title":"Systematic review: the efficacy of intermittent and on‐demand therapy with histamine H<sub>2</sub>‐receptor antagonists or proton pump inhibitors for gastro‐oesophageal reflux disease patients","year":2005,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Omeprazole; Heartburn; Medicine; Lansoprazole; Ranitidine; Proton-pump inhibitor; Cimetidine; Gastroenterology; Internal medicine; Famotidine; Esomeprazole; Rabeprazole; Histamine H2 receptor; Reflux; Esophagitis; Disease; Antagonist; Receptor","score_opus":0.03324886826751101,"score_gpt":0.3517205219018935,"score_spread":0.3184716536343825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964829068","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034949273,0.9344374,0.000002856868,0.0003955714,0.0004333776,0.02924191,0.0004895169,0.000046980545,0.000003131855],"genre_scores_gemma":[0.008121963,0.97808105,0.000064151296,0.006902114,0.0003460916,0.004883106,0.0013000253,0.0001748344,0.00012665345],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9957947,0.000656475,0.0015090432,0.0008026314,0.0005651142,0.0006720053],"domain_scores_gemma":[0.9967989,0.0006962342,0.0012741317,0.00066430226,0.00018332999,0.0003831536],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042916852,0.0010769006,0.003074873,0.00020143419,0.00020362595,0.000024261766,0.00035793718,0.00018333175,0.000051754258],"category_scores_gemma":[0.0000050148137,0.0005256706,0.0006301296,0.00023932022,0.0004045891,0.00008246277,0.00009529553,0.00049752556,0.000019327354],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009044872,0.010047688,0.0022036775,0.7433127,0.06316254,0.0004267089,0.00025301107,8.3227445e-7,0.00016153882,0.0000025539052,0.0017847313,0.16959913],"study_design_scores_gemma":[0.041745055,0.03139821,0.0010288992,0.39252084,0.37371185,0.00031223486,0.000035158788,0.000018105673,0.005876399,0.000002914033,0.1521198,0.0012305224],"about_ca_topic_score_codex":0.0000010934064,"about_ca_topic_score_gemma":4.2468076e-7,"teacher_disagreement_score":0.35079187,"about_ca_system_score_codex":0.00043149755,"about_ca_system_score_gemma":0.00032668206,"threshold_uncertainty_score":0.9997195},"labels":[],"label_agreement":null},{"id":"W1965137158","doi":"10.1046/j.1365-2036.2001.01134.x","title":"<i>Helicobacter pylori</i> eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage","year":2001,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Helicobacter pylori; Incidence (geometry); Surgery; Spirillaceae; Maintenance therapy; Internal medicine; Gastroenterology; Helicobacter pylori infection; Randomized controlled trial; Chemotherapy; Gastritis","score_opus":0.06727944541103131,"score_gpt":0.37362174128173664,"score_spread":0.30634229587070533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965137158","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033095576,0.90768427,0.00031025143,0.042845506,0.0023881767,0.012746494,0.0003766357,0.000399013,0.00015405574],"genre_scores_gemma":[0.00042235438,0.79091334,0.0017378422,0.20090348,0.000995908,0.0018275842,0.00022548434,0.0003815883,0.0025924158],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99384296,0.00065257185,0.0015014488,0.0017057876,0.0006081081,0.0016891272],"domain_scores_gemma":[0.997084,0.00019765875,0.0005296117,0.0011001264,0.0003466663,0.0007419131],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00049082923,0.0016299698,0.003371268,0.0005895515,0.00029166086,0.000053242267,0.00072255847,0.0006216377,0.0019250237],"category_scores_gemma":[0.0000011737367,0.0010965229,0.00049559574,0.0011545909,0.00033645317,0.00017495286,0.00026553744,0.00146323,0.00067573466],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013359719,0.0037194248,0.0069645843,0.0026245848,0.12529588,0.0010958922,0.009446336,0.000014550965,0.001916026,0.00000169679,0.019490773,0.81607056],"study_design_scores_gemma":[0.0041436185,0.0039485847,0.0001678392,0.0025876064,0.028331202,0.0011701663,0.00017514436,0.000011635797,0.00065632624,0.0000010836618,0.9579109,0.0008958895],"about_ca_topic_score_codex":0.00008890498,"about_ca_topic_score_gemma":0.00007355125,"teacher_disagreement_score":0.9384201,"about_ca_system_score_codex":0.0009777774,"about_ca_system_score_gemma":0.0005330509,"threshold_uncertainty_score":0.99964476},"labels":[],"label_agreement":null},{"id":"W1965543988","doi":"10.1111/j.1365-2036.2006.02874.x","title":"Healing rates for moderate and severe oesophagitis: author's reply","year":2006,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Esomeprazole; Omeprazole; Medicine; Internal medicine; Gastroenterology; Surgery","score_opus":0.03416564188138811,"score_gpt":0.36515465569448324,"score_spread":0.33098901381309515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965543988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987708,0.0037249967,0.00019491253,0.00638512,0.00047311882,0.0010609225,0.00009312483,0.00010903707,0.00025078034],"genre_scores_gemma":[0.9642621,0.00021059999,0.0035001852,0.029767437,0.00035032473,0.00012302361,0.00026178465,0.00004808291,0.0014764467],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986636,0.00006615087,0.00031025766,0.00038813206,0.00012788546,0.00044399465],"domain_scores_gemma":[0.9994417,0.000118420496,0.0000927026,0.00014656527,0.00007301986,0.00012759602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013537468,0.00025886085,0.00033713816,0.00007922173,0.00022441108,0.00002359982,0.00006227794,0.000085349784,0.0001124741],"category_scores_gemma":[1.6647414e-7,0.00022779661,0.00008983124,0.00007720248,0.00011357532,0.00010031146,0.000035038003,0.00015329383,0.000013146297],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014663706,0.0067938487,0.62805563,0.00072547264,0.062298603,0.003885336,0.0015917539,0.0009281881,0.22864603,0.0011006936,0.02643531,0.024875425],"study_design_scores_gemma":[0.053234056,0.0063883085,0.09556701,0.000103170125,0.048260815,0.0018401269,0.00026804634,0.013723017,0.74856484,0.0102147665,0.02093181,0.0009040626],"about_ca_topic_score_codex":0.00005320083,"about_ca_topic_score_gemma":0.000002756008,"teacher_disagreement_score":0.53248864,"about_ca_system_score_codex":0.00008651904,"about_ca_system_score_gemma":0.000057443154,"threshold_uncertainty_score":0.92892766},"labels":[],"label_agreement":null},{"id":"W1965901564","doi":"10.1111/apt.12073","title":"Impact of <i>Clostridium difficile</i> colitis on 5‐year health outcomes in patients with ulcerative colitis","year":2012,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research; Centers for Disease Control and Prevention; Institute for Clinical Evaluative Sciences","keywords":"Medicine; Colectomy; Ulcerative colitis; Internal medicine; Hazard ratio; Population; Clostridium Difficile Colitis; Odds ratio; Clostridium difficile; Cohort study; Retrospective cohort study; Colitis; Cohort; Adverse effect; Mortality rate; Confidence interval; Environmental health; Disease","score_opus":0.03090693798618136,"score_gpt":0.3615683211903252,"score_spread":0.33066138320414384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965901564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945897,0.00022152229,0.0000016574662,0.0021156056,0.0003139493,0.0017433751,0.0005404016,0.000038913848,0.00043489342],"genre_scores_gemma":[0.99353766,0.00040097753,0.00007117687,0.005298225,0.00017045201,0.00007024478,0.00027299137,0.00006516235,0.0001131271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968474,0.00036329508,0.0006151887,0.00038024093,0.0006552848,0.0011385954],"domain_scores_gemma":[0.9985004,0.00028360126,0.00023192326,0.00035302184,0.00018534382,0.00044568162],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000317302,0.00042298844,0.00087487645,0.00031685265,0.000111540285,0.000010238288,0.00018129648,0.00014039378,0.00094478525],"category_scores_gemma":[0.0000012710684,0.00032239076,0.00021274551,0.00046171632,0.00026787227,0.00012548894,0.00007986063,0.00059296074,0.00004875662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015264754,0.009016103,0.9627344,0.000062174746,0.0060807928,0.000021631395,0.0007769949,0.00002251081,0.0037149156,0.00003884039,0.0013350846,0.0009318171],"study_design_scores_gemma":[0.013648577,0.010969224,0.91552055,0.00006687555,0.0010107236,0.000010889743,0.00020062388,0.000016402313,0.057908148,0.000003576868,0.00036244022,0.00028198372],"about_ca_topic_score_codex":0.00053727056,"about_ca_topic_score_gemma":0.00003214429,"teacher_disagreement_score":0.054193232,"about_ca_system_score_codex":0.0011683231,"about_ca_system_score_gemma":0.000484321,"threshold_uncertainty_score":0.99996847},"labels":[],"label_agreement":null},{"id":"W1966080857","doi":"10.1111/j.1365-2036.2006.02983.x","title":"Predictors of treatment response in patients with non‐erosive reflux disease","year":2006,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Heartburn; Medicine; Nerd; Esomeprazole; Reflux; Proton-pump inhibitor; Internal medicine; Gastroenterology; Omeprazole; GERD; Esophagitis; Disease","score_opus":0.011029188775317968,"score_gpt":0.28453624213461065,"score_spread":0.2735070533592927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966080857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99803305,0.00016010295,0.0000026687235,0.00032289358,0.00018304607,0.0010665134,0.00012481003,0.000025823841,0.0000811134],"genre_scores_gemma":[0.99734,0.000043337495,0.00016803862,0.0015861135,0.000060299146,0.00009144754,0.0003142364,0.00003485685,0.00036163678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986762,0.00014094877,0.00032234535,0.00030129106,0.00021458823,0.0003446669],"domain_scores_gemma":[0.99934924,0.000083456296,0.00012436051,0.00022346374,0.000069087466,0.00015042062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006965292,0.0002674481,0.00035168751,0.00016650178,0.00004662539,0.0000034899542,0.00007441771,0.000059168455,0.00013853364],"category_scores_gemma":[1.4518304e-7,0.00019252997,0.00008283246,0.00017281943,0.00016184026,0.00007025491,0.000023711216,0.000101274105,0.00001457061],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021303602,0.004093677,0.9643141,0.000013383489,0.0034075005,0.00033691907,0.00013327057,0.00008982001,0.0061166184,0.0000013309034,0.000050992036,0.00013880183],"study_design_scores_gemma":[0.018964784,0.008063221,0.94369084,0.000021711585,0.006784469,0.000002532706,0.000014558768,0.000028881408,0.022165164,0.000009109894,0.00017592793,0.000078777244],"about_ca_topic_score_codex":0.000061519444,"about_ca_topic_score_gemma":0.0000044091767,"teacher_disagreement_score":0.020623226,"about_ca_system_score_codex":0.0004764449,"about_ca_system_score_gemma":0.0001763839,"threshold_uncertainty_score":0.78511447},"labels":[],"label_agreement":null},{"id":"W1966097130","doi":"10.1046/j.1365-2036.2003.01611.x","title":"The mechanisms of prednisone inhibition of inflammation in Crohn's disease involve changes in intestinal permeability, mucosal TNFα production and nuclear factor kappa B expression","year":2003,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; McGill University","funders":"Fonds de Recherche du Québec - Santé; Crohn's and Colitis Foundation of Canada; Crohn's and Colitis Foundation","keywords":"Medicine; Gastroenterology; Prednisone; Internal medicine; Crohn's disease; Intestinal permeability; Tumor necrosis factor alpha; Inflammatory bowel disease; Immunology; Disease","score_opus":0.015200458545321576,"score_gpt":0.2656437410471547,"score_spread":0.2504432825018331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966097130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982892,0.0003525694,0.000023840768,0.00046133195,0.0001886641,0.0006446997,0.00002363695,0.000006795712,0.000009242497],"genre_scores_gemma":[0.9989489,0.00044562193,0.00017099237,0.00025757265,0.000052548243,0.000058159792,0.00004080992,0.000018163066,0.0000072826892],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99870175,0.00040106598,0.00031292922,0.00027107834,0.00012603423,0.00018714045],"domain_scores_gemma":[0.99948484,0.000030063145,0.00017734799,0.00017947593,0.00007299261,0.0000552708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032015235,0.00014954057,0.00012620383,0.00007640274,0.00006567488,0.000006552522,0.000088499735,0.00008584843,0.000025806285],"category_scores_gemma":[0.000008352262,0.00013265814,0.00003240062,0.00007858251,0.0002385359,0.000018160494,0.000079083315,0.00010998203,5.4716384e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012780648,0.00021672904,0.025206078,0.00007595551,0.00010449476,0.000014036712,0.00039629714,0.000064079366,0.9721558,0.0001513827,0.000011264792,0.0003258181],"study_design_scores_gemma":[0.001004032,0.00015969283,0.11910835,0.000042451018,0.00018819653,0.0000034931375,0.0004115336,0.0001701672,0.8778546,0.0008410218,0.00009112022,0.00012533028],"about_ca_topic_score_codex":0.000008301689,"about_ca_topic_score_gemma":0.00013230085,"teacher_disagreement_score":0.09430119,"about_ca_system_score_codex":0.000042101885,"about_ca_system_score_gemma":0.00006912063,"threshold_uncertainty_score":0.5409642},"labels":[],"label_agreement":null},{"id":"W1966300375","doi":"10.1111/j.1365-2036.2012.05188.x","title":"Randomised clinical trial: pre‐dosing with taribavirin before starting pegylated interferon vs. standard combination regimen in treatment‐naïve patients with chronic hepatitis C genotype 1","year":2012,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Valeant Pharmaceuticals International; Genentech; Vertex Pharmaceuticals; Gilead Sciences; Bristol-Myers Squibb","keywords":"Medicine; Regimen; Dosing; Pegylated interferon; Internal medicine; Gastroenterology; Ribavirin; Hepatitis C; Clinical trial; Chronic hepatitis; Genotype; Pharmacology; Virology; Virus","score_opus":0.051962284321419326,"score_gpt":0.3926172085960663,"score_spread":0.340654924274647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966300375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99209887,0.0006268949,0.000064824795,0.001090235,0.0004949654,0.0053631407,0.0000471482,0.000087657776,0.00012629214],"genre_scores_gemma":[0.995118,0.0007592949,0.00047097373,0.0022765766,0.00028280815,0.00031743335,0.00053148903,0.000102572914,0.00014084893],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961716,0.0009670654,0.00089941226,0.00048627585,0.0005648447,0.0009108371],"domain_scores_gemma":[0.9984871,0.00032552573,0.00034095283,0.00033209333,0.00021299261,0.00030131423],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008885353,0.00041001113,0.00083441,0.0002481286,0.00016506533,0.000029619914,0.00016289075,0.00020928704,0.00050676864],"category_scores_gemma":[0.000003017224,0.0003073828,0.00010777119,0.00034923316,0.00031473726,0.00037470873,0.00007129522,0.00061561645,0.00002484],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27664974,0.0023218908,0.6967446,0.000029086797,0.0046720826,0.00003947227,0.0014493047,0.000013533941,0.00089615845,0.000002299369,0.00008297313,0.01709883],"study_design_scores_gemma":[0.6625584,0.064228304,0.2476346,0.00019321153,0.006460683,0.000007307116,0.00006422582,0.0012668977,0.012451155,0.000013531598,0.004649763,0.00047194588],"about_ca_topic_score_codex":0.0007797096,"about_ca_topic_score_gemma":0.0011463901,"teacher_disagreement_score":0.44911003,"about_ca_system_score_codex":0.001980458,"about_ca_system_score_gemma":0.00046590366,"threshold_uncertainty_score":0.99993783},"labels":[],"label_agreement":null},{"id":"W1966302438","doi":"10.1046/j.1365-2036.2001.00831.x","title":"Duration of effect of lansoprazole on gastric pH and acid secretion in normal male volunteers","year":2001,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Lansoprazole; Gastrin; Gastric acid; Placebo; Pentagastrin; Medicine; Internal medicine; Pharmacokinetics; Endocrinology; Omeprazole; Chemistry; Gastroenterology; Secretion; Pharmacology","score_opus":0.015031386090013601,"score_gpt":0.2944080026832254,"score_spread":0.27937661659321184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966302438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996657,0.000548574,0.000021549753,0.0018632736,0.0002566495,0.0004570042,0.000013272692,0.000016517077,0.00016617344],"genre_scores_gemma":[0.99541014,0.0013920934,0.00006960595,0.0029346538,0.000057516867,0.000024788258,0.00005180604,0.000014874624,0.000044518714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883515,0.00021151602,0.00037573196,0.0001929749,0.00013125928,0.0002533678],"domain_scores_gemma":[0.9995638,0.000099767196,0.00013182258,0.00010649741,0.00004832771,0.000049792736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002561968,0.00017179613,0.00036883855,0.00022845804,0.000031905332,0.0000013995134,0.00005877187,0.00010498677,0.00015716179],"category_scores_gemma":[7.775456e-7,0.00015261926,0.000046848796,0.00020768464,0.00019853818,0.00007113751,0.00003564964,0.00025719492,0.000006893609],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031276569,0.000192072,0.5867514,0.00003494103,0.001648071,0.00003253309,0.0003195154,0.00002658662,0.407065,0.0000010378699,0.000044672128,0.00075653935],"study_design_scores_gemma":[0.011653425,0.008464178,0.5232101,0.00007386401,0.00481392,0.00032010974,0.00015286739,0.0009230891,0.44991356,0.0000033791248,0.00034599312,0.00012549308],"about_ca_topic_score_codex":0.000047154575,"about_ca_topic_score_gemma":0.000021277554,"teacher_disagreement_score":0.063541256,"about_ca_system_score_codex":0.00007067942,"about_ca_system_score_gemma":0.000016559196,"threshold_uncertainty_score":0.6223633},"labels":[],"label_agreement":null},{"id":"W1968552480","doi":"10.1111/apt.12007","title":"Partial symptom‐response to proton pump inhibitors in patients with non‐erosive reflux disease or reflux oesophagitis – a <i>post hoc</i> analysis of 5796 patients","year":2012,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Cilag; Eisai; AstraZeneca; Pfizer","keywords":"Heartburn; Medicine; Reflux; Esomeprazole; Internal medicine; Gastroenterology; Omeprazole; GERD; Proton-pump inhibitor; Pantoprazole; Reflux esophagitis; Esophagitis; Disease","score_opus":0.012545650162113436,"score_gpt":0.30525241467654113,"score_spread":0.2927067645144277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968552480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99465436,0.000107832086,0.0000043524137,0.00041549193,0.00039944876,0.003832817,0.0005273673,0.00003924649,0.000019074294],"genre_scores_gemma":[0.9882037,0.000032994743,0.00019406306,0.009726634,0.00010089792,0.0006573685,0.0008792076,0.00007238022,0.00013275555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967275,0.00038824393,0.0007358573,0.00056709617,0.00067785784,0.00090340513],"domain_scores_gemma":[0.99802554,0.00014879322,0.00031284118,0.0004462356,0.00030457298,0.00076201645],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002723309,0.0005133001,0.00084627763,0.00071990944,0.000110731475,0.000013466071,0.00020206113,0.0001315254,0.00048618374],"category_scores_gemma":[0.000003355075,0.00037877704,0.00022129911,0.0012265602,0.00018788129,0.00029959148,0.00017289752,0.00026657162,0.000052494703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05540818,0.0073515708,0.91614944,0.00004905659,0.014302245,0.00015289815,0.001180104,0.00003853331,0.0043734526,4.330761e-7,0.000054479533,0.00093959074],"study_design_scores_gemma":[0.016724465,0.008178787,0.90802956,0.000054967342,0.028432483,0.0000014727092,0.000047636975,0.000029079078,0.038073752,9.196293e-7,0.0002193697,0.00020750149],"about_ca_topic_score_codex":0.000035296966,"about_ca_topic_score_gemma":0.0000068323707,"teacher_disagreement_score":0.038683716,"about_ca_system_score_codex":0.0004476821,"about_ca_system_score_gemma":0.00019638015,"threshold_uncertainty_score":0.9998664},"labels":[],"label_agreement":null},{"id":"W1968590038","doi":"10.1111/apt.12732","title":"Letter: treatment of <scp>HB</scp>eAg+ chronic hepatitis B – is tenofovir truly superior to entecavir?","year":2014,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Gilead Sciences; Bristol-Myers Squibb","keywords":"Entecavir; Medicine; Tenofovir; HBeAg; Internal medicine; Chronic hepatitis; Gastroenterology; Hepatitis B; Prospective cohort study; Retrospective cohort study; Hepatitis B virus; Immunology; HBsAg; Virus; Lamivudine; Human immunodeficiency virus (HIV)","score_opus":0.04054535250595682,"score_gpt":0.32383804480256495,"score_spread":0.28329269229660814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968590038","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24501686,0.01103802,0.000042998694,0.7339953,0.003706753,0.0039314716,0.0011952819,0.00023765092,0.0008356515],"genre_scores_gemma":[0.023050884,0.02003499,0.0004353847,0.94184923,0.008496839,0.0007281918,0.00081180845,0.00026084384,0.004331815],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.994832,0.0004905545,0.0012294999,0.0012049713,0.00078337686,0.0014596197],"domain_scores_gemma":[0.9973684,0.0007015463,0.00046122,0.0009675157,0.00022654643,0.00027477293],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018668892,0.0012538224,0.002248879,0.0005399706,0.00024737426,0.00002654042,0.0005333048,0.0009180992,0.0013611497],"category_scores_gemma":[0.0000012687443,0.0011352584,0.0006903603,0.00033089312,0.0005666093,0.00009304192,0.00021243781,0.0011278145,0.0007551248],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010343786,0.0006506738,0.026785051,0.00034862192,0.031124339,0.0011441696,0.0021944765,0.0000027715055,0.044827037,9.299085e-7,0.88790643,0.004912068],"study_design_scores_gemma":[0.0039268783,0.0066503286,0.0014602686,0.00013570719,0.022766039,0.0001414151,0.000016072612,0.00003902462,0.10210697,0.000009084739,0.86239654,0.0003516613],"about_ca_topic_score_codex":0.00290689,"about_ca_topic_score_gemma":0.00034519954,"teacher_disagreement_score":0.22196597,"about_ca_system_score_codex":0.0018120134,"about_ca_system_score_gemma":0.00039270098,"threshold_uncertainty_score":0.9995517},"labels":[],"label_agreement":null},{"id":"W1968763379","doi":"10.1111/j.1365-2036.2009.04120.x","title":"Inaccurate endoscopy: a better explanation for placebo‐associated endoscopic ulcers: authors’ reply","year":2009,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Pain Management and Placebo Effect","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Endoscopy; Placebo; Internal medicine; Pathology; Alternative medicine","score_opus":0.06126367054767927,"score_gpt":0.34865367076618714,"score_spread":0.28739000021850786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968763379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94213486,0.00029611078,0.0037911872,0.041487094,0.004068359,0.004831497,0.0001550333,0.00068781467,0.0025480574],"genre_scores_gemma":[0.80935144,0.00029720934,0.00040257417,0.18862058,0.00026133048,0.00021819565,0.00010971605,0.000033202698,0.00070574874],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965012,0.0015307528,0.0003951993,0.00062083546,0.00026672462,0.0006853065],"domain_scores_gemma":[0.9973089,0.0020546974,0.00026167388,0.00023613518,0.000035985344,0.000102574755],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014353242,0.00034409904,0.00030531737,0.00021315229,0.00036832373,0.000069751666,0.00043788526,0.00012454609,0.00028835784],"category_scores_gemma":[0.000011718492,0.00034485178,0.00012863614,0.00031806206,0.00009642786,0.00035096696,0.000047724432,0.0002914073,0.00008088897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001113074,0.00038252643,0.0013611753,0.000018799125,0.0010705825,0.00004192795,0.0006039105,0.00006652249,0.9714922,0.0001948663,0.017261785,0.006392682],"study_design_scores_gemma":[0.008028254,0.0011379096,0.0009834863,0.000025992456,0.0031324625,0.0000053481867,0.00008152541,0.0144923,0.90635824,0.0021350717,0.06310241,0.00051697914],"about_ca_topic_score_codex":0.000011585731,"about_ca_topic_score_gemma":0.0000039375163,"teacher_disagreement_score":0.14713348,"about_ca_system_score_codex":0.00019578762,"about_ca_system_score_gemma":0.000039948107,"threshold_uncertainty_score":0.99990034},"labels":[],"label_agreement":null},{"id":"W1969326488","doi":"10.1111/j.1365-2036.2006.02996.x","title":"Systematic review: the impact of gastro‐oesophageal reflux disease on work productivity","year":2006,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"AstraZeneca","keywords":"Presenteeism; Absenteeism; Medicine; Reflux; Disease; Gastro-; Productivity; Medical prescription; Internal medicine; Population; Physical therapy; Environmental health; Psychology","score_opus":0.04966169304694141,"score_gpt":0.4146028432788816,"score_spread":0.3649411502319402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969326488","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008798405,0.9890642,0.0000010134348,0.00032257673,0.0004533862,0.00882634,0.00031061147,0.000060592283,0.000081418206],"genre_scores_gemma":[0.0056481296,0.9879477,0.000026010168,0.0030815757,0.0004001736,0.0009371987,0.0009540179,0.00013357331,0.0008716286],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9952021,0.0014189364,0.0013946007,0.0007280172,0.00057725515,0.000679089],"domain_scores_gemma":[0.99671674,0.00047878711,0.0011814054,0.0012146228,0.000117623196,0.00029084348],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006022034,0.001032685,0.0039329696,0.00019819931,0.00015157768,0.000013844308,0.0005031975,0.00015544335,0.00021993007],"category_scores_gemma":[0.0000029257528,0.00052837934,0.0019822072,0.00057115173,0.0003083485,0.00006200663,0.00011360269,0.0008642244,0.00015578023],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054817006,0.0052557746,0.001957741,0.8578859,0.10983792,0.0021850325,0.00003634882,0.000009908502,0.00000721039,0.0000037880513,0.009345253,0.0129269855],"study_design_scores_gemma":[0.002602204,0.003007111,0.00170998,0.3019084,0.6735111,0.00040006012,0.000003393373,0.0000046713403,0.000044519486,0.00001834706,0.01631018,0.00048003474],"about_ca_topic_score_codex":0.00001581344,"about_ca_topic_score_gemma":2.0151668e-7,"teacher_disagreement_score":0.56367314,"about_ca_system_score_codex":0.0006785796,"about_ca_system_score_gemma":0.00047619114,"threshold_uncertainty_score":0.99971676},"labels":[],"label_agreement":null},{"id":"W1969391248","doi":"10.1111/j.1365-2036.2008.03855.x","title":"The effect of naloxone‐3‐glucuronide on colonic transit time in healthy men after acute morphine administration: a placebo‐controlled double‐blinded crossover preclinical volunteer study","year":2008,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Peter's Hospital","funders":"Inselspital, Universitätsspital Bern; Bundesamt für Gesundheit; University of Bern","keywords":"Medicine; Placebo; Morphine; Crossover study; Opioid; Anesthesia; (+)-Naloxone; Volunteer; Pharmacokinetics; Analgesic; Constipation; Pharmacology; Internal medicine","score_opus":0.03451081481072818,"score_gpt":0.3711450760023717,"score_spread":0.3366342611916435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969391248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805995,0.0006602791,0.0000072766275,0.013280381,0.00023170898,0.0049813353,0.000019843788,0.00004050412,0.00017915732],"genre_scores_gemma":[0.9918583,0.00021313303,0.00005448027,0.006737517,0.000095411495,0.00053215964,0.000025348825,0.000033321565,0.0004503367],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969172,0.000754027,0.00091959257,0.00046339765,0.00042340037,0.0005223969],"domain_scores_gemma":[0.99782544,0.0013697222,0.00022311356,0.00034375643,0.000076880424,0.00016110425],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009781318,0.00036745417,0.0009194238,0.000109910136,0.00020734424,0.000011849486,0.00022062946,0.00013066828,0.00042074037],"category_scores_gemma":[0.0000030727365,0.00025632125,0.0002542095,0.00022677913,0.00048001076,0.000082530154,0.000042357802,0.00067528995,0.00004946677],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85818887,0.004089207,0.1229237,0.00003450927,0.008102608,0.00048795738,0.0010071477,0.000071779585,0.0046987794,0.0000015123981,0.00028749648,0.00010643764],"study_design_scores_gemma":[0.5598501,0.16234241,0.23231633,0.00009493168,0.023830833,0.00061720895,0.00030939316,0.0035305154,0.015546488,0.000028216145,0.0009965256,0.0005370678],"about_ca_topic_score_codex":0.000051074705,"about_ca_topic_score_gemma":0.00013660567,"teacher_disagreement_score":0.2983388,"about_ca_system_score_codex":0.00014153543,"about_ca_system_score_gemma":0.00027561825,"threshold_uncertainty_score":0.9999889},"labels":[],"label_agreement":null},{"id":"W1970002505","doi":"10.1111/j.1365-2036.2009.04038.x","title":"Meta‐analysis: incidence of endoscopic gastric and duodenal ulcers in placebo arms of randomized placebo‐controlled NSAID trials","year":2009,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Placebo; Medicine; Incidence (geometry); Aspirin; Internal medicine; Clinical trial; Randomized controlled trial; Gastroenterology; Surgery; Pathology","score_opus":0.09962831415885678,"score_gpt":0.4039541796054529,"score_spread":0.3043258654465961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970002505","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0066082594,0.9834035,0.0000334987,0.00018205035,0.00042665438,0.009211931,0.00006995849,0.000024076366,0.000040048562],"genre_scores_gemma":[0.0051723565,0.9916857,0.0004157921,0.0012729727,0.00019750408,0.0010129149,0.00011845813,0.0000526352,0.00007165079],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9868418,0.0075889025,0.0038524389,0.00062250387,0.0005479499,0.00054637855],"domain_scores_gemma":[0.9867604,0.009566068,0.0029518155,0.00039901547,0.000115886854,0.00020686255],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.009372628,0.0008734792,0.022887275,0.001717642,0.000044034507,0.000009176429,0.00031196652,0.000492119,0.00063386525],"category_scores_gemma":[0.000023350758,0.0005786344,0.004431072,0.00095646014,0.00049363164,0.0000820271,0.000075897435,0.00078047125,0.000005299071],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11674258,0.00042654361,0.000063391286,0.0045980494,0.8661045,0.00014763894,0.00033558873,0.00003446708,0.00051395374,0.000007570393,0.000031464926,0.010994269],"study_design_scores_gemma":[0.22389983,0.00042541232,0.000005581058,0.00064571045,0.771669,0.00003840382,0.000029299583,0.00017834762,0.0008373858,0.00001645397,0.0020084118,0.00024620868],"about_ca_topic_score_codex":0.00006148491,"about_ca_topic_score_gemma":0.0000131275765,"teacher_disagreement_score":0.10715724,"about_ca_system_score_codex":0.00015787981,"about_ca_system_score_gemma":0.0006094774,"threshold_uncertainty_score":0.9996665},"labels":[],"label_agreement":null},{"id":"W1971129717","doi":"10.1046/j.1365-2036.2000.014s2002.x","title":"Review article: control of gall‐bladder motor function","year":2000,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Sphincter of Oddi; Cholecystokinin; Internal medicine; Gallbladder; Endocrinology; Medicine; Acetylcholine; Cholinergic; Common bile duct; Contraction (grammar); Muscle contraction; Sphincter; Anatomy; Receptor","score_opus":0.08867521292325208,"score_gpt":0.3719195038554301,"score_spread":0.283244290932178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971129717","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000111183974,0.9966903,0.000002788933,0.00017041214,0.00088830217,0.0015708867,0.00018244564,0.000068807065,0.00031491154],"genre_scores_gemma":[0.0004026728,0.90719664,0.0000070237784,0.091639824,0.00031014116,0.00013677166,0.00002437783,0.00007970227,0.00020283098],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965519,0.0011194682,0.00093563006,0.000698693,0.00019102545,0.000503313],"domain_scores_gemma":[0.9983981,0.00053359964,0.0005605193,0.00036507333,0.00003372278,0.000108987886],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014213404,0.0005345848,0.0016468612,0.000106816515,0.00010896262,0.000010266629,0.0005617127,0.00018721241,0.0037016757],"category_scores_gemma":[6.6608465e-7,0.0004276891,0.000580507,0.00033087772,0.00032085233,0.00011072407,0.00008546153,0.0005904899,0.000517161],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033002452,0.0007129404,0.0000010620099,0.010427153,0.0044371444,0.00005747605,0.000011501571,0.0000027813112,0.27214143,0.000067229,0.004782725,0.70702857],"study_design_scores_gemma":[0.0006046678,0.0007133584,0.0000011028263,0.0020753131,0.02960637,0.00006482139,0.0000010358074,0.0000115973235,0.0029193307,0.000039835,0.9636402,0.00032232483],"about_ca_topic_score_codex":0.000004542616,"about_ca_topic_score_gemma":2.2314137e-7,"teacher_disagreement_score":0.95885754,"about_ca_system_score_codex":0.000050152677,"about_ca_system_score_gemma":0.00011511242,"threshold_uncertainty_score":0.9998175},"labels":[],"label_agreement":null},{"id":"W1972782119","doi":"10.1111/j.1365-2036.2008.03866.x","title":"More statistical analysis is needed for the meta‐analysis of genetic association studies: authors’ reply","year":2008,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Chen; Meta-analysis; Medicine; Ethnic group; Association (psychology); Declaration; Genetic association; Statistical analysis; Econometrics; Statistics; Computer science; Epistemology; Mathematics; Internal medicine; Genetics; Sociology; Biology; Philosophy","score_opus":0.11230567731971967,"score_gpt":0.4063556511992703,"score_spread":0.2940499738795506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972782119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91565114,0.023935372,0.027894901,0.029759824,0.00057645363,0.00092555286,0.0012136439,0.000021317237,0.000021799691],"genre_scores_gemma":[0.9260557,0.008216615,0.0063283695,0.057586633,0.00017325472,0.00025632407,0.0005352459,0.000025848523,0.00082197617],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99790627,0.00043410476,0.0006412645,0.00044106506,0.0001948943,0.00038237826],"domain_scores_gemma":[0.9976105,0.0011150473,0.0005055069,0.0003791502,0.00032620342,0.00006359801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007724835,0.00023043547,0.0008952621,0.00017789159,0.00029694472,0.00000493836,0.00028029142,0.00018887488,0.00024811455],"category_scores_gemma":[0.000012520898,0.00017409275,0.0010033082,0.0007027704,0.00028948672,0.0000033982562,0.000091907896,0.00011665864,0.0000023792238],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096829506,0.00012753755,0.06193847,0.0000053510644,0.90641344,0.0000011828537,0.00078423065,0.0060510035,0.010060678,0.000007540508,0.014460872,0.00005287063],"study_design_scores_gemma":[0.00060764793,0.00027458783,0.061042197,2.2280085e-7,0.91071266,0.0000020670477,0.00080097,0.0076994244,0.0083840955,0.00006809445,0.01021084,0.00019716226],"about_ca_topic_score_codex":0.00016794169,"about_ca_topic_score_gemma":0.0000581954,"teacher_disagreement_score":0.02782681,"about_ca_system_score_codex":0.00007032386,"about_ca_system_score_gemma":0.00007093667,"threshold_uncertainty_score":0.70992965},"labels":[],"label_agreement":null},{"id":"W1972965712","doi":"10.1111/j.1365-2036.2008.03804.x","title":"Systematic review: persistence and severity in gastro‐oesophageal reflux disease","year":2008,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"AstraZeneca; Abbott Laboratories","keywords":"GERD; Medicine; Reflux; Internal medicine; Disease; Placebo; Incidence (geometry); Gastroenterology; Persistence (discontinuity); Proton-pump inhibitor; Pathology","score_opus":0.059637461776762296,"score_gpt":0.3757946753825735,"score_spread":0.31615721360581117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972965712","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00054073316,0.993671,7.035346e-7,0.0002386237,0.0003120757,0.004993849,0.00013553593,0.000057437825,0.000050064777],"genre_scores_gemma":[0.00075424614,0.9853211,0.0001421036,0.011941073,0.00011532388,0.00068209745,0.00046996257,0.00008849837,0.00048556906],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9962194,0.00078058563,0.0011730848,0.0007875432,0.00038941504,0.00064997317],"domain_scores_gemma":[0.9982245,0.00022945089,0.00046650195,0.0005392008,0.000056523593,0.00048385156],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002401452,0.000838628,0.0035544303,0.0002509468,0.00012965774,0.000012258438,0.00027717324,0.00021467502,0.0001668347],"category_scores_gemma":[0.0000017881753,0.0006357924,0.0006137352,0.00032028678,0.00027826993,0.00010377273,0.00015013039,0.0007547953,0.00011050702],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010839819,0.001189886,0.0027014245,0.95272046,0.020461032,0.013139377,0.00010001958,1.12687964e-7,0.0000021245235,0.0000013376352,0.00045332068,0.00912252],"study_design_scores_gemma":[0.0053395987,0.0012011939,0.0015800305,0.4866472,0.45422027,0.0057603354,0.000032052467,0.000030155374,0.000009035006,0.00001035653,0.044368435,0.00080135104],"about_ca_topic_score_codex":0.0000057047723,"about_ca_topic_score_gemma":7.3339373e-7,"teacher_disagreement_score":0.46607324,"about_ca_system_score_codex":0.0005014163,"about_ca_system_score_gemma":0.00036335003,"threshold_uncertainty_score":0.99960935},"labels":[],"label_agreement":null},{"id":"W1974832426","doi":"10.1111/j.1365-2036.2006.02873.x","title":"Physicians’ approaches to the use of gastroprotective strategies in low‐risk non‐steroidal anti‐inflammatory drug users","year":2006,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Health Research Board; University of Manitoba","keywords":"Medicine; Drug; Logistic regression; Intensive care medicine; Alternative medicine; Internal medicine; Pharmacology; Pathology","score_opus":0.04575564056126771,"score_gpt":0.26709886886313006,"score_spread":0.22134322830186234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974832426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956404,0.00023677414,0.00019959497,0.001448411,0.0005713847,0.0017820774,0.000029669145,0.000040142764,0.000051546387],"genre_scores_gemma":[0.99463314,0.00008495166,0.00045760695,0.004055352,0.00047605703,0.00015664277,0.00002793557,0.000048549908,0.000059776914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979918,0.00038667367,0.00047190682,0.00035531487,0.00028669345,0.0005076082],"domain_scores_gemma":[0.9991198,0.00020710992,0.00023293216,0.00031069806,0.00005353893,0.00007587566],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000382829,0.00032077348,0.00046335295,0.00018713654,0.00011852101,0.000022358838,0.00020230813,0.00010327414,0.00004173335],"category_scores_gemma":[4.1032828e-7,0.00024609498,0.00014034298,0.0002821563,0.00028581033,0.0002286128,0.000071768896,0.0005160854,0.00002468531],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032589918,0.0017267554,0.38603723,0.00029461633,0.0053823204,0.00026321533,0.008242842,0.043522347,0.54525405,0.000088324145,0.0023199345,0.0036093919],"study_design_scores_gemma":[0.006071965,0.00088884484,0.35846713,0.00018626511,0.004519755,0.000027589154,0.0030345959,0.0083899265,0.61392736,0.000082616345,0.003878387,0.00052552985],"about_ca_topic_score_codex":0.00048619145,"about_ca_topic_score_gemma":0.00026233826,"teacher_disagreement_score":0.06867336,"about_ca_system_score_codex":0.00013764603,"about_ca_system_score_gemma":0.00013268144,"threshold_uncertainty_score":0.9999991},"labels":[],"label_agreement":null},{"id":"W1975441923","doi":"10.1046/j.1365-2036.2000.00690.x","title":"Review article: proteinase‐activated receptors — novel signals for gastrointestinal pathophysiology","year":2000,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Tryptase; Protease-activated receptor; Receptor; Gastrointestinal tract; Thrombin; Trypsin; Protease-activated receptor 2; Extracellular; Proteolytic enzymes; Pathophysiology; Cell biology; Biology; Biochemistry; Mast cell; Immunology; Endocrinology; Enzyme","score_opus":0.1073135685719005,"score_gpt":0.4005217177133871,"score_spread":0.29320814914148663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975441923","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000058677684,0.98962426,0.00018046271,0.0015312952,0.0006111413,0.0076253465,0.00016081796,0.0001598874,0.000048092348],"genre_scores_gemma":[0.0000066857183,0.94030637,0.0034073691,0.052714,0.0004902207,0.0015461597,0.0011226381,0.00015072271,0.00025583289],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967596,0.00043350947,0.0011279809,0.0007706715,0.00021082282,0.000697412],"domain_scores_gemma":[0.998241,0.0003452679,0.00059019896,0.0004204309,0.00015348836,0.00024960918],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003804528,0.0007605552,0.0025476876,0.0001828792,0.00016114168,0.000011722933,0.00029002936,0.00031235788,0.0037153366],"category_scores_gemma":[0.0000013018408,0.00063113763,0.0007900583,0.00041782178,0.00016361002,0.00007151285,0.000065477245,0.00070635596,0.00017480442],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061009,0.0029850407,0.0000026759121,0.040606514,0.018894628,0.000051244388,0.00002706444,0.0000020744844,0.122225285,0.000040899566,0.0082512135,0.80630326],"study_design_scores_gemma":[0.00221604,0.001695024,7.100301e-7,0.022570921,0.070231855,0.00048412016,0.0000063569064,0.000030861982,0.0068082544,0.00007673646,0.89539206,0.00048708761],"about_ca_topic_score_codex":0.000004349866,"about_ca_topic_score_gemma":3.2130785e-7,"teacher_disagreement_score":0.8871408,"about_ca_system_score_codex":0.00019530985,"about_ca_system_score_gemma":0.00043650987,"threshold_uncertainty_score":0.999614},"labels":[],"label_agreement":null},{"id":"W1975601232","doi":"10.1111/j.1365-2036.2010.04231.x","title":"Meta‐analysis: targeting the intestinal microbiota in prophylaxis for post‐operative Crohn’s disease","year":2010,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Placebo; Relative risk; Crohn's disease; Internal medicine; Metronidazole; Number needed to treat; Antibiotics; Adverse effect; Meta-analysis; Gastroenterology; Ornidazole; Confidence interval; Randomized controlled trial; Surgery; Disease; Pathology","score_opus":0.05319550293036866,"score_gpt":0.36599084741474536,"score_spread":0.3127953444843767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975601232","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037127626,0.990779,0.000042520613,0.00037435413,0.00055979326,0.003426617,0.0010738209,0.000020175596,0.000010944317],"genre_scores_gemma":[0.0013534668,0.98117656,0.0006219042,0.009188726,0.00067646144,0.002646468,0.0038843525,0.0001488043,0.00030328796],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99643695,0.0010169619,0.00082996016,0.00093943026,0.00014619163,0.00063048466],"domain_scores_gemma":[0.9983402,0.00019434503,0.00045572885,0.00061711,0.00020952652,0.00018307695],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00066652155,0.0007835501,0.0013517763,0.00022405077,0.00027001608,0.000055343135,0.0009288906,0.00042200633,0.0002590554],"category_scores_gemma":[0.000003136265,0.0005380967,0.0021151237,0.00032146525,0.0003866156,0.000010243162,0.00030856294,0.00078375277,0.000021242262],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014070694,0.00091569975,0.00017567753,0.002699819,0.95300037,0.0005210637,0.00023897443,0.0001070892,0.022886338,0.000020028061,0.00077730895,0.017250538],"study_design_scores_gemma":[0.00046377318,0.00012604447,0.00008891277,0.000039800907,0.5774543,0.000009393281,0.00003348498,0.00003086125,0.00060555997,0.000007740553,0.42062014,0.00051993725],"about_ca_topic_score_codex":0.000015302312,"about_ca_topic_score_gemma":0.00008261661,"teacher_disagreement_score":0.41984284,"about_ca_system_score_codex":0.00007488766,"about_ca_system_score_gemma":0.00070694846,"threshold_uncertainty_score":0.99970704},"labels":[],"label_agreement":null},{"id":"W1976335410","doi":"10.1111/j.1365-2036.2004.02257.x","title":"Do physicians correctly assess patient symptom severity in gastro‐oesophageal reflux disease?","year":2004,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; McMaster University; McGill University; AstraZeneca (Canada); McGill University Health Centre","funders":"","keywords":"Medicine; Heartburn; Quality of life (healthcare); Esomeprazole; Reflux; Internal medicine; Disease; Severity of illness; Gastro-; GERD; Physical therapy; Gastroenterology","score_opus":0.029526108721846845,"score_gpt":0.33247830976225196,"score_spread":0.3029522010404051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976335410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950831,0.0007662189,0.000039611536,0.0015162048,0.0011098849,0.000978176,0.000100195306,0.000109797445,0.00029682316],"genre_scores_gemma":[0.9744631,0.00022061102,0.0006331504,0.023928357,0.00020826388,0.0001263431,0.00024816903,0.00006061854,0.00011136074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763495,0.00017347925,0.00044306598,0.00058608607,0.00040496813,0.0007574556],"domain_scores_gemma":[0.99904907,0.00006904079,0.00014609518,0.00034684115,0.000069214206,0.00031973294],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000107115564,0.00042912673,0.0005014995,0.00016516786,0.00013724125,0.00002150314,0.00018495254,0.00010761926,0.0003183881],"category_scores_gemma":[3.6302512e-7,0.00039845947,0.00018875232,0.00028611944,0.0001866623,0.00017386436,0.00009506437,0.00047358905,0.00012416509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018364228,0.0077941567,0.9456825,0.00007166893,0.0068447944,0.008141066,0.0013264252,0.00049462455,0.018642018,0.00003986737,0.00026165377,0.00886479],"study_design_scores_gemma":[0.017875046,0.0027899726,0.91661096,0.00013468377,0.010100763,0.00016476716,0.00031149725,0.00019192796,0.050165385,0.00052468287,0.00075653894,0.00037380136],"about_ca_topic_score_codex":0.00004763946,"about_ca_topic_score_gemma":0.0000074755962,"teacher_disagreement_score":0.031523366,"about_ca_system_score_codex":0.00068064453,"about_ca_system_score_gemma":0.00021971753,"threshold_uncertainty_score":0.99984676},"labels":[],"label_agreement":null},{"id":"W1976582380","doi":"10.1111/j.1365-2036.2005.02605.x","title":"Review article: gastro‐oesophageal reflux disease – the extent of the problem","year":2005,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Heartburn; Medicine; Reflux; Gastro-; Internal medicine; Helicobacter pylori; Disease; Gastroenterology; Epidemiology","score_opus":0.06247341711808853,"score_gpt":0.40234702114330284,"score_spread":0.3398736040252143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976582380","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017591263,0.9905948,0.0000013102236,0.0035912895,0.00049336924,0.004787849,0.00016871908,0.00004333438,0.00014343942],"genre_scores_gemma":[0.0009692702,0.9583234,0.00018958445,0.038405247,0.0004406862,0.00055011915,0.00016900396,0.000096887685,0.0008557825],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99635595,0.00083285593,0.0011087158,0.0005526813,0.00050280255,0.0006469874],"domain_scores_gemma":[0.9977236,0.000204624,0.00072324055,0.00095963856,0.00010029079,0.00028860255],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040932448,0.00071300037,0.0016638372,0.00007416109,0.00021614728,0.000011712744,0.000702492,0.00015294462,0.0008832639],"category_scores_gemma":[6.8448435e-7,0.00034274787,0.0011654944,0.00041616804,0.0004556542,0.000062949846,0.0002811428,0.00086797046,0.00014690937],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014454772,0.0022551971,0.0014003256,0.02373796,0.030008616,0.00044053225,0.00006608648,0.000002216155,0.000035223264,0.00002203535,0.008554329,0.9333329],"study_design_scores_gemma":[0.0012691251,0.00030027065,0.00052454293,0.008804314,0.16502407,0.00022477156,0.0000039520164,0.0000046502087,0.000058603247,0.000019692432,0.82362473,0.0001412695],"about_ca_topic_score_codex":0.0000043362525,"about_ca_topic_score_gemma":8.583615e-7,"teacher_disagreement_score":0.93319166,"about_ca_system_score_codex":0.00030525378,"about_ca_system_score_gemma":0.0005314249,"threshold_uncertainty_score":0.9999024},"labels":[],"label_agreement":null},{"id":"W1977367746","doi":"10.1046/j.1365-2036.2000.00851.x","title":"The effect of inflammation severity and of treatment on the production and release of TNFα by colonic explants in inflammatory bowel disease","year":2000,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Medical Research Council; Medical Research Council Canada","keywords":"Medicine; Inflammatory bowel disease; Inflammation; Tumor necrosis factor alpha; Ileitis; Gastroenterology; Internal medicine; Crohn's disease; Colitis; Cytokine; Basal (medicine); Proinflammatory cytokine; Explant culture; Disease; Pathology; Immunology; In vitro; Biology","score_opus":0.006794647710771815,"score_gpt":0.25426913951629,"score_spread":0.24747449180551817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977367746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971716,0.001418497,1.9317275e-7,0.00047884817,0.00007299024,0.0007683696,0.00007153329,0.0000033177612,0.000014671209],"genre_scores_gemma":[0.99518925,0.0043794313,0.000002173494,0.00020965555,0.00003748554,0.000087177505,0.000035046683,0.000011129907,0.00004862111],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988591,0.0004498848,0.00027295493,0.00019081823,0.00008787587,0.00013938188],"domain_scores_gemma":[0.99946105,0.00011271856,0.00014487447,0.00020920066,0.00002327453,0.0000488515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028366156,0.00014963612,0.00012851755,0.000025860452,0.00007740758,0.0000038408793,0.00009461899,0.000059084745,0.000023464985],"category_scores_gemma":[0.0000024738474,0.000098130535,0.000041246465,0.00003573276,0.00035764507,0.000008562265,0.00002930048,0.000061506966,6.8610393e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009774663,0.00016281134,0.14133584,0.00009895038,0.0010941491,0.000008641315,0.00027424895,0.00026046197,0.84207904,0.000010393874,0.00021028056,0.004690535],"study_design_scores_gemma":[0.001502989,0.0010536455,0.12066793,0.000029347972,0.0008674695,0.0000031592251,0.000050161467,0.0003000318,0.87433046,0.00002130244,0.001061847,0.00011167448],"about_ca_topic_score_codex":0.000017040647,"about_ca_topic_score_gemma":0.00002301128,"teacher_disagreement_score":0.032251425,"about_ca_system_score_codex":0.00003059095,"about_ca_system_score_gemma":0.00005557664,"threshold_uncertainty_score":0.4001647},"labels":[],"label_agreement":null},{"id":"W1978881027","doi":"10.1111/apt.13135","title":"Appropriate and timely antimicrobial therapy in cirrhotic patients with spontaneous bacterial peritonitis‐associated septic shock: a retrospective cohort study","year":2015,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital; University of Alberta Hospital; University of Alberta","funders":"","keywords":"Medicine; Spontaneous bacterial peritonitis; Septic shock; Internal medicine; Retrospective cohort study; Antimicrobial; Intensive care unit; Cirrhosis; Peritonitis; Odds ratio; Cohort; Gastroenterology; Liver disease; Sepsis; Microbiology","score_opus":0.01606722579851983,"score_gpt":0.2658961867644973,"score_spread":0.24982896096597745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978881027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99665886,0.00008611935,0.0000012596025,0.00017660447,0.00040966136,0.0024547498,0.00009242971,0.00005471842,0.00006557971],"genre_scores_gemma":[0.99665856,0.00019374846,0.000037171045,0.0024263146,0.00009521558,0.000058549434,0.00045665732,0.000042195767,0.000031578555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844724,0.00027402668,0.00026563994,0.0004009125,0.0002876784,0.00032450218],"domain_scores_gemma":[0.9994404,0.000039695853,0.00009714175,0.00012242264,0.00014667268,0.00015369787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018570329,0.00025994878,0.0004181455,0.000118095115,0.00007694689,0.000022960798,0.00007632551,0.00008865444,0.00014906618],"category_scores_gemma":[1.3007951e-7,0.00022160771,0.00003644429,0.00016926814,0.00012303577,0.00013184216,0.000022275737,0.00023573652,0.000011343025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009244921,0.0031256445,0.963003,0.000010394988,0.011743207,0.00094762945,0.0035944472,0.000005050197,0.008199426,4.7624403e-7,0.000011130671,0.000114679795],"study_design_scores_gemma":[0.028514195,0.0045301085,0.95276564,0.00002703136,0.011671242,0.00010567626,0.00029770724,0.00008866995,0.0017356662,0.000014147044,0.000008736361,0.00024116038],"about_ca_topic_score_codex":0.00019405017,"about_ca_topic_score_gemma":0.00008137708,"teacher_disagreement_score":0.019269275,"about_ca_system_score_codex":0.00030945352,"about_ca_system_score_gemma":0.0001490486,"threshold_uncertainty_score":0.90369004},"labels":[],"label_agreement":null},{"id":"W1981220433","doi":"10.1046/j.1365-2036.2002.01305.x","title":"Consensus report: clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome","year":2002,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Novartis Pharma; National Institutes of Health","keywords":"Irritable bowel syndrome; Medicine; Psychosocial; Intensive care medicine; Organic disease; Constipation; Quality of life (healthcare); Disease; Psychiatry; Internal medicine","score_opus":0.13316180035353267,"score_gpt":0.42178027582372507,"score_spread":0.28861847547019237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981220433","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013387804,0.99395794,0.000018870587,0.0013857556,0.00056025584,0.0021936751,0.000087127184,0.000059604914,0.0003980018],"genre_scores_gemma":[0.00045833577,0.9926304,0.0042921333,0.0016796304,0.00005761963,0.00013116527,0.00011398986,0.000068238565,0.0005684726],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967018,0.00042819083,0.0013478176,0.00079453713,0.00027592594,0.00045176077],"domain_scores_gemma":[0.9981415,0.00047743958,0.0006337818,0.0004265723,0.00009156201,0.00022913638],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005796038,0.00053142913,0.0020196196,0.00017941627,0.000093099996,0.000009254157,0.00019434789,0.00029657717,0.00082971],"category_scores_gemma":[0.0000012813614,0.00048060375,0.0005318994,0.0002118418,0.0005686822,0.000031958913,0.00019506193,0.00068616786,0.00003089388],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010880188,0.01741769,0.0051094256,0.08205239,0.21923536,0.04986777,0.0005523076,0.0000023684772,0.000024061446,0.0010061961,0.010330196,0.6133142],"study_design_scores_gemma":[0.0045531685,0.0037346967,0.0007787372,0.008154101,0.22713782,0.020691458,0.0011816322,0.000028359958,0.000014597858,0.0002995605,0.7327553,0.00067054125],"about_ca_topic_score_codex":0.000032087024,"about_ca_topic_score_gemma":0.0000021519543,"teacher_disagreement_score":0.72242516,"about_ca_system_score_codex":0.0001379867,"about_ca_system_score_gemma":0.000103892664,"threshold_uncertainty_score":0.99976456},"labels":[],"label_agreement":null},{"id":"W1981328205","doi":"10.1111/j.1365-2036.2008.03772.x","title":"Predictive factors associated with immunosuppressive agent use in ulcerative colitis: a case–control study","year":2008,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Ulcerative colitis; Azathioprine; Pancolitis; Internal medicine; Inflammatory bowel disease; Odds ratio; Logistic regression; Mercaptopurine; Colectomy; Disease; Univariate analysis; Gastroenterology; Epidemiology; Multivariate analysis; Colonoscopy; Colorectal cancer; Cancer","score_opus":0.02993984765217441,"score_gpt":0.2851310656799531,"score_spread":0.2551912180277787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981328205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969974,0.00015554811,0.00003113757,0.0000454717,0.00026453263,0.0018223661,0.000615061,0.00003225998,0.000036186077],"genre_scores_gemma":[0.99604553,0.0000720619,0.000013102433,0.0031446503,0.00008180303,0.00028246178,0.00019715939,0.00005102119,0.00011218714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738294,0.0010783237,0.00034309636,0.0005176771,0.00019347624,0.00048447493],"domain_scores_gemma":[0.9991554,0.00011520923,0.00018436095,0.0002684477,0.0001470522,0.00012950419],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017194262,0.00036673367,0.000287052,0.00008923857,0.0002597501,0.000017159386,0.0001989466,0.00015397913,0.00012295865],"category_scores_gemma":[0.0000017936043,0.00033129175,0.00008553173,0.00011846743,0.0003005145,0.000028365514,0.00008788066,0.00025936312,0.000003960318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006827539,0.0026235785,0.90738493,0.000004357472,0.023528289,0.017749606,0.0046904343,0.0011887426,0.035724923,0.0000015146633,0.00025244083,0.000023621986],"study_design_scores_gemma":[0.011555482,0.0019346674,0.9627294,0.000010227902,0.0035998865,0.00019697667,0.0025507025,0.00027839807,0.016626665,0.0000031680956,0.00009646814,0.00041798732],"about_ca_topic_score_codex":0.00009301881,"about_ca_topic_score_gemma":0.00090977515,"teacher_disagreement_score":0.055344418,"about_ca_system_score_codex":0.00016937767,"about_ca_system_score_gemma":0.00019486935,"threshold_uncertainty_score":0.99991393},"labels":[],"label_agreement":null},{"id":"W1983828007","doi":"10.1111/apt.12563","title":"Systematic review with meta‐analysis: clinical manifestations and management of autoimmune hepatitis in the elderly","year":2013,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Medicine; Autoimmune hepatitis; Meta-analysis; MEDLINE; Intensive care medicine; Hepatitis; Dermatology; Immunology; Internal medicine","score_opus":0.14118526213018712,"score_gpt":0.4402243767143856,"score_spread":0.29903911458419846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983828007","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016954479,0.99214137,0.000007681822,0.00067818974,0.00006724125,0.0067997826,0.0000609993,0.000013347567,0.00006183257],"genre_scores_gemma":[0.00008774672,0.9917216,0.0002820018,0.0059521864,0.000015771835,0.0014845865,0.00028093287,0.000027898726,0.00014729801],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9957208,0.0020130717,0.0014721883,0.00030813392,0.00026728102,0.00021851347],"domain_scores_gemma":[0.9978993,0.0005798911,0.00075407844,0.00063076965,0.00007206132,0.00006388664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009378744,0.00038410176,0.004050293,0.00017536097,0.00006563454,0.000012804327,0.0003478,0.00010412247,0.0004146673],"category_scores_gemma":[2.1964031e-7,0.00019872698,0.0011248027,0.0005988183,0.00020829414,0.00006445489,0.00008672544,0.00043703918,0.000016204403],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000987381,0.000419967,0.00006460739,0.41144824,0.58486193,0.000094384515,0.000042920998,1.6300294e-7,7.029269e-8,0.00002150137,0.000060631693,0.002975705],"study_design_scores_gemma":[0.00052213046,0.0005461887,0.00041503375,0.04216348,0.9463843,0.000098209064,0.000117182135,0.000011819997,1.2417092e-7,0.0000032539083,0.009576732,0.00016152883],"about_ca_topic_score_codex":0.00016991643,"about_ca_topic_score_gemma":0.000009477272,"teacher_disagreement_score":0.36928475,"about_ca_system_score_codex":0.000043776476,"about_ca_system_score_gemma":0.000080251186,"threshold_uncertainty_score":0.8103851},"labels":[],"label_agreement":null},{"id":"W1983972130","doi":"10.1046/j.1365-2036.2002.01285.x","title":"Impact of<i> Helicobacter pylori </i>eradication on heartburn in patients with gastric or duodenal ulcer disease — results from a randomized trial programme","year":2002,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"AstraZeneca","keywords":"Medicine; Heartburn; Internal medicine; Gastroenterology; Helicobacter pylori; Omeprazole; Risk factor; Randomized controlled trial; Incidence (geometry); Odds ratio; Disease; Reflux","score_opus":0.037370362965843396,"score_gpt":0.3110557070954672,"score_spread":0.2736853441296238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983972130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901004,0.00021702427,0.000008893299,0.00503111,0.00051218533,0.0037283602,0.00030339803,0.00006255265,0.000036115383],"genre_scores_gemma":[0.9906502,0.0004585551,0.00027279512,0.007318241,0.00031547504,0.00030560134,0.00055729435,0.00005376454,0.00006809566],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964449,0.0007261959,0.0011027657,0.00059694453,0.00044018656,0.00068903505],"domain_scores_gemma":[0.9979149,0.00060806156,0.0005934134,0.00038759774,0.00017765188,0.0003183648],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038295504,0.0004576063,0.0012044251,0.00033097394,0.00007604171,0.00001205931,0.00016419851,0.00015314539,0.00064330496],"category_scores_gemma":[0.000012632259,0.00029364543,0.00028725076,0.00042902882,0.0004268276,0.00013701624,0.00005169015,0.00057486666,0.000041137173],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74966025,0.0046286164,0.22842842,0.0000072636044,0.01453813,0.000060457845,0.0007040898,0.000035966365,0.00033685524,2.5481899e-7,0.00026587522,0.0013338107],"study_design_scores_gemma":[0.70424086,0.0075905616,0.2791131,0.00006120109,0.007998,0.00000452184,0.000014822841,0.00047102745,0.00014764791,0.0000040128693,0.00018244897,0.00017175435],"about_ca_topic_score_codex":0.00017012453,"about_ca_topic_score_gemma":0.000014849271,"teacher_disagreement_score":0.050684698,"about_ca_system_score_codex":0.00029076004,"about_ca_system_score_gemma":0.000112902555,"threshold_uncertainty_score":0.99995154},"labels":[],"label_agreement":null},{"id":"W1984084356","doi":"10.1111/j.1365-2036.2012.04995.x","title":"Letter: thiopurine blood monitoring for patients with inflammatory bowel disease","year":2012,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Thiopurine methyltransferase; Medicine; Inflammatory bowel disease; Mercaptopurine; Ulcerative colitis; Intensive care medicine; Azathioprine; Internal medicine; Disease","score_opus":0.021671364249901903,"score_gpt":0.3020151112209608,"score_spread":0.2803437469710589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984084356","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37713522,0.003044002,0.000055972137,0.6072407,0.004876083,0.0065076356,0.0007343119,0.0003157563,0.0000903273],"genre_scores_gemma":[0.018834412,0.000580172,0.00089476805,0.95296484,0.02105794,0.000998717,0.0026638254,0.00039579478,0.0016095277],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959826,0.00019971827,0.0005761516,0.00076855364,0.0009861804,0.001486804],"domain_scores_gemma":[0.9977418,0.00051495974,0.00031376167,0.0006665065,0.00031804113,0.00044488447],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019452332,0.00081113196,0.00069200504,0.00030945108,0.00023737636,0.000031604763,0.00050764746,0.000644802,0.00038379538],"category_scores_gemma":[7.7700696e-7,0.00066564884,0.00026142632,0.00013360268,0.00038162793,0.00019626091,0.00022118972,0.0020254385,0.000085064195],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051163197,0.0015942698,0.23681821,0.0014895573,0.041859936,0.0015806091,0.0002090799,0.000005975412,0.002772454,0.0000010858439,0.70820796,0.00034451767],"study_design_scores_gemma":[0.02203156,0.0014524753,0.013819826,0.00023131825,0.069708735,0.00005062753,0.000010297767,0.00006481327,0.0069432184,0.000012741174,0.8847965,0.00087789283],"about_ca_topic_score_codex":0.000009787719,"about_ca_topic_score_gemma":2.6123053e-7,"teacher_disagreement_score":0.3583008,"about_ca_system_score_codex":0.0008742227,"about_ca_system_score_gemma":0.0006732633,"threshold_uncertainty_score":0.9995795},"labels":[],"label_agreement":null},{"id":"W1984263718","doi":"10.1111/apt.12682","title":"Systematic review with meta‐analysis: the incidence of advanced neoplasia after polypectomy in patients with and without low‐risk adenomas","year":2014,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Colonoscopy; Incidence (geometry); Dysplasia; Adenoma; Polypectomy; Internal medicine; Gastroenterology; Relative risk; Colorectal cancer; Meta-analysis; Cancer; Confidence interval","score_opus":0.0186903892056285,"score_gpt":0.32573878990056143,"score_spread":0.30704840069493294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984263718","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0068599973,0.9883944,0.000027284666,0.00010697231,0.00006507107,0.0044796867,0.000031999196,0.000025149633,0.000009477073],"genre_scores_gemma":[0.041141238,0.9543696,0.00015420793,0.0028537328,0.000028856375,0.0013285531,0.000044218996,0.000052951953,0.000026640224],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99691623,0.0009982758,0.0009014759,0.0005028684,0.00039715602,0.00028401273],"domain_scores_gemma":[0.9978508,0.00032161,0.0011068659,0.00050519,0.0001254119,0.00009016313],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005331195,0.00054001156,0.0044611176,0.0002853735,0.000062787374,0.000010166438,0.00020369451,0.00013326036,0.00006870664],"category_scores_gemma":[0.0000011497926,0.00026625095,0.00050309085,0.0009449144,0.00026027238,0.0000742564,0.00006446542,0.0005999776,0.0000033459062],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033732646,0.00023243441,0.0062852413,0.33889592,0.64723647,0.000015538448,0.00018373046,0.000012225436,7.924644e-7,4.5553188e-7,0.0000038096168,0.003760114],"study_design_scores_gemma":[0.0014490114,0.0022693586,0.0010289361,0.046987917,0.9467347,0.0000521209,0.00002122813,0.000019906276,0.00000980575,7.3797395e-7,0.0011580037,0.00026822658],"about_ca_topic_score_codex":0.00008126645,"about_ca_topic_score_gemma":0.00014373095,"teacher_disagreement_score":0.2994983,"about_ca_system_score_codex":0.00011095235,"about_ca_system_score_gemma":0.00014703133,"threshold_uncertainty_score":0.99997896},"labels":[],"label_agreement":null},{"id":"W1984331451","doi":"10.1046/j.1365-2036.2000.00703.x","title":"Lack of a pharmacokinetic interaction between lansoprazole or pantoprazole and theophylline","year":2000,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Lansoprazole; Theophylline; Pharmacokinetics; Cmax; Pantoprazole; Pharmacology; Medicine; Cmin; Concomitant; Area under the curve; Drug interaction; Oral administration; Proton-pump inhibitor; Crossover study; Internal medicine; Omeprazole; Placebo","score_opus":0.0929900052098096,"score_gpt":0.4115644576347454,"score_spread":0.3185744524249358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984331451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970507,0.00058514776,0.000017557646,0.001011125,0.00016458736,0.00044682215,0.000048524475,0.000046826073,0.0006286943],"genre_scores_gemma":[0.9893385,0.001774632,0.00033976472,0.007024805,0.00020782597,0.0000220928,0.00010191042,0.000030353702,0.0011601221],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988692,0.00009164533,0.00034261268,0.00025656744,0.00015487621,0.0002851256],"domain_scores_gemma":[0.9994631,0.00012073229,0.00009599806,0.00014303613,0.0000385444,0.00013863517],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009672285,0.00022124912,0.00038139988,0.000088972185,0.0000621144,0.0000062397494,0.00008342019,0.000074683965,0.0044665593],"category_scores_gemma":[1.1684781e-7,0.00016538709,0.000072255745,0.00013472012,0.00014977573,0.00009368636,0.000029127106,0.0002153924,0.000055458575],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007873781,0.0032449854,0.47850537,0.00022923191,0.031060837,0.0009803898,0.0011623914,0.00010168128,0.22807612,0.000011320746,0.00049548293,0.2482584],"study_design_scores_gemma":[0.031672325,0.007376845,0.32604766,0.000105078936,0.051508952,0.00069379853,0.00018919671,0.003792577,0.5563209,0.00012325775,0.021706892,0.00046253728],"about_ca_topic_score_codex":0.000028023584,"about_ca_topic_score_gemma":0.0000011783887,"teacher_disagreement_score":0.32824475,"about_ca_system_score_codex":0.000042005962,"about_ca_system_score_gemma":0.00003217529,"threshold_uncertainty_score":0.9964435},"labels":[],"label_agreement":null},{"id":"W1985110054","doi":"10.1111/j.1365-2036.2005.02648.x","title":"Review article: endocannabinoids and their receptors in the enteric nervous system","year":2005,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; Canadian Association of Gastroenterology","keywords":"Enteric nervous system; Endocannabinoid system; Cannabinoid receptor; Gastrointestinal tract; Receptor; Cannabinoid; Medicine; Nervous system; Irritable bowel syndrome; Pharmacology; Neuroscience; Biology; Internal medicine; Agonist","score_opus":0.05934677270054484,"score_gpt":0.3931298152260362,"score_spread":0.33378304252549135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985110054","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017734543,0.98064226,8.511287e-7,0.014297328,0.0006613596,0.003818176,0.000048341713,0.000057488593,0.00029686777],"genre_scores_gemma":[0.00007179099,0.956079,0.000013277656,0.041049924,0.000651104,0.0010448967,0.00013462089,0.00008950937,0.00086587586],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99594367,0.0013561281,0.0009800605,0.0006246403,0.0003246614,0.0007708375],"domain_scores_gemma":[0.9987852,0.00010274231,0.0002742896,0.000562375,0.000072026254,0.00020336948],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011164951,0.0006715678,0.0019310039,0.00025913725,0.00014504565,0.000037529164,0.0005247876,0.00027020712,0.0005635626],"category_scores_gemma":[6.524915e-7,0.00038760048,0.00047670654,0.00072662556,0.00032303232,0.00007078503,0.00017869283,0.00133665,0.00006555804],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048113256,0.00031229953,0.000017826986,0.025313983,0.0032109101,0.00013239286,0.00025974,1.282518e-7,0.00004999516,0.000010916094,0.043492027,0.9271517],"study_design_scores_gemma":[0.0008631475,0.00036490415,0.000016636839,0.010294914,0.015678555,0.0018613326,0.00031067594,0.000016886665,0.000025542795,0.0000013644332,0.9702597,0.0003063289],"about_ca_topic_score_codex":0.000049627153,"about_ca_topic_score_gemma":0.000009001463,"teacher_disagreement_score":0.9268453,"about_ca_system_score_codex":0.0005443292,"about_ca_system_score_gemma":0.00039746208,"threshold_uncertainty_score":0.9998576},"labels":[],"label_agreement":null},{"id":"W1985424042","doi":"10.1111/apt.12177","title":"Systematic review: gastric cancer incidence in pernicious anaemia","year":2012,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":235,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Incidence (geometry); Internal medicine; Gastroenterology; Meta-analysis; Pernicious anaemia; Relative risk; Confidence interval","score_opus":0.07445918309642094,"score_gpt":0.4121878819648122,"score_spread":0.3377286988683913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985424042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034431323,0.9912243,0.0000028705433,0.0009271506,0.0014740538,0.006107322,0.000034436176,0.000070535185,0.00012489289],"genre_scores_gemma":[0.00003592189,0.9622069,0.00005164213,0.034342192,0.00045037415,0.0015538627,0.00016023415,0.00009913607,0.0010997326],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99612504,0.00055931153,0.0015128532,0.0005502354,0.00044255127,0.000810032],"domain_scores_gemma":[0.998121,0.0002743011,0.0007999244,0.00054950226,0.00005909108,0.00019616597],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00068523095,0.00074615265,0.004007638,0.0005146554,0.000065455875,0.000013143416,0.0005255544,0.00026102542,0.0014555564],"category_scores_gemma":[8.3414085e-7,0.0005756872,0.00062529946,0.0009502233,0.00010675533,0.0001177928,0.00021231158,0.000925431,0.00022292008],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029037878,0.0002722292,0.00090644136,0.9184223,0.01735252,0.00022455478,0.00008351343,4.8653874e-7,0.0000043392997,0.0000022589907,0.002233806,0.060468506],"study_design_scores_gemma":[0.0009556011,0.00013441841,0.000047433132,0.24402256,0.32731703,0.00024700363,0.000026593696,0.0000070622023,0.0000026074667,0.0000013488122,0.42679885,0.00043950402],"about_ca_topic_score_codex":0.00015203452,"about_ca_topic_score_gemma":0.00003268322,"teacher_disagreement_score":0.67439973,"about_ca_system_score_codex":0.0013282171,"about_ca_system_score_gemma":0.0003722681,"threshold_uncertainty_score":0.99966943},"labels":[],"label_agreement":null},{"id":"W1986727655","doi":"10.1111/j.1365-2036.2008.03905.x","title":"Canadian consensus guidelines on long‐term nonsteroidal anti‐inflammatory drug therapy and the need for gastroprotection: benefits versus risks","year":2008,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Calgary","funders":"Procter and Gamble; Pfizer; Allergan; American Heart Association","keywords":"Medicine; Proton-pump inhibitor; Naproxen; Nonsteroidal; Internal medicine; Drug; COX-2 inhibitor; Lower risk; Clinical trial; Naproxen Sodium; Risk assessment; Intensive care medicine; Pharmacology; Confidence interval; Alternative medicine","score_opus":0.11008281860555531,"score_gpt":0.3488717079892668,"score_spread":0.2387888893837115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986727655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97363484,0.0035559216,0.000005693623,0.017377933,0.002690904,0.0024969256,0.000048535778,0.000069085065,0.00012018643],"genre_scores_gemma":[0.96073407,0.0034889868,0.00015639847,0.033721987,0.0013496627,0.0002684297,0.000045608504,0.00006175874,0.00017312657],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981811,0.00021646512,0.00043009422,0.00036450685,0.00023204269,0.0005757654],"domain_scores_gemma":[0.99861676,0.00044620535,0.00015350361,0.0002749649,0.0001953125,0.00031323513],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050745654,0.0003636934,0.00044510217,0.00017347813,0.0006794295,0.000015728685,0.00014758171,0.00015241269,0.00019468815],"category_scores_gemma":[0.0000019507754,0.00025956277,0.00016208529,0.00010750562,0.0005724878,0.000037190268,0.000027009752,0.00038199918,0.000020172161],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1881733,0.0012881185,0.49101073,0.00039278562,0.051289532,0.0024846066,0.0069447844,0.0010629263,0.113152444,0.00054247165,0.045189153,0.09846915],"study_design_scores_gemma":[0.26767853,0.0078574605,0.3038036,0.00028112755,0.016763223,0.002837782,0.0010530174,0.005855526,0.3160442,0.00006164793,0.07561436,0.0021495076],"about_ca_topic_score_codex":0.0027210135,"about_ca_topic_score_gemma":0.001981088,"teacher_disagreement_score":0.20289177,"about_ca_system_score_codex":0.00013656665,"about_ca_system_score_gemma":0.00036897595,"threshold_uncertainty_score":0.99998564},"labels":[],"label_agreement":null},{"id":"W1987306105","doi":"10.1111/j.1365-2036.2009.04008.x","title":"Meta‐analysis: yield of diagnostic tests for coeliac disease in dyspepsia","year":2009,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Health Sciences Centre; McMaster University Medical Centre","funders":"","keywords":"Medicine; Coeliac disease; Serology; Internal medicine; Biopsy; Gastroenterology; Odds ratio; Confidence interval; Meta-analysis; Disease; Antibody; Immunology","score_opus":0.25534775306219165,"score_gpt":0.4745425475314197,"score_spread":0.21919479446922807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987306105","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029426363,0.99226594,0.000033294215,0.001617354,0.00017875433,0.0051907343,0.0005770874,0.000035668036,0.000071770235],"genre_scores_gemma":[0.0004920025,0.9893244,0.00013456555,0.0067606573,0.00016137032,0.0014856621,0.00124411,0.00006224307,0.00033501277],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99690914,0.00032967603,0.000995348,0.00065834745,0.000426626,0.00068088085],"domain_scores_gemma":[0.9959901,0.0025289438,0.00035467005,0.00056159595,0.00010352483,0.0004611683],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004942612,0.0005871819,0.003570096,0.00095442974,0.000050844254,0.000012754589,0.00036917764,0.00017879889,0.0009867814],"category_scores_gemma":[0.0000056788963,0.00046988635,0.0028004984,0.0009505749,0.00015737569,0.000058267586,0.00012506019,0.00040948248,0.000024456704],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000491383,0.0025154662,0.00015016654,0.011779275,0.89859116,0.00041040414,0.00002575309,0.00002846511,0.000017623825,0.00003328315,0.0021373415,0.08381969],"study_design_scores_gemma":[0.00079841755,0.00031081386,0.000082839964,0.00038942264,0.609441,0.0000019323809,0.000006511605,0.00003726395,0.00001747924,0.000043849188,0.38866228,0.00020817237],"about_ca_topic_score_codex":0.000049285132,"about_ca_topic_score_gemma":0.000024410076,"teacher_disagreement_score":0.38652495,"about_ca_system_score_codex":0.00020300224,"about_ca_system_score_gemma":0.0005239987,"threshold_uncertainty_score":0.99992645},"labels":[],"label_agreement":null},{"id":"W1988085185","doi":"10.1111/apt.12169","title":"The natural history of gastro‐oesophageal reflux symptoms in the community and its effects on survival: a longitudinal 10‐year follow‐up study","year":2012,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Health Sciences Centre; McMaster University Medical Centre","funders":"McMaster University; AstraZeneca","keywords":"Medicine; Internal medicine; Irritable bowel syndrome; Quality of life (healthcare); Asymptomatic; Reflux; Odds ratio; Natural history; Hazard ratio; Univariate analysis; Multivariate analysis; Body mass index; Confidence interval; Gastroenterology; Disease","score_opus":0.05375388764962509,"score_gpt":0.34761087581085304,"score_spread":0.29385698816122796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988085185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99114835,0.00524342,2.3854125e-7,0.00035859883,0.0017484652,0.0012586898,0.0000075949556,0.000022975366,0.00021167606],"genre_scores_gemma":[0.9958222,0.00012946289,0.000011566971,0.003021618,0.00017145203,0.000100894635,0.000026304899,0.000028805693,0.0006877099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969456,0.0016346619,0.00031623102,0.000194964,0.00038509705,0.00052343943],"domain_scores_gemma":[0.9981869,0.0011494379,0.00013739905,0.00036087868,0.000054256005,0.000111158384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010771329,0.00029408792,0.0003915352,0.000089283145,0.00023757834,0.000007763675,0.0002928457,0.00007004994,0.00006020715],"category_scores_gemma":[0.0000023568377,0.00017139952,0.000100252335,0.00012647618,0.00020484482,0.00009774478,0.00011109282,0.0007931734,0.000021090858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024243451,0.0038648667,0.97498935,0.000049680264,0.0066399984,0.00018568,0.0058470247,6.889e-7,0.0043746107,0.000046744644,0.00037693465,0.001200043],"study_design_scores_gemma":[0.012795135,0.005834855,0.9692296,0.00002256151,0.0060654627,0.00005327108,0.0009966153,0.000023307322,0.0042862436,0.0000123061345,0.0005808125,0.000099861965],"about_ca_topic_score_codex":0.000049302213,"about_ca_topic_score_gemma":0.000022912865,"teacher_disagreement_score":0.01037079,"about_ca_system_score_codex":0.00033201854,"about_ca_system_score_gemma":0.000059156286,"threshold_uncertainty_score":0.69894695},"labels":[],"label_agreement":null},{"id":"W1988306998","doi":"10.1046/j.1365-2036.2001.00941.x","title":"A dose‐ranging, placebo‐controlled, randomized trial of alosetron in patients with functional dyspepsia","year":2001,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Placebo; Dose-ranging study; Adverse effect; Abdominal pain; Internal medicine; Constipation; Randomized controlled trial; Gastroenterology; Postprandial; Anesthesia; Surgery; Double blind","score_opus":0.01791414591029936,"score_gpt":0.28202900196239417,"score_spread":0.2641148560520948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988306998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99315196,0.0002380669,0.000114858485,0.0019727917,0.0003853554,0.0034219944,0.000007412532,0.000029692013,0.00067783654],"genre_scores_gemma":[0.99339175,0.00008806368,0.00038323045,0.0055964505,0.00009802346,0.0001572695,0.00009934595,0.000022105136,0.00016374397],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982101,0.0003323924,0.0005425774,0.00026234123,0.00031499934,0.0003375891],"domain_scores_gemma":[0.99906677,0.00040729358,0.00019934482,0.00014490468,0.000094212664,0.00008746357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004740086,0.00023155844,0.0008578196,0.00020970809,0.00004762274,0.0000044000776,0.00008268661,0.00007346825,0.00087298517],"category_scores_gemma":[0.0000023299447,0.00017465495,0.000189334,0.00020210771,0.00029774295,0.000078339865,0.000023914708,0.00027022423,0.00001123589],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89147705,0.0028800834,0.10027511,0.000015105045,0.0040499265,0.000018127172,0.000114950126,0.000115019946,0.0007030019,0.000013588761,0.00007252335,0.00026549178],"study_design_scores_gemma":[0.9663068,0.0037454916,0.021982498,0.000031380183,0.006707729,0.000015509238,0.000083345956,0.00052428385,0.00020157389,0.00006664796,0.00021689574,0.00011782796],"about_ca_topic_score_codex":0.000056014807,"about_ca_topic_score_gemma":0.00001771608,"teacher_disagreement_score":0.07829261,"about_ca_system_score_codex":0.00008583393,"about_ca_system_score_gemma":0.00009764897,"threshold_uncertainty_score":0.9558575},"labels":[],"label_agreement":null},{"id":"W1989369838","doi":"10.1046/j.1365-2036.2003.01523.x","title":"Therapeutic value of a gastroenterology consultation in irritable bowel syndrome","year":2003,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Manitoba Health","funders":"Crohn's and Colitis Foundation","keywords":"Irritable bowel syndrome; Medicine; Internal medicine; Intervention (counseling); Distress; Intensive care medicine; Physical therapy; Psychiatry","score_opus":0.021751108831398497,"score_gpt":0.30080035612993067,"score_spread":0.2790492472985322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989369838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952537,0.0008379781,0.00023348568,0.0022490567,0.00028300117,0.00059789285,0.000010046616,0.00003028901,0.00050458405],"genre_scores_gemma":[0.9819397,0.00016846451,0.0014982299,0.016227158,0.000010020555,0.000034993165,0.000025665862,0.000022170916,0.00007359698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998329,0.00036297104,0.00044326394,0.0002783386,0.0001536283,0.00043278682],"domain_scores_gemma":[0.9993741,0.00018662051,0.00012317467,0.00015668152,0.000069834445,0.00008959874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032148158,0.00019913762,0.00039180447,0.00018451845,0.000042855525,0.0000035465448,0.00010070245,0.000086871725,0.00050524774],"category_scores_gemma":[0.0000015320013,0.00019883823,0.00008807471,0.00021030221,0.0002784619,0.00007907459,0.000019897125,0.00028835115,0.00001871811],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046740156,0.0029508066,0.7953681,0.00014205546,0.0033931928,0.00021709048,0.0008363077,0.000415641,0.19094187,0.00075904425,0.00006165886,0.00024023576],"study_design_scores_gemma":[0.050814446,0.0196698,0.8096738,0.00023032259,0.015417989,0.005261045,0.0043510236,0.003716998,0.08273001,0.0053388258,0.0021558339,0.00063992094],"about_ca_topic_score_codex":0.00007184257,"about_ca_topic_score_gemma":0.000027016806,"teacher_disagreement_score":0.10821186,"about_ca_system_score_codex":0.000084948224,"about_ca_system_score_gemma":0.00010412887,"threshold_uncertainty_score":0.81083876},"labels":[],"label_agreement":null},{"id":"W1989523897","doi":"10.1111/j.1365-2036.2012.05189.x","title":"Review article: non‐malignant haematological complications of anti‐tumour necrosis factor alpha therapy","year":2012,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"Cilag; UCB Pharma; Biogen; Sanofi; AstraZeneca; Genentech; Amgen","keywords":"Medicine; Adalimumab; Infliximab; Etanercept; Adverse effect; Internal medicine; Tumor necrosis factor alpha; Immunology; Gastroenterology; Oncology","score_opus":0.0958549959762631,"score_gpt":0.3878390665469855,"score_spread":0.2919840705707224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989523897","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026167128,0.9944484,0.000012548815,0.00039355404,0.00035607436,0.0017078379,0.00036896885,0.000019402345,0.00007646636],"genre_scores_gemma":[0.0048744665,0.9840998,0.0001811674,0.009164825,0.00011880979,0.00038090802,0.0010540289,0.000076128876,0.000049864142],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975945,0.00035347338,0.00081399886,0.0005667679,0.00014604194,0.00052521477],"domain_scores_gemma":[0.9985897,0.00005431804,0.00057877175,0.0005388534,0.00008639866,0.00015194606],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014349275,0.0006102746,0.001479956,0.00005239669,0.00012761801,0.000010379209,0.000542435,0.00039256082,0.000359137],"category_scores_gemma":[2.509892e-7,0.00045453856,0.0006358401,0.00019843252,0.00024077031,0.000008405734,0.00018289353,0.00024214717,0.00006924152],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008884703,0.006546976,0.001398627,0.010709428,0.05280864,0.000021478167,0.00008802356,7.104844e-7,0.046301164,0.000029680457,0.0059371046,0.8760693],"study_design_scores_gemma":[0.0009935942,0.0003577059,0.00012874762,0.0012175441,0.020536881,0.00008946094,0.000004267506,0.0000010319625,0.021235451,0.00000975742,0.9549637,0.00046186315],"about_ca_topic_score_codex":0.000017646396,"about_ca_topic_score_gemma":0.0000023913465,"teacher_disagreement_score":0.9490266,"about_ca_system_score_codex":0.00003979737,"about_ca_system_score_gemma":0.00021993823,"threshold_uncertainty_score":0.9997906},"labels":[],"label_agreement":null},{"id":"W1990831946","doi":"10.1046/j.1365-2036.2001.01037.x","title":"Review article: lymphatic vessel pumping and inflammation—the role of spontaneous constrictions and underlying electrical pacemaker potentials","year":2001,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Fondation pour la Recherche Médicale; Heart and Stroke Foundation of Canada; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Lymphatic system; Tissue fluid; Medicine; Homeostasis; Inflammation; Lymphatic vessel; Mechanism (biology); Interstitial fluid; Neuroscience; Anatomy; Pathology; Internal medicine; Biology","score_opus":0.060311162258001434,"score_gpt":0.3769573869307039,"score_spread":0.3166462246727025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990831946","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002289845,0.9942603,0.000015210347,0.0010246161,0.00016925152,0.0020845418,0.000020715748,0.000034690387,0.000100805286],"genre_scores_gemma":[0.0022763782,0.9925683,0.00004951978,0.004658887,0.0001515766,0.00014945363,0.00005989626,0.00003799025,0.000047979476],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978513,0.00052344025,0.00079935533,0.00031467548,0.0002086714,0.00030254194],"domain_scores_gemma":[0.99825,0.00080841844,0.00046874484,0.00023557317,0.00007861793,0.00015863514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031226157,0.0003465759,0.0013196842,0.00013890641,0.00018409188,0.000021593842,0.00008627495,0.00015436682,0.00016032519],"category_scores_gemma":[0.0000030862877,0.00024039649,0.0001961656,0.0003997728,0.00026026397,0.000066212524,0.00006583347,0.0000852997,0.000011112547],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007723016,0.00027222093,0.0002989977,0.021236371,0.014730594,0.0003620388,0.00012368031,4.771741e-7,0.00089867716,0.000110754365,0.00028919402,0.96159977],"study_design_scores_gemma":[0.0017904836,0.0002791485,0.0000547195,0.015637768,0.17550631,0.02134648,0.00020152246,0.00017416252,0.00013141516,0.0001306641,0.7843716,0.00037572256],"about_ca_topic_score_codex":0.000011833635,"about_ca_topic_score_gemma":8.2210886e-7,"teacher_disagreement_score":0.961224,"about_ca_system_score_codex":0.00013758255,"about_ca_system_score_gemma":0.00036529888,"threshold_uncertainty_score":0.9803085},"labels":[],"label_agreement":null},{"id":"W1992118657","doi":"10.1111/j.1365-2036.2009.04037.x","title":"Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections","year":2009,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":214,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Procter and Gamble; Pfizer; Amgen","keywords":"Medicine; Infliximab; Ulcerative colitis; Inflammatory bowel disease; Azathioprine; Internal medicine; Clostridium difficile; Thiopurine methyltransferase; Relative risk; Gastroenterology; Crohn's disease; Immunology; Antibiotics; Disease; Confidence interval","score_opus":0.00349494635319812,"score_gpt":0.22908903533565028,"score_spread":0.22559408898245217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992118657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986077,0.00042389613,0.0000035197643,0.00018010433,0.00010622308,0.0005865827,0.00005659359,0.000009013673,0.000026366319],"genre_scores_gemma":[0.9969417,0.00022617448,0.000040584822,0.0026347495,0.00006272295,0.000029430195,0.000038751314,0.000018796603,0.000007102681],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896276,0.00028458855,0.00024704408,0.00022309406,0.00008769233,0.00019480995],"domain_scores_gemma":[0.99950826,0.00003017818,0.00016245374,0.00018798356,0.000041159343,0.00006997902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001826161,0.00018046059,0.00013695087,0.000047357185,0.00011564789,0.000013670103,0.00009725271,0.00006454569,0.000019576544],"category_scores_gemma":[8.56468e-7,0.0001360627,0.00004002954,0.00004235968,0.00047846997,0.00001421127,0.000069129674,0.000121997735,6.4622793e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008023702,0.0002837188,0.97001225,0.00001535852,0.0015373883,0.000004441894,0.00050015264,0.00020697962,0.018770639,0.0000375317,0.000010293951,0.00059754145],"study_design_scores_gemma":[0.011099796,0.00029954853,0.9841777,0.000010014541,0.001378152,0.0000014668258,0.00006320154,0.00022238106,0.002208971,0.000100800986,0.00026192743,0.00017605528],"about_ca_topic_score_codex":0.000023999122,"about_ca_topic_score_gemma":0.000020290357,"teacher_disagreement_score":0.016561668,"about_ca_system_score_codex":0.000016546059,"about_ca_system_score_gemma":0.000054356326,"threshold_uncertainty_score":0.5548476},"labels":[],"label_agreement":null},{"id":"W1993044499","doi":"10.1111/apt.12053","title":"The rising incidence of eosinophilic oesophagitis is associated with increasing biopsy rates: a population‐based study","year":2012,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"Health Research Board","keywords":"Medicine; Eosinophilic esophagitis; Incidence (geometry); Dysphagia; Population; Biopsy; Gastroenterology; Internal medicine; Disease; Surgery","score_opus":0.034726163665617676,"score_gpt":0.3462033962424816,"score_spread":0.3114772325768639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993044499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99111485,0.0043130545,0.000015037218,0.00254469,0.0004585836,0.0013581144,0.000037952836,0.00009644185,0.000061255436],"genre_scores_gemma":[0.98629147,0.00008735681,0.00040119654,0.0127288215,0.00022575095,0.000065965025,0.00007476645,0.00007392559,0.000050742798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968939,0.00078221253,0.0006590552,0.00036014363,0.00060077256,0.0007039037],"domain_scores_gemma":[0.9974878,0.00112926,0.00047724182,0.00045998083,0.00024062132,0.0002050884],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011171689,0.00037126464,0.000545117,0.00018297449,0.00048582867,0.000027372202,0.0002775738,0.00013394943,0.0002432455],"category_scores_gemma":[0.0000056686786,0.00027392776,0.000110167945,0.0006625282,0.00031848418,0.00027119345,0.00009006056,0.00042093385,0.0000136384815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007803474,0.001765553,0.95591784,0.000017315067,0.006270513,0.00007009831,0.0015075891,0.000011693206,0.03303042,0.0000066251737,0.000046423513,0.0005755646],"study_design_scores_gemma":[0.005435846,0.0013256051,0.9303598,0.00011466169,0.011591034,0.00019941392,0.0007041368,0.00039253864,0.049486525,0.000038182225,0.00006304296,0.0002892605],"about_ca_topic_score_codex":0.0006016806,"about_ca_topic_score_gemma":0.00003130616,"teacher_disagreement_score":0.025558105,"about_ca_system_score_codex":0.00036771782,"about_ca_system_score_gemma":0.00016537175,"threshold_uncertainty_score":0.9999713},"labels":[],"label_agreement":null},{"id":"W1993511159","doi":"10.1111/apt.12107","title":"Commentary: detection of infliximab levels and anti‐infliximab antibodies","year":2012,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Infliximab; Medicine; Monoclonal antibody; Antibody; Immunology; Internal medicine; Drug; Inflammatory bowel disease; Tumor necrosis factor alpha; Disease; Pharmacology","score_opus":0.022038582187641525,"score_gpt":0.2911773900027336,"score_spread":0.2691388078150921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993511159","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90201724,0.006356775,0.000039211132,0.0879848,0.001938431,0.0008601209,0.00066735526,0.000041680025,0.00009440532],"genre_scores_gemma":[0.36104172,0.0012045886,0.000112550726,0.634101,0.0023371866,0.000049435414,0.0009446229,0.00009784916,0.00011107445],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99761283,0.0004210762,0.0005317434,0.0005473056,0.00024953048,0.0006375219],"domain_scores_gemma":[0.99887323,0.00005158498,0.0004110431,0.00045206657,0.0001121237,0.00009996768],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022214971,0.00057954807,0.0004882437,0.0001533744,0.00016341044,0.000018738778,0.00036175846,0.0008227921,0.00015573298],"category_scores_gemma":[3.3163042e-7,0.00060748804,0.00019296116,0.00006714321,0.00057937816,0.000019888274,0.00033410423,0.0007332155,0.000013687726],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037409776,0.00018816051,0.010808502,0.00022908366,0.009962284,0.0001305469,0.00015049419,0.0000053441877,0.8456301,8.9786704e-7,0.13191624,0.0006042671],"study_design_scores_gemma":[0.0021180145,0.00022445814,0.008885507,0.000021088297,0.0069534313,0.00005716966,0.00004278889,0.000021172074,0.44132164,0.000015648688,0.53973246,0.00060660933],"about_ca_topic_score_codex":0.000029484801,"about_ca_topic_score_gemma":0.000008048566,"teacher_disagreement_score":0.5461162,"about_ca_system_score_codex":0.000059724993,"about_ca_system_score_gemma":0.00007292461,"threshold_uncertainty_score":0.99963766},"labels":[],"label_agreement":null},{"id":"W1993814109","doi":"10.1111/j.1365-2036.2004.02194.x","title":"International validation of ReQuest in patients with endoscopy‐negative gastro‐oesophageal reflux disease","year":2004,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Reflux; Cronbach's alpha; Construct validity; Internal medicine; Intraclass correlation; Esophagogastroduodenoscopy; Gastroenterology; Endoscopy; Disease; Rating scale; Gastro-; Psychometrics; Clinical psychology; Psychology","score_opus":0.014289779714584998,"score_gpt":0.305799735042829,"score_spread":0.291509955328244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993814109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99780273,0.000048472786,0.000029316232,0.00074024795,0.0003270862,0.00068470073,0.00012664087,0.000026000786,0.00021479854],"genre_scores_gemma":[0.9948509,0.00004791176,0.0018535623,0.0024846662,0.000074026146,0.000047288147,0.0005613877,0.00002736851,0.000052938176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987209,0.00007501163,0.00031615276,0.00028481247,0.00033421844,0.00026893936],"domain_scores_gemma":[0.9993795,0.000040174687,0.0001568634,0.00015416995,0.00012270537,0.00014655304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000072204835,0.00021193958,0.00025670757,0.0001710104,0.000039977404,0.000005920706,0.00011866513,0.00004751537,0.0002912014],"category_scores_gemma":[5.290252e-7,0.00017342076,0.000058332233,0.0001503757,0.00015093265,0.00017674499,0.00003824391,0.00018256436,0.0000154711],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031631584,0.0026106066,0.98672765,0.000018158755,0.0030705712,0.0002954555,0.00025899863,0.00018052646,0.0034076339,0.000019983667,0.000008903698,0.0002383763],"study_design_scores_gemma":[0.022693962,0.0018674508,0.87258124,0.000051500236,0.0030070804,0.000005192235,0.000027612272,0.000014057927,0.099487424,0.0001508306,0.000033552016,0.00008008965],"about_ca_topic_score_codex":0.000026680955,"about_ca_topic_score_gemma":0.0000014546836,"teacher_disagreement_score":0.11414638,"about_ca_system_score_codex":0.00033616007,"about_ca_system_score_gemma":0.00011893898,"threshold_uncertainty_score":0.7071893},"labels":[],"label_agreement":null},{"id":"W1994516209","doi":"10.1111/j.1365-2036.2005.02431.x","title":"<i>Controlled trial of interventions to increase testing and treatment for </i>Helicobacter pylori<i> and reduce medication use in patients with chronic acid‐related symptoms</i>","year":2005,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Agency for Healthcare Research and Quality","keywords":"Medicine; Helicobacter pylori; Proton-pump inhibitor; Internal medicine; Psychological intervention; Proton pump; Pharmacist; Randomized controlled trial; Intervention (counseling); Gastroenterology; Histamine; Intensity (physics); Physical therapy; Pharmacy; Family medicine; Nursing","score_opus":0.036344486118703195,"score_gpt":0.3224860767284479,"score_spread":0.28614159060974476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994516209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98931843,0.0005124371,0.000017433096,0.005048315,0.00023209512,0.0047774836,0.000050647028,0.000034557586,0.000008599412],"genre_scores_gemma":[0.99348235,0.00030910847,0.0012367346,0.0039227623,0.00013086108,0.0007446939,0.000088279674,0.000033036617,0.000052194173],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99829495,0.00017012536,0.0006781885,0.00037707985,0.00012679459,0.00035288828],"domain_scores_gemma":[0.9989033,0.0003811747,0.00024252567,0.00016411411,0.00015361953,0.00015526834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023148034,0.0002740691,0.0006168977,0.00023220212,0.00008294292,0.000008434617,0.00006411282,0.00011449595,0.00002141243],"category_scores_gemma":[0.000006725033,0.00021521591,0.000076576776,0.00017404888,0.00020308571,0.00015553254,0.000057533805,0.00017048423,0.0000018344313],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22759037,0.0041087824,0.69994855,0.00007278061,0.01643625,0.0000069087714,0.0008793599,0.000026892456,0.03400865,0.0000030863036,0.000067968336,0.016850425],"study_design_scores_gemma":[0.64992046,0.026259376,0.29862428,0.00023333178,0.017769545,0.000019935023,0.00004048986,0.00030012988,0.006036263,0.0000047269154,0.00056239666,0.00022905732],"about_ca_topic_score_codex":0.0000772309,"about_ca_topic_score_gemma":0.00012852013,"teacher_disagreement_score":0.4223301,"about_ca_system_score_codex":0.0003059507,"about_ca_system_score_gemma":0.00007455176,"threshold_uncertainty_score":0.87762505},"labels":[],"label_agreement":null},{"id":"W1994835085","doi":"10.1111/j.1365-2036.2009.03989.x","title":"Risk of upper gastrointestinal bleeding with oral bisphosphonates and non steroidal anti‐inflammatory drugs: a case‐control study","year":2009,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Bone health and treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; McGill University; University of British Columbia; Kingston Health Sciences Centre; Queen's University; Vancouver Coastal Health Research Institute; Vancouver Coastal Health","funders":"University of Ghana Business School","keywords":"Medicine; Internal medicine; Odds ratio; Cohort; Upper gastrointestinal bleeding; Bisphosphonate; Cohort study; Osteoporosis; Endoscopy","score_opus":0.013113995241099673,"score_gpt":0.3047719062512454,"score_spread":0.2916579110101457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994835085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99659073,0.00088060414,0.00001928585,0.00091566105,0.00011026661,0.0013559913,0.000043519238,0.00004395028,0.00004000427],"genre_scores_gemma":[0.99293846,0.00016600241,0.0010706043,0.00567792,0.000043364045,0.000026805996,0.000007820145,0.00002657364,0.00004242371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849474,0.00014866146,0.000381326,0.00033241796,0.00020270735,0.00044015865],"domain_scores_gemma":[0.99919915,0.000127527,0.00021117453,0.00015767584,0.0000867436,0.00021774857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027023038,0.0002887685,0.00048939756,0.00012123851,0.00016554537,0.00000887228,0.00006116916,0.00005188594,0.000091484435],"category_scores_gemma":[2.2466816e-7,0.00021807554,0.000055468005,0.00011910599,0.00014977234,0.00010072035,0.000021291842,0.00031714127,0.000004655797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038206195,0.0017342028,0.965353,0.000029446634,0.005531518,0.0021054833,0.0011281894,0.0000120858895,0.0151487375,9.330617e-7,0.000019071136,0.005116718],"study_design_scores_gemma":[0.03205236,0.015470775,0.904124,0.00008053264,0.02631295,0.005121986,0.0023402532,0.0010663581,0.01312195,0.000014493733,0.000048529175,0.00024582015],"about_ca_topic_score_codex":0.00029114334,"about_ca_topic_score_gemma":0.000028137498,"teacher_disagreement_score":0.061229,"about_ca_system_score_codex":0.00007114423,"about_ca_system_score_gemma":0.00009702333,"threshold_uncertainty_score":0.8892862},"labels":[],"label_agreement":null},{"id":"W1995938443","doi":"10.1111/apt.13181","title":"Systematic review: thalidomide and thalidomide analogues for treatment of inflammatory bowel disease","year":2015,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Thalidomide; Medicine; Discontinuation; Adverse effect; Internal medicine; Ulcerative colitis; Randomized controlled trial; Inflammatory bowel disease; Gastroenterology; Cochrane Library; Crohn's disease; Meta-analysis; Placebo; Disease; Pathology; Alternative medicine","score_opus":0.10748600083664463,"score_gpt":0.43582567701576763,"score_spread":0.328339676179123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995938443","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023168781,0.9831442,0.0000030622505,0.00036174493,0.00026932432,0.014949295,0.00096770475,0.000045265748,0.000027662616],"genre_scores_gemma":[0.00004254906,0.99152875,0.00017122515,0.0017129811,0.00020609348,0.0038387585,0.0019587236,0.000111076166,0.00042986116],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99627054,0.0007932694,0.0013596226,0.0006007363,0.0004111232,0.0005647228],"domain_scores_gemma":[0.9967226,0.00081152876,0.0009822234,0.0006245268,0.00021344655,0.00064570474],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005345033,0.0007941927,0.0042569693,0.0002808478,0.00009559565,0.000013489445,0.0002316673,0.00020754122,0.000068749694],"category_scores_gemma":[0.000005377471,0.0005231153,0.00088406925,0.00014533997,0.00028531614,0.00007305356,0.00008411177,0.00014399068,0.000029272689],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009399604,0.0012094065,0.00026605165,0.90278316,0.07480855,0.0003804586,0.000101720274,1.9621766e-7,0.000022967093,0.000007839708,0.00085416617,0.018625502],"study_design_scores_gemma":[0.010476477,0.0022859338,0.00002379385,0.18343692,0.50597596,0.0002423983,0.000047701993,0.000061714425,0.00014569814,0.000041955846,0.29666987,0.0005915722],"about_ca_topic_score_codex":0.000020854312,"about_ca_topic_score_gemma":0.0000030435608,"teacher_disagreement_score":0.7193463,"about_ca_system_score_codex":0.0005988114,"about_ca_system_score_gemma":0.00080038613,"threshold_uncertainty_score":0.99972206},"labels":[],"label_agreement":null},{"id":"W1996762000","doi":"10.1046/j.1365-2036.2003.01463.x","title":"Indicators and predictors of response to anti‐viral therapy in chronic hepatitis C","year":2003,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Ribavirin; Hepatocellular carcinoma; Interferon; Cirrhosis; Viral load; Liver biopsy; Pegylated interferon; Hepatitis C; Internal medicine; Viral hepatitis; Immunology; Gastroenterology; Biopsy; Chronic hepatitis; Virus","score_opus":0.06869186745555833,"score_gpt":0.4262803413978528,"score_spread":0.3575884739422945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996762000","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19212694,0.8040239,0.0000010096651,0.00031340527,0.00042927012,0.0028272069,0.00016709941,0.000028319822,0.00008284829],"genre_scores_gemma":[0.0064561474,0.98860687,0.00009076856,0.0039492273,0.00016898445,0.00032133088,0.00010423603,0.00013089081,0.00017153581],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952552,0.0018595215,0.0010284291,0.00065459165,0.00048450683,0.0007177638],"domain_scores_gemma":[0.99835604,0.0005357877,0.000282889,0.00044051785,0.00005556124,0.00032922495],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010241324,0.0005729512,0.0020623219,0.0014994468,0.00006538562,0.000011718906,0.00034092116,0.00048469513,0.00071828376],"category_scores_gemma":[0.0000018692324,0.00050078734,0.00025255638,0.001010529,0.00041880866,0.00007310517,0.0001505752,0.00097092614,0.000045770783],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011931419,0.00062463956,0.042191196,0.0030072154,0.01442121,0.00041242794,0.0005449142,0.0000014237495,0.00393175,0.0000040263276,0.00072797533,0.93294007],"study_design_scores_gemma":[0.0027670811,0.0029685432,0.0031734183,0.0013886179,0.005217161,0.000052095846,0.000008724581,0.0000057107477,0.0015061897,0.0000024743529,0.9825487,0.00036128235],"about_ca_topic_score_codex":0.00021232151,"about_ca_topic_score_gemma":0.000034279055,"teacher_disagreement_score":0.9818207,"about_ca_system_score_codex":0.0010288344,"about_ca_system_score_gemma":0.0017064243,"threshold_uncertainty_score":0.99974436},"labels":[],"label_agreement":null},{"id":"W1999440853","doi":"10.1111/apt.13123","title":"Letter: reversibility of hepatic fibrosis and immunosuppression withdrawal in patients with autoimmune hepatitis/primary biliary cirrhosis overlap syndrome","year":2015,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Immunosuppression; Overlap syndrome; Autoimmune hepatitis; Medicine; Primary biliary cirrhosis; Gastroenterology; Cirrhosis; Internal medicine; Fibrosis; Liver biopsy; Hepatitis; Immunology; Biopsy; Disease","score_opus":0.01249274304056136,"score_gpt":0.25210947534212896,"score_spread":0.2396167323015676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999440853","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95507026,0.0035298874,0.0000010795158,0.038502682,0.0006303334,0.0016063866,0.0005481518,0.00004630281,0.00006491506],"genre_scores_gemma":[0.42435455,0.0016092584,0.0003025412,0.5694451,0.00020083095,0.00007235211,0.0036055306,0.000118511496,0.00029132876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966261,0.0006460885,0.0007967261,0.0006746282,0.00068255677,0.0005739195],"domain_scores_gemma":[0.9981494,0.00024029659,0.00048050733,0.00078334473,0.00021740585,0.00012906925],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002798344,0.00062793266,0.0012876709,0.0003139397,0.00011114511,0.000015677511,0.0003350519,0.0005684007,0.00039459352],"category_scores_gemma":[6.8621324e-7,0.00052933575,0.00018142113,0.00028180127,0.0006267341,0.0002809975,0.00035779108,0.0016584917,0.0000082841],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031354395,0.0014996426,0.89367044,0.0011650164,0.0078099384,0.00038499813,0.00033913273,0.0000017642011,0.0022850567,9.289645e-8,0.08939056,0.00031793682],"study_design_scores_gemma":[0.010689189,0.0035031678,0.949993,0.0007339076,0.016848834,0.000056138153,0.00003267647,0.00004536189,0.0007402867,0.000025395448,0.016739126,0.00059291197],"about_ca_topic_score_codex":0.0013693001,"about_ca_topic_score_gemma":0.000003963557,"teacher_disagreement_score":0.5309424,"about_ca_system_score_codex":0.0006123633,"about_ca_system_score_gemma":0.0003400373,"threshold_uncertainty_score":0.9997158},"labels":[],"label_agreement":null},{"id":"W2000390985","doi":"10.1046/j.1365-2036.2000.00864.x","title":"A randomized controlled trial to assess alendronate‐associated injury of the upper gastrointestinal tract","year":2000,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Bone health and treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Placebo; Gastroenterology; Internal medicine; Duodenum; Alendronic acid; Antrum; Esophagogastroduodenoscopy; Prostaglandin E2; Randomized controlled trial; Prostaglandin E; Stomach; Endoscopy; Osteoporosis; Pathology; Bisphosphonate","score_opus":0.04284308466715503,"score_gpt":0.3706140366855408,"score_spread":0.3277709520183858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000390985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821918,0.00029804374,0.0000032589312,0.0085397465,0.00073606975,0.007235782,0.000044159788,0.000046188507,0.0009049346],"genre_scores_gemma":[0.9643103,0.00022187101,0.00023416565,0.032369625,0.0001058603,0.0005880841,0.000030537394,0.000032937325,0.002106638],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99709135,0.0009972103,0.0008205911,0.00027103806,0.00033990564,0.00047991012],"domain_scores_gemma":[0.9985296,0.00067175826,0.00026811918,0.00022586453,0.00009481289,0.00020984137],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007252362,0.00028235797,0.001384823,0.00008795091,0.00013215783,0.0000061000824,0.00016899128,0.00009302055,0.0031978567],"category_scores_gemma":[0.0000037157383,0.00017318284,0.00053371425,0.00020192312,0.00020179835,0.00004553839,0.000027522883,0.00034226378,0.000054547352],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97448415,0.0034965232,0.006978103,0.000010192226,0.006703688,0.000027968174,0.00014880003,0.000007331148,0.0067916233,0.0000055681353,0.00039688285,0.00094919425],"study_design_scores_gemma":[0.96905184,0.0023245069,0.003456749,0.000054698845,0.017511351,0.0000904283,0.000021562477,0.0001899635,0.0061779423,0.000034007884,0.0009647507,0.00012220211],"about_ca_topic_score_codex":0.00012467436,"about_ca_topic_score_gemma":0.0000062587615,"teacher_disagreement_score":0.02382988,"about_ca_system_score_codex":0.00015835516,"about_ca_system_score_gemma":0.00030049123,"threshold_uncertainty_score":0.9977133},"labels":[],"label_agreement":null},{"id":"W2000658018","doi":"10.1046/j.1365-2036.2002.01289.x","title":"Systematic review: the effectiveness of budesonide therapy for Crohn's disease","year":2002,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Budesonide; Medicine; Placebo; Adverse effect; Corticosteroid; Crohn's disease; Internal medicine; Randomized controlled trial; Gastroenterology; Clinical trial; Disease; Pathology","score_opus":0.029033950149305588,"score_gpt":0.3489422643288514,"score_spread":0.3199083141795458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000658018","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016995835,0.9864547,0.000026573662,0.00007243106,0.000625046,0.012122349,0.00048921036,0.000019450204,0.000020264031],"genre_scores_gemma":[0.00009039994,0.9863653,0.00001922576,0.0072601265,0.0002708144,0.004896906,0.00082650007,0.00013608557,0.00013462463],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946561,0.0030890543,0.0009887378,0.00060020335,0.00022229236,0.00044364567],"domain_scores_gemma":[0.9973231,0.0006382771,0.00077094365,0.00096059276,0.0001605251,0.00014654509],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013357953,0.00068970706,0.0017015006,0.00006986932,0.00015946313,0.00001533187,0.0009868157,0.00025525803,0.00007205024],"category_scores_gemma":[0.0000050115577,0.00045444866,0.0012884663,0.00013449971,0.00029538208,0.000006091893,0.00014645416,0.00022962345,0.000022233779],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092378544,0.00047803944,0.000011922863,0.95884514,0.03207169,0.00009075653,0.0000126180375,0.000004040528,0.00045979625,0.00001957967,0.0016901395,0.0053925184],"study_design_scores_gemma":[0.0020180794,0.00035095893,0.00006935515,0.13137269,0.15240414,0.000034068282,0.000008098185,0.000015000033,0.0005215795,0.000030051126,0.71221274,0.0009632293],"about_ca_topic_score_codex":0.00000159614,"about_ca_topic_score_gemma":7.269624e-7,"teacher_disagreement_score":0.82747245,"about_ca_system_score_codex":0.00007552335,"about_ca_system_score_gemma":0.00027199654,"threshold_uncertainty_score":0.9997907},"labels":[],"label_agreement":null},{"id":"W2002183730","doi":"10.1111/j.1365-2036.2005.02403.x","title":"Diagnosis and treatment of autoimmune hepatitis at age 65 and older","year":2005,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Medicine; Autoimmune hepatitis; Gastroenterology; Hepatitis; Anti-nuclear antibody; Internal medicine; Azathioprine; Jaundice; Prednisone; Ascites; Liver biopsy; Immunology; Biopsy; Antibody; Disease; Autoantibody","score_opus":0.03461944905238035,"score_gpt":0.323852228152244,"score_spread":0.28923277909986367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002183730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97072774,0.024594648,7.6292105e-7,0.00394922,0.00012455137,0.00043230277,0.000047876933,0.00002255959,0.00010032625],"genre_scores_gemma":[0.9135781,0.07760144,0.0002061888,0.00795675,0.00008368123,0.000051019153,0.000058118443,0.000016044043,0.0004486443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931026,0.00007113417,0.0001908364,0.000167083,0.000079558406,0.0001811465],"domain_scores_gemma":[0.99958956,0.000091754235,0.000060862236,0.00013855471,0.000021660839,0.000097621196],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000036560436,0.00015474294,0.00027516994,0.00004795168,0.00009797542,0.0000044257918,0.00003913791,0.000053839256,0.0012942902],"category_scores_gemma":[5.48674e-8,0.00012967856,0.000059100963,0.000046043864,0.00022355902,0.000060679984,0.00006346243,0.00005583404,0.000007678214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005359914,0.002147877,0.8184524,0.00004524808,0.00800113,0.000071161485,0.002236522,0.0000016412795,0.092013665,0.000008261344,0.0005141122,0.07597198],"study_design_scores_gemma":[0.0061947405,0.0014583718,0.8521591,0.000024062041,0.0115774665,0.000049955674,0.00009504769,0.0001923524,0.09758733,0.000007702443,0.030512126,0.00014176073],"about_ca_topic_score_codex":0.00031944606,"about_ca_topic_score_gemma":0.000017837347,"teacher_disagreement_score":0.07583022,"about_ca_system_score_codex":0.000121160236,"about_ca_system_score_gemma":0.000019828702,"threshold_uncertainty_score":0.99961865},"labels":[],"label_agreement":null},{"id":"W2002206804","doi":"10.1046/j.1365-2036.2003.01399.x","title":"Lipid‐induced colonic hypersensitivity in irritable bowel syndrome: the role of 5‐HT<sub>3</sub> receptors","year":2003,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"Vetenskapsrådet","keywords":"Irritable bowel syndrome; Medicine; Gastroenterology; Internal medicine; Placebo; Distension; Barostat; Visceral pain; Receptor; Nociception; Pathology","score_opus":0.018685131637438648,"score_gpt":0.26932803092130225,"score_spread":0.25064289928386363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002206804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99376315,0.00095884677,0.000003391319,0.0030989717,0.0005466405,0.0007495223,0.000009453215,0.00003697899,0.0008330543],"genre_scores_gemma":[0.9914563,0.00030428203,0.00015327176,0.007943407,0.000034227796,0.00003510695,0.000016885106,0.000030451465,0.000026123178],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99801195,0.0005109205,0.0004017814,0.00033195692,0.00022373867,0.00051966344],"domain_scores_gemma":[0.9990934,0.000320112,0.00013470039,0.0002586075,0.00007772178,0.00011541875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005684431,0.0002520451,0.00040819592,0.00012306005,0.000117225456,0.000006538802,0.00014223896,0.00012489092,0.000174063],"category_scores_gemma":[0.0000037361785,0.00021468195,0.0001331828,0.00036037536,0.0003022259,0.00009162974,0.00004720022,0.00053940737,0.000036062956],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070657016,0.0013585553,0.061206374,0.000032108095,0.0013170106,0.000085937274,0.00047221663,0.00005157297,0.93317163,0.000059676917,0.00009022427,0.0014481279],"study_design_scores_gemma":[0.005464823,0.0023864852,0.075882,0.00007180899,0.0039415685,0.0010198329,0.0033738117,0.00045983784,0.90344405,0.00047509998,0.003188551,0.00029215118],"about_ca_topic_score_codex":0.00014049697,"about_ca_topic_score_gemma":0.00010144574,"teacher_disagreement_score":0.029727595,"about_ca_system_score_codex":0.00014423537,"about_ca_system_score_gemma":0.00019172282,"threshold_uncertainty_score":0.8754476},"labels":[],"label_agreement":null},{"id":"W2002256622","doi":"10.1111/j.1365-2036.2005.02445.x","title":"Managing dyspepsia without alarm signs in primary care: new national guidance for England and Wales","year":2005,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Primary care; ALARM; MEDLINE; Medical emergency; Family medicine; Political science","score_opus":0.03235649907824717,"score_gpt":0.34135556418446666,"score_spread":0.3089990651062195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002256622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98576057,0.006318666,0.00014028995,0.005800114,0.00021971205,0.0009493088,0.00003924265,0.000042916716,0.0007291529],"genre_scores_gemma":[0.96817,0.0006274045,0.0073380424,0.022641873,0.00039420702,0.00006294583,0.00019158836,0.000028418499,0.00054555695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989745,0.000042479656,0.00022786402,0.000282267,0.00016861621,0.0003042844],"domain_scores_gemma":[0.99960786,0.00008676925,0.0000607142,0.00007994076,0.000050127976,0.000114574876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000110608,0.00018971057,0.00024281813,0.00010482008,0.000075480944,0.000009546876,0.000070814865,0.00006426355,0.00006269423],"category_scores_gemma":[2.0274311e-7,0.00017321942,0.00004612259,0.000068617155,0.000070783964,0.00010210487,0.000034808556,0.00013557696,0.00000919002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018913154,0.00095591723,0.81026924,0.00021958587,0.007184082,0.00021771503,0.0033840241,0.00018178417,0.10557662,0.00006434018,0.0009913282,0.069064066],"study_design_scores_gemma":[0.13656217,0.0070346245,0.49900118,0.00026140906,0.022043299,0.00058974803,0.00045354047,0.0039198757,0.18524615,0.0019062068,0.14194444,0.00103735],"about_ca_topic_score_codex":0.000012785696,"about_ca_topic_score_gemma":0.000018295093,"teacher_disagreement_score":0.31126803,"about_ca_system_score_codex":0.0003251722,"about_ca_system_score_gemma":0.00013534269,"threshold_uncertainty_score":0.70636827},"labels":[],"label_agreement":null},{"id":"W2002413889","doi":"10.1111/j.1365-2036.2009.04134.x","title":"Rotterdam score predicts early mortality in Budd‐Chiari syndrome, and surgical shunting prolongs transplant‐free survival","year":2009,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; University of Alberta","funders":"","keywords":"Medicine; Liver transplantation; Model for End-Stage Liver Disease; Budd–Chiari syndrome; Surgery; Internal medicine; Transplantation; Logistic regression; Liver disease; Gastroenterology; Inferior vena cava","score_opus":0.029927683490388945,"score_gpt":0.3091702664259358,"score_spread":0.2792425829355469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002413889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948475,0.00088126864,0.000010122496,0.0026412054,0.00029635493,0.0008311204,0.00009523626,0.00008616632,0.0003110724],"genre_scores_gemma":[0.9922096,0.0010752223,0.000060317423,0.006239597,0.0001387645,0.00002724647,0.0002057862,0.000020928192,0.000022524342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982982,0.00018159662,0.00038242486,0.00040606648,0.000295949,0.00043572608],"domain_scores_gemma":[0.99943066,0.0000955454,0.000071527065,0.0001889593,0.00002945262,0.00018383969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027445157,0.00025616752,0.00038059664,0.00013070564,0.00009254615,0.000017654476,0.00014553203,0.00014591504,0.00014603545],"category_scores_gemma":[5.4723152e-8,0.00024081071,0.00007898392,0.00017195664,0.00013812755,0.00021506242,0.000020527998,0.00037642443,0.0000067459277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017837879,0.0006843226,0.97751474,0.00010273477,0.004448283,0.0031269293,0.0013187672,0.0000076854185,0.010505988,0.000044545504,0.000009527453,0.00045266346],"study_design_scores_gemma":[0.00927812,0.000891873,0.96932024,0.00009206547,0.013224138,0.0004851397,0.00005201504,0.00025663833,0.0059187612,0.00021528616,0.00004276391,0.00022294278],"about_ca_topic_score_codex":0.00015060895,"about_ca_topic_score_gemma":0.000035184996,"teacher_disagreement_score":0.008775855,"about_ca_system_score_codex":0.00004510951,"about_ca_system_score_gemma":0.00006646846,"threshold_uncertainty_score":0.98199755},"labels":[],"label_agreement":null},{"id":"W2003058447","doi":"10.1111/j.1365-2036.2012.05087.x","title":"Commentary: what is the optimal <scp>PPI</scp> dosing following endoscopic haemostasis in acute ulcer bleeding?","year":2012,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre; McMaster University","funders":"Takeda Canada; Boston Scientific Corporation; AstraZeneca","keywords":"Medicine; Randomized controlled trial; Blinding; Regimen; Randomization; Population; Confidence interval; Internal medicine; Intensive care medicine","score_opus":0.039520400304224323,"score_gpt":0.3312858085879475,"score_spread":0.29176540828372316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003058447","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32250202,0.0130607365,0.0000052999258,0.6588037,0.003769908,0.0015946801,0.000087339955,0.000091192276,0.000085111686],"genre_scores_gemma":[0.042561058,0.007422854,0.0013287606,0.9437698,0.0030737307,0.00038093718,0.0008813099,0.00020962725,0.00037191727],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954264,0.00036880482,0.00085368764,0.00089536875,0.0007329918,0.0017227503],"domain_scores_gemma":[0.9972147,0.0014919887,0.00041611618,0.0005790536,0.000076630415,0.00022151238],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00048647932,0.0010690801,0.0012209227,0.00037288488,0.0004013839,0.00018522993,0.0005892539,0.00058690924,0.0004581427],"category_scores_gemma":[7.5528544e-7,0.00082124444,0.00065702846,0.00038435037,0.00032225501,0.0004989122,0.00033482251,0.0030121054,0.000117936404],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093192204,0.0010340128,0.11152775,0.000111647125,0.0468298,0.003217869,0.0025846339,0.0000072821463,0.0049334913,0.0000010052137,0.8279044,0.0017549393],"study_design_scores_gemma":[0.009187564,0.001687165,0.0030952732,0.0012861298,0.11775084,0.00070880697,0.0017621727,0.00014651773,0.0575944,0.000025937952,0.806297,0.00045819583],"about_ca_topic_score_codex":0.00026350896,"about_ca_topic_score_gemma":0.000005958545,"teacher_disagreement_score":0.28496608,"about_ca_system_score_codex":0.0009657183,"about_ca_system_score_gemma":0.00011813269,"threshold_uncertainty_score":0.99942386},"labels":[],"label_agreement":null},{"id":"W2003219693","doi":"10.1111/apt.13024","title":"Systematic review with meta‐analysis: magnetic resonance enterography signs for the detection of inflammation and intestinal damage in Crohn's disease","year":2014,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Inflammation; Medicine; Crohn's disease; Disease; Pathology; Magnetic resonance imaging; Internal medicine; Gastroenterology; Radiology","score_opus":0.027008360809179115,"score_gpt":0.3203174268686439,"score_spread":0.2933090660594648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003219693","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00049901067,0.99489015,0.00043701136,0.000061668376,0.0000622206,0.003943433,0.000097015116,0.000007806542,0.0000016885705],"genre_scores_gemma":[0.0013875621,0.994305,0.000082005274,0.0011930584,0.000064415486,0.0026116516,0.0002916304,0.000042621847,0.000022038988],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.997265,0.0010650319,0.0008290438,0.00045382517,0.00015034791,0.0002367415],"domain_scores_gemma":[0.9983927,0.00025029722,0.0006465747,0.00050125405,0.0001291283,0.00008006651],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006419982,0.00042011432,0.0015764913,0.00016371999,0.00007672913,0.000017565215,0.00031232653,0.000117289484,0.000021172904],"category_scores_gemma":[0.000003340877,0.0002748295,0.0008596215,0.00032683287,0.00021955426,0.000008301127,0.00008388214,0.00016223751,7.105021e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005675391,0.0002017053,0.00014088405,0.6649249,0.32459894,0.000099903154,0.000036808757,0.00003713315,0.0012835987,0.000008823798,0.000018405945,0.008081315],"study_design_scores_gemma":[0.0004927635,0.00022984327,0.00025939965,0.010687716,0.97294384,0.000012924949,0.000012978958,0.0001558789,0.00017570484,0.0000037748587,0.014705207,0.00031999368],"about_ca_topic_score_codex":0.0000043696487,"about_ca_topic_score_gemma":0.00007401795,"teacher_disagreement_score":0.6542372,"about_ca_system_score_codex":0.000022909027,"about_ca_system_score_gemma":0.00010986162,"threshold_uncertainty_score":0.9999704},"labels":[],"label_agreement":null},{"id":"W2004398477","doi":"10.1111/j.1365-2036.2004.02035.x","title":"The cost‐effectiveness of high‐dose oral proton pump inhibition after endoscopy in the acute treatment of peptic ulcer bleeding","year":2004,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; McGill University Health Centre; Montreal General Hospital","funders":"Canadian Association of Gastroenterology","keywords":"Medicine; Placebo; Proton-pump inhibitor; Endoscopy; Oral administration; Internal medicine; Surgery","score_opus":0.0702308082475799,"score_gpt":0.40287437832943374,"score_spread":0.33264357008185386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004398477","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16433468,0.82220125,0.0000035127634,0.0005865737,0.0004882554,0.012202775,0.00013620112,0.000022141641,0.000024579522],"genre_scores_gemma":[0.14567971,0.84778935,0.0001269359,0.0003278745,0.00009944377,0.005696793,0.00021160168,0.000057040314,0.000011262009],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99715775,0.0007818804,0.0008291978,0.0004315268,0.00033331857,0.0004663062],"domain_scores_gemma":[0.99778616,0.0011942681,0.0005100775,0.00034387058,0.0000952185,0.00007037417],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057884335,0.0005932991,0.001583709,0.00019432239,0.000102868,0.000016328577,0.00019448766,0.00016933188,0.00007025659],"category_scores_gemma":[6.152136e-7,0.00030802062,0.00051624596,0.00034895696,0.00035236083,0.000060093655,0.000054072025,0.00034944637,0.00001178149],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030199708,0.061199635,0.04783015,0.076425865,0.24559845,0.0060043586,0.0048894193,0.00011112911,0.020197785,0.0005771233,0.0001079449,0.5068584],"study_design_scores_gemma":[0.05206853,0.046910584,0.010008042,0.068801954,0.56273973,0.002563227,0.0005412332,0.000025882397,0.13163488,0.0005460532,0.122681744,0.001478145],"about_ca_topic_score_codex":0.00018361559,"about_ca_topic_score_gemma":0.000007811219,"teacher_disagreement_score":0.5053803,"about_ca_system_score_codex":0.0010013265,"about_ca_system_score_gemma":0.0003147977,"threshold_uncertainty_score":0.9999372},"labels":[],"label_agreement":null},{"id":"W2006813092","doi":"10.1111/j.1365-2036.2006.02942.x","title":"Introduction: the Scientific and clinical rationale for extended acid suppression","year":2006,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Renal function and acid-base balance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Omeprazole; Pharmacodynamics; Pharmacokinetics; Proton-pump inhibitor; GERD; Gastric acid; Pharmacology; Pharmacy; Clinical pharmacology; Intensive care medicine; Gastroenterology; Disease; Internal medicine; Reflux; Stomach","score_opus":0.03743190458325399,"score_gpt":0.36349258701449033,"score_spread":0.3260606824312363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006813092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88103503,0.0023797122,0.0006274184,0.10917581,0.005448952,0.0010795613,0.000026727093,0.000059972666,0.00016680139],"genre_scores_gemma":[0.94267786,0.00043985926,0.0014952254,0.041380957,0.005853814,0.0001203764,0.00046633283,0.00002525458,0.0075402996],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989917,0.00010578806,0.00027893865,0.00030310743,0.0001433344,0.0001770969],"domain_scores_gemma":[0.99944115,0.00016865427,0.00007940727,0.00016140955,0.000097479184,0.000051896408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042231873,0.0001106798,0.00015258731,0.000041531122,0.00036392765,0.00002804013,0.00006752163,0.00006138288,0.00058905187],"category_scores_gemma":[6.867845e-7,0.00007325483,0.00008187679,0.00010203557,0.00039666574,0.00007558255,0.00002693144,0.0001672907,0.00002196525],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012993986,0.0005665816,0.006332468,0.000018173889,0.0011765339,0.000005039152,0.000043078253,0.000013007051,0.8215122,0.00032178688,0.16586271,0.0028489945],"study_design_scores_gemma":[0.003545834,0.0003972858,0.013025257,0.000006438799,0.0028006001,0.000080604994,0.00007494754,0.0011958779,0.40225405,0.0004451059,0.57607174,0.00010229149],"about_ca_topic_score_codex":0.000003137558,"about_ca_topic_score_gemma":0.0000027078097,"teacher_disagreement_score":0.4192582,"about_ca_system_score_codex":0.000029024042,"about_ca_system_score_gemma":0.000060992294,"threshold_uncertainty_score":0.64497054},"labels":[],"label_agreement":null},{"id":"W2007211118","doi":"10.1046/j.1365-2036.2003.t01-1-01736.x","title":"The economic impact of irritable bowel syndrome","year":2003,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Irritable bowel syndrome; Medicine; Indirect costs; Functional gastrointestinal disorder; Intensive care medicine; Internal medicine","score_opus":0.061126642554776366,"score_gpt":0.40766935641513835,"score_spread":0.346542713860362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007211118","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002503159,0.99460566,0.0000022300826,0.0002074044,0.0007302283,0.0012336251,0.00011177276,0.000028898337,0.0005770322],"genre_scores_gemma":[0.00061554875,0.99717,0.00010376871,0.0012893698,0.00006470841,0.00006803707,0.000122012185,0.00006696557,0.0004996173],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978445,0.0003501586,0.0007688365,0.000360976,0.00013220342,0.0005432983],"domain_scores_gemma":[0.9985215,0.0004639984,0.00041490846,0.0004044382,0.00004041976,0.0001547099],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003602519,0.000488958,0.0014138795,0.00011858811,0.00015436682,0.000013576698,0.00033653615,0.0002013348,0.0010213708],"category_scores_gemma":[3.6157914e-7,0.0003184815,0.000995705,0.00012890756,0.00040145716,0.000054138465,0.00007003093,0.00061067246,0.00015198428],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026204684,0.0033794185,0.0047504613,0.023694374,0.33473185,0.00090160617,0.00030534688,0.00026793932,0.0003649353,0.00023306093,0.024253728,0.60449684],"study_design_scores_gemma":[0.0016313572,0.002473961,0.0001523744,0.0010399219,0.0647866,0.0028819682,0.000049525668,0.00004736366,0.000018359422,0.00009557035,0.9265103,0.0003127332],"about_ca_topic_score_codex":0.00013224603,"about_ca_topic_score_gemma":0.0000073732294,"teacher_disagreement_score":0.90225655,"about_ca_system_score_codex":0.000872173,"about_ca_system_score_gemma":0.0013308898,"threshold_uncertainty_score":0.99992675},"labels":[],"label_agreement":null},{"id":"W2007661163","doi":"10.1111/apt.12170","title":"Red blood cell transfusion is associated with increased rebleeding in patients with nonvariceal upper gastrointestinal bleeding","year":2012,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"National Institute for Health and Care Research; Canadian Association of Gastroenterology","keywords":"Medicine; Upper gastrointestinal bleeding; Confounding; Blood transfusion; Gastrointestinal bleeding; Internal medicine; Red Blood Cell Transfusion; Logistic regression; Prospective cohort study; Observational study; Endoscopy; Surgery","score_opus":0.016638871274067376,"score_gpt":0.2567086758052097,"score_spread":0.2400698045311423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007661163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969984,0.00014022962,0.000018322657,0.0012394817,0.00013642729,0.0009530472,0.000028134531,0.00008522187,0.00040069013],"genre_scores_gemma":[0.9897879,0.00005810218,0.004343315,0.005320084,0.000135115,0.000069047244,0.00017437617,0.000075199365,0.000036889127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976771,0.000109608496,0.0004018424,0.00043068593,0.00045607507,0.0009246797],"domain_scores_gemma":[0.99891573,0.00022674758,0.00020655582,0.00015997949,0.00016605185,0.00032491525],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029892896,0.00044112932,0.00049693475,0.0002306425,0.00016377583,0.000017981129,0.00011931131,0.00008292618,0.0004468236],"category_scores_gemma":[7.518611e-7,0.00033471096,0.00008508163,0.00040509953,0.00012037294,0.00023639655,0.000040315892,0.0004966911,0.000012015204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022937735,0.0076750754,0.9454191,0.000028131337,0.0027177585,0.0001156394,0.00046274436,0.000010046501,0.041131176,0.0000017089837,0.0000973589,0.000047523066],"study_design_scores_gemma":[0.024880007,0.0075841956,0.90841234,0.000528846,0.01716681,0.0002291901,0.00021391096,0.00013223931,0.04048671,0.0000020905068,0.00003994955,0.00032371003],"about_ca_topic_score_codex":0.0001604634,"about_ca_topic_score_gemma":0.000009143564,"teacher_disagreement_score":0.03700672,"about_ca_system_score_codex":0.00033179915,"about_ca_system_score_gemma":0.0000825445,"threshold_uncertainty_score":0.9999105},"labels":[],"label_agreement":null},{"id":"W2007879037","doi":"10.1111/apt.12555","title":"Randomised clinical trial: individualised vs. weight‐based dosing of azathioprine in Crohn's disease","year":2013,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; University of North Carolina at Chapel Hill; Medical Center, University of Pittsburgh; National Institutes of Health; Hospital for Sick Children; University of Alberta; Crohn's and Colitis Foundation; London Health Sciences Centre; Johns Hopkins University; University of Pittsburgh; Crohn's and Colitis Foundation of America","keywords":"Medicine; Dosing; Thiopurine methyltransferase; Azathioprine; Internal medicine; Gastroenterology; Weight loss; Clinical trial; Crohn's disease; Surgery; Disease; Obesity","score_opus":0.03376615730857864,"score_gpt":0.34448988076159825,"score_spread":0.31072372345301963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007879037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951369,0.00048428559,0.000044499702,0.0010207418,0.00092126033,0.0022359255,0.000049814076,0.000024545303,0.00008199465],"genre_scores_gemma":[0.97840065,0.00032610405,0.00037401455,0.019794492,0.00039452402,0.00032570254,0.0002726186,0.000052330033,0.000059595593],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9969747,0.0009034114,0.00096248364,0.0005027986,0.00021656243,0.00044006354],"domain_scores_gemma":[0.99871,0.00014049585,0.00032822893,0.00044351481,0.0001070697,0.0002707271],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006923375,0.0003101904,0.00040999844,0.0001258405,0.00006910139,0.000018524659,0.0004141512,0.00021554754,0.00068250165],"category_scores_gemma":[0.0000040507916,0.00030218306,0.00029752866,0.00012123674,0.00035722027,0.000016764345,0.00014178602,0.000237089,0.000030370975],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4069018,0.004245369,0.22394857,0.00012261413,0.005873628,0.000495868,0.00013147216,0.00040146752,0.3535837,0.000022330152,0.0025647432,0.0017084331],"study_design_scores_gemma":[0.41739932,0.0007109264,0.46703398,0.000033317814,0.004098602,0.0000022004813,0.000038801856,0.0012817399,0.10416719,0.0001284577,0.00442067,0.0006847802],"about_ca_topic_score_codex":0.000020688367,"about_ca_topic_score_gemma":0.0000064057317,"teacher_disagreement_score":0.2494165,"about_ca_system_score_codex":0.000034638124,"about_ca_system_score_gemma":0.000314418,"threshold_uncertainty_score":0.999943},"labels":[],"label_agreement":null},{"id":"W2008076771","doi":"10.1111/apt.12042","title":"Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs","year":2012,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Autoimmune hepatitis; Regimen; Corticosteroid; Tacrolimus; Adverse effect; Rituximab; Hepatitis; Internal medicine; Budesonide; Jaundice; Transplantation; Lymphoma","score_opus":0.046051427335556394,"score_gpt":0.3665314667342657,"score_spread":0.3204800393987093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008076771","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00095049635,0.99364614,0.0000026838175,0.0005518187,0.0002443413,0.004275116,0.00021213666,0.00004023081,0.00007703481],"genre_scores_gemma":[0.00025252916,0.99357086,0.0001265927,0.004172873,0.000071266324,0.00067407324,0.000550697,0.00006656109,0.00051456457],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99704504,0.0010154819,0.0008834814,0.000357923,0.0002639418,0.00043412467],"domain_scores_gemma":[0.9986243,0.00036863057,0.00042522285,0.00036535133,0.000057152083,0.00015934686],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047502803,0.0005699031,0.0025583003,0.00023732538,0.0001236571,0.000016781107,0.00015128175,0.00013390304,0.0005176229],"category_scores_gemma":[3.1662555e-7,0.00039076273,0.00034640246,0.00021881501,0.00023883984,0.000115082184,0.0000890343,0.00036445228,0.00003105596],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010847431,0.0017321707,0.0021176361,0.88625175,0.06298322,0.00048546793,0.00043861466,2.1990382e-7,0.0000105323115,0.000029360837,0.0001234996,0.0447428],"study_design_scores_gemma":[0.004653995,0.0015269486,0.0003191936,0.37092206,0.44329563,0.00096092897,0.00013333478,0.000030008412,0.000010102708,0.000002917494,0.17748575,0.0006591308],"about_ca_topic_score_codex":0.00014059871,"about_ca_topic_score_gemma":0.0000038013814,"teacher_disagreement_score":0.51532966,"about_ca_system_score_codex":0.0006900902,"about_ca_system_score_gemma":0.0004203258,"threshold_uncertainty_score":0.99985445},"labels":[],"label_agreement":null},{"id":"W2009548090","doi":"10.1111/j.1365-2036.2009.03940.x","title":"Increased health costs from mandated Therapeutic Substitution of proton pump inhibitors in British Columbia","year":2009,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Society of Intestinal Research; University of British Columbia; Fraser Institute","funders":"Ministry of Health, British Columbia","keywords":"Medicine; Reimbursement; Health care; Drug; Population; Family medicine; Christian ministry; Environmental health; Pharmacology","score_opus":0.019592212940945587,"score_gpt":0.3169109654070856,"score_spread":0.29731875246614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009548090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944292,0.0018388127,0.000008795964,0.0010100665,0.00024333378,0.0022280368,0.00011395698,0.00006487031,0.0000629315],"genre_scores_gemma":[0.9797676,0.00087049825,0.00018891288,0.01827192,0.000089039495,0.00007709377,0.00066132273,0.00002394913,0.0000496615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980504,0.0002651445,0.0005773487,0.00038092694,0.00027306125,0.0004530983],"domain_scores_gemma":[0.99927837,0.000055943605,0.0002211078,0.00019818833,0.00006578577,0.00018063655],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002099472,0.00019748577,0.00053105515,0.000100518286,0.00010153887,0.000025585803,0.00012029152,0.00013116324,0.0004798787],"category_scores_gemma":[3.0243422e-7,0.00026190473,0.00009866914,0.0002897917,0.00014563781,0.00011709945,0.000022285638,0.00029088586,0.000013669345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060193776,0.003360135,0.88236654,0.000037149828,0.0029398582,0.00057441526,0.0001982887,0.0000042455276,0.08676406,0.0000022389931,0.0001433969,0.02300776],"study_design_scores_gemma":[0.0132534,0.0026658818,0.88389117,0.00014847227,0.0024188994,0.00007134396,0.000057406396,0.00014134879,0.09655736,0.00017808277,0.00047025652,0.00014636232],"about_ca_topic_score_codex":0.013855666,"about_ca_topic_score_gemma":0.0019268396,"teacher_disagreement_score":0.022861397,"about_ca_system_score_codex":0.00049074984,"about_ca_system_score_gemma":0.00022930374,"threshold_uncertainty_score":0.9999833},"labels":[],"label_agreement":null},{"id":"W2010625095","doi":"10.1111/j.1365-2036.2008.03813.x","title":"Fluctuation of gastrointestinal symptoms in the community: a 10‐year longitudinal follow‐up study","year":2008,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; McMaster University Medical Centre","funders":"Johnson and Johnson; McMaster University; AstraZeneca","keywords":"Medicine; Longitudinal study; Internal medicine; Gastroenterology; Pathology","score_opus":0.0760744103806514,"score_gpt":0.3400972192202127,"score_spread":0.2640228088395613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010625095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951663,0.00016423757,0.000023118511,0.0031443064,0.00030035008,0.001009024,0.000011044669,0.000039892195,0.00014170464],"genre_scores_gemma":[0.9930125,0.00010068899,0.00018837643,0.006343655,0.00009782487,0.00008395686,0.000048150938,0.000024472545,0.00010038203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974377,0.0010593957,0.00053921796,0.0002347622,0.00030975978,0.0004191291],"domain_scores_gemma":[0.998888,0.0003515558,0.00017088186,0.00037023536,0.0001609844,0.00005833959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006621921,0.0002611117,0.00045553234,0.00019269608,0.00026879355,0.000004054883,0.00032835183,0.000062785795,0.00023295512],"category_scores_gemma":[0.0000023507253,0.00020197353,0.00009799705,0.0003521711,0.0005125998,0.0000839467,0.00013025408,0.00089061336,0.000033227647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002114599,0.0029287476,0.96418583,0.000013133649,0.0053667584,0.00021858615,0.009344358,0.000011497668,0.015167361,0.000002126225,0.0005115153,0.00013546825],"study_design_scores_gemma":[0.013034829,0.00891256,0.9610046,0.00003919759,0.006738731,0.0012059433,0.0065535675,0.0000894045,0.002075431,0.000014990897,0.00019267594,0.00013804594],"about_ca_topic_score_codex":0.00020660443,"about_ca_topic_score_gemma":0.000111797155,"teacher_disagreement_score":0.01309193,"about_ca_system_score_codex":0.00011090678,"about_ca_system_score_gemma":0.00007170653,"threshold_uncertainty_score":0.82362413},"labels":[],"label_agreement":null},{"id":"W2010889758","doi":"10.1046/j.1365-2036.2003.01758.x","title":"Cyclo‐oxygenase‐2 over‐expression in sporadic colorectal carcinoma without lymph node involvement","year":2003,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Colorectal cancer; Phenotype; Oxygenase; Lymph node; Internal medicine; Immunohistochemistry; Lymph; Oncology; Pathology; Gastroenterology; Cancer; Gene; Biology; Genetics","score_opus":0.01879400379817895,"score_gpt":0.2980811646896546,"score_spread":0.27928716089147565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010889758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941288,0.0019051979,0.000013605554,0.00042661314,0.0017802179,0.0010446594,0.000013459013,0.0000750986,0.00061233167],"genre_scores_gemma":[0.98094606,0.0003511969,0.00040665464,0.017632224,0.00029446126,0.00013778076,0.000070088085,0.00006579005,0.000095716205],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99758834,0.00039727337,0.0004924473,0.00048295408,0.00035718223,0.0006817784],"domain_scores_gemma":[0.9991439,0.00011504899,0.00015282758,0.00027407298,0.000044213775,0.00026996734],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004950515,0.00039028298,0.0005370009,0.00023954303,0.00013093307,0.000010337511,0.00015106845,0.00021697192,0.0009327997],"category_scores_gemma":[7.142378e-7,0.00035188155,0.00012911897,0.00025475345,0.00017584633,0.00011143118,0.000053391814,0.00039703576,0.00006746681],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000766787,0.00053560274,0.5369712,0.000056439676,0.00070516014,0.000381407,0.00047900007,0.000017751287,0.4595433,0.000021402648,0.0004080211,0.00011396346],"study_design_scores_gemma":[0.012131037,0.000511172,0.22254115,0.0000715526,0.0022902386,0.00010777248,0.00026343446,0.00074633234,0.7549716,0.000055682485,0.0059072706,0.0004027261],"about_ca_topic_score_codex":0.0000756671,"about_ca_topic_score_gemma":0.000014394903,"teacher_disagreement_score":0.31443003,"about_ca_system_score_codex":0.0004966607,"about_ca_system_score_gemma":0.00027490116,"threshold_uncertainty_score":0.9999805},"labels":[],"label_agreement":null},{"id":"W2010933154","doi":"10.1111/j.1365-2036.2006.02840.x","title":"Personal view: the management of chronic hepatitis B infection","year":2006,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Adefovir; Entecavir; Lamivudine; Medicine; Seroconversion; Pegylated interferon; Nucleoside analogue; Hepatitis B; Drug resistance; Population; Immunology; Virology; Hepatitis B virus; Internal medicine; Chronic hepatitis; Gastroenterology; Nucleoside; Virus; Ribavirin; Biology","score_opus":0.064055484858943,"score_gpt":0.38948531678569176,"score_spread":0.3254298319267488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010933154","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039393295,0.9943201,0.000014976154,0.0005320024,0.0014581316,0.002268629,0.00010632616,0.00005862614,0.00084729865],"genre_scores_gemma":[0.0003130142,0.99426377,0.00008479581,0.0030462733,0.0006819018,0.00047121037,0.0002951652,0.00008242051,0.00076146325],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99767506,0.00034806613,0.000785523,0.00040511027,0.00035140588,0.00043486248],"domain_scores_gemma":[0.99898356,0.00014480448,0.0004379853,0.00030386273,0.00007426081,0.000055553293],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002602985,0.00051873643,0.0014319199,0.00015288722,0.0001973881,0.000008045594,0.00020773645,0.00021213149,0.00070165435],"category_scores_gemma":[4.9245045e-8,0.0003591217,0.0005729539,0.00034794674,0.0003784827,0.00004433421,0.00018731489,0.0005666559,0.0001271902],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000294844,0.0006003915,0.002287279,0.017772924,0.071222246,0.00013072907,0.00012378849,0.0000010410573,0.000022905393,0.00002690397,0.0064268433,0.90135545],"study_design_scores_gemma":[0.00068585627,0.0004057273,0.0007117408,0.0023969868,0.106767066,0.00009508944,0.0000040709297,0.00002617027,0.000057705718,0.000007016881,0.8886106,0.00023197525],"about_ca_topic_score_codex":0.0013556575,"about_ca_topic_score_gemma":0.00033149452,"teacher_disagreement_score":0.90112346,"about_ca_system_score_codex":0.0007568812,"about_ca_system_score_gemma":0.00020361268,"threshold_uncertainty_score":0.9998861},"labels":[],"label_agreement":null},{"id":"W2011804255","doi":"10.1046/j.1365-2036.2003.01554.x","title":"One‐week triple therapy with esomeprazole, clarithromycin and metronidazole provides effective eradication of <i>Helicobacter pylori</i> infection","year":2003,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); Dalhousie University","funders":"","keywords":"Omeprazole; Esomeprazole; Medicine; Clarithromycin; Metronidazole; Helicobacter pylori; Internal medicine; Urea breath test; Gastroenterology; Placebo; Regimen; Breath test; Proton-pump inhibitor; Antibiotics; Helicobacter pylori infection; Microbiology; Pathology","score_opus":0.02638184441704534,"score_gpt":0.2921832684635229,"score_spread":0.26580142404647755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011804255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99070174,0.002790039,0.00025143902,0.003733393,0.00039724496,0.0018624023,0.000016990574,0.000088993234,0.0001577598],"genre_scores_gemma":[0.9791009,0.004960485,0.00092626,0.014474453,0.00009833959,0.00029056388,0.000049006354,0.000056702873,0.000043320546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978771,0.00047378094,0.00045180175,0.00048470136,0.00023925418,0.00047336478],"domain_scores_gemma":[0.99892914,0.00018744441,0.00027888615,0.0002574678,0.00021168936,0.000135342],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036581917,0.00036194004,0.00061446993,0.0002487846,0.0001697281,0.00001172775,0.00008067879,0.00019738848,0.000092143986],"category_scores_gemma":[0.0000011499034,0.00031186582,0.00008219215,0.00037479293,0.0005467411,0.00022294545,0.00003712981,0.00054473564,0.000009575651],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034560233,0.002226657,0.46548387,0.00006637762,0.025652822,0.000010469636,0.00095095794,0.000017268785,0.49510726,0.000049983915,0.00011119333,0.0068670996],"study_design_scores_gemma":[0.015183702,0.008037659,0.43498507,0.000053998818,0.0093019195,0.00014238982,0.00018293566,0.000055975695,0.5246381,0.00008444671,0.0070421183,0.00029166718],"about_ca_topic_score_codex":0.00010670429,"about_ca_topic_score_gemma":0.00002645651,"teacher_disagreement_score":0.030498799,"about_ca_system_score_codex":0.00017346362,"about_ca_system_score_gemma":0.00009356762,"threshold_uncertainty_score":0.99993336},"labels":[],"label_agreement":null},{"id":"W2012484960","doi":"10.1111/j.1365-2036.2005.02649.x","title":"Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin","year":2005,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":263,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"AstraZeneca","keywords":"Medicine; Aspirin; Internal medicine; Incidence (geometry); Odds ratio; Helicobacter pylori; Gastroenterology; Confidence interval; Asymptomatic; Duodenum; Population","score_opus":0.01146906944599588,"score_gpt":0.28080422751261724,"score_spread":0.26933515806662134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012484960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965813,0.0020654004,0.00001988907,0.00025867645,0.000059379505,0.00096667605,0.000009705925,0.000018094428,0.000020865527],"genre_scores_gemma":[0.99714774,0.0012727025,0.0008344708,0.00049346784,0.0001273394,0.00007428732,0.0000029763921,0.000018145813,0.000028857306],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99900657,0.00011101861,0.00023900974,0.00022711616,0.00019556252,0.00022074347],"domain_scores_gemma":[0.99948025,0.000065603315,0.00015285939,0.0001502544,0.00006634521,0.00008470253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015062245,0.00018251754,0.00032044522,0.000085244734,0.000049986797,0.000001815066,0.0000628617,0.000052067007,0.00009630731],"category_scores_gemma":[2.09053e-7,0.00013578362,0.000057662437,0.00008131765,0.00029319827,0.00008563975,0.000028620098,0.00011578671,0.0000021550736],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020459257,0.0004034347,0.19948737,0.0003850557,0.0047154967,0.000040073828,0.0014258536,0.00010794307,0.7894332,0.0000023340085,0.0000019562706,0.0019513477],"study_design_scores_gemma":[0.004709344,0.003357955,0.09027582,0.00012278726,0.005305005,0.000089344205,0.000090132125,0.0002021401,0.89560425,0.0000028462653,0.00013340804,0.00010696229],"about_ca_topic_score_codex":0.00003503685,"about_ca_topic_score_gemma":0.000009201015,"teacher_disagreement_score":0.10921156,"about_ca_system_score_codex":0.00013954617,"about_ca_system_score_gemma":0.000096681346,"threshold_uncertainty_score":0.5537095},"labels":[],"label_agreement":null},{"id":"W2012964005","doi":"10.1111/j.1365-2036.2004.02284.x","title":"Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario","year":2004,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":294,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Western University; McMaster University","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care","keywords":"Irritable bowel syndrome; Medicine; Intestinal permeability; Lactulose; Gastroenterology; Internal medicine; Diarrhea; Etiology; Constipation; Abdominal pain; Small intestinal bacterial overgrowth","score_opus":0.008196133706756509,"score_gpt":0.2423013854358155,"score_spread":0.234105251729059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012964005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99698037,0.00005794223,0.00002134642,0.0018582582,0.00011511289,0.0008564602,0.000038498372,0.000022521293,0.000049515344],"genre_scores_gemma":[0.99354887,0.000012577189,0.0021231147,0.0040726606,0.000008248783,0.000071280774,0.00009849448,0.000026542533,0.00003821171],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812645,0.00009308707,0.0005455242,0.00042235816,0.00024186964,0.00057071674],"domain_scores_gemma":[0.99942183,0.000029432878,0.00009856736,0.0002198947,0.00009802021,0.00013226701],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016419069,0.00029140664,0.0004920831,0.00018415217,0.00002807108,0.000006542903,0.00014513072,0.00007134311,0.00048483902],"category_scores_gemma":[4.0512282e-7,0.00025734308,0.00008255687,0.00019306764,0.00032767613,0.00017018415,0.00008353487,0.000471384,0.000009152187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010884733,0.00426471,0.9794031,0.00007289074,0.0009632964,0.0005282275,0.001134776,0.00008437967,0.0025864698,9.898018e-7,0.0000034039786,0.000073045645],"study_design_scores_gemma":[0.015535805,0.005693351,0.974029,0.00026319982,0.0018215176,0.00029885885,0.00013099788,0.000018281702,0.0019261042,0.0001159769,0.000016040687,0.00015086071],"about_ca_topic_score_codex":0.009710084,"about_ca_topic_score_gemma":0.014259136,"teacher_disagreement_score":0.0053740726,"about_ca_system_score_codex":0.0006556003,"about_ca_system_score_gemma":0.00020026848,"threshold_uncertainty_score":0.9999879},"labels":[],"label_agreement":null},{"id":"W2013323458","doi":"10.1111/apt.12933","title":"Editorial: healing of refractory reflux oesophagitis – an ongoing unmet clinical need","year":2014,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Pfizer Pharmaceuticals; AstraZeneca","keywords":"Medicine; Refractory (planetary science); Regurgitation (circulation); Internal medicine; Concomitant; Gastroenterology; Reflux; Logistic regression; Disease","score_opus":0.03801845080119557,"score_gpt":0.4153632101675441,"score_spread":0.3773447593663485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013323458","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031368215,0.0016116184,0.000015070042,0.00030536685,0.9650563,0.00084845535,0.00045210664,0.00017244204,0.00017044229],"genre_scores_gemma":[0.052381985,0.0029024219,0.0011788431,0.0037691726,0.9359052,0.00006325119,0.0031590348,0.0002526368,0.00038740973],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933683,0.0011989354,0.0019016827,0.0011676978,0.0014409813,0.0009223475],"domain_scores_gemma":[0.99390644,0.002678574,0.0011853129,0.0009454709,0.0006705723,0.0006136564],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0016201076,0.0009068676,0.0021487041,0.00035181342,0.0002140536,0.00003125802,0.0005805806,0.0020324106,0.0004553508],"category_scores_gemma":[0.000018672285,0.00084107573,0.00061135634,0.0002316256,0.00060262706,0.00022567321,0.00019694923,0.0026619278,0.00009093052],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018643496,0.0027524708,0.0046011275,0.00025944557,0.01947614,0.0003453664,0.00016579054,0.000005264897,0.003510486,0.0000027769324,0.9646234,0.002393366],"study_design_scores_gemma":[0.0118435705,0.010076888,0.00046725632,0.00018069551,0.039941035,0.000020142148,0.000040279967,0.00004751007,0.0042442237,0.000071129136,0.9326464,0.00042089386],"about_ca_topic_score_codex":0.00013484857,"about_ca_topic_score_gemma":0.0000071043623,"teacher_disagreement_score":0.031977043,"about_ca_system_score_codex":0.0004393081,"about_ca_system_score_gemma":0.0009435685,"threshold_uncertainty_score":0.999639},"labels":[],"label_agreement":null},{"id":"W2015352744","doi":"10.1111/j.1365-2036.2004.02053.x","title":"Patients' fears and unmet needs in inflammatory bowel disease","year":2004,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Quality of life (healthcare); Inflammatory bowel disease; Disease; Life expectancy; Anxiety; Population; Depression (economics); Intensive care medicine; Ulcerative colitis; Health care; Physical therapy; Psychiatry; Internal medicine; Nursing","score_opus":0.016203272904809052,"score_gpt":0.3065811109119593,"score_spread":0.2903778380071502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015352744","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.072412476,0.9250177,0.0000017297534,0.00006097086,0.00072983245,0.0014408142,0.0002701642,0.000027322612,0.000038969374],"genre_scores_gemma":[0.0020729904,0.9917141,0.000037547194,0.0039041876,0.0002874432,0.00027453844,0.0014439395,0.00013895001,0.00012630965],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99737924,0.00048420197,0.00068408187,0.00066239387,0.00020099277,0.00058907736],"domain_scores_gemma":[0.99881613,0.000035267167,0.0002959598,0.00046051134,0.00005053261,0.00034158494],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002067227,0.0007031984,0.00063099724,0.000312458,0.0001063831,0.00003300956,0.0004447978,0.00044428988,0.00009165556],"category_scores_gemma":[7.219378e-7,0.00070770027,0.0002636108,0.00015026741,0.00032480372,0.000013559317,0.00036280762,0.0004350662,0.000045183016],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007666138,0.009936281,0.21897592,0.08433274,0.09279015,0.006894654,0.0015391352,0.00051293423,0.0037272233,0.00059307285,0.006382468,0.56664926],"study_design_scores_gemma":[0.003225868,0.00021623078,0.0059673954,0.0010229347,0.014539873,0.000013592336,0.000024350835,0.000005444421,0.000077815035,0.00005262114,0.9737064,0.0011474735],"about_ca_topic_score_codex":0.0000060392476,"about_ca_topic_score_gemma":0.0000066723273,"teacher_disagreement_score":0.96732396,"about_ca_system_score_codex":0.00020024875,"about_ca_system_score_gemma":0.0006709968,"threshold_uncertainty_score":0.9995374},"labels":[],"label_agreement":null},{"id":"W2015909994","doi":"10.1111/apt.12899","title":"Randomised clinical trial: the long‐term safety and tolerability of naloxegol in patients with pain and opioid‐induced constipation","year":2014,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AcelRx Pharmaceuticals; Association of Canadian Universities for Research in Astronomy; Teva Pharmaceutical Industries; AstraZeneca; Ironwood Pharmaceuticals, Incorporated; Bristol-Myers Squibb","keywords":"Medicine; Tolerability; Adverse effect; Nausea; Discontinuation; Constipation; Opioid; Internal medicine; Anesthesia","score_opus":0.03577685887529612,"score_gpt":0.3392654320222529,"score_spread":0.30348857314695676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015909994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574095,0.0000977625,0.0001968938,0.0019116896,0.00013486725,0.0018729548,0.0000050907884,0.000011333522,0.00002847758],"genre_scores_gemma":[0.9923895,0.00006666962,0.00014438231,0.007299628,0.000035970108,0.000021525146,0.000030138232,0.000008929719,0.0000032607247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785465,0.0010598451,0.0005526639,0.00023809467,0.000129871,0.00016488673],"domain_scores_gemma":[0.9981491,0.0013775561,0.0001729547,0.00015269151,0.0000685464,0.00007916304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017964714,0.00013947689,0.00041199333,0.00003948839,0.000058986956,0.000005055467,0.000060468315,0.000067588655,0.000045397286],"category_scores_gemma":[0.000013087506,0.0000922048,0.00004543115,0.00007154826,0.0004938094,0.000046107707,0.00003191606,0.0002479981,4.3431658e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.185602,0.00083210866,0.7992848,0.000035733912,0.00051567046,0.0000010301377,0.00018653256,0.0000019305264,0.00035944363,0.000004381028,0.000003765975,0.013172615],"study_design_scores_gemma":[0.20885296,0.0054141027,0.7834796,0.0000295497,0.0014706457,0.0000030000147,0.000049323044,0.00036449052,0.00020271387,0.000040077113,0.000030975265,0.00006259542],"about_ca_topic_score_codex":0.000032393695,"about_ca_topic_score_gemma":0.000035916186,"teacher_disagreement_score":0.023250973,"about_ca_system_score_codex":0.00002221905,"about_ca_system_score_gemma":0.00005085058,"threshold_uncertainty_score":0.37600026},"labels":[],"label_agreement":null},{"id":"W2016772058","doi":"10.1111/apt.12254","title":"The impact of intensifying acid suppression on sleep disturbance related to gastro‐oesophageal reflux disease in primary care","year":2013,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); McMaster University","funders":"McMaster University; AstraZeneca Canada","keywords":"Esomeprazole; Medicine; GERD; Sleep disorder; Reflux; Internal medicine; Sleep (system call); Quality of life (healthcare); Physical therapy; Disease; Insomnia; Psychiatry","score_opus":0.01594130386537013,"score_gpt":0.3321505956882207,"score_spread":0.31620929182285057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016772058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99483037,0.0018622509,0.0000025669126,0.0011963312,0.0004047991,0.0013997344,0.00004946766,0.00003844018,0.00021603548],"genre_scores_gemma":[0.9945775,0.00015770078,0.00014556802,0.004460218,0.000052033476,0.00015011104,0.00021985038,0.00004344564,0.00019356469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815,0.00019630672,0.00044611076,0.0003774743,0.00027572492,0.00055441645],"domain_scores_gemma":[0.9988953,0.0001407479,0.00013521641,0.00038026238,0.0001258504,0.00032264457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102026264,0.00032516842,0.00039376327,0.00013081264,0.00014524098,0.000014065369,0.0002159981,0.00008258616,0.00020132953],"category_scores_gemma":[0.0000011524567,0.00020138771,0.000197043,0.00022525723,0.00015610406,0.00010821107,0.00011105332,0.00040003343,0.00008810095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029229887,0.0009278362,0.86798686,0.000054914435,0.0034414544,0.000515993,0.0010702452,0.00032261098,0.114863,0.0000035317798,0.000495731,0.0073948354],"study_design_scores_gemma":[0.004341902,0.0021203982,0.96036845,0.00009171364,0.0015285541,0.000013675906,0.00012800332,0.00031313708,0.0309126,0.00004804129,0.000035055236,0.00009845268],"about_ca_topic_score_codex":0.000068624424,"about_ca_topic_score_gemma":0.0000010281173,"teacher_disagreement_score":0.092381604,"about_ca_system_score_codex":0.0006086844,"about_ca_system_score_gemma":0.00009770668,"threshold_uncertainty_score":0.82123524},"labels":[],"label_agreement":null},{"id":"W2016829028","doi":"10.1111/apt.12911","title":"Editorial: drug monitoring targets for optimising adalimumab in Crohn's disease","year":2014,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"UCB Pharma; Genentech; Prometheus","keywords":"Adalimumab; Medicine; Infliximab; Internal medicine; Crohn's disease; Gastroenterology; Therapeutic drug monitoring; Disease; Population; Drug; Antibody; Immunology; Pharmacology; Pharmacokinetics","score_opus":0.010693398772783259,"score_gpt":0.307854837642376,"score_spread":0.29716143886959273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016829028","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026353627,0.0030153664,0.00008650919,0.00021933553,0.96804273,0.001439391,0.0007545197,0.000059948285,0.000028544064],"genre_scores_gemma":[0.0076904967,0.0017479518,0.0004957786,0.0013500815,0.9840875,0.00064567063,0.003316579,0.0002718011,0.00039411685],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99605346,0.00046383435,0.00073639315,0.001164,0.0005881924,0.00099413],"domain_scores_gemma":[0.99792993,0.00030636523,0.00040230737,0.00064910436,0.0003407026,0.00037157236],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007175841,0.0008182253,0.00057484297,0.00018193606,0.00024882736,0.000070402,0.0008576625,0.0009938965,0.00004442835],"category_scores_gemma":[0.000009540114,0.0009391367,0.00037743448,0.00008625598,0.00021110632,0.000019220683,0.0003138842,0.0007816586,0.000018110073],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048434897,0.00031377908,0.0007078781,0.00022299492,0.0030364885,0.0001496334,0.00007694635,0.00070075004,0.01924169,0.0000011275785,0.9705345,0.00017074359],"study_design_scores_gemma":[0.0052453247,0.00013634423,0.00051179144,0.00008049966,0.004737814,6.503118e-7,0.000036275374,0.00016085789,0.010075005,0.00007119701,0.9779735,0.0009706988],"about_ca_topic_score_codex":0.00003147758,"about_ca_topic_score_gemma":0.000019673096,"teacher_disagreement_score":0.01866313,"about_ca_system_score_codex":0.00027397036,"about_ca_system_score_gemma":0.00082660484,"threshold_uncertainty_score":0.9993059},"labels":[],"label_agreement":null},{"id":"W2016837388","doi":"10.1111/j.1365-2036.2009.04075.x","title":"Systematic review: secondary prevention with band ligation, pharmacotherapy or combination therapy after bleeding from oesophageal varices","year":2009,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Capital District Health Authority","funders":"","keywords":"Medicine; Internal medicine; Adverse effect; Ligation; Pharmacotherapy; Gastroenterology; Esophageal varices; Varices; Randomized controlled trial; Relative risk; Portal hypertension; Confidence interval; Cirrhosis","score_opus":0.040502774799302255,"score_gpt":0.3706909122852881,"score_spread":0.33018813748598586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016837388","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00073954294,0.9890541,0.000067293135,0.00035492372,0.0004528288,0.008937268,0.00019353312,0.00013493931,0.00006559646],"genre_scores_gemma":[0.0005015858,0.9701021,0.00014474853,0.023329299,0.00040363838,0.0018806268,0.0032343,0.000116605836,0.00028710632],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99630207,0.00084463623,0.001236731,0.0006901388,0.00053064205,0.00039581172],"domain_scores_gemma":[0.9980614,0.0003462236,0.00089387293,0.0003475117,0.00016760112,0.00018337314],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038587966,0.00080063415,0.0023723007,0.00027186892,0.0001611099,0.00005194809,0.00027178694,0.00028674552,0.0021432955],"category_scores_gemma":[9.316677e-8,0.0005273624,0.00046955224,0.00043941164,0.00009530313,0.0003999094,0.000013020328,0.00060804636,0.00006850146],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038716435,0.0026284314,0.0000851449,0.7009415,0.20482346,0.00082370744,0.0008489156,6.3554734e-7,0.00045190047,0.000007770926,0.0004024516,0.08511443],"study_design_scores_gemma":[0.01033133,0.002528164,0.00009180961,0.299229,0.6547387,0.00032519878,0.00004493915,0.000021444432,0.0019731773,0.00009995747,0.029638289,0.0009779807],"about_ca_topic_score_codex":0.000015821155,"about_ca_topic_score_gemma":0.000003164456,"teacher_disagreement_score":0.44991523,"about_ca_system_score_codex":0.00024779694,"about_ca_system_score_gemma":0.00054955005,"threshold_uncertainty_score":0.9997178},"labels":[],"label_agreement":null},{"id":"W2017092019","doi":"10.1111/apt.12938","title":"Review article: the economic impact of the irritable bowel syndrome","year":2014,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":453,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Medical Research Council; University of Nottingham; Nottingham University Hospitals NHS Trust","keywords":"Irritable bowel syndrome; Medicine; Absenteeism; Quality of life (healthcare); Presenteeism; Psychological intervention; Indirect costs; Life expectancy; Health care; Intensive care medicine; Environmental health; Internal medicine; Psychiatry; Population; Nursing","score_opus":0.051500773814821564,"score_gpt":0.39885361104754496,"score_spread":0.3473528372327234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017092019","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016318527,0.99311733,0.0000016466216,0.0022756325,0.00052567787,0.002163573,0.0000720327,0.00002448347,0.00018778005],"genre_scores_gemma":[0.0012127483,0.9795956,0.000027469887,0.018725984,0.00010010288,0.000092826114,0.00004865329,0.000051579824,0.00014503759],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99759734,0.0006662715,0.0008243401,0.00033472216,0.00014540255,0.000431907],"domain_scores_gemma":[0.9982225,0.00041214665,0.00053902366,0.0006751585,0.000042137755,0.000109043154],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00059285987,0.00044748632,0.0015994313,0.00005282348,0.00012956363,0.000008544749,0.00059785834,0.00013681727,0.0013888048],"category_scores_gemma":[0.0000013568072,0.0002245757,0.0012847651,0.00018661047,0.00043730327,0.000045531735,0.00016585227,0.00073195604,0.00016967097],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075622345,0.002524475,0.0057403846,0.20157889,0.1612496,0.0001415955,0.0002879802,0.00020577245,0.00037856793,0.00011429095,0.11194909,0.5150731],"study_design_scores_gemma":[0.0009795107,0.0009862008,0.00049662375,0.015984032,0.106708854,0.002259055,0.000013740672,0.00008401809,0.000017703369,0.00005854202,0.87215966,0.00025204505],"about_ca_topic_score_codex":0.00014501368,"about_ca_topic_score_gemma":0.000007742401,"teacher_disagreement_score":0.7602106,"about_ca_system_score_codex":0.0005068963,"about_ca_system_score_gemma":0.0008205305,"threshold_uncertainty_score":0.99952406},"labels":[],"label_agreement":null},{"id":"W2017384919","doi":"10.1111/apt.12545","title":"Letter: acute severe ulcerative colitis - should all patients be treated equally? Authors' reply","year":2013,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Medicine; Ulcerative colitis; Comorbidity; Colectomy; Cohort; Population; Internal medicine; Excess mortality; Disease; Mortality rate; Colitis; Surgery","score_opus":0.03174254110881921,"score_gpt":0.30543770759965194,"score_spread":0.27369516649083275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017384919","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45799536,0.00047576928,0.00001841651,0.5266921,0.0048065837,0.003993581,0.0047820527,0.00020541753,0.0010307102],"genre_scores_gemma":[0.007363373,0.00064246956,0.00014485353,0.9557139,0.0043807705,0.0005504051,0.023978736,0.00027360232,0.0069518345],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948025,0.0011929482,0.00082620187,0.0013939637,0.0005266307,0.0012577963],"domain_scores_gemma":[0.99787307,0.0000678832,0.00054074614,0.00091701985,0.0003371454,0.00026412276],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019750989,0.001127051,0.00065353897,0.0001617718,0.00026470126,0.00008833174,0.00093618437,0.001621662,0.001694725],"category_scores_gemma":[7.035477e-7,0.0011490762,0.00043327207,0.000103607585,0.00042237854,0.000029006631,0.00042514363,0.0016219424,0.00022343291],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010424154,0.0002728235,0.0014837174,0.0000538505,0.02714416,0.0011869979,0.00016995605,0.000008172198,0.017697636,0.0000015195934,0.9507513,0.00018742718],"study_design_scores_gemma":[0.0035019724,0.0006968284,0.0024083483,0.000017836386,0.012401695,0.00003949584,0.000013564095,0.000035216537,0.021526886,0.000026043605,0.9581001,0.0012320338],"about_ca_topic_score_codex":0.00008544536,"about_ca_topic_score_gemma":0.000023056247,"teacher_disagreement_score":0.45063198,"about_ca_system_score_codex":0.00024857922,"about_ca_system_score_gemma":0.00022610695,"threshold_uncertainty_score":0.99967444},"labels":[],"label_agreement":null},{"id":"W2018162620","doi":"10.1046/j.1365-2036.2001.01114.x","title":"Systematic review: the use of somatostatin or octreotide in refractory diarrhoea","year":2001,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Octreotide; Medicine; Somatostatin; Randomized controlled trial; Meta-analysis; Internal medicine; Subgroup analysis; Refractory (planetary science); Gastroenterology","score_opus":0.19920946882806204,"score_gpt":0.4521098533066956,"score_spread":0.2529003844786336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018162620","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001060935,0.9912564,0.000005089365,0.0023749631,0.0003377985,0.0057398584,0.00013325165,0.000028605216,0.000017938188],"genre_scores_gemma":[0.000010007478,0.95610374,0.00015157388,0.04182763,0.00012568253,0.0007705581,0.0003640765,0.000079518344,0.0005671848],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99195653,0.004112331,0.0023377396,0.00047516738,0.00032663735,0.00079161173],"domain_scores_gemma":[0.996556,0.0014896537,0.0009769495,0.00070438185,0.00009002308,0.00018301971],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012353497,0.0005824658,0.004611834,0.00029259166,0.00006218745,0.000009603092,0.00053317205,0.00024740872,0.00065900624],"category_scores_gemma":[0.000025708128,0.00031571943,0.0006467172,0.0005492003,0.0004152525,0.00010539977,0.00018376861,0.0012121995,0.000075085496],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004464166,0.00079388876,0.00017391487,0.9233623,0.021307115,0.0011870229,0.00006806992,0.0000012906138,0.000052211926,0.0000025062193,0.020395767,0.03220947],"study_design_scores_gemma":[0.0008792828,0.0007557011,0.000006315006,0.23967004,0.043131873,0.0010589744,0.000024955796,0.000022824386,0.0000047984645,0.00000251331,0.71424985,0.00019287092],"about_ca_topic_score_codex":0.00012091894,"about_ca_topic_score_gemma":0.000044517794,"teacher_disagreement_score":0.6938541,"about_ca_system_score_codex":0.00032722752,"about_ca_system_score_gemma":0.0003659508,"threshold_uncertainty_score":0.9999295},"labels":[],"label_agreement":null},{"id":"W2018785013","doi":"10.1111/j.1365-2036.2008.03790.x","title":"Clinical trial: radiofrequency energy delivery in proton pump inhibitor‐dependent gastro‐oesophageal reflux disease patients","year":2008,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Ipsen; AstraZeneca; Janssen Pharmaceuticals; Sanofi; Cilag; Institut National de la Santé et de la Recherche Médicale","keywords":"Medicine; Proton-pump inhibitor; Discontinuation; Reflux; Internal medicine; Gastroenterology; Regimen; Randomized controlled trial; Quality of life (healthcare); Clinical endpoint; Prospective cohort study; Disease","score_opus":0.06079360859285807,"score_gpt":0.361302498209738,"score_spread":0.30050888961687994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018785013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936798,0.0010666023,0.000007908255,0.00043445342,0.0018693695,0.0026128148,0.00006581052,0.00010105103,0.00016216336],"genre_scores_gemma":[0.9808896,0.0026226144,0.00025374218,0.013949456,0.00070853415,0.00055570796,0.00046225314,0.00007910452,0.00047894687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959877,0.00063753827,0.0011441667,0.00080720294,0.00060145935,0.00082192844],"domain_scores_gemma":[0.99837166,0.00014997975,0.0002738829,0.00044029203,0.00012494272,0.000639222],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030976333,0.00050863024,0.000748358,0.00025833558,0.0001875856,0.000011260182,0.00025916073,0.00021726843,0.00042895976],"category_scores_gemma":[0.0000016724446,0.0004500146,0.00033082196,0.0002384422,0.00034574003,0.00022246053,0.00012370796,0.00057586434,0.00008461934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031105563,0.009284191,0.9452016,0.0000327705,0.0034045037,0.0063224114,0.00011701129,0.000008692638,0.0008332252,0.0000050088634,0.00024080752,0.0034442227],"study_design_scores_gemma":[0.31111586,0.013319799,0.6438952,0.0000731377,0.010240003,0.00014742593,0.000030697982,0.00019729981,0.01661468,0.00011607696,0.003747386,0.0005023922],"about_ca_topic_score_codex":0.0000677846,"about_ca_topic_score_gemma":0.0000032416565,"teacher_disagreement_score":0.30130637,"about_ca_system_score_codex":0.00047120213,"about_ca_system_score_gemma":0.00037467334,"threshold_uncertainty_score":0.99979514},"labels":[],"label_agreement":null},{"id":"W2019294456","doi":"10.1111/j.1365-2036.2005.02686.x","title":"Anti‐cyclic citrullinated peptide antibodies in type 1 autoimmune hepatitis","year":2005,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Medicine; Autoantibody; Autoimmune hepatitis; Rheumatoid arthritis; Immunology; Rheumatoid factor; Antibody; Primary biliary cirrhosis; Hepatitis C virus; Hepatitis; Autoimmune disease; Arthritis; Virus","score_opus":0.029873607177220148,"score_gpt":0.33233291261782066,"score_spread":0.3024593054406005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019294456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855574,0.0069008474,0.0000027330582,0.0057521965,0.00062945683,0.00042144465,0.000019005482,0.000098144126,0.0006187945],"genre_scores_gemma":[0.9579263,0.012657498,0.00028607616,0.027987618,0.00015973239,0.000012612632,0.00018764609,0.000034347748,0.0007481743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865323,0.0001550088,0.00036077097,0.00025275155,0.00015700274,0.0004212442],"domain_scores_gemma":[0.9994259,0.000070319526,0.000084704516,0.00024446548,0.00007627669,0.00009835044],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013136448,0.00022992396,0.0003844424,0.00016248244,0.00011316336,0.000011125442,0.00016747632,0.00010275228,0.0023287896],"category_scores_gemma":[3.0708833e-7,0.00021786786,0.00009824701,0.0002687071,0.00017812719,0.00015910747,0.000091410584,0.0004087553,0.00020851444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000614053,0.0013614527,0.70779765,0.000030487352,0.004270902,0.00012674648,0.00053431926,0.00006120229,0.2811183,0.000018783447,0.0013260572,0.002740055],"study_design_scores_gemma":[0.004086698,0.00049094635,0.9111938,0.000044100867,0.0042368365,0.000052345054,0.00014325364,0.001942755,0.047480732,0.000030251162,0.030029438,0.000268852],"about_ca_topic_score_codex":0.0009928263,"about_ca_topic_score_gemma":0.000096530166,"teacher_disagreement_score":0.23363757,"about_ca_system_score_codex":0.000173932,"about_ca_system_score_gemma":0.00010886204,"threshold_uncertainty_score":0.9985832},"labels":[],"label_agreement":null},{"id":"W2020439913","doi":"10.1046/j.1365-2036.2003.01661.x","title":"Mild to moderate Crohn's disease – defining the basis for a new treatment algorithm","year":2003,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Sulfasalazine; Medicine; Budesonide; Crohn's disease; Placebo; Adverse effect; Internal medicine; Gastroenterology; Disease; Randomized controlled trial; Inflammatory bowel disease; Antibiotics; Corticosteroid; Ulcerative colitis; Pathology; Alternative medicine","score_opus":0.05157727154408636,"score_gpt":0.3627277990346909,"score_spread":0.3111505274906045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020439913","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021467006,0.99189204,0.0008601589,0.00053540897,0.0012107235,0.0038467941,0.0013610659,0.000031089377,0.00004804629],"genre_scores_gemma":[0.00001040051,0.9685174,0.0024670323,0.022761067,0.00084341015,0.0020576217,0.0013033306,0.00018694984,0.0018527354],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971707,0.0004973623,0.0005639088,0.0008800938,0.0001652595,0.00072270166],"domain_scores_gemma":[0.99837124,0.00011211865,0.00025122802,0.00068441546,0.000073622425,0.00050737016],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020384694,0.0008321342,0.0007804545,0.00009681805,0.00036048357,0.00005519791,0.0005651864,0.00029090533,0.0001475327],"category_scores_gemma":[8.0976275e-7,0.0006181294,0.0008343166,0.00012897071,0.00011175368,0.00000623291,0.000147161,0.00017984322,0.000085828215],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014505115,0.00065973605,0.000016936,0.0009757713,0.035286546,0.0003673135,0.00016187593,0.0001882842,0.0001986369,0.00005808288,0.02073242,0.93990386],"study_design_scores_gemma":[0.0011848335,0.00027423847,0.000014061884,0.00016287246,0.034043174,0.000014698778,0.000016175109,0.0000808523,0.0004203228,0.000030319574,0.96313524,0.00062320294],"about_ca_topic_score_codex":0.0000127899775,"about_ca_topic_score_gemma":0.000009980071,"teacher_disagreement_score":0.94240284,"about_ca_system_score_codex":0.0002352408,"about_ca_system_score_gemma":0.0013042409,"threshold_uncertainty_score":0.999627},"labels":[],"label_agreement":null},{"id":"W2021431886","doi":"10.1111/apt.12252","title":"Meta‐analysis: oral or enteral nutritional supplementation in cirrhosis","year":2013,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority; University of Alberta","funders":"","keywords":"Medicine; Jadad scale; Enteral administration; Cirrhosis; Randomized controlled trial; Subgroup analysis; Parenteral nutrition; Malnutrition; Meta-analysis; Internal medicine; Relative risk; Adverse effect; Pediatrics; Intensive care medicine; Cochrane Library; Confidence interval","score_opus":0.28174367809865386,"score_gpt":0.4571193052990275,"score_spread":0.17537562720037364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021431886","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042358047,0.9953049,0.000019177842,0.0006666654,0.00029482864,0.002281617,0.00092542154,0.000042811607,0.000040996016],"genre_scores_gemma":[0.00043613918,0.9756913,0.0004420074,0.00857509,0.00017754354,0.0013195354,0.013000148,0.00004870166,0.00030949814],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9974309,0.0005390503,0.00082676124,0.000505604,0.0003102213,0.0003874496],"domain_scores_gemma":[0.99912256,0.00023233377,0.00025104693,0.00018993189,0.000060374674,0.00014373797],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017111763,0.00049496425,0.0021732599,0.00074498734,0.00006541425,0.00002388662,0.00017429951,0.00021350828,0.018540805],"category_scores_gemma":[1.4318499e-8,0.00036479556,0.0014262673,0.000703018,0.00007593821,0.00019275563,0.000030941294,0.00038329195,0.00016016925],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035155602,0.0008870966,0.00038905692,0.0031107534,0.9883764,0.00019465174,0.00016431246,0.0000021939816,0.00002752007,0.0000075702196,0.0002677183,0.0062211817],"study_design_scores_gemma":[0.0024631938,0.00022151473,0.0000861174,0.00018061798,0.8995921,0.000051236326,0.00004633286,0.000029358438,0.00010442899,0.000015548829,0.09693282,0.0002767372],"about_ca_topic_score_codex":0.00018188855,"about_ca_topic_score_gemma":0.00006751456,"teacher_disagreement_score":0.0966651,"about_ca_system_score_codex":0.00021626022,"about_ca_system_score_gemma":0.00024268738,"threshold_uncertainty_score":0.9998804},"labels":[],"label_agreement":null},{"id":"W2021586865","doi":"10.1111/apt.12435","title":"Cost and health consequences of treatment of primary biliary cirrhosis with ursodeoxycholic acid","year":2013,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ursodeoxycholic acid; Medicine; Primary biliary cirrhosis; Gastroenterology; Cirrhosis; Internal medicine; Primary (astronomy); Biliary cirrhosis; Disease; Autoimmune disease","score_opus":0.0914428774129262,"score_gpt":0.3605035541629028,"score_spread":0.2690606767499766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021586865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814588,0.010422458,0.0000052206638,0.006662044,0.00009119109,0.0011599669,0.00005986483,0.000016937369,0.00012350616],"genre_scores_gemma":[0.96975857,0.013354915,0.00054519315,0.016113225,0.000030245577,0.00007310971,0.00006683102,0.000015066156,0.00004286646],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991001,0.00011957764,0.00027646543,0.00017497821,0.0001083079,0.00022061002],"domain_scores_gemma":[0.9993504,0.000062959974,0.00017655776,0.00018598493,0.000075422424,0.00014865967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007351273,0.00016387284,0.0004354248,0.00007423444,0.00006182833,0.0000034638147,0.00006868,0.000042905587,0.00045613837],"category_scores_gemma":[3.8416914e-8,0.00011523129,0.000057956026,0.000104187966,0.0006117508,0.00008684487,0.000025353822,0.00007373503,0.000004191579],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009578488,0.0024559177,0.45056546,0.00022755851,0.0113839265,0.000008927064,0.0019244252,0.0000024018325,0.50986767,0.000010742571,0.0003477193,0.022247411],"study_design_scores_gemma":[0.0092324875,0.013909508,0.58197427,0.00009169084,0.0101582585,0.00010466323,0.001242722,0.00005744266,0.38129953,0.000069796304,0.0016416478,0.00021796393],"about_ca_topic_score_codex":0.0018659626,"about_ca_topic_score_gemma":0.0000048969055,"teacher_disagreement_score":0.13140881,"about_ca_system_score_codex":0.00016809073,"about_ca_system_score_gemma":0.00031069558,"threshold_uncertainty_score":0.49943954},"labels":[],"label_agreement":null},{"id":"W2022101088","doi":"10.1111/j.1365-2036.2006.02762.x","title":"Three‐year oral pantoprazole administration is effective for patients with Zollinger–Ellison syndrome and other hypersecretory conditions","year":2006,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; U.S. Department of Veterans Affairs","keywords":"Pantoprazole; Medicine; Zollinger-Ellison syndrome; Gastroenterology; Dose; Internal medicine; Adverse effect; Gastric acid; Clinical endpoint; Oral administration; Proton-pump inhibitor; Randomized controlled trial; Stomach; Omeprazole","score_opus":0.02119001476678872,"score_gpt":0.34071123560295186,"score_spread":0.31952122083616313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022101088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952732,0.00034626212,0.0000924093,0.0014441416,0.0001636852,0.0022358762,0.00028744224,0.00005485779,0.00010216472],"genre_scores_gemma":[0.99056584,0.000050823794,0.0011672486,0.0074539897,0.00009910528,0.0002942638,0.00022047294,0.000048696107,0.00009958251],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988414,0.00006020012,0.00018823252,0.0003306875,0.00021728626,0.00036220058],"domain_scores_gemma":[0.99939173,0.0001907684,0.0000877384,0.00012811793,0.000099842706,0.000101819314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006443763,0.00020502586,0.00025335455,0.000096008655,0.00016241256,0.000015341233,0.000068673624,0.00002334994,0.0002722545],"category_scores_gemma":[3.1168608e-7,0.00017302122,0.00005073775,0.00010065962,0.00027459074,0.00013238685,0.00002215021,0.00018800498,0.0000133962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008138678,0.0031406917,0.91213477,0.00021244044,0.00615159,0.0005484936,0.00019233563,0.000014643138,0.06579194,0.0002663719,0.0026232197,0.0007848205],"study_design_scores_gemma":[0.0546758,0.039342012,0.500673,0.00015397194,0.020278128,0.0015372821,0.00056790805,0.0011829846,0.30456188,0.0032773337,0.07236094,0.0013887911],"about_ca_topic_score_codex":0.000055734265,"about_ca_topic_score_gemma":0.000047891503,"teacher_disagreement_score":0.4114618,"about_ca_system_score_codex":0.00007291575,"about_ca_system_score_gemma":0.000059150043,"threshold_uncertainty_score":0.7055601},"labels":[],"label_agreement":null},{"id":"W2022547798","doi":"10.1111/j.1365-2036.2005.02699.x","title":"Comprehension and awareness of symptoms in women with dyspepsia","year":2005,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Novartis Pharma; Novartis","keywords":"Medicine; Bloating; Irritable bowel syndrome; Nausea; Internal medicine; Disease; Abdominal pain; Gastroenterology; Constipation","score_opus":0.020329455741335926,"score_gpt":0.3053243420262085,"score_spread":0.2849948862848726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022547798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952872,0.00066558085,0.000022987853,0.00357358,0.00004506115,0.00027065622,0.000003783464,0.0000205029,0.00011064065],"genre_scores_gemma":[0.9864599,0.0001799139,0.0008656003,0.012412041,0.000028533348,0.000014467114,0.000007643803,0.00001254732,0.000019367915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99922246,0.000058209454,0.00019740243,0.0001811579,0.00010510739,0.0002356399],"domain_scores_gemma":[0.9996642,0.00006681512,0.00005448121,0.00009959139,0.000034409735,0.000080519225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008847371,0.00012715773,0.00024669693,0.000088306144,0.000029722061,0.0000023183645,0.000052724754,0.00004056911,0.0001929496],"category_scores_gemma":[8.713562e-8,0.00010632119,0.000015219708,0.00011425897,0.0002229591,0.000060715367,0.000031808155,0.00015035582,0.0000034255268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008483506,0.0015320604,0.77293634,0.00011215536,0.0019600901,0.00004949724,0.0019193465,0.00029944646,0.20094119,0.000019107143,0.00005091226,0.01169635],"study_design_scores_gemma":[0.018935284,0.006095063,0.9205039,0.00017571356,0.0031312676,0.0003919609,0.0018295455,0.0029491324,0.042338967,0.0001160704,0.0032501093,0.0002829921],"about_ca_topic_score_codex":0.000041226205,"about_ca_topic_score_gemma":0.000027996562,"teacher_disagreement_score":0.15860222,"about_ca_system_score_codex":0.000066893066,"about_ca_system_score_gemma":0.000050558483,"threshold_uncertainty_score":0.43356523},"labels":[],"label_agreement":null},{"id":"W2025373282","doi":"10.1046/j.1365-2036.2002.01172.x","title":"The non‐inherited gastrointestinal polyposis syndromes","year":2002,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pathological; Gastroenterology; Dermatology; Internal medicine; Pathology","score_opus":0.11027166981581676,"score_gpt":0.3950289893039919,"score_spread":0.2847573194881751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025373282","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003803085,0.99303526,0.0000074812324,0.0013570539,0.0023200891,0.002148036,0.000070050715,0.00011481614,0.0005669301],"genre_scores_gemma":[0.00015762085,0.9891259,0.00064006576,0.006680015,0.0006294203,0.00043206415,0.00011873914,0.00018255005,0.0020336227],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99668694,0.0003957162,0.0008913818,0.00066986895,0.00044320952,0.0009128804],"domain_scores_gemma":[0.99781007,0.00077461556,0.0004331064,0.00062317395,0.00010460732,0.00025440572],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025079623,0.00084072846,0.0016393213,0.0001807882,0.0003639784,0.000043793447,0.0006651874,0.00029921663,0.0020712507],"category_scores_gemma":[7.219152e-7,0.0005649795,0.0007214234,0.00046678755,0.00057728076,0.000037423386,0.00022095842,0.0012886131,0.0003955667],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029879194,0.0007184425,0.00031252604,0.003694374,0.03661749,0.0006041696,0.00012677691,0.0000018043653,0.00097336055,0.0000028209056,0.017004514,0.93964493],"study_design_scores_gemma":[0.00091904594,0.001183189,0.000041028048,0.0019157783,0.059109043,0.004119657,0.00002976641,0.000064106775,0.00017126341,0.0000053058197,0.93201745,0.00042436065],"about_ca_topic_score_codex":0.000022158349,"about_ca_topic_score_gemma":0.0000042450806,"teacher_disagreement_score":0.93922055,"about_ca_system_score_codex":0.00060814474,"about_ca_system_score_gemma":0.0003763475,"threshold_uncertainty_score":0.99968016},"labels":[],"label_agreement":null},{"id":"W2025565377","doi":"10.1111/j.1365-2036.2006.03083.x","title":"Injection of botulinum toxin before pneumatic dilatation in achalasia treatment: a randomized‐controlled trial","year":2006,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; McMaster University Medical Centre","funders":"Tehran University of Medical Sciences and Health Services","keywords":"Medicine; Achalasia; Botulinum toxin; Surgery; Anesthesia; Esophagus","score_opus":0.015537320983851336,"score_gpt":0.31792411078954735,"score_spread":0.302386789805696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025565377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99205947,0.0006202673,0.000028520595,0.0005608333,0.00064271735,0.0056219487,0.000013413707,0.00003994839,0.0004128556],"genre_scores_gemma":[0.9969427,0.0001783514,0.00026762788,0.0007688971,0.00022074059,0.00079810567,0.00021899208,0.000028715056,0.0005758445],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979071,0.00041824137,0.00088241877,0.00026589943,0.00021748185,0.00030882872],"domain_scores_gemma":[0.9991311,0.00026881948,0.00033988518,0.00015365003,0.00004760665,0.000058961006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032961773,0.00029089296,0.0013374283,0.0002708618,0.00005437601,0.000006684045,0.00006226693,0.00012275853,0.00021455703],"category_scores_gemma":[8.2369985e-7,0.00020658765,0.0003847379,0.00018600149,0.00013492929,0.00009771911,0.000014646502,0.00013294052,0.000016356606],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9467644,0.005287472,0.02162553,0.000036080382,0.0123891635,0.00019132809,0.0007702966,0.00019334027,0.010958686,0.000063656145,0.000018451965,0.0017015988],"study_design_scores_gemma":[0.9621416,0.0039355312,0.0038069584,0.000019364792,0.015761163,0.000046171033,0.00004519768,0.0014267144,0.012218231,0.00052212435,0.000013591817,0.000063405976],"about_ca_topic_score_codex":0.00019429263,"about_ca_topic_score_gemma":0.000045691628,"teacher_disagreement_score":0.017818572,"about_ca_system_score_codex":0.00030043867,"about_ca_system_score_gemma":0.00009060709,"threshold_uncertainty_score":0.84243995},"labels":[],"label_agreement":null},{"id":"W2026650756","doi":"10.1111/apt.13210","title":"Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype","year":2015,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Autoimmune hepatitis; Medicine; Autoantibody; Hepatitis; Cirrhosis; Gastroenterology; Immunology; Internal medicine; Serology; Antibody","score_opus":0.08719095502969706,"score_gpt":0.3858844781079656,"score_spread":0.2986935230782686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026650756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802314,0.010753083,5.5822863e-7,0.0068442607,0.0013730264,0.0004653554,0.000020499549,0.000036684833,0.0002751205],"genre_scores_gemma":[0.94985485,0.007168188,0.00008235035,0.042231042,0.00023612873,0.000010160948,0.00012323765,0.000022496968,0.00027155087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879396,0.00029656445,0.00031270616,0.00021065609,0.0001392073,0.00024688084],"domain_scores_gemma":[0.9992225,0.0001541978,0.00007232601,0.00024232242,0.00016505907,0.00014355515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003259961,0.00015250238,0.00026543858,0.000041837127,0.000072007526,0.000009770148,0.00015814573,0.000098177276,0.0006686108],"category_scores_gemma":[0.0000025294503,0.00011029856,0.000043986784,0.00024017709,0.0002548395,0.00007853241,0.00013966793,0.0004088142,0.00009512651],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050584897,0.0009425792,0.9736874,0.00003582238,0.0031978812,0.000087083674,0.0017625323,0.0000047842263,0.0016030335,0.000034034576,0.0065519717,0.007034382],"study_design_scores_gemma":[0.007412627,0.002393291,0.94896716,0.00006149662,0.004062442,0.000037525577,0.00070077454,0.0015786773,0.00040461915,0.00014915719,0.034024674,0.00020758763],"about_ca_topic_score_codex":0.00072494027,"about_ca_topic_score_gemma":0.000058134116,"teacher_disagreement_score":0.03538678,"about_ca_system_score_codex":0.00007280663,"about_ca_system_score_gemma":0.00021525045,"threshold_uncertainty_score":0.73208195},"labels":[],"label_agreement":null},{"id":"W2027462422","doi":"10.1046/j.1365-2036.2001.00914.x","title":"The prescribing of acid suppressants prior to the endoscopic diagnosis of Barrett’s oesophagus and oesophagitis","year":2001,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Medicine; Barrett's oesophagus; Gastroenterology; Internal medicine; Endoscopy; Esophagitis; Adenocarcinoma; Esophageal disease; Omeprazole; Reflux; Esophagus; Cancer; Disease","score_opus":0.0391550805583726,"score_gpt":0.350575077067444,"score_spread":0.31141999650907143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027462422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8317743,0.15221468,0.000007738417,0.014095317,0.0003530611,0.0013945504,0.0000708803,0.000018183007,0.00007131585],"genre_scores_gemma":[0.97746414,0.016081508,0.00012238893,0.0057284753,0.00013975978,0.00028864105,0.000011444221,0.000024590428,0.00013905845],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983784,0.0002119672,0.00035660467,0.00026172833,0.00035400726,0.00043727198],"domain_scores_gemma":[0.99887764,0.0004038464,0.00011322463,0.000331389,0.00009830335,0.00017561947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027388785,0.00019660563,0.0003203736,0.00007145686,0.00024136485,0.000013211119,0.00027591895,0.000055248565,0.00034960164],"category_scores_gemma":[0.000001879731,0.00011526372,0.00008758316,0.00020509785,0.0003775525,0.000063702304,0.00016336542,0.00021912111,0.000008405828],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002296732,0.00074541516,0.9069377,0.000089569665,0.01012048,0.00026785675,0.0016606263,0.0000111050285,0.030576607,0.000051185438,0.0019188536,0.045323826],"study_design_scores_gemma":[0.0042170174,0.0020927663,0.17210475,0.000053571872,0.0038593775,0.000070589864,0.0002760971,0.00005327878,0.81376284,0.00007250959,0.0033419318,0.00009530364],"about_ca_topic_score_codex":0.00018302926,"about_ca_topic_score_gemma":0.000040092935,"teacher_disagreement_score":0.7831862,"about_ca_system_score_codex":0.00007678173,"about_ca_system_score_gemma":0.00008753817,"threshold_uncertainty_score":0.47003183},"labels":[],"label_agreement":null},{"id":"W2028066935","doi":"10.1111/j.1365-2036.2006.02891.x","title":"Small intestinal cancer in England &amp; Wales and Scotland: time trends in incidence, mortality and survival","year":2006,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Intestinal Cancer; Medicine; Demography; Cancer registry; Cancer; Social deprivation; Mortality rate; Cancer incidence; Quarter (Canadian coin); Colorectal cancer; Surgery; Internal medicine; Geography","score_opus":0.061346313675478555,"score_gpt":0.3545524163705916,"score_spread":0.29320610269511305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028066935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953246,0.002889213,0.000008622656,0.00101698,0.00023793944,0.00016758854,0.000014211833,0.00003499317,0.00030586944],"genre_scores_gemma":[0.9975124,0.0005715763,0.00014442415,0.0012386702,0.00021752478,0.000035293615,0.000038826118,0.000014154449,0.0002271528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989866,0.00013170487,0.0002452035,0.00028722224,0.000104869614,0.00024442677],"domain_scores_gemma":[0.99965924,0.00012236493,0.000057207715,0.00007671206,0.000023348663,0.00006110991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027695118,0.00016196968,0.0002720349,0.00023224506,0.000044345117,0.000010775988,0.00004337378,0.000082266255,0.00019289076],"category_scores_gemma":[3.4847343e-7,0.0001522733,0.000024240173,0.00025569744,0.00014869013,0.000058195554,0.00004753918,0.00027362833,0.0000019154852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001995221,0.0001403939,0.95207894,0.000017881093,0.0002918098,0.00005176277,0.00027452921,0.000036323196,0.03354909,0.0000018361555,0.000030085872,0.011532156],"study_design_scores_gemma":[0.0043930593,0.0005739429,0.9855783,0.00004493788,0.0009728635,0.000099040975,0.000026844536,0.0016340828,0.004698128,0.00008611205,0.0017240383,0.00016864919],"about_ca_topic_score_codex":0.010173851,"about_ca_topic_score_gemma":0.038354512,"teacher_disagreement_score":0.033499386,"about_ca_system_score_codex":0.00012493027,"about_ca_system_score_gemma":0.000041924864,"threshold_uncertainty_score":0.99641746},"labels":[],"label_agreement":null},{"id":"W2028129991","doi":"10.1111/j.1365-2036.2006.03126.x","title":"Review article: medical therapy for fistulizing Crohn's disease","year":2006,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Infliximab; Crohn's disease; Azathioprine; Disease; Medical therapy; Maintenance therapy; Internal medicine; Surgery; Chemotherapy","score_opus":0.045695421876487015,"score_gpt":0.3901708557242968,"score_spread":0.34447543384780976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028129991","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022118041,0.9941756,0.00004793658,0.00063846866,0.00097168563,0.0033930773,0.00045076222,0.000050151648,0.000051153933],"genre_scores_gemma":[0.000013272272,0.9416588,0.00009421846,0.051800944,0.0014694051,0.0014565933,0.0030778989,0.00016518777,0.00026368984],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99666446,0.00061078573,0.00089068915,0.00084326975,0.00030828052,0.0006825168],"domain_scores_gemma":[0.9983418,0.00010706947,0.00039938767,0.000623203,0.00010706438,0.00042144748],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005323465,0.0007325496,0.0010130398,0.000072760056,0.00020061703,0.000024296194,0.00079653604,0.00045594655,0.00050126016],"category_scores_gemma":[0.0000023323105,0.000644413,0.00095452985,0.00012567716,0.00026380285,0.000007671455,0.00019816888,0.00035182817,0.00005800443],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010628558,0.0014668112,0.00011695645,0.039190594,0.023841634,0.0013259321,0.000011877472,0.0000037110565,0.00038287393,0.000026977537,0.20430857,0.72826123],"study_design_scores_gemma":[0.0012961393,0.000100130404,0.00006523927,0.002771292,0.019195596,0.00002715835,0.0000013845731,0.0000135111695,0.000080092505,0.000018252473,0.9757952,0.00063600304],"about_ca_topic_score_codex":0.0000034764064,"about_ca_topic_score_gemma":0.00000418327,"teacher_disagreement_score":0.77148664,"about_ca_system_score_codex":0.00008440596,"about_ca_system_score_gemma":0.000976009,"threshold_uncertainty_score":0.9996007},"labels":[],"label_agreement":null},{"id":"W2029004976","doi":"10.1111/j.1365-2036.2007.03524.x","title":"Evidence of allelic heterogeneity for associations between the <i>NOD2/CARD15</i> gene and ulcerative colitis among North Indians","year":2007,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Ulcerative colitis; Inflammatory bowel disease; NOD2; Medicine; Single-nucleotide polymorphism; Gastroenterology; Crohn's disease; Allele; Allele frequency; Internal medicine; Population; Disease; Immunology; Genotype; Genetics; Biology; Gene","score_opus":0.037658106597498714,"score_gpt":0.3285158447815781,"score_spread":0.29085773818407934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029004976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966601,0.00092331815,0.0004775472,0.0003728063,0.00017672559,0.0008367331,0.0005229082,0.000009872967,0.000019984036],"genre_scores_gemma":[0.99250156,0.000669872,0.00022476794,0.005895408,0.00032133205,0.000066208064,0.00027546738,0.000023992501,0.000021405822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987298,0.00020914087,0.00032742016,0.00027974328,0.00012551453,0.00032836583],"domain_scores_gemma":[0.99914914,0.00020665966,0.00021084442,0.00020164468,0.00013398853,0.0000977234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005237541,0.00017675948,0.00017741304,0.000033739158,0.00023590423,0.000011174876,0.00022896072,0.00012264302,0.000010512103],"category_scores_gemma":[0.0000016740806,0.00015916608,0.00010846708,0.0000659299,0.00033194668,0.000012114464,0.00010379098,0.00010828538,0.0000011861445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005490441,0.00008687015,0.8522488,0.000019717167,0.0051527075,0.0000104496185,0.00035612725,0.000040649193,0.14046475,0.000006673332,0.0003423684,0.00072187005],"study_design_scores_gemma":[0.00073756825,0.00019883738,0.7349893,0.000004301952,0.0017356286,0.000002124621,0.00004928701,0.000016052434,0.26137164,0.000019575446,0.00074192183,0.00013376478],"about_ca_topic_score_codex":0.00003431587,"about_ca_topic_score_gemma":0.0009842203,"teacher_disagreement_score":0.12090688,"about_ca_system_score_codex":0.000042242445,"about_ca_system_score_gemma":0.00008418466,"threshold_uncertainty_score":0.6490605},"labels":[],"label_agreement":null},{"id":"W2030153228","doi":"10.1046/j.1365-2036.2003.01640.x","title":"Randomized, double‐blind, placebo‐controlled trial of prednisolone in post‐infectious irritable bowel syndrome","year":2003,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"University of Nottingham; AstraZeneca","keywords":"Enterochromaffin cell; Irritable bowel syndrome; Medicine; Gastroenterology; Prednisolone; Internal medicine; Lamina propria; Placebo; Abdominal pain; Lymphocyte; Serotonin; Pathology","score_opus":0.03062201935260886,"score_gpt":0.3226835841637025,"score_spread":0.2920615648110937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030153228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98527265,0.0012716864,0.00004909738,0.0020053752,0.000944617,0.0073309625,0.000007444249,0.000056822017,0.0030613753],"genre_scores_gemma":[0.99290067,0.00036637438,0.00037726306,0.005310312,0.00004772353,0.0005599276,0.000031931646,0.000034562312,0.0003712333],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971467,0.0007861839,0.0009043753,0.00037565164,0.00026609696,0.0005209592],"domain_scores_gemma":[0.998529,0.0007018665,0.00027130713,0.00023582033,0.000120535355,0.0001414626],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001296878,0.00032408678,0.0013734176,0.0002891915,0.00007691269,0.000008954889,0.00013417206,0.00016413629,0.00089790596],"category_scores_gemma":[0.00000793418,0.00028533323,0.0003703909,0.00025533725,0.00038624994,0.00011442318,0.000033950044,0.00044930427,0.000026368047],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97714376,0.0035540557,0.0017794512,0.000052333122,0.006486943,0.00010908619,0.000259277,0.00015569064,0.010288956,0.00010089224,0.000034024608,0.000035524783],"study_design_scores_gemma":[0.9800726,0.0038683084,0.00013622064,0.00003232852,0.01004538,0.00045657667,0.00022135628,0.00026856348,0.0042755487,0.0003460021,0.00010417099,0.00017290645],"about_ca_topic_score_codex":0.0002069138,"about_ca_topic_score_gemma":0.00004817453,"teacher_disagreement_score":0.0076280516,"about_ca_system_score_codex":0.000110238274,"about_ca_system_score_gemma":0.00025185078,"threshold_uncertainty_score":0.9999599},"labels":[],"label_agreement":null},{"id":"W2030521221","doi":"10.1111/apt.12290","title":"Systematic review: the quality of the scientific evidence and conflicts of interest in international inflammatory bowel disease practice guidelines","year":2013,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Pfizer","keywords":"Medicine; Guideline; Inflammatory bowel disease; Family medicine; Evidence-based medicine; Grading (engineering); Internal medicine; Conflict of interest; Gastroenterology; MEDLINE; Systematic review; Alternative medicine; Disease; Pathology; Political science","score_opus":0.6516456457648078,"score_gpt":0.6082420890079715,"score_spread":0.04340355675683627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030521221","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016745685,0.9536122,0.0000031720392,0.03699082,0.0014332143,0.0062013394,0.00006821663,0.000009339224,0.000007106875],"genre_scores_gemma":[0.00042184832,0.96264,0.00013646434,0.036115564,0.00012635304,0.00035852744,0.00007767086,0.00002925897,0.00009434871],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9910215,0.0030839273,0.0047312686,0.00041991504,0.00053978927,0.00020356153],"domain_scores_gemma":[0.98406285,0.009162437,0.004462114,0.0008516343,0.0013555733,0.000105396524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0079811765,0.00034129497,0.0015175648,0.00014163897,0.000075932934,0.000027474778,0.00075717556,0.00011902506,0.00015782252],"category_scores_gemma":[0.0013367105,0.00018685679,0.0003801302,0.0003121673,0.00072821823,0.0003446354,0.0004648076,0.0006365883,0.000013329941],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036611303,0.000877231,0.0007607722,0.95278686,0.016418189,0.000020287001,0.0005035411,0.0000026492194,0.00052759034,0.00010502004,0.0072499514,0.020381784],"study_design_scores_gemma":[0.0012993232,0.00011959877,0.00027329166,0.39771456,0.12163303,0.00009657549,0.0005063333,0.00015579218,0.0000700124,0.00004735483,0.4777784,0.0003057231],"about_ca_topic_score_codex":0.00014499085,"about_ca_topic_score_gemma":0.000033445445,"teacher_disagreement_score":0.5550723,"about_ca_system_score_codex":0.00017141954,"about_ca_system_score_gemma":0.0005777067,"threshold_uncertainty_score":0.7619799},"labels":[],"label_agreement":null},{"id":"W2031139877","doi":"10.1111/apt.12161","title":"Pharmacokinetic profiles for oral and subcutaneous methotrexate in patients with Crohn's disease","year":2012,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"London Health Sciences Centre","keywords":"Bioequivalence; Bioavailability; Pharmacokinetics; Medicine; Methotrexate; Confidence interval; Pharmacology; Adverse effect; Gastroenterology; Internal medicine","score_opus":0.026141101769903512,"score_gpt":0.33745193059976086,"score_spread":0.31131082882985733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031139877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943305,0.0011298999,0.00008542533,0.0016958844,0.00028737105,0.0022917658,0.00009223637,0.000043770015,0.000043139888],"genre_scores_gemma":[0.9840588,0.00023939162,0.0024669429,0.012404096,0.00015538148,0.00025791783,0.00016640068,0.000066988825,0.00018409952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821204,0.00016512543,0.00025915029,0.00032249774,0.000280398,0.0007607871],"domain_scores_gemma":[0.9989828,0.000270235,0.00007520402,0.00015917038,0.00009506509,0.0004175282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023974635,0.00027154436,0.0003325502,0.00016412864,0.00008506313,0.000010825373,0.00011710294,0.00007279244,0.00026984868],"category_scores_gemma":[8.220555e-7,0.00021153927,0.000047890233,0.00017932346,0.0002623181,0.00015103382,0.00008058927,0.00023324932,0.000012521139],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036011513,0.002799813,0.9256801,0.0002646825,0.006000829,0.0004093948,0.00066210673,0.000023346067,0.017401138,0.000022271804,0.00091490056,0.009809907],"study_design_scores_gemma":[0.051921755,0.0028528934,0.88616353,0.00006820586,0.01935051,0.00012007546,0.00012677962,0.00380391,0.023868611,0.00006393704,0.010971692,0.0006881195],"about_ca_topic_score_codex":0.00002477128,"about_ca_topic_score_gemma":0.000001709879,"teacher_disagreement_score":0.039516587,"about_ca_system_score_codex":0.00032163647,"about_ca_system_score_gemma":0.00017075278,"threshold_uncertainty_score":0.86263216},"labels":[],"label_agreement":null},{"id":"W2031228905","doi":"10.1111/apt.13054","title":"Frequent proviral integration of the human betaretrovirus in biliary epithelium of patients with autoimmune and idiopathic liver disease","year":2014,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alberta Innovates - Health Solutions; Alberta Innovates - Technology Futures; Canadian Institutes of Health Research; Canadian Liver Foundation; Alberta Cancer Foundation; Alberta Innovates; Gilead Sciences","keywords":"Primary biliary cirrhosis; Medicine; Autoimmune hepatitis; Pathology; Lymph; Cirrhosis; Primary sclerosing cholangitis; Hepatitis; Liver disease; Lymph node; Intrahepatic bile ducts; Epithelium; Liver transplantation; Gastroenterology; Immunology; Disease; Internal medicine; Bile duct; Transplantation","score_opus":0.01593414685548231,"score_gpt":0.26661371648529536,"score_spread":0.250679569629813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031228905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997525,0.0011320977,0.0000093268345,0.00042221378,0.0001300195,0.00070764864,0.00004650848,0.0000095638325,0.000017635517],"genre_scores_gemma":[0.99712783,0.00015867181,0.000041700776,0.0025429074,0.000025283922,0.000018607547,0.000054586933,0.000015276588,0.000015157634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890196,0.0003025361,0.00030385595,0.00015802382,0.0001824645,0.00015117663],"domain_scores_gemma":[0.9993945,0.000038768583,0.00017799095,0.00024461563,0.00008287923,0.00006128332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001704536,0.0001447138,0.000255816,0.00007381931,0.0000667501,0.000002812844,0.00012720918,0.000044430057,0.000059373262],"category_scores_gemma":[6.447652e-7,0.00009148049,0.00006338632,0.00011471525,0.00036635806,0.00008965253,0.0000796942,0.00021299381,7.7153425e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009424936,0.0011230034,0.8976049,0.000116124465,0.0007498807,0.0000022790307,0.0005227921,0.0000060812,0.097537495,0.000036258443,0.0000050458652,0.0013536828],"study_design_scores_gemma":[0.003427192,0.0010251607,0.9637096,0.00010624178,0.0037795305,7.010661e-7,0.00006337835,0.00037042543,0.0273147,0.00006824913,0.00004707217,0.00008777051],"about_ca_topic_score_codex":0.00042768335,"about_ca_topic_score_gemma":0.000017253287,"teacher_disagreement_score":0.070222795,"about_ca_system_score_codex":0.000057704572,"about_ca_system_score_gemma":0.00007403775,"threshold_uncertainty_score":0.37304664},"labels":[],"label_agreement":null},{"id":"W2032883658","doi":"10.1111/j.1365-2036.2004.02286.x","title":"Increased use of low anterior resection for veterans with rectal cancer","year":2004,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Abdominoperineal resection; Resection; Colorectal cancer; Surgery; Rectum; Cancer; Internal medicine","score_opus":0.05946212001210344,"score_gpt":0.36412273047972193,"score_spread":0.3046606104676185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032883658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957643,0.00067832996,0.000085312946,0.0015372655,0.00047075984,0.001250465,0.00013014501,0.00004683905,0.00003659075],"genre_scores_gemma":[0.98976207,0.0007267993,0.0012327532,0.0076334435,0.00014874233,0.00033543716,0.000056312678,0.000039321403,0.000065105916],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989694,0.00006032606,0.00024838233,0.00027656349,0.00016594853,0.00027938146],"domain_scores_gemma":[0.99939877,0.00013430462,0.00011085919,0.00013687334,0.000116113566,0.00010307282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006801388,0.00019379689,0.00034474695,0.00009191146,0.00007053791,0.000006575801,0.00006279968,0.00007997384,0.00021098417],"category_scores_gemma":[2.521344e-7,0.0001537524,0.00011302369,0.0001828179,0.00015730296,0.00011668686,0.00001996048,0.0001321313,0.0000025673671],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06870893,0.0017074889,0.04409105,0.00015984187,0.015839685,0.00013296731,0.00060505606,0.00023861902,0.86466825,0.0000052809,0.00006561248,0.0037772038],"study_design_scores_gemma":[0.023040237,0.0104573835,0.024416018,0.00021806045,0.00962009,0.000120450626,0.000055218847,0.00017781851,0.9287937,0.000021633066,0.0028583624,0.00022100059],"about_ca_topic_score_codex":0.00090593065,"about_ca_topic_score_gemma":0.00025179633,"teacher_disagreement_score":0.064125456,"about_ca_system_score_codex":0.00038929965,"about_ca_system_score_gemma":0.0001769829,"threshold_uncertainty_score":0.62698406},"labels":[],"label_agreement":null},{"id":"W2033164094","doi":"10.1111/j.1365-2036.2010.04236.x","title":"Clinical trial: short‐term effects of combination of satavaptan, a selective vasopressin V<sub>2</sub> receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia – a randomized, double‐blind, placebo‐controlled study","year":2010,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"Sanofi","keywords":"Medicine; Cirrhosis; Ascites; Spironolactone; Internal medicine; Furosemide; Placebo; Gastroenterology; Diuretic; Randomized controlled trial; Tolvaptan; Adverse effect; Antagonist; Endocrinology; Vasopressin; Aldosterone; Receptor; Pathology","score_opus":0.02072073433655851,"score_gpt":0.33765143449427454,"score_spread":0.316930700157716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033164094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886063,0.00015899604,0.000010058434,0.00009910051,0.00056985026,0.0104742125,0.00003194561,0.000023033013,0.000026541704],"genre_scores_gemma":[0.9980957,0.0005648624,0.000079886835,0.0005899437,0.00007188398,0.00041336406,0.00014522024,0.00003617441,0.000002953024],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972424,0.0008517084,0.00086658145,0.00040850477,0.0003983267,0.00023250154],"domain_scores_gemma":[0.99736995,0.0017330616,0.00039152123,0.00019270858,0.00019108778,0.00012166148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087816623,0.0003036488,0.001268713,0.00025158894,0.00006205353,0.000010346468,0.00010733088,0.00017702277,0.0000144620635],"category_scores_gemma":[0.0000024296983,0.00022917934,0.00015675629,0.00019100713,0.00041573186,0.000117398115,0.000023071445,0.00050256966,9.454646e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5952245,0.0061933124,0.33999923,0.000082870014,0.013262426,0.000008095431,0.0007006411,0.000001204093,0.04396705,0.000007210203,0.0000025206098,0.0005509441],"study_design_scores_gemma":[0.68321234,0.006534341,0.1087298,0.00007694809,0.032164574,0.000001207902,0.00004850222,0.00008282599,0.16899395,0.000013593778,5.819737e-7,0.00014131078],"about_ca_topic_score_codex":0.000019306131,"about_ca_topic_score_gemma":0.000022781429,"teacher_disagreement_score":0.23126943,"about_ca_system_score_codex":0.000042106232,"about_ca_system_score_gemma":0.00012384157,"threshold_uncertainty_score":0.9345662},"labels":[],"label_agreement":null},{"id":"W2033219095","doi":"10.1111/apt.13074","title":"Irritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating","year":2015,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; Population Health Research Institute","funders":"Canadian Association of Gastroenterology","keywords":"Medicine; Bloating; Irritable bowel syndrome; Gastroenterology; Internal medicine; Abdominal pain","score_opus":0.03738933833266675,"score_gpt":0.2936906157460473,"score_spread":0.2563012774133806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033219095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938439,0.0001304153,0.000040516392,0.004479242,0.00018839282,0.0007525526,0.000031062853,0.00007146156,0.00046244325],"genre_scores_gemma":[0.9850393,0.000020702793,0.0007912863,0.013675235,0.000023583383,0.00004148171,0.00025442187,0.00003297235,0.00012100039],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827665,0.00021618161,0.00037465987,0.00033745097,0.00034270567,0.00045237437],"domain_scores_gemma":[0.9991008,0.00014959477,0.00017448298,0.00014158561,0.00025813145,0.0001754123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032945615,0.00023624374,0.0003254022,0.00013477282,0.000083264065,0.000014612387,0.00011359911,0.00010248031,0.00024510542],"category_scores_gemma":[0.000004368351,0.00021802467,0.00003964475,0.00037942955,0.00011606402,0.00018444296,0.000040153875,0.00035068984,0.000036162095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007504225,0.0017441547,0.9858355,0.00002661147,0.0016711616,0.00007707209,0.0021270746,0.00015194177,0.0068205087,0.0000045018337,0.0006132091,0.00017786921],"study_design_scores_gemma":[0.023519466,0.006871326,0.9419729,0.00026601105,0.0062060133,0.00013087755,0.0034963894,0.006020712,0.010437505,0.00038496847,0.00020042017,0.00049338967],"about_ca_topic_score_codex":0.00022839969,"about_ca_topic_score_gemma":0.00015235614,"teacher_disagreement_score":0.04386255,"about_ca_system_score_codex":0.0003064838,"about_ca_system_score_gemma":0.00019243422,"threshold_uncertainty_score":0.8890788},"labels":[],"label_agreement":null},{"id":"W2033315477","doi":"10.1111/j.1365-2036.2011.04967.x","title":"Review article: a decision‐making algorithm for the management of pregnancy in the inflammatory bowel disease patient","year":2012,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Pregnancy; Inflammatory bowel disease; Infliximab; Ulcerative colitis; Azathioprine; Fertility; Disease; Adalimumab; Obstetrics; Intensive care medicine; Internal medicine; Population","score_opus":0.07777325413996351,"score_gpt":0.42082612343017683,"score_spread":0.34305286929021334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033315477","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009013357,0.9894809,0.0004952126,0.001016781,0.00085266226,0.007992722,0.000097781856,0.00001791268,0.000037009922],"genre_scores_gemma":[0.0000821806,0.97454995,0.0009634409,0.0212002,0.00015160264,0.0029110669,0.00007458245,0.000043912325,0.000023068746],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99751115,0.00038124542,0.0010055075,0.00029748658,0.00036370143,0.00044089023],"domain_scores_gemma":[0.9976466,0.00094282324,0.00056308205,0.00066992105,0.000053735057,0.00012388454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007534178,0.00036659252,0.000799436,0.000095738134,0.00011016154,0.0000061556884,0.00050641946,0.00010881919,0.00020084057],"category_scores_gemma":[0.0000010412141,0.00019419506,0.00045503306,0.0002672371,0.00017024894,0.0000719413,0.000118378535,0.00041680626,0.00001646754],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053363437,0.00052792666,0.00002245176,0.028081583,0.006285491,0.000037514197,0.00023439717,4.1531032e-7,6.8249295e-7,0.000019198036,0.00073977665,0.9639972],"study_design_scores_gemma":[0.0009567037,0.000114299975,0.00011266256,0.13300467,0.093165874,0.000034670364,0.00006754154,0.00007594457,0.0000050200883,0.0000384587,0.77225906,0.00016510388],"about_ca_topic_score_codex":9.62557e-7,"about_ca_topic_score_gemma":3.03814e-7,"teacher_disagreement_score":0.9638321,"about_ca_system_score_codex":0.00013932078,"about_ca_system_score_gemma":0.00021477857,"threshold_uncertainty_score":0.79190445},"labels":[],"label_agreement":null},{"id":"W2033483114","doi":"10.1111/j.1365-2036.2006.02857.x","title":"Levofloxacin‐based rescue regimens after <i>Helicobacter pylori</i> treatment failure: how strong is the evidence?","year":2006,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; McMaster University","funders":"","keywords":"Medicine; Levofloxacin; Clarithromycin; Helicobacter pylori; Internal medicine; Meta-analysis; Tolerability; Regimen; Metronidazole; Generalizability theory; Odds ratio; Tinidazole; Antibiotics; Adverse effect; Statistics","score_opus":0.05221597885625946,"score_gpt":0.309732734512831,"score_spread":0.25751675565657156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033483114","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09602532,0.0062896535,0.00003110257,0.89114857,0.0027285183,0.0028381636,0.0005758251,0.00025888713,0.000103987564],"genre_scores_gemma":[0.0359039,0.0018703095,0.0003058783,0.943553,0.006491545,0.0014155882,0.0011336005,0.0003296981,0.008996491],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99298507,0.0011782843,0.0010358008,0.0017306304,0.0009375699,0.0021326153],"domain_scores_gemma":[0.9963873,0.0007720702,0.00053272385,0.0016967705,0.0003862916,0.00022483866],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.00036689546,0.0018250343,0.0017234009,0.00042528714,0.0004932114,0.00011346749,0.0007852641,0.0016211203,0.0014517971],"category_scores_gemma":[9.4439554e-7,0.0012677327,0.0009254149,0.0004382225,0.0013105471,0.00026535807,0.00027190833,0.0040642223,0.00042381554],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014023923,0.00048946595,0.02317517,0.000115124,0.044004172,0.0022842772,0.00048851006,0.000008830486,0.0061842683,2.6610167e-7,0.92163545,0.00021205047],"study_design_scores_gemma":[0.006387973,0.002999729,0.0038588233,0.00029814223,0.06749203,0.00020852586,0.0000994381,0.00008799151,0.012321143,0.000010475116,0.9053902,0.00084553106],"about_ca_topic_score_codex":0.00018811123,"about_ca_topic_score_gemma":0.00016260461,"teacher_disagreement_score":0.06012142,"about_ca_system_score_codex":0.0015255567,"about_ca_system_score_gemma":0.00043557593,"threshold_uncertainty_score":0.999675},"labels":[],"label_agreement":null},{"id":"W2034126900","doi":"10.1111/apt.12313","title":"Meta‐analysis: peri‐operative anti‐ <scp>TNF</scp> α treatment and post‐operative complications in patients with inflammatory bowel disease","year":2013,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"American Gastroenterological Association","keywords":"Medicine; Odds ratio; Internal medicine; Ulcerative colitis; Inflammatory bowel disease; Perioperative; Meta-analysis; Gastroenterology; Confidence interval; Surgery; Disease","score_opus":0.03577937100372532,"score_gpt":0.33187199657068656,"score_spread":0.29609262556696125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034126900","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19524002,0.79979193,0.000006884365,0.00008973086,0.00010195283,0.0034559579,0.0012480293,0.000026137872,0.00003933565],"genre_scores_gemma":[0.010236278,0.9762359,0.00013405884,0.0036945024,0.00011878103,0.0028189004,0.006288102,0.00013739092,0.00033609002],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9963627,0.0010467207,0.00072912755,0.0010908748,0.0002040214,0.00056659296],"domain_scores_gemma":[0.9981731,0.00010985819,0.0004186608,0.00066001905,0.0002608923,0.00037743582],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013218721,0.0010176097,0.0015514952,0.00032846257,0.00025513076,0.000069391346,0.0003929566,0.000301485,0.00012826321],"category_scores_gemma":[7.273334e-7,0.00074722024,0.00074877864,0.000251147,0.00044146526,0.00003509875,0.00020419857,0.0002946377,0.000045712786],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021042072,0.0021807395,0.027096383,0.0008994658,0.9644227,0.00011737082,0.00065720006,0.00027686046,0.000418318,0.000024204366,0.00017323649,0.0035230792],"study_design_scores_gemma":[0.0027069969,0.00066871155,0.04536017,0.00008814904,0.8165288,0.000004668202,0.00014986278,0.0000496596,0.00016820102,0.000003562505,0.13362876,0.0006424901],"about_ca_topic_score_codex":0.00001995848,"about_ca_topic_score_gemma":0.000047587087,"teacher_disagreement_score":0.18500374,"about_ca_system_score_codex":0.00018287782,"about_ca_system_score_gemma":0.00053945463,"threshold_uncertainty_score":0.9994979},"labels":[],"label_agreement":null},{"id":"W2034245128","doi":"10.1111/j.1365-2036.2005.02528.x","title":"Omeprazole delays gastric emptying in healthy volunteers: an effect prevented by tegaserod","year":2005,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Omeprazole; Gastric emptying; Medicine; Tegaserod; Gastroenterology; Proton-pump inhibitor; Placebo; Stomach; Internal medicine; Crossover study; Constipation","score_opus":0.02005983718529961,"score_gpt":0.3420011526732221,"score_spread":0.3219413154879225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034245128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98728323,0.0020563405,0.00014446146,0.009038338,0.00022502845,0.0009810937,0.000023806651,0.00011539936,0.00013232928],"genre_scores_gemma":[0.95379484,0.00027764938,0.0013007605,0.044065446,0.00015800193,0.00006944674,0.00021141204,0.000042554188,0.00007986459],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977141,0.0004206535,0.00047145257,0.00048221418,0.00022677037,0.000684797],"domain_scores_gemma":[0.99914765,0.00017090251,0.00009684584,0.00025998088,0.000042759348,0.00028188585],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004886407,0.00031604504,0.00041362573,0.0002116216,0.00011595154,0.000012522546,0.00019732081,0.0001124734,0.00061865355],"category_scores_gemma":[0.0000011222762,0.0003119229,0.000100633406,0.00034771956,0.00013892107,0.0002506404,0.000053094744,0.00059315114,0.000076542536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014243909,0.006660372,0.67628425,0.00016790176,0.0025955054,0.00012288241,0.0009710207,0.0007954865,0.27471912,0.0000037870263,0.0034878312,0.019947939],"study_design_scores_gemma":[0.16283533,0.11679613,0.3239796,0.0006876193,0.035273645,0.0035078,0.0046299133,0.09050976,0.19336991,0.00018263959,0.06497606,0.0032516054],"about_ca_topic_score_codex":0.00023146093,"about_ca_topic_score_gemma":0.00014217233,"teacher_disagreement_score":0.35230464,"about_ca_system_score_codex":0.00029585,"about_ca_system_score_gemma":0.00009876524,"threshold_uncertainty_score":0.9999333},"labels":[],"label_agreement":null},{"id":"W2034282428","doi":"10.1111/j.1365-2036.2012.05128.x","title":"Review article: current treatment options and management of functional dyspepsia","year":2012,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":212,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Health Services Research and Development; GlaxoSmithKline; AstraZeneca","keywords":"Medicine; Functional gastrointestinal disorder; Prokinetic agent; Tricyclic antidepressant; Placebo; Therapeutic effect; Irritable bowel syndrome; Tricyclic; Internal medicine; Cisapride; Antidepressant; Intensive care medicine; Pharmacology; Alternative medicine","score_opus":0.19794004966560108,"score_gpt":0.4318591734435808,"score_spread":0.23391912377797974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034282428","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000085291365,0.99650633,0.000019393918,0.0007238434,0.0005011552,0.0019589455,0.00005440688,0.000028725723,0.00012188786],"genre_scores_gemma":[0.000028660215,0.9964052,0.0004430949,0.0022903816,0.000119663455,0.00025267925,0.00032076682,0.000030746076,0.000108816785],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984542,0.00018706905,0.0005842112,0.00031300928,0.00015114254,0.0003103666],"domain_scores_gemma":[0.99922705,0.00008644186,0.00023768189,0.00023805267,0.000044309236,0.00016644088],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016544272,0.00038014093,0.0010758019,0.00009515357,0.00006386229,0.000003484675,0.000077660734,0.00007507415,0.00084221136],"category_scores_gemma":[7.55122e-8,0.0002943824,0.00031515458,0.00017854568,0.00019107325,0.000045853623,0.000071888266,0.00024283465,0.00006235004],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008398181,0.0018746002,0.00019679792,0.056047514,0.014203054,0.000013886612,0.000019797862,3.7955996e-7,0.000012242195,0.00007412803,0.00058358366,0.92689],"study_design_scores_gemma":[0.0009965826,0.00047003274,0.00019656008,0.011925261,0.1643491,0.000243841,0.000014287694,0.000003699919,0.000005975059,0.00001152875,0.82164454,0.00013857296],"about_ca_topic_score_codex":0.0000042680235,"about_ca_topic_score_gemma":9.09372e-7,"teacher_disagreement_score":0.92675143,"about_ca_system_score_codex":0.00017602401,"about_ca_system_score_gemma":0.000088097106,"threshold_uncertainty_score":0.9999508},"labels":[],"label_agreement":null},{"id":"W2034545752","doi":"10.1111/j.1365-2036.2009.03966.x","title":"Evaluation of the meaningfulness of health‐related quality of life improvements as assessed by the SF‐36 and the EQ‐5D VAS in patients with active Crohn’s disease","year":2009,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Minimal clinically important difference; Medicine; Certolizumab pegol; Visual analogue scale; Quality of life (healthcare); Physical therapy; Randomized controlled trial; Clinical trial; EQ-5D; Disease; Severity of illness; Health related quality of life; Internal medicine; Adalimumab","score_opus":0.03266739989800522,"score_gpt":0.32208922324773437,"score_spread":0.28942182334972916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034545752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99585676,0.0009025246,0.000006213353,0.0014602143,0.00011509307,0.0015259801,0.000102322934,0.000002646905,0.00002824381],"genre_scores_gemma":[0.99385715,0.00006185145,0.0000045066267,0.0059134993,0.000010756762,0.000053338426,0.00007963548,0.000011850866,0.0000073970114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962489,0.0023412635,0.0005466573,0.00022012483,0.00045862937,0.00018443172],"domain_scores_gemma":[0.99857116,0.0000788307,0.000692282,0.00032115018,0.0002820479,0.00005451676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018278765,0.00016297943,0.00023609874,0.000023591245,0.00010585423,0.0000042898623,0.00028424393,0.00006432909,0.000030383826],"category_scores_gemma":[0.0000085193,0.000092323804,0.00007192626,0.00010599881,0.00046006645,0.000012061581,0.00008190662,0.00012634828,2.0972543e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.089680634,0.00809379,0.48124826,0.00028643117,0.022702731,0.0000041971357,0.0065146345,0.0024588718,0.3515059,0.00035549508,0.00049292564,0.036656126],"study_design_scores_gemma":[0.012077629,0.00035143422,0.9243844,0.000015185517,0.0020585104,1.6984053e-7,0.00026141957,0.0002947384,0.060057335,0.0003676711,0.000020696292,0.000110782625],"about_ca_topic_score_codex":0.00013522673,"about_ca_topic_score_gemma":0.000019234756,"teacher_disagreement_score":0.4431362,"about_ca_system_score_codex":0.000050356466,"about_ca_system_score_gemma":0.0004220422,"threshold_uncertainty_score":0.37648556},"labels":[],"label_agreement":null},{"id":"W2034712695","doi":"10.1111/apt.12257","title":"Letter: is blood transfusion really a risk factor for rebleeding in nonvariceal gastrointestinal bleeding? Authors’ reply","year":2013,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"National Institute for Health and Care Research","keywords":"Medicine; Interim; Blood transfusion; Randomized controlled trial; Interim analysis; Gastrointestinal bleeding; Upper gastrointestinal bleeding; Intensive care medicine; Internal medicine; General surgery; Surgery; Endoscopy","score_opus":0.040331126918521816,"score_gpt":0.31280491907377767,"score_spread":0.27247379215525586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034712695","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2406527,0.00063326926,0.00015197614,0.7509195,0.0017005694,0.0044916198,0.0010585877,0.00023748794,0.00015427555],"genre_scores_gemma":[0.014730663,0.0016757695,0.0153599875,0.95899016,0.006362535,0.00094581913,0.0006680139,0.0003136021,0.0009534485],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945295,0.0002554384,0.001331121,0.0015625823,0.0006717125,0.0016496665],"domain_scores_gemma":[0.9970805,0.0010382946,0.0007518466,0.0005138537,0.00031640384,0.00029910632],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00049076515,0.0011935344,0.0014403746,0.00065774,0.00030318185,0.00008870139,0.00046591717,0.00060746126,0.0015090195],"category_scores_gemma":[0.0000033450763,0.0010909297,0.00065575563,0.00033958346,0.00023870754,0.00018636892,0.00012002387,0.0036638216,0.0000681818],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013872018,0.0023313386,0.13052589,0.00066412456,0.015922068,0.0028784224,0.0011231685,0.000007584936,0.07209358,0.0000021977462,0.7715375,0.0015269516],"study_design_scores_gemma":[0.045262035,0.031798605,0.039887942,0.004607209,0.1820549,0.00850552,0.00027004018,0.0024565554,0.051189143,0.00029534954,0.6302675,0.0034051696],"about_ca_topic_score_codex":0.00094974536,"about_ca_topic_score_gemma":0.0000151763215,"teacher_disagreement_score":0.22592203,"about_ca_system_score_codex":0.000604545,"about_ca_system_score_gemma":0.00024891464,"threshold_uncertainty_score":0.9994037},"labels":[],"label_agreement":null},{"id":"W2034777528","doi":"10.1046/j.1365-2036.2000.00808.x","title":"Non‐absorbable antibiotics for managing intestinal gas production and gas‐related symptoms","year":2000,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hydrogen's biological and therapeutic effects","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Università di Bologna","keywords":"Rifaximin; Medicine; Lactulose; Activated charcoal; Gastroenterology; Breath test; Internal medicine; Excretion; Small intestinal bacterial overgrowth; Flatulence; Bloating; Irritable bowel syndrome; Antibiotics; Abdominal pain; Surgery; Microbiology; Chemistry","score_opus":0.01844841398331601,"score_gpt":0.3019149418067711,"score_spread":0.28346652782345505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034777528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830213,0.0015701586,0.000036593814,0.012658306,0.00058082223,0.0013961612,0.000008508323,0.00014224411,0.0005858833],"genre_scores_gemma":[0.97801095,0.002893906,0.00073054835,0.016665159,0.0003204447,0.000021583588,0.00008205981,0.000043201875,0.0012321197],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99840504,0.00009616392,0.00034278724,0.0005029676,0.0001284844,0.0005245761],"domain_scores_gemma":[0.9993863,0.00013232873,0.00008352975,0.00018214896,0.0000594975,0.00015618469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030699835,0.00029980586,0.00038280766,0.00008391972,0.00022197497,0.000015326168,0.000111222434,0.00016203002,0.0008022732],"category_scores_gemma":[5.6762775e-7,0.00024349811,0.00010158315,0.00019781328,0.00030292032,0.000082332685,0.00003601012,0.0003072777,0.000058020334],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030813739,0.0013932219,0.018799026,0.0002375901,0.010592043,0.00011269922,0.00064488105,0.00017345596,0.8122815,0.00012867716,0.00045787898,0.15209769],"study_design_scores_gemma":[0.012104098,0.008839891,0.005149756,0.00031878604,0.02507611,0.0018699432,0.00023884104,0.03418173,0.87226814,0.0051797107,0.03366506,0.0011079428],"about_ca_topic_score_codex":0.00001655962,"about_ca_topic_score_gemma":0.0000015652788,"teacher_disagreement_score":0.15098974,"about_ca_system_score_codex":0.0000662875,"about_ca_system_score_gemma":0.000034108107,"threshold_uncertainty_score":0.99295646},"labels":[],"label_agreement":null},{"id":"W2035551117","doi":"10.1111/j.1365-2036.2006.02791.x","title":"CDP571, a humanized monoclonal antibody to tumour necrosis factor‐α, for steroid‐dependent Crohn's disease: a randomized, double‐blind, placebo‐controlled trial","year":2006,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"UCB Pharma","keywords":"Medicine; Placebo; Prednisone; Crohn's disease; Prednisolone; Azathioprine; Internal medicine; Gastroenterology; Discontinuation; Clinical endpoint; Adverse effect; Randomized controlled trial; Budesonide; Surgery; Corticosteroid; Disease; Pathology","score_opus":0.024013469638633572,"score_gpt":0.33218571436006755,"score_spread":0.308172244721434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035551117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979994,0.00095689925,0.0009827,0.0010653067,0.0017404725,0.014581111,0.000506345,0.000069006484,0.000104189516],"genre_scores_gemma":[0.97888273,0.00015824154,0.00052616955,0.0102570765,0.0019074443,0.00535364,0.0011209702,0.00012911869,0.0016646077],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99638426,0.0006002046,0.00093821913,0.00089222804,0.0003551136,0.00082998816],"domain_scores_gemma":[0.9984657,0.00017744847,0.00035621884,0.00043404446,0.00019887918,0.0003676937],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00062328903,0.0006353475,0.00090741855,0.00016850489,0.00035281666,0.00009888174,0.00054828974,0.00023263069,0.00037366696],"category_scores_gemma":[0.0000025175789,0.00059217,0.0007983228,0.00008973849,0.00022827208,0.000021526592,0.00021313863,0.0001914911,0.000038560487],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6638298,0.000683731,0.00014454978,0.000020817773,0.005063316,0.00009314825,0.000050555256,0.00025628565,0.32915524,0.000032509488,0.00062884635,0.000041172083],"study_design_scores_gemma":[0.9377531,0.00044617488,0.00080241886,0.000008436976,0.007887011,0.0000050212448,0.00002381046,0.00042459447,0.049055133,0.00012169641,0.002834085,0.00063856354],"about_ca_topic_score_codex":0.00003940541,"about_ca_topic_score_gemma":0.000046234087,"teacher_disagreement_score":0.2801001,"about_ca_system_score_codex":0.00010481145,"about_ca_system_score_gemma":0.00030145323,"threshold_uncertainty_score":0.999653},"labels":[],"label_agreement":null},{"id":"W2035690213","doi":"10.1111/j.1365-2036.2004.02140.x","title":"Review article: gastric pH — the most relevant predictor of benefit in reflux disease?","year":2004,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Esomeprazole; Internal medicine; Gastroenterology; Reflux; Crossover study; Proton-pump inhibitor; Gastric acid; Disease; Helicobacter pylori; Stomach; Pathology","score_opus":0.04894391911518482,"score_gpt":0.3810989167073648,"score_spread":0.33215499759218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035690213","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010772188,0.99368125,0.0000010587867,0.0009890995,0.00044557545,0.0034238053,0.00028826587,0.000037826485,0.00005590192],"genre_scores_gemma":[0.001508068,0.9857492,0.00009762815,0.011218348,0.00017210246,0.00041160974,0.0005484956,0.000090756395,0.00020383344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99692523,0.00031874998,0.0012174511,0.0005459532,0.0003893734,0.00060322054],"domain_scores_gemma":[0.9982265,0.00024252053,0.00054332457,0.0006381528,0.00008074022,0.00026874288],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031884614,0.0006311351,0.0019018954,0.00019638441,0.000076199,0.000006853067,0.00040598708,0.00018111114,0.0005708953],"category_scores_gemma":[0.0000015086108,0.00038924432,0.00052733417,0.00076050183,0.0002512036,0.00006242531,0.00013632656,0.00075139105,0.000095486845],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006362011,0.0072276294,0.008977708,0.1370638,0.05588839,0.00409972,0.00017494925,0.000015478307,0.00012917677,0.000072586095,0.0021355688,0.7835788],"study_design_scores_gemma":[0.0070144236,0.0015179924,0.002811421,0.0706552,0.2878867,0.00051045703,0.000011647683,0.000013812966,0.00013266712,0.00018843407,0.6288237,0.00043352335],"about_ca_topic_score_codex":0.00001659057,"about_ca_topic_score_gemma":0.0000016867601,"teacher_disagreement_score":0.78314525,"about_ca_system_score_codex":0.00054613093,"about_ca_system_score_gemma":0.0006782149,"threshold_uncertainty_score":0.99985594},"labels":[],"label_agreement":null},{"id":"W2035700500","doi":"10.1111/j.1365-2036.2012.05046.x","title":"Letter: thiopurines during pregnancy and intrauterine exposure to metabolites – author's reply","year":2012,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Fetus; Medicine; Metabolism; Pregnancy; Placenta; Enzyme; Mercaptopurine; Endocrinology; Internal medicine; Pharmacology; Biochemistry; Chemistry; Biology; Genetics","score_opus":0.03878323308462174,"score_gpt":0.33286118475355375,"score_spread":0.294077951668932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035700500","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.061109673,0.045864124,0.000018012808,0.8871269,0.0037801522,0.0015561003,0.0001380833,0.00023028327,0.00017664266],"genre_scores_gemma":[0.017644538,0.011960686,0.00080822466,0.9554908,0.009191016,0.00034581343,0.00041154624,0.00013953382,0.004007809],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99693,0.00027009763,0.0006665342,0.0007263241,0.00042411487,0.0009829364],"domain_scores_gemma":[0.99843454,0.0001445936,0.00028120892,0.00065813266,0.00008790065,0.00039360518],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017627898,0.00066922756,0.00086872897,0.00034760244,0.00018086363,0.000028359314,0.0003114658,0.0005578382,0.0009518157],"category_scores_gemma":[0.0000013180245,0.0005871927,0.00017108723,0.00020097858,0.00021935978,0.00021041947,0.00023048602,0.0017261277,0.00008180659],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057431543,0.00048710438,0.004755659,0.0017241167,0.022240495,0.0017986911,0.002507729,8.048011e-7,0.2222264,0.000008691268,0.7321291,0.011546923],"study_design_scores_gemma":[0.0023385505,0.00042542082,0.0038119424,0.0006875175,0.015230681,0.0006877978,0.000019521107,0.0000022244005,0.07773142,0.000025582534,0.8985335,0.0005058341],"about_ca_topic_score_codex":0.000020490083,"about_ca_topic_score_gemma":7.156499e-7,"teacher_disagreement_score":0.16640443,"about_ca_system_score_codex":0.00012369016,"about_ca_system_score_gemma":0.00010241892,"threshold_uncertainty_score":0.99996144},"labels":[],"label_agreement":null},{"id":"W2036144913","doi":"10.1111/apt.12940","title":"Adalimumab dose escalation is effective for managing secondary loss of response in Crohn's disease","year":2014,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"Janssen Canada; AbbVie Canada; Alberta Innovates - Health Solutions; AbbVie","keywords":"Adalimumab; Medicine; Internal medicine; Crohn's disease; Retrospective cohort study; Univariate analysis; Gastroenterology; Disease; Surgery; Multivariate analysis","score_opus":0.0086841898356109,"score_gpt":0.29162514478965207,"score_spread":0.28294095495404115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036144913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966057,0.00045328954,0.0005235006,0.00086193957,0.00032686672,0.0010159744,0.00014090516,0.000013304021,0.00005849923],"genre_scores_gemma":[0.9881294,0.000086395135,0.0001983934,0.010970468,0.00014890771,0.0002002878,0.00015940366,0.00003818335,0.000068575326],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984258,0.0005136481,0.00029244478,0.00036920153,0.00010135845,0.00029757016],"domain_scores_gemma":[0.9992921,0.00013229437,0.000133999,0.00026364182,0.0000702359,0.000107771215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005061624,0.00020473335,0.00017598874,0.00010260062,0.00007400863,0.0000073290316,0.00019348651,0.00010588521,0.000080280406],"category_scores_gemma":[0.000001802825,0.00022441227,0.00012752015,0.0000686309,0.00016519404,0.0000125797715,0.000087871216,0.00010597338,0.000005449219],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08783774,0.00072103745,0.053735353,0.00024154417,0.0031840152,0.00015591967,0.00057775155,0.001038509,0.8440493,0.00008678574,0.0006917707,0.0076803197],"study_design_scores_gemma":[0.009741942,0.0006586697,0.7482928,0.00002646081,0.0020231013,0.0000042247184,0.00007891871,0.0041623753,0.22768013,0.0009553325,0.00594297,0.00043305222],"about_ca_topic_score_codex":0.0000056974277,"about_ca_topic_score_gemma":0.0000059433078,"teacher_disagreement_score":0.6945575,"about_ca_system_score_codex":0.00005406611,"about_ca_system_score_gemma":0.00010810756,"threshold_uncertainty_score":0.9151267},"labels":[],"label_agreement":null},{"id":"W2036344615","doi":"10.1111/apt.12292","title":"Meta‐analysis: colonoscopic post‐polypectomy bleeding in patients on continued clopidogrel therapy","year":2013,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"Medicine; Clopidogrel; Polypectomy; Colonoscopy; Internal medicine; Antithrombotic; Surgery; Relative risk; Aspirin; Colorectal cancer; Confidence interval; Cancer","score_opus":0.13149381803152568,"score_gpt":0.3822268265572356,"score_spread":0.2507330085257099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036344615","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018368747,0.9761936,0.0000020263562,0.00026119355,0.00074226793,0.0040686596,0.00014104608,0.000104577055,0.000117883],"genre_scores_gemma":[0.0025613026,0.97769785,0.000054387703,0.016954597,0.00029786388,0.00086272927,0.0011834078,0.00014735124,0.00024052056],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9955966,0.0010254215,0.0010949656,0.0009519344,0.00054747076,0.0007835968],"domain_scores_gemma":[0.9980934,0.0003412414,0.0005123231,0.00064886274,0.0001578429,0.00024631308],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003692535,0.0010536275,0.0055351127,0.0009637855,0.00013607024,0.000040769046,0.00045463955,0.0005653233,0.0026484847],"category_scores_gemma":[2.9303183e-7,0.0007855618,0.0047995406,0.0010453773,0.0002057249,0.00012120764,0.0000826132,0.0009552087,0.00023987975],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006042368,0.0015639173,0.0011258806,0.00070845895,0.9049855,0.00009099128,0.00009376229,0.0000037821844,0.000019181734,0.000004823031,0.00016160937,0.090637855],"study_design_scores_gemma":[0.004354792,0.0009967831,0.00039960287,0.00021670191,0.642313,0.00000840645,0.00002128374,0.000004017133,0.000100788726,0.0000032587889,0.35112953,0.00045179372],"about_ca_topic_score_codex":0.00007096531,"about_ca_topic_score_gemma":0.000004307202,"teacher_disagreement_score":0.35096794,"about_ca_system_score_codex":0.0002703637,"about_ca_system_score_gemma":0.00025804798,"threshold_uncertainty_score":0.9994595},"labels":[],"label_agreement":null},{"id":"W2037521719","doi":"10.1046/j.1365-2036.2004.01861.x","title":"Do we need a new gastro‐oesophageal reflux disease questionnaire?","year":2004,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"GERD; Medicine; Disease; Quality of life (healthcare); Gastro-; Reflux; Reliability (semiconductor); Clinical trial; Physical therapy; Internal medicine","score_opus":0.06824044531850186,"score_gpt":0.40410774384255704,"score_spread":0.33586729852405517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037521719","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021403881,0.9929941,0.000034971636,0.001700631,0.0018170113,0.0027032269,0.00019152771,0.0002664319,0.00007801785],"genre_scores_gemma":[0.0025694997,0.9853438,0.00083750684,0.005512384,0.0013923906,0.00028759227,0.0009864621,0.0002518946,0.0028184284],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99575055,0.0004151869,0.0010561363,0.0011072943,0.0005824968,0.0010883439],"domain_scores_gemma":[0.9972064,0.00011526884,0.0004984404,0.00076272734,0.00008371517,0.001333463],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0001740365,0.0013053834,0.0023435848,0.00044597962,0.00021919083,0.000049586306,0.0004674609,0.00045725342,0.0014478974],"category_scores_gemma":[6.8505193e-7,0.0010487429,0.0011319207,0.00046903596,0.00026255377,0.0001495009,0.0001867533,0.0011410109,0.0009881],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093011244,0.0039708326,0.0032062444,0.014817118,0.07334207,0.018085118,0.00027936194,0.000009258946,0.00003578616,0.00010117563,0.002987856,0.88223505],"study_design_scores_gemma":[0.008991192,0.0015690388,0.00047928048,0.010727406,0.23852172,0.0008486066,0.000013534268,0.000005331767,0.00005699222,0.00041794524,0.7377797,0.0005892901],"about_ca_topic_score_codex":0.000027726983,"about_ca_topic_score_gemma":8.449781e-7,"teacher_disagreement_score":0.8816458,"about_ca_system_score_codex":0.0012567558,"about_ca_system_score_gemma":0.002320082,"threshold_uncertainty_score":0.9999698},"labels":[],"label_agreement":null},{"id":"W2039168286","doi":"10.1046/j.1365-2036.2003.01735.x","title":"Colorectal cancer chemotherapy","year":2003,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Oxaliplatin; Capecitabine; Irinotecan; Colorectal cancer; Oncology; Chemotherapy; Internal medicine; Cancer; Disease; Clinical trial","score_opus":0.08149286674405326,"score_gpt":0.4299835944371758,"score_spread":0.34849072769312256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039168286","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042618194,0.9920073,8.105669e-7,0.00087729166,0.0024394733,0.00226663,0.00016325654,0.000103215236,0.0017158425],"genre_scores_gemma":[0.000027370808,0.9769952,0.000098623976,0.0188641,0.00058736396,0.0011883553,0.00018347103,0.00015097756,0.0019044812],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99762917,0.00021348914,0.0005976538,0.00066877715,0.0002622592,0.0006286485],"domain_scores_gemma":[0.9990799,0.00013961233,0.00029742953,0.00023326994,0.000076473654,0.00017333009],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011017378,0.00082044635,0.0023362574,0.0001762428,0.00020060797,0.000016090191,0.00019836576,0.00037170757,0.0037299187],"category_scores_gemma":[5.776297e-8,0.00061432965,0.0007365211,0.00036038624,0.000255394,0.000044516055,0.000069279165,0.00060819095,0.00010736995],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039013146,0.0009032777,0.00022951605,0.0023003377,0.10064907,0.00017678927,0.00020704724,2.0893522e-7,0.00010144574,0.0000062080344,0.0056966655,0.88933927],"study_design_scores_gemma":[0.0022072291,0.0007319515,0.000026435084,0.0007260346,0.0984962,0.00018740633,0.000024534485,0.000001787163,0.00029880926,0.000006639522,0.896858,0.0004349678],"about_ca_topic_score_codex":0.0000512877,"about_ca_topic_score_gemma":0.000014203954,"teacher_disagreement_score":0.8911613,"about_ca_system_score_codex":0.0009647771,"about_ca_system_score_gemma":0.00063709414,"threshold_uncertainty_score":0.9996308},"labels":[],"label_agreement":null},{"id":"W2039625275","doi":"10.1111/apt.13086","title":"Familial colorectal cancer risk by subsite of primary cancer: a population-based study in Utah","year":2015,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Cancer Institute; U.S. Public Health Service; Myriad Genetics; Huntsman Cancer Foundation; Cook Medical; American Society for Gastrointestinal Endoscopy; American College of Gastroenterology; ACG Institute for Clinical Research and Education","keywords":"Medicine; Colorectal cancer; Rectum; Internal medicine; Population; Cancer registry; Cancer; Oncology; Gastroenterology; Proportional hazards model; First-degree relatives; Colonoscopy; Family history","score_opus":0.04183019723030047,"score_gpt":0.3535626173153537,"score_spread":0.31173242008505325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039625275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906375,0.0045282533,0.0000052499327,0.00087437074,0.0017016565,0.0018107856,0.0003182053,0.000047254798,0.00007676658],"genre_scores_gemma":[0.9913643,0.0005756064,0.00017297664,0.007045205,0.00018268282,0.0004194562,0.00013272956,0.000052518553,0.000054535587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976966,0.00038671296,0.00056751334,0.00044084518,0.00048857945,0.00041978227],"domain_scores_gemma":[0.99902165,0.0001756686,0.0002690882,0.00019638134,0.00015247815,0.00018474011],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003559028,0.00030571216,0.0006144746,0.00017991448,0.00005450557,0.0000054835486,0.0002052562,0.00015129513,0.000512574],"category_scores_gemma":[9.359787e-7,0.00029395244,0.000091043956,0.00040485355,0.00013207475,0.000060053884,0.000066711335,0.0004199732,0.000005211239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003809678,0.0014935797,0.8664662,0.000028802458,0.0023949975,0.000019413523,0.0010031841,0.0013044949,0.12100705,1.2930342e-7,0.0008199295,0.0016525361],"study_design_scores_gemma":[0.015330357,0.0030426665,0.8478691,0.0000336827,0.007175622,0.0000039530423,0.00046161914,0.0017116708,0.12321137,0.000017118335,0.00079797825,0.0003448752],"about_ca_topic_score_codex":0.014033587,"about_ca_topic_score_gemma":0.0026411486,"teacher_disagreement_score":0.018597115,"about_ca_system_score_codex":0.0013153973,"about_ca_system_score_gemma":0.0007522238,"threshold_uncertainty_score":0.99995124},"labels":[],"label_agreement":null},{"id":"W2040315722","doi":"10.1046/j.1365-2036.2003.01407.x","title":"Complementary studies of the gastrointestinal safety of the cyclo‐oxygenase‐2‐selective inhibitor etoricoxib","year":2003,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Etoricoxib; Medicine; Placebo; Naproxen; Rheumatoid arthritis; Gastroenterology; Ibuprofen; Osteoarthritis; Celecoxib; Internal medicine; Pharmacology; Anesthesia; Surgery","score_opus":0.03825984517311523,"score_gpt":0.3358953364549293,"score_spread":0.2976354912818141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040315722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925677,0.0016356693,0.000009936098,0.0020989245,0.0021499556,0.0011570537,0.0000452762,0.0000181531,0.00031732657],"genre_scores_gemma":[0.9911628,0.00021518684,0.00029985493,0.007933978,0.0002420678,0.000031579908,0.000006018677,0.000027492602,0.0000810669],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99784553,0.00065375585,0.00054947374,0.00023028857,0.00036113267,0.00035979017],"domain_scores_gemma":[0.99864626,0.0004021882,0.00035401346,0.0003240268,0.00020357115,0.000069916954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004972547,0.00025454263,0.00047027585,0.000055723132,0.00022565365,0.0000018050298,0.00023821244,0.000051535688,0.00018244397],"category_scores_gemma":[0.000004221822,0.00014883975,0.00023555297,0.00032448454,0.00063655304,0.000042885375,0.00012384537,0.0003894365,0.0000038860826],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010007948,0.0006516197,0.26024598,0.00016215474,0.0060859877,0.00001665915,0.0015080004,0.00004061617,0.7258564,0.00030007752,0.003979892,0.00015177466],"study_design_scores_gemma":[0.004085508,0.0008469169,0.043513708,0.00014828981,0.0060326154,0.00016149794,0.0011497224,0.00003831581,0.9392705,0.00017580709,0.004428179,0.00014892245],"about_ca_topic_score_codex":0.00002143049,"about_ca_topic_score_gemma":0.000017337772,"teacher_disagreement_score":0.21673228,"about_ca_system_score_codex":0.00022358165,"about_ca_system_score_gemma":0.00023317733,"threshold_uncertainty_score":0.60695094},"labels":[],"label_agreement":null},{"id":"W2040539759","doi":"10.1111/apt.12611","title":"Commentary: what factors are important in diagnosing hepatic fibrosis?","year":2014,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"","keywords":"Medicine; Cirrhosis; Portal hypertension; Fibrosis; Von Willebrand factor; Gastroenterology; Internal medicine; Endothelial dysfunction; Liver biopsy; Liver disease; Hepatic fibrosis; Platelet; Pathology; Biopsy","score_opus":0.039289241237941,"score_gpt":0.3201965239340536,"score_spread":0.28090728269611265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040539759","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33381426,0.010158498,5.949297e-7,0.652416,0.0018658547,0.001490468,0.00015708752,0.00007812183,0.000019146375],"genre_scores_gemma":[0.082562126,0.023576641,0.000054174154,0.8871809,0.0017438921,0.0003537319,0.004328584,0.00015390459,0.000046034766],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962931,0.0004825696,0.00088606385,0.0008720817,0.0005224168,0.0009437287],"domain_scores_gemma":[0.997838,0.0007840414,0.0005299333,0.00056433136,0.00006053642,0.00022311385],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001694455,0.0009006229,0.0012987776,0.00035605958,0.00015542246,0.00009242566,0.00031622476,0.0006430605,0.0010293936],"category_scores_gemma":[2.8516885e-7,0.00077614037,0.0004455433,0.00020625802,0.00022541551,0.00027666683,0.0001358758,0.0015622665,0.000061167244],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016194805,0.0014007002,0.45063046,0.00026993547,0.01411052,0.003032311,0.000388213,0.000002678001,0.00033288152,3.647144e-7,0.5293715,0.0002985188],"study_design_scores_gemma":[0.00970823,0.0015063565,0.054880437,0.0017037988,0.069058955,0.000079341786,0.0006823397,0.00016322585,0.01600432,0.000077589924,0.84480566,0.0013297251],"about_ca_topic_score_codex":0.00044571623,"about_ca_topic_score_gemma":0.000039700433,"teacher_disagreement_score":0.39575002,"about_ca_system_score_codex":0.00091600034,"about_ca_system_score_gemma":0.0001081665,"threshold_uncertainty_score":0.9998838},"labels":[],"label_agreement":null},{"id":"W2041258060","doi":"10.1111/apt.12342","title":"Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa‐2b/ribavirin","year":2013,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Okanagan University College; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"Genentech","keywords":"Medicine; Dosing; Boceprevir; Ribavirin; Internal medicine; Regimen; Gastroenterology; Sofosbuvir; Combination therapy; Chronic hepatitis; Immunology; Virus","score_opus":0.03052755626079509,"score_gpt":0.32880342614981345,"score_spread":0.29827586988901833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041258060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99219704,0.0005693499,0.00006457602,0.0035145807,0.00011328864,0.0032028216,0.000028083388,0.00012813375,0.00018214343],"genre_scores_gemma":[0.98774946,0.00080532697,0.00034608683,0.009468404,0.00011008134,0.00044901128,0.00009846398,0.00007985105,0.00089331396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99649847,0.0009022738,0.00047323594,0.00074354897,0.00045471863,0.000927774],"domain_scores_gemma":[0.998313,0.0003429546,0.00014157449,0.00039985433,0.0002789335,0.0005236877],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038580503,0.00044573235,0.0005994598,0.00025529982,0.00023686592,0.00006663221,0.0002759546,0.00022080101,0.0021667208],"category_scores_gemma":[0.000004353367,0.0003596301,0.00006795394,0.00036607354,0.000518766,0.00028667017,0.000250397,0.0005323111,0.00019922924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014517387,0.00055115257,0.67273027,0.000062480016,0.0033643814,0.0002821705,0.0009222869,0.000022834629,0.2911586,0.0000026079788,0.0015780902,0.014807784],"study_design_scores_gemma":[0.015608643,0.030789057,0.8733943,0.00015978835,0.003304051,0.000041411018,0.00016880235,0.003411369,0.068005055,0.000015255228,0.0043525645,0.00074966927],"about_ca_topic_score_codex":0.0019006153,"about_ca_topic_score_gemma":0.00018960383,"teacher_disagreement_score":0.22315353,"about_ca_system_score_codex":0.0012036924,"about_ca_system_score_gemma":0.00029026595,"threshold_uncertainty_score":0.99988556},"labels":[],"label_agreement":null},{"id":"W2041750210","doi":"10.1111/j.1365-2036.2009.04101.x","title":"Systematic review: the short‐term and long‐term efficacy of adalimumab following discontinuation of infliximab","year":2009,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Association of Gastroenterology; Canadian Institutes of Health Research; Procter and Gamble; Abbott Laboratories; Abbott Fund","keywords":"Infliximab; Medicine; Adalimumab; Discontinuation; Randomized controlled trial; Internal medicine; Adverse effect; Refractory (planetary science); Meta-analysis; Gastroenterology; Disease","score_opus":0.024380038171895296,"score_gpt":0.3516515928786201,"score_spread":0.32727155470672475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041750210","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019653477,0.97648466,0.000008617489,0.000060001803,0.000284595,0.003410796,0.00006927638,0.000009702221,0.000018873081],"genre_scores_gemma":[0.0052475077,0.9917998,0.000016278378,0.0019573302,0.00012537595,0.00018586333,0.0005724588,0.000055356875,0.000040040253],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9968193,0.0009106385,0.0013187119,0.00041877088,0.00024161472,0.0002909601],"domain_scores_gemma":[0.9982123,0.00013626121,0.00085353694,0.00064987486,0.000072949166,0.00007510865],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005896489,0.0005026282,0.0015870164,0.00007784149,0.00008175698,0.000012091674,0.00056918524,0.0002496044,0.000017675115],"category_scores_gemma":[0.0000027826063,0.0003525976,0.0007393221,0.0001123758,0.00021662684,0.000010544277,0.00018406034,0.00021893384,0.0000026388643],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004246366,0.0013193429,0.000656622,0.81973505,0.074447624,0.00018046632,0.00032395526,0.0000039874294,0.010703102,0.0000141043565,0.000510185,0.091680914],"study_design_scores_gemma":[0.005442506,0.0014430874,0.0025970286,0.3334226,0.61754584,0.00022973151,0.000063159074,0.000014516477,0.005131159,0.0000107176065,0.0318695,0.0022301783],"about_ca_topic_score_codex":0.0000013330224,"about_ca_topic_score_gemma":0.0000029894152,"teacher_disagreement_score":0.5430982,"about_ca_system_score_codex":0.000042361484,"about_ca_system_score_gemma":0.00016667809,"threshold_uncertainty_score":0.9998926},"labels":[],"label_agreement":null},{"id":"W2046404013","doi":"10.1046/j.1365-2036.2003.01646.x","title":"The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment – Prompt Endoscopy (CADET–PE) study","year":2003,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":277,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; McMaster University; McGill University; University of Guelph; AstraZeneca (Canada); University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Helicobacter pylori; Endoscopy; Reflux; Referral; Peptic; GERD; Peptic ulcer; Disease","score_opus":0.024360788295606006,"score_gpt":0.30280560542258644,"score_spread":0.27844481712698044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046404013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99242395,0.00052501494,0.0000010635146,0.0023444458,0.0002139751,0.0041132784,0.00005542493,0.000026230118,0.00029659466],"genre_scores_gemma":[0.99294895,0.00023653061,0.00034561157,0.0060359556,0.000017981552,0.00021878685,0.0000586379,0.000035847832,0.00010172469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969632,0.00076328404,0.00075206294,0.0004976686,0.0003937532,0.00063005526],"domain_scores_gemma":[0.998322,0.00047498336,0.00023343471,0.00045120844,0.00026098208,0.00025737516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038849664,0.00037877358,0.0004385792,0.00012996563,0.00039508883,0.000020359063,0.00034786024,0.000097446886,0.00008636136],"category_scores_gemma":[0.000007215235,0.0002207907,0.00007985073,0.0004192762,0.0007777486,0.00006832222,0.00003449747,0.00052290596,0.000007860563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012702909,0.0017921266,0.9902187,0.00011087006,0.0016767646,0.000049014285,0.003087685,0.000026447357,0.0014984963,0.000013851667,0.000025042014,0.00023070737],"study_design_scores_gemma":[0.012708653,0.013149544,0.9603428,0.00011525249,0.0055647385,0.000011353576,0.003290151,0.000025869285,0.004259745,0.000028876972,0.0003177267,0.00018524849],"about_ca_topic_score_codex":0.0066019176,"about_ca_topic_score_gemma":0.017243981,"teacher_disagreement_score":0.029875861,"about_ca_system_score_codex":0.0007617657,"about_ca_system_score_gemma":0.0013536119,"threshold_uncertainty_score":0.99801683},"labels":[],"label_agreement":null},{"id":"W2046521127","doi":"10.1111/j.1365-2036.2012.05088.x","title":"Meta‐analysis: vasoactive medications for the management of acute variceal bleeds","year":2012,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":239,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Terlipressin; Medicine; Vasoactive; Octreotide; Vasopressin; Vasoactive intestinal peptide; Meta-analysis; Somatostatin; Internal medicine; Placebo; Randomized controlled trial; Relative risk; Confidence interval; Neuropeptide","score_opus":0.19711722570178164,"score_gpt":0.439740078915428,"score_spread":0.24262285321364635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046521127","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000046770424,0.99384457,0.0012291751,0.00067659706,0.00039221477,0.0027548182,0.00093113637,0.000026814649,0.00014001499],"genre_scores_gemma":[0.00032062654,0.9926183,0.00063873833,0.0025972384,0.00018100141,0.0014058065,0.0019599416,0.000040509727,0.00023784488],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99838763,0.00019665655,0.00054992,0.0002964309,0.00026749325,0.00030184846],"domain_scores_gemma":[0.9985354,0.0005146877,0.00040592722,0.00035027487,0.000082344806,0.000111352834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032139185,0.00035188178,0.0015383463,0.00023051935,0.00013487342,0.000005414063,0.00029406484,0.00015412485,0.0007562924],"category_scores_gemma":[2.3593577e-10,0.0002150652,0.0018291485,0.0005398632,0.00014495396,0.000068091234,0.000041414274,0.00024358237,0.000019778689],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121260775,0.00042804508,0.0000067115548,0.0037140565,0.9906885,0.000010954652,0.00024687985,0.0000018188643,0.000006123713,0.00013340212,0.0000048064576,0.0046374663],"study_design_scores_gemma":[0.0008104025,0.000104412386,0.000035746787,0.000088095636,0.96347743,0.000016921327,0.000075495176,0.000026034697,0.00008126025,0.000019249515,0.035106536,0.00015839908],"about_ca_topic_score_codex":0.000016738622,"about_ca_topic_score_gemma":0.0000011143617,"teacher_disagreement_score":0.03510173,"about_ca_system_score_codex":0.000075952106,"about_ca_system_score_gemma":0.00012752498,"threshold_uncertainty_score":0.8770104},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"meta_analysis","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"meta_analysis","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2047070488","doi":"10.1111/j.1365-2036.2005.02336.x","title":"A randomized, double‐blind, placebo‐controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor‐α, in patients with corticosteroid‐dependent Crohn's disease","year":2005,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Toronto; Robarts Clinical Trials; Université de Montréal; University of Calgary; Western University","funders":"","keywords":"Medicine; Corticosteroid; Placebo; Internal medicine; Gastroenterology; Prednisolone; Crohn's disease; Clinical endpoint; Randomized controlled trial; Adverse effect; Surgery; Disease; Pathology","score_opus":0.017225610050871407,"score_gpt":0.30664944887056533,"score_spread":0.2894238388196939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047070488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99042994,0.00020628315,0.000048004866,0.00039878392,0.000441424,0.008273444,0.00012968744,0.00002011592,0.00005233821],"genre_scores_gemma":[0.993017,0.000091738,0.00017417019,0.004927867,0.00026327348,0.00096618495,0.0003295902,0.00006256561,0.00016760995],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99700683,0.000571939,0.00088313455,0.0005985253,0.00039924172,0.00054034713],"domain_scores_gemma":[0.998687,0.0000779816,0.000380659,0.00036645192,0.000170572,0.0003172987],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037779938,0.00045525996,0.00080194254,0.00019145769,0.00009759739,0.000028854694,0.00038524295,0.00014495545,0.00029529558],"category_scores_gemma":[0.0000023059963,0.00038870802,0.00029229742,0.000110166715,0.00020986487,0.00002476245,0.00017442001,0.00019568324,0.000021866506],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90807134,0.0022432182,0.011350703,0.000016750513,0.0045334743,0.000064525855,0.00017411089,0.000426434,0.07298284,0.000004200232,0.000043362226,0.00008903758],"study_design_scores_gemma":[0.9564094,0.00073278166,0.01991158,0.000014987675,0.0036417556,9.779151e-7,0.000016197506,0.00017824216,0.018544093,0.000005470525,0.00013608865,0.0004084511],"about_ca_topic_score_codex":0.000021638014,"about_ca_topic_score_gemma":0.000049975253,"teacher_disagreement_score":0.05443875,"about_ca_system_score_codex":0.00009600203,"about_ca_system_score_gemma":0.000236617,"threshold_uncertainty_score":0.9998565},"labels":[],"label_agreement":null},{"id":"W2047940354","doi":"10.1111/j.1365-2036.2004.01878.x","title":"The methodological quality of trials affects estimates of treatment efficacy in functional (non‐ulcer) dyspepsia","year":2004,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Jadad scale; Medicine; Relative risk; Internal medicine; Confidence interval; Randomized controlled trial; Clinical trial; Meta-analysis; Cochrane Library","score_opus":0.42120042542470354,"score_gpt":0.52305986019298,"score_spread":0.10185943476827647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047940354","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022147777,0.9714479,0.00004340602,0.001235132,0.0013901426,0.0035304327,0.00012691501,0.000040331866,0.000037968573],"genre_scores_gemma":[0.0021596954,0.99496406,0.0010027492,0.0009495681,0.00020610809,0.00037687473,0.0002411182,0.000059055405,0.000040759616],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9910971,0.0048108688,0.002559918,0.00061028264,0.0002965121,0.000625319],"domain_scores_gemma":[0.98511744,0.012438928,0.00173344,0.0004707379,0.00012320613,0.000116255185],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0039757364,0.0007766248,0.0058020493,0.00028985625,0.00012144914,0.000005790985,0.00031806406,0.0005768595,0.00016974888],"category_scores_gemma":[0.000032337848,0.00044421633,0.0011166251,0.00040835614,0.0010031264,0.000037981208,0.00015945564,0.00078539515,0.000015425665],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011187999,0.009755872,0.011370492,0.01070418,0.33801,0.00020037644,0.0010262799,0.00013012119,0.008643284,0.00010208762,0.00041389404,0.6084554],"study_design_scores_gemma":[0.060646914,0.025940277,0.041466583,0.011201659,0.4847874,0.0005849944,0.00033401963,0.000034580095,0.009990843,0.00038439012,0.3630341,0.00159425],"about_ca_topic_score_codex":0.00009627136,"about_ca_topic_score_gemma":0.000018606956,"teacher_disagreement_score":0.6068612,"about_ca_system_score_codex":0.000920983,"about_ca_system_score_gemma":0.00068813807,"threshold_uncertainty_score":0.999801},"labels":[],"label_agreement":null},{"id":"W2048247993","doi":"10.1111/j.1365-2036.2009.04133.x","title":"Predictors of gastroduodenal erosions in patients taking low‐dose aspirin","year":2009,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"","keywords":"Medicine; Aspirin; Helicobacter pylori; Gastroenterology; Internal medicine; Endoscopy; Helicobacter pylori infection","score_opus":0.023535759032118877,"score_gpt":0.3088632191882477,"score_spread":0.28532746015612886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048247993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99420166,0.00027006262,0.000010892801,0.0038697643,0.00081837556,0.000616421,0.00003164237,0.00005613222,0.00012507579],"genre_scores_gemma":[0.975581,0.00025069813,0.0002761356,0.023575364,0.00015223387,0.000018639572,0.0000889318,0.000024554254,0.00003245309],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980108,0.00017483445,0.00062623696,0.00035784085,0.00025175896,0.0005784871],"domain_scores_gemma":[0.9992047,0.00005943362,0.00025485925,0.00022813215,0.00012306363,0.0001298361],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018149629,0.00028175596,0.0005031047,0.00026688792,0.00007284098,0.0000034574218,0.0001797908,0.00014407234,0.0001593089],"category_scores_gemma":[9.638194e-7,0.0002644199,0.00010425192,0.00028168876,0.00023565127,0.00010377705,0.00008187372,0.00052386837,0.000016976317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014459939,0.0020131653,0.90691423,0.0000141816145,0.003509981,0.000034473407,0.0006122601,0.000050105227,0.083895385,0.0000020411085,0.000288365,0.0012198165],"study_design_scores_gemma":[0.008845209,0.0033379511,0.96228695,0.00007889441,0.0035116558,0.000012843566,0.000072043425,0.000079858255,0.021359568,0.000010098068,0.0002762117,0.00012868739],"about_ca_topic_score_codex":0.000015811804,"about_ca_topic_score_gemma":0.000007727675,"teacher_disagreement_score":0.062535815,"about_ca_system_score_codex":0.00017327229,"about_ca_system_score_gemma":0.0000547943,"threshold_uncertainty_score":0.9999808},"labels":[],"label_agreement":null},{"id":"W2048914465","doi":"10.1111/j.1365-2036.2008.03760.x","title":"Meta‐analysis: tumour invasion‐related genetic polymorphisms and gastric cancer susceptibility","year":2008,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"Deutscher Akademischer Austauschdienst","keywords":"Meta-analysis; Medicine; CDH1; Genetic association; Genotype; Internal medicine; Cancer; Genetic predisposition; Oncology; Genome-wide association study; Genetics; Gene; Biology; Single-nucleotide polymorphism; Disease; Cell; Cadherin","score_opus":0.08873581002561023,"score_gpt":0.350042971349797,"score_spread":0.26130716132418674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048914465","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047730505,0.9933347,0.000025466266,0.00016922966,0.000620508,0.00083911046,0.00017058823,0.000036866917,0.000030463594],"genre_scores_gemma":[0.0016657381,0.9923209,0.0003728038,0.003088743,0.00030103783,0.00047417262,0.0008359679,0.000103923434,0.0008366972],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9963471,0.0006470742,0.0009298222,0.0011816294,0.00026571436,0.0006286382],"domain_scores_gemma":[0.9986492,0.000077320954,0.00053112156,0.0004484281,0.000094527066,0.00019941462],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023621442,0.00086394843,0.0021056377,0.00030844143,0.00024105891,0.000026097701,0.00057652494,0.0006186111,0.0014921988],"category_scores_gemma":[2.3552153e-7,0.00072200975,0.0013936503,0.0006940111,0.00040312437,0.000007840764,0.0003337378,0.0004706421,0.000026491556],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006331974,0.00021241195,0.0005023903,0.0004179831,0.9604111,0.000050860188,0.00008274246,0.00006321101,0.011029026,6.956526e-7,0.0015433556,0.02562294],"study_design_scores_gemma":[0.0005057438,0.00015350191,0.00006102111,0.00004288591,0.66297096,0.00013766409,0.000008629647,0.000009862682,0.0030315416,0.000009005473,0.33238894,0.0006802792],"about_ca_topic_score_codex":0.00008655445,"about_ca_topic_score_gemma":0.000034938847,"teacher_disagreement_score":0.33084556,"about_ca_system_score_codex":0.000107254455,"about_ca_system_score_gemma":0.00053909334,"threshold_uncertainty_score":0.9995231},"labels":[],"label_agreement":null},{"id":"W2049038831","doi":"10.1111/j.1365-2036.2007.03523.x","title":"Hospitalization for gastrointestinal adverse events attributable to the use of low‐dose aspirin among patients 50 years or older also using non‐steroidal anti‐inflammatory drugs: a retrospective cohort study","year":2007,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Arthritis Society; McGill University; Chiesi Farmaceutici; McGill University Health Centre; Pfizer; Eli Lilly and Company","keywords":"Medicine; Aspirin; Rofecoxib; Celecoxib; Diclofenac; Naproxen; Acetaminophen; Ibuprofen; Piroxicam; Internal medicine; Hazard ratio; Medical prescription; Antipyretic; Gastroenterology; Analgesic; Pharmacology; Confidence interval; Cyclooxygenase","score_opus":0.026067018725813476,"score_gpt":0.31626826055297147,"score_spread":0.290201241827158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049038831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905541,0.000021496278,0.0013439491,0.000053122676,0.0010381303,0.0068806354,0.00007108633,0.00003475494,0.0000027536403],"genre_scores_gemma":[0.9961028,0.000010320769,0.0010124483,0.0022213438,0.00028461323,0.00012973146,0.00009777336,0.00007242496,0.00006851809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758244,0.00018224171,0.000664773,0.00044471677,0.0005147889,0.0006110441],"domain_scores_gemma":[0.99851775,0.00023154504,0.00037073912,0.00031661158,0.00036337314,0.00020000203],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009579863,0.0003307786,0.00054318126,0.0002035612,0.00018045423,0.000008838783,0.00018523884,0.00009550342,0.00009166581],"category_scores_gemma":[0.0000057647608,0.0002610012,0.00014110899,0.00030111114,0.00013690809,0.0002372882,0.00011528656,0.000247695,0.00001005509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025398112,0.0014172532,0.9726195,0.00007139892,0.0024221407,0.00006122906,0.0015228628,0.00056421076,0.018399552,3.9361964e-7,0.00022067604,0.00016100927],"study_design_scores_gemma":[0.0075624855,0.0026398997,0.9660751,0.00017399677,0.0045301314,0.0000141594655,0.00046006983,0.0019438912,0.016088268,9.955687e-7,0.00027377805,0.00023722164],"about_ca_topic_score_codex":0.0000937311,"about_ca_topic_score_gemma":0.000039576244,"teacher_disagreement_score":0.006750904,"about_ca_system_score_codex":0.00044717497,"about_ca_system_score_gemma":0.00014534059,"threshold_uncertainty_score":0.9999842},"labels":[],"label_agreement":null},{"id":"W2049143320","doi":"10.1111/j.1365-2036.2006.02748.x","title":"Treating chronic hepatitis C with pegylated interferon alfa‐2a (40 KD) and ribavirin in clinical practice","year":2006,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Toronto Western Hospital; Toronto General Hospital; University Health Network; Royal Victoria Hospital; Vancouver Hospital and Health Sciences Centre; BC Centre for Disease Control; Queen Elizabeth II Health Sciences Centre; University of Alberta; University of Calgary","funders":"F. Hoffmann-La Roche","keywords":"Ribavirin; Medicine; Internal medicine; Pegylated interferon; Adverse effect; Gastroenterology; Clinical trial; Randomized controlled trial; Hepatitis C; Cirrhosis; Hepatitis C virus; Immunology; Virus","score_opus":0.03742171039494784,"score_gpt":0.410042578304414,"score_spread":0.37262086790946614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049143320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98534226,0.0031883998,0.00004101405,0.007713516,0.00022104033,0.00092208764,0.00002099592,0.000072740324,0.0024779548],"genre_scores_gemma":[0.98055893,0.005918149,0.0013943159,0.011099428,0.00040637839,0.000075237906,0.00012108412,0.00006320537,0.00036327218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99710715,0.00069437403,0.0007363989,0.0005217792,0.0003379973,0.0006022748],"domain_scores_gemma":[0.99860597,0.0006977954,0.0001724488,0.00024090674,0.000119665245,0.00016318903],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074185396,0.0002821081,0.0004852556,0.00019466205,0.00010767429,0.000026932554,0.00013865149,0.00018853972,0.0005592094],"category_scores_gemma":[0.0000027864262,0.0002481988,0.00006213442,0.000310445,0.00041651994,0.00025084862,0.0001113847,0.0009014867,0.000054323373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004388593,0.001701624,0.8926084,0.00007301893,0.004245984,0.0016841395,0.00037756783,0.000044519973,0.04072614,0.00002285326,0.0010189476,0.053108234],"study_design_scores_gemma":[0.04551544,0.02219795,0.63334286,0.00046888244,0.015277889,0.0011352872,0.0004885177,0.021358693,0.057376463,0.000112552574,0.20137483,0.0013506655],"about_ca_topic_score_codex":0.004315735,"about_ca_topic_score_gemma":0.00243553,"teacher_disagreement_score":0.25926554,"about_ca_system_score_codex":0.0004602739,"about_ca_system_score_gemma":0.00028966277,"threshold_uncertainty_score":0.999997},"labels":[],"label_agreement":null},{"id":"W2050498853","doi":"10.1046/j.1365-2036.16.s4.13.x","title":"Esomeprazole in the treatment of Helicobacter pylori","year":2002,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Esomeprazole; Omeprazole; Proton-pump inhibitor; Clarithromycin; Helicobacter pylori; Amoxicillin; Medicine; Gastroenterology; Internal medicine; Antibiotics; Microbiology; Biology","score_opus":0.09955069606171751,"score_gpt":0.38331240194597843,"score_spread":0.2837617058842609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050498853","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0073783994,0.9860794,7.3196594e-7,0.0025980019,0.001122441,0.0024418905,0.00010894297,0.00004381739,0.00022638387],"genre_scores_gemma":[0.00029755416,0.9883698,0.00005695191,0.009633421,0.00048591933,0.0005515018,0.00024861033,0.00008900199,0.0002672408],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99644196,0.0007591725,0.0011928014,0.00058796385,0.0002819706,0.00073615374],"domain_scores_gemma":[0.9982954,0.00044245447,0.00046236775,0.00063140853,0.000070470334,0.0000978476],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023537352,0.0008086306,0.0025353897,0.000417037,0.00008704011,0.000008736519,0.00042968648,0.00046496818,0.00046794358],"category_scores_gemma":[2.3466339e-7,0.00050171465,0.00066815614,0.0005463247,0.00042763108,0.000057232366,0.00006763918,0.000735844,0.00017300916],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004774664,0.009907333,0.0064988895,0.0028220327,0.11494871,0.00094187364,0.0052460413,0.000001400471,0.00016710744,0.000006801683,0.0020080802,0.85697424],"study_design_scores_gemma":[0.0031049738,0.0028014907,0.00025983478,0.0006152331,0.07083176,0.0003421495,0.00011071986,0.000004654228,0.00008485089,0.0000025511401,0.92160475,0.00023702941],"about_ca_topic_score_codex":0.00003279147,"about_ca_topic_score_gemma":0.00001353075,"teacher_disagreement_score":0.9195967,"about_ca_system_score_codex":0.0004923581,"about_ca_system_score_gemma":0.00010428368,"threshold_uncertainty_score":0.99974346},"labels":[],"label_agreement":null},{"id":"W2051273236","doi":"10.1111/j.1365-2036.2005.02368.x","title":"A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study","year":2005,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McMaster University Medical Centre","funders":"","keywords":"Esomeprazole; Pantoprazole; Heartburn; Medicine; Gastroenterology; Internal medicine; Randomized controlled trial; Reflux; Omeprazole; Disease","score_opus":0.10513806902324971,"score_gpt":0.41882004928439376,"score_spread":0.313681980261144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051273236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98584443,0.0020603575,0.000034638513,0.0010712174,0.0008428444,0.009895973,0.000069822774,0.00006586468,0.00011486213],"genre_scores_gemma":[0.99317336,0.0001835318,0.00036757134,0.004101731,0.0003697391,0.0015007475,0.00008257783,0.000051626022,0.00016909624],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99675953,0.000760336,0.00087950774,0.0005397387,0.00045563927,0.00060525676],"domain_scores_gemma":[0.9974679,0.0013165299,0.00041889993,0.0004198636,0.00021144819,0.00016535795],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007102424,0.00047947935,0.0013300091,0.00014281446,0.00037749662,0.0000214345,0.00031124713,0.00008664125,0.00022990354],"category_scores_gemma":[0.0000016404789,0.0003275387,0.000299073,0.00022233796,0.0003197632,0.00014687766,0.00011962723,0.0003607383,0.000030190457],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6601404,0.048526935,0.038238008,0.000068985006,0.15209366,0.00039673652,0.0750229,0.000833447,0.021079231,0.000036846857,0.00070706627,0.0028557694],"study_design_scores_gemma":[0.8520104,0.014464163,0.008840859,0.000021215892,0.052240904,0.000029498084,0.025081255,0.0018178307,0.044809286,0.000037568283,0.00038876082,0.00025821012],"about_ca_topic_score_codex":0.00008587201,"about_ca_topic_score_gemma":0.000049410253,"teacher_disagreement_score":0.19187003,"about_ca_system_score_codex":0.00019652965,"about_ca_system_score_gemma":0.000104363164,"threshold_uncertainty_score":0.9999177},"labels":[],"label_agreement":null},{"id":"W2052058263","doi":"10.1111/j.1365-2036.2004.01926.x","title":"Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis","year":2004,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"LEO Pharma","keywords":"Medicine; Placebo; Ulcerative colitis; Low molecular weight heparin; Internal medicine; Gastroenterology; Colitis; Heparin; Anticoagulant; Randomized controlled trial; Surgery; Pathology","score_opus":0.01630205368032429,"score_gpt":0.2980629460373393,"score_spread":0.281760892357015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052058263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99590576,0.00024707403,0.00012705284,0.0015960447,0.00023616014,0.0013948141,0.00011285288,0.000011032412,0.00036922234],"genre_scores_gemma":[0.98142654,0.0006109331,0.00027781434,0.016931925,0.00012780611,0.00038610568,0.00014917814,0.00003487663,0.00005480409],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827486,0.0003736602,0.00032511342,0.00043098922,0.00017168274,0.00042371496],"domain_scores_gemma":[0.9993496,0.00003337381,0.0001031276,0.00033016386,0.00007394945,0.00010978182],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012418609,0.0003183959,0.00025173408,0.00007873964,0.00009679201,0.000013616936,0.0003259731,0.00013749523,0.00006707248],"category_scores_gemma":[3.1826212e-7,0.00026707276,0.00013580143,0.00012831012,0.00017292726,0.000009975244,0.000059426722,0.00011345837,0.000020861913],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035178497,0.004898646,0.0023702646,0.00003392599,0.00824621,0.0007712254,0.007662575,0.013476552,0.92462677,0.00041307762,0.0003634895,0.001958782],"study_design_scores_gemma":[0.006212167,0.0015678538,0.018921865,0.000010260228,0.0009545539,0.000014479049,0.0003327592,0.00008754461,0.96793705,0.00017288829,0.0035004765,0.00028807792],"about_ca_topic_score_codex":0.00009536026,"about_ca_topic_score_gemma":0.00031001575,"teacher_disagreement_score":0.043310322,"about_ca_system_score_codex":0.00019133271,"about_ca_system_score_gemma":0.00019398189,"threshold_uncertainty_score":0.9999781},"labels":[],"label_agreement":null},{"id":"W2052183446","doi":"10.1111/apt.12255","title":"Phase <scp>II</scp> clinical trial of phlebotomy for non‐alcoholic fatty liver disease","year":2013,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institutes of Health; Canadian Liver Foundation; Gilead Sciences","keywords":"Phlebotomy; Medicine; Fatty liver; Internal medicine; Gastroenterology; Liver biopsy; Alcoholic liver disease; Steatosis; Steatohepatitis; Liver disease; Biopsy; Disease; Cirrhosis","score_opus":0.09792837406698486,"score_gpt":0.4250244583096705,"score_spread":0.32709608424268566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052183446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98812926,0.0016661305,0.000033356213,0.0021990575,0.0013021666,0.006223488,0.00025793756,0.000054271764,0.00013434284],"genre_scores_gemma":[0.96728784,0.0027536363,0.0005502388,0.025931604,0.00096376217,0.0018010945,0.00036578035,0.000055114062,0.00029090853],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99779373,0.00018471506,0.00075016235,0.0005029955,0.0002680843,0.0005002819],"domain_scores_gemma":[0.9977044,0.0008601482,0.00027716756,0.00037858103,0.00019261459,0.00058711105],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024601046,0.00034021796,0.00065785216,0.00010632097,0.00015888334,0.000012940434,0.00020745317,0.00014214698,0.0004932223],"category_scores_gemma":[0.0000025097052,0.00028114516,0.0005971516,0.00011845429,0.00030580544,0.00014401258,0.000108967084,0.00020090854,0.0001105239],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.109032005,0.2733444,0.22791758,0.00080630137,0.14321306,0.00062630454,0.0024017626,0.000014410866,0.07147358,0.00017490925,0.10379002,0.06720565],"study_design_scores_gemma":[0.62415963,0.024868872,0.0739434,0.000086388965,0.09923353,0.000011691378,0.00021108058,0.0029202425,0.12726405,0.0002883427,0.046681665,0.00033107912],"about_ca_topic_score_codex":0.000055348577,"about_ca_topic_score_gemma":0.0000011273537,"teacher_disagreement_score":0.51512766,"about_ca_system_score_codex":0.0000890582,"about_ca_system_score_gemma":0.00023304753,"threshold_uncertainty_score":0.99996406},"labels":[],"label_agreement":null},{"id":"W2052762718","doi":"10.1111/apt.12978","title":"Letter: oral B12 replacement in Crohn's disease – is B12 by injection obsolete?","year":2014,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Vitamin B12; Crohn's disease; Gastroenterology; Ileitis; Internal medicine; Disease; Iron deficiency; Anemia","score_opus":0.016612190899665858,"score_gpt":0.28593423831726555,"score_spread":0.2693220474175997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052762718","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38637516,0.0033093984,0.00013451844,0.60158175,0.0047439924,0.0023952078,0.0010581366,0.00011327301,0.0002885847],"genre_scores_gemma":[0.01994748,0.0006460049,0.000055755303,0.967365,0.0037447966,0.0003422236,0.005359448,0.00017535566,0.0023638853],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959641,0.00081471656,0.0006738252,0.0012066971,0.00039355867,0.00094708084],"domain_scores_gemma":[0.9985082,0.000036519228,0.000352134,0.0008168289,0.00008080721,0.00020552542],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003101554,0.00079097855,0.0004562085,0.00017797755,0.00016182057,0.00004863132,0.00063704676,0.00088708557,0.0007394817],"category_scores_gemma":[5.72932e-7,0.00087593566,0.00029767473,0.000108896136,0.00029290013,0.00001578561,0.0002679035,0.0011554358,0.00013164812],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014711886,0.0002356286,0.004485957,0.000107679734,0.0032787593,0.0012258245,0.000051527473,0.000037758582,0.033945642,4.93225e-7,0.95497227,0.00018725939],"study_design_scores_gemma":[0.0026889802,0.00028118378,0.0018782597,0.000025076408,0.0034996087,0.000019575678,0.000008974781,0.0001326294,0.014106561,0.000029381259,0.9764432,0.0008865807],"about_ca_topic_score_codex":0.00005142524,"about_ca_topic_score_gemma":0.0000131838,"teacher_disagreement_score":0.3664277,"about_ca_system_score_codex":0.0002463442,"about_ca_system_score_gemma":0.00020817296,"threshold_uncertainty_score":0.99936914},"labels":[],"label_agreement":null},{"id":"W2054380045","doi":"10.1111/apt.12560","title":"Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir","year":2013,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Bristol-Myers Squibb; National Institute on Drug Abuse; Association of Medical Microbiology and Infectious Disease Canada; Genentech; National Institutes of Health; Sanofi; Bayer HealthCare; Vertex Pharmaceuticals; F. Hoffmann-La Roche; Janssen Pharmaceuticals; Gilead Sciences; Pfizer","keywords":"Medicine; Telaprevir; Adverse effect; Discontinuation; Internal medicine; Cirrhosis; Gastroenterology; Ribavirin; Fibrosis; Hepatitis C; Hepatitis C virus; Immunology","score_opus":0.011281194991084851,"score_gpt":0.304378270259872,"score_spread":0.29309707526878714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054380045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969698,0.000050882616,0.0000013939242,0.00035238563,0.00005769393,0.0020665429,0.000035289413,0.00003165416,0.00043436032],"genre_scores_gemma":[0.9965263,0.00021308068,0.00013069973,0.0024821504,0.000024369507,0.00027131828,0.0001298217,0.00005225891,0.00017000934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805516,0.00045787267,0.00027550728,0.00032283354,0.0004600867,0.00042855373],"domain_scores_gemma":[0.9991131,0.00025207896,0.00011005242,0.0002631225,0.00011645584,0.00014519227],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015654233,0.0002795883,0.00047863097,0.00023702745,0.000045775196,0.0000020249286,0.00014036056,0.00009827145,0.0013070909],"category_scores_gemma":[5.0394544e-7,0.00018636005,0.000057477617,0.000355171,0.00017270922,0.00013855452,0.000040599865,0.00031698126,0.000133917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00563884,0.001111902,0.9749068,0.00008403955,0.0030856936,0.00002694638,0.00009155758,0.000026241438,0.006033223,4.4933626e-7,0.00010760831,0.008886688],"study_design_scores_gemma":[0.016736643,0.02062917,0.8555318,0.0001785744,0.0023405124,0.0000023901014,0.000009522681,0.00020445423,0.10383936,9.360737e-7,0.00033830144,0.00018830452],"about_ca_topic_score_codex":0.0011429433,"about_ca_topic_score_gemma":0.000036915684,"teacher_disagreement_score":0.11937498,"about_ca_system_score_codex":0.0002252993,"about_ca_system_score_gemma":0.00005979421,"threshold_uncertainty_score":0.99960583},"labels":[],"label_agreement":null},{"id":"W2055562038","doi":"10.1046/j.1365-2036.2001.01113.x","title":"Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis","year":2001,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Centre; University of Toronto","funders":"Medical Research Council; Crohn's and Colitis Foundation of Canada; Crohn's and Colitis Foundation","keywords":"Colitis; Oxidative stress; Internal medicine; Dextran; Lipid peroxidation; Ulcerative colitis; Sodium; Chemistry; Inflammation; Medicine; Endocrinology; Antioxidant; Vitamin E; Biochemistry; Gastroenterology","score_opus":0.018752784188317006,"score_gpt":0.3405334397906135,"score_spread":0.3217806556022965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055562038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970899,0.00016755809,0.000004171217,0.0013680666,0.000115110066,0.0010685823,0.000019264082,0.000013737938,0.00015357739],"genre_scores_gemma":[0.9966037,0.00073190883,0.00006734883,0.0022579415,0.00003622531,0.00006705055,0.0001944755,0.000015426485,0.00002590292],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894154,0.0003055237,0.00021628333,0.00018283424,0.00015124389,0.00020255834],"domain_scores_gemma":[0.9995979,0.00013603,0.000105400686,0.000082378094,0.00002912494,0.000049166974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019904257,0.00015545795,0.00025857036,0.00014387319,0.000040086437,0.000004452951,0.000043009917,0.00006458065,0.00022421345],"category_scores_gemma":[2.7904687e-7,0.0001271676,0.000019766643,0.000161832,0.00010295055,0.00009997902,0.00001642906,0.00014566066,0.0000034217678],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022220481,0.00063084427,0.32014143,0.00023669102,0.0010792487,0.00008314708,0.0025054337,0.00011136866,0.63366526,0.00007759813,0.000069348585,0.01917911],"study_design_scores_gemma":[0.01465186,0.0064782314,0.09870786,0.000041686075,0.0027819676,0.000013181606,0.0004998588,0.00011252556,0.8763336,0.000013589754,0.00023802088,0.00012765203],"about_ca_topic_score_codex":0.00019141605,"about_ca_topic_score_gemma":0.0001785211,"teacher_disagreement_score":0.24266829,"about_ca_system_score_codex":0.000060934726,"about_ca_system_score_gemma":0.00004217525,"threshold_uncertainty_score":0.5185744},"labels":[],"label_agreement":null},{"id":"W2055851996","doi":"10.1111/j.1365-2036.2012.05214.x","title":"Long‐term outcome of a third anti‐<scp>TNF</scp> monoclonal antibody after the failure of two prior anti‐<scp>TNF</scp>s in inflammatory bowel disease","year":2012,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ulcerative colitis; Inflammatory bowel disease; Tumor necrosis factor alpha; Internal medicine; Hazard ratio; Gastroenterology; Disease; Infliximab; Colitis; TNF inhibitor; Immunology; Confidence interval","score_opus":0.01359716434251156,"score_gpt":0.30824928808732516,"score_spread":0.2946521237448136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055851996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992096,0.00503141,0.000039487328,0.00026407765,0.0008857503,0.0012162061,0.00033751517,0.000035287263,0.0000942322],"genre_scores_gemma":[0.99229825,0.0006751009,0.00015820343,0.005546716,0.00054596615,0.00015186961,0.0003158867,0.000106904874,0.00020112692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959792,0.0006731199,0.0011266752,0.00063804816,0.0004697172,0.0011132412],"domain_scores_gemma":[0.9977143,0.00021307498,0.0006160273,0.0008660399,0.00017640571,0.00041414515],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007283702,0.0006689937,0.00057550473,0.00021528442,0.000151599,0.000028457482,0.00089647935,0.00032543822,0.0000728892],"category_scores_gemma":[0.000008391129,0.00057350623,0.00044139725,0.00020297969,0.0008126864,0.000074679185,0.0005352693,0.0004976663,0.000035098594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025483264,0.00069368444,0.6481458,0.00016136514,0.0019492639,0.00014531374,0.0005096405,0.00010185852,0.34758717,0.000021491005,0.00035766963,0.000071935596],"study_design_scores_gemma":[0.0030596338,0.000120103155,0.82997566,0.00003683498,0.0025098117,0.000025780771,0.00022488114,0.00008951056,0.16093381,0.000025740623,0.0028153493,0.00018289142],"about_ca_topic_score_codex":0.000019641011,"about_ca_topic_score_gemma":0.00003063842,"teacher_disagreement_score":0.18665336,"about_ca_system_score_codex":0.00007128906,"about_ca_system_score_gemma":0.000276498,"threshold_uncertainty_score":0.99967164},"labels":[],"label_agreement":null},{"id":"W2056586250","doi":"10.1111/apt.13139","title":"Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease – a <scp>SONIC </scp><i>post hoc</i> analysis","year":2015,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":192,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Gastroenterology; Internal medicine; Azathioprine; Infliximab; Post-hoc analysis; Crohn's disease; Randomized controlled trial; Disease","score_opus":0.02323095278838993,"score_gpt":0.31436523448396303,"score_spread":0.2911342816955731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056586250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951755,0.0025185768,0.000034738856,0.0001481578,0.0004464194,0.0015452219,0.0000757721,0.000027533648,0.000028080687],"genre_scores_gemma":[0.9908734,0.0007330961,0.00019760965,0.006947186,0.000183011,0.00015044273,0.00080656534,0.000043291097,0.000065374734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969625,0.00095627987,0.0006591381,0.0007240369,0.00021057553,0.0004874648],"domain_scores_gemma":[0.99842817,0.00014430194,0.00030204174,0.0004390795,0.00018313504,0.00050329854],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00073232205,0.000377599,0.00048297152,0.00015591153,0.00010473069,0.000028345841,0.00030575058,0.0002435837,0.000026613197],"category_scores_gemma":[0.0000123508535,0.00030716235,0.00023822876,0.00024682796,0.00034468464,0.000019613197,0.00019466384,0.0002368175,0.000008799297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.327108,0.002203189,0.6426846,0.000022505259,0.014545938,0.0003996276,0.00022556481,0.00032962355,0.010772384,0.0000026122534,0.00036561055,0.0013403822],"study_design_scores_gemma":[0.309048,0.0028370046,0.66445774,0.000012330889,0.015919682,0.0000029927332,0.00024537818,0.0009322561,0.001843985,0.000042080414,0.004253176,0.00040539342],"about_ca_topic_score_codex":0.000011668397,"about_ca_topic_score_gemma":0.000032945507,"teacher_disagreement_score":0.021773163,"about_ca_system_score_codex":0.000068570036,"about_ca_system_score_gemma":0.00028492033,"threshold_uncertainty_score":0.9999381},"labels":[],"label_agreement":null},{"id":"W2057191292","doi":"10.1046/j.1365-2036.2003.01389.x","title":"Immunopathogenetic and therapeutic aspects of autoimmune hepatitis","year":2002,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Medicine; Autoimmune hepatitis; Immunology; Azathioprine; Tacrolimus; Hepatitis; Ursodeoxycholic acid; Primary biliary cirrhosis; Transplantation; Gastroenterology; Internal medicine; Disease","score_opus":0.06007370181647658,"score_gpt":0.35258641952518954,"score_spread":0.29251271770871295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057191292","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040136194,0.9929929,0.0000019118402,0.00016148042,0.00069748936,0.0014726858,0.00015519402,0.00005792452,0.00044681583],"genre_scores_gemma":[0.0037493147,0.99236196,0.000076995515,0.0029364,0.0001472854,0.0000903957,0.00020555402,0.00011275527,0.00031931425],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99751675,0.0005012208,0.0008412464,0.00044379977,0.0002495772,0.00044739142],"domain_scores_gemma":[0.99851716,0.00022246379,0.00047039244,0.00056092796,0.00008090655,0.0001481554],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015744589,0.00061862636,0.0020393413,0.0002414818,0.00013081364,0.000013245886,0.0003056336,0.00032161325,0.0016489918],"category_scores_gemma":[1.7928905e-7,0.0005208989,0.0005337921,0.0002882365,0.00043674518,0.00004512648,0.00019458238,0.00062478665,0.000054180964],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010313001,0.001157993,0.00050200935,0.007940221,0.037654217,0.00013467812,0.0002225604,1.7652246e-7,0.0023075703,0.000048084104,0.000070986345,0.94985837],"study_design_scores_gemma":[0.0022318284,0.0014775036,0.0018290157,0.0026952554,0.1881606,0.0006008273,0.000035526846,0.00007243896,0.0004684478,0.000060259925,0.8017757,0.00059259665],"about_ca_topic_score_codex":0.00009408349,"about_ca_topic_score_gemma":8.370758e-7,"teacher_disagreement_score":0.9492658,"about_ca_system_score_codex":0.00015838395,"about_ca_system_score_gemma":0.00026290896,"threshold_uncertainty_score":0.99972427},"labels":[],"label_agreement":null},{"id":"W2057243367","doi":"10.1046/j.1365-2036.2003.01409.x","title":"Rectal tissue, plasma and urine concentrations of mesalazine after single and multiple administrations of 500 mg suppositories to healthy volunteers and ulcerative proctitis patients","year":2002,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Royal Victoria Hospital; BioPhage Pharma (Canada); Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Mesalazine; Suppository; Medicine; Pharmacokinetics; Proctitis; Rectum; Urine; Ulcerative colitis; Gastroenterology; Bioavailability; Rectal administration; Antipyretic; Internal medicine; Urology; Pharmacology; Analgesic","score_opus":0.011844027699799036,"score_gpt":0.26613545764031254,"score_spread":0.2542914299405135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057243367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99780715,0.00062733894,0.000013562303,0.00049336924,0.00015875333,0.0005181644,0.00032874098,0.0000056547674,0.000047263147],"genre_scores_gemma":[0.9977226,0.00041442778,0.00041994583,0.0011647823,0.000056774836,0.000033560107,0.00010368453,0.000013887272,0.000070295435],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999259,0.00008209933,0.00022515516,0.00021392453,0.00006993508,0.00014989646],"domain_scores_gemma":[0.9996096,0.000028191233,0.00007363077,0.00008274361,0.00009683127,0.000109022105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000033652093,0.00013191621,0.00013219373,0.000033578934,0.00008154678,0.000008401042,0.0000444178,0.00006464551,0.000063444786],"category_scores_gemma":[0.0000013304476,0.00013994896,0.000016850752,0.000040697305,0.00026195144,0.000014574788,0.000057071305,0.000048409947,7.284392e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016138952,0.00056508544,0.20315658,0.00007458904,0.0010012715,0.0000095293435,0.0015753917,0.000010506943,0.79089534,0.000009912606,0.00047004927,0.0006178488],"study_design_scores_gemma":[0.0040339087,0.0037509778,0.16288522,0.000015606385,0.0010606545,0.0000182545,0.00028092222,0.00035946493,0.82243407,0.000006648028,0.004884265,0.00027003858],"about_ca_topic_score_codex":0.000012414896,"about_ca_topic_score_gemma":0.00012087721,"teacher_disagreement_score":0.040271357,"about_ca_system_score_codex":0.00001392407,"about_ca_system_score_gemma":0.000025897763,"threshold_uncertainty_score":0.5706953},"labels":[],"label_agreement":null},{"id":"W2058763083","doi":"10.1046/j.1365-2036.2002.01347.x","title":"Long‐term safety of tegaserod in patients with constipation‐predominant irritable bowel syndrome","year":2002,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Tegaserod; Medicine; Irritable bowel syndrome; Constipation; Adverse effect; Abdominal pain; Internal medicine; Discontinuation; Tolerability; Flatulence; Gastroenterology","score_opus":0.01804285960276368,"score_gpt":0.26182477717225106,"score_spread":0.24378191756948736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058763083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693507,0.0003900962,0.000049026516,0.0013302307,0.0001399347,0.00077452365,0.00004367074,0.000025414975,0.00031204708],"genre_scores_gemma":[0.99529517,0.00010534382,0.0005624246,0.003784814,0.000012269993,0.000019291092,0.0000928289,0.000020312063,0.00010753602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869686,0.000096655625,0.00039601323,0.00025857222,0.00021122166,0.0003406761],"domain_scores_gemma":[0.9994051,0.00009377521,0.00012744863,0.00018198114,0.000090629015,0.00010107455],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011635648,0.00019624465,0.00034634685,0.00013042385,0.00005866539,0.000003887337,0.000110297915,0.000063275744,0.0019362654],"category_scores_gemma":[5.8329283e-7,0.00016965049,0.000054773474,0.00019458628,0.00030143067,0.00011041709,0.00003676714,0.00022847188,0.000028018369],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028377974,0.0028943503,0.9905436,0.00006779661,0.0011368082,0.000089870955,0.00020722637,0.00006323518,0.0015226203,0.0000054387565,0.00008401578,0.0005472438],"study_design_scores_gemma":[0.014152277,0.0029163172,0.977789,0.00010713155,0.002451319,0.00009873283,0.00007271037,0.00029512058,0.0018940311,0.000013883319,0.000069973285,0.00013950533],"about_ca_topic_score_codex":0.00005098566,"about_ca_topic_score_gemma":0.000027117983,"teacher_disagreement_score":0.012754598,"about_ca_system_score_codex":0.00009890196,"about_ca_system_score_gemma":0.000038562197,"threshold_uncertainty_score":0.9989761},"labels":[],"label_agreement":null},{"id":"W2059305453","doi":"10.1111/j.1365-2036.2008.03910.x","title":"The role of fatty acid hydrolase gene variants in inflammatory bowel disease","year":2008,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Fatty acid amide hydrolase; SNP; Single-nucleotide polymorphism; Inflammatory bowel disease; Ulcerative colitis; Anandamide; Phenotype; Biology; Immunology; Medicine; Internal medicine; Gene; Molecular biology; Disease; Genotype; Genetics","score_opus":0.018177023019823876,"score_gpt":0.3033652269853976,"score_spread":0.2851882039655737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059305453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798158,0.009985458,0.0000034408924,0.008983693,0.00026993663,0.0006307322,0.00003578928,0.00002323321,0.00025191525],"genre_scores_gemma":[0.9873394,0.004547596,0.00004088586,0.006783526,0.00016663673,0.00011091679,0.000026832411,0.000032041575,0.0009522114],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833,0.00020227287,0.00038544566,0.00025571976,0.0003552236,0.00047134294],"domain_scores_gemma":[0.9992167,0.00003831496,0.000091774345,0.00032466868,0.00008262819,0.00024592972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030783017,0.0001823449,0.00022461556,0.00011844986,0.00020301896,0.0000067123397,0.0002423123,0.00007758064,0.00039925962],"category_scores_gemma":[7.3327124e-7,0.00013790917,0.000118749,0.00017391425,0.00050499174,0.00006948442,0.00011008005,0.00036884722,0.000023281185],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002651073,0.00074031804,0.19484763,0.000030763313,0.0017305112,0.00053194416,0.0004563281,0.000040436506,0.79554844,0.00003344856,0.0014282694,0.0019608415],"study_design_scores_gemma":[0.0048456304,0.0004007904,0.3022046,0.000015761665,0.001406744,0.0001232047,0.00023628188,0.0023452952,0.64055854,0.00018522865,0.047467772,0.00021014009],"about_ca_topic_score_codex":0.000055183256,"about_ca_topic_score_gemma":0.000009117819,"teacher_disagreement_score":0.1549899,"about_ca_system_score_codex":0.0001284209,"about_ca_system_score_gemma":0.00041818063,"threshold_uncertainty_score":0.5623773},"labels":[],"label_agreement":null},{"id":"W2060221993","doi":"10.1046/j.1365-2036.2003.01412.x","title":"Cost‐effectiveness in Canada of intravenous proton pump inhibitors for all patients presenting with acute upper gastrointestinal bleeding","year":2003,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Research (Canada); St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Proton-pump inhibitor; Upper gastrointestinal bleeding; Gastrointestinal bleeding; Peptic; Endoscopy; Cohort; Cohort study; Surgery; Intensive care medicine; Peptic ulcer; Internal medicine","score_opus":0.03508823173818018,"score_gpt":0.3151854858528615,"score_spread":0.28009725411468134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060221993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951386,0.000060404986,0.00006911603,0.00039379016,0.0002205889,0.004008751,0.00003789153,0.000015491349,0.000055390425],"genre_scores_gemma":[0.9950689,0.000030383138,0.002829473,0.0011525977,0.00004065346,0.0007569185,0.0000712044,0.00004297669,0.0000068615946],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99832976,0.0001207937,0.0003939102,0.00034556273,0.00025215003,0.0005578544],"domain_scores_gemma":[0.9990147,0.00034935586,0.0002044937,0.000112838825,0.00018512926,0.00013349247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022022531,0.00028040624,0.0004353253,0.00011263726,0.00006511763,0.000007215884,0.00008811438,0.000031962787,0.000041693478],"category_scores_gemma":[0.000001775038,0.00023248968,0.00006855948,0.00015828206,0.00008059734,0.000071622715,0.000027853652,0.00021751545,7.6653293e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014113064,0.0014134103,0.9677667,0.00016000155,0.0030700858,0.00015298688,0.00014665064,0.00014167656,0.02550914,0.0000094726065,0.000033614964,0.00018493288],"study_design_scores_gemma":[0.01710517,0.0066076573,0.29936522,0.00051763764,0.009541423,0.00057936745,0.00040015246,0.00043529746,0.6646637,0.000037740152,0.00042111758,0.00032555562],"about_ca_topic_score_codex":0.02875739,"about_ca_topic_score_gemma":0.0062488825,"teacher_disagreement_score":0.6684015,"about_ca_system_score_codex":0.0008084642,"about_ca_system_score_gemma":0.0005744559,"threshold_uncertainty_score":0.9777102},"labels":[],"label_agreement":null},{"id":"W2062155368","doi":"10.1111/j.1365-2036.2009.04112.x","title":"Review article: chronic viral infection in the anti‐tumour necrosis factor therapy era in inflammatory bowel disease","year":2009,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"AstraZeneca; Pfizer","keywords":"Medicine; Certolizumab pegol; Inflammatory bowel disease; Adalimumab; Infliximab; Immunology; Context (archaeology); Viral hepatitis; Disease; Tumor necrosis factor alpha; Internal medicine","score_opus":0.028850843036528358,"score_gpt":0.34479178132395305,"score_spread":0.3159409382874247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062155368","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10373602,0.89242035,0.0000011899529,0.00040863233,0.00045735113,0.002831395,0.000096994176,0.000028091712,0.00001996624],"genre_scores_gemma":[0.0052942843,0.96835905,0.0000062425074,0.024387315,0.0005829031,0.0006745597,0.0005803836,0.0000916235,0.000023643543],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953289,0.001857261,0.0010396813,0.0007787283,0.0002560329,0.0007394077],"domain_scores_gemma":[0.9985979,0.000063711304,0.00043389353,0.0006875297,0.000049293398,0.0001676261],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005978836,0.00080029364,0.0008579666,0.0002017967,0.0001294699,0.000050292827,0.0007363721,0.00038898012,0.00018037486],"category_scores_gemma":[0.0000015213982,0.0006289165,0.00059003703,0.00028286126,0.0001973611,0.000029076553,0.00012868221,0.00087270845,0.00006369002],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016494398,0.0053484654,0.03959028,0.04007313,0.013903763,0.0028054637,0.00044657526,0.00023198953,0.021503057,0.000040618947,0.011548542,0.86285865],"study_design_scores_gemma":[0.0022135936,0.00030256354,0.040908102,0.0040373793,0.0057731904,0.00003577082,0.0000049266787,0.000027951573,0.00039928447,0.000030113088,0.94525325,0.0010138542],"about_ca_topic_score_codex":0.000023167104,"about_ca_topic_score_gemma":0.000055487017,"teacher_disagreement_score":0.93370473,"about_ca_system_score_codex":0.00032043277,"about_ca_system_score_gemma":0.0008521782,"threshold_uncertainty_score":0.9996162},"labels":[],"label_agreement":null},{"id":"W2063000521","doi":"10.1111/j.1365-2036.2006.02829.x","title":"The prevalence of risk factors for gastrointestinal complications and use of gastroprotection among persons hospitalized for cardiovascular disease","year":2006,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Aspirin; Proton-pump inhibitor; Internal medicine; Gastrointestinal disease; Disease; Gastrointestinal bleeding; Risk factor; Intensive care medicine","score_opus":0.02690421751039171,"score_gpt":0.2776513275388849,"score_spread":0.25074711002849315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063000521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9721029,0.0060091554,0.018717926,0.00017282323,0.00008017144,0.0019437594,0.0009479446,0.000023606439,0.0000017284486],"genre_scores_gemma":[0.99596024,0.0014823017,0.0019496286,0.00012482094,0.00006569272,0.00025287535,0.000112267124,0.000024376055,0.000027805236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901736,0.0001268712,0.00025936088,0.00022925447,0.0001594395,0.00020773557],"domain_scores_gemma":[0.9989331,0.00040900905,0.00016480991,0.0002631478,0.00015431947,0.000075651216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020465652,0.00015409019,0.0002766099,0.00004267619,0.00025711415,0.000008404119,0.00008022859,0.000030104398,0.000006903605],"category_scores_gemma":[0.0000029484502,0.00011731232,0.0007285316,0.0000633196,0.000489749,0.000071972536,0.00001843515,0.000078845456,9.734059e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039908867,0.0006681761,0.9396389,0.000510633,0.028826255,0.0000034695454,0.00015392964,0.001503492,0.022007195,0.00009425102,0.00014516631,0.0024576543],"study_design_scores_gemma":[0.0051180082,0.00077385985,0.9178666,0.00007033092,0.059245113,0.000021582744,0.00020448776,0.0028495982,0.010003249,0.00022134832,0.003463403,0.00016243508],"about_ca_topic_score_codex":0.0001379732,"about_ca_topic_score_gemma":0.0000020736743,"teacher_disagreement_score":0.03041886,"about_ca_system_score_codex":0.000026748867,"about_ca_system_score_gemma":0.000042738655,"threshold_uncertainty_score":0.47838575},"labels":[],"label_agreement":null},{"id":"W2064863653","doi":"10.1046/j.1365-2036.2003.01424.x","title":"<i>Helicobacter</i> DNA in bile: correlation with hepato‐biliary diseases","year":2003,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Gastroenterology; Helicobacter; Endoscopic retrograde cholangiopancreatography; Medicine; Primary sclerosing cholangitis; Internal medicine; Gallstones; Helicobacter pylori; Polymerase chain reaction; Biology; Pancreatitis; Gene; Disease","score_opus":0.01950610468681988,"score_gpt":0.28649122198442645,"score_spread":0.26698511729760654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064863653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99064994,0.0016405792,0.000058222646,0.0052417163,0.0008731259,0.00090067135,0.000035722293,0.00013101938,0.00046901344],"genre_scores_gemma":[0.95257545,0.0012107848,0.00031090507,0.045285422,0.00011149966,0.00013669643,0.00012680539,0.0000609999,0.00018146996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977037,0.0004004742,0.00047726298,0.0005222607,0.00023287456,0.00066342705],"domain_scores_gemma":[0.99908227,0.00017741785,0.00014193617,0.00029962108,0.0001025826,0.00019617571],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018778704,0.0003906893,0.0005085775,0.00023202224,0.00012621797,0.000009961089,0.00012751984,0.00016950896,0.00042138444],"category_scores_gemma":[0.0000010332252,0.00032787575,0.00008772107,0.00042635127,0.0003666817,0.000182149,0.000049174887,0.0005609733,0.00008471451],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014481802,0.0011032264,0.9649386,0.00002457365,0.0063336506,0.000303041,0.0004252594,0.00005488463,0.024315272,0.00001661568,0.00059444696,0.00044225188],"study_design_scores_gemma":[0.027707724,0.004649051,0.85543054,0.0001761457,0.028785894,0.00091500155,0.00086560484,0.00067080685,0.04479923,0.00013570942,0.034946706,0.00091761275],"about_ca_topic_score_codex":0.000028292032,"about_ca_topic_score_gemma":0.000040929503,"teacher_disagreement_score":0.10950808,"about_ca_system_score_codex":0.00025172735,"about_ca_system_score_gemma":0.0001396167,"threshold_uncertainty_score":0.9999173},"labels":[],"label_agreement":null},{"id":"W2065218266","doi":"10.1111/j.1365-2036.2009.03972.x","title":"Treatment of ulcerative colitis from the patient’s perspective: a survey of preferences and satisfaction with therapy","year":2009,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Procter & Gamble (Canada); Telus (Canada); University of British Columbia","funders":"","keywords":"Medicine; Ulcerative colitis; Perspective (graphical); Patient satisfaction; MEDLINE; Internal medicine; Physical therapy; Surgery; Disease","score_opus":0.025663804838812962,"score_gpt":0.30203675071886044,"score_spread":0.27637294588004746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065218266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99688584,0.0018584954,0.000008739318,0.0003567228,0.00006860627,0.0004593071,0.00031029218,0.0000043528,0.000047620026],"genre_scores_gemma":[0.9951647,0.00321789,0.00007274147,0.0013598078,0.000038545524,0.00002312009,0.0001083002,0.000008410152,0.0000064640117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990424,0.00038522665,0.00015912013,0.00020712067,0.00008688798,0.000119256845],"domain_scores_gemma":[0.9994852,0.00006138509,0.00014006464,0.00014482069,0.00013465872,0.00003387284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005175649,0.0001473878,0.0001454236,0.000016104548,0.00006395291,0.000005176499,0.00006992179,0.000054903052,0.000049724156],"category_scores_gemma":[2.2626453e-7,0.00009573694,0.000033188036,0.000043921882,0.00022522497,0.00000637424,0.000011993851,0.00003664543,3.639549e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013295941,0.00071535836,0.6101951,0.0000028475965,0.0078087985,0.000011583006,0.003700315,0.00003628981,0.34692255,0.000041344992,0.00010849709,0.017161401],"study_design_scores_gemma":[0.0017714243,0.0028916157,0.83138794,0.0000026707744,0.0004910314,0.0000027189349,0.00047362596,0.000014399138,0.16266145,0.000072631025,0.00014472245,0.0000857923],"about_ca_topic_score_codex":0.0017404746,"about_ca_topic_score_gemma":0.0014614171,"teacher_disagreement_score":0.22119284,"about_ca_system_score_codex":0.000029454914,"about_ca_system_score_gemma":0.00008636926,"threshold_uncertainty_score":0.39040393},"labels":[],"label_agreement":null},{"id":"W2065235857","doi":"10.1111/apt.12499","title":"Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from <scp>CHARM</scp> and <scp>ADHERE</scp>","year":2013,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"UCB Pharma; Relypsa; Takeda Oncology; Merck Sharp and Dohme; Genentech; Norgine; Astellas Pharma; Eisai; Ironwood Pharmaceuticals, Incorporated; Therakos; AbbVie; Novo Nordisk; Teva Pharmaceutical Industries; Gilead Sciences; Procter and Gamble; Atlantic Healthcare; Amgen; ActoGeniX; Sanofi; Otsuka America; Celgene; Pfizer; Biogen; GlaxoSmithKline; Tillotts Pharma; Shire; Orexigen Therapeutics; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Adalimumab; Medicine; Crohn's disease; Adverse effect; Internal medicine; Clinical endpoint; Surgery; Maintenance therapy; Clinical trial; Gastroenterology; Disease; Chemotherapy","score_opus":0.0230151932692611,"score_gpt":0.29332778744895227,"score_spread":0.27031259417969117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065235857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943701,0.0026022918,0.000030990468,0.00015537965,0.0003796644,0.00086477713,0.0015087711,0.000019195024,0.000068808986],"genre_scores_gemma":[0.9910254,0.0015675745,0.00036528215,0.004831025,0.00023362899,0.000118198914,0.0011562597,0.00006573991,0.00063691335],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99800646,0.00024594404,0.00043642148,0.0006829288,0.00018389497,0.00044432812],"domain_scores_gemma":[0.99825215,0.00013518127,0.00020821486,0.0008682344,0.00009916312,0.0004370701],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012556906,0.00034448603,0.00031327832,0.000085219996,0.00006737908,0.000019383593,0.0005307082,0.00016988377,0.00027689233],"category_scores_gemma":[0.0000051799093,0.0003452498,0.00011103188,0.00008682332,0.0002693286,0.000031028492,0.0005538322,0.00010694514,0.000050204853],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068427157,0.00054901914,0.04519891,0.000058573438,0.0048362524,0.00021915215,0.0008882566,0.00003496566,0.9350513,0.000004446594,0.010384662,0.0020901873],"study_design_scores_gemma":[0.006073783,0.00085280294,0.5648303,0.000053510386,0.0062999795,0.000007964648,0.0010992392,0.000697443,0.35894653,0.00023501599,0.06067802,0.00022542306],"about_ca_topic_score_codex":0.00019533148,"about_ca_topic_score_gemma":0.00002493746,"teacher_disagreement_score":0.57610476,"about_ca_system_score_codex":0.000059048816,"about_ca_system_score_gemma":0.0001892471,"threshold_uncertainty_score":0.9998999},"labels":[],"label_agreement":null},{"id":"W2066087297","doi":"10.1111/j.1365-2036.2004.02233.x","title":"Pantoprazole provides rapid and sustained symptomatic relief in patients treated for erosive oesophagitis","year":2004,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Pantoprazole; Medicine; Heartburn; Placebo; Gastroenterology; Internal medicine; Esophagitis; GERD; Regurgitation (circulation); Randomized controlled trial; Omeprazole; Reflux; Disease","score_opus":0.03304253488440835,"score_gpt":0.3524561726747991,"score_spread":0.3194136377903908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066087297","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02165288,0.96916693,0.0000018686447,0.00016000657,0.00036964103,0.008199203,0.0003238334,0.00008805431,0.000037577458],"genre_scores_gemma":[0.017277163,0.9760736,0.00031229458,0.0022913418,0.00011996123,0.0012367443,0.0022376927,0.00015076142,0.00030039632],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9971901,0.00021835385,0.00089696585,0.0007152542,0.00023126476,0.0007480619],"domain_scores_gemma":[0.99867207,0.00029376568,0.00040915125,0.0002859074,0.00011443518,0.00022469416],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001481002,0.0007956927,0.0019962466,0.00039067885,0.00012984656,0.000025122697,0.00017387257,0.0003854665,0.00009064103],"category_scores_gemma":[0.0000011686249,0.0006301787,0.0003534685,0.00027106603,0.00019214452,0.00011684774,0.00008841952,0.00040773014,0.00002034681],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013618892,0.008286756,0.03791759,0.040668357,0.060915224,0.0017588717,0.00074823963,0.000001625092,0.000046855093,0.000029693778,0.0004188063,0.8478461],"study_design_scores_gemma":[0.1446545,0.033707794,0.014665638,0.024061643,0.49680388,0.00065046025,0.00021394875,0.000088347646,0.0017703058,0.00046588122,0.28029114,0.002626467],"about_ca_topic_score_codex":0.000022922604,"about_ca_topic_score_gemma":0.000001862474,"teacher_disagreement_score":0.8452196,"about_ca_system_score_codex":0.00084376667,"about_ca_system_score_gemma":0.00037560152,"threshold_uncertainty_score":0.99961495},"labels":[],"label_agreement":null},{"id":"W2066258287","doi":"10.1046/j.1365-2036.2001.00107.x","title":"Review article: should we kill or should we save <i>Helicobacter pylori</i>?","year":2001,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Helicobacter pylori; Cancer; Gastroenterology; Disease; Intestinal metaplasia; Gastritis; Internal medicine; Dysplasia; Atrophic gastritis; Immunology","score_opus":0.1849229488171046,"score_gpt":0.42279053735714617,"score_spread":0.23786758854004156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066258287","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007582815,0.9273515,0.000009693052,0.06321923,0.0037010964,0.0046708896,0.00023099923,0.00039376784,0.00034704208],"genre_scores_gemma":[0.000004711136,0.7736404,0.00021347712,0.22124185,0.0014561749,0.00077760284,0.00047971724,0.00032604026,0.0018600269],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99153376,0.0013463732,0.0026532952,0.001696135,0.0006939806,0.002076457],"domain_scores_gemma":[0.9959159,0.00074238994,0.0010253614,0.0013181311,0.00031972505,0.0006784793],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.00077198265,0.0021164098,0.005785707,0.00049825583,0.00031667398,0.00003681227,0.00095257704,0.0013250597,0.004450621],"category_scores_gemma":[0.0000040912673,0.0015106477,0.001345813,0.0013696186,0.0007798647,0.00023280569,0.00062136044,0.0037193766,0.0014590627],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089018943,0.0017205988,0.0005517346,0.02938189,0.10693032,0.0018836355,0.00026726245,4.296803e-7,0.00023797604,0.0000038075323,0.15325569,0.7048765],"study_design_scores_gemma":[0.0026613774,0.0012065037,0.000014730078,0.021321546,0.16772038,0.0021930528,0.000037335736,0.0000039355286,0.00008330098,0.0000069466855,0.80395633,0.00079457246],"about_ca_topic_score_codex":0.000018237763,"about_ca_topic_score_gemma":0.000028124134,"teacher_disagreement_score":0.7040819,"about_ca_system_score_codex":0.0008870504,"about_ca_system_score_gemma":0.00057917467,"threshold_uncertainty_score":0.99997145},"labels":[],"label_agreement":null},{"id":"W2067352325","doi":"10.1111/j.1365-2036.2006.02775.x","title":"Validation of a symptom diary for patients with gastro‐oesophageal reflux disease","year":2006,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; AstraZeneca (Canada); McGill University Health Centre; McMaster University","funders":"AstraZeneca","keywords":"Heartburn; Medicine; Antacid; Reflux; Esomeprazole; Gastro-; Quality of life (healthcare); Internal medicine; Disease; Ambulatory; Esophageal disease; Gastroenterology; Physical therapy; Esophagus","score_opus":0.011114805811695742,"score_gpt":0.2865257121553065,"score_spread":0.27541090634361076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067352325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972766,0.00021658531,0.00019630864,0.00035145803,0.00021615272,0.0013632573,0.0002584616,0.00004745474,0.00007369185],"genre_scores_gemma":[0.9935423,0.000020541975,0.0017244664,0.0023585733,0.00017279261,0.00015263642,0.0017461595,0.000045974884,0.00023651791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986607,0.00008255705,0.0003228057,0.00030554752,0.0002667261,0.0003616628],"domain_scores_gemma":[0.9992137,0.00011623813,0.0001706213,0.00019589317,0.00015195098,0.00015161924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008945553,0.00024877815,0.00031208972,0.00010581104,0.00009147365,0.0000064229657,0.0000905987,0.000056306722,0.00014905991],"category_scores_gemma":[2.4703394e-7,0.00019477728,0.00011986612,0.00011369346,0.00013621687,0.00010775864,0.00002676756,0.00009898375,0.000010080921],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026904917,0.0030097868,0.98321563,0.000071595954,0.003767203,0.000079764606,0.000040560306,0.000042560827,0.0063132253,0.000020695927,0.00025998597,0.0004885093],"study_design_scores_gemma":[0.017184678,0.0031477357,0.8821578,0.000029434672,0.018276807,0.0000066319403,0.000010326191,0.00014462713,0.07845585,0.00018069374,0.00027471938,0.00013070075],"about_ca_topic_score_codex":0.000011217788,"about_ca_topic_score_gemma":4.079946e-7,"teacher_disagreement_score":0.10105783,"about_ca_system_score_codex":0.000107554995,"about_ca_system_score_gemma":0.000085217114,"threshold_uncertainty_score":0.79427874},"labels":[],"label_agreement":null},{"id":"W2067869836","doi":"10.1111/j.1365-2036.2007.03367.x","title":"Generation of dyspeptic symptoms by direct acid infusion into the stomach of healthy Japanese subjects","year":2007,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Hyogo College of Medicine","keywords":"Medicine; Stomach; Gastroenterology; Nausea; Internal medicine; Gastric acid; Bloating; Reflux; Visual analogue scale; Anesthesia","score_opus":0.03314826515719678,"score_gpt":0.3497567883563396,"score_spread":0.31660852319914284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067869836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99525845,0.0025441558,0.000018764718,0.00077357964,0.00045328337,0.00065749546,0.000018282477,0.000026322547,0.00024965825],"genre_scores_gemma":[0.9903973,0.0005533397,0.0001955467,0.008373414,0.00013447023,0.00001837721,0.00016421259,0.000026195816,0.00013715703],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985254,0.00015477824,0.00046292125,0.00022949358,0.0003033055,0.00032412622],"domain_scores_gemma":[0.9991857,0.00014192074,0.00022434517,0.0002345359,0.00009879196,0.00011473541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003600413,0.00020537198,0.00034624766,0.00010675318,0.000113301765,0.0000030521996,0.00013339301,0.000100419886,0.00017099504],"category_scores_gemma":[4.932645e-7,0.00014219963,0.00009588846,0.00022360594,0.00021915679,0.000059119335,0.00004838273,0.00018048425,0.000010706487],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008885655,0.0009945694,0.041231915,0.000043740598,0.0036684356,0.00004182396,0.0023848342,0.000006460007,0.9448306,0.0000038652956,0.00023067571,0.0056745247],"study_design_scores_gemma":[0.0043615745,0.0032646973,0.017624214,0.00001339989,0.0047164503,0.00003014129,0.00018589436,0.00022479435,0.9691095,0.0000084066705,0.00038597916,0.00007494511],"about_ca_topic_score_codex":0.00013774898,"about_ca_topic_score_gemma":0.00001601806,"teacher_disagreement_score":0.024278913,"about_ca_system_score_codex":0.00013908104,"about_ca_system_score_gemma":0.00006827955,"threshold_uncertainty_score":0.57987326},"labels":[],"label_agreement":null},{"id":"W2067951449","doi":"10.1111/j.1365-2036.2009.03962.x","title":"Clinical trial: factors associated with resolution of heartburn in patients with reflux oesophagitis – results from the EXPO study","year":2009,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Janssen Canada; AstraZeneca; Abbott Laboratories","keywords":"Heartburn; Medicine; Gastroenterology; Reflux; Internal medicine; Esophageal disease; Esophagitis; Esophagogastric junction; Esophagus; Adenocarcinoma; Disease","score_opus":0.08661144059818575,"score_gpt":0.38015071662309097,"score_spread":0.2935392760249052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067951449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99634445,0.0001430896,0.0000012167101,0.00066406105,0.0002574676,0.0023413294,0.00017338687,0.00003770111,0.00003730316],"genre_scores_gemma":[0.99544626,0.0000491214,0.00007693171,0.003539729,0.00008276168,0.000022897937,0.00072220695,0.00002608907,0.00003398586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99720466,0.000717222,0.00079625245,0.00044678777,0.00046940756,0.00036568512],"domain_scores_gemma":[0.99843025,0.00057723187,0.00038454466,0.00036160147,0.00013439693,0.000111954745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049295335,0.00028828738,0.0005996052,0.000085419364,0.000095946336,0.000009154413,0.0001615348,0.00012045644,0.000045172623],"category_scores_gemma":[0.00000421677,0.00016202904,0.000092657996,0.00033265678,0.00018246735,0.00010081617,0.000029637093,0.0004251301,0.0000035925107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06800859,0.010900432,0.9125606,9.712502e-7,0.006360542,0.00015276259,0.0011413617,0.000009755232,0.0000606684,3.7955894e-7,0.0000638155,0.0007401707],"study_design_scores_gemma":[0.16528815,0.030278407,0.7987117,0.00004070589,0.0049665337,6.3890116e-7,0.00016474558,0.000010563844,0.00043922965,0.0000111880945,0.000017587852,0.00007054526],"about_ca_topic_score_codex":0.00009960638,"about_ca_topic_score_gemma":0.000048093738,"teacher_disagreement_score":0.11384885,"about_ca_system_score_codex":0.00015818699,"about_ca_system_score_gemma":0.00009081782,"threshold_uncertainty_score":0.66073525},"labels":[],"label_agreement":null},{"id":"W2068288338","doi":"10.1046/j.0953-0673.2003.01728.x","title":"Functional bowel disorders and irritable bowel syndrome in Europe","year":2003,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Irritable bowel syndrome; Medicine; Psychosocial; Functional gastrointestinal disorder; Internal medicine; Abdominal pain; Functional constipation; Comorbidity; Gastroenterology; Constipation; Intensive care medicine; Psychiatry","score_opus":0.057281002148361015,"score_gpt":0.3390786947879154,"score_spread":0.2817976926395544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068288338","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015043062,0.9939651,0.00001352645,0.0013654853,0.0007639823,0.0013205945,0.000044958466,0.000055366403,0.0009666944],"genre_scores_gemma":[0.00030892345,0.9886273,0.00026077396,0.009218627,0.00005857348,0.000112644055,0.00031849288,0.000090478454,0.0010041717],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974517,0.00039788068,0.000657179,0.0006639744,0.00022557232,0.00060368114],"domain_scores_gemma":[0.9990985,0.00022530259,0.00018428636,0.0002374579,0.000052852494,0.00020159566],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002930285,0.0005900029,0.0011995629,0.00031419992,0.0001126487,0.000017575585,0.00015417337,0.0002485419,0.0009655628],"category_scores_gemma":[0.0000010549946,0.0005431917,0.00021266207,0.0004835129,0.00032730913,0.00010310306,0.000091141716,0.0009756746,0.00011604726],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028176995,0.014288245,0.040336646,0.049800564,0.056719106,0.0040111006,0.0005065563,0.00007312598,0.00026980383,0.00043742423,0.015778104,0.8149616],"study_design_scores_gemma":[0.0028605624,0.0009111723,0.0020705333,0.0012920841,0.020972157,0.0023224636,0.000058789516,0.000023542692,0.0000022281893,0.000098242155,0.9689693,0.00041892898],"about_ca_topic_score_codex":0.000046148107,"about_ca_topic_score_gemma":0.000026044338,"teacher_disagreement_score":0.9531912,"about_ca_system_score_codex":0.00015136194,"about_ca_system_score_gemma":0.00033220582,"threshold_uncertainty_score":0.99994767},"labels":[],"label_agreement":null},{"id":"W2068567051","doi":"10.1046/j.1365-2036.2004.01819.x","title":"Monitoring methotrexate‐induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?","year":2004,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Methotrexate; Psoriasis; Cirrhosis; Liver biopsy; Biopsy; Gastroenterology; Cumulative dose; Internal medicine; Fibrosis; Hepatic fibrosis; Dermatology","score_opus":0.031709774280325946,"score_gpt":0.27361313867565334,"score_spread":0.2419033643953274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068567051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925366,0.002458185,0.000005966949,0.000328532,0.0037558204,0.0006820819,0.00009452121,0.000109639244,0.000028624518],"genre_scores_gemma":[0.997139,0.00076094177,0.00051343103,0.0009432177,0.00019097704,0.00013971493,0.00017346871,0.000055503406,0.00008377002],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783456,0.00044046203,0.00041467277,0.000541988,0.00009067529,0.00067761744],"domain_scores_gemma":[0.9991983,0.00016355944,0.00023260213,0.0002748916,0.000080070626,0.000050530994],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000163334,0.0004672944,0.0005151911,0.00023130087,0.00026370687,0.000019271924,0.00030654308,0.00033166283,0.00032199355],"category_scores_gemma":[4.851046e-7,0.00039828086,0.00010834043,0.00032588252,0.00016423326,0.00022300135,0.00009029763,0.00032210123,0.00018705444],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052073104,0.002066696,0.4671095,0.00004123646,0.013608116,0.0000776802,0.0022224577,0.00019175936,0.500319,0.0000101405685,0.000033694134,0.009112387],"study_design_scores_gemma":[0.015693897,0.00092724524,0.3105814,0.000079248886,0.006568849,0.0000084199455,0.0004407426,0.0000015668357,0.6648793,0.000029473482,0.0003382023,0.00045165044],"about_ca_topic_score_codex":0.00040813282,"about_ca_topic_score_gemma":0.00007196339,"teacher_disagreement_score":0.16456029,"about_ca_system_score_codex":0.0002774016,"about_ca_system_score_gemma":0.000075868935,"threshold_uncertainty_score":0.99984694},"labels":[],"label_agreement":null},{"id":"W2069266103","doi":"10.1111/j.1365-2036.2004.02085.x","title":"The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole","year":2004,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Esomeprazole; Omeprazole; Heartburn; Medicine; Gastroenterology; Proton-pump inhibitor; Reflux; Internal medicine; Endoscopy; GERD; Disease","score_opus":0.008269028564297457,"score_gpt":0.29521568759850975,"score_spread":0.2869466590342123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069266103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965884,0.0009496742,0.0000017394116,0.00041389477,0.00008895462,0.001801151,0.000069230235,0.00001532695,0.00007163845],"genre_scores_gemma":[0.9987317,0.00028278853,0.0001368032,0.0004422309,0.000025344212,0.00021964492,0.00006993427,0.000033036482,0.000058567406],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985283,0.00021773699,0.00030390808,0.0002690842,0.00032097724,0.00036000312],"domain_scores_gemma":[0.99897677,0.00027498745,0.00022066702,0.0003457549,0.00006527315,0.00011653577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011352614,0.00030978004,0.00041083657,0.00007029154,0.00014764017,0.0000059519543,0.00016998238,0.000048465943,0.000068607274],"category_scores_gemma":[5.9284326e-7,0.00011855412,0.00007692306,0.00023061862,0.00041153093,0.00008185208,0.000045566263,0.0001690669,0.000005141818],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033374984,0.0017296463,0.9364538,0.000031029376,0.007059535,0.00010387944,0.0007257376,0.00015312216,0.016363028,0.000006414587,0.0000042830925,0.003994542],"study_design_scores_gemma":[0.031155942,0.025239311,0.22545661,0.00008027796,0.007036174,0.0000068465692,0.00013891286,0.000018542862,0.7105655,0.000042971264,0.00017995793,0.00007893782],"about_ca_topic_score_codex":0.00007293589,"about_ca_topic_score_gemma":0.000023540975,"teacher_disagreement_score":0.71099716,"about_ca_system_score_codex":0.00028368804,"about_ca_system_score_gemma":0.00018150224,"threshold_uncertainty_score":0.48344967},"labels":[],"label_agreement":null},{"id":"W2069389812","doi":"10.1111/j.1365-2036.2006.02781.x","title":"Comparison of the effects of fasting morning, fasting evening and fed bedtime administration of tenatoprazole on intragastric pH in healthy volunteers: a randomized three‐way crossover study","year":2006,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Bedtime; Dosing; Medicine; Morning; Crossover study; Evening; Washout; Pharmacokinetics; Oral administration; Dose–response relationship; Internal medicine; Animal science; Anesthesia; Placebo","score_opus":0.023064039169189043,"score_gpt":0.34266125766408784,"score_spread":0.3195972184948988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069389812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571025,0.00086789945,0.000052338106,0.0009354524,0.0003541351,0.0020204124,0.000007727072,0.000019264875,0.000032499516],"genre_scores_gemma":[0.9986939,0.00003797943,0.00018615864,0.0009189129,0.00005666715,0.00006328128,0.000010811386,0.00002396756,0.000008341986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99733925,0.000609641,0.001116314,0.00030070593,0.00027769463,0.00035639183],"domain_scores_gemma":[0.9978408,0.0010748156,0.0007488121,0.00017126054,0.00012091797,0.000043380325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066362554,0.00026595625,0.0011187006,0.00021028997,0.000109416025,0.000004423561,0.00013329626,0.00010763984,0.000010543555],"category_scores_gemma":[0.000014707996,0.00020186436,0.000109743356,0.0003268456,0.00048310668,0.00006073269,0.00010722707,0.0005238516,4.800576e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051817235,0.0021315415,0.84264565,0.0001674157,0.0038849607,0.000013848747,0.0026513985,0.00027375444,0.09577055,0.000003620898,0.000011648848,0.000628347],"study_design_scores_gemma":[0.1736086,0.009452221,0.6805587,0.00037245598,0.008372837,0.000031056272,0.0010066163,0.006585519,0.119821504,0.0000187808,0.0000062797576,0.00016543588],"about_ca_topic_score_codex":0.0002453312,"about_ca_topic_score_gemma":0.0001295475,"teacher_disagreement_score":0.16208698,"about_ca_system_score_codex":0.00009161755,"about_ca_system_score_gemma":0.00006684355,"threshold_uncertainty_score":0.82317895},"labels":[],"label_agreement":null},{"id":"W2069635476","doi":"10.1111/apt.12817","title":"Letter: limitations of studies to evaluate the significance of anti-tumour necrosis factor serum levels in Crohn's disease - authors' reply","year":2014,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Infliximab; Trough (economics); Crohn's disease; Trough level; Disease; Internal medicine; Trough Concentration; Pharmacokinetics; Population; Pharmacodynamics; Gastroenterology","score_opus":0.09642871056559602,"score_gpt":0.3523305254271489,"score_spread":0.25590181486155283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069635476","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7126168,0.0013209278,0.000026510215,0.2824796,0.0010116241,0.001444831,0.0010741428,0.000013810677,0.000011734427],"genre_scores_gemma":[0.4848703,0.00045302292,0.00007092267,0.5133632,0.00068881735,0.00020488058,0.00012883599,0.000057606627,0.00016240093],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964717,0.0011343461,0.0008158977,0.0006767852,0.00036664485,0.00053461187],"domain_scores_gemma":[0.99815357,0.00028705056,0.00042714388,0.00072094233,0.00030032615,0.000110979134],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046574775,0.0005051856,0.00057126745,0.00016275405,0.00012029888,0.000013934033,0.00076976646,0.00028865106,0.000065836306],"category_scores_gemma":[0.000009314051,0.00042804237,0.0002816182,0.00016920501,0.0005376333,0.000010383577,0.00027176747,0.00057513017,0.000012459084],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006933638,0.00025343266,0.006936514,0.00043884877,0.009549558,0.00041225037,0.00087657786,0.00092443096,0.66074795,0.0000033220283,0.318843,0.00032075748],"study_design_scores_gemma":[0.0026795787,0.00046270638,0.29701227,0.00015949036,0.010850629,0.0000059940207,0.00017341539,0.000121324476,0.3060849,0.0001719588,0.38112295,0.0011547672],"about_ca_topic_score_codex":0.000018913399,"about_ca_topic_score_gemma":0.000017764683,"teacher_disagreement_score":0.35466304,"about_ca_system_score_codex":0.00007619728,"about_ca_system_score_gemma":0.00028752777,"threshold_uncertainty_score":0.99981713},"labels":[],"label_agreement":null},{"id":"W2070186039","doi":"10.1111/apt.12597","title":"Commentary: the ss469415590 <scp>SNP</scp> – an <scp>IL</scp>28B marker looking for a home","year":2014,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"SNP; Single-nucleotide polymorphism; Hepatitis C virus; Medicine; Population; Genotype; Odds ratio; Hepatitis C; Immunology; Virology; Genetics; Biology; Internal medicine; Virus; Gene","score_opus":0.07143295888173731,"score_gpt":0.3747512299851718,"score_spread":0.30331827110343446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070186039","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.078514524,0.0045315404,0.00028896047,0.8994619,0.0047883145,0.008115839,0.0015051545,0.00043347353,0.0023602438],"genre_scores_gemma":[0.0066782646,0.0035058314,0.0007592422,0.9653416,0.012320098,0.0014320157,0.0052629975,0.0005931831,0.004106717],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9906698,0.0022187878,0.0012469105,0.0015795553,0.001513594,0.002771357],"domain_scores_gemma":[0.99057627,0.0062462017,0.00062080973,0.0016334119,0.0004036961,0.0005196368],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0020160768,0.001401496,0.0017037999,0.0006180336,0.0008713126,0.0001785572,0.0019281256,0.0015786497,0.0006127893],"category_scores_gemma":[0.0000102243885,0.0011448535,0.0007216644,0.0004732454,0.0011389664,0.00029851406,0.0005633546,0.005414538,0.0003488246],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001302443,0.00054025045,0.005573606,0.0003984967,0.020495892,0.00071822375,0.0010228056,0.0000049367027,0.01248601,0.000007744785,0.9554957,0.0031261046],"study_design_scores_gemma":[0.006092001,0.0020837344,0.00038028051,0.0001168364,0.017381573,0.00021872114,0.00034582056,0.001652991,0.009694321,0.0002518147,0.9615113,0.00027061123],"about_ca_topic_score_codex":0.0003232487,"about_ca_topic_score_gemma":0.000049195118,"teacher_disagreement_score":0.07183626,"about_ca_system_score_codex":0.0008201114,"about_ca_system_score_gemma":0.00044133334,"threshold_uncertainty_score":0.9998735},"labels":[],"label_agreement":null},{"id":"W2070335189","doi":"10.1111/j.1365-2036.2008.03722.x","title":"Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long‐term outcome and survival","year":2008,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Autoimmune hepatitis; Medicine; Overlap syndrome; Gastroenterology; Internal medicine; Primary biliary cirrhosis; Primary sclerosing cholangitis; Hepatitis; Disease","score_opus":0.15328049773883276,"score_gpt":0.40807508983877927,"score_spread":0.2547945920999465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070335189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944634,0.0034890724,0.0000042910783,0.0006705551,0.00047900205,0.0007349105,0.00007173496,0.000039195183,0.000047877253],"genre_scores_gemma":[0.9929268,0.004321014,0.000070362854,0.0021690726,0.000054390115,0.000040296116,0.00017750818,0.000025533358,0.00021505507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980642,0.00078182423,0.0003666774,0.000238505,0.0003148902,0.00023389408],"domain_scores_gemma":[0.9991233,0.0001451028,0.00013140294,0.00030798963,0.000162058,0.00013014165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046829158,0.00021363667,0.0004066407,0.00010697781,0.00016077691,0.0000048625593,0.000093502225,0.000080086706,0.000887847],"category_scores_gemma":[6.2438977e-7,0.0001853932,0.000102509104,0.000104934414,0.0002748756,0.00015139175,0.00004725776,0.00011538065,0.000009110308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026506162,0.0013047273,0.91447234,0.000023370807,0.005537082,0.00007098877,0.00095498614,0.000009157697,0.07281048,0.0000028078355,0.000013041905,0.0021503682],"study_design_scores_gemma":[0.007611081,0.0039193965,0.9634656,0.000013895421,0.015085456,0.00020167217,0.000154516,0.00091301696,0.008326706,0.000008321142,0.00015036302,0.00015001452],"about_ca_topic_score_codex":0.00045227946,"about_ca_topic_score_gemma":0.000011434016,"teacher_disagreement_score":0.06448378,"about_ca_system_score_codex":0.00036768542,"about_ca_system_score_gemma":0.00029019767,"threshold_uncertainty_score":0.9721302},"labels":[],"label_agreement":null},{"id":"W2072018739","doi":"10.1111/apt.12549","title":"Letter: guidelines for the management of autoimmune hepatitis","year":2013,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Medicine; Autoimmune hepatitis; Liver biopsy; Declaration; Intensive care medicine; Hepatitis; Biopsy; Internal medicine","score_opus":0.09529635103811537,"score_gpt":0.37198382332131036,"score_spread":0.276687472283195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072018739","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005105741,0.016521625,0.00014254611,0.9718023,0.002910584,0.0029998838,0.00030467982,0.00005722898,0.00015540583],"genre_scores_gemma":[0.00051119947,0.02230303,0.0016373124,0.9653431,0.002825635,0.00052502035,0.001006581,0.000086209475,0.005761911],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99812514,0.00012123163,0.00066446356,0.00031960208,0.00031524443,0.00045432683],"domain_scores_gemma":[0.99836737,0.0002602,0.0003294509,0.0006316749,0.00036840697,0.000042883035],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017894711,0.00039793603,0.00056952925,0.00008700142,0.00017581198,0.000015162787,0.0005266189,0.00029323116,0.0018346993],"category_scores_gemma":[1.16775425e-7,0.0002753093,0.00042310674,0.00010162953,0.00028589263,0.00006047373,0.00019958647,0.00074419833,0.00004862004],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016887276,0.00017499483,0.00037687077,0.0006239203,0.052370165,0.00007178585,0.000060219765,0.0000035011979,0.0018773325,0.000006327629,0.94014347,0.0041225553],"study_design_scores_gemma":[0.0023607735,0.0003856236,0.0023586168,0.00012695394,0.06271718,0.000019879215,0.00004716612,0.00050388504,0.0023756013,0.000047649577,0.9288209,0.00023577365],"about_ca_topic_score_codex":0.00043077138,"about_ca_topic_score_gemma":6.068303e-7,"teacher_disagreement_score":0.011322552,"about_ca_system_score_codex":0.000105477826,"about_ca_system_score_gemma":0.000070413415,"threshold_uncertainty_score":0.9999699},"labels":[],"label_agreement":null},{"id":"W2072282353","doi":"10.1111/j.1365-2036.2004.02171.x","title":"There is no difference in the disease severity of gastro‐oesophageal reflux disease between patients infected and not infected with Helicobacter pylori","year":2004,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"GERD; Medicine; Internal medicine; Gastroenterology; Helicobacter pylori; Reflux; Gastro-; Disease; Proton-pump inhibitor; Quality of life (healthcare); Endoscopy; Prospective cohort study","score_opus":0.02154137272155247,"score_gpt":0.29768775224084276,"score_spread":0.2761463795192903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072282353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99692893,0.00017745477,0.000008031248,0.001223098,0.00010259514,0.0011423153,0.00035462322,0.000036986727,0.00002596777],"genre_scores_gemma":[0.9877693,0.00016822545,0.000107389846,0.011328752,0.00009623501,0.000079319914,0.0003819616,0.000035447687,0.00003336646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981605,0.00021985694,0.00036421878,0.00041575247,0.000384024,0.00045567186],"domain_scores_gemma":[0.9989145,0.00012796112,0.00016118528,0.00033124862,0.00012984236,0.00033530546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009372843,0.00038086885,0.00042815707,0.00011103326,0.000107346925,0.000015582084,0.0001755638,0.00007615188,0.00013127364],"category_scores_gemma":[0.0000012346324,0.0002427331,0.000086701286,0.00023653671,0.00031740067,0.00012227104,0.0000828844,0.0003595023,0.000017303997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002088421,0.0016843114,0.9912201,0.00007841143,0.0022578454,0.00034345174,0.0004924479,0.0000028870431,0.0012189097,0.0000036921606,0.000009097821,0.0006003847],"study_design_scores_gemma":[0.011338987,0.0014989654,0.97761196,0.00005913205,0.005997038,0.0000050117073,0.000015469686,0.000013063832,0.0032459833,0.00006485912,0.0000307908,0.00011871603],"about_ca_topic_score_codex":0.000059472117,"about_ca_topic_score_gemma":0.0000051505467,"teacher_disagreement_score":0.013608157,"about_ca_system_score_codex":0.00012944861,"about_ca_system_score_gemma":0.00014767914,"threshold_uncertainty_score":0.9898369},"labels":[],"label_agreement":null},{"id":"W2072385774","doi":"10.1046/j.1365-2036.2000.00745.x","title":"Review article: new insights into the pathogenesis of radiation‐induced intestinal dysfunction","year":2000,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Medical Research Council; Medical Research Council Canada; Fondation pour la Recherche Médicale","keywords":"Pathogenesis; Medicine; Radiation Enteritis; Ionizing radiation; Disease; Radiation therapy; Mechanism (biology); Enteritis; Intestinal Disorder; Immunology; Intestinal mucosa; Cancer research; Pathology; Internal medicine","score_opus":0.05121770425184785,"score_gpt":0.37341196476755045,"score_spread":0.3221942605157026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072385774","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007405532,0.9924172,0.000011518127,0.0030635276,0.0008797727,0.0027179518,0.000007388938,0.000069407324,0.00009268771],"genre_scores_gemma":[0.00014010565,0.96778,0.0001290236,0.03045184,0.00078070775,0.00017257892,0.00027950748,0.00008259614,0.0001836234],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968921,0.00094347546,0.0010739134,0.00045014918,0.00033526483,0.000305076],"domain_scores_gemma":[0.99777377,0.00067707145,0.00070831657,0.0005548083,0.000100374236,0.00018565326],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003900824,0.00052351755,0.0015560724,0.00021085494,0.00013456555,0.000009661686,0.00035202567,0.0002874077,0.0012051397],"category_scores_gemma":[0.0000029475068,0.00035303066,0.0005134584,0.0007195303,0.00014538897,0.000104916115,0.000054596356,0.0006687398,0.00018663057],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056377303,0.00022043061,0.000027294676,0.007800163,0.0069855764,0.000019256238,0.00023046196,0.0000019904649,0.0014601806,0.000004459143,0.005484324,0.9777095],"study_design_scores_gemma":[0.0010694538,0.00062307727,0.00005880235,0.006419735,0.08350498,0.0001645415,0.0000103227985,0.000024222662,0.0011220153,0.000019031899,0.906723,0.00026076715],"about_ca_topic_score_codex":0.00005472163,"about_ca_topic_score_gemma":0.000004107482,"teacher_disagreement_score":0.9774487,"about_ca_system_score_codex":0.00028448997,"about_ca_system_score_gemma":0.00082041987,"threshold_uncertainty_score":0.9998922},"labels":[],"label_agreement":null},{"id":"W2073452890","doi":"10.1046/j.1365-2036.2002.01274.x","title":"Meta‐analysis: the efficacy of intravenous H<sub>2</sub>‐receptor antagonists in bleeding peptic ulcer","year":2002,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"H2020 European Research Council; McMaster University","keywords":"Medicine; Odds ratio; Internal medicine; Gastroenterology; Placebo; Randomized controlled trial; Histamine H2 receptor; Surgery; Receptor; Antagonist; Pathology","score_opus":0.12872960465226577,"score_gpt":0.37116660583023237,"score_spread":0.2424370011779666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073452890","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007379304,0.9887064,0.0000029157115,0.001212516,0.0004539328,0.0020474547,0.00009656876,0.00004628969,0.000054630906],"genre_scores_gemma":[0.016892392,0.97969526,0.00020035412,0.00214088,0.0002814731,0.0003979399,0.00025231583,0.00010054844,0.00003885999],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9963726,0.00049589534,0.0013088298,0.00070542167,0.00042175935,0.0006955097],"domain_scores_gemma":[0.9971742,0.0013417852,0.0007380855,0.00048125375,0.00009428319,0.00017039887],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004992171,0.0008360453,0.0040801684,0.00064125995,0.00012761635,0.000023997345,0.00042792386,0.00025804754,0.00090633763],"category_scores_gemma":[8.5669274e-7,0.00053092313,0.0024737453,0.001198729,0.00033158177,0.000051153867,0.00013126872,0.0009203373,0.00011866332],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011764582,0.0033956803,0.00037253625,0.0018645361,0.9505907,0.0002135412,0.00039224687,0.000030791423,0.0013700044,0.000009291739,0.00032314507,0.04131983],"study_design_scores_gemma":[0.001569484,0.00086060725,0.00010705594,0.0007207601,0.950415,0.00019705608,0.00005689805,0.00003562229,0.0021748194,0.0000033752594,0.043531988,0.00032733983],"about_ca_topic_score_codex":0.000053750216,"about_ca_topic_score_gemma":0.0000086078,"teacher_disagreement_score":0.043208845,"about_ca_system_score_codex":0.00036233306,"about_ca_system_score_gemma":0.0001675047,"threshold_uncertainty_score":0.99971426},"labels":[],"label_agreement":null},{"id":"W2073886498","doi":"10.1111/apt.12573","title":"Characteristics of functional bowel disorder patients: a cross‐sectional survey using the Rome III criteria","year":2013,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University","funders":"Hamilton Health Sciences","keywords":"Irritable bowel syndrome; Medicine; Functional constipation; Constipation; Anxiety; Depression (economics); Functional gastrointestinal disorder; Cohort; Internal medicine; Demographics; Abdominal pain; Psychiatry; Demography","score_opus":0.0545062848930335,"score_gpt":0.34003367115100924,"score_spread":0.28552738625797575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073886498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99684805,0.00012149689,0.00042272484,0.0007261108,0.0010587821,0.0006306274,0.00011983417,0.000026652633,0.000045727644],"genre_scores_gemma":[0.98885125,0.000038591334,0.00022611058,0.010139037,0.00014403593,0.00003343816,0.0004220359,0.000025254009,0.00012023847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841326,0.00023011178,0.0004986017,0.00026256475,0.0002765607,0.00031887178],"domain_scores_gemma":[0.9988313,0.00024531968,0.00019538139,0.00019028237,0.00044481514,0.00009292144],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027041978,0.00021189678,0.00025799597,0.000072269555,0.0002122379,0.000024882325,0.00014080021,0.00008318285,0.0043500653],"category_scores_gemma":[0.0000026248229,0.00016394134,0.00011463048,0.00014910154,0.00046850377,0.00016062181,0.00007981816,0.00028535377,0.000031051102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010945149,0.001078837,0.9768939,0.000026212385,0.0014307547,0.0000015380648,0.00011907464,0.000040896186,0.018908849,0.000004379726,0.00024693567,0.00015413336],"study_design_scores_gemma":[0.0030741405,0.0005361101,0.9919132,0.000009475975,0.0010091359,0.00003534035,0.00007159711,0.0025172636,0.00046397778,0.000056634468,0.00019644618,0.00011668932],"about_ca_topic_score_codex":0.00064889225,"about_ca_topic_score_gemma":0.000019499155,"teacher_disagreement_score":0.01844487,"about_ca_system_score_codex":0.00007877641,"about_ca_system_score_gemma":0.00009452461,"threshold_uncertainty_score":0.9965601},"labels":[],"label_agreement":null},{"id":"W2075115765","doi":"10.1111/apt.12522","title":"Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: results from a 29‐year cohort study","year":2013,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ursodeoxycholic acid; Medicine; Primary biliary cirrhosis; Internal medicine; Gastroenterology; Liver transplantation; Biliary cirrhosis; Cohort; Cirrhosis; Surrogate endpoint; Transplantation; Disease; Autoimmune disease","score_opus":0.02913688870636902,"score_gpt":0.3126122507452596,"score_spread":0.28347536203889057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075115765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932707,0.00040256535,6.8004846e-7,0.0030865974,0.00034498874,0.0022958952,0.0004918348,0.000049468228,0.000057278834],"genre_scores_gemma":[0.98246104,0.00018554625,0.00034316455,0.016346233,0.00011679749,0.00019506304,0.00021192816,0.000049159204,0.00009105869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725026,0.00070827745,0.00066770974,0.00057225086,0.00037261954,0.0004288933],"domain_scores_gemma":[0.9984781,0.00028834463,0.0002094092,0.0006304994,0.00008939896,0.00030421186],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005085828,0.00030203856,0.0005932303,0.00035719087,0.00007666183,0.000014905987,0.00036174708,0.00017229407,0.0010703037],"category_scores_gemma":[0.000004178755,0.00028436462,0.00012316267,0.00044818607,0.00020213799,0.00013349533,0.0003613353,0.00042455157,0.0001781311],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017074442,0.0022291802,0.5641084,0.000012843677,0.0026499967,0.000033769003,0.0021672386,0.0000012694595,0.4096434,7.499549e-8,0.0020220622,0.000057315712],"study_design_scores_gemma":[0.008283302,0.0011859072,0.8847597,0.00005907713,0.003402431,0.000002893314,0.0011748449,0.000013152359,0.100601226,0.000003918759,0.0002878927,0.00022562515],"about_ca_topic_score_codex":0.0012957616,"about_ca_topic_score_gemma":0.00000770852,"teacher_disagreement_score":0.32065132,"about_ca_system_score_codex":0.00037235842,"about_ca_system_score_gemma":0.00011769681,"threshold_uncertainty_score":0.99996084},"labels":[],"label_agreement":null},{"id":"W2075683915","doi":"10.1111/j.1365-2036.2006.03137.x","title":"An open‐label study of rabeprazole in patients with Zollinger–Ellison syndrome or idiopathic gastric acid hypersecretion","year":2006,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada","keywords":"Zollinger-Ellison syndrome; Rabeprazole; Medicine; Gastric acid; Gastroenterology; Omeprazole; Gastrinoma; Lansoprazole; Internal medicine; Proton-pump inhibitor; Placebo; Basal (medicine); Stomach; Gastrin; Pathology; Secretion","score_opus":0.04449798669099434,"score_gpt":0.3689303498097475,"score_spread":0.3244323631187531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075683915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99622196,0.00039290354,0.0000085299935,0.00028653003,0.0001650378,0.0028277661,0.000018375411,0.00004122222,0.000037673828],"genre_scores_gemma":[0.9975212,0.000121952944,0.0005062991,0.0014674539,0.000046236706,0.00013404134,0.000092217786,0.00005760044,0.000052960175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975129,0.00042114907,0.00051624794,0.00049930636,0.0005239835,0.0005264247],"domain_scores_gemma":[0.9991081,0.0000628419,0.0002090324,0.00035176176,0.00013883089,0.00012948159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024380123,0.00027874866,0.00054823904,0.00032808862,0.00009076194,0.000019791158,0.00042492332,0.000023577224,0.00017024917],"category_scores_gemma":[4.985182e-7,0.00021644929,0.000021331745,0.00064478075,0.00015471381,0.00037970347,0.00012103246,0.00043657073,0.000009893972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016925685,0.03539454,0.77850735,0.00007601503,0.0013475684,0.0027026425,0.00030127543,0.00016179994,0.1639625,0.0000032056093,0.000026105681,0.0005913047],"study_design_scores_gemma":[0.13290142,0.1301988,0.61148447,0.00018342998,0.0071799,0.000936285,0.0023524242,0.0008128087,0.1128267,0.00009014036,0.00025367682,0.00077996263],"about_ca_topic_score_codex":0.00044348146,"about_ca_topic_score_gemma":0.00018886795,"teacher_disagreement_score":0.16702291,"about_ca_system_score_codex":0.00014967585,"about_ca_system_score_gemma":0.00013098722,"threshold_uncertainty_score":0.8826546},"labels":[],"label_agreement":null},{"id":"W2076555171","doi":"10.1046/j.1365-2036.2000.00911.x","title":"One‐week triple therapy with esomeprazole provides effective eradication of <i>Helicobacter pylori</i> in duodenal ulcer disease","year":2000,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); Saint John Regional Hospital; Queen Elizabeth II Health Sciences Centre","funders":"AstraZeneca","keywords":"Esomeprazole; Omeprazole; Medicine; Gastroenterology; Internal medicine; Helicobacter pylori; Clarithromycin; Amoxicillin; Proton-pump inhibitor; Urea breath test; Adverse effect; Breath test; Antibiotics; Helicobacter pylori infection; Microbiology","score_opus":0.02256149231964377,"score_gpt":0.29004044653076516,"score_spread":0.2674789542111214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076555171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98408395,0.002091545,0.000014203589,0.011127209,0.0002306901,0.0021444748,0.00005122021,0.00007823758,0.00017846606],"genre_scores_gemma":[0.9647595,0.003762208,0.00025651988,0.030191634,0.00018321148,0.00047354534,0.0001183445,0.00006270199,0.00019233588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764514,0.00037008704,0.00055785436,0.0005348246,0.0003109834,0.0005811024],"domain_scores_gemma":[0.99897903,0.00016873423,0.00018408096,0.0003316247,0.0001323919,0.0002041579],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024276657,0.0003792657,0.0006252152,0.00023365342,0.000098668934,0.00000873082,0.00019301078,0.00013422525,0.0007444964],"category_scores_gemma":[5.530411e-7,0.0003239039,0.000112628506,0.0004004956,0.00052229065,0.00021538947,0.00003707841,0.0005276865,0.000049258953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04599547,0.007305831,0.68548137,0.00009819708,0.024011144,0.00016321379,0.002879918,0.00012119003,0.19504745,0.000006288065,0.00039029523,0.03849964],"study_design_scores_gemma":[0.029998537,0.006207026,0.831046,0.00014722157,0.00861125,0.000056110293,0.00015507256,0.00038245437,0.113054395,0.00006642159,0.009829629,0.00044592266],"about_ca_topic_score_codex":0.00008280036,"about_ca_topic_score_gemma":0.000025640351,"teacher_disagreement_score":0.1455646,"about_ca_system_score_codex":0.00020297144,"about_ca_system_score_gemma":0.0001351591,"threshold_uncertainty_score":0.9999213},"labels":[],"label_agreement":null},{"id":"W2076877577","doi":"10.1111/apt.12514","title":"Systematic review with meta‐analysis: race‐specific effects of alcohol and tobacco on the risk of oesophageal squamous cell carcinoma","year":2013,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institutes of Health; Damon Runyon Cancer Research Foundation","keywords":"Medicine; Meta-analysis; Odds ratio; Confidence interval; Demography; Incidence (geometry); Population; Cancer; Internal medicine; Oncology; Environmental health","score_opus":0.06416111398675922,"score_gpt":0.3638929269672763,"score_spread":0.2997318129805171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076877577","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00078101427,0.9868921,0.0000019579595,0.00025601534,0.00007698554,0.011774339,0.00014678827,0.00001666581,0.000054119762],"genre_scores_gemma":[0.023011783,0.97214806,0.000060741964,0.0019886307,0.00005227062,0.002408529,0.000103289574,0.00007339207,0.00015330115],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9947841,0.0023852175,0.0011471203,0.0005842568,0.0006486011,0.00045066356],"domain_scores_gemma":[0.9944242,0.0029228376,0.0013596296,0.00092476327,0.0001609248,0.00020764075],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00073727994,0.00076171546,0.0064957296,0.000322889,0.0001040692,0.000011871963,0.0003960017,0.00017223757,0.000550457],"category_scores_gemma":[0.0000014287948,0.0003556176,0.0016934536,0.00071037747,0.00034993823,0.00004507092,0.000103133796,0.0007089427,0.000032821594],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011675518,0.0006852689,0.0001310916,0.4745874,0.52306825,0.00020181149,0.000065977336,8.5424654e-7,0.00001056515,0.0000066125326,0.00018566631,0.000939765],"study_design_scores_gemma":[0.0016539934,0.0027470656,0.000030098772,0.013447792,0.9788965,0.000051250885,0.000022604658,0.000003196144,0.0018992614,0.0000032744344,0.0010341292,0.00021080872],"about_ca_topic_score_codex":0.000102216036,"about_ca_topic_score_gemma":0.0000037753362,"teacher_disagreement_score":0.46113962,"about_ca_system_score_codex":0.00016617673,"about_ca_system_score_gemma":0.00021340446,"threshold_uncertainty_score":0.99988955},"labels":[],"label_agreement":null},{"id":"W2077925759","doi":"10.1111/j.1365-2036.2009.03990.x","title":"Clinical trial: factors associated with freedom from relapse of heartburn in patients with healed reflux oesophagitis ‐ results from the maintenance phase of the EXPO study","year":2009,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Janssen Canada; AstraZeneca; Abbott Laboratories","keywords":"Heartburn; Esomeprazole; Medicine; Internal medicine; Proton-pump inhibitor; Gastroenterology; GERD; Reflux esophagitis; Reflux; Pantoprazole; Esophagitis; Omeprazole; Disease","score_opus":0.07581368628091885,"score_gpt":0.37882140814153964,"score_spread":0.3030077218606208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077925759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99445933,0.0001837257,0.000001455474,0.0009474417,0.0004364765,0.0029091504,0.0010210006,0.000023676377,0.000017770553],"genre_scores_gemma":[0.9958377,0.00006104387,0.000094902,0.0033173857,0.000079631805,0.000025304274,0.0005186037,0.000031856856,0.000033611566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99636745,0.0009868386,0.00120724,0.0004940094,0.0005628758,0.0003815541],"domain_scores_gemma":[0.9972444,0.0010241629,0.0008122594,0.00062510674,0.00017894707,0.000115085626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005152718,0.0003479882,0.000864723,0.000060270908,0.00009826463,0.000007224753,0.00033258993,0.00013187554,0.0000585582],"category_scores_gemma":[0.000011676876,0.00016895465,0.00016478189,0.00038596257,0.00039171916,0.00008700128,0.000056482615,0.00055906636,0.0000016312781],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08332857,0.01763541,0.8878699,0.0000014215792,0.008189847,0.00009823511,0.0019137617,0.000012834928,0.00027508705,4.2900834e-7,0.00010778676,0.00056673354],"study_design_scores_gemma":[0.24102095,0.020774728,0.73106724,0.00009553682,0.0052612857,4.1815957e-7,0.00024714932,0.000013135064,0.0014091018,0.000026196987,0.000013137201,0.00007115116],"about_ca_topic_score_codex":0.00040281826,"about_ca_topic_score_gemma":0.00012245795,"teacher_disagreement_score":0.15769237,"about_ca_system_score_codex":0.00014038039,"about_ca_system_score_gemma":0.00013757683,"threshold_uncertainty_score":0.68897706},"labels":[],"label_agreement":null},{"id":"W2078554097","doi":"10.1111/j.1365-2036.2005.02387.x","title":"Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease","year":2005,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Saint-Luc","funders":"","keywords":"Medicine; Paracentesis; Ascites; Surgery; Complication; Liver disease; Internal medicine","score_opus":0.015579435426792033,"score_gpt":0.2846785821251181,"score_spread":0.2690991466983261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078554097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955787,0.0010821505,0.0000958578,0.0016878727,0.00016885357,0.0012063078,0.0001174817,0.000034613357,0.000028175735],"genre_scores_gemma":[0.9800523,0.0001918419,0.0015464207,0.017356813,0.00014023826,0.00010350185,0.0005014452,0.000029337616,0.00007808084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989887,0.000057285128,0.00019668798,0.0002664408,0.00018536145,0.00030556056],"domain_scores_gemma":[0.99952483,0.00010788606,0.000053287018,0.0001104587,0.000041947493,0.00016160631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007418757,0.00018620337,0.00020668782,0.000097193384,0.000086584616,0.000008834136,0.00007540386,0.000043461554,0.00022559834],"category_scores_gemma":[5.6203938e-8,0.00015929998,0.00010966143,0.00009786449,0.000047721172,0.00022358485,0.00001173746,0.000107973625,0.000022122314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011632964,0.0015444469,0.97401273,0.00010273605,0.0077345665,0.0001648725,0.0005282139,0.00010977868,0.0011013645,0.00000487432,0.00010649981,0.002956973],"study_design_scores_gemma":[0.028461715,0.0007352595,0.9072068,0.0000940991,0.05244806,0.0000070191527,0.000086439424,0.002923882,0.0067806584,0.000021219252,0.00088037696,0.0003544672],"about_ca_topic_score_codex":0.000014933626,"about_ca_topic_score_gemma":0.00001480836,"teacher_disagreement_score":0.06680591,"about_ca_system_score_codex":0.00010879802,"about_ca_system_score_gemma":0.000073535906,"threshold_uncertainty_score":0.64960647},"labels":[],"label_agreement":null},{"id":"W2079175995","doi":"10.1111/j.1365-2036.2004.02248.x","title":"Meta‐analysis: the efficacy, adverse events, and adherence related to first‐line anti‐<scp>Helicobacter pylori</scp> quadruple therapies","year":2004,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Metronidazole; Omeprazole; Helicobacter pylori; Proton-pump inhibitor; Regimen; Internal medicine; Clarithromycin; Adverse effect; Amoxicillin; Gastroenterology; Drug resistance; Tetracycline; Pharmacology; Antibiotics; Microbiology","score_opus":0.0894182317054488,"score_gpt":0.3702053803688568,"score_spread":0.28078714866340804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079175995","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020943098,0.9669179,0.000018897814,0.006378904,0.0012441438,0.0039584446,0.0002696711,0.0002323455,0.000036611884],"genre_scores_gemma":[0.003466261,0.97529703,0.00024796816,0.018544273,0.00025426142,0.00077207445,0.0004947696,0.00019849776,0.00072486454],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9936754,0.0011398947,0.0018153118,0.0014889911,0.0005488645,0.0013315403],"domain_scores_gemma":[0.9957926,0.001553886,0.0008756081,0.0010902643,0.00024199841,0.00044560476],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0008396415,0.001614723,0.0053090625,0.000756963,0.00056644256,0.00002556622,0.0008621367,0.0007843697,0.00042655473],"category_scores_gemma":[0.000004407972,0.0010390601,0.002244467,0.0018254233,0.0007040947,0.00015630604,0.0005844912,0.002025089,0.0003481742],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011951511,0.00079510827,0.0014336859,0.0010657377,0.9871618,0.00015634706,0.0023982099,0.00009465757,0.000052719202,0.000007653045,0.0002637491,0.006450813],"study_design_scores_gemma":[0.0021089085,0.0008810334,0.00081789604,0.00038398325,0.63580763,0.00017467946,0.00018811911,0.000007735653,0.000034399214,0.0000128546435,0.35933244,0.00025029542],"about_ca_topic_score_codex":0.0001252494,"about_ca_topic_score_gemma":0.00007963,"teacher_disagreement_score":0.3590687,"about_ca_system_score_codex":0.00031618463,"about_ca_system_score_gemma":0.00029761432,"threshold_uncertainty_score":0.99966},"labels":[],"label_agreement":null},{"id":"W2080272565","doi":"10.1111/j.1365-2036.2009.04088.x","title":"Prospective assessment of the effect on quality of life of anti‐tumour necrosis factor therapy for perineal Crohn’s fistulas","year":2009,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Anorectal Disease Treatments and Outcomes","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McMaster University","keywords":"Medicine; Infliximab; Adalimumab; Crohn's disease; Quality of life (healthcare); Inflammatory bowel disease; Internal medicine; Fistula; Prospective cohort study; Magnetic resonance imaging; Gastroenterology; Disease; Surgery; Radiology","score_opus":0.0437915057253612,"score_gpt":0.40684094206247023,"score_spread":0.363049436337109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080272565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99500275,0.00039953814,0.000010817078,0.0017558613,0.00026265546,0.0021257629,0.00027463012,0.000016570702,0.0001514012],"genre_scores_gemma":[0.99311584,0.00020836819,0.00013999401,0.0062986333,0.000055865654,0.00005870933,0.000027473034,0.000019064835,0.000076022014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858123,0.00021579272,0.00047544533,0.00023585184,0.00027271514,0.00021894358],"domain_scores_gemma":[0.99890804,0.0003178953,0.0003604591,0.00023028074,0.0001049895,0.00007836174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015463954,0.00024160894,0.0006923373,0.00005495047,0.00007534602,0.0000028894563,0.00015596587,0.000071867194,0.00018455496],"category_scores_gemma":[0.0000012178709,0.00014369785,0.00041077627,0.00011686399,0.00020381816,0.000035037807,0.000025136247,0.00012595796,5.1308837e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040347246,0.0017071388,0.61021984,0.000075341835,0.005516953,0.0000014514225,0.00025840543,0.000011648146,0.37694103,0.00006162358,0.00005781421,0.0011140264],"study_design_scores_gemma":[0.0064235064,0.004764308,0.6504334,0.000017200513,0.0016612821,6.2492745e-7,0.000037651465,0.000037930546,0.33646432,0.000035292487,0.00005200961,0.00007242509],"about_ca_topic_score_codex":0.000060807666,"about_ca_topic_score_gemma":0.000002176518,"teacher_disagreement_score":0.040476717,"about_ca_system_score_codex":0.00010551881,"about_ca_system_score_gemma":0.0001405458,"threshold_uncertainty_score":0.5859828},"labels":[],"label_agreement":null},{"id":"W2080730492","doi":"10.1046/j.1365-2036.2001.01044.x","title":"H<sub>2</sub>‐receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta‐analysis of randomized controlled clinical trials","year":2001,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Epigastric pain; Placebo; Odds ratio; Meta-analysis; Internal medicine; Randomized controlled trial; Confidence interval; Clinical trial; Alternative medicine; Pathology","score_opus":0.29543411743732884,"score_gpt":0.484177256517002,"score_spread":0.18874313907967316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080730492","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005290574,0.98325866,0.000061809646,0.0013801141,0.0006175843,0.009038592,0.00026281216,0.000019156836,0.000070690156],"genre_scores_gemma":[0.002448524,0.9922755,0.00012627275,0.002559682,0.00023790666,0.0013885153,0.0008872839,0.000040434603,0.000035918252],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97854084,0.014545325,0.005380381,0.000605859,0.0005168439,0.00041072984],"domain_scores_gemma":[0.97533005,0.021042455,0.0028320302,0.000491295,0.00017638903,0.00012774854],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.009944794,0.0007754379,0.024508636,0.00079273863,0.0000619764,0.000010168837,0.00028839507,0.00039771968,0.0015413857],"category_scores_gemma":[0.00002989557,0.00040506307,0.016292376,0.0010950464,0.0008578591,0.00003746812,0.000030342177,0.00054618885,0.000015060198],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13180937,0.0068086796,0.00011024228,0.00065494486,0.83630276,0.000038491533,0.00012995188,0.000020620448,0.00018571688,0.000012501876,0.00010951985,0.02381722],"study_design_scores_gemma":[0.18874212,0.0015036266,0.000022347742,0.00013436613,0.7803219,0.000033124667,0.00008597397,0.00008424455,0.00007007974,0.000018168035,0.028825799,0.00015828885],"about_ca_topic_score_codex":0.000054354907,"about_ca_topic_score_gemma":0.00003354729,"teacher_disagreement_score":0.05693275,"about_ca_system_score_codex":0.00015952534,"about_ca_system_score_gemma":0.0005572595,"threshold_uncertainty_score":0.99984014},"labels":[],"label_agreement":null},{"id":"W2081073380","doi":"10.1111/j.1365-2036.2008.03784.x","title":"Meta‐analysis: <i>Helicobacter pylori</i>‘test and treat’ compared with empirical acid suppression for managing dyspepsia","year":2008,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Health Sciences Centre; McMaster University Medical Centre","funders":"","keywords":"Medicine; Helicobacter pylori; Meta-analysis; Confidence interval; Internal medicine; Pound (networking); Randomized controlled trial; Relative risk; Test (biology); Gastroenterology; Surgery","score_opus":0.150714554551185,"score_gpt":0.3989561562354758,"score_spread":0.24824160168429082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081073380","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011272298,0.9900424,0.000093349605,0.0047012162,0.00038203294,0.00293698,0.00046951114,0.0001767831,0.00007052704],"genre_scores_gemma":[0.00048167186,0.9764053,0.0011675532,0.018623168,0.00034565802,0.0010661364,0.0014315969,0.00018427847,0.00029459197],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9955945,0.0005268978,0.0011659963,0.0013114208,0.00034781796,0.0010533422],"domain_scores_gemma":[0.9973489,0.0008616165,0.0006148842,0.0006199642,0.00019316029,0.0003614832],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00021485571,0.0013437874,0.005991838,0.00070248335,0.0003893464,0.000030086509,0.0003518732,0.00053808937,0.00020332131],"category_scores_gemma":[5.4827774e-7,0.00090991764,0.0015355067,0.00072599767,0.0006948712,0.0001392191,0.00024364635,0.0010790997,0.000024020877],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091947924,0.00079246017,0.0039883466,0.0016702486,0.98099184,0.0003340448,0.00041121652,0.0000027520007,0.0001285798,4.9574845e-7,0.0024473146,0.008313199],"study_design_scores_gemma":[0.0027810226,0.0010826383,0.00013756912,0.00019897376,0.6401462,0.0006603814,0.000038649276,0.000042472744,0.00012016257,0.0000019917693,0.3543946,0.0003953434],"about_ca_topic_score_codex":0.000014633095,"about_ca_topic_score_gemma":0.00001695155,"teacher_disagreement_score":0.35194728,"about_ca_system_score_codex":0.00023363729,"about_ca_system_score_gemma":0.00016971467,"threshold_uncertainty_score":0.99993134},"labels":[],"label_agreement":null},{"id":"W2081341089","doi":"10.1046/j.1365-2036.2002.01341.x","title":"Dose ranging pharmacokinetic trial of high‐dose alicaforsen (intercellular adhesion molecule‐1 antisense oligodeoxynucleotide) (ISIS 2302) in active Crohn's disease","year":2002,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Crohn's disease; Pharmacokinetics; Gastroenterology; Infliximab; Internal medicine; Cmax; Nausea; Intercellular Adhesion Molecule-1; Surgery; Disease; Inflammation","score_opus":0.01861753327339881,"score_gpt":0.27973732355045855,"score_spread":0.2611197902770597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081341089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950191,0.0016053695,0.000028181345,0.00069116004,0.0008273555,0.0014760765,0.00017660881,0.000039197585,0.00013694688],"genre_scores_gemma":[0.98965013,0.002929756,0.00012317451,0.006237608,0.00037521037,0.00012660181,0.0002446725,0.000098128694,0.000214731],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968531,0.0006587342,0.00071168336,0.00074188726,0.00032221113,0.0007123791],"domain_scores_gemma":[0.99869025,0.000057968213,0.00029977027,0.00053697836,0.000105932115,0.00030907537],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025921268,0.0005047847,0.0004347662,0.00026395734,0.00011727499,0.000019866653,0.00047847626,0.00020145351,0.00079897774],"category_scores_gemma":[0.000002328068,0.00054010726,0.00033272585,0.00025673714,0.00030940078,0.000031317268,0.0002597069,0.00025868684,0.0000451095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052266035,0.0018413927,0.0010607374,0.0000869799,0.0027798533,0.002360278,0.0003407434,0.00059741625,0.9357433,0.000011649556,0.0008333977,0.0020782468],"study_design_scores_gemma":[0.08953911,0.00083775405,0.022949805,0.00008955712,0.0057178685,0.000025546335,0.0001738606,0.0048132804,0.87283623,0.00006873766,0.0019454287,0.0010028157],"about_ca_topic_score_codex":0.00003760476,"about_ca_topic_score_gemma":0.000009795918,"teacher_disagreement_score":0.06290703,"about_ca_system_score_codex":0.00009303267,"about_ca_system_score_gemma":0.00007004312,"threshold_uncertainty_score":0.999705},"labels":[],"label_agreement":null},{"id":"W2081361527","doi":"10.1111/j.1365-2036.2006.02774.x","title":"Validation of a 7‐point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials","year":2006,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); University of Alberta; McGill University; McMaster University; Dalhousie University","funders":"AstraZeneca Canada","keywords":"Medicine; Intraclass correlation; Quality of life (healthcare); Rating scale; Construct validity; Internal medicine; Severity of illness; Clinical trial; Physical therapy; Heartburn; Correlation; Psychometrics; Disease; Reflux; Clinical psychology; Statistics","score_opus":0.07257987465301458,"score_gpt":0.4067707054394033,"score_spread":0.3341908307863887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081361527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98915577,0.00038591836,0.00018562368,0.008432401,0.00035295307,0.0011267281,0.000057865025,0.000020718817,0.0002820112],"genre_scores_gemma":[0.9894605,0.00004144647,0.0006715095,0.009641132,0.0001076699,0.000021376502,0.000031956377,0.000011047228,0.000013352493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99668276,0.0012012093,0.0012824985,0.0002706685,0.000297182,0.00026570217],"domain_scores_gemma":[0.9986165,0.00057415286,0.000345053,0.00024758323,0.00013193446,0.00008477575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023035281,0.00018213282,0.0006834829,0.00006342127,0.000035529407,0.0000048229836,0.0001724039,0.000112554975,0.0001902155],"category_scores_gemma":[0.0000100101,0.00013832634,0.00024999402,0.00026372526,0.00027039077,0.000059786318,0.00006738278,0.00025139662,0.000007900251],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006588275,0.0028925424,0.896471,0.00006119742,0.0022411307,0.000014285917,0.00030723447,0.0004904659,0.08385236,0.00008744581,0.0009588808,0.006035187],"study_design_scores_gemma":[0.0112819625,0.0032371029,0.8613164,0.00014839231,0.008158033,0.00012317616,0.00040634922,0.0005799241,0.111995794,0.001861164,0.00066804216,0.00022367606],"about_ca_topic_score_codex":0.00048676154,"about_ca_topic_score_gemma":0.00008251549,"teacher_disagreement_score":0.03515461,"about_ca_system_score_codex":0.00011039223,"about_ca_system_score_gemma":0.00013550371,"threshold_uncertainty_score":0.5640785},"labels":[],"label_agreement":null},{"id":"W2081841312","doi":"10.1046/j.1365-2036.2003.01446.x","title":"A randomized, double‐blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro‐oesophageal reflux disease over 5 years","year":2003,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada; Eisai","keywords":"Rabeprazole; Omeprazole; Medicine; Proton-pump inhibitor; Reflux; Gastroenterology; Internal medicine; Randomized controlled trial; Gastro-; Maintenance therapy; Esophageal disease; Disease; Surgery; Chemotherapy; Esophagus","score_opus":0.04042320068666163,"score_gpt":0.34411884254921493,"score_spread":0.3036956418625533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081841312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99498636,0.00051825837,0.000007865283,0.000646981,0.00019936616,0.003334338,0.000109854554,0.000007894828,0.00018909534],"genre_scores_gemma":[0.9969073,0.00028867097,0.00015475242,0.002115613,0.00004785473,0.00010520489,0.000048084232,0.000026513544,0.0003060243],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975597,0.00067045,0.0006964669,0.00029941404,0.00041338772,0.00036052638],"domain_scores_gemma":[0.9984025,0.00056554546,0.00043379073,0.00040224864,0.00007788712,0.00011803397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071728195,0.00028050816,0.00087668456,0.00010053026,0.000063385516,0.000005689582,0.00024160223,0.00006993926,0.00037159078],"category_scores_gemma":[0.0000037512355,0.00014482212,0.00017924617,0.00031392573,0.0008111128,0.00006741007,0.000057204674,0.00027772944,0.0000019303359],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9610634,0.0025558795,0.02651576,0.000060818405,0.004423255,0.00017491308,0.0007003394,0.000091839494,0.0041280948,0.000049833172,0.0001387302,0.00009716738],"study_design_scores_gemma":[0.9427747,0.0015001118,0.038113847,0.000074595635,0.008411626,0.000036504793,0.00014591393,0.00010075842,0.008393938,0.000033013468,0.00033134787,0.000083660445],"about_ca_topic_score_codex":0.000021841603,"about_ca_topic_score_gemma":0.000013432101,"teacher_disagreement_score":0.018288687,"about_ca_system_score_codex":0.000056142835,"about_ca_system_score_gemma":0.00022663028,"threshold_uncertainty_score":0.59056747},"labels":[],"label_agreement":null},{"id":"W2081849687","doi":"10.1111/apt.13044","title":"Letter: a case supporting the use of rescue infliximab therapy for fulminant ulcerative colitis in pregnancy – authors’ reply","year":2015,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Medicine; Infliximab; Ulcerative colitis; Discontinuation; Rescue therapy; Pregnancy; Fulminant; Refractory (planetary science); Tacrolimus; Inflammatory bowel disease; Colitis; Intensive care medicine; Surgery; Internal medicine; Disease; Transplantation","score_opus":0.1503598968787936,"score_gpt":0.40069663023705965,"score_spread":0.25033673335826606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081849687","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04428337,0.006956691,0.00010283588,0.937322,0.0025091353,0.0077336975,0.00094569183,0.0000805279,0.00006603991],"genre_scores_gemma":[0.014255471,0.0026904284,0.00067089516,0.97628105,0.0019564577,0.0013336721,0.0008232367,0.00012780339,0.001861015],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957708,0.0009216031,0.0012739094,0.00066268665,0.00047323704,0.00089778035],"domain_scores_gemma":[0.99685395,0.0010795264,0.0008085833,0.00076102413,0.00034069968,0.00015619044],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008895761,0.0005700904,0.0010028903,0.00029821333,0.00016578079,0.0000248919,0.00034667982,0.000640407,0.00022059256],"category_scores_gemma":[0.000010958368,0.00041205477,0.00030008898,0.00028170328,0.0005380494,0.00021306344,0.000090142516,0.0018953854,0.0000054234392],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025316193,0.000577504,0.0005929398,0.00037591354,0.00802183,0.007269726,0.007472303,0.000011554655,0.0030857197,0.000005526261,0.9588046,0.0112507725],"study_design_scores_gemma":[0.009400552,0.0016688653,0.00026602796,0.0008834008,0.005852669,0.002038345,0.00021882846,0.00034278654,0.015507153,0.00007812901,0.96332914,0.0004141091],"about_ca_topic_score_codex":0.00040377362,"about_ca_topic_score_gemma":0.000075628166,"teacher_disagreement_score":0.03895901,"about_ca_system_score_codex":0.00035775948,"about_ca_system_score_gemma":0.00091529096,"threshold_uncertainty_score":0.9998331},"labels":[],"label_agreement":null},{"id":"W2082499416","doi":"10.1111/j.0953-0673.2004.01830.x","title":"Should NSAID/low‐dose aspirin takers be tested routinely for <i>H. pylori</i> infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing","year":2004,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Aspirin; Internal medicine; Helicobacter pylori; Proton-pump inhibitor; Gastroenterology; Helicobacter pylori infection; Peptic ulcer; Nonsteroidal; Peptic","score_opus":0.07162629431429302,"score_gpt":0.3873854663363114,"score_spread":0.31575917202201836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082499416","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12924524,0.8483586,0.0003675415,0.0060821394,0.0009093775,0.010043274,0.0047991597,0.00016826247,0.00002643592],"genre_scores_gemma":[0.0071584187,0.9733988,0.0008934256,0.013355098,0.00036274747,0.0024040763,0.0021978214,0.00018618083,0.000043431704],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9967397,0.0003735905,0.0012190861,0.00085691916,0.00013915842,0.00067157816],"domain_scores_gemma":[0.99749684,0.00086962734,0.0007771831,0.0003169715,0.00032687033,0.00021247739],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043041882,0.00080561446,0.0020039862,0.00037884762,0.00028562563,0.0000170502,0.000118614626,0.0006940279,0.000015423337],"category_scores_gemma":[0.0000045730744,0.00071549515,0.0004294191,0.00030059097,0.0005946417,0.00014553718,0.00013745751,0.00082574174,0.000001484721],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017210502,0.004443703,0.11949125,0.029837914,0.2227408,0.00008532355,0.0026868812,0.000027778664,0.00535995,0.000029809607,0.0008772203,0.59720886],"study_design_scores_gemma":[0.043123055,0.012585867,0.09814955,0.008613919,0.50961924,0.0010333454,0.000105376195,0.00006239461,0.0017284576,0.00016773565,0.32286742,0.0019436296],"about_ca_topic_score_codex":0.00012931734,"about_ca_topic_score_gemma":0.00002997877,"teacher_disagreement_score":0.5952652,"about_ca_system_score_codex":0.00047481555,"about_ca_system_score_gemma":0.00027607512,"threshold_uncertainty_score":0.9995296},"labels":[],"label_agreement":null},{"id":"W2083050753","doi":"10.1111/j.1365-2036.2012.05155.x","title":"Gastrointestinal symptoms before and during menses in women with <scp>IBD</scp>","year":2012,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"Vertex Pharmaceuticals; Abbott Canada","keywords":"Medicine; Menstrual cycle; Ulcerative colitis; Internal medicine; Cohort; Abdominal pain; Inflammatory bowel disease; Gastroenterology; Population; Young adult; Gynecology; Disease; Hormone","score_opus":0.006996249010585591,"score_gpt":0.24883633526753804,"score_spread":0.24184008625695244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083050753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987538,0.0005734153,0.0000075065814,0.00009506613,0.00013058509,0.00027692126,0.000019706642,0.00002210707,0.00012091057],"genre_scores_gemma":[0.99503994,0.000100444406,0.00026343315,0.004033138,0.00026009747,0.0000910301,0.000032158066,0.000039634804,0.00014012423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986359,0.000121723104,0.00018626539,0.00027524313,0.00010322637,0.0006776423],"domain_scores_gemma":[0.9995021,0.000022272894,0.000077355755,0.00016186299,0.000028691327,0.00020771912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015489382,0.00023868895,0.0001438537,0.00006392655,0.00009416253,0.00001165605,0.00013735057,0.000058466037,0.00004580957],"category_scores_gemma":[4.5951697e-7,0.00022072508,0.000025273865,0.00006071606,0.00020886853,0.000018445782,0.0001226096,0.0001477791,0.000008920547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050250784,0.00020893672,0.5341765,0.000026323833,0.0009413828,0.000114213486,0.00062483817,0.000020631427,0.46316117,0.0000053796634,0.00007150131,0.00014659372],"study_design_scores_gemma":[0.0033162364,0.0007064386,0.88182956,0.000021436368,0.0006721296,0.00046320312,0.0007857208,0.00003699542,0.11013762,0.000017931612,0.0018492882,0.00016346977],"about_ca_topic_score_codex":0.0000046914633,"about_ca_topic_score_gemma":0.000015041184,"teacher_disagreement_score":0.35302356,"about_ca_system_score_codex":0.00006946016,"about_ca_system_score_gemma":0.000051951356,"threshold_uncertainty_score":0.90009075},"labels":[],"label_agreement":null},{"id":"W2083146436","doi":"10.1111/apt.12503","title":"Prevalence of Epstein–Barr Virus in a population of patients with inflammatory bowel disease: a prospective cohort study","year":2013,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Seroprevalence; Population; Inflammatory bowel disease; Azathioprine; Serology; Internal medicine; Ulcerative colitis; Prospective cohort study; Immunology; Cohort; Disease; Crohn's disease; Antibody; Environmental health","score_opus":0.00880105152844211,"score_gpt":0.2810089156120387,"score_spread":0.2722078640835966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083146436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545145,0.0005864343,0.0000010494217,0.0001424171,0.00010244689,0.003613509,0.000039918606,0.000017397027,0.000045394536],"genre_scores_gemma":[0.99829406,0.00019777687,0.000019046749,0.001071989,0.000016172182,0.0002941609,0.000041080682,0.000021334985,0.00004435818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987458,0.00012717376,0.0003738587,0.00024158403,0.00030696258,0.00020459504],"domain_scores_gemma":[0.99933577,0.00003088728,0.00024862099,0.00016187032,0.00014771182,0.00007516839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114653994,0.00015990977,0.00028505386,0.00010888024,0.000031827683,0.0000026152875,0.000088269524,0.00005127614,0.00038293106],"category_scores_gemma":[4.5279145e-7,0.00013475431,0.000044877597,0.00015828211,0.00011222307,0.0001397313,0.00003086228,0.000142112,0.0000036253048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019561637,0.0026201247,0.9883528,0.00013027174,0.0028538168,0.000005292388,0.0008539128,0.00006116536,0.0030023938,0.0000024170809,0.000035268793,0.0001263834],"study_design_scores_gemma":[0.008424733,0.0013958089,0.9839416,0.00004282166,0.0043026255,1.8116904e-7,0.00024147618,0.00013388257,0.0013469072,0.000047937112,0.0000048183933,0.00011717406],"about_ca_topic_score_codex":0.0005190823,"about_ca_topic_score_gemma":0.000049979786,"teacher_disagreement_score":0.0064685694,"about_ca_system_score_codex":0.00019930287,"about_ca_system_score_gemma":0.00008763756,"threshold_uncertainty_score":0.54951215},"labels":[],"label_agreement":null},{"id":"W2084330241","doi":"10.1111/j.1365-2036.2004.01865.x","title":"Economic evaluation of <scp>Helicobacter pylori</scp> eradication in the CADET‐<scp>Hp</scp> randomized controlled trial of <scp>H. pylori</scp>‐positive primary care patients with uninvestigated dyspepsia","year":2004,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Surrey Place Centre; McGill University; AstraZeneca (Canada); Dalhousie University; McMaster University","funders":"","keywords":"Medicine; Helicobacter pylori; Omeprazole; Internal medicine; Clarithromycin; Randomized controlled trial; Gastroenterology; Cost effectiveness; Placebo; Alternative medicine; Pathology","score_opus":0.019196035660330617,"score_gpt":0.28764987318263263,"score_spread":0.268453837522302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084330241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807773,0.0018958263,0.000021364509,0.0014857725,0.0014232616,0.013445019,0.00020009028,0.000074448646,0.0006769197],"genre_scores_gemma":[0.98625433,0.0009567764,0.000243922,0.009025976,0.00032674443,0.0015169693,0.0015213904,0.00010614662,0.00004774007],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9918261,0.0031833649,0.0021635445,0.00084877166,0.0010691842,0.0009090001],"domain_scores_gemma":[0.9929884,0.0032955138,0.0018079903,0.000610565,0.0010777571,0.00021977101],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026584321,0.0008473031,0.0027280655,0.00061302586,0.00021570356,0.000024143765,0.0005462123,0.0004886081,0.00001731376],"category_scores_gemma":[0.000071116825,0.00061676535,0.00044917516,0.0005297044,0.0015147208,0.00033290606,0.00012772677,0.0010322235,0.000022958606],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.452681,0.009175034,0.2502506,0.00040552154,0.1369078,0.00009328994,0.073365934,0.0068343747,0.067965426,0.00015736511,0.0012093235,0.0009543243],"study_design_scores_gemma":[0.85681236,0.004029649,0.069572866,0.00016029709,0.038510393,0.000021759972,0.002769255,0.00038203428,0.027270133,0.000108272805,0.00027036996,0.000092609924],"about_ca_topic_score_codex":0.00022980006,"about_ca_topic_score_gemma":0.00008651882,"teacher_disagreement_score":0.40413135,"about_ca_system_score_codex":0.0013147283,"about_ca_system_score_gemma":0.00094519655,"threshold_uncertainty_score":0.99962837},"labels":[],"label_agreement":null},{"id":"W2084549982","doi":"10.1111/apt.12863","title":"Escalation to weekly dosing recaptures response in adalimumab‐treated patients with moderately to severely active ulcerative colitis","year":2014,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Generalitat Valenciana; AbbVie","keywords":"Dosing; Medicine; Adalimumab; Adverse effect; Ulcerative colitis; Internal medicine; Tumor necrosis factor alpha","score_opus":0.01030489199654834,"score_gpt":0.2705890432070683,"score_spread":0.26028415121051995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084549982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99683297,0.0000151718505,0.0002936966,0.00119191,0.00018615824,0.0011628651,0.000118229196,0.000026331463,0.00017267346],"genre_scores_gemma":[0.97582084,0.0000087587505,0.0005123478,0.022960484,0.000102354345,0.00015182032,0.0002598335,0.000051402447,0.00013216354],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9977166,0.0008730974,0.00027125044,0.0005270305,0.00018319512,0.00042883412],"domain_scores_gemma":[0.9992153,0.00006696513,0.000092857044,0.0002385008,0.00017883336,0.00020756276],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024164555,0.0003016981,0.0002030748,0.00014466292,0.00014106471,0.000027315937,0.0001896116,0.00014936895,0.00006067429],"category_scores_gemma":[0.0000022385266,0.00029390957,0.00004501962,0.00017691778,0.00007471825,0.000020650952,0.00009536967,0.00014877947,0.000028139739],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6151971,0.0011138689,0.038625926,0.000020874413,0.0038622776,0.00009358744,0.0030746744,0.016404105,0.31656817,0.000024052102,0.0014320018,0.003583314],"study_design_scores_gemma":[0.0037668403,0.0016171102,0.8173756,0.00001942221,0.0004785382,0.0000025187626,0.00011586353,0.00046393005,0.17304742,0.000023003982,0.0026947637,0.0003950106],"about_ca_topic_score_codex":0.000047975187,"about_ca_topic_score_gemma":0.00021294912,"teacher_disagreement_score":0.77874964,"about_ca_system_score_codex":0.00017255048,"about_ca_system_score_gemma":0.00010150297,"threshold_uncertainty_score":0.9999513},"labels":[],"label_agreement":null},{"id":"W2085537273","doi":"10.1046/j.1365-2036.2000.00100.x","title":"Helicobacter pylori <i>and gastric cancer − the clinicians' point of view</i>","year":2000,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Helicobacter pylori; Medicine; Cancer; Gastroenterology; Internal medicine; Incidence (geometry); Atrophic gastritis; Epidemiology; Gastritis; Stomach cancer","score_opus":0.06694711566481544,"score_gpt":0.38465922961328464,"score_spread":0.3177121139484692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085537273","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032147393,0.98523456,0.0000022606057,0.0072755027,0.001712092,0.0020774459,0.00026815943,0.00006469158,0.00015057682],"genre_scores_gemma":[0.00012365148,0.9545099,0.00006768041,0.043571424,0.00076315383,0.0004079825,0.00013672483,0.0001280366,0.0002914101],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99583757,0.00078666746,0.0015418201,0.00073248096,0.0002896765,0.00081181177],"domain_scores_gemma":[0.9978439,0.0005393228,0.00072072685,0.00057921075,0.0001312897,0.00018554609],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046520913,0.00088028156,0.0028020474,0.00027460244,0.00018210262,0.000012147236,0.00045491854,0.0005227094,0.0008906322],"category_scores_gemma":[5.58023e-7,0.00056873326,0.000605961,0.00049730693,0.0009704087,0.00007723616,0.00025314157,0.0016066175,0.00008414526],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000537822,0.00061952055,0.0024369557,0.0028341694,0.0912758,0.0000973439,0.00058990245,8.7066684e-7,0.00012799312,0.0000023998302,0.0039638546,0.8975134],"study_design_scores_gemma":[0.001772927,0.00077408616,0.0002015301,0.0016782479,0.11796354,0.0004221586,0.000049696235,0.0000032897851,0.00006087913,0.000005339696,0.8767926,0.00027570975],"about_ca_topic_score_codex":0.00005931419,"about_ca_topic_score_gemma":0.000012020822,"teacher_disagreement_score":0.89723766,"about_ca_system_score_codex":0.00020796111,"about_ca_system_score_gemma":0.00030159214,"threshold_uncertainty_score":0.9996764},"labels":[],"label_agreement":null},{"id":"W2085650694","doi":"10.1111/j.1365-2036.2006.03115.x","title":"Pre‐endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non‐variceal upper gastrointestinal bleeding","year":2006,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Adverse effect; Upper gastrointestinal bleeding; Endoscopy; Gastrointestinal bleeding; Internal medicine; Proton-pump inhibitor; Gastroenterology; Retrospective cohort study; Surgery","score_opus":0.016116049751865303,"score_gpt":0.29497123111716267,"score_spread":0.27885518136529736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085650694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99334955,0.000103319006,0.00003794961,0.0023968061,0.00036350236,0.0034501874,0.000051952717,0.00012620389,0.00012050216],"genre_scores_gemma":[0.9813609,0.00006340788,0.015166461,0.002042853,0.00029650325,0.00059231353,0.00026015085,0.0000935786,0.00012379253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966444,0.00012254275,0.000780144,0.0008040007,0.0005962468,0.0010526952],"domain_scores_gemma":[0.99871296,0.00018023433,0.00036668123,0.00026744173,0.0002317038,0.00024096336],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020099543,0.0007264377,0.0007625837,0.00034790314,0.00018646699,0.000036446774,0.0002393515,0.00006573727,0.00025114365],"category_scores_gemma":[7.526831e-7,0.00055126613,0.00019244857,0.00034619647,0.00026428813,0.00025757976,0.00009782221,0.00066207536,0.000031523217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004685893,0.007289332,0.9600072,0.000038787213,0.00225461,0.00040732493,0.00009010937,0.00006428537,0.024628414,0.0000044167587,0.00011843867,0.0004111911],"study_design_scores_gemma":[0.020114264,0.015082566,0.92699707,0.0006823914,0.0044891047,0.0005014929,0.00007562329,0.00016602573,0.031396985,0.000017275088,0.00011024351,0.00036693577],"about_ca_topic_score_codex":0.00022422892,"about_ca_topic_score_gemma":0.0000147134215,"teacher_disagreement_score":0.033010103,"about_ca_system_score_codex":0.0005370078,"about_ca_system_score_gemma":0.00020274278,"threshold_uncertainty_score":0.9996939},"labels":[],"label_agreement":null},{"id":"W2085950678","doi":"10.1111/j.1365-2036.2008.03865.x","title":"Systematic review: impact of non‐adherence to 5‐aminosalicylic acid products on the frequency and cost of ulcerative colitis flares","year":2008,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Systems, Applications & Products in Data Processing (Canada)","funders":"Genentech; National Institutes of Health; Shire; Procter and Gamble; Crohn's and Colitis Foundation of America","keywords":"Medicine; Ulcerative colitis; MEDLINE; Internal medicine; Randomized controlled trial; Inflammatory bowel disease; Comorbidity; Disease; Intensive care medicine","score_opus":0.03965498665969515,"score_gpt":0.3681393377354633,"score_spread":0.3284843510757682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085950678","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011571156,0.98006374,0.0000026984235,0.00010731649,0.00019459092,0.007362349,0.0006287425,0.0000071157615,0.00006226795],"genre_scores_gemma":[0.004370913,0.9907392,0.000037544465,0.0033901446,0.00012035911,0.0009884341,0.00024315197,0.000057530422,0.000052680163],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9966852,0.0012082303,0.0010030841,0.00053013436,0.00022459248,0.00034875542],"domain_scores_gemma":[0.99790996,0.00013698757,0.0008589095,0.00071811606,0.00024777037,0.00012826841],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034255048,0.00058169273,0.0015644426,0.00009546915,0.0000975963,0.0000078055855,0.0005949084,0.00021257215,0.000065069784],"category_scores_gemma":[0.000009512142,0.000379247,0.00043641284,0.00021488269,0.00030255568,0.0000067520095,0.00016784944,0.00024587268,0.000018616103],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008239937,0.0010757511,0.00012343563,0.81610364,0.07407948,0.0002570027,0.0008635708,0.000008199823,0.079370275,0.000049776852,0.016689295,0.010555587],"study_design_scores_gemma":[0.005114914,0.016733807,0.0019746704,0.507389,0.2033572,0.0012788567,0.00029250924,0.0000229284,0.17243443,0.000048688365,0.08594987,0.0054031336],"about_ca_topic_score_codex":0.000025230544,"about_ca_topic_score_gemma":0.000007302743,"teacher_disagreement_score":0.30871463,"about_ca_system_score_codex":0.00009926315,"about_ca_system_score_gemma":0.00060999347,"threshold_uncertainty_score":0.99986595},"labels":[],"label_agreement":null},{"id":"W2086150474","doi":"10.1111/j.1365-2036.2005.02715.x","title":"Review article: the unmet needs in delayed‐release proton‐pump inhibitor therapy in 2005","year":2005,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Medicine; Proton-pump inhibitor; Upper gastrointestinal bleeding; Helicobacter pylori; Internal medicine; Gastroenterology; Stress ulcer; Drug; Gastrointestinal bleeding; Disease; Pharmacotherapy; Intensive care medicine; Pharmacology; Endoscopy","score_opus":0.06614123331474973,"score_gpt":0.3896232621389343,"score_spread":0.32348202882418453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086150474","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008634094,0.96172917,6.4691824e-7,0.018793145,0.0007733921,0.009873441,0.00006162845,0.000082995255,0.000051493564],"genre_scores_gemma":[0.00014859534,0.8691701,0.000042828797,0.12672444,0.00065036386,0.0028257763,0.00016524011,0.00013957747,0.00013302609],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937497,0.0018308894,0.001978647,0.00075390755,0.00034961704,0.0013372554],"domain_scores_gemma":[0.9979642,0.00042289137,0.00056403154,0.0007302923,0.00009446209,0.00022409146],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012898613,0.0010614501,0.002884432,0.00064899074,0.00012721568,0.000015934442,0.0006321342,0.0005762896,0.0007985827],"category_scores_gemma":[0.000002150822,0.0007173123,0.0005212234,0.001381515,0.00051166967,0.00014166076,0.00023840579,0.0028736505,0.00026330163],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011345672,0.0033534565,0.0055503077,0.0078598615,0.035416372,0.0005776853,0.0008813208,0.000007674529,0.00019048394,0.0000029426878,0.009042626,0.9359827],"study_design_scores_gemma":[0.0043265535,0.0008733074,0.00013461539,0.009280815,0.021936072,0.0003572458,0.00006353682,0.000018313194,0.00011335168,0.000003262984,0.96245176,0.000441186],"about_ca_topic_score_codex":0.000070425565,"about_ca_topic_score_gemma":0.00010139346,"teacher_disagreement_score":0.95340914,"about_ca_system_score_codex":0.000840787,"about_ca_system_score_gemma":0.00046619968,"threshold_uncertainty_score":0.9995278},"labels":[],"label_agreement":null},{"id":"W2086281185","doi":"10.1111/j.1365-2036.2012.05050.x","title":"Randomised clinical trial: the safety and efficacy of long‐acting octreotide in patients with portal hypertension","year":2012,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Octreotide; Portal hypertension; Clinical trial; Internal medicine; Gastroenterology; Intensive care medicine; Somatostatin; Cirrhosis","score_opus":0.045891402320213284,"score_gpt":0.3478117040193244,"score_spread":0.3019203016991111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086281185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971894,0.000514648,0.000009699719,0.0005036792,0.00037398536,0.0013247886,0.0000083440045,0.000011681278,0.00006375518],"genre_scores_gemma":[0.9939967,0.0006816013,0.00004384036,0.0050154957,0.0001353814,0.000009328049,0.00009667934,0.000014029979,0.0000069576877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988358,0.00026675334,0.00041497406,0.00013818684,0.00014818173,0.00019611759],"domain_scores_gemma":[0.99902564,0.00060586684,0.0001419773,0.00010183599,0.000036508707,0.00008816932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045126703,0.00011693172,0.00029121232,0.00004293947,0.000052973573,0.0000022842796,0.000045095745,0.000051201245,0.00007410416],"category_scores_gemma":[3.201029e-7,0.00007101889,0.00006336099,0.00007547634,0.00013857766,0.00009434172,0.00001412961,0.00018437165,0.000002292122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2812434,0.0014061129,0.7100783,0.000016459966,0.0047839056,0.000020971474,0.00039269656,0.0000026721061,0.00037242714,0.0000018321002,0.0000066230527,0.0016745505],"study_design_scores_gemma":[0.2952598,0.0007033136,0.6860543,0.00002292515,0.015934942,0.000010183351,0.000075540505,0.000028040378,0.0018091046,9.381926e-7,0.000037321064,0.0000636071],"about_ca_topic_score_codex":0.000020109246,"about_ca_topic_score_gemma":0.000002944196,"teacher_disagreement_score":0.024024045,"about_ca_system_score_codex":0.00001546341,"about_ca_system_score_gemma":0.000038258953,"threshold_uncertainty_score":0.28960663},"labels":[],"label_agreement":null},{"id":"W2086687708","doi":"10.1111/j.1365-2036.2012.05033.x","title":"Systematic review: faecal transplantation for the treatment of <i><scp>C</scp>lostridium difficile</i>‐associated disease","year":2012,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary; Institute of Health Economics","funders":"University of Alberta","keywords":"Medicine; Clostridium difficile; Pseudomembranous colitis; Transplantation; Enterocolitis; Enema; Internal medicine; Cochrane Library; CINAHL; Disease; MEDLINE; Intensive care medicine; Probiotic; Randomized controlled trial; Surgery; Antibiotics","score_opus":0.0845214577895866,"score_gpt":0.3917215550711516,"score_spread":0.307200097281565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086687708","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005144375,0.98016554,0.000016960434,0.0006087477,0.00093909394,0.015522158,0.0021264546,0.00007181725,0.000034762506],"genre_scores_gemma":[0.0001997636,0.9889371,0.000013081402,0.0022061896,0.0006153005,0.0037143584,0.0033044845,0.00016178684,0.00084797305],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99511385,0.00081230514,0.0017981407,0.0006047219,0.0007066499,0.0009643382],"domain_scores_gemma":[0.9926837,0.0049135108,0.0009745108,0.00075461395,0.0002610748,0.00041258597],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00062606833,0.0009432224,0.0037208677,0.00022581461,0.00025595658,0.000019840709,0.0004953617,0.0003793464,0.00012444466],"category_scores_gemma":[0.000008511849,0.0005778633,0.0019430172,0.0005462723,0.00028602275,0.000058713948,0.000043293552,0.00047370337,0.000061285435],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002837503,0.0056828996,0.000013005573,0.90231746,0.069436714,0.00008784218,0.0003705409,0.0000017305263,0.00047234815,0.000008248738,0.0021667627,0.019158727],"study_design_scores_gemma":[0.0025839156,0.0013529933,0.0000035819887,0.06327146,0.5294842,0.00007546968,0.000074112846,0.000050850358,0.0026926105,0.0000016013215,0.40018257,0.00022662933],"about_ca_topic_score_codex":0.000020126543,"about_ca_topic_score_gemma":0.0000030222266,"teacher_disagreement_score":0.839046,"about_ca_system_score_codex":0.0008581409,"about_ca_system_score_gemma":0.0006769962,"threshold_uncertainty_score":0.9996673},"labels":[],"label_agreement":null},{"id":"W2086896742","doi":"10.1046/j.1365-2036.2003.01434.x","title":"Efficacy and safety of single‐triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of <i>Helicobacter pylori</i>: an international multicentre study","year":2003,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital; Hôpital Saint-François d'Assise; Université de Montréal","funders":"","keywords":"Metronidazole; Omeprazole; Medicine; Helicobacter pylori; Tetracycline; Gastroenterology; Internal medicine; Urea breath test; Regimen; Breath test; Antibiotics; Microbiology; Helicobacter pylori infection; Biology","score_opus":0.03169434824698801,"score_gpt":0.3189123333530624,"score_spread":0.2872179851060744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086896742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507904,0.0010446188,0.00013844979,0.0016483689,0.00027212367,0.0016678984,0.00010933461,0.000013236829,0.000026899355],"genre_scores_gemma":[0.9962706,0.00123052,0.0012055482,0.0011062397,0.000047996793,0.000050103416,0.000043987748,0.000026756246,0.000018222167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852425,0.00019232115,0.0005584493,0.0002977954,0.00018910045,0.00023807178],"domain_scores_gemma":[0.9986843,0.0003788001,0.000376055,0.00021930464,0.00026828036,0.00007327577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034403824,0.0002212215,0.00044583963,0.00015584676,0.0000895738,0.0000050389845,0.00014210129,0.000076451055,0.000030204437],"category_scores_gemma":[0.000003761781,0.00015519602,0.000045021166,0.0001744279,0.00052979717,0.00013418272,0.0000451689,0.00018708607,2.7082802e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071040057,0.0039579365,0.6256191,0.000060465118,0.023322407,0.000004268886,0.0034928848,0.000061121995,0.33404347,0.000025281719,0.000020765247,0.0022882773],"study_design_scores_gemma":[0.034164015,0.009030673,0.73494816,0.00005398619,0.019153304,0.00005268842,0.0045587863,0.00040468952,0.19500168,0.000008855707,0.0024156491,0.00020750535],"about_ca_topic_score_codex":0.000035820183,"about_ca_topic_score_gemma":0.000035706835,"teacher_disagreement_score":0.13904181,"about_ca_system_score_codex":0.000041118157,"about_ca_system_score_gemma":0.00004465348,"threshold_uncertainty_score":0.632871},"labels":[],"label_agreement":null},{"id":"W2087665620","doi":"10.1111/j.1365-2036.2006.02947.x","title":"Review article: the modern diagnosis and management of haemochromatosis","year":2006,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Hemochromatosis; Disease; Medicine; Genetic testing; Pathogenesis; Pathology; Internal medicine","score_opus":0.07021476992091466,"score_gpt":0.39367688859851757,"score_spread":0.3234621186776029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087665620","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013196067,0.99452573,0.000007783935,0.0019618066,0.0002878604,0.0025831645,0.000053797015,0.000029854913,0.00041805735],"genre_scores_gemma":[0.00001209304,0.9740541,0.00023117011,0.024707166,0.00009214499,0.00054593675,0.00011997613,0.00005703311,0.00018036542],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981087,0.00029110664,0.0007046812,0.0003582984,0.00021622615,0.00032101193],"domain_scores_gemma":[0.99900424,0.00015619947,0.0003247504,0.00040546007,0.000033604334,0.00007576265],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027494854,0.00041118107,0.0014511879,0.00008137746,0.00008821801,0.0000069055004,0.00023887378,0.00013950057,0.0002899575],"category_scores_gemma":[8.835433e-8,0.00026287482,0.00034374328,0.00026889372,0.00030295047,0.000038541657,0.0001511707,0.00025150977,0.0000145879085],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020146827,0.00045653377,0.00008121155,0.09690525,0.0092431875,0.00003708871,0.000035978293,3.9944777e-7,0.000009618042,0.000036135247,0.015832942,0.8773415],"study_design_scores_gemma":[0.00075411855,0.00006078735,0.00003135772,0.009398692,0.1852909,0.000066680186,0.000011993732,0.000006904244,0.000058151916,0.00003777601,0.8040946,0.0001880116],"about_ca_topic_score_codex":0.000022763074,"about_ca_topic_score_gemma":0.0000012182802,"teacher_disagreement_score":0.8771535,"about_ca_system_score_codex":0.000040672534,"about_ca_system_score_gemma":0.000057257555,"threshold_uncertainty_score":0.99998236},"labels":[],"label_agreement":null},{"id":"W2089240629","doi":"10.1111/j.1365-2036.2008.03782.x","title":"Long‐term outcome of using allopurinol co‐therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease","year":2008,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Thiopurine methyltransferase; Medicine; Allopurinol; Azathioprine; Gastroenterology; Internal medicine; Inflammatory bowel disease; Ulcerative colitis; Combination therapy; Mercaptopurine; Pharmacology; Disease","score_opus":0.10411577391449682,"score_gpt":0.40989526524402875,"score_spread":0.3057794913295319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089240629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959544,0.0010781724,0.0001532613,0.00039259548,0.00016944007,0.0020599952,0.000060224305,0.00005820643,0.00007371647],"genre_scores_gemma":[0.9916849,0.0013251472,0.000663199,0.0056737624,0.00022211419,0.00013819168,0.0000767005,0.00008424174,0.00013172171],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972678,0.00021073411,0.0008621604,0.00047498642,0.000451703,0.00073261687],"domain_scores_gemma":[0.9985691,0.00040809426,0.00026679374,0.00033052004,0.00012391647,0.00030161816],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003312109,0.00038967835,0.00062570814,0.00032187116,0.0001865919,0.000008796542,0.00027316774,0.0001700874,0.000296979],"category_scores_gemma":[0.0000022682373,0.00036883497,0.00022397659,0.00020065824,0.00040587384,0.00018408478,0.0000946093,0.00039574195,0.000008248247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005503173,0.0009438673,0.7821976,0.00020091946,0.0024257125,0.0008965437,0.00053284847,0.00032322775,0.20638907,0.00000922555,0.00002457434,0.0005532314],"study_design_scores_gemma":[0.043775316,0.0017565978,0.5281305,0.00018106587,0.0033637465,0.0005737845,0.00022517121,0.023770235,0.39715096,0.00007128107,0.00026660194,0.000734735],"about_ca_topic_score_codex":0.00021791701,"about_ca_topic_score_gemma":0.000011861045,"teacher_disagreement_score":0.25406712,"about_ca_system_score_codex":0.0009423293,"about_ca_system_score_gemma":0.0008782996,"threshold_uncertainty_score":0.9998764},"labels":[],"label_agreement":null},{"id":"W2089292260","doi":"10.1111/apt.12651","title":"Systematic review with meta‐analysis: the declining risk of colorectal cancer in ulcerative colitis","year":2014,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":263,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ulcerative colitis; Internal medicine; Incidence (geometry); Meta-analysis; Colorectal cancer; Confidence interval; Gastroenterology; Population; Cumulative incidence; Relative risk; Cancer; Disease; Cohort","score_opus":0.033301674972675555,"score_gpt":0.36583353672350477,"score_spread":0.3325318617508292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089292260","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00051439967,0.9950959,0.00001778662,0.000073694166,0.00014287124,0.0035787043,0.0005380014,0.000009005593,0.000029613913],"genre_scores_gemma":[0.00077242526,0.9916905,0.000045106975,0.004175856,0.00008308763,0.0028313291,0.00028867877,0.00006485029,0.0000481464],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9931719,0.004394946,0.001260365,0.00056239765,0.00023611917,0.00037432378],"domain_scores_gemma":[0.99730694,0.000348712,0.0015820818,0.00053648726,0.00014334933,0.0000824443],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001362738,0.00060822343,0.0036163065,0.000140417,0.000103540224,0.000012172333,0.00064615125,0.0002483274,0.000241888],"category_scores_gemma":[0.000002122121,0.00035647897,0.0015363687,0.00045077497,0.0003076054,0.000005596014,0.00013541331,0.0004195083,0.000007773456],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017322753,0.00009662899,0.00008989677,0.1568307,0.84218293,0.000035309986,0.00006360672,0.00010630833,0.000014735707,0.0000044676754,0.000058502268,0.00034366033],"study_design_scores_gemma":[0.00041967008,0.00015050663,0.00005156552,0.011172752,0.9773363,0.00001457304,0.000028324528,0.000035136956,0.00009247512,0.0000021875326,0.010326772,0.00036977217],"about_ca_topic_score_codex":0.00005452693,"about_ca_topic_score_gemma":0.00089846144,"teacher_disagreement_score":0.14565794,"about_ca_system_score_codex":0.000069016234,"about_ca_system_score_gemma":0.00042736254,"threshold_uncertainty_score":0.9998887},"labels":[],"label_agreement":null},{"id":"W2090256315","doi":"10.1111/j.1365-2036.2009.03953.x","title":"Interleukin 10 (<i>IL‐10</i>) gene variants and susceptibility for paediatric onset Crohn’s disease","year":2009,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Children's Hospital; Children's Hospital of Eastern Ontario; McGill University Health Centre; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Institutes of Health Research; Crohn's and Colitis Foundation of Canada","keywords":"Single-nucleotide polymorphism; Haplotype; Genotype; Medicine; SNP; Crohn's disease; Inflammatory bowel disease; Ulcerative colitis; Allele; Disease; Immunology; Case-control study; Gene; Gastroenterology; Internal medicine; Genetics; Biology","score_opus":0.014799865453273687,"score_gpt":0.2910558351731847,"score_spread":0.276255969719911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090256315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950617,0.0016293305,0.00015127247,0.0011929899,0.0003901584,0.00087141874,0.0006166934,0.0000373711,0.000049091173],"genre_scores_gemma":[0.97406644,0.0005646379,0.0005392158,0.022832463,0.0005433555,0.0000911801,0.0006960082,0.000037688176,0.00062903727],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982285,0.0002182985,0.00033227899,0.00062037766,0.00011842138,0.00048215975],"domain_scores_gemma":[0.9990516,0.00004362424,0.00011762017,0.00037929034,0.00010308729,0.0003048001],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027835194,0.00032039112,0.00019942874,0.000065151384,0.00018132299,0.000027759168,0.0002786139,0.0001517479,0.0004753904],"category_scores_gemma":[0.0000019158292,0.000331585,0.00014989411,0.00006662613,0.00018256242,0.000014453521,0.000114167735,0.00011033463,0.000027073698],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014817103,0.0014130275,0.025872817,0.00007883241,0.0035450063,0.00039747308,0.00015278766,0.00006993274,0.9263043,0.00002345763,0.022831097,0.0044941553],"study_design_scores_gemma":[0.0112633025,0.0019811578,0.7371787,0.000011554324,0.010283082,0.000046668953,0.00009176309,0.0012153026,0.18696299,0.0012679693,0.048259977,0.0014375417],"about_ca_topic_score_codex":0.0000027855963,"about_ca_topic_score_gemma":0.00000820311,"teacher_disagreement_score":0.7393413,"about_ca_system_score_codex":0.000052875996,"about_ca_system_score_gemma":0.00016358228,"threshold_uncertainty_score":0.99991363},"labels":[],"label_agreement":null},{"id":"W2090379722","doi":"10.1111/apt.12990","title":"The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long‐term nucleos(t)ide analogue therapy","year":2014,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"Astellas Pharma; Canadian Institutes of Health Research; Canadian Liver Foundation; Wenzel Family Foundation; Gilead Sciences; Alberta Innovates - Technology Futures; Bristol-Myers Squibb","keywords":"Medicine; Entecavir; Hepatocellular carcinoma; Internal medicine; Adefovir; Lamivudine; Gastroenterology; Incidence (geometry); Telbivudine; Hepatitis B; Cirrhosis; Proportional hazards model; HBeAg; Chronic hepatitis; Hepatitis B virus; HBsAg; Immunology; Virus","score_opus":0.023198917252216258,"score_gpt":0.2922796235205358,"score_spread":0.2690807062683196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090379722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99398804,0.0017808743,0.000009050544,0.0024462875,0.00038186015,0.0012290806,0.00003108341,0.00003257737,0.00010115032],"genre_scores_gemma":[0.9797272,0.0045365756,0.000051321735,0.015295888,0.0001417044,0.00009385699,0.0000517108,0.000057168923,0.000044574783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976804,0.00034549384,0.0005343797,0.00042962885,0.0004580787,0.0005519694],"domain_scores_gemma":[0.9986717,0.00030838163,0.0002569984,0.00048549034,0.00017148466,0.00010593699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031344872,0.00035058893,0.0005265799,0.00014660392,0.00022388599,0.000011444371,0.00031178363,0.00011017944,0.00018114097],"category_scores_gemma":[0.0000010993009,0.00024406583,0.000099595236,0.00029192696,0.0005118932,0.000087226814,0.000084820174,0.0003748776,0.000028236365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015141404,0.00058674766,0.975005,0.000029922143,0.0024480585,0.000033964523,0.0007578371,0.00000591654,0.013788732,0.000015316926,0.00020870358,0.0056056674],"study_design_scores_gemma":[0.00603603,0.004087475,0.90052557,0.00007767537,0.0009821433,0.000004672166,0.000010073279,0.00043753843,0.08662311,0.000025233216,0.0009744627,0.0002160051],"about_ca_topic_score_codex":0.0018147284,"about_ca_topic_score_gemma":0.001254757,"teacher_disagreement_score":0.074479416,"about_ca_system_score_codex":0.00038413238,"about_ca_system_score_gemma":0.0001538002,"threshold_uncertainty_score":0.99527156},"labels":[],"label_agreement":null},{"id":"W2090808327","doi":"10.1046/j.1365-2036.2000.00817.x","title":"Bioavailability of four ursodeoxycholic acid preparations","year":2000,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"Medical Research Council Canada","keywords":"Ursodeoxycholic acid; Cmax; Bioavailability; Medicine; Pharmacology; Internal medicine; Pharmacokinetics","score_opus":0.04787725617388047,"score_gpt":0.343875895227604,"score_spread":0.2959986390537235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090808327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927567,0.0015452157,0.000006030738,0.0024994,0.00021843244,0.0004928931,0.00007005339,0.000051810825,0.0023594634],"genre_scores_gemma":[0.9814515,0.0013985788,0.00030690536,0.015807165,0.000108063694,0.000027348817,0.000070732865,0.00001612337,0.00081359345],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99898297,0.00015205488,0.00029214474,0.00020297377,0.00014152579,0.00022831403],"domain_scores_gemma":[0.99936837,0.00005289918,0.00006414017,0.00033035775,0.000068995425,0.00011522507],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011848069,0.00014534502,0.00024098708,0.000050417766,0.00009882023,0.0000044106723,0.00013748828,0.000071646704,0.014544241],"category_scores_gemma":[1.2485542e-7,0.00013209098,0.00013549013,0.00016033115,0.00025350615,0.0001001507,0.00002946289,0.00017413608,0.00014638547],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031784468,0.004776198,0.14767686,0.000099701516,0.01536069,0.000026680955,0.0015756966,0.000032664368,0.80900574,0.000027697022,0.0041927006,0.01404695],"study_design_scores_gemma":[0.008653012,0.0024202436,0.339929,0.000035734804,0.030495835,0.00011600694,0.00031075103,0.00098133,0.53709835,0.00033323653,0.07917143,0.00045505035],"about_ca_topic_score_codex":0.00008678224,"about_ca_topic_score_gemma":0.0000020288624,"teacher_disagreement_score":0.27190736,"about_ca_system_score_codex":0.000060405415,"about_ca_system_score_gemma":0.0001000555,"threshold_uncertainty_score":0.9863566},"labels":[],"label_agreement":null},{"id":"W2091756720","doi":"10.1046/j.1365-2036.2000.00751.x","title":"Rifaximin versus chlortetracycline in the short‐term treatment of small intestinal bacterial overgrowth","year":2000,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Travel-related health issues","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Rifaximin; Medicine; Tolerability; Gastroenterology; Internal medicine; Malabsorption; Antibiotics; Small intestinal bacterial overgrowth; Lactulose; Chlortetracycline; Breath test; Pharmacology; Microbiology; Adverse effect; Irritable bowel syndrome; Helicobacter pylori; Biology","score_opus":0.09250608591400745,"score_gpt":0.38315718152844547,"score_spread":0.290651095614438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091756720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913785,0.0012575822,0.0000018567657,0.0046273344,0.00087247154,0.000987791,0.00003009172,0.000043841676,0.00080056454],"genre_scores_gemma":[0.9893394,0.004014263,0.00051469886,0.0051768087,0.00053964416,0.000068373054,0.0001810816,0.00003644491,0.00012929844],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99814177,0.00023046251,0.00062682317,0.00031933392,0.00020398693,0.00047764086],"domain_scores_gemma":[0.9990957,0.00037598438,0.000092166374,0.00028754308,0.000034651242,0.00011397505],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020326742,0.00029776836,0.00046318883,0.00012395886,0.000072252704,0.0000066387847,0.00021081777,0.00015688111,0.0029939306],"category_scores_gemma":[3.0200718e-7,0.000217973,0.000117038595,0.00022445436,0.00023045279,0.00005457279,0.000015363667,0.00032638054,0.00004294678],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10462096,0.020840727,0.19375283,0.00022793401,0.019342443,0.001997082,0.021788774,0.000117019874,0.42364925,0.0000727613,0.00043708377,0.21315315],"study_design_scores_gemma":[0.06382795,0.037282612,0.5940558,0.00018793425,0.028685275,0.00064550876,0.0009746981,0.0010106345,0.2230908,0.0000845126,0.0493099,0.0008443853],"about_ca_topic_score_codex":0.00029516107,"about_ca_topic_score_gemma":0.00010952073,"teacher_disagreement_score":0.40030298,"about_ca_system_score_codex":0.00024085537,"about_ca_system_score_gemma":0.0001338227,"threshold_uncertainty_score":0.9979175},"labels":[],"label_agreement":null},{"id":"W2095168343","doi":"10.1111/apt.12873","title":"The incidence rate of colectomy for medically refractory ulcerative colitis has declined in parallel with increasing anti‐TNF use: a time‐trend study","year":2014,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ministry of Health; University of Calgary; University of Alberta Hospital; University of Alberta","funders":"Alberta Innovates; Alberta Innovates - Health Solutions","keywords":"Ulcerative colitis; Medicine; Colectomy; Incidence (geometry); Infliximab; Internal medicine; Refractory (planetary science); Population; Gastroenterology; Inflammatory bowel disease; Surgery; Colitis; Disease","score_opus":0.01977953622177625,"score_gpt":0.3023386923808298,"score_spread":0.2825591561590535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095168343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974696,0.0001529312,0.00024013863,0.0005611575,0.00014048498,0.0013536363,0.000047696885,0.000013190524,0.000021185368],"genre_scores_gemma":[0.9936463,0.00014285017,0.00062156236,0.0050026355,0.00012786368,0.00023886676,0.00010608492,0.000037985283,0.00007580456],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99729556,0.0013238086,0.00044423595,0.0003893542,0.00015715629,0.0003898841],"domain_scores_gemma":[0.99859744,0.00059505214,0.00025756858,0.00029853755,0.00014742943,0.00010395996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011518535,0.0002503585,0.0002741375,0.00005533506,0.00025232247,0.000037974452,0.00033623583,0.000114204755,0.000038475944],"category_scores_gemma":[0.000009851277,0.00019295141,0.000064647735,0.000102647355,0.0005324359,0.000018667028,0.00010797524,0.00016230081,0.0000032044761],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042706303,0.002274424,0.21526887,0.000052958298,0.009557366,0.00016748467,0.0014379587,0.0006844505,0.72506213,0.00006024289,0.0012308415,0.0014969951],"study_design_scores_gemma":[0.02642828,0.006565192,0.84532064,0.00007307834,0.004880819,0.000040013725,0.0008201896,0.0053093606,0.08091688,0.00016815936,0.028513143,0.0009642174],"about_ca_topic_score_codex":0.00008483245,"about_ca_topic_score_gemma":0.0009036341,"teacher_disagreement_score":0.64414525,"about_ca_system_score_codex":0.000050143903,"about_ca_system_score_gemma":0.00029010573,"threshold_uncertainty_score":0.786833},"labels":[],"label_agreement":null},{"id":"W2095190106","doi":"10.1111/j.1365-2036.2005.02466.x","title":"Heartburn‐dominant, uninvestigated dyspepsia: a comparison of ‘PPI‐start’ and ‘H<sub>2</sub>‐RA‐start’ management strategies in primary care – the CADET‐HR Study","year":2005,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); University of Alberta; McGill University; Dalhousie University; McMaster University","funders":"AstraZeneca Canada; AstraZeneca","keywords":"Heartburn; Medicine; Ranitidine; Omeprazole; Proton-pump inhibitor; Internal medicine; Gastroenterology; Antagonist; Nerd; GERD; Reflux; Receptor; Disease","score_opus":0.03101024658191801,"score_gpt":0.33588420856689805,"score_spread":0.30487396198498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095190106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916296,0.0042727417,0.00000443026,0.0013241062,0.00018787333,0.0021177924,0.000028089242,0.00003959126,0.00039575002],"genre_scores_gemma":[0.9945705,0.0006950721,0.00032991194,0.0040216437,0.00007243434,0.00011308675,0.00010484533,0.00004054155,0.00005195886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777234,0.0003179729,0.0006122084,0.00044172435,0.00035034076,0.000505421],"domain_scores_gemma":[0.9991831,0.00010458976,0.00017737321,0.00032171124,0.000064632935,0.00014857516],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022653153,0.00038174796,0.00063613465,0.0001972036,0.00016087241,0.000021045642,0.00018334686,0.00009979052,0.00004655584],"category_scores_gemma":[1.4920715e-7,0.00028599432,0.000082241284,0.00028743286,0.0003954816,0.00015161707,0.00014926562,0.00043767475,0.000014863415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021897934,0.006930945,0.7367888,0.00038152756,0.018390078,0.0013531854,0.021437678,0.0005212812,0.19404796,0.00005234824,0.00042822582,0.017478168],"study_design_scores_gemma":[0.024253722,0.005245984,0.61252075,0.00012193102,0.018902889,0.00009468677,0.02795255,0.0004899336,0.30877,0.00007375346,0.0012294225,0.00034438088],"about_ca_topic_score_codex":0.000049352235,"about_ca_topic_score_gemma":0.00011429353,"teacher_disagreement_score":0.12426806,"about_ca_system_score_codex":0.0002892752,"about_ca_system_score_gemma":0.00011609622,"threshold_uncertainty_score":0.99995923},"labels":[],"label_agreement":null},{"id":"W2095823529","doi":"10.1046/j.1365-2036.2002.01312.x","title":"The treatment of irritable bowel syndrome","year":2002,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Irritable bowel syndrome; Medicine; Tegaserod; Referral; Disease; Psychopathology; Organic disease; Internal medicine; Psychiatry; Intensive care medicine; Family medicine","score_opus":0.09666179060340997,"score_gpt":0.3817104041035341,"score_spread":0.2850486135001241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095823529","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005362582,0.9957757,0.000001851284,0.00086894893,0.00066425564,0.0016028141,0.00006386017,0.00004284997,0.00044343504],"genre_scores_gemma":[0.00011741895,0.9961983,0.00014745056,0.0012879076,0.00010085918,0.00016234926,0.00011702777,0.000058887003,0.0018097739],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979889,0.0002547428,0.00069416466,0.00036103546,0.00020807769,0.00049312855],"domain_scores_gemma":[0.99859375,0.0005041014,0.00031311376,0.000403067,0.00005303786,0.000132936],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012762866,0.00049041305,0.0014064534,0.00010575012,0.00018181127,0.000010304153,0.0002511994,0.00018400622,0.00067778793],"category_scores_gemma":[2.1879475e-7,0.0003045973,0.0006728494,0.00020291848,0.0003958379,0.000033045955,0.000036062458,0.00030168978,0.00012406541],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034948575,0.0053266822,0.00026283364,0.0045819115,0.043844197,0.0004409814,0.00021492185,0.0000019396082,0.00004161784,0.000020296296,0.0014697986,0.9434453],"study_design_scores_gemma":[0.0014197276,0.003986148,0.00002488104,0.000738905,0.06526175,0.0010733355,0.000054295284,0.000017054386,0.000029708597,0.000020592755,0.9272112,0.00016237145],"about_ca_topic_score_codex":0.000037401318,"about_ca_topic_score_gemma":0.000005487853,"teacher_disagreement_score":0.94328296,"about_ca_system_score_codex":0.00027189168,"about_ca_system_score_gemma":0.00016093525,"threshold_uncertainty_score":0.99994063},"labels":[],"label_agreement":null},{"id":"W2098295867","doi":"10.1111/j.1365-2036.2010.04446.x","title":"Maintenance of clinical benefit in Crohn’s disease patients after discontinuation of infliximab: long‐term follow‐up of a single centre cohort","year":2010,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Misericordia Community Hospital; Royal Alexandra Hospital; University of Alberta Hospital; University of Alberta","funders":"Canadian Association of Gastroenterology; Crohn's and Colitis Foundation of Canada","keywords":"Infliximab; Medicine; Discontinuation; Crohn's disease; Internal medicine; Cohort; Surgery; Disease; Maintenance therapy; Gastroenterology; Chemotherapy","score_opus":0.014388931678821229,"score_gpt":0.30482409502893665,"score_spread":0.29043516335011543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098295867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980462,0.00015599481,0.000009061354,0.00007327888,0.00083842076,0.00059944816,0.0002419712,0.000004307425,0.000031323307],"genre_scores_gemma":[0.9983106,0.00010557588,0.00009280688,0.0010000581,0.000086998916,0.000035422752,0.00026811412,0.000025329568,0.000075091375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829584,0.0001426094,0.000819404,0.0003173292,0.00017266536,0.00025214523],"domain_scores_gemma":[0.99887043,0.000034223216,0.0004374166,0.00032978092,0.00021181855,0.000116309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024336594,0.00018763197,0.00030653394,0.00006258743,0.000017116856,0.000003054614,0.00023554117,0.00015210104,0.00015623835],"category_scores_gemma":[0.0000038986163,0.00018482197,0.00019512631,0.00006453441,0.0003541319,0.000014902888,0.00013146117,0.0001469984,0.0000019644217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041769934,0.001563257,0.8277208,0.00004149122,0.0008092706,0.000027690812,0.00010174416,0.000011770747,0.1646295,0.0000056128924,0.000036986843,0.00087483693],"study_design_scores_gemma":[0.0041965875,0.0001654276,0.91641414,0.000024825258,0.0010928655,2.522851e-7,0.00001508322,0.00003683979,0.07777916,0.0000212035,0.00010661534,0.00014702056],"about_ca_topic_score_codex":0.000012677599,"about_ca_topic_score_gemma":0.00021324647,"teacher_disagreement_score":0.088693276,"about_ca_system_score_codex":0.000016482953,"about_ca_system_score_gemma":0.00010167767,"threshold_uncertainty_score":0.7536821},"labels":[],"label_agreement":null},{"id":"W2098976313","doi":"10.1111/j.1365-2036.2006.03160.x","title":"Oral rabeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects","year":2006,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Pantoprazole; Rabeprazole; Medicine; Crossover study; Washout; Gastroenterology; Proton-pump inhibitor; Internal medicine; Anesthesia; Placebo; Omeprazole","score_opus":0.022212689277464878,"score_gpt":0.3274736484963749,"score_spread":0.30526095921891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098976313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833362,0.001055111,0.0000073229317,0.012890182,0.001227058,0.0012449581,0.000027201162,0.000057768833,0.00015420458],"genre_scores_gemma":[0.9735851,0.00018097936,0.000058769194,0.025806304,0.00018180584,0.00007334559,0.000048056976,0.000040740186,0.00002485467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711436,0.00067678443,0.00074721535,0.0004144098,0.00030280996,0.00074442994],"domain_scores_gemma":[0.9989159,0.00031013967,0.0002877265,0.0003354328,0.000062664665,0.00008812589],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040237512,0.0003775742,0.0008421683,0.00024858047,0.00014050097,0.0000058497462,0.00027765604,0.0001994495,0.000075842254],"category_scores_gemma":[0.0000011966661,0.000279049,0.00013457942,0.0005624889,0.00042506747,0.00005215111,0.000116784715,0.001017783,0.000025276657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007977084,0.0018802065,0.91160077,0.000061328894,0.0033554912,0.00006753562,0.000547924,0.00022967304,0.06989159,0.0000065843496,0.0012383915,0.0031434407],"study_design_scores_gemma":[0.015815279,0.015112912,0.73644835,0.00007957992,0.0053886077,0.00011045592,0.00012806624,0.00041601405,0.22407341,0.000020552256,0.0021842746,0.00022247444],"about_ca_topic_score_codex":0.00024832206,"about_ca_topic_score_gemma":0.00019527608,"teacher_disagreement_score":0.17515238,"about_ca_system_score_codex":0.00030940067,"about_ca_system_score_gemma":0.00009200228,"threshold_uncertainty_score":0.99996614},"labels":[],"label_agreement":null},{"id":"W2099808513","doi":"10.1111/apt.12733","title":"A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease","year":2014,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Robarts Clinical Trials; Mount Sinai Hospital; Western University","funders":"","keywords":"Infliximab; Medicine; Gastroenterology; Internal medicine; Crohn's disease; Prospective cohort study; Cohort; C-reactive protein; Disease; Inflammation","score_opus":0.013378962627871197,"score_gpt":0.283118498677295,"score_spread":0.2697395360494238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099808513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971271,0.000030046984,0.000016213173,0.00031027416,0.00009465141,0.0023625558,0.00003057093,0.000011032002,0.000017519009],"genre_scores_gemma":[0.9965925,0.0000029772173,0.000027067925,0.002923567,0.00015663845,0.00015892075,0.00009524558,0.000022174758,0.000020872663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987023,0.00035356372,0.00020545753,0.0003556824,0.0001495301,0.00023350661],"domain_scores_gemma":[0.9994218,0.00008601383,0.00007724953,0.00022373669,0.00006056869,0.0001306301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022673965,0.00018167628,0.0001264538,0.000027136108,0.00015189589,0.000020528287,0.00014376447,0.000040904833,0.000010985745],"category_scores_gemma":[0.0000029832293,0.00014289965,0.000022926584,0.00008322528,0.000138468,0.000012663283,0.00008840954,0.00012360765,0.0000048101642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018455444,0.0005213516,0.9959426,0.000005169402,0.00064413506,0.000014998265,0.0003326009,0.000058955426,0.0004506857,0.0000048060515,0.000017270599,0.00016191935],"study_design_scores_gemma":[0.0049522053,0.00068647525,0.99183255,0.000005149383,0.001478763,4.3345008e-7,0.00005408246,0.00003760663,0.0006751749,0.000013787633,0.000086787244,0.00017695533],"about_ca_topic_score_codex":0.0000067417923,"about_ca_topic_score_gemma":0.00003258552,"teacher_disagreement_score":0.0041099833,"about_ca_system_score_codex":0.000044811834,"about_ca_system_score_gemma":0.00005338737,"threshold_uncertainty_score":0.58272785},"labels":[],"label_agreement":null},{"id":"W2100653577","doi":"10.1111/j.1365-2036.2005.02643.x","title":"Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study<sup>1</sup>","year":2005,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McMaster University Medical Centre","funders":"","keywords":"Esomeprazole; Pantoprazole; Medicine; Gastroenterology; Internal medicine; Heartburn; Reflux; Esophagitis; Omeprazole; Disease","score_opus":0.04270401027810986,"score_gpt":0.3390478915289819,"score_spread":0.296343881250872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100653577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760921,0.005687517,0.000034034085,0.011889061,0.00043576636,0.003906341,0.0017387639,0.00009291944,0.00012352473],"genre_scores_gemma":[0.9589841,0.0035027678,0.0010316388,0.033478405,0.00080185494,0.00047098607,0.0008731115,0.00009008493,0.0007670865],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996596,0.00033071666,0.00095938623,0.0007763032,0.00047691955,0.0008606791],"domain_scores_gemma":[0.99757546,0.0008076593,0.00042783385,0.00070791715,0.00025066195,0.000230443],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004670569,0.0005734918,0.00083714,0.00010848034,0.00031668317,0.000026006737,0.0005072844,0.00016992287,0.0003549814],"category_scores_gemma":[0.0000024875571,0.00039777704,0.00032065395,0.00026715721,0.00033644485,0.00020748755,0.000117296484,0.00044433525,0.00006811613],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.071712136,0.033716206,0.4207359,0.000101373385,0.11142733,0.0014823896,0.045458227,0.0019353398,0.21044287,0.0000525143,0.05004133,0.05289439],"study_design_scores_gemma":[0.25004598,0.02300784,0.16757381,0.00026326074,0.025927173,0.00018261027,0.007163615,0.006448929,0.4536011,0.00052468874,0.06412569,0.001135323],"about_ca_topic_score_codex":0.00013188166,"about_ca_topic_score_gemma":0.000032833934,"teacher_disagreement_score":0.2531621,"about_ca_system_score_codex":0.00021745301,"about_ca_system_score_gemma":0.00015742994,"threshold_uncertainty_score":0.9998474},"labels":[],"label_agreement":null},{"id":"W2101433234","doi":"10.1111/j.1365-2036.2011.04618.x","title":"Systematic review: the presenting international normalised ratio (INR) as a predictor of outcome in patients with upper nonvariceal gastrointestinal bleeding","year":2011,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Upper gastrointestinal bleeding; Internal medicine; Confidence interval; Cohort; Predictive value of tests; Gastroenterology; Intensive care medicine; Endoscopy","score_opus":0.04394080816305686,"score_gpt":0.34438556561421607,"score_spread":0.30044475745115923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101433234","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047237496,0.98578656,0.000008443558,0.00065690745,0.0005552177,0.007880766,0.00010126104,0.000048125483,0.00023894315],"genre_scores_gemma":[0.002750747,0.9908013,0.0006729649,0.003899963,0.00018363923,0.0009664307,0.000493931,0.00010336451,0.00012769869],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.99623126,0.00037317627,0.0018506607,0.0004917514,0.00055541133,0.0004977474],"domain_scores_gemma":[0.99716103,0.0005745013,0.0014514189,0.0003846432,0.00029844468,0.0001299826],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005944976,0.0006528077,0.0023678113,0.00027949942,0.00008456328,0.000020814723,0.00054377905,0.00009406349,0.00035404795],"category_scores_gemma":[0.000008413669,0.0003744416,0.0004633203,0.0003195778,0.00018478766,0.00012822739,0.00018611303,0.0007002366,0.000036738955],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005136758,0.0040855426,0.5635015,0.39628053,0.033850346,0.0002189591,0.0003327761,0.0000025271788,0.000010844936,0.000039190523,0.00035574002,0.00080840354],"study_design_scores_gemma":[0.0076690307,0.0038010154,0.011631596,0.68331283,0.28297997,0.0015403205,0.00010038698,0.0000840293,0.000029233439,0.000005904031,0.0081471875,0.0006985312],"about_ca_topic_score_codex":0.00007245036,"about_ca_topic_score_gemma":0.0000024510214,"teacher_disagreement_score":0.55186987,"about_ca_system_score_codex":0.0003593116,"about_ca_system_score_gemma":0.00018454506,"threshold_uncertainty_score":0.9998708},"labels":[],"label_agreement":null},{"id":"W2103656186","doi":"10.1111/j.1365-2036.2008.03799.x","title":"Clinical trial: randomized controlled study of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol","year":2008,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université de Montréal; University of Alberta","funders":"","keywords":"Lamivudine; Ursodeoxycholic acid; Zidovudine; Medicine; Primary biliary cirrhosis; Internal medicine; Placebo; Gastroenterology; Alkaline phosphatase; Randomized controlled trial; Cirrhosis; Immunology; Human immunodeficiency virus (HIV); Viral disease; Virus; Hepatitis B virus; Pathology; Enzyme; Biology","score_opus":0.05922175148013105,"score_gpt":0.3666753039337077,"score_spread":0.30745355245357664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103656186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813929,0.0007650841,0.0000080107575,0.00058368035,0.0005489696,0.016546398,0.00005951178,0.000040907897,0.000054530134],"genre_scores_gemma":[0.98764235,0.0023631214,0.0002439445,0.008531097,0.00015458002,0.0008011232,0.0001433207,0.000041850246,0.000078623496],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967598,0.0011516161,0.00109405,0.00039734153,0.00031816508,0.00027905486],"domain_scores_gemma":[0.9957799,0.0030213878,0.00046526175,0.00031890735,0.0002580086,0.00015658957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010172217,0.00031574015,0.0023639172,0.0001284221,0.00016239082,0.0000041672374,0.0001254308,0.00010186465,0.00015400918],"category_scores_gemma":[0.000007652391,0.000200317,0.00038410252,0.00011948761,0.00055021135,0.00007042766,0.00006365744,0.0002565601,0.0000014469879],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78893185,0.019517558,0.16343015,0.000043395892,0.026678259,0.000008736924,0.00033692265,0.0000017177372,0.000541832,0.0000016527439,0.00016371805,0.00034421496],"study_design_scores_gemma":[0.8644815,0.027296972,0.06838444,0.000022373131,0.03893138,0.0000029111557,0.00017945084,0.00011648546,0.00026277028,0.000011509574,0.00014087567,0.00016931204],"about_ca_topic_score_codex":0.000029041488,"about_ca_topic_score_gemma":9.055796e-7,"teacher_disagreement_score":0.095045716,"about_ca_system_score_codex":0.000059157665,"about_ca_system_score_gemma":0.000138797,"threshold_uncertainty_score":0.816869},"labels":[],"label_agreement":null},{"id":"W2105246122","doi":"10.1111/j.1365-2036.2008.03753.x","title":"Review article: treatment algorithms to maximize remission and minimize corticosteroid dependence in patients with inflammatory bowel disease","year":2008,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Calgary","funders":"UCB Pharma; Zalicus; Teva Pharmaceutical Industries; Genentech; Celgene; AstraZeneca; UCB Celltech; Biogen; Procter and Gamble; Bristol-Myers Squibb; Abbott Laboratories","keywords":"Medicine; Infliximab; Ulcerative colitis; Azathioprine; Adalimumab; Inflammatory bowel disease; Methotrexate; Mercaptopurine; Crohn's disease; Internal medicine; Disease; Gastroenterology; Immunology","score_opus":0.02217264269578638,"score_gpt":0.3099236730613774,"score_spread":0.287751030365591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105246122","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.045570895,0.95063657,0.000005911276,0.00011941691,0.00023816893,0.0032203712,0.00017880539,0.000021979566,0.000007888473],"genre_scores_gemma":[0.00018834704,0.9893217,0.00026595383,0.00863369,0.0001276537,0.00063030474,0.0006516182,0.00010562145,0.000075093485],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99700594,0.00051772315,0.00075903576,0.00091871514,0.00024610313,0.00055247557],"domain_scores_gemma":[0.9984048,0.000043428005,0.00032450864,0.00059210474,0.00008322068,0.00055192446],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011465646,0.00075059006,0.00086029276,0.00012160286,0.00011496906,0.000016905788,0.00033149574,0.00023202188,0.000065741995],"category_scores_gemma":[0.0000014959332,0.00059921807,0.00020700513,0.00013115803,0.00017273278,0.000015827205,0.00023055222,0.00022797326,0.000032270436],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008585428,0.004454954,0.08974597,0.02302399,0.018276608,0.003518872,0.00023962914,0.000051111416,0.0006958773,0.0000012997716,0.003974134,0.84743214],"study_design_scores_gemma":[0.0064806114,0.0010238375,0.022766456,0.008508166,0.018829267,0.0000715674,0.0000096521435,0.00002010555,0.00020094903,0.0000023353632,0.94059443,0.0014926279],"about_ca_topic_score_codex":0.0000039001006,"about_ca_topic_score_gemma":0.0000065318977,"teacher_disagreement_score":0.9366203,"about_ca_system_score_codex":0.00022634976,"about_ca_system_score_gemma":0.00047195333,"threshold_uncertainty_score":0.99964595},"labels":[],"label_agreement":null},{"id":"W2106159140","doi":"10.1111/j.1365-2036.2008.03788.x","title":"Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease","year":2008,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Thiopurine methyltransferase; Medicine; Azathioprine; ITPA; Inflammatory bowel disease; Adverse effect; Pharmacogenetics; Internal medicine; Gastroenterology; Mercaptopurine; Metabolite; Genotype; Pharmacology; Prospective cohort study; Disease; Immunology","score_opus":0.05532934038525691,"score_gpt":0.36496242759695313,"score_spread":0.30963308721169625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106159140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99346733,0.00260323,0.0000044169356,0.001340879,0.00019127755,0.0022039749,0.000039850824,0.0000061092555,0.00014292108],"genre_scores_gemma":[0.9950201,0.0032760303,0.00006119026,0.0013255986,0.00008761199,0.00015213514,0.000014156503,0.0000190376,0.000044150238],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976872,0.0005457695,0.0004862489,0.0001938009,0.0008612424,0.0002257407],"domain_scores_gemma":[0.99877125,0.00025517907,0.00023665965,0.00036049346,0.00031485868,0.00006158139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048779033,0.0001723368,0.00028110802,0.000108486645,0.000059574762,9.908284e-7,0.00026651917,0.000057210305,0.00018179933],"category_scores_gemma":[0.0000016866255,0.000101606645,0.00014368519,0.0002946804,0.0006929741,0.0000340373,0.000051063576,0.0001391375,0.0000022886366],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028694083,0.004389401,0.6784487,0.000104642684,0.0050753024,0.00005471813,0.007700259,0.0011054279,0.2988442,0.000026286367,0.00013027451,0.0012513936],"study_design_scores_gemma":[0.013183808,0.0009741287,0.4782459,0.000028585839,0.009782106,0.00003831358,0.0003218876,0.008200616,0.48869047,0.00008996041,0.00035858498,0.00008563071],"about_ca_topic_score_codex":0.00004862486,"about_ca_topic_score_gemma":0.000005792949,"teacher_disagreement_score":0.2002028,"about_ca_system_score_codex":0.00056593877,"about_ca_system_score_gemma":0.0010594298,"threshold_uncertainty_score":0.41433987},"labels":[],"label_agreement":null},{"id":"W2109327526","doi":"10.1111/apt.12433","title":"Commentary: non-haemodynamic effects of beta-blockers in cirrhosis - more than meets the eye?","year":2013,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre; University of Toronto","funders":"","keywords":"Propensity score matching; Medicine; Cirrhosis; Internal medicine; Prospective cohort study; Confounding; Retrospective cohort study; Cohort study; Ascites; Cohort; Hemodynamics","score_opus":0.01220990717810027,"score_gpt":0.29697909602202194,"score_spread":0.28476918884392166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109327526","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3793811,0.0016980995,0.0000035598093,0.61581784,0.0009319713,0.0019638892,0.00014249148,0.000028540508,0.000032528616],"genre_scores_gemma":[0.23046805,0.0025498588,0.00007924458,0.76356566,0.00070390373,0.00026811266,0.002170827,0.00007978699,0.00011452565],"study_design_codex":"not_applicable","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9975908,0.00039389505,0.0005378949,0.00047147842,0.00043993175,0.0005660045],"domain_scores_gemma":[0.9986587,0.00047531552,0.00027814574,0.00043804446,0.000061558756,0.00008821951],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013333576,0.0005320466,0.0007620824,0.0002748757,0.000099031655,0.0000114723125,0.00042211224,0.00047356475,0.00029806903],"category_scores_gemma":[3.251411e-8,0.00040296506,0.00029780384,0.0002225098,0.00039200575,0.000107029045,0.000070419715,0.00140175,0.000038732775],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011228723,0.0012939309,0.08091423,0.0031323342,0.12110569,0.00240381,0.0043434254,0.000020859998,0.057252627,0.000002246353,0.7278909,0.0005170401],"study_design_scores_gemma":[0.02850157,0.0025410254,0.12219469,0.0015958257,0.45393634,0.00012491512,0.0007113393,0.0024296422,0.22550103,0.00014552093,0.1603709,0.0019471879],"about_ca_topic_score_codex":0.0011819769,"about_ca_topic_score_gemma":0.000022336199,"teacher_disagreement_score":0.56752,"about_ca_system_score_codex":0.00021540392,"about_ca_system_score_gemma":0.000098226934,"threshold_uncertainty_score":0.9998422},"labels":[],"label_agreement":null},{"id":"W2111281606","doi":"10.1046/j.1365-2036.2002.01321.x","title":"Lactose — a potential prebiotic","year":2002,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Digestive system and related health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Prebiotic; Medicine; Lactose; Lactose intolerance; Ingestion; Population; Food science; Intensive care medicine; Environmental health; Internal medicine; Biology","score_opus":0.05200047566320773,"score_gpt":0.3696835977513743,"score_spread":0.3176831220881666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111281606","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012832084,0.99477553,0.00002250535,0.00014867586,0.0026408,0.0012435772,0.00013401269,0.000042147018,0.00086444063],"genre_scores_gemma":[0.0002573232,0.9905983,0.000062176645,0.0038126055,0.0011792704,0.00009322663,0.0008610031,0.00013267309,0.003003382],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971026,0.0006547689,0.000679469,0.00073562976,0.00017919471,0.0006483392],"domain_scores_gemma":[0.9989021,0.00003278505,0.0003950348,0.00042521965,0.000054349748,0.00019050504],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019730834,0.0006484236,0.0010294399,0.00013174994,0.0001739738,0.000022756762,0.00051690073,0.00094012514,0.00046073747],"category_scores_gemma":[1.3658557e-7,0.00054127385,0.00055315316,0.00016309002,0.00019168088,0.000004408429,0.00020062839,0.00054926495,0.00038961924],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018329971,0.0025153055,0.00005799222,0.013704635,0.11734457,0.00047374892,0.00019818511,0.00003459095,0.008127354,0.000030166051,0.029802138,0.827528],"study_design_scores_gemma":[0.0006878955,0.00046088884,0.0000019574047,0.00050161604,0.02263417,0.00028220788,0.0000113861115,0.000008930639,0.00036071948,0.0000034542982,0.97454077,0.0005060228],"about_ca_topic_score_codex":0.000008937108,"about_ca_topic_score_gemma":0.000001268007,"teacher_disagreement_score":0.9447386,"about_ca_system_score_codex":0.00009362843,"about_ca_system_score_gemma":0.00026079404,"threshold_uncertainty_score":0.9997039},"labels":[],"label_agreement":null},{"id":"W2111585639","doi":"10.1111/j.1365-2036.2006.03088.x","title":"Oral V<sub>2</sub> receptor antagonist (RWJ‐351647) in patients with cirrhosis and ascites: a randomized, double‐blind, placebo‐controlled, single ascending dose study","year":2006,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Electrolyte and hormonal disorders","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Cirrhosis; Tolerability; Internal medicine; Ascites; Gastroenterology; Furosemide; Free water clearance; Placebo; Diuretic; Urine osmolality; Concomitant; Vasopressin; Pharmacokinetics; Endocrinology; Pharmacology; Adverse effect; Urology","score_opus":0.01844251744701554,"score_gpt":0.2868652187913212,"score_spread":0.2684227013443057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111585639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99005246,0.0018061557,0.000009470096,0.0014664879,0.00019832465,0.0059678615,0.000015429143,0.00007415953,0.00040965318],"genre_scores_gemma":[0.992462,0.000564878,0.00011390239,0.0059000514,0.00014691582,0.000474345,0.00019589551,0.00007544638,0.0000665574],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99708027,0.00044993576,0.00072877016,0.00060698274,0.00042744793,0.0007066148],"domain_scores_gemma":[0.9989263,0.00035764623,0.00025792452,0.0002040374,0.00010630561,0.00014780175],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00065414276,0.00050235266,0.0012801765,0.0003856334,0.00023192594,0.000054350225,0.00014971393,0.00014543507,0.00010466845],"category_scores_gemma":[7.238132e-7,0.0003970848,0.00016708125,0.00039180697,0.00034818138,0.00021048788,0.00006681044,0.00048299346,0.00001589769],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72762555,0.0065460163,0.11047231,0.000023564837,0.008619784,0.000043911252,0.0004975996,0.0000211886,0.14485976,0.000012591249,0.00020453685,0.0010731895],"study_design_scores_gemma":[0.9334424,0.003859174,0.015955819,0.000036630005,0.013618496,0.0000113987735,0.00044673326,0.00017676101,0.03173142,0.000041379943,0.00022182707,0.0004579552],"about_ca_topic_score_codex":0.00023833927,"about_ca_topic_score_gemma":0.00022037333,"teacher_disagreement_score":0.20581685,"about_ca_system_score_codex":0.00022751935,"about_ca_system_score_gemma":0.00009627146,"threshold_uncertainty_score":0.9998481},"labels":[],"label_agreement":null},{"id":"W2112245728","doi":"10.1111/apt.13378","title":"Systematic review: instruments to assess abdominal pain in irritable bowel syndrome","year":2015,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Irritable bowel syndrome; Abdominal pain; Provocation test; Barostat; Physical therapy; Rating scale; Chronic pain; Internal medicine; Alternative medicine; Pathology","score_opus":0.10493671958389514,"score_gpt":0.4086568091761647,"score_spread":0.3037200895922696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112245728","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029817116,0.98958665,0.000018285318,0.0010534622,0.0005604119,0.008217473,0.000060632516,0.00006480127,0.00014010356],"genre_scores_gemma":[0.000043666147,0.9615095,0.0009958148,0.03557542,0.000058411366,0.001094618,0.00030795622,0.000096962394,0.00031764375],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99433553,0.0019078502,0.0017250255,0.0007090444,0.0005285406,0.0007940256],"domain_scores_gemma":[0.99805415,0.00032129325,0.0004920845,0.00055228453,0.00012719199,0.00045297015],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002979354,0.00079024816,0.0042472645,0.00042558738,0.000067698034,0.000021435311,0.0005486141,0.0002666458,0.00033882583],"category_scores_gemma":[0.00001032863,0.0006655587,0.00047491363,0.0006602688,0.0001105728,0.00011354552,0.00019348059,0.00093970285,0.0003842553],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020034173,0.0012420467,0.0001116429,0.9626127,0.008894778,0.00080401986,0.00006555803,0.0000011522823,0.00001036188,0.0000022689587,0.0031816529,0.022873498],"study_design_scores_gemma":[0.00239793,0.0028387161,0.000015020265,0.63512695,0.12680964,0.0033488113,0.0001752684,0.00005226918,0.0000044498074,0.000021263704,0.2285056,0.0007041181],"about_ca_topic_score_codex":0.00004816139,"about_ca_topic_score_gemma":0.000011573245,"teacher_disagreement_score":0.32748577,"about_ca_system_score_codex":0.0008722178,"about_ca_system_score_gemma":0.0006256511,"threshold_uncertainty_score":0.99957955},"labels":[],"label_agreement":null},{"id":"W2114268371","doi":"10.1046/j.1365-2036.2002.01168.x","title":"Acid suppression in healthy subjects following lansoprazole or pantoprazole","year":2002,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; McMaster University","funders":"","keywords":"Lansoprazole; Pantoprazole; Crossover study; Medicine; Washout; Gastric acid; Gastroenterology; Internal medicine; Proton-pump inhibitor; Pharmacology; Omeprazole; Stomach; Placebo","score_opus":0.0618782307672643,"score_gpt":0.36144807431175335,"score_spread":0.29956984354448907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114268371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924356,0.0025537915,0.000010657429,0.002741824,0.00097542815,0.00064401486,0.00001230198,0.000091014896,0.0005353927],"genre_scores_gemma":[0.9689552,0.0012444183,0.00036495013,0.028493727,0.00013847717,0.000064796855,0.00006795754,0.00004363961,0.0006268311],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99822503,0.00014384757,0.00035983857,0.0003809672,0.00024705887,0.000643245],"domain_scores_gemma":[0.9993707,0.00008911437,0.00008178994,0.00022574594,0.000020162344,0.00021247803],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013321608,0.00028140217,0.00040845128,0.00017069886,0.00012752016,0.0000107222,0.00013544674,0.0001343231,0.0019419712],"category_scores_gemma":[3.45518e-7,0.00021640224,0.00012766298,0.00025047493,0.000058266083,0.00014255494,0.000058358455,0.00035825805,0.0001624575],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048703454,0.006219253,0.7658018,0.00010302847,0.009435632,0.013728149,0.0018332319,0.000045090885,0.18431951,0.0000071322424,0.0019741813,0.011662672],"study_design_scores_gemma":[0.08311051,0.013210266,0.17940454,0.0002147957,0.019913675,0.0010509153,0.00059608556,0.008265442,0.6787773,0.000063544954,0.014504619,0.00088831916],"about_ca_topic_score_codex":0.000028159508,"about_ca_topic_score_gemma":0.000012828352,"teacher_disagreement_score":0.58639723,"about_ca_system_score_codex":0.00019623247,"about_ca_system_score_gemma":0.000042403,"threshold_uncertainty_score":0.9989704},"labels":[],"label_agreement":null},{"id":"W2115112939","doi":"10.1111/apt.12869","title":"Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease","year":2014,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":188,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adalimumab; Medicine; Internal medicine; Gastroenterology; Crohn's disease; Disease; Immunology; Logistic regression; Drug-naïve; Drug; Pharmacology","score_opus":0.009706952557712738,"score_gpt":0.31250787246004297,"score_spread":0.3028009199023302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115112939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99862117,0.000356247,0.0000062545428,0.00023117459,0.00022068156,0.00038535602,0.00015754973,0.000009386158,0.000012209654],"genre_scores_gemma":[0.99444205,0.00016235701,0.00007271528,0.00507828,0.00009125041,0.000014802007,0.00008214523,0.000028550707,0.000027844675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980399,0.00082843733,0.0003920687,0.0003767383,0.00013824522,0.0002246348],"domain_scores_gemma":[0.99923635,0.00008862342,0.00015325191,0.00022845206,0.000085244275,0.00020810761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006082444,0.00019526656,0.0002184955,0.00006006787,0.000054186552,0.000007581712,0.00012709342,0.0000974377,0.000026443977],"category_scores_gemma":[0.0000035905125,0.00017780805,0.000035841724,0.00005651334,0.0005357411,0.000013072297,0.00011772863,0.00012937971,0.0000017200908],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023355352,0.0003901905,0.95217335,0.00002706962,0.00095358735,0.000051067356,0.00009035849,0.000013636915,0.022725163,0.0000063930647,0.00007187229,0.00014195417],"study_design_scores_gemma":[0.0063932105,0.0006016884,0.98472714,0.000013201128,0.00088770734,7.119545e-7,0.000030982468,0.000051792947,0.0055448767,0.000017047085,0.0015422617,0.00018938124],"about_ca_topic_score_codex":0.000005559598,"about_ca_topic_score_gemma":0.0000049216087,"teacher_disagreement_score":0.032553785,"about_ca_system_score_codex":0.000009409789,"about_ca_system_score_gemma":0.00017220406,"threshold_uncertainty_score":0.7250802},"labels":[],"label_agreement":null},{"id":"W2116306941","doi":"10.1111/j.1365-2036.2011.04603.x","title":"A British Society of Paediatric Gastroenterology, Hepatology and Nutrition survey of the effectiveness and safety of adalimumab in children with inflammatory bowel disease","year":2011,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Adalimumab; Hepatology; Internal medicine; Ulcerative colitis; Inflammatory bowel disease; Infliximab; Immunosuppression; Adverse effect; Gastroenterology; Crohn's disease; Disease","score_opus":0.008236309066942102,"score_gpt":0.22942189061132237,"score_spread":0.22118558154438028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116306941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972614,0.0016889954,0.000017546476,0.000025853982,0.000056862154,0.0007039498,0.00023928503,0.0000033301203,0.0000027897036],"genre_scores_gemma":[0.99699914,0.0022493321,0.000067978384,0.00053512875,0.000016405422,0.00004412451,0.00006980748,0.000017175038,8.773855e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983169,0.00084903714,0.00030775997,0.00025402493,0.00007975366,0.00019255867],"domain_scores_gemma":[0.9994156,0.00004607024,0.00021500244,0.00017496046,0.00008649978,0.00006190012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039969588,0.00015046776,0.00022019596,0.0000358654,0.000033223023,0.0000015701308,0.000155825,0.00010550322,0.000016949209],"category_scores_gemma":[8.886824e-7,0.00013976835,0.000066268054,0.00006948966,0.00078371237,0.000009426113,0.00015825914,0.00010251504,5.404511e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0085124085,0.0004210417,0.9575143,0.00016434377,0.001700302,0.0000055788873,0.00007072788,0.000008595127,0.031504948,0.0000032692672,0.000018833547,0.00007567663],"study_design_scores_gemma":[0.0047397064,0.00039939693,0.9706706,0.000026827884,0.00094834325,0.000027430311,0.000026354075,0.000042140673,0.022991832,0.000025943977,0.0000042347415,0.000097213335],"about_ca_topic_score_codex":0.00025993254,"about_ca_topic_score_gemma":0.00034593866,"teacher_disagreement_score":0.0131562995,"about_ca_system_score_codex":0.000014906693,"about_ca_system_score_gemma":0.00009898496,"threshold_uncertainty_score":0.5699588},"labels":[],"label_agreement":null},{"id":"W2116706930","doi":"10.1111/j.0269-2813.2004.01803.x","title":"Helminths as therapeutic agents for inflammatory bowel disease","year":2004,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Parasites and Host Interactions","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; Canadian Association of Gastroenterology; Crohn's and Colitis Foundation of Canada","keywords":"Disease; Immunology; Inflammatory bowel disease; Medicine; Helminths; Helminth infections; Pathological; Helminthiasis; Inflammation; Immune system; Pathology","score_opus":0.06378993910056498,"score_gpt":0.4118038696972125,"score_spread":0.34801393059664754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116706930","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016204295,0.9881021,0.000042495256,0.00051810173,0.007026595,0.0028752682,0.00090867374,0.00016863436,0.00019611759],"genre_scores_gemma":[0.00018584452,0.9782719,0.000032504784,0.0103958985,0.00031375248,0.0013471346,0.002754705,0.00016950775,0.006528735],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99673516,0.0005020429,0.0009301002,0.0008264127,0.00007373138,0.000932579],"domain_scores_gemma":[0.9980881,0.00058430794,0.0005698671,0.00053641334,0.00009014189,0.000131132],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00019784835,0.00092207745,0.0012997842,0.00031923054,0.0005312813,0.00003631473,0.0008103412,0.0007012535,0.0042859185],"category_scores_gemma":[5.8164903e-7,0.00082061585,0.0011197462,0.00014706333,0.0004045333,0.00015031188,0.00016885882,0.00094537466,0.0034528382],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024988027,0.005111211,0.00023085842,0.01734206,0.2866877,0.00033036064,0.0011220808,0.0000518035,0.006206368,0.0026074108,0.02093463,0.65687674],"study_design_scores_gemma":[0.0017903083,0.00030393436,0.000017863607,0.0011420883,0.056746174,0.00014010568,0.000039180413,0.0000022558584,0.0005015593,0.00030299916,0.9383068,0.0007067096],"about_ca_topic_score_codex":0.000027859604,"about_ca_topic_score_gemma":0.0000041270555,"teacher_disagreement_score":0.91737217,"about_ca_system_score_codex":0.0004896759,"about_ca_system_score_gemma":0.0008366708,"threshold_uncertainty_score":0.99942446},"labels":[],"label_agreement":null},{"id":"W2118992568","doi":"10.1111/j.1365-2036.2010.04328.x","title":"Meta‐analysis: factors affecting placebo response rate in the irritable bowel syndrome","year":2010,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Placebo; Medicine; Irritable bowel syndrome; Meta-analysis; Randomized controlled trial; Internal medicine; Confidence interval; Abdominal pain; MEDLINE; Alternative medicine; Pathology","score_opus":0.16083017271575975,"score_gpt":0.40400694974962914,"score_spread":0.2431767770338694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118992568","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032263417,0.96296287,0.000008723389,0.0015845393,0.00042850332,0.0025191638,0.000082474915,0.000074168616,0.00007612106],"genre_scores_gemma":[0.011817896,0.9762126,0.00018702725,0.010600675,0.00007787616,0.0003011094,0.00037237583,0.000099653844,0.0003307377],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9922169,0.005070747,0.00089375465,0.00072193245,0.0003281387,0.0007685194],"domain_scores_gemma":[0.9933067,0.005429481,0.00043731654,0.0006145934,0.000050992563,0.0001609302],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0041849534,0.000812499,0.0032117858,0.00070099434,0.00021874472,0.000042840446,0.00060710014,0.00042092777,0.0010667947],"category_scores_gemma":[0.000005629963,0.0005172384,0.0021726585,0.001212899,0.00027937916,0.00010793975,0.00011356624,0.0024406805,0.00006371828],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029008149,0.0016773851,0.0009818204,0.0029864185,0.98494536,0.0013121256,0.001358212,0.000035612702,0.0002607141,0.0000026850673,0.00011786709,0.0034209888],"study_design_scores_gemma":[0.0011264762,0.00063063635,0.0007577071,0.00018690225,0.8502879,0.00060044933,0.00059707765,0.00001755964,0.000034009583,0.000010877324,0.1454324,0.00031797303],"about_ca_topic_score_codex":0.00013046138,"about_ca_topic_score_gemma":0.0001233775,"teacher_disagreement_score":0.14531453,"about_ca_system_score_codex":0.00015124018,"about_ca_system_score_gemma":0.00033031334,"threshold_uncertainty_score":0.9998607},"labels":[],"label_agreement":null},{"id":"W2119543398","doi":"10.1111/j.1365-2036.2008.03725.x","title":"Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904‐Z","year":2008,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; McMaster University Medical Centre","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Allergan; McMaster University","keywords":"Esomeprazole; Omeprazole; Proton-pump inhibitor; Medicine; Nocturnal; Gastric acid; Pharmacokinetics; Internal medicine; Gastroenterology; Pharmacology; Pharmacodynamics; Stomach","score_opus":0.038746558763800766,"score_gpt":0.29467958100931674,"score_spread":0.25593302224551595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119543398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917777,0.00064944936,0.00016715164,0.0038323365,0.0005961414,0.002636149,0.00009676063,0.00013017535,0.00011410978],"genre_scores_gemma":[0.9892496,0.0010696388,0.0012389371,0.00735838,0.0002735268,0.00040472054,0.000117146265,0.00006182574,0.00022625896],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99763066,0.00018477139,0.0005670073,0.0005129682,0.00040567032,0.0006989556],"domain_scores_gemma":[0.9987896,0.00008873047,0.00030718278,0.0003527525,0.0002713541,0.00019035595],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002240748,0.00040560178,0.00067398866,0.00021621409,0.00022567433,0.0000037318446,0.00021221288,0.00022512279,0.00019857212],"category_scores_gemma":[9.192742e-7,0.00031451587,0.00010188074,0.00037087736,0.0007551038,0.00018897072,0.00016032506,0.0006960416,0.000015814216],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005335127,0.001949807,0.43424463,0.00008537437,0.008927033,0.00012629863,0.00086125,0.000023832552,0.5470687,3.723774e-7,0.0012816716,0.000095917785],"study_design_scores_gemma":[0.022004891,0.0101814205,0.14136878,0.00016254387,0.01315444,0.0017478601,0.00019009039,0.00042641218,0.8033111,0.000004646572,0.00708625,0.00036157423],"about_ca_topic_score_codex":0.000040280756,"about_ca_topic_score_gemma":0.0000051210636,"teacher_disagreement_score":0.29287586,"about_ca_system_score_codex":0.00014047445,"about_ca_system_score_gemma":0.0002001935,"threshold_uncertainty_score":0.9999307},"labels":[],"label_agreement":null},{"id":"W2120744945","doi":"10.1111/j.1365-2036.2005.02504.x","title":"Review article: the changing epidemiology of hepatocellular carcinoma in Canada","year":2005,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Epidemiology; MEDLINE; Carcinoma; Oncology; Environmental health; Internal medicine; Political science","score_opus":0.11153029060158978,"score_gpt":0.390777424809014,"score_spread":0.2792471342074242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120744945","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038262636,0.9895429,2.38251e-7,0.0036738308,0.0003812161,0.002444159,0.00009624283,0.0000087976405,0.000026362117],"genre_scores_gemma":[0.004203048,0.9339245,0.000020673591,0.06092216,0.00019439291,0.0004600899,0.00021401509,0.00004256855,0.000018532231],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969164,0.0009108502,0.0010626795,0.00038554272,0.00015399835,0.00057050644],"domain_scores_gemma":[0.99804914,0.00088685035,0.00046302855,0.00041881116,0.000042153173,0.0001400194],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053461455,0.00042691742,0.0022285806,0.00012548197,0.000055371376,9.570188e-7,0.00026539923,0.000116522526,0.0006452168],"category_scores_gemma":[7.861724e-7,0.00026951157,0.0004195548,0.0003778674,0.00011449925,0.000024512654,0.00010514403,0.00043308534,0.000020095395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006804929,0.0011503702,0.14216094,0.031453714,0.028805874,0.0007160222,0.00015438354,0.0000043510677,0.000003932769,0.000027009577,0.004341149,0.7911142],"study_design_scores_gemma":[0.0010024873,0.00012513885,0.0010650749,0.010540052,0.10059845,0.0001233409,0.000047524773,0.00011660715,0.000054481792,0.000004544763,0.8860747,0.00024755095],"about_ca_topic_score_codex":0.08340514,"about_ca_topic_score_gemma":0.013534226,"teacher_disagreement_score":0.8817336,"about_ca_system_score_codex":0.0011293798,"about_ca_system_score_gemma":0.0018608784,"threshold_uncertainty_score":0.9999757},"labels":[],"label_agreement":null},{"id":"W2121945496","doi":"10.1111/j.1365-2036.2008.03854.x","title":"The effect of mesalazine therapy on quality of life in patients with mildly and moderately active ulcerative colitis","year":2008,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Mesalazine; Medicine; Ulcerative colitis; Internal medicine; Quality of life (healthcare); Inflammatory bowel disease; Gastroenterology; Randomized controlled trial; Clinical trial; Colitis; Disease","score_opus":0.016359495001002755,"score_gpt":0.29070869999436216,"score_spread":0.2743492049933594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121945496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985653,0.00035132657,0.0000026862463,0.0001237183,0.00008049216,0.00072617026,0.0000892691,0.000004008715,0.000057011715],"genre_scores_gemma":[0.9970639,0.0008986804,0.000016857046,0.0018390734,0.000029801837,0.00005454789,0.00006226866,0.000019310992,0.000015585907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983887,0.0007347193,0.00029031836,0.00023217355,0.00015451378,0.00019957309],"domain_scores_gemma":[0.9993256,0.00015038687,0.00019266832,0.00017912759,0.00009197673,0.000060270035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021447595,0.00019294328,0.0002480367,0.000033656994,0.00010790394,0.0000028008112,0.00013083886,0.00008101221,0.000013537651],"category_scores_gemma":[0.0000011334542,0.00013010972,0.0000491673,0.000056938163,0.0004726484,0.000007464273,0.000040950035,0.00011068971,6.3221285e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14189127,0.00065651914,0.773653,0.000033457825,0.006008763,0.000013574332,0.00073503057,0.00024363385,0.075194374,0.000023471033,0.00013690608,0.0014100457],"study_design_scores_gemma":[0.0072680134,0.0023677177,0.75360405,0.000004620752,0.00014736218,6.207864e-7,0.000024165765,0.000021637206,0.23636174,0.00000652067,0.00008444132,0.0001090802],"about_ca_topic_score_codex":0.000032049855,"about_ca_topic_score_gemma":0.000045269982,"teacher_disagreement_score":0.16116737,"about_ca_system_score_codex":0.00002190259,"about_ca_system_score_gemma":0.00008253889,"threshold_uncertainty_score":0.53057206},"labels":[],"label_agreement":null},{"id":"W2123747652","doi":"10.1111/apt.12910","title":"Polymorphisms of <i><scp>HLA</scp>‐<scp>DP</scp></i> are associated with response to peginterferon in Caucasian patients with chronic hepatitis B","year":2014,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Sociale en Geesteswetenschappen, NWO; Stichting voor Lever- en Maag-Darm Onderzoek; Erasmus+; Virgo Consortium; Bristol-Myers Squibb","keywords":"Medicine; HBeAg; Odds ratio; Immunology; Genotype; Gastroenterology; Hepatitis B virus; Internal medicine; Hepatitis B; Seroconversion; Virology; HBsAg; Virus; Biology; Gene","score_opus":0.015090047338127424,"score_gpt":0.27011319375685267,"score_spread":0.25502314641872526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123747652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946677,0.0006560906,0.00004226431,0.0020180957,0.00044090455,0.0015029847,0.0001884923,0.00010105456,0.000382393],"genre_scores_gemma":[0.98006374,0.00030327018,0.00019826299,0.018234573,0.00013150928,0.00017407119,0.00013078465,0.00012591535,0.00063787866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99641526,0.0007721967,0.00063748314,0.0006368523,0.0005849113,0.000953322],"domain_scores_gemma":[0.9972479,0.0012943948,0.00044858622,0.00043122485,0.00028650314,0.0002914196],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052489346,0.00055206445,0.0009678589,0.00041426765,0.00015568586,0.000014815944,0.00029808772,0.00019890786,0.0000636254],"category_scores_gemma":[0.000022399077,0.00047051665,0.000097214266,0.00063752756,0.00040307737,0.00014613062,0.00015500821,0.00051800755,0.000049740236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011360957,0.001257039,0.9592897,0.00004652118,0.0051522814,0.00011928229,0.0031552427,0.0000489542,0.026547251,0.0000033156302,0.0028857638,0.00035852546],"study_design_scores_gemma":[0.011006867,0.009976235,0.9120302,0.00040922582,0.0037327053,0.000017914124,0.00026032494,0.00014792566,0.05052404,0.000008295116,0.011725698,0.00016051828],"about_ca_topic_score_codex":0.0016566009,"about_ca_topic_score_gemma":0.009755175,"teacher_disagreement_score":0.04725948,"about_ca_system_score_codex":0.0009188768,"about_ca_system_score_gemma":0.00025414888,"threshold_uncertainty_score":0.99977463},"labels":[],"label_agreement":null},{"id":"W2123772935","doi":"10.1111/j.1365-2036.2004.02132.x","title":"Review article: towards consistency in the endoscopic diagnosis of Barrett's oesophagus and columnar metaplasia","year":2004,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Barrett's oesophagus; Medicine; Endoscopy; Intestinal metaplasia; Metaplasia; Gastroenterology; Internal medicine; Reflux; General surgery; Adenocarcinoma; Disease; Cancer","score_opus":0.0868573778526502,"score_gpt":0.4266799131959969,"score_spread":0.3398225353433467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123772935","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029405238,0.99237657,1.9062374e-7,0.0027947358,0.00020510021,0.0041307537,0.00011955341,0.000017210154,0.0000618463],"genre_scores_gemma":[0.0025231335,0.9805156,0.00008789915,0.015071983,0.00008576597,0.0015297938,0.00011786225,0.00004425332,0.00002371792],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969919,0.00082044845,0.0008584903,0.00045961305,0.00038167628,0.000487924],"domain_scores_gemma":[0.99856746,0.0005034937,0.00028604007,0.0004119412,0.000064123524,0.00016696114],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057814654,0.0004697633,0.001984497,0.00016344231,0.000081612474,0.000011862241,0.00030957203,0.00017416103,0.00067268556],"category_scores_gemma":[0.0000017808144,0.00030277472,0.00037181776,0.0004940484,0.00044180878,0.00005754223,0.00009718019,0.0006892214,0.000023452552],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000162687,0.0023351284,0.0072515314,0.11027756,0.030714754,0.0021274588,0.00039154844,2.2351604e-7,0.000006492059,0.00006413511,0.0013671048,0.8453014],"study_design_scores_gemma":[0.010946304,0.005190439,0.0022674985,0.07107547,0.28660613,0.0013439185,0.00014170166,0.0000026337514,0.0013070685,0.00019452015,0.62021905,0.00070527714],"about_ca_topic_score_codex":0.00020247922,"about_ca_topic_score_gemma":0.000021989783,"teacher_disagreement_score":0.8445961,"about_ca_system_score_codex":0.00036787725,"about_ca_system_score_gemma":0.00080370187,"threshold_uncertainty_score":0.9999424},"labels":[],"label_agreement":null},{"id":"W2126084953","doi":"10.1111/j.1365-2036.2006.02813.x","title":"The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy","year":2006,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; McGill University; AstraZeneca (Canada); University of Alberta; Dalhousie University","funders":"AstraZeneca Canada; AstraZeneca","keywords":"Medicine; Barrett's oesophagus; Reflux; Gastroenterology; Intestinal metaplasia; Internal medicine; Endoscopy; Biopsy; Barrett's esophagus; GERD; Cohort; Metaplasia; Adenocarcinoma; Helicobacter pylori; Cancer; Disease","score_opus":0.010162893940740688,"score_gpt":0.27544614246850535,"score_spread":0.26528324852776464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126084953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97018147,0.026813364,6.277728e-7,0.0006966583,0.00010124582,0.0017502806,0.00013017838,0.000014261171,0.00031193809],"genre_scores_gemma":[0.9972566,0.00070022565,0.0002151869,0.0013471878,0.00003083356,0.00010438745,0.00021430067,0.000028124481,0.000103197686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834126,0.00017304668,0.00036365987,0.00027147768,0.00038237555,0.0004681908],"domain_scores_gemma":[0.99909127,0.00015853159,0.00014536481,0.00024069578,0.00018431222,0.00017982062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013714565,0.00020505562,0.00030606432,0.00015238402,0.00011501929,0.000005846629,0.00019327961,0.000066554065,0.00009504363],"category_scores_gemma":[3.9904845e-7,0.0001433632,0.000047616086,0.00029916497,0.0004732476,0.0000676938,0.000035869904,0.00023634787,0.000002433878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010667121,0.00032351637,0.99352723,0.0004220977,0.0020447858,0.00010121117,0.00021866043,0.000043685603,0.001959633,0.000024074629,0.000059790746,0.00020859679],"study_design_scores_gemma":[0.0061650327,0.0016995262,0.9090218,0.00013281236,0.0024365566,0.0000061250394,0.00007929367,0.000022411294,0.0802387,0.000039923096,0.00005694488,0.00010086558],"about_ca_topic_score_codex":0.01806587,"about_ca_topic_score_gemma":0.015630078,"teacher_disagreement_score":0.08450543,"about_ca_system_score_codex":0.0008025103,"about_ca_system_score_gemma":0.0013917112,"threshold_uncertainty_score":0.98847294},"labels":[],"label_agreement":null},{"id":"W2126270777","doi":"10.1111/j.1365-2036.2006.02944.x","title":"Review article: acid‐related disease – what are the unmet clinical needs?","year":2006,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Dosing; Proton-pump inhibitor; Intensive care medicine; Disease; Internal medicine","score_opus":0.10832030596808973,"score_gpt":0.4561188754427035,"score_spread":0.3477985694746138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126270777","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005318553,0.98939633,9.850165e-7,0.004208454,0.0021068407,0.0034681435,0.00011781014,0.000109236724,0.000060368337],"genre_scores_gemma":[0.0004074384,0.9196688,0.000032378408,0.07701261,0.00053012936,0.00033740344,0.001097759,0.00012489234,0.0007886178],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99528533,0.0013645448,0.0015939758,0.0006569244,0.00038464894,0.00071454456],"domain_scores_gemma":[0.9972903,0.0004733152,0.0008327097,0.00084556185,0.00009031391,0.0004677623],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00063508976,0.0008404742,0.0025047155,0.00014492139,0.00021157562,0.000048465245,0.00047611882,0.0003590581,0.0010030952],"category_scores_gemma":[0.0000014824722,0.0004988595,0.0014167313,0.0006314505,0.0004490368,0.0001761164,0.00017798292,0.0013333631,0.00085472345],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013223826,0.002748111,0.003173615,0.014187116,0.0557353,0.0028552476,0.000026623085,4.314086e-7,0.0000026919001,0.000009439869,0.017374942,0.90375423],"study_design_scores_gemma":[0.0017229235,0.00027763718,0.00029723262,0.010660006,0.23262183,0.00019202016,0.000016599162,0.000005124902,0.000008375317,0.000020590713,0.75397044,0.00020722461],"about_ca_topic_score_codex":0.0000030909566,"about_ca_topic_score_gemma":4.637261e-7,"teacher_disagreement_score":0.903547,"about_ca_system_score_codex":0.00023915945,"about_ca_system_score_gemma":0.00036457303,"threshold_uncertainty_score":0.9999232},"labels":[],"label_agreement":null},{"id":"W2127553042","doi":"10.1111/j.1365-2036.2007.03565.x","title":"New algorithm for the treatment of gastro‐oesophageal reflux disease","year":2007,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; GERD; Heartburn; Disease; Pharmacist; Intensive care medicine; Disease management; Reflux; Primary care physician; Health care; Gastro-; Primary care; Pharmacy; Family medicine; Internal medicine","score_opus":0.03838304683398636,"score_gpt":0.3698950760455947,"score_spread":0.33151202921160833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127553042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9328582,0.016060865,0.03643034,0.0050793514,0.0030595826,0.0057129515,0.0004113467,0.00016418548,0.00022311854],"genre_scores_gemma":[0.96580625,0.001372586,0.020480411,0.008039545,0.0010199749,0.00011373815,0.00022180051,0.00006312113,0.002882595],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851537,0.00004099513,0.00037638543,0.0003048136,0.00022991345,0.00053252344],"domain_scores_gemma":[0.99879247,0.00033709165,0.00013250364,0.0003006695,0.00007184341,0.00036541797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015120806,0.00029636238,0.0003573909,0.00008819014,0.00015059559,0.000006458885,0.00014094956,0.00006661177,0.0003901279],"category_scores_gemma":[1.5045418e-7,0.00018973832,0.0002906973,0.00012752437,0.00014654572,0.000049030565,0.000020475705,0.0000941698,0.000021219792],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057057873,0.006975409,0.15723392,0.000052338473,0.044828173,0.0014932521,0.0010243428,0.000022803728,0.020769073,0.000055741577,0.0017686099,0.76007056],"study_design_scores_gemma":[0.053402472,0.022077497,0.35593778,0.000033104225,0.111385204,0.00017000813,0.00031589324,0.0024186105,0.3957926,0.00038575038,0.057697687,0.00038337294],"about_ca_topic_score_codex":0.00003225657,"about_ca_topic_score_gemma":0.0000025855522,"teacher_disagreement_score":0.7596872,"about_ca_system_score_codex":0.00021670497,"about_ca_system_score_gemma":0.00015670511,"threshold_uncertainty_score":0.77373046},"labels":[],"label_agreement":null},{"id":"W2131203751","doi":"10.1111/apt.13150","title":"Reduced risk of relapse after long‐term nucleos(t)ide analogue consolidation therapy for chronic hepatitis B","year":2015,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Cilag; Norgine; Stichting voor Lever- en Maag-Darm Onderzoek; Gilead Sciences; Bristol-Myers Squibb","keywords":"Medicine; Discontinuation; Gastroenterology; Internal medicine; Hepatitis B; Immunology","score_opus":0.05458594192411146,"score_gpt":0.3561579222297373,"score_spread":0.3015719803056258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131203751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98542774,0.008685323,0.00017987096,0.0024429439,0.0011080174,0.0016846504,0.00029023035,0.000074587246,0.00010663487],"genre_scores_gemma":[0.96866405,0.019543925,0.0008222484,0.009692598,0.0004688177,0.0003638564,0.00024684845,0.000065763226,0.00013190886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980773,0.00027446248,0.0005635109,0.00037908638,0.00025929362,0.0004463696],"domain_scores_gemma":[0.9986415,0.00022297884,0.00030875424,0.00031752913,0.00032869235,0.00018052688],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003907938,0.00030129842,0.0005522271,0.00015571836,0.0001123777,0.000008989742,0.00015153062,0.00015612971,0.00038836294],"category_scores_gemma":[0.0000024811152,0.00027684317,0.0001812231,0.00017628529,0.0003720357,0.00013669672,0.00006471925,0.0002463403,0.000040289677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004239404,0.00080122513,0.8481823,0.00008020235,0.016035277,0.00006418348,0.0021117926,0.000016798533,0.1161883,0.0000136008275,0.0035350248,0.008731861],"study_design_scores_gemma":[0.02037774,0.006358565,0.56350136,0.000097799915,0.016339429,0.00007334959,0.00008961214,0.0006535926,0.37720996,0.0002958121,0.0144419,0.00056089554],"about_ca_topic_score_codex":0.0007847207,"about_ca_topic_score_gemma":0.00067244214,"teacher_disagreement_score":0.284681,"about_ca_system_score_codex":0.00040788457,"about_ca_system_score_gemma":0.00032095893,"threshold_uncertainty_score":0.99996835},"labels":[],"label_agreement":null},{"id":"W2134607569","doi":"10.1046/j.1365-2036.2004.01808.x","title":"High‐dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost‐effectiveness analysis","year":2004,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Université de Montréal; McGill University Health Centre","funders":"Jewish General Hospital; University of Alberta; Canadian Association of Gastroenterology; McGill University Health Centre; McMaster University; London Health Sciences Centre; American College of Gastroenterology; McGill University; Hamilton Health Sciences","keywords":"Medicine; Proton-pump inhibitor; Peptic; Cost effectiveness; Anesthesia; Intensive care medicine; Emergency medicine; Surgery; Internal medicine; Peptic ulcer","score_opus":0.020118363760193526,"score_gpt":0.294898503216929,"score_spread":0.27478013945673546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134607569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99459773,0.00012355004,0.000015201954,0.0015768115,0.000086927255,0.0035699704,0.000012438999,0.0000057299053,0.000011635256],"genre_scores_gemma":[0.99548703,0.0003848073,0.00019444957,0.0031043168,0.000014704497,0.0007317458,0.000068386005,0.000013585212,9.770982e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862915,0.00020185608,0.00026953194,0.00026323035,0.00033823328,0.00029801414],"domain_scores_gemma":[0.99948955,0.00018401958,0.00011370038,0.0001406186,0.00003404509,0.000038051534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035933062,0.00021474226,0.00034718323,0.00016694996,0.000091904556,0.00001403766,0.00010879943,0.000031477048,0.000012786786],"category_scores_gemma":[1.6460895e-7,0.00012525567,0.00006385611,0.0005099295,0.00008460668,0.00006453975,0.00002389538,0.00020451128,3.3580596e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089909206,0.0016925217,0.9794524,0.00005865474,0.013123745,0.0005225742,0.0011200405,0.00058263814,0.0019424238,0.000029278224,0.0000013715604,0.00057528313],"study_design_scores_gemma":[0.012902727,0.002308967,0.95904434,0.00017643401,0.0144794965,0.000014373011,0.00078556174,0.00002093343,0.010128694,0.000032878586,0.000009387698,0.00009622129],"about_ca_topic_score_codex":0.054397985,"about_ca_topic_score_gemma":0.022609903,"teacher_disagreement_score":0.031788085,"about_ca_system_score_codex":0.00044685087,"about_ca_system_score_gemma":0.00008629423,"threshold_uncertainty_score":0.9952249},"labels":[],"label_agreement":null},{"id":"W2137830660","doi":"10.1111/j.1365-2036.2005.02455.x","title":"Gastro‐oesophageal reflux is more prevalent in Western dyspeptics: a prospective comparison of British and South‐East Asian patients with dyspepsia","year":2005,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Universiti Malaya","keywords":"Medicine; Heartburn; Internal medicine; Gastroenterology; Epidemiology; Reflux; GERD; Helicobacter pylori; Dysphagia; Prospective cohort study; Regurgitation (circulation); Alcohol consumption; Disease; Surgery; Alcohol","score_opus":0.018265341007464596,"score_gpt":0.3094731846168642,"score_spread":0.2912078436093996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137830660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952711,0.0005662068,0.000029742396,0.0027755299,0.00005977516,0.0010642731,0.00010541375,0.000031004645,0.00009699397],"genre_scores_gemma":[0.9924385,0.000026986125,0.0018251641,0.005435213,0.00006023238,0.000031451975,0.000050163082,0.000031822026,0.0001004819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838907,0.00008354231,0.00044363138,0.0004051462,0.00028320376,0.00039539544],"domain_scores_gemma":[0.9993718,0.000026049955,0.00017163465,0.00016590202,0.00011444549,0.00015012753],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0000934905,0.00024101975,0.00047128103,0.00010430492,0.000050043465,0.000011117224,0.00010997352,0.00007614848,0.0001939991],"category_scores_gemma":[3.311866e-7,0.00025117348,0.000051722705,0.00014029675,0.0004023028,0.00012558307,0.00006495823,0.00036665474,0.000008732609],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001960503,0.0022593823,0.9840524,0.000096322154,0.0011317509,0.000027615624,0.007352882,0.000027262504,0.00074867706,8.187935e-7,0.00008022367,0.002262172],"study_design_scores_gemma":[0.0100399945,0.0031185402,0.9796568,0.00015513942,0.0023837157,0.0000633342,0.0026861734,0.00042914646,0.0012119072,0.000010283778,0.000093211725,0.00015175853],"about_ca_topic_score_codex":0.00005358608,"about_ca_topic_score_gemma":0.00020022997,"teacher_disagreement_score":0.008079492,"about_ca_system_score_codex":0.00012920558,"about_ca_system_score_gemma":0.000053460666,"threshold_uncertainty_score":0.99999404},"labels":[],"label_agreement":null},{"id":"W2140118261","doi":"10.1111/apt.12927","title":"Editorial: can we afford the new direct‐acting antivirals for treatment of genotype 1 hepatitis C?","year":2014,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Simeprevir; Sofosbuvir; Medicine; Telaprevir; Boceprevir; Ribavirin; Daclatasvir; Virology; Hepatitis C virus; Hepatitis C; Internal medicine; Virus","score_opus":0.04801404551805096,"score_gpt":0.3906910451965377,"score_spread":0.34267699967848675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140118261","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009457594,0.0043486618,0.000042731994,0.008167374,0.9814402,0.0031865297,0.0012258034,0.00008953819,0.00055339583],"genre_scores_gemma":[0.0019292125,0.045785654,0.00037018763,0.0018809787,0.94555926,0.0003733454,0.001270965,0.00021252102,0.002617859],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959106,0.00053548254,0.0008381878,0.00070100214,0.0011045013,0.00091025134],"domain_scores_gemma":[0.99409455,0.003918548,0.00055663346,0.0006544628,0.00050937466,0.0002664593],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006365677,0.0006707062,0.0014317972,0.0002237333,0.00028145913,0.000034193166,0.00050864776,0.0009285731,0.00036905636],"category_scores_gemma":[0.000012504427,0.0004955383,0.00047125938,0.00023352145,0.0003313082,0.00006474596,0.00011339184,0.0006055569,0.000032299682],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017316936,0.0004185899,0.00045544837,0.0001692894,0.01640443,0.000014299346,0.0007312566,0.00000381246,0.013616823,0.0000017454093,0.9318893,0.034563288],"study_design_scores_gemma":[0.005660475,0.0049813674,0.0000053315557,0.00008615791,0.015912646,0.0000013711214,0.00003300936,0.00008642169,0.047354873,0.000057698642,0.925478,0.00034265834],"about_ca_topic_score_codex":0.004515314,"about_ca_topic_score_gemma":0.00095728674,"teacher_disagreement_score":0.041436993,"about_ca_system_score_codex":0.0008811371,"about_ca_system_score_gemma":0.0019334311,"threshold_uncertainty_score":0.9997496},"labels":[],"label_agreement":null},{"id":"W2140819427","doi":"10.1111/j.1365-2036.2005.02391.x","title":"Meta‐analysis: proton‐pump inhibition in high‐risk patients with acute peptic ulcer bleeding","year":2005,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital","funders":"McGill University; Arthritis Society; AstraZeneca Canada; AstraZeneca","keywords":"Medicine; Proton-pump inhibitor; Placebo; Dosing; Internal medicine; Proton pump; Peptic; Gastroenterology; Population; Effective dose (radiation); Pharmacology; Peptic ulcer; Pathology; Nuclear medicine","score_opus":0.07452722596868856,"score_gpt":0.36492640941389043,"score_spread":0.2903991834452019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140819427","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0339812,0.9584135,0.000010015325,0.0006368298,0.00021208034,0.0063012247,0.000306351,0.00009891561,0.000039908755],"genre_scores_gemma":[0.007070112,0.98410803,0.0011799781,0.0028801407,0.0002359657,0.0026573944,0.001658448,0.00012973475,0.00008017848],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9964946,0.000390476,0.0010142926,0.00089929363,0.0004943036,0.00070703914],"domain_scores_gemma":[0.99820876,0.00028494452,0.0007899693,0.0003553981,0.00014426188,0.00021668819],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003213749,0.00095325743,0.0036262604,0.00088472565,0.00013526661,0.000032937936,0.0001524637,0.00026278882,0.0010148936],"category_scores_gemma":[2.2589103e-7,0.0006437944,0.0013062132,0.0010389149,0.00014749377,0.00015003436,0.00009709318,0.0009837731,0.000091239854],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029953654,0.003192167,0.019509448,0.0010805923,0.9619965,0.00044889768,0.00008667288,0.000039352697,0.000005586242,0.000002742366,0.000048289305,0.013290235],"study_design_scores_gemma":[0.0041221245,0.0018531546,0.0010021733,0.0008623779,0.9604794,0.00010337506,0.00001439776,0.00002081775,0.00009948196,0.00000523524,0.030987935,0.00044955942],"about_ca_topic_score_codex":0.00012784063,"about_ca_topic_score_gemma":0.000024066981,"teacher_disagreement_score":0.030939646,"about_ca_system_score_codex":0.0006838904,"about_ca_system_score_gemma":0.00018890717,"threshold_uncertainty_score":0.9998983},"labels":[],"label_agreement":null},{"id":"W2146233339","doi":"10.1111/j.1365-2036.2006.03048.x","title":"Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy","year":2006,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University; University of Calgary","funders":"","keywords":"Ursodeoxycholic acid; Medicine; Methotrexate; Internal medicine; Primary biliary cirrhosis; Gastroenterology; Adverse effect; Hepatology; Biliary cirrhosis; Asymptomatic; Cholestasis; Disease; Autoimmune disease","score_opus":0.052529802229545806,"score_gpt":0.3342603387528234,"score_spread":0.2817305365232776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146233339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97461396,0.014707217,0.00007151053,0.0064558075,0.00037849203,0.003347997,0.0003193123,0.000058562506,0.000047139096],"genre_scores_gemma":[0.94243157,0.011184999,0.00083136937,0.044053823,0.00028140692,0.0005888463,0.00040476798,0.000083062645,0.00014017767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979578,0.0003356293,0.0005338929,0.0004074052,0.00028946775,0.00047575933],"domain_scores_gemma":[0.9982594,0.0006071279,0.000257772,0.00055719155,0.00017515637,0.0001433303],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021143007,0.00040642166,0.0006739828,0.00016663359,0.0002339341,0.00001538662,0.00032198522,0.00012034427,0.0002135562],"category_scores_gemma":[5.2816824e-7,0.00026646917,0.0003898209,0.00031719005,0.0002621498,0.00007845833,0.000056554472,0.0001371008,0.000008967955],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01683132,0.009365057,0.13670267,0.00010214502,0.021457685,0.000007860708,0.0016554851,0.000026827773,0.7724298,0.0000132182395,0.007189933,0.03421799],"study_design_scores_gemma":[0.019851206,0.0061234664,0.46056896,0.00006112176,0.007424702,0.0000069235266,0.00032676876,0.00022928434,0.47336912,0.00015413064,0.031471334,0.00041297488],"about_ca_topic_score_codex":0.00022749313,"about_ca_topic_score_gemma":0.000001949371,"teacher_disagreement_score":0.3238663,"about_ca_system_score_codex":0.00032713503,"about_ca_system_score_gemma":0.00011728003,"threshold_uncertainty_score":0.9999788},"labels":[],"label_agreement":null},{"id":"W2147173269","doi":"10.1111/apt.13384","title":"Editorial: towards extended acid suppression - the search continues","year":2015,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Pfizer Pharmaceuticals","keywords":"GERD; Medicine; Omeprazole; Proton-pump inhibitor; Regimen; Medical prescription; Internal medicine; Gastric acid; Helicobacter pylori; Lansoprazole; Disease; Gastroenterology; Intensive care medicine; Reflux; Pharmacotherapy; Pharmacology; Stomach","score_opus":0.035312135707601826,"score_gpt":0.3841122829704825,"score_spread":0.34880014726288067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147173269","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0042682025,0.0037066648,0.0000025767756,0.0017975005,0.98751736,0.0013456335,0.000522619,0.00015379164,0.00068562565],"genre_scores_gemma":[0.016511789,0.00214222,0.000118153126,0.0033298936,0.9715148,0.00017561739,0.0027792673,0.0001573101,0.0032709246],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99515665,0.00062753935,0.0005742737,0.00074829836,0.001990319,0.0009029255],"domain_scores_gemma":[0.9974829,0.00045951892,0.0002555991,0.00067922816,0.0007372218,0.0003855405],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00081273477,0.0007401965,0.0009463386,0.00014867717,0.00028739375,0.00006130646,0.0006475756,0.0011279752,0.0006682206],"category_scores_gemma":[0.00000411443,0.00047213642,0.000315093,0.00018366256,0.00045052328,0.0001224834,0.0003482375,0.0022589923,0.00023044371],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015164241,0.0008017746,0.00021420563,0.000055162098,0.014770345,0.00037754772,0.00040528798,8.333848e-7,0.0067881807,6.6124073e-7,0.97356844,0.0015011544],"study_design_scores_gemma":[0.0073883496,0.0018519955,0.00015154952,0.000052775627,0.023840092,0.000023010538,0.00009387981,0.000012321788,0.025836386,0.000050449617,0.9404822,0.00021697047],"about_ca_topic_score_codex":0.00008930504,"about_ca_topic_score_gemma":0.0000025870522,"teacher_disagreement_score":0.033086203,"about_ca_system_score_codex":0.0005488786,"about_ca_system_score_gemma":0.0012686108,"threshold_uncertainty_score":0.999773},"labels":[],"label_agreement":null},{"id":"W2160197471","doi":"10.1111/j.1365-2036.2008.03924.x","title":"Proton pump inhibitors increase significantly the risk of<i>Clostridium difficile</i>infection in a low‐endemicity, non‐outbreak hospital setting","year":2008,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Clostridium difficile; Internal medicine; Proton-pump inhibitor; Logistic regression; Antibiotics; Retrospective cohort study; Outbreak; Epidemiology; Univariate analysis; Intensive care medicine; Multivariate analysis; Microbiology","score_opus":0.01868682648674923,"score_gpt":0.2972378971292758,"score_spread":0.27855107064252654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160197471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916721,0.00052124774,0.000013882939,0.0031517043,0.00064723106,0.0034781673,0.00010949368,0.000087450084,0.00031871058],"genre_scores_gemma":[0.99030256,0.006232095,0.000044450873,0.0021668097,0.00066363637,0.00033701703,0.00009498654,0.00007704476,0.00008142065],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996146,0.00059378345,0.0009721695,0.00064780965,0.00074167736,0.000898548],"domain_scores_gemma":[0.998059,0.0005545582,0.00041773953,0.00050033507,0.00022046777,0.00024792453],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008910896,0.0004946682,0.0006713474,0.00035618062,0.00040108484,0.000016466154,0.00033676083,0.00029147384,0.00026216396],"category_scores_gemma":[0.000008241519,0.00038788517,0.00034794866,0.00089896854,0.0006989581,0.00014159388,0.0002657283,0.0014972467,0.000048520073],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018155988,0.003475336,0.4136602,0.00019286115,0.0035062765,0.00033512944,0.0017095539,0.00021774152,0.57343316,0.0000022873298,0.0008240247,0.00082781346],"study_design_scores_gemma":[0.005353412,0.0014974623,0.030353237,0.00010906743,0.0032699313,0.00018220312,0.00043739998,0.0019467537,0.95547307,0.000014609001,0.0009889466,0.00037393224],"about_ca_topic_score_codex":0.0029855422,"about_ca_topic_score_gemma":0.000047407237,"teacher_disagreement_score":0.38330698,"about_ca_system_score_codex":0.0004698031,"about_ca_system_score_gemma":0.00053362566,"threshold_uncertainty_score":0.9998573},"labels":[],"label_agreement":null},{"id":"W2160232557","doi":"10.1111/j.1365-2036.2012.05141.x","title":"The safety and efficacy of antitumour necrosis factor‐alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series","year":2012,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Inflammatory bowel disease; Liver transplantation; Tumor necrosis factor alpha; Inflammatory Bowel Diseases; Transplantation; Gastroenterology; Necrosis; Disease; Internal medicine","score_opus":0.020906884925975516,"score_gpt":0.2984293593391145,"score_spread":0.277522474413139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160232557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910474,0.00607056,0.0000035000191,0.00094702037,0.00032096874,0.0011945724,0.00039417978,0.0000152269595,0.000006599925],"genre_scores_gemma":[0.9810124,0.014520894,0.00003722299,0.0041400786,0.000076907716,0.000036201996,0.00012523541,0.000021413662,0.000029666928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901485,0.00014402697,0.0002963268,0.00013719739,0.00011394652,0.00029364508],"domain_scores_gemma":[0.9992364,0.00024013882,0.000101079444,0.00014866609,0.000109887435,0.00016383218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013177046,0.00017392647,0.00018858157,0.00005153574,0.00023325073,0.00000922871,0.00008101635,0.00004973495,0.000081150545],"category_scores_gemma":[6.412264e-7,0.00012742291,0.000092291724,0.00006012861,0.000231645,0.0002462517,0.000027364891,0.00012411842,0.0000015312859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027215391,0.0014392158,0.9568922,0.00017784821,0.0022626081,0.00009461806,0.0040648314,0.0000031652864,0.0052528186,0.000020503456,0.00003211933,0.0025446883],"study_design_scores_gemma":[0.010579371,0.0007122783,0.97670394,0.000022255983,0.0028802692,0.00005787987,0.00020679856,0.00003889266,0.006862792,0.0000061130904,0.0017915743,0.00013785974],"about_ca_topic_score_codex":0.000085969994,"about_ca_topic_score_gemma":0.000007570083,"teacher_disagreement_score":0.019811723,"about_ca_system_score_codex":0.000062617044,"about_ca_system_score_gemma":0.00009864536,"threshold_uncertainty_score":0.51961553},"labels":[],"label_agreement":null},{"id":"W2160341742","doi":"10.1111/j.1365-2036.2007.03271.x","title":"Symptom overlap in patients with upper gastrointestinal complaints in the Canadian confirmatory acid suppression test (CAST) study: further psychometric validation of the reflux disease questionnaire","year":2007,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal General Hospital; McMaster University; AstraZeneca (Canada); McGill University Health Centre; University of Alberta","funders":"AstraZeneca","keywords":"Heartburn; Esomeprazole; Medicine; Internal medicine; Proton-pump inhibitor; Reflux; Gastroenterology; Cronbach's alpha; Physical therapy; Disease; Psychometrics; Clinical psychology","score_opus":0.01727000783715297,"score_gpt":0.3055568731328222,"score_spread":0.2882868652956692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160341742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970784,0.000083946405,0.0000035076591,0.00081984187,0.00020781244,0.0016759408,0.000044925942,0.000011271362,0.00007432495],"genre_scores_gemma":[0.9957564,0.000004120658,0.00005994066,0.003981412,0.00003608333,0.000038811184,0.000083873325,0.00002461242,0.000014764731],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981465,0.00030087467,0.00038646918,0.00027147215,0.00047021994,0.00042450643],"domain_scores_gemma":[0.9991128,0.00013711744,0.00015846359,0.00030349332,0.00010750925,0.00018063972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004142651,0.00023603028,0.00023620069,0.00036868075,0.00014335282,0.000011361,0.0002300419,0.000047286223,0.00010779224],"category_scores_gemma":[0.0000029786133,0.00013793116,0.00005411713,0.0005916028,0.00017849756,0.000091655435,0.000032019278,0.00035394813,0.00000932815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008147949,0.0034880564,0.993573,0.000015216844,0.00036961117,0.00018131967,0.00072562543,0.00001566624,0.000465294,0.0000021694473,0.0000275661,0.0003216442],"study_design_scores_gemma":[0.007836645,0.0012730749,0.9878348,0.000105983134,0.0012337686,0.000025324416,0.00027271337,0.000021179007,0.0012935343,0.000009109598,0.000021731776,0.00007210324],"about_ca_topic_score_codex":0.0017100592,"about_ca_topic_score_gemma":0.0032485116,"teacher_disagreement_score":0.00702185,"about_ca_system_score_codex":0.00042419197,"about_ca_system_score_gemma":0.00019931847,"threshold_uncertainty_score":0.5624669},"labels":[],"label_agreement":null},{"id":"W2161723853","doi":"10.1111/apt.13001","title":"A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity","year":2014,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":235,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"UCB Pharma; Genentech; Atlantic Healthcare; Relypsa; Astellas Pharma; ActoGeniX; Shire; Bristol-Myers Squibb; Eli Lilly and Company; Orexigen Therapeutics; Biogen; Celgene; Therakos; Novo Nordisk; Teva Pharmaceutical Industries; Gilead Sciences; Takeda Oncology; Tillotts Pharma; Amgen; Pfizer; Ironwood Pharmaceuticals, Incorporated","keywords":"Medicine; Receiver operating characteristic; Crohn's disease; Internal medicine; Disease; Abdominal pain; Methotrexate; Physical therapy; Gastroenterology","score_opus":0.033008522508965084,"score_gpt":0.34303526685302105,"score_spread":0.31002674434405597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161723853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917882,0.0001932876,0.0062432606,0.00050882937,0.00027061065,0.0008943958,0.00005608879,0.000008080126,0.000037210273],"genre_scores_gemma":[0.9970364,0.000035507954,0.0006432846,0.001871316,0.000068342306,0.00025065916,0.000052347714,0.000018690089,0.000023436736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837476,0.00032128286,0.00050964276,0.00030281293,0.00026432073,0.00022715553],"domain_scores_gemma":[0.998618,0.000088141634,0.0005071166,0.0004933335,0.00022222729,0.000071163515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071350095,0.0001940376,0.00024867494,0.000051983017,0.00021268682,0.000007240523,0.00031390577,0.00006198343,0.000027567952],"category_scores_gemma":[0.0000032545797,0.00012482645,0.00028437367,0.00013546727,0.00024732735,0.000005343909,0.00012740416,0.000102016034,3.135307e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025776753,0.00086743466,0.60797197,0.00005562899,0.063809134,0.000009455883,0.00055985653,0.002221915,0.31919008,0.000088475485,0.00013852924,0.0025098221],"study_design_scores_gemma":[0.0008341035,0.00014209557,0.89461714,0.0000025871493,0.017134229,5.251099e-7,0.000103180304,0.00168318,0.08319133,0.00003802867,0.0021107493,0.00014285889],"about_ca_topic_score_codex":0.000006403677,"about_ca_topic_score_gemma":0.000038212707,"teacher_disagreement_score":0.28664514,"about_ca_system_score_codex":0.00005412767,"about_ca_system_score_gemma":0.00022956617,"threshold_uncertainty_score":0.5090275},"labels":[],"label_agreement":null},{"id":"W2165097785","doi":"10.1111/apt.13126","title":"Letter: reversibility of hepatic fibrosis and immunosuppression withdrawal in patients with autoimmune hepatitis/primary biliary cirrhosis overlap syndrome – author's reply","year":2015,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Medicine; Primary biliary cirrhosis; Overlap syndrome; Autoimmune hepatitis; Azathioprine; Immunosuppression; Cirrhosis; Liver transplantation; Liver disease; Fibrosis; Hepatitis; Disease; Gastroenterology; Immunology; Internal medicine; Transplantation","score_opus":0.014894395734417918,"score_gpt":0.26311077329027033,"score_spread":0.2482163775558524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165097785","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92332643,0.0032601892,0.0000013505659,0.07020075,0.0007735269,0.0017538359,0.0005633129,0.000059633163,0.000060970742],"genre_scores_gemma":[0.33006504,0.0011242582,0.00040232195,0.6637556,0.00022834014,0.000084859494,0.003707068,0.00013597083,0.00049655384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959763,0.00082205946,0.0009644782,0.0008222423,0.00077650056,0.00063836796],"domain_scores_gemma":[0.99769294,0.00027951165,0.0006122711,0.0010002736,0.0002607785,0.00015421968],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041151347,0.0006964725,0.0014192528,0.00035748002,0.00013611322,0.000019815061,0.00037864936,0.000576296,0.00037496546],"category_scores_gemma":[0.0000012789449,0.00059313996,0.00020985355,0.00033179618,0.0006779685,0.00031769497,0.0004086617,0.0018823262,0.0000083901405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036491097,0.0014866987,0.8257687,0.0011733078,0.008030611,0.00047135854,0.00043395092,0.0000019059561,0.002152901,1.18899514e-7,0.1564799,0.00035141196],"study_design_scores_gemma":[0.010030808,0.003924508,0.93209594,0.0008258262,0.017583843,0.00007367184,0.000041228937,0.00005575877,0.0007396183,0.0000326888,0.033925965,0.0006701278],"about_ca_topic_score_codex":0.0018174611,"about_ca_topic_score_gemma":0.000003844917,"teacher_disagreement_score":0.59355485,"about_ca_system_score_codex":0.0006939154,"about_ca_system_score_gemma":0.00040231764,"threshold_uncertainty_score":0.999652},"labels":[],"label_agreement":null},{"id":"W2165589813","doi":"10.1111/j.1365-2036.2008.03864.x","title":"Small bowel polyps and tumours: endoscopic detection and treatment by double‐balloon enteroscopy","year":2008,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Enteroscopy; Double-balloon enteroscopy; Peutz–Jeghers syndrome; Endoscopy; Gastroenterology; Incidence (geometry); Radiology; Internal medicine","score_opus":0.0541896166029542,"score_gpt":0.3021872329136753,"score_spread":0.24799761631072106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165589813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911112,0.004661906,0.000019816162,0.0030766,0.00029684324,0.00067133945,0.000019448664,0.00007151014,0.000071324626],"genre_scores_gemma":[0.98418784,0.009179463,0.0006666486,0.00542012,0.00012017312,0.00012079851,0.000042664367,0.00003148155,0.00023078022],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988765,0.000051007337,0.00022547167,0.00038590323,0.0001103585,0.00035073154],"domain_scores_gemma":[0.99949133,0.00007861368,0.00008049487,0.000114424394,0.000028758464,0.00020638209],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000050261744,0.0002988649,0.00031164679,0.00008197744,0.00021489804,0.000014035413,0.00004461899,0.00006704847,0.00007870908],"category_scores_gemma":[9.14523e-8,0.00024864936,0.000057678157,0.000060847557,0.00021038437,0.00006106599,0.0000368256,0.00013914616,0.000010532405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008814793,0.0013461933,0.4928402,0.000016267433,0.0031803546,0.00017678447,0.00047903418,7.787751e-7,0.49894378,0.0000024294152,0.00017776455,0.0019549117],"study_design_scores_gemma":[0.019212408,0.009312736,0.118916504,0.000053482257,0.00996061,0.0013751723,0.00017692828,0.00013109585,0.83812207,0.000009022032,0.002504387,0.00022555822],"about_ca_topic_score_codex":0.00035942462,"about_ca_topic_score_gemma":0.00002717666,"teacher_disagreement_score":0.37392372,"about_ca_system_score_codex":0.00019677247,"about_ca_system_score_gemma":0.0000325643,"threshold_uncertainty_score":0.9999966},"labels":[],"label_agreement":null},{"id":"W2167285064","doi":"10.1111/j.1365-2036.2004.02215.x","title":"Outcomes in elderly patients following surgery for colorectal cancer in the veterans affairs health care system","year":2004,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Frailty in Older Adults","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Colorectal cancer; Veterans Affairs; Cancer; Proportional hazards model; Cohort; Surgery; Cohort study; Internal medicine","score_opus":0.030414393614063638,"score_gpt":0.3538086806408653,"score_spread":0.3233942870268017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167285064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758742,0.0021748221,0.000012501823,0.017088678,0.002049743,0.0025773852,0.00013426493,0.000051938277,0.0000364903],"genre_scores_gemma":[0.978519,0.00017800943,0.00013794679,0.020225206,0.0001036525,0.0006282121,0.00015702294,0.000042564527,0.000008355001],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979799,0.00024591232,0.00055908714,0.00033530052,0.00027381702,0.0006059999],"domain_scores_gemma":[0.999071,0.0005095937,0.00012786302,0.00016265521,0.000048430476,0.00008045475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003496608,0.00026478272,0.0005883741,0.00019478958,0.00011917954,0.000011281501,0.00019003097,0.00010825677,0.000016696287],"category_scores_gemma":[7.392418e-7,0.00020714171,0.0002226654,0.00024428873,0.00006417327,0.000096307995,0.000024096613,0.00030735924,0.0000043106306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012291907,0.0012470349,0.94892603,0.00044954338,0.0037904766,0.00016183259,0.03313279,0.00030717245,0.0026243248,0.000011181469,0.00038500124,0.007735406],"study_design_scores_gemma":[0.07003777,0.005844422,0.83351594,0.0012601052,0.0072435746,0.00006887072,0.061660722,0.0002752165,0.015753143,0.000039930692,0.003161311,0.0011390146],"about_ca_topic_score_codex":0.0013407387,"about_ca_topic_score_gemma":0.002086911,"teacher_disagreement_score":0.11541012,"about_ca_system_score_codex":0.0013554533,"about_ca_system_score_gemma":0.00036008985,"threshold_uncertainty_score":0.8446994},"labels":[],"label_agreement":null},{"id":"W2167977552","doi":"10.1111/j.1365-2036.2008.03904.x","title":"Clinical trial: intravenous pantoprazole vs. ranitidine for the prevention of peptic ulcer rebleeding: a multicentre, multinational, randomized trial","year":2008,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; McGill University","funders":"","keywords":"Pantoprazole; Medicine; Ranitidine; Internal medicine; Gastroenterology; Randomized controlled trial; Esophagogastroduodenoscopy; Endoscopy; Omeprazole","score_opus":0.12964256957333198,"score_gpt":0.41701953593735747,"score_spread":0.2873769663640255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167977552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789017,0.0010416085,0.00041070092,0.0071526943,0.002006264,0.010349063,0.000025996718,0.000053198874,0.000058791815],"genre_scores_gemma":[0.98486596,0.0040491186,0.00388535,0.0045533064,0.0010772456,0.0011098256,0.00011750825,0.000042175045,0.00029950286],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973473,0.0004063558,0.0011975538,0.00035815677,0.00032815186,0.0003624663],"domain_scores_gemma":[0.99408394,0.004738196,0.00056437386,0.00020398718,0.00029387217,0.00011560153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015206068,0.0002753325,0.0009839599,0.00009882649,0.00024594658,0.000008849468,0.00016786801,0.00011260742,0.00032400226],"category_scores_gemma":[0.000027532396,0.0001842952,0.0007005837,0.00012516991,0.00051575556,0.00006718139,0.00004653685,0.00027449013,0.000011069556],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9716748,0.0074769873,0.0019678886,0.000036164787,0.013176581,0.000025068326,0.0003786484,0.000028116261,0.0029235848,0.000052859472,0.00094850414,0.0013108179],"study_design_scores_gemma":[0.9482712,0.009126404,0.0011231847,0.000058751928,0.029601233,0.00009366354,0.00013082736,0.0037185827,0.006076143,0.00006793348,0.0015954851,0.00013659321],"about_ca_topic_score_codex":0.000045062847,"about_ca_topic_score_gemma":0.0000027792994,"teacher_disagreement_score":0.023403581,"about_ca_system_score_codex":0.00009748493,"about_ca_system_score_gemma":0.00018900399,"threshold_uncertainty_score":0.75153404},"labels":[],"label_agreement":null},{"id":"W2170684362","doi":"10.1111/apt.13465","title":"Combined ursodeoxycholic acid (<scp>UDCA</scp>) and fenofibrate in primary biliary cholangitis patients with incomplete<scp>UDCA</scp>response may improve outcomes","year":2015,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; Toronto Western Hospital; Public Health Ontario; Centre for Global Health Research; University of Toronto; University Health Network","funders":"Medical Research Council","keywords":"Ursodeoxycholic acid; Fenofibrate; Medicine; Gastroenterology; Internal medicine; Primary (astronomy)","score_opus":0.024364500367877427,"score_gpt":0.284808488986843,"score_spread":0.2604439886189656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170684362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99300116,0.0019574242,0.000006188304,0.0015793672,0.00082042685,0.0017702476,0.00032620417,0.00014192908,0.0003970465],"genre_scores_gemma":[0.95568866,0.00050386175,0.00040699716,0.041816086,0.00011458475,0.00012409469,0.0005820451,0.00011393072,0.0006497729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99635893,0.00084803347,0.00062026264,0.00068537786,0.00057236536,0.00091504026],"domain_scores_gemma":[0.9973959,0.000852295,0.00028753973,0.0005848687,0.00022814694,0.00065126916],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006401489,0.0006381027,0.0008800597,0.00039130446,0.00021185956,0.000064523454,0.00039945406,0.00023957223,0.000047970476],"category_scores_gemma":[0.000009577457,0.00052786927,0.00014273645,0.00044184146,0.00050705,0.0005302634,0.0003977933,0.0007199828,0.000060078182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028554439,0.0024909473,0.9158609,0.00008556078,0.004611546,0.00015680237,0.0020714512,0.0000047858175,0.06938391,0.000004308634,0.0014974128,0.0009769512],"study_design_scores_gemma":[0.025805926,0.0037847469,0.93934727,0.0000488741,0.0042548375,0.00002914903,0.0008031537,0.00011355726,0.02070144,0.0000799406,0.0048438157,0.00018728424],"about_ca_topic_score_codex":0.0002342442,"about_ca_topic_score_gemma":0.000007872865,"teacher_disagreement_score":0.04868247,"about_ca_system_score_codex":0.0004309043,"about_ca_system_score_gemma":0.00038335292,"threshold_uncertainty_score":0.9997173},"labels":[],"label_agreement":null},{"id":"W2172519764","doi":"10.1111/apt.13460","title":"A validated web‐based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variables","year":2015,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Agency for Healthcare Research and Quality","keywords":"Medicine; Serology; Crohn's disease; Disease; Crohn disease; Internal medicine; Immunology; Antibody","score_opus":0.04304942035667971,"score_gpt":0.3442491144141748,"score_spread":0.3011996940574951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172519764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941303,0.00015631974,0.0003720463,0.002445416,0.0007829612,0.0012224038,0.00075903843,0.00009353965,0.000037958824],"genre_scores_gemma":[0.885401,0.000056620833,0.0015216253,0.111645676,0.00022367739,0.00023122858,0.00079570204,0.00006459014,0.000059845093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99678236,0.00090949,0.0005933129,0.00081530365,0.0003305118,0.00056899013],"domain_scores_gemma":[0.9981527,0.00013692719,0.00018228166,0.0006106342,0.0001618613,0.0007556246],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005142659,0.00047253803,0.00035786894,0.0001316177,0.00015626897,0.00005326456,0.00044551175,0.0002638416,0.00014258194],"category_scores_gemma":[0.000012317853,0.00042764083,0.00015504382,0.00014773659,0.0002892647,0.000011805992,0.00020258849,0.00022297488,0.00003219324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011330287,0.0018355942,0.9099923,0.000044989585,0.003985847,0.0011050635,0.000055407567,0.009126813,0.054609645,0.000010065474,0.007542082,0.00036192904],"study_design_scores_gemma":[0.015243068,0.0018265262,0.9387536,0.000019780562,0.00586912,0.0000050476897,0.000028570134,0.015921514,0.0073370812,0.00007013952,0.014061255,0.0008642829],"about_ca_topic_score_codex":0.0000058419846,"about_ca_topic_score_gemma":0.000005443462,"teacher_disagreement_score":0.10920026,"about_ca_system_score_codex":0.000051223422,"about_ca_system_score_gemma":0.00059022434,"threshold_uncertainty_score":0.99981755},"labels":[],"label_agreement":null},{"id":"W2222377009","doi":"10.1111/apt.13516","title":"Patients with large‐duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without <scp>IBD</scp>","year":2016,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Medicine; Primary sclerosing cholangitis; Gastroenterology; Internal medicine; Liver transplantation; Inflammatory bowel disease; Ulcerative colitis; Concomitant; Liver biopsy; Liver disease; Biopsy; Transplantation; Disease","score_opus":0.033349589942519756,"score_gpt":0.30715383371060057,"score_spread":0.2738042437680808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2222377009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99504125,0.0005634068,0.00007488622,0.0017330488,0.00019286515,0.001466709,0.0007131871,0.00008768769,0.0001269439],"genre_scores_gemma":[0.95698583,0.0005166936,0.00046821107,0.040557098,0.00019007812,0.00010237832,0.0002627625,0.00008452547,0.0008324269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978651,0.0002801269,0.00031086113,0.00051382557,0.00036816078,0.0006619495],"domain_scores_gemma":[0.99857926,0.00024301106,0.00018306074,0.00034397573,0.00017333054,0.0004773843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013588001,0.00043691386,0.00050566596,0.00010564273,0.00033890057,0.000048710663,0.00015732592,0.000084660336,0.0002988139],"category_scores_gemma":[0.0000011660219,0.00024323507,0.00007968163,0.00011865398,0.0004940109,0.00045073885,0.0001464594,0.00028585512,0.000015229754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006261802,0.0012567047,0.9823092,0.000086188666,0.0050786417,0.00026703364,0.00096119696,2.1868225e-7,0.0017066929,0.0000037456848,0.000545162,0.0015234121],"study_design_scores_gemma":[0.018055025,0.0015656163,0.9656635,0.000240147,0.009223083,0.000026644182,0.00038626196,0.000020076772,0.001613412,0.000014362345,0.0029797326,0.00021213264],"about_ca_topic_score_codex":0.00004906756,"about_ca_topic_score_gemma":0.000025645968,"teacher_disagreement_score":0.038824048,"about_ca_system_score_codex":0.00021018538,"about_ca_system_score_gemma":0.00021163515,"threshold_uncertainty_score":0.9918839},"labels":[],"label_agreement":null},{"id":"W2232215721","doi":"10.1111/apt.13513","title":"Prevalence, symptom patterns and management of episodic diarrhoea in the community: a population‐based survey in 11 countries","year":2016,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Population; Environmental health; Diarrhea; Developing country; MEDLINE; Family medicine; Internal medicine; Economic growth","score_opus":0.049565444185520516,"score_gpt":0.3279554855285897,"score_spread":0.2783900413430692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2232215721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99337405,0.00027527608,0.00005001687,0.00552465,0.0000634744,0.0006176205,0.00006372844,0.000010535109,0.00002066397],"genre_scores_gemma":[0.99013925,0.001038991,0.000080878315,0.008624771,0.0000075804924,0.000039710187,0.000043248154,0.000009054987,0.000016534852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829054,0.000925678,0.00029440544,0.00013646911,0.00014526705,0.00020764937],"domain_scores_gemma":[0.99888724,0.00077237305,0.00007833418,0.00020308993,0.000026523414,0.00003241874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009286365,0.00012770174,0.00019715575,0.000117015115,0.000054972752,0.000004470217,0.00015762067,0.00003854499,0.00011947353],"category_scores_gemma":[8.4090067e-7,0.00008426571,0.00002842881,0.00014283035,0.00018105848,0.00005885184,0.000049366394,0.00016440921,0.0000019854124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004900354,0.00054399343,0.99717534,0.0002785948,0.00028309092,0.000016271464,0.0003499078,0.000006461463,0.00031265258,0.000024539233,0.000014339143,0.00050478213],"study_design_scores_gemma":[0.0038281188,0.0003598745,0.9937065,0.0002533323,0.0008477085,0.000010049889,0.0003622053,0.000060732484,0.00035562454,0.00009743001,0.000051291485,0.0000671026],"about_ca_topic_score_codex":0.0019969607,"about_ca_topic_score_gemma":0.0018947823,"teacher_disagreement_score":0.003468802,"about_ca_system_score_codex":0.00005735585,"about_ca_system_score_gemma":0.000020997817,"threshold_uncertainty_score":0.34362558},"labels":[],"label_agreement":null},{"id":"W2267782951","doi":"10.1111/apt.13519","title":"Editorial: fenofibrate as second‐line therapy in high risk <scp>PBC</scp> – more answers or more questions? Authors' reply","year":2016,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research; Public Health Ontario; University of Toronto; University Health Network","funders":"Pfizer","keywords":"Fenofibrate; Medicine; Internal medicine; First line therapy; Line (geometry)","score_opus":0.019310950325730405,"score_gpt":0.34713241639515924,"score_spread":0.32782146606942886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2267782951","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1685518,0.0043930127,0.0000049249097,0.0034786363,0.8186556,0.0018677897,0.0026956243,0.00026678474,0.00008582295],"genre_scores_gemma":[0.0018373434,0.049130686,0.00016536824,0.018259,0.91883063,0.00031596774,0.0031480482,0.00031696004,0.007996022],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99372643,0.001278534,0.0012548637,0.0012945578,0.001213527,0.001232064],"domain_scores_gemma":[0.9940082,0.0026941677,0.0009063428,0.0011776385,0.0006182822,0.00059539184],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0010182589,0.0012165823,0.0015555711,0.0005240145,0.00038921903,0.00007576793,0.00088842446,0.001767308,0.0024258182],"category_scores_gemma":[0.000029886367,0.000915853,0.00046701467,0.00051774917,0.0007142299,0.0004036656,0.00028912054,0.0031838592,0.00023412658],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005176294,0.0014536873,0.0024190426,0.0001289932,0.014647858,0.0002751177,0.0010161577,0.0000073934852,0.008518725,0.0000028126976,0.9654427,0.0009112119],"study_design_scores_gemma":[0.015249951,0.004139971,0.001282638,0.00024752243,0.011706975,0.00001901794,0.0004424831,0.00003201993,0.0082693165,0.00021303631,0.95792305,0.00047402288],"about_ca_topic_score_codex":0.0017801756,"about_ca_topic_score_gemma":0.000037948983,"teacher_disagreement_score":0.16671446,"about_ca_system_score_codex":0.00082146854,"about_ca_system_score_gemma":0.002172629,"threshold_uncertainty_score":0.9995286},"labels":[],"label_agreement":null},{"id":"W2276029718","doi":"10.1111/apt.13568","title":"A comparison of the gut microbiome between long‐term users and non‐users of proton pump inhibitors","year":2016,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Janssen Canada; Canadian Institutes of Health Research; Takeda Canada; AbbVie Canada; Science Foundation Ireland; Mylan; Amgen","keywords":"Bacteroidetes; Firmicutes; Microbiome; Confounding; Gut flora; UniFrac; Medicine; Beta diversity; Alpha diversity; Population; Proton-pump inhibitor; Biology; Internal medicine; Bioinformatics; Immunology; Environmental health; Ecology; Species diversity; Genetics; Bacteria; Biodiversity","score_opus":0.05505738470253866,"score_gpt":0.38287447415895604,"score_spread":0.32781708945641735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2276029718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99203557,0.00059935945,0.0000054771376,0.00536659,0.0002486957,0.001590843,0.00009101424,0.000017473309,0.000044975888],"genre_scores_gemma":[0.99817073,0.0005657187,0.000025404008,0.00083277124,0.0001603534,0.00004338979,0.00001660075,0.000033165077,0.00015188256],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982619,0.00014786432,0.00056388864,0.00030257902,0.0003240337,0.00039970747],"domain_scores_gemma":[0.9989612,0.00021425214,0.00024823926,0.00032801522,0.00011518726,0.00013308911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022836385,0.00023250237,0.00053374545,0.00015600854,0.00008882006,0.0000055657674,0.0002685604,0.00015124491,0.00020154042],"category_scores_gemma":[7.809179e-7,0.00014211344,0.00015421853,0.00027999256,0.0007875942,0.000060347622,0.00022125762,0.0002672439,0.0000079898955],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034972167,0.00027870218,0.4386696,0.00010848276,0.0018960857,0.0000032312919,0.00028756203,3.2764098e-7,0.55686754,4.1903212e-7,0.00013539194,0.0014029534],"study_design_scores_gemma":[0.0036398787,0.0007756811,0.117800616,0.0001382028,0.0031314741,0.000011180355,0.00012514701,0.000007932758,0.873534,0.0000030935407,0.00070883957,0.0001239539],"about_ca_topic_score_codex":0.000057810645,"about_ca_topic_score_gemma":0.000006203919,"teacher_disagreement_score":0.32086897,"about_ca_system_score_codex":0.00013424027,"about_ca_system_score_gemma":0.00015669505,"threshold_uncertainty_score":0.5795218},"labels":[],"label_agreement":null},{"id":"W2277236411","doi":"10.1111/apt.13546","title":"<i>Clostridium difficile</i> associated risk of death score (<scp>CARDS</scp>): a novel severity score to predict mortality among hospitalised patients with <i>C. difficile</i> infection","year":2016,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; University of Calgary","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health","keywords":"Medicine; Clostridium difficile; Internal medicine; Logistic regression; Odds ratio; Framingham Risk Score; Cohort; Multivariate analysis; Disease","score_opus":0.02595755215844482,"score_gpt":0.2888929043444415,"score_spread":0.2629353521859967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2277236411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919204,0.00018220989,0.0001946816,0.0005035266,0.0007672102,0.003268596,0.0026653,0.0002486484,0.00024944032],"genre_scores_gemma":[0.99558973,0.0008420878,0.00007694102,0.002139647,0.0003240109,0.00022388792,0.0004544701,0.0001462206,0.00020302179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946384,0.00040368023,0.0010366067,0.0010985064,0.0015191456,0.0013036906],"domain_scores_gemma":[0.9962255,0.0006705013,0.0006622855,0.0008193845,0.00091916946,0.00070319546],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006229756,0.0008114423,0.0011369003,0.00035511077,0.00031962953,0.000035320656,0.00042826717,0.00044154283,0.00017947308],"category_scores_gemma":[0.00003213219,0.0005890591,0.00040056318,0.0009899857,0.0005969332,0.0002692385,0.0003265651,0.0008013807,0.00003298572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008915915,0.0047955746,0.79588246,0.000074248135,0.009620006,0.000031940635,0.00020429555,0.000047225694,0.18650989,0.0000027997905,0.0014083529,0.00053159357],"study_design_scores_gemma":[0.010214275,0.0028335492,0.5957939,0.00020548886,0.008377106,0.0000071891095,0.000041514202,0.00009214893,0.381661,0.000006862665,0.00052368036,0.00024330064],"about_ca_topic_score_codex":0.0010128752,"about_ca_topic_score_gemma":0.00014143059,"teacher_disagreement_score":0.20008859,"about_ca_system_score_codex":0.0009648364,"about_ca_system_score_gemma":0.00044256324,"threshold_uncertainty_score":0.9996561},"labels":[],"label_agreement":null},{"id":"W2297263427","doi":"10.1111/apt.13584","title":"A real‐world study focused on the long‐term efficacy of mycophenolate mofetil as first‐line treatment of autoimmune hepatitis","year":2016,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Medicine; Prednisolone; Azathioprine; Mycophenolate; Gastroenterology; Internal medicine; Autoimmune hepatitis; Hepatitis; Maintenance therapy; Cirrhosis; Surgery; Chemotherapy; Transplantation; Disease","score_opus":0.05173744045339859,"score_gpt":0.34829255289470523,"score_spread":0.2965551124413066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2297263427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915014,0.0008731415,0.000003053976,0.005113393,0.0003668063,0.0017737466,0.00008190258,0.00004156701,0.00024498018],"genre_scores_gemma":[0.9886704,0.00789989,0.000017365897,0.0021679522,0.000096531796,0.00008501616,0.000026643494,0.00003872556,0.0009974958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983102,0.00032714827,0.0005294917,0.00026891395,0.0002620181,0.00030224735],"domain_scores_gemma":[0.99821925,0.00070061634,0.00027502936,0.0006159795,0.00009501339,0.00009412054],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015203412,0.0002903847,0.00053964305,0.00012308848,0.0001362995,0.0000041938997,0.00024346232,0.000046859106,0.0024007868],"category_scores_gemma":[6.290909e-7,0.00015754269,0.00022292831,0.00020525153,0.00026863086,0.000051904186,0.00007932278,0.00010894675,0.00004450493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011940883,0.026550164,0.7470541,0.000053552358,0.033513915,0.00015415187,0.0036259666,0.000008339777,0.15463485,0.000059059203,0.00014484774,0.022260197],"study_design_scores_gemma":[0.02100338,0.015444211,0.821162,0.000105519284,0.014504208,0.0000069495263,0.000103684324,0.0000327597,0.12687798,0.000040927967,0.0005498495,0.0001685309],"about_ca_topic_score_codex":0.001731986,"about_ca_topic_score_gemma":0.00008035332,"teacher_disagreement_score":0.07410793,"about_ca_system_score_codex":0.0002267282,"about_ca_system_score_gemma":0.00013381314,"threshold_uncertainty_score":0.99851114},"labels":[],"label_agreement":null},{"id":"W2330470789","doi":"10.1111/apt.13594","title":"Vedolizumab induction therapy for inflammatory bowel disease in clinical practice – a nationwide consecutive German cohort study","year":2016,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vedolizumab; Medicine; Internal medicine; Ulcerative colitis; Inflammatory bowel disease; Faecal calprotectin; Calprotectin; Gastroenterology; Cohort; Crohn's disease; Clinical endpoint; Infliximab; Disease; Clinical trial","score_opus":0.025813353569907632,"score_gpt":0.37937445871889197,"score_spread":0.3535611051489843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330470789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929873,0.00047095018,0.00011714068,0.0018544497,0.0011977978,0.0031880704,0.00008917917,0.000036312354,0.00005881787],"genre_scores_gemma":[0.98378277,0.0012575408,0.00013188591,0.012948687,0.00063939526,0.00092798605,0.00011089242,0.000058173668,0.00014266973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970019,0.0009999336,0.0006840849,0.0006766168,0.00022507741,0.00041238326],"domain_scores_gemma":[0.9985728,0.0002749158,0.00030082156,0.00040132366,0.00025258315,0.00019751715],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011050475,0.00030304104,0.00022185726,0.00010812336,0.00014544552,0.000017145334,0.00028836576,0.00018126251,0.0000713287],"category_scores_gemma":[0.000012773476,0.0002583035,0.00015652506,0.00006928804,0.00029206945,0.00004503722,0.00010113584,0.00017262688,0.000023959938],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014070996,0.0023815043,0.901606,0.000011262545,0.005687972,0.00018939169,0.00026890292,0.000023150067,0.0725373,0.000042260788,0.0010165985,0.002164664],"study_design_scores_gemma":[0.011111417,0.000817133,0.95367587,0.000010059305,0.0018048297,0.000008821258,0.00022151736,0.00005888908,0.008871529,0.00012993703,0.022887364,0.00040264058],"about_ca_topic_score_codex":0.000010418493,"about_ca_topic_score_gemma":0.000027247816,"teacher_disagreement_score":0.06366578,"about_ca_system_score_codex":0.0001030187,"about_ca_system_score_gemma":0.00041048738,"threshold_uncertainty_score":0.99998695},"labels":[],"label_agreement":null},{"id":"W2345549351","doi":"10.1111/apt.13626","title":"Editorial: autoimmune hepatitis – identifying options for treatment. Authors’ reply","year":2016,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Medicine; Azathioprine; Autoimmune hepatitis; Context (archaeology); Randomized controlled trial; Cochrane collaboration; Intensive care medicine; Hepatitis; Internal medicine; Disease","score_opus":0.04062979083610949,"score_gpt":0.38453582040982,"score_spread":0.34390602957371047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345549351","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018996316,0.006126894,0.000085704254,0.0031502277,0.9829156,0.0021964528,0.0032831691,0.0002594884,0.00008286291],"genre_scores_gemma":[0.0002211034,0.024024544,0.00033687678,0.0025347776,0.95684576,0.00079493655,0.005506502,0.00020202735,0.009533469],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966618,0.0003404153,0.0007865675,0.0007855601,0.0006297709,0.00079589355],"domain_scores_gemma":[0.99669236,0.0012268911,0.0004729062,0.00076742773,0.00055309077,0.00028730457],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039429378,0.00072812557,0.0010757819,0.00023995723,0.000556507,0.00006518489,0.00042433335,0.00094454194,0.0011670623],"category_scores_gemma":[0.0000042994825,0.0005981314,0.0007276301,0.00014747605,0.00027985414,0.0002312815,0.00016286258,0.00057875284,0.00013054133],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016326846,0.0009925812,0.0004215836,0.00014573049,0.027405167,0.00002519066,0.00021693228,4.82705e-7,0.016673671,0.000008317534,0.9514138,0.0010638576],"study_design_scores_gemma":[0.009271313,0.0022395428,0.00026254877,0.00016322028,0.05482632,0.000007052762,0.000039710307,0.00002362968,0.0033252037,0.0001387976,0.92919344,0.0005092549],"about_ca_topic_score_codex":0.00083527475,"about_ca_topic_score_gemma":0.00001602566,"teacher_disagreement_score":0.02742115,"about_ca_system_score_codex":0.0012325638,"about_ca_system_score_gemma":0.0010748443,"threshold_uncertainty_score":0.999746},"labels":[],"label_agreement":null},{"id":"W2395912281","doi":"10.1111/apt.13653","title":"Randomised clinical trial: a phase 1, dose‐ranging study of the anti‐matrix metalloproteinase‐9 monoclonal antibody GS‐5745 versus placebo for ulcerative colitis","year":2016,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"Gilead Sciences","keywords":"Medicine; Ulcerative colitis; Placebo; Monoclonal antibody; Gastroenterology; Internal medicine; Dose-ranging study; Colitis; Matrix metalloproteinase; Antibody; Clinical trial; Monoclonal; Immunology; Double blind; Pathology; Disease","score_opus":0.058703450691468574,"score_gpt":0.428510324086686,"score_spread":0.3698068733952174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395912281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891626,0.0002091739,0.0002856639,0.0004929019,0.0021225833,0.0074150795,0.00025815036,0.000022956312,0.0000308405],"genre_scores_gemma":[0.99657565,0.00020660131,0.00017220477,0.0013507318,0.00063014793,0.0007526525,0.00008046642,0.00005600853,0.0001755453],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965281,0.0013385959,0.00085684063,0.00057442504,0.000237877,0.00046415647],"domain_scores_gemma":[0.99829763,0.00045163452,0.00046225425,0.0004817822,0.00017439293,0.00013228177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011107723,0.0003509056,0.00049424614,0.000057132358,0.00025091882,0.000015087622,0.0005089178,0.00018729984,0.00013034229],"category_scores_gemma":[0.000009548044,0.00023519549,0.0004862361,0.000094369396,0.00038227445,0.000016707658,0.00019226295,0.00014608767,0.0000054151665],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5207362,0.0025116606,0.0013117718,0.000015080827,0.011388861,0.000028176595,0.00014589856,0.000020555,0.46281654,0.000014704676,0.00025483957,0.0007557012],"study_design_scores_gemma":[0.7745003,0.005663721,0.003524443,0.000014751665,0.008544604,0.000005047122,0.00034374907,0.00015322535,0.20327623,0.000023785617,0.003561272,0.00038886603],"about_ca_topic_score_codex":0.000010847401,"about_ca_topic_score_gemma":0.000027164273,"teacher_disagreement_score":0.25954032,"about_ca_system_score_codex":0.00004843549,"about_ca_system_score_gemma":0.00027665411,"threshold_uncertainty_score":0.95909935},"labels":[],"label_agreement":null},{"id":"W2402419524","doi":"10.1111/apt.13659","title":"Review article: long‐term safety of nucleoside and nucleotide analogues in <scp>HBV</scp>‐monoinfected patients","year":2016,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Bristol-Myers Squibb","keywords":"Entecavir; Medicine; Lactic acidosis; Renal function; Internal medicine; Hepatitis B; Toxicity; Hepatitis B virus; Intensive care medicine; Gastroenterology; Virology; Lamivudine; Virus","score_opus":0.04729572926454936,"score_gpt":0.3694401123569394,"score_spread":0.32214438309239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402419524","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020029522,0.97566396,0.0000016297297,0.00033901856,0.00046651927,0.0029487542,0.00031010382,0.00006021961,0.0001802757],"genre_scores_gemma":[0.000908409,0.986586,0.000075138996,0.011679855,0.00014032613,0.00014602796,0.0002905823,0.00011367376,0.000060041868],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960589,0.0007455388,0.0016115756,0.0006426157,0.0002801507,0.00066125474],"domain_scores_gemma":[0.99738383,0.0010649913,0.000749488,0.00042938272,0.00016813094,0.00020416224],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043649983,0.00070465077,0.0030254982,0.00032024525,0.00009013666,0.000007297774,0.0002543457,0.0002892412,0.00024378391],"category_scores_gemma":[0.000010227234,0.0005314481,0.00036178032,0.0004566851,0.000465592,0.00012347572,0.00029494136,0.0005715081,0.0001068944],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007894714,0.0013558434,0.17505813,0.04156004,0.021429172,0.00016447037,0.00030925966,4.7393005e-8,0.0003274156,0.000006943801,0.0041048652,0.75560486],"study_design_scores_gemma":[0.003916334,0.0007826194,0.052657504,0.05825676,0.053590868,0.00005778309,0.000008778133,0.0000019822369,0.00027347566,0.000013079403,0.8300966,0.00034421266],"about_ca_topic_score_codex":0.000079849946,"about_ca_topic_score_gemma":0.00011252246,"teacher_disagreement_score":0.82599175,"about_ca_system_score_codex":0.00033741439,"about_ca_system_score_gemma":0.00019165677,"threshold_uncertainty_score":0.9997137},"labels":[],"label_agreement":null},{"id":"W2404971681","doi":"10.1111/apt.13671","title":"The efficacy and safety of either infliximab or adalimumab in 362 patients with anti‐<scp>TNF</scp>‐α naïve Crohn's disease","year":2016,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Infliximab; Adalimumab; Interquartile range; Internal medicine; Crohn's disease; Gastroenterology; Surgery; Disease","score_opus":0.008162735756504332,"score_gpt":0.25768485469442043,"score_spread":0.2495221189379161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404971681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975213,0.0008280311,0.000016981263,0.0004223622,0.0002068421,0.0007791923,0.0001530556,0.000013342966,0.000058914775],"genre_scores_gemma":[0.9950158,0.001262121,0.00004706373,0.003175583,0.00008858358,0.000056279176,0.00005288064,0.000047906342,0.00025375758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837095,0.0002680827,0.0003536107,0.00039102152,0.00018931167,0.00042702584],"domain_scores_gemma":[0.9989799,0.00021885302,0.0001828906,0.0003583023,0.00009952766,0.0001604811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017977819,0.00027885937,0.000198732,0.00005108011,0.00014502968,0.000012932906,0.00029895073,0.000103821454,0.00004435854],"category_scores_gemma":[0.000003824818,0.00015560124,0.000056164492,0.000087522894,0.00055731507,0.00001681402,0.0001730464,0.00010120979,0.000006443287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023764398,0.001571604,0.80746853,0.00006260678,0.005743299,0.00029788172,0.00038664957,0.00007120792,0.15171935,0.000051593954,0.00093724683,0.0079256445],"study_design_scores_gemma":[0.013950279,0.00044753065,0.9420465,0.00003504167,0.0011699671,0.0000030333645,0.00007808443,0.000017301683,0.026207678,0.000027857159,0.015843052,0.0001736488],"about_ca_topic_score_codex":0.000005615143,"about_ca_topic_score_gemma":0.000028001741,"teacher_disagreement_score":0.134578,"about_ca_system_score_codex":0.000039892017,"about_ca_system_score_gemma":0.00017147184,"threshold_uncertainty_score":0.63452345},"labels":[],"label_agreement":null},{"id":"W2414582587","doi":"10.1046/j.1365-2036.2002.01371.x","title":"Haemochromatosis","year":2002,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Phlebotomy; Transferrin saturation; Medicine; Hemochromatosis; Liver biopsy; Cirrhosis; Liver transplantation; Hereditary hemochromatosis; Gastroenterology; Liver disease; Genetic testing; Internal medicine; Disease; Biopsy; Transplantation; Ferritin; Serum ferritin","score_opus":0.10153718563348135,"score_gpt":0.3995227933389254,"score_spread":0.297985607705444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414582587","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000035428588,0.99317706,0.0000046087707,0.0006538426,0.0018616255,0.001379957,0.00007325899,0.00015080992,0.0026633935],"genre_scores_gemma":[0.0000051475204,0.9712686,0.00029157056,0.02503578,0.0006669282,0.00015712524,0.00039642095,0.00014493465,0.0020334811],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99760324,0.00028270777,0.0006816589,0.0005569951,0.0002790094,0.0005963624],"domain_scores_gemma":[0.99888873,0.0001341235,0.00027056332,0.00045313366,0.00003816093,0.00021527964],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012949853,0.0006755341,0.0020622567,0.00029173555,0.00013040037,0.0000151741615,0.0003128515,0.00047402698,0.007005719],"category_scores_gemma":[9.637196e-8,0.00055254635,0.0007327103,0.00034057657,0.00023336978,0.00006331042,0.00010552691,0.00069655984,0.0013726124],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004171769,0.0008105986,0.000017188704,0.008084263,0.0147517435,0.00021860468,0.00010659676,1.4971434e-7,0.00005165638,0.000021169853,0.018008213,0.9578881],"study_design_scores_gemma":[0.0012616924,0.000143333,0.0000025343093,0.00059287425,0.15258497,0.00034045533,0.000020043952,0.0000038378403,0.000060583716,0.0000076074925,0.84460825,0.00037382412],"about_ca_topic_score_codex":0.000011088999,"about_ca_topic_score_gemma":5.009658e-7,"teacher_disagreement_score":0.9575143,"about_ca_system_score_codex":0.00013242959,"about_ca_system_score_gemma":0.00018729584,"threshold_uncertainty_score":0.9996926},"labels":[],"label_agreement":null},{"id":"W2476548567","doi":"10.1111/apt.13757","title":"Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point‐of‐care quantitative test with two established <scp>ELISA</scp> assays","year":2016,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"Merck Sharp and Dohme","keywords":"Medicine; Infliximab; Point of care; Dosing; Therapeutic drug monitoring; Intraclass correlation; Drug; Point-of-care testing; Turnaround time; Pharmacology; Internal medicine; Immunology; Pathology; Disease","score_opus":0.030791268130534597,"score_gpt":0.3330664802583923,"score_spread":0.3022752121278577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2476548567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99651736,0.0012765008,0.0001479092,0.00006164815,0.00021025036,0.0014450814,0.00013182938,0.000018420695,0.00019102736],"genre_scores_gemma":[0.9984429,0.00011772746,0.0008300891,0.0002369242,0.00010713915,0.000100577825,0.000027936347,0.0000504703,0.00008625232],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977907,0.00046030426,0.00056835014,0.00049021904,0.0003174453,0.00037300322],"domain_scores_gemma":[0.997904,0.00041729945,0.0006229811,0.0004059089,0.0005210693,0.00012874654],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002092212,0.00038875116,0.0005223395,0.00013448772,0.00007662133,0.00000841629,0.00042850623,0.00009319818,0.000024138795],"category_scores_gemma":[0.0000033915737,0.0002891688,0.00012039897,0.00020795346,0.0004439417,0.000043039814,0.00015525853,0.0001524999,0.0000030074632],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018277534,0.0014670166,0.27381146,0.000043825665,0.008379577,0.000018145201,0.015380349,0.00012067216,0.698604,0.000018335755,0.000075254386,0.0002535914],"study_design_scores_gemma":[0.009236629,0.003745782,0.07552749,0.000053265827,0.0036158478,0.0000047970575,0.032972597,0.00002486506,0.87447804,0.00004510298,0.000118169184,0.00017741037],"about_ca_topic_score_codex":0.00007858437,"about_ca_topic_score_gemma":0.0000687886,"teacher_disagreement_score":0.19828399,"about_ca_system_score_codex":0.00006633352,"about_ca_system_score_gemma":0.0003232327,"threshold_uncertainty_score":0.9999561},"labels":[],"label_agreement":null},{"id":"W2479308360","doi":"10.1111/apt.13764","title":"The impact of delayed biliary decompression and anti‐microbial therapy in 260 patients with cholangitis‐associated septic shock","year":2016,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gallbladder and Bile Duct Disorders","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Surrey Memorial Hospital; University of Alberta Hospital; University of Alberta","funders":"","keywords":"Medicine; Septic shock; Internal medicine; Decompression; Shock (circulatory); Gastroenterology; Retrospective cohort study; Odds ratio; Mortality rate; Surgery; Sepsis","score_opus":0.013700370901008094,"score_gpt":0.3048897147663563,"score_spread":0.29118934386534817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2479308360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99714226,0.0008621689,0.0000030429242,0.0010068859,0.000144266,0.00073350396,0.000052320782,0.000022525785,0.00003304044],"genre_scores_gemma":[0.99501216,0.0029503119,0.00002067713,0.001860468,0.000027287113,0.00001685564,0.000050027073,0.00002841427,0.000033800858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884623,0.0001442816,0.00027766716,0.00023033818,0.00015201347,0.0003494716],"domain_scores_gemma":[0.9993502,0.00020715628,0.0001250374,0.0001558829,0.000086965134,0.00007476158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015124638,0.00020852595,0.00028762096,0.00008671323,0.000094518866,0.000007398413,0.00012045324,0.00009326436,0.00018322225],"category_scores_gemma":[4.870275e-7,0.00009731233,0.000081550505,0.00015416229,0.00026555147,0.00009002788,0.00004116415,0.00015841077,0.0000028706115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002192011,0.00088673213,0.6791424,0.0000034545947,0.003953897,0.000007549773,0.00025303342,0.000005573478,0.30770582,5.638813e-7,0.00040854418,0.005440384],"study_design_scores_gemma":[0.019455118,0.0026296608,0.9494599,0.00006455362,0.0011177724,0.000011859225,0.00008376666,0.00006747579,0.026690727,0.000040567815,0.0001914635,0.00018711502],"about_ca_topic_score_codex":0.00014145212,"about_ca_topic_score_gemma":0.000035928675,"teacher_disagreement_score":0.2810151,"about_ca_system_score_codex":0.000102027734,"about_ca_system_score_gemma":0.000090353475,"threshold_uncertainty_score":0.39682817},"labels":[],"label_agreement":null},{"id":"W2484844246","doi":"10.1111/apt.13725","title":"Symptomatic suspected gluten exposure is common among patients with coeliac disease on a gluten‐free diet","year":2016,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital; University of Manitoba","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Institutes of Health Research; Canadian Association of Gastroenterology","keywords":"Medicine; Coeliac disease; Gluten free; Gluten; Gastroenterology; Disease; Internal medicine; Immunology; Pathology","score_opus":0.014018861893557022,"score_gpt":0.28963990912033105,"score_spread":0.27562104722677405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2484844246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97676796,0.00059615297,0.000012877018,0.019253792,0.00030413657,0.001997094,0.0003443206,0.0001719801,0.0005516947],"genre_scores_gemma":[0.96303284,0.0009526884,0.000049296574,0.034409203,0.00016172515,0.00023570145,0.00026179428,0.00007383751,0.0008229117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973897,0.00020809947,0.00035046134,0.0005345,0.0007685232,0.0007487317],"domain_scores_gemma":[0.99808097,0.00017819252,0.00013162021,0.000731339,0.00015329942,0.0007245932],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012945628,0.00039265753,0.00041427152,0.00019533656,0.0001735549,0.000024169636,0.00035084784,0.000063513624,0.0019306011],"category_scores_gemma":[0.0000011120688,0.00024867852,0.00014957356,0.00022896961,0.00037656818,0.00016662615,0.00021415755,0.00021875229,0.00015589496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019019071,0.004689691,0.9162984,0.00018819261,0.01635672,0.00064888195,0.00018399856,0.0000026861674,0.002617412,0.00006502222,0.035364185,0.0045657745],"study_design_scores_gemma":[0.025344744,0.0062396284,0.93971175,0.00031240302,0.012380664,0.0000034342431,0.000072114,0.00012188015,0.0045649363,0.00024865786,0.010495303,0.0005044869],"about_ca_topic_score_codex":0.00003467414,"about_ca_topic_score_gemma":0.00001652782,"teacher_disagreement_score":0.024868883,"about_ca_system_score_codex":0.00030718115,"about_ca_system_score_gemma":0.00011872454,"threshold_uncertainty_score":0.99999654},"labels":[],"label_agreement":null},{"id":"W2496243310","doi":"10.1111/apt.13727","title":"An index with improved diagnostic accuracy for the diagnosis of Crohn's disease derived from the Lennard‐Jones criteria","year":2016,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Allergan; Bristol-Myers Squibb; Samsung; Genentech; Norgine; Celltrion; Astellas Pharma; Kyowa Hakko Kirin; Mitsubishi Tanabe Pharma Corporation; AbbVie; Danone; Takeda Pharmaceuticals U.S.A.; Therakos; Celgene; BioClinica; Pfizer; Biogen; Gilead Sciences; Amgen; Abbott Laboratories; Dr. Falk Pharma; IC Design Education Center; Eli Lilly and Company; Meso Scale Diagnostics","keywords":"Medicine; Gold standard (test); Logistic regression; Diagnostic accuracy; Gastroenterology; Disease; Internal medicine; Ulcerative colitis; Pathology","score_opus":0.019118285730687787,"score_gpt":0.30919762800273803,"score_spread":0.29007934227205023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2496243310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98858595,0.0019149705,0.0013475858,0.005378296,0.0004653695,0.001365256,0.00092028314,0.000020070573,0.000002202214],"genre_scores_gemma":[0.9813506,0.0019340783,0.00011916677,0.014795457,0.000535154,0.0010325614,0.00016231212,0.000054502587,0.000016148602],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985411,0.0002962496,0.00027564712,0.00040732068,0.00012494344,0.000354722],"domain_scores_gemma":[0.99761003,0.0012867872,0.00019698938,0.0006257394,0.00013950081,0.00014096235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017285375,0.00027881557,0.00016822392,0.000019478499,0.00024438472,0.000024150155,0.0006562763,0.00009042203,0.00023273137],"category_scores_gemma":[0.000009038634,0.00014115556,0.00012902368,0.000046112345,0.00054038595,0.00002389133,0.000120635865,0.00007654145,0.0000036210351],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072138724,0.00042592076,0.16839515,0.000016947526,0.0051270514,0.000042884374,0.00019206462,0.000036941674,0.81388503,0.00000797714,0.0010911977,0.0035649745],"study_design_scores_gemma":[0.0038846543,0.0004200451,0.6668733,0.000023725375,0.0054487367,0.0000021895448,0.00019006178,0.00033617084,0.3161018,0.0001253317,0.006272016,0.0003220189],"about_ca_topic_score_codex":0.000053128217,"about_ca_topic_score_gemma":0.00008397638,"teacher_disagreement_score":0.4984781,"about_ca_system_score_codex":0.000022148106,"about_ca_system_score_gemma":0.00015869125,"threshold_uncertainty_score":0.5756157},"labels":[],"label_agreement":null},{"id":"W2513212194","doi":"10.1111/apt.13768","title":"Letter: comparative safety and efficacy of infliximab vs. adalimumab in Crohn's disease – should one consider disease location? Authors’ reply","year":2016,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Infliximab; Adalimumab; Crohn's disease; Observational study; Post-hoc analysis; Internal medicine; Disease; Subgroup analysis; Post hoc; Cohort; Clinical trial; Significant difference; Cohort study; Prospective cohort study; Confidence interval","score_opus":0.04118914863577056,"score_gpt":0.3272570579514191,"score_spread":0.2860679093156485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513212194","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3360062,0.006218821,0.00010621032,0.6511652,0.0013023625,0.0029729458,0.0020563933,0.000062546744,0.00010932381],"genre_scores_gemma":[0.19822074,0.0011056664,0.00007802816,0.79606986,0.001908545,0.00015386421,0.0018577257,0.000105032654,0.0005005645],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959673,0.00094999233,0.0009276751,0.0010719475,0.0003871989,0.00069586415],"domain_scores_gemma":[0.9978394,0.0002643695,0.0005135044,0.00082926376,0.00021842672,0.00033506387],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029505248,0.0007070686,0.0006936679,0.00021205073,0.00013825933,0.000025728485,0.0004799599,0.00049211027,0.00027756853],"category_scores_gemma":[0.0000043354694,0.00069271744,0.00020821585,0.0001244874,0.0010374187,0.000023890792,0.0003455504,0.00078465085,0.000022012899],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044363905,0.0016511007,0.026049068,0.0010163368,0.018798742,0.006027908,0.00067504996,0.00037359027,0.03411795,0.00005019797,0.86620504,0.00067113666],"study_design_scores_gemma":[0.011269041,0.00023810174,0.14136937,0.00022285931,0.008889416,0.000010405765,0.000022770575,0.00012037283,0.0070587685,0.00015347154,0.8293662,0.0012791901],"about_ca_topic_score_codex":0.000021465195,"about_ca_topic_score_gemma":0.000011998239,"teacher_disagreement_score":0.14490464,"about_ca_system_score_codex":0.00014289618,"about_ca_system_score_gemma":0.00063298,"threshold_uncertainty_score":0.99955237},"labels":[],"label_agreement":null},{"id":"W2513256751","doi":"10.1111/apt.13771","title":"Systematic review: pre‐ and post‐operative prognostic value of cardiopulmonary exercise testing in liver transplant candidates","year":2016,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Cardiovascular and exercise physiology","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"University of Texas Press","keywords":"Medicine; Liver transplantation; Confidence interval; Internal medicine; MEDLINE; Meta-analysis; Cirrhosis; Liver disease; Transplantation; Surgery","score_opus":0.026861069812639974,"score_gpt":0.33617490776173675,"score_spread":0.3093138379490968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513256751","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010818593,0.9912319,0.00000283581,0.00008179761,0.00025315012,0.0070274216,0.0002487038,0.00003222555,0.00004007394],"genre_scores_gemma":[0.0016043907,0.99540204,0.00007481711,0.0014842297,0.00010609984,0.0009089653,0.00028888424,0.00008225739,0.000048315567],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9963482,0.0010330495,0.0012940213,0.000607012,0.0002670534,0.00045063577],"domain_scores_gemma":[0.9979885,0.00089518836,0.00040579683,0.00042843402,0.00014521288,0.00013683288],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006257444,0.0006473104,0.0058257566,0.00025984898,0.000059966816,0.0000053492395,0.00022339773,0.00028272267,0.000042024156],"category_scores_gemma":[0.0000037290588,0.0004259924,0.0007575516,0.00029614623,0.0002632467,0.00007437255,0.00010551654,0.00047261608,0.000021771206],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003977577,0.0002892882,0.000085271655,0.937767,0.025883626,0.00061326975,0.00037554058,9.270716e-7,0.0010894585,0.000002538749,0.00003504651,0.033460252],"study_design_scores_gemma":[0.0011759271,0.00046764986,0.00013922925,0.723584,0.27053165,0.0017647364,0.00002547087,0.000040079485,0.00028061902,0.0000049051814,0.0015221974,0.0004635592],"about_ca_topic_score_codex":0.0001246155,"about_ca_topic_score_gemma":0.0000020804998,"teacher_disagreement_score":0.24464802,"about_ca_system_score_codex":0.00016009805,"about_ca_system_score_gemma":0.00031928282,"threshold_uncertainty_score":0.99981916},"labels":[],"label_agreement":null},{"id":"W2524096512","doi":"10.1111/apt.13801","title":"Single‐centre experience of the macrophage activation marker soluble (s)CD163 – associations with disease activity and treatment response in patients with autoimmune hepatitis","year":2016,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novo Nordisk Fonden; Novo Nordisk; Alberta Innovates - Health Solutions; Savvaerksejer Jeppe Juhl og Hustru Ovita Juhls Mindelegat","keywords":"Medicine; Autoimmune hepatitis; CD163; Immunology; Autoimmune disease; Macrophage; Disease; Immunopathology; Hepatitis; Internal medicine","score_opus":0.016809987147988977,"score_gpt":0.2686243603173933,"score_spread":0.2518143731694043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524096512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995426,0.000088645225,0.000007893532,0.0035407483,0.000086323176,0.00073188724,0.00009503832,0.000012437158,0.000011037551],"genre_scores_gemma":[0.99818575,0.0001249016,0.000039002694,0.0012204789,0.000010574485,0.000036768874,0.000018291557,0.000016386934,0.0003478606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896413,0.00032860384,0.00014347087,0.00018419161,0.00017999236,0.00019959948],"domain_scores_gemma":[0.9993066,0.00018343527,0.00014471904,0.00021724895,0.0000694968,0.00007849936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006558947,0.00015270045,0.00018345467,0.000046163026,0.00012211064,0.000006134025,0.00006888833,0.000036056645,0.0001806329],"category_scores_gemma":[9.782744e-7,0.00008038642,0.000038338672,0.00013811537,0.00022664061,0.00017977494,0.000048460537,0.00007105321,0.0000011126946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01991812,0.0019954122,0.85772794,0.0000065061436,0.00122415,0.000005462836,0.0008234687,0.000001941616,0.116463415,0.0000011938856,0.0000082940505,0.0018240911],"study_design_scores_gemma":[0.0075009624,0.0012398321,0.9412376,0.00006433226,0.0016045425,5.719455e-7,0.00009158283,0.000034254597,0.04798633,0.0000030456163,0.00014139236,0.00009551138],"about_ca_topic_score_codex":0.00024211484,"about_ca_topic_score_gemma":0.000025508538,"teacher_disagreement_score":0.0835097,"about_ca_system_score_codex":0.00041092443,"about_ca_system_score_gemma":0.00013109345,"threshold_uncertainty_score":0.3278063},"labels":[],"label_agreement":null},{"id":"W2528527650","doi":"10.1111/apt.13793","title":"Letter: gastritis in paediatric patients with coeliac disease – authors' reply","year":2016,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Coeliac disease; Medicine; Gastritis; Gastroenterology; Gluten free; Gluten; Stomach; Internal medicine; Disease; Pathology","score_opus":0.01653100052137295,"score_gpt":0.2931016727478751,"score_spread":0.2765706722265021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528527650","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013670962,0.003444318,0.000015574378,0.97707087,0.0013488256,0.0031880182,0.0008710631,0.00012289298,0.00026749805],"genre_scores_gemma":[0.0042088004,0.0045266254,0.000069868096,0.9795141,0.005502006,0.00046389634,0.003118833,0.00016128352,0.0024345827],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99557984,0.00045274105,0.00056760956,0.000976563,0.0010524805,0.0013707372],"domain_scores_gemma":[0.99823743,0.00019658096,0.00021997782,0.00066216406,0.00015686701,0.0005269987],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002616893,0.00064486335,0.0006929439,0.0006708612,0.00010583994,0.000033848675,0.00038177706,0.0002890278,0.0017223479],"category_scores_gemma":[8.0467464e-7,0.0004918861,0.00024099906,0.00036522467,0.00030776116,0.00014214036,0.0002547007,0.00167827,0.00021655571],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023895188,0.0007309277,0.055746157,0.0003739349,0.005993859,0.006186,0.00002497774,9.946275e-7,0.00009207612,8.378924e-7,0.9240842,0.0043765362],"study_design_scores_gemma":[0.010225176,0.000822186,0.015490322,0.00019643512,0.01189818,0.0000073952096,0.000005392022,0.00001081639,0.00011042216,0.000031991964,0.96070015,0.0005015475],"about_ca_topic_score_codex":0.000046959227,"about_ca_topic_score_gemma":0.0000037271416,"teacher_disagreement_score":0.040255837,"about_ca_system_score_codex":0.0005972467,"about_ca_system_score_gemma":0.0003705094,"threshold_uncertainty_score":0.9997533},"labels":[],"label_agreement":null},{"id":"W2548288139","doi":"10.1111/apt.13846","title":"Poor predictive value of lower gastrointestinal alarm features in the diagnosis of colorectal cancer in 1981 patients in secondary care","year":2016,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; Population Health Research Institute","funders":"Canadian Association of Gastroenterology","keywords":"Medicine; Colorectal cancer; Predictive value; ALARM; Gastrointestinal cancer; Value (mathematics); Internal medicine; Cancer; Gastroenterology; Intensive care medicine; Statistics","score_opus":0.0129739685024676,"score_gpt":0.30195776896148796,"score_spread":0.28898380045902033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548288139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959348,0.001312361,0.0000032253174,0.001306237,0.00036585514,0.0007362198,0.00016660435,0.000010059826,0.00016465047],"genre_scores_gemma":[0.9970787,0.00047610432,0.00006964721,0.0020475406,0.000055799374,0.00023385377,0.000016139302,0.000015487996,0.000006738469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868596,0.00024395833,0.00035678543,0.00023698244,0.0002179648,0.00025835336],"domain_scores_gemma":[0.99930996,0.00032702246,0.00014127226,0.00009424645,0.00009122638,0.000036274167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017896359,0.00016206196,0.0003051724,0.00021276258,0.000021326648,0.0000018485485,0.00013632521,0.00007482101,0.00016756698],"category_scores_gemma":[0.0000018708434,0.000108557644,0.000073371004,0.0003079253,0.0001866521,0.00006944629,0.000045355064,0.00032547774,6.7669845e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014390004,0.00075470767,0.9394051,0.000045466935,0.0003808596,0.000041246694,0.0023975112,0.000074824755,0.03318416,0.0000017648366,0.000102325874,0.00922204],"study_design_scores_gemma":[0.0063201385,0.0060732723,0.85874265,0.00028056244,0.0005979033,0.000022006558,0.0008298922,0.000070196525,0.12688513,0.000016175161,0.00007210266,0.000089974856],"about_ca_topic_score_codex":0.0018541665,"about_ca_topic_score_gemma":0.0022197908,"teacher_disagreement_score":0.09370097,"about_ca_system_score_codex":0.00035139007,"about_ca_system_score_gemma":0.00016475689,"threshold_uncertainty_score":0.44268522},"labels":[],"label_agreement":null},{"id":"W2551516232","doi":"10.1111/apt.13852","title":"Effects of vedolizumab on health‐related quality of life in patients with ulcerative colitis: results from the randomised <scp>GEMINI</scp> 1 trial","year":2016,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"UCB Pharma; Janssen Biotech; Genentech; Kyowa Hakko Kirin; Takeda Pharmaceuticals International; Biogen; Celgene; Novo Nordisk; Teva Pharmaceutical Industries; Gilead Sciences; ActoGeniX; Sanofi; Tillotts Pharma; Amgen; Pfizer; Ironwood Pharmaceuticals, Incorporated; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Vedolizumab; Medicine; Minimal clinically important difference; Ulcerative colitis; Placebo; Quality of life (healthcare); Internal medicine; Crohn's disease; Inflammatory bowel disease; Faecal calprotectin; Pouchitis; Population; Randomization; Clinical trial; Physical therapy; Randomized controlled trial; Disease; Calprotectin","score_opus":0.015765280930519116,"score_gpt":0.2839675321953106,"score_spread":0.2682022512647915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551516232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571055,0.0002682889,0.000006173763,0.0005179996,0.0004168624,0.0023860496,0.00062595325,0.000009031966,0.000059068563],"genre_scores_gemma":[0.994369,0.00021967529,0.000023995886,0.0048485957,0.00010681377,0.00011220702,0.00025989578,0.000026918653,0.000032907592],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962983,0.0018813196,0.00088759547,0.0003789029,0.0002389104,0.0003149528],"domain_scores_gemma":[0.99731255,0.0014387172,0.00070778735,0.00032546688,0.000107086176,0.000108371896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000579647,0.0002429704,0.00044461217,0.000042024007,0.000064290805,0.0000036922686,0.00027485462,0.00015288978,0.000017478736],"category_scores_gemma":[0.000028118167,0.00015160226,0.00011249363,0.00008143156,0.0003348314,0.00000815873,0.000066843866,0.0001348805,0.0000042491442],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8719686,0.00224967,0.02136401,0.00005532835,0.008120727,0.000013777702,0.0014322879,0.000046045185,0.092186905,0.000024163153,0.0016476959,0.0008907512],"study_design_scores_gemma":[0.4489098,0.0024200713,0.41116524,0.000063189385,0.00063769147,1.4755884e-7,0.00009747158,0.000004547487,0.13629058,0.000049483937,0.00025452237,0.00010727987],"about_ca_topic_score_codex":0.00012371178,"about_ca_topic_score_gemma":0.00007221932,"teacher_disagreement_score":0.42305884,"about_ca_system_score_codex":0.00006170723,"about_ca_system_score_gemma":0.0002929832,"threshold_uncertainty_score":0.6182161},"labels":[],"label_agreement":null},{"id":"W2551867019","doi":"10.1111/apt.13838","title":"Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy","year":2016,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"UCB Pharma; Relypsa; Takeda Oncology; Genentech; Norgine; Tillotts Pharma; Astellas Pharma; Celltrion; Eisai; Ironwood Pharmaceuticals, Incorporated; Therakos; AbbVie; Novo Nordisk; Teva Pharmaceutical Industries; Gilead Sciences; Procter and Gamble; Celgene; Pfizer; Biogen; GlaxoSmithKline; Shire; Orexigen Therapeutics; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Atlantic Healthcare; Amgen; ActoGeniX; Sanofi; Zalicus; Abbott Laboratories","keywords":"Adalimumab; Medicine; Ulcerative colitis; Combination therapy; Internal medicine; Adverse effect; Maintenance therapy; Crohn's disease; Placebo; Concomitant; Gastroenterology; Disease; Chemotherapy; Pathology","score_opus":0.007973978760768238,"score_gpt":0.25191173948789003,"score_spread":0.24393776072712178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551867019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971638,0.0003671584,0.000019954374,0.00046584022,0.0001739759,0.0015222796,0.00026717514,0.0000062587374,0.000013607916],"genre_scores_gemma":[0.9955945,0.0012805216,0.000019218298,0.0028339638,0.000047728885,0.00008461587,0.00005380468,0.00003262835,0.00005300755],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99833035,0.0005034632,0.0003739054,0.00032826306,0.00020249568,0.00026154536],"domain_scores_gemma":[0.9990213,0.00028661478,0.00023551917,0.00022432211,0.00013216786,0.000100081794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015884142,0.0002659561,0.00025979595,0.000057095345,0.000075747805,0.0000055869978,0.00021418695,0.000072671246,0.00018055145],"category_scores_gemma":[0.0000021979615,0.00015131194,0.00007190566,0.00006569606,0.0006159366,0.000012091724,0.00006184756,0.00009344439,0.000001592074],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2400513,0.0030152346,0.36541313,0.000115074305,0.010399415,0.0001525847,0.00033228655,0.00006589639,0.37695798,0.00028004582,0.0003101124,0.002906934],"study_design_scores_gemma":[0.020624638,0.0010286387,0.77268994,0.00006993936,0.00057786604,4.567888e-7,0.000017084181,0.000013457636,0.20436247,0.000018532939,0.0004256864,0.00017127799],"about_ca_topic_score_codex":0.0000066422836,"about_ca_topic_score_gemma":0.000006395598,"teacher_disagreement_score":0.40727684,"about_ca_system_score_codex":0.000046133493,"about_ca_system_score_gemma":0.00014794088,"threshold_uncertainty_score":0.6170322},"labels":[],"label_agreement":null},{"id":"W2552690718","doi":"10.1111/apt.13847","title":"Systematic review with meta‐analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis","year":2016,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":253,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute; University of Calgary","funders":"Canadian Institutes of Health Research; UCB Pharma; National Institutes of Health; Celltrion; Amgen","keywords":"Medicine; Vedolizumab; Infliximab; Ulcerative colitis; Azathioprine; Internal medicine; Adalimumab; Odds ratio; Placebo; Randomized controlled trial; Inflammatory bowel disease; Crohn's disease; Confidence interval; Meta-analysis; Number needed to treat; Surgery; Disease; Relative risk; Pathology","score_opus":0.06287299922234953,"score_gpt":0.3637547067551146,"score_spread":0.3008817075327651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552690718","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023622394,0.97147644,0.00001677668,0.00006687349,0.000045193603,0.0041095885,0.0006535131,0.000007708752,0.0000015324007],"genre_scores_gemma":[0.009995572,0.9874634,0.000059182432,0.00075435644,0.00003236301,0.0010996944,0.0005486527,0.000035250854,0.000011502361],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99707484,0.0012024577,0.00081015314,0.00057213806,0.00009251348,0.00024786778],"domain_scores_gemma":[0.9981589,0.00059551024,0.00075414986,0.00027555236,0.00010415982,0.000111764326],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057318865,0.0004620484,0.00260302,0.00016085485,0.000078155856,0.000016005913,0.00012617541,0.00015046525,0.000011180208],"category_scores_gemma":[0.0000039931156,0.00030437362,0.00041618838,0.00013439338,0.00040592486,0.000015410871,0.0000915635,0.00009592817,3.2335717e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012958904,0.0002615289,0.0002826545,0.35461044,0.641872,0.00008660394,0.0002071673,0.0000050543167,0.00013106005,0.000018121862,0.000077234174,0.0011522674],"study_design_scores_gemma":[0.0010066829,0.00018233332,0.0023717498,0.023558876,0.971021,0.000016246493,0.00005094809,0.000013583535,0.00013422304,0.000014287032,0.0010795816,0.00055046484],"about_ca_topic_score_codex":0.0000053441076,"about_ca_topic_score_gemma":0.0000081471735,"teacher_disagreement_score":0.3310516,"about_ca_system_score_codex":0.00002947912,"about_ca_system_score_gemma":0.00016436231,"threshold_uncertainty_score":0.9999408},"labels":[],"label_agreement":null},{"id":"W2574762966","doi":"10.1111/apt.13913","title":"Review article: dose optimisation of infliximab for acute severe ulcerative colitis","year":2017,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute; Robarts Clinical Trials; Western University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Infliximab; Medicine; Ulcerative colitis; Dosing; Regimen; Internal medicine; Colectomy; Surgery; Disease","score_opus":0.07125058431304385,"score_gpt":0.4219820698800754,"score_spread":0.3507314855670316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574762966","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00043601845,0.99396586,0.000016960668,0.00018256341,0.0005909493,0.003461087,0.0012161146,0.000015047905,0.000115397735],"genre_scores_gemma":[0.000035924557,0.98740053,0.0004086856,0.008187352,0.00037579334,0.00089945574,0.0022045693,0.00008417423,0.00040354038],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99775183,0.00045447028,0.0007560902,0.00052377884,0.00012873046,0.00038510349],"domain_scores_gemma":[0.9980513,0.0000605215,0.00091772916,0.0006357331,0.0002111395,0.00012362037],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035344125,0.00049772346,0.0011009548,0.00005906781,0.00017848179,0.000018267558,0.00057884393,0.00038097406,0.00016401429],"category_scores_gemma":[0.0000016477479,0.00047108284,0.0006027431,0.000052199786,0.00026019523,0.000014309964,0.00018422423,0.00020783812,0.000019790588],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002478091,0.0008606072,0.00002974549,0.05156194,0.10772174,0.00014181784,0.00015803814,0.000014384016,0.004656462,0.00006302295,0.032444928,0.79986924],"study_design_scores_gemma":[0.0015341415,0.0002668054,0.00002279378,0.002515268,0.057323154,0.00005447937,0.000006717052,0.000010824838,0.0015334953,0.00002010379,0.93625236,0.00045988476],"about_ca_topic_score_codex":0.0000031231982,"about_ca_topic_score_gemma":0.0000063433663,"teacher_disagreement_score":0.9038074,"about_ca_system_score_codex":0.00008568969,"about_ca_system_score_gemma":0.0005620418,"threshold_uncertainty_score":0.9997741},"labels":[],"label_agreement":null},{"id":"W2578370055","doi":"10.1111/apt.13949","title":"Derivation and validation of a diagnostic test for irritable bowel syndrome using latent class analysis","year":2017,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Canadian Association of Gastroenterology","keywords":"Medicine; Irritable bowel syndrome; Latent class model; Internal medicine; Cohort; Colonoscopy; Gastroenterology; Receiver operating characteristic; Diagnostic test; Area under the curve; Pediatrics; Statistics; Colorectal cancer","score_opus":0.05877894786665684,"score_gpt":0.3527287507355205,"score_spread":0.2939498028688637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578370055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99434936,0.00024846272,0.0014320145,0.003238026,0.000112523885,0.0005481173,0.000039264243,0.000014478512,0.000017749771],"genre_scores_gemma":[0.9949246,0.00013946537,0.0030474998,0.0017196841,0.000026181315,0.00002282045,0.00008425671,0.0000121828325,0.000023282162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992398,0.000034944904,0.00024404422,0.00019700133,0.000097851786,0.00018635452],"domain_scores_gemma":[0.9988292,0.00061511167,0.0002117255,0.00017803241,0.00010263681,0.0000633129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018021197,0.00011840204,0.00026420728,0.00011042489,0.00022240725,0.000017742894,0.00008294427,0.000051965068,0.00005997806],"category_scores_gemma":[0.000014916212,0.00011741466,0.00008836925,0.00007951442,0.0001793942,0.00013456156,0.00004153306,0.00007863848,9.638421e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029426764,0.000511889,0.84206635,0.00010192491,0.0053085983,0.000012408008,0.00010813924,0.00044568803,0.1508208,0.0000104035935,0.000018036779,0.00030151184],"study_design_scores_gemma":[0.005374764,0.0017707286,0.812685,0.00006689365,0.066925794,0.00012163038,0.0001663737,0.039428458,0.07271988,0.00045281762,0.00010833327,0.0001793293],"about_ca_topic_score_codex":0.00013955048,"about_ca_topic_score_gemma":0.000013319836,"teacher_disagreement_score":0.07810092,"about_ca_system_score_codex":0.000045241104,"about_ca_system_score_gemma":0.000036987207,"threshold_uncertainty_score":0.47880307},"labels":[],"label_agreement":null},{"id":"W2589071744","doi":"10.1111/apt.13972","title":"Systematic review with meta‐analysis: the impact of <i>Clostridium difficile</i> infection on the short‐ and long‐term risks of colectomy in inflammatory bowel disease","year":2017,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Colectomy; Ulcerative colitis; Internal medicine; Observational study; Inflammatory bowel disease; Clostridium difficile; Meta-analysis; Gastroenterology; Disease","score_opus":0.19570396835258239,"score_gpt":0.46607344341471285,"score_spread":0.2703694750621305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589071744","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028505377,0.9627896,0.0000010033751,0.0005582912,0.00006422592,0.007784634,0.00025068887,0.00001708141,0.00002911332],"genre_scores_gemma":[0.0590389,0.93872815,9.787894e-7,0.00083266443,0.00007334088,0.0010753141,0.00014790341,0.00006728525,0.00003547035],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9949083,0.0017502856,0.0015606144,0.00056617084,0.00070940226,0.00050523604],"domain_scores_gemma":[0.9954887,0.0013701438,0.0012766103,0.0014398412,0.00021269753,0.0002120198],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014437914,0.0008039143,0.0047845608,0.0004877495,0.00019483808,0.000036001136,0.00061759586,0.00022176787,0.00029253226],"category_scores_gemma":[0.0000085360325,0.00036108328,0.002388706,0.00075029506,0.00072477816,0.00006315678,0.0001933581,0.0011584806,0.000005977518],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005874551,0.001023418,0.0016284788,0.323839,0.6715701,0.0001430364,0.00005559707,0.000028420867,0.00010531718,0.0000041636094,0.00009643702,0.0009185535],"study_design_scores_gemma":[0.0007148725,0.0008016856,0.00084026763,0.04334195,0.9526912,0.000057670044,0.000009382434,0.000043394524,0.0006105664,0.0000011496442,0.00057426165,0.0003136062],"about_ca_topic_score_codex":0.0001869246,"about_ca_topic_score_gemma":0.000031621883,"teacher_disagreement_score":0.28112108,"about_ca_system_score_codex":0.0002953205,"about_ca_system_score_gemma":0.00084830885,"threshold_uncertainty_score":0.9998841},"labels":[],"label_agreement":null},{"id":"W2592621897","doi":"10.1111/apt.13995","title":"Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis","year":2017,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute for Health and Care Research","keywords":"Medicine; Rheumatoid arthritis; Disease; Clinical trial; Arthritis; Vedolizumab; Crohn's disease; Inflammatory bowel disease; Physical therapy; Internal medicine; Intensive care medicine; Immunology","score_opus":0.0916255167277932,"score_gpt":0.42270751451623806,"score_spread":0.3310819977884448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592621897","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014855412,0.9909414,0.0000015684437,0.0029391374,0.0004720602,0.0037697644,0.00013777488,0.00009613848,0.00015659753],"genre_scores_gemma":[0.0010587159,0.9812892,0.000050259358,0.016246751,0.0001531974,0.0007078466,0.00023844404,0.0001590008,0.00009656856],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952807,0.0010344012,0.001317746,0.0008623061,0.00046190424,0.0010429529],"domain_scores_gemma":[0.9975008,0.00033204225,0.00053494883,0.000916002,0.000086822176,0.00062938675],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000923341,0.00087888766,0.003341013,0.00036335093,0.00037676923,0.00012114073,0.00058238016,0.00029839922,0.0008526505],"category_scores_gemma":[0.0000037919367,0.0007508955,0.000543517,0.00025697597,0.00076972425,0.00028783132,0.00034000204,0.0013096437,0.0001141413],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019348283,0.0004497657,0.0005484169,0.01147642,0.0074155205,0.0014023872,0.000087214554,8.280457e-8,0.00003535334,0.000024963028,0.00067192304,0.97769445],"study_design_scores_gemma":[0.002846775,0.00022600514,0.0009317081,0.07188358,0.0034886675,0.00058062,0.000020278494,0.000024872332,0.000019779243,0.00019304169,0.9191546,0.00063011236],"about_ca_topic_score_codex":0.00012197449,"about_ca_topic_score_gemma":0.00004247796,"teacher_disagreement_score":0.9770644,"about_ca_system_score_codex":0.00024229927,"about_ca_system_score_gemma":0.0007676283,"threshold_uncertainty_score":0.9994942},"labels":[],"label_agreement":null},{"id":"W2593531649","doi":"10.1111/apt.14016","title":"Clinical, endoscopic and radiographic outcomes with ustekinumab in medically‐refractory Crohn's disease: real world experience from a multicentre cohort","year":2017,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta; University of Calgary","funders":"Canadian Association of Gastroenterology","keywords":"Medicine; Ustekinumab; Refractory (planetary science); Crohn's disease; Cohort; Crohn disease; Cohort study; Internal medicine; Endoscopy; Disease; Gastroenterology; Infliximab","score_opus":0.02138611916536306,"score_gpt":0.35046355062273615,"score_spread":0.3290774314573731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593531649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99683785,0.0010102735,0.000008687314,0.000652496,0.00062244944,0.00066673436,0.00007658618,0.000022296983,0.00010262128],"genre_scores_gemma":[0.98815304,0.004558926,0.00028325125,0.006325144,0.00023808955,0.00013445728,0.00012636792,0.00003945931,0.00014125701],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791247,0.0003144255,0.00043569566,0.00069014006,0.00022179184,0.00042550656],"domain_scores_gemma":[0.9985178,0.000096392956,0.00026724994,0.00071986485,0.00004346406,0.000355194],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002140583,0.00031945837,0.0003332433,0.0000826068,0.0003087348,0.000051702456,0.00054285204,0.00013956492,0.00018814],"category_scores_gemma":[0.0000026435234,0.000277378,0.00010263068,0.000044679295,0.0010767905,0.000028862452,0.000244632,0.00027372836,0.0000054934435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016504657,0.00042125935,0.98802894,0.000011424859,0.0026539578,0.0010683599,0.00014984212,0.000004175189,0.0052530593,0.0000029783578,0.00010317256,0.0006523879],"study_design_scores_gemma":[0.0052363444,0.00010158088,0.9883243,0.000023981427,0.0017436688,0.0000013953014,0.000093510746,0.0001115167,0.0008445913,0.000012094353,0.003224537,0.00028249723],"about_ca_topic_score_codex":0.00030222425,"about_ca_topic_score_gemma":0.0013632233,"teacher_disagreement_score":0.008684807,"about_ca_system_score_codex":0.000034920027,"about_ca_system_score_gemma":0.00014417671,"threshold_uncertainty_score":0.9999678},"labels":[],"label_agreement":null},{"id":"W2598864494","doi":"10.1111/apt.14030","title":"Systematic review with meta‐analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials","year":2017,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":293,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute; University of Calgary","funders":"UCB Pharma; National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; Canadian Institutes of Health Research; AbbVie; Merck; Amgen","keywords":"Medicine; Infliximab; Ulcerative colitis; Internal medicine; Maintenance therapy; Azathioprine; Placebo; Gastroenterology; Crohn's disease; Randomized controlled trial; Adalimumab; Odds ratio; Vedolizumab; Meta-analysis; Clinical endpoint; Surgery; Disease; Pathology; Chemotherapy","score_opus":0.16876965601171978,"score_gpt":0.440513190622076,"score_spread":0.2717435346103562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598864494","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034403433,0.98561186,0.000057905218,0.00006875928,0.000073269744,0.009845449,0.00089473464,0.00000407515,0.0000036023341],"genre_scores_gemma":[0.007444316,0.9893015,0.00014489584,0.0005971844,0.00005136179,0.001899371,0.0005171736,0.000024515422,0.000019679068],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99435383,0.003089658,0.0016961044,0.00050551747,0.00011501138,0.00023988586],"domain_scores_gemma":[0.9956646,0.00079444575,0.0028589915,0.0003630597,0.0002125232,0.00010636659],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022405437,0.0004919296,0.00772871,0.00016949835,0.000087408785,0.000013826082,0.0002284687,0.00018775337,0.000010476785],"category_scores_gemma":[0.000025205882,0.0003096939,0.0011715651,0.000107703614,0.00046095863,0.000010556479,0.000077428565,0.00014715946,1.6210615e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006029934,0.0002814849,0.00002506704,0.2521665,0.740735,0.000040291416,0.00007952068,0.000020098625,0.000117595,0.00003954606,0.000022861306,0.0004420725],"study_design_scores_gemma":[0.0048629795,0.00030526414,0.00021224226,0.012819034,0.98051,0.000008050985,0.00004671595,0.00004122704,0.0000895401,0.000013112493,0.0007744342,0.00031737456],"about_ca_topic_score_codex":0.000008691009,"about_ca_topic_score_gemma":0.000032597527,"teacher_disagreement_score":0.23977502,"about_ca_system_score_codex":0.000032086362,"about_ca_system_score_gemma":0.00029178776,"threshold_uncertainty_score":0.9999355},"labels":[],"label_agreement":null},{"id":"W2599037333","doi":"10.1111/apt.13996","title":"Letter: <scp>NICE</scp> referral criteria for lower gastrointestinal alarm features – not ideal but not poor either. Authors' reply","year":2017,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Phonocardiography and Auscultation Techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; Population Health Research Institute","funders":"Canadian Association of Gastroenterology","keywords":"Medicine; Nice; Referral; Ideal (ethics); Family medicine; Epistemology; Computer science","score_opus":0.05911838218407575,"score_gpt":0.36829984968749613,"score_spread":0.30918146750342035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599037333","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03544707,0.0014944717,0.0006199907,0.94597954,0.007788159,0.0042550457,0.0026298556,0.0009541485,0.00083170447],"genre_scores_gemma":[0.010990731,0.00044764075,0.008847727,0.95757437,0.011953515,0.00070901966,0.0026852153,0.00028389783,0.0065079043],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951381,0.00047677086,0.00095488573,0.0013554425,0.0006811219,0.0013936595],"domain_scores_gemma":[0.99663836,0.0007566865,0.0009157298,0.001016496,0.00040725045,0.0002654822],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0007693269,0.0011489668,0.0014165234,0.00048792225,0.0006287335,0.00015322192,0.000987079,0.0009681122,0.00022978819],"category_scores_gemma":[0.000008521909,0.0010713792,0.0011944128,0.00014941378,0.0007500659,0.00026958028,0.00019606642,0.0034175683,0.00004239359],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008755407,0.00021676598,0.00015973269,0.00021867997,0.008136012,0.0012918814,0.0002026026,4.8782016e-7,0.21061654,0.0000029584323,0.77773076,0.0005480548],"study_design_scores_gemma":[0.0036489794,0.0019874298,0.0008755193,0.00024143384,0.014907318,0.0012492123,0.000051358264,0.000028081618,0.2065416,0.000117463554,0.76995903,0.0003925573],"about_ca_topic_score_codex":0.00013168764,"about_ca_topic_score_gemma":0.0000037113177,"teacher_disagreement_score":0.024456339,"about_ca_system_score_codex":0.00022453007,"about_ca_system_score_gemma":0.00024684556,"threshold_uncertainty_score":0.99917364},"labels":[],"label_agreement":null},{"id":"W2600689924","doi":"10.1111/apt.13987","title":"Editorial: co‐existing immune‐mediated disease in inflammatory bowel diseases – a new disease severity indicator?","year":2017,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital","funders":"","keywords":"Medicine; Inflammatory bowel disease; Disease; Inflammatory Bowel Diseases; Immune system; Immunology; Crohn disease; Intensive care medicine; Internal medicine","score_opus":0.013123733538634252,"score_gpt":0.3131138280961038,"score_spread":0.2999900945574695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600689924","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06815591,0.007950752,0.00000475203,0.00036754197,0.91607684,0.001728099,0.0054706475,0.00015604675,0.00008939916],"genre_scores_gemma":[0.015846169,0.0042647985,0.000025976839,0.0021777377,0.9551756,0.00044885144,0.02089425,0.00035035968,0.000816263],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935606,0.00089067477,0.0012073406,0.0017350806,0.0012364973,0.0013698044],"domain_scores_gemma":[0.9947628,0.0003159707,0.001181049,0.0017549667,0.00025117808,0.001734056],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00059727515,0.0013461352,0.0008303738,0.0003265279,0.00058256823,0.0002121559,0.0020785974,0.0013998289,0.0002758575],"category_scores_gemma":[0.000064511354,0.0015389315,0.000590073,0.0000949453,0.0008173967,0.0000639397,0.00084049406,0.0015684837,0.00017804849],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008076809,0.00071998726,0.0498353,0.00034242,0.0044194413,0.0013082817,0.00008262925,0.000060343016,0.005173254,0.0000019159731,0.929871,0.00010857595],"study_design_scores_gemma":[0.005887344,0.00012184517,0.04254871,0.00014378935,0.007528878,0.0000010040658,0.000021370839,0.00008187975,0.00045408914,0.00008666106,0.94154817,0.0015762555],"about_ca_topic_score_codex":0.00012117977,"about_ca_topic_score_gemma":0.00005247458,"teacher_disagreement_score":0.052309737,"about_ca_system_score_codex":0.00042441572,"about_ca_system_score_gemma":0.006508421,"threshold_uncertainty_score":0.99992895},"labels":[],"label_agreement":null},{"id":"W2602959813","doi":"10.1111/apt.14019","title":"Letter: dose optimising infliximab in acute severe ulcerative colitis – authors' reply","year":2017,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Infliximab; Ulcerative colitis; Colitis; Internal medicine; Gastroenterology; Disease","score_opus":0.02099272165591892,"score_gpt":0.3118688729001171,"score_spread":0.2908761512441982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602959813","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35538954,0.0013090636,0.000029565854,0.63047385,0.006408439,0.0028333904,0.0015337294,0.00011973882,0.0019026479],"genre_scores_gemma":[0.011199343,0.0009073596,0.0004355333,0.97367686,0.005765549,0.00026874355,0.0034100441,0.00020281604,0.004133737],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99578476,0.00087845454,0.00069139403,0.0012242191,0.00034362392,0.0010775393],"domain_scores_gemma":[0.9979437,0.000054389213,0.000571263,0.0011390789,0.00013713632,0.00015445189],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003678387,0.00086144963,0.00061738316,0.00020074744,0.00037912955,0.000121848614,0.0011256302,0.0012860601,0.0003653081],"category_scores_gemma":[0.0000010270195,0.0009623321,0.00032151892,0.00006957262,0.00052968145,0.000031478445,0.00049619743,0.0018763227,0.000076010816],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002017999,0.00016274946,0.000833472,0.00008292445,0.012252534,0.012150691,0.00029185737,0.000100606434,0.029300751,0.0000016228358,0.94242555,0.00037926272],"study_design_scores_gemma":[0.0043536643,0.00027611124,0.0028754256,0.00005941541,0.0054707373,0.00025942622,0.000021904792,0.000110433444,0.017480187,0.00005492867,0.9678595,0.0011782655],"about_ca_topic_score_codex":0.000054005697,"about_ca_topic_score_gemma":0.00004430125,"teacher_disagreement_score":0.3441902,"about_ca_system_score_codex":0.0002573625,"about_ca_system_score_gemma":0.00044796852,"threshold_uncertainty_score":0.9992827},"labels":[],"label_agreement":null},{"id":"W2603330120","doi":"10.1111/apt.14040","title":"The effects of pregnancy on the pharmacokinetics of infliximab and adalimumab in inflammatory bowel disease","year":2017,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"Health Research Board","keywords":"Medicine; Infliximab; Adalimumab; Gastroenterology; Internal medicine; Ulcerative colitis; Inflammatory bowel disease; Pregnancy; Pharmacokinetics; Rheumatoid arthritis; Disease","score_opus":0.020716813213262773,"score_gpt":0.33121496478897555,"score_spread":0.31049815157571276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603330120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9712629,0.015145851,0.0000030383653,0.011508747,0.000678791,0.0011119737,0.000015349866,0.0000120049,0.00026138328],"genre_scores_gemma":[0.97709,0.016962767,0.000011882351,0.005632522,0.000066275505,0.00009374695,0.000004023055,0.000017310578,0.00012147501],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99882317,0.00018742755,0.00034423475,0.0001688721,0.00023247364,0.00024380314],"domain_scores_gemma":[0.99816465,0.0007977334,0.00034009278,0.0005293125,0.00004915929,0.000119033066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025752198,0.00016473875,0.00021174637,0.000056316352,0.00022124837,0.000010112003,0.00033715728,0.000056876284,0.000035791516],"category_scores_gemma":[0.000011301775,0.000098540506,0.000065959415,0.0000402671,0.00082738954,0.00007276736,0.000104028295,0.00027532416,0.0000021584456],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065650283,0.0023482088,0.3703806,0.0016903295,0.009521513,0.00023545446,0.0037855671,0.000020673164,0.55740803,0.0017147564,0.001186492,0.045143344],"study_design_scores_gemma":[0.012915532,0.0009577567,0.46528965,0.0017381591,0.0062043327,0.000010152916,0.0001467774,0.00072978076,0.50726056,0.00054269435,0.0039995536,0.00020505255],"about_ca_topic_score_codex":0.000010854864,"about_ca_topic_score_gemma":0.0000020833763,"teacher_disagreement_score":0.09490903,"about_ca_system_score_codex":0.0000345818,"about_ca_system_score_gemma":0.00013756986,"threshold_uncertainty_score":0.40183654},"labels":[],"label_agreement":null},{"id":"W2603952611","doi":"10.1111/apt.14052","title":"Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the <scp>OT</scp>‐0401 and <scp>REVERSE</scp> randomised clinical studies","year":2017,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Genentech; Ikaria; Intercept Pharmaceuticals; AbbVie; Gilead Sciences","keywords":"Terlipressin; Hepatorenal syndrome; Medicine; Placebo; Renal function; Albumin; Internal medicine; Gastroenterology; Creatinine; Urology; Anesthesia; Surgery; Cirrhosis; Pathology","score_opus":0.05370620661905318,"score_gpt":0.3711902203506113,"score_spread":0.3174840137315581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603952611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953696,0.0023748016,0.000008339794,0.00048224512,0.00040195664,0.0011604687,0.00010110211,0.0000167064,0.00008473984],"genre_scores_gemma":[0.99359787,0.0030123605,0.00012511158,0.0028359084,0.00006604705,0.000044845037,0.000072769624,0.000028550512,0.00021654401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975584,0.0005399659,0.0007424911,0.00043647355,0.0003709983,0.00035167532],"domain_scores_gemma":[0.9971389,0.0014479503,0.00065366155,0.00046100368,0.0001534806,0.0001449854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006808689,0.00031682578,0.0012167011,0.00024472864,0.00017237775,0.0000151454215,0.0002925167,0.00016901056,0.000028381348],"category_scores_gemma":[0.000007329775,0.00022124822,0.0002633414,0.00031856995,0.0010457158,0.00017408299,0.00011692636,0.0003694137,0.0000028477425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011020315,0.00081601,0.7882596,0.00032953298,0.16708294,0.00055284123,0.0068451217,0.00016886827,0.024319697,0.000007544177,0.00047509596,0.00012244516],"study_design_scores_gemma":[0.084052354,0.0011993397,0.62201613,0.00031087518,0.2568173,0.00009352241,0.0022647579,0.0024804557,0.030457811,0.000021751117,0.00018470679,0.000100996396],"about_ca_topic_score_codex":0.00025647986,"about_ca_topic_score_gemma":0.00016274421,"teacher_disagreement_score":0.16624346,"about_ca_system_score_codex":0.00010441547,"about_ca_system_score_gemma":0.00031083176,"threshold_uncertainty_score":0.90222406},"labels":[],"label_agreement":null},{"id":"W2604321694","doi":"10.1111/apt.14027","title":"Editorial: vedolizumab in pregnancy – is gut selectivity as good for baby as it is for mum?","year":2017,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Vedolizumab; Medicine; Pregnancy; MEDLINE; Obstetrics; Internal medicine; Inflammatory bowel disease; Biochemistry; Disease; Genetics","score_opus":0.040548712893207536,"score_gpt":0.4200077115173035,"score_spread":0.37945899862409593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604321694","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031935875,0.00594639,0.0000641015,0.013871227,0.9704041,0.0059012054,0.002126733,0.00011146586,0.0012554055],"genre_scores_gemma":[0.0013432241,0.011719908,0.00025510875,0.026312558,0.9459807,0.0027100598,0.0018627502,0.0002223394,0.009593314],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99562645,0.00020752753,0.00089341635,0.0011795138,0.00093216886,0.001160908],"domain_scores_gemma":[0.99525464,0.002004623,0.00084228034,0.0009262571,0.00059272617,0.00037950196],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0007593081,0.0008284099,0.0014078714,0.00029440326,0.00037347543,0.000051944317,0.00082713034,0.0020690265,0.0007100174],"category_scores_gemma":[0.000052447784,0.00082583795,0.00051834335,0.00014203473,0.00029968016,0.0002889295,0.00013161218,0.0015808287,0.00009214815],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004039249,0.0011104527,0.00008168514,0.0006376856,0.009283181,0.000021436445,0.0011151923,3.346594e-7,0.0053978977,0.000008905817,0.9741438,0.004160151],"study_design_scores_gemma":[0.021087833,0.0030709924,0.00001872047,0.0012248986,0.016102266,0.000014440519,0.0000574949,0.000049232454,0.026465582,0.0010085024,0.9302647,0.00063530164],"about_ca_topic_score_codex":0.00021070753,"about_ca_topic_score_gemma":0.0000303826,"teacher_disagreement_score":0.04387909,"about_ca_system_score_codex":0.000776443,"about_ca_system_score_gemma":0.0038370213,"threshold_uncertainty_score":0.9994193},"labels":[],"label_agreement":null},{"id":"W2604725648","doi":"10.1111/apt.14012","title":"Editorial: latent class analysis to improve confidence in the diagnosis of <scp>IBS</scp> – authors’ reply","year":2017,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"National Institutes of Health; Valeant Pharmaceuticals International; Ironwood Pharmaceuticals, Incorporated","keywords":"Medicine; Class (philosophy); Epistemology; Philosophy","score_opus":0.032040288967804836,"score_gpt":0.35499973254446154,"score_spread":0.32295944357665674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604725648","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033649158,0.0009229639,0.00002433361,0.007460858,0.95546675,0.0017755764,0.00045461813,0.00004844222,0.00019729233],"genre_scores_gemma":[0.036133375,0.0022093402,0.00023628544,0.014012298,0.9454643,0.0005592279,0.00071783015,0.00008681253,0.00058054656],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954218,0.0006316627,0.0010056683,0.00092527166,0.0012734064,0.00074213935],"domain_scores_gemma":[0.9932143,0.004015231,0.000792976,0.0011812104,0.00054676185,0.00024953388],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017969724,0.0006035207,0.0013444574,0.00050999556,0.0001880046,0.000057356905,0.001206143,0.00071404956,0.000096065574],"category_scores_gemma":[0.000111876914,0.00048731174,0.00056753977,0.0005684894,0.000482505,0.00011307529,0.00024262957,0.001960019,0.0000305988],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005911439,0.0010033203,0.016381582,0.00012300858,0.014811104,0.00007233319,0.0012006745,0.000053907886,0.002441755,0.000003748648,0.96311945,0.00019795122],"study_design_scores_gemma":[0.002988018,0.0025259093,0.0040196422,0.00012449254,0.061676107,0.0000051592674,0.0005662999,0.00008048762,0.0026888137,0.00011147622,0.92503923,0.00017438653],"about_ca_topic_score_codex":0.0016663757,"about_ca_topic_score_gemma":0.00037053975,"teacher_disagreement_score":0.046865,"about_ca_system_score_codex":0.00023813992,"about_ca_system_score_gemma":0.00057014555,"threshold_uncertainty_score":0.9997578},"labels":[],"label_agreement":null},{"id":"W2604820284","doi":"10.1111/apt.14029","title":"Letter: the coeliac stomach – a significant increase in tissue transglutaminase antibodies is associated with gastritis","year":2017,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Tissue transglutaminase; Medicine; Stomach; Gastritis; Gastroenterology; Antibody; Coeliac disease; Atrophic gastritis; Internal medicine; Pathology; Immunology; Enzyme; Biochemistry; Disease; Biology","score_opus":0.036344422397070496,"score_gpt":0.3418479971378764,"score_spread":0.3055035747408059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604820284","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.069356345,0.0044199405,0.000010064056,0.92049104,0.0004682165,0.003442829,0.0011329186,0.000095424824,0.00058323826],"genre_scores_gemma":[0.071227536,0.005904585,0.000028378101,0.9147963,0.0015085158,0.00042130647,0.00210525,0.00013426517,0.0038738616],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958523,0.00068447104,0.0004980468,0.00079865847,0.00092642073,0.0012401184],"domain_scores_gemma":[0.99814755,0.00036419602,0.00030444327,0.00082012493,0.00013827441,0.00022538655],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005385615,0.0006872704,0.0009319857,0.0003424311,0.0003723638,0.000102866885,0.000712964,0.0004132627,0.0013136104],"category_scores_gemma":[0.0000014534143,0.000494159,0.00021685768,0.00020949928,0.00093558524,0.00012702207,0.00016930536,0.0024048607,0.00008239922],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011969167,0.0008583256,0.0021216387,0.00027380724,0.016161397,0.03047406,0.00029285546,0.0000015433991,0.0070560286,5.6484777e-7,0.93892324,0.002639621],"study_design_scores_gemma":[0.007356066,0.001288832,0.0036637143,0.00037365005,0.019656025,0.0001306578,0.00007764788,0.000085431086,0.0074362173,0.000016440832,0.9593631,0.00055219245],"about_ca_topic_score_codex":0.0010133026,"about_ca_topic_score_gemma":0.00012231861,"teacher_disagreement_score":0.030343402,"about_ca_system_score_codex":0.00043099193,"about_ca_system_score_gemma":0.0003916535,"threshold_uncertainty_score":0.99989665},"labels":[],"label_agreement":null},{"id":"W2604995339","doi":"10.1111/apt.14002","title":"Editorial: latent class analysis to improve confidence in the diagnosis of <scp>IBS</scp>","year":2017,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Complementary and Integrative Health; National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; Valeant Pharmaceuticals International; Ironwood Pharmaceuticals, Incorporated","keywords":"Medicine; Latent class model; Confidence interval; Class (philosophy); Internal medicine; Artificial intelligence; Statistics; Computer science","score_opus":0.02897786262075018,"score_gpt":0.3498256603590828,"score_spread":0.3208477977383326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604995339","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036925577,0.0010376574,0.000020217542,0.004089527,0.95559037,0.0016052073,0.0004462695,0.00003637788,0.0002488077],"genre_scores_gemma":[0.05397582,0.002664451,0.00016102681,0.0086165145,0.9330686,0.00048383154,0.0006370131,0.00007028265,0.00032248787],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99616647,0.00046258615,0.0008235327,0.0007473121,0.0011356655,0.0006644173],"domain_scores_gemma":[0.9939974,0.003796139,0.0006192666,0.0009250552,0.0004634317,0.00019873994],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011844311,0.00053984416,0.0012146393,0.00044823476,0.00015408045,0.00004647665,0.0011011697,0.00067429454,0.00011276334],"category_scores_gemma":[0.000062080566,0.00043085104,0.0005024442,0.00048375342,0.00044204126,0.00009805288,0.00020953902,0.0016306238,0.00003219492],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004887771,0.0010388835,0.016035778,0.00011895508,0.015415954,0.000057124933,0.0008867608,0.000049299055,0.0026194116,0.000002725036,0.9630949,0.00019147077],"study_design_scores_gemma":[0.0035147797,0.0025240863,0.004155711,0.00011819642,0.07126408,0.0000041560165,0.00057105004,0.00009693264,0.0031190834,0.0000952817,0.91436756,0.00016907642],"about_ca_topic_score_codex":0.0012155899,"about_ca_topic_score_gemma":0.00044946017,"teacher_disagreement_score":0.05584813,"about_ca_system_score_codex":0.0002046404,"about_ca_system_score_gemma":0.0004920888,"threshold_uncertainty_score":0.99981433},"labels":[],"label_agreement":null},{"id":"W2607938551","doi":"10.1111/apt.14082","title":"The risk of gastric cancer in patients with gastric intestinal metaplasia in 5‐year follow‐up","year":2017,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Chulalongkorn University","keywords":"Medicine; Cancer; Internal medicine; Dysplasia; Gastroenterology; Retrospective cohort study; Population; Intestinal metaplasia; Odds ratio; Cohort study","score_opus":0.02288884649103418,"score_gpt":0.3079085253239596,"score_spread":0.28501967883292545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607938551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948313,0.00066759135,0.000007136519,0.0029258595,0.00072880025,0.00071345514,0.000044397897,0.000015941563,0.000065510016],"genre_scores_gemma":[0.99580836,0.0020266909,0.0002439896,0.0016558261,0.00006187933,0.00009363105,0.000013438497,0.00003079911,0.00006535968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981111,0.00027209206,0.0004807551,0.00032329315,0.00023976924,0.0005729896],"domain_scores_gemma":[0.99872804,0.00020083382,0.00044413563,0.00039253582,0.00015312732,0.00008133559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035656916,0.00027243205,0.0004788339,0.00021056393,0.00024571686,0.000012091176,0.00037545088,0.0000891502,0.00007096454],"category_scores_gemma":[0.0000044498865,0.00018311781,0.00007212201,0.00023763503,0.0005911865,0.000116891955,0.00016008735,0.0007091227,0.000008250067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049960664,0.00047506078,0.9829839,0.000010153986,0.0072137234,0.00003061002,0.0003232989,0.000033101533,0.0011265049,0.0000013667988,0.00010455279,0.002701686],"study_design_scores_gemma":[0.01579785,0.00169203,0.97483253,0.000059574166,0.0057826606,0.000011453685,0.00015053788,0.000089882895,0.0012133395,0.00001135714,0.0002524754,0.00010633191],"about_ca_topic_score_codex":0.00042773425,"about_ca_topic_score_gemma":0.00084579736,"teacher_disagreement_score":0.010801784,"about_ca_system_score_codex":0.00020938835,"about_ca_system_score_gemma":0.00010226015,"threshold_uncertainty_score":0.7467328},"labels":[],"label_agreement":null},{"id":"W2607955450","doi":"10.1111/apt.14075","title":"Systematic review: the safety of vedolizumab for the treatment of inflammatory bowel disease","year":2017,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Vedolizumab; Medicine; Placebo; Adverse effect; Internal medicine; Cohort; Incidence (geometry); Inflammatory bowel disease; Surgery; Disease; Pathology","score_opus":0.10638308744458437,"score_gpt":0.4420548028618828,"score_spread":0.33567171541729846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607955450","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000037228322,0.98268324,0.000015374866,0.0029327082,0.00089878816,0.013010845,0.00040614544,0.000015308808,0.000033845772],"genre_scores_gemma":[0.000032784803,0.99154884,0.000011111294,0.004979718,0.0002481946,0.0024159153,0.00022075603,0.00004654749,0.00049616495],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99736834,0.0005029715,0.00133938,0.00024680572,0.00027251028,0.0002699877],"domain_scores_gemma":[0.99505687,0.0015794632,0.0018214604,0.0012946816,0.000111901674,0.00013564211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006398374,0.000411641,0.0022354075,0.00006517051,0.00021343332,0.0000043370615,0.00061767607,0.00013030568,0.00009850585],"category_scores_gemma":[0.000006687232,0.00018356403,0.0011143528,0.00006433153,0.0005009647,0.00003711358,0.000040791514,0.00018886317,0.000009834423],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037512693,0.0006767268,0.000009647155,0.84640735,0.05284597,0.000012328149,0.00027806498,4.2976774e-7,0.000008864013,0.00002479091,0.0013462505,0.09801443],"study_design_scores_gemma":[0.0011535888,0.00032261218,0.000010264104,0.15618232,0.25458673,0.000021489474,0.000015803262,0.000012640405,0.000040381114,0.000005377526,0.58755237,0.00009644821],"about_ca_topic_score_codex":0.0000051251786,"about_ca_topic_score_gemma":6.6044146e-7,"teacher_disagreement_score":0.69022506,"about_ca_system_score_codex":0.00021740797,"about_ca_system_score_gemma":0.0008071474,"threshold_uncertainty_score":0.7485524},"labels":[],"label_agreement":null},{"id":"W2609056523","doi":"10.1111/apt.14063","title":"Systematic review with meta‐analysis: proximal disease extension in limited ulcerative colitis","year":2017,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"National Center for Advancing Translational Sciences; Crohn's and Colitis Foundation","keywords":"Ulcerative colitis; Medicine; Internal medicine; Meta-analysis; Disease; Gastroenterology; Epidemiology; Colitis; Extension (predicate logic)","score_opus":0.08129583899214149,"score_gpt":0.383434824010196,"score_spread":0.30213898501805453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609056523","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000075751814,0.9924598,0.000009762029,0.00018712055,0.00015630695,0.006603484,0.00043592535,0.000026331882,0.000045522844],"genre_scores_gemma":[0.0001662256,0.9848551,0.00006197657,0.00857154,0.00012967277,0.003566687,0.0021688538,0.00011365499,0.00036629307],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9943991,0.0023927162,0.001180563,0.0011144003,0.00032675313,0.00058652397],"domain_scores_gemma":[0.99678266,0.000085994965,0.0012009323,0.0014439046,0.00018652278,0.00029997434],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007306019,0.00096040993,0.0040949318,0.00028244837,0.00020316117,0.00005035933,0.0008420044,0.00030648935,0.00019641193],"category_scores_gemma":[0.0000029247165,0.00069205597,0.0018936939,0.0002983754,0.00028555398,0.000018217432,0.0002458548,0.00041795842,0.000039677794],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047949995,0.00035150175,0.000015227827,0.31917298,0.67811775,0.0012727496,0.000017581551,0.000009650004,0.000012363631,0.0000055630903,0.00014341141,0.0004017058],"study_design_scores_gemma":[0.0005820943,0.00013974213,0.0000673218,0.022804782,0.9302145,0.000035188772,0.000007748001,0.000021464093,0.000014924917,0.0000029695789,0.04540017,0.00070908986],"about_ca_topic_score_codex":0.000008755142,"about_ca_topic_score_gemma":0.00009940249,"teacher_disagreement_score":0.2963682,"about_ca_system_score_codex":0.00012715632,"about_ca_system_score_gemma":0.000687788,"threshold_uncertainty_score":0.9995531},"labels":[],"label_agreement":null},{"id":"W2610285506","doi":"10.1111/apt.14049","title":"Editorial: variability in adalimumab trough and peak serum concentrations","year":2017,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"KU Leuven; UCB Pharma; Pfizer","keywords":"Medicine; Adalimumab; Trough (economics); Internal medicine","score_opus":0.010424380469773942,"score_gpt":0.30773318832358043,"score_spread":0.2973088078538065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610285506","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02459045,0.0006891989,0.000009488804,0.00045577667,0.9720308,0.0007975517,0.001155454,0.000028773076,0.00024247468],"genre_scores_gemma":[0.021994479,0.0030569825,0.000058600224,0.001444129,0.9706995,0.00016034412,0.0020601589,0.000090218426,0.00043558388],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99683636,0.00079543295,0.0005325355,0.0008816837,0.0003752678,0.00057872245],"domain_scores_gemma":[0.9983233,0.00022675979,0.00034692822,0.00072584266,0.00020650201,0.00017062285],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008874806,0.00052469,0.0004298321,0.00006270756,0.00028193937,0.00007414071,0.00063314557,0.0012931664,0.00010997558],"category_scores_gemma":[0.000011051869,0.0005214144,0.00013457128,0.00003775665,0.0004931105,0.000020887408,0.00033335545,0.0008037808,0.000012683789],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010003672,0.00027604355,0.0018035953,0.00006832822,0.0028283815,0.000057772184,0.00009862744,0.000012849102,0.028262628,0.0000054626325,0.96536016,0.0002257947],"study_design_scores_gemma":[0.0037076662,0.00019078293,0.0013162041,0.000019379264,0.0029848623,0.0000024216479,0.000028950582,0.00003510584,0.003968693,0.00011804126,0.9870841,0.00054380076],"about_ca_topic_score_codex":0.000059064594,"about_ca_topic_score_gemma":0.0001853638,"teacher_disagreement_score":0.024293935,"about_ca_system_score_codex":0.00014841622,"about_ca_system_score_gemma":0.0010018838,"threshold_uncertainty_score":0.99972373},"labels":[],"label_agreement":null},{"id":"W2610753795","doi":"10.1111/apt.14092","title":"Misbalance in type <scp>III</scp> collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's disease","year":2017,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"ZonMw","keywords":"Medicine; Biomarker; Serology; Crohn's disease; Disease; Immunology; Pathology; Antibody; Biochemistry; Chemistry","score_opus":0.036655948759302504,"score_gpt":0.3272770532435511,"score_spread":0.2906211044842486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610753795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658614,0.00049081474,0.00020032644,0.00061629515,0.0005424407,0.001010328,0.00013878063,0.000022948334,0.00039190947],"genre_scores_gemma":[0.98992884,0.00030908448,0.00040554788,0.007710789,0.00023749584,0.00020338393,0.00070085336,0.000033571894,0.0004704287],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985532,0.00011308134,0.0003343968,0.00042153234,0.00013561735,0.0004421344],"domain_scores_gemma":[0.998998,0.00005825131,0.0002713031,0.0003841185,0.000121004356,0.0001673439],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000271417,0.00025824923,0.00017428023,0.000054214444,0.00040962704,0.0000695432,0.00044261466,0.00017760691,0.000024080067],"category_scores_gemma":[0.000009748888,0.00026039704,0.00010238937,0.00004564696,0.00018163453,0.000043166252,0.00014199546,0.000085100626,0.000013911259],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029111977,0.0005733465,0.058323503,0.000057523397,0.0014161918,0.00021348434,0.00019233447,0.00015000891,0.93239254,0.000043176165,0.0023486344,0.0013780376],"study_design_scores_gemma":[0.0066855885,0.00028367204,0.9131425,0.0000144076,0.0012733113,0.000016525635,0.0001653457,0.0076499972,0.06301046,0.00017000655,0.0073407367,0.0002474143],"about_ca_topic_score_codex":0.000051083513,"about_ca_topic_score_gemma":0.0001379145,"teacher_disagreement_score":0.8693821,"about_ca_system_score_codex":0.00005911079,"about_ca_system_score_gemma":0.00017186541,"threshold_uncertainty_score":0.9999848},"labels":[],"label_agreement":null},{"id":"W2611391367","doi":"10.1111/apt.14036","title":"Editorial: the impact of the placebo effect in Crohn's disease","year":2017,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Pain Management and Placebo Effect","field":"Neuroscience","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Janssen Canada","keywords":"Medicine; Crohn's disease; Placebo; Crohn disease; Internal medicine; MEDLINE; Disease; Gastroenterology; Alternative medicine; Pathology","score_opus":0.02211637022431031,"score_gpt":0.3603006186037181,"score_spread":0.3381842483794078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611391367","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017191207,0.00046616938,0.0000017616024,0.0007407488,0.9778875,0.0028147697,0.00040480867,0.000046222074,0.00044682232],"genre_scores_gemma":[0.06689579,0.0012909655,9.794791e-7,0.001606183,0.9289464,0.00029206253,0.000061673425,0.000090733294,0.00081521785],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9894812,0.007590604,0.00047252342,0.0007084909,0.0010275033,0.0007196523],"domain_scores_gemma":[0.98168385,0.016218442,0.0007474225,0.0011840641,0.000052450625,0.00011379941],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004053476,0.00067759986,0.00065479934,0.00015231167,0.0005503968,0.000111617956,0.0031591803,0.00049357204,0.00019756661],"category_scores_gemma":[0.00009859837,0.0003726646,0.0006268176,0.00024709405,0.000856595,0.00018483208,0.00065021677,0.0018882045,0.000048461865],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003405369,0.00019605408,0.0017091413,0.00007562335,0.0015711675,0.00006434456,0.00011373434,0.00027711233,0.01605444,0.0000019049373,0.9761846,0.0003464796],"study_design_scores_gemma":[0.0055318493,0.00041288597,0.002367238,0.00013047915,0.007926389,7.271821e-7,0.00000618153,0.0011221265,0.014552285,0.00026141462,0.96706843,0.00061997544],"about_ca_topic_score_codex":0.00034575522,"about_ca_topic_score_gemma":0.000023081171,"teacher_disagreement_score":0.04970458,"about_ca_system_score_codex":0.00032895233,"about_ca_system_score_gemma":0.0005320333,"threshold_uncertainty_score":0.9998725},"labels":[],"label_agreement":null},{"id":"W2611449195","doi":"10.1111/apt.14074","title":"Editorial: the impact of the placebo effect in Crohn's disease – author's reply","year":2017,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Pain Management and Placebo Effect","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Placebo; Crohn's disease; Crohn disease; Gastroenterology; Disease; Internal medicine; Alternative medicine; Pathology","score_opus":0.02652098190471685,"score_gpt":0.3700259111890536,"score_spread":0.34350492928433674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611449195","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013592139,0.00046145316,0.0000023839066,0.0018007384,0.9800509,0.0031809155,0.00043615684,0.0000647721,0.00041054847],"genre_scores_gemma":[0.049772844,0.00090939295,0.0000017273899,0.0030541725,0.94417393,0.00035562948,0.00007696816,0.00011392695,0.0015413965],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9872309,0.009285073,0.000595693,0.0008924065,0.0011809735,0.00081498135],"domain_scores_gemma":[0.980049,0.017235553,0.00096976093,0.0015352678,0.00006773701,0.000142649],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00586307,0.0007667281,0.0007507257,0.00018301974,0.0006597431,0.00013975608,0.0033836504,0.00050741964,0.0001901775],"category_scores_gemma":[0.00017367997,0.00043386634,0.0007101298,0.00030071865,0.00092591636,0.00021663196,0.000738083,0.002175491,0.000047640762],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004093792,0.00020656362,0.0015721455,0.00008268322,0.0016993186,0.00008730587,0.00015464639,0.00025950882,0.013936924,0.0000023621933,0.9775206,0.00038419137],"study_design_scores_gemma":[0.004116592,0.0003962204,0.001995538,0.00011917904,0.006624972,8.8228785e-7,0.0000066242283,0.0010006543,0.010060684,0.00025020936,0.97487307,0.00055536086],"about_ca_topic_score_codex":0.0004807422,"about_ca_topic_score_gemma":0.000020989652,"teacher_disagreement_score":0.036180705,"about_ca_system_score_codex":0.00038586865,"about_ca_system_score_gemma":0.0006354471,"threshold_uncertainty_score":0.9998113},"labels":[],"label_agreement":null},{"id":"W2611617026","doi":"10.1111/apt.14117","title":"The frequency of acute kidney injury in patients with chronic hepatitis C virus infection treated with sofosbuvir‐based regimens","year":2017,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research; Public Health Ontario; University of Toronto","funders":"University of Arkansas for Medical Sciences","keywords":"Medicine; Sofosbuvir; Telaprevir; Internal medicine; Boceprevir; Regimen; Acute kidney injury; Renal function; Creatinine; Gastroenterology; Hepatitis C virus; Ribavirin; Immunology","score_opus":0.021136869962335925,"score_gpt":0.33819810589439636,"score_spread":0.3170612359320604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611617026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953742,0.00007825274,0.000016838798,0.002312952,0.000189492,0.0013976062,0.00022128466,0.00003914763,0.00037021757],"genre_scores_gemma":[0.9931098,0.002479502,0.00013819803,0.0036722266,0.000072925795,0.00015707102,0.00019535568,0.000057340818,0.000117580574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980294,0.0002635408,0.000362613,0.000344833,0.00046119,0.00053843606],"domain_scores_gemma":[0.9985231,0.00007507986,0.0003165194,0.0006732566,0.00022830578,0.00018372523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024783288,0.0002759652,0.00037666323,0.0001739947,0.00046100965,0.000032377735,0.00030028136,0.00012737431,0.00027834644],"category_scores_gemma":[0.000001374579,0.0001815612,0.000061907995,0.00020404847,0.00079526997,0.00022021758,0.00006909646,0.00048044694,0.000020177076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029009448,0.0006453798,0.9492387,0.0000291829,0.005844526,0.0000689383,0.000064447995,0.000003899197,0.03765263,0.0000052215455,0.0003493037,0.0031968197],"study_design_scores_gemma":[0.01057369,0.0056700823,0.8218173,0.00010569979,0.003954734,0.0000038135217,0.0000015280564,0.0003553434,0.1544982,0.000012982357,0.002792056,0.00021456399],"about_ca_topic_score_codex":0.01114592,"about_ca_topic_score_gemma":0.0023138735,"teacher_disagreement_score":0.12742141,"about_ca_system_score_codex":0.00054270175,"about_ca_system_score_gemma":0.00062499795,"threshold_uncertainty_score":0.99543893},"labels":[],"label_agreement":null},{"id":"W2612875473","doi":"10.1111/apt.14093","title":"Editorial: is it time for therapeutic drug monitoring of anti‐<scp>TNF</scp> agents during pregnancy? Maybe, maybe not. Author's reply","year":2017,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Pregnancy; Drug; Intensive care medicine; Pharmacology","score_opus":0.0492825322805658,"score_gpt":0.3872244019861578,"score_spread":0.33794186970559204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612875473","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00998189,0.007928849,0.00001755024,0.00479132,0.97189474,0.003324236,0.0015245209,0.00021266507,0.00032424144],"genre_scores_gemma":[0.006811669,0.01763215,0.00035236805,0.003754799,0.9394967,0.00063294836,0.0010014994,0.0003777857,0.029940112],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934725,0.0003605347,0.001582778,0.0013770314,0.0017974377,0.0014097213],"domain_scores_gemma":[0.992962,0.001965895,0.0020695755,0.0016632375,0.000809743,0.0005295209],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0009205479,0.0011566172,0.0019395142,0.00043728238,0.0006963525,0.000075724405,0.0014069421,0.0015418491,0.00030591147],"category_scores_gemma":[0.00004238663,0.0011290134,0.0007699392,0.00019859297,0.000557745,0.00040414784,0.00030937284,0.0019449804,0.000114663664],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063815014,0.00071676716,0.00056440546,0.0012036274,0.0176566,0.000053163098,0.0035194322,0.0000022298084,0.080287956,7.557493e-7,0.8945208,0.00083611277],"study_design_scores_gemma":[0.00801877,0.00055072765,0.0005241074,0.002358338,0.021740481,0.00001610598,0.00027626543,0.0000384251,0.20433931,0.000038477854,0.7617212,0.00037780538],"about_ca_topic_score_codex":0.000059880473,"about_ca_topic_score_gemma":3.7581074e-7,"teacher_disagreement_score":0.13279963,"about_ca_system_score_codex":0.0005263397,"about_ca_system_score_gemma":0.0013292476,"threshold_uncertainty_score":0.99975437},"labels":[],"label_agreement":null},{"id":"W2619235990","doi":"10.1111/apt.14153","title":"The use of selective serotonin receptor inhibitors (<scp>SSRI</scp>s) is not associated with increased risk of endoscopy‐refractory bleeding, rebleeding or mortality in peptic ulcer bleeding","year":2017,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Odense Universitetshospital","keywords":"Medicine; Refractory (planetary science); Endoscopy; Gastroenterology; Internal medicine; Peptic ulcer; Serotonin; Surgery; Receptor","score_opus":0.07814820331176026,"score_gpt":0.3418269705799049,"score_spread":0.26367876726814465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619235990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99692726,0.0002080106,0.0000029849098,0.0007075349,0.0004325124,0.0014211854,0.00015557968,0.000046300658,0.00009864905],"genre_scores_gemma":[0.99613696,0.0013756766,0.0007320398,0.0012306859,0.00013959901,0.00015252942,0.000041449715,0.00007201429,0.00011902249],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969312,0.0003118173,0.00087003567,0.0005645746,0.0005964678,0.0007258967],"domain_scores_gemma":[0.9948059,0.002485203,0.0016210328,0.00046887717,0.0004161428,0.00020284987],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009432266,0.0004916779,0.0008869579,0.00021220309,0.0005712089,0.00006370718,0.00037352223,0.00018788243,0.00009830181],"category_scores_gemma":[0.00006845073,0.0003305933,0.00020054908,0.00030444423,0.00072937604,0.00037116598,0.00015966977,0.0007577924,0.0000047945778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012073958,0.0014306589,0.82700235,0.000043503635,0.0126469275,0.000049393504,0.0011793863,0.000028134622,0.15530579,0.0000050246413,0.00095319207,0.00014823664],"study_design_scores_gemma":[0.0067993365,0.0030539553,0.48755577,0.0005429571,0.012840873,0.00002074296,0.0008055343,0.0006601258,0.48713621,0.000010456122,0.00043163364,0.00014241676],"about_ca_topic_score_codex":0.0022888624,"about_ca_topic_score_gemma":0.0002456227,"teacher_disagreement_score":0.3394466,"about_ca_system_score_codex":0.00054096465,"about_ca_system_score_gemma":0.0002844493,"threshold_uncertainty_score":0.9999146},"labels":[],"label_agreement":null},{"id":"W2623251124","doi":"10.1111/apt.14077","title":"Editorial: the Millennium study cohort―evaluating environmental determinates of <scp>IBD</scp> in the 21st century","year":2017,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Cohort; Environmental health; Cohort study; MEDLINE; Internal medicine; Political science","score_opus":0.013939862462504924,"score_gpt":0.31616155897050524,"score_spread":0.3022216965080003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623251124","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42019013,0.0030293681,1.4422886e-7,0.000046795038,0.5745973,0.0016678872,0.00032424374,0.000008522474,0.00013561262],"genre_scores_gemma":[0.15091567,0.009548169,0.0000138735095,0.0010420873,0.8363983,0.00052642054,0.0012509078,0.00012128959,0.00018329761],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99504316,0.0017712008,0.0007446693,0.0007773644,0.0010247425,0.0006388659],"domain_scores_gemma":[0.99697673,0.00079525553,0.0008508611,0.0011977539,0.000097789474,0.00008158232],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020451813,0.00064118055,0.0004914883,0.000080162215,0.00045872352,0.0000630776,0.0021466736,0.0007930447,0.00003549069],"category_scores_gemma":[0.00001659721,0.00046271176,0.000269381,0.00005033923,0.0006846343,0.000015209563,0.00060168316,0.0010652057,0.000016234215],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046242384,0.0014943075,0.0139534045,0.000057815098,0.0075226193,0.00009650829,0.0018456093,0.000029094621,0.08727789,4.6900783e-7,0.8867171,0.0005427616],"study_design_scores_gemma":[0.003593985,0.0011457228,0.007535023,0.000022661497,0.008940486,0.000004797441,0.004822664,0.000021296299,0.008224779,0.000009865798,0.96538216,0.00029656556],"about_ca_topic_score_codex":0.000065063214,"about_ca_topic_score_gemma":0.00007110987,"teacher_disagreement_score":0.26927447,"about_ca_system_score_codex":0.00011355204,"about_ca_system_score_gemma":0.00036771086,"threshold_uncertainty_score":0.99978244},"labels":[],"label_agreement":null},{"id":"W2624476637","doi":"10.1111/apt.14118","title":"Editorial: the diminishing returns of normalisation of the oesophageal mucosa―Authors' reply","year":2017,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Gastroenterology; General surgery; Intensive care medicine; Internal medicine","score_opus":0.023098132833156173,"score_gpt":0.34270408680975173,"score_spread":0.3196059539765956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624476637","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029061284,0.0009121923,0.0000016326247,0.0018286868,0.96611303,0.0012417169,0.0005358368,0.00003289729,0.00027270784],"genre_scores_gemma":[0.27069074,0.000701906,0.00006659722,0.0015597163,0.7255184,0.00005899071,0.0004932638,0.000079376645,0.0008310066],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961407,0.0005600971,0.0009218641,0.0005033734,0.0013829417,0.0004910094],"domain_scores_gemma":[0.99547905,0.00096412795,0.0016771569,0.0012616277,0.00049908046,0.000118951975],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009832196,0.000531283,0.0009080124,0.000100899015,0.00042157024,0.00003136584,0.0010993747,0.0007652648,0.00013912498],"category_scores_gemma":[0.00001901606,0.00031165418,0.00050988974,0.00013518553,0.0007800155,0.00015382117,0.0003442169,0.0016629042,0.000008923008],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072408497,0.0005409966,0.0050485525,0.0001637577,0.012824287,0.000050590566,0.0010416821,0.000004420693,0.005421292,0.000004182243,0.97381896,0.0003572151],"study_design_scores_gemma":[0.0069255703,0.0016401144,0.004098972,0.00021637477,0.050769504,0.000022616958,0.00011843896,0.000027559288,0.07244796,0.00013778986,0.86335117,0.0002439394],"about_ca_topic_score_codex":0.00017639411,"about_ca_topic_score_gemma":0.000011493492,"teacher_disagreement_score":0.24162945,"about_ca_system_score_codex":0.00021730631,"about_ca_system_score_gemma":0.0007288605,"threshold_uncertainty_score":0.99993354},"labels":[],"label_agreement":null},{"id":"W2625740605","doi":"10.1111/apt.14173","title":"Systematic review with meta‐analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis","year":2017,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":258,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Health and Medical Research Council","keywords":"Ulcerative colitis; Medicine; Meta-analysis; Fecal bacteriotherapy; Gastroenterology; Internal medicine; Transplantation; Colitis; MEDLINE; Immunology; Antibiotics; Microbiology; Clostridium difficile; Disease","score_opus":0.2040930666019682,"score_gpt":0.46352730538287995,"score_spread":0.25943423878091176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625740605","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024668074,0.97933173,0.00025719305,0.0014350951,0.00017796853,0.016997386,0.0017416436,0.000017493183,0.00001684227],"genre_scores_gemma":[0.00008879086,0.99157685,0.00014427744,0.0011456056,0.00017314547,0.004650217,0.0017639314,0.00006685353,0.0003903192],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99709344,0.0005901322,0.0010579209,0.0005382668,0.0003320084,0.00038822083],"domain_scores_gemma":[0.9959781,0.0016408312,0.0012212407,0.0005971897,0.0004618139,0.000100801386],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008472992,0.0005406996,0.0045990995,0.00024473638,0.0003647807,0.00002245939,0.0004075422,0.0002895278,0.00014819158],"category_scores_gemma":[0.000003179097,0.00029308366,0.0023210784,0.0003721174,0.0002601539,0.000070487535,0.000033193646,0.00047604105,0.0000028861912],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012007368,0.00019109556,6.495182e-8,0.42319444,0.5679878,0.0000067131377,0.00010562878,0.0000011729875,0.00036727986,0.0000037945115,0.00016969952,0.0067715757],"study_design_scores_gemma":[0.0012624823,0.00077832764,9.121949e-7,0.032305352,0.910409,0.0001270697,0.0000848103,0.000028871813,0.0075997952,0.0000016670442,0.04716432,0.00023742225],"about_ca_topic_score_codex":0.000035835696,"about_ca_topic_score_gemma":0.000022757493,"teacher_disagreement_score":0.39088908,"about_ca_system_score_codex":0.0002531854,"about_ca_system_score_gemma":0.0005664944,"threshold_uncertainty_score":0.99995214},"labels":[],"label_agreement":null},{"id":"W2688898320","doi":"10.1111/apt.14190","title":"The development of a magnetic resonance imaging index for fistulising Crohn's disease","year":2017,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Anorectal Disease Treatments and Outcomes","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"National Institute for Health and Care Research","keywords":"Intraclass correlation; Magnetic resonance imaging; Reliability (semiconductor); Medicine; Index (typography); Gold standard (test); Nuclear medicine; Confidence interval; Surgery; Statistics; Radiology; Psychometrics; Mathematics; Internal medicine; Computer science; Physics","score_opus":0.035535061281916976,"score_gpt":0.3616160753014483,"score_spread":0.3260810140195313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2688898320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9693232,0.019980857,0.00013343857,0.00824726,0.00066590495,0.0012187625,0.000054026037,0.00003308402,0.00034341906],"genre_scores_gemma":[0.99117994,0.00037478763,0.0009781398,0.0064177504,0.0001007992,0.000119671815,0.000026091382,0.000026361025,0.0007764753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902815,0.00003153214,0.00027489406,0.00021004796,0.00015180121,0.00030357906],"domain_scores_gemma":[0.9991972,0.00012892613,0.00015736691,0.00031589594,0.00006826851,0.00013233547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012224916,0.0001687439,0.00020099487,0.000030585732,0.0009511026,0.000030884872,0.00023456638,0.000024494608,0.000081930906],"category_scores_gemma":[9.939671e-7,0.00011518178,0.000114209375,0.000024848869,0.0003320882,0.000074019,0.00009163108,0.000076061304,0.0000046380464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00581704,0.00073651515,0.7597344,0.000086376494,0.0029555308,0.00015720096,0.0009251228,0.0000017592248,0.007940236,0.00007005524,0.0007359128,0.22083986],"study_design_scores_gemma":[0.0041194772,0.00009342515,0.9470891,0.000040842424,0.004342719,0.000003775897,0.00015833465,0.00070931844,0.0057293926,0.00017263967,0.037405077,0.00013594436],"about_ca_topic_score_codex":0.000011689242,"about_ca_topic_score_gemma":0.000009857755,"teacher_disagreement_score":0.22070391,"about_ca_system_score_codex":0.000082536746,"about_ca_system_score_gemma":0.00020240301,"threshold_uncertainty_score":0.73152083},"labels":[],"label_agreement":null},{"id":"W2726704291","doi":"10.1111/apt.14161","title":"Editorial: hepatitis C direct acting anti‐viral agents and the kidney","year":2017,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Medicine; Virology; Kidney; Hepatitis C; Internal medicine","score_opus":0.035213960647746956,"score_gpt":0.39080726283737055,"score_spread":0.3555933021896236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2726704291","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015350732,0.0015115672,0.0000013290074,0.008190142,0.9809573,0.0017239961,0.0007009734,0.00011756773,0.0052619944],"genre_scores_gemma":[0.0036741889,0.047828395,0.00005135209,0.012836359,0.932147,0.0002077218,0.00094083115,0.00018293437,0.0021311904],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948134,0.0010394907,0.00065604394,0.00086100725,0.0016550681,0.0009750023],"domain_scores_gemma":[0.99568045,0.0020450037,0.0005367859,0.000873291,0.00039115973,0.00047328987],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0016438182,0.000687712,0.001360519,0.00020090838,0.0009471333,0.00019529046,0.0008577804,0.0011607363,0.0006548969],"category_scores_gemma":[0.00005634242,0.0005159148,0.00029482067,0.00010452723,0.0014577395,0.00022793288,0.00061048503,0.002991382,0.00012464944],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014357602,0.00016942248,0.0033254852,0.00014881337,0.015267028,0.00016343106,0.0003935056,3.275163e-7,0.0009837667,0.0000012451318,0.9740625,0.0040486893],"study_design_scores_gemma":[0.011011022,0.00038878105,0.00010338152,0.00014890275,0.014717624,0.000005988265,0.00001804868,0.0001603443,0.0012729472,0.000027337683,0.9717295,0.0004161241],"about_ca_topic_score_codex":0.002186385,"about_ca_topic_score_gemma":0.00006476576,"teacher_disagreement_score":0.04881033,"about_ca_system_score_codex":0.00038428203,"about_ca_system_score_gemma":0.0012783682,"threshold_uncertainty_score":0.9997292},"labels":[],"label_agreement":null},{"id":"W2727800537","doi":"10.1111/apt.14160","title":"Editorial: the risk of cancer in patients with gastric intestinal metaplasia—Authors’ reply","year":2017,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Gastroenterology; Intestinal metaplasia; Cancer; Internal medicine; Metaplasia; General surgery","score_opus":0.01549616386341765,"score_gpt":0.320321320671084,"score_spread":0.3048251568076663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2727800537","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11876159,0.0014572163,0.000002736073,0.002293233,0.8753182,0.0013589957,0.0007258224,0.000046504312,0.000035691563],"genre_scores_gemma":[0.010930244,0.005931348,0.00017241568,0.0025943357,0.97908735,0.00033673356,0.0005235069,0.00016393105,0.000260149],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956911,0.0007418082,0.00094645965,0.00078061176,0.0010330741,0.0008069294],"domain_scores_gemma":[0.9954707,0.0010425939,0.0015414993,0.0008415518,0.0009586775,0.00014496884],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00086951215,0.00074469787,0.001360867,0.00032031402,0.0002804204,0.000020806729,0.0007932342,0.0007202911,0.00012370288],"category_scores_gemma":[0.000023868144,0.00048586738,0.00020587158,0.00027125876,0.0010693213,0.00012102653,0.00030939587,0.0037566768,0.000012667012],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050815674,0.0005519652,0.40887907,0.000046013887,0.029085282,0.000020664344,0.00026860894,0.000012140753,0.00011682197,6.962091e-8,0.5554987,0.00043906507],"study_design_scores_gemma":[0.015155918,0.004475814,0.13022041,0.00032935166,0.0744399,0.000005559075,0.000065076114,0.000014186915,0.00039265506,0.000008210872,0.77450913,0.0003837769],"about_ca_topic_score_codex":0.0010033415,"about_ca_topic_score_gemma":0.00031857844,"teacher_disagreement_score":0.27865866,"about_ca_system_score_codex":0.000444233,"about_ca_system_score_gemma":0.00065235223,"threshold_uncertainty_score":0.9997593},"labels":[],"label_agreement":null},{"id":"W2729024434","doi":"10.1111/apt.14187","title":"Editorial: hepatitis C direct acting antiviral agents and the kidney—authors’ reply","year":2017,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research; University of Toronto","funders":"AbbVie Canada; Merck Canada; Gilead Sciences","keywords":"Medicine; Virology; Hepatitis C; Kidney; Internal medicine","score_opus":0.039864374829586546,"score_gpt":0.3957784302275003,"score_spread":0.35591405539791376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2729024434","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00062446936,0.0012430403,0.0000027845706,0.012721852,0.9735895,0.0018860437,0.0005921632,0.00013836958,0.009201788],"genre_scores_gemma":[0.0038637295,0.035891153,0.00008733539,0.018334208,0.93698525,0.00024193908,0.00089861976,0.00020700925,0.0034907318],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939151,0.0014292828,0.00077098806,0.0010431963,0.0017970501,0.0010444195],"domain_scores_gemma":[0.9949267,0.002412057,0.0006729395,0.0010782056,0.0004534087,0.00045670022],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0024746167,0.0007485106,0.0013799429,0.00022932095,0.0010166431,0.00022296148,0.0008956111,0.0011399243,0.000370276],"category_scores_gemma":[0.00009671464,0.0005718079,0.00033646374,0.00014652972,0.0015711958,0.00025961804,0.0006800094,0.0034928534,0.00011349447],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002208341,0.00016935127,0.0029238358,0.00014946566,0.014600036,0.00020050936,0.00056665554,1.11254465e-7,0.0007955875,0.0000013999161,0.967905,0.010479703],"study_design_scores_gemma":[0.009970767,0.0004830442,0.0000708803,0.0001860046,0.01423247,0.0000049872624,0.000025828142,0.00014915067,0.0014605685,0.000042762826,0.9729137,0.00045987635],"about_ca_topic_score_codex":0.0022483747,"about_ca_topic_score_gemma":0.00008481228,"teacher_disagreement_score":0.036604214,"about_ca_system_score_codex":0.00041443418,"about_ca_system_score_gemma":0.0013248125,"threshold_uncertainty_score":0.99967337},"labels":[],"label_agreement":null},{"id":"W2733569545","doi":"10.1111/apt.14166","title":"Editorial: gut selective immunosuppression—is it a double edged sword? Authors’ reply","year":2017,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"SWORD; Immunosuppression; Medicine; Immunology; World Wide Web; Computer science","score_opus":0.019842594121866317,"score_gpt":0.3463338000159914,"score_spread":0.32649120589412506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2733569545","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004369758,0.00193289,0.0000067770493,0.001180178,0.9890217,0.0012726276,0.0009796582,0.0000797484,0.0011566298],"genre_scores_gemma":[0.0017702893,0.003079241,0.00008963479,0.008422593,0.97263986,0.00044347072,0.0039762985,0.00027099048,0.009307599],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949563,0.0005949563,0.00082956895,0.0015906541,0.000943431,0.0010850889],"domain_scores_gemma":[0.9960043,0.00015591581,0.0009720283,0.001703638,0.00082026614,0.00034387744],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0007939005,0.0010737727,0.000751566,0.0001524348,0.00089576596,0.00016110695,0.0019227079,0.0024470647,0.0006041963],"category_scores_gemma":[0.000007933487,0.0011185737,0.0005295514,0.000084585605,0.00053859194,0.00003231789,0.0008621579,0.0018401004,0.00021460917],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055200052,0.00030790342,0.00008091308,0.000057649562,0.012867599,0.000091259564,0.0002694564,0.0000062102495,0.15593272,6.652709e-7,0.82478607,0.000079572084],"study_design_scores_gemma":[0.005786881,0.00043060852,0.000054239685,0.000052822295,0.008468264,0.00000574329,0.00004954535,0.000009470697,0.08130762,0.00004112984,0.90278435,0.0010093328],"about_ca_topic_score_codex":0.000104219245,"about_ca_topic_score_gemma":0.00003082618,"teacher_disagreement_score":0.0779983,"about_ca_system_score_codex":0.00025936944,"about_ca_system_score_gemma":0.0018747878,"threshold_uncertainty_score":0.99912643},"labels":[],"label_agreement":null},{"id":"W2735922657","doi":"10.1111/apt.14185","title":"Editorial: different tests for different drugs in Crohn’s disease, or different tests for different people?","year":2017,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Disease; Crohn's disease; Crohn disease; Internal medicine","score_opus":0.020741780797867527,"score_gpt":0.33932830394770264,"score_spread":0.3185865231498351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735922657","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38263568,0.0010583897,0.000046982404,0.00043651366,0.6058997,0.004705553,0.0051345844,0.00007397467,0.000008626774],"genre_scores_gemma":[0.12885799,0.0038964462,0.000037902028,0.0013454943,0.840752,0.0071718157,0.015539651,0.0005328329,0.0018658388],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925002,0.00057735346,0.0014887627,0.0023294543,0.0011033007,0.0020009568],"domain_scores_gemma":[0.9943103,0.0013747517,0.0011392318,0.0017831587,0.000533708,0.00085884455],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00035773197,0.0022259066,0.0018529833,0.00031608096,0.0007002003,0.00023866032,0.0021983613,0.0019486464,0.00015809285],"category_scores_gemma":[0.000047334852,0.0017679414,0.0011154623,0.00006846807,0.00043645187,0.000033038017,0.0009184264,0.0011411924,0.000011221842],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0220693,0.0033888484,0.0108741475,0.001060161,0.0076254546,0.0000720963,0.00020878091,0.0000144271025,0.028624527,0.000006666285,0.92552054,0.0005350811],"study_design_scores_gemma":[0.026983757,0.0021530006,0.11853525,0.00037438932,0.020064544,0.0000030026742,0.00009405839,0.00029250822,0.014287617,0.00043582133,0.8132034,0.003572664],"about_ca_topic_score_codex":0.000030509402,"about_ca_topic_score_gemma":0.0014777367,"teacher_disagreement_score":0.25377768,"about_ca_system_score_codex":0.0007486395,"about_ca_system_score_gemma":0.0008482204,"threshold_uncertainty_score":0.99934703},"labels":[],"label_agreement":null},{"id":"W2736144485","doi":"10.1111/apt.14218","title":"Tenofovir disoproxil fumarate significantly decreases serum lipoprotein levels compared with entecavir nucleos(t)ide analogue therapy in chronic hepatitis B carriers","year":2017,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; Canadian Liver Foundation","keywords":"Medicine; Dyslipidemia; Entecavir; Internal medicine; Gastroenterology; Diabetes mellitus; Propensity score matching; Hepatitis B; Endocrinology; Hepatitis B virus; Immunology; Disease; Lamivudine; Virus","score_opus":0.06161967427200823,"score_gpt":0.3417131579339913,"score_spread":0.2800934836619831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736144485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98714983,0.0037403347,0.000030538587,0.00555149,0.00045167695,0.00228128,0.00031362104,0.00013288508,0.00034831912],"genre_scores_gemma":[0.97848755,0.0072420794,0.00026397005,0.01288365,0.000339888,0.00039761813,0.00008913788,0.00010129979,0.00019479517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967358,0.00034235205,0.000650248,0.00078295,0.0004624998,0.001026165],"domain_scores_gemma":[0.9981065,0.00014221988,0.0004282727,0.0008500165,0.0001594968,0.0003134878],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034374863,0.00063904736,0.0009750841,0.00023500324,0.00081797334,0.00007855104,0.00059256674,0.0001821762,0.0007437194],"category_scores_gemma":[0.0000019099507,0.00053869473,0.00015761102,0.0002076356,0.0011130739,0.0003495099,0.00018606818,0.0005950685,0.0000634768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018819232,0.00070312317,0.7782076,0.00006624495,0.010118334,0.0009961312,0.0011779749,0.000058896105,0.19307554,0.000013939961,0.00040650996,0.0132937925],"study_design_scores_gemma":[0.012887162,0.0031168559,0.796633,0.00018769603,0.0029494532,0.000066024,0.00022185143,0.00071116636,0.17229459,0.00007923629,0.010140406,0.0007125832],"about_ca_topic_score_codex":0.021496017,"about_ca_topic_score_gemma":0.031294744,"teacher_disagreement_score":0.020780958,"about_ca_system_score_codex":0.0008707826,"about_ca_system_score_gemma":0.0005864804,"threshold_uncertainty_score":0.99970645},"labels":[],"label_agreement":null},{"id":"W2736266120","doi":"10.1111/apt.14186","title":"Editorial: migration studies to determine risk and cause of inflammatory bowel disease","year":2017,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Medicine; Inflammatory bowel disease; Inflammatory Bowel Diseases; Disease; Gastroenterology; Crohn's disease; Internal medicine; MEDLINE; Intensive care medicine","score_opus":0.017987839287946,"score_gpt":0.32866482756754795,"score_spread":0.31067698827960194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736266120","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31444025,0.003950586,0.0000039498855,0.00013715481,0.679706,0.0006566907,0.0010798193,0.000019423243,0.0000061390547],"genre_scores_gemma":[0.01087507,0.022227012,0.000079932346,0.00092398725,0.96421117,0.00022694442,0.0010075821,0.00011652405,0.00033181362],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974378,0.00038089766,0.0005652916,0.000737,0.00046468663,0.0004143222],"domain_scores_gemma":[0.9975546,0.00016841237,0.0006792051,0.0007684117,0.0005045798,0.00032478757],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045177923,0.0005676689,0.0004540261,0.00012743766,0.00028405277,0.000034891425,0.0005436592,0.00063158874,0.000015739848],"category_scores_gemma":[0.000026582857,0.0005791983,0.00017036674,0.000028974622,0.00048297373,0.00001848935,0.00050851563,0.00042478237,0.00001148083],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002717076,0.00013383044,0.007163457,0.00024667138,0.009513576,0.00008868481,0.00021015479,0.00003894395,0.04328622,4.7084103e-7,0.93640316,0.00019777581],"study_design_scores_gemma":[0.002115407,0.0004368869,0.0028348295,0.00007027117,0.014358985,0.0000011288412,0.000054872275,0.000022840924,0.013883041,0.00003539123,0.9655415,0.0006448567],"about_ca_topic_score_codex":0.000025789695,"about_ca_topic_score_gemma":0.00017279584,"teacher_disagreement_score":0.30356517,"about_ca_system_score_codex":0.0000773609,"about_ca_system_score_gemma":0.000542841,"threshold_uncertainty_score":0.9996659},"labels":[],"label_agreement":null},{"id":"W2747068248","doi":"10.1111/apt.14246","title":"Editorial: faecal microbiota transplantation for ulcerative colitis—not quite there yet? Authors’ reply","year":2017,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Fecal bacteriotherapy; Ulcerative colitis; Medicine; Transplantation; Colitis; Gastroenterology; Internal medicine; Microbiology; Clostridium difficile; Biology; Disease; Antibiotics","score_opus":0.04251662213748137,"score_gpt":0.3874039048976903,"score_spread":0.3448872827602089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2747068248","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013155164,0.0010604381,0.00002162611,0.005700605,0.96848875,0.003595499,0.007478115,0.00015764263,0.00034215758],"genre_scores_gemma":[0.0024079597,0.01161371,0.00015855621,0.0037084066,0.96490544,0.0005988236,0.009920328,0.00026952155,0.006417244],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99470496,0.0004772557,0.0009721694,0.001327094,0.0012585407,0.0012600078],"domain_scores_gemma":[0.9951845,0.0019107048,0.00060368393,0.0008738285,0.0010252347,0.00040203793],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.001044922,0.00094203785,0.0013559022,0.00028361505,0.0008108909,0.00017848257,0.00083398115,0.0019175371,0.000579929],"category_scores_gemma":[0.0000136005365,0.00091140287,0.000625504,0.00014446926,0.0005918357,0.00017112176,0.00014940575,0.0025592677,0.00010242677],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016018521,0.00054172624,0.000009731147,0.0005239732,0.010771116,0.0001350009,0.0004885651,0.0000018406569,0.15968329,0.000005223843,0.81086534,0.0009556496],"study_design_scores_gemma":[0.009434721,0.0017897331,0.000042469102,0.0002049767,0.018637912,0.000029688314,0.00010080111,0.00003904862,0.19399343,0.000024321344,0.7750924,0.00061049574],"about_ca_topic_score_codex":0.00036265576,"about_ca_topic_score_gemma":0.00010853417,"teacher_disagreement_score":0.03577296,"about_ca_system_score_codex":0.00086981273,"about_ca_system_score_gemma":0.0020506235,"threshold_uncertainty_score":0.99974185},"labels":[],"label_agreement":null},{"id":"W2754219589","doi":"10.1111/apt.14282","title":"Letter: lipid‐lowering effect of tenofovir disoproxil fumarate in chronic hepatitis B—more evidence is needed. Authors’ reply","year":2017,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Tenofovir; Medicine; Chronic hepatitis; Virology; Hepatitis B; Gastroenterology; Internal medicine; Virus; Human immunodeficiency virus (HIV)","score_opus":0.050127318321198454,"score_gpt":0.3697435532546246,"score_spread":0.31961623493342617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754219589","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32441184,0.014756568,0.0000056834997,0.6542013,0.0037335197,0.0024280709,0.00020189756,0.0001167234,0.00014437718],"genre_scores_gemma":[0.11282966,0.023239922,0.00007676933,0.8550461,0.00623123,0.00048418817,0.00021818517,0.00022220143,0.0016517589],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99477124,0.00069081085,0.0012485735,0.001214282,0.0007838295,0.001291267],"domain_scores_gemma":[0.9964997,0.00092120224,0.0009475224,0.0013409429,0.00014787399,0.00014273859],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0008880586,0.0010922581,0.0021783165,0.0005098692,0.00031642287,0.00004354166,0.0009055963,0.0008983582,0.0008381606],"category_scores_gemma":[0.0000069159714,0.0009937359,0.00049229554,0.00025375898,0.0010151352,0.00031800583,0.00053992856,0.0033271664,0.00013237058],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007499502,0.00012703185,0.12984443,0.002107964,0.013144595,0.0035129164,0.0014269236,0.0000052978235,0.06001032,1.38951e-7,0.78526205,0.003808362],"study_design_scores_gemma":[0.0045676506,0.004038919,0.011267386,0.002836425,0.019971203,0.00016995933,0.000010837536,0.00025646496,0.17050384,0.000008771072,0.7852828,0.0010857657],"about_ca_topic_score_codex":0.010376624,"about_ca_topic_score_gemma":0.00046955532,"teacher_disagreement_score":0.21158217,"about_ca_system_score_codex":0.0014884782,"about_ca_system_score_gemma":0.0004334065,"threshold_uncertainty_score":0.9992513},"labels":[],"label_agreement":null},{"id":"W2757094555","doi":"10.1111/apt.14338","title":"Review article: changes in the epidemiology of inflammatory bowel disease—clues for aetiology","year":2017,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Epidemiology; Etiology; Breastfeeding; Inflammatory bowel disease; Crohn's disease; Disease; Microbiome; Odds ratio; Gut flora; Ulcerative colitis; Immunology; Internal medicine; Pediatrics; Bioinformatics; Biology","score_opus":0.1691302948466917,"score_gpt":0.4733855058304839,"score_spread":0.30425521098379216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757094555","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00049813977,0.99208975,0.000008045099,0.0037334294,0.0006316083,0.0027100975,0.00030562017,0.0000072292373,0.000016053928],"genre_scores_gemma":[0.00010056745,0.9533223,0.00008622204,0.04400445,0.00051645044,0.00079556485,0.0010673692,0.000047910253,0.000059162372],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962423,0.0016469317,0.00090608245,0.0005582491,0.000057796573,0.00058867346],"domain_scores_gemma":[0.99772626,0.0004363831,0.00092391693,0.0007545405,0.00006731241,0.00009160429],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017267253,0.00044388516,0.0014037401,0.00009189477,0.00015349248,0.0000033369395,0.0009949823,0.0004281444,0.000047361274],"category_scores_gemma":[0.000007784261,0.00031669278,0.00044546076,0.00005801305,0.00058683375,0.0000041650574,0.00018055613,0.00035373465,0.000009623939],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012215278,0.0020490882,0.007982445,0.23584138,0.029425874,0.00006874357,0.00045760212,0.0000081187145,0.013795914,0.00048613606,0.09543078,0.6132324],"study_design_scores_gemma":[0.0005074871,0.00033975288,0.00029390855,0.0026437882,0.009132725,0.000027801203,0.000013618398,0.0000022579782,0.000116153606,0.000071631446,0.9865757,0.00027515064],"about_ca_topic_score_codex":0.000010984396,"about_ca_topic_score_gemma":0.000054682798,"teacher_disagreement_score":0.89114493,"about_ca_system_score_codex":0.00004348731,"about_ca_system_score_gemma":0.00039443147,"threshold_uncertainty_score":0.99992853},"labels":[],"label_agreement":null},{"id":"W2761350109","doi":"10.1111/apt.14366","title":"Beta‐blockers in hospitalised patients with cirrhosis and ascites: mortality and factors determining discontinuation and reinitiation","year":2017,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta","funders":"Yale Liver Center; National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Discontinuation; Medicine; Ascites; Cirrhosis; Internal medicine; Gastroenterology; Portal hypertension","score_opus":0.03923458088969513,"score_gpt":0.32435852118114844,"score_spread":0.2851239402914533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761350109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984602,0.00021936493,0.0000060502944,0.00070038403,0.00008208987,0.00046010382,0.0000373762,0.000012498921,0.00002195763],"genre_scores_gemma":[0.99788696,0.0006421394,0.000094935705,0.0011479658,0.000023191065,0.000016332719,0.00017370823,0.000011476056,0.0000033118165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993534,0.000048221653,0.0001434651,0.00021681638,0.000106125815,0.00013194364],"domain_scores_gemma":[0.99962974,0.000056041965,0.00011410003,0.00009584074,0.000028918483,0.00007534544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000072569936,0.00012807788,0.00015988188,0.00006204591,0.00017243205,0.000035073663,0.00003330436,0.000041084393,0.000012001317],"category_scores_gemma":[1.3793458e-7,0.0001071031,0.000013347111,0.000023495191,0.00016620311,0.00036109178,0.000019310686,0.00008038023,2.3721478e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002492415,0.0001146247,0.9937735,0.000031814638,0.0019795091,0.000012935104,0.0016446459,3.9844863e-7,0.0014815119,0.0000029499752,0.0000013899692,0.00070743513],"study_design_scores_gemma":[0.0051698117,0.00038778168,0.9801176,0.00004695424,0.008407127,0.0000019553602,0.0002724626,0.00027032307,0.005186968,0.000020735688,0.0000053060903,0.000112967],"about_ca_topic_score_codex":0.00014081527,"about_ca_topic_score_gemma":0.00007930733,"teacher_disagreement_score":0.013655936,"about_ca_system_score_codex":0.000024228393,"about_ca_system_score_gemma":0.000018260518,"threshold_uncertainty_score":0.43675378},"labels":[],"label_agreement":null},{"id":"W2762422255","doi":"10.1111/apt.14373","title":"Systematic review and meta‐analysis: assessment of factors affecting disability in inflammatory bowel disease and the reliability of the inflammatory bowel disease disability index","year":2017,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Københavns Universitet","keywords":"Medicine; Inflammatory bowel disease; Disease; Meta-analysis; Internal medicine; Inflammatory Bowel Diseases; Reliability (semiconductor); Index (typography); Gastroenterology; Intensive care medicine","score_opus":0.03624036371699569,"score_gpt":0.36629220653005146,"score_spread":0.3300518428130558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762422255","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14968883,0.8416961,0.0000026131843,0.00027954765,0.00016102039,0.0075628352,0.00059018465,0.00001255203,0.000006311303],"genre_scores_gemma":[0.29081133,0.7075008,0.000006424248,0.0005865407,0.00004084581,0.0008583585,0.00012961458,0.00005235766,0.000013721201],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9891488,0.006523079,0.0022900042,0.0010808626,0.00048338922,0.00047388158],"domain_scores_gemma":[0.9934586,0.0008229527,0.0024985424,0.0027483425,0.00014320012,0.0003283248],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0037020654,0.00095906097,0.0036551696,0.00007772662,0.00031341656,0.000041579675,0.0012478916,0.0003104953,0.000045474197],"category_scores_gemma":[0.00006308203,0.0005478814,0.00246535,0.0001875844,0.0042312182,0.00003997062,0.0011312228,0.0006630808,4.0190486e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034922882,0.0005893337,0.2565827,0.5584522,0.18372479,0.000013526828,0.00010431763,0.00008182448,0.000013027938,0.000021428234,0.0000068664035,0.000060765276],"study_design_scores_gemma":[0.00094457634,0.000029441406,0.17429517,0.0041169287,0.8195937,0.0000019043619,0.00006126827,0.000109610875,0.000011719092,0.00004947654,0.00028825193,0.0004979068],"about_ca_topic_score_codex":0.00004584712,"about_ca_topic_score_gemma":0.0000838305,"teacher_disagreement_score":0.63586897,"about_ca_system_score_codex":0.00019126463,"about_ca_system_score_gemma":0.0005942782,"threshold_uncertainty_score":0.99969727},"labels":[],"label_agreement":null},{"id":"W2762469244","doi":"10.1111/apt.14362","title":"<scp>HB</scp>eAg levels at week 24 predict response to 8 years of tenofovir in <scp>HB</scp>eAg‐positive chronic hepatitis B patients","year":2017,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Gilead Sciences","keywords":"HBeAg; Medicine; Seroconversion; HBsAg; Gastroenterology; Internal medicine; Hepatitis B virus; Chronic hepatitis; Hepatitis B; Immunology; Virus","score_opus":0.040223097496348545,"score_gpt":0.3288358937813199,"score_spread":0.28861279628497133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762469244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894672,0.0018719606,0.000013486021,0.002162555,0.002123658,0.002393058,0.0011379797,0.000096495,0.0007335912],"genre_scores_gemma":[0.9776572,0.0030700518,0.0003623693,0.015420534,0.0003909689,0.00026239714,0.00014159767,0.00014257386,0.0025523314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951515,0.0008202763,0.0010674772,0.0009149432,0.0007765127,0.0012692444],"domain_scores_gemma":[0.99560905,0.0020933622,0.0006372157,0.0009221727,0.0003194788,0.0004187426],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008813782,0.0006360985,0.0011527458,0.00047337773,0.00051624124,0.000036326746,0.00076210574,0.000343879,0.00018804593],"category_scores_gemma":[0.000084181345,0.000680621,0.00025302137,0.0003086698,0.0008636644,0.00031906023,0.00091806724,0.00069515675,0.00029354406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009189115,0.0016464901,0.82922333,0.000092369664,0.0068691834,0.00046055118,0.007355529,0.000032809457,0.13525265,0.0000049127743,0.015190518,0.0029527491],"study_design_scores_gemma":[0.008043788,0.0044658394,0.82372385,0.00020440888,0.003094441,0.000022443071,0.00020010096,0.0001339851,0.121874206,0.000029090343,0.038050983,0.00015683912],"about_ca_topic_score_codex":0.0020982027,"about_ca_topic_score_gemma":0.0021921485,"teacher_disagreement_score":0.022860466,"about_ca_system_score_codex":0.0015316418,"about_ca_system_score_gemma":0.00043714241,"threshold_uncertainty_score":0.99956447},"labels":[],"label_agreement":null},{"id":"W2764071025","doi":"10.1111/apt.14368","title":"Review article: consensus statements on therapeutic drug monitoring of anti‐tumour necrosis factor therapy in inflammatory bowel diseases","year":2017,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":276,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bible College","funders":"Gastroenterological Society of Australia; AbbVie; Takeda Pharmaceuticals U.S.A.; Pfizer","keywords":"Medicine; Therapeutic drug monitoring; Infliximab; Adalimumab; Inflammatory bowel disease; Intensive care medicine; Dosing; Drug; Biosimilar; Disease; Internal medicine; Pharmacology","score_opus":0.07897866906373673,"score_gpt":0.4131626218953791,"score_spread":0.3341839528316424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2764071025","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12103406,0.8748527,3.4217584e-7,0.000111493675,0.0010731618,0.0023174172,0.0005621457,0.000028694647,0.000019965404],"genre_scores_gemma":[0.015551384,0.9799373,0.000017578834,0.0031862177,0.0003421043,0.00040755924,0.00029769185,0.00016700546,0.00009315474],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99546576,0.0011762616,0.0013829434,0.0008806419,0.00035282935,0.00074155757],"domain_scores_gemma":[0.99716985,0.00013300026,0.0012737146,0.0010623407,0.00013168565,0.0002294113],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040086827,0.0009552251,0.00151205,0.00021211895,0.00019298121,0.00004333567,0.0010382019,0.00033275192,0.0001362783],"category_scores_gemma":[0.0000024654878,0.0008524828,0.00069028896,0.00011255169,0.00040786713,0.000021014765,0.00023664562,0.0005128132,0.000044129967],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026277113,0.0048995386,0.10373627,0.055366326,0.058624294,0.0012660351,0.00036854314,0.000060114984,0.05320577,0.000014670569,0.0043383287,0.7154924],"study_design_scores_gemma":[0.005537295,0.0006676777,0.024666151,0.018977657,0.020337367,0.000028556611,0.000059050886,0.000009466458,0.016247451,0.000035274403,0.9111968,0.0022372112],"about_ca_topic_score_codex":0.000014073729,"about_ca_topic_score_gemma":0.0000034478935,"teacher_disagreement_score":0.9068585,"about_ca_system_score_codex":0.00015962949,"about_ca_system_score_gemma":0.00061263243,"threshold_uncertainty_score":0.99939257},"labels":[],"label_agreement":null},{"id":"W2769684727","doi":"10.1111/apt.14421","title":"Exposure‐response relationship of certolizumab pegol induction and maintenance therapy in patients with Crohn's disease","year":2017,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"UCB Pharma","keywords":"Certolizumab pegol; Medicine; Crohn's disease; Internal medicine; Maintenance therapy; Gastroenterology; Population; Area under the curve; Disease; Clinical endpoint; Placebo; Calprotectin; Inflammatory bowel disease; Randomized controlled trial; Immunology; Adalimumab; Chemotherapy; Pathology","score_opus":0.01790490233379709,"score_gpt":0.2798904618170557,"score_spread":0.2619855594832586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769684727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981678,0.00025939697,0.000008647913,0.0008014384,0.00019044176,0.00049783,0.000045645953,0.0000068362174,0.000021979258],"genre_scores_gemma":[0.99862784,0.0002015643,0.00006865329,0.00085115916,0.000052800468,0.000047389844,0.000059665974,0.000025268846,0.00006566406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989508,0.00024482977,0.00019874168,0.0002813735,0.000113806476,0.00021047404],"domain_scores_gemma":[0.9992227,0.000024343666,0.00019875362,0.00037908938,0.00008182085,0.000093297785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097681375,0.00016826847,0.00012145099,0.0000574198,0.000181343,0.000016427486,0.0002041393,0.00008565068,0.000028635919],"category_scores_gemma":[0.000002155844,0.00015107206,0.00003662891,0.000027386786,0.00033837615,0.000024393421,0.00007420624,0.00010988035,0.0000017610273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032095253,0.0003295678,0.9398503,0.000010974203,0.0005450472,0.0001222919,0.00011560953,0.000020672718,0.026044521,0.000012145955,0.000042969437,0.0008106539],"study_design_scores_gemma":[0.006350713,0.00041834236,0.985807,0.000010929458,0.0002991849,0.0000041184776,0.000031180592,0.000018170853,0.0065314868,0.00004908656,0.0003123823,0.00016741893],"about_ca_topic_score_codex":0.000010410372,"about_ca_topic_score_gemma":0.000011401168,"teacher_disagreement_score":0.045956694,"about_ca_system_score_codex":0.000029131665,"about_ca_system_score_gemma":0.00009871747,"threshold_uncertainty_score":0.616054},"labels":[],"label_agreement":null},{"id":"W2769773150","doi":"10.1111/apt.14420","title":"Long‐term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis","year":2017,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bible College","funders":"AbbVie","keywords":"Medicine; Adalimumab; Ulcerative colitis; Internal medicine; Gastroenterology; Incidence (geometry); Crohn's disease; Tuberculosis; Adverse effect; Placebo; Population; Inflammatory bowel disease; Disease; Colitis; Pathology","score_opus":0.04520030416414466,"score_gpt":0.39167788850233587,"score_spread":0.3464775843381912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769773150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99723995,0.00008347417,0.00001548531,0.00038441777,0.00046219496,0.0013143449,0.00042588342,0.0000065474405,0.00006768586],"genre_scores_gemma":[0.9937286,0.0007173791,0.000074721895,0.004772981,0.0001766689,0.000101634716,0.00031146404,0.000035270892,0.000081326885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962237,0.0016403755,0.0010971904,0.00047884605,0.00018332676,0.0003765764],"domain_scores_gemma":[0.9982539,0.00017055718,0.00067221286,0.00054616714,0.00016263536,0.00019456472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011752913,0.00027719777,0.00055684295,0.00007335548,0.0001272553,0.00002157591,0.00046615282,0.00017489506,0.00021730477],"category_scores_gemma":[0.000021825746,0.00022563436,0.00016434891,0.0000452674,0.0005266934,0.000024700383,0.00018579302,0.00021457473,0.0000050456956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.077533804,0.0013414526,0.91481787,0.000042074782,0.0020296837,0.0006604997,0.00009701743,0.00003258445,0.001299312,0.000012052217,0.00009861378,0.0020350204],"study_design_scores_gemma":[0.018237136,0.000488024,0.9758662,0.00005065715,0.0012659989,0.000001131403,0.000030116074,0.000044473796,0.003562213,0.000014948238,0.00017715839,0.00026193078],"about_ca_topic_score_codex":0.00003588503,"about_ca_topic_score_gemma":0.0010201563,"teacher_disagreement_score":0.06104833,"about_ca_system_score_codex":0.00006547979,"about_ca_system_score_gemma":0.00037578738,"threshold_uncertainty_score":0.92011017},"labels":[],"label_agreement":null},{"id":"W2775018401","doi":"10.1111/apt.14381","title":"Editorial: Non‐breaking news! High‐dose <scp>PPI</scp>s likely do not cause fractures","year":2017,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; MEDLINE; Intensive care medicine","score_opus":0.03568157477505099,"score_gpt":0.4034261600697845,"score_spread":0.36774458529473353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775018401","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010813076,0.0059296875,0.0000037730679,0.0043173903,0.9748047,0.0024885905,0.00080830377,0.00023354474,0.0006009623],"genre_scores_gemma":[0.0039189113,0.025968678,0.00021842173,0.0236803,0.93959,0.00035412246,0.0026817287,0.00038724675,0.003200607],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9911447,0.00065047445,0.0013442832,0.0016573701,0.0028480568,0.002355083],"domain_scores_gemma":[0.9909785,0.003938349,0.0011836985,0.0017048183,0.00097408274,0.0012205481],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0013773341,0.0013392534,0.002065061,0.0005745908,0.0010946135,0.00026724773,0.0014631966,0.0035451108,0.00070815877],"category_scores_gemma":[0.00004827723,0.0012243297,0.00051732943,0.00024087683,0.00074555946,0.0003776671,0.0006286186,0.006507714,0.0005076357],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015786308,0.00084243546,0.00052335707,0.00058090716,0.01107246,0.00048182707,0.00050481624,0.0000031919596,0.015920797,0.0000015253478,0.96546906,0.003020963],"study_design_scores_gemma":[0.010886646,0.00164618,0.0005520893,0.00029323393,0.016537081,0.000029191613,0.00011331994,0.000018190998,0.012173827,0.00003497825,0.95728016,0.00043508623],"about_ca_topic_score_codex":0.002277183,"about_ca_topic_score_gemma":0.0001746185,"teacher_disagreement_score":0.03521469,"about_ca_system_score_codex":0.0009235379,"about_ca_system_score_gemma":0.0037305711,"threshold_uncertainty_score":0.99993587},"labels":[],"label_agreement":null},{"id":"W2779648522","doi":"10.1111/apt.14483","title":"<scp>HLA</scp>‐<scp>DQA</scp>1‐<scp>HLA</scp>‐<scp>DRB</scp>1 polymorphism is a major predictor of azathioprine‐induced pancreatitis in patients with inflammatory bowel disease","year":2017,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Canadian Institutes of Health Research; Canadian Association of Gastroenterology; Cancer Care Ontario","keywords":"Medicine; Azathioprine; Inflammatory bowel disease; Internal medicine; Gastroenterology; Genotype; Single-nucleotide polymorphism; Pancreatitis; Human leukocyte antigen; Crohn's disease; Cohort; Immunology; Acute pancreatitis; Ulcerative colitis; Disease; Antigen; Biology; Genetics","score_opus":0.01679271597223922,"score_gpt":0.2851488721447069,"score_spread":0.26835615617246766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2779648522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98595977,0.0024501237,0.000048475682,0.0010089058,0.0017825394,0.00480993,0.0013207572,0.00033921306,0.0022803082],"genre_scores_gemma":[0.9724963,0.0020369808,0.0005437525,0.014567426,0.0013135335,0.00078766,0.0008094316,0.0005649555,0.0068800026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98852324,0.00089389685,0.0022024722,0.0022417181,0.0028494566,0.0032892383],"domain_scores_gemma":[0.98814183,0.0042173257,0.0018305602,0.0027871153,0.0009201387,0.0021030477],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0011063688,0.001878584,0.0022107873,0.0011959575,0.00095505035,0.0002094599,0.0025364037,0.0010506863,0.000233265],"category_scores_gemma":[0.00029716265,0.001741979,0.0006146172,0.00077111187,0.002074817,0.001118653,0.001449685,0.0022445736,0.0003717422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075868797,0.004391482,0.86607707,0.00083081104,0.016077505,0.0022443777,0.0070834477,0.000042985415,0.059427083,0.000064214735,0.042476643,0.0005257045],"study_design_scores_gemma":[0.055327196,0.0042116963,0.77785015,0.00075562403,0.015315033,0.00016585273,0.002273265,0.0023526936,0.10835574,0.00023688383,0.032788962,0.00036689025],"about_ca_topic_score_codex":0.0006853303,"about_ca_topic_score_gemma":0.00006645601,"teacher_disagreement_score":0.08822689,"about_ca_system_score_codex":0.0020006362,"about_ca_system_score_gemma":0.0028766086,"threshold_uncertainty_score":0.99939585},"labels":[],"label_agreement":null},{"id":"W2783230085","doi":"10.1111/apt.14435","title":"Letter: the safety of herpes zoster vaccination for patients with inflammatory bowel disease being treated with anti‐<scp>TNF</scp> medications","year":2018,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Genentech; Celgene; Amgen; Pfizer; Celltrion; Eli Lilly and Company","keywords":"Medicine; Inflammatory bowel disease; Vaccination; Tumor necrosis factor alpha; Disease; Dermatology; Immunology; Internal medicine","score_opus":0.012074703522744949,"score_gpt":0.2790171633617298,"score_spread":0.2669424598389849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783230085","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7840565,0.00043792263,0.00022109045,0.20718633,0.0008014441,0.005916129,0.00085688673,0.00014283445,0.00038089958],"genre_scores_gemma":[0.1901037,0.00055557885,0.00034073213,0.79897493,0.002233496,0.0009867129,0.0054417597,0.0002144529,0.0011486481],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978139,0.00023048362,0.0005327698,0.00049797696,0.0004396085,0.00048529264],"domain_scores_gemma":[0.9978973,0.00055700785,0.00050103175,0.000502095,0.0004206153,0.00012192448],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015543048,0.0005111423,0.0004944942,0.00022579287,0.0003985862,0.00001907124,0.00022741701,0.00032077235,0.0001942705],"category_scores_gemma":[9.4813527e-7,0.00031013245,0.00016218168,0.00020626781,0.00036723624,0.00013887408,0.000048850405,0.0005138033,0.00001746059],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00213735,0.0032631925,0.47557962,0.00069402193,0.08435237,0.00020669546,0.001020567,0.000022994764,0.00021637503,0.000009143722,0.42492118,0.007576501],"study_design_scores_gemma":[0.009177699,0.0013100224,0.0852194,0.00017287476,0.041796178,0.000011598998,0.000025451498,0.0000826488,0.0022341895,0.000021453629,0.859758,0.00019045219],"about_ca_topic_score_codex":0.000022063396,"about_ca_topic_score_gemma":0.000007687399,"teacher_disagreement_score":0.5939528,"about_ca_system_score_codex":0.00023771224,"about_ca_system_score_gemma":0.00022949265,"threshold_uncertainty_score":0.9999351},"labels":[],"label_agreement":null},{"id":"W2787643951","doi":"10.1111/apt.14537","title":"Systematic review: the natural history of alpha‐1 antitrypsin deficiency, and associated liver disease","year":2018,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Birmingham; National Institute for Health and Care Research","keywords":"Liver transplantation; Medicine; Cirrhosis; Natural history; Liver disease; Alpha 1-antitrypsin deficiency; Transplantation; Disease; Penetrance; Internal medicine; Pediatrics; Phenotype; Genetics; Biology; Gene","score_opus":0.02802272059422697,"score_gpt":0.3087088074620065,"score_spread":0.28068608686777957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787643951","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008562384,0.9962054,0.000003654372,0.00009130361,0.0013119003,0.0021487554,0.0001060076,0.000012757802,0.00003462627],"genre_scores_gemma":[0.00030662594,0.9871423,0.000015289874,0.011060903,0.00019942276,0.0002037209,0.00041804876,0.000049684517,0.0006040037],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99739426,0.00094759575,0.0006952318,0.00045345325,0.00020281824,0.00030665033],"domain_scores_gemma":[0.9985337,0.000074937976,0.00073075574,0.0004668799,0.00010287914,0.000090804286],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055378216,0.00043237518,0.0010880706,0.000053950553,0.00008855713,0.0000069847097,0.0005181107,0.00022448123,0.00005276458],"category_scores_gemma":[0.0000039528104,0.00028648906,0.0004133442,0.00009350179,0.00038901737,0.000006838686,0.00024993985,0.00026779578,0.000015161125],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013417934,0.00086528657,0.000004959374,0.81423545,0.03072753,0.000067057896,0.00013691655,1.016358e-7,0.015607026,0.00004190708,0.13398245,0.004197119],"study_design_scores_gemma":[0.00042199405,0.00039409898,8.489266e-7,0.059005152,0.09511311,0.000055972294,0.000007875373,0.00002156656,0.0019573518,0.000012842161,0.8424443,0.00056488934],"about_ca_topic_score_codex":0.000010045448,"about_ca_topic_score_gemma":0.0000025688867,"teacher_disagreement_score":0.7552303,"about_ca_system_score_codex":0.00015266293,"about_ca_system_score_gemma":0.00039500507,"threshold_uncertainty_score":0.99995875},"labels":[],"label_agreement":null},{"id":"W2791020082","doi":"10.1111/apt.14562","title":"Letter: predicting azathioprine‐associated pancreatitis in <scp>IBD</scp>—phenotype or genotype? Authors' reply","year":2018,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Pancreatitis Pathology and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Genotype; Azathioprine; Pancreatitis; Phenotype; Gastroenterology; Internal medicine; Genetics; Disease; Gene; Biology","score_opus":0.03473010082298853,"score_gpt":0.31316089852957546,"score_spread":0.2784307977065869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791020082","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5384616,0.00487665,0.000021846185,0.4415643,0.006924659,0.003235537,0.00069553615,0.0006966768,0.0035231917],"genre_scores_gemma":[0.021308918,0.0030737242,0.0008727743,0.94881165,0.009451471,0.0004202851,0.0032641857,0.00028600267,0.012511001],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940505,0.0010998396,0.0011952189,0.0014243226,0.0006060403,0.001624056],"domain_scores_gemma":[0.99672216,0.0013104597,0.00069895276,0.0008287453,0.00021755876,0.00022214088],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00066490815,0.0011115763,0.0017028698,0.00054907246,0.00034185158,0.000036069363,0.0005022192,0.0019818642,0.001270734],"category_scores_gemma":[0.000015062046,0.0009881639,0.00033499236,0.0005531262,0.00063494203,0.00014756195,0.00024511968,0.0036500897,0.00048622346],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051305507,0.0008090501,0.10974626,0.00019315947,0.027275126,0.026007801,0.0016655572,0.0000036580252,0.005689769,0.000003402416,0.82753736,0.0005557883],"study_design_scores_gemma":[0.009166597,0.0029637797,0.020948285,0.00037513045,0.0345176,0.0011805382,0.00008318342,0.00013503646,0.008541444,0.00011827309,0.9214557,0.00051443215],"about_ca_topic_score_codex":0.00038597954,"about_ca_topic_score_gemma":0.00013728524,"teacher_disagreement_score":0.5171527,"about_ca_system_score_codex":0.001000816,"about_ca_system_score_gemma":0.0005114466,"threshold_uncertainty_score":0.99964225},"labels":[],"label_agreement":null},{"id":"W2791772998","doi":"10.1111/apt.14555","title":"Letter: extensive intestinal metaplasia is associated with the presence of incomplete intestinal metaplasia subtype and could be an easier marker for high risk of gastric cancer Authors' reply","year":2018,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Intestinal metaplasia; Gastroenterology; Metaplasia; Cancer; Internal medicine; Pathology","score_opus":0.043916006368011906,"score_gpt":0.3189970731285621,"score_spread":0.2750810667605502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791772998","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5746622,0.0010071879,0.00013790821,0.42044577,0.00077656226,0.0016876017,0.0012243388,0.000049978993,0.000008425644],"genre_scores_gemma":[0.13073723,0.0009275758,0.0025579983,0.8627912,0.0013665723,0.00042003344,0.00065105467,0.00017719247,0.00037118664],"study_design_codex":"not_applicable","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9951636,0.0012987627,0.0010142509,0.0010000685,0.0005932335,0.0009300655],"domain_scores_gemma":[0.9937658,0.0019805676,0.0018667957,0.000644827,0.0015945092,0.00014751796],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00092933775,0.00086346426,0.0016678991,0.00032771524,0.0002684191,0.00001704363,0.00055705395,0.00054586394,0.0002298834],"category_scores_gemma":[0.000029719533,0.00060020026,0.00021583546,0.00043624427,0.002697265,0.00014347037,0.00026308664,0.0025812169,0.0000020577854],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00858505,0.00050496386,0.22825195,0.00026588803,0.118351504,0.00033058244,0.0016673707,0.000007288158,0.01634647,0.0000017071256,0.62526053,0.0004267131],"study_design_scores_gemma":[0.021221362,0.032778814,0.28386205,0.0012381127,0.38393742,0.0019447563,0.00057677785,0.0018251134,0.0349756,0.00014230495,0.23585282,0.0016448862],"about_ca_topic_score_codex":0.00064914883,"about_ca_topic_score_gemma":0.0001387357,"teacher_disagreement_score":0.443925,"about_ca_system_score_codex":0.00020764206,"about_ca_system_score_gemma":0.0002694052,"threshold_uncertainty_score":0.99971986},"labels":[],"label_agreement":null},{"id":"W2796221124","doi":"10.1111/apt.14606","title":"Systematic review with meta‐analysis: association between acetaminophen and nonsteroidal anti‐inflammatory drugs (<scp>NSAID</scp>s) and risk of Crohn's disease and ulcerative colitis exacerbation","year":2018,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Samsung; Crohn's and Colitis Foundation; American Gastroenterological Association; AbbVie","keywords":"Medicine; Exacerbation; Ulcerative colitis; Internal medicine; Relative risk; Acetaminophen; Gastroenterology; Meta-analysis; Inflammatory bowel disease; Crohn's disease; Disease; Confidence interval; Pharmacology","score_opus":0.02624908724272687,"score_gpt":0.3168431062582247,"score_spread":0.29059401901549786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796221124","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06954011,0.92438906,0.000010392139,0.000074547694,0.000115946474,0.0054438384,0.00037285627,0.00003810633,0.000015144251],"genre_scores_gemma":[0.0020770004,0.99547017,0.00007464643,0.0010029578,0.00023279877,0.00057483464,0.00033622666,0.00007509325,0.00015626183],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99437284,0.0027105622,0.0012705999,0.00069192844,0.0005220232,0.0004320201],"domain_scores_gemma":[0.9945878,0.002151868,0.0022561674,0.000382104,0.00024174595,0.00038034568],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002016915,0.0007685221,0.005634893,0.00036706025,0.00022042249,0.00003641538,0.0001380882,0.0003438821,0.000038200385],"category_scores_gemma":[0.000010630385,0.0005408043,0.00059588597,0.00037918187,0.0004174425,0.00018879423,0.000110568486,0.00051594205,0.0000071385384],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056186487,0.00006942458,0.006198965,0.35966,0.63261646,0.00006125945,0.0005053132,2.068934e-7,0.0000033536824,0.0000025138702,0.00009654046,0.00072979956],"study_design_scores_gemma":[0.0012328763,0.00032423437,0.0057587908,0.022926738,0.9660683,0.000025408997,0.00007259141,0.00003345233,0.000048793063,0.0000047377544,0.0032579694,0.0002460593],"about_ca_topic_score_codex":0.00002093918,"about_ca_topic_score_gemma":0.000010821917,"teacher_disagreement_score":0.33673328,"about_ca_system_score_codex":0.00018831358,"about_ca_system_score_gemma":0.00026476968,"threshold_uncertainty_score":0.99970436},"labels":[],"label_agreement":null},{"id":"W2797202721","doi":"10.1111/apt.14609","title":"Editorial: the prevalence of <i>Helicobacter pylori</i> infection worldwide—knowns and unknowns","year":2018,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Helicobacter pylori; Helicobacter Infections; MEDLINE; Gastroenterology; Biology","score_opus":0.01707548779291046,"score_gpt":0.3127000085561697,"score_spread":0.29562452076325924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797202721","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06624549,0.003006327,0.0000059388967,0.0038761492,0.92499757,0.0011977694,0.00042301818,0.00012545564,0.00012230137],"genre_scores_gemma":[0.003560797,0.035236,0.000060893562,0.0057605137,0.95354784,0.00017875449,0.00024981867,0.00013795464,0.0012674041],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958545,0.00060985395,0.0010008081,0.0008906742,0.00083584996,0.0008083374],"domain_scores_gemma":[0.9962039,0.001206164,0.0007161555,0.00068914494,0.0009948853,0.00018973612],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00084769074,0.0007985014,0.0010730799,0.00026209952,0.00032090853,0.000026225032,0.0004404508,0.0012286734,0.00031923613],"category_scores_gemma":[0.000010599292,0.0005960684,0.00024400852,0.0003489163,0.0018241478,0.00016213254,0.00047664536,0.0023419152,0.00006389092],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015447907,0.00039683725,0.021233838,0.00051645114,0.022447687,0.000010918125,0.0006009658,6.3687725e-7,0.008157231,8.056423e-7,0.94477296,0.00031690937],"study_design_scores_gemma":[0.003638955,0.002201522,0.004704315,0.00019896527,0.043767657,0.000026718688,0.00002427594,0.000008383599,0.0037076212,0.000019602516,0.9413689,0.0003331217],"about_ca_topic_score_codex":0.00017029054,"about_ca_topic_score_gemma":0.000069683774,"teacher_disagreement_score":0.06268469,"about_ca_system_score_codex":0.0002797761,"about_ca_system_score_gemma":0.0003590778,"threshold_uncertainty_score":0.9999597},"labels":[],"label_agreement":null},{"id":"W2800354113","doi":"10.1111/apt.14688","title":"Systematic review: safety of mesalazine in ulcerative colitis","year":2018,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":179,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Shire","keywords":"Mesalazine; Medicine; Ulcerative colitis; Adverse effect; Internal medicine; Adverse Event Reporting System; Incidence (geometry); Dosing; Renal function; Gastroenterology; Disease","score_opus":0.02358014853310412,"score_gpt":0.3491978774057759,"score_spread":0.32561772887267176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800354113","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010728791,0.9945386,0.0000053750973,0.000056401346,0.00054427114,0.004097147,0.0004079018,0.000012762722,0.00023022277],"genre_scores_gemma":[0.000024783301,0.9917841,0.000055848424,0.005817236,0.00025245454,0.00060304056,0.0010573689,0.00008766284,0.00031751933],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99529135,0.0018995367,0.001605591,0.0005779377,0.00020152364,0.00042403382],"domain_scores_gemma":[0.99811924,0.00009688578,0.00089704804,0.00063064176,0.00014828329,0.00010793193],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008061187,0.0005963415,0.0020925002,0.00013621312,0.000056405268,0.0000062632994,0.00062348257,0.00038131227,0.00027493216],"category_scores_gemma":[0.0000023722819,0.0005217798,0.0005504757,0.00020524744,0.0003111117,0.0000062880836,0.0002284538,0.00027518644,0.00007320849],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044697648,0.0004109546,0.000018810999,0.96492416,0.027578222,0.00019812411,0.000074074436,0.0000010758512,0.00027843242,0.000019652505,0.0042501325,0.0017994046],"study_design_scores_gemma":[0.0019436033,0.00049665145,0.00004429167,0.24152026,0.10148214,0.000120902885,0.000033974735,0.000008135592,0.0007675314,0.000013528765,0.652437,0.0011320127],"about_ca_topic_score_codex":0.0000047850285,"about_ca_topic_score_gemma":0.00003286872,"teacher_disagreement_score":0.7234039,"about_ca_system_score_codex":0.00014363942,"about_ca_system_score_gemma":0.00044860915,"threshold_uncertainty_score":0.9997234},"labels":[],"label_agreement":null},{"id":"W2800563378","doi":"10.1111/apt.14634","title":"Editorial: hepatocellular carcinoma as a consequence of hepatitis C direct‐acting anti‐virals—the great urban myth of hepatology","year":2018,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Hepatology; Hepatocellular carcinoma; Internal medicine; Carcinoma; Mythology; Gastroenterology","score_opus":0.032635228131350426,"score_gpt":0.35410929377309286,"score_spread":0.3214740656417424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800563378","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1580339,0.0038025733,0.000004797955,0.0018836071,0.8318751,0.0019507676,0.0010088596,0.00008956447,0.0013508548],"genre_scores_gemma":[0.19749787,0.010647373,0.00013232465,0.004086002,0.7858648,0.00019087705,0.0007615111,0.00023088357,0.0005883899],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923059,0.0016541324,0.001691757,0.0010807549,0.0020803951,0.0011871052],"domain_scores_gemma":[0.9924163,0.0031377042,0.0012823178,0.0011779084,0.0016699404,0.00031582388],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0014840151,0.0008811896,0.0022699987,0.0004761994,0.00028993151,0.000025370047,0.001145341,0.001675668,0.001321426],"category_scores_gemma":[0.00005089958,0.00074927555,0.0005189032,0.00060512015,0.0029667881,0.00015034809,0.00047347636,0.0023031672,0.000112590504],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012867637,0.00039759142,0.062980585,0.0004515448,0.0109049855,0.0007195223,0.00061318406,5.8383887e-7,0.052045792,0.0000034985096,0.8701579,0.00043807345],"study_design_scores_gemma":[0.003057645,0.0025461412,0.000064548076,0.00017381068,0.011286554,0.000055837572,0.00005618993,0.00022842769,0.13658318,0.000034234847,0.8454529,0.00046051256],"about_ca_topic_score_codex":0.010333762,"about_ca_topic_score_gemma":0.000120094104,"teacher_disagreement_score":0.084537394,"about_ca_system_score_codex":0.00061851856,"about_ca_system_score_gemma":0.0031271798,"threshold_uncertainty_score":0.99999857},"labels":[],"label_agreement":null},{"id":"W2802550165","doi":"10.1111/apt.14796","title":"Proton pump inhibitor and histamine‐2 receptor antagonist use and risk of liver cancer in two population‐based studies","year":2018,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Queen's University Belfast; Queen's University; Cancer Research UK; University of Aberdeen; United Kingdom Clinical Research Collaboration","keywords":"Medicine; Internal medicine; Odds ratio; Cancer; Hazard ratio; Liver cancer; Population; Confidence interval; Prospective cohort study; Cohort; Cohort study; Oncology; Gastroenterology; Environmental health","score_opus":0.054900344863894404,"score_gpt":0.39040686931258256,"score_spread":0.33550652444868817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802550165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958689,0.0023846964,0.0000014272105,0.00037716664,0.00028166315,0.0009626035,0.00010290531,0.000016491404,0.0000041001863],"genre_scores_gemma":[0.9922106,0.0047320444,0.0006167799,0.0020449406,0.00015049356,0.00010224639,0.000038486418,0.000019658317,0.00008473684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990376,0.00013399331,0.000255807,0.0002514661,0.00011676662,0.00020434432],"domain_scores_gemma":[0.9994885,0.0001104446,0.00013434867,0.00010090524,0.00009243942,0.00007338719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011334872,0.00017691859,0.00030898247,0.00011065608,0.00008995082,0.000006649001,0.000033362263,0.00004311942,0.0001325245],"category_scores_gemma":[8.721103e-7,0.00014319224,0.000029114617,0.0001020053,0.0003252601,0.000104578896,0.00004290908,0.00012523818,0.0000026238997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007388272,0.0003563767,0.96226096,0.00007233738,0.0032314064,0.000040659277,0.00048114234,0.000002339847,0.03111224,0.0000014736246,0.000037817834,0.0016643882],"study_design_scores_gemma":[0.008423963,0.0012388056,0.7824698,0.0000622769,0.005759165,0.000009183072,0.000063504755,0.0003965047,0.20100532,0.00001453157,0.00046334608,0.00009362041],"about_ca_topic_score_codex":0.0008849106,"about_ca_topic_score_gemma":0.00019875317,"teacher_disagreement_score":0.17979121,"about_ca_system_score_codex":0.00014606505,"about_ca_system_score_gemma":0.000039015842,"threshold_uncertainty_score":0.583921},"labels":[],"label_agreement":null},{"id":"W2802950892","doi":"10.1111/apt.14672","title":"Systematic review with meta‐analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis","year":2018,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta; Robarts Clinical Trials; University of Calgary; Western University","funders":"Institute of Nutrition, Metabolism and Diabetes; Canadian Institutes of Health Research; Canadian Association of Gastroenterology","keywords":"Medicine; Placebo; Internal medicine; Meta-analysis; Ulcerative colitis; Confidence interval; Randomized controlled trial; Clinical trial; Surgery; Gastroenterology; Pathology; Disease","score_opus":0.07671367558320634,"score_gpt":0.3816676808401279,"score_spread":0.30495400525692157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802950892","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010540114,0.994776,0.000010611261,0.000081178034,0.000103629696,0.0037728655,0.00017898835,0.0000065372824,0.000016142121],"genre_scores_gemma":[0.0006085822,0.9960495,0.00011833633,0.0016384233,0.000054322536,0.0011576772,0.00026711257,0.000031378317,0.000074646254],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9940428,0.0037070697,0.0013081778,0.0005651135,0.000118045544,0.00025875398],"domain_scores_gemma":[0.99793804,0.0002478711,0.001319153,0.0003142445,0.00010526011,0.00007545182],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016933378,0.0004883604,0.004077322,0.00019256673,0.000062985826,0.000011056872,0.00019479677,0.00024662554,0.00008434145],"category_scores_gemma":[0.000006211132,0.00032656372,0.00050944305,0.00023138925,0.00042144928,0.00000953567,0.00009192926,0.00018549865,0.0000019011464],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005301525,0.00012976963,0.00003391303,0.33779573,0.66071826,0.00007958817,0.00008841367,0.0000013503721,0.00013941208,0.000014771561,0.00016414832,0.0003044735],"study_design_scores_gemma":[0.0010631388,0.00032849523,0.000025303932,0.012704601,0.97537726,0.000056623994,0.00005085457,0.0000036775205,0.00028046564,0.000008829531,0.009775944,0.0003247842],"about_ca_topic_score_codex":0.000011253197,"about_ca_topic_score_gemma":0.000092995826,"teacher_disagreement_score":0.32509112,"about_ca_system_score_codex":0.000056967827,"about_ca_system_score_gemma":0.00016695976,"threshold_uncertainty_score":0.99991864},"labels":[],"label_agreement":null},{"id":"W2805710372","doi":"10.1111/apt.14821","title":"Systematic review with meta‐analysis: prevalence, risk factors and costs of aminosalicylate use in Crohn's disease","year":2018,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Robarts Clinical Trials; University of Calgary; Western University","funders":"Canadian Institutes of Health Research; Canadian Association of Gastroenterology","keywords":"Medicine; Crohn's disease; Meta-analysis; Disease; Internal medicine; Gastroenterology","score_opus":0.04403702449339548,"score_gpt":0.33959687032089036,"score_spread":0.2955598458274949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805710372","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01707407,0.9780899,0.0000059686404,0.000009889529,0.000085068714,0.0035657347,0.0011530495,0.000012963652,0.0000033283927],"genre_scores_gemma":[0.0018283277,0.99541146,0.000033775006,0.0013433315,0.00004312316,0.0005829293,0.0006077162,0.000074820906,0.000074544856],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99518543,0.0022402254,0.0011425895,0.0007931746,0.00024597178,0.0003926236],"domain_scores_gemma":[0.9974863,0.00018773411,0.0012328309,0.00073535857,0.00012345194,0.00023436084],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005652997,0.00077413226,0.0030128513,0.0002768491,0.000069493944,0.00002157856,0.0004479641,0.00023603205,0.000093992414],"category_scores_gemma":[0.0000034147215,0.00052178104,0.0011480143,0.0003912178,0.00040442406,0.000018156648,0.00019263479,0.00025648548,0.0000058325127],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016798599,0.0002252813,0.0033908542,0.38815105,0.60768723,0.00021388041,0.000027060296,0.0000036917406,0.000010247395,0.0000015003837,0.00005117818,0.000070058726],"study_design_scores_gemma":[0.00035247192,0.00010894106,0.0010416848,0.018566754,0.97689366,0.0000074332415,0.0000067885794,0.000011389816,0.000033295433,9.448129e-7,0.0024708556,0.0005057726],"about_ca_topic_score_codex":0.000038200553,"about_ca_topic_score_gemma":0.000063641375,"teacher_disagreement_score":0.3695843,"about_ca_system_score_codex":0.00006251821,"about_ca_system_score_gemma":0.00024018122,"threshold_uncertainty_score":0.9997234},"labels":[],"label_agreement":null},{"id":"W2805842749","doi":"10.1111/apt.14658","title":"Editorial: validating reliability of the eosinophilic oesophagitis histological scoring system (<scp>EOE</scp>‐<scp>HSS</scp>)—an important first step. Authors’ reply","year":2018,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Eosinophilic esophagitis; Medicine; Reliability (semiconductor); Pathology; Disease","score_opus":0.02247534497561934,"score_gpt":0.3089817148557359,"score_spread":0.2865063698801166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805842749","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17782378,0.004903066,0.000010993157,0.0007460463,0.81119716,0.0032063103,0.0010783431,0.0006109198,0.00042334822],"genre_scores_gemma":[0.057922903,0.001644858,0.0009027832,0.003088925,0.9333698,0.00041837763,0.0011586214,0.0005109797,0.0009827074],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98525274,0.0022623697,0.0039109546,0.0029678757,0.00345487,0.0021511805],"domain_scores_gemma":[0.9817887,0.008341511,0.0037363584,0.003332572,0.0019005411,0.0009003456],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0042489283,0.0019558696,0.0032064435,0.00044859422,0.001133461,0.00012274402,0.00257863,0.003377466,0.00012648186],"category_scores_gemma":[0.00042893007,0.0016177188,0.0011206116,0.000966294,0.0024034707,0.00044880508,0.0012639067,0.0049479217,0.00007332244],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021858918,0.0013505587,0.012291626,0.0013944734,0.006953639,0.00031366153,0.0015036489,0.000014923004,0.012904786,0.000020276502,0.9629474,0.00008639928],"study_design_scores_gemma":[0.0058307797,0.0036585883,0.0015268279,0.0010262127,0.028569546,0.0002580417,0.00091486995,0.0002590813,0.034766387,0.0001277647,0.9226278,0.0004340948],"about_ca_topic_score_codex":0.00090620917,"about_ca_topic_score_gemma":0.000055892524,"teacher_disagreement_score":0.12217265,"about_ca_system_score_codex":0.0028026171,"about_ca_system_score_gemma":0.0019107912,"threshold_uncertainty_score":0.9993185},"labels":[],"label_agreement":null},{"id":"W2806054828","doi":"10.1111/apt.14633","title":"Editorial: validating reliability of the eosinophilic oesophagitis histological scoring system (<scp>EOE</scp>‐<scp>HSS</scp>)—an important first step","year":2018,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Eosinophilic esophagitis; Reliability (semiconductor); Dysphagia; Dermatology; Gastroenterology; Internal medicine; Surgery; Disease","score_opus":0.020134129795476206,"score_gpt":0.3029838399844925,"score_spread":0.28284971018901633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806054828","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20456178,0.0051509184,0.000009236501,0.0004121882,0.784962,0.002886263,0.0010511068,0.00049435406,0.00047213095],"genre_scores_gemma":[0.07625521,0.0018758054,0.0006947528,0.002008108,0.91662395,0.0003722706,0.0010938245,0.00045361533,0.0006224327],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98699987,0.0017968032,0.0033990748,0.0025609687,0.0032202671,0.0020230452],"domain_scores_gemma":[0.98351085,0.008089648,0.0031472945,0.0027720423,0.0017095879,0.00077055197],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.003030971,0.0018417939,0.0030102783,0.00040544133,0.0010054772,0.000105376486,0.002441796,0.0033417703,0.000129311],"category_scores_gemma":[0.00026967342,0.001510354,0.0010332891,0.00085453043,0.002333091,0.00041459184,0.0011679287,0.0043003215,0.00007919306],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019437683,0.0014780735,0.013663257,0.0015026846,0.007417094,0.00027832857,0.0012161044,0.000017369572,0.015062541,0.000019581566,0.95905864,0.00009194908],"study_design_scores_gemma":[0.0068584247,0.0037434523,0.0015119215,0.0010162325,0.031622004,0.00023588845,0.00094483804,0.00027642612,0.04107807,0.00011329015,0.9121643,0.00043516414],"about_ca_topic_score_codex":0.00068744225,"about_ca_topic_score_gemma":0.00006634145,"teacher_disagreement_score":0.13166197,"about_ca_system_score_codex":0.002601628,"about_ca_system_score_gemma":0.0017202972,"threshold_uncertainty_score":0.9994327},"labels":[],"label_agreement":null},{"id":"W2806097616","doi":"10.1111/apt.14646","title":"Editorial: genotype 3 <scp>HCV</scp>—who still needs ribavirin in a pan‐genotypic era?","year":2018,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Ribavirin; Genotype; Medicine; Virology; Hepacivirus; Hepatitis C; Hepatitis C virus; Biology; Virus; Genetics; Gene","score_opus":0.028690249123274062,"score_gpt":0.363283134299065,"score_spread":0.33459288517579094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806097616","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030818108,0.0044471896,0.000008830214,0.0008306301,0.9584895,0.0025513547,0.0007511367,0.00023998601,0.0018633093],"genre_scores_gemma":[0.0025604654,0.014799843,0.00024442296,0.0069685285,0.96774155,0.00040338642,0.0020363345,0.00044314982,0.0048023434],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9912401,0.0012169512,0.0014464784,0.0013692232,0.0025598782,0.0021673697],"domain_scores_gemma":[0.99397016,0.002801828,0.00048231255,0.0011128352,0.0010014644,0.00063138106],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0016802098,0.0012379905,0.0018992529,0.0014235638,0.00023207483,0.00009236581,0.001256529,0.0030536647,0.0012309748],"category_scores_gemma":[0.0000416532,0.0012566737,0.0003874495,0.0012609763,0.00088358356,0.0002377531,0.000644861,0.005580259,0.0015522913],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009761606,0.0009065871,0.0022529252,0.00022572387,0.009579896,0.0003048031,0.001564019,0.000003705234,0.014845043,0.0000030198055,0.96661556,0.0027225714],"study_design_scores_gemma":[0.00798967,0.0022205324,0.000308913,0.00017345886,0.007840918,0.0000075096214,0.000119207914,0.00010470135,0.0063556377,0.00007535906,0.97435814,0.00044593206],"about_ca_topic_score_codex":0.0013319027,"about_ca_topic_score_gemma":0.00036703714,"teacher_disagreement_score":0.028257644,"about_ca_system_score_codex":0.0017879901,"about_ca_system_score_gemma":0.0030214337,"threshold_uncertainty_score":0.999682},"labels":[],"label_agreement":null},{"id":"W2806491070","doi":"10.1111/apt.14640","title":"Editorial: let's take a break from studying the <scp>PPI</scp>‐fracture association","year":2018,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Association (psychology); Internal medicine; Psychotherapist; Psychology","score_opus":0.01725382422838282,"score_gpt":0.3211997811877031,"score_spread":0.30394595695932025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806491070","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026296435,0.0019569765,0.0000065662352,0.0013567333,0.9674174,0.0015066687,0.00097492523,0.0001888832,0.0002953641],"genre_scores_gemma":[0.012438466,0.0016022207,0.00011118648,0.014544527,0.962729,0.00020566038,0.0044447896,0.00019843182,0.003725759],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99464357,0.0006672143,0.00074262026,0.000961959,0.0019581213,0.0010264881],"domain_scores_gemma":[0.993173,0.004324276,0.0009499161,0.00066603627,0.0006186053,0.00026813464],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0007705471,0.0009176449,0.0010885448,0.0001467881,0.0005413696,0.00011004277,0.00064509845,0.0018491755,0.000480506],"category_scores_gemma":[0.000022699767,0.00065959693,0.0004230715,0.00023714582,0.00021408322,0.0001602361,0.00022466399,0.002710045,0.00047991297],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015109411,0.00083831494,0.005319488,0.000024111514,0.0434341,0.00016448981,0.0010201038,0.0000022785323,0.0016270255,1.6216534e-7,0.94716436,0.00025450598],"study_design_scores_gemma":[0.0064997175,0.001135978,0.0010775005,0.00004675755,0.0500744,0.00000480351,0.00016103608,0.000010903036,0.0028242273,0.000068853755,0.9379811,0.00011468037],"about_ca_topic_score_codex":0.00032200044,"about_ca_topic_score_gemma":0.000024470022,"teacher_disagreement_score":0.01385797,"about_ca_system_score_codex":0.0014981412,"about_ca_system_score_gemma":0.000640704,"threshold_uncertainty_score":0.99959075},"labels":[],"label_agreement":null},{"id":"W2809196018","doi":"10.1111/apt.14853","title":"An expert consensus to standardise definitions, diagnosis and treatment targets for anti‐fibrotic stricture therapies in Crohn's disease","year":2018,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":258,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bible College","funders":"National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute for Health and Care Research","keywords":"Medicine; Crohn's disease; Crohn disease; Disease; Consensus conference; Intensive care medicine; MEDLINE; Internal medicine","score_opus":0.06703002966705561,"score_gpt":0.37762167343103514,"score_spread":0.3105916437639795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809196018","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05185784,0.9395404,0.00002354262,0.00029413594,0.0006383268,0.0039235046,0.0036865233,0.000029639441,0.000006086951],"genre_scores_gemma":[0.0027286275,0.985225,0.0007071751,0.0051992624,0.0007762374,0.0032086817,0.0020076549,0.00012877282,0.000018583669],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99730027,0.0005497254,0.0005388715,0.0009157199,0.0001319024,0.00056352],"domain_scores_gemma":[0.99866325,0.00012471611,0.00019395642,0.00051033427,0.00009124293,0.0004165086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001646212,0.00072550663,0.0008249295,0.00019648077,0.00021673755,0.000047246333,0.00029532242,0.0003215515,0.0000870931],"category_scores_gemma":[0.0000014622742,0.0006264423,0.00032979352,0.000108193344,0.00026889108,0.000008648222,0.00009732509,0.000121696954,0.000008806539],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015602756,0.0117700845,0.013708994,0.010758885,0.08635553,0.0050910283,0.0032631871,0.00017260024,0.006977352,0.00013898427,0.041279446,0.80488116],"study_design_scores_gemma":[0.0023112379,0.0010545601,0.0014094167,0.00040089473,0.01000233,0.000013294397,0.00009542848,0.000010255089,0.0006042143,0.0000468004,0.9832315,0.0008200802],"about_ca_topic_score_codex":0.000011926726,"about_ca_topic_score_gemma":0.000040580195,"teacher_disagreement_score":0.94195205,"about_ca_system_score_codex":0.00018356959,"about_ca_system_score_gemma":0.00047355017,"threshold_uncertainty_score":0.9996187},"labels":[],"label_agreement":null},{"id":"W2852318325","doi":"10.1111/apt.14900","title":"Hepatic steatosis is highly prevalent across the paediatric age spectrum, including in pre‐school age children","year":2018,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Steatosis; Fatty liver; Context (archaeology); Population; Internal medicine; Quartile; Cohort; Adipose tissue; Anthropometry; Gastroenterology; Disease; Confidence interval","score_opus":0.03165251127558835,"score_gpt":0.3486064198176821,"score_spread":0.3169539085420937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2852318325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823337,0.004895695,0.0000022242461,0.009796104,0.0006182689,0.002006103,0.000120805424,0.0000731955,0.00015389653],"genre_scores_gemma":[0.94653744,0.005263984,0.00006668357,0.046638057,0.00086362805,0.00027580946,0.00010413225,0.000052008883,0.00019825497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761564,0.00029216535,0.00047633186,0.00054418127,0.00036288824,0.0007087897],"domain_scores_gemma":[0.9989128,0.00020070495,0.00015344197,0.000452216,0.00003944891,0.000241363],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030339643,0.0003818332,0.0004372165,0.00012158469,0.00032832054,0.00004157515,0.00033166457,0.00011742388,0.0012830104],"category_scores_gemma":[5.275285e-7,0.000273195,0.00020983997,0.0003917402,0.00031789756,0.000120279976,0.00026030059,0.000349983,0.00022148961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006002387,0.0023513609,0.97317094,0.00004399634,0.0108092865,0.0003136366,0.005266976,0.0000053169924,0.003908547,0.000007736689,0.0022448595,0.0012770916],"study_design_scores_gemma":[0.006811589,0.0012467385,0.920938,0.000054599954,0.014754638,0.000037529833,0.0001777552,0.0001357297,0.053389158,0.00013768963,0.0020033652,0.00031319048],"about_ca_topic_score_codex":0.00051977055,"about_ca_topic_score_gemma":0.00010697648,"teacher_disagreement_score":0.052232936,"about_ca_system_score_codex":0.00047157734,"about_ca_system_score_gemma":0.00010147085,"threshold_uncertainty_score":0.99997205},"labels":[],"label_agreement":null},{"id":"W2861824477","doi":"10.1111/apt.14837","title":"Letter: vedolizumab drug levels in cord and maternal blood in women with inflammatory bowel disease","year":2018,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"Region Midtjylland","keywords":"Medicine; Vedolizumab; Drug; Inflammatory bowel disease; Pregnancy; Disease; Gastroenterology; Internal medicine; Pharmacology","score_opus":0.02140975816380773,"score_gpt":0.30076877898754345,"score_spread":0.2793590208237357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2861824477","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7161284,0.0021546814,0.0000010199503,0.28005105,0.00072018796,0.0007870648,0.00007677179,0.000041712352,0.000039108316],"genre_scores_gemma":[0.21076415,0.0017924532,0.000048896683,0.78458214,0.0018074929,0.00019195497,0.00011477322,0.00007531475,0.0006228207],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974574,0.0002927581,0.0005203739,0.0005643348,0.00036995116,0.0007951902],"domain_scores_gemma":[0.99898034,0.000117733674,0.00022713488,0.00035945897,0.000048033784,0.00026731787],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026137062,0.00047570464,0.00054924865,0.00038818456,0.000057518682,0.000017482525,0.00025483058,0.00031991932,0.0006940192],"category_scores_gemma":[4.9575215e-7,0.00041054198,0.00004028603,0.00014811555,0.00052158977,0.0001409729,0.00009326385,0.0015521003,0.000027553524],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022897076,0.0015984777,0.38387617,0.0024939997,0.019756239,0.03140917,0.006834498,0.000005473247,0.018594284,0.0000021883843,0.5087266,0.0038057854],"study_design_scores_gemma":[0.027947986,0.0019323565,0.35080686,0.0020842417,0.011123115,0.00051759917,0.00011308618,0.000062061765,0.008319482,0.00012349758,0.59587604,0.0010937133],"about_ca_topic_score_codex":0.000038011913,"about_ca_topic_score_gemma":0.000010382922,"teacher_disagreement_score":0.50536424,"about_ca_system_score_codex":0.00032827954,"about_ca_system_score_gemma":0.00046321214,"threshold_uncertainty_score":0.99983466},"labels":[],"label_agreement":null},{"id":"W2884858741","doi":"10.1111/apt.14908","title":"Editorial: aminosalicylates in Crohn's disease—prevalence, risks, costs and time to reassess? Authors’ reply","year":2018,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Crohn's disease; Crohn disease; Disease; Intensive care medicine; Internal medicine","score_opus":0.012174759446633383,"score_gpt":0.3221810347442543,"score_spread":0.3100062752976209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884858741","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12796168,0.001962623,0.0000024434498,0.0005014456,0.866326,0.001374794,0.0016592202,0.000066291694,0.00014550182],"genre_scores_gemma":[0.0029593487,0.0030435382,0.00010206568,0.0062971744,0.9825522,0.00032588738,0.002354262,0.00019331965,0.0021722107],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956519,0.0007801358,0.00068705395,0.00143387,0.0006138698,0.0008331951],"domain_scores_gemma":[0.997705,0.00021299334,0.000327387,0.0007924671,0.00035566796,0.0006065029],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007967302,0.00078092463,0.0005273685,0.00023770594,0.00018787794,0.000086919885,0.00078525604,0.0010676292,0.00041943672],"category_scores_gemma":[0.000018470168,0.0008547496,0.00016353553,0.00016749202,0.00044097574,0.000022335362,0.00062968093,0.00071399723,0.00028082298],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033484134,0.00025177744,0.0024116174,0.0001296119,0.0022085703,0.0002831599,0.000053821794,0.000007950452,0.021976605,8.750763e-7,0.96912354,0.00020406123],"study_design_scores_gemma":[0.0019428807,0.00034904177,0.01241276,0.00009822766,0.0040604696,0.0000023567761,0.000011707383,0.0000289521,0.0023278857,0.000035136236,0.9778424,0.0008881787],"about_ca_topic_score_codex":0.00008967384,"about_ca_topic_score_gemma":0.00002717178,"teacher_disagreement_score":0.12500232,"about_ca_system_score_codex":0.00024994614,"about_ca_system_score_gemma":0.00073180214,"threshold_uncertainty_score":0.9993903},"labels":[],"label_agreement":null},{"id":"W2886918176","doi":"10.1111/apt.14919","title":"Real‐world clinical, endoscopic and radiographic efficacy of vedolizumab for the treatment of inflammatory bowel disease","year":2018,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials; University of Calgary","funders":"Canadian Institutes of Health Research; Canadian Association of Gastroenterology","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Internal medicine; Gastroenterology; Inflammatory bowel disease; Retrospective cohort study; Crohn's disease; Cohort; Surgery; Disease","score_opus":0.03003877253553839,"score_gpt":0.3540813051816713,"score_spread":0.3240425326461329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886918176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99442226,0.003323932,0.000027178661,0.00028230128,0.0006787517,0.0010963471,0.00011882097,0.000011759486,0.000038641116],"genre_scores_gemma":[0.984141,0.013437926,0.00018548727,0.0012785115,0.00064334954,0.00012483569,0.00007043561,0.00003357433,0.00008490526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860793,0.00021598718,0.00049040915,0.00032897707,0.00009651512,0.00026018047],"domain_scores_gemma":[0.99886304,0.00021933691,0.00024808318,0.00042538473,0.000106419975,0.00013771132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002040052,0.0002193066,0.00022486753,0.000075981734,0.0001564235,0.0000055990668,0.00023279761,0.00008310577,0.000047749523],"category_scores_gemma":[9.543004e-7,0.00016963662,0.00023885342,0.000070466,0.0011646317,0.0000056362333,0.000055340533,0.00005141479,0.0000017708533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012768515,0.0022572072,0.75040346,0.00013838231,0.0176165,0.00002484498,0.00042828065,0.000040924642,0.20918334,0.00015578019,0.0010039314,0.005978811],"study_design_scores_gemma":[0.010374383,0.0028564553,0.7880803,0.000016891316,0.009704558,0.0000016304281,0.00006862999,0.00039788382,0.155483,0.000072796196,0.03268674,0.0002567391],"about_ca_topic_score_codex":0.000015982894,"about_ca_topic_score_gemma":0.000047403664,"teacher_disagreement_score":0.053700324,"about_ca_system_score_codex":0.000019215768,"about_ca_system_score_gemma":0.00013367727,"threshold_uncertainty_score":0.6917581},"labels":[],"label_agreement":null},{"id":"W2886945992","doi":"10.1111/apt.14860","title":"Editorial: antigenic response to <scp>CT</scp>‐P13 and infliximab originator in <scp>IBD</scp> shows similar epitope recognition—evidence from basic science supports safe switching to biosimilars. Authors’ reply","year":2018,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital","funders":"","keywords":"Biosimilar; Medicine; Epitope; Infliximab; Antigen; Immunology; Computational biology; Biology; Tumor necrosis factor alpha; Internal medicine","score_opus":0.031047618336150964,"score_gpt":0.347741876224587,"score_spread":0.3166942578884361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886945992","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29231825,0.004936189,0.00004743022,0.0039043098,0.6953689,0.0017132857,0.0015129349,0.00016003176,0.000038659127],"genre_scores_gemma":[0.012534408,0.011197706,0.009312697,0.073404856,0.8891403,0.0005917562,0.0008865035,0.00047289405,0.0024588692],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9883807,0.0033706352,0.0018600604,0.0031939417,0.0007747409,0.0024199747],"domain_scores_gemma":[0.9800068,0.016473886,0.0007756204,0.0012330012,0.00087519945,0.0006354824],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.008503455,0.0014742333,0.0018892463,0.0014315953,0.0009437261,0.00026482352,0.0022074191,0.0020054758,0.0006608352],"category_scores_gemma":[0.0010856485,0.0014255486,0.0003295402,0.0017086441,0.0017076967,0.000671332,0.0014928218,0.003424525,0.00055030646],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007506542,0.00026579952,0.00042412334,0.000029685434,0.0017894333,0.00009034703,0.0011464303,0.0000014989126,0.413324,5.369067e-7,0.58102906,0.0011484115],"study_design_scores_gemma":[0.0020026418,0.0014998438,0.00034473732,0.00030980044,0.0032608057,0.000024003237,0.00032060515,0.000011573263,0.27435368,0.00021261825,0.7172828,0.0003769436],"about_ca_topic_score_codex":0.000324348,"about_ca_topic_score_gemma":0.00009045471,"teacher_disagreement_score":0.27978384,"about_ca_system_score_codex":0.0008711698,"about_ca_system_score_gemma":0.0019237883,"threshold_uncertainty_score":0.9998007},"labels":[],"label_agreement":null},{"id":"W2887662833","doi":"10.1111/apt.14858","title":"Editorial: biologic therapies for primary sclerosing cholangitis—more disappointment than promise?","year":2018,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; University of Calgary","funders":"","keywords":"Medicine; Primary sclerosing cholangitis; Disappointment; Ursodeoxycholic acid; Internal medicine; Gastroenterology; Disease","score_opus":0.03111912584977598,"score_gpt":0.34579053883243227,"score_spread":0.3146714129826563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887662833","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028304655,0.0074025937,0.000013797198,0.0018895436,0.9568067,0.0033114527,0.0019345165,0.00023677685,0.00009994199],"genre_scores_gemma":[0.00095543906,0.007446948,0.00055905094,0.009016661,0.9714236,0.0006036406,0.009115927,0.00019615244,0.00068254996],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99651545,0.0003152391,0.0006736573,0.0008822002,0.0007174284,0.0008960223],"domain_scores_gemma":[0.9972881,0.00080105197,0.0004653018,0.0006404249,0.0005339183,0.00027117142],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005367409,0.00083256897,0.0010934479,0.00017005848,0.00049507973,0.000078909805,0.00058844435,0.0011386521,0.00045381347],"category_scores_gemma":[0.0000031648194,0.00068492384,0.00057767506,0.00015161806,0.00071643054,0.00018061824,0.00028506134,0.0010922641,0.000053672356],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037950894,0.0012075534,0.0006180057,0.0003701935,0.019446816,0.000009615143,0.0005361664,2.0155467e-7,0.029165637,0.0000012805176,0.9441181,0.0007313719],"study_design_scores_gemma":[0.007819491,0.0035096803,0.0009449984,0.00021427491,0.026976459,0.0000055358432,0.00024154736,0.000008629965,0.0050180955,0.00009606488,0.9545126,0.00065263774],"about_ca_topic_score_codex":0.00008561155,"about_ca_topic_score_gemma":0.0000022775516,"teacher_disagreement_score":0.027349217,"about_ca_system_score_codex":0.0007224878,"about_ca_system_score_gemma":0.0008243538,"threshold_uncertainty_score":0.9995602},"labels":[],"label_agreement":null},{"id":"W2896437365","doi":"10.1111/apt.15001","title":"Systematic review with meta‐analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome","year":2018,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":598,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"American College of Gastroenterology; Health Research","keywords":"Synbiotics; Medicine; Irritable bowel syndrome; Rifaximin; Internal medicine; Placebo; Randomized controlled trial; Meta-analysis; Adverse effect; Gastroenterology; Antibiotics; Probiotic; Alternative medicine","score_opus":0.0647723968429816,"score_gpt":0.361768939476695,"score_spread":0.2969965426337134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896437365","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001897137,0.99121326,0.000021703985,0.00090945326,0.00013172334,0.007363133,0.00010400159,0.000039070354,0.000027952781],"genre_scores_gemma":[0.0016494007,0.99269205,0.0010226486,0.004216169,0.000033069286,0.000025330659,0.00017519646,0.00008544396,0.00010071519],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9951229,0.001148824,0.0019204948,0.00075022737,0.00043251598,0.0006250365],"domain_scores_gemma":[0.9963073,0.001206093,0.0011736699,0.00092407863,0.00021571179,0.00017314855],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013043917,0.000880247,0.0069128363,0.00043107744,0.00011035341,0.000025601865,0.0005452237,0.00029097966,0.000111193454],"category_scores_gemma":[0.0000085262,0.00050123245,0.0012812314,0.001288755,0.0010662809,0.00007482364,0.00019199771,0.0008631335,0.000016335329],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008878268,0.00085887546,0.00013121245,0.53272897,0.46591353,0.00009796159,0.00007045172,0.000006547294,0.0000017155569,0.000009721115,0.000044803106,0.000047398513],"study_design_scores_gemma":[0.00084551226,0.001485001,0.000040947063,0.09311055,0.9019019,0.00094440556,0.00007783737,0.0000508075,0.000016191043,0.000005697457,0.0011900372,0.0003311378],"about_ca_topic_score_codex":0.00004054939,"about_ca_topic_score_gemma":0.000052841864,"teacher_disagreement_score":0.43961844,"about_ca_system_score_codex":0.000113683556,"about_ca_system_score_gemma":0.00033525983,"threshold_uncertainty_score":0.99974394},"labels":[],"label_agreement":null},{"id":"W2899100906","doi":"10.1111/apt.15033","title":"Systematic review: predictive biomarkers of therapeutic response in inflammatory bowel disease—personalised medicine in its infancy","year":2018,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"Celltrion; Ablynx; Samsung; Norgine; Celgene; Teva Pharmaceutical Industries; Biogen; Gilead Sciences; Pfizer; Amgen","keywords":"Medicine; MEDLINE; Cochrane Library; Biomarker; Disease; Clinical trial; Inflammatory bowel disease; Precision medicine; Intensive care medicine; Prospective cohort study; Meta-analysis; Internal medicine; Oncology; Bioinformatics; Pathology","score_opus":0.022917758384152886,"score_gpt":0.3417073066454733,"score_spread":0.3187895482613204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899100906","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00584653,0.9868123,0.0000029966002,0.0002249098,0.0006234494,0.00610743,0.0003162734,0.000024386523,0.00004174022],"genre_scores_gemma":[0.0013822046,0.99000347,0.000009541577,0.006085891,0.00023949661,0.0014498621,0.00059582444,0.0001459733,0.00008774587],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99082094,0.0047298474,0.002357108,0.0009509682,0.00046109542,0.00068002346],"domain_scores_gemma":[0.99698675,0.00035995778,0.0012793852,0.0009191579,0.00019072753,0.00026404436],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023330485,0.0009622007,0.0021967983,0.00059842865,0.00006381894,0.000008736298,0.0010145287,0.0005238895,0.00019930307],"category_scores_gemma":[0.000021122298,0.00082477985,0.0005835387,0.0004480102,0.0006817671,0.000021652211,0.00025520954,0.00046179723,0.000034135366],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011664275,0.0008410024,0.0014407852,0.9463841,0.032574877,0.0009602921,0.00047084762,0.00001070564,0.003427848,0.000010105784,0.001513175,0.00070202653],"study_design_scores_gemma":[0.009868142,0.0020804913,0.005397203,0.7324888,0.14090912,0.00010202688,0.00029375634,0.0002399342,0.00064261846,0.000045042652,0.10480055,0.0031323347],"about_ca_topic_score_codex":0.000006150553,"about_ca_topic_score_gemma":0.000009242007,"teacher_disagreement_score":0.21389528,"about_ca_system_score_codex":0.00026446316,"about_ca_system_score_gemma":0.0010774668,"threshold_uncertainty_score":0.9994203},"labels":[],"label_agreement":null},{"id":"W2899651933","doi":"10.1111/apt.15034","title":"Loss of tolerance to glycoprotein 2 isoforms 1 and 4 is associated with Crohn’s disease of the pouch","year":2018,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Pouch; Medicine; Ulcerative colitis; Gastroenterology; Internal medicine; Crohn's disease; Pouchitis; Disease; Surgery","score_opus":0.009867889746907837,"score_gpt":0.2671574613221572,"score_spread":0.25728957157524934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899651933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99786943,0.00028293522,0.000024628107,0.00089652714,0.00016571124,0.00052771386,0.00017225396,0.000006190098,0.00005462089],"genre_scores_gemma":[0.98423696,0.000056648907,0.00007845389,0.015291311,0.00009615799,0.000032963937,0.000018865316,0.000021663715,0.0001669986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99907994,0.000097181095,0.00020929781,0.00024451152,0.00014252619,0.00022654167],"domain_scores_gemma":[0.99930096,0.00001196365,0.00014829737,0.00028402876,0.00014577003,0.000108964225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010625748,0.000160018,0.00014422329,0.000025899986,0.00009209302,0.0000043581545,0.00025152077,0.00006984076,0.0001083272],"category_scores_gemma":[8.059077e-7,0.00011538655,0.000057633646,0.00009878567,0.0005357527,0.0000060919688,0.00014713404,0.000065499655,0.0000029975306],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004339186,0.0003333369,0.15409157,0.000037442966,0.002956779,0.000037695216,0.0005006933,0.00003128259,0.83659554,0.000016404512,0.0007890731,0.00027099205],"study_design_scores_gemma":[0.0016109003,0.00040543816,0.32282805,0.000028446713,0.0012009605,0.0000037957952,0.00004156061,0.00006764857,0.6719846,0.000049437444,0.0016075391,0.00017160851],"about_ca_topic_score_codex":0.000012118877,"about_ca_topic_score_gemma":0.000024729705,"teacher_disagreement_score":0.1687365,"about_ca_system_score_codex":0.00001836734,"about_ca_system_score_gemma":0.00011446153,"threshold_uncertainty_score":0.4705327},"labels":[],"label_agreement":null},{"id":"W2899941886","doi":"10.1111/apt.14997","title":"Systematic review: efficacy and safety of switching patients between reference and biosimilar infliximab","year":2018,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Robarts Clinical Trials; Western University","funders":"Allergan; Akebia Therapeutics; Janssen Pharmaceuticals; Ablynx","keywords":"Biosimilar; Medicine; Infliximab; MEDLINE; Intensive care medicine; Pharmacology; Internal medicine; Tumor necrosis factor alpha","score_opus":0.06518226559974113,"score_gpt":0.38392252269095883,"score_spread":0.31874025709121767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899941886","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021524525,0.99620956,0.000008601751,0.00020954972,0.00044935296,0.0024844361,0.0003433867,0.000029944653,0.000049900413],"genre_scores_gemma":[0.00010498898,0.9946312,0.00020880032,0.0045827236,0.00005157882,0.000054641747,0.00025435296,0.000044856813,0.00006688345],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952256,0.0019981032,0.0016195942,0.00062759744,0.0000788252,0.0004502581],"domain_scores_gemma":[0.9969475,0.0014621279,0.0010141167,0.00039761345,0.00011038156,0.00006825101],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009935817,0.0006405496,0.003469844,0.00016488072,0.00018513984,0.000010907922,0.000457615,0.0007372036,0.00020361772],"category_scores_gemma":[0.000005769768,0.0004475656,0.00023270017,0.00021542804,0.000638859,0.00006345808,0.0004043069,0.00074916886,0.000027301356],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018430148,0.00056657643,0.0002457286,0.81660354,0.06995705,0.0000054426596,0.00015975026,5.471207e-9,0.0006124628,0.000030049943,0.0013787854,0.110256314],"study_design_scores_gemma":[0.0025305517,0.0010313517,0.00007006294,0.17707941,0.23192506,0.000048185648,0.000015124408,5.914164e-7,0.00076388445,0.000027279777,0.5856998,0.00080872286],"about_ca_topic_score_codex":0.0000061499395,"about_ca_topic_score_gemma":5.9991754e-7,"teacher_disagreement_score":0.6395241,"about_ca_system_score_codex":0.00006257294,"about_ca_system_score_gemma":0.00007027435,"threshold_uncertainty_score":0.9997976},"labels":[],"label_agreement":null},{"id":"W2901884599","doi":"10.1111/apt.15044","title":"Systematic review with meta‐analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis","year":2018,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Transjugular intrahepatic portosystemic shunt; Portal vein thrombosis; Thrombosis; Portal hypertension; Radiology; Cirrhosis; Surgery; Internal medicine","score_opus":0.0881921015691142,"score_gpt":0.3827273951354615,"score_spread":0.29453529356634733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901884599","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000339888,0.9886752,0.00020022158,0.0003778452,0.00023121848,0.009355221,0.0007190318,0.0000714413,0.00002992706],"genre_scores_gemma":[0.0015950378,0.9842318,0.00019910603,0.005634787,0.00017676436,0.0022781468,0.0057097124,0.00011060135,0.00006404064],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99582505,0.00074231013,0.0017080324,0.0008092956,0.0004713786,0.00044391205],"domain_scores_gemma":[0.9976676,0.00033036276,0.0010697313,0.0004877811,0.00019378246,0.00025073346],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008551075,0.00082022854,0.005745579,0.00040538693,0.00014717087,0.000028640203,0.00022599053,0.00028133395,0.000616973],"category_scores_gemma":[2.6033473e-7,0.0005602018,0.0017451171,0.00061361835,0.0001759805,0.0001774042,0.00001573044,0.00030097488,0.00001329087],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006112946,0.00014486186,0.000017062634,0.42441264,0.5749844,0.0000762309,0.00014590884,3.1231684e-7,0.000008427324,0.000006601165,0.000052614225,0.00008982028],"study_design_scores_gemma":[0.0010170562,0.00066739036,0.000006202827,0.050551593,0.9446358,0.00034185284,0.00007385231,0.000048521877,0.000043264576,0.0000062199097,0.002127914,0.00048030406],"about_ca_topic_score_codex":0.00004921536,"about_ca_topic_score_gemma":0.000054861615,"teacher_disagreement_score":0.37386104,"about_ca_system_score_codex":0.00011464925,"about_ca_system_score_gemma":0.00040633325,"threshold_uncertainty_score":0.99968493},"labels":[],"label_agreement":null},{"id":"W2902274419","doi":"10.1111/apt.15068","title":"Depression in cirrhosis – a prospective evaluation of the prevalence, predictors and development of a screening nomogram","year":2018,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; University of Alberta Hospital; University of Alberta","funders":"","keywords":"Medicine; Depression (economics); Cirrhosis; Nomogram; Anxiety; Quality of life (healthcare); Odds ratio; Internal medicine; Hospital Anxiety and Depression Scale; Prospective cohort study; Psychiatry","score_opus":0.044882327875186985,"score_gpt":0.34760352416823054,"score_spread":0.30272119629304356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902274419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99791247,0.0008260366,0.00005681471,0.000090545895,0.00011246243,0.0009090138,0.000012670976,0.0000072774114,0.000072701594],"genre_scores_gemma":[0.99864507,0.0001982006,0.0006102774,0.00043543312,0.00003091627,0.000056204117,0.000010876335,0.000006876903,0.000006138426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991192,0.00013820556,0.00022615828,0.0001470179,0.00026763915,0.00010176327],"domain_scores_gemma":[0.99961096,0.000039360595,0.0001052705,0.00008022864,0.00013469828,0.000029486473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031574865,0.00008023285,0.00011981496,0.00007460297,0.00005375944,0.0000014140131,0.0000570078,0.000041405383,0.00010882679],"category_scores_gemma":[1.0224331e-7,0.000058599566,0.00002421304,0.0001367551,0.0001727506,0.00005819825,0.0000222104,0.00007033631,5.182e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059113203,0.00023785191,0.91738135,0.0001257191,0.002641441,5.616403e-7,0.0065019554,0.0000054821453,0.069753,9.662153e-7,0.0000018926092,0.0027586569],"study_design_scores_gemma":[0.0024599351,0.00013098228,0.67324895,0.00011623048,0.008316401,0.0000029803055,0.00015975496,0.0008074434,0.3146978,0.000014280236,0.000009513163,0.000035762656],"about_ca_topic_score_codex":0.000016236612,"about_ca_topic_score_gemma":0.000015620486,"teacher_disagreement_score":0.2449448,"about_ca_system_score_codex":0.000045019362,"about_ca_system_score_gemma":0.00012315022,"threshold_uncertainty_score":0.23896208},"labels":[],"label_agreement":null},{"id":"W2902375658","doi":"10.1111/apt.15029","title":"Severe vitamin D deficiency is a prognostic biomarker in autoimmune hepatitis","year":2018,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Alberta Hospital; Alberta Hospital Edmonton","funders":"American College of Gastroenterology","keywords":"Medicine; Autoimmune hepatitis; Biomarker; Hepatitis; Immunology; vitamin D deficiency; Vitamin D and neurology; Hepatitis a virus; Internal medicine; Virus","score_opus":0.04220476416928673,"score_gpt":0.36246750610419504,"score_spread":0.32026274193490833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902375658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809892,0.0031973673,0.000019976898,0.012159643,0.00070841704,0.0011107997,0.000034775403,0.00009225932,0.0016875637],"genre_scores_gemma":[0.96963567,0.0021900865,0.00049769226,0.026098747,0.00013458324,0.00015043459,0.000032231204,0.000042850064,0.0012177039],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774903,0.0002137089,0.00041721395,0.0004685863,0.00037928345,0.0007721788],"domain_scores_gemma":[0.99911344,0.00021983252,0.00008321106,0.00029534538,0.00016617985,0.000121999314],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036088264,0.00029085495,0.0004011113,0.00029649006,0.0002092133,0.00001408391,0.0002450796,0.00013052326,0.0021789423],"category_scores_gemma":[0.0000019726194,0.0002543565,0.00009576386,0.00060782896,0.00080623163,0.000113141774,0.00023053066,0.00036123727,0.0003350088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004694846,0.0016897311,0.6630135,0.000114119895,0.005182228,0.00045871115,0.0031971985,7.2221513e-7,0.3063094,0.000015058262,0.00893097,0.010618886],"study_design_scores_gemma":[0.005698053,0.0020138682,0.9394446,0.00010084855,0.0033513007,0.0002313081,0.00041968646,0.0016266777,0.035574373,0.00007855091,0.011077677,0.00038303965],"about_ca_topic_score_codex":0.00024474013,"about_ca_topic_score_gemma":0.00006669214,"teacher_disagreement_score":0.2764311,"about_ca_system_score_codex":0.00027358258,"about_ca_system_score_gemma":0.00017194216,"threshold_uncertainty_score":0.9999909},"labels":[],"label_agreement":null},{"id":"W2902524762","doi":"10.1111/apt.15022","title":"Editorial: microbial translocation and immune activation profiling during treatment of chronic HCV","year":2018,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Immune system; Chromosomal translocation; Profiling (computer programming); Immunology; Genetics; Biology; Gene; Computer science","score_opus":0.02527578139288235,"score_gpt":0.363144808302157,"score_spread":0.3378690269092747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902524762","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10155585,0.003922433,0.000010990023,0.00047898747,0.8918744,0.0018387096,0.00020708043,0.000059807393,0.000051747353],"genre_scores_gemma":[0.014260831,0.024623726,0.00020118825,0.000095185496,0.9587515,0.00016812986,0.0015730273,0.00010995403,0.00021642986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974489,0.00024862008,0.00065643556,0.0005418542,0.00062851014,0.00047565319],"domain_scores_gemma":[0.9985582,0.00029994044,0.00031056942,0.00030518186,0.00040884857,0.00011723587],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027074234,0.00042369246,0.0007457102,0.00027401623,0.00016655786,0.000017432962,0.00015606124,0.0008311912,0.00023111228],"category_scores_gemma":[0.0000016642526,0.00040741698,0.00014238614,0.00016960324,0.0003704414,0.00012324813,0.000050237028,0.0005717034,0.00001708499],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021867459,0.00070244516,0.000084612715,0.00037679917,0.0080664,0.000008332731,0.00049783615,0.0000019493018,0.87055093,3.222096e-7,0.11172328,0.005800357],"study_design_scores_gemma":[0.005627114,0.0021089958,0.000019212792,0.00010553293,0.0038196133,0.0000019765391,0.00001545314,0.000053808966,0.5292428,0.000003188253,0.458838,0.00016433826],"about_ca_topic_score_codex":0.00038142063,"about_ca_topic_score_gemma":0.000018704699,"teacher_disagreement_score":0.34711468,"about_ca_system_score_codex":0.0014080888,"about_ca_system_score_gemma":0.0010466145,"threshold_uncertainty_score":0.99983776},"labels":[],"label_agreement":null},{"id":"W2902876253","doi":"10.1111/apt.15032","title":"Editorial: treating strictures in inflammatory bowel disease—authors’ reply","year":2018,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Inflammatory bowel disease; Inflammatory Bowel Diseases; Disease; Gastroenterology; Intensive care medicine; General surgery; Internal medicine","score_opus":0.008723501520169603,"score_gpt":0.2968867066588012,"score_spread":0.2881632051386316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902876253","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06639754,0.0021255778,0.0000050207177,0.00022554937,0.92933756,0.00094427355,0.000732003,0.00008460677,0.00014789694],"genre_scores_gemma":[0.0030821532,0.0018314263,0.00008319872,0.0043711406,0.98520446,0.00030273746,0.004149331,0.00024494992,0.0007305819],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950129,0.00083013903,0.0009610013,0.0013723818,0.000837008,0.0009865607],"domain_scores_gemma":[0.99750423,0.00020716386,0.00056554977,0.00094797416,0.00035555553,0.00041952083],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000753766,0.0009442444,0.00049512635,0.0002726492,0.00024753765,0.00008574238,0.0010161,0.0015057982,0.00023381542],"category_scores_gemma":[0.000015229728,0.0010095175,0.00033993612,0.00013527459,0.00046093148,0.00002146596,0.0004827005,0.0011740815,0.000075153366],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002934066,0.00027869546,0.0050368523,0.00012778718,0.003711303,0.00025383773,0.000118908996,0.00008385493,0.017806716,0.0000014633879,0.9695658,0.00008072689],"study_design_scores_gemma":[0.002939148,0.00030683813,0.0019587444,0.00006464329,0.0041080164,0.0000014938676,0.000044416134,0.000053460764,0.004103897,0.00007040375,0.9853798,0.00096912927],"about_ca_topic_score_codex":0.00004408319,"about_ca_topic_score_gemma":0.00006126529,"teacher_disagreement_score":0.063315384,"about_ca_system_score_codex":0.0002996691,"about_ca_system_score_gemma":0.0013497358,"threshold_uncertainty_score":0.99979043},"labels":[],"label_agreement":null},{"id":"W2906509712","doi":"10.1111/apt.15090","title":"Systematic review with meta‐analysis: high prevalence and cost of continued aminosalicylate use in patients with ulcerative colitis escalated to immunosuppressive and biological therapies","year":2018,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Robarts Clinical Trials; University of Calgary; Western University","funders":"Institute of Nutrition, Metabolism and Diabetes; Canadian Institutes of Health Research; Canadian Association of Gastroenterology","keywords":"Medicine; Concomitant; Internal medicine; Ulcerative colitis; Placebo; Population; Meta-analysis; Clinical trial; Randomized controlled trial; Disease; Alternative medicine; Environmental health; Pathology","score_opus":0.03168581277712153,"score_gpt":0.3120248104657506,"score_spread":0.2803389976886291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906509712","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11673967,0.8765197,0.000007679499,0.000023326196,0.000033390923,0.0058895713,0.0007763478,0.000009024394,0.0000013442897],"genre_scores_gemma":[0.013861262,0.982172,0.00013958148,0.0020776938,0.000017733593,0.0011196738,0.0005402746,0.000046010806,0.00002573471],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.996202,0.0017418882,0.0008346338,0.00070893473,0.00017656888,0.00033600928],"domain_scores_gemma":[0.99829316,0.00016530427,0.00075677887,0.00039873278,0.00026096337,0.00012506936],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032911467,0.0006226419,0.0026619122,0.00015890764,0.0000655744,0.000026334656,0.0002693634,0.00023970514,0.000051509393],"category_scores_gemma":[0.000002427207,0.00038289494,0.00026519457,0.00029239318,0.00052847294,0.000018171964,0.00017265457,0.00018173431,0.0000019340616],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025323774,0.00045007485,0.0052973963,0.15901661,0.8318373,0.00007753092,0.00028188547,0.000002452725,0.00007397763,0.000004860147,0.00003704659,0.0003885215],"study_design_scores_gemma":[0.0021337802,0.0015528285,0.021445926,0.020846536,0.9513722,0.000014836037,0.00002322701,0.000003164003,0.00012729832,0.0000016226246,0.0017123435,0.00076622283],"about_ca_topic_score_codex":0.00002268981,"about_ca_topic_score_gemma":0.0000554837,"teacher_disagreement_score":0.13817008,"about_ca_system_score_codex":0.000034011904,"about_ca_system_score_gemma":0.00009184293,"threshold_uncertainty_score":0.9998623},"labels":[],"label_agreement":null},{"id":"W2909047581","doi":"10.1111/apt.15116","title":"Systematic review with meta‐analysis: review of donor features, procedures and outcomes in 168 clinical studies of faecal microbiota transplantation","year":2019,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"South Health Campus; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Adverse effect; Ulcerative colitis; Confidence interval; Incidence (geometry); Clostridium difficile; Inflammatory bowel disease; Gastroenterology; Transplantation; Meta-analysis; Disease; Antibiotics","score_opus":0.17191417619305063,"score_gpt":0.49054728621314353,"score_spread":0.31863311002009287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909047581","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041994758,0.990469,4.5574953e-7,0.001236035,0.00008864902,0.0074812053,0.00028312235,0.000011821864,0.000009798742],"genre_scores_gemma":[0.000057042107,0.99342513,0.000071654395,0.005411296,0.00002839551,0.00044345483,0.000364495,0.00004748121,0.00015106877],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9943396,0.0014548398,0.002773474,0.00062131166,0.00046510334,0.0003456756],"domain_scores_gemma":[0.9962389,0.0015669827,0.0012929604,0.00052475475,0.00027655775,0.00009985923],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016185663,0.00064112403,0.012813652,0.00043590672,0.000029757539,0.0000046890373,0.0003097032,0.00026196113,0.0001146444],"category_scores_gemma":[0.0000069977077,0.00036816328,0.0019351403,0.00094008504,0.00036212403,0.000043361215,0.00006641514,0.00074714446,0.000005075846],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090004025,0.00034145956,0.0000616133,0.6006777,0.3982317,0.00003262961,0.000037365986,1.18791434e-7,0.000030961568,7.791041e-7,0.000107793785,0.00038788375],"study_design_scores_gemma":[0.00079253985,0.0004593138,0.0000138585065,0.31295186,0.68351734,0.0001291712,0.0000322987,3.9442415e-7,0.00016395286,2.2145593e-7,0.0017471159,0.00019191562],"about_ca_topic_score_codex":0.000025035832,"about_ca_topic_score_gemma":0.000036530477,"teacher_disagreement_score":0.28772584,"about_ca_system_score_codex":0.00010462684,"about_ca_system_score_gemma":0.00051635085,"threshold_uncertainty_score":0.99987704},"labels":[],"label_agreement":null},{"id":"W2909868967","doi":"10.1111/apt.15092","title":"Comparative outcomes in patients with ulcer‐ vs non‐ulcer‐related acute upper gastrointestinal bleeding in the United Kingdom: a nationwide cohort of 4474 patients","year":2019,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Internal medicine; Upper gastrointestinal bleeding; Aspirin; Gastroenterology; Cohort; Odds ratio; Stress ulcer; Logistic regression; Cohort study; Endoscopy","score_opus":0.02457444953548923,"score_gpt":0.3149844762495424,"score_spread":0.2904100267140532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909868967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957828,0.000012340362,0.0000031333643,0.0015249863,0.00019094338,0.002266289,0.00003688338,0.00002212347,0.00016051906],"genre_scores_gemma":[0.99436104,0.000012885783,0.0006958665,0.0043534166,0.000014359394,0.00010083788,0.00040220807,0.000030400817,0.000029011868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787146,0.00017925323,0.00062287657,0.00038149703,0.00048366684,0.00046122403],"domain_scores_gemma":[0.9986884,0.00044826485,0.000319382,0.00020426523,0.00026172964,0.00007795741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026453173,0.0003589414,0.00068529375,0.00042895458,0.000063189174,0.0000129211,0.00021642858,0.000058336154,0.00019725806],"category_scores_gemma":[0.0000011451774,0.00023814494,0.00009579005,0.00061116036,0.00016015372,0.00013269,0.00006229027,0.0004634668,0.000028193946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018491417,0.0042025717,0.9876992,0.00002083979,0.0039105294,0.000035696205,0.0008918829,0.0002238855,0.0010749458,0.000018707724,0.000056786117,0.000015785497],"study_design_scores_gemma":[0.017004402,0.0051992666,0.97086155,0.00025426623,0.004096844,0.00002741659,0.00024315357,0.00071007526,0.0013912258,0.000009394284,0.000029725301,0.00017269171],"about_ca_topic_score_codex":0.00030175285,"about_ca_topic_score_gemma":0.000020088237,"teacher_disagreement_score":0.01683769,"about_ca_system_score_codex":0.00025452403,"about_ca_system_score_gemma":0.00006770593,"threshold_uncertainty_score":0.9711269},"labels":[],"label_agreement":null},{"id":"W2911689495","doi":"10.1111/apt.15148","title":"Systematic review with meta‐analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation","year":2019,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Liver transplantation; Primary sclerosing cholangitis; Meta-analysis; Gastroenterology; Internal medicine; Transplantation; Risk factor; Disease","score_opus":0.11539426223525093,"score_gpt":0.3748845755795871,"score_spread":0.25949031334433614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911689495","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001663637,0.9880022,0.00009090401,0.00006381093,0.0002940542,0.009371081,0.0019460545,0.00005166123,0.000013907956],"genre_scores_gemma":[0.00007467787,0.9863343,0.0001792352,0.0068292934,0.000078366626,0.0017179572,0.0045836065,0.000095808915,0.00010675134],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9966525,0.0010611023,0.0009878128,0.00056025805,0.00033524758,0.00040308328],"domain_scores_gemma":[0.99759233,0.00067159673,0.0009026982,0.00054706563,0.00013236291,0.00015396482],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004215315,0.00073282054,0.005339489,0.0002770601,0.0001320736,0.00002804942,0.0002594625,0.00020070121,0.00059751247],"category_scores_gemma":[3.7091974e-7,0.00045222315,0.003200105,0.00044630776,0.000085270025,0.0001596076,0.000037481743,0.0005369027,0.000036449906],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017560969,0.00021186855,0.000021471875,0.5091786,0.48932183,0.000021193513,0.0000893738,4.6798795e-7,7.814904e-7,2.1053019e-7,0.000030776733,0.0009478764],"study_design_scores_gemma":[0.00082060666,0.00061917154,0.00007449603,0.06949438,0.91705287,0.000052930758,0.000019963953,0.000011280174,0.000007867858,4.7983923e-7,0.01143483,0.00041115523],"about_ca_topic_score_codex":0.000039331524,"about_ca_topic_score_gemma":0.0000035349904,"teacher_disagreement_score":0.43968418,"about_ca_system_score_codex":0.00026886526,"about_ca_system_score_gemma":0.00022868405,"threshold_uncertainty_score":0.99979293},"labels":[],"label_agreement":null},{"id":"W2911702913","doi":"10.1111/apt.15155","title":"Editorial: identifying candidates for pegylated interferon add‐on to entecavir therapy in patients with HBeAg‐positive chronic hepatitis B – authors' reply","year":2019,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Entecavir; Medicine; Pegylated interferon; Chronic hepatitis; Gastroenterology; HBeAg; Virology; Internal medicine; Intensive care medicine; Hepatitis B virus; HBsAg; Virus; Lamivudine; Ribavirin","score_opus":0.017579403855362344,"score_gpt":0.3339741326793574,"score_spread":0.31639472882399505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911702913","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1378933,0.0010199542,0.00001870542,0.0010216037,0.85107434,0.006717638,0.0020900492,0.00012973217,0.000034687226],"genre_scores_gemma":[0.065233305,0.005097881,0.00015425935,0.010833012,0.9097746,0.0014768216,0.0064225574,0.00036607252,0.00064146315],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948843,0.0004124142,0.0010128533,0.0013756215,0.001183574,0.0011312141],"domain_scores_gemma":[0.9964231,0.001337921,0.0005309609,0.00060280965,0.00085693336,0.00024826208],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053951814,0.0010430185,0.0015543054,0.0006226289,0.00024045828,0.00006423257,0.00049066986,0.0008846971,0.00022917308],"category_scores_gemma":[0.000010575567,0.0009188995,0.0002379783,0.0003924383,0.00019939407,0.00019361921,0.0002106627,0.0017366899,0.0001190873],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02105825,0.0010486423,0.03420228,0.0001834669,0.014560455,0.000029725406,0.0013409316,0.000015994021,0.002430799,6.368806e-7,0.9230716,0.0020571775],"study_design_scores_gemma":[0.02118042,0.029928781,0.0055125603,0.0010921122,0.0057532876,0.0000010991497,0.000027188174,0.00003646564,0.010583482,0.000008935621,0.924913,0.0009626837],"about_ca_topic_score_codex":0.0037755868,"about_ca_topic_score_gemma":0.0024820531,"teacher_disagreement_score":0.07265999,"about_ca_system_score_codex":0.0029707223,"about_ca_system_score_gemma":0.0008203898,"threshold_uncertainty_score":0.99932617},"labels":[],"label_agreement":null},{"id":"W2913127674","doi":"10.1111/apt.15091","title":"Editorial: the role of vitamin D in autoimmune hepatitis—authors' reply","year":2019,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Autoimmune hepatitis; Vitamin D and neurology; Hepatitis; Immunology; Dermatology; Internal medicine","score_opus":0.009688511709223979,"score_gpt":0.30260067736109125,"score_spread":0.2929121656518673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913127674","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027070055,0.006972796,5.691113e-7,0.0012159316,0.962703,0.0012806421,0.00043383698,0.000048275462,0.00027492995],"genre_scores_gemma":[0.013357664,0.011273198,0.00003277474,0.0042474023,0.9684501,0.00010190082,0.0013233497,0.00011452642,0.0010990301],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966746,0.00063830084,0.00083878345,0.00048013395,0.00084218837,0.0005260247],"domain_scores_gemma":[0.99702716,0.0012218653,0.0004944682,0.0008509795,0.0003046388,0.000100880134],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007304825,0.0004808252,0.00096022256,0.00019169397,0.0001061989,0.000017722821,0.0006807158,0.0007812998,0.00061262917],"category_scores_gemma":[0.000004305788,0.00037609722,0.00032709248,0.00026900572,0.00033729023,0.0001101419,0.0003053095,0.0021061392,0.000069552174],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015515913,0.00096410693,0.007495944,0.00014388868,0.008126208,0.000016638163,0.0006345288,0.000004683861,0.022862086,0.000006003612,0.9575574,0.00063692476],"study_design_scores_gemma":[0.0039718407,0.00094847806,0.0026563297,0.0001431484,0.013722577,0.0000033777203,0.0002705917,0.00010889951,0.0053106006,0.00006243151,0.97249144,0.0003103108],"about_ca_topic_score_codex":0.0033500649,"about_ca_topic_score_gemma":0.000018414199,"teacher_disagreement_score":0.017551485,"about_ca_system_score_codex":0.0003735301,"about_ca_system_score_gemma":0.0009501732,"threshold_uncertainty_score":0.9998691},"labels":[],"label_agreement":null},{"id":"W2913578719","doi":"10.1111/apt.15075","title":"Editorial: the role of vitamin D in autoimmune hepatitis","year":2019,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"European Association for the Study of the Liver; Alberta Innovates - Health Solutions","keywords":"Medicine; Autoimmune hepatitis; Vitamin D and neurology; MEDLINE; Hepatitis; Immunology; Internal medicine","score_opus":0.008839004415454415,"score_gpt":0.29706817216661485,"score_spread":0.2882291677511604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913578719","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030687325,0.007132376,3.7978907e-7,0.0006503618,0.9597346,0.0010497036,0.00042007642,0.0000336439,0.0002915182],"genre_scores_gemma":[0.017306961,0.014426733,0.000020822916,0.0021945988,0.96405137,0.00008089145,0.0011577499,0.00008847374,0.0006723854],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99744916,0.00042759374,0.0006336725,0.0003547505,0.0006995937,0.00043520037],"domain_scores_gemma":[0.99766374,0.0010570996,0.00035829216,0.00061173696,0.00023712234,0.00007201165],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042390195,0.0003987449,0.0008120958,0.00015553292,0.00008008288,0.000012581634,0.00056577846,0.0007089057,0.00066988956],"category_scores_gemma":[0.0000019098686,0.00030706156,0.00026833705,0.00021418282,0.00028900144,0.00008808659,0.00024665063,0.0015985527,0.00006856647],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011727292,0.0009028557,0.00817711,0.00013058852,0.008335805,0.000012117578,0.00048635303,0.000004365033,0.024620848,0.000004668182,0.9554196,0.00073298434],"study_design_scores_gemma":[0.003958064,0.0008074094,0.002815257,0.00011420755,0.013246228,0.0000022324202,0.00021792532,0.000096922624,0.005174011,0.000043820077,0.9732681,0.00025581633],"about_ca_topic_score_codex":0.0027583973,"about_ca_topic_score_gemma":0.000022282557,"teacher_disagreement_score":0.019446837,"about_ca_system_score_codex":0.000323313,"about_ca_system_score_gemma":0.0008125449,"threshold_uncertainty_score":0.99993813},"labels":[],"label_agreement":null},{"id":"W2913926637","doi":"10.1111/apt.15098","title":"Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B","year":2019,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; University Health Network","funders":"","keywords":"Entecavir; Medicine; HBeAg; HBsAg; Gastroenterology; Internal medicine; Pegylated interferon; Combination therapy; Hepatitis B virus; Regimen; Hepatitis B; PEG ratio; Immunology; Antigen; Chronic hepatitis; Virus; Lamivudine; Ribavirin","score_opus":0.018373695787163646,"score_gpt":0.306336180893107,"score_spread":0.28796248510594336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913926637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98327416,0.0014290365,0.00009860824,0.009628276,0.00081452855,0.003248774,0.0013699746,0.00006713816,0.00006949833],"genre_scores_gemma":[0.9763766,0.008593928,0.00023543445,0.014123805,0.00013218515,0.0001111997,0.0001643272,0.0000653554,0.00019719271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99667346,0.00081731466,0.0007473892,0.0006545917,0.00042771408,0.00067951606],"domain_scores_gemma":[0.9983999,0.00053861697,0.0002040538,0.00042342834,0.0002223755,0.00021164182],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066054816,0.00044321714,0.00076866406,0.00030350688,0.00015578719,0.000020738673,0.00029086779,0.0001746285,0.0010756818],"category_scores_gemma":[0.000005474065,0.00039712363,0.0001112735,0.0005719476,0.0002474821,0.00019201229,0.00032581258,0.00040998767,0.00016284366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025040915,0.00027767313,0.57378864,0.00005185579,0.002358683,0.000086982756,0.0038770214,0.00010519323,0.41382527,0.000002732662,0.0009899868,0.0021318675],"study_design_scores_gemma":[0.0023385133,0.004815466,0.71810466,0.00035635577,0.0007517829,0.000038350456,0.00008492217,0.0006794407,0.26847786,0.000008887839,0.004049896,0.00029387613],"about_ca_topic_score_codex":0.009131785,"about_ca_topic_score_gemma":0.009192324,"teacher_disagreement_score":0.1453474,"about_ca_system_score_codex":0.00070618873,"about_ca_system_score_gemma":0.000237966,"threshold_uncertainty_score":0.99984807},"labels":[],"label_agreement":null},{"id":"W2914547283","doi":"10.1111/apt.15141","title":"Comparison of the metabolomic profiles of irritable bowel syndrome patients with ulcerative colitis patients and healthy controls: new insights into pathophysiology and potential biomarkers","year":2019,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McMaster University; University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Innovates Bio Solutions; Alberta Innovates - Health Solutions","keywords":"Irritable bowel syndrome; Medicine; Ulcerative colitis; Gastroenterology; Internal medicine; Pathophysiology; Urinary system; Metabolomics; Urine; Metabolome; Disease; Metabolite; Bioinformatics","score_opus":0.007597904296582486,"score_gpt":0.2646730419010584,"score_spread":0.2570751376044759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914547283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99349236,0.0047429632,0.000012778174,0.00029767986,0.00040164287,0.00095279777,0.000079446196,0.000003524824,0.000016795811],"genre_scores_gemma":[0.99618703,0.0015852049,0.0003610514,0.0016786699,0.000024440884,0.000020678286,0.00009722223,0.000018965904,0.00002675495],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998658,0.00025003304,0.0003592412,0.00035460107,0.00013397093,0.00024413278],"domain_scores_gemma":[0.9992561,0.00003944817,0.00034426086,0.00016800535,0.00012392814,0.00006829179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007781498,0.00022620156,0.00050100026,0.000061754705,0.000112887974,0.0000058584124,0.00015808242,0.00010979299,0.000022478798],"category_scores_gemma":[6.990011e-7,0.00015757317,0.0000575353,0.000095540694,0.0003709336,0.00001241455,0.00021367542,0.00010824397,5.7763714e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036843277,0.00058225536,0.39213762,0.00006728749,0.006667296,5.065597e-7,0.00041578282,0.000020292473,0.59567404,0.000056193185,0.00018961109,0.0005048288],"study_design_scores_gemma":[0.009708028,0.005088403,0.7749026,0.000014577936,0.0021524134,0.0000022723862,0.00033833104,0.00011311254,0.20617938,0.00022572045,0.0009939983,0.00028120706],"about_ca_topic_score_codex":0.00008813482,"about_ca_topic_score_gemma":0.000028297804,"teacher_disagreement_score":0.38949463,"about_ca_system_score_codex":0.000016914679,"about_ca_system_score_gemma":0.00007422695,"threshold_uncertainty_score":0.6425647},"labels":[],"label_agreement":null},{"id":"W2918012568","doi":"10.1111/apt.15158","title":"Outcomes following restrictive or liberal red blood cell transfusion in patients with lower gastrointestinal bleeding","year":2019,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Blood transfusion and management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University","funders":"","keywords":"Medicine; Confounding; Odds ratio; Blood transfusion; Logistic regression; Internal medicine; Gastrointestinal bleeding; Upper gastrointestinal bleeding; Packed red blood cells; Surgery; Endoscopy","score_opus":0.012187329734802509,"score_gpt":0.2650703280009172,"score_spread":0.25288299826611466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918012568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99397016,0.000048058067,0.000021806767,0.0021592553,0.0006775915,0.001831719,0.0000058332357,0.00007508381,0.0012105234],"genre_scores_gemma":[0.9854489,0.00009271995,0.0014148528,0.011816118,0.0000349918,0.000038773345,0.000041905103,0.00005057102,0.0010611528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982956,0.00008932481,0.00035244282,0.00043539607,0.00035127523,0.0004759766],"domain_scores_gemma":[0.9994773,0.00008311972,0.00007842904,0.00019176789,0.000045766228,0.00012361945],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013777567,0.00030294608,0.00042605717,0.00021871895,0.00007927064,0.0000113843325,0.00013833353,0.000067717505,0.0010127813],"category_scores_gemma":[1.3536342e-7,0.00022077633,0.00012852805,0.00030150305,0.000044035205,0.00014681234,0.000045770623,0.0004040003,0.000026133417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004766151,0.003149648,0.95956343,0.00004340255,0.0026695917,0.0002727249,0.00032229835,0.00002627322,0.028911872,0.000002252445,0.00007073332,0.00020159836],"study_design_scores_gemma":[0.061775226,0.008254589,0.89992636,0.00020395264,0.01420895,0.000023678436,0.0003570841,0.00014242313,0.014172061,0.000008043034,0.00050042983,0.0004272226],"about_ca_topic_score_codex":0.00004656665,"about_ca_topic_score_gemma":0.00001854182,"teacher_disagreement_score":0.059637114,"about_ca_system_score_codex":0.000088874935,"about_ca_system_score_gemma":0.000065142754,"threshold_uncertainty_score":0.9999004},"labels":[],"label_agreement":null},{"id":"W2919464683","doi":"10.1111/apt.15182","title":"Editorial: is there a causal link between non‐selective beta blockers and portal vein thrombosis in cirrhosis?","year":2019,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Vancouver General Hospital","funders":"University of Alberta; Pfizer","keywords":"Medicine; Cirrhosis; Portal vein thrombosis; Thrombosis; BETA (programming language); Internal medicine; Cardiology; Portal vein; Portal hypertension; Gastroenterology","score_opus":0.018277062562719437,"score_gpt":0.3304667813900486,"score_spread":0.31218971882732915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919464683","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1210781,0.002873601,0.0000017322332,0.0032439816,0.86957836,0.0015710961,0.0014560693,0.00006627307,0.00013078377],"genre_scores_gemma":[0.08153016,0.012105316,0.00004287922,0.002763612,0.8996212,0.00009841222,0.0035652367,0.0001340818,0.0001390832],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99693733,0.00022670599,0.0005984123,0.00085757714,0.0007687856,0.00061121356],"domain_scores_gemma":[0.9982214,0.0007703596,0.00028549478,0.0002918022,0.00020519867,0.00022572024],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00028453255,0.0006394712,0.0010427007,0.0002947294,0.00011007695,0.000032718952,0.00024292084,0.0013134367,0.00031359078],"category_scores_gemma":[2.4434993e-7,0.00062671164,0.00019710002,0.00024641186,0.00020828904,0.00018411642,0.00007414538,0.0017094295,0.00006255261],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011542636,0.00029788612,0.04372778,0.00037895836,0.04991036,0.00012231528,0.00245956,8.930749e-7,0.0037552945,9.3316424e-7,0.89802706,0.00016468148],"study_design_scores_gemma":[0.023782302,0.0033780094,0.02435089,0.0006006751,0.23564507,0.00001280294,0.000506273,0.000059769896,0.024003161,0.00010774486,0.6860088,0.0015444941],"about_ca_topic_score_codex":0.00063832395,"about_ca_topic_score_gemma":0.000042375254,"teacher_disagreement_score":0.21201827,"about_ca_system_score_codex":0.0002809827,"about_ca_system_score_gemma":0.0008103557,"threshold_uncertainty_score":0.9999831},"labels":[],"label_agreement":null},{"id":"W2920711010","doi":"10.1111/apt.15144","title":"Editorial: ulcer‐related vs non‐ulcer‐nonvariceal upper gastrointestinal bleeding—which has worse outcomes?","year":2019,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Upper gastrointestinal bleeding; Gastroenterology; Duodenal ulcer; Internal medicine; General surgery; Endoscopy","score_opus":0.02073811525079943,"score_gpt":0.31673726136528624,"score_spread":0.2959991461144868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920711010","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02470953,0.00046278632,0.000014287858,0.008774688,0.961872,0.002629504,0.00047795623,0.00042391583,0.0006353699],"genre_scores_gemma":[0.016080951,0.0008793177,0.0020456805,0.005857678,0.96740115,0.00037315805,0.0034973717,0.00052255887,0.0033421433],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913609,0.0003257541,0.0017725318,0.0019657337,0.0024536802,0.0021213803],"domain_scores_gemma":[0.9925795,0.0028885033,0.0011547094,0.0009853083,0.0015747664,0.00081716443],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.00105121,0.0019775946,0.0026594007,0.00073133165,0.0004987915,0.00022040478,0.0009729666,0.0015020467,0.0022933702],"category_scores_gemma":[0.000024365154,0.001743557,0.00091649237,0.0007668837,0.000498806,0.00027936135,0.00051951926,0.0047891736,0.0016248104],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022826947,0.0030905085,0.10005979,0.00025055333,0.021976367,0.00040857936,0.00019872669,0.000040245828,0.0049971356,0.0000036899269,0.86662483,0.00006687578],"study_design_scores_gemma":[0.021708002,0.011034156,0.008977061,0.0013123673,0.08175096,0.0006088345,0.00013627918,0.00029963817,0.0012884944,0.000038830432,0.87128025,0.001565141],"about_ca_topic_score_codex":0.0006093841,"about_ca_topic_score_gemma":0.000030794283,"teacher_disagreement_score":0.09108273,"about_ca_system_score_codex":0.0017322664,"about_ca_system_score_gemma":0.0020547824,"threshold_uncertainty_score":0.9997942},"labels":[],"label_agreement":null},{"id":"W2921349086","doi":"10.1111/apt.15189","title":"Editorial: blood transfusion for lower gastrointestinal bleeding—authors’ reply","year":2019,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Blood transfusion; Gastrointestinal bleeding; Intensive care medicine; General surgery; Gastroenterology; Internal medicine","score_opus":0.020239123199728884,"score_gpt":0.32297246768845916,"score_spread":0.3027333444887303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921349086","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010955784,0.00069341133,0.00029787084,0.005937826,0.9864216,0.004375533,0.00044899207,0.0002937546,0.0004354444],"genre_scores_gemma":[0.0001216938,0.004375406,0.0018037187,0.016130755,0.96968484,0.00038615745,0.0017928348,0.00027300837,0.0054316125],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99556816,0.00016773936,0.00094196986,0.0012675425,0.0010487871,0.0010057861],"domain_scores_gemma":[0.9971865,0.00091346604,0.00034717727,0.00062348886,0.00058676774,0.0003425956],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008753615,0.0008980243,0.0011989734,0.0003325784,0.00024817407,0.000050816016,0.0005182219,0.00088793016,0.0010886063],"category_scores_gemma":[0.0000034431923,0.00085413444,0.0006819305,0.00022243532,0.0001988979,0.00011853074,0.00012395473,0.0020086372,0.000098722616],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005191386,0.002004166,0.00005616976,0.00057201873,0.012883524,0.00007798295,0.00016431061,0.0000038361795,0.059494093,0.000008834387,0.91922253,0.00032111554],"study_design_scores_gemma":[0.01637343,0.005841608,0.0000052824544,0.00032507826,0.07442304,0.000049088754,0.00007949433,0.000049281065,0.006513687,0.000038263424,0.8957059,0.0005958574],"about_ca_topic_score_codex":0.00009190827,"about_ca_topic_score_gemma":0.000011330504,"teacher_disagreement_score":0.061539512,"about_ca_system_score_codex":0.00022096394,"about_ca_system_score_gemma":0.00061097817,"threshold_uncertainty_score":0.9998245},"labels":[],"label_agreement":null},{"id":"W2921818363","doi":"10.1111/apt.15180","title":"Letter: severe vitamin D deficiency is a prognostic biomarker in autoimmune hepatitis—offender or bystander? Authors’ reply","year":2019,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"University of Alberta","keywords":"Bystander effect; Medicine; Biomarker; Autoimmune hepatitis; Vitamin D and neurology; Immunology; Hepatitis; Internal medicine","score_opus":0.06641039647970395,"score_gpt":0.35623429083714087,"score_spread":0.28982389435743694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921818363","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.058030143,0.0074408283,0.000027013342,0.9244453,0.003782679,0.004907505,0.0004039847,0.00023452412,0.00072807417],"genre_scores_gemma":[0.03139613,0.0048112767,0.00033955768,0.9391565,0.00117804,0.00057937676,0.00079595204,0.00026151678,0.021481654],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99288136,0.0009984664,0.0012576994,0.0015679981,0.001314107,0.0019803604],"domain_scores_gemma":[0.99686426,0.0012700248,0.0004336273,0.0010420021,0.00024852934,0.00014153057],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008052844,0.0011536443,0.0016615588,0.00091767363,0.0002683938,0.00006070694,0.00078042666,0.0011432426,0.0033463866],"category_scores_gemma":[0.0000066781186,0.0009274834,0.00039413758,0.0008633463,0.00075703143,0.00019341648,0.0005770251,0.0042157234,0.00041130747],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061809435,0.0007172619,0.032914966,0.0010770168,0.012661668,0.007417238,0.0012284253,0.0000018828878,0.0096963085,6.256515e-7,0.9324836,0.0011828854],"study_design_scores_gemma":[0.008511235,0.001854698,0.04671202,0.00060143374,0.012085697,0.0009466832,0.000176798,0.0005570695,0.0014786449,0.000026257787,0.92580867,0.0012407857],"about_ca_topic_score_codex":0.00034624484,"about_ca_topic_score_gemma":0.00003227913,"teacher_disagreement_score":0.026634015,"about_ca_system_score_codex":0.0011727691,"about_ca_system_score_gemma":0.0008046782,"threshold_uncertainty_score":0.9993176},"labels":[],"label_agreement":null},{"id":"W2923519186","doi":"10.1111/apt.15214","title":"Early combined immunosuppression may be effective and safe in older patients with Crohn’s disease: post hoc analysis of REACT","year":2019,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University Hospital; Robarts Clinical Trials","funders":"Crohn's and Colitis Foundation; National Institute of Diabetes and Digestive and Kidney Diseases; American College of Gastroenterology","keywords":"Medicine; Immunosuppression; Crohn's disease; Internal medicine; Post-hoc analysis; Hazard ratio; Adverse effect; Surgery; Relative risk; Disease; Confidence interval","score_opus":0.0037539213093564583,"score_gpt":0.24965916626218607,"score_spread":0.24590524495282962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923519186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980239,0.00046517936,0.0000018203754,0.00014439531,0.00013807275,0.00096858694,0.00021724735,0.00000676837,0.00003400341],"genre_scores_gemma":[0.996141,0.00011972874,0.000024887218,0.002759131,0.00001585326,0.000051336923,0.00080335984,0.000026033353,0.000058629605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987482,0.00025876786,0.00023399871,0.00036744622,0.00014880106,0.00024279332],"domain_scores_gemma":[0.9993253,0.00005189076,0.00014440056,0.00028256705,0.00009889581,0.0000969668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010336098,0.00021545832,0.00025654706,0.00015434227,0.00004255862,0.000008260427,0.00015347358,0.00009642525,0.00017968492],"category_scores_gemma":[3.86568e-7,0.00018729611,0.000090277026,0.00015882895,0.0001477613,0.000015292906,0.00011621451,0.0001089901,0.0000032386802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011498757,0.0005284535,0.7785861,0.000026453085,0.00781083,0.000033683904,0.00017844059,0.00008389463,0.20102713,0.0000027308417,0.000026160435,0.0001973712],"study_design_scores_gemma":[0.005613745,0.0007116782,0.9714797,0.000014707038,0.0064169695,2.9415918e-7,0.00004101748,0.00009348053,0.015253336,0.0000024340795,0.00016482716,0.0002078237],"about_ca_topic_score_codex":0.000036664584,"about_ca_topic_score_gemma":0.000015990709,"teacher_disagreement_score":0.19289358,"about_ca_system_score_codex":0.000033725006,"about_ca_system_score_gemma":0.000051203107,"threshold_uncertainty_score":0.7637714},"labels":[],"label_agreement":null},{"id":"W2930597421","doi":"10.1111/apt.15154","title":"Letter: vitamin D deficiency and autoimmune hepatitis – from research to treatment—authors' reply","year":2019,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Autoimmune hepatitis; Vitamin D and neurology; vitamin D deficiency; MEDLINE; Hepatitis; Immunology; Internal medicine","score_opus":0.07614531361809122,"score_gpt":0.3752575137026548,"score_spread":0.2991122000845636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2930597421","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38418227,0.0063568186,0.000005491788,0.60486794,0.0018692085,0.0017283543,0.00067703734,0.000080881655,0.00023201805],"genre_scores_gemma":[0.017805599,0.005582698,0.00027884412,0.9629376,0.0030377768,0.00019189529,0.0024146526,0.00014011035,0.00761083],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99584055,0.001009514,0.0005350699,0.0009854514,0.0006206563,0.0010087499],"domain_scores_gemma":[0.9977108,0.00078580563,0.00014893449,0.0009862619,0.0001754282,0.00019272474],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035042857,0.0006052651,0.00087697577,0.0004219998,0.00035327306,0.00006548965,0.00043295242,0.0005736748,0.0018425388],"category_scores_gemma":[8.7440344e-7,0.00053713296,0.00023145806,0.00031213512,0.00039211905,0.0001156768,0.000369054,0.0021028863,0.0005715764],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060093234,0.0006707953,0.02461795,0.000112520676,0.010225518,0.0010578354,0.0011502253,9.662838e-7,0.0236935,0.0000012299073,0.9339113,0.0039571803],"study_design_scores_gemma":[0.0030785026,0.0029687285,0.024608886,0.000097792006,0.012962699,0.000050317765,0.000071174465,0.000049393915,0.0044001136,0.00002870221,0.95122313,0.00046058354],"about_ca_topic_score_codex":0.0065345746,"about_ca_topic_score_gemma":0.000015506934,"teacher_disagreement_score":0.36637667,"about_ca_system_score_codex":0.00068459706,"about_ca_system_score_gemma":0.0003157074,"threshold_uncertainty_score":0.999708},"labels":[],"label_agreement":null},{"id":"W2938047985","doi":"10.1111/apt.15234","title":"Letter: meta‐analysis of prebiotics, probiotics, synbiotics and antibiotics in IBS. Authors’ reply","year":2019,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Synbiotics; Medicine; Antibiotics; Intensive care medicine; Microbiology; Probiotic; Biology; Bacteria","score_opus":0.07206810186635591,"score_gpt":0.3319977482736459,"score_spread":0.25992964640729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2938047985","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.050086353,0.007103897,0.00009021304,0.937683,0.0014225055,0.002700375,0.0006227639,0.00010620441,0.00018470101],"genre_scores_gemma":[0.06683191,0.0013882127,0.0029766164,0.92625505,0.00048614954,0.000003208116,0.0011743064,0.000117718744,0.0007668225],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99566257,0.0005672291,0.0012976472,0.0010741991,0.00052663294,0.00087170006],"domain_scores_gemma":[0.9974148,0.0007317011,0.0006613817,0.00085340795,0.00021389152,0.00012476665],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00059764076,0.0008308108,0.0029387756,0.0011903559,0.00006492354,0.000028086286,0.00039744403,0.0008966234,0.00039674185],"category_scores_gemma":[0.0000033783676,0.0007734725,0.0010183038,0.000853549,0.00081848074,0.00009541835,0.00023533878,0.0026780735,0.00001683285],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007534878,0.0012286253,0.049593706,0.0017515905,0.7780555,0.00067886483,0.00051709835,0.00037285764,0.0042630895,0.000009051516,0.16272105,0.00005511004],"study_design_scores_gemma":[0.0020997568,0.0015639701,0.0033050473,0.0000810587,0.9065232,0.00009015047,0.00007969573,0.0016872446,0.0051212907,0.000038215872,0.07884388,0.0005664517],"about_ca_topic_score_codex":0.00019354494,"about_ca_topic_score_gemma":0.00005593316,"teacher_disagreement_score":0.12846778,"about_ca_system_score_codex":0.00016093437,"about_ca_system_score_gemma":0.00020703804,"threshold_uncertainty_score":0.99962276},"labels":[],"label_agreement":null},{"id":"W2938788352","doi":"10.1111/apt.15250","title":"Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn’s disease","year":2019,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Western University; Robarts Clinical Trials","funders":"","keywords":"Medicine; Biopsy; CD68; Gastroenterology; Crohn's disease; Histopathology; Pathology; Proinflammatory cytokine; Inflammatory bowel disease; Internal medicine; Immunohistochemistry; Disease; Inflammation","score_opus":0.03772179758318824,"score_gpt":0.3704068724527665,"score_spread":0.33268507486957827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2938788352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99810475,0.00031407614,0.00019665611,0.00004888866,0.00008966825,0.0011396775,0.00009068876,0.0000030283265,0.000012578172],"genre_scores_gemma":[0.99903756,0.000022794813,0.00038031494,0.0001832594,0.000013333911,0.000108746615,0.00023668617,0.000013432283,0.000003846047],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989518,0.00021736871,0.00020691338,0.00026585694,0.00021661272,0.00014146137],"domain_scores_gemma":[0.99933505,0.00002458984,0.00016948057,0.00014798836,0.00027650487,0.000046378165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022163108,0.00013877334,0.00018012649,0.00006337865,0.000022683174,0.0000022983659,0.00009871909,0.000079189886,0.00004086849],"category_scores_gemma":[7.864585e-7,0.00012686988,0.00005350214,0.000055114597,0.00017119423,0.000013265078,0.000031409134,0.000064688356,2.123166e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00702583,0.00084897195,0.12773561,0.0000539713,0.0017739419,0.0000013226522,0.00006399813,0.001404828,0.86044735,0.0000048779953,0.0000050026933,0.0006342947],"study_design_scores_gemma":[0.005635668,0.0004157302,0.861832,0.0000097385,0.0038188456,4.0443922e-7,0.000039713657,0.004588682,0.12351271,0.00001266759,0.000007347008,0.00012649968],"about_ca_topic_score_codex":0.0000075401113,"about_ca_topic_score_gemma":0.0000027696017,"teacher_disagreement_score":0.73693466,"about_ca_system_score_codex":0.00011835585,"about_ca_system_score_gemma":0.00025421774,"threshold_uncertainty_score":0.5173603},"labels":[],"label_agreement":null},{"id":"W2941814174","doi":"10.1111/apt.15244","title":"Letter: paradoxical skin eruptions during anti‐TNF‐α treatment of Crohn's disease","year":2019,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Galderma; Agence Nationale pour la Gestion des Déchets Radioactifs; Hospital for Sick Children; Celgene","keywords":"Medicine; Crohn's disease; Disease; Dermatology; Crohn disease; Intensive care medicine; Pathology","score_opus":0.028013382770196465,"score_gpt":0.31266047888849935,"score_spread":0.28464709611830286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941814174","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50850546,0.0046137134,0.0000050941785,0.48330334,0.001553847,0.0014980673,0.00024416714,0.000094930074,0.00018135368],"genre_scores_gemma":[0.06549688,0.0064276187,0.000059910064,0.91967046,0.0027803094,0.00015996485,0.0016087048,0.00015144271,0.0036447307],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99736637,0.00023761841,0.00073681783,0.0006048281,0.0003752853,0.00067909306],"domain_scores_gemma":[0.99867195,0.00013440399,0.00035122217,0.0006665808,0.00006290751,0.00011293858],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000059787515,0.0006378952,0.0010580671,0.0002727332,0.0001471133,0.000012365482,0.0002568626,0.0005370189,0.0019112728],"category_scores_gemma":[1.328818e-7,0.0005639474,0.0006055201,0.00014162791,0.00043383418,0.000099199795,0.00007265084,0.0008629,0.00025444594],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030711854,0.0040424108,0.019718241,0.0013714732,0.06190656,0.010434792,0.0010288893,0.00009990317,0.05765035,0.0000065474355,0.83844805,0.0022215783],"study_design_scores_gemma":[0.0059515527,0.0006349136,0.03417407,0.000080596765,0.02604701,0.00006149118,0.000031834057,0.00006805506,0.01287662,0.0000117831505,0.9195664,0.000495661],"about_ca_topic_score_codex":0.00003151215,"about_ca_topic_score_gemma":5.96502e-7,"teacher_disagreement_score":0.4430086,"about_ca_system_score_codex":0.00030155547,"about_ca_system_score_gemma":0.00028117164,"threshold_uncertainty_score":0.9996812},"labels":[],"label_agreement":null},{"id":"W2942080591","doi":"10.1111/apt.15236","title":"Letter: nonselective beta‐blockers, endoscopic therapy and portal vein thrombosis in cirrhosis","year":2019,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Galderma; Agence Nationale pour la Gestion des Déchets Radioactifs; Hospital for Sick Children; Celgene","keywords":"Medicine; Cirrhosis; Portal vein thrombosis; Gastroenterology; Internal medicine","score_opus":0.04028223194967855,"score_gpt":0.3132760670519402,"score_spread":0.27299383510226166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942080591","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47597498,0.005500043,0.000002699356,0.515334,0.0010362461,0.0016503315,0.00023309365,0.000066179564,0.0002024284],"genre_scores_gemma":[0.112588815,0.014890221,0.00010609194,0.86886406,0.0014102375,0.00012911901,0.001717059,0.00009461821,0.00019977949],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976552,0.0003093264,0.0004240882,0.00069470564,0.00033074405,0.0005859174],"domain_scores_gemma":[0.9991617,0.00027585364,0.00017348288,0.00026078548,0.00005313871,0.00007498938],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000113247705,0.0005360887,0.00073574815,0.0003533333,0.00008366863,0.000021799204,0.0001713032,0.0005818924,0.0011314512],"category_scores_gemma":[2.2830694e-8,0.0005101166,0.00016823356,0.00019494875,0.00019902435,0.00012950902,0.000032524087,0.0014982615,0.00007530018],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015409009,0.0010023422,0.22717802,0.000697094,0.11107313,0.0036794913,0.0035369575,0.0000021318049,0.05321411,0.000004521148,0.5972701,0.00080124306],"study_design_scores_gemma":[0.035046536,0.0040557967,0.098067395,0.0005918278,0.14413907,0.00037751836,0.00027310717,0.00013660903,0.13383916,0.000118463075,0.5812632,0.0020913421],"about_ca_topic_score_codex":0.00023299055,"about_ca_topic_score_gemma":0.0000130746375,"teacher_disagreement_score":0.36338615,"about_ca_system_score_codex":0.00014857699,"about_ca_system_score_gemma":0.00019992715,"threshold_uncertainty_score":0.99978167},"labels":[],"label_agreement":null},{"id":"W2943140621","doi":"10.1111/apt.15265","title":"Targets to improve quality of care for patients with hepatic encephalopathy: data from a multi‐centre cohort","year":2019,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Valeant Pharmaceuticals International; Office of Research and Development; U.S. Department of Veterans Affairs","keywords":"Rifaximin; Lactulose; Medicine; Hepatic encephalopathy; Internal medicine; Cirrhosis; Cohort; Liver disease; Cohort study; Retrospective cohort study; Model for End-Stage Liver Disease; Pneumonia; Gastroenterology; Liver transplantation; Antibiotics","score_opus":0.0282535000880579,"score_gpt":0.3404256829009464,"score_spread":0.3121721828128885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943140621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911406,0.0005540678,0.00019440494,0.0002532573,0.00044726962,0.0029909126,0.0043785707,0.000024189363,0.000016731708],"genre_scores_gemma":[0.9825993,0.000112068155,0.0022221722,0.005972479,0.0000628018,0.000047536265,0.008929828,0.00002573832,0.000028086048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875385,0.00008562651,0.00029781339,0.0004167973,0.00022470462,0.00022119125],"domain_scores_gemma":[0.9990146,0.00015834252,0.00012692096,0.000392519,0.00019099822,0.00011657376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008638084,0.00016993283,0.000342576,0.00004489738,0.000041117968,0.0000041438025,0.00019771911,0.00005526671,0.00026194804],"category_scores_gemma":[1.45158e-7,0.00014084521,0.00005125627,0.00006778995,0.000042453335,0.000126418,0.00004900859,0.000079987556,0.000029695126],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047375676,0.00071831705,0.9328402,0.0002431885,0.009772632,0.0000034856273,0.002215333,0.000006372319,0.049137972,0.0000017719622,0.00002410139,0.00029905894],"study_design_scores_gemma":[0.018183727,0.0014505573,0.86510926,0.0000783525,0.034476515,3.5961037e-7,0.0009616129,0.0007917716,0.07824741,0.000010143146,0.00040816778,0.0002821307],"about_ca_topic_score_codex":0.0002989271,"about_ca_topic_score_gemma":0.000065900516,"teacher_disagreement_score":0.06773095,"about_ca_system_score_codex":0.00006163495,"about_ca_system_score_gemma":0.00010084901,"threshold_uncertainty_score":0.57435006},"labels":[],"label_agreement":null},{"id":"W2944723384","doi":"10.1111/apt.15286","title":"A clinical predictive model for post‐hospitalisation venous thromboembolism in patients with inflammatory bowel disease","year":2019,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Logistic regression; Venous thromboembolism; Inflammatory bowel disease; Internal medicine; Incidence (geometry); Univariate analysis; Intensive care unit; Multivariate analysis; Emergency medicine; Disease; Thrombosis","score_opus":0.016274529183632747,"score_gpt":0.30817811046913274,"score_spread":0.2919035812855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944723384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99197656,0.0002263054,0.00017409048,0.0019106934,0.0008191695,0.0046105906,0.000116557036,0.00006897941,0.00009707646],"genre_scores_gemma":[0.9666329,0.00030144321,0.00038790292,0.03161225,0.00016313978,0.00033543294,0.00042210007,0.00006591524,0.00007893338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811906,0.00010404113,0.0005135124,0.0005110267,0.00029673093,0.00045560984],"domain_scores_gemma":[0.99900836,0.000112459165,0.00018634519,0.00031334173,0.00017831779,0.00020117],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028211548,0.00028361243,0.00058691646,0.0001445537,0.00007630338,0.000012289684,0.00016120657,0.00012221475,0.00013748251],"category_scores_gemma":[6.2606046e-7,0.0002465587,0.00014356803,0.0000893725,0.00013718264,0.00020592229,0.00007654169,0.0002540458,0.0000355661],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006106275,0.009021261,0.9691197,0.00020113785,0.007838298,0.000018626031,0.0016358881,0.003881051,0.00038252675,0.00016651672,0.00074089126,0.0008877814],"study_design_scores_gemma":[0.012961208,0.003965855,0.9371579,0.000070626906,0.0082130935,5.257339e-7,0.00015399631,0.03641426,0.00010706809,0.00020157907,0.00047664472,0.00027723302],"about_ca_topic_score_codex":0.000013983406,"about_ca_topic_score_gemma":0.0000069637913,"teacher_disagreement_score":0.032533206,"about_ca_system_score_codex":0.00021033573,"about_ca_system_score_gemma":0.00021752692,"threshold_uncertainty_score":0.9999987},"labels":[],"label_agreement":null},{"id":"W2945651855","doi":"10.1111/apt.15297","title":"Systematic review with meta‐analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel disease","year":2019,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of British Columbia; Robarts Clinical Trials; University of Calgary","funders":"National Cancer Institute; Canadian Institutes of Health Research; Crohn's and Colitis Canada; Canadian Association of Gastroenterology","keywords":"Medicine; Placebo; Internal medicine; Tofacitinib; Gastroenterology; Inflammatory bowel disease; Relative risk; Ulcerative colitis; Adverse effect; Janus kinase; Confidence interval; Disease; Cytokine; Pathology","score_opus":0.03790166367927629,"score_gpt":0.3407933302505959,"score_spread":0.3028916665713196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945651855","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029784458,0.9898908,0.000031931027,0.00008395343,0.00020705545,0.008622491,0.00083710504,0.000020619715,0.000008192592],"genre_scores_gemma":[0.00015430276,0.99274015,0.00011541644,0.0034696062,0.000097002245,0.001537555,0.001622032,0.00012316079,0.0001407433],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9959274,0.0010503446,0.001432239,0.00085269636,0.0002739043,0.00046341983],"domain_scores_gemma":[0.99716824,0.00019338075,0.001243857,0.0009262485,0.00017872237,0.0002895637],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00072077534,0.000882396,0.0035580785,0.00021513866,0.0001064779,0.000017443175,0.00051640277,0.0002903875,0.00006743106],"category_scores_gemma":[0.0000025248828,0.00064462697,0.0019554677,0.00022635517,0.00029843306,0.000013510321,0.0002089335,0.00023306206,0.000009878242],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058999396,0.00018147672,0.00002595449,0.48260266,0.5160028,0.000052009673,0.000011347993,0.000021628677,0.00006339397,0.0000066662274,0.00013204906,0.00031002302],"study_design_scores_gemma":[0.0012857098,0.00023048998,0.000015734062,0.012977712,0.928386,0.000011837977,0.000008300995,0.000013147254,0.00009851179,0.000001696015,0.056346957,0.00062395725],"about_ca_topic_score_codex":0.0000023168031,"about_ca_topic_score_gemma":0.000005226426,"teacher_disagreement_score":0.46962494,"about_ca_system_score_codex":0.000057753416,"about_ca_system_score_gemma":0.0005169385,"threshold_uncertainty_score":0.9996005},"labels":[],"label_agreement":null},{"id":"W2946181699","doi":"10.1111/apt.15317","title":"Determinants of diagnostic delay in autoimmune atrophic gastritis","year":2019,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Società Italiana di Medicina Interna","keywords":"Medicine; Interquartile range; Internal medicine; Pediatrics","score_opus":0.019788203771527867,"score_gpt":0.30825007538853516,"score_spread":0.2884618716170073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946181699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930407,0.0025266735,0.000003222083,0.0023541895,0.001108157,0.0008213003,0.000025799212,0.00004390761,0.0000760942],"genre_scores_gemma":[0.9852744,0.0027623312,0.00022141731,0.011442824,0.00006755186,0.000052915213,0.000029145878,0.000040076124,0.000109366374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803746,0.00020601798,0.00064923795,0.00035306855,0.00017950097,0.0005747219],"domain_scores_gemma":[0.99893695,0.000434858,0.00017886325,0.0002816986,0.000085764164,0.00008183991],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021250475,0.0002716948,0.00067897525,0.00022938167,0.000039208237,0.0000029220623,0.00019179157,0.00016276746,0.00052603794],"category_scores_gemma":[0.0000016894047,0.00026348545,0.000108999404,0.00026095082,0.00026329665,0.000087986075,0.00013481005,0.0004711602,0.00013471999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064574607,0.00056059484,0.8852765,0.000052007,0.0032374747,0.0003475922,0.0003463382,0.000025584366,0.10810178,0.0000012844556,0.00008487585,0.0013202009],"study_design_scores_gemma":[0.010043687,0.0027267195,0.9488581,0.0001588826,0.0052184993,0.00040028497,0.0001578491,0.00040044668,0.030303746,0.000019360883,0.0015079471,0.00020447411],"about_ca_topic_score_codex":0.00009319032,"about_ca_topic_score_gemma":0.000037395454,"teacher_disagreement_score":0.07779803,"about_ca_system_score_codex":0.0001388024,"about_ca_system_score_gemma":0.00007126954,"threshold_uncertainty_score":0.99998176},"labels":[],"label_agreement":null},{"id":"W2946888867","doi":"10.1111/apt.15283","title":"Editorial: combination immunosuppressive therapy to treat Crohn’s disease – ready for all age groups? Authors' reply","year":2019,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; University Hospital; Western University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health","keywords":"Medicine; Crohn's disease; Disease; Crohn disease; Internal medicine; Intensive care medicine; Gerontology","score_opus":0.019511208837172434,"score_gpt":0.33448945836849264,"score_spread":0.3149782495313202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946888867","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036461107,0.0016682715,0.000041043502,0.00083341065,0.95297736,0.0042088726,0.0036493384,0.00009038504,0.00007022389],"genre_scores_gemma":[0.002460199,0.0027402714,0.00011720578,0.0149906,0.943905,0.0016520726,0.030702254,0.00033795298,0.0030944424],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99560785,0.0006047375,0.0007448226,0.0014289032,0.0006995262,0.00091416476],"domain_scores_gemma":[0.9969198,0.0003295654,0.00051837164,0.0011300971,0.0006370401,0.00046509574],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055325474,0.0009551543,0.00064063893,0.00017944901,0.000259246,0.0001118238,0.0010924082,0.001231509,0.000114170194],"category_scores_gemma":[0.000011766396,0.0009876812,0.00045297632,0.000088146335,0.00019614205,0.000026733484,0.00032107107,0.00064153044,0.00009239271],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014196792,0.00064877514,0.000054426422,0.000108121036,0.0056229997,0.00014487848,0.00018332568,0.000040530325,0.12453754,0.000007910553,0.85424995,0.00020472403],"study_design_scores_gemma":[0.007638543,0.0011459402,0.00036099626,0.000029727968,0.0057490715,0.0000010954312,0.000032188673,0.00001849636,0.014756207,0.00011593527,0.96914685,0.0010049633],"about_ca_topic_score_codex":0.000041513038,"about_ca_topic_score_gemma":0.000007973707,"teacher_disagreement_score":0.11489686,"about_ca_system_score_codex":0.00030029105,"about_ca_system_score_gemma":0.0007629544,"threshold_uncertainty_score":0.9992574},"labels":[],"label_agreement":null},{"id":"W2953365743","doi":"10.1111/apt.15307","title":"Editorial: assessing histological disease activity in Crohn’s disease—a call for standardisation of mucosal biopsy location. Authors' reply","year":2019,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Biopsy; Crohn disease; Disease; Crohn's disease; Gastroenterology; Internal medicine; Pathology; Dermatology","score_opus":0.017009486726976723,"score_gpt":0.335872410055352,"score_spread":0.3188629233283753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953365743","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1344157,0.0013082337,0.00061594293,0.0004398579,0.8588966,0.0017454794,0.0025277196,0.00003647745,0.000013991247],"genre_scores_gemma":[0.1381151,0.00048231726,0.0002550725,0.0011100244,0.8521717,0.0005039229,0.0069336137,0.0001516032,0.0002766148],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963918,0.0006679818,0.0007053579,0.0010265667,0.0006474681,0.00056082517],"domain_scores_gemma":[0.9974057,0.00034907923,0.0006752081,0.00064626173,0.00061561615,0.00030811096],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007791362,0.00056904444,0.00056194374,0.00016209658,0.00013875331,0.000042603,0.00048818768,0.00088052545,0.000039247363],"category_scores_gemma":[0.000038799204,0.00060434174,0.0003174744,0.000121500234,0.00035690525,0.00003535025,0.00020869003,0.00057902775,0.0000055627265],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015885286,0.0008583476,0.0042704865,0.0006562135,0.0022935153,0.00008837644,0.000048561178,0.00049453386,0.04670149,0.000006190988,0.9284841,0.00021292691],"study_design_scores_gemma":[0.00604434,0.00034849794,0.03236748,0.00010997609,0.008582866,8.4815224e-7,0.000031081483,0.00065368874,0.0035385333,0.00012586283,0.94711673,0.0010801223],"about_ca_topic_score_codex":0.000039488485,"about_ca_topic_score_gemma":0.000014606509,"teacher_disagreement_score":0.04316296,"about_ca_system_score_codex":0.0005091429,"about_ca_system_score_gemma":0.0028481632,"threshold_uncertainty_score":0.9996408},"labels":[],"label_agreement":null},{"id":"W2955020078","doi":"10.1111/apt.15306","title":"Systematic review with meta‐analysis: association between <i>Helicobacter pylori</i> CagA seropositivity and odds of inflammatory bowel disease","year":2019,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Agency for Healthcare Research and Quality","keywords":"CagA; Odds ratio; Helicobacter pylori; Medicine; Inflammatory bowel disease; Meta-analysis; Immunology; Ulcerative colitis; Internal medicine; Gastroenterology; Disease; Biology; Virulence; Genetics","score_opus":0.05218774771002074,"score_gpt":0.34525960502625724,"score_spread":0.29307185731623653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955020078","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012461169,0.99052304,0.00001128126,0.0019586978,0.00022732411,0.005329403,0.0006171222,0.00007092289,0.000016081893],"genre_scores_gemma":[0.00044296155,0.98481023,0.000037034017,0.012815359,0.00013262982,0.0006605265,0.0007294912,0.00010767774,0.00026408187],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99394053,0.002136723,0.0018641631,0.0008121956,0.0006029506,0.0006434376],"domain_scores_gemma":[0.9953629,0.00092744594,0.0022797852,0.0007590173,0.0003630629,0.00030780514],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011768582,0.0010125493,0.00907267,0.00043731643,0.00010852074,0.00001564896,0.0003084521,0.00042903534,0.000096806434],"category_scores_gemma":[0.0000029653572,0.0006938023,0.0016907022,0.00062564167,0.00025694483,0.00016057938,0.00021667997,0.0010148492,0.00004108583],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006963575,0.00013632691,0.011084719,0.34430793,0.64410883,0.000044924087,0.0000471101,4.639105e-7,0.0000048482157,5.892758e-7,0.00007078158,0.0001238617],"study_design_scores_gemma":[0.000961905,0.00040472212,0.001030801,0.033789728,0.95462763,0.000031063606,0.000010957052,0.00000318878,0.00001288615,6.2914484e-7,0.008740933,0.00038557855],"about_ca_topic_score_codex":0.000016382359,"about_ca_topic_score_gemma":0.000008963948,"teacher_disagreement_score":0.3105188,"about_ca_system_score_codex":0.00048156438,"about_ca_system_score_gemma":0.00031116727,"threshold_uncertainty_score":0.9995513},"labels":[],"label_agreement":null},{"id":"W2956486349","doi":"10.1111/apt.15378","title":"Systematic review with meta‐analysis of over 90 000 patients. Does fast‐track review diagnose colorectal cancer earlier?","year":2019,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Colorectal cancer; Cancer; Referral; Stage (stratigraphy); Internal medicine; Population; Meta-analysis; Fast track; Cancer stage; Oncology; Surgery; Family medicine","score_opus":0.058846866188665706,"score_gpt":0.3903823656931925,"score_spread":0.3315354995045268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956486349","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019870806,0.98847294,0.0000030834437,0.0003071424,0.0006539319,0.00951788,0.0007038191,0.00007572086,0.00006678123],"genre_scores_gemma":[0.00009081384,0.9776337,0.00003874661,0.01778673,0.00010213917,0.0032161982,0.0007235847,0.00011948285,0.0002886117],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99468905,0.0011894656,0.0019327664,0.0008927803,0.00077942375,0.0005165222],"domain_scores_gemma":[0.995874,0.000765282,0.0020771017,0.0007212838,0.00036798255,0.00019436449],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006732875,0.0009784233,0.0112939,0.00047380637,0.00008482591,0.000013207127,0.0004129327,0.00031032602,0.003608751],"category_scores_gemma":[0.0000024234507,0.00055360125,0.003277052,0.0019001914,0.00019065301,0.00011659362,0.000117735115,0.00078564545,0.000036496476],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021575298,0.00026257624,0.00006183789,0.50800544,0.4850569,0.00001219744,0.000026105437,0.0000016069029,0.0000026220105,2.9980322e-7,0.00032529552,0.006029391],"study_design_scores_gemma":[0.00062775635,0.0013926266,0.00002486401,0.1823036,0.7611,0.000021419171,0.000005732503,0.000011536286,0.000049213806,2.3101641e-7,0.054041762,0.00042130376],"about_ca_topic_score_codex":0.00025325737,"about_ca_topic_score_gemma":0.00009182601,"teacher_disagreement_score":0.32570183,"about_ca_system_score_codex":0.00046631947,"about_ca_system_score_gemma":0.00042223115,"threshold_uncertainty_score":0.99969155},"labels":[],"label_agreement":null},{"id":"W2958008825","doi":"10.1111/apt.15379","title":"Letter: immunogenicity of anti‐TNF in elderly IBD patients—authors' reply","year":2019,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital; Western University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Immunogenicity; Medicine; Tumor necrosis factor alpha; Immunology; Antibody","score_opus":0.01578775180819503,"score_gpt":0.26299108128214055,"score_spread":0.24720332947394552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2958008825","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68831414,0.05305901,0.000008544854,0.2339888,0.021004207,0.0021728524,0.00063266244,0.00012995885,0.00068983866],"genre_scores_gemma":[0.23664466,0.0014713655,0.000011627431,0.7561232,0.00012678793,0.000046117515,0.0032512222,0.000108191816,0.0022168497],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99475414,0.0013169238,0.001491691,0.00096714264,0.0001708566,0.0012992438],"domain_scores_gemma":[0.9975351,0.00047243494,0.0009098548,0.000922384,0.00015232342,0.000007915821],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0005107189,0.0008648153,0.0013915362,0.00054121605,0.00020864766,0.000016867602,0.0013885484,0.0017411931,0.0023123007],"category_scores_gemma":[0.0000010425864,0.00087265746,0.0005097194,0.0003851075,0.0008170399,0.00018704028,0.00032630982,0.003973062,0.00070325774],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074563234,0.0016678576,0.0054394486,0.00022770175,0.016049229,0.00007857349,0.0013403476,0.00003491465,0.37002072,0.0000055574287,0.60052055,0.0038694413],"study_design_scores_gemma":[0.005580593,0.0007700057,0.0021804024,0.00007879699,0.0035493376,0.000020405942,0.000081158636,0.0000047866483,0.09052052,0.00003580276,0.8963917,0.00078652287],"about_ca_topic_score_codex":0.0005925141,"about_ca_topic_score_gemma":0.0000025972631,"teacher_disagreement_score":0.52213436,"about_ca_system_score_codex":0.00018951601,"about_ca_system_score_gemma":0.00020284952,"threshold_uncertainty_score":0.99955475},"labels":[],"label_agreement":null},{"id":"W2959143810","doi":"10.1111/apt.15408","title":"No increased risk of nephrotoxicity associated with 5‐aminosalicylic acid in IBD: a population‐based cohort and nested case‐control study","year":2019,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"Takeda Pharmaceutical Company","keywords":"Medicine; Nephrotoxicity; Internal medicine; Ulcerative colitis; Population; Inflammatory bowel disease; Cohort; Concomitant; Cohort study; Odds ratio; Retrospective cohort study; Nested case-control study; Gastroenterology; Disease; Kidney; Environmental health","score_opus":0.007185736842418533,"score_gpt":0.2598315536907105,"score_spread":0.25264581684829196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2959143810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970629,0.000114559996,0.000009269807,0.000029043298,0.00010278628,0.002388055,0.00024541904,0.000019224057,0.000028713579],"genre_scores_gemma":[0.9964034,0.000018044419,0.000049246843,0.0030952431,0.000043685977,0.00013243919,0.0001992296,0.000035921745,0.00002280627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977987,0.0009576078,0.00036889012,0.00041408843,0.00016306149,0.00029764927],"domain_scores_gemma":[0.99913293,0.00008719382,0.00027907445,0.00029735174,0.00010827889,0.000095184405],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048237634,0.0002647032,0.00031982976,0.000104740895,0.00007387648,0.000009496466,0.00014292149,0.00014952577,0.00012372232],"category_scores_gemma":[0.0000023656166,0.00024968953,0.000058443686,0.00013623098,0.00009761971,0.000012265364,0.0000522076,0.00017140772,0.0000050550925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019520307,0.0007347164,0.8000828,0.000012701531,0.0040482767,0.00026950508,0.000051200972,0.0002704939,0.19253752,5.442141e-7,0.00000694702,0.00003324342],"study_design_scores_gemma":[0.011206604,0.0010080663,0.9632509,0.000009104821,0.003915924,0.000024870033,0.00008316885,0.002233295,0.01798277,0.0000025986994,0.000022245857,0.00026046942],"about_ca_topic_score_codex":0.0005440046,"about_ca_topic_score_gemma":0.0006965623,"teacher_disagreement_score":0.17455475,"about_ca_system_score_codex":0.00006129507,"about_ca_system_score_gemma":0.000111222565,"threshold_uncertainty_score":0.9999955},"labels":[],"label_agreement":null},{"id":"W2961400103","doi":"10.1111/apt.15419","title":"Review article: biological mechanisms for symptom causation by individual FODMAP subgroups ‐ the case for a more personalised approach to dietary restriction","year":2019,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Institute of Nutrition, Metabolism and Diabetes; National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Institutes of Health Research; National Institutes of Health; Crohn's and Colitis Canada; Canadian Nutrition Society","keywords":"Medicine; Causation; Intensive care medicine; Epistemology","score_opus":0.20143019138291834,"score_gpt":0.41611309226603654,"score_spread":0.2146829008831182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2961400103","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00080576836,0.9757852,0.0026161594,0.005033916,0.0004875464,0.014042998,0.0011467899,0.00007148278,0.000010170712],"genre_scores_gemma":[0.00027257472,0.9322988,0.0029839447,0.056108207,0.00022684339,0.0032254802,0.0047640884,0.00007152274,0.000048551025],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99730223,0.0004584753,0.00074119016,0.00073393603,0.00019940498,0.0005647371],"domain_scores_gemma":[0.9980713,0.00091178535,0.00034749278,0.00035251546,0.00013236747,0.00018450877],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00084633677,0.00056074804,0.0013411067,0.00010808707,0.000270212,0.000022396769,0.0003039886,0.00030714285,0.000052995045],"category_scores_gemma":[0.0000068401982,0.0003725871,0.0006589114,0.00032655598,0.00015234624,0.00006572341,0.00008891819,0.00050652924,0.00001469197],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004748463,0.0075796936,0.00016069633,0.14794645,0.054785497,0.00018286855,0.0013406049,0.000021149712,0.002115545,0.00059860834,0.14013803,0.6403824],"study_design_scores_gemma":[0.0040010433,0.005043111,0.00002297271,0.004236592,0.15057136,0.0027633058,0.0006502433,0.0005278485,0.000056913497,0.00019118412,0.83126074,0.0006746658],"about_ca_topic_score_codex":0.000025787964,"about_ca_topic_score_gemma":0.0000016936881,"teacher_disagreement_score":0.6911227,"about_ca_system_score_codex":0.00020680665,"about_ca_system_score_gemma":0.00016336396,"threshold_uncertainty_score":0.9998726},"labels":[],"label_agreement":null},{"id":"W2962966992","doi":"10.1111/apt.15425","title":"The reduction of faecal calprotectin during exclusive enteral nutrition is lost rapidly after food re‐introduction","year":2019,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Engineering and Physical Sciences Research Council; Natural Environment Research Council; Sight Research UK","keywords":"Medicine; Calprotectin; Parenteral nutrition; Enteral administration; Feces; Gastroenterology; Faecal calprotectin; Internal medicine; Reduction (mathematics); Intensive care medicine; Microbiology; Biology; Inflammatory bowel disease","score_opus":0.007046263284814817,"score_gpt":0.2531449510750179,"score_spread":0.24609868779020308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962966992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937963,0.0010268323,0.000015248645,0.0025073003,0.0016586811,0.0008916471,0.00005033294,0.00001281817,0.000040872623],"genre_scores_gemma":[0.99584854,0.0006164551,0.00005345825,0.0015564887,0.0012710787,0.00012165668,0.00007608153,0.000030646268,0.0004255812],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99866223,0.0002306397,0.00029925993,0.0003715781,0.0001435457,0.00029272918],"domain_scores_gemma":[0.99937695,0.000010923802,0.00016154081,0.00031251434,0.000084026,0.000054032476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012935333,0.00019277334,0.00012891207,0.000047449274,0.00014423465,0.000013289566,0.00017440323,0.00013473337,0.00043138032],"category_scores_gemma":[2.4426237e-7,0.00017355829,0.00013416666,0.00006736037,0.00016969655,0.000015879477,0.00010108384,0.00017298605,0.000037485435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044419556,0.00021590333,0.0020791136,0.00005258094,0.0018645921,0.000006391782,0.0002162654,0.00003349182,0.9902639,0.0000049861346,0.00063666,0.00018417985],"study_design_scores_gemma":[0.00224152,0.0005472678,0.007435197,0.000009332228,0.00071801787,0.000035966226,0.00038099693,0.00004369746,0.9788738,0.000053350654,0.009473122,0.00018771409],"about_ca_topic_score_codex":0.0000028060683,"about_ca_topic_score_gemma":0.0000037726822,"teacher_disagreement_score":0.011390061,"about_ca_system_score_codex":0.00005060261,"about_ca_system_score_gemma":0.000038184513,"threshold_uncertainty_score":0.70775014},"labels":[],"label_agreement":null},{"id":"W2965629326","doi":"10.1111/apt.15388","title":"Editorial: the overlap between dyspepsia and gastro‐oesophageal reflux—is duodenal eosinophilia the missing link?","year":2019,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Gastro-; Medicine; Eosinophilia; Reflux; Gastroenterology; Internal medicine; Disease","score_opus":0.020230840554414195,"score_gpt":0.33349123010476894,"score_spread":0.31326038955035473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965629326","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00714914,0.012933503,0.0000064141464,0.045511853,0.9309225,0.0021980857,0.0008765229,0.00016260897,0.00023937687],"genre_scores_gemma":[0.009714566,0.003602485,0.00017449076,0.03064342,0.95277303,0.00009440609,0.0010377867,0.00030414807,0.0016556398],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99316067,0.00090025633,0.001181033,0.0013510449,0.0020920685,0.0013149396],"domain_scores_gemma":[0.99266243,0.004322757,0.0007734627,0.0013907693,0.00046151734,0.0003890872],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0014128743,0.0012488888,0.0015480028,0.00021421305,0.00084391865,0.00019852119,0.0012651862,0.0018740031,0.0005402506],"category_scores_gemma":[0.000009435676,0.0008230648,0.00044218678,0.00034653605,0.0014494868,0.00021963014,0.0006363727,0.005264518,0.00019523992],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006819312,0.00014838629,0.0041399007,0.00017501578,0.014028585,0.00010270265,0.0007606966,0.0000010481094,0.004554101,0.000004865276,0.973457,0.0019457601],"study_design_scores_gemma":[0.005199238,0.0013773461,0.0021608954,0.0002008182,0.036890782,0.000083947154,0.0001033376,0.000051190367,0.003110324,0.00023560574,0.9499677,0.00061882037],"about_ca_topic_score_codex":0.00015809963,"about_ca_topic_score_gemma":0.0000044098706,"teacher_disagreement_score":0.023489313,"about_ca_system_score_codex":0.00061555277,"about_ca_system_score_gemma":0.0011042997,"threshold_uncertainty_score":0.999422},"labels":[],"label_agreement":null},{"id":"W2966076355","doi":"10.1111/apt.15377","title":"Editorial: screening for oesophageal varices after directly acting anti‐viral therapy—do not let your guard down","year":2019,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Varices; Gastroenterology; Internal medicine","score_opus":0.03148324893017952,"score_gpt":0.348028684620811,"score_spread":0.3165454356906315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966076355","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033094294,0.0045160465,0.00011432978,0.0006910659,0.9566731,0.0023746907,0.0022530414,0.00019732662,0.00008611714],"genre_scores_gemma":[0.049379107,0.006109025,0.0004651822,0.007372993,0.930978,0.0003776845,0.0047003007,0.00022643001,0.00039125062],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960033,0.0003064022,0.000728563,0.001008897,0.001069098,0.0008836965],"domain_scores_gemma":[0.99704534,0.0014598455,0.0004787115,0.00040760543,0.00038945506,0.00021903671],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057105685,0.0008333934,0.0010673938,0.0002744136,0.00027185454,0.00010771033,0.00041905558,0.0011449403,0.00048115465],"category_scores_gemma":[7.821837e-7,0.0007602452,0.0005395607,0.00015129663,0.00014496081,0.00038555797,0.000075783384,0.0013490424,0.00006945403],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027367035,0.0008662584,0.002137999,0.0007252907,0.07754352,0.00019979631,0.0020979138,0.00002478539,0.043664224,0.0000016288961,0.8421372,0.0032343084],"study_design_scores_gemma":[0.015900156,0.001643411,0.00049982517,0.00020530686,0.07169142,0.000008098886,0.00015394244,0.00009154192,0.029672047,0.000019954006,0.8792675,0.0008467598],"about_ca_topic_score_codex":0.00013993628,"about_ca_topic_score_gemma":0.0000033019478,"teacher_disagreement_score":0.037130293,"about_ca_system_score_codex":0.00020406683,"about_ca_system_score_gemma":0.00054218236,"threshold_uncertainty_score":0.99948484},"labels":[],"label_agreement":null},{"id":"W2967729387","doi":"10.1111/apt.15418","title":"Letter: <i>Lactobacillus rhamnosus</i> GG offers no benefit over placebo in children with acute gastroenteritis","year":2019,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Probiotics and Fermented Foods","field":"Agricultural and Biological Sciences","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Lactobacillus rhamnosus; Medicine; Placebo; Acute gastroenteritis; Probiotic; Lactobacillus; Internal medicine; Gastroenterology; Microbiology; Pediatrics; Bacteria; Alternative medicine; Pathology","score_opus":0.011346292896130558,"score_gpt":0.22740042797720844,"score_spread":0.21605413508107787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967729387","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7124571,0.00029697747,7.6750285e-7,0.28246936,0.0012944676,0.0014923336,0.0016209453,0.00008325984,0.00028474117],"genre_scores_gemma":[0.048780642,0.0012175458,0.00005308336,0.94227,0.002581233,0.00007990459,0.004003869,0.000019170484,0.0009945539],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99679494,0.00020438801,0.00049513724,0.000919497,0.0004161732,0.0011698651],"domain_scores_gemma":[0.99925065,0.00012267806,0.00029686533,0.0001819837,0.000058022844,0.00008978174],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012936792,0.000756121,0.00069411175,0.000066879824,0.00015258543,0.000083693536,0.00086604763,0.00069509255,0.0015246929],"category_scores_gemma":[5.4644197e-8,0.00036308795,0.00022246863,0.00024614573,0.00023207348,0.0001625578,0.0002528869,0.0018234387,0.0001602845],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017890739,0.00061388925,0.082866855,0.000034745826,0.022558589,0.0007134417,0.000074618,0.000020111667,0.17772165,0.0000019849952,0.7119449,0.0016601479],"study_design_scores_gemma":[0.0053053056,0.003488063,0.030301364,0.000106476065,0.0064235753,0.00033185104,0.000015259078,0.000060495997,0.0055703204,0.000021559634,0.9470047,0.0013710803],"about_ca_topic_score_codex":0.00026807585,"about_ca_topic_score_gemma":0.00010522322,"teacher_disagreement_score":0.6636765,"about_ca_system_score_codex":0.00023280275,"about_ca_system_score_gemma":0.000027364977,"threshold_uncertainty_score":0.9998821},"labels":[],"label_agreement":null},{"id":"W2967857860","doi":"10.1111/apt.15421","title":"Editorial: understanding sex and gender dimorphism in chronic diseases may improve outcomes","year":2019,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Sex and Gender in Healthcare","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; University of Calgary","funders":"Pfizer","keywords":"Sexual dimorphism; Medicine; Sex characteristics; Internal medicine","score_opus":0.07987812449625208,"score_gpt":0.3991600035057714,"score_spread":0.3192818790095193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967857860","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034193378,0.0130592855,0.000008287801,0.0023944625,0.9786943,0.001623583,0.00059673894,0.000104048304,0.00009994099],"genre_scores_gemma":[0.020551594,0.009771595,0.000026200609,0.007044586,0.9601775,0.00012334186,0.0011152072,0.00016900139,0.0010210142],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99597806,0.0003592161,0.00069915655,0.0010764879,0.0009710276,0.00091604935],"domain_scores_gemma":[0.99704087,0.0017514902,0.00026002486,0.0005190966,0.00011678248,0.0003117353],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00049810443,0.0007177298,0.001186869,0.00038595524,0.00015304181,0.00004007653,0.00029475836,0.0013213891,0.00028743214],"category_scores_gemma":[0.0000029659875,0.0006553631,0.0002004635,0.00017578786,0.00026665488,0.00012678887,0.00022385574,0.0019420368,0.000032971286],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006862454,0.0002780585,0.02483485,0.0011176915,0.010121375,0.000104907245,0.0008816877,0.000006595413,0.0023400697,0.000012465159,0.9591342,0.0004818575],"study_design_scores_gemma":[0.010234924,0.0010664592,0.0008763612,0.000088181514,0.014111793,0.0000090895555,0.00085557636,0.00011951674,0.00046964,0.0006621143,0.97075987,0.0007464948],"about_ca_topic_score_codex":0.00024045605,"about_ca_topic_score_gemma":0.000034972843,"teacher_disagreement_score":0.02395849,"about_ca_system_score_codex":0.0031553544,"about_ca_system_score_gemma":0.0016585446,"threshold_uncertainty_score":0.9999751},"labels":[],"label_agreement":null},{"id":"W2970313684","doi":"10.1111/apt.15457","title":"Letter: previous exposure to corticosteroids increases the risk of post‐discharge venous thromboembolic events in patients with inflammatory bowel disease—author's reply","year":2019,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Inflammatory bowel disease; Venous thromboembolic disease; Venous thromboembolism; Disease; Gastroenterology; Intensive care medicine; Internal medicine; Thrombosis","score_opus":0.011991635227304932,"score_gpt":0.2653017280169257,"score_spread":0.25331009278962074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970313684","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8050609,0.0016715622,0.0000021856442,0.18574563,0.0010970947,0.005857535,0.00047900833,0.000058335183,0.00002775168],"genre_scores_gemma":[0.3493292,0.0008935625,0.000027780196,0.6473448,0.0008181134,0.0003833689,0.00090745965,0.00015489284,0.00014079388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950629,0.00090231275,0.0010973195,0.000956925,0.0009984897,0.0009820652],"domain_scores_gemma":[0.9970828,0.00028694997,0.0008558105,0.0013277101,0.00024477654,0.00020191689],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004335,0.00086390815,0.0015009115,0.00042317164,0.0001707728,0.00002066717,0.00074986846,0.00035143003,0.00032115888],"category_scores_gemma":[0.0000030713652,0.0006142005,0.00032738224,0.00027741815,0.00024416068,0.0001458729,0.00039849934,0.0016789235,0.000103491155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017866581,0.004720748,0.6676712,0.00079455914,0.017738523,0.00023296446,0.0010401111,0.00012626757,0.00035065284,0.0000016308064,0.30518505,0.0003516277],"study_design_scores_gemma":[0.0051764646,0.0043074903,0.8225203,0.00047804663,0.028983312,0.0000064881524,0.00005155714,0.000010779387,0.00018361073,0.000012878608,0.13769014,0.00057891535],"about_ca_topic_score_codex":0.00041974016,"about_ca_topic_score_gemma":0.000030725194,"teacher_disagreement_score":0.4615992,"about_ca_system_score_codex":0.00035380715,"about_ca_system_score_gemma":0.00028843078,"threshold_uncertainty_score":0.9996309},"labels":[],"label_agreement":null},{"id":"W2971659591","doi":"10.1111/apt.15479","title":"A stepwise thrombolysis regimen in the management of acute portal vein thrombosis in patients with evidence of intestinal ischaemia","year":2019,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Association for the Study of the Liver","keywords":"Medicine; Thrombolysis; Portal vein thrombosis; Thrombosis; Surgery; Bowel infarction; Regimen; Deep vein; Portal hypertension; Fibrinolytic agent; Internal medicine; Myocardial infarction; Tissue plasminogen activator; Cirrhosis","score_opus":0.023653255356474202,"score_gpt":0.3189771466762581,"score_spread":0.29532389131978387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971659591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784863,0.00029030087,0.0000057478396,0.0005602414,0.00007038218,0.0010282624,0.000018645094,0.0000063929906,0.00017142313],"genre_scores_gemma":[0.9968638,0.0007804311,0.00027951426,0.0019427248,0.000008567925,0.000032008575,0.00006865831,0.000011814248,0.000012468896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988812,0.000117254436,0.00031783557,0.0002037239,0.00030232783,0.00017766462],"domain_scores_gemma":[0.99949163,0.00008515723,0.00014485249,0.00020088372,0.000048711026,0.000028747088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017935998,0.00013779753,0.00028351342,0.00011944655,0.000013964226,0.0000023594932,0.00016853161,0.000037401558,0.00020227824],"category_scores_gemma":[1.4794292e-8,0.00009567084,0.000052636366,0.00030442007,0.00010083265,0.00014926936,0.000027876968,0.00014682297,0.000005946302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031028355,0.0011732624,0.96535563,0.00031005134,0.014732439,0.00007601014,0.0027773143,0.00002367774,0.012242642,0.000027991093,0.000009891487,0.00016822419],"study_design_scores_gemma":[0.0062271603,0.001470692,0.9468411,0.0005521912,0.027897377,0.0000052036116,0.0008745614,0.00006925876,0.015942175,0.000017638517,0.0000032363555,0.00009937154],"about_ca_topic_score_codex":0.00007597377,"about_ca_topic_score_gemma":0.000007553732,"teacher_disagreement_score":0.018514527,"about_ca_system_score_codex":0.00004301429,"about_ca_system_score_gemma":0.000043189248,"threshold_uncertainty_score":0.39013436},"labels":[],"label_agreement":null},{"id":"W2980186459","doi":"10.1111/apt.15480","title":"Editorial: potassium‐competitive acid blockers for acid‐related diseases—tegoprazan, a new kid on the block","year":2019,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Potassium; Block (permutation group theory); Pharmacology; Chemistry","score_opus":0.016064946437613043,"score_gpt":0.31975803731556285,"score_spread":0.3036930908779498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980186459","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026235539,0.0017980663,0.0000024166595,0.007948236,0.9804066,0.004362072,0.0023077505,0.00019854799,0.00035277166],"genre_scores_gemma":[0.016557021,0.0010004115,0.00014647802,0.012200646,0.9578752,0.0005192904,0.005121966,0.0003018926,0.006277105],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951861,0.00037299652,0.00079727656,0.0011875345,0.0012954168,0.001160692],"domain_scores_gemma":[0.99557537,0.0020586534,0.00059827254,0.0008116847,0.0003992142,0.00055682857],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003045266,0.0011824103,0.0013117968,0.00023191715,0.0003658074,0.000062334075,0.00068910886,0.0013414384,0.0010442637],"category_scores_gemma":[0.000011111646,0.00084061146,0.00078485114,0.00025811707,0.0003184237,0.00009883758,0.00017704665,0.002097027,0.0005643195],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035345915,0.0012905255,0.00026249755,0.00008497492,0.040822808,0.00016466466,0.00018502092,0.0000042999714,0.00412799,0.000028038681,0.9492019,0.0002926959],"study_design_scores_gemma":[0.015802018,0.004763537,0.00005665507,0.00011502456,0.06234537,0.000014980562,0.00006595032,0.00003096155,0.010972115,0.00014949929,0.9052718,0.00041208355],"about_ca_topic_score_codex":0.00003443228,"about_ca_topic_score_gemma":0.000002927494,"teacher_disagreement_score":0.043930087,"about_ca_system_score_codex":0.00077625684,"about_ca_system_score_gemma":0.0016891388,"threshold_uncertainty_score":0.99995506},"labels":[],"label_agreement":null},{"id":"W2980326969","doi":"10.1111/apt.15511","title":"Declining hospitalisation and surgical intervention rates in patients with Crohn's disease: a population‐based cohort","year":2019,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Robarts Clinical Trials; Western University; Children's Hospital of Eastern Ontario; Institute for Clinical Evaluative Sciences; Lawson Health Research Institute","funders":"Crohn's and Colitis Canada; Ontario Ministry of Health and Long-Term Care; Western University; Canadian Association of Gastroenterology; Schulich School of Medicine and Dentistry; Academic Medical Organization of Southwestern Ontario; Lawson Health Research Institute","keywords":"Medicine; Crohn's disease; Cohort; Disease; Intervention (counseling); Cohort study; Population; Crohn disease; Surgery; Pediatrics; Internal medicine; Environmental health","score_opus":0.006580103549982441,"score_gpt":0.2753436834504511,"score_spread":0.2687635799004687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980326969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987213,0.00020569963,0.000011792258,0.00012379237,0.0002020359,0.0006799206,0.000027255119,0.000012078514,0.000016135986],"genre_scores_gemma":[0.9968534,0.000029760124,0.00006670639,0.0016694077,0.000048755035,0.000049168364,0.0012273898,0.00002229013,0.000033104163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990227,0.00016868206,0.0002092563,0.00030268964,0.00011557497,0.0001810997],"domain_scores_gemma":[0.9996258,0.000018676796,0.00009432296,0.00013798311,0.000046490186,0.00007671153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014038847,0.00014918018,0.00011220693,0.0000582276,0.000045188473,0.000014933621,0.000077794495,0.000068325906,0.00013482143],"category_scores_gemma":[2.8715618e-7,0.00014187847,0.000043051718,0.00005231086,0.000053152595,0.000016601138,0.00004324678,0.00007438444,0.0000065657196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023888664,0.00026139722,0.9953796,0.00002037729,0.0005257224,0.000033447104,0.000015543741,0.00030477563,0.00085637136,0.000005748492,0.000013244937,0.00019485512],"study_design_scores_gemma":[0.005102355,0.00021482853,0.99216706,0.000016557142,0.00057590374,5.239806e-7,0.000013578063,0.0006077029,0.0009007802,0.0000139012955,0.00021116341,0.00017562996],"about_ca_topic_score_codex":0.000017236614,"about_ca_topic_score_gemma":0.000012995738,"teacher_disagreement_score":0.0032125744,"about_ca_system_score_codex":0.00003902811,"about_ca_system_score_gemma":0.000034236135,"threshold_uncertainty_score":0.57856363},"labels":[],"label_agreement":null},{"id":"W2980367746","doi":"10.1111/apt.15533","title":"Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response","year":2019,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Norgine; Gilead Sciences; Stichting voor Lever- en Maag-Darm Onderzoek; Intercept Pharmaceuticals; National Institute for Health and Care Research; Falk Foundation","keywords":"Medicine; Internal medicine; Fibrosis; Gastroenterology; Hazard ratio; Proportional hazards model; Stage (stratigraphy); Liver biopsy; Hepatic fibrosis; Context (archaeology); Cohort; Biopsy; Confidence interval","score_opus":0.042405381269911196,"score_gpt":0.3404118364125575,"score_spread":0.29800645514264634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980367746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956052,0.0014261182,0.0000011846512,0.0010622754,0.0003192853,0.001017664,0.0004682781,0.00003966497,0.00006034599],"genre_scores_gemma":[0.9846638,0.0007203053,0.00019308677,0.013423586,0.00005792337,0.0000414803,0.00026403661,0.000035758032,0.00060001644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998221,0.00034221762,0.00047772203,0.00036295853,0.00025341252,0.00034271655],"domain_scores_gemma":[0.9990321,0.00016033015,0.00012910385,0.0004502758,0.000047169517,0.00018104218],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025856483,0.00025599505,0.00047508115,0.00018592076,0.000035971472,0.0000073133006,0.00018815823,0.00015208528,0.0021031224],"category_scores_gemma":[2.9125178e-7,0.00022052617,0.00016787252,0.00016897224,0.00013014166,0.00016350673,0.00010295118,0.00024158217,0.00003936559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006838066,0.0016679072,0.5292964,0.000054628938,0.0017381911,0.000032155876,0.00068157556,0.0000027877784,0.45937777,6.0147454e-7,0.00005559417,0.0002542932],"study_design_scores_gemma":[0.007976224,0.0033251855,0.7315558,0.000029318257,0.0028837775,0.000013381887,0.00028378243,0.00012507233,0.25213012,0.000005309456,0.0015001086,0.00017192554],"about_ca_topic_score_codex":0.0002820038,"about_ca_topic_score_gemma":0.0000018993771,"teacher_disagreement_score":0.20724766,"about_ca_system_score_codex":0.0005154314,"about_ca_system_score_gemma":0.00017842432,"threshold_uncertainty_score":0.9988091},"labels":[],"label_agreement":null},{"id":"W2980445751","doi":"10.1111/apt.15504","title":"Safety of first year vaccination in children born to mothers with inflammatory bowel disease and exposed <i>in utero</i> to anti‐TNFα agents: a French nationwide population‐based cohort","year":2019,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital","funders":"Agence Nationale de la Recherche","keywords":"Medicine; Vaccination; Pediatrics; Population; Adverse effect; Inflammatory bowel disease; Cohort; Disease; Concomitant; Immunology; Internal medicine; Environmental health","score_opus":0.009996546229410156,"score_gpt":0.28503378689924447,"score_spread":0.2750372406698343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980445751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99341244,0.00015605979,0.000086594526,0.0039146966,0.00012105075,0.002188912,0.00004881383,0.000022132355,0.000049281763],"genre_scores_gemma":[0.9864332,0.00014987889,0.00040073929,0.012658837,0.000031009393,0.000082041224,0.00017088049,0.000022197935,0.000051224884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887973,0.000077584504,0.00033989965,0.00026911835,0.00022590246,0.0002077925],"domain_scores_gemma":[0.9994062,0.00006151048,0.000104393104,0.00019812514,0.00004494545,0.00018480154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021838724,0.00015037501,0.00022700001,0.0003131427,0.000030658328,0.000004473034,0.00008343203,0.00005729103,0.00029640005],"category_scores_gemma":[0.0000015640001,0.0001396144,0.000027157987,0.000250243,0.00002203018,0.00011725122,0.000025194724,0.00012021174,0.000010519932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068991614,0.00033899918,0.99144745,0.000050624254,0.0006050734,0.000009347295,0.0005572763,0.0010950201,0.0049120565,0.000004538465,0.00008074246,0.00020893106],"study_design_scores_gemma":[0.0062497295,0.0002612742,0.987788,0.00017077735,0.0006566519,0.000003549734,0.000054475207,0.0008155704,0.0036462627,0.0000066081247,0.00021575921,0.00013129684],"about_ca_topic_score_codex":0.00011793693,"about_ca_topic_score_gemma":0.00008487714,"teacher_disagreement_score":0.00874414,"about_ca_system_score_codex":0.00016311702,"about_ca_system_score_gemma":0.000100156554,"threshold_uncertainty_score":0.56933105},"labels":[],"label_agreement":null},{"id":"W2980528742","doi":"10.1111/apt.15540","title":"Natural history of autoimmune atrophic gastritis: a prospective, single centre, long‐term experience","year":2019,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Gastroenterology; Internal medicine; Atrophic gastritis; Hazard ratio; Interquartile range; Stage (stratigraphy); Prospective cohort study; Dysplasia; Atrophy; Gastritis; Proportional hazards model; Pathology; Stomach; Confidence interval","score_opus":0.022602666859179447,"score_gpt":0.2832727813992759,"score_spread":0.2606701145400965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980528742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809058,0.011623947,0.000006261521,0.002323999,0.0037826698,0.0009659921,0.000013890962,0.00011324333,0.00026423146],"genre_scores_gemma":[0.9857009,0.00066813006,0.00024461662,0.010934916,0.00013133569,0.00004214668,0.000048003705,0.000048522754,0.0021814117],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99792975,0.00016125062,0.0005285353,0.00049071474,0.00026278762,0.00062697515],"domain_scores_gemma":[0.9990404,0.000069774105,0.00024329941,0.0003494077,0.00019150773,0.000105570536],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000098208344,0.0003432346,0.00062410044,0.00016142348,0.00005221581,0.0000039595125,0.00024269416,0.00014022655,0.0010449733],"category_scores_gemma":[5.335428e-7,0.000329749,0.00016133208,0.00016683007,0.0006292567,0.00015902672,0.0001630085,0.00056755665,0.000085052],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011221899,0.0007510259,0.49398714,0.000044254266,0.0059881657,0.00008859952,0.0022171887,0.0000018242844,0.4950941,0.0000023244238,0.00030882406,0.00039436936],"study_design_scores_gemma":[0.012819385,0.0032337108,0.90288895,0.00015595336,0.0074867625,0.00034102178,0.00051667466,0.00011930334,0.06735235,0.00000936526,0.004686527,0.00038999438],"about_ca_topic_score_codex":0.00002334978,"about_ca_topic_score_gemma":0.000006926807,"teacher_disagreement_score":0.42774174,"about_ca_system_score_codex":0.0009895414,"about_ca_system_score_gemma":0.00012512109,"threshold_uncertainty_score":0.9999155},"labels":[],"label_agreement":null},{"id":"W2980686546","doi":"10.1111/apt.15474","title":"Editorial: aminosalicylates and nephrotoxicity—an issue put to rest","year":2019,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Nephrotoxicity and Medicinal Plants","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Rest (music); Medicine; Nephrotoxicity; Pharmacology; Internal medicine; Toxicity","score_opus":0.018713776109488458,"score_gpt":0.35466600973967977,"score_spread":0.33595223363019133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980686546","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.039621804,0.001091326,0.00000331625,0.0050322036,0.9499167,0.0034259807,0.00051621924,0.00018807888,0.00020436868],"genre_scores_gemma":[0.0009269709,0.002991401,0.00023330262,0.052622106,0.93852025,0.00019699233,0.0015803187,0.00018110755,0.002747563],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951797,0.00036713228,0.00075227284,0.0014681999,0.0012602278,0.00097242615],"domain_scores_gemma":[0.9966661,0.0009799469,0.00029701798,0.0008936416,0.00032069522,0.00084261026],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000918078,0.0008792255,0.0014205002,0.0004349328,0.00020629265,0.000062595784,0.000525151,0.0016972509,0.0005134657],"category_scores_gemma":[0.000008996308,0.0008222063,0.0001553094,0.00027248185,0.00027617262,0.00022997045,0.0002907861,0.0022330123,0.00052187854],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026690767,0.00052806654,0.00010309995,0.0002688179,0.005728532,0.00012650489,0.0007458065,0.0000017022367,0.16577022,0.0000012122612,0.82340217,0.000654818],"study_design_scores_gemma":[0.0046791704,0.004481962,0.00005776965,0.00022558882,0.014821092,0.00004894783,0.0002127145,0.00002778484,0.032422766,0.000022765833,0.9423282,0.0006712399],"about_ca_topic_score_codex":0.0004201113,"about_ca_topic_score_gemma":0.00004978646,"teacher_disagreement_score":0.13334745,"about_ca_system_score_codex":0.0003316088,"about_ca_system_score_gemma":0.00070578506,"threshold_uncertainty_score":0.99959874},"labels":[],"label_agreement":null},{"id":"W2981369898","doi":"10.1111/apt.15563","title":"<i>HLADQA1*05</i> genotype predicts anti‐drug antibody formation and loss of response during infliximab therapy for inflammatory bowel disease","year":2019,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Academic Medical Organization of Southwestern Ontario; Lawson Health Research Institute","keywords":"Infliximab; Medicine; Discontinuation; Internal medicine; Adverse effect; Inflammatory bowel disease; Gastroenterology; Relative risk; Crohn's disease; Immunology; Confidence interval; Disease","score_opus":0.007811605568876999,"score_gpt":0.2745191577501854,"score_spread":0.2667075521813084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981369898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949512,0.0022337835,0.000040161183,0.00044359814,0.0005225975,0.0015367223,0.00022328286,0.000032740416,0.000015896348],"genre_scores_gemma":[0.9929951,0.00252642,0.000100252306,0.0035825432,0.0001796628,0.000094917086,0.00033650463,0.000059030757,0.00012556536],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983259,0.00028539,0.00041832693,0.00040588772,0.00017278154,0.00039175243],"domain_scores_gemma":[0.99904174,0.00006097839,0.00024337514,0.00037050573,0.00011615481,0.00016723802],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037245612,0.00029766216,0.00021197161,0.00010166931,0.00013609248,0.00001580833,0.0002545932,0.00013146164,0.000047960573],"category_scores_gemma":[0.0000011312375,0.00030289197,0.0001311683,0.00005519771,0.0002095494,0.000044516255,0.00013809811,0.000113510265,0.00000902589],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016109271,0.00019248646,0.15614372,0.0001872874,0.0012463343,0.000020666652,0.00025598615,0.0002293177,0.8253843,0.000009097755,0.00013181951,0.000089691996],"study_design_scores_gemma":[0.008138368,0.00038216618,0.49026766,0.00002317295,0.0008133524,0.000012308055,0.00007679803,0.00055106345,0.4928242,0.00005166001,0.006485543,0.00037370788],"about_ca_topic_score_codex":0.000002195103,"about_ca_topic_score_gemma":0.0000021785168,"teacher_disagreement_score":0.33412394,"about_ca_system_score_codex":0.00003625133,"about_ca_system_score_gemma":0.00016263132,"threshold_uncertainty_score":0.9999423},"labels":[],"label_agreement":null},{"id":"W2982410008","doi":"10.1111/apt.15555","title":"Efficacy and safety of tofacitinib dose de‐escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open","year":2019,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McMaster University; Population Health Research Institute","funders":"Pfizer","keywords":"Tofacitinib; Medicine; Ulcerative colitis; Internal medicine; Dosing; Adverse effect; Maintenance therapy; Open label; Gastroenterology; Surgery; Chemotherapy; Rheumatoid arthritis","score_opus":0.012800657827441008,"score_gpt":0.28694696017447446,"score_spread":0.27414630234703347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982410008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961123,0.00006888791,0.00006798045,0.00015954256,0.0001047081,0.0019486923,0.0014371324,0.0000064342203,0.000094338066],"genre_scores_gemma":[0.9945273,0.00014219226,0.0009067251,0.0018226338,0.000058533333,0.000049332397,0.0024237158,0.000021814158,0.000047794914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895567,0.00016612027,0.00026548567,0.0003486565,0.000078908415,0.00018515413],"domain_scores_gemma":[0.9993784,0.00010292216,0.00017820342,0.00015542658,0.00010653735,0.0000785055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016553659,0.00016178406,0.00016319455,0.00002579666,0.00008269601,0.00001973854,0.0001182801,0.000111234025,0.000041585758],"category_scores_gemma":[0.0000011582657,0.00015242734,0.000025026598,0.000030802694,0.00012499999,0.00002370886,0.000115587995,0.00006127769,0.0000014524662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22037077,0.0013116819,0.40393576,0.00008404848,0.008330229,0.0000092221435,0.0025005932,0.0004005762,0.35320437,0.00013051326,0.00035008354,0.009372142],"study_design_scores_gemma":[0.030357668,0.001094387,0.9252535,0.000024510662,0.0012398077,0.0000011723171,0.00011342953,0.0006800281,0.03889064,0.00009534386,0.002009812,0.00023971038],"about_ca_topic_score_codex":0.000025560901,"about_ca_topic_score_gemma":0.000021578982,"teacher_disagreement_score":0.5213177,"about_ca_system_score_codex":0.000027908738,"about_ca_system_score_gemma":0.000072735435,"threshold_uncertainty_score":0.62158066},"labels":[],"label_agreement":null},{"id":"W2984433764","doi":"10.1111/apt.15534","title":"Editorial: effect of exercise on physical frailty in patients with chronic liver disease","year":2019,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Disease; Liver disease; Physical therapy; MEDLINE; Chronic disease; Chronic liver disease; Gerontology; Internal medicine; Cirrhosis","score_opus":0.014103774942259766,"score_gpt":0.3454356403459775,"score_spread":0.33133186540371773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984433764","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13811299,0.0009928851,2.8595792e-7,0.0002865237,0.85786223,0.0023860885,0.00029374583,0.00004009985,0.00002514472],"genre_scores_gemma":[0.039311692,0.001771594,0.000012855417,0.0015169458,0.95534724,0.00016615663,0.0016383525,0.000111015564,0.00012413635],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99732536,0.00028794084,0.0004046672,0.0005306848,0.00097464625,0.00047671972],"domain_scores_gemma":[0.9980496,0.0009027294,0.000279997,0.00035941778,0.00017602189,0.00023224395],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022889308,0.00047193444,0.0010383071,0.00023761875,0.000053487445,0.000006440592,0.00020761664,0.00043604916,0.00019916928],"category_scores_gemma":[0.0000011418309,0.00037130958,0.00015867624,0.00016356642,0.00017319969,0.000063869564,0.000062459905,0.0015017384,0.000076736076],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030681962,0.0026312463,0.017575296,0.0024933899,0.0020528946,0.000032935674,0.000113521164,0.000013408836,0.00032401195,8.197438e-7,0.94344974,0.0006307712],"study_design_scores_gemma":[0.045728784,0.014530239,0.00574734,0.0024300462,0.019482337,2.2086441e-7,0.0000037801578,0.00012790249,0.0032100298,0.000009934834,0.9081793,0.0005501013],"about_ca_topic_score_codex":0.000049007358,"about_ca_topic_score_gemma":0.0000027157098,"teacher_disagreement_score":0.0988013,"about_ca_system_score_codex":0.00070767454,"about_ca_system_score_gemma":0.0006116763,"threshold_uncertainty_score":0.9998739},"labels":[],"label_agreement":null},{"id":"W2985172642","doi":"10.1111/apt.15568","title":"Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission","year":2019,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Crohn's and Colitis Foundation; National Institute of Diabetes and Digestive and Kidney Diseases; Crohn's and Colitis Foundation of Canada; Foundation for the National Institutes of Health","keywords":"Medicine; Internal medicine; Ulcerative colitis; Confidence interval; Gastroenterology; Prospective cohort study; Confounding; Endoscopy; Inflammatory bowel disease; Disease; Surgery","score_opus":0.012600494790282484,"score_gpt":0.24586850525376477,"score_spread":0.23326801046348228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985172642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980204,0.000065375905,0.000012199019,0.00008482117,0.00018552455,0.0010182955,0.00040985693,0.000014912111,0.00018862738],"genre_scores_gemma":[0.99614173,0.00008566767,0.00014392368,0.0021822245,0.000025325498,0.000046859972,0.0012380104,0.00003421782,0.00010206102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980808,0.0005968582,0.00036315602,0.00041513462,0.00021306699,0.00033098747],"domain_scores_gemma":[0.9989613,0.000054629076,0.0004552564,0.00026685998,0.00017926769,0.00008264648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018351537,0.00026371182,0.000294318,0.00008130976,0.00009167826,0.0000068992963,0.00019647175,0.00015526745,0.00024402604],"category_scores_gemma":[0.0000011664483,0.00022587273,0.000055321118,0.00012717013,0.0002624018,0.00002067531,0.000067266075,0.00021278355,0.000007874285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033827326,0.00034351306,0.85610497,0.0000183246,0.002092736,0.000022613469,0.00039842093,0.00026391083,0.13718392,0.000003942069,0.00013925594,0.000045649886],"study_design_scores_gemma":[0.00795768,0.0012220168,0.9490989,0.000048576887,0.0012030898,0.000001640011,0.00009316854,0.00038775158,0.03930966,0.000014629674,0.00039474163,0.00026815178],"about_ca_topic_score_codex":0.000078647216,"about_ca_topic_score_gemma":0.00016691117,"teacher_disagreement_score":0.097874254,"about_ca_system_score_codex":0.00014276184,"about_ca_system_score_gemma":0.00010817185,"threshold_uncertainty_score":0.92108226},"labels":[],"label_agreement":null},{"id":"W2985995052","doi":"10.1111/apt.15570","title":"Editorial: evolving histological assessment of NASH. Authors' reply","year":2019,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Intensive care medicine","score_opus":0.023392326666407188,"score_gpt":0.37321637880537134,"score_spread":0.34982405213896417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985995052","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00303342,0.005821872,0.0000046417986,0.0015863794,0.9864527,0.0015578654,0.000597901,0.00011064359,0.0008345905],"genre_scores_gemma":[0.007964152,0.004990453,0.0005498969,0.005272916,0.97746915,0.00023884798,0.00254639,0.00012591999,0.000842285],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956721,0.0004233411,0.0009304715,0.00094922597,0.0014033742,0.00062149594],"domain_scores_gemma":[0.99622136,0.0015385328,0.0007152918,0.0007000385,0.0005277987,0.00029696187],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00051646656,0.00069647393,0.0014819234,0.00022100312,0.000121308054,0.000022968978,0.00041826407,0.0011270387,0.0017803577],"category_scores_gemma":[0.0000035581709,0.00058952573,0.0005749112,0.00016767642,0.00027583793,0.00010390327,0.00023891614,0.0014586942,0.00006605858],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059881166,0.0029573385,0.006233378,0.0002944802,0.029330282,0.00012123125,0.000103983555,0.000004864488,0.003299851,0.0000087001035,0.95686877,0.00017831274],"study_design_scores_gemma":[0.0058052493,0.0023308685,0.0012085945,0.00016799841,0.058771975,0.000005618773,0.000045422836,0.00008065153,0.0016517424,0.000026191738,0.92948043,0.0004252527],"about_ca_topic_score_codex":0.00016229642,"about_ca_topic_score_gemma":0.000002184844,"teacher_disagreement_score":0.029441696,"about_ca_system_score_codex":0.0012638911,"about_ca_system_score_gemma":0.0016489298,"threshold_uncertainty_score":0.9996556},"labels":[],"label_agreement":null},{"id":"W2987263877","doi":"10.1111/apt.15559","title":"Editorial: how safe is it to administer the BCG vaccination to babies exposed to anti‐TNFα medications antenatally? Authors' reply","year":2019,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital","funders":"","keywords":"Medicine; Vaccination; Pediatrics; Family medicine; Intensive care medicine; Virology","score_opus":0.039163279038473664,"score_gpt":0.3846829963201888,"score_spread":0.34551971728171516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987263877","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006607642,0.0005314796,0.00019421481,0.31539002,0.6789455,0.0031722456,0.0006577176,0.00010140315,0.00034665706],"genre_scores_gemma":[0.003199566,0.0013615848,0.00039973718,0.23494332,0.74233615,0.0006772676,0.0011021636,0.00013524957,0.015844958],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947376,0.00045961147,0.0009050841,0.0011510627,0.0018451056,0.0009015087],"domain_scores_gemma":[0.9947793,0.001545235,0.00046359713,0.0014055326,0.000862094,0.0009442365],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013925727,0.00073619233,0.00096867286,0.00052381697,0.0003644313,0.000094529525,0.0011979333,0.0009243175,0.0020891593],"category_scores_gemma":[0.00008100873,0.00056944287,0.00026937938,0.0006384955,0.000117232375,0.00018404501,0.0003657181,0.0015329608,0.0010177629],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009477934,0.0003533592,0.00004872109,0.00010905011,0.0051552625,0.0000187401,0.005129622,0.0000030775652,0.01961058,0.0000036427855,0.9672479,0.0013722584],"study_design_scores_gemma":[0.0028598416,0.0018768462,0.00021096657,0.00036570124,0.008958537,0.000016974413,0.00064500445,0.000014226922,0.016974116,0.000011658137,0.96752435,0.00054178946],"about_ca_topic_score_codex":0.000045150522,"about_ca_topic_score_gemma":0.000017102293,"teacher_disagreement_score":0.08044671,"about_ca_system_score_codex":0.0006194861,"about_ca_system_score_gemma":0.0015821086,"threshold_uncertainty_score":0.99976003},"labels":[],"label_agreement":null},{"id":"W2989665281","doi":"10.1111/apt.15577","title":"Prevalence of endoscopic improvement and remission according to patient‐reported outcomes in ulcerative colitis","year":2019,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Calgary; Western University","funders":"Yale University; National Institutes of Health; Crohn's and Colitis Foundation; National Institute of Diabetes and Digestive and Kidney Diseases; Takeda Oncology; American College of Gastroenterology; McMaster University","keywords":"Medicine; Ulcerative colitis; Gastroenterology; Internal medicine; Colitis; MEDLINE; Endoscopy; Disease","score_opus":0.012188573143633221,"score_gpt":0.2962248386652083,"score_spread":0.2840362655215751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989665281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982753,0.00014714581,0.000007199868,0.00019607553,0.00033768517,0.00091155205,0.000035118715,0.000006846673,0.000083098734],"genre_scores_gemma":[0.99433374,0.0002256147,0.00017517652,0.0049824542,0.00002302706,0.000060291863,0.000020170031,0.000016442431,0.00016309862],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889225,0.00011893861,0.00032296972,0.0003265996,0.000109113855,0.00023012808],"domain_scores_gemma":[0.99952066,0.000024391293,0.00012805988,0.00019463323,0.000049263486,0.00008299581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000121439276,0.00015992485,0.00016724673,0.00006192467,0.000031550684,0.000005217523,0.0001172142,0.00007337732,0.00010690182],"category_scores_gemma":[7.3775783e-7,0.00015587504,0.000039414106,0.000050366674,0.000052072373,0.000009013712,0.00016541095,0.00007539839,0.000004102561],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000423701,0.00008826585,0.4534034,0.000042667572,0.0004914661,0.000013484704,0.00016599901,0.000021899412,0.544689,0.0000023871544,0.000015485948,0.0006422333],"study_design_scores_gemma":[0.0017898572,0.00063420436,0.42508188,0.000022846098,0.00038813442,0.000002643994,0.0002993772,0.000045831257,0.5713037,0.000014221041,0.00027176473,0.00014548142],"about_ca_topic_score_codex":0.000018654704,"about_ca_topic_score_gemma":0.000009723575,"teacher_disagreement_score":0.02832153,"about_ca_system_score_codex":0.000041110663,"about_ca_system_score_gemma":0.00006425182,"threshold_uncertainty_score":0.63563997},"labels":[],"label_agreement":null},{"id":"W2990317796","doi":"10.1111/apt.15596","title":"Pregnant women with IBD are more likely to be adherent to biologic therapies than other medications","year":2019,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"M.S.I. Foundation","keywords":"Medicine; Pregnancy; Medical prescription; Adverse effect; Drug class; Internal medicine; Inflammatory bowel disease; Obstetrics; Drug; Disease","score_opus":0.04238374692601309,"score_gpt":0.3466479195081741,"score_spread":0.304264172582161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990317796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9085444,0.0018378966,0.00014248268,0.08599816,0.00063363847,0.0022592482,0.00009057726,0.00014527857,0.0003482856],"genre_scores_gemma":[0.78298527,0.0005625804,0.00052913436,0.21300052,0.00017225275,0.0006720576,0.000040561394,0.00004803676,0.0019895637],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980656,0.00013688121,0.00032343346,0.0004905349,0.00034943412,0.0006341345],"domain_scores_gemma":[0.9985845,0.000118212985,0.00015623937,0.00050658,0.0000969834,0.0005375002],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002377547,0.00032038236,0.00043212017,0.00019095158,0.00011070087,0.000011560271,0.0003300438,0.00012935234,0.003432156],"category_scores_gemma":[7.482254e-7,0.00021862166,0.00006158856,0.0003418305,0.00016660003,0.000083447856,0.00008152574,0.00028084422,0.00037329074],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060757226,0.0035047554,0.2251951,0.00020160842,0.029767795,0.00006480303,0.051141404,0.00010268915,0.6554831,0.00010738232,0.009440449,0.018915156],"study_design_scores_gemma":[0.01313835,0.01377938,0.31148323,0.0011659438,0.007825996,0.00015689347,0.01600795,0.00007475382,0.18436156,0.00011209738,0.45059437,0.0012994788],"about_ca_topic_score_codex":0.000030109632,"about_ca_topic_score_gemma":0.000014388821,"teacher_disagreement_score":0.47112158,"about_ca_system_score_codex":0.00023786932,"about_ca_system_score_gemma":0.00020591823,"threshold_uncertainty_score":0.99747884},"labels":[],"label_agreement":null},{"id":"W2994715706","doi":"10.1111/apt.15578","title":"Editorial: blood biomarkers for advanced liver fibrosis in non‐alcoholic fatty liver disease—not a simple choice?","year":2019,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre; University of Toronto","funders":"","keywords":"Medicine; Fatty liver; Alcoholic liver disease; Gastroenterology; Liver fibrosis; Disease; Liver disease; Internal medicine; Fibrosis; Cirrhosis","score_opus":0.021001576817399965,"score_gpt":0.3342504874840932,"score_spread":0.31324891066669325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994715706","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.051562082,0.006329927,0.000003284012,0.0007875761,0.93028057,0.006477382,0.004420543,0.00011592722,0.000022697528],"genre_scores_gemma":[0.014947166,0.022384305,0.00025950852,0.0076833395,0.9424949,0.0027634033,0.008746033,0.00029040256,0.00043089644],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99551386,0.00023842028,0.0008158669,0.0013804872,0.00095264084,0.0010987067],"domain_scores_gemma":[0.9948541,0.0030922613,0.00043709384,0.0007123894,0.00033783884,0.0005663424],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026626248,0.0010350177,0.0013615857,0.000378073,0.00017972813,0.00005094238,0.00049784954,0.0009497029,0.00077989703],"category_scores_gemma":[0.00000815715,0.0008936738,0.0007056014,0.00030003005,0.00021179393,0.0002355932,0.0002248482,0.0007883844,0.00010857299],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016001608,0.004866995,0.008306309,0.0009953954,0.034872983,0.00032106397,0.00022592505,0.00001576568,0.0041476744,7.19708e-7,0.92920965,0.0010358964],"study_design_scores_gemma":[0.031689785,0.002459096,0.0066068727,0.0003404665,0.0845714,0.000002644454,0.000037273516,0.00020920161,0.0074118935,0.000009757344,0.86578166,0.00087997655],"about_ca_topic_score_codex":0.00060548104,"about_ca_topic_score_gemma":0.00010484821,"teacher_disagreement_score":0.06342803,"about_ca_system_score_codex":0.00082882424,"about_ca_system_score_gemma":0.0011835279,"threshold_uncertainty_score":0.9993514},"labels":[],"label_agreement":null},{"id":"W2994967047","doi":"10.1111/apt.15581","title":"Review article: clinical pharmacology of current and investigational hepatitis B virus therapies","year":2019,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; HBsAg; Hepatitis B virus; Hepatitis B; Pharmacokinetics; Drug; Internal medicine; Clinical trial; Pharmacology; Virus; Virology","score_opus":0.2464467679843872,"score_gpt":0.4991786279890949,"score_spread":0.2527318600047077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994967047","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001522624,0.9894827,0.000002744159,0.001495168,0.003936048,0.0031206473,0.00033436905,0.00005582866,0.000049899492],"genre_scores_gemma":[0.000054356315,0.9548957,0.0002153314,0.0431698,0.0009310177,0.0003137729,0.00027335153,0.00009050984,0.000056214703],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99519545,0.0013421527,0.001930216,0.0007039654,0.0003316356,0.0004965903],"domain_scores_gemma":[0.99716806,0.0010925792,0.00094452745,0.0003482959,0.00021074423,0.00023578887],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00077903905,0.0006750659,0.0035787032,0.00019404801,0.00010380628,0.000007256253,0.0002787253,0.0003274263,0.0012840449],"category_scores_gemma":[0.0000028999825,0.00055351673,0.0006042515,0.00032438364,0.0011150033,0.00009188113,0.00028551547,0.0011090034,0.00018676362],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103610706,0.0011591915,0.014799063,0.07646553,0.048343394,0.00004627798,0.00017455641,1.1657771e-7,0.0004196824,0.000038865364,0.033302248,0.82514745],"study_design_scores_gemma":[0.001356678,0.00057076954,0.00047855682,0.013632026,0.09847185,0.00010400055,0.0000029370276,0.0000115648045,0.00016993607,0.000024183082,0.88481075,0.00036676397],"about_ca_topic_score_codex":0.000117364776,"about_ca_topic_score_gemma":0.000033305474,"teacher_disagreement_score":0.8515085,"about_ca_system_score_codex":0.00016124742,"about_ca_system_score_gemma":0.0007620184,"threshold_uncertainty_score":0.9996916},"labels":[],"label_agreement":null},{"id":"W2995025604","doi":"10.1111/apt.15583","title":"Letter: histology is relevant for risk stratification in primary biliary cholangitis","year":2019,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre; University of Toronto","funders":"Academy of Medical Sciences; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Risk stratification; Histology; Internal medicine; Gastroenterology","score_opus":0.034442041585288845,"score_gpt":0.312641335957948,"score_spread":0.27819929437265917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995025604","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09632916,0.0077747763,0.000037571088,0.8867505,0.0034711293,0.0035637424,0.0015578087,0.00008885382,0.00042641672],"genre_scores_gemma":[0.003588328,0.005514529,0.00040447156,0.97903913,0.0023748672,0.00027260176,0.006463341,0.000110969835,0.0022317315],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99736524,0.0004363565,0.0006393964,0.0006917305,0.0002486777,0.00061862555],"domain_scores_gemma":[0.99826926,0.0005186889,0.0004027479,0.000647327,0.00010114022,0.0000608487],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025458896,0.00046926047,0.0007821835,0.0002919707,0.00011601389,0.00001554653,0.00034672627,0.00080872717,0.0008250173],"category_scores_gemma":[5.0134173e-7,0.00045473292,0.0003258547,0.0001349817,0.000215029,0.00012254703,0.000083097875,0.0021294167,0.00012614245],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008091606,0.00046328106,0.013429012,0.0004850569,0.0067272275,0.00017666683,0.00029821208,0.0000014907062,0.013052712,9.869418e-7,0.96275985,0.001796371],"study_design_scores_gemma":[0.004878493,0.0008445344,0.013212369,0.00006338128,0.018996954,0.0000592366,0.000024523515,0.0001577714,0.0027479585,0.00011991189,0.9584581,0.0004367407],"about_ca_topic_score_codex":0.0002665,"about_ca_topic_score_gemma":0.0000037376064,"teacher_disagreement_score":0.092740834,"about_ca_system_score_codex":0.0006782312,"about_ca_system_score_gemma":0.00033973585,"threshold_uncertainty_score":0.99979043},"labels":[],"label_agreement":null},{"id":"W2995103782","doi":"10.1111/apt.15609","title":"A clinical decision support tool may help to optimise vedolizumab therapy in Crohn’s disease","year":2019,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Crohn's and Colitis Foundation; Takeda Pharmaceuticals U.S.A.","keywords":"Vedolizumab; Medicine; Disease; Onset of action; Internal medicine; Crohn's disease; Surgery","score_opus":0.024701441424628334,"score_gpt":0.35649459674841744,"score_spread":0.3317931553237891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995103782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952812,0.00044562982,0.000065781,0.00085700984,0.0015884545,0.0014779532,0.0000760968,0.00003221337,0.00017562015],"genre_scores_gemma":[0.9387909,0.0014723502,0.0008991927,0.057374034,0.00041516277,0.00015189938,0.00019245372,0.00007300305,0.00063098443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736726,0.000369582,0.0006455451,0.0007802771,0.00024265463,0.0005946963],"domain_scores_gemma":[0.9987153,0.000071130016,0.000115387644,0.00065153226,0.000079801386,0.0003668391],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005103107,0.00035807918,0.0003041533,0.00011989046,0.00007038081,0.000025821559,0.0005318529,0.00021523301,0.0015245765],"category_scores_gemma":[0.0000015073904,0.00035590588,0.00023484758,0.00012701124,0.00012033949,0.00001659656,0.00026212167,0.00024662283,0.0005571119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03472424,0.002259455,0.7071263,0.000032906002,0.0031279249,0.0017359029,0.00021526385,0.00169497,0.19990465,0.000024896959,0.009383577,0.039769925],"study_design_scores_gemma":[0.011654197,0.0012132272,0.869851,0.000023909677,0.0008282795,0.000016061242,0.00008013507,0.0004687777,0.02007622,0.00008320701,0.09485464,0.0008503447],"about_ca_topic_score_codex":0.0000073152905,"about_ca_topic_score_gemma":0.000010717116,"teacher_disagreement_score":0.17982842,"about_ca_system_score_codex":0.000077154866,"about_ca_system_score_gemma":0.0003411139,"threshold_uncertainty_score":0.9998893},"labels":[],"label_agreement":null},{"id":"W2995738649","doi":"10.1111/apt.15560","title":"Letter: the gluten‐free diet as a bottom‐up approach for irritable bowel syndrome. Authors' reply","year":2019,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Crohn's and Colitis Canada","keywords":"Irritable bowel syndrome; Medicine; Gluten free; Gastroenterology; Gluten; Internal medicine; Pathology","score_opus":0.039689121697339506,"score_gpt":0.3087080898780669,"score_spread":0.2690189681807274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995738649","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0051772133,0.0022082604,0.0003701091,0.9776501,0.0077326805,0.005003418,0.00038148914,0.00022234347,0.0012543933],"genre_scores_gemma":[0.0015020481,0.00023148346,0.00369811,0.9716937,0.0056038755,0.00070418895,0.0024696894,0.00021953693,0.013877373],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954176,0.00047994612,0.00079040765,0.0012006625,0.0007054339,0.0014059333],"domain_scores_gemma":[0.9970462,0.00082487165,0.00040186913,0.0013695247,0.00020504545,0.00015253935],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00075652637,0.00089906296,0.0010785854,0.00020994658,0.0003980984,0.00006874144,0.0011775236,0.0008537712,0.00057653186],"category_scores_gemma":[0.0000050681306,0.0007045344,0.0006738905,0.00022905089,0.000623974,0.00014601872,0.00031706004,0.004149236,0.00016306767],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024840266,0.00047997295,0.00064186525,0.0006423121,0.009831302,0.0003085435,0.00023464179,0.000011550796,0.0011351217,0.000007560042,0.9841417,0.000081382284],"study_design_scores_gemma":[0.006506806,0.0046115564,0.0001891373,0.00009706805,0.023080036,0.0018363077,0.00017333096,0.00073651085,0.00044326708,0.00055093615,0.96118605,0.0005889811],"about_ca_topic_score_codex":0.00025437295,"about_ca_topic_score_gemma":0.0000027524127,"teacher_disagreement_score":0.02295566,"about_ca_system_score_codex":0.00025714247,"about_ca_system_score_gemma":0.00036368784,"threshold_uncertainty_score":0.99954057},"labels":[],"label_agreement":null},{"id":"W2996399916","doi":"10.1111/apt.15588","title":"Editorial: rapid assessment of health‐related quality of life in primary biliary cholangitis—no excuse not to ask","year":2019,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Toronto General Hospital; University Health Network","funders":"","keywords":"Excuse; Medicine; Ask price; Gastroenterology; Internal medicine; Law","score_opus":0.04209211596197059,"score_gpt":0.3949322321365967,"score_spread":0.3528401161746261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996399916","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14398791,0.0033964836,0.0000017683589,0.0014712728,0.8470106,0.0022659102,0.0015406484,0.000048530936,0.00027686942],"genre_scores_gemma":[0.036964264,0.012119055,0.0003580488,0.018320393,0.92560387,0.00012695014,0.0057828133,0.00019773058,0.0005268671],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931803,0.0016022639,0.0025004311,0.0006854381,0.0013881603,0.00064345944],"domain_scores_gemma":[0.994968,0.0017887753,0.0014154456,0.00086563145,0.00062194397,0.00034021365],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026880354,0.00058384205,0.0025118329,0.00042978412,0.000070814254,0.000010123102,0.0005875534,0.0009465172,0.0010039526],"category_scores_gemma":[0.000015475385,0.0005693198,0.00042802657,0.00039557437,0.00023980555,0.00014963203,0.0003751568,0.0018795453,0.0000429103],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048124567,0.003254145,0.010271431,0.0019196772,0.011347792,0.000008237624,0.00044985558,0.000013905828,0.030299278,0.0000021246485,0.93698615,0.0006349535],"study_design_scores_gemma":[0.02670663,0.0064022145,0.108900905,0.00075606373,0.01040563,0.0000019660365,0.0002870381,0.000037376212,0.0017009726,0.000019409366,0.84382457,0.0009572459],"about_ca_topic_score_codex":0.002894127,"about_ca_topic_score_gemma":0.000007437408,"teacher_disagreement_score":0.10702365,"about_ca_system_score_codex":0.0010326053,"about_ca_system_score_gemma":0.0044299606,"threshold_uncertainty_score":0.9999093},"labels":[],"label_agreement":null},{"id":"W2997070537","doi":"10.1111/apt.15574","title":"Editorial: how can we best promote the routine use of scores that are accurate at predicting outcomes in patients with upper gastrointestinal bleeding?","year":2019,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital","funders":"","keywords":"Medicine; MEDLINE; Intensive care medicine; Internal medicine","score_opus":0.03277336877730386,"score_gpt":0.2953539311879538,"score_spread":0.2625805624106499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997070537","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.547741,0.00021744047,7.706118e-7,0.00464525,0.44445935,0.0020334441,0.00084832846,0.000049937516,0.0000044957906],"genre_scores_gemma":[0.2769527,0.0009701437,0.0012630038,0.0016636419,0.715288,0.00038029713,0.0020851106,0.00037850445,0.0010186168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958007,0.00022062904,0.00070462003,0.0008718639,0.0014657727,0.0009364489],"domain_scores_gemma":[0.9953077,0.0019894736,0.0012930331,0.0005349598,0.0006719695,0.00020285687],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034903645,0.0009676361,0.0014298997,0.00025846827,0.00019376347,0.000079323036,0.00044938448,0.0003530649,0.00007900378],"category_scores_gemma":[0.000022469543,0.0006064873,0.00026947568,0.0002205604,0.0003799889,0.00017881647,0.00035419836,0.0015683405,0.000011381413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022798458,0.0013945926,0.7284848,0.00016429712,0.0047889315,0.00004916599,0.00014222533,0.000031589327,0.00023589887,2.5942407e-7,0.26239693,0.000031471853],"study_design_scores_gemma":[0.04680934,0.02785982,0.6263341,0.010002266,0.06995935,0.0001238882,0.0007326795,0.00017458368,0.0050794366,0.000008857792,0.2111547,0.0017610108],"about_ca_topic_score_codex":0.0006382539,"about_ca_topic_score_gemma":0.00021042525,"teacher_disagreement_score":0.2708286,"about_ca_system_score_codex":0.0009132143,"about_ca_system_score_gemma":0.0003641329,"threshold_uncertainty_score":0.9996387},"labels":[],"label_agreement":null},{"id":"W3000326363","doi":"10.1111/apt.15617","title":"Editorial: histologic normalisation in ulcerative colitis","year":2020,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Ulcerative colitis; Colitis; Dermatology; Pathology; Gastroenterology; Disease","score_opus":0.012955455806098592,"score_gpt":0.2938849476110238,"score_spread":0.2809294918049252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000326363","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011875271,0.00058883993,0.00001029744,0.00055707264,0.9850799,0.00083731103,0.00070163637,0.000047863075,0.0003018003],"genre_scores_gemma":[0.004952299,0.001720486,0.000075022755,0.0069376556,0.97904843,0.00026831077,0.006618846,0.00010944641,0.00026951786],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966916,0.0008221606,0.0005939499,0.00084717845,0.0004819225,0.0005631977],"domain_scores_gemma":[0.9987829,0.00013264938,0.0003401794,0.00033378665,0.00023556028,0.0001749474],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00035799207,0.00057246524,0.00045721084,0.00011319963,0.00012498967,0.000032068972,0.00057559524,0.0013835023,0.00022966415],"category_scores_gemma":[0.000004987064,0.0006471326,0.0001838635,0.00011892825,0.0002595283,0.000014313974,0.00024866938,0.0009447127,0.000085581065],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029311746,0.00017834248,0.00039648518,0.000054782413,0.0025195717,0.00017750866,0.00019473754,0.00004568513,0.01874444,0.0000040082996,0.9746717,0.00008151863],"study_design_scores_gemma":[0.002917076,0.00042591317,0.0005705223,0.0000141221435,0.002250184,0.0000021581795,0.00005687758,0.00003319699,0.0049817106,0.000041835832,0.9881063,0.00060009083],"about_ca_topic_score_codex":0.000058483372,"about_ca_topic_score_gemma":0.0002818503,"teacher_disagreement_score":0.013762729,"about_ca_system_score_codex":0.00033612442,"about_ca_system_score_gemma":0.0008209773,"threshold_uncertainty_score":0.9999129},"labels":[],"label_agreement":null},{"id":"W3000539932","doi":"10.1111/apt.15587","title":"Systematic review with meta‐analysis: risk of adverse pregnancy‐related outcomes in inflammatory bowel disease","year":2020,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Odds ratio; Pregnancy; Chorioamnionitis; Obstetrics; Inflammatory bowel disease; Placental abruption; Gestational diabetes; Premature rupture of membranes; Internal medicine; Gestational age; Disease; Gestation","score_opus":0.04668319657563858,"score_gpt":0.3747192285507868,"score_spread":0.32803603197514825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000539932","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001731891,0.99117935,0.000008721983,0.0008651837,0.00016963328,0.007325119,0.0003284837,0.0000707106,0.00003545947],"genre_scores_gemma":[0.0001736075,0.99115735,0.00005559718,0.0062963953,0.0000195455,0.0016221874,0.00038331925,0.00007708176,0.00021490993],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9944026,0.001814077,0.002254833,0.0006037911,0.00052228017,0.00040241284],"domain_scores_gemma":[0.9958858,0.00058638735,0.0021740287,0.0008353664,0.00008755668,0.00043086192],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005955391,0.00077501504,0.0077010114,0.0005016229,0.00004750825,0.0000029529801,0.00043338432,0.00023752158,0.0006822844],"category_scores_gemma":[0.0000066565017,0.00047549026,0.0026449743,0.000996584,0.00023033442,0.000108599525,0.00008202746,0.0009011127,0.000053607484],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047925278,0.00031460283,0.0006893464,0.4325472,0.56559956,0.00028489728,0.00009172519,0.0000036160857,5.815525e-7,0.000003117916,0.000011861727,0.00040558394],"study_design_scores_gemma":[0.0011408866,0.00014713108,0.00008643207,0.1975757,0.7956124,0.000021896505,0.000018670402,0.000022559003,0.000003839105,0.0000032404835,0.0050766324,0.0002906396],"about_ca_topic_score_codex":0.0000101075575,"about_ca_topic_score_gemma":0.0000033512729,"teacher_disagreement_score":0.23497151,"about_ca_system_score_codex":0.00018676867,"about_ca_system_score_gemma":0.000868394,"threshold_uncertainty_score":0.9997697},"labels":[],"label_agreement":null},{"id":"W3000711104","doi":"10.1111/apt.15618","title":"Patient‐reported outcomes in a large North American cohort living with chronic hepatitis B virus: a cross‐sectional analysis","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre; University of Toronto","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Center for Advancing Translational Sciences; National Institute on Alcohol Abuse and Alcoholism","keywords":"Medicine; Cross-sectional study; Cohort; Chronic hepatitis; Cohort study; Virus; Virology; Internal medicine; Pathology","score_opus":0.0262825676075716,"score_gpt":0.33049062384950456,"score_spread":0.304208056241933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000711104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963308,0.00046290105,0.00009861689,0.0017852436,0.00017058033,0.0008183923,0.00015321639,0.0001261623,0.0000540924],"genre_scores_gemma":[0.95552176,0.0016105009,0.0002451708,0.042056,0.00013227214,0.0002029721,0.00015266228,0.000047847432,0.000030824427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974106,0.00020635956,0.0006818049,0.0006167992,0.0004614715,0.00062296295],"domain_scores_gemma":[0.9988993,0.0002108077,0.00031743528,0.00022299566,0.00013483306,0.0002146537],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014714057,0.00035714978,0.0008729494,0.0002681056,0.0001908528,0.00002143946,0.00012664765,0.00005891851,0.0008529242],"category_scores_gemma":[0.0000022580523,0.000312923,0.00020929376,0.0014515959,0.00034094084,0.00012953139,0.00013739886,0.00044377422,0.000033292108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028665786,0.0006614194,0.9388618,0.00002041151,0.056330305,0.0003581193,0.0012918543,0.00025691075,0.0016506366,6.444374e-7,0.000055466917,0.00022581282],"study_design_scores_gemma":[0.0018126062,0.0015010164,0.9763796,0.000009286471,0.015854849,0.000019596611,0.00004311539,0.0022993716,0.0009444201,4.852173e-7,0.0008459632,0.00028970087],"about_ca_topic_score_codex":0.009292613,"about_ca_topic_score_gemma":0.055343933,"teacher_disagreement_score":0.04605132,"about_ca_system_score_codex":0.00050430873,"about_ca_system_score_gemma":0.00020744496,"threshold_uncertainty_score":0.9999323},"labels":[],"label_agreement":null},{"id":"W3002299634","doi":"10.1111/apt.15639","title":"Opioid prescriptions are associated with hepatic encephalopathy in a national cohort of patients with compensated cirrhosis","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Allergan; National Institutes of Health; Valeant Pharmaceuticals International; Bausch Health; National Institute of Diabetes and Digestive and Kidney Diseases; Gilead Sciences","keywords":"Medicine; Cirrhosis; Opioid; Medical prescription; Internal medicine; Hepatic encephalopathy; Cohort; Decompensation; Hazard ratio; Cohort study; Confidence interval; Pharmacology","score_opus":0.02396898970530644,"score_gpt":0.2672063924175778,"score_spread":0.24323740271227137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002299634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99760085,0.00011461255,0.000022526347,0.00095642114,0.00005134001,0.00085493416,0.00029225167,0.000033747307,0.00007329419],"genre_scores_gemma":[0.9865875,0.00010861655,0.000089906585,0.011951331,0.000022401426,0.000056963483,0.0011600844,0.000018022663,0.0000051528637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989244,0.00011142667,0.00024334915,0.00020868386,0.0003463842,0.0001657852],"domain_scores_gemma":[0.99940294,0.00007672573,0.00014745766,0.00005529037,0.00022265092,0.00009490846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059783066,0.0001424486,0.0002553894,0.00008022653,0.000044194487,0.0000038402763,0.00006895372,0.000048049227,0.00020988005],"category_scores_gemma":[1.8256873e-7,0.000116691765,0.000033345397,0.0002982441,0.00010896927,0.00010446862,0.000010317764,0.00014699103,0.0000050299254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020976192,0.0008563183,0.9806401,0.000052505115,0.009163674,0.00003434998,0.0012817018,0.000074760246,0.005759285,0.0000043177997,0.000024064771,0.000011271447],"study_design_scores_gemma":[0.008029709,0.00091136625,0.9700954,0.000087168424,0.012726508,0.0000015455176,0.00012917066,0.000930018,0.0069418657,0.00000978645,0.00001711748,0.00012034676],"about_ca_topic_score_codex":0.00004025126,"about_ca_topic_score_gemma":0.000028721077,"teacher_disagreement_score":0.011013351,"about_ca_system_score_codex":0.000095916235,"about_ca_system_score_gemma":0.00013377849,"threshold_uncertainty_score":0.47585523},"labels":[],"label_agreement":null},{"id":"W3007866620","doi":"10.1111/apt.15655","title":"Letter: increased risk of caesarean section for women with IBD—more questions than answers. Authors' reply","year":2020,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Section (typography); Caesarean section; Family medicine; Pregnancy; Genetics; Computer science","score_opus":0.026579610729069867,"score_gpt":0.31801493568129063,"score_spread":0.29143532495222074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007866620","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0407493,0.0010603752,0.00065657217,0.95100313,0.0020906625,0.0026053747,0.0014725588,0.00022888994,0.00013313026],"genre_scores_gemma":[0.033968933,0.0011200729,0.0007332461,0.9553126,0.0051038284,0.00060169556,0.0022347462,0.00012567357,0.000799174],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973402,0.00042484232,0.0005892728,0.00061933685,0.00041177808,0.00061456487],"domain_scores_gemma":[0.9980312,0.00035600457,0.00067477184,0.0004901447,0.00017855431,0.00026931617],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030751852,0.00049029547,0.0008024828,0.00024870882,0.00019434156,0.000010431471,0.00026236978,0.00049417623,0.00035138326],"category_scores_gemma":[0.0000033178562,0.00041513282,0.00019520642,0.00026166282,0.0004296163,0.00010307105,0.000040742794,0.0018808845,0.000007625908],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034084707,0.00037446257,0.004389249,0.000667671,0.02616559,0.00027833087,0.0028271258,0.000005639165,0.018905295,0.0000011666456,0.9419491,0.0010278866],"study_design_scores_gemma":[0.005729077,0.0030061807,0.0015337036,0.0002793165,0.02701794,0.0001343988,0.00020610553,0.00013128895,0.016035764,0.00006124099,0.9454579,0.00040711163],"about_ca_topic_score_codex":0.00029798213,"about_ca_topic_score_gemma":0.00000853143,"teacher_disagreement_score":0.0067803664,"about_ca_system_score_codex":0.000382713,"about_ca_system_score_gemma":0.0005188717,"threshold_uncertainty_score":0.99983007},"labels":[],"label_agreement":null},{"id":"W3008968246","doi":"10.1111/apt.15640","title":"Editorial: choosing an appropriate risk stratification tool for nonalcoholic fatty liver disease—one size does not fit all","year":2020,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Nonalcoholic fatty liver disease; Medicine; Risk stratification; Liver disease; Internal medicine; Fatty liver; Disease; Gastroenterology","score_opus":0.04758253713262061,"score_gpt":0.35209244591635674,"score_spread":0.3045099087837361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008968246","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017090214,0.0020456475,0.000035209065,0.0042514103,0.9619402,0.004920275,0.009471342,0.00023631821,0.00000935571],"genre_scores_gemma":[0.013976018,0.009935235,0.0010517905,0.01060589,0.95084834,0.0016896118,0.011556785,0.00021256041,0.00012379083],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99565494,0.00043128745,0.0007963952,0.0013376639,0.0010834828,0.00069621886],"domain_scores_gemma":[0.99581194,0.0017737631,0.0006496825,0.00062219595,0.00046999753,0.00067244406],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034331673,0.00086166966,0.0010114495,0.000098107535,0.00033197875,0.00011661027,0.00042990656,0.00073459407,0.0004329078],"category_scores_gemma":[0.000011737971,0.00069747865,0.00053790753,0.00012043521,0.00019433044,0.00027645187,0.00011318308,0.0009793787,0.000053859985],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00980796,0.005929243,0.0018787994,0.00062348245,0.04475645,0.00007120326,0.00059125025,0.000018750878,0.015504715,0.000008573501,0.9179808,0.0028287664],"study_design_scores_gemma":[0.010472843,0.0015544456,0.0032708177,0.00012644262,0.14510661,6.762776e-7,0.000037837584,0.0005043489,0.013390825,0.00020369684,0.8244714,0.0008600108],"about_ca_topic_score_codex":0.00017455213,"about_ca_topic_score_gemma":0.000013129263,"teacher_disagreement_score":0.100350164,"about_ca_system_score_codex":0.0005689974,"about_ca_system_score_gemma":0.00080512435,"threshold_uncertainty_score":0.99954766},"labels":[],"label_agreement":null},{"id":"W3010513579","doi":"10.1111/apt.15695","title":"Analysis of 61 exclusive enteral nutrition formulas used in the management of active Crohn’s disease—new insights into dietary disease triggers","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Natural Environment Research Council; University of Glasgow; Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Directorate for Biological Sciences; Sight Research UK","keywords":"Medicine; Crohn's disease; Food additive; Food science; Dietary management; Disease; Parenteral nutrition; Internal medicine; Gastroenterology; Chemistry","score_opus":0.023905049369496105,"score_gpt":0.3050632984382195,"score_spread":0.2811582490687234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010513579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955015,0.0014777697,0.00010102513,0.0017065369,0.00011303938,0.00093273615,0.0001326258,0.000008149611,0.000026586858],"genre_scores_gemma":[0.9880756,0.0012118303,0.00009257867,0.00954314,0.00010473648,0.00010183681,0.0008363601,0.000019428162,0.000014486058],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99844104,0.0003021264,0.00041023333,0.0003803181,0.00023380085,0.00023246533],"domain_scores_gemma":[0.9992178,0.000030931937,0.00020605056,0.00028908916,0.000042590356,0.0002135201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006643341,0.00023606069,0.00027519304,0.00014090331,0.00007530175,0.000008736522,0.00041647675,0.000062673804,0.00009215294],"category_scores_gemma":[3.0757545e-7,0.00020534286,0.00032223293,0.0003699677,0.00019851417,0.000020365924,0.00015690488,0.000109545246,0.0000020748491],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06354489,0.0062992973,0.11675826,0.0013189932,0.14010446,0.002642944,0.017543178,0.0073827207,0.63877296,0.00024119219,0.0010418014,0.004349309],"study_design_scores_gemma":[0.009294412,0.0005078523,0.82944626,0.000057072986,0.06196472,6.1698256e-7,0.002690566,0.0048814793,0.08726033,0.00045687493,0.0028503232,0.00058951444],"about_ca_topic_score_codex":0.000017199976,"about_ca_topic_score_gemma":0.000018169381,"teacher_disagreement_score":0.71268797,"about_ca_system_score_codex":0.000039031565,"about_ca_system_score_gemma":0.00010241715,"threshold_uncertainty_score":0.8373639},"labels":[],"label_agreement":null},{"id":"W3013427169","doi":"10.1111/apt.15684","title":"Letter: immunogenicity of infliximab—ready for routine prediction? Authors' reply","year":2020,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Immunogenicity; Infliximab; Medicine; Biosimilar; Intensive care medicine; Immunology; Internal medicine; Tumor necrosis factor alpha; Antibody","score_opus":0.029826064254735454,"score_gpt":0.3039235024927864,"score_spread":0.27409743823805094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013427169","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13144404,0.0030640878,0.0005483629,0.8438632,0.00694371,0.004238576,0.0094894,0.00018404456,0.00022459951],"genre_scores_gemma":[0.01148374,0.00039374913,0.0004575154,0.968245,0.008078845,0.00033216082,0.010195582,0.00016424844,0.00064912473],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99703866,0.00039591157,0.00083947805,0.00083586056,0.00028071064,0.0006093836],"domain_scores_gemma":[0.9983864,0.00006834689,0.00056061085,0.0006515387,0.00022162117,0.00011149577],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023038789,0.00059299567,0.0005256305,0.0000932112,0.00016292631,0.000017814476,0.00070651755,0.00074541813,0.00017379013],"category_scores_gemma":[0.0000013809722,0.0006423073,0.00044128587,0.00008405595,0.0003585166,0.000009846883,0.00026716563,0.0008563187,0.000020834093],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014362419,0.0001199632,0.0008733527,0.00016527875,0.011556071,0.00014878469,0.00007024921,0.00002431959,0.2530141,0.0000019947254,0.7325258,0.00006380056],"study_design_scores_gemma":[0.00267717,0.0005839706,0.0003298935,0.000012966821,0.008163736,0.000019781466,0.000010518686,0.00014012706,0.13992068,0.000038255173,0.8476536,0.0004492565],"about_ca_topic_score_codex":0.000016411728,"about_ca_topic_score_gemma":0.0000018784724,"teacher_disagreement_score":0.124381855,"about_ca_system_score_codex":0.00008067608,"about_ca_system_score_gemma":0.00026719438,"threshold_uncertainty_score":0.9996028},"labels":[],"label_agreement":null},{"id":"W3016108076","doi":"10.1111/apt.15699","title":"Letter: pregnant women with IBD are more likely to be adherent to biologic therapies than other medications—authors’ reply","year":2020,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine","score_opus":0.0637404523380936,"score_gpt":0.34274982780374025,"score_spread":0.27900937546564664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016108076","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02328737,0.0034164768,0.00020800262,0.9669244,0.0015920921,0.0036002006,0.00050542934,0.00035241,0.000113593385],"genre_scores_gemma":[0.009905688,0.0012946933,0.00082557625,0.97805536,0.0041904026,0.0022043057,0.00057390385,0.00020631007,0.002743743],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953754,0.00050289073,0.00078791165,0.0012667987,0.00084597577,0.0012210167],"domain_scores_gemma":[0.997218,0.00025989837,0.00053906074,0.0010022938,0.00017233258,0.00080841297],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031144125,0.0009154916,0.0011600029,0.00039733917,0.00024001345,0.000035837464,0.0008521412,0.00058510544,0.0021888348],"category_scores_gemma":[0.0000030438825,0.0006601184,0.0001821367,0.00056683325,0.00042867372,0.00009665168,0.00020161536,0.0020875433,0.000276581],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014762069,0.00042916034,0.0018165002,0.0002224352,0.018371409,0.00057476957,0.011589964,0.0000038901126,0.015151702,0.0000015480506,0.9475441,0.0028183393],"study_design_scores_gemma":[0.0023717207,0.003482933,0.0019553895,0.00074833847,0.0066223154,0.00010486106,0.00074585335,0.0000059509516,0.010033942,0.00002567845,0.97318196,0.00072104734],"about_ca_topic_score_codex":0.000051478557,"about_ca_topic_score_gemma":0.000007505702,"teacher_disagreement_score":0.025637895,"about_ca_system_score_codex":0.0005387796,"about_ca_system_score_gemma":0.00045942198,"threshold_uncertainty_score":0.99958503},"labels":[],"label_agreement":null},{"id":"W3017378163","doi":"10.1111/apt.15726","title":"Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; University of Calgary; Robarts Clinical Trials","funders":"AbbVie; Gilead Sciences; Pfizer","keywords":"Medicine; Cognitive interview; Interpretability; Patient-reported outcome; Cognition; Ulcerative colitis; Inflammatory bowel disease; Pharmacoeconomics; Disease; Family medicine; Quality of life (healthcare); Internal medicine; Psychiatry; Pathology; Nursing","score_opus":0.015733429704075375,"score_gpt":0.28438633325422824,"score_spread":0.26865290355015287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017378163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99636,0.00072477147,0.00012263605,0.0019298862,0.0001279734,0.00062242465,0.000096278076,0.000007792431,0.000008212459],"genre_scores_gemma":[0.98336643,0.0001716368,0.0003357441,0.015867688,0.000112348884,0.00007145424,0.0000406102,0.0000167652,0.000017302596],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99928504,0.000092967595,0.00017076149,0.00022136932,0.000064939144,0.00016493442],"domain_scores_gemma":[0.9995967,0.00001324801,0.00008065063,0.00008887798,0.000051993597,0.0001685155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007145669,0.00013761874,0.00009785309,0.000010383957,0.00015477477,0.000008907575,0.00010347721,0.0000511303,0.000012201637],"category_scores_gemma":[0.0000010153624,0.00011378933,0.000040504005,0.000028263747,0.00021885634,0.000006191894,0.0001214919,0.000050102528,5.55325e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073235626,0.00023599171,0.07069498,0.00029746894,0.007312408,0.000044807075,0.003346925,0.000037244292,0.9051055,0.00030089723,0.0010051867,0.004295075],"study_design_scores_gemma":[0.0025408515,0.00017415897,0.79556686,0.000022325125,0.0020384213,0.000004487568,0.00015037326,0.00042861816,0.19289742,0.000072477844,0.0058574467,0.00024655493],"about_ca_topic_score_codex":0.0000011745659,"about_ca_topic_score_gemma":0.0000103960765,"teacher_disagreement_score":0.7248719,"about_ca_system_score_codex":0.000015556278,"about_ca_system_score_gemma":0.0001809532,"threshold_uncertainty_score":0.4640194},"labels":[],"label_agreement":null},{"id":"W3017396921","doi":"10.1111/apt.15719","title":"Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn’s disease","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Crohn's disease; Infliximab; Adalimumab; Ustekinumab; Internal medicine; Vedolizumab; Refractory (planetary science); Golimumab; Concomitant; Clinical trial; Maintenance therapy; Surgery; Gastroenterology; Cohort; Disease; Chemotherapy","score_opus":0.017961995133248324,"score_gpt":0.3002074370836827,"score_spread":0.2822454419504344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017396921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99593544,0.0018331865,0.000037160466,0.0014263616,0.000057667607,0.0005436465,0.00010672233,0.000015026661,0.000044762117],"genre_scores_gemma":[0.98946685,0.0022178527,0.00016284335,0.007756966,0.00010193831,0.000046355053,0.00020675114,0.000019894536,0.000020545913],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989832,0.000172557,0.00023439463,0.00033089984,0.00007592247,0.00020302764],"domain_scores_gemma":[0.99943167,0.00006740401,0.00009843528,0.00016880628,0.00003252357,0.00020115399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005338746,0.00018769373,0.00016324884,0.000032692744,0.00005415842,0.0000034741622,0.00013394242,0.00006093199,0.00008063792],"category_scores_gemma":[6.7427874e-7,0.00015370305,0.00003763793,0.00006717941,0.00028677555,0.000004728407,0.00005965883,0.00007781053,0.0000043068067],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024160482,0.0015609917,0.09838611,0.000052810872,0.0057026595,0.0012016535,0.0008183991,0.002437084,0.86033416,0.000025223388,0.000072513714,0.005247923],"study_design_scores_gemma":[0.06921725,0.010536933,0.6293106,0.000076182776,0.019462045,0.000052113406,0.00093156105,0.0075038597,0.2013911,0.00008397791,0.059378657,0.0020557076],"about_ca_topic_score_codex":0.000010759051,"about_ca_topic_score_gemma":0.000019646695,"teacher_disagreement_score":0.65894306,"about_ca_system_score_codex":0.000037814603,"about_ca_system_score_gemma":0.00014675812,"threshold_uncertainty_score":0.62678283},"labels":[],"label_agreement":null},{"id":"W3019934700","doi":"10.1111/apt.15716","title":"Letter: corticosteroid use alongside tofacitinib in OCTAVE Open. Authors' reply","year":2020,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McMaster University; Population Health Research Institute","funders":"Pfizer","keywords":"Tofacitinib; Medicine; Octave (electronics); Open label; Corticosteroid; Dermatology; Surgery; Internal medicine; Randomized controlled trial","score_opus":0.044448492620893704,"score_gpt":0.3122662275785071,"score_spread":0.2678177349576134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3019934700","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30390874,0.0006509753,0.000026230444,0.6881767,0.0031934103,0.0025624165,0.001195402,0.000082655926,0.00020349024],"genre_scores_gemma":[0.012539738,0.0003967699,0.00028545107,0.9755547,0.003790028,0.0002929325,0.005722813,0.00022105308,0.0011965096],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99531674,0.0009924207,0.00092712924,0.0014252542,0.00033742472,0.0010010096],"domain_scores_gemma":[0.99826235,0.00008491133,0.00044943768,0.0008849045,0.000096554024,0.00022185575],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002308139,0.0008379307,0.00064629293,0.0001498196,0.00015355652,0.00017847783,0.0015128123,0.00086226163,0.00055498653],"category_scores_gemma":[0.0000020891205,0.00094018836,0.00028131725,0.0001476413,0.00033921885,0.000038029106,0.0010955274,0.0018677803,0.00016451492],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010403971,0.00015610638,0.0041171485,0.00006683828,0.0047001513,0.014949224,0.00015000725,0.000015667207,0.08038943,9.458992e-7,0.894259,0.00015511076],"study_design_scores_gemma":[0.002911094,0.0003038177,0.0015285849,0.000029745932,0.003057979,0.00011915774,0.000024937415,0.000051709692,0.03493172,0.000032945234,0.95606494,0.00094336795],"about_ca_topic_score_codex":0.00009822938,"about_ca_topic_score_gemma":0.000047486577,"teacher_disagreement_score":0.291369,"about_ca_system_score_codex":0.00014705193,"about_ca_system_score_gemma":0.00033230527,"threshold_uncertainty_score":0.9993049},"labels":[],"label_agreement":null},{"id":"W3021653697","doi":"10.1111/apt.15749","title":"Outcomes after hepatic encephalopathy in population‐based cohorts of patients with cirrhosis","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; Michigan Institute for Clinical and Health Research; National Institutes of Health; Valeant Pharmaceuticals International","keywords":"Medicine; Rifaximin; Hepatic encephalopathy; Internal medicine; Cirrhosis; Hazard ratio; Ascites; Gastroenterology; Encephalopathy; Population; Liver disease; Cohort; Lactulose; Incidence (geometry); Confidence interval","score_opus":0.0148865136985815,"score_gpt":0.2746200465007298,"score_spread":0.2597335328021483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021653697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973189,0.0001461332,0.000026651387,0.0017094001,0.0000890449,0.000592271,0.00008017958,0.000022271814,0.000015096831],"genre_scores_gemma":[0.9666858,0.000048680642,0.00019750168,0.032595057,0.000020762345,0.00004640715,0.00038680944,0.000016716425,0.0000022966046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991319,0.00007525244,0.00025287937,0.00018447061,0.00020342002,0.00015208307],"domain_scores_gemma":[0.99964625,0.00005868689,0.00007731006,0.00008149106,0.00004545191,0.00009078609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000034457084,0.0001361571,0.0002639522,0.00007889229,0.00001963649,0.0000023289765,0.0000523883,0.000040986626,0.00043742184],"category_scores_gemma":[4.4303853e-8,0.00011026544,0.000051986608,0.00016415579,0.000043558754,0.00008486118,0.000008582427,0.00009308327,0.00000720094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024621761,0.00050895667,0.99260193,0.00009725026,0.0026469044,0.000045258104,0.0007054797,0.00003997855,0.0008035883,0.0000010014895,0.0000028669738,0.00008460648],"study_design_scores_gemma":[0.0057190354,0.0004225134,0.9771746,0.000026930706,0.01110875,4.063595e-7,0.00002769566,0.00032411396,0.0050748177,0.0000071346353,0.0000111123,0.0001029276],"about_ca_topic_score_codex":0.000074967145,"about_ca_topic_score_gemma":0.000012165908,"teacher_disagreement_score":0.03088566,"about_ca_system_score_codex":0.00004174765,"about_ca_system_score_gemma":0.000045547404,"threshold_uncertainty_score":0.47894627},"labels":[],"label_agreement":null},{"id":"W3023449760","doi":"10.1111/apt.15758","title":"Anticholinergic, anti‐depressant and other medication use is associated with clinically relevant oesophageal manometric abnormalities","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Medicine; High resolution manometry; Odds ratio; Anticholinergic; Internal medicine; Esophageal motility disorder; Achalasia; Anesthesia; Gastroenterology; Esophagus","score_opus":0.06740909847519327,"score_gpt":0.33653112642274924,"score_spread":0.26912202794755596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023449760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924092,0.0009654405,0.00004952288,0.005431572,0.00017075196,0.00058617623,0.00013814028,0.000111583664,0.00013759105],"genre_scores_gemma":[0.8934996,0.0011666476,0.00057563843,0.10416117,0.00016192274,0.000024216408,0.00013160263,0.000052318985,0.0002268777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998004,0.00018988557,0.0005096607,0.00048601907,0.0003792238,0.0004311978],"domain_scores_gemma":[0.99881077,0.000314537,0.0002436943,0.00018952512,0.000093046314,0.000348452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020567108,0.00031754907,0.0005197496,0.00013236022,0.00012953546,0.000030442301,0.00012986964,0.00014684747,0.00055872794],"category_scores_gemma":[0.000003001969,0.00023615803,0.00008543406,0.00032329164,0.00029878446,0.000177725,0.000074611715,0.0003450002,0.000035768826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011092075,0.00090685446,0.97601575,0.00003892205,0.013886609,0.0010705718,0.0010197485,0.000008186933,0.00457423,0.000012019871,0.0006222607,0.0007356687],"study_design_scores_gemma":[0.024582537,0.007436403,0.90461445,0.00007625039,0.032155197,0.00023509517,0.00023165249,0.0024144973,0.02394689,0.00003692161,0.0038321756,0.0004379357],"about_ca_topic_score_codex":0.00002429342,"about_ca_topic_score_gemma":6.885618e-7,"teacher_disagreement_score":0.098909624,"about_ca_system_score_codex":0.000062714826,"about_ca_system_score_gemma":0.00007748476,"threshold_uncertainty_score":0.9630245},"labels":[],"label_agreement":null},{"id":"W3026001080","doi":"10.1111/apt.15784","title":"Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Szegedi Tudományegyetem; Radboud Universitair Medisch Centrum; Universiteit Gent; Universitair Ziekenhuis Gent; Tel Aviv University; Universiteit Maastricht; Technion-Israel Institute of Technology; Radboud Universiteit; McGill University; McGill University Health Centre; Hebrew University of Jerusalem; University College Dublin; Univerza v Ljubljani; Maastricht Universitair Medisch Centrum; University Hospital Southampton NHS Foundation Trust","keywords":"Medicine; Ustekinumab; Crohn's disease; Retrospective cohort study; Maintenance therapy; Internal medicine; Surgery; Disease; Chemotherapy; Adalimumab","score_opus":0.009994915174726837,"score_gpt":0.26538268422415684,"score_spread":0.25538776904943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026001080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99708515,0.00022846131,0.00017030005,0.0004614397,0.00017139775,0.0015997991,0.00025497857,0.000018802015,0.000009662138],"genre_scores_gemma":[0.9932193,0.000084557774,0.00010827495,0.006231856,0.000042716,0.000104553386,0.0001539215,0.000047507692,0.000007306289],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977601,0.00082234823,0.0003180977,0.0004932846,0.00025462252,0.00035153728],"domain_scores_gemma":[0.99910486,0.0000757488,0.00012855553,0.00026259787,0.00017176796,0.00025649602],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003147517,0.00027492805,0.00023771114,0.00008057164,0.00006225857,0.000010825557,0.00025408296,0.000086596214,0.000048912963],"category_scores_gemma":[0.0000028871277,0.00024874203,0.00007667744,0.00020193691,0.00014850337,0.000011640661,0.000104431834,0.00012826842,0.0000072676016],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39360008,0.00096602645,0.17383482,0.00007381738,0.0010253577,0.0005145673,0.0004676115,0.004747465,0.42396712,0.0000049877867,0.000055752564,0.0007423817],"study_design_scores_gemma":[0.011165303,0.0026608931,0.9206298,0.000038647002,0.00040746486,0.0000023137252,0.000058146998,0.00021329233,0.06342305,0.000010258976,0.0010483728,0.00034244213],"about_ca_topic_score_codex":0.000006075905,"about_ca_topic_score_gemma":0.0000049337295,"teacher_disagreement_score":0.746795,"about_ca_system_score_codex":0.00011971149,"about_ca_system_score_gemma":0.00024362977,"threshold_uncertainty_score":0.9999965},"labels":[],"label_agreement":null},{"id":"W3028440170","doi":"10.1111/apt.15748","title":"Letter: mesalazine—a safe drug with rare serious adverse events? Authors’ reply","year":2020,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Mesalazine; Adverse effect; Drug; Intensive care medicine; Dermatology; Pharmacology; Internal medicine; Ulcerative colitis","score_opus":0.019292688680100402,"score_gpt":0.2769125440846666,"score_spread":0.25761985540456617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028440170","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008801269,0.0014653087,0.000096311174,0.9823048,0.003893484,0.002154911,0.00028836765,0.0004039394,0.0005915938],"genre_scores_gemma":[0.0033239268,0.0011294875,0.0016195711,0.9692475,0.006319087,0.00017689297,0.0032251738,0.00033528748,0.014623075],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956618,0.00031685169,0.000810865,0.0012363401,0.0008901803,0.001083973],"domain_scores_gemma":[0.9982896,0.00010005682,0.0004482595,0.0007079179,0.00013454312,0.000319667],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018115294,0.0010778016,0.0013396224,0.00024385285,0.00026843252,0.000011860797,0.0005786474,0.00060581515,0.0023484866],"category_scores_gemma":[1.2566551e-7,0.00087453297,0.0004635219,0.00036629368,0.0003176988,0.00013521788,0.00009034718,0.0036618619,0.00029266172],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022821256,0.00027540154,0.0011004157,0.00050966267,0.022545788,0.01928122,0.0007734209,0.000007783935,0.011428331,0.0000018517271,0.9415387,0.00025531845],"study_design_scores_gemma":[0.005432654,0.0007058648,0.00019225867,0.00020499856,0.035296,0.00033092647,0.00010418144,0.000027629902,0.01542717,0.000043454595,0.94138944,0.00084542047],"about_ca_topic_score_codex":0.000039806113,"about_ca_topic_score_gemma":0.000013264921,"teacher_disagreement_score":0.018950293,"about_ca_system_score_codex":0.0003044798,"about_ca_system_score_gemma":0.00039768798,"threshold_uncertainty_score":0.9993705},"labels":[],"label_agreement":null},{"id":"W3031319207","doi":"10.1111/apt.15836","title":"Real‐world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Terlipressin; Hepatorenal syndrome; Medicine; Creatinine; Renal function; Internal medicine; Dialysis; Acute kidney injury; Gastroenterology; Cirrhosis; Kidney disease; Liver transplantation; Renal replacement therapy; Surgery; Intensive care medicine; Transplantation","score_opus":0.03694943638136442,"score_gpt":0.31480264823542303,"score_spread":0.2778532118540586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031319207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944681,0.00012357415,0.000007267,0.0046358565,0.0000737304,0.00057527295,0.000077632634,0.00002142004,0.000017144408],"genre_scores_gemma":[0.9817284,0.00027937774,0.000057453733,0.017726075,0.00003729766,0.000023399061,0.00011575545,0.000018617631,0.00001364677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992375,0.00009280753,0.00014887363,0.00020450163,0.00013128069,0.00018503831],"domain_scores_gemma":[0.9996954,0.00005944647,0.00005182803,0.000076926495,0.00001584657,0.000100558034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000027728418,0.00016656554,0.0002119314,0.000051080868,0.0000678681,0.000009574446,0.000051404506,0.000027591077,0.000107690845],"category_scores_gemma":[7.574979e-9,0.000098893266,0.000034624456,0.00009158423,0.00007039986,0.00008496241,0.0000149346215,0.00010022523,0.000003309912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007527152,0.00030065677,0.9901532,0.000027266122,0.0055331197,0.00019258425,0.0014241075,0.000012078813,0.0013650022,0.0000014656886,0.0000051894,0.00023261971],"study_design_scores_gemma":[0.0065829623,0.0006827113,0.9751009,0.000024094034,0.013592214,0.000010961273,0.00012715405,0.000431573,0.0032708542,0.000002666377,0.000066329616,0.00010757915],"about_ca_topic_score_codex":0.0005831165,"about_ca_topic_score_gemma":0.00013066243,"teacher_disagreement_score":0.015052294,"about_ca_system_score_codex":0.00008045157,"about_ca_system_score_gemma":0.00004067402,"threshold_uncertainty_score":0.403275},"labels":[],"label_agreement":null},{"id":"W3033616463","doi":"10.1111/apt.15787","title":"Review article: bugs, inflammation and mood—a microbiota‐based approach to psychiatric symptoms in inflammatory bowel diseases","year":2020,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Deutsche Forschungsgemeinschaft","keywords":"Gut flora; Medicine; Anxiety; Gut–brain axis; Inflammatory bowel disease; Mood disorders; Mood; Depression (economics); Microbiome; Irritable bowel syndrome; Disease; Immunology; Psychiatry; Bioinformatics; Internal medicine; Biology","score_opus":0.020496828643109453,"score_gpt":0.3289301431356116,"score_spread":0.3084333144925021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033616463","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002060508,0.99347264,0.000024005943,0.0012342974,0.00033225588,0.0026139417,0.00019422767,0.00002952444,0.000038601367],"genre_scores_gemma":[0.00019598838,0.97367597,0.00038867083,0.023621287,0.00040680592,0.00030400572,0.0012991227,0.000084899686,0.000023243898],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971891,0.0005359785,0.0008513359,0.00081948383,0.00010121918,0.00050289463],"domain_scores_gemma":[0.9989626,0.000036285765,0.00032479377,0.0003608569,0.000042977485,0.0002724942],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021292258,0.00058903097,0.0009811636,0.00018645302,0.0001008814,0.000028007687,0.00039037067,0.00036462658,0.00003829328],"category_scores_gemma":[7.5715406e-7,0.0005588929,0.00024380597,0.00036125325,0.00010626631,0.000008796596,0.00020273907,0.0004063813,0.00004950425],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008022298,0.0025150387,0.0025539459,0.19060108,0.018352132,0.000062505285,0.0003159689,0.00006569187,0.18854299,0.000039467726,0.045563813,0.55058515],"study_design_scores_gemma":[0.0010268117,0.00024955347,0.00011972847,0.0018024903,0.009170224,0.000036630594,0.0000075005205,0.000018371276,0.000531613,0.0000023940281,0.9864678,0.0005668853],"about_ca_topic_score_codex":0.000007135578,"about_ca_topic_score_gemma":0.000005402555,"teacher_disagreement_score":0.94090396,"about_ca_system_score_codex":0.0001150351,"about_ca_system_score_gemma":0.00049736066,"threshold_uncertainty_score":0.99968624},"labels":[],"label_agreement":null},{"id":"W3037474108","doi":"10.1111/apt.15831","title":"Editorial: no man’s oesophagus is an island—authors' reply","year":2020,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; General surgery; Psychoanalysis; Psychology","score_opus":0.025483884703790968,"score_gpt":0.34868872492017833,"score_spread":0.32320484021638735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037474108","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017282113,0.0016066455,0.0000033434285,0.0027204813,0.9901037,0.0014100474,0.0016649149,0.00032805474,0.0004345582],"genre_scores_gemma":[0.002118238,0.0016479898,0.00041484553,0.04966962,0.9349222,0.00017851661,0.006298187,0.00030573917,0.0044446746],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99441504,0.0004171137,0.0009291511,0.0015582695,0.0016037746,0.0010766737],"domain_scores_gemma":[0.99685514,0.0003677619,0.00049315434,0.00086507417,0.00056451623,0.00085437694],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00033594432,0.0011782885,0.0014890867,0.00022250233,0.0002799501,0.00007382464,0.00066531653,0.0015211796,0.002995564],"category_scores_gemma":[0.0000037061104,0.0010567708,0.0004881283,0.00025159208,0.0002571588,0.00022547368,0.0002427401,0.0026313805,0.0016612848],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002075483,0.0012517956,0.0011383996,0.00013842147,0.023987435,0.0016349939,0.0004992066,5.7698185e-7,0.001710265,5.543916e-7,0.9672708,0.00029209675],"study_design_scores_gemma":[0.008681329,0.0051938654,0.00008694906,0.000041979496,0.038291413,0.000027904998,0.000024314328,0.0000356298,0.0044597103,0.000041240583,0.94269806,0.00041758112],"about_ca_topic_score_codex":0.00009949868,"about_ca_topic_score_gemma":0.0000039212223,"teacher_disagreement_score":0.05518155,"about_ca_system_score_codex":0.00056057394,"about_ca_system_score_gemma":0.00080580515,"threshold_uncertainty_score":0.99977505},"labels":[],"label_agreement":null},{"id":"W3038123023","doi":"10.1111/apt.15876","title":"No benefit of continuing vs stopping 5‐aminosalicylates in patients with ulcerative colitis escalated to anti‐metabolite therapy","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; University Hospital; Western University; Tellabs (Canada)","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; ACG Institute for Clinical Research and Education; Crohn's and Colitis Foundation of America","keywords":"Medicine; Ulcerative colitis; Metabolite; Internal medicine; Hazard ratio; Proportional hazards model; Colectomy; Disease; Confidence interval","score_opus":0.010184322153216005,"score_gpt":0.253103801293124,"score_spread":0.24291947913990797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038123023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980036,0.00022395777,0.00001578029,0.00043671922,0.0001751328,0.0009037343,0.00015727931,0.000019585374,0.00006420642],"genre_scores_gemma":[0.9798071,0.00021631215,0.00022952653,0.019314086,0.000107335225,0.00004300522,0.00021427112,0.000044408658,0.000023954513],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99848133,0.00017963318,0.00037180376,0.00042353017,0.00016206398,0.00038161606],"domain_scores_gemma":[0.9992726,0.000022057204,0.00015208796,0.0001762326,0.00021279173,0.00016427046],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001002368,0.0002768543,0.00031292916,0.00006960088,0.000050101546,0.000013148149,0.00024547972,0.00011206118,0.00010183506],"category_scores_gemma":[7.603372e-7,0.00026301751,0.00006884891,0.00017812276,0.00011779053,0.000015705516,0.00010097744,0.00013727281,0.000014114347],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011948303,0.0003704799,0.4573881,0.000024132252,0.0028307345,0.000031298052,0.0012133543,0.0005971035,0.5241047,0.000016943091,0.000094591145,0.0013802594],"study_design_scores_gemma":[0.005903507,0.0010533273,0.7536686,0.000017843404,0.00040145958,6.3069905e-7,0.0000654373,0.00013616364,0.23537163,0.000004555647,0.003068028,0.00030882825],"about_ca_topic_score_codex":0.000018656434,"about_ca_topic_score_gemma":0.000011743443,"teacher_disagreement_score":0.29628047,"about_ca_system_score_codex":0.000027251064,"about_ca_system_score_gemma":0.000050717368,"threshold_uncertainty_score":0.9999822},"labels":[],"label_agreement":null},{"id":"W3039245504","doi":"10.1111/apt.15927","title":"Review article: prognostic significance of body composition abnormalities in patients with cirrhosis","year":2020,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Alberta Hospital; Alberta Hospital Edmonton","funders":"Institute of Nutrition, Metabolism and Diabetes","keywords":"Medicine; Cirrhosis; Sarcopenia; Adipose tissue; Liver transplantation; Body mass index; Hepatocellular carcinoma; Decompensation; Internal medicine; Transplantation; Gastroenterology","score_opus":0.06223152138859981,"score_gpt":0.3908376209329915,"score_spread":0.3286060995443917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039245504","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007190321,0.9929083,0.0000040004056,0.0018849154,0.00020730171,0.00408419,0.000106092906,0.000038847473,0.00004729181],"genre_scores_gemma":[0.0009188394,0.96342534,0.00031529652,0.034263942,0.00009329198,0.00034872623,0.00057816354,0.00004878144,0.000007605576],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977198,0.0004360827,0.0009443682,0.00033087705,0.00024165149,0.00032717225],"domain_scores_gemma":[0.9988865,0.00021302464,0.000473151,0.00017491827,0.00011339848,0.00013897681],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019977188,0.0003374628,0.0016752305,0.00015252165,0.00004891784,0.0000045332595,0.00013816518,0.00012239371,0.0003181566],"category_scores_gemma":[3.140136e-7,0.0002756119,0.00015531489,0.0004373984,0.00015193128,0.00006407012,0.00003745396,0.0005551524,0.000024122666],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015476759,0.00624468,0.039855458,0.57492423,0.01761553,0.00021674528,0.00043668845,8.467359e-7,0.00021263617,0.000044598222,0.003464901,0.355436],"study_design_scores_gemma":[0.004045971,0.0015165291,0.0012770745,0.07685802,0.0501738,0.000036974296,0.000020624828,0.000009897793,0.00020882135,0.000007885047,0.86545324,0.00039117056],"about_ca_topic_score_codex":0.000011098099,"about_ca_topic_score_gemma":6.916604e-7,"teacher_disagreement_score":0.8619883,"about_ca_system_score_codex":0.00022650126,"about_ca_system_score_gemma":0.00027216988,"threshold_uncertainty_score":0.9999696},"labels":[],"label_agreement":null},{"id":"W3040911709","doi":"10.1111/apt.15790","title":"Fewer gastrointestinal bleeds with ticagrelor and prasugrel compared with clopidogrel in patients with acute coronary syndrome following percutaneous coronary intervention","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Tellabs (Canada)","funders":"Agency for Healthcare Research and Quality","keywords":"Medicine; Prasugrel; Clopidogrel; Ticagrelor; Acute coronary syndrome; Percutaneous coronary intervention; Internal medicine; Cardiology; Hazard ratio; Myocardial infarction; Conventional PCI; Confidence interval","score_opus":0.012965283200558769,"score_gpt":0.25493470716851485,"score_spread":0.2419694239679561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040911709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99616784,0.0011659027,0.00021039449,0.0010595935,0.0000770353,0.00117499,0.00003332572,0.00009000477,0.000020906406],"genre_scores_gemma":[0.98938626,0.00015803953,0.0017009611,0.008312137,0.000033937486,0.00003499799,0.00027509552,0.00007221075,0.00002634985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981777,0.00016645002,0.00030508288,0.00051008054,0.00040342798,0.00043725077],"domain_scores_gemma":[0.9993153,0.00005848812,0.000114160095,0.00017360334,0.00007522329,0.0002632313],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008658184,0.0003935378,0.00059551885,0.00008778638,0.00011611861,0.000018515513,0.00012726092,0.00006300683,0.00017386537],"category_scores_gemma":[1.3227097e-7,0.00028926154,0.00013658367,0.00022638879,0.0002973304,0.00018010118,0.00006078428,0.0003875079,0.000010097428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03321542,0.0011004361,0.92083895,0.00007749175,0.026389755,0.014924092,0.00041386345,0.000096127085,0.0019833893,0.0000015469258,0.000023601899,0.00093531545],"study_design_scores_gemma":[0.033116214,0.023659566,0.88972986,0.00045411068,0.031775024,0.018886203,0.000743258,0.0005819418,0.00035632943,0.000003833271,0.00015388365,0.00053976924],"about_ca_topic_score_codex":0.000015721018,"about_ca_topic_score_gemma":0.000005665707,"teacher_disagreement_score":0.031109093,"about_ca_system_score_codex":0.0000946187,"about_ca_system_score_gemma":0.00009506043,"threshold_uncertainty_score":0.99995595},"labels":[],"label_agreement":null},{"id":"W3043052663","doi":"10.1111/apt.15932","title":"Leucocyte ratios are biomarkers of mortality in patients with acute decompensation of cirrhosis and acute‐on‐chronic liver failure","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Medical Research Council; European Association for the Study of the Liver; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Medicine; Decompensation; Cirrhosis; Internal medicine; Gastroenterology; Liver failure","score_opus":0.022221962808137336,"score_gpt":0.2871240947362342,"score_spread":0.26490213192809686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043052663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99780166,0.00024993307,0.000027471197,0.0010483084,0.000045570727,0.00063547713,0.00016656554,0.000011994925,0.000013041433],"genre_scores_gemma":[0.99455816,0.0008174252,0.00013386813,0.004174964,0.000022969194,0.000013713485,0.0002646664,0.000013105096,0.0000011395638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917555,0.00008676054,0.0002407472,0.00020037108,0.00017154675,0.0001249962],"domain_scores_gemma":[0.99957615,0.00004590476,0.00015665805,0.00008369053,0.000062540705,0.00007506357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042346554,0.00013487777,0.00025472892,0.00007246193,0.000025240613,0.000002372864,0.000053273114,0.00005450705,0.000118110955],"category_scores_gemma":[3.3293723e-8,0.00011553783,0.000039700553,0.00014457788,0.00011351249,0.00010519086,0.000013618617,0.00009696257,0.0000021129476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048723887,0.00041874553,0.90781415,0.0002057802,0.029152064,0.00005722081,0.0012112393,0.000024599934,0.055963032,0.0000056937956,0.00002503367,0.00025007248],"study_design_scores_gemma":[0.008958143,0.0018888596,0.7882105,0.00006187724,0.029146245,0.000002490344,0.00013527907,0.0004996959,0.17097485,0.0000043646696,0.000010929557,0.00010675859],"about_ca_topic_score_codex":0.000029272984,"about_ca_topic_score_gemma":0.0000214811,"teacher_disagreement_score":0.11960363,"about_ca_system_score_codex":0.000053166244,"about_ca_system_score_gemma":0.000067064146,"threshold_uncertainty_score":0.4711496},"labels":[],"label_agreement":null},{"id":"W3043174949","doi":"10.1111/apt.15919","title":"Letter: combination of biologics in inflammatory bowel diseases. Authors' reply","year":2020,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Inflammatory Bowel Diseases; Inflammatory bowel disease; Internal medicine; Dermatology; Gastroenterology","score_opus":0.016016912553889637,"score_gpt":0.2743657497247615,"score_spread":0.25834883717087187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043174949","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40230602,0.003031735,0.0000338495,0.58770967,0.0036153102,0.0019800235,0.0010370063,0.00010793437,0.00017843374],"genre_scores_gemma":[0.056494124,0.0008217497,0.0000772535,0.9350067,0.0026057342,0.0001454331,0.0045444192,0.00011621257,0.00018839404],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965776,0.000828523,0.0008478109,0.0008464814,0.00030890445,0.0005906499],"domain_scores_gemma":[0.9985661,0.00006423464,0.0005572349,0.0005685169,0.000117720316,0.00012620362],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019990587,0.0005953988,0.00048007493,0.00020242755,0.00008273827,0.000019606388,0.0007448383,0.0008238517,0.00015732512],"category_scores_gemma":[0.0000018910226,0.0006432362,0.0003001035,0.00013074573,0.00047158453,0.0000126818695,0.00033501588,0.0011458313,0.000034061795],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008384209,0.0003045104,0.029207319,0.0003127662,0.004266356,0.0020279314,0.000110503825,0.00005558227,0.11062625,0.0000080105865,0.85210407,0.00013829225],"study_design_scores_gemma":[0.0031829532,0.00050121883,0.011586723,0.000040356288,0.0039790203,0.000014267684,0.000025839207,0.00018557817,0.03153825,0.0002303867,0.9478028,0.0009126036],"about_ca_topic_score_codex":0.000011473781,"about_ca_topic_score_gemma":0.0000039054994,"teacher_disagreement_score":0.34729698,"about_ca_system_score_codex":0.00011514196,"about_ca_system_score_gemma":0.00029003335,"threshold_uncertainty_score":0.9996019},"labels":[],"label_agreement":null},{"id":"W3045287174","doi":"10.1111/apt.15925","title":"Systematic review with meta‐analysis: limited benefits from early colonoscopy in acute lower gastrointestinal bleeding","year":2020,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; McGill University Health Centre","funders":"","keywords":"Medicine; Colonoscopy; Observational study; Randomized controlled trial; Odds ratio; Lower gastrointestinal bleeding; Internal medicine; Adverse effect; Blood transfusion; Meta-analysis; Surgery; Colorectal cancer; Cancer","score_opus":0.08221626066104055,"score_gpt":0.36408581840154447,"score_spread":0.28186955774050393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045287174","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037965918,0.990995,0.000011436569,0.0022331267,0.00016115393,0.005692155,0.0003820237,0.00012445419,0.000021022117],"genre_scores_gemma":[0.00017619945,0.9810029,0.0034560894,0.012125416,0.00013215403,0.00201355,0.0009020677,0.00015427278,0.000037324764],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9949264,0.000626047,0.0018643532,0.001205342,0.000579785,0.0007981069],"domain_scores_gemma":[0.9965038,0.0010981294,0.0012315908,0.0005720969,0.00017416447,0.00042026312],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00037307263,0.0013406401,0.010227441,0.00045247897,0.00009860188,0.00005203889,0.0005004912,0.00017660487,0.00071471545],"category_scores_gemma":[0.0000020563962,0.00089917314,0.0023874599,0.0017616707,0.00014611358,0.00011548278,0.00015757553,0.0011463844,0.0001778751],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034743658,0.0010342994,0.00072949193,0.12402313,0.87022954,0.0032307783,0.000041892043,0.0000052797423,0.000011938563,0.0000030741346,0.00010343442,0.00023972239],"study_design_scores_gemma":[0.0011424955,0.0033637637,0.000036615216,0.17112082,0.820505,0.00082829944,0.0000136002445,0.000028082435,0.000015242575,0.0000011500648,0.0025073646,0.0004375706],"about_ca_topic_score_codex":0.00012952907,"about_ca_topic_score_gemma":0.000022716462,"teacher_disagreement_score":0.049724527,"about_ca_system_score_codex":0.0005243267,"about_ca_system_score_gemma":0.00031614973,"threshold_uncertainty_score":0.9999345},"labels":[],"label_agreement":null},{"id":"W3045933478","doi":"10.1111/apt.15988","title":"Patients with severe acute‐on‐chronic liver failure are disadvantaged by model for end‐stage liver disease‐based organ allocation policy","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Model for End-Stage Liver Disease; Liver transplantation; United Network for Organ Sharing; Liver disease; Hazard ratio; Internal medicine; Cohort; Confidence interval; Proportional hazards model; Chronic liver disease; Transplantation; Cirrhosis","score_opus":0.02349899486293486,"score_gpt":0.2949674507421404,"score_spread":0.27146845587920554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045933478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96155244,0.0007915346,0.0065752803,0.021934802,0.00011994694,0.0033361474,0.00547336,0.00019428474,0.000022207898],"genre_scores_gemma":[0.9163686,0.00054635317,0.00034770928,0.07667616,0.00022102948,0.00014922585,0.0055053793,0.00007180682,0.00011370652],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99851745,0.00008757793,0.0002248683,0.0004760955,0.00031327803,0.00038074897],"domain_scores_gemma":[0.99907625,0.00008923759,0.00013938664,0.00018389935,0.00011988548,0.00039132824],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000033529348,0.00033367466,0.00027148382,0.00007818918,0.00018014712,0.00001562612,0.00015341726,0.00008855274,0.0003512571],"category_scores_gemma":[1.4567745e-7,0.00028620596,0.00011005943,0.0001671276,0.000111177455,0.00020962486,0.00001926332,0.00021326188,0.000033685945],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13892579,0.015074516,0.4027856,0.005708534,0.13661748,0.0010139706,0.013540472,0.02731944,0.23494463,0.00038341328,0.018822635,0.0048635267],"study_design_scores_gemma":[0.09195721,0.010058175,0.05307922,0.0003568777,0.19060527,0.000011415113,0.00053516426,0.51246804,0.13253902,0.000052644707,0.0060914867,0.002245452],"about_ca_topic_score_codex":0.000015174524,"about_ca_topic_score_gemma":0.000012089162,"teacher_disagreement_score":0.48514864,"about_ca_system_score_codex":0.00025693962,"about_ca_system_score_gemma":0.00037892006,"threshold_uncertainty_score":0.999959},"labels":[],"label_agreement":null},{"id":"W3047863077","doi":"10.1111/apt.16026","title":"Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healing","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health","keywords":"Medicine; Ulcerative colitis; Gastroenterology; Internal medicine; Colitis; Endoscopy; Wound healing; Surgery; Disease","score_opus":0.023045898607787416,"score_gpt":0.3059051637652946,"score_spread":0.28285926515750714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047863077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99682605,0.0002616395,0.000027243692,0.0022336822,0.00011197335,0.00041611126,0.000051111045,0.000013772738,0.000058413345],"genre_scores_gemma":[0.98127437,0.00027415788,0.0002373471,0.01802483,0.00005516581,0.000031032705,0.000060076356,0.000014682782,0.000028365315],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989323,0.00022224433,0.00026435513,0.00029570042,0.00007810875,0.00020731869],"domain_scores_gemma":[0.9996109,0.000033451233,0.00006800621,0.00009126022,0.000029861581,0.00016654946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000082695915,0.00015744202,0.00020993083,0.00003796734,0.00004103124,0.0000035675594,0.00011591345,0.00010314026,0.000081872626],"category_scores_gemma":[0.0000014710366,0.0001459738,0.000041164232,0.00006826581,0.00010629531,0.000004423093,0.000078577665,0.00009324458,0.0000024111876],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012925126,0.000102793325,0.4648731,0.000018229908,0.0008756262,0.00006248054,0.0006030175,0.00006826579,0.5316457,0.0000075287967,0.00023426194,0.00021647374],"study_design_scores_gemma":[0.0030202533,0.00087625725,0.6401767,0.0000109041475,0.0007869369,0.0000038079722,0.00019550326,0.00025699518,0.35090053,0.000012827989,0.003547506,0.00021174672],"about_ca_topic_score_codex":0.00001738727,"about_ca_topic_score_gemma":0.000023541566,"teacher_disagreement_score":0.18074517,"about_ca_system_score_codex":0.0000326818,"about_ca_system_score_gemma":0.000045574074,"threshold_uncertainty_score":0.59526384},"labels":[],"label_agreement":null},{"id":"W3049272660","doi":"10.1111/apt.15977","title":"Editorial: pregnancy and the gastroenterologist","year":2020,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Pregnancy; MEDLINE; Obstetrics; Gastroenterology","score_opus":0.020429858107993054,"score_gpt":0.33410683158978616,"score_spread":0.31367697348179313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049272660","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007082002,0.018558,0.00002127167,0.028095374,0.9513568,0.0012794741,0.00021118169,0.000123714,0.0002833151],"genre_scores_gemma":[0.00069648045,0.0363875,0.00006914743,0.028332453,0.9330909,0.00023381125,0.0005898513,0.00007144155,0.0005283699],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99729204,0.0004299345,0.0005155019,0.0005558399,0.0007078761,0.00049883284],"domain_scores_gemma":[0.9978279,0.0009935836,0.00035339862,0.00038671613,0.00015050445,0.00028789203],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036498636,0.00046532697,0.00080672844,0.00006806407,0.00018819331,0.000028962695,0.00038322515,0.0006697702,0.00021938304],"category_scores_gemma":[0.00000864261,0.00030896868,0.00020067814,0.00010630958,0.0011510359,0.00007702821,0.00020051855,0.0019301084,0.000045691173],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003199293,0.00016327156,0.00012116569,0.00015474475,0.009817115,0.00003611316,0.00036767471,1.9716235e-7,0.0009343556,0.0000068816657,0.98441523,0.00078393193],"study_design_scores_gemma":[0.014646657,0.0008229076,0.000024971703,0.0003541257,0.025650967,0.000017045339,0.000046678975,0.00002519755,0.0005966739,0.000071235765,0.9575569,0.00018663566],"about_ca_topic_score_codex":0.000031893527,"about_ca_topic_score_gemma":0.0000023968967,"teacher_disagreement_score":0.02685835,"about_ca_system_score_codex":0.000119133925,"about_ca_system_score_gemma":0.0004416703,"threshold_uncertainty_score":0.9999362},"labels":[],"label_agreement":null},{"id":"W3049686259","doi":"10.1111/apt.15826","title":"A single nucleotide polymorphism genetic risk score to aid diagnosis of coeliac disease: a pilot study in clinical care","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Human Genome Research Institute; Juvenile Diabetes Research Foundation International; University of Alberta; Diabetes UK; National Institutes of Health; Wellcome Trust","keywords":"Coeliac disease; Medicine; Single-nucleotide polymorphism; Human leukocyte antigen; Cohort; Receiver operating characteristic; Genotyping; Internal medicine; Immunology; Disease; Genotype; Genetics; Biology; Antigen; Gene","score_opus":0.10726686854269771,"score_gpt":0.3945888557560094,"score_spread":0.2873219872133117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049686259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776718,0.007157693,0.000011291059,0.011303919,0.00032876251,0.0032703392,0.00015707234,0.00005099803,0.00004811463],"genre_scores_gemma":[0.9584001,0.004035657,0.00016736583,0.036650244,0.00032765555,0.00030785406,0.00004581368,0.000048599188,0.000016728989],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997228,0.00053870224,0.00070424075,0.0005750374,0.00045831525,0.00049565244],"domain_scores_gemma":[0.99832165,0.00019587849,0.00013168107,0.00033241295,0.000101935075,0.0009164306],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023569532,0.00025801844,0.0005290956,0.00017441873,0.00006513096,0.000011413298,0.00027674585,0.000034164455,0.00059418543],"category_scores_gemma":[0.0000048486927,0.00024927882,0.0001554091,0.0004246969,0.00016592567,0.000047662357,0.00032975213,0.00034334383,0.000074878786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008338538,0.009801163,0.9531732,0.00015639733,0.004848438,0.00087286945,0.0012112443,0.000053772237,0.0076118545,0.0000012259122,0.0021677376,0.011763552],"study_design_scores_gemma":[0.0145075945,0.025507107,0.9227456,0.00007986762,0.015303877,0.0000017138582,0.0021011822,0.00022951723,0.004454605,0.000013967629,0.014722657,0.00033231013],"about_ca_topic_score_codex":0.00027977378,"about_ca_topic_score_gemma":0.000069837726,"teacher_disagreement_score":0.030427607,"about_ca_system_score_codex":0.00015080757,"about_ca_system_score_gemma":0.00018675544,"threshold_uncertainty_score":0.99999595},"labels":[],"label_agreement":null},{"id":"W3067790092","doi":"10.1111/apt.16023","title":"Review article: pathophysiology and management of primary biliary cholangitis","year":2020,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Obeticholic acid; Intensive care medicine; Disease; Liver disease; Primary biliary cirrhosis; Primary sclerosing cholangitis; Clinical trial; Cholestasis; Internal medicine","score_opus":0.06581898063089268,"score_gpt":0.37413154617778854,"score_spread":0.30831256554689584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3067790092","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024547448,0.996093,8.969735e-7,0.0009795855,0.00029336495,0.002013561,0.00015812933,0.00003690825,0.00017911826],"genre_scores_gemma":[0.0000079130705,0.94895476,0.00021489857,0.05001668,0.000118884425,0.00012319433,0.00046918934,0.00004885064,0.000045647637],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99817365,0.00039553558,0.0006296548,0.00039650305,0.00013398346,0.0002706797],"domain_scores_gemma":[0.9990513,0.00010533464,0.000295348,0.00034287994,0.000038882914,0.00016628686],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013743412,0.00038209252,0.0018795064,0.00006810737,0.00005271397,0.000003693686,0.0002045937,0.00014330164,0.0004327858],"category_scores_gemma":[1.07984924e-7,0.0003057106,0.00038417935,0.00024428146,0.00021840516,0.00005118411,0.00032197766,0.0004258954,0.00004528545],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090690315,0.00041945284,0.0000403655,0.14468925,0.023344431,0.00024473193,0.000024003499,1.2460714e-8,0.00024296451,0.0000070244823,0.0027526286,0.82814443],"study_design_scores_gemma":[0.0008990265,0.00040141513,0.00028167473,0.015742898,0.1451415,0.0000950357,0.00001194488,0.0000017304916,0.000029660046,0.00001665573,0.8371678,0.00021065859],"about_ca_topic_score_codex":0.000007993275,"about_ca_topic_score_gemma":4.7086566e-8,"teacher_disagreement_score":0.8344152,"about_ca_system_score_codex":0.000105177394,"about_ca_system_score_gemma":0.00013489362,"threshold_uncertainty_score":0.9999395},"labels":[],"label_agreement":null},{"id":"W3080180919","doi":"10.1111/apt.16050","title":"Systematic review with meta‐analysis: comparative risk of lymphoma with anti‐tumour necrosis factor agents and/or thiopurines in patients with inflammatory bowel disease","year":2020,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Thiopurine methyltransferase; Internal medicine; Inflammatory bowel disease; Gastroenterology; Combination therapy; Cochrane Library; Lymphoma; Meta-analysis; Disease","score_opus":0.03373649248350878,"score_gpt":0.3177119768077463,"score_spread":0.2839754843242375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080180919","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.062411983,0.93131095,0.0000047414987,0.00003698006,0.00004283922,0.0050047543,0.001163678,0.00002026085,0.000003830625],"genre_scores_gemma":[0.025793763,0.97015566,0.00007783557,0.0019723158,0.000034387227,0.0009625153,0.0008745343,0.000104071245,0.000024898283],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99551004,0.0015693018,0.001151644,0.0009031001,0.00043615693,0.00042976456],"domain_scores_gemma":[0.997101,0.00010287541,0.001650286,0.00062176865,0.00020141923,0.0003226626],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021348285,0.001033789,0.0038756682,0.00022418586,0.00010131588,0.000024725983,0.00052349037,0.00017492991,0.00008891358],"category_scores_gemma":[0.000001391744,0.000589684,0.00067991647,0.00046884638,0.00034782922,0.000026256419,0.00018676436,0.00024793408,0.000005770767],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024724775,0.0007106168,0.038274992,0.25947577,0.6984099,0.00033988192,0.00013242355,0.000048897582,0.0000065506465,8.8350384e-7,0.00003646557,0.00009110468],"study_design_scores_gemma":[0.0025604996,0.0007044502,0.02070639,0.014153347,0.9588629,0.000008214079,0.00003397443,0.000019384539,0.000045349847,5.0089113e-7,0.0020770037,0.00082797906],"about_ca_topic_score_codex":0.000010143684,"about_ca_topic_score_gemma":0.000048410406,"teacher_disagreement_score":0.26045296,"about_ca_system_score_codex":0.000073529234,"about_ca_system_score_gemma":0.00054541253,"threshold_uncertainty_score":0.9996555},"labels":[],"label_agreement":null},{"id":"W3082374255","doi":"10.1111/apt.16060","title":"Long‐term safety of vedolizumab for inflammatory bowel disease","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":191,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bible College","funders":"Takeda Pharmaceutical Company","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Internal medicine; Discontinuation; Gastroenterology; Adverse effect; Inflammatory bowel disease; Crohn's disease; Disease","score_opus":0.019661955096939774,"score_gpt":0.292556701332228,"score_spread":0.2728947462352882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082374255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994112,0.0013819834,0.0006748988,0.0018605865,0.0004850811,0.0009851112,0.00039600173,0.00003550532,0.00006878778],"genre_scores_gemma":[0.97241664,0.00055974076,0.0002046354,0.025383424,0.00064003136,0.00011135993,0.00055098673,0.00006281915,0.00007036962],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985313,0.00013908574,0.00040802025,0.00041599196,0.0001416493,0.0003639804],"domain_scores_gemma":[0.9990855,0.000029597362,0.00017557591,0.00028097228,0.000102953316,0.00032538633],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000114739974,0.0002664924,0.00019118114,0.000034032037,0.00010687533,0.0000079563515,0.00037535417,0.000120932054,0.00019079866],"category_scores_gemma":[0.0000010509177,0.00028615168,0.00022205157,0.000047243335,0.00023222083,0.0000105867375,0.00015861976,0.00010677817,0.00001670515],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016926842,0.00035398043,0.13531835,0.00034714537,0.0062435935,0.00013053518,0.00027433413,0.00045772054,0.8364483,0.00007479232,0.0025074831,0.00091689645],"study_design_scores_gemma":[0.012673671,0.0010583376,0.40547934,0.000028577962,0.009376819,0.000009236667,0.000101640624,0.0013469256,0.5344274,0.00009519786,0.034381464,0.0010213965],"about_ca_topic_score_codex":7.7974187e-7,"about_ca_topic_score_gemma":0.0000022020054,"teacher_disagreement_score":0.30202094,"about_ca_system_score_codex":0.000030277082,"about_ca_system_score_gemma":0.0002284277,"threshold_uncertainty_score":0.99995905},"labels":[],"label_agreement":null},{"id":"W3087245797","doi":"10.1111/apt.16072","title":"Systematic review and network meta‐analysis: efficacy of drugs for functional dyspepsia","year":2020,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Placebo; Relative risk; Internal medicine; Meta-analysis; Adverse effect; Confidence interval; Randomized controlled trial; Alternative medicine","score_opus":0.1240390178918571,"score_gpt":0.39574519478207876,"score_spread":0.27170617689022164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087245797","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000014884678,0.9915199,0.00018832023,0.0020739404,0.00015209008,0.0058826865,0.00011924985,0.000037939455,0.000024339359],"genre_scores_gemma":[0.000017038326,0.97647315,0.00071912614,0.021345666,0.00013036987,0.00064169057,0.0005464303,0.00004810673,0.00007844138],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9970721,0.0005609293,0.0013035724,0.0005136642,0.00022037044,0.0003293639],"domain_scores_gemma":[0.99726474,0.0013537752,0.0007857812,0.00030798226,0.000114882845,0.00017286437],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056430005,0.00053390575,0.007403071,0.00014204909,0.00007862644,0.000007102012,0.0001853951,0.00014594171,0.0004129293],"category_scores_gemma":[0.0000028695322,0.00039119628,0.0025869033,0.0006309361,0.00017685216,0.000034832527,0.00007684653,0.00038222945,0.000012172381],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008940769,0.00015876905,0.0000029317193,0.45114028,0.5475806,0.0000046405034,0.000017433536,0.0000036281288,7.7577414e-7,0.000012892058,0.00037839304,0.0006102563],"study_design_scores_gemma":[0.00082425546,0.00046339154,0.000002462408,0.019756485,0.9157158,0.000084999425,0.000018393068,0.000032798118,0.0000010493554,0.000015736041,0.062902056,0.00018255638],"about_ca_topic_score_codex":0.000004062473,"about_ca_topic_score_gemma":0.0000010912158,"teacher_disagreement_score":0.4313838,"about_ca_system_score_codex":0.00005626231,"about_ca_system_score_gemma":0.00019287188,"threshold_uncertainty_score":0.99985397},"labels":[],"label_agreement":null},{"id":"W3088219274","doi":"10.1111/apt.16083","title":"Evaluating the optimum number of biopsies to assess histological inflammation in ulcerative colitis: a retrospective cohort study","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Crohn's and Colitis Foundation; American Gastroenterological Association","keywords":"Medicine; Biopsy; Ulcerative colitis; Histopathology; Confidence interval; Sampling (signal processing); Internal medicine; Gastroenterology; Prospective cohort study; Radiology; Pathology; Disease","score_opus":0.06482980748076186,"score_gpt":0.39164112307793664,"score_spread":0.3268113155971748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088219274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99573714,0.000043770073,0.000050329174,0.0018809394,0.00020289236,0.0018213196,0.00003467601,0.000015735855,0.00021319857],"genre_scores_gemma":[0.9899129,0.000030943916,0.00035032097,0.009082412,0.00019651826,0.00033181388,0.000048307014,0.000020729256,0.000026032305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977877,0.0008960001,0.00040533938,0.0004129037,0.00024308333,0.00025495683],"domain_scores_gemma":[0.9992873,0.00005492658,0.00016750592,0.00019803419,0.0002063589,0.00008587834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005998942,0.0002020621,0.00024622845,0.000030314322,0.000103111684,0.000012966618,0.00029391615,0.000094300696,0.00021540301],"category_scores_gemma":[0.0000074251707,0.00017051726,0.00006639002,0.00017124892,0.00016705293,0.000010916194,0.00019767346,0.00018632779,0.000017836903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024656723,0.00026432905,0.6584134,0.000009747079,0.0021679609,0.000046229936,0.0019514405,0.0012482606,0.3331269,0.00003113072,0.0001576297,0.00011726684],"study_design_scores_gemma":[0.002035897,0.0013153107,0.9272917,0.000005179165,0.0013721308,0.0000064298447,0.0015871722,0.0015701355,0.06437673,0.00003890708,0.00016830699,0.00023211239],"about_ca_topic_score_codex":0.000023433331,"about_ca_topic_score_gemma":0.00006031672,"teacher_disagreement_score":0.26887825,"about_ca_system_score_codex":0.00010727779,"about_ca_system_score_gemma":0.000117383424,"threshold_uncertainty_score":0.6953492},"labels":[],"label_agreement":null},{"id":"W3088249120","doi":"10.1111/apt.16075","title":"Exposure sources, amounts and time course of gluten ingestion and excretion in patients with coeliac disease on a gluten‐free diet","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria General Hospital; St. Boniface Hospital; University of Manitoba","funders":"Institute of Nutrition, Metabolism and Diabetes; National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Association of Gastroenterology; Manitoba Health Research Council; Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España; Canadian Celiac Association; Harvard Medical School","keywords":"Medicine; Gluten; Ingestion; Coeliac disease; Urine; Gluten free; Asymptomatic; Population; Excretion; Cohort; Gastroenterology; Physiology; Internal medicine; Disease; Environmental health; Pathology","score_opus":0.013380164878595743,"score_gpt":0.2713313004122899,"score_spread":0.2579511355336942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088249120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872787,0.0017494675,0.0000039757597,0.009830855,0.000035531993,0.0009193242,0.00011904278,0.000023238681,0.000039863375],"genre_scores_gemma":[0.9869464,0.0012333749,0.000042060637,0.011367007,0.00005285761,0.000035404944,0.00028073258,0.000020589227,0.000021578095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989306,0.00010847861,0.0001792479,0.00027861705,0.00027147372,0.00023161189],"domain_scores_gemma":[0.99936914,0.000048741946,0.00007064828,0.00013359336,0.000054247314,0.00032364164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098551194,0.00016490772,0.00023120736,0.00007869915,0.00004425904,0.000008767461,0.00007148243,0.000035676214,0.000102067155],"category_scores_gemma":[9.604705e-7,0.00013603052,0.000026200414,0.00011932483,0.00018951161,0.00007906513,0.00010094711,0.00015370517,0.0000044890403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04303512,0.0019775212,0.9401766,0.0003242482,0.0031557695,0.00012391806,0.000588031,0.000033599743,0.0033291648,0.000022492974,0.0015848002,0.005648749],"study_design_scores_gemma":[0.015267474,0.0065904525,0.9693582,0.000113011585,0.0038297784,0.0000012566246,0.00013107619,0.0013123556,0.0012302941,0.000042607182,0.0019347855,0.00018870103],"about_ca_topic_score_codex":0.000016066904,"about_ca_topic_score_gemma":0.0000029215573,"teacher_disagreement_score":0.02918162,"about_ca_system_score_codex":0.00004730888,"about_ca_system_score_gemma":0.000050947143,"threshold_uncertainty_score":0.55471635},"labels":[],"label_agreement":null},{"id":"W3092035844","doi":"10.1046/j.1365-2036.2003.01743.x","title":"Oral esomeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects","year":2003,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); McMaster University; Hamilton Health Sciences","funders":"AstraZeneca Canada","keywords":"Esomeprazole; Pantoprazole; Medicine; Crossover study; Proton-pump inhibitor; Gastroenterology; Internal medicine; Oral administration; Washout; Adverse effect; Pharmacology; Omeprazole","score_opus":0.02768127138127984,"score_gpt":0.3543726217825647,"score_spread":0.32669135040128483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092035844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99595904,0.0007418901,0.0000040188834,0.00090053835,0.00082330435,0.0011939842,0.000016744665,0.000028717706,0.00033178364],"genre_scores_gemma":[0.98895794,0.000119189805,0.000108309134,0.010603862,0.0000495094,0.000059600326,0.000027997292,0.000034229415,0.000039350736],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977081,0.0005941773,0.00047730884,0.0003377923,0.00031328376,0.0005693704],"domain_scores_gemma":[0.999097,0.00023534894,0.00019235289,0.00030422595,0.000031684016,0.00013941678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000309454,0.00031167574,0.0006250549,0.00017550953,0.00010610547,0.000005956569,0.00018081808,0.00012534602,0.00021099477],"category_scores_gemma":[0.0000013868244,0.00021533355,0.00013144517,0.00045773064,0.00017396554,0.000043910422,0.000038971477,0.0005747772,0.00004157501],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033318389,0.0032698913,0.9597111,0.000074897296,0.003022651,0.00023781008,0.0005841223,0.000107186606,0.021953877,0.000030039217,0.00015061705,0.007526004],"study_design_scores_gemma":[0.020974489,0.02094431,0.34195957,0.000055431225,0.005416994,0.0001496682,0.00010065706,0.00019470492,0.6088735,0.000041469146,0.0011184919,0.00017071443],"about_ca_topic_score_codex":0.000042403917,"about_ca_topic_score_gemma":0.00001376985,"teacher_disagreement_score":0.6177515,"about_ca_system_score_codex":0.0002684124,"about_ca_system_score_gemma":0.00013816972,"threshold_uncertainty_score":0.87810475},"labels":[],"label_agreement":null},{"id":"W3093557857","doi":"10.1111/apt.16098","title":"Editorial: is age just a number when it comes to treatment of inflammatory bowel disease?","year":2020,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Inflammatory bowel disease; Disease; MEDLINE; Inflammatory Bowel Diseases; Gastroenterology; Internal medicine","score_opus":0.018470579076622994,"score_gpt":0.3203437808497691,"score_spread":0.30187320177314614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093557857","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02942166,0.0010379729,0.000006806158,0.0022750648,0.96191424,0.0015531913,0.0035485798,0.000062428175,0.00018004637],"genre_scores_gemma":[0.0023919535,0.0028964845,0.00015261219,0.013798473,0.97424316,0.00042988494,0.004307878,0.00023596782,0.001543583],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961982,0.00039497015,0.00083240826,0.0010913181,0.0007878989,0.00069521245],"domain_scores_gemma":[0.9976055,0.00013463381,0.00043493373,0.0008132287,0.00031979408,0.00069190044],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000161084,0.0009247319,0.0007133966,0.00010059733,0.00014845363,0.00004045193,0.0008334547,0.0009744433,0.0007670893],"category_scores_gemma":[0.0000035297899,0.0009531689,0.00054151827,0.00008395652,0.0003123778,0.000013020997,0.00037664612,0.00038617602,0.00025864918],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004352718,0.00059680274,0.0019646618,0.00019657181,0.012172628,0.0003540497,0.0008399566,0.00002110741,0.032346983,0.0000015781701,0.94704354,0.000109408094],"study_design_scores_gemma":[0.003339969,0.0006845189,0.0002765926,0.00003439158,0.010294926,0.0000011101178,0.000083600265,0.000007755631,0.015702253,0.00002747294,0.9687582,0.0007891723],"about_ca_topic_score_codex":0.000037183345,"about_ca_topic_score_gemma":0.000028775748,"teacher_disagreement_score":0.027029706,"about_ca_system_score_codex":0.00027083635,"about_ca_system_score_gemma":0.0011324324,"threshold_uncertainty_score":0.9992919},"labels":[],"label_agreement":null},{"id":"W3093715541","doi":"10.1111/apt.16119","title":"Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bible College","funders":"Janssen Research and Development; National Institute of Diabetes and Digestive and Kidney Diseases; United European Gastroenterology; European Crohn's and Colitis Organisation","keywords":"Medicine; Ustekinumab; Placebo; Adverse effect; Ulcerative colitis; Maintenance therapy; Internal medicine; Colonoscopy; Intention-to-treat analysis; Randomized controlled trial; Surgery; Randomization; Colorectal cancer; Chemotherapy; Infliximab; Cancer","score_opus":0.02135319283023908,"score_gpt":0.30384583331998777,"score_spread":0.2824926404897487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093715541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994732,0.0010810398,0.00043408858,0.0017815253,0.00020772572,0.0012834102,0.00035226395,0.0000117771915,0.00011613839],"genre_scores_gemma":[0.9385788,0.001827066,0.0006658915,0.058359902,0.00022934448,0.00016999227,0.00007979905,0.000034974382,0.000054218046],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99895877,0.00015715332,0.00020401107,0.00035123542,0.000079561185,0.00024928642],"domain_scores_gemma":[0.99952763,0.000057142817,0.000116037045,0.00012789437,0.000090827634,0.00008043623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008675045,0.00018162924,0.00019796724,0.000014548219,0.000066645516,0.0000071262766,0.00015145387,0.000106597385,0.00009205754],"category_scores_gemma":[6.8968257e-7,0.00019084744,0.000098804914,0.00004873171,0.00025835863,0.000009927783,0.000071556184,0.000083147555,0.000004137486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013811432,0.00023946817,0.0038384502,0.00008586765,0.009231709,0.000045540644,0.004044306,0.000037524638,0.95306957,0.00017917897,0.007532781,0.007884165],"study_design_scores_gemma":[0.009020052,0.001961469,0.034727886,0.00001073287,0.0013097638,0.000010316675,0.00041488963,0.00031154294,0.8621626,0.0003156652,0.08936539,0.0003896832],"about_ca_topic_score_codex":0.000007790158,"about_ca_topic_score_gemma":0.0000038361886,"teacher_disagreement_score":0.09090697,"about_ca_system_score_codex":0.000019877729,"about_ca_system_score_gemma":0.00006334265,"threshold_uncertainty_score":0.77825326},"labels":[],"label_agreement":null},{"id":"W3096728261","doi":"10.1111/apt.16123","title":"Real‐world clinical and virological outcomes in a retrospective multiethnic cohort study of 341 untreated and tenofovir disoproxil fumarate‐treated chronic hepatitis B pregnant patients in North America","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Medicine; Pregnancy; HBeAg; Retrospective cohort study; Obstetrics; HBsAg; Cohort; Hepatitis B; Cohort study; Internal medicine; Hepatitis B virus; Immunology; Virus","score_opus":0.04055863522992777,"score_gpt":0.3523803286955787,"score_spread":0.311821693465651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096728261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948854,0.0007332764,4.975622e-7,0.0010108048,0.000107167965,0.003098503,0.000084806765,0.000049584996,0.000029951667],"genre_scores_gemma":[0.97653633,0.019308733,0.000052006995,0.0037262943,0.000037546968,0.00020808807,0.00007619573,0.000034377805,0.000020428657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969,0.0006778755,0.0009891046,0.00073289167,0.000264459,0.00043562189],"domain_scores_gemma":[0.998993,0.00030603562,0.00025023244,0.00018556922,0.00009109945,0.00017406265],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018896173,0.00037160373,0.0013235225,0.00017735157,0.00007298366,0.0000059007925,0.00011491481,0.000120859964,0.0000730597],"category_scores_gemma":[0.0000056923113,0.00029778152,0.00006507192,0.00059007906,0.0006395973,0.000085021966,0.00024231299,0.00057018653,0.000005085087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013531408,0.0039517004,0.9847512,0.000035651665,0.004686329,0.00019792352,0.0029658526,0.000006707008,0.0005590606,4.7520243e-7,0.000020903215,0.0014710174],"study_design_scores_gemma":[0.013275212,0.009533768,0.972697,0.000030023377,0.0028517065,0.0000014057474,0.0001682069,0.0010194267,0.00016227418,0.000004075142,0.00003162992,0.00022528168],"about_ca_topic_score_codex":0.013798131,"about_ca_topic_score_gemma":0.061532944,"teacher_disagreement_score":0.047734812,"about_ca_system_score_codex":0.00027602486,"about_ca_system_score_gemma":0.00007056528,"threshold_uncertainty_score":0.9999474},"labels":[],"label_agreement":null},{"id":"W3097717312","doi":"10.1111/apt.16142","title":"The significance of histological activity measurements in immune checkpoint inhibitor colitis","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Colitis; Microscopic colitis; Medicine; Internal medicine; Gastroenterology; Odds ratio; Colectomy; Adverse effect; Ulcerative colitis; Biopsy; Ischemic colitis; Collagenous colitis; Colorectal cancer; Inflammatory bowel disease; Cancer; Disease","score_opus":0.08620234354203679,"score_gpt":0.3363254510010588,"score_spread":0.250123107459022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097717312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96225345,0.005128487,0.000014889864,0.030813659,0.0005761045,0.00091554626,0.000014567413,0.000030916894,0.00025236575],"genre_scores_gemma":[0.9823544,0.0014882651,0.000076782686,0.015801096,0.00012820814,0.00007700813,0.00000751708,0.000017580895,0.000049122722],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984378,0.0002617674,0.00046137054,0.00025871032,0.0002603152,0.0003200363],"domain_scores_gemma":[0.9993544,0.00014530862,0.00019756827,0.00016196963,0.000056830788,0.000083928346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040043786,0.00017988225,0.00035685758,0.000035409234,0.000097682045,0.0000058745727,0.00019624646,0.00009591359,0.00029766804],"category_scores_gemma":[9.410093e-7,0.0001328478,0.0001509879,0.00024554427,0.0004281857,0.000050786184,0.000054094387,0.00031366578,0.00000766153],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013114881,0.00043625393,0.010296366,0.00003695304,0.0028393911,0.000018973455,0.00044016546,0.0000033949793,0.9658812,0.0000033872916,0.00027163263,0.006657372],"study_design_scores_gemma":[0.0058872662,0.0011477515,0.062961355,0.00002275379,0.0012520466,0.000012917895,0.00018175451,0.00014946821,0.91049576,0.0000161492,0.017727122,0.0001456309],"about_ca_topic_score_codex":0.00015909945,"about_ca_topic_score_gemma":0.000024700594,"teacher_disagreement_score":0.055385448,"about_ca_system_score_codex":0.0002604734,"about_ca_system_score_gemma":0.00015553588,"threshold_uncertainty_score":0.5417376},"labels":[],"label_agreement":null},{"id":"W3097809518","doi":"10.1111/apt.16147","title":"Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Ulcerative colitis; Complete remission; Spontaneous remission; Gastroenterology; Colitis; Internal medicine; Pathology; Disease; Chemotherapy; Alternative medicine","score_opus":0.02134010759586439,"score_gpt":0.285651686375515,"score_spread":0.2643115787796506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097809518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935998,0.00010777197,0.000042991105,0.0025800716,0.00050116424,0.0009104493,0.0021103949,0.000024711891,0.00012267416],"genre_scores_gemma":[0.94822556,0.00024042305,0.0006290426,0.045303315,0.00041327917,0.00028932176,0.004564474,0.000040010036,0.0002945936],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984988,0.00016407314,0.00033927715,0.0005008532,0.000147154,0.0003498325],"domain_scores_gemma":[0.99936897,0.00006772529,0.00013567026,0.00014094144,0.00010937448,0.00017730819],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008423757,0.00024985458,0.00019690304,0.000041919233,0.00014072614,0.00000971234,0.00022333593,0.00019159046,0.0016698475],"category_scores_gemma":[0.0000032421003,0.00021878186,0.00010369053,0.000057076973,0.0001121139,0.0000127279445,0.000111209825,0.00014973308,0.000014374468],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010836905,0.00074860075,0.04833394,0.0001004858,0.0016109365,0.00008037156,0.0004075386,0.00014151166,0.90457064,0.000062172854,0.03107543,0.002031473],"study_design_scores_gemma":[0.010039272,0.0012965248,0.16639583,0.000039424136,0.0011249246,0.0000030464048,0.000119635355,0.0010663837,0.67730993,0.00030796594,0.14165424,0.0006428518],"about_ca_topic_score_codex":0.0000052065866,"about_ca_topic_score_gemma":0.000020559937,"teacher_disagreement_score":0.22726072,"about_ca_system_score_codex":0.00010212796,"about_ca_system_score_gemma":0.00010815251,"threshold_uncertainty_score":0.9992428},"labels":[],"label_agreement":null},{"id":"W3110489661","doi":"10.1111/apt.16172","title":"Hepatitis B virus RNA decline without concomitant viral antigen decrease is associated with a low probability of sustained response and hepatitis B surface antigen loss","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Stichting voor Lever- en Maag-Darm Onderzoek; Gilead Sciences; Bristol-Myers Squibb","keywords":"HBsAg; HBeAg; Medicine; Hepatitis B virus; Concomitant; Hepatitis B; Viral load; Immunology; Antigen; Virology; Virus; Internal medicine; Gastroenterology","score_opus":0.029151402839279222,"score_gpt":0.3116485763925301,"score_spread":0.2824971735532509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110489661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798243,0.0017796109,0.00008649153,0.015358528,0.00013186008,0.0018606688,0.00069689995,0.00024053678,0.000021120135],"genre_scores_gemma":[0.94282067,0.009993376,0.001162648,0.04567495,0.000077738245,0.00003853407,0.00008093521,0.00011863538,0.000032543197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964122,0.0009017192,0.00080913544,0.0006961688,0.0005145213,0.00066626683],"domain_scores_gemma":[0.9976666,0.00062446424,0.00041829242,0.00031735693,0.0004664724,0.0005068011],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006886823,0.0005171669,0.0011645374,0.00008295458,0.00022975424,0.00001950115,0.0002193713,0.00019678916,0.00026748597],"category_scores_gemma":[0.000028760742,0.0004594959,0.00013558903,0.00040041617,0.0010565866,0.00017121842,0.00026042288,0.00041177735,0.000012386425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012059177,0.0006869246,0.787474,0.00009654554,0.009149066,0.0005854333,0.0027853965,0.000009924142,0.18662784,0.0000045155844,0.00036726834,0.0001539114],"study_design_scores_gemma":[0.0119305905,0.0052157855,0.60567135,0.00014632649,0.0063166553,0.00006160127,0.00015256702,0.0028233284,0.3659038,0.00009616269,0.0010770698,0.000604789],"about_ca_topic_score_codex":0.0057753166,"about_ca_topic_score_gemma":0.0023597092,"teacher_disagreement_score":0.18180266,"about_ca_system_score_codex":0.0002933187,"about_ca_system_score_gemma":0.000615815,"threshold_uncertainty_score":0.99978566},"labels":[],"label_agreement":null},{"id":"W3110951267","doi":"10.1111/apt.16184","title":"Derivation and validation of a novel method to subgroup patients with functional dyspepsia: beyond upper gastrointestinal symptoms","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Cohort; Nausea; Internal medicine; Latent class model; Cluster (spacecraft); Epigastric pain; Postprandial; Cohort study; Depression (economics); Vomiting","score_opus":0.030219257844291324,"score_gpt":0.2928911057146947,"score_spread":0.2626718478704034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110951267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91587377,0.000030764324,0.07330785,0.010046461,0.000056406992,0.00057932775,0.0000299978,0.000033316686,0.000042103493],"genre_scores_gemma":[0.8902558,0.000003083807,0.07852045,0.030914592,0.000067708934,0.000019524205,0.00018865154,0.000021487223,0.000008725151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891657,0.000067328416,0.00026575386,0.00030159642,0.00023871523,0.00021004994],"domain_scores_gemma":[0.99931717,0.00012043946,0.00010895991,0.00008094863,0.00018826802,0.00018420514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010823886,0.00017948498,0.0002342224,0.00008080425,0.00006216913,0.0000070989554,0.000056988778,0.000032977787,0.00021787324],"category_scores_gemma":[0.0000018415693,0.00015956309,0.000041101346,0.00020873612,0.00010472104,0.00010721142,0.00004703293,0.00017015511,0.000005158113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005523706,0.00088978384,0.74051964,0.000059702474,0.0010149005,0.0000037575373,0.00032074904,0.0003706844,0.24997306,0.000042398107,0.00012561539,0.001155984],"study_design_scores_gemma":[0.014408057,0.012469462,0.9148103,0.00008326088,0.0057535055,0.00022060562,0.00035237073,0.003276805,0.04797901,0.000055857316,0.00033972153,0.0002510288],"about_ca_topic_score_codex":0.000013560898,"about_ca_topic_score_gemma":0.0000011697266,"teacher_disagreement_score":0.20199405,"about_ca_system_score_codex":0.000040990846,"about_ca_system_score_gemma":0.000053717253,"threshold_uncertainty_score":0.65067935},"labels":[],"label_agreement":null},{"id":"W3115436888","doi":"10.1111/apt.16183","title":"Letter: rates and determinants of significant liver inflammation in chronic hepatitis B virus‐infected patients with low ALT levels in the absence of significant fibrosis—authors' reply","year":2020,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre; University Health Network","funders":"","keywords":"Medicine; Chronic hepatitis; Fibrosis; Gastroenterology; Liver fibrosis; Internal medicine; Hepatitis B virus; Inflammation; Virus; Virology","score_opus":0.028758390426396916,"score_gpt":0.2953236483904777,"score_spread":0.26656525796408076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115436888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9430602,0.0006731046,0.0000061934743,0.053395603,0.00020895852,0.0022304452,0.00039777195,0.000020853337,0.0000068717613],"genre_scores_gemma":[0.7455656,0.0029659753,0.000113816815,0.25056407,0.00035311803,0.00014547151,0.00022531397,0.00005668846,0.000009939211],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964943,0.0007758719,0.001089316,0.0005854188,0.00054897537,0.0005061075],"domain_scores_gemma":[0.9980267,0.0006587051,0.00074258633,0.00034371292,0.00017374594,0.000054508426],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029635712,0.000510442,0.0010579957,0.00029832876,0.00007128413,0.000012652554,0.00029509736,0.00029309426,0.00011854314],"category_scores_gemma":[0.0000040477594,0.00038413866,0.000089282614,0.00041693827,0.0006576116,0.00013535091,0.00011890785,0.0011755041,0.000006362237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005327695,0.00028258387,0.8594895,0.0010831131,0.0019908804,0.0008033026,0.0031500887,0.0000128763195,0.11671673,4.4637932e-7,0.014642161,0.001295562],"study_design_scores_gemma":[0.0044458555,0.0027994022,0.8051391,0.00086421723,0.0029469344,0.000010651586,0.000027403748,0.0007286939,0.17329878,0.000013738235,0.009225479,0.0004997432],"about_ca_topic_score_codex":0.005260664,"about_ca_topic_score_gemma":0.00194291,"teacher_disagreement_score":0.19749458,"about_ca_system_score_codex":0.00031063412,"about_ca_system_score_gemma":0.0002696169,"threshold_uncertainty_score":0.99986106},"labels":[],"label_agreement":null},{"id":"W3116793093","doi":"10.1111/apt.16139","title":"Editorial: acid suppression with potassium‐competitive acid blockers dismissing genotype concerns","year":2020,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Potassium; Genotype; Pharmacology; Internal medicine; Gastroenterology; Endocrinology; Biochemistry; Gene; Biology; Chemistry","score_opus":0.01922098274512315,"score_gpt":0.32681563453926454,"score_spread":0.3075946517941414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116793093","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035666123,0.0018707878,0.000016909251,0.0024164647,0.9892769,0.0013279634,0.0008782166,0.00022268473,0.0004234968],"genre_scores_gemma":[0.052254356,0.0009651686,0.001155172,0.0051149805,0.93477505,0.00012254601,0.0047574593,0.0002395409,0.00061570277],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956883,0.00031697255,0.00058993674,0.001115661,0.0013670973,0.0009220328],"domain_scores_gemma":[0.99778086,0.00033338598,0.00047723655,0.00043483792,0.00036594732,0.00060773053],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014425641,0.0010249825,0.0012459606,0.00014864677,0.00032730767,0.000061616134,0.00041956367,0.00102871,0.0010318137],"category_scores_gemma":[0.0000021456322,0.00080039696,0.00027531144,0.00023208003,0.00044900508,0.00015498715,0.00021913729,0.0021671143,0.00021143067],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042867316,0.00065585045,0.0011530068,0.00013289081,0.02389347,0.0015658849,0.0004641606,0.0000017339245,0.045397095,0.0000010815902,0.92193514,0.00051297236],"study_design_scores_gemma":[0.010611178,0.0036056133,0.000096145166,0.00016704576,0.03869538,0.000027908063,0.000100584366,0.000012632163,0.10096509,0.000010370419,0.845309,0.000399045],"about_ca_topic_score_codex":0.000027786738,"about_ca_topic_score_gemma":0.0000028484153,"teacher_disagreement_score":0.076626115,"about_ca_system_score_codex":0.00063144177,"about_ca_system_score_gemma":0.00089580636,"threshold_uncertainty_score":0.9998814},"labels":[],"label_agreement":null},{"id":"W3118597865","doi":"10.1111/apt.16248","title":"An expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trials","year":2021,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bible College","funders":"","keywords":"Medicine; Crohn's disease; Clinical trial; Disease; Biopsy; Internal medicine; Histopathology; Pathology; Gastroenterology","score_opus":0.10174819907174622,"score_gpt":0.4779789360575919,"score_spread":0.3762307369858457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118597865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906526,0.0013787738,0.00023897368,0.0055126697,0.00085216336,0.00087184546,0.00042930638,0.000016017118,0.000047621845],"genre_scores_gemma":[0.97510195,0.00068814785,0.00038203923,0.023122307,0.0003368926,0.0001553622,0.00014627156,0.00002868859,0.000038317598],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9930507,0.0049083116,0.0007729438,0.0006304276,0.0002616914,0.0003759493],"domain_scores_gemma":[0.9980358,0.0003303087,0.00024603296,0.000686366,0.00015017735,0.0005513099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020451644,0.0002713675,0.00047205348,0.000046178062,0.00011774866,0.000018570854,0.00034450376,0.00013404619,0.0003002497],"category_scores_gemma":[0.000021811633,0.00021589808,0.00032660426,0.00010861634,0.00042278873,0.000007832102,0.00021738744,0.0002476161,0.0000036662025],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020535097,0.004855314,0.2460068,0.000045051947,0.0040940633,0.0041810316,0.00013346205,0.0010979015,0.7107406,0.00009288506,0.0037713088,0.004446424],"study_design_scores_gemma":[0.0040129647,0.00037123964,0.9557809,0.000014202188,0.00263577,0.000004884235,0.00015290608,0.00087374204,0.023574766,0.00008715758,0.012117628,0.0003738002],"about_ca_topic_score_codex":0.000008836214,"about_ca_topic_score_gemma":0.000032695174,"teacher_disagreement_score":0.70977414,"about_ca_system_score_codex":0.000088173285,"about_ca_system_score_gemma":0.0010726019,"threshold_uncertainty_score":0.8804068},"labels":[],"label_agreement":null},{"id":"W3121089146","doi":"10.1111/apt.16207","title":"Keep calm and carry on—managing non‐TNF antagonist biologics in pregnancy","year":2021,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Pregnancy; Antagonist; Carry (investment); Internal medicine; Genetics","score_opus":0.036802424867047746,"score_gpt":0.2947696672250619,"score_spread":0.25796724235801416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121089146","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.063277796,0.39727885,0.000019785944,0.508741,0.021949742,0.0033529063,0.000688188,0.0002497991,0.004441914],"genre_scores_gemma":[0.09201915,0.018098194,0.00006233522,0.87774324,0.0015650323,0.00034661754,0.002839111,0.00016974228,0.0071565625],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950632,0.0015120405,0.0007537297,0.0015185134,0.000087988345,0.0010645505],"domain_scores_gemma":[0.998388,0.00042180892,0.00036584953,0.0007064695,0.00008361578,0.00003426112],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00029839767,0.00082978106,0.0011215642,0.0003332531,0.00031624443,0.00003543001,0.00056391297,0.0015991728,0.00077299896],"category_scores_gemma":[6.741312e-7,0.00076547894,0.00020357266,0.00025424655,0.0006961394,0.00009837399,0.000321066,0.0030547604,0.00019906368],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058796053,0.001195673,0.03406378,0.001274558,0.044209223,0.0084118135,0.003941757,0.000032793367,0.42315513,0.000064977394,0.46313053,0.019931804],"study_design_scores_gemma":[0.0056521907,0.0011734369,0.002567597,0.001295952,0.0064768055,0.00078283943,0.0005098312,0.000005961953,0.10241996,0.00044686612,0.8768393,0.0018292652],"about_ca_topic_score_codex":0.00020114033,"about_ca_topic_score_gemma":0.000020211088,"teacher_disagreement_score":0.41370878,"about_ca_system_score_codex":0.00019776111,"about_ca_system_score_gemma":0.00015219179,"threshold_uncertainty_score":0.99969697},"labels":[],"label_agreement":null},{"id":"W3122068315","doi":"10.1111/apt.16219","title":"Editorial: microRNAs for the diagnosis of fatty liver disease in the population—are we inching closer towards the target?","year":2021,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"H2020 Health; Instituto de Salud Carlos III; Canadian Association for the Study of the Liver","keywords":"Zhàng; Medicine; Fatty liver; Population; microRNA; Disease; Internal medicine; Gene; Genetics; Environmental health","score_opus":0.027104288561653974,"score_gpt":0.32476129468060866,"score_spread":0.2976570061189547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3122068315","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02542754,0.04758307,0.000116041745,0.0075795357,0.91506094,0.0022766066,0.0019398876,0.000012666912,0.000003734226],"genre_scores_gemma":[0.03789532,0.01899594,0.00015495658,0.0038723426,0.9335251,0.0010421199,0.0043460643,0.000098124314,0.00007002642],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971045,0.0008618657,0.00055786903,0.0005506569,0.00053142384,0.00039367488],"domain_scores_gemma":[0.99741113,0.0010129809,0.00052942504,0.00069194235,0.00029198176,0.00006255661],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00080507074,0.0004303392,0.00035335487,0.00005501109,0.00032496714,0.000055223016,0.0010990546,0.00056225114,0.000080929436],"category_scores_gemma":[0.000015194025,0.00026559888,0.0003916149,0.00016330212,0.00025325426,0.000012496597,0.00030358793,0.0005851045,0.0000014836493],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006350904,0.00035530742,0.003385729,0.00014747739,0.0037852034,0.000005659635,0.0002651952,0.00046134408,0.018046374,0.000004139434,0.9725108,0.0003976752],"study_design_scores_gemma":[0.0011513766,0.000094318006,0.0027399193,0.00005318634,0.005231475,7.858825e-7,0.00013392339,0.000121615514,0.020257931,0.00009809335,0.9698209,0.0002964421],"about_ca_topic_score_codex":0.00028027772,"about_ca_topic_score_gemma":0.000121879195,"teacher_disagreement_score":0.028587129,"about_ca_system_score_codex":0.000112071604,"about_ca_system_score_gemma":0.00039089893,"threshold_uncertainty_score":0.9999796},"labels":[],"label_agreement":null},{"id":"W3122710640","doi":"10.1111/apt.16233","title":"Editorial: HBV cure—the quest for biomarkers to predict off‐treatment sustained response. Authors' reply","year":2021,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Medicine; Intensive care medicine; Internal medicine","score_opus":0.02730043074009421,"score_gpt":0.373111005925477,"score_spread":0.34581057518538283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3122710640","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001318904,0.006981131,0.00002372507,0.06298919,0.9206386,0.005506569,0.002212586,0.00026432754,0.00006496793],"genre_scores_gemma":[0.0002105382,0.010716995,0.00056106196,0.023788463,0.95439917,0.0025788392,0.0023513502,0.00029748434,0.0050960965],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934227,0.0014284394,0.0011516166,0.001430925,0.0012591338,0.001307197],"domain_scores_gemma":[0.9908829,0.0057600415,0.0004569901,0.0010847587,0.001342427,0.000472903],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020767807,0.0011096869,0.0015466178,0.00034265948,0.0007046151,0.00007603424,0.00060563424,0.0011577425,0.0002642979],"category_scores_gemma":[0.00007769959,0.0008697264,0.0006169644,0.0004911401,0.0004628003,0.000090021116,0.00036442946,0.0011109024,0.000059741385],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019202229,0.00087985443,0.00028683827,0.00013329684,0.047974773,0.00019298632,0.0012911186,0.000003452581,0.008219628,0.000002506692,0.9209776,0.0008357499],"study_design_scores_gemma":[0.0069160867,0.006811926,0.000048077083,0.00015063018,0.036511973,0.000012217268,0.00038269465,0.000030156263,0.006415889,0.00001991042,0.9420683,0.0006321874],"about_ca_topic_score_codex":0.0010591473,"about_ca_topic_score_gemma":0.0005169466,"teacher_disagreement_score":0.039200727,"about_ca_system_score_codex":0.002799168,"about_ca_system_score_gemma":0.0031931011,"threshold_uncertainty_score":0.99937534},"labels":[],"label_agreement":null},{"id":"W3127624277","doi":"10.1111/apt.16235","title":"Editorial: will clusters for anxiety, depression, sleep disturbance and fatigue symptoms predict treatment outcomes in functional dyspepsia?","year":2021,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health; University of Alberta; Alberta Health Services","funders":"","keywords":"Medicine; Depression (economics); Anxiety; Sleep disorder; Disturbance (geology); Depressive symptoms; Psychiatry; Gerontology; Physical therapy; Clinical psychology; Intensive care medicine; Insomnia","score_opus":0.021333685180292283,"score_gpt":0.3187451508812542,"score_spread":0.29741146570096194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127624277","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02220254,0.0035993902,0.00020126662,0.0026863632,0.968459,0.0020107725,0.00071775523,0.000088416644,0.000034502424],"genre_scores_gemma":[0.012468056,0.0033362429,0.00058372685,0.0038387042,0.9729896,0.0008221711,0.0051798006,0.00013238635,0.0006492849],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969568,0.00020113811,0.00065724493,0.0009620941,0.0006090703,0.00061364606],"domain_scores_gemma":[0.9975967,0.001331307,0.00025418302,0.0003328623,0.00025337425,0.00023158471],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023821663,0.0006856139,0.0010317288,0.00016041989,0.00016956941,0.000034205914,0.00017387113,0.00069907046,0.00013250101],"category_scores_gemma":[0.000009922624,0.0005939268,0.0002783584,0.00013592279,0.00029257327,0.0001533752,0.00012264734,0.000781188,0.0000023218154],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004461368,0.0019215164,0.13389221,0.0002519994,0.008751114,0.00003285547,0.0002464313,0.00011566257,0.0007971784,0.0000013618825,0.848287,0.0012412997],"study_design_scores_gemma":[0.022182249,0.0032681522,0.00841601,0.00023754615,0.01650372,0.000029004963,0.00021800387,0.0006148564,0.00048667192,0.000081855986,0.94742316,0.0005387416],"about_ca_topic_score_codex":0.00013827377,"about_ca_topic_score_gemma":0.00010697893,"teacher_disagreement_score":0.12547621,"about_ca_system_score_codex":0.00059012044,"about_ca_system_score_gemma":0.00043248234,"threshold_uncertainty_score":0.9996512},"labels":[],"label_agreement":null},{"id":"W3127938899","doi":"10.1111/apt.16253","title":"Editorial: is hyperbaric oxygen a therapeutic opportunity for refractory perianal Crohn's disease?","year":2021,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut du Savoir Montfort; Francophone University Association; University of British Columbia; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Hyperbaric oxygen; Medicine; Refractory (planetary science); Crohn's disease; Crohn disease; Disease; Hyperbaric oxygenation; Surgery; Internal medicine","score_opus":0.020022097334064196,"score_gpt":0.31307012269392637,"score_spread":0.2930480253598622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127938899","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0072294236,0.009080366,0.000054290245,0.00086678634,0.9764054,0.0015555953,0.0046304413,0.00007899709,0.00009874359],"genre_scores_gemma":[0.0015420193,0.0061411858,0.0001173104,0.021441346,0.9536381,0.0007672198,0.013649279,0.00033556434,0.0023680024],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949872,0.0007180098,0.0008023261,0.0015463565,0.000877151,0.0010689623],"domain_scores_gemma":[0.9964101,0.0002715563,0.00053345284,0.0011327631,0.000883295,0.00076885195],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00059294864,0.0010664425,0.00073971396,0.0001415018,0.00046942363,0.00011549143,0.0011049147,0.001734746,0.0010065099],"category_scores_gemma":[0.000011014222,0.0011624546,0.00080786063,0.00013092575,0.00039803854,0.000023633527,0.00042953365,0.0010144756,0.000038892722],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039860113,0.0006807601,0.00008694589,0.00022190463,0.014454305,0.00027867366,0.000097935445,0.000008937182,0.045012377,0.000002644686,0.9348524,0.00031708917],"study_design_scores_gemma":[0.0033229268,0.00037095905,0.0003378704,0.000031119005,0.013272606,0.0000028357977,0.00008833581,0.00003915055,0.0029314293,0.00009607006,0.9783632,0.0011434545],"about_ca_topic_score_codex":0.000021484355,"about_ca_topic_score_gemma":0.000017148235,"teacher_disagreement_score":0.04351083,"about_ca_system_score_codex":0.00028139495,"about_ca_system_score_gemma":0.004452238,"threshold_uncertainty_score":0.9999067},"labels":[],"label_agreement":null},{"id":"W3128515318","doi":"10.1111/apt.16245","title":"Editorial: the microscope holds the key to predict need for biologic therapy in immunotherapy‐checkpoint inhibitory colitis. Authors' reply","year":2021,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Microscopic Colitis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Immunotherapy; Colitis; Key (lock); Cancer research; Internal medicine; Cancer; Computer science","score_opus":0.025652055881298853,"score_gpt":0.3445678806241511,"score_spread":0.31891582474285224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128515318","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029987123,0.014666387,0.000019790858,0.02744327,0.9184051,0.008145552,0.0010923676,0.00016194816,0.000078428304],"genre_scores_gemma":[0.0009901137,0.015011007,0.00035181033,0.06870555,0.9079781,0.0028777334,0.0014943515,0.00028612878,0.0023052066],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929745,0.0014480494,0.0016263332,0.0014616504,0.0009899352,0.0014995346],"domain_scores_gemma":[0.9935645,0.0032753458,0.0006072527,0.0015426009,0.00073978625,0.00027052272],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.002752365,0.0011355912,0.0015757232,0.00030730644,0.0005568047,0.00016039943,0.0014448102,0.0016622851,0.0006293305],"category_scores_gemma":[0.000027905427,0.0007649184,0.0006582418,0.00069480465,0.00077026564,0.00009978272,0.00043749122,0.003110424,0.000036068657],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047927983,0.000552296,0.0002090667,0.000084587846,0.0058848495,0.000038444217,0.0021732706,0.0000048869233,0.17710195,0.0000037713646,0.8082218,0.0009322605],"study_design_scores_gemma":[0.009784104,0.002843859,0.00030850168,0.00023438066,0.002845632,0.000023029153,0.0004997619,0.000012082297,0.04235789,0.0000802881,0.94036776,0.0006427049],"about_ca_topic_score_codex":0.0011446031,"about_ca_topic_score_gemma":0.000200615,"teacher_disagreement_score":0.13474406,"about_ca_system_score_codex":0.0012373937,"about_ca_system_score_gemma":0.0023089666,"threshold_uncertainty_score":0.9996338},"labels":[],"label_agreement":null},{"id":"W3133635904","doi":"10.1111/apt.16289","title":"Letter: is the radiation therapy causing an IBD flare, or the IBD predisposing to radiation toxicity?","year":2021,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center; University of Toronto; University of Calgary","funders":"","keywords":"Medicine; Radiation therapy; Toxicity; Flare; Dermatology; Internal medicine","score_opus":0.04302551900367846,"score_gpt":0.3437495201246225,"score_spread":0.30072400112094405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133635904","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.084303275,0.0058874604,0.0001330682,0.90159017,0.004163075,0.0035515095,0.00015119456,0.00016551725,0.00005470445],"genre_scores_gemma":[0.011887054,0.0038126851,0.00023116497,0.9645314,0.016128324,0.00029971046,0.0017069356,0.00021254676,0.0011901722],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99471843,0.0017566934,0.00077674945,0.0009429746,0.0009257103,0.00087943196],"domain_scores_gemma":[0.9968237,0.0011523863,0.0005198949,0.0011018942,0.00022866984,0.00017340895],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00082133256,0.00078825816,0.0007426856,0.00028571364,0.00079222856,0.00020329369,0.0006131656,0.00083253084,0.0012642974],"category_scores_gemma":[0.0000033295344,0.00045494334,0.00032438894,0.0006530666,0.00023949394,0.00035889036,0.00011389132,0.002489175,0.0000589639],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006923616,0.00026173439,0.0008241447,0.00007650714,0.010261988,0.00046734928,0.004467094,0.00016296904,0.06128518,0.0000015693615,0.8964389,0.025060214],"study_design_scores_gemma":[0.0027080036,0.001160778,0.0012710801,0.00006300537,0.007977959,0.00027024286,0.00012849117,0.001106844,0.079823464,0.000014598454,0.9049484,0.00052710815],"about_ca_topic_score_codex":0.00009640011,"about_ca_topic_score_gemma":0.000019240131,"teacher_disagreement_score":0.07241622,"about_ca_system_score_codex":0.00065875513,"about_ca_system_score_gemma":0.00051207154,"threshold_uncertainty_score":0.9998121},"labels":[],"label_agreement":null},{"id":"W3134538015","doi":"10.1111/apt.16305","title":"Review article: comprehensive analysis of cirrhotic cardiomyopathy","year":2021,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Medicine; Cirrhosis; Liver transplantation; Cardiomyopathy; Internal medicine; Transplantation; Systematic review; Intensive care medicine; Epidemiology; MEDLINE; Cardiology; Heart failure","score_opus":0.09774569370872088,"score_gpt":0.4245766389552556,"score_spread":0.3268309452465347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134538015","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00043168923,0.9973945,0.000010100189,0.00017841399,0.0003781514,0.0011827213,0.00033451605,0.000029991259,0.000059927024],"genre_scores_gemma":[0.00014310768,0.97829336,0.000053767417,0.017900921,0.00010695474,0.00008512427,0.003349158,0.000041023162,0.000026589587],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99765056,0.000592552,0.00081449363,0.00042607746,0.00024713817,0.00026917362],"domain_scores_gemma":[0.9986373,0.0002680916,0.00036199088,0.00039391857,0.00019617939,0.00014247515],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013171072,0.00038739704,0.003212778,0.00034951812,0.000044703746,0.0000049498176,0.0001522851,0.00016223126,0.0011476983],"category_scores_gemma":[4.9540425e-8,0.00033245535,0.0015674568,0.0013668361,0.000121170786,0.000044370787,0.000042483916,0.00032744417,0.000036876998],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006145233,0.0005222252,0.0003025947,0.07588948,0.82537407,0.0005273536,0.00012969927,0.000005060898,0.00021058341,0.00000770243,0.00044191148,0.09652785],"study_design_scores_gemma":[0.0005192987,0.00008526722,0.00008281957,0.009511465,0.7140163,0.000075647105,0.000019125324,0.000014903534,0.000114017916,9.198961e-7,0.2753824,0.00017782534],"about_ca_topic_score_codex":0.000017327153,"about_ca_topic_score_gemma":0.0000010046956,"teacher_disagreement_score":0.2749405,"about_ca_system_score_codex":0.00010739199,"about_ca_system_score_gemma":0.00034022404,"threshold_uncertainty_score":0.99991274},"labels":[],"label_agreement":null},{"id":"W3135147383","doi":"10.1111/apt.16288","title":"Standardisation of intestinal ultrasound scoring in clinical trials for luminal Crohn’s disease","year":2021,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bible College","funders":"National Institute for Health and Care Research","keywords":"Medicine; Vascularity; Clinical trial; Crohn's disease; Disease; Voting; Internal medicine; Pathology","score_opus":0.10728937667722238,"score_gpt":0.4356088522334852,"score_spread":0.32831947555626284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135147383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960988,0.001029659,0.0007844178,0.00030040956,0.000982739,0.00054910075,0.00021391695,0.000008035348,0.000032896445],"genre_scores_gemma":[0.9940539,0.00051247084,0.00083963963,0.003373063,0.00065269944,0.00009264694,0.0003865506,0.0000258064,0.000063242536],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99751997,0.0009061141,0.0008435434,0.00036043406,0.000121604884,0.00024830553],"domain_scores_gemma":[0.99885374,0.00037463062,0.00025820546,0.00021546033,0.00017105826,0.00012690217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017374273,0.00016234002,0.00030543059,0.00004439754,0.000054981483,0.000010626467,0.00014677922,0.00009982088,0.00011326316],"category_scores_gemma":[0.00003832982,0.00017268886,0.000253581,0.00006373382,0.00018590453,0.000008542978,0.00006752538,0.000121178135,0.000002005812],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069998135,0.0005627638,0.28695416,0.000084188236,0.0022706692,0.00023216233,0.00006797292,0.00021721149,0.70031613,0.00004041973,0.00055423443,0.0017002431],"study_design_scores_gemma":[0.0074242135,0.00032326148,0.558995,0.000043021777,0.004788247,0.000019039508,0.0002316696,0.00028733542,0.4219446,0.00035575376,0.0052339192,0.00035395526],"about_ca_topic_score_codex":0.0000030992874,"about_ca_topic_score_gemma":0.000018488025,"teacher_disagreement_score":0.27837157,"about_ca_system_score_codex":0.000043292428,"about_ca_system_score_gemma":0.00046549624,"threshold_uncertainty_score":0.70420474},"labels":[],"label_agreement":null},{"id":"W3136343028","doi":"10.1111/apt.16316","title":"Letter: the combination of histologic remission and Mayo endoscopic score 1 as a suitable therapeutic target in ulcerative colitis—authors' reply","year":2021,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Ulcerative colitis; Gastroenterology; Internal medicine; Colitis; Surgery; General surgery; Dermatology; Disease","score_opus":0.02159582082102495,"score_gpt":0.286438299577706,"score_spread":0.26484247875668104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136343028","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6955334,0.00978782,0.000026662474,0.29030386,0.0018123601,0.0019036109,0.0001926352,0.000030243615,0.00040942777],"genre_scores_gemma":[0.16721296,0.0018677404,0.00010437853,0.826532,0.00078879745,0.00021718272,0.0015763794,0.00008101226,0.0016195185],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960806,0.001698468,0.0006064954,0.00076378474,0.00029045084,0.00056025054],"domain_scores_gemma":[0.99866354,0.00014884517,0.00042201203,0.00054038555,0.00015519325,0.00006999096],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049610983,0.0004981459,0.00048375496,0.00012882389,0.00018558252,0.000031457133,0.0004632673,0.000738531,0.00034374231],"category_scores_gemma":[0.000002716599,0.00043103416,0.00015270151,0.00014279588,0.000529508,0.000014809166,0.00026165225,0.0011462694,0.0000059062986],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021370328,0.0007065939,0.026329495,0.0005782913,0.008729564,0.0028719248,0.0013115727,0.00005093934,0.42234024,0.00009841212,0.5341598,0.000686151],"study_design_scores_gemma":[0.0040972475,0.000774386,0.014973135,0.00013191835,0.003375225,0.00012432694,0.00021717863,0.00011807804,0.13712467,0.0008993673,0.8374052,0.0007592813],"about_ca_topic_score_codex":0.00006742964,"about_ca_topic_score_gemma":0.000027288605,"teacher_disagreement_score":0.5362282,"about_ca_system_score_codex":0.00014373813,"about_ca_system_score_gemma":0.00035636406,"threshold_uncertainty_score":0.99981415},"labels":[],"label_agreement":null},{"id":"W3137256548","doi":"10.1111/apt.16336","title":"Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult‐to‐treat primary biliary cholangitis","year":2021,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Inventiva Pharma; Gilead Sciences; GlaxoSmithKline","keywords":"Fibrate; Medicine; Obeticholic acid; Internal medicine; Ursodeoxycholic acid; Bezafibrate; Gastroenterology; Fenofibrate; Odds ratio; Combination therapy; Statin","score_opus":0.01088982829050629,"score_gpt":0.2595547030617235,"score_spread":0.24866487477121724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137256548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963592,0.0008140787,0.000004577022,0.0017782069,0.000065485394,0.00072232063,0.00014055723,0.000022690798,0.00009287444],"genre_scores_gemma":[0.97284365,0.0002168446,0.0006562325,0.025490008,0.000028858261,0.00003962726,0.0006054734,0.000028662425,0.0000906401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988342,0.00009586096,0.00023272572,0.00029715698,0.00024978007,0.00029030052],"domain_scores_gemma":[0.9991626,0.00006226468,0.00006494507,0.0002487794,0.00027691352,0.00018450491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000049447102,0.00020808038,0.0003140267,0.00012036066,0.00005324769,0.000010749836,0.000117881114,0.00006895074,0.00040141502],"category_scores_gemma":[5.444156e-7,0.00016332993,0.000041886335,0.0005300849,0.00009329927,0.00014340613,0.000109810135,0.00017961695,0.000019381743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025602053,0.003977504,0.6583646,0.00012818388,0.001302823,0.00006815489,0.0009974567,0.000010240675,0.33069745,0.0000012182771,0.0012118977,0.00068026956],"study_design_scores_gemma":[0.005281956,0.0014590457,0.57531625,0.00008799887,0.0019186236,0.0000090496005,0.000087452456,0.00001673285,0.4154902,0.000001811721,0.00018982845,0.00014104505],"about_ca_topic_score_codex":0.00010652579,"about_ca_topic_score_gemma":0.0000050066938,"teacher_disagreement_score":0.084792756,"about_ca_system_score_codex":0.00015377105,"about_ca_system_score_gemma":0.00013805153,"threshold_uncertainty_score":0.6660401},"labels":[],"label_agreement":null},{"id":"W3137528620","doi":"10.1111/apt.16314","title":"Editorial: an expert consensus to standardise the assessment of histological disease activity in Crohn’s disease clinical trials—a missing link. Authors' reply","year":2021,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Crohn's disease; Clinical trial; Disease; Crohn disease; Consensus conference; MEDLINE; Link (geometry); Medical physics; Pathology; Internal medicine; Intensive care medicine","score_opus":0.07101095203798516,"score_gpt":0.4639877891365786,"score_spread":0.39297683709859343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137528620","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10604237,0.0026765384,0.00009685719,0.006686268,0.88006616,0.0019409942,0.002429585,0.000041821895,0.00001939767],"genre_scores_gemma":[0.03421591,0.0021207386,0.00040724472,0.00910915,0.9513922,0.00041615742,0.002080896,0.0001498092,0.00010792014],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9837373,0.010845582,0.0019510699,0.0016091276,0.0011010136,0.0007559046],"domain_scores_gemma":[0.9938494,0.0018273392,0.0010658659,0.001487179,0.0005998128,0.0011703966],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0066529703,0.0008123269,0.0014026033,0.00013361912,0.0002695848,0.00008143283,0.0009295274,0.0011471596,0.00017325832],"category_scores_gemma":[0.00029137678,0.0006792756,0.0008515698,0.00016565986,0.00075809675,0.00001536509,0.0006082644,0.0016311341,0.0000031530128],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021445245,0.0019025451,0.0024289489,0.00010655438,0.0041990657,0.00131028,0.00008869069,0.00016944995,0.024738008,0.0000031302568,0.94145435,0.0021537552],"study_design_scores_gemma":[0.004715617,0.00060515216,0.017751224,0.00009513979,0.0072972937,0.0000012009245,0.00006436759,0.00025754282,0.0010234346,0.000047648296,0.9673189,0.00082251115],"about_ca_topic_score_codex":0.000051661027,"about_ca_topic_score_gemma":0.000049442257,"teacher_disagreement_score":0.071826465,"about_ca_system_score_codex":0.00038943742,"about_ca_system_score_gemma":0.0055605127,"threshold_uncertainty_score":0.99956584},"labels":[],"label_agreement":null},{"id":"W3138039053","doi":"10.1111/apt.16328","title":"An expert consensus to standardise clinical, endoscopic and histologic items and inclusion and outcome criteria for evaluation of pouchitis disease activity in clinical trials","year":2021,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bible College","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Pouchitis; Clinical trial; Inclusion (mineral); Disease; Outcome (game theory); MEDLINE; Internal medicine; Intensive care medicine; Inflammatory bowel disease","score_opus":0.33133864898257653,"score_gpt":0.5924918790975139,"score_spread":0.26115323011493735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138039053","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42846215,0.568114,0.000014696069,0.00018278291,0.00056271895,0.00203063,0.0006267299,0.0000046886175,0.0000016448174],"genre_scores_gemma":[0.08442966,0.9115499,0.00032538417,0.0025217338,0.00031408912,0.00035992792,0.0004530903,0.000041862553,0.000004343053],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.988953,0.008091016,0.0016484101,0.0008461929,0.00020290748,0.0002584856],"domain_scores_gemma":[0.9975963,0.0008904763,0.0006430236,0.0003636317,0.00016111405,0.0003454078],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0077509154,0.00039274668,0.0017635045,0.000107183245,0.00019985199,0.000018937626,0.00017560029,0.0004268196,0.000034562912],"category_scores_gemma":[0.0000815855,0.0003554268,0.00030303295,0.00005488864,0.0003902784,0.000008721631,0.0008439103,0.00021530109,2.1336966e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047363103,0.0012607718,0.014140285,0.002707955,0.0051647904,0.00011910528,0.00019622006,0.00000296763,0.0072276415,0.0000062196955,0.00040418678,0.96403354],"study_design_scores_gemma":[0.03426784,0.005104674,0.02254493,0.0021010507,0.08738608,0.000048972157,0.00019264841,0.0009942775,0.0010319882,0.00021361973,0.8440922,0.0020217525],"about_ca_topic_score_codex":0.000009901475,"about_ca_topic_score_gemma":0.0000285299,"teacher_disagreement_score":0.9620118,"about_ca_system_score_codex":0.00006883342,"about_ca_system_score_gemma":0.0005371016,"threshold_uncertainty_score":0.9998898},"labels":[],"label_agreement":null},{"id":"W3138598227","doi":"10.1111/apt.16327","title":"Editorial: methotrexate in patients with Crohn's disease refractory to anti‐TNF therapy—moving backwards yet forward?","year":2021,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Methotrexate; Refractory (planetary science); Crohn's disease; Internal medicine; Disease; Infliximab; Gastroenterology","score_opus":0.00819757944818776,"score_gpt":0.28896028289760844,"score_spread":0.28076270344942067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138598227","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29611725,0.0012532033,0.000010635133,0.0001394672,0.7000408,0.0012641499,0.0010902999,0.000040491628,0.000043693122],"genre_scores_gemma":[0.010733293,0.0027664073,0.00031248562,0.0088042235,0.9674639,0.0004037722,0.008705886,0.00038158207,0.000428451],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948558,0.0009611063,0.00070766703,0.0014415067,0.0010399582,0.0009939512],"domain_scores_gemma":[0.9972689,0.00018515179,0.00039516317,0.0009369521,0.00066006393,0.00055378344],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00054323795,0.0009722904,0.0007317541,0.00024506694,0.00018511753,0.000084618434,0.00086166227,0.0010170118,0.00028500485],"category_scores_gemma":[0.00001075686,0.00094469293,0.00028545834,0.00025242768,0.00021250398,0.000030395888,0.00046609214,0.001016047,0.00004103874],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010711252,0.0011665022,0.00843804,0.000089388705,0.0063563515,0.0005115523,0.00011288727,0.0001656766,0.009820539,4.3709693e-7,0.9620888,0.00053852383],"study_design_scores_gemma":[0.0074349707,0.00057756517,0.022905434,0.00008588162,0.0028722822,3.3787424e-7,0.00003240323,0.0000051801217,0.002987351,0.000007445731,0.9619685,0.001122695],"about_ca_topic_score_codex":0.000042438955,"about_ca_topic_score_gemma":0.000047154255,"teacher_disagreement_score":0.28538397,"about_ca_system_score_codex":0.00030704984,"about_ca_system_score_gemma":0.0015913423,"threshold_uncertainty_score":0.99930036},"labels":[],"label_agreement":null},{"id":"W3139135461","doi":"10.1111/apt.16313","title":"Editorial: use of intestinal ultrasound in the scoring of Crohn’s disease activity in clinical trials – is it ready for prime time yet? Authors’ reply","year":2021,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Crohn's disease; Clinical trial; Crohn disease; Disease; Prime (order theory); Gastroenterology; Internal medicine","score_opus":0.11608119558507168,"score_gpt":0.4402325492770148,"score_spread":0.3241513536919431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139135461","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34031266,0.00047150315,0.000017602215,0.000431547,0.6545744,0.0018676714,0.002308048,0.000008711411,0.000007892321],"genre_scores_gemma":[0.02215825,0.0022646151,0.00032486542,0.0037575462,0.9671772,0.00043718453,0.0034209182,0.00013882326,0.00032060535],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918491,0.004249673,0.001947759,0.0008901639,0.0005695357,0.0004937724],"domain_scores_gemma":[0.9898925,0.0072656516,0.0013740514,0.00084041967,0.00047121843,0.0001561755],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006757047,0.0005087839,0.0011237288,0.00013937938,0.00006395735,0.000035406647,0.0007417279,0.0009063724,0.000087657245],"category_scores_gemma":[0.00066023285,0.00045979355,0.00058866804,0.00015649998,0.00042883639,0.000025456638,0.00022746134,0.00096172775,0.0000030949477],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01624376,0.0013063386,0.0023548158,0.00018720698,0.002984689,0.00010806491,0.0001809824,0.000025022184,0.15284847,0.0000012291433,0.8235661,0.00019332286],"study_design_scores_gemma":[0.007792962,0.00093537435,0.0074763424,0.0002781217,0.010231655,0.0000030623855,0.00009957015,0.00010390101,0.058982074,0.000062077765,0.91324764,0.0007872253],"about_ca_topic_score_codex":0.00011395816,"about_ca_topic_score_gemma":0.000044617613,"teacher_disagreement_score":0.3181544,"about_ca_system_score_codex":0.00011106025,"about_ca_system_score_gemma":0.0017650897,"threshold_uncertainty_score":0.99978536},"labels":[],"label_agreement":null},{"id":"W3140678648","doi":"10.1111/apt.16346","title":"MAFLD considerations as a part of the global hepatitis C elimination effort: an international perspective","year":2021,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bible College","funders":"","keywords":"Medicine; Perspective (graphical); Hepatitis; Intensive care medicine; Hepatitis C; MEDLINE; Virology","score_opus":0.07273729937674403,"score_gpt":0.4328029030862627,"score_spread":0.3600656037095187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3140678648","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021995858,0.9883031,9.1531683e-7,0.0039141485,0.0019865362,0.0015193884,0.00096754654,0.000025785504,0.0010829562],"genre_scores_gemma":[0.004637341,0.9846686,0.00008795959,0.008836853,0.00034491371,0.00030479833,0.0010088128,0.000028003744,0.00008270883],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982982,0.0003114961,0.00048442883,0.00040067348,0.00031603893,0.00018915787],"domain_scores_gemma":[0.9987908,0.00015164359,0.00032153944,0.00032008233,0.00030686837,0.00010905927],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000083427214,0.00031605698,0.00077830325,0.000062304614,0.00012408374,0.000021346572,0.00017185608,0.00015780087,0.0024669503],"category_scores_gemma":[0.0000011034423,0.00022879911,0.00052632083,0.00017133387,0.00017673864,0.00009790065,0.000106695574,0.00021343012,0.00002568496],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039555845,0.028851384,0.06663427,0.004006057,0.49147323,0.0020565188,0.0030799296,0.000019864565,0.0000740474,0.059272423,0.007877442,0.33625928],"study_design_scores_gemma":[0.0024732314,0.00070305803,0.0035748493,0.002327341,0.18447635,0.0005547062,0.0003728679,0.000022083232,0.0006203491,0.00058815826,0.80390495,0.00038207768],"about_ca_topic_score_codex":0.0002329466,"about_ca_topic_score_gemma":0.0000710936,"teacher_disagreement_score":0.7960275,"about_ca_system_score_codex":0.0009219789,"about_ca_system_score_gemma":0.00088353094,"threshold_uncertainty_score":0.9984449},"labels":[],"label_agreement":null},{"id":"W3142308901","doi":"10.1111/apt.16338","title":"Letter: genetic variation in the <i>HLA‐DQA1*05</i> allele predicts tumour necrosis factor‐α antagonist immunogenicity – does location matter?","year":2021,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Immunogenicity; Human leukocyte antigen; Medicine; Allele; Variation (astronomy); Genetic variation; Immunology; Genetics; Antigen; Biology; Gene; Environmental health","score_opus":0.018371479326641457,"score_gpt":0.25065746007171913,"score_spread":0.23228598074507767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3142308901","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4130712,0.019144908,0.00009282265,0.5526049,0.012142909,0.0019508925,0.0006857411,0.00017248312,0.00013412781],"genre_scores_gemma":[0.28850815,0.0028328449,0.00005444709,0.70104265,0.0011462315,0.0002739014,0.004468493,0.00010580302,0.0015674419],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99300796,0.003078995,0.0011829886,0.0011912301,0.00019411035,0.001344713],"domain_scores_gemma":[0.99760425,0.0005924136,0.00069089985,0.0009200493,0.00016710108,0.000025284806],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00037409543,0.0009849683,0.00096950616,0.0002899146,0.0006148554,0.000108534914,0.0015921039,0.001980498,0.0031455876],"category_scores_gemma":[7.872142e-7,0.0007484123,0.00034060355,0.00042249582,0.0007460146,0.00017775195,0.00035431286,0.0038511127,0.00080213166],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016288845,0.00045883984,0.00091587997,0.000067119225,0.0057740067,0.00023412243,0.0011031897,0.000012241498,0.68310934,0.0000010217128,0.30797982,0.00018150928],"study_design_scores_gemma":[0.0032905457,0.0003484196,0.0054979213,0.000042541116,0.005343561,0.0004675997,0.00013810367,0.000012609766,0.316649,0.00007949421,0.6673005,0.0008297049],"about_ca_topic_score_codex":0.001065116,"about_ca_topic_score_gemma":0.00009713708,"teacher_disagreement_score":0.36646038,"about_ca_system_score_codex":0.00035269774,"about_ca_system_score_gemma":0.00027077488,"threshold_uncertainty_score":0.99997586},"labels":[],"label_agreement":null},{"id":"W3143507834","doi":"10.1111/apt.16358","title":"Trends in paediatric inflammatory bowel disease‐attributable direct costs: a population‐based analysis","year":2021,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Inflammatory bowel disease; Indirect costs; Population; Disease burden; Health care; Crohn's disease; Pediatrics; Resource use; Disease; Emergency medicine; Demography; Environmental health; Internal medicine","score_opus":0.011613807798829699,"score_gpt":0.2861963713176908,"score_spread":0.2745825635188611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3143507834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99456346,0.0033806928,0.000050390885,0.0007663573,0.00040892544,0.00021008545,0.00029665753,0.00004286203,0.00028056712],"genre_scores_gemma":[0.98300624,0.00038595535,0.00014049331,0.010993862,0.00028061133,0.00010748039,0.0046304027,0.000044675056,0.00041028435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976042,0.0005608196,0.0004519354,0.0006313237,0.00023218455,0.00051954406],"domain_scores_gemma":[0.9989737,0.00004606561,0.00014658905,0.00048361818,0.00010641995,0.00024360148],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002609402,0.0003162515,0.00028942252,0.00045666914,0.00013451662,0.000029321183,0.00025644992,0.00016494139,0.000932009],"category_scores_gemma":[0.0000013547534,0.00036047024,0.00034821813,0.00090263446,0.000073736985,0.000016934064,0.00014041371,0.00017932558,0.000019233572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006601605,0.00046447292,0.9454137,0.000019983332,0.006183978,0.0005232163,0.000021732165,0.011428669,0.034163725,0.000008923388,0.000726704,0.0003847035],"study_design_scores_gemma":[0.002551201,0.000051704956,0.95464116,0.000005418455,0.011890172,0.0000025201896,0.000040261675,0.0045369035,0.020435076,0.000016061924,0.005340564,0.0004889712],"about_ca_topic_score_codex":0.000036639954,"about_ca_topic_score_gemma":0.00029045186,"teacher_disagreement_score":0.013728649,"about_ca_system_score_codex":0.00021824372,"about_ca_system_score_gemma":0.00026311775,"threshold_uncertainty_score":0.9999813},"labels":[],"label_agreement":null},{"id":"W3143863796","doi":"10.1111/apt.15374","title":"Letter: pre‐operative anti‐TNF therapy in Crohn’s disease is not associated with increased complications following elective surgery","year":2019,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Crohn's disease; Surgery; Crohn disease; Disease; General surgery; Internal medicine","score_opus":0.02293475787200473,"score_gpt":0.29742973120810035,"score_spread":0.2744949733360956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3143863796","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8852276,0.0007532171,0.000016297536,0.11024107,0.00065410923,0.0020256832,0.00097085146,0.00005300261,0.000058121852],"genre_scores_gemma":[0.3264664,0.00040495172,0.000017440527,0.66659635,0.0007184861,0.00042330322,0.004980195,0.00014364357,0.0002491859],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9957411,0.0012095516,0.0005948585,0.0011616957,0.0004073652,0.00088540796],"domain_scores_gemma":[0.99821794,0.00032618523,0.00042018213,0.0007109023,0.00018839953,0.000136407],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030388968,0.0008192476,0.00069187314,0.00025458014,0.00023668355,0.000059276368,0.00056142313,0.0006908648,0.00016032874],"category_scores_gemma":[0.0000021867259,0.0007918179,0.00043847391,0.0002313829,0.00028682384,0.00002827778,0.00013352507,0.0011349454,0.000038209266],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035185115,0.0010268283,0.1730793,0.0000681411,0.031757653,0.0038422425,0.0003939232,0.00013287277,0.10851389,8.271691e-7,0.67749983,0.00016598975],"study_design_scores_gemma":[0.007063579,0.00036631955,0.7148696,0.00015583882,0.0068828017,0.000013213215,0.00003090967,0.00024481514,0.05061343,0.000018579585,0.21758501,0.0021559002],"about_ca_topic_score_codex":0.00007463182,"about_ca_topic_score_gemma":0.000030036359,"teacher_disagreement_score":0.55876124,"about_ca_system_score_codex":0.00028212485,"about_ca_system_score_gemma":0.00088696694,"threshold_uncertainty_score":0.99945325},"labels":[],"label_agreement":null},{"id":"W3150160902","doi":"10.1111/apt.15200","title":"Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission – confounded by the gut microbiome? Authors’ reply","year":2019,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McMaster University; University of Alberta","funders":"","keywords":"Medicine; Irritable bowel syndrome; Ulcerative colitis; Gastroenterology; Internal medicine; Microbiome; Adenocarcinoma; Gut flora; Colitis; Gut microbiome; Bioinformatics; Immunology; Disease; Cancer","score_opus":0.01920244485155221,"score_gpt":0.3414865109879456,"score_spread":0.3222840661363934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3150160902","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61050713,0.0036219917,0.0000062852714,0.0018833284,0.38064897,0.0020874783,0.0012324475,0.0000072310254,0.000005142103],"genre_scores_gemma":[0.48470867,0.01059707,0.0001208376,0.0054097692,0.48687825,0.0003946844,0.011389348,0.00013651447,0.00036485615],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99605787,0.0014671183,0.00084780174,0.00086287316,0.00020228402,0.00056202686],"domain_scores_gemma":[0.9978791,0.0012017785,0.00042925205,0.00028932112,0.00010858055,0.00009197871],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021193298,0.00045331172,0.00067086366,0.00010419924,0.00024256826,0.00007550187,0.00045552116,0.0012422116,0.0000112995485],"category_scores_gemma":[0.000009832723,0.00033556556,0.00012797283,0.00011639178,0.00043146525,0.000015862348,0.00019984729,0.0009153333,0.0000016656359],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021635988,0.00014267597,0.004967237,0.00007947901,0.0021439537,0.0000026961743,0.00026072506,2.2680821e-7,0.20619474,0.0000010864718,0.78393126,0.00011232994],"study_design_scores_gemma":[0.008506362,0.0018163812,0.048067898,0.00005722602,0.0033921793,0.000026523352,0.0003619448,0.000025891344,0.00806275,0.00006026597,0.9290459,0.00057664217],"about_ca_topic_score_codex":0.00030693426,"about_ca_topic_score_gemma":0.00018138927,"teacher_disagreement_score":0.198132,"about_ca_system_score_codex":0.00013577819,"about_ca_system_score_gemma":0.00041721752,"threshold_uncertainty_score":0.99990964},"labels":[],"label_agreement":null},{"id":"W3151986918","doi":"10.1111/apt.12793","title":"Editorial: anti-viral therapy for prevention of perinatal HBV transmission - extending therapy beyond birth and the risk of post-partum flare","year":2014,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"China Scholarship Council; Gilead Sciences; Bristol-Myers Squibb","keywords":"Medicine; Lamivudine; Pregnancy; Seroconversion; Subclinical infection; Hepatitis B; Viral load; Hepatitis B virus; Transmission (telecommunications); Pediatrics; Obstetrics; Internal medicine; Immunology; Virus","score_opus":0.01586003534350262,"score_gpt":0.3332390194145111,"score_spread":0.3173789840710085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3151986918","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14963631,0.026400581,0.000120372526,0.0011742185,0.8176154,0.0036637993,0.0013070808,0.000055836914,0.00002639673],"genre_scores_gemma":[0.06536043,0.19608049,0.00041031447,0.0011902984,0.7354909,0.00034030527,0.00077446445,0.00016736965,0.00018539862],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962498,0.00088713394,0.0009634759,0.00059512083,0.00080952595,0.00049492717],"domain_scores_gemma":[0.995759,0.0021359494,0.0009565297,0.00037765378,0.0006670162,0.00010383907],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013989834,0.0006267794,0.001549021,0.00020477861,0.00033789198,0.000017277798,0.0003517418,0.0007309054,0.00015464636],"category_scores_gemma":[0.0000096972435,0.00042336495,0.0005544138,0.00013036793,0.0009574493,0.00012161416,0.000090757974,0.0009240017,0.0000014661222],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037571516,0.0012762572,0.0028940253,0.0010254434,0.043802932,0.000007105472,0.004074363,0.0000071065083,0.15205821,0.00003170689,0.7158589,0.041392427],"study_design_scores_gemma":[0.028968574,0.0055321814,0.0006573712,0.00018520688,0.010212075,0.000004863576,0.00011162038,0.00013030104,0.052020222,0.0002886935,0.9015018,0.0003871054],"about_ca_topic_score_codex":0.00036109,"about_ca_topic_score_gemma":0.000018816778,"teacher_disagreement_score":0.18564288,"about_ca_system_score_codex":0.00008841966,"about_ca_system_score_gemma":0.00030256802,"threshold_uncertainty_score":0.99982184},"labels":[],"label_agreement":null},{"id":"W3156728328","doi":"10.1111/apt.16366","title":"Editorial: standardising inclusion and outcome criteria for pouchitis—a fragile consensus perhaps but a first step in the right direction. Authors' reply","year":2021,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Pouchitis; Inclusion (mineral); Outcome (game theory); Internal medicine; Psychology; Mathematical economics; Social psychology","score_opus":0.02709750396395841,"score_gpt":0.390231449207351,"score_spread":0.36313394524339254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156728328","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003550195,0.009584195,0.00004059558,0.023558741,0.95886153,0.0024419455,0.0016350657,0.00007712178,0.0002506233],"genre_scores_gemma":[0.002201586,0.00862111,0.0003883087,0.00988673,0.97498125,0.00056614185,0.0022503284,0.00011371142,0.000990818],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99568284,0.00069865334,0.00077225216,0.00083838333,0.0012709958,0.00073686446],"domain_scores_gemma":[0.9964139,0.0022098792,0.00023846165,0.00047253404,0.0004070572,0.00025817874],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019377922,0.0005141617,0.0008683775,0.00026932053,0.0008733039,0.00012661662,0.0003100634,0.00051339273,0.00042466246],"category_scores_gemma":[0.000030223004,0.0004070922,0.0002692855,0.00022680422,0.0002927999,0.0000701274,0.00075594574,0.0012776437,0.000003735021],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027005493,0.00059508596,0.00015209464,0.0006484812,0.0042385706,0.0004189196,0.0006867135,0.0000019708286,0.0017883233,0.000006760397,0.9879375,0.0008250227],"study_design_scores_gemma":[0.007128341,0.00070935703,0.00007144833,0.00019403052,0.008968303,0.000021367274,0.0004714589,0.00015208025,0.00035465407,0.00008810987,0.981484,0.000356867],"about_ca_topic_score_codex":0.00042285526,"about_ca_topic_score_gemma":0.00015962655,"teacher_disagreement_score":0.016119748,"about_ca_system_score_codex":0.00060904707,"about_ca_system_score_gemma":0.0005756739,"threshold_uncertainty_score":0.9998381},"labels":[],"label_agreement":null},{"id":"W3157658688","doi":"10.1111/apt.16347","title":"Editorial: enhancing colorectal cancer screening participation—the check is in the mail","year":2021,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"University of Calgary","keywords":"Medicine; Colorectal cancer; Colorectal cancer screening; Family medicine; MEDLINE; Internal medicine; Cancer; Oncology; Colonoscopy","score_opus":0.03264580104511154,"score_gpt":0.3731861583603935,"score_spread":0.3405403573152819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157658688","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034179345,0.0057200803,0.000037288577,0.009318392,0.9493992,0.0010133961,0.00011622101,0.000079915124,0.00013621796],"genre_scores_gemma":[0.027274575,0.0029553382,0.00007117144,0.016332433,0.9516092,0.0009575905,0.00036483447,0.00008702983,0.00034785902],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99606407,0.00068986265,0.00067217427,0.00067109923,0.0012198961,0.0006828776],"domain_scores_gemma":[0.997266,0.0015703015,0.0003418343,0.0003695617,0.0003497782,0.00010253403],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0011541321,0.00049678684,0.0006635015,0.00013872338,0.0004026647,0.00008474793,0.00044476258,0.00079724466,0.0007104306],"category_scores_gemma":[0.0000074847776,0.0003517499,0.0002736969,0.00064491597,0.00023030522,0.0001040244,0.00014384577,0.0026296598,0.00001765067],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003394704,0.00021371219,0.00048130867,0.000057815352,0.004402573,0.00004299542,0.0029967919,0.000044130673,0.009299716,3.7008724e-7,0.97708464,0.0019812582],"study_design_scores_gemma":[0.0027892035,0.0011134004,0.0004508032,0.00015144126,0.011106916,0.000012908446,0.0008078923,0.00034327904,0.03227512,0.000010088351,0.9505897,0.00034924297],"about_ca_topic_score_codex":0.0018807813,"about_ca_topic_score_gemma":0.0016389199,"teacher_disagreement_score":0.026494922,"about_ca_system_score_codex":0.00058921543,"about_ca_system_score_gemma":0.0009729449,"threshold_uncertainty_score":0.9998934},"labels":[],"label_agreement":null},{"id":"W3157976196","doi":"10.1111/apt.16388","title":"One‐year outcomes with ustekinumab therapy in infliximab‐refractory paediatric ulcerative colitis: a multicentre prospective study","year":2021,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Stollery Children's Hospital; Alberta Children's Hospital; Children's Hospital of Eastern Ontario; University of Calgary; University of Alberta; Hospital for Sick Children; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Western University; University of Toronto; SickKids Foundation","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Ustekinumab; Vedolizumab; Ulcerative colitis; Infliximab; Clinical endpoint; Internal medicine; Faecal calprotectin; Refractory (planetary science); Gastroenterology; Intention-to-treat analysis; Surgery; Calprotectin; Inflammatory bowel disease; Clinical trial; Tumor necrosis factor alpha; Disease","score_opus":0.01589458324235767,"score_gpt":0.2921277296981889,"score_spread":0.27623314645583125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157976196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643177,0.0007857857,0.0000082711795,0.0003098276,0.00031874314,0.0018277299,0.000064520595,0.000033556225,0.00021978466],"genre_scores_gemma":[0.99055946,0.0007034997,0.00019392568,0.007533297,0.0002153258,0.00037251072,0.00012600778,0.00006687985,0.00022908188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736714,0.00075002515,0.00038152502,0.0007008192,0.00027692842,0.0005235362],"domain_scores_gemma":[0.9990238,0.000063865446,0.0001570619,0.00039315477,0.00022885253,0.00013325707],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018945477,0.00038370973,0.0003483481,0.0001014476,0.00013606677,0.000033672142,0.0002551714,0.00015602162,0.00028785158],"category_scores_gemma":[0.0000011296765,0.00036889402,0.000104927785,0.00022799261,0.00015957873,0.00002449462,0.00015194729,0.00031807408,0.000025602547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006011258,0.0054169013,0.9416119,0.000014994377,0.009525376,0.00071774557,0.0027678644,0.00014442025,0.033068415,0.000012355862,0.00007989001,0.00062887114],"study_design_scores_gemma":[0.018947136,0.0014293016,0.9342227,0.000007816021,0.001539936,0.000007957286,0.0043630097,0.000036721325,0.038015176,0.000024276267,0.0008953554,0.0005105997],"about_ca_topic_score_codex":0.000026677675,"about_ca_topic_score_gemma":0.0006411995,"teacher_disagreement_score":0.012935878,"about_ca_system_score_codex":0.00016798728,"about_ca_system_score_gemma":0.00042507565,"threshold_uncertainty_score":0.9998763},"labels":[],"label_agreement":null},{"id":"W3157982664","doi":"10.1111/apt.16376","title":"Editorial: trends in paediatric inflammatory bowel disease attributable direct costs—authors' reply","year":2021,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Inflammatory bowel disease; Inflammatory Bowel Diseases; Disease; Internal medicine","score_opus":0.008917522299747741,"score_gpt":0.28944862989111475,"score_spread":0.280531107591367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157982664","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020181872,0.010929283,0.0000024677784,0.00045730802,0.9652019,0.00067015825,0.0021355404,0.000101611375,0.00031981987],"genre_scores_gemma":[0.0027543725,0.00718941,0.00003349169,0.004091271,0.9651043,0.0004432903,0.017637255,0.00028560325,0.0024610022],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99337727,0.0014125087,0.0011226087,0.0017577227,0.001040153,0.0012897537],"domain_scores_gemma":[0.9968549,0.00026363187,0.00056283764,0.0011957737,0.00046967602,0.0006531571],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010937816,0.0011012435,0.000802204,0.00049063406,0.00024511278,0.00010142186,0.0010261413,0.0017034985,0.00053708185],"category_scores_gemma":[0.000017681672,0.0012697321,0.0005763921,0.00043845124,0.00030127345,0.000031678246,0.00073631684,0.0016183459,0.000061724146],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025479596,0.00057731423,0.0052282517,0.0001259148,0.0044019422,0.0009880201,0.000048556296,0.00021250821,0.011751067,0.0000012020803,0.9738606,0.00025664823],"study_design_scores_gemma":[0.0038487378,0.00019044953,0.0012332343,0.000047339334,0.0064174416,0.0000021727021,0.000036733083,0.000054132932,0.0037309271,0.000010493533,0.98322016,0.001208153],"about_ca_topic_score_codex":0.000064544234,"about_ca_topic_score_gemma":0.00010649119,"teacher_disagreement_score":0.0174275,"about_ca_system_score_codex":0.0006543992,"about_ca_system_score_gemma":0.00187184,"threshold_uncertainty_score":0.9995925},"labels":[],"label_agreement":null},{"id":"W3168396703","doi":"10.1111/apt.16407","title":"Umbrella review of 42 systematic reviews with meta‐analyses: the safety of proton pump inhibitors","year":2021,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"Ethicon","keywords":"Medicine; Meta-analysis; Systematic review; MEDLINE; Intensive care medicine; Internal medicine; Biochemistry; Chemistry","score_opus":0.2785832208115611,"score_gpt":0.48465747001475284,"score_spread":0.20607424920319173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168396703","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010503191,0.9816514,0.000006160176,0.00025742137,0.00023738836,0.017580891,0.0000917938,0.000017283592,0.00014711065],"genre_scores_gemma":[0.000046739115,0.9908576,0.00024399074,0.0051969327,0.00010381344,0.0027689796,0.00039838563,0.0000918346,0.0002917465],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9922902,0.003243725,0.0028759246,0.0005627533,0.0006252902,0.000402082],"domain_scores_gemma":[0.9949928,0.00076965126,0.0028075532,0.0010187918,0.00027050337,0.00014068649],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016302244,0.00090354134,0.009513969,0.00016246787,0.000084961575,0.000006518584,0.00044849937,0.00021058826,0.00082552095],"category_scores_gemma":[0.0000037961686,0.00040191438,0.0024364316,0.00079335587,0.00030990245,0.00005081675,0.0001343413,0.00061399135,0.000033755987],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039511346,0.0005507743,0.000021304144,0.74355537,0.24888696,0.00016544618,0.000040813542,2.4877608e-7,0.000025102236,0.0000028717159,0.00015997779,0.0065516555],"study_design_scores_gemma":[0.0006914338,0.00052279053,6.2732937e-7,0.23840798,0.5771167,0.00028041657,0.000011765038,5.245584e-7,0.0008918184,7.273982e-7,0.18195635,0.000118826276],"about_ca_topic_score_codex":0.000011020157,"about_ca_topic_score_gemma":6.1400146e-7,"teacher_disagreement_score":0.50514734,"about_ca_system_score_codex":0.00018778007,"about_ca_system_score_gemma":0.0005382928,"threshold_uncertainty_score":0.9998433},"labels":[],"label_agreement":null},{"id":"W3170717976","doi":"10.1111/apt.16394","title":"Editorial: tobacco use in functional dyspepsia—another smoking gun?","year":2021,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Tobacco use; MEDLINE; Dermatology; Family medicine; Environmental health; Population","score_opus":0.04241173443116685,"score_gpt":0.32283015728234093,"score_spread":0.2804184228511741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170717976","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01327373,0.0013591418,0.000023324637,0.0020603084,0.9821432,0.00066728576,0.0001590255,0.00011033839,0.00020364425],"genre_scores_gemma":[0.0014546819,0.00087470067,0.0003658673,0.013919493,0.97949857,0.000087540764,0.0024426172,0.00014637351,0.0012101328],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99614865,0.00037821458,0.0007440602,0.00091199204,0.0010602307,0.00075682957],"domain_scores_gemma":[0.99739534,0.0013269517,0.00026026054,0.00045110303,0.00040103233,0.00016532441],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000459582,0.0006441986,0.0008798973,0.00030054603,0.00012295453,0.00006508106,0.0002634807,0.0010605578,0.002998198],"category_scores_gemma":[0.000012749911,0.00067597616,0.00029906092,0.00034617048,0.00025459516,0.0002174477,0.00017906306,0.0025314149,0.000059920898],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023280329,0.0011684297,0.017998427,0.00007916261,0.005237036,0.00022810737,0.0001064495,0.0000445523,0.0041891197,0.0000022399574,0.96840507,0.00021337466],"study_design_scores_gemma":[0.0068417396,0.0006743219,0.0017603559,0.00021361052,0.00872876,0.000028408827,0.00016729166,0.000024588913,0.0005740569,0.000040494535,0.9805213,0.00042505906],"about_ca_topic_score_codex":0.00046071055,"about_ca_topic_score_gemma":0.00030665868,"teacher_disagreement_score":0.016238073,"about_ca_system_score_codex":0.0006195177,"about_ca_system_score_gemma":0.0009564236,"threshold_uncertainty_score":0.9997698},"labels":[],"label_agreement":null},{"id":"W3174033930","doi":"10.1111/apt.16444","title":"Comorbidity before and after a diagnosis of inflammatory bowel disease","year":2021,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Comorbidity; Inflammatory bowel disease; Internal medicine; Hazard ratio; Epidemiology; Disease; Incidence (geometry); Proportional hazards model; Diabetes mellitus; Confidence interval","score_opus":0.010254986518105257,"score_gpt":0.2726320890184636,"score_spread":0.26237710250035834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174033930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950741,0.0033365365,0.000008942242,0.00074165367,0.00035457293,0.00023665208,0.00019334797,0.0000139375825,0.000040238836],"genre_scores_gemma":[0.98617303,0.0020154237,0.00011740219,0.011020331,0.00020414166,0.00014970625,0.00018250634,0.000031668667,0.00010578441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988063,0.0002028829,0.00025568582,0.00035018133,0.0001253814,0.00025959045],"domain_scores_gemma":[0.99928594,0.0000199303,0.00009028163,0.00030365342,0.00010063878,0.00019955152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010344781,0.00020458359,0.0001434511,0.00003467176,0.00006925211,0.00000961774,0.00013577283,0.00010354396,0.00035341052],"category_scores_gemma":[7.123671e-7,0.00021800621,0.00010857032,0.0000444267,0.00029420832,0.000009634443,0.00023499536,0.00010503984,0.0000076759325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009344746,0.00032778806,0.88224894,0.00009742463,0.002426917,0.00061439985,0.00012899142,0.000018256698,0.1122435,0.000020176562,0.00054896646,0.00039015818],"study_design_scores_gemma":[0.001528335,0.00011531355,0.7801184,0.000015240659,0.0027676835,0.000015321311,0.00006927916,0.00007214849,0.20455834,0.00012718019,0.01035564,0.00025711118],"about_ca_topic_score_codex":0.0000029171217,"about_ca_topic_score_gemma":0.00004410455,"teacher_disagreement_score":0.10213054,"about_ca_system_score_codex":0.000019342984,"about_ca_system_score_gemma":0.0001702301,"threshold_uncertainty_score":0.8890035},"labels":[],"label_agreement":null},{"id":"W3176710754","doi":"10.1111/apt.16488","title":"Internal medicine hospitalisations and liver disease: a comparative disease burden analysis of a multicentre cohort","year":2021,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Toronto General Hospital; University of Toronto; University Health Network","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; University of Toronto; Canadian Cancer Society","keywords":"Medicine; Cohort; Cohort study; Internal medicine; Liver disease; Disease; MEDLINE; Intensive care medicine","score_opus":0.03555251541799591,"score_gpt":0.3482767413658147,"score_spread":0.3127242259478188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176710754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850931,0.009871832,0.00012264794,0.0038705862,0.00015831084,0.0004279639,0.00031745393,0.000023296594,0.000114782626],"genre_scores_gemma":[0.98749006,0.0049572876,0.00008964391,0.0058224085,0.00011444289,0.000028496228,0.0013113588,0.000010257394,0.00017607455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889076,0.00015546734,0.00027704609,0.00028671807,0.00023136359,0.00015863497],"domain_scores_gemma":[0.99909186,0.00016699922,0.00009706487,0.00015688957,0.00016778415,0.00031937368],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000064657506,0.00015887945,0.00038319948,0.00016758658,0.00006784259,0.000005573898,0.00005883584,0.00002975095,0.0014558585],"category_scores_gemma":[2.0387577e-7,0.00014038432,0.00012457633,0.0003351415,0.00027474662,0.00009067918,0.000030232419,0.000103270904,0.000005094952],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019001554,0.00059564254,0.8353681,0.00012448807,0.1385521,0.0006538729,0.005285342,0.0001460964,0.017064566,0.00007688235,0.00012335407,0.000109406414],"study_design_scores_gemma":[0.0024029564,0.0000857963,0.67291087,0.000049714086,0.31071553,0.0000050825543,0.00058906723,0.010655246,0.002307993,0.000020017304,0.00016152678,0.00009618167],"about_ca_topic_score_codex":0.00018613288,"about_ca_topic_score_gemma":0.00002676797,"teacher_disagreement_score":0.17216343,"about_ca_system_score_codex":0.000042088945,"about_ca_system_score_gemma":0.00011353023,"threshold_uncertainty_score":0.99945694},"labels":[],"label_agreement":null},{"id":"W3178382159","doi":"10.1111/apt.16508","title":"Systematic review: hepatitis C viraemic allografts to hepatitis C‐negative recipients in solid organ transplantation","year":2021,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hepatitis C; Internal medicine; Hepatitis C virus; Transplantation; Liver transplantation; Hepatitis; Gastroenterology; Immunology; Virus","score_opus":0.061657960358922265,"score_gpt":0.4396094115687126,"score_spread":0.37795145120979035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178382159","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00055081974,0.9846876,0.000028279364,0.0011684638,0.0010018606,0.011740349,0.0005541053,0.00009102986,0.00017748772],"genre_scores_gemma":[0.000118861586,0.96322596,0.00039386173,0.030185437,0.00019741997,0.0030493196,0.0022061665,0.0002192933,0.0004036696],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9910521,0.0031296273,0.002525096,0.001161065,0.0009708381,0.0011612916],"domain_scores_gemma":[0.996876,0.0009201538,0.00061208085,0.0007756413,0.00034469937,0.00047141148],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011510627,0.0009934832,0.005415004,0.0008840053,0.00015038141,0.00003995668,0.00064852653,0.0005429694,0.0015767997],"category_scores_gemma":[0.00001477971,0.00091150275,0.0007071648,0.0018077694,0.00016667202,0.00016713177,0.00020341287,0.0014570514,0.00063919753],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001179086,0.0010473088,0.0016344173,0.89410955,0.030989952,0.0044559315,0.0011068153,0.0000015798604,0.00038077333,0.000004251074,0.0032082398,0.0629433],"study_design_scores_gemma":[0.002338916,0.00095452106,0.000096859214,0.7302578,0.115799755,0.0006085006,0.000030765885,0.000032564767,0.0006970431,0.0000071943555,0.14802921,0.0011468458],"about_ca_topic_score_codex":0.00088222907,"about_ca_topic_score_gemma":0.0007728515,"teacher_disagreement_score":0.1638517,"about_ca_system_score_codex":0.0017590035,"about_ca_system_score_gemma":0.00095252594,"threshold_uncertainty_score":0.9993359},"labels":[],"label_agreement":null},{"id":"W3178794474","doi":"10.1111/apt.16518","title":"Continued 5ASA use after initiation of anti‐TNF or immunomodulator confers no benefit in IBD: a population‐based study","year":2021,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Mount Sinai Hospital; University of Manitoba","funders":"","keywords":"Medicine; Population; Medical prescription; Ulcerative colitis; Inflammatory bowel disease; Internal medicine; Pediatrics; Disease; Pharmacology","score_opus":0.022464074959150124,"score_gpt":0.3037851153825667,"score_spread":0.28132104042341655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178794474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99839497,0.00021370292,0.000012700958,0.0001126648,0.00046662716,0.0006392858,0.0001313496,0.0000130497465,0.000015672647],"genre_scores_gemma":[0.99228895,0.00005875867,0.00019879865,0.0064954567,0.00009260563,0.00009929635,0.0006067386,0.000036240344,0.00012314857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842393,0.000321102,0.00046676453,0.00037001382,0.00015007892,0.0002681231],"domain_scores_gemma":[0.99918425,0.000042600554,0.00016801342,0.00032313052,0.00021881732,0.00006317705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015538915,0.00022214452,0.00024793472,0.00008906646,0.00004969495,0.000018846653,0.00014789934,0.00013284813,0.0005631651],"category_scores_gemma":[0.0000019707918,0.00022796832,0.000095790914,0.00012562782,0.0000571949,0.000021085852,0.00008936805,0.0001159194,0.000010782977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024011626,0.0008528776,0.63091224,0.00001772902,0.001396483,0.00022467025,0.00012411817,0.00025887764,0.36372983,0.0000024224646,0.000024529385,0.00005501405],"study_design_scores_gemma":[0.0051273177,0.00030965154,0.8719341,0.000012357388,0.0011814907,0.0000039268507,0.000146286,0.00028178896,0.12011669,0.000006250468,0.00063532963,0.0002448183],"about_ca_topic_score_codex":0.000053373606,"about_ca_topic_score_gemma":0.0002219298,"teacher_disagreement_score":0.24361315,"about_ca_system_score_codex":0.000055688815,"about_ca_system_score_gemma":0.00019762313,"threshold_uncertainty_score":0.92962784},"labels":[],"label_agreement":null},{"id":"W3186665270","doi":"10.1111/apt.16538","title":"Serum hepatitis B virus RNA level is associated with biochemical relapse in patients with chronic hepatitis B infection who discontinue nucleos(t)ide analogue treatment","year":2021,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"National Natural Science Foundation of China","keywords":"Discontinuation; Medicine; Hepatitis B virus; Internal medicine; Gastroenterology; Hepatitis B; Virus; Immunology","score_opus":0.027100097359082684,"score_gpt":0.28976859845971026,"score_spread":0.26266850110062756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186665270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993964,0.0012671071,0.000018608662,0.002444957,0.0003491311,0.0009960057,0.00073277054,0.00015775749,0.00006965059],"genre_scores_gemma":[0.9789814,0.009562316,0.00017086456,0.009831565,0.00014095104,0.00017323109,0.0007203486,0.00013719888,0.00028217596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739707,0.00029811964,0.00052171317,0.00067539886,0.00040474653,0.00070296443],"domain_scores_gemma":[0.99887294,0.00013817646,0.0002321829,0.00032333628,0.00025898102,0.00017438427],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000105790634,0.00051225274,0.0008051087,0.00017450613,0.00021245782,0.000019979394,0.000095523734,0.000212605,0.00038491734],"category_scores_gemma":[0.0000019555132,0.00042508284,0.00012280543,0.0005749004,0.00030607148,0.00019850055,0.000092129325,0.0004121056,0.000038608756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064016925,0.002154569,0.9701835,0.000026817574,0.012278254,0.000495525,0.00086963584,0.000013703163,0.0104377465,0.0000025859097,0.0010507473,0.001846729],"study_design_scores_gemma":[0.01173942,0.0032743313,0.85347235,0.00020769237,0.00568572,0.000022709028,0.000013168886,0.00015976606,0.123388834,0.000009559534,0.0016334772,0.000392996],"about_ca_topic_score_codex":0.018199665,"about_ca_topic_score_gemma":0.097093076,"teacher_disagreement_score":0.11671119,"about_ca_system_score_codex":0.0022003814,"about_ca_system_score_gemma":0.00038628068,"threshold_uncertainty_score":0.9998201},"labels":[],"label_agreement":null},{"id":"W3188374641","doi":"10.1111/apt.16542","title":"Letter: mind the gap—search and publication date of systematic reviews and meta‐analysis. Authors' reply","year":2021,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Meta-analysis; MEDLINE; Systematic review; Pathology; Law","score_opus":0.8240815018752717,"score_gpt":0.5524400984087937,"score_spread":0.271641403466478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3188374641","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00060518016,0.1636291,0.00072269014,0.8293922,0.0004897946,0.0047460212,0.0001772879,0.000004840193,0.000232881],"genre_scores_gemma":[0.0009486446,0.0074247913,0.0012912548,0.97591066,0.0005115908,0.000584923,0.00034382322,0.000039921757,0.012944392],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9244259,0.05879503,0.011058901,0.0017684452,0.0034775091,0.0004742389],"domain_scores_gemma":[0.9746657,0.010978758,0.008105048,0.004850085,0.001266683,0.00013369859],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.1048158,0.0007964763,0.011872768,0.00089954433,0.00028785976,0.0008371591,0.0026137007,0.00039312398,0.013195607],"category_scores_gemma":[0.00016057551,0.00034706743,0.003949887,0.0023308604,0.0004840032,0.0002556304,0.00053331535,0.0012667406,0.00023385865],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000043067903,0.000037539565,0.00010581661,0.0028371038,0.41023082,0.000019842677,0.0005195906,0.0000049026703,0.00023299297,0.000016933336,0.58580494,0.00018521612],"study_design_scores_gemma":[0.00008944224,0.000023459965,0.000016377731,0.000032744203,0.49239463,0.000027464366,0.000077415025,0.00063947146,0.00013193667,0.00003541777,0.50636524,0.00016644399],"about_ca_topic_score_codex":0.000041322648,"about_ca_topic_score_gemma":0.000015834887,"teacher_disagreement_score":0.15620431,"about_ca_system_score_codex":0.000025833095,"about_ca_system_score_gemma":0.000086011685,"threshold_uncertainty_score":0.99989814},"labels":[],"label_agreement":null},{"id":"W3191705001","doi":"10.1111/apt.16545","title":"Editorial: acute gastrointestinal bleeding—proposed new study outcomes. Authors' reply","year":2021,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Gastrointestinal bleeding; MEDLINE; Intensive care medicine; Internal medicine; Gastroenterology; General surgery; Law","score_opus":0.027954435493690147,"score_gpt":0.3604736349096856,"score_spread":0.33251919941599545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191705001","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011199256,0.00070809247,0.000016804917,0.008831168,0.97582585,0.0026338545,0.0002554254,0.00040784874,0.00012172212],"genre_scores_gemma":[0.0011600773,0.0005915414,0.0040591345,0.006560925,0.9805915,0.00018607867,0.0019299457,0.00033375816,0.004587083],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926396,0.00039992467,0.001447159,0.0018718624,0.0022336694,0.0014077952],"domain_scores_gemma":[0.9948047,0.0014742585,0.0008080491,0.0009588472,0.0010076823,0.0009464916],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00078742695,0.0015311883,0.0022898894,0.00037964026,0.00035498443,0.00016409824,0.0006836181,0.0006137598,0.001205071],"category_scores_gemma":[0.000019432271,0.0013504091,0.00076945795,0.0004584896,0.00024197638,0.0001605239,0.0004920817,0.003356291,0.00018128424],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014676614,0.006208169,0.041830692,0.000069243586,0.042871222,0.002851474,0.0002760779,0.0000035283088,0.005479333,9.901117e-7,0.8987704,0.0001711908],"study_design_scores_gemma":[0.017850688,0.014381321,0.0014516679,0.0005024315,0.13874786,0.0004305816,0.0004286684,0.000016168418,0.0019933379,0.000023859635,0.82325274,0.0009206554],"about_ca_topic_score_codex":0.00076654693,"about_ca_topic_score_gemma":0.000028259998,"teacher_disagreement_score":0.095876634,"about_ca_system_score_codex":0.0011636522,"about_ca_system_score_gemma":0.0023032683,"threshold_uncertainty_score":0.9997437},"labels":[],"label_agreement":null},{"id":"W3193964348","doi":"10.1111/apt.16474","title":"Letter: ginger as anti‐emetic for acute gastroenteritis in children—interpreting evidence gingerly","year":2021,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Ethics and Legal Issues in Pediatric Healthcare","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Acute gastroenteritis; MEDLINE; Pharmacology; Pediatrics; Biology","score_opus":0.05357083205903621,"score_gpt":0.4107842967964482,"score_spread":0.35721346473741195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193964348","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13291365,0.016921572,0.00006032272,0.8444375,0.0032900213,0.0020076237,0.00021908569,0.000089212794,0.00006105946],"genre_scores_gemma":[0.045571074,0.013172404,0.0014352289,0.9290688,0.00842299,0.00030435305,0.0012307148,0.00018775206,0.00060666003],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953114,0.0006216929,0.0010234832,0.0011365662,0.00057692034,0.0013299716],"domain_scores_gemma":[0.9977818,0.0008499377,0.00037948517,0.0005468321,0.00026848668,0.00017346512],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00070074335,0.00070351275,0.001237072,0.00041199004,0.00018289364,0.000072186725,0.00051564636,0.0010356155,0.0007579101],"category_scores_gemma":[0.0000044971275,0.00074351684,0.00042939538,0.00030641467,0.00027832962,0.00015868366,0.000214816,0.004905612,0.00003299435],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007547364,0.00047013437,0.070353344,0.0015132879,0.02833765,0.008047743,0.0020737099,0.000008521427,0.015728252,0.0000043316954,0.8700756,0.0026326866],"study_design_scores_gemma":[0.004791131,0.0025746971,0.001505032,0.002653313,0.039752778,0.0022008966,0.00010626951,0.00030092764,0.0071840608,0.00008226918,0.9377108,0.0011378013],"about_ca_topic_score_codex":0.00038329285,"about_ca_topic_score_gemma":0.000009447395,"teacher_disagreement_score":0.08734257,"about_ca_system_score_codex":0.0004972922,"about_ca_system_score_gemma":0.00047879163,"threshold_uncertainty_score":0.9995016},"labels":[],"label_agreement":null},{"id":"W3195548332","doi":"10.1111/apt.16562","title":"Editorial: liver disease in secondary care—‘money or your life’. Authors' reply","year":2021,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Disease; Gerontology; Internal medicine","score_opus":0.02660078139399293,"score_gpt":0.34179392213814763,"score_spread":0.3151931407441547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195548332","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0069955075,0.021899244,0.0000029046805,0.0013269271,0.9662906,0.0012130382,0.0020121462,0.00013831414,0.00012130343],"genre_scores_gemma":[0.0042601493,0.024193252,0.000073237425,0.015143939,0.9412265,0.0002061115,0.013880245,0.00016364933,0.0008529408],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99587196,0.00055407436,0.0007855554,0.0010497895,0.0010542603,0.0006843417],"domain_scores_gemma":[0.99740535,0.0006292625,0.00026520304,0.0005276707,0.00042226675,0.00075023767],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002758296,0.00069719664,0.0009185419,0.00031773868,0.00015474633,0.00004937797,0.00033793692,0.00090287137,0.0023122032],"category_scores_gemma":[0.0000022578417,0.0006517927,0.0003356356,0.00030942043,0.00017729522,0.00022715707,0.000116624025,0.0021440315,0.00009944462],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011335249,0.0008234256,0.0016548558,0.0012234616,0.019982606,0.0040862984,0.002311255,0.0000072645325,0.0010261516,9.1311574e-7,0.95726794,0.0002805641],"study_design_scores_gemma":[0.0095831,0.00054310454,0.0011104019,0.00032952393,0.08657159,0.0000071957165,0.00042708818,0.00002887475,0.0012598883,0.0000120670675,0.89948684,0.0006403507],"about_ca_topic_score_codex":0.0005877968,"about_ca_topic_score_gemma":0.00008826442,"teacher_disagreement_score":0.066588975,"about_ca_system_score_codex":0.00051909446,"about_ca_system_score_gemma":0.005081023,"threshold_uncertainty_score":0.9995933},"labels":[],"label_agreement":null},{"id":"W3196113321","doi":"10.1111/apt.16554","title":"Editorial: 5‐ASA in IBD patients on biologics—'stop or continue'? Authors' reply","year":2021,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; University of Manitoba","funders":"AbbVie Canada; Janssen Canada; Merck Canada; Takeda Canada; Pfizer Canada; Pfizer","keywords":"Medicine; Family medicine; Intensive care medicine","score_opus":0.02884503218124339,"score_gpt":0.37778637954300726,"score_spread":0.34894134736176385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196113321","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004476119,0.0016375956,0.0000013180186,0.004076055,0.9863093,0.0021702277,0.0006189856,0.00012110132,0.00058932323],"genre_scores_gemma":[0.0004729894,0.0167166,0.000064025015,0.018887445,0.95206624,0.0002767601,0.006926325,0.00013054551,0.0044590966],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945129,0.00075415324,0.00086662197,0.0012100942,0.0015341638,0.0011220513],"domain_scores_gemma":[0.9968517,0.0011327827,0.00032535288,0.00069559267,0.0005258803,0.00046871474],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008429631,0.00072513026,0.0011473151,0.0004644799,0.00013725045,0.000056543664,0.00050172245,0.0010262385,0.0017459929],"category_scores_gemma":[0.0000308667,0.00059401704,0.00032503833,0.00044481482,0.0002501355,0.00008520799,0.00043913772,0.002279162,0.00015517884],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008353362,0.0031942453,0.0008176681,0.00022556951,0.00795122,0.00070624653,0.000116276344,0.0000025849604,0.0008876663,0.000004015968,0.9757546,0.0019865292],"study_design_scores_gemma":[0.011113244,0.0031169795,0.00026463144,0.00022152954,0.0061698556,0.0000012676601,0.000109705055,0.000011716714,0.0013116349,0.000022515143,0.97715366,0.0005032408],"about_ca_topic_score_codex":0.0001966984,"about_ca_topic_score_gemma":0.00004084158,"teacher_disagreement_score":0.03424306,"about_ca_system_score_codex":0.000951923,"about_ca_system_score_gemma":0.0010871139,"threshold_uncertainty_score":0.99965113},"labels":[],"label_agreement":null},{"id":"W3198074525","doi":"10.1111/apt.16570","title":"Editorial: only steps away from primetime? Hepatitis B virus RNA as a routine marker to guide HBV treatment decisions—authors' reply","year":2021,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Virology; Hepatitis B virus; Virus; Schulze method; Hepatitis a virus; Epistemology; Philosophy","score_opus":0.02668408268612621,"score_gpt":0.36337353643297654,"score_spread":0.33668945374685033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198074525","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024067797,0.009939932,0.000033545108,0.0062355353,0.9510132,0.0030726346,0.0043652304,0.0006354093,0.00063673494],"genre_scores_gemma":[0.0004435026,0.052085586,0.003906754,0.029913059,0.89967275,0.0006785281,0.0047138934,0.00067570235,0.007910251],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99007684,0.0013285709,0.0021684226,0.002394183,0.0024971657,0.0015348048],"domain_scores_gemma":[0.99060804,0.004749666,0.00074884115,0.0017059469,0.0012086666,0.0009788689],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0009484961,0.0017711269,0.0029292232,0.00050033565,0.00056190946,0.00012775867,0.0008008718,0.0017391919,0.0028995718],"category_scores_gemma":[0.00009569791,0.00165672,0.00081924844,0.0006515076,0.00031055068,0.00017141158,0.00086895726,0.0019845467,0.0013841556],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027605863,0.0017797567,0.006100662,0.000028932553,0.045045126,0.0012163194,0.0010214001,0.0000035120565,0.018594863,0.000001543606,0.91834104,0.0051062405],"study_design_scores_gemma":[0.0071349293,0.0036089523,0.0009875527,0.00038221636,0.03812915,0.000025133073,0.00007828688,0.000013195644,0.02719522,0.000040068753,0.9212524,0.0011528571],"about_ca_topic_score_codex":0.07676532,"about_ca_topic_score_gemma":0.008132707,"teacher_disagreement_score":0.06863261,"about_ca_system_score_codex":0.0038610674,"about_ca_system_score_gemma":0.0039097355,"threshold_uncertainty_score":0.9999629},"labels":[],"label_agreement":null},{"id":"W3198489974","doi":"10.1111/apt.16593","title":"Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population‐based cohort study","year":2021,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Tillotts Pharma; Region Midtjylland; Vifor Pharma; Gilead Sciences; University of Alberta; Pfizer; Amgen","keywords":"Medicine; Vedolizumab; Pediatrics; Prospective cohort study; Cohort; Cohort study; Population; Internal medicine; Environmental health; Disease","score_opus":0.023074358174930743,"score_gpt":0.34719213383333875,"score_spread":0.324117775658408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198489974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994226,0.00062402955,0.000034597488,0.0023199841,0.0003635636,0.0022689833,0.000018234257,0.000051798717,0.00009283895],"genre_scores_gemma":[0.98733544,0.00015052348,0.0007712006,0.011234138,0.000049410246,0.0002352477,0.00007837478,0.000018480947,0.00012715177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985519,0.00021749032,0.00032283098,0.00043784588,0.00019372614,0.00027623083],"domain_scores_gemma":[0.99937564,0.00013235983,0.00005607184,0.00016639124,0.00009290589,0.00017662407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020522255,0.00017769195,0.00028901387,0.00012287153,0.0001294824,0.000009226,0.00005778599,0.00006902667,0.00047410742],"category_scores_gemma":[0.000004559975,0.00018012308,0.000036599205,0.00037096458,0.000067135756,0.00008933923,0.000051611547,0.00025487045,0.000022969463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059776974,0.0026668257,0.98203284,0.000024993456,0.0012104601,0.00007473402,0.0023030057,0.000044169097,0.009581029,0.0000023664636,0.00003775289,0.0014240859],"study_design_scores_gemma":[0.00652928,0.00040461466,0.97911483,0.00006016196,0.001515438,0.000051613275,0.0015627431,0.00026744182,0.009917854,0.000014134679,0.00040491112,0.0001569796],"about_ca_topic_score_codex":0.00033591918,"about_ca_topic_score_gemma":0.00077112747,"teacher_disagreement_score":0.008914154,"about_ca_system_score_codex":0.00051118265,"about_ca_system_score_gemma":0.00030910643,"threshold_uncertainty_score":0.7345206},"labels":[],"label_agreement":null},{"id":"W3202626485","doi":"10.1111/apt.16626","title":"Agreement between local and central reading of endoscopic disease activity in ulcerative colitis: results from the tofacitinib OCTAVE trials","year":2021,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Octave (electronics); Medicine; Tofacitinib; Confidence interval; Odds ratio; Internal medicine; Placebo; Surgery; Gastroenterology; Pathology","score_opus":0.041956030207972485,"score_gpt":0.32962833934759495,"score_spread":0.28767230913962244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202626485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944447,0.00059340557,0.00013110423,0.0014097489,0.0002709011,0.0005351755,0.002554434,0.0000057384154,0.00005478859],"genre_scores_gemma":[0.9945229,0.00076437887,0.00007268933,0.0034819515,0.0002595564,0.000039092578,0.00080763525,0.000015187652,0.00003659941],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9971246,0.0015040287,0.00047999845,0.00041751246,0.00014448845,0.00032938464],"domain_scores_gemma":[0.9989633,0.00036378033,0.00020925509,0.0002616539,0.00005755908,0.00014446999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045003256,0.00020369509,0.00031443048,0.000023500706,0.00008773337,0.000014852424,0.0001557434,0.000098025754,0.000107358035],"category_scores_gemma":[0.000007126646,0.00017791164,0.00010062781,0.000063118016,0.0002831059,0.000010636874,0.00016657337,0.00015719591,0.0000020020404],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014950926,0.0005794479,0.24498917,0.000047661175,0.009248288,0.00049658114,0.0016039661,0.0001838996,0.72214967,0.00005602224,0.00059417606,0.0051001804],"study_design_scores_gemma":[0.0052313753,0.00010290141,0.55990654,0.000025600952,0.0019512171,0.0000011065354,0.00040765948,0.00009684623,0.4306267,0.00010875162,0.0013840649,0.00015725975],"about_ca_topic_score_codex":0.000101599486,"about_ca_topic_score_gemma":0.00019170328,"teacher_disagreement_score":0.31491736,"about_ca_system_score_codex":0.000058789054,"about_ca_system_score_gemma":0.00025944482,"threshold_uncertainty_score":0.7255026},"labels":[],"label_agreement":null},{"id":"W3203614826","doi":"10.1111/apt.16572","title":"Editorial: time to retire Rome IV and the Montreal definition?","year":2021,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Diverticular Disease and Complications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; MEDLINE; Classics; Law; History; Political science","score_opus":0.015363690039503271,"score_gpt":0.30082568221821404,"score_spread":0.28546199217871077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203614826","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009348058,0.0052907704,0.0000047580165,0.018032106,0.97199106,0.0011932552,0.0005046066,0.00009555693,0.0019530832],"genre_scores_gemma":[0.00024918476,0.0031180053,0.000090035515,0.024730815,0.96690893,0.00035866722,0.0024388533,0.00006540442,0.0020401017],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978366,0.00031390687,0.00035949,0.00052974134,0.00061009283,0.00035020206],"domain_scores_gemma":[0.9980594,0.00075555756,0.000119624245,0.00046824466,0.00034214312,0.00025505028],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002499604,0.00035482988,0.00059147726,0.00008283785,0.0002524521,0.000056640663,0.00026799744,0.0004240104,0.0011420259],"category_scores_gemma":[0.0000032286262,0.00027421582,0.00020793783,0.0001863064,0.00029225953,0.000048757298,0.00023517279,0.00070078886,0.00049012806],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001230234,0.00032953624,0.000011842154,0.00003188363,0.009264224,0.00003893908,0.00017329834,0.0000016317002,0.0013020706,0.000017135335,0.9873381,0.00026106727],"study_design_scores_gemma":[0.005339943,0.00023736937,0.00008981808,0.000057297388,0.033666026,0.000011753259,0.000048324346,0.000051414878,0.00017943628,0.00025335676,0.9598118,0.00025346255],"about_ca_topic_score_codex":0.000103683116,"about_ca_topic_score_gemma":0.0000074752916,"teacher_disagreement_score":0.027526341,"about_ca_system_score_codex":0.00013032342,"about_ca_system_score_gemma":0.00042157396,"threshold_uncertainty_score":0.99997103},"labels":[],"label_agreement":null},{"id":"W3204506994","doi":"10.1111/apt.16587","title":"Editorial: time to retire Rome IV and the Montreal definition? Authors' reply","year":2021,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Biliary and Gastrointestinal Fistulas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Classics; Gerontology; History","score_opus":0.01569288686097267,"score_gpt":0.3005357776501146,"score_spread":0.28484289078914193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204506994","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011166049,0.0021326933,0.0000043506225,0.04011405,0.95370084,0.0012347108,0.00038576522,0.00013363584,0.0011773418],"genre_scores_gemma":[0.00011199926,0.001369898,0.0004960036,0.032212235,0.95816827,0.00016267983,0.0015931005,0.00010775765,0.005778059],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99624604,0.0007523482,0.00068100466,0.000886661,0.0008295051,0.0006044615],"domain_scores_gemma":[0.99615,0.0022281816,0.00025669407,0.00058873964,0.00041936475,0.0003570321],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010088885,0.0006156054,0.0010513784,0.000120093915,0.0003197678,0.00006203286,0.00034413044,0.0007040949,0.0010721114],"category_scores_gemma":[0.00001885998,0.00046919615,0.00027184724,0.00025538335,0.00058376585,0.000077722754,0.00031683967,0.0021676018,0.00026264336],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00544855,0.00027939852,0.000039658695,0.000073108,0.0059637376,0.00021998724,0.00029939617,0.0000020455498,0.0021513423,0.000008435194,0.9852864,0.00022792838],"study_design_scores_gemma":[0.006929926,0.0012705136,0.000075332566,0.00016817258,0.021476377,0.00015893823,0.00006446684,0.000053032134,0.00033846317,0.00028369325,0.9688073,0.00037379705],"about_ca_topic_score_codex":0.0002259779,"about_ca_topic_score_gemma":0.000016537448,"teacher_disagreement_score":0.016479125,"about_ca_system_score_codex":0.0002086065,"about_ca_system_score_gemma":0.00048006704,"threshold_uncertainty_score":0.99984103},"labels":[],"label_agreement":null},{"id":"W3215621197","doi":"10.1111/apt.16718","title":"Systematic review: disease activity indices for immune checkpoint inhibitor‐associated enterocolitis","year":2021,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Disease; Enterocolitis; Adverse effect; Cochrane Library; Severity of illness; Inflammatory bowel disease; Ulcerative colitis; MEDLINE; Intensive care medicine; Gastroenterology; Meta-analysis","score_opus":0.054567318656296646,"score_gpt":0.3961754524137198,"score_spread":0.34160813375742316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215621197","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012356172,0.9827098,0.0000064725514,0.0014499165,0.0018327406,0.013017335,0.0007375805,0.00010483551,0.000017707805],"genre_scores_gemma":[0.000046051562,0.97403735,0.000026512454,0.017747007,0.00038507115,0.004755665,0.0021659904,0.00015352668,0.0006828288],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9952986,0.0011034765,0.0017452394,0.00075792574,0.00041080033,0.0006839457],"domain_scores_gemma":[0.9968259,0.000568406,0.0015323998,0.00063503534,0.00017550866,0.0002627555],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00093871023,0.0008746486,0.004815309,0.00020492352,0.00021035303,0.000037444424,0.00039234466,0.0003901357,0.0005899495],"category_scores_gemma":[0.0000041954713,0.0007108447,0.0025084724,0.00044546474,0.00019799618,0.00010937338,0.00014007733,0.00064476504,0.00002491056],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073338515,0.0013092301,0.0000049793744,0.8765656,0.09856341,0.00014510006,0.00006636393,2.4029013e-8,0.0006609736,9.709073e-7,0.0015691067,0.02038087],"study_design_scores_gemma":[0.0026270584,0.00043388957,0.000006330862,0.39459413,0.24879572,0.00008573106,0.00002063348,0.0000042622005,0.00052332715,0.0000020224547,0.35241073,0.0004961627],"about_ca_topic_score_codex":0.000028338634,"about_ca_topic_score_gemma":0.000004313692,"teacher_disagreement_score":0.48197144,"about_ca_system_score_codex":0.0011401548,"about_ca_system_score_gemma":0.0009060578,"threshold_uncertainty_score":0.99953425},"labels":[],"label_agreement":null},{"id":"W4200183458","doi":"10.1111/apt.16735","title":"A nationwide cohort study of the incidence of inflammatory bowel disease in Sweden from 1990 to 2014","year":2021,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Inflammatory bowel disease; Incidence (geometry); Cohort; Inflammatory Bowel Diseases; Cohort study; Disease; Internal medicine","score_opus":0.01180157219732874,"score_gpt":0.29330598256042445,"score_spread":0.2815044103630957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200183458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99765307,0.00055084075,0.00000788423,0.00039237356,0.00041927682,0.00083972234,0.00009899581,0.000005863335,0.000031966032],"genre_scores_gemma":[0.9944477,0.00013402065,0.000052654887,0.005018949,0.00009193471,0.00010731233,0.000068467685,0.000021415488,0.000057565623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982685,0.00047596302,0.00043698732,0.0003649475,0.0002535526,0.00020005708],"domain_scores_gemma":[0.9990298,0.00004648226,0.00017190957,0.000503651,0.00014400843,0.000104125684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022003503,0.00017097266,0.00017641227,0.000053187883,0.0000538757,0.0000053516123,0.00040990682,0.00007192934,0.00014350118],"category_scores_gemma":[0.000003059891,0.00015889244,0.0000876858,0.000120535704,0.000113675,0.000008791029,0.00036598614,0.000115275085,0.0000075561234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040756178,0.0004834533,0.64364535,0.000010699292,0.0010757091,0.000058321493,0.00028274133,0.001000392,0.3528161,0.0000028888464,0.000197556,0.000019205016],"study_design_scores_gemma":[0.0012091734,0.00007468618,0.821578,0.00001205975,0.0010662863,8.1684874e-7,0.00024696017,0.00008379122,0.17519617,0.000035430745,0.00036762434,0.00012899193],"about_ca_topic_score_codex":0.00014937703,"about_ca_topic_score_gemma":0.0006670245,"teacher_disagreement_score":0.17793263,"about_ca_system_score_codex":0.000038508482,"about_ca_system_score_gemma":0.00029973494,"threshold_uncertainty_score":0.64794457},"labels":[],"label_agreement":null},{"id":"W4200577699","doi":"10.1111/apt.16730","title":"Incidence, outcomes, and impact of COVID‐19 on inflammatory bowel disease: propensity matched research network analysis","year":2021,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Inflammatory bowel disease; Incidence (geometry); Population; Internal medicine; Cohort study; Retrospective cohort study; Relative risk; Propensity score matching; Coronavirus disease 2019 (COVID-19); Disease; Infectious disease (medical specialty); Confidence interval","score_opus":0.042735777373143234,"score_gpt":0.37999471694826403,"score_spread":0.3372589395751208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200577699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99644107,0.0017804923,0.000030864016,0.0009016822,0.00016133332,0.0004663206,0.0001254584,0.000018401788,0.00007436918],"genre_scores_gemma":[0.9904937,0.0010802333,0.00009775873,0.007442112,0.00016680872,0.00005137184,0.00037764787,0.000032576787,0.0002577518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969888,0.0010931703,0.000391007,0.00058455876,0.00035697862,0.0005854908],"domain_scores_gemma":[0.9983624,0.0001201029,0.00015680319,0.0005874272,0.00026867332,0.0005045565],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009346676,0.00027878507,0.0003549908,0.00015631298,0.00027457028,0.000024973668,0.00028987208,0.00015666112,0.00037022433],"category_scores_gemma":[0.000006149084,0.00025383368,0.00030688642,0.0003779456,0.00046717344,0.00001199476,0.00043458102,0.00027716765,0.000011262984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021344784,0.00031560948,0.87589127,0.000051755884,0.019098299,0.0005421029,0.00009605702,0.0051851193,0.094596215,0.00003970567,0.001996074,0.000053302792],"study_design_scores_gemma":[0.0015843969,0.00023777259,0.9770677,0.0000076527685,0.0062486934,0.000008874978,0.00008118872,0.0003954386,0.012347149,0.00019938378,0.0015210777,0.0003006862],"about_ca_topic_score_codex":0.000036360598,"about_ca_topic_score_gemma":0.00007361766,"teacher_disagreement_score":0.1011764,"about_ca_system_score_codex":0.00013067208,"about_ca_system_score_gemma":0.0009886125,"threshold_uncertainty_score":0.9999914},"labels":[],"label_agreement":null},{"id":"W4200584543","doi":"10.1111/apt.16717","title":"Systematic review with meta‐analysis: COVID‐19 outcomes in patients receiving anti‐TNF treatments","year":2021,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Internal medicine; Observational study; Coronavirus disease 2019 (COVID-19); Adverse effect; Intensive care unit; MEDLINE; Disease; Infectious disease (medical specialty)","score_opus":0.192779615664722,"score_gpt":0.5248047859042109,"score_spread":0.33202517023948885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200584543","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025798407,0.9869892,0.000008511826,0.0035369254,0.00018369895,0.008984544,0.00017950131,0.00006904098,0.000022749537],"genre_scores_gemma":[0.00006691092,0.93220925,0.000105924584,0.06357654,0.00003786397,0.002421597,0.0008187606,0.00010154124,0.0006616277],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9906692,0.0035721548,0.0025386785,0.00126074,0.0010857233,0.0008735333],"domain_scores_gemma":[0.9873053,0.009629131,0.0011683094,0.0011156463,0.0002607857,0.0005208463],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017361531,0.0011507155,0.016218591,0.00075197115,0.00016744797,0.000027324424,0.00057722925,0.00030645754,0.0011036841],"category_scores_gemma":[0.00012132968,0.0006765627,0.0035802207,0.0021336975,0.0002723573,0.00009571395,0.00039812736,0.0010840172,0.00007075293],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002961122,0.0012627542,0.0026790448,0.38036603,0.6141774,0.0002986849,0.000039382,0.0000029510345,1.0745285e-7,5.3121414e-7,0.000065437875,0.0010780728],"study_design_scores_gemma":[0.0022238144,0.0005673003,0.00013683512,0.05184464,0.9043024,0.0000066023804,0.00001725102,0.0000043022274,8.316907e-7,0.000001359362,0.04043951,0.00045511537],"about_ca_topic_score_codex":0.00009662629,"about_ca_topic_score_gemma":0.000030421072,"teacher_disagreement_score":0.3285214,"about_ca_system_score_codex":0.0014115714,"about_ca_system_score_gemma":0.0012864479,"threshold_uncertainty_score":0.99980944},"labels":[],"label_agreement":null},{"id":"W4206739074","doi":"10.1111/apt.16753","title":"Randomised clinical trial: a phase 1b study of GB004, an oral HIF‐1α stabiliser, for treatment of ulcerative colitis","year":2022,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Ulcerative colitis; Placebo; Internal medicine; Adverse effect; Gastroenterology; Pharmacodynamics; Dysgeusia; Pharmacokinetics; Nausea; Inflammatory bowel disease; Colitis; Disease; Pathology","score_opus":0.1093511981041874,"score_gpt":0.44778777513990425,"score_spread":0.33843657703571683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206739074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98899835,0.002077885,0.000048310445,0.00018126961,0.0031454735,0.0048083486,0.000711524,0.00001140253,0.000017454877],"genre_scores_gemma":[0.9926,0.0020952695,0.00022269765,0.0018211798,0.0009894026,0.001547913,0.0005129143,0.000043830743,0.00016679641],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99691516,0.0012700101,0.0008274879,0.00049949304,0.0001805732,0.0003072445],"domain_scores_gemma":[0.99885213,0.00015505611,0.00039167533,0.00036015164,0.0001261577,0.000114848815],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006687567,0.000258435,0.00073695247,0.00006601593,0.00018245248,0.000005530574,0.0002663992,0.00009234252,0.0002866636],"category_scores_gemma":[0.00000108879,0.00024678514,0.0003286513,0.00010983529,0.00020194463,0.000008282779,0.0000920982,0.00008390607,3.108297e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.53746516,0.049389653,0.0002449107,0.000013792548,0.013541356,0.0000038274384,0.0022772439,0.00015769934,0.3790797,0.000008583787,0.001149877,0.01666822],"study_design_scores_gemma":[0.61378986,0.069322616,0.00012887229,9.606465e-7,0.007653529,0.0000050558992,0.002665031,0.00020850316,0.177255,0.00003031989,0.12869701,0.0002432431],"about_ca_topic_score_codex":0.00012416727,"about_ca_topic_score_gemma":0.00014304898,"teacher_disagreement_score":0.20182471,"about_ca_system_score_codex":0.00006363977,"about_ca_system_score_gemma":0.00026870563,"threshold_uncertainty_score":0.99999845},"labels":[],"label_agreement":null},{"id":"W4212856481","doi":"10.1111/apt.16805","title":"Resolution of dominant patient‐reported outcome at end of induction predicts clinical and endoscopic remission in Crohn’s disease","year":2022,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Internal medicine; Odds ratio; Crohn's disease; Confounding; Gastroenterology; Logistic regression; Post-hoc analysis; Severity of illness; Clinical trial; Disease; Surgery","score_opus":0.038732651046004186,"score_gpt":0.3360995419783202,"score_spread":0.297366890932316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212856481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99756575,0.0010059527,0.0000045892893,0.00018605133,0.0006484902,0.0004713777,0.00009064942,0.0000053451836,0.000021814147],"genre_scores_gemma":[0.9981246,0.0003898999,0.00006120669,0.0010589157,0.000054267974,0.00005748599,0.00018109611,0.000016350681,0.00005615255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981233,0.00050865154,0.000692633,0.00031457352,0.00017755221,0.00018327941],"domain_scores_gemma":[0.99926597,0.000028074342,0.00034122626,0.00022012948,0.00004032063,0.000104255654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036358475,0.00013361026,0.00019063614,0.0000779166,0.00009213239,0.0000014448883,0.00011038396,0.000079667174,0.0001525046],"category_scores_gemma":[0.0000024051976,0.00013936116,0.00007729131,0.0000710893,0.00027371445,0.000007071954,0.0003309628,0.00015340078,3.920186e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003205124,0.0004016894,0.5551184,0.000029290313,0.00045971942,0.000120118515,0.00009171842,0.00014603451,0.43979782,0.0000026462383,0.00012555404,0.00050187844],"study_design_scores_gemma":[0.0032545002,0.00043478626,0.8603666,0.000008814157,0.0011346176,0.000012151142,0.00011535378,0.0002770015,0.13208798,0.00003164279,0.0021476822,0.0001289046],"about_ca_topic_score_codex":0.000019608397,"about_ca_topic_score_gemma":0.000008366696,"teacher_disagreement_score":0.30770984,"about_ca_system_score_codex":0.000062449086,"about_ca_system_score_gemma":0.00012141764,"threshold_uncertainty_score":0.5682983},"labels":[],"label_agreement":null},{"id":"W4212871088","doi":"10.1111/apt.16788","title":"Review article: switching patients with chronic hepatitis B to tenofovir alafenamide—a review of current data","year":2022,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Gilead Sciences","keywords":"Tenofovir alafenamide; Medicine; Entecavir; Tenofovir; Renal function; Hepatitis B; Internal medicine; Hepatitis B virus; Creatinine; Chronic hepatitis; Gastroenterology; Urology; Immunology; Human immunodeficiency virus (HIV); Viral load; Virus; Lamivudine","score_opus":0.1396497451120938,"score_gpt":0.43688146253182936,"score_spread":0.29723171741973553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212871088","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003976165,0.98810875,0.0000112535145,0.0015215188,0.0011168072,0.007835142,0.0012412983,0.00007124384,0.000054206466],"genre_scores_gemma":[0.0000063122275,0.93898916,0.00022583734,0.055697523,0.00027220257,0.0008757136,0.0037480942,0.00016244606,0.000022726575],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946086,0.00093298394,0.0018228685,0.0010757737,0.0008304632,0.00072935096],"domain_scores_gemma":[0.9964128,0.0004089512,0.0010424925,0.0016652826,0.00019889053,0.00027157326],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00090809294,0.00086251914,0.0038770537,0.00021945532,0.00021023837,0.0000077747745,0.0011200709,0.000102334816,0.003467365],"category_scores_gemma":[0.0000070956467,0.0006582231,0.0003721041,0.0009586553,0.00014330991,0.00015881234,0.0014978467,0.0011569256,0.00013948043],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030921095,0.00063870574,0.0019599518,0.26965362,0.012117696,0.000034147855,0.000030255118,1.10246596e-7,0.0000037552513,0.0000016295128,0.019752413,0.6957768],"study_design_scores_gemma":[0.0006892486,0.0007920821,0.000104695166,0.19613701,0.08870223,0.000032559412,8.34779e-7,0.0000030256158,0.000004509983,9.045935e-7,0.71312886,0.00040401457],"about_ca_topic_score_codex":0.0002530906,"about_ca_topic_score_gemma":0.00014421355,"teacher_disagreement_score":0.69537276,"about_ca_system_score_codex":0.0010611898,"about_ca_system_score_gemma":0.0012952713,"threshold_uncertainty_score":0.9995869},"labels":[],"label_agreement":null},{"id":"W4214515365","doi":"10.1111/apt.16846","title":"Review article: therapeutic targets for the pharmacologic management of coeliac disease—the future beyond a gluten‐free diet","year":2022,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Context (archaeology); Intensive care medicine; Clinical trial; Disease; Narrative review; Gluten free; Bioinformatics; Internal medicine","score_opus":0.07912552744173036,"score_gpt":0.4171741318529134,"score_spread":0.33804860441118306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214515365","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000021755104,0.95463324,0.00002735872,0.02577959,0.0019945838,0.016340071,0.00090254936,0.000078724304,0.0002417183],"genre_scores_gemma":[0.000010522758,0.9082336,0.00007310584,0.080108225,0.0007599386,0.009085719,0.0009590493,0.0001336199,0.0006362473],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951232,0.00094641786,0.0011383408,0.0008296943,0.0009126258,0.0010496959],"domain_scores_gemma":[0.99636936,0.0010447724,0.0006314626,0.0014522494,0.00012283317,0.00037934954],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014329675,0.00083780795,0.0017522732,0.000160876,0.00064141006,0.00002951497,0.0018127287,0.00012487217,0.0055841017],"category_scores_gemma":[0.0000011368548,0.00047675028,0.0016311764,0.00077493297,0.00052216917,0.00007475035,0.0011134272,0.0009867459,0.00003854178],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014598601,0.0013578703,0.00000460346,0.064768896,0.070536,0.00020460195,0.00003527016,0.0000032976488,0.000009679011,0.000268194,0.16165094,0.6997008],"study_design_scores_gemma":[0.0021628344,0.0006240327,0.000014447283,0.0019382086,0.20853466,0.000021689455,0.00016083979,0.00004579612,0.000008872524,0.0002466461,0.78590655,0.00033544225],"about_ca_topic_score_codex":0.0000058519017,"about_ca_topic_score_gemma":0.0000019714346,"teacher_disagreement_score":0.6993653,"about_ca_system_score_codex":0.00042734118,"about_ca_system_score_gemma":0.00044200502,"threshold_uncertainty_score":0.99976844},"labels":[],"label_agreement":null},{"id":"W4220669040","doi":"10.1111/apt.16896","title":"Letter: potential selection bias in real‐world comparison of ustekinumab versus vedolizumab as a second‐line treatment for Crohn’s disease—authors’ reply","year":2022,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Vedolizumab; Ustekinumab; Medicine; Crohn's disease; Selection (genetic algorithm); Selection bias; Crohn disease; Dermatology; Internal medicine; Disease; Artificial intelligence; Pathology; Infliximab; Computer science","score_opus":0.06538865677292843,"score_gpt":0.36385045561024887,"score_spread":0.29846179883732044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220669040","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9063503,0.0016231211,0.00003012063,0.07931035,0.006358932,0.0037519836,0.0023118828,0.00007597173,0.00018730621],"genre_scores_gemma":[0.3074681,0.0008931704,0.00024080559,0.65797913,0.0072239097,0.002095348,0.018788623,0.00034854072,0.00496237],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99606586,0.00082317536,0.00095457176,0.001040838,0.00035482776,0.0007607168],"domain_scores_gemma":[0.99839246,0.00011874111,0.0006647919,0.0005650023,0.00011697772,0.00014199718],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002352259,0.0007092003,0.00069453754,0.00037388143,0.00022452131,0.000025839709,0.00049862306,0.0004428525,0.001385549],"category_scores_gemma":[0.0000012571886,0.0007896789,0.00053221534,0.0001901814,0.00020684944,0.000013094755,0.00019820056,0.0007788816,0.000010130897],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07149853,0.0022593571,0.0051651835,0.00047179218,0.02203377,0.002460668,0.00039380393,0.0027696467,0.07357905,0.000008291826,0.81828386,0.0010760243],"study_design_scores_gemma":[0.011597147,0.0028835395,0.0023748174,0.000019255609,0.009553978,0.0000129563705,0.000057660858,0.0009150587,0.03720577,0.000032448403,0.93455327,0.0007940935],"about_ca_topic_score_codex":0.00021663519,"about_ca_topic_score_gemma":0.0004101446,"teacher_disagreement_score":0.59888226,"about_ca_system_score_codex":0.00071492436,"about_ca_system_score_gemma":0.0006368226,"threshold_uncertainty_score":0.99952734},"labels":[],"label_agreement":null},{"id":"W4220680365","doi":"10.1111/apt.16883","title":"Review article: paradoxical psoriasis as a consequence of tumour necrosis factor antagonists in patients with inflammatory bowel disease","year":2022,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Psoriasis; Medicine; Inflammatory bowel disease; Disease; Dermatology; Ulcerative colitis; Population; Crohn's disease; Ustekinumab; Immunology; Adalimumab; Internal medicine","score_opus":0.039079317589170416,"score_gpt":0.3201587357453049,"score_spread":0.28107941815613446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220680365","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05686216,0.93843025,2.2923928e-7,0.00016285754,0.0010276829,0.002217639,0.001236551,0.000048379723,0.000014221118],"genre_scores_gemma":[0.0037096823,0.99011815,0.000016480455,0.0036021215,0.0000339318,0.0007385911,0.0016181474,0.000081406964,0.00008146335],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955412,0.0017771818,0.0011297503,0.00074596977,0.00014357576,0.0006623018],"domain_scores_gemma":[0.9980454,0.0005420669,0.0007654464,0.00048303205,0.000054790693,0.00010928428],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000253885,0.0007747421,0.0018336814,0.0002407879,0.00019142037,0.000008989581,0.00062363717,0.00030871184,0.0042916914],"category_scores_gemma":[0.000001832747,0.00062302296,0.00046954822,0.00039696138,0.0004856933,0.00011094672,0.00020644351,0.00068084645,0.00017454097],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007623505,0.010395858,0.046080794,0.03704008,0.085538104,0.0014994671,0.00058034004,0.0000043403534,0.0023302163,0.000043265383,0.0023283912,0.80653566],"study_design_scores_gemma":[0.0062257405,0.0010186876,0.0056968583,0.005449681,0.062158488,0.000091817354,0.000023942408,3.6801242e-7,0.0010361833,0.000019411487,0.917243,0.0010358486],"about_ca_topic_score_codex":0.00003581522,"about_ca_topic_score_gemma":0.000005037016,"teacher_disagreement_score":0.9149146,"about_ca_system_score_codex":0.00033332963,"about_ca_system_score_gemma":0.0006736556,"threshold_uncertainty_score":0.9996221},"labels":[],"label_agreement":null},{"id":"W4220698681","doi":"10.1111/apt.16780","title":"Editorial: therapeutic phlebotomy for iron overload—start with a diagnosis before bleeding","year":2022,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Phlebotomy; Medicine; Bloodletting; Hemochromatosis; Iron Isotopes; Intensive care medicine; Internal medicine; Pathology; Alternative medicine","score_opus":0.017594413401445675,"score_gpt":0.3199172016505144,"score_spread":0.3023227882490687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220698681","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028226136,0.008926375,0.000031834337,0.0026317257,0.9798211,0.00408156,0.0012018569,0.00025782367,0.00022515],"genre_scores_gemma":[0.00078477827,0.006375306,0.00044656222,0.014430237,0.96791774,0.004059509,0.0044015213,0.00042472675,0.0011596187],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948175,0.00027715258,0.00077993044,0.0012354373,0.0016307299,0.0012592777],"domain_scores_gemma":[0.99691474,0.0012316421,0.0005507291,0.00063347694,0.00035991,0.0003095075],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006665238,0.0010911176,0.001408378,0.0003837719,0.00062812655,0.0000647453,0.0006514789,0.0010330257,0.0027676045],"category_scores_gemma":[0.000002607201,0.0009544817,0.00048599302,0.00037664114,0.00038620006,0.00021242847,0.00022349988,0.0020835926,0.000027272963],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058216355,0.0011530991,0.0010778065,0.0005584403,0.010587108,0.000040378683,0.00081492023,0.00002013806,0.0016943006,0.000015451795,0.9767424,0.0014743637],"study_design_scores_gemma":[0.013915985,0.004074113,0.000033990098,0.000060133247,0.06592256,0.0000106522275,0.0005172703,0.000023055894,0.0011447729,0.000106913314,0.91340744,0.00078312686],"about_ca_topic_score_codex":0.00016828209,"about_ca_topic_score_gemma":0.000032214124,"teacher_disagreement_score":0.063334934,"about_ca_system_score_codex":0.000605113,"about_ca_system_score_gemma":0.0011126585,"threshold_uncertainty_score":0.9992906},"labels":[],"label_agreement":null},{"id":"W4220710756","doi":"10.1111/apt.16866","title":"Editorial: is it not just <scp>PRO</scp>s, but the most important individual <scp>PRO</scp>, that really matters in Crohn’s disease? Authors’ reply","year":2022,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McMaster University; Population Health Research Institute","funders":"","keywords":"Crohn's disease; Medicine; Crohn disease; Disease; Immunology; Internal medicine","score_opus":0.026312234117432973,"score_gpt":0.30893867260785285,"score_spread":0.28262643849041985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220710756","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11908645,0.0025271685,0.0000037373209,0.00486182,0.8598252,0.002767172,0.010663563,0.00011958621,0.00014531653],"genre_scores_gemma":[0.0039489293,0.0070318175,0.00005287301,0.11199081,0.85454756,0.0017272347,0.015992388,0.00055044395,0.004157965],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9898161,0.001707012,0.001742574,0.0023998618,0.0023581046,0.0019763438],"domain_scores_gemma":[0.9944445,0.001109375,0.0014813216,0.0018879633,0.00035473434,0.0007221151],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0023092295,0.0016500497,0.001024824,0.00035409868,0.00085037516,0.0002635967,0.0031392302,0.0016737701,0.00038505797],"category_scores_gemma":[0.000057306712,0.0015769579,0.0006793948,0.00038817394,0.0008291426,0.00005593003,0.0018851304,0.00316158,0.0000731305],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078970025,0.0006297091,0.0042084777,0.0001732593,0.008398426,0.0013392598,0.0013487659,0.000060555278,0.014646252,0.0000030542174,0.9683454,0.000057128407],"study_design_scores_gemma":[0.003629228,0.0003280626,0.0042598066,0.000044137585,0.009728271,0.0000145499,0.0017553915,0.000033570246,0.00996935,0.000047780057,0.9696839,0.00050595554],"about_ca_topic_score_codex":0.00028969412,"about_ca_topic_score_gemma":0.00010888801,"teacher_disagreement_score":0.115137525,"about_ca_system_score_codex":0.0005532529,"about_ca_system_score_gemma":0.0027559598,"threshold_uncertainty_score":0.99962467},"labels":[],"label_agreement":null},{"id":"W4220906819","doi":"10.1111/apt.16803","title":"Editorial: <scp>anti‐TNF</scp> combination therapy for inflammatory bowel disease–one size does not fit all","year":2022,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"","keywords":"Medicine; Inflammatory bowel disease; Tumor necrosis factor alpha; Inflammatory Bowel Diseases; Disease; Immunology; Gastroenterology; Internal medicine","score_opus":0.014466988151664043,"score_gpt":0.2961796664891882,"score_spread":0.28171267833752417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220906819","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0873873,0.0020052532,0.000012502874,0.0005825234,0.90207237,0.00294142,0.0048044287,0.00014479266,0.000049396996],"genre_scores_gemma":[0.0042562312,0.011803197,0.00009535282,0.009184167,0.9560144,0.0025197607,0.013103676,0.0004204433,0.002602801],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99432087,0.0008182079,0.00096951943,0.0015077938,0.0012481018,0.0011354876],"domain_scores_gemma":[0.99589515,0.001260598,0.00083477865,0.0009669609,0.0005926009,0.00044993332],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00096783275,0.0011210962,0.0006932657,0.00016795973,0.00057755056,0.00010767365,0.0014234981,0.0013391312,0.00036237226],"category_scores_gemma":[0.000033488013,0.0011100682,0.00067981414,0.00009889388,0.0003808871,0.000037295813,0.00056092866,0.0011117604,0.00002369404],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025797237,0.0010535262,0.000385831,0.00020359864,0.011855399,0.000049059352,0.00011683798,0.000090895905,0.13773623,0.000016207752,0.84581375,0.00009894998],"study_design_scores_gemma":[0.007931543,0.0007152978,0.00064679363,0.000019271385,0.0065111057,8.2418035e-7,0.000079918245,0.000049495593,0.032518376,0.00017825612,0.9507357,0.00061345525],"about_ca_topic_score_codex":0.000012969599,"about_ca_topic_score_gemma":0.000009500442,"teacher_disagreement_score":0.10521786,"about_ca_system_score_codex":0.00033568777,"about_ca_system_score_gemma":0.0013339506,"threshold_uncertainty_score":0.9999573},"labels":[],"label_agreement":null},{"id":"W4220952985","doi":"10.1111/apt.16875","title":"Editorial: some of the obstacles in managing mood disorders in <scp>IBD</scp>","year":2022,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Manitoba","funders":"","keywords":"Medicine; Mood; Mood disorders; Psychiatry; Anxiety","score_opus":0.016513892359135952,"score_gpt":0.29238044119054707,"score_spread":0.2758665488314111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220952985","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.041724492,0.0012223733,4.1810836e-7,0.0013317019,0.95376325,0.0010198653,0.0002789053,0.00006439586,0.0005946083],"genre_scores_gemma":[0.06941681,0.013498843,0.000015107655,0.0061884234,0.9097062,0.00036461608,0.00012307342,0.00021009037,0.00047688198],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99510926,0.0012557181,0.0007639345,0.000905531,0.001118439,0.00084712415],"domain_scores_gemma":[0.994683,0.0042424332,0.0004869907,0.00049376424,0.000026068667,0.00006774426],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000503891,0.00054883544,0.0006187715,0.00044216757,0.00021598309,0.00003225925,0.0019621504,0.00051912555,0.00020383006],"category_scores_gemma":[0.00002369181,0.0005078425,0.00024453417,0.0008794054,0.0005407075,0.00024550906,0.00077558926,0.0023327742,0.000009885188],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001306803,0.0010115383,0.00069347693,0.00009669395,0.00053626066,0.000010926694,0.0018920122,0.00050904736,0.066816874,0.00006106051,0.92786586,0.00037557987],"study_design_scores_gemma":[0.0039098137,0.00019401989,0.00022712773,0.000036489757,0.0005788066,8.4192766e-7,0.001241673,0.00012110317,0.027780669,0.0029025043,0.962756,0.00025094918],"about_ca_topic_score_codex":0.00029225004,"about_ca_topic_score_gemma":0.0005157765,"teacher_disagreement_score":0.04405709,"about_ca_system_score_codex":0.00038552986,"about_ca_system_score_gemma":0.00037083201,"threshold_uncertainty_score":0.9999689},"labels":[],"label_agreement":null},{"id":"W4220990603","doi":"10.1111/apt.16804","title":"Mild neoterminal ileal post‐operative recurrence of Crohn’s disease conveys higher risk for severe endoscopic disease progression than isolated anastomotic lesions","year":2022,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Crohn's and Colitis Foundation","keywords":"Medicine; Crohn's disease; Disease; Retrospective cohort study; Internal medicine; Surgery; Gastroenterology; Logistic regression; Anastomosis; Cohort; Inflammatory bowel disease; Severity of illness; Colonoscopy; Cancer; Colorectal cancer","score_opus":0.019180052217940877,"score_gpt":0.3226939247625525,"score_spread":0.3035138725446116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220990603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911301,0.002068173,0.00008591765,0.00079828396,0.0010825376,0.0016206225,0.0031700924,0.000030228655,0.000014059357],"genre_scores_gemma":[0.9920427,0.0003024363,0.00019828988,0.004737428,0.00020225256,0.00062940555,0.0015521711,0.000056085075,0.000279207],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975152,0.0007804563,0.00039777573,0.0005968123,0.00024006126,0.00046969103],"domain_scores_gemma":[0.99873763,0.00006109114,0.00029363832,0.00038111012,0.00016576283,0.00036073627],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019719116,0.00034246885,0.00023683175,0.000084984174,0.00057020714,0.000013837713,0.00043349675,0.000078111814,0.0006958155],"category_scores_gemma":[0.0000017749662,0.00034456246,0.00021535985,0.00011206254,0.0002999174,0.000018128321,0.00033863934,0.0002687733,0.0000060973193],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08069074,0.00639441,0.3557457,0.0005541617,0.012489017,0.0017283913,0.0014132115,0.004243039,0.5238756,0.00011954071,0.006098851,0.006647365],"study_design_scores_gemma":[0.013566979,0.004040764,0.8998548,0.000092833,0.015768675,0.000020405323,0.0005578893,0.0067237453,0.043083955,0.0002640082,0.014589406,0.0014365581],"about_ca_topic_score_codex":0.0000149005355,"about_ca_topic_score_gemma":0.000006588755,"teacher_disagreement_score":0.5441091,"about_ca_system_score_codex":0.000081811944,"about_ca_system_score_gemma":0.00047500728,"threshold_uncertainty_score":0.99990064},"labels":[],"label_agreement":null},{"id":"W4221036755","doi":"10.1111/apt.16848","title":"Persistence of treatment in patients with ulcerative colitis who responded to tofacitinib therapy: data from the open‐label, long‐term extension study, <scp>OCTAVE</scp> open","year":2022,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Pfizer","keywords":"Tofacitinib; Medicine; Discontinuation; Janus kinase inhibitor; Ulcerative colitis; Post-hoc analysis; Internal medicine; Open label; Gastroenterology; Persistence (discontinuity); Surgery; Clinical trial","score_opus":0.08895926622687746,"score_gpt":0.3544098147730109,"score_spread":0.2654505485461335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221036755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913878,0.00023203604,0.000002851604,0.00031968195,0.00020936433,0.005016607,0.002742468,0.0000070114106,0.00008217278],"genre_scores_gemma":[0.98302674,0.0001509027,0.00009815615,0.013339473,0.000052522075,0.0006238773,0.0023872757,0.000046417917,0.0002746396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996727,0.001413607,0.00037503857,0.00084666867,0.000268655,0.00036905732],"domain_scores_gemma":[0.9983157,0.00013080762,0.00021825568,0.0011117277,0.00011331454,0.000110211666],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045780174,0.00032056862,0.0003340709,0.000053311865,0.00036702806,0.00006428534,0.0024573463,0.000055936405,0.00029492614],"category_scores_gemma":[0.0000015185512,0.00024772843,0.000036716214,0.00018973333,0.00015656158,0.0000398408,0.0029189996,0.0001620772,0.0000046414298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02574878,0.0077977325,0.8831425,0.0000048216234,0.008844159,0.00021730491,0.0061542504,0.00021891177,0.06380734,0.000005214237,0.0021572511,0.0019017471],"study_design_scores_gemma":[0.018287605,0.007324169,0.949002,0.000010844499,0.0010950151,0.0000027620556,0.0023970283,0.000042826403,0.0137654375,0.000008393957,0.0078737615,0.00019010587],"about_ca_topic_score_codex":0.0003887864,"about_ca_topic_score_gemma":0.0008098429,"teacher_disagreement_score":0.06585956,"about_ca_system_score_codex":0.00018233067,"about_ca_system_score_gemma":0.00036214115,"threshold_uncertainty_score":0.9999975},"labels":[],"label_agreement":null},{"id":"W4225146132","doi":"10.1111/apt.16950","title":"The knowledge and skills needed to perform intestinal ultrasound for inflammatory bowel diseases—an international Delphi consensus survey","year":2022,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Ultrasound in Clinical Applications","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Novo Nordisk Fonden","keywords":"Medicine; Inflammatory Bowel Diseases; Delphi method; Delphi; MEDLINE; Inflammatory bowel disease; Gastroenterology; Ultrasound; Internal medicine; Medical physics; Radiology; Artificial intelligence; Disease","score_opus":0.049229320903220235,"score_gpt":0.39699322868274795,"score_spread":0.3477639077795277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225146132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98553795,0.00046698525,0.00006010306,0.010483628,0.0011458448,0.0014965411,0.000624884,0.00006763304,0.00011644855],"genre_scores_gemma":[0.961544,0.00034141165,0.0008898767,0.034638748,0.00042780553,0.0009733311,0.00072541385,0.0000453994,0.0004140279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998322,0.00028173058,0.00046109568,0.00038463637,0.0002123014,0.0003382137],"domain_scores_gemma":[0.9931538,0.0059442697,0.00012403303,0.00028730926,0.00021460031,0.00027599765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085436634,0.00019967716,0.0002061619,0.000076513206,0.0008057331,0.000032127908,0.00038930026,0.000049242495,0.0006782353],"category_scores_gemma":[0.000018960305,0.00016912921,0.000079609585,0.00014888494,0.0003645066,0.000052499592,0.00019058363,0.00037845588,0.000017158522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008366262,0.0053170267,0.81907815,0.000044082568,0.010875576,0.000016213215,0.0032447823,0.00014976297,0.12036594,0.0006395381,0.020916779,0.010985871],"study_design_scores_gemma":[0.008013371,0.003126603,0.6472061,0.000013257172,0.0062163486,0.00039367206,0.0026051856,0.0034209245,0.004315721,0.000990656,0.32312942,0.0005687322],"about_ca_topic_score_codex":0.000049340797,"about_ca_topic_score_gemma":0.000057221514,"teacher_disagreement_score":0.30221263,"about_ca_system_score_codex":0.00022746345,"about_ca_system_score_gemma":0.00021604037,"threshold_uncertainty_score":0.7426201},"labels":[],"label_agreement":null},{"id":"W4281903017","doi":"10.1111/apt.17050","title":"Strongly increased risk of gastric and duodenal ulcers among new users of low‐dose aspirin: results from two large cohorts with new‐user design","year":2022,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Bundesministerium für Familie, Senioren, Frauen und Jugend; Medical Research Council Canada; Ministerium für Soziales, Gesundheit, Frauen und Familie, Saarland; Northwest Regional Development Agency; Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg; Scottish Government Health and Social Care Directorate; Bundesministerium für Bildung und Forschung; Llywodraeth Cymru; British Heart Foundation; Wellcome Trust","keywords":"Aspirin; Medicine; Hazard ratio; Internal medicine; Low dose aspirin; Gastroenterology; Incidence (geometry); Cohort study; Risk factor; Confidence interval; Proportional hazards model; Population; Cohort; Environmental health","score_opus":0.017257092086966994,"score_gpt":0.2679034749777676,"score_spread":0.2506463828908006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281903017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926453,0.0044819037,0.0010100139,0.00022144616,0.00016467436,0.0008895845,0.00052311417,0.00003983572,0.000024078585],"genre_scores_gemma":[0.9944012,0.0017378773,0.0010807989,0.0021187884,0.00016260968,0.000018346853,0.00033859097,0.000051452622,0.000090343834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761224,0.00059803016,0.00047044337,0.00043932136,0.00049828656,0.00038165433],"domain_scores_gemma":[0.9986459,0.0002730934,0.00036981452,0.000350049,0.00005853656,0.0003026173],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047660497,0.00029528287,0.0006347055,0.00015603384,0.00015826098,0.000006720654,0.00018929633,0.000065219516,0.000719632],"category_scores_gemma":[7.8730113e-7,0.0002665088,0.00022087025,0.0002922864,0.00025529007,0.000107044536,0.000109887595,0.0003791293,0.0000016403499],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055874497,0.0012493427,0.8013417,0.000042628024,0.07262263,0.00040739262,0.0014172682,0.012017132,0.049016327,0.000005348857,0.0018526664,0.004153053],"study_design_scores_gemma":[0.14501017,0.0076067094,0.5817524,0.00014829244,0.09608212,0.00023651739,0.0030204735,0.0033148318,0.15720269,0.00011918698,0.0045574075,0.00094920193],"about_ca_topic_score_codex":0.0025990482,"about_ca_topic_score_gemma":0.000046997942,"teacher_disagreement_score":0.21958932,"about_ca_system_score_codex":0.000089245535,"about_ca_system_score_gemma":0.00048334347,"threshold_uncertainty_score":0.9999787},"labels":[],"label_agreement":null},{"id":"W4281971089","doi":"10.1111/apt.17063","title":"Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohnʼs disease","year":2022,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Rijksuniversiteit Groningen","keywords":"Medicine; Crohn's disease; Serology; Hazard ratio; Gastroenterology; Internal medicine; Pathology; Disease; Immunology; Antibody; Confidence interval","score_opus":0.012130957027776133,"score_gpt":0.2694512437205373,"score_spread":0.2573202866927612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281971089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99478596,0.0039852094,0.0000010381898,0.00067324407,0.00007396015,0.00038268595,0.00008190002,0.0000053127974,0.000010704673],"genre_scores_gemma":[0.9982066,0.0003935126,0.000028179275,0.001223684,0.000046171026,0.000027270993,0.000049717448,0.000011278828,0.0000135548535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991127,0.00026348676,0.00013451911,0.00021742121,0.00012638958,0.00014546126],"domain_scores_gemma":[0.9995541,0.000046439614,0.0001840042,0.00010234161,0.000047029756,0.00006609737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017536178,0.00012384573,0.00010744409,0.000022055547,0.00019512908,0.0000071084633,0.00010716539,0.000050453513,0.00003913233],"category_scores_gemma":[8.361809e-7,0.0000881708,0.000019090387,0.000068148096,0.00025541912,0.0000063255056,0.0002454759,0.000082699844,2.3048056e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050891414,0.00019834227,0.60572124,0.000049975104,0.0027387685,0.000077255885,0.00036495592,0.00011076896,0.38497323,0.000006535527,0.00030672984,0.00036308222],"study_design_scores_gemma":[0.0026290829,0.0008658643,0.9751803,0.000013574701,0.0019037115,0.000016491831,0.0011770971,0.0006990717,0.016397305,0.000014271043,0.00090455584,0.0001986725],"about_ca_topic_score_codex":0.0000026032333,"about_ca_topic_score_gemma":0.000006461668,"teacher_disagreement_score":0.3694591,"about_ca_system_score_codex":0.00001047913,"about_ca_system_score_gemma":0.000052425385,"threshold_uncertainty_score":0.35955006},"labels":[],"label_agreement":null},{"id":"W4282923108","doi":"10.1111/apt.16961","title":"Editorial: seeing the light at the end of gastroscope—Complications after elective procedures are ready for <scp>NICE</scp>, bright decision aid tools","year":2022,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Esophageal and GI Pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Nice; General surgery; Surgery; Computer science","score_opus":0.023748085476992913,"score_gpt":0.3463548685779005,"score_spread":0.32260678310090757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282923108","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016018935,0.011473942,0.000046721845,0.005521691,0.95970017,0.004065796,0.0028351909,0.00008018926,0.000257384],"genre_scores_gemma":[0.005589738,0.0022988692,0.0003221527,0.012662538,0.9705406,0.003781185,0.0023271292,0.00018885713,0.0022889203],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99616414,0.00052882684,0.0008223736,0.00085197284,0.0009065835,0.0007261172],"domain_scores_gemma":[0.99092,0.006774167,0.000853058,0.00075071666,0.00057788356,0.00012415327],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008574202,0.00060182007,0.00087166135,0.0001472581,0.0008213847,0.00003376389,0.00082929066,0.0006435987,0.00045779583],"category_scores_gemma":[0.00003978328,0.0003776882,0.0003668531,0.00029520615,0.0005698247,0.000112078415,0.00048807188,0.0016955816,0.000028218732],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021667923,0.00047447433,0.0006261611,0.00013774387,0.00492168,0.000026177231,0.0010567328,0.000014977558,0.025198884,0.0000075904723,0.96504515,0.00032362776],"study_design_scores_gemma":[0.003515825,0.0012464923,0.00069945044,0.00008452824,0.012583366,0.00004956861,0.00030482557,0.000010551871,0.018972132,0.00020600337,0.96217734,0.00014991678],"about_ca_topic_score_codex":0.000027456485,"about_ca_topic_score_gemma":0.00007770614,"teacher_disagreement_score":0.010840458,"about_ca_system_score_codex":0.0005479208,"about_ca_system_score_gemma":0.0007367032,"threshold_uncertainty_score":0.9998675},"labels":[],"label_agreement":null},{"id":"W4282936026","doi":"10.1111/apt.16935","title":"Editorial: <scp>COVID</scp>‐19 vaccines are safe and effective in patients with inflammatory bowel disease—but many unanswered questions remain","year":2022,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health; Institute for Clinical Evaluative Sciences; SickKids Foundation; University of Toronto","funders":"","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Inflammatory bowel disease; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Inflammatory Bowel Diseases; Coronavirus Infections; Disease; MEDLINE; Intensive care medicine; Virology; Infectious disease (medical specialty); Internal medicine; Outbreak","score_opus":0.0112766895097171,"score_gpt":0.32150278498016366,"score_spread":0.31022609547044655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282936026","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34362212,0.0029567636,0.000004158464,0.000325603,0.64855003,0.0035805167,0.0007623342,0.00014619954,0.0000522388],"genre_scores_gemma":[0.007364184,0.00090578635,0.0000437514,0.048974175,0.939045,0.0018528241,0.0012900853,0.00032703584,0.00019716601],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99433297,0.0011762164,0.0006907392,0.0012136482,0.0016291032,0.0009573206],"domain_scores_gemma":[0.9949839,0.0032030535,0.00044910726,0.00060636294,0.0004398638,0.00031771412],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0008225258,0.0008420841,0.000979282,0.00068942533,0.00041491422,0.00005471812,0.0005203765,0.0007451854,0.00006638539],"category_scores_gemma":[0.000049685383,0.000775941,0.00017345206,0.0004600703,0.00037770707,0.00020851864,0.0004580619,0.002719289,0.000020375423],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005370212,0.0011785706,0.4111133,0.00056357513,0.00564653,0.000389347,0.00042497023,0.00000817345,0.00116888,0.000003401908,0.5740204,0.00011268441],"study_design_scores_gemma":[0.015799532,0.0016003272,0.054107524,0.00017664065,0.007350174,0.000003614546,0.00024967964,0.000033948985,0.00035258042,0.00007931365,0.9198937,0.00035295833],"about_ca_topic_score_codex":0.00031983454,"about_ca_topic_score_gemma":0.00011018735,"teacher_disagreement_score":0.35700575,"about_ca_system_score_codex":0.0016844181,"about_ca_system_score_gemma":0.0022667425,"threshold_uncertainty_score":0.99958146},"labels":[],"label_agreement":null},{"id":"W4283016260","doi":"10.1111/apt.17045","title":"Review article: obesity and colorectal cancer","year":2022,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Overweight; Obesity; Colorectal cancer; Body mass index; Epidemiology; Cancer; Population; Hazard ratio; Internal medicine; Surgery; Environmental health; Confidence interval","score_opus":0.10444584850849406,"score_gpt":0.44021817534207947,"score_spread":0.3357723268335854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283016260","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00082623784,0.9945682,2.526622e-7,0.001022464,0.0012219199,0.0019918582,0.00021326638,0.00005919527,0.000096585165],"genre_scores_gemma":[0.000015557813,0.9548137,0.000016148835,0.043807697,0.00032901016,0.0005982626,0.00021194576,0.000069243586,0.00013840375],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99813855,0.00029144928,0.0005136608,0.00048056117,0.00019821976,0.00037758576],"domain_scores_gemma":[0.99916065,0.00017309772,0.0002649677,0.00019640311,0.000023453924,0.00018140278],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022748398,0.00043234564,0.0016394159,0.00009027178,0.00016726246,0.000008536152,0.00016320257,0.00015329996,0.011091767],"category_scores_gemma":[1.6912426e-7,0.0003554348,0.0003441185,0.0002888701,0.00017325541,0.000043423428,0.00018907696,0.00084425876,0.000026220388],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007913885,0.0003506382,0.00049190805,0.0236044,0.01640282,0.000100072364,0.00007352163,8.299896e-8,0.00007207734,0.0000024764531,0.010483758,0.9483391],"study_design_scores_gemma":[0.0006216011,0.00025278656,0.000049311828,0.0037344776,0.10103125,0.00023843315,0.0000100295465,0.0000032040507,0.000046243702,0.0000026801008,0.8937349,0.0002750995],"about_ca_topic_score_codex":0.00016440301,"about_ca_topic_score_gemma":0.000013723502,"teacher_disagreement_score":0.948064,"about_ca_system_score_codex":0.0004913168,"about_ca_system_score_gemma":0.0004289495,"threshold_uncertainty_score":0.9998898},"labels":[],"label_agreement":null},{"id":"W4283399492","doi":"10.1111/apt.16979","title":"Editorial: it's time to standardise competencies in intestinal ultrasound","year":2022,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Ultrasound in Clinical Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"South Health Campus; University of Calgary; BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Ultrasound; Medical physics; Radiology","score_opus":0.027603927927536027,"score_gpt":0.37357599945943715,"score_spread":0.3459720715319011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283399492","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017275865,0.0005377557,0.000018402749,0.0076631256,0.9849666,0.0019373699,0.0018848315,0.00018238816,0.0010819844],"genre_scores_gemma":[0.0001484934,0.0012531914,0.0015919576,0.021744106,0.96778864,0.00080380816,0.0040540104,0.00016671124,0.0024490666],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951148,0.0004257202,0.0011700778,0.0010237456,0.0014903697,0.00077530456],"domain_scores_gemma":[0.9888987,0.00932792,0.0003305863,0.00066942285,0.00039428746,0.00037906747],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011452752,0.0006419499,0.001149257,0.0003359281,0.000251159,0.00004446927,0.0008242392,0.0007087889,0.021164848],"category_scores_gemma":[0.000039913753,0.0006642673,0.00027627108,0.00063945435,0.0004028831,0.000091755704,0.00037578572,0.00333801,0.00094925676],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015201872,0.0012017074,0.00036179874,0.000053273856,0.0035483486,0.00003679479,0.0002920383,0.000029517967,0.02646792,0.0000028693464,0.9663652,0.000120331686],"study_design_scores_gemma":[0.003402039,0.0018872116,0.000058356913,0.00007443609,0.008385088,0.000023209319,0.0001766468,0.000010929909,0.0005396663,0.00014390796,0.98475593,0.0005425884],"about_ca_topic_score_codex":0.00016043933,"about_ca_topic_score_gemma":0.00003539766,"teacher_disagreement_score":0.025928253,"about_ca_system_score_codex":0.0014402063,"about_ca_system_score_gemma":0.0012985545,"threshold_uncertainty_score":0.99982864},"labels":[],"label_agreement":null},{"id":"W4286696947","doi":"10.1111/apt.17153","title":"Real‐world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases","year":2022,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Cilag; ZonMw; Celltrion; Gilead Sciences; GlaxoSmithKline; Achmea; Pfizer; Norgine; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Vedolizumab; Medicine; Discontinuation; Ulcerative colitis; Adverse effect; Internal medicine; Inflammatory bowel disease; Gastroenterology; Disease","score_opus":0.015775645241839005,"score_gpt":0.2954949382348914,"score_spread":0.2797192929930524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286696947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958902,0.0005368424,0.0001668919,0.0003186924,0.0008490024,0.0011304572,0.0010128283,0.000033701275,0.00006136712],"genre_scores_gemma":[0.99158424,0.00032261494,0.00040676582,0.0056238426,0.00029834083,0.00095197017,0.0004361727,0.00006268705,0.0003133799],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99821305,0.00020191257,0.00040517913,0.0005338914,0.0001836317,0.00046231423],"domain_scores_gemma":[0.99908435,0.00006864859,0.00018993249,0.0004110008,0.000063045314,0.00018303136],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000082657156,0.00029837817,0.00024831874,0.00009002131,0.0003034942,0.0000105944155,0.0004389657,0.000051385745,0.00032817648],"category_scores_gemma":[5.960918e-7,0.00031737922,0.00017590134,0.00008377259,0.00010451092,0.000007972384,0.00024631215,0.000094599294,0.000005954369],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009159132,0.0007754811,0.016365424,0.00002306934,0.0032828515,0.00034732468,0.0021345797,0.0021228492,0.9632896,0.000040685612,0.0008090772,0.0016499166],"study_design_scores_gemma":[0.013296817,0.007288281,0.050966866,0.00003340658,0.008402451,0.00009579642,0.0036859177,0.0017414966,0.79524994,0.0005990074,0.11670907,0.0019309389],"about_ca_topic_score_codex":0.00020065637,"about_ca_topic_score_gemma":0.0001345295,"teacher_disagreement_score":0.16803966,"about_ca_system_score_codex":0.00026887073,"about_ca_system_score_gemma":0.00022944155,"threshold_uncertainty_score":0.9999278},"labels":[],"label_agreement":null},{"id":"W4287878569","doi":"10.1111/apt.17087","title":"Editorial: a formula shake each day keeps the complications away – the tolerability and effect of orally‐delivered enteral nutrition in improving post‐operative outcomes in patients with Crohn's disease","year":2022,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Tolerability; Crohn's disease; Parenteral nutrition; Shake; Enteral administration; Disease; Crohn disease; Surgery; Internal medicine; General surgery; Gastroenterology; Intensive care medicine; Adverse effect","score_opus":0.004341358755219885,"score_gpt":0.27222844871124174,"score_spread":0.26788708995602184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4287878569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81988925,0.00031981006,0.0000019044684,0.00036444128,0.1749245,0.0027410649,0.0017465856,0.000008464549,0.0000039925703],"genre_scores_gemma":[0.89009464,0.00019941122,0.000015608906,0.001525907,0.100641824,0.0015890301,0.0058455365,0.000070346185,0.000017709544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99671626,0.0014403937,0.0005046481,0.0005735539,0.00042227426,0.00034288684],"domain_scores_gemma":[0.9983569,0.00047869416,0.00036847594,0.00048833655,0.0002256134,0.00008201846],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006331813,0.0004183475,0.0004111449,0.000077445846,0.00024705782,0.000032064254,0.0005351395,0.00024090419,0.00004555391],"category_scores_gemma":[0.000012432705,0.00027249043,0.00012791653,0.000101128564,0.0003564701,0.000022937596,0.0003678349,0.00068604073,6.296919e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039231278,0.0051622326,0.80275595,0.0005648099,0.0075377477,0.00007854985,0.0018292962,0.00043957485,0.016517593,0.000009505714,0.1252194,0.00065405125],"study_design_scores_gemma":[0.02132489,0.0027882406,0.8887289,0.000072105446,0.004796396,7.3363185e-7,0.00023369055,0.00021349538,0.0012123929,0.00002531782,0.0797614,0.00084242836],"about_ca_topic_score_codex":0.00016751052,"about_ca_topic_score_gemma":0.00022757251,"teacher_disagreement_score":0.08597296,"about_ca_system_score_codex":0.00018757455,"about_ca_system_score_gemma":0.00028701665,"threshold_uncertainty_score":0.9999727},"labels":[],"label_agreement":null},{"id":"W4287879358","doi":"10.1111/apt.17072","title":"Editorial: quality assessment in <scp>IBD</scp> in high‐resource countries can lead to quality improvement clues for <scp>IBD</scp> management worldwide","year":2022,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Manitoba","funders":"","keywords":"Medicine; Quality (philosophy); Resource (disambiguation); Computer science; Computer network","score_opus":0.016293910421917513,"score_gpt":0.34184316567562123,"score_spread":0.3255492552537037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4287879358","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27881116,0.00089298916,0.000062318395,0.00086019933,0.70947045,0.00497584,0.004552087,0.00009541743,0.0002795473],"genre_scores_gemma":[0.014057724,0.0030421296,0.0008749098,0.022775821,0.9271231,0.008525045,0.01783662,0.0005091115,0.0052554957],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9903184,0.0019297355,0.002103155,0.0021612453,0.0016537393,0.0018337277],"domain_scores_gemma":[0.9951821,0.0018363844,0.0010124384,0.0012228529,0.00034593933,0.00040028017],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0039510895,0.0013043305,0.0012826348,0.0005219187,0.00041310219,0.00012790553,0.0017352509,0.0011442675,0.00006789223],"category_scores_gemma":[0.000042395706,0.0015329006,0.00045072037,0.00036730664,0.00036621542,0.000030374016,0.0015069706,0.0015986924,0.000014379316],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009324298,0.0012556153,0.0027218317,0.0006619903,0.006139578,0.000119032724,0.00085391005,0.0007194484,0.025462037,0.00009024919,0.9606473,0.00039657898],"study_design_scores_gemma":[0.007774707,0.0009327117,0.0027244757,0.00004808049,0.0024374826,6.2729276e-7,0.003158818,0.00001720191,0.010645619,0.00018791616,0.97159404,0.00047829925],"about_ca_topic_score_codex":0.00098927,"about_ca_topic_score_gemma":0.0025631567,"teacher_disagreement_score":0.26475343,"about_ca_system_score_codex":0.0020757788,"about_ca_system_score_gemma":0.0012801288,"threshold_uncertainty_score":0.99997085},"labels":[],"label_agreement":null},{"id":"W4290547731","doi":"10.1111/apt.17135","title":"Editorial: further support for exclusive enteral nutrition in paediatric Crohn's disease","year":2022,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Crohn's disease; Parenteral nutrition; Enteral administration; Crohn disease; Intensive care medicine; Disease; Gastroenterology; Pediatrics; Internal medicine","score_opus":0.008841360269197367,"score_gpt":0.2978691481085681,"score_spread":0.2890277878393708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290547731","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0143542485,0.0018553766,0.000012975538,0.00039024363,0.97620106,0.0024622143,0.004650048,0.000040674167,0.000033179393],"genre_scores_gemma":[0.0020011973,0.0032658326,0.000065237524,0.004003971,0.96349996,0.0028830506,0.02342725,0.00019863993,0.00065483863],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99651146,0.00053037616,0.0006280987,0.0010058951,0.0005600644,0.00076410477],"domain_scores_gemma":[0.99855167,0.00018992645,0.00035641386,0.00047159294,0.00017337334,0.00025705076],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039967473,0.0006291489,0.00042927862,0.00023903364,0.00020589874,0.000037174574,0.00071541365,0.0007624293,0.0009271428],"category_scores_gemma":[0.0000037177572,0.00074706174,0.0004163103,0.00012739244,0.00015381949,0.000017169421,0.00045854354,0.00076640217,0.000017373544],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009185981,0.0010726252,0.00048090477,0.0002131646,0.0025914323,0.00039351103,0.000109446395,0.00007240647,0.008725129,0.0000013995286,0.9770691,0.000084916566],"study_design_scores_gemma":[0.007195865,0.00050005945,0.00028578707,0.000011762617,0.004679644,0.000001416801,0.000089975445,0.00003317711,0.00081783417,0.000089444045,0.98559326,0.00070174696],"about_ca_topic_score_codex":0.000009138773,"about_ca_topic_score_gemma":0.000014268428,"teacher_disagreement_score":0.018777201,"about_ca_system_score_codex":0.00026417535,"about_ca_system_score_gemma":0.0009416867,"threshold_uncertainty_score":0.9999862},"labels":[],"label_agreement":null},{"id":"W4292452126","doi":"10.1111/apt.17179","title":"Systematic review and meta‐analysis: efficacy of peppermint oil in irritable bowel syndrome","year":2022,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Irritable bowel syndrome; Adverse effect; Placebo; Internal medicine; Meta-analysis; Number needed to treat; Antispasmodic; Abdominal pain; Relative risk; Randomized controlled trial; Confidence interval; Traditional medicine; Alternative medicine","score_opus":0.09784534684363755,"score_gpt":0.3893306166778712,"score_spread":0.2914852698342337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292452126","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007942599,0.99652326,9.0796095e-7,0.0008304133,0.00007700445,0.002266157,0.00010623884,0.000028196648,0.00008839451],"genre_scores_gemma":[0.00010512695,0.9896655,0.00011727672,0.008717946,0.000007729276,0.0007418675,0.00025894685,0.00004958836,0.00033602942],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9958802,0.0012094008,0.0016110799,0.0005767035,0.00031258818,0.00041004873],"domain_scores_gemma":[0.99777347,0.0008798948,0.0006878453,0.00048012534,0.000038949835,0.00013972202],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009725763,0.0005783402,0.007934743,0.0005250064,0.0000665828,0.000006766171,0.00032298695,0.00013018386,0.002981573],"category_scores_gemma":[0.0000033689075,0.00045047485,0.0017113208,0.000986765,0.00018762499,0.000054195687,0.00019232291,0.00075191533,0.000012531987],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028074699,0.0006369783,0.000009529849,0.5768465,0.42183927,0.00016390948,0.000042699423,0.000002184351,0.0000013262603,0.0000023646376,0.000017570772,0.0004095765],"study_design_scores_gemma":[0.0007655898,0.00046042012,0.000008937888,0.017530968,0.9676563,0.0010425409,0.00007216311,0.000008634527,8.654807e-7,0.000003746906,0.01221667,0.00023313685],"about_ca_topic_score_codex":0.00007817521,"about_ca_topic_score_gemma":0.000011779516,"teacher_disagreement_score":0.55931556,"about_ca_system_score_codex":0.00015928234,"about_ca_system_score_gemma":0.00020708218,"threshold_uncertainty_score":0.9997947},"labels":[],"label_agreement":null},{"id":"W4292582410","doi":"10.1111/apt.17185","title":"Review article: guide to tofacitinib dosing in patients with ulcerative colitis","year":2022,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Tofacitinib; Medicine; Dosing; Ulcerative colitis; Janus kinase inhibitor; Context (archaeology); Clinical trial; Inflammatory bowel disease; Internal medicine; Disease; Intensive care medicine; Rheumatoid arthritis","score_opus":0.02693813839584826,"score_gpt":0.35142583011867917,"score_spread":0.32448769172283093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292582410","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0057756333,0.98939943,0.000004561708,0.00013604562,0.000425913,0.0034158733,0.00060763216,0.000020963387,0.0002139358],"genre_scores_gemma":[0.00004327373,0.9564505,0.00014400306,0.04005992,0.00014169376,0.00090600253,0.0020304886,0.000101336766,0.00012274335],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99684024,0.0009596745,0.0007134544,0.00070915575,0.0002315733,0.00054588215],"domain_scores_gemma":[0.9989728,0.00004839671,0.0002834211,0.0004418278,0.00007038526,0.00018317095],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033029518,0.0005425096,0.0008369316,0.0001169105,0.00013844609,0.00001711194,0.00045813445,0.00016114158,0.0013232486],"category_scores_gemma":[0.0000010645907,0.00050135265,0.00021762884,0.00028306167,0.000101413665,0.000009035159,0.0003227354,0.00037633313,0.000048443708],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040637953,0.0027995529,0.0050651925,0.02383173,0.032321576,0.00096715306,0.00031462763,0.000062747975,0.00024740692,0.00002284648,0.052412804,0.8778906],"study_design_scores_gemma":[0.0014299303,0.00037439825,0.00059664436,0.0018103754,0.0076739304,0.0000113251745,0.000012734166,7.510245e-7,0.00007825927,0.0000011405438,0.9874621,0.00054840953],"about_ca_topic_score_codex":0.000008582997,"about_ca_topic_score_gemma":0.000026611347,"teacher_disagreement_score":0.9350493,"about_ca_system_score_codex":0.00027931653,"about_ca_system_score_gemma":0.00041829425,"threshold_uncertainty_score":0.9997438},"labels":[],"label_agreement":null},{"id":"W4292686086","doi":"10.1111/apt.17141","title":"Editorial: <scp>IBD</scp> and the risk of dementia ‐ the jury is still out","year":2022,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Crohn's and Colitis Canada","keywords":"Medicine; Dementia; Jury; Disease; Internal medicine","score_opus":0.12284400864223512,"score_gpt":0.40576217458001257,"score_spread":0.28291816593777747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292686086","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033854747,0.034631517,0.000038115246,0.017196998,0.9374394,0.0018083525,0.004940242,0.000044292952,0.0005156388],"genre_scores_gemma":[0.001035389,0.037348136,0.00011799636,0.053752083,0.9055461,0.0005848839,0.0003961254,0.00013701404,0.0010822443],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9910174,0.0028679913,0.0040469854,0.0009208218,0.00046134277,0.00068544486],"domain_scores_gemma":[0.9720728,0.020967035,0.005758849,0.0009019387,0.0001611735,0.00013822354],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.023172913,0.00056397304,0.0017948978,0.00024421286,0.0008079412,0.00009074252,0.0013779283,0.0006552922,0.0011120932],"category_scores_gemma":[0.0001597959,0.0004824849,0.00039117658,0.00018493382,0.0009263825,0.00022299917,0.0005526409,0.00188393,0.00025519327],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008992738,0.00013193296,0.001023949,0.00012414507,0.016166542,4.7226735e-7,0.0071525504,0.000036027493,0.0000060254165,0.00038771692,0.97484404,0.00003664925],"study_design_scores_gemma":[0.0037650405,0.00018406843,0.00009844917,0.00001421366,0.0056503997,0.0000011046649,0.0016041058,0.00032482893,0.00003063069,0.0035072388,0.9846111,0.00020883385],"about_ca_topic_score_codex":0.0015684621,"about_ca_topic_score_gemma":0.00007585025,"teacher_disagreement_score":0.03655509,"about_ca_system_score_codex":0.0004837228,"about_ca_system_score_gemma":0.00047876625,"threshold_uncertainty_score":0.99980104},"labels":[],"label_agreement":null},{"id":"W4292687258","doi":"10.1111/apt.17142","title":"Editorial: slow progress to optimising <i>H. pylori</i> eradication treatment with antisecretory drugs","year":2022,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Helicobacter pylori; Helicobacter Infections; Intensive care medicine; Gastroenterology; Pharmacology; Internal medicine","score_opus":0.01692993077589677,"score_gpt":0.31662129595944094,"score_spread":0.29969136518354417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292687258","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016468167,0.003321388,0.000014685264,0.011299878,0.96491337,0.0028985234,0.0005937211,0.00036863377,0.00012161492],"genre_scores_gemma":[0.00090054655,0.0058412417,0.0012159738,0.011069722,0.97427315,0.0016779213,0.003853158,0.00033594487,0.00083236693],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945849,0.0005404523,0.0008378178,0.0014125768,0.001430237,0.0011939713],"domain_scores_gemma":[0.9972378,0.0004939386,0.00053852156,0.00075534184,0.0005117795,0.0004625992],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043632966,0.0011254636,0.0014266872,0.0004651658,0.00058156205,0.000046598205,0.0005213766,0.0008458815,0.00043199203],"category_scores_gemma":[0.0000012644592,0.0009887769,0.000243237,0.00050072744,0.00054483593,0.00015279259,0.00031002774,0.0020139753,0.00006554954],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006256304,0.0013159135,0.0019048422,0.00007247788,0.0459388,0.0002196412,0.0020839483,0.000036673886,0.002978972,2.9790775e-7,0.9371479,0.0020442149],"study_design_scores_gemma":[0.008953856,0.0115833655,0.000067562796,0.00009450503,0.037553824,0.000038428687,0.0003012065,0.000021094083,0.001908589,0.0000015876362,0.9388838,0.0005922261],"about_ca_topic_score_codex":0.000114975315,"about_ca_topic_score_gemma":0.0000120702725,"teacher_disagreement_score":0.01556762,"about_ca_system_score_codex":0.0025955313,"about_ca_system_score_gemma":0.0010258307,"threshold_uncertainty_score":0.99925625},"labels":[],"label_agreement":null},{"id":"W4292692904","doi":"10.1111/apt.17195","title":"Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe <scp>acute‐on‐chronic</scp> liver failure","year":2022,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Terlipressin; Medicine; Hepatorenal syndrome; Placebo; Internal medicine; Gastroenterology; Incidence (geometry); Respiratory failure; Cirrhosis; Pathology","score_opus":0.017870489594962416,"score_gpt":0.255321396047551,"score_spread":0.2374509064525886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292692904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758667,0.0011393492,8.404488e-7,0.0002932078,0.00013075024,0.0006339612,0.00016889317,0.00003227525,0.000014047219],"genre_scores_gemma":[0.98790836,0.00027391134,0.00007159493,0.011273551,0.00004109645,0.000048741065,0.00030226907,0.00003358189,0.000046889465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873435,0.00020555075,0.00017538019,0.00035149604,0.00025841082,0.00027479176],"domain_scores_gemma":[0.9994985,0.00011760252,0.000070582864,0.00013177955,0.00005093507,0.00013063209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000075664764,0.00021640629,0.00023630382,0.00014882567,0.0001676082,0.00001929961,0.000075853706,0.00006787689,0.0001606723],"category_scores_gemma":[8.441289e-8,0.00019075452,0.000023649716,0.00018658668,0.00012805565,0.00022801377,0.00006258588,0.0003842602,0.00000583875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014285558,0.00052776845,0.98461556,0.00008038544,0.006532223,0.00093892973,0.0011664286,0.00003194498,0.0039021503,0.000007803996,0.00061238935,0.00015583973],"study_design_scores_gemma":[0.016448164,0.006555857,0.9533728,0.00007651802,0.015107829,0.0002615395,0.00038054056,0.00015436715,0.0023779543,0.000010618006,0.005054128,0.00019967883],"about_ca_topic_score_codex":0.000027500791,"about_ca_topic_score_gemma":0.000030919597,"teacher_disagreement_score":0.031242777,"about_ca_system_score_codex":0.00014301474,"about_ca_system_score_gemma":0.00012032731,"threshold_uncertainty_score":0.77787435},"labels":[],"label_agreement":null},{"id":"W4294990800","doi":"10.1111/apt.17197","title":"Letter: efficacy of peppermint oil in irritable bowel syndrome—authors' reply","year":2022,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Irritable bowel syndrome; Medicine; Gastroenterology; Traditional medicine; Internal medicine","score_opus":0.03395797134337623,"score_gpt":0.3114087833939419,"score_spread":0.27745081205056565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294990800","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23758623,0.0019282528,0.0000023653786,0.7571854,0.0016726486,0.0006454949,0.00014202084,0.000084948675,0.0007526249],"genre_scores_gemma":[0.02851502,0.0004494238,0.0004268465,0.96571976,0.0006543245,0.00013310577,0.0010410332,0.00012167788,0.0029388177],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961281,0.0005743993,0.0009844117,0.0008287866,0.0005957811,0.00088851625],"domain_scores_gemma":[0.99834204,0.00050082145,0.00037460277,0.00059292075,0.000070056434,0.00011955562],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048678165,0.00058658386,0.00106452,0.00049771846,0.00011950258,0.0000109336925,0.00050306146,0.000393527,0.00537027],"category_scores_gemma":[0.0000020824828,0.0006226481,0.0003809073,0.00037819223,0.00041557316,0.00008187431,0.00026767034,0.0037674792,0.000043547978],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028968786,0.0026497715,0.0107226,0.0010825612,0.007788921,0.01057479,0.0007568659,0.000098261095,0.009658994,0.0000023489074,0.95268154,0.0010864537],"study_design_scores_gemma":[0.0074201277,0.0031439308,0.004084316,0.00021794661,0.010967858,0.0020654972,0.0001860805,0.00010247947,0.0014878645,0.000051435083,0.9697577,0.00051480834],"about_ca_topic_score_codex":0.00045019397,"about_ca_topic_score_gemma":0.000011080124,"teacher_disagreement_score":0.20907122,"about_ca_system_score_codex":0.00038552668,"about_ca_system_score_gemma":0.00027709917,"threshold_uncertainty_score":0.99962246},"labels":[],"label_agreement":null},{"id":"W4296808121","doi":"10.1111/apt.17226","title":"Liver transplant‐free survival according to alkaline phosphatase and <scp>GLOBE</scp> score in patients with primary biliary cholangitis treated with ursodeoxycholic acid","year":2022,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta Hospital; University of Alberta; Toronto General Hospital; University Health Network","funders":"Norgine; European Association for the Study of the Liver; National Institute for Health and Care Research; Gilead Sciences; Intercept Pharmaceuticals; Wellcome Trust; Dr. Falk Pharma; GlaxoSmithKline; Falk Foundation","keywords":"Medicine; Ursodeoxycholic acid; Internal medicine; Gastroenterology; Liver transplantation; Population; Alkaline phosphatase; Cohort; Transplantation; Biology","score_opus":0.01887004848688842,"score_gpt":0.2563371772661479,"score_spread":0.2374671287792595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296808121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993952,0.0025769814,0.000006582448,0.00047170313,0.00018460721,0.0013418227,0.0013014697,0.000068522546,0.00009635621],"genre_scores_gemma":[0.9740305,0.000698794,0.00017389534,0.023010302,0.00006664592,0.00013002174,0.0017550244,0.00006346065,0.000071349714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980494,0.00027032377,0.00027477634,0.00047929143,0.00041061512,0.0005155953],"domain_scores_gemma":[0.9990747,0.00013048439,0.00009561979,0.0003648329,0.00006176854,0.00027258196],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018525716,0.0003485322,0.00044933474,0.00021610978,0.00026761286,0.000018841374,0.00028230628,0.000059717924,0.00026292301],"category_scores_gemma":[3.8886756e-7,0.00029005535,0.000055800534,0.0004929863,0.00014599258,0.00021658462,0.00021590656,0.0005062838,0.0000066861535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053329044,0.0021695646,0.9777899,0.0000665645,0.0035664355,0.0004513989,0.0010165534,0.00003249632,0.0075023156,0.0000029288037,0.00044829524,0.001620692],"study_design_scores_gemma":[0.022282615,0.0047372617,0.9534733,0.00007112483,0.0075418083,0.000084163265,0.00083952845,0.00008379096,0.008107664,0.000004799923,0.0025329122,0.00024098219],"about_ca_topic_score_codex":0.000563925,"about_ca_topic_score_gemma":0.000026997279,"teacher_disagreement_score":0.024316503,"about_ca_system_score_codex":0.0002466083,"about_ca_system_score_gemma":0.000108908,"threshold_uncertainty_score":0.9999552},"labels":[],"label_agreement":null},{"id":"W4297261176","doi":"10.1111/apt.17236","title":"Gut metagenome‐derived signature predicts hepatic decompensation and mortality in NAFLD‐related cirrhosis","year":2022,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Institute of Environmental Health Sciences; National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases; American Association for the Study of Liver Diseases; National Cancer Institute; National Institute on Alcohol Abuse and Alcoholism","keywords":"Medicine; Cirrhosis; Decompensation; Metagenomics; Gastroenterology; Internal medicine; Signature (topology); Biology; Gene","score_opus":0.027319507647665036,"score_gpt":0.31572737367265413,"score_spread":0.2884078660249891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297261176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877759,0.0073281964,0.0000014702513,0.0030243124,0.0004563237,0.0011408771,0.00010005542,0.000054608896,0.000118234835],"genre_scores_gemma":[0.97972167,0.0017101966,0.00007676263,0.017580016,0.000039753068,0.0003631746,0.0004440009,0.000027533863,0.000036902646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983475,0.00038332018,0.00033739532,0.00038374605,0.0002588081,0.00028921003],"domain_scores_gemma":[0.9994006,0.00014102315,0.00011405898,0.00017743706,0.00002959279,0.00013727263],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002313351,0.00022062978,0.00034816845,0.00015216392,0.0001942829,0.000009331749,0.000096358264,0.00006932889,0.0023508861],"category_scores_gemma":[2.1045001e-7,0.00021349885,0.0000913366,0.00023670583,0.000091006375,0.000081814265,0.00012742831,0.0003338355,0.0000087098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047866965,0.0028403664,0.87912697,0.000041385287,0.018524868,0.00047216416,0.0020041836,0.00021436818,0.09477108,0.000033894303,0.00017867895,0.0013134072],"study_design_scores_gemma":[0.00760109,0.0008663943,0.9554227,0.000013137255,0.021204542,0.00004414306,0.00046999904,0.002136853,0.010871768,0.00029794482,0.00083697034,0.00023443355],"about_ca_topic_score_codex":0.00015953377,"about_ca_topic_score_gemma":0.000014375181,"teacher_disagreement_score":0.08389931,"about_ca_system_score_codex":0.00031913604,"about_ca_system_score_gemma":0.00008654705,"threshold_uncertainty_score":0.9985611},"labels":[],"label_agreement":null},{"id":"W4297463011","doi":"10.1111/apt.17188","title":"Editorial: the immunogenicity to second anti‐TNF therapy (IMSAT) therapeutic drug monitoring study—defining the risk of the in‐class switch","year":2022,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Immunogenicity; Drug class; Drug; Intensive care medicine; Pharmacotherapy; Tumor necrosis factor alpha; Pharmacology; Immunology; Oncology; Internal medicine; Antibody","score_opus":0.020953354389105297,"score_gpt":0.33003013455532393,"score_spread":0.30907678016621865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297463011","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15082926,0.024622522,0.0000015512179,0.0031264934,0.8181291,0.0025302467,0.0006444782,0.00005302564,0.00006331777],"genre_scores_gemma":[0.34303543,0.013383899,0.00004013487,0.009628129,0.6310227,0.0009459279,0.00011999967,0.0002808655,0.0015429282],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9871115,0.008587386,0.0014216661,0.0010814471,0.0006322326,0.0011657793],"domain_scores_gemma":[0.9896703,0.0073680244,0.0010680036,0.0015747782,0.00026459436,0.000054345343],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005525027,0.0009979237,0.0013333821,0.00020266589,0.0015909305,0.00007112237,0.004023724,0.0010440262,0.0017780873],"category_scores_gemma":[0.000016500298,0.00052749715,0.00071449514,0.0010014682,0.0009992437,0.00009111923,0.0015001674,0.0066147996,0.00003124417],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002266444,0.0017991245,0.018589789,0.000027537357,0.03745728,0.000007154658,0.0059134173,0.00008395252,0.079305515,0.000013844455,0.85118264,0.0033533336],"study_design_scores_gemma":[0.0037707724,0.0008440887,0.0051100464,0.00003065439,0.007865595,0.0000052862238,0.0032585787,0.000005078401,0.0506658,0.00012649667,0.9277343,0.00058331166],"about_ca_topic_score_codex":0.0010071179,"about_ca_topic_score_gemma":0.00020191164,"teacher_disagreement_score":0.19220617,"about_ca_system_score_codex":0.0004189652,"about_ca_system_score_gemma":0.00056107435,"threshold_uncertainty_score":0.99971765},"labels":[],"label_agreement":null},{"id":"W4304822937","doi":"10.1111/apt.17241","title":"Urgency for bowel movements is a highly discriminatory symptom of active disease in persons with IBD (the Manitoba Living with IBD study)","year":2022,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Manitoba Health; University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Inflammatory bowel disease; Ulcerative colitis; Disease; Faecal calprotectin; Internal medicine; Calprotectin; Crohn's disease; Prospective cohort study; Gastroenterology; Severity of illness","score_opus":0.014795180762845644,"score_gpt":0.2737536266384234,"score_spread":0.25895844587557776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304822937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965318,0.000351042,0.000022444292,0.0004554806,0.00022464783,0.0019774425,0.00038862572,0.000012357835,0.000036158868],"genre_scores_gemma":[0.99109584,0.000046972542,0.000039265033,0.007072364,0.00007958272,0.0013406321,0.00010179549,0.00005931976,0.00016422055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820447,0.0003548511,0.00026982278,0.00048765846,0.00028056657,0.00040263246],"domain_scores_gemma":[0.99919885,0.000055837816,0.00019695458,0.00036671065,0.00006658013,0.000115055525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002168695,0.00028873465,0.00019333455,0.000087400906,0.00033266036,0.000008591323,0.00043365094,0.000038652594,0.0001677684],"category_scores_gemma":[4.0892937e-7,0.00023117856,0.0000994759,0.00012430949,0.00020494865,0.000015266023,0.0002639621,0.00019082267,0.0000011197478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011914327,0.005469868,0.84697324,0.00010753027,0.01308731,0.00025632663,0.0088586,0.001169458,0.11112516,0.000022793456,0.0005774864,0.00043791425],"study_design_scores_gemma":[0.010499773,0.004989168,0.8894089,0.00004000855,0.010758187,0.000011899644,0.03855946,0.0007372083,0.039809566,0.000053479962,0.0041294172,0.0010029693],"about_ca_topic_score_codex":0.00008176069,"about_ca_topic_score_gemma":0.0001690529,"teacher_disagreement_score":0.07131559,"about_ca_system_score_codex":0.00012925628,"about_ca_system_score_gemma":0.00026091665,"threshold_uncertainty_score":0.94271886},"labels":[],"label_agreement":null},{"id":"W4306405348","doi":"10.1111/apt.17247","title":"Assessing the clinical value of faecal bile acid profiling to predict recurrence in primary <i>Clostridioides difficile</i> infection","year":2022,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NIHR Imperial Biomedical Research Centre; Medical Research Council Canada; Medical Research Council; National Institute for Health and Care Research; American College of Gastroenterology","keywords":"Clostridioides; Medicine; Gastroenterology; Internal medicine; Receiver operating characteristic; Multivariate analysis; Bile acid; Diarrhea; Univariate analysis","score_opus":0.07862141524126076,"score_gpt":0.421707466516894,"score_spread":0.34308605127563324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306405348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904241,0.0012016159,0.000055282446,0.0047069825,0.0014109714,0.0016830212,0.0000710368,0.00005844182,0.00038857386],"genre_scores_gemma":[0.98824537,0.001052686,0.00035574232,0.009432285,0.00040685272,0.00029450975,0.00012812369,0.000043392738,0.000041011026],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959481,0.0011321519,0.0009916587,0.00056107563,0.0007625558,0.000604497],"domain_scores_gemma":[0.99838084,0.0007050405,0.00022291289,0.00040128577,0.00011539697,0.00017452314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019201018,0.0002767518,0.0005609177,0.00027621532,0.0003432503,0.000025936723,0.00037616008,0.00011815,0.00032521356],"category_scores_gemma":[0.0000069520606,0.0002298324,0.00023212582,0.0010385807,0.00030564543,0.00012263477,0.00056342303,0.0014973267,0.000012233977],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014433098,0.0025178196,0.22657739,0.00009155101,0.0015093284,0.000081908234,0.0003285209,0.0010039633,0.7532698,0.000018224093,0.00085487176,0.01230336],"study_design_scores_gemma":[0.004572526,0.0033911674,0.056237046,0.00007517019,0.0027854573,0.00014524713,0.0008576168,0.0024884476,0.92252326,0.000035146528,0.006546067,0.00034282706],"about_ca_topic_score_codex":0.00013260827,"about_ca_topic_score_gemma":0.000004153534,"teacher_disagreement_score":0.17034033,"about_ca_system_score_codex":0.0006786546,"about_ca_system_score_gemma":0.0007112863,"threshold_uncertainty_score":0.93722934},"labels":[],"label_agreement":null},{"id":"W4307582688","doi":"10.1111/apt.17265","title":"Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence","year":2022,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hotchkiss Brain Institute; Alberta Health Services; Alberta Health; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cannabis; Cannabis Dependence; Population; Pandemic; Depression (economics); Pediatrics; Cohort; Young adult; Prevalence; Demography; Psychiatry; Environmental health; Coronavirus disease 2019 (COVID-19); Internal medicine; Disease; Infectious disease (medical specialty)","score_opus":0.06292535486845302,"score_gpt":0.37145396517686086,"score_spread":0.30852861030840784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307582688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9475278,0.013450917,6.7276034e-7,0.03722589,0.00016695827,0.0014586028,0.000096139804,0.000013736429,0.000059240367],"genre_scores_gemma":[0.9896372,0.003881135,0.000033494445,0.004836138,0.000043119304,0.000582278,0.00009233329,0.000021669828,0.0008726187],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975783,0.00073574384,0.00038750865,0.00032738436,0.00061436684,0.00035665632],"domain_scores_gemma":[0.99943936,0.000019563087,0.00014511512,0.00019542585,0.00009119436,0.00010934772],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00072063616,0.00016259126,0.00038651697,0.00022403471,0.00015747236,0.000004010911,0.00011135909,0.000026575632,0.001670318],"category_scores_gemma":[3.481315e-7,0.00015348382,0.0000627837,0.00040543266,0.00016912425,0.000042436666,0.00010456182,0.0002111083,0.000002258586],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022439638,0.0038489443,0.3603039,0.0005192565,0.008828212,0.0002548537,0.013589436,0.0043223826,0.055524368,0.000009676029,0.00430926,0.54624575],"study_design_scores_gemma":[0.01986586,0.01670704,0.81592137,0.000039136943,0.011448567,0.00071213476,0.006167324,0.011037912,0.006126528,0.000038244663,0.11139434,0.00054155727],"about_ca_topic_score_codex":0.0017768135,"about_ca_topic_score_gemma":0.00015513027,"teacher_disagreement_score":0.5457042,"about_ca_system_score_codex":0.0010489759,"about_ca_system_score_gemma":0.0007333846,"threshold_uncertainty_score":0.9992423},"labels":[],"label_agreement":null},{"id":"W4309096724","doi":"10.1111/apt.17261","title":"Non‐invasive monitoring and treat‐to‐target approach are cost‐effective in patients with mild–moderate ulcerative colitis","year":2022,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Ferring","keywords":"Medicine; Ulcerative colitis; Faecal calprotectin; Internal medicine; Clinical trial; Incidence (geometry); Calprotectin; Inflammatory bowel disease; Disease","score_opus":0.010890505458321494,"score_gpt":0.26147941776304606,"score_spread":0.2505889123047246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309096724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963543,0.0001763538,0.000038407987,0.00013423908,0.00023503939,0.0026460418,0.00028023962,0.000013358691,0.00012203583],"genre_scores_gemma":[0.9927673,0.000054393513,0.00035080255,0.0043516075,0.00012222693,0.0019199082,0.00031200773,0.000049381633,0.00007242487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828976,0.0003924534,0.00019121522,0.0005466265,0.00017266738,0.0004072679],"domain_scores_gemma":[0.99945855,0.000030202023,0.00010645977,0.0001811702,0.00007888898,0.00014470067],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013524316,0.0002885513,0.00022493325,0.000095206306,0.0002948739,0.00001730487,0.0001747879,0.000068904366,0.00004009883],"category_scores_gemma":[2.9107153e-7,0.00029623968,0.000042586827,0.0001261853,0.000111971116,0.000013354201,0.00024047513,0.00022938382,0.0000027565807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015465111,0.0012407266,0.93647975,0.000042386415,0.0035516738,0.00022704362,0.0018770327,0.0073249387,0.0329438,0.000004236306,0.00030797682,0.0005353279],"study_design_scores_gemma":[0.0079583805,0.0012648132,0.8849745,0.000010228544,0.00084251066,0.000010201129,0.0010040306,0.00023164265,0.10238967,0.000015392638,0.0008251538,0.0004735061],"about_ca_topic_score_codex":0.00001850764,"about_ca_topic_score_gemma":0.00001559118,"teacher_disagreement_score":0.06944588,"about_ca_system_score_codex":0.00018180694,"about_ca_system_score_gemma":0.00009170784,"threshold_uncertainty_score":0.999949},"labels":[],"label_agreement":null},{"id":"W4309665292","doi":"10.1111/apt.17290","title":"Systematic review: early feeding practices and the risk of coeliac disease. A 2022 update and revision","year":2022,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Research, Development and Innovation Office; Instituto de Salud Carlos III; Fondazione Celiachia; Azrieli Foundation; Eurospital; European Commission; Thermo Fisher Scientific","keywords":"Medicine; Breastfeeding; Observational study; Population; Gluten; Cohort study; Randomized controlled trial; Weaning; Breast feeding; Coeliac disease; Pediatrics; Internal medicine; Immunology; Disease; Environmental health; Pathology","score_opus":0.053802891553166386,"score_gpt":0.4114468309827944,"score_spread":0.357643939429628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309665292","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000779761,0.98771304,0.0000019661743,0.0030870968,0.00023256798,0.008629335,0.00019590918,0.00002405274,0.000038048223],"genre_scores_gemma":[0.000023108936,0.9903576,0.000021223006,0.008197958,0.0001016098,0.00088084163,0.00022061574,0.000054512522,0.0001425276],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947641,0.0027458423,0.0009822339,0.00051170745,0.0006416309,0.00035448885],"domain_scores_gemma":[0.9956977,0.0015855863,0.0018500541,0.00051890325,0.00006049544,0.00028727413],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028815225,0.00043074897,0.0023843676,0.0001893401,0.00027305062,0.00003350439,0.0003143555,0.000064694854,0.0007007572],"category_scores_gemma":[0.000025434832,0.00025759343,0.00046466885,0.00032996424,0.00040252946,0.000107644,0.00067628187,0.0007710011,0.000012129583],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006549269,0.00025363255,0.000037823404,0.894411,0.039516225,0.00011833458,0.000068954054,6.4061375e-8,0.000003393558,0.0000711256,0.0022930326,0.06257148],"study_design_scores_gemma":[0.0014558948,0.00019219864,0.000007886519,0.06683529,0.31339908,0.000043547378,0.00007509312,0.00002919309,8.8745725e-7,0.000023167686,0.61776906,0.00016869699],"about_ca_topic_score_codex":0.000040090177,"about_ca_topic_score_gemma":5.742776e-7,"teacher_disagreement_score":0.82757574,"about_ca_system_score_codex":0.000120380595,"about_ca_system_score_gemma":0.00020420052,"threshold_uncertainty_score":0.9999876},"labels":[],"label_agreement":null},{"id":"W4309967198","doi":"10.1111/apt.17299","title":"Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D <scp>HBeAg</scp>‐positive chronic hepatitis B","year":2022,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"Gilead Sciences","keywords":"HBsAg; Medicine; Hepatitis B virus; HBeAg; Hepatitis B; Genotype; Internal medicine; Biomarker; Cohort; Immunology; Virology; Gastroenterology; Virus; Biology","score_opus":0.013342614430507492,"score_gpt":0.268125628672648,"score_spread":0.2547830142421405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309967198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903341,0.0029364014,0.00007700061,0.00070100516,0.00047858412,0.0020813248,0.003254858,0.000060990347,0.00007571814],"genre_scores_gemma":[0.9774677,0.012026047,0.00028960934,0.008109142,0.00024428373,0.0006522142,0.00065139856,0.000095751806,0.00046383997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977802,0.00023304844,0.00042942615,0.00056478987,0.00048796218,0.0005045924],"domain_scores_gemma":[0.9986572,0.00046475363,0.00028070502,0.000189219,0.00030362693,0.00010446181],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001966858,0.00038837176,0.00056149426,0.00012589057,0.0006378877,0.000008203722,0.00010984478,0.000090554146,0.0011743667],"category_scores_gemma":[0.0000015495706,0.0003579195,0.0001312295,0.00022846347,0.00038233242,0.00014544898,0.00024600123,0.00032487235,0.0000101000005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00445612,0.0011140115,0.94225436,0.00007675456,0.0131862005,0.000032754175,0.0018241791,0.000024475074,0.033338357,0.0000045251118,0.0030184586,0.00066982245],"study_design_scores_gemma":[0.011516588,0.0056489664,0.9077835,0.0000389827,0.004343412,0.000041661515,0.000063209976,0.0010585794,0.06118703,0.000028601115,0.008085536,0.00020391129],"about_ca_topic_score_codex":0.0013218478,"about_ca_topic_score_gemma":0.00074081356,"teacher_disagreement_score":0.034470823,"about_ca_system_score_codex":0.00060060574,"about_ca_system_score_gemma":0.00017696644,"threshold_uncertainty_score":0.9998873},"labels":[],"label_agreement":null},{"id":"W4311024218","doi":"10.1111/apt.17309","title":"Faecal microbiota transplantation for recurrent <i>C. difficile</i> infections: challenges and improvement opportunities for clinical practice and healthcare systems","year":2022,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"Ferring; National Institute for Health and Care Research","keywords":"Medicine; C difficile; Fecal bacteriotherapy; Clinical Practice; Transplantation; Intensive care medicine; Health care; Clostridium difficile; Clinical microbiology; Infection control; Immunology; Microbiology; Internal medicine; Antibiotics; Family medicine; Biology","score_opus":0.3667813122577013,"score_gpt":0.493345684012623,"score_spread":0.12656437175492175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311024218","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00070700044,0.98118114,0.000016100586,0.00639179,0.0020197644,0.0077259843,0.0018711892,0.000053544092,0.00003350752],"genre_scores_gemma":[0.000056625002,0.99034,0.00012986065,0.003137675,0.0008043978,0.0032887582,0.0020282457,0.00010042012,0.00011404905],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966072,0.00065182004,0.00115164,0.00078646716,0.00026787314,0.00053498964],"domain_scores_gemma":[0.99562275,0.003237661,0.00045563007,0.0002420597,0.00017848208,0.00026342872],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011930098,0.0005184137,0.0014936208,0.00022193158,0.00037575432,0.00003829381,0.00013878691,0.0003735138,0.000033200897],"category_scores_gemma":[0.0000043479577,0.00046884874,0.00036352145,0.00008932998,0.0002178143,0.00007799259,0.00011044381,0.00081922475,0.0000011860536],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014325691,0.001242481,0.0000012813088,0.034578923,0.0098860385,0.000043685533,0.00024198103,1.7241778e-7,0.00014110826,0.00007715141,0.0012251476,0.95112944],"study_design_scores_gemma":[0.0031978686,0.007380557,0.0000014983357,0.0010534807,0.04277346,0.00062158867,0.0016131971,0.000043710206,0.00008287727,0.0000036981191,0.9428766,0.0003514762],"about_ca_topic_score_codex":0.000027904885,"about_ca_topic_score_gemma":0.0000074468912,"teacher_disagreement_score":0.950778,"about_ca_system_score_codex":0.00036007678,"about_ca_system_score_gemma":0.0005953774,"threshold_uncertainty_score":0.9997763},"labels":[],"label_agreement":null},{"id":"W4311577704","doi":"10.1111/apt.17323","title":"Editorial: terlipressin in patients with <scp>ACLF</scp> grade 3—too late? Authorsʼ reply","year":2022,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Terlipressin; Medicine; Gastroenterology; Internal medicine; Intensive care medicine; Cirrhosis","score_opus":0.016470187791612224,"score_gpt":0.29975781471425644,"score_spread":0.2832876269226442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311577704","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09515046,0.0010503856,0.0000010187184,0.0014917734,0.90039885,0.0013208818,0.0002378057,0.00013997374,0.0002088613],"genre_scores_gemma":[0.0042699086,0.00081818714,0.00015416561,0.0143684335,0.97084576,0.00018805686,0.005430774,0.00025126766,0.003673451],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99510115,0.0005027126,0.0007855089,0.00093258865,0.0019277405,0.000750307],"domain_scores_gemma":[0.9974659,0.0009246299,0.00046172502,0.00051591697,0.00035002365,0.00028182013],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005450999,0.0006891619,0.0010529405,0.00045518714,0.00024623974,0.000036534282,0.00039623567,0.0008514112,0.0005342016],"category_scores_gemma":[0.000006668693,0.0005938362,0.00018932256,0.00041089254,0.00022486343,0.00016567526,0.00022940066,0.0025636305,0.00004285231],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013680393,0.0014847888,0.007471476,0.000050804614,0.0044355458,0.00015081452,0.00046542994,0.000024761033,0.0021349387,0.0000012398627,0.9819499,0.00046226455],"study_design_scores_gemma":[0.011856226,0.0019291969,0.006617382,0.00006716174,0.008271623,0.0000053691333,0.00007898064,0.00006150973,0.00062629033,0.00002493179,0.9702072,0.00025411524],"about_ca_topic_score_codex":0.00015608106,"about_ca_topic_score_gemma":0.000010880706,"teacher_disagreement_score":0.09088055,"about_ca_system_score_codex":0.00074763247,"about_ca_system_score_gemma":0.0006904337,"threshold_uncertainty_score":0.9997375},"labels":[],"label_agreement":null},{"id":"W4311580221","doi":"10.1111/apt.17316","title":"Editorial: cannabis use disorders at the emergency department, a sign of a growing cannabinoid emergency—authors' reply","year":2022,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Emergency department; Cannabis; Sign (mathematics); Cannabinoid; Medical emergency; Psychiatry; Internal medicine","score_opus":0.02101087340281458,"score_gpt":0.3418683094474299,"score_spread":0.3208574360446153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311580221","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016314095,0.008328036,0.0000025996856,0.03205856,0.9373917,0.0031751727,0.002411811,0.00012255662,0.00019548614],"genre_scores_gemma":[0.0005298721,0.029212618,0.000016098471,0.0036023743,0.8827167,0.0022172276,0.0039351415,0.0003918449,0.07737808],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9905322,0.0013686385,0.0018251698,0.0014901493,0.00317604,0.0016077557],"domain_scores_gemma":[0.9960323,0.00019483437,0.0010134188,0.0014318218,0.0008110642,0.0005165533],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017363115,0.0011060785,0.0013816141,0.0004593969,0.0010600915,0.00003322394,0.0012283357,0.00089742144,0.02349045],"category_scores_gemma":[0.000025173164,0.0009208123,0.001105623,0.0010446948,0.00060695055,0.00029077043,0.0012459712,0.0033388298,0.000032483305],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030384806,0.0009976657,0.0012873182,0.00033211455,0.014593611,0.000055786015,0.00083314965,0.000048108235,0.01663199,0.000004177216,0.96160537,0.0005722102],"study_design_scores_gemma":[0.0029205445,0.0019042679,0.00020870341,0.000026604088,0.016357796,0.000014797225,0.00042193744,0.000025502657,0.0033245957,0.000049694765,0.9739892,0.0007563889],"about_ca_topic_score_codex":0.006259361,"about_ca_topic_score_gemma":0.0010390595,"teacher_disagreement_score":0.0771826,"about_ca_system_score_codex":0.0017384341,"about_ca_system_score_gemma":0.0019964208,"threshold_uncertainty_score":0.99932426},"labels":[],"label_agreement":null},{"id":"W4312185556","doi":"10.1111/apt.17368","title":"Review article: diagnosis, pathophysiology and management of atrial fibrillation in cirrhosis and portal hypertension","year":2022,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"Canadian Institutes of Health Research; National Center for Advancing Translational Sciences; Vanderbilt Institute for Clinical and Translational Research","keywords":"Medicine; Pathophysiology; Cirrhosis; Portal hypertension; Atrial fibrillation; Cardiology; Internal medicine; Intensive care medicine","score_opus":0.06993192327416153,"score_gpt":0.3673166935173466,"score_spread":0.29738477024318505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312185556","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015527875,0.9823212,2.2879703e-7,0.00023865831,0.0002247445,0.0015931999,0.00007250263,0.0000110237315,0.0000105898525],"genre_scores_gemma":[0.0006001899,0.9948582,0.000043790445,0.0036843556,0.00008345448,0.00009464175,0.0006090115,0.000023020984,0.0000033482652],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9986386,0.0002893297,0.0004910637,0.00031271734,0.00011313338,0.00015517336],"domain_scores_gemma":[0.9994274,0.00018549203,0.00019941635,0.00011543844,0.000013154606,0.00005910643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015536351,0.00021593305,0.00090780214,0.00011522041,0.0000416617,0.0000021032577,0.000045229706,0.00008879838,0.0003421408],"category_scores_gemma":[5.0521287e-8,0.00018866474,0.00016641882,0.00017225058,0.00007287087,0.00004465899,0.00006369803,0.00016968058,0.000002096476],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030896746,0.0001682515,0.0024275559,0.07736693,0.022496317,0.0006810662,0.000084943145,0.0000014208123,0.00006638545,0.000014213945,0.00012360419,0.8962603],"study_design_scores_gemma":[0.005021803,0.0008851572,0.0028068584,0.021633191,0.49074093,0.0004895661,0.00006812526,0.000045440014,0.000055745357,0.00005866634,0.47772408,0.00047043807],"about_ca_topic_score_codex":0.000017064269,"about_ca_topic_score_gemma":9.965744e-7,"teacher_disagreement_score":0.8957899,"about_ca_system_score_codex":0.00004109664,"about_ca_system_score_gemma":0.000043377666,"threshold_uncertainty_score":0.7693525},"labels":[],"label_agreement":null},{"id":"W4312203523","doi":"10.1111/apt.17302","title":"Editorial: routine use of intestinal ultrasound in ulcerative colitis—are we missing the appendix?","year":2022,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Appendicitis Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Ulcerative colitis; Appendix; Gastroenterology; Colitis; Internal medicine; General surgery; Disease","score_opus":0.048592983950007336,"score_gpt":0.3521339358854642,"score_spread":0.3035409519354569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312203523","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006092769,0.0016359112,0.000015202952,0.0070733023,0.9821116,0.0021091914,0.0007863029,0.00006221814,0.00011352407],"genre_scores_gemma":[0.0058675907,0.016303858,0.00020820391,0.008896783,0.96470934,0.00044189594,0.0029265557,0.00015930262,0.0004864753],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954472,0.000931399,0.0010038008,0.00071969436,0.0012210549,0.0006768035],"domain_scores_gemma":[0.9933619,0.0049232366,0.0008589378,0.0004860974,0.00023264145,0.00013718719],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008028002,0.00061719684,0.0010971099,0.00028892956,0.00027793404,0.000057060694,0.00054663303,0.00044406985,0.0038644925],"category_scores_gemma":[0.000017430588,0.0005173556,0.00025432304,0.00038507005,0.0005140425,0.00015350556,0.00043189083,0.0022776835,0.00002218543],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019428728,0.0011453521,0.0023285947,0.00018163843,0.0064220657,0.00023769635,0.0010247788,0.00005250684,0.0010145685,0.00002346644,0.9851623,0.00046411814],"study_design_scores_gemma":[0.004338441,0.0009930431,0.0006008187,0.0003554245,0.011065702,0.000029657569,0.0019395957,0.000041840813,0.0011630903,0.000091626964,0.978988,0.00039273794],"about_ca_topic_score_codex":0.00093890744,"about_ca_topic_score_gemma":0.00027282137,"teacher_disagreement_score":0.017402245,"about_ca_system_score_codex":0.00093296776,"about_ca_system_score_gemma":0.0005255322,"threshold_uncertainty_score":0.9997278},"labels":[],"label_agreement":null},{"id":"W4313339765","doi":"10.1111/apt.17360","title":"Meta‐analysis: Use of proton pump inhibitors and risk of gastric cancer in patients requiring gastric acid suppression","year":2022,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; Cochrane","funders":"","keywords":"Medicine; Confounding; Meta-analysis; Relative risk; Proton-pump inhibitor; Cancer; Internal medicine; Publication bias; Randomized controlled trial; Confidence interval; MEDLINE; Random effects model; Gastroenterology","score_opus":0.11675550023984221,"score_gpt":0.3719195071535747,"score_spread":0.2551640069137325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313339765","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13576698,0.8599462,0.0000027568358,0.0001117904,0.00040878568,0.0030819045,0.00065729115,0.000022010154,0.0000022830368],"genre_scores_gemma":[0.0042036697,0.993564,0.000117121024,0.0006118633,0.000052224994,0.0010550518,0.00030753823,0.00007138405,0.000017150554],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9951719,0.0015420697,0.001615681,0.00069323473,0.00042044735,0.000556668],"domain_scores_gemma":[0.9974079,0.00038605565,0.0015715502,0.00038958254,0.00012031873,0.00012458753],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004971483,0.00065540324,0.0040513105,0.001499023,0.00009537911,0.0000055658265,0.00023833963,0.00029252117,0.00054711144],"category_scores_gemma":[0.0000021836563,0.0005212429,0.00093407143,0.0016129519,0.00032533225,0.00014480625,0.00048001448,0.0012524182,0.0000010953453],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054773013,0.0008571895,0.31005508,0.002440517,0.66475135,0.000022552214,0.00024898903,0.00003816493,0.00015537834,5.0405788e-8,0.000032091517,0.020850882],"study_design_scores_gemma":[0.0025418678,0.0013399385,0.005290957,0.00042856205,0.950969,0.000013680183,0.00003302634,0.000020624055,0.0007060439,6.432943e-7,0.038423467,0.00023220181],"about_ca_topic_score_codex":0.0002534043,"about_ca_topic_score_gemma":0.000022295706,"teacher_disagreement_score":0.30476412,"about_ca_system_score_codex":0.0003114221,"about_ca_system_score_gemma":0.00014953513,"threshold_uncertainty_score":0.9997239},"labels":[],"label_agreement":null},{"id":"W4315620344","doi":"10.1111/apt.17370","title":"Systematic review with meta‐analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease","year":2023,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"School for Public Health Research; Crohn's and Colitis UK; National Institute for Health and Care Research; International Seafood Sustainability Foundation; Wellcome Trust","keywords":"Medicine; Meta-analysis; Inflammatory bowel disease; Disease; Intensive care medicine; MEDLINE; Inflammatory Bowel Diseases; Internal medicine","score_opus":0.06149204477535343,"score_gpt":0.41262513332284356,"score_spread":0.35113308854749015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315620344","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0066638985,0.98527086,9.590341e-7,0.00034251076,0.00007255215,0.006913403,0.00070746464,0.000022883352,0.0000054991115],"genre_scores_gemma":[0.00039605587,0.9832502,0.000010303856,0.0073806066,0.00006227454,0.008334582,0.00035441015,0.00010949915,0.0001020927],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9935433,0.002965477,0.0019313191,0.0007956307,0.00031788665,0.00044633378],"domain_scores_gemma":[0.99611163,0.0014305088,0.0010058539,0.001026911,0.00009474844,0.00033034265],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00186275,0.00084028486,0.004411047,0.00031751732,0.000076740114,0.000022477243,0.0007315399,0.00025734035,0.0002125608],"category_scores_gemma":[0.000016630405,0.0004531552,0.0035151779,0.00046507694,0.000382638,0.000008533156,0.0003042608,0.00037318267,0.000106616906],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090286974,0.0005117156,0.0062472085,0.08744851,0.90368867,0.00021284948,0.000023125327,0.00013743939,8.1462116e-7,0.000003251992,0.00064676476,0.00017677556],"study_design_scores_gemma":[0.0012512187,0.00046187773,0.0013642394,0.010397083,0.984414,0.00000366032,0.0000054437514,0.000019637853,0.0000030057695,0.0000048720262,0.0015467907,0.0005281961],"about_ca_topic_score_codex":0.00002746835,"about_ca_topic_score_gemma":0.000025473895,"teacher_disagreement_score":0.0807253,"about_ca_system_score_codex":0.00008046504,"about_ca_system_score_gemma":0.00036383147,"threshold_uncertainty_score":0.99979204},"labels":[],"label_agreement":null},{"id":"W4316683778","doi":"10.1111/apt.17392","title":"Antioxidants, minerals and vitamins in relation to Crohn's disease and ulcerative colitis: A Mendelian randomization study","year":2023,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research","funders":"Medical Research Council; Hjärt-Lungfonden; Cancerfonden; Science Fund for Distinguished Young Scholars of Zhejiang Province; National Natural Science Foundation of China; Vetenskapsrådet; Cancer Research UK; Key Project of Research and Development Plan of Hunan Province","keywords":"Mendelian randomization; Medicine; Ulcerative colitis; Gastroenterology; Internal medicine; Lycopene; Vitamin D and neurology; Inflammatory bowel disease; Crohn's disease; Antioxidant; Disease; Genotype; Biology; Biochemistry","score_opus":0.016512132310578173,"score_gpt":0.3062850071177489,"score_spread":0.28977287480717073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4316683778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972417,0.000196829,0.000029729139,0.0008023223,0.00016788345,0.0014396172,0.00007094804,0.000025102403,0.00002590003],"genre_scores_gemma":[0.9940933,0.0005887649,0.00006292515,0.004538708,0.000078682875,0.00020769374,0.00018235801,0.000024919967,0.00022267556],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986723,0.00037548237,0.00023679588,0.00037848542,0.00009649647,0.00024041279],"domain_scores_gemma":[0.99959266,0.00003069641,0.000054154363,0.00012692373,0.00004063599,0.00015490047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028951146,0.00017262231,0.00014666076,0.0001447675,0.00010976416,0.000022054388,0.00007169002,0.000060841103,0.000021473095],"category_scores_gemma":[0.0000015640671,0.00018207544,0.000024957404,0.0001624475,0.000073629155,0.00001617711,0.00010976664,0.00006747682,0.0000084921285],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01560499,0.00073661294,0.33691657,0.000046877434,0.0030734425,0.0009503717,0.0029186835,0.0012018105,0.6362284,0.000042498155,0.0013595999,0.00092017004],"study_design_scores_gemma":[0.007941782,0.0002154769,0.9850078,0.000008724652,0.00090397027,0.0000028820543,0.0005801041,0.0011585398,0.003430025,0.000050647424,0.00048668034,0.00021331948],"about_ca_topic_score_codex":0.000016121563,"about_ca_topic_score_gemma":0.00014375638,"teacher_disagreement_score":0.64809126,"about_ca_system_score_codex":0.000027266717,"about_ca_system_score_gemma":0.000047820995,"threshold_uncertainty_score":0.7424821},"labels":[],"label_agreement":null},{"id":"W4321607274","doi":"10.1111/apt.17351","title":"Editorial: real‐world evidence of tofacitinib and vedolizumab in ulcerative colitis—are we one step closer to better positioning therapies after <scp>anti‐TNF</scp> failure?","year":2023,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Alberta Innovates; Leona M. and Harry B. Helmsley Charitable Trust","keywords":"Tofacitinib; Vedolizumab; Medicine; Ulcerative colitis; Colitis; Tumor necrosis factor alpha; Internal medicine; Disease","score_opus":0.018989123541643987,"score_gpt":0.3141637851460536,"score_spread":0.2951746616044096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321607274","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4532131,0.0010845091,0.000007963087,0.0010223433,0.5418905,0.0011045882,0.0016077842,0.00004362543,0.000025568854],"genre_scores_gemma":[0.06371975,0.011453727,0.0004631616,0.0044145696,0.91667104,0.0009710447,0.0014518689,0.00028675035,0.0005681138],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959512,0.0008507886,0.000791798,0.0010045657,0.0006392999,0.0007623509],"domain_scores_gemma":[0.99763364,0.0007970382,0.00044985552,0.00047440757,0.00042692083,0.00021816173],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005464447,0.0006828167,0.0007338161,0.00032581927,0.00014031601,0.00007152,0.00050023885,0.0008817002,0.00008067888],"category_scores_gemma":[0.000012910137,0.0007618138,0.00018480034,0.00026005096,0.00035763602,0.000040000476,0.0004485085,0.00078088813,0.000024914727],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024633491,0.00024015433,0.004086312,0.00036419643,0.0055986275,0.00019240889,0.0012972491,0.00003130468,0.06979782,0.0000044784906,0.9157607,0.00016342624],"study_design_scores_gemma":[0.004103468,0.0007859673,0.018016454,0.000996207,0.003839409,0.000002664504,0.00070142717,0.000010629229,0.036259558,0.000088679335,0.9345141,0.00068146037],"about_ca_topic_score_codex":0.0001319533,"about_ca_topic_score_gemma":0.0016575741,"teacher_disagreement_score":0.38949335,"about_ca_system_score_codex":0.00018282616,"about_ca_system_score_gemma":0.00040051245,"threshold_uncertainty_score":0.9994833},"labels":[],"label_agreement":null},{"id":"W4321749455","doi":"10.1111/apt.17433","title":"Meta‐analysis: Placebo rates in microscopic colitis randomised trials and applications for future drug development using a historical control arm","year":2023,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Microscopic Colitis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Calgary","funders":"","keywords":"Placebo; Medicine; Meta-analysis; Internal medicine; Clinical trial; Budesonide; Randomized controlled trial; Microscopic colitis; Publication bias; Collagenous colitis; Surgery; Colitis; Inflammatory bowel disease; Disease; Pathology; Asthma; Alternative medicine","score_opus":0.24589708341520675,"score_gpt":0.46190198159851975,"score_spread":0.216004898183313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321749455","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020190941,0.9804291,0.00053718087,0.0008870304,0.00064509275,0.016831173,0.00039378443,0.00006956133,0.0000051764564],"genre_scores_gemma":[0.00002241991,0.9792308,0.0021638577,0.00397319,0.00077518943,0.01223933,0.0006281242,0.00010870192,0.00085835473],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99488264,0.0013245578,0.0021437672,0.00082860206,0.00020366943,0.00061678013],"domain_scores_gemma":[0.995258,0.0032791598,0.00083526626,0.0003198383,0.000098386976,0.00020935679],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020779865,0.0007057088,0.007559972,0.0007718404,0.00019886979,0.00003240683,0.00024193515,0.0003941877,0.00028844186],"category_scores_gemma":[0.0000020053765,0.0005890171,0.0015278603,0.00076206075,0.00010936847,0.000039814404,0.00007982619,0.0005138069,0.0000098868495],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027660183,0.0005452225,0.00003603676,0.008385271,0.96932274,0.000043124168,0.00048661328,0.0000042796987,0.0003381755,0.000010473053,0.00063232554,0.01742974],"study_design_scores_gemma":[0.015831444,0.000045366807,0.0000034920256,0.00015382447,0.5079875,0.000019890407,0.000033299762,0.000026902284,0.00011542198,0.0000108288295,0.47553477,0.00023725937],"about_ca_topic_score_codex":0.00013829856,"about_ca_topic_score_gemma":0.00015339213,"teacher_disagreement_score":0.47490245,"about_ca_system_score_codex":0.0016253894,"about_ca_system_score_gemma":0.0010760407,"threshold_uncertainty_score":0.99965614},"labels":[],"label_agreement":null},{"id":"W4363648797","doi":"10.1111/apt.17509","title":"Review article: Risk of cardiovascular events in patients with inflammatory bowel disease receiving small molecule drugs","year":2023,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute","funders":"Pfizer","keywords":"Medicine; Tofacitinib; Rheumatoid arthritis; Population; Inflammatory bowel disease; Internal medicine; Disease; Intensive care medicine","score_opus":0.02100104211313396,"score_gpt":0.29168553605213954,"score_spread":0.27068449393900557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4363648797","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07498494,0.92286247,0.00001092708,0.000012908433,0.0003936777,0.0015656276,0.0001442521,0.000020072033,0.000005109225],"genre_scores_gemma":[0.00077637855,0.9965248,0.000049956507,0.0013844344,0.00020704823,0.00023633351,0.00066559814,0.0001347998,0.000020655129],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966928,0.0010190171,0.0008514953,0.0006727236,0.00028485942,0.00047914614],"domain_scores_gemma":[0.99846846,0.00006581557,0.00053217553,0.00067097886,0.00010138645,0.00016121278],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007972958,0.00053706364,0.0012661709,0.00014968107,0.00007054,0.000005198101,0.00050036365,0.00022474988,0.00002415587],"category_scores_gemma":[0.000003106049,0.00045890053,0.000837581,0.00031030102,0.00010607732,0.0000085587735,0.0002495024,0.000399598,0.000015806165],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018093273,0.0034508582,0.09297246,0.15909247,0.3660861,0.00012502438,0.00048936886,0.0015689329,0.0012547381,0.0000062701106,0.001304554,0.3718399],"study_design_scores_gemma":[0.005506535,0.00035662373,0.0040607103,0.02336654,0.18078658,0.000004506603,0.00002721307,0.000024250023,0.0012088564,0.000011601482,0.7830258,0.0016208021],"about_ca_topic_score_codex":0.000025975634,"about_ca_topic_score_gemma":0.000003689023,"teacher_disagreement_score":0.78172123,"about_ca_system_score_codex":0.000055960267,"about_ca_system_score_gemma":0.00027356687,"threshold_uncertainty_score":0.99978626},"labels":[],"label_agreement":null},{"id":"W4365443818","doi":"10.1111/apt.17498","title":"Review article: Putting some muscle into sarcopenia—the pathogenesis, assessment and clinical impact of muscle loss in patients with inflammatory bowel disease","year":2023,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Sarcopenia; Medicine; Bioelectrical impedance analysis; Inflammatory bowel disease; Malnutrition; Ulcerative colitis; Disease; Malabsorption; Internal medicine; Intensive care medicine; Body mass index","score_opus":0.09103368312781962,"score_gpt":0.4847573704644386,"score_spread":0.393723687336619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365443818","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0850843,0.90971655,7.1011374e-7,0.0015202999,0.0002856398,0.0032746282,0.0000784579,0.000037518625,0.0000019251663],"genre_scores_gemma":[0.0020319023,0.98278314,0.00018764929,0.014268517,0.00020232581,0.0002160412,0.00021781509,0.000086227854,0.0000063801003],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9962264,0.0010521901,0.001490447,0.00047994507,0.0003067246,0.0004443283],"domain_scores_gemma":[0.9979704,0.00054300966,0.0006590565,0.00039138363,0.000099881145,0.0003362872],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013740276,0.000407885,0.0014686817,0.00017016615,0.00012652551,0.0000103696875,0.00021687301,0.0001495419,0.000117508556],"category_scores_gemma":[0.00000192065,0.000263815,0.0003498418,0.00033215797,0.00031162435,0.00010050394,0.00017440198,0.0007860075,0.000015909187],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002995126,0.0018848422,0.369515,0.077214114,0.007073956,0.00019134046,0.00009448831,0.0000015064505,0.000017637689,0.0000069720304,0.0006622979,0.54303837],"study_design_scores_gemma":[0.0067127026,0.0010155973,0.76737154,0.047242966,0.0402769,0.000011752022,0.000023455534,0.00006842469,0.0000012856558,0.000056659963,0.13675994,0.00045878367],"about_ca_topic_score_codex":0.000025559322,"about_ca_topic_score_gemma":0.0000051555935,"teacher_disagreement_score":0.54257953,"about_ca_system_score_codex":0.00040195283,"about_ca_system_score_gemma":0.0008903356,"threshold_uncertainty_score":0.9999814},"labels":[],"label_agreement":null},{"id":"W4365444253","doi":"10.1111/apt.17512","title":"Evaluation of a downstaging, bidirectional version of the Montreal classification of Crohn's disease: Analysis of 5‐year follow‐up data from the prospective BioCrohn study","year":2023,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Bundesministerium für Bildung und Forschung; Deutsche Forschungsgemeinschaft","keywords":"Medicine; Hazard ratio; Proportional hazards model; Disease; Crohn's disease; Confidence interval; Cohort; Complication; Internal medicine; Cohort study; Surgery; Regression analysis; Statistics","score_opus":0.05473808731566979,"score_gpt":0.3515650969270308,"score_spread":0.296827009611361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365444253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962929,0.00036574577,0.000008606484,0.00016769444,0.00030465066,0.0008201246,0.0020025184,0.0000059822646,0.00003180748],"genre_scores_gemma":[0.9983745,0.00013733395,0.000009762754,0.00011493924,0.000048426497,0.00003970683,0.0012397603,0.000011167127,0.000024376946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980026,0.0007070108,0.00035399184,0.00030330676,0.0005216515,0.000111475456],"domain_scores_gemma":[0.9983935,0.000075205884,0.00040332784,0.00070782524,0.00039097245,0.00002917947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008758329,0.00011758987,0.00018204146,0.00009258152,0.00007615014,0.0000028016277,0.0005191389,0.000051476927,0.00012087603],"category_scores_gemma":[0.0000058366036,0.00008546229,0.00014955559,0.0005080723,0.00025594296,0.000010641976,0.0002739105,0.00006248057,0.000001472064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018479569,0.00058128656,0.5956449,0.000009174336,0.022364752,0.0000014396178,0.0005041305,0.0011043112,0.37695962,0.0000041826147,0.00067812705,0.00030009486],"study_design_scores_gemma":[0.0018282403,0.000073176554,0.90510434,0.0000053030085,0.03475733,5.6650194e-8,0.0008827632,0.008254658,0.04893446,0.000041809166,0.000053405336,0.00006442992],"about_ca_topic_score_codex":0.00025420968,"about_ca_topic_score_gemma":0.00029670904,"teacher_disagreement_score":0.32802516,"about_ca_system_score_codex":0.000037501693,"about_ca_system_score_gemma":0.00025413078,"threshold_uncertainty_score":0.3485051},"labels":[],"label_agreement":null},{"id":"W4365457433","doi":"10.1111/apt.17471","title":"Editorial: in search of environmental risk factors of Crohn's disease and ulcerative colitis with mendelian randomisation—authors' reply","year":2023,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Microscopic Colitis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research","funders":"Science Fund for Distinguished Young Scholars of Zhejiang Province; Cancer Research UK","keywords":"Mendelian randomization; Medicine; Confounding; Ulcerative colitis; Inflammatory bowel disease; Vitamin D and neurology; Internal medicine; Disease; Observational study; Genetic association; Gastroenterology; Immunology; Single-nucleotide polymorphism; Genetics; Biology; Genetic variants; Genotype","score_opus":0.016766937431061207,"score_gpt":0.3197446645380042,"score_spread":0.302977727106943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365457433","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43315634,0.00039160703,0.0000025474378,0.000270077,0.56080276,0.0014872187,0.003854732,0.000025380054,0.0000093352255],"genre_scores_gemma":[0.16359909,0.014859742,0.00016507402,0.00046893329,0.8169196,0.00022756582,0.0028314795,0.00022482217,0.0007036828],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99646807,0.0007102576,0.0008128863,0.0006436092,0.00090162206,0.00046358004],"domain_scores_gemma":[0.99679905,0.0019753533,0.0004732571,0.0003499317,0.00012524366,0.00027716567],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00066802074,0.00046190436,0.0010788642,0.00035171234,0.00008662969,0.000011271718,0.00019172736,0.00043836312,0.00043508108],"category_scores_gemma":[0.000009655781,0.0004162925,0.00013150876,0.00021733613,0.0007439392,0.0000827861,0.00015264387,0.0010956523,0.0000037125617],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05320016,0.0013731599,0.039570276,0.00079265254,0.020248054,0.00030597937,0.0067596436,0.00003398498,0.0177435,0.0000026407536,0.8595632,0.0004067886],"study_design_scores_gemma":[0.099074826,0.0060108444,0.23637936,0.0010886011,0.06143494,0.000009038044,0.0036084463,0.00020770094,0.0421502,0.00014296077,0.54825014,0.0016429238],"about_ca_topic_score_codex":0.0018754799,"about_ca_topic_score_gemma":0.00014412591,"teacher_disagreement_score":0.311313,"about_ca_system_score_codex":0.0004641152,"about_ca_system_score_gemma":0.0006902114,"threshold_uncertainty_score":0.9998289},"labels":[],"label_agreement":null},{"id":"W4365458171","doi":"10.1111/apt.17468","title":"Letter: disentangling the role of redox‐active compounds in the development of inflammatory bowel diseases—moving towards causal associations. Authors' reply","year":2023,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research","funders":"Science Fund for Distinguished Young Scholars of Zhejiang Province; Cancer Research UK","keywords":"Medicine; Inflammatory Bowel Diseases; Inflammatory bowel disease; Internal medicine; Disease","score_opus":0.016737142609976045,"score_gpt":0.28781568958593257,"score_spread":0.2710785469759565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365458171","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89684266,0.0015710697,0.000010546049,0.096625686,0.0018660963,0.0017012572,0.0011005343,0.00004987976,0.00023225712],"genre_scores_gemma":[0.4302187,0.00027345153,0.0001489912,0.5612861,0.0031917528,0.00045815852,0.004071778,0.00018008478,0.00017097988],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996158,0.0011491457,0.0010118337,0.0005400653,0.0005775087,0.0005634714],"domain_scores_gemma":[0.9980989,0.00025172503,0.0008177624,0.0006253892,0.00015058459,0.00005561201],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00076956255,0.0004708888,0.00041252715,0.00016242592,0.00026092955,0.000024145673,0.001035746,0.00045176438,0.000029320869],"category_scores_gemma":[0.000004324005,0.00037182847,0.0002846062,0.00018750035,0.00040299812,0.00001470828,0.0003724792,0.0009985088,0.000007812604],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021148054,0.0011936761,0.17044581,0.00065352314,0.039603,0.0011944026,0.017146306,0.00052628544,0.24322213,0.000031347776,0.521172,0.0026967262],"study_design_scores_gemma":[0.0031189064,0.00024888737,0.18258135,0.00014831082,0.0106966775,0.000018888237,0.0027842205,0.00041197686,0.14287458,0.00038343485,0.65529823,0.0014345454],"about_ca_topic_score_codex":0.000033780194,"about_ca_topic_score_gemma":0.0000695969,"teacher_disagreement_score":0.466624,"about_ca_system_score_codex":0.00022486055,"about_ca_system_score_gemma":0.00073599536,"threshold_uncertainty_score":0.99987334},"labels":[],"label_agreement":null},{"id":"W4366083042","doi":"10.1111/apt.17510","title":"A translational pharmacokinetic/pharmacodynamic approach supports optimal vonoprazan dosing for erosive oesophagitis and <i>Helicobacter pylori</i> infection","year":2023,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Pharmacokinetics; Pharmacodynamics; Dosing; Medicine; Pharmacology; Gastric acid; Helicobacter pylori; Gastroenterology; Internal medicine; Stomach","score_opus":0.029977883413606396,"score_gpt":0.3216206372308074,"score_spread":0.291642753817201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366083042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98032254,0.00072927854,0.0012796528,0.013098997,0.0016860191,0.0020762477,0.00028893017,0.0004053195,0.000113034504],"genre_scores_gemma":[0.96098155,0.0034634091,0.0019939137,0.030372629,0.00077090494,0.0006594505,0.0013852818,0.00012946331,0.00024342994],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99724394,0.00018231738,0.00061843375,0.00076127093,0.00027404324,0.0009199897],"domain_scores_gemma":[0.99894965,0.00022836331,0.0001852269,0.00017800803,0.00020012342,0.00025861696],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037035844,0.0005172927,0.00058128213,0.00039734453,0.00039241786,0.000031542586,0.00012437803,0.00022608493,0.00016693151],"category_scores_gemma":[7.06327e-7,0.0005227973,0.0001954704,0.00046146804,0.00043165692,0.0002765363,0.00010874017,0.0005673928,0.00003380202],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00454388,0.0011480319,0.21785922,0.00028820065,0.03552636,0.00018515256,0.002918521,0.0007635273,0.71984935,0.000023495479,0.0064449115,0.010449349],"study_design_scores_gemma":[0.07483041,0.00620949,0.42977312,0.00016086418,0.09262422,0.0026187329,0.0007231571,0.104310885,0.20414124,0.00020011897,0.082083784,0.0023239932],"about_ca_topic_score_codex":0.000027731614,"about_ca_topic_score_gemma":0.000003945029,"teacher_disagreement_score":0.5157081,"about_ca_system_score_codex":0.00012921247,"about_ca_system_score_gemma":0.000087732304,"threshold_uncertainty_score":0.99972236},"labels":[],"label_agreement":null},{"id":"W4366602773","doi":"10.1111/apt.17526","title":"Physiologically‐based pharmacokinetic modelling to predict intragastric rifabutin concentrations in the treatment of <i>Helicobacter pylori</i> infection","year":2023,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"U.S. Department of Veterans Affairs","keywords":"Rifabutin; Pharmacokinetics; Regimen; Pharmacology; Medicine; Helicobacter pylori; Dosing; Physiologically based pharmacokinetic modelling; Antibacterial agent; Gastroenterology; Antibiotics; Internal medicine; Chemistry; Clarithromycin","score_opus":0.05850287960138327,"score_gpt":0.3325899750027761,"score_spread":0.2740870954013928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366602773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98417044,0.00021964309,0.00045811082,0.012579636,0.0006848327,0.0016379065,0.0000627012,0.00013425462,0.00005249008],"genre_scores_gemma":[0.97111297,0.0035097306,0.00022691087,0.024225535,0.00026354354,0.0004006482,0.00020830221,0.000028584316,0.000023795243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977451,0.00040681314,0.0005816309,0.00040736934,0.00023655227,0.00062254013],"domain_scores_gemma":[0.99908394,0.0003082815,0.00013107817,0.00025148774,0.000112965434,0.00011222466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024635092,0.00032641104,0.00046455394,0.00031117702,0.0001298593,0.000008242345,0.00016682532,0.00012518726,0.00010668422],"category_scores_gemma":[6.697395e-7,0.00023384551,0.00014263432,0.0010686986,0.00021339115,0.000061011062,0.00003444581,0.0003076572,0.000060633225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029592488,0.004841919,0.45340538,0.000053827916,0.00923385,0.00017312198,0.004534851,0.068450615,0.4507288,0.000008925753,0.0014178345,0.0041916203],"study_design_scores_gemma":[0.03101549,0.021862995,0.5704628,0.00013017046,0.023840161,0.000091919785,0.0007613928,0.11351233,0.19585672,0.000070307404,0.04163717,0.0007585045],"about_ca_topic_score_codex":0.00008029175,"about_ca_topic_score_gemma":0.000015239235,"teacher_disagreement_score":0.25487208,"about_ca_system_score_codex":0.00021798888,"about_ca_system_score_gemma":0.000071909155,"threshold_uncertainty_score":0.9535943},"labels":[],"label_agreement":null},{"id":"W4366815763","doi":"10.1111/apt.17480","title":"Letter: Potassium‐competitive acid blockers may increase the risk of gastric cancer after <i>Helicobacter pylori</i> eradication—a retrospective multicentre‐cohort analysis. Authors' reply","year":2023,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Cochrane; Impact; McMaster University Medical Centre","funders":"","keywords":"Medicine; Helicobacter pylori; Cancer; Internal medicine; Retrospective cohort study; Gastroenterology; Cohort; Cohort study","score_opus":0.015530177873908464,"score_gpt":0.2912376221436693,"score_spread":0.2757074442697608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366815763","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23326173,0.002855335,0.000024546802,0.7544903,0.0033829014,0.002599562,0.0030437885,0.00025534935,0.00008645978],"genre_scores_gemma":[0.09111569,0.009948812,0.00031137618,0.8886518,0.0048360517,0.0014430749,0.0019330509,0.0002614693,0.0014986708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9918876,0.0020809104,0.0016627952,0.0017254392,0.0010756571,0.0015675735],"domain_scores_gemma":[0.9951507,0.00075376465,0.0016641291,0.0014083738,0.00075018546,0.0002728859],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00094718754,0.0013018462,0.0022166108,0.0011032994,0.00040475122,0.000038187314,0.0008182184,0.00100386,0.0012432779],"category_scores_gemma":[0.000008628537,0.0010076761,0.0011036973,0.0020665226,0.0015658026,0.0001532423,0.00046337,0.005761292,0.00015961494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001140451,0.00024485472,0.49682721,0.000051254523,0.20215483,0.0005212869,0.00068904966,0.000013441701,0.0017495215,3.8291418e-7,0.29653615,0.0000715621],"study_design_scores_gemma":[0.0033131451,0.0005394594,0.41308385,0.00008538645,0.28775588,0.00006417217,0.00012916056,0.00013043593,0.0024681455,0.000007277089,0.29186913,0.0005539475],"about_ca_topic_score_codex":0.0016332873,"about_ca_topic_score_gemma":0.0002642453,"teacher_disagreement_score":0.14214605,"about_ca_system_score_codex":0.0012102019,"about_ca_system_score_gemma":0.0002959392,"threshold_uncertainty_score":0.9999733},"labels":[],"label_agreement":null},{"id":"W4366816180","doi":"10.1111/apt.17445","title":"Letter: fulminant onset complicated inflammatory bowel disease (IBD) – a unique subtype? Authors' reply","year":2023,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute for Health and Care Research","keywords":"Medicine; Fulminant; Inflammatory bowel disease; Gastroenterology; Inflammatory Bowel Diseases; Disease; Internal medicine","score_opus":0.021425909014908488,"score_gpt":0.28894098741223917,"score_spread":0.2675150783973307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366816180","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30999225,0.0017373747,0.000050634346,0.675714,0.0061238506,0.0029244043,0.0027265383,0.00057587796,0.00015505127],"genre_scores_gemma":[0.009563897,0.001110629,0.000084629406,0.96369207,0.0062971245,0.000664491,0.013179127,0.00045565754,0.0049524033],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99432003,0.0012115696,0.0009846394,0.0016033576,0.00051602535,0.0013643793],"domain_scores_gemma":[0.9970789,0.00011038147,0.0005980331,0.0015584007,0.00021099385,0.00044327287],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049461826,0.0011348116,0.0005746888,0.00029616777,0.00037379583,0.00007020569,0.0013161959,0.0011937732,0.00036365105],"category_scores_gemma":[0.0000022185236,0.0012191868,0.00053517916,0.00019686975,0.0006887176,0.000016823573,0.0006551572,0.001903101,0.0006396007],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012569507,0.0001776075,0.005383228,0.00025929936,0.0075280457,0.008071401,0.00006245669,0.000047711914,0.039586995,0.0000030956485,0.9375688,0.000054446355],"study_design_scores_gemma":[0.0015697554,0.00020036376,0.011456448,0.000058344795,0.0067118737,0.00006520667,0.000014249396,0.00017706538,0.011689019,0.00009915383,0.96663094,0.0013275571],"about_ca_topic_score_codex":0.000032139622,"about_ca_topic_score_gemma":0.000018502202,"teacher_disagreement_score":0.30042836,"about_ca_system_score_codex":0.00020663353,"about_ca_system_score_gemma":0.0007457171,"threshold_uncertainty_score":0.9990258},"labels":[],"label_agreement":null},{"id":"W4366816349","doi":"10.1111/apt.17493","title":"Letter: diagnostic delay in inflammatory bowel disease—Authors' reply","year":2023,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute for Health and Care Research","keywords":"Medicine; Inflammatory bowel disease; Inflammatory Bowel Diseases; Disease; Gastroenterology; Intensive care medicine; Internal medicine; General surgery","score_opus":0.015945167466547693,"score_gpt":0.28131389249279165,"score_spread":0.265368725026244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366816349","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37560862,0.004084393,0.000017934299,0.60736656,0.008944375,0.002548652,0.0009914429,0.0002880985,0.00014994766],"genre_scores_gemma":[0.009103656,0.0021286707,0.000041237683,0.9715876,0.0091177765,0.00073193,0.005013022,0.00036937246,0.0019067144],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950607,0.00095258653,0.000900047,0.0013564683,0.00047610208,0.0012541201],"domain_scores_gemma":[0.99792206,0.0002842423,0.00036048712,0.0010603131,0.00009616042,0.0002767613],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004525744,0.00091813295,0.00045279367,0.00035291156,0.0001756017,0.000060104685,0.0010210476,0.0010338095,0.0002574136],"category_scores_gemma":[0.0000054700417,0.0010345076,0.00039589123,0.0001677266,0.0004278712,0.000017060665,0.0005126729,0.0018256232,0.00048161158],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005230131,0.00014310895,0.025385814,0.0002169142,0.0043673925,0.017550346,0.00007090189,0.0002581575,0.008623128,0.0000018379848,0.9427803,0.00007909955],"study_design_scores_gemma":[0.0018228146,0.00013400028,0.021248592,0.00007524773,0.0043420033,0.000026396921,0.000013739865,0.00011928494,0.0024114288,0.00009155218,0.96857905,0.0011359008],"about_ca_topic_score_codex":0.000027850287,"about_ca_topic_score_gemma":0.0000359975,"teacher_disagreement_score":0.36650497,"about_ca_system_score_codex":0.00020508686,"about_ca_system_score_gemma":0.00044766176,"threshold_uncertainty_score":0.99921054},"labels":[],"label_agreement":null},{"id":"W4367669310","doi":"10.1111/apt.17534","title":"Review article: Functional dyspepsia and pregnancy—Effects and management in a special population","year":2023,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Psychological intervention; Pregnancy; Breastfeeding; Narrative review; Population; MEDLINE; Intensive care medicine; Family medicine; Pediatrics; Nursing; Environmental health","score_opus":0.09426063293358693,"score_gpt":0.3955688935515928,"score_spread":0.30130826061800586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367669310","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005745699,0.9953833,0.0000037250952,0.0007354403,0.00041894166,0.002739104,0.000009166218,0.000042211137,0.00009349383],"genre_scores_gemma":[0.000028903416,0.99276155,0.00016209649,0.0062758797,0.00019251622,0.00022562436,0.00019567527,0.000036820544,0.00012093073],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984904,0.00022250401,0.00046341642,0.00041234968,0.0001395284,0.00027179185],"domain_scores_gemma":[0.9994572,0.00016950646,0.00013277444,0.0001307295,0.00001537814,0.00009443518],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018169075,0.00030513183,0.00086883816,0.00017458879,0.0000548172,0.000008554494,0.000054059223,0.00010273841,0.00013204533],"category_scores_gemma":[7.2545396e-7,0.00027212317,0.00010327222,0.00027905838,0.00009481247,0.000053727836,0.000096866446,0.00034085178,0.0000344732],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011373693,0.0003840721,0.0023504396,0.13728996,0.005313207,0.00029229105,0.000036002963,4.5778174e-7,0.000005452351,0.00008854204,0.0011629378,0.8529629],"study_design_scores_gemma":[0.006022459,0.0011522366,0.03143617,0.20576286,0.12906699,0.0006995029,0.000049659,0.00007156344,0.0000031346165,0.00076340354,0.62426955,0.0007024703],"about_ca_topic_score_codex":0.000014243129,"about_ca_topic_score_gemma":0.000018606992,"teacher_disagreement_score":0.8522604,"about_ca_system_score_codex":0.00010738224,"about_ca_system_score_gemma":0.00003302834,"threshold_uncertainty_score":0.9999731},"labels":[],"label_agreement":null},{"id":"W4377938900","doi":"10.1111/apt.17555","title":"Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease","year":2023,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cervical intraepithelial neoplasia; Internal medicine; Cumulative incidence; Inflammatory bowel disease; Proportional hazards model; Ustekinumab; Vedolizumab; Cervical cancer; Cohort; Gastroenterology; Cancer; Disease; Adalimumab","score_opus":0.013306134883295377,"score_gpt":0.2974286911263479,"score_spread":0.28412255624305255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377938900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952644,0.0019405347,0.0000040349073,0.0015667111,0.000109511966,0.0008978121,0.00009686379,0.00009052198,0.000029578243],"genre_scores_gemma":[0.9880717,0.007957705,0.00007844672,0.0034572755,0.000057405865,0.00023072946,0.000049000646,0.000046840527,0.000050915733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794483,0.00034338547,0.00039759802,0.0003219254,0.00038166554,0.0006105932],"domain_scores_gemma":[0.99884844,0.0002569378,0.000101162805,0.0002717321,0.00008786292,0.00043386413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036155092,0.00024420753,0.00038011308,0.0003952045,0.00009664858,0.000010162373,0.00017942199,0.00006804061,0.00045520728],"category_scores_gemma":[0.000001968682,0.000203978,0.00006368042,0.0005248747,0.0002717566,0.0001263325,0.000115901836,0.00032827354,0.00007077594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018023245,0.00076944043,0.9346645,0.00007489598,0.006607639,0.0004890882,0.004694464,0.001069101,0.030810058,0.000022187216,0.00021636636,0.002559031],"study_design_scores_gemma":[0.007370321,0.002319823,0.97859526,0.0001304241,0.00035656136,0.000016957398,0.0017567681,0.0005682637,0.00676459,0.0002258041,0.0016541455,0.00024110998],"about_ca_topic_score_codex":0.0001846138,"about_ca_topic_score_gemma":0.00004731321,"teacher_disagreement_score":0.043930747,"about_ca_system_score_codex":0.00015560462,"about_ca_system_score_gemma":0.00024359529,"threshold_uncertainty_score":0.8317981},"labels":[],"label_agreement":null},{"id":"W4378515139","doi":"10.1111/apt.17527","title":"Editorial: composite kidney outcomes in studies with patients with cirrhosis and <scp>AKI</scp>—Are we ready to “<scp>MAKE</scp>” the switch?","year":2023,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre; University Health Network","funders":"Research Committee, Aristotle University of Thessaloniki","keywords":"Cirrhosis; Medicine; Intensive care medicine; Gastroenterology","score_opus":0.025538049733212755,"score_gpt":0.3294687711586448,"score_spread":0.30393072142543204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378515139","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23313119,0.0020903964,0.0000018733734,0.0034998867,0.756896,0.0024082272,0.0017818455,0.00015961542,0.000030963907],"genre_scores_gemma":[0.016738866,0.025647307,0.00014091593,0.022523122,0.9264515,0.0010608553,0.0060564782,0.00044642863,0.0009344968],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961831,0.00033726092,0.0005969587,0.0008676357,0.0012575082,0.0007575648],"domain_scores_gemma":[0.9938895,0.0043454487,0.00040669297,0.00040193662,0.0005506657,0.00040575227],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033434352,0.0008228597,0.0011817002,0.0003430717,0.00029332392,0.00005758201,0.00035765223,0.0004928186,0.000004526992],"category_scores_gemma":[0.0000067846654,0.00052329875,0.000105246276,0.00047502373,0.00031420804,0.00015114827,0.00014603158,0.001158313,0.00003738451],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083542947,0.0006250113,0.17180362,0.0004302186,0.046051264,0.00013748324,0.004901146,0.000012673737,0.0002935823,0.000001192488,0.77485764,0.00005076037],"study_design_scores_gemma":[0.02266973,0.0036689374,0.05000537,0.0012830405,0.11646746,0.000005478725,0.0034691652,0.000007904672,0.001617729,0.00005382051,0.80036736,0.00038401736],"about_ca_topic_score_codex":0.00019446494,"about_ca_topic_score_gemma":0.00019306956,"teacher_disagreement_score":0.21639232,"about_ca_system_score_codex":0.0002807281,"about_ca_system_score_gemma":0.00035517753,"threshold_uncertainty_score":0.9997219},"labels":[],"label_agreement":null},{"id":"W4378516571","doi":"10.1111/apt.17548","title":"Letter: delays to diagnosis of <scp>IBD</scp>—Challenges requiring a systematic approach. Authors’ reply","year":2023,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute for Health and Care Research","keywords":"Medicine; Intensive care medicine","score_opus":0.04677902925969345,"score_gpt":0.29841309511110464,"score_spread":0.2516340658514112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378516571","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38912782,0.02777726,0.00041423916,0.5517534,0.01292169,0.013637775,0.0018301253,0.00072990684,0.0018077582],"genre_scores_gemma":[0.009507454,0.0041151643,0.000642987,0.97509515,0.0051907934,0.0024988984,0.0012551552,0.0004055043,0.0012888779],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99504244,0.0010137843,0.0011192338,0.0012703843,0.0005338108,0.0010203533],"domain_scores_gemma":[0.99737555,0.00036195247,0.00067449955,0.001191071,0.00018080397,0.00021613824],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008112483,0.00084840297,0.00094933517,0.00034900114,0.00016008868,0.000033882105,0.0011760942,0.0010387942,0.0000252724],"category_scores_gemma":[0.0000072630983,0.00087591994,0.00049963326,0.00019458566,0.00025557395,0.000012859179,0.00062687416,0.00097652344,0.0001372568],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011980196,0.00023500482,0.00042520743,0.011208207,0.018651433,0.0010203162,0.0010497407,0.000253984,0.027447622,0.000007027441,0.9395222,0.000059453698],"study_design_scores_gemma":[0.0021459323,0.0009378249,0.00052896497,0.0013341352,0.025389733,0.00009514563,0.00067403965,0.0002494103,0.076939166,0.000098752476,0.8905324,0.0010745411],"about_ca_topic_score_codex":0.000015151285,"about_ca_topic_score_gemma":0.00000830847,"teacher_disagreement_score":0.42334175,"about_ca_system_score_codex":0.00013195147,"about_ca_system_score_gemma":0.00016856013,"threshold_uncertainty_score":0.99936914},"labels":[],"label_agreement":null},{"id":"W4378639877","doi":"10.1111/apt.17568","title":"Systematic review and meta‐analysis of randomised controlled trials: Medical therapies for the treatment and prevention of pouchitis","year":2023,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Respiratory and Cough-Related Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; McGill University; McGill University Health Centre; University of Calgary; Western University","funders":"","keywords":"Medicine; Pouchitis; Placebo; Metronidazole; Internal medicine; Budesonide; Vedolizumab; Randomized controlled trial; Clinical trial; Meta-analysis; Ulcerative colitis; Alternative medicine; Disease; Antibiotics","score_opus":0.29191412917101633,"score_gpt":0.5150247698443825,"score_spread":0.22311064067336617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378639877","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024963427,0.9759612,0.00002970729,0.0014034079,0.00008842369,0.022300843,0.00016996128,0.000015356247,0.0000061489495],"genre_scores_gemma":[0.00001894895,0.99093604,0.00001730854,0.0017432455,0.00004658544,0.0066936826,0.00010544029,0.000038941176,0.0003997897],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99135864,0.0050886255,0.002610492,0.00033228187,0.00038476934,0.00022521937],"domain_scores_gemma":[0.980307,0.017560406,0.0015609243,0.0003302169,0.00013646197,0.0001050264],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0077405456,0.00043588236,0.016056288,0.00035654794,0.00009791971,0.000008861938,0.00019915684,0.0002813279,0.00063466805],"category_scores_gemma":[0.000031735195,0.00018747471,0.004375756,0.0005001178,0.0003262095,0.000025014044,0.00003777875,0.00025447126,0.0000012414996],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013772363,0.00020871918,2.563859e-7,0.2223787,0.7673296,0.000005350305,0.00008884908,2.8635182e-7,0.000010359288,0.00000978954,0.000025614832,0.008565282],"study_design_scores_gemma":[0.024461191,0.00097236247,2.5516536e-7,0.011077313,0.9556333,0.000017153154,0.000069114394,0.00006762531,0.000023528924,0.000016686405,0.007547795,0.000113721355],"about_ca_topic_score_codex":0.000012503976,"about_ca_topic_score_gemma":0.0000053802614,"teacher_disagreement_score":0.2113014,"about_ca_system_score_codex":0.00004496908,"about_ca_system_score_gemma":0.00030775156,"threshold_uncertainty_score":0.99855137},"labels":[],"label_agreement":null},{"id":"W4380302240","doi":"10.1111/apt.17540","title":"Editorial: faecal incontinence in ulcerative colitis","year":2023,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Ulcerative colitis; Medicine; Fecal incontinence; Colitis; Gastroenterology; Intensive care medicine; Internal medicine; Disease","score_opus":0.011302802767041369,"score_gpt":0.311041724574725,"score_spread":0.29973892180768363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380302240","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022395441,0.00025215241,0.000004959324,0.0002532417,0.9751803,0.00071881776,0.0009847841,0.00007264124,0.00013765802],"genre_scores_gemma":[0.0016258095,0.0025391562,0.00003994312,0.0020792226,0.9882963,0.00036890246,0.0038588454,0.00018058823,0.0010112562],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963499,0.000694049,0.0006262578,0.0009453462,0.0005793569,0.00080509],"domain_scores_gemma":[0.9984857,0.00032392697,0.00027427098,0.00045173374,0.00028062594,0.00018373558],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00061620906,0.0006195011,0.00047778094,0.00016631267,0.00013030738,0.00004175064,0.0007419391,0.0015106085,0.00013692823],"category_scores_gemma":[0.000007919652,0.00070141826,0.0001989928,0.00017922986,0.00032473696,0.000012138119,0.00042670022,0.0010502074,0.00017382007],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021537817,0.00018602672,0.00035993135,0.00004970659,0.0032088195,0.00027512858,0.00011299547,0.000034905413,0.017063042,0.000002352228,0.9764591,0.0000942068],"study_design_scores_gemma":[0.0032422186,0.0002863661,0.00090855494,0.000034510038,0.0018070668,0.0000013321411,0.00006453254,0.00003086215,0.005336054,0.00004654835,0.9875713,0.0006706569],"about_ca_topic_score_codex":0.00011075319,"about_ca_topic_score_gemma":0.0006701214,"teacher_disagreement_score":0.020769631,"about_ca_system_score_codex":0.00021502338,"about_ca_system_score_gemma":0.00087591854,"threshold_uncertainty_score":0.99978566},"labels":[],"label_agreement":null},{"id":"W4380356059","doi":"10.1111/apt.17545","title":"Letter: expanding the role for decision aids in <scp>IBD</scp> into pregnancy‐related topics","year":2023,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Pregnancy; Decision aids; Immunology; Obstetrics; Alternative medicine; Pathology","score_opus":0.03671120287935453,"score_gpt":0.35627390434847844,"score_spread":0.3195627014691239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380356059","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028380036,0.025267793,0.00034863278,0.9297154,0.010514256,0.004746724,0.00013449272,0.00034534663,0.00054733764],"genre_scores_gemma":[0.0061617377,0.0065350584,0.0005418445,0.97503084,0.0042568576,0.0009142302,0.00090802286,0.0001741304,0.0054772776],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969096,0.0002968655,0.0008127207,0.0006455159,0.0004660758,0.0008692156],"domain_scores_gemma":[0.9961645,0.0027346355,0.00033148966,0.00057271,0.00007697833,0.00011967513],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048867747,0.0005143961,0.00068704935,0.00039345547,0.00024039578,0.00002624494,0.0005767858,0.0009775714,0.0001219803],"category_scores_gemma":[0.00001255204,0.0003919258,0.00030409847,0.00042145827,0.00025369987,0.00011861409,0.00015314102,0.002236354,0.00009689797],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013345739,0.00027512154,0.0023910922,0.0003316976,0.008496753,0.00052281475,0.0047545726,0.000016494489,0.014214694,0.000015393924,0.9168773,0.051970594],"study_design_scores_gemma":[0.003875422,0.0005709541,0.00031290934,0.001288674,0.007104535,0.000056015917,0.00031422515,0.0002742867,0.015926335,0.0018913957,0.9682008,0.00018443714],"about_ca_topic_score_codex":0.000035255107,"about_ca_topic_score_gemma":0.000008458505,"teacher_disagreement_score":0.051786155,"about_ca_system_score_codex":0.0003742089,"about_ca_system_score_gemma":0.00024941948,"threshold_uncertainty_score":0.99985325},"labels":[],"label_agreement":null},{"id":"W4380371767","doi":"10.1111/apt.17529","title":"Editorial: improving the use of Montreal classification through a bidirectional approach","year":2023,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; MEDLINE; Political science","score_opus":0.04448219376245721,"score_gpt":0.3114245777632497,"score_spread":0.2669423840007925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380371767","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0055391584,0.00039214196,0.00011543612,0.00013957333,0.99210215,0.0006828306,0.00091270596,0.00006078532,0.00005521374],"genre_scores_gemma":[0.0007169081,0.0019451651,0.00029000166,0.00086274144,0.99016404,0.00029774703,0.0049744006,0.00014038949,0.0006086147],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973165,0.00049457035,0.00052447396,0.00065418484,0.000596111,0.00041418552],"domain_scores_gemma":[0.9980865,0.00040748907,0.00050409144,0.0005622324,0.000371168,0.000068507994],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003830219,0.00041987782,0.00030024385,0.00006453971,0.00021477831,0.000039290942,0.00056943373,0.0009671216,0.000022969323],"category_scores_gemma":[0.000008581878,0.00035648607,0.00025502802,0.00013999066,0.00037516622,0.000018590456,0.00025755554,0.00062563934,0.000017651417],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084553135,0.00020427651,0.00006373829,0.000058649086,0.005031092,0.000005062253,0.00009355525,0.0001924179,0.10062361,0.0000030823799,0.89270055,0.00017841258],"study_design_scores_gemma":[0.0010868375,0.00014748069,0.00028984083,0.000008483393,0.0048373933,0.0000013165816,0.000065415545,0.00049341784,0.0056894906,0.000018447776,0.98702353,0.00033832196],"about_ca_topic_score_codex":0.0003122293,"about_ca_topic_score_gemma":0.000049090526,"teacher_disagreement_score":0.09493411,"about_ca_system_score_codex":0.00009904352,"about_ca_system_score_gemma":0.0005861757,"threshold_uncertainty_score":0.9998887},"labels":[],"label_agreement":null},{"id":"W4381598849","doi":"10.1111/apt.17617","title":"Systematic review and meta‐analysis: Association between liver fibrosis and subclinical atherosclerosis in nonalcoholic fatty liver disease","year":2023,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nonalcoholic fatty liver disease; Subclinical infection; Internal medicine; Gastroenterology; Odds ratio; Fibrosis; Fatty liver; Metabolic syndrome; Disease; Obesity","score_opus":0.18835446874905792,"score_gpt":0.4240838810891605,"score_spread":0.23572941234010258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381598849","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005609427,0.99175876,5.823146e-7,0.0011743685,0.000060846265,0.0053078094,0.0010742791,0.000059758164,0.000002638226],"genre_scores_gemma":[0.0004278863,0.9859347,0.000032019172,0.01020703,0.00008761049,0.0021969678,0.00088051666,0.00008389677,0.00014937935],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99547875,0.0014489351,0.0013690628,0.0008411866,0.00040526764,0.00045682534],"domain_scores_gemma":[0.9961112,0.002208571,0.00077371445,0.00040259594,0.000073121664,0.00043075878],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00083553384,0.0007129696,0.006645565,0.00036225855,0.00010364654,0.000037240567,0.00018099454,0.00031424433,0.00031741514],"category_scores_gemma":[0.0000036059992,0.00051716104,0.0018380121,0.00073852844,0.00011053376,0.00009834111,0.00019604937,0.00044930805,0.00010011664],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014574788,0.000455493,0.009983308,0.31008446,0.6789258,0.00007456509,0.000046471723,1.0903625e-7,1.8266603e-7,0.0000016089896,0.0000797634,0.00033362783],"study_design_scores_gemma":[0.0008174122,0.0001278924,0.01207535,0.018825755,0.96596146,0.0000037215787,0.0000057824604,0.000012196134,0.0000012221748,0.000003842619,0.0018050111,0.0003603388],"about_ca_topic_score_codex":0.00011078803,"about_ca_topic_score_gemma":0.000020025393,"teacher_disagreement_score":0.29125872,"about_ca_system_score_codex":0.0004437209,"about_ca_system_score_gemma":0.00014137427,"threshold_uncertainty_score":0.999728},"labels":[],"label_agreement":null},{"id":"W4381839133","doi":"10.1111/apt.17603","title":"Editorial: Predicting paediatric ulcerative colitis outcomes—how can we improve?","year":2023,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"","keywords":"Medicine; Ulcerative colitis; Colitis; Intensive care medicine; MEDLINE; Internal medicine; Disease","score_opus":0.01091658126064989,"score_gpt":0.29186690280048955,"score_spread":0.2809503215398397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381839133","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0109687075,0.00057224365,0.0000062405984,0.0018023243,0.9800664,0.0012332738,0.005092721,0.00020446046,0.00005358052],"genre_scores_gemma":[0.0015513219,0.005085398,0.00005251383,0.002148321,0.9813817,0.00057741825,0.0060068904,0.00035565987,0.00284074],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951133,0.00076943164,0.00068012654,0.0013076972,0.000935171,0.001194273],"domain_scores_gemma":[0.9971602,0.0006234731,0.0006144434,0.0007048181,0.0005209992,0.00037609108],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00064292684,0.0010094921,0.0007208667,0.00020384279,0.00039515112,0.00011088163,0.0009600655,0.0019861362,0.00009226895],"category_scores_gemma":[0.000019716945,0.0010565588,0.00046375644,0.00021206877,0.0003118003,0.000017087688,0.0006304283,0.0013723425,0.00007687139],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009822882,0.00016531484,0.0008755562,0.00012049742,0.012309988,0.0001576292,0.00016460901,0.00001990743,0.01623061,0.0000012152751,0.9687278,0.00024453574],"study_design_scores_gemma":[0.0036615373,0.00050375966,0.00034767718,0.000021440263,0.008975026,0.0000016299254,0.00016554224,0.000040398292,0.005928346,0.000043502965,0.97932,0.0009911617],"about_ca_topic_score_codex":0.00008048722,"about_ca_topic_score_gemma":0.00030353013,"teacher_disagreement_score":0.010592128,"about_ca_system_score_codex":0.00034041112,"about_ca_system_score_gemma":0.0013956559,"threshold_uncertainty_score":0.9993095},"labels":[],"label_agreement":null},{"id":"W4381839765","doi":"10.1111/apt.17560","title":"Editorial: Alcohol‐related liver disease is the primary driver of cirrhosis‐related hospital admissions in the <scp>COVID</scp>‐19 era—What can be done?","year":2023,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Novo Nordisk; Bristol-Myers Squibb Canada; Intercept Pharmaceuticals; Gilead Sciences; AstraZeneca; Allergan; Bristol-Myers Squibb","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Alcoholic liver disease; 2019-20 coronavirus outbreak; Cirrhosis; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Betacoronavirus; Liver disease; Coronavirus Infections; Alcohol; Disease; MEDLINE; Pandemic; Intensive care medicine; Medical emergency; Emergency medicine; Internal medicine; Family medicine; Virology; Infectious disease (medical specialty); Outbreak","score_opus":0.023020862625722484,"score_gpt":0.3210541471206959,"score_spread":0.2980332844949734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381839765","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.059404258,0.017209925,1.2303417e-7,0.01925826,0.8978351,0.0036752648,0.002398548,0.00015716958,0.000061379375],"genre_scores_gemma":[0.029282676,0.13750087,0.00001866715,0.06416713,0.75394577,0.0016620107,0.011667597,0.00040131804,0.0013539466],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99381113,0.0010960124,0.0011326588,0.0011130935,0.0018660738,0.0009810271],"domain_scores_gemma":[0.9899289,0.0071063684,0.00069508434,0.0010620473,0.0003457403,0.0008618595],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00077838224,0.0009887095,0.0011306724,0.00033099513,0.000440512,0.00009285864,0.0011028833,0.0010914174,0.00060049846],"category_scores_gemma":[0.00003635311,0.0006431616,0.0008201817,0.0008212759,0.00064099487,0.00025465526,0.0004072197,0.0023379389,0.00008942978],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003042588,0.0038528938,0.006542997,0.00021269101,0.0246953,0.00086459116,0.009412585,0.000017049371,0.00029057413,0.000007720435,0.9536209,0.00017845913],"study_design_scores_gemma":[0.009871935,0.0009927028,0.011754406,0.00038680332,0.06610854,0.000005658984,0.0014604366,0.00004638253,0.00023631201,0.00015088185,0.9086499,0.00033599697],"about_ca_topic_score_codex":0.0007985107,"about_ca_topic_score_gemma":0.000031369258,"teacher_disagreement_score":0.14388928,"about_ca_system_score_codex":0.0008988836,"about_ca_system_score_gemma":0.0027094292,"threshold_uncertainty_score":0.9999637},"labels":[],"label_agreement":null},{"id":"W4384818602","doi":"10.1111/apt.17650","title":"Early serum ammonia variation in critically ill patients with cirrhosis: A multicentre cohort study","year":2023,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health; University of Alberta; Alberta Health Services","funders":"Canada Research Chairs; Canadian Liver Foundation","keywords":"Medicine; Cohort; Hepatic encephalopathy; Internal medicine; Cirrhosis; Cohort study; Intensive care; Pediatrics; Intensive care medicine","score_opus":0.013493484260272194,"score_gpt":0.29413832117653327,"score_spread":0.2806448369162611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384818602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957238,0.000040001225,0.00001018091,0.001669222,0.00028295896,0.0020572676,0.00006104893,0.000114693445,0.000040845847],"genre_scores_gemma":[0.9831842,0.00011857179,0.00008804578,0.01611298,0.00005745472,0.00014513469,0.00022185677,0.000031123935,0.000040606155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985764,0.00017359141,0.00026426246,0.00032942917,0.00031615896,0.0003401437],"domain_scores_gemma":[0.99932057,0.000093889714,0.000049623242,0.00014163023,0.00028140366,0.00011290595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001451343,0.00017921683,0.00022582767,0.00017440577,0.000076981865,0.000012363868,0.000081331986,0.00006237598,0.00016769905],"category_scores_gemma":[1.7634692e-7,0.00015752547,0.000036959107,0.00035307562,0.000047493595,0.00015685544,0.000020829999,0.00018286714,0.00010634768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016660843,0.0022668522,0.98058045,0.000032027445,0.009367982,0.0002596557,0.0035691014,0.000021148468,0.0020591328,0.0000023204595,0.000015850257,0.0001593856],"study_design_scores_gemma":[0.012277954,0.0009667187,0.96269584,0.000026329302,0.022182222,0.0000023644882,0.0005638855,0.00047043894,0.0006295786,0.000011079874,0.000020724978,0.00015286203],"about_ca_topic_score_codex":0.000210681,"about_ca_topic_score_gemma":0.000059104445,"teacher_disagreement_score":0.01788462,"about_ca_system_score_codex":0.000101154365,"about_ca_system_score_gemma":0.00005811651,"threshold_uncertainty_score":0.6423702},"labels":[],"label_agreement":null},{"id":"W4385298153","doi":"10.1111/apt.17626","title":"Editorial: The use of Baveno <scp>VI</scp> and <scp>VII</scp> criteria in patients with hepatocellular carcinoma","year":2023,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"","keywords":"Hepatocellular carcinoma; Medicine; Cancer research; Gastroenterology; Internal medicine","score_opus":0.02784159446840588,"score_gpt":0.2858194614785325,"score_spread":0.2579778670101266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385298153","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5076552,0.00054112467,0.0000017482229,0.00007384477,0.48994848,0.0010350063,0.000691112,0.000043255146,0.000010218658],"genre_scores_gemma":[0.115991905,0.005290762,0.00007653596,0.0022330706,0.86821175,0.0002257579,0.0073516234,0.00028159,0.00033698182],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966483,0.00045367144,0.00064936455,0.00064992526,0.0009933161,0.00060539047],"domain_scores_gemma":[0.99509555,0.0035476862,0.0003773901,0.00040395762,0.00037271128,0.00020269377],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032899622,0.0005806713,0.0008001372,0.00028018735,0.00014294918,0.000044625893,0.0003028227,0.0006777555,0.000021607017],"category_scores_gemma":[0.000004767647,0.00044224088,0.00013656834,0.00032700965,0.00037881287,0.00022832058,0.00011023901,0.0009998125,0.00001951673],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006345084,0.0006345884,0.19498764,0.00043742123,0.011759995,0.0001352474,0.0020915887,0.000006040992,0.0018081025,0.000001136657,0.7874649,0.00003883482],"study_design_scores_gemma":[0.018705333,0.0025439363,0.07862579,0.0003521616,0.067677766,0.000004160731,0.00044570176,0.00020261905,0.0069455476,0.000036887828,0.8242431,0.00021698476],"about_ca_topic_score_codex":0.0005578764,"about_ca_topic_score_gemma":0.00003031221,"teacher_disagreement_score":0.3916633,"about_ca_system_score_codex":0.00015314885,"about_ca_system_score_gemma":0.00039316915,"threshold_uncertainty_score":0.99980295},"labels":[],"label_agreement":null},{"id":"W4385898583","doi":"10.1111/apt.17666","title":"Systematic review with meta‐analysis: Medical therapies for treatment of ulcerative proctitis","year":2023,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University; Western University","funders":"U.S. National Library of Medicine","keywords":"Medicine; Placebo; Ulcerative colitis; Relative risk; Budesonide; Internal medicine; Maintenance therapy; Randomized controlled trial; Surgery; Gastroenterology; Confidence interval; Corticosteroid; Chemotherapy; Disease","score_opus":0.08177742267499027,"score_gpt":0.4031365235726986,"score_spread":0.3213591008977083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385898583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001133279,0.99189335,0.000074220916,0.0002331006,0.00013682258,0.0068584704,0.00074795424,0.000032060765,0.00001266975],"genre_scores_gemma":[0.000008528116,0.9875644,0.000112860216,0.0028881696,0.0001476887,0.0069481684,0.0018240507,0.000118790726,0.000387331],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9965889,0.0010055659,0.0010888672,0.0006268858,0.0003276411,0.00036215337],"domain_scores_gemma":[0.99803346,0.00022292844,0.0008674963,0.0005642375,0.0001697966,0.00014208975],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045776757,0.0007021584,0.0043269875,0.00016615371,0.00009915302,0.000011093091,0.0004685224,0.00032336425,0.0002766286],"category_scores_gemma":[0.0000012145915,0.00043496198,0.0025119414,0.00032969986,0.00022636588,0.0000052118417,0.00006425083,0.0000883824,0.000016097556],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008946872,0.00023856346,9.347969e-7,0.26613244,0.73268014,0.000056226305,0.0000442877,0.0000017246775,0.0000098872815,0.000005735197,0.00014532082,0.0005952772],"study_design_scores_gemma":[0.0006057259,0.00074892596,5.217396e-7,0.009279925,0.9105612,0.000027971117,0.00002588631,0.000006831398,0.00013558047,0.0000034587733,0.07823656,0.0003674058],"about_ca_topic_score_codex":0.0000062733357,"about_ca_topic_score_gemma":0.000053770967,"teacher_disagreement_score":0.2568525,"about_ca_system_score_codex":0.00007609206,"about_ca_system_score_gemma":0.0005396185,"threshold_uncertainty_score":0.9998102},"labels":[],"label_agreement":null},{"id":"W4387033369","doi":"10.1111/apt.17728","title":"Randomised clinical trial: Efficacy and safety of <scp>on‐demand</scp> vonoprazan versus placebo for non‐erosive reflux disease","year":2023,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Nerd; Heartburn; Placebo; Adverse effect; Internal medicine; Reflux; Dosing; Gastroenterology; Clinical endpoint; Clinical trial; Anesthesia; Disease; GERD","score_opus":0.09693331041389054,"score_gpt":0.428632267300006,"score_spread":0.33169895688611545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387033369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99106735,0.0002536141,0.000019802983,0.0010003324,0.001957193,0.005262016,0.00017643483,0.000091551265,0.00017170593],"genre_scores_gemma":[0.9910512,0.0015672473,0.0002088108,0.0051131924,0.0004369113,0.00039989,0.00041926518,0.000061051935,0.0007424517],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976963,0.0002897081,0.00074220035,0.0005194479,0.0002488381,0.0005035355],"domain_scores_gemma":[0.99451387,0.0044268817,0.0002661175,0.00029467218,0.00008282649,0.00041565357],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006420063,0.00033264642,0.00076635275,0.00014923836,0.00016171842,0.000009184093,0.00014495543,0.00015394735,0.00005546174],"category_scores_gemma":[0.000019150864,0.00027294,0.00031356997,0.00018486107,0.00030522628,0.00005486183,0.000078362005,0.0002628578,0.00005079269],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9426399,0.0032062114,0.011413986,0.00011754135,0.025866462,0.0003947985,0.00043296305,0.000045017405,0.008022067,0.00002710322,0.004097284,0.003736675],"study_design_scores_gemma":[0.911068,0.011853212,0.03341736,0.000039908446,0.023957277,0.0000038569683,0.000085176114,0.0005058209,0.015143331,0.000050938484,0.0037931611,0.000081955724],"about_ca_topic_score_codex":0.0000019228683,"about_ca_topic_score_gemma":3.9709056e-7,"teacher_disagreement_score":0.031571887,"about_ca_system_score_codex":0.00007067723,"about_ca_system_score_gemma":0.00012759506,"threshold_uncertainty_score":0.9999723},"labels":[],"label_agreement":null},{"id":"W4387241936","doi":"10.1111/apt.17733","title":"In severe alcohol‐related hepatitis, acute kidney injury is prevalent, associated with mortality independent of liver disease severity, and can be predicted using <scp>IL</scp>‐8 and <scp>micro‐RNAs</scp>","year":2023,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre","funders":"NIHR Imperial Biomedical Research Centre; Health Technology Assessment Programme; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Internal medicine; Acute kidney injury; Alcoholic hepatitis; Renal function; Creatinine; Gastroenterology; Prednisolone; Incidence (geometry); Proportional hazards model; Liver function; Liver disease; Alcoholic liver disease; Cirrhosis","score_opus":0.07000009467955262,"score_gpt":0.37484977721665597,"score_spread":0.3048496825371033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387241936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920592,0.00084469514,0.0000019335564,0.0021098491,0.0003198353,0.0018073054,0.0026947423,0.00013244175,0.000030011306],"genre_scores_gemma":[0.9490109,0.012519514,0.000049643182,0.03703904,0.00005376603,0.0000611158,0.0008165762,0.00006686434,0.0003825903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99709445,0.0005256085,0.0006166708,0.00060945726,0.00047255366,0.00068123196],"domain_scores_gemma":[0.9981495,0.0003734968,0.00037653354,0.00025796186,0.0001546812,0.0006877929],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005505256,0.0004154039,0.00065855234,0.00034167638,0.000205199,0.000019675354,0.00014071183,0.00030779946,0.00011940196],"category_scores_gemma":[0.00001043244,0.00040597524,0.00007782937,0.00059001317,0.00046495654,0.00020693975,0.00022711745,0.0006706749,0.0000037639736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021566372,0.0005536015,0.93600637,0.00044628154,0.008917839,0.0005481594,0.0027427818,0.000005251314,0.04524881,0.0000036258134,0.005214427,0.00009721156],"study_design_scores_gemma":[0.007823576,0.0005363339,0.96038705,0.00026674586,0.012645801,0.00010271761,0.00011976438,0.0050895894,0.011928567,0.000054421067,0.00092298986,0.0001224421],"about_ca_topic_score_codex":0.0008679565,"about_ca_topic_score_gemma":0.00012074676,"teacher_disagreement_score":0.0430483,"about_ca_system_score_codex":0.0003034534,"about_ca_system_score_gemma":0.00050853536,"threshold_uncertainty_score":0.9998392},"labels":[],"label_agreement":null},{"id":"W4387597793","doi":"10.1111/apt.17725","title":"Letter: Exploring the clinical utility of ammonia in critically ill patients with cirrhosis: More to do? Authors' reply","year":2023,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health; University of Alberta; Alberta Health Services","funders":"Research Committee, Aristotle University of Thessaloniki; Canadian Liver Foundation; Canadian Association for the Study of the Liver","keywords":"Critically ill; Medicine; Cirrhosis; Intensive care medicine; Internal medicine","score_opus":0.08367790344187809,"score_gpt":0.3719938543934186,"score_spread":0.2883159509515405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387597793","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53090537,0.000107209366,0.00000983654,0.46630356,0.0012443414,0.0011313122,0.00023007602,0.000049432405,0.000018855511],"genre_scores_gemma":[0.13398963,0.00041015085,0.00017054573,0.8632314,0.0011656919,0.0002529097,0.0006521796,0.00007910447,0.000048357433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99682456,0.0005474125,0.00087049743,0.00065030897,0.0005795281,0.00052771],"domain_scores_gemma":[0.9981074,0.0006532701,0.00016372671,0.0004996898,0.000436687,0.0001392595],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047216477,0.0003793753,0.0006567342,0.00020970477,0.00007799497,0.000013186582,0.00033316942,0.00027979142,0.00013439894],"category_scores_gemma":[0.0000012113992,0.00027249494,0.00019800485,0.00032310397,0.00034237755,0.00010372008,0.00007855888,0.0016760351,0.000041479318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054506357,0.0013763297,0.6835809,0.0006874771,0.029788475,0.0016011338,0.0031967608,0.000006227041,0.00025695734,0.000001625991,0.27163664,0.002416833],"study_design_scores_gemma":[0.0069072703,0.0015186116,0.8183573,0.0005102761,0.05140334,0.000010503468,0.000273665,0.00004336991,0.0017277682,0.00003927999,0.11868848,0.0005201455],"about_ca_topic_score_codex":0.00014128877,"about_ca_topic_score_gemma":0.000013735848,"teacher_disagreement_score":0.39692786,"about_ca_system_score_codex":0.00007603616,"about_ca_system_score_gemma":0.00014120027,"threshold_uncertainty_score":0.9999727},"labels":[],"label_agreement":null},{"id":"W4388033326","doi":"10.1111/apt.17764","title":"Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks","year":2023,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Gilead Sciences","keywords":"Medicine; Tenofovir alafenamide; Internal medicine; Population; Blood pressure; Tenofovir; Gastroenterology; Endocrinology; Immunology; Human immunodeficiency virus (HIV); Viral load","score_opus":0.02333187561602789,"score_gpt":0.29462647855568663,"score_spread":0.27129460293965874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388033326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909748,0.0011675387,0.00015854425,0.00090547866,0.00011409997,0.005227092,0.0012313662,0.00018638781,0.00003468167],"genre_scores_gemma":[0.99045396,0.003041358,0.0006377938,0.001023978,0.00008399089,0.0017167656,0.002188105,0.00012788885,0.0007261674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977496,0.00018134042,0.00046312308,0.0005992046,0.00037093344,0.0006357805],"domain_scores_gemma":[0.9984112,0.00016524986,0.00026275363,0.00060905155,0.00025706599,0.00029467983],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017169904,0.00039360678,0.0006321945,0.00019226632,0.00035063922,0.000009213643,0.00016093008,0.000108064945,0.00023491544],"category_scores_gemma":[7.195234e-7,0.00025625405,0.00020007798,0.0006265355,0.00026332063,0.00010439152,0.000046351393,0.00023311857,0.000075477954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073540527,0.0019681887,0.9442913,0.00034917885,0.036668826,0.00007941257,0.00024043322,0.0010149317,0.0008026719,0.000006651935,0.00031136142,0.0069129704],"study_design_scores_gemma":[0.025753386,0.008674889,0.90057087,0.00022981521,0.0487389,0.000009908488,0.000043166452,0.0076834233,0.0029536292,0.00003054322,0.004863552,0.00044794517],"about_ca_topic_score_codex":0.00045533828,"about_ca_topic_score_gemma":0.00005568211,"teacher_disagreement_score":0.043720476,"about_ca_system_score_codex":0.0003534337,"about_ca_system_score_gemma":0.00047509297,"threshold_uncertainty_score":0.999989},"labels":[],"label_agreement":null},{"id":"W4388034582","doi":"10.1111/apt.17755","title":"Open‐label, clinical trial extension: Two‐year safety and efficacy results of seladelpar in patients with primary biliary cholangitis","year":2023,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Toronto Liver Centre","funders":"National Institute for Health and Care Research; CymaBay Therapeutics","keywords":"Medicine; Tolerability; Cholestasis; Internal medicine; Gastroenterology; Bilirubin; Alkaline phosphatase; Clinical endpoint; Adverse effect; Liver injury; Primary biliary cirrhosis; Ursodeoxycholic acid; Steatohepatitis; Clinical trial; Fatty liver","score_opus":0.09639709592743903,"score_gpt":0.4060993288660343,"score_spread":0.3097022329385952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388034582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950356,0.00030888862,3.986871e-7,0.0018477805,0.00053065555,0.0018058381,0.00018459854,0.00004046791,0.00024579765],"genre_scores_gemma":[0.98534817,0.0026031493,0.00026208154,0.010658667,0.00015989818,0.000018094397,0.00080782705,0.000034679753,0.00010746441],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9979103,0.00045464773,0.0007089903,0.00039934352,0.00023422742,0.00029244932],"domain_scores_gemma":[0.9987638,0.00046538454,0.00018899157,0.0003368993,0.000093455936,0.0001514547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007419697,0.00018927423,0.00054681423,0.00011920026,0.0000855787,0.000010665687,0.00023240189,0.00010156428,0.00010291763],"category_scores_gemma":[0.000002229048,0.00015044857,0.000054923974,0.00035542902,0.00027721783,0.00015825381,0.00038194988,0.00038102007,0.000018829285],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5945976,0.008379726,0.3768086,0.00005861876,0.0054941,0.0001145414,0.00038594083,0.000009134408,0.0019203515,0.000007105487,0.0024085345,0.009815723],"study_design_scores_gemma":[0.29994914,0.0053049815,0.6891576,0.000055504195,0.0029972433,0.000003320132,0.00007874309,0.000058815476,0.00028896544,0.000008944916,0.0019610429,0.00013567669],"about_ca_topic_score_codex":0.00009716326,"about_ca_topic_score_gemma":0.000002848757,"teacher_disagreement_score":0.312349,"about_ca_system_score_codex":0.000061175204,"about_ca_system_score_gemma":0.00016043732,"threshold_uncertainty_score":0.61351144},"labels":[],"label_agreement":null},{"id":"W4388870686","doi":"10.1111/apt.17766","title":"Editorial: On‐demand vonoprazan for<scp>NERD</scp>– when should it be ‘demanded’? Authors' reply","year":2023,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Nerd; World Wide Web; Medical physics; Internal medicine; Computer science; Reflux","score_opus":0.06644762363099538,"score_gpt":0.39214791477236993,"score_spread":0.32570029114137455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388870686","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017909097,0.0007166648,0.000020050222,0.006641228,0.9848703,0.0028817703,0.0020921072,0.0005395819,0.0004473497],"genre_scores_gemma":[0.00053329376,0.0018860751,0.00038735935,0.029551623,0.92332476,0.0009241653,0.0070969583,0.00051045895,0.035785303],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99302936,0.0004115985,0.0012290459,0.0017434998,0.0018738316,0.0017126441],"domain_scores_gemma":[0.99175113,0.005313298,0.00068804587,0.0009857266,0.0005373852,0.0007244266],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.001193347,0.0014181248,0.0018133369,0.00049707165,0.00050257886,0.000093486895,0.00073407503,0.002213758,0.0002904487],"category_scores_gemma":[0.00004475414,0.001261238,0.0007739139,0.00029245403,0.00034382756,0.00016480555,0.00027707755,0.0026548274,0.00038718642],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092335115,0.0011960731,0.0003165463,0.00025685848,0.031781964,0.0005722139,0.00063807634,0.000011965058,0.0009969877,0.0000063605744,0.96303385,0.00026576192],"study_design_scores_gemma":[0.011976734,0.005139013,0.000041298565,0.00011944699,0.035557747,0.000011203944,0.000093000104,0.000046081586,0.004559065,0.00033815886,0.94185036,0.00026789276],"about_ca_topic_score_codex":0.00007908023,"about_ca_topic_score_gemma":0.000014180703,"teacher_disagreement_score":0.061545573,"about_ca_system_score_codex":0.00075347995,"about_ca_system_score_gemma":0.0007848522,"threshold_uncertainty_score":0.9998569},"labels":[],"label_agreement":null},{"id":"W4389069047","doi":"10.1111/apt.17816","title":"Efficacy and safety of upadacitinib for 16‐week extended induction and 52‐week maintenance therapy in patients with moderately to severely active ulcerative colitis","year":2023,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Genentech; Eisai; Celltrion; AbbVie; Gilead Sciences; Mylan; GlaxoSmithKline; Amgen; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Maintenance therapy; Ulcerative colitis; Clinical trial; Internal medicine; Population; Surgery; Chemotherapy","score_opus":0.022757601316765942,"score_gpt":0.29054089834555186,"score_spread":0.2677832970287859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389069047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972487,0.000053988082,0.00008989963,0.00040285967,0.00012899046,0.0016923127,0.0003375882,0.000014407991,0.000031214935],"genre_scores_gemma":[0.99551237,0.0005136502,0.00021086815,0.0030808079,0.00004919707,0.00018921417,0.00034628305,0.000034141693,0.000063490916],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99880373,0.00015765743,0.00023588054,0.00039536922,0.00009698887,0.0003103817],"domain_scores_gemma":[0.9994912,0.000051500712,0.000105249565,0.00011969621,0.00014000005,0.0000923375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013888684,0.00021081095,0.00019974065,0.00008680104,0.000101782956,0.000009756538,0.00008806367,0.00010099871,0.00001491625],"category_scores_gemma":[9.662425e-7,0.00019450861,0.000028708,0.00012038337,0.0001760206,0.000018427882,0.00006337634,0.00009340097,0.0000011670827],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72249705,0.0028553377,0.021979365,0.00013730909,0.010789805,0.000059415204,0.0052470183,0.0013401415,0.18694608,0.00017824564,0.0011123901,0.046857867],"study_design_scores_gemma":[0.01252549,0.0025989457,0.8958532,0.00001735438,0.00027718337,0.000002825496,0.0003492424,0.00012557775,0.08698846,0.00012196957,0.0008842232,0.00025548422],"about_ca_topic_score_codex":0.00001557326,"about_ca_topic_score_gemma":0.0000445194,"teacher_disagreement_score":0.8738739,"about_ca_system_score_codex":0.000049620045,"about_ca_system_score_gemma":0.00007393841,"threshold_uncertainty_score":0.7931831},"labels":[],"label_agreement":null},{"id":"W4389639589","doi":"10.1111/apt.17787","title":"Editorial: Moving towards prognostic endoscopic scoring in IBD","year":2023,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal disorders and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; MEDLINE; Internal medicine; Gastroenterology; General surgery","score_opus":0.028932715605766567,"score_gpt":0.34923739432657186,"score_spread":0.3203046787208053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389639589","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02063255,0.0013413175,0.0000039604697,0.00081858446,0.9754289,0.0012664057,0.00012718367,0.00024396722,0.00013714617],"genre_scores_gemma":[0.004808242,0.0025176594,0.0003268022,0.0010494133,0.98886114,0.00036032128,0.0012454657,0.00022697003,0.00060398685],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965276,0.00018563369,0.0006684138,0.0008030043,0.00086626655,0.0009490747],"domain_scores_gemma":[0.9980289,0.001006871,0.0002475281,0.0003251638,0.00018626051,0.00020528764],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032238534,0.0006693205,0.00092275307,0.00040262612,0.00011715024,0.000035770056,0.0003217263,0.0006404502,0.00015074023],"category_scores_gemma":[0.000012551311,0.0006485485,0.0002088593,0.00040067575,0.0001459641,0.000098291166,0.00021842167,0.0016875536,0.00019961715],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057019363,0.0009814965,0.020612413,0.00030050037,0.0071045137,0.000789073,0.0001924745,0.0000150465075,0.0030079058,7.959918e-7,0.96554565,0.00087994966],"study_design_scores_gemma":[0.016514732,0.0034502607,0.0047526285,0.0013553842,0.03116855,0.000021889035,0.0002296139,0.0001505375,0.0016424056,0.00017389802,0.9397326,0.0008074729],"about_ca_topic_score_codex":0.00069611863,"about_ca_topic_score_gemma":0.00007723652,"teacher_disagreement_score":0.02581301,"about_ca_system_score_codex":0.000630427,"about_ca_system_score_gemma":0.00079540483,"threshold_uncertainty_score":0.9995966},"labels":[],"label_agreement":null},{"id":"W4389640328","doi":"10.1111/apt.17771","title":"Editorial: Unmasking the silent threat—acute kidney injury in alcohol‐associated hepatitis","year":2023,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre; University Health Network","funders":"","keywords":"Medicine; Acute kidney injury; Alcohol; MEDLINE; Acute hepatitis; Hepatitis; Internal medicine","score_opus":0.059102182123707304,"score_gpt":0.4217333437301587,"score_spread":0.36263116160645137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389640328","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005755545,0.0006819265,0.0000014422208,0.011012853,0.9786394,0.0021289103,0.0013200697,0.00034582987,0.00011398282],"genre_scores_gemma":[0.0018633505,0.03185286,0.000019882442,0.036276564,0.9237637,0.00036150534,0.004860273,0.00020772689,0.00079415005],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946359,0.0009639985,0.0010229839,0.0008458944,0.0013508032,0.0011804177],"domain_scores_gemma":[0.9959108,0.002184414,0.00057259295,0.0005578013,0.0003405719,0.00043378057],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.001575496,0.0007622679,0.0011811723,0.00041665978,0.0003775863,0.0000479982,0.0005480196,0.0017566364,0.0007239434],"category_scores_gemma":[0.000023073671,0.0006304622,0.00032677848,0.00065069064,0.00033247485,0.00010787622,0.00021236666,0.0037528197,0.00045948135],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010498583,0.00035634285,0.005990913,0.00015044551,0.01306748,0.00020299605,0.00045323872,0.0000024749193,0.0013006728,0.000002074797,0.97691417,0.00050931046],"study_design_scores_gemma":[0.0064381957,0.00082854327,0.0028167586,0.00039987173,0.01872804,0.0000052381797,0.000026760501,0.00017391496,0.0005233395,0.000058834034,0.9694745,0.0005259996],"about_ca_topic_score_codex":0.0017763985,"about_ca_topic_score_gemma":0.00018801064,"teacher_disagreement_score":0.054875754,"about_ca_system_score_codex":0.0012771362,"about_ca_system_score_gemma":0.0017942676,"threshold_uncertainty_score":0.99961466},"labels":[],"label_agreement":null},{"id":"W4389640450","doi":"10.1111/apt.17786","title":"Editorial: Unmasking the silent threat—acute kidney injury in alcohol‐associated hepatitis. Authors' reply","year":2023,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre","funders":"NIHR Imperial Biomedical Research Centre; Health Technology Assessment Programme; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Acute kidney injury; Alcohol; Acute hepatitis; Kidney; Hepatitis; Internal medicine; Gastroenterology; Biochemistry","score_opus":0.05977060370745415,"score_gpt":0.4234801449609327,"score_spread":0.3637095412534786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389640450","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046994677,0.00068066956,0.0000018587662,0.018609969,0.9718132,0.0024093434,0.0012327647,0.0004436064,0.000109105145],"genre_scores_gemma":[0.0014407497,0.022855619,0.000029634935,0.05799372,0.9108485,0.00040462674,0.0049424595,0.00024099294,0.0012436883],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935123,0.0013105627,0.0012710461,0.0010548411,0.0015298255,0.0013214392],"domain_scores_gemma":[0.9952232,0.0023417787,0.00074590405,0.0007304288,0.00040929244,0.0005493505],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0024688488,0.0008570175,0.0013304875,0.00047732584,0.00045243098,0.00006017147,0.0006265511,0.0018491917,0.0006613464],"category_scores_gemma":[0.00004347912,0.00071656494,0.00037257385,0.00075209286,0.00037354982,0.00012618439,0.00025095022,0.004637317,0.00041401168],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013350928,0.00038814923,0.005531363,0.0001666729,0.012750019,0.0002465767,0.00060638285,0.0000027105468,0.0012709368,0.0000029100927,0.9772348,0.00046442694],"study_design_scores_gemma":[0.006064552,0.00090442965,0.0027626746,0.0004410794,0.018372042,0.000006762588,0.000030777323,0.0001911352,0.0005138691,0.00007825875,0.97005403,0.00058038556],"about_ca_topic_score_codex":0.0021670568,"about_ca_topic_score_gemma":0.00014772652,"teacher_disagreement_score":0.060964707,"about_ca_system_score_codex":0.00141976,"about_ca_system_score_gemma":0.002077182,"threshold_uncertainty_score":0.9995285},"labels":[],"label_agreement":null},{"id":"W4390016115","doi":"10.1111/apt.17836","title":"Burden of perianal disease in Crohn's disease: Accelerating medical therapy and high rates of perianal surgery over the last four decades – Results from a population‐based study over four decades","year":2023,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Anorectal Disease Treatments and Outcomes","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Nemzeti Kutatási, Fejlesztési és Innovaciós Alap","keywords":"Medicine; Cohort; Fistulotomy; Surgery; Population; Cohort study; Perianal Abscess; Disease; Anal canal; Internal medicine; Anal fistula; Abscess; Rectum; Fistula","score_opus":0.08462219133237066,"score_gpt":0.3725962972605792,"score_spread":0.28797410592820855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390016115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924943,0.0015822033,0.0000014457842,0.0042450274,0.00023070605,0.00092066097,0.00048340607,0.000038993545,0.000003247808],"genre_scores_gemma":[0.9945924,0.0007981486,0.000035534023,0.003662196,0.0002482382,0.00008166293,0.0005067656,0.000041433763,0.000033582917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974146,0.0004823905,0.0007094966,0.00043267023,0.000611206,0.00034963197],"domain_scores_gemma":[0.9976532,0.0014579531,0.00025222905,0.00026425408,0.000058967365,0.0003133814],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039237534,0.00031688446,0.00059153,0.00023858462,0.0001585558,0.00002367852,0.00018175875,0.0000854764,0.0009997924],"category_scores_gemma":[0.000013084145,0.00021458104,0.00019101145,0.00039127652,0.00021497883,0.000118453645,0.00009658963,0.00020515452,0.0000024375088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007651849,0.00088231574,0.9824543,0.000036841342,0.0040306477,0.00072810875,0.0008618564,0.00018076079,0.0014188573,0.000006615932,0.00015483145,0.0015930344],"study_design_scores_gemma":[0.008420669,0.00016806148,0.9814559,0.000092913935,0.0031431364,0.0000012491297,0.0005695079,0.0054548923,0.00039749118,0.000073679956,0.000046536188,0.00017592499],"about_ca_topic_score_codex":0.0019954867,"about_ca_topic_score_gemma":0.00015977428,"teacher_disagreement_score":0.0052741314,"about_ca_system_score_codex":0.0000715884,"about_ca_system_score_gemma":0.0003181541,"threshold_uncertainty_score":0.99991345},"labels":[],"label_agreement":null},{"id":"W4390448767","doi":"10.1111/apt.17859","title":"Review article: Advances in the management of lower gastrointestinal bleeding","year":2023,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Montreal General Hospital","funders":"","keywords":"Medicine; Lower gastrointestinal bleeding; Colonoscopy; Gold standard (test); Intensive care medicine; Etiology; Diverticulosis; Triage; General surgery; Radiology; Surgery; Colorectal cancer; Medical emergency; Internal medicine","score_opus":0.04323599606101783,"score_gpt":0.36838273578344555,"score_spread":0.3251467397224277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390448767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9327164,0.038251247,0.00001393101,0.025934443,0.0003591658,0.0014096979,0.000010295277,0.0000895904,0.0012152062],"genre_scores_gemma":[0.8797373,0.0926723,0.001864919,0.025353571,0.00008263058,0.00018088597,0.000030157362,0.000022403756,0.00005582079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987841,0.00007252022,0.0003515594,0.0002184915,0.00022475659,0.00034853883],"domain_scores_gemma":[0.99946624,0.00017102167,0.00010163828,0.00016580599,0.0000438266,0.000051472365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043629608,0.00016576317,0.0002663883,0.00008827534,0.00005134831,0.0000047085414,0.00015972488,0.000015329337,0.00020242775],"category_scores_gemma":[2.7890266e-7,0.00011436855,0.00009596413,0.0005412092,0.000106685206,0.00007144129,0.00005813278,0.00017646737,0.00006439904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021962195,0.009125086,0.80733967,0.008170476,0.012698888,0.008575651,0.0008055597,0.00034006577,0.091290325,0.000995599,0.02090489,0.037557542],"study_design_scores_gemma":[0.030163497,0.021601204,0.61697364,0.051567834,0.115515456,0.008874596,0.007322434,0.0027431478,0.049851257,0.0014607103,0.092410535,0.0015156906],"about_ca_topic_score_codex":0.000006479197,"about_ca_topic_score_gemma":0.0000012354967,"teacher_disagreement_score":0.19036606,"about_ca_system_score_codex":0.000057843525,"about_ca_system_score_gemma":0.000016628179,"threshold_uncertainty_score":0.46638143},"labels":[],"label_agreement":null},{"id":"W4390666338","doi":"10.1111/apt.17869","title":"Systematic review with meta‐analysis: Steatosis severity and subclinical atherosclerosis in metabolic dysfunction‐associated steatotic liver disease","year":2024,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Steatosis; Medicine; Internal medicine; Meta-analysis; Subclinical infection; Fatty liver; Odds ratio; Subgroup analysis; Gastroenterology; Disease","score_opus":0.05309993378475255,"score_gpt":0.33469780109301794,"score_spread":0.2815978673082654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390666338","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41031197,0.5820099,0.000008632899,0.0048447186,0.00013372136,0.0024080018,0.00015702234,0.000114277704,0.000011745692],"genre_scores_gemma":[0.83220065,0.14238182,0.00003504806,0.024144443,0.000028679864,0.00092115055,0.00013916446,0.000039448354,0.00010961303],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99731183,0.00073666335,0.0006283361,0.00061567384,0.00035735595,0.00035012627],"domain_scores_gemma":[0.99862367,0.0005134085,0.00012943527,0.00032792235,0.000073145384,0.0003324076],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049944734,0.00039787806,0.0017867113,0.00023474648,0.00008739461,0.000040527826,0.00010347084,0.000081348786,0.00071512925],"category_scores_gemma":[0.0000011894285,0.00026242703,0.0007268414,0.0008577398,0.00014353426,0.00015845158,0.000057487203,0.00026505208,0.000039510905],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024713902,0.002172267,0.08452542,0.023633124,0.88862514,0.00038937418,0.000204072,0.000011211479,0.000051335413,0.000028281942,0.00008822339,0.000024427447],"study_design_scores_gemma":[0.001483661,0.00023813578,0.083981976,0.0031023733,0.90968764,0.000011594392,0.00004492583,0.0010475408,0.00012643998,0.00000976457,0.000041835945,0.00022413145],"about_ca_topic_score_codex":0.00012406042,"about_ca_topic_score_gemma":0.0000581733,"teacher_disagreement_score":0.4396281,"about_ca_system_score_codex":0.00015871238,"about_ca_system_score_gemma":0.00012727377,"threshold_uncertainty_score":0.9999828},"labels":[],"label_agreement":null},{"id":"W4391109400","doi":"10.1111/apt.17853","title":"Editorial: Extending upadacitinib induction dosing in ulcerative colitis—A delicate balance of efficacy and safety. Author's reply","year":2024,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Dosing; Ulcerative colitis; Balance (ability); Intensive care medicine; Pharmacology; Internal medicine; Physical therapy","score_opus":0.014860096458920122,"score_gpt":0.3267008799195291,"score_spread":0.311840783460609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391109400","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1275374,0.0020575116,0.000013491603,0.00032905582,0.8685003,0.00081102265,0.00064017583,0.00003636314,0.00007467728],"genre_scores_gemma":[0.029459268,0.0056016934,0.00014184335,0.0010842137,0.9613188,0.00012807013,0.0018660197,0.00014151572,0.00025860642],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969208,0.000544576,0.00077753386,0.00089341716,0.0003830952,0.0004805447],"domain_scores_gemma":[0.9987338,0.00020361312,0.00038503754,0.00033765475,0.00021467793,0.00012522654],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071913004,0.0004940471,0.00048136924,0.00018641533,0.000120114724,0.000040436164,0.0003044169,0.0008741098,0.000039392537],"category_scores_gemma":[0.000007909474,0.00054498995,0.000118061216,0.00015270284,0.00034521657,0.000018695286,0.0002671235,0.0009091814,0.0000075541057],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057160053,0.00018897366,0.00017981337,0.00022928957,0.003664763,0.00008985697,0.00032082174,0.000049620376,0.18103641,0.000013228753,0.80779314,0.00071807805],"study_design_scores_gemma":[0.0036225298,0.0003674641,0.0010482143,0.00018438595,0.00305305,0.000009183808,0.00009544461,0.000062980536,0.023540707,0.000089985915,0.9673582,0.00056786695],"about_ca_topic_score_codex":0.000049998733,"about_ca_topic_score_gemma":0.00004361155,"teacher_disagreement_score":0.15956505,"about_ca_system_score_codex":0.00018419145,"about_ca_system_score_gemma":0.0004612604,"threshold_uncertainty_score":0.9997002},"labels":[],"label_agreement":null},{"id":"W4391537925","doi":"10.1111/apt.17894","title":"Worldwide population prevalence and impact of sub‐diagnostic gastrointestinal symptoms","year":2024,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University; Population Health Research Institute","funders":"Danone Nutricia Research","keywords":"Medicine; Quality of life (healthcare); Depression (economics); Epidemiology; Anxiety; Gastrointestinal disease; Population; Health care; Internal medicine; Pediatrics; Disease; Gerontology; Psychiatry; Environmental health","score_opus":0.018112008275962817,"score_gpt":0.33278587432567686,"score_spread":0.31467386604971403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391537925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936943,0.004084356,0.000119799515,0.001329619,0.00018133498,0.00042023152,0.000031613057,0.00008525935,0.00005345808],"genre_scores_gemma":[0.99745536,0.00041596434,0.0005849517,0.0013245258,0.000081508595,0.000014035708,0.000049800252,0.000023247296,0.000050602193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989182,0.00008705252,0.00029015378,0.00027960498,0.00014869859,0.00027634326],"domain_scores_gemma":[0.9990849,0.0005612403,0.00005938131,0.000120129196,0.00004975453,0.00012462691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015439045,0.00019305303,0.00023166386,0.00014309374,0.000045169738,0.000013112781,0.00006807716,0.000034090146,0.00032786586],"category_scores_gemma":[0.0000030250949,0.0001669208,0.00012146916,0.00018634099,0.00020439606,0.00011391873,0.000040489274,0.0002465599,0.000013512831],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053330814,0.00026882405,0.9122654,0.000356689,0.0014404134,0.000095265175,0.000107573,0.0000835263,0.08231802,0.000023890898,0.00012914588,0.0023779229],"study_design_scores_gemma":[0.0012255393,0.0031265179,0.97821826,0.0005293389,0.0069400193,0.0014789987,0.000034147808,0.0037548388,0.0042352728,0.00029251954,0.000033351153,0.00013117318],"about_ca_topic_score_codex":0.00012629565,"about_ca_topic_score_gemma":0.000006951034,"teacher_disagreement_score":0.07808275,"about_ca_system_score_codex":0.00010018986,"about_ca_system_score_gemma":0.000083491796,"threshold_uncertainty_score":0.68068326},"labels":[],"label_agreement":null},{"id":"W4391775240","doi":"10.1111/apt.17879","title":"Editorial: The prevalence and outcomes of perianal Crohn's disease across the treatment eras—Authors' reply","year":2024,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Crohn's disease; Disease; MEDLINE; Dermatology; Internal medicine","score_opus":0.010028206753661383,"score_gpt":0.3255222809317503,"score_spread":0.3154940741780889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391775240","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1710285,0.010216523,0.0000011659802,0.0018279132,0.8129296,0.001010853,0.0029468262,0.000027125503,0.000011517928],"genre_scores_gemma":[0.011783868,0.016777316,0.000011089769,0.0035604078,0.9638284,0.00042637263,0.00065042765,0.00012770233,0.002834456],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99702626,0.0005638573,0.0005353042,0.000808276,0.00054268213,0.0005236166],"domain_scores_gemma":[0.998093,0.0003453444,0.00030257867,0.0008782924,0.00019265167,0.00018814718],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057300983,0.00062369485,0.00039843365,0.00003461953,0.00037683902,0.00009235429,0.0007933795,0.00048100526,0.000082804894],"category_scores_gemma":[0.0000058843025,0.0003696882,0.00037195484,0.000072470284,0.00095945207,0.000009646629,0.00038251566,0.0005635976,0.000014639513],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018804516,0.00029731766,0.0028949785,0.00023957543,0.012755335,0.0001337598,0.0006721993,0.000014080369,0.00408366,0.0000041888097,0.97682023,0.00020422478],"study_design_scores_gemma":[0.0012274893,0.00032786894,0.0074831196,0.000023982695,0.014479565,0.0000020973382,0.000093234616,0.000017838374,0.0014476504,0.00004990742,0.97448355,0.00036370746],"about_ca_topic_score_codex":0.0000507673,"about_ca_topic_score_gemma":0.000032288066,"teacher_disagreement_score":0.15924463,"about_ca_system_score_codex":0.00010162623,"about_ca_system_score_gemma":0.00057962607,"threshold_uncertainty_score":0.9998755},"labels":[],"label_agreement":null},{"id":"W4392361886","doi":"10.1111/apt.17918","title":"Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound","year":2024,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Victoria; Université de Sherbrooke; University of Calgary","funders":"Leona M. and Harry B. Helmsley Charitable Trust","keywords":"Medicine; Crohn's disease; Radiology; Ultrasound; Magnetic resonance imaging; Disease; Clinical Practice; Internal medicine; Gastroenterology; Physical therapy","score_opus":0.029483577702472976,"score_gpt":0.3469215739755094,"score_spread":0.3174379962730364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392361886","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005718207,0.9906774,0.0000019143527,0.00006208847,0.00096827385,0.0023569071,0.00015231772,0.000038406586,0.000024455283],"genre_scores_gemma":[0.00052523095,0.99363345,0.00006416408,0.0039646123,0.00035674777,0.00086381263,0.00038559714,0.00013364131,0.000072756215],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9967678,0.00078162807,0.0009222406,0.00083843904,0.0001892812,0.0005006209],"domain_scores_gemma":[0.99858874,0.00030145768,0.00036472772,0.00046392385,0.000041403528,0.00023973043],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040824476,0.00078840915,0.0011459254,0.00021030461,0.000106309,0.00006537419,0.00044125062,0.00022416827,0.000021286514],"category_scores_gemma":[0.000011649101,0.0006595554,0.00037652903,0.00016140005,0.00015355545,0.0000072291064,0.00023132905,0.00062611373,0.00004529418],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020645042,0.00041042344,0.0014247051,0.97410125,0.0118947495,0.005701681,0.00006783039,0.000011528879,0.00015732642,0.000023679595,0.0012800097,0.0047203545],"study_design_scores_gemma":[0.0013104402,0.00036029203,0.0015776848,0.7041652,0.22311923,0.0004330544,0.00006949915,0.000016950695,0.00023960575,0.000065966015,0.066312216,0.0023298475],"about_ca_topic_score_codex":0.0000058012706,"about_ca_topic_score_gemma":0.000004470718,"teacher_disagreement_score":0.26993605,"about_ca_system_score_codex":0.00016247715,"about_ca_system_score_gemma":0.00028734983,"threshold_uncertainty_score":0.99958557},"labels":[],"label_agreement":null},{"id":"W4392652588","doi":"10.1111/apt.17936","title":"Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis‐associated inflammatory bowel disease (<scp>PSC‐IBD</scp>): A matched analysis from the Paediatric <scp>PSC</scp> Consortium","year":2024,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; University of Alberta; Children's Hospital Research Institute of Manitoba; University of Toronto; SickKids Foundation; Hospital for Sick Children; Public Health Ontario","funders":"PSC Partners Seeking a Cure","keywords":"Medicine; Inflammatory bowel disease; Primary sclerosing cholangitis; Gastroenterology; Ulcerative colitis; Internal medicine; Inflammatory Bowel Diseases; Disease","score_opus":0.025524600200662998,"score_gpt":0.3066344099316434,"score_spread":0.28110980973098043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392652588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812057,0.010978798,0.0000167452,0.0019727524,0.0013289463,0.0019735324,0.002002387,0.0004702139,0.00005091789],"genre_scores_gemma":[0.9555942,0.0030064336,0.000055090426,0.037506845,0.00042866723,0.00024088587,0.0024203165,0.00018028122,0.00056730694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99302953,0.0019066769,0.0016822059,0.0011938263,0.00087855035,0.0013092161],"domain_scores_gemma":[0.9923877,0.004629711,0.00069877837,0.0009566006,0.00025919755,0.0010680276],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014104225,0.000953,0.0014321296,0.0005321504,0.0004515907,0.00021578127,0.0007237855,0.00042886453,0.00022161956],"category_scores_gemma":[0.00007183111,0.00073939457,0.001166105,0.0013727187,0.0007566882,0.0005940589,0.00044502446,0.0018550454,0.0000698027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061681686,0.0022553022,0.93305326,0.00012236155,0.05518207,0.0009938397,0.001315696,0.000076006254,0.0024221973,0.0000027114645,0.0037020165,0.00025773986],"study_design_scores_gemma":[0.0087405965,0.00028330414,0.90139747,0.0001903027,0.07995733,0.0000023373195,0.0008487343,0.0071249628,0.00025174848,0.00007918053,0.00085529534,0.00026871712],"about_ca_topic_score_codex":0.00038290757,"about_ca_topic_score_gemma":0.00016135481,"teacher_disagreement_score":0.035534095,"about_ca_system_score_codex":0.0010143102,"about_ca_system_score_gemma":0.0015358019,"threshold_uncertainty_score":0.9995057},"labels":[],"label_agreement":null},{"id":"W4392653083","doi":"10.1111/apt.17903","title":"Editorial: The tsunami of steatotic liver disease in India, the Asia‐Pacific region and the world","year":2024,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Medicine","score_opus":0.014090541641709545,"score_gpt":0.30432220466632504,"score_spread":0.2902316630246155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392653083","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0051338244,0.050775357,2.0853685e-7,0.020371683,0.9203421,0.0028537945,0.0002563534,0.000037002894,0.00022969201],"genre_scores_gemma":[0.12964122,0.03265292,0.0000028361694,0.004300884,0.83099043,0.00071920187,0.00029944346,0.000097345226,0.0012957341],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968893,0.0008522531,0.0005372197,0.00053447194,0.00078482437,0.00040193106],"domain_scores_gemma":[0.9951912,0.0036621038,0.0002664422,0.0006050941,0.00012437609,0.00015075634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006420281,0.000496324,0.000656229,0.00018382841,0.00019847586,0.000055125813,0.00043657934,0.0002703252,0.00009473886],"category_scores_gemma":[0.0000032620724,0.0002301629,0.00032576846,0.0003640039,0.0011868147,0.00006199579,0.00024293539,0.0013625079,0.000026446],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003045067,0.0007233871,0.0042079184,0.00023450673,0.012235214,0.00027605958,0.0011560532,0.0000036986773,0.000012757546,0.00014861635,0.9776691,0.0002875806],"study_design_scores_gemma":[0.006820995,0.00026369593,0.0039040402,0.0003184705,0.065801896,0.000005689384,0.00036264153,0.00012038408,0.00010638264,0.0003917013,0.9216596,0.00024450026],"about_ca_topic_score_codex":0.00028581094,"about_ca_topic_score_gemma":0.000050188133,"teacher_disagreement_score":0.1245074,"about_ca_system_score_codex":0.00026581294,"about_ca_system_score_gemma":0.0004973623,"threshold_uncertainty_score":0.93857706},"labels":[],"label_agreement":null},{"id":"W4392653139","doi":"10.1111/apt.17911","title":"Editorial: Corticosteroids for severe checkpoint inhibitor‐induced liver injury—Not one size fits all?","year":2024,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre; University Health Network","funders":"","keywords":"Medicine; Liver injury; MEDLINE; Internal medicine; Gastroenterology; Law","score_opus":0.05068220988759353,"score_gpt":0.3770141414325321,"score_spread":0.32633193154493856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392653139","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024010144,0.0013923461,0.0000015790448,0.0037304682,0.96447325,0.003879166,0.00214036,0.0002957439,0.00007694214],"genre_scores_gemma":[0.0061418097,0.004564598,0.00021779908,0.008990534,0.9733205,0.00096422393,0.001830278,0.0003982342,0.0035720253],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99429196,0.00029655133,0.00096984213,0.0013735226,0.0017183133,0.0013498288],"domain_scores_gemma":[0.99568117,0.0021313766,0.00033318208,0.0006212713,0.00061356655,0.000619415],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00044963212,0.0010309119,0.0012928448,0.00029495356,0.00020538783,0.00010987472,0.00048747496,0.0015049861,0.0006588872],"category_scores_gemma":[0.00001461182,0.0009455591,0.0006082558,0.00026074413,0.00023069506,0.0001784861,0.00042532632,0.0026793887,0.0005291918],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008511697,0.0013426563,0.0000052564046,0.00055834005,0.026059188,0.0002893751,0.00013902002,2.5961154e-7,0.24177091,8.278395e-7,0.7200203,0.0013021973],"study_design_scores_gemma":[0.009293408,0.007479039,0.000012799778,0.00026680852,0.029607221,0.000026483358,0.000018065102,0.00002946506,0.17427027,0.000053019317,0.778365,0.0005784085],"about_ca_topic_score_codex":0.00009504366,"about_ca_topic_score_gemma":0.000017523082,"teacher_disagreement_score":0.067500636,"about_ca_system_score_codex":0.0010846347,"about_ca_system_score_gemma":0.0013137152,"threshold_uncertainty_score":0.99979126},"labels":[],"label_agreement":null},{"id":"W4392656654","doi":"10.1111/apt.17882","title":"Editorial: Shorter course of intravenous terlipressin in acute variceal bleeding ‐ the promise, controversies and future directions","year":2024,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Terlipressin; Medicine; Intensive care medicine; General surgery; Internal medicine; Cirrhosis","score_opus":0.008103751986451496,"score_gpt":0.3061769644781119,"score_spread":0.2980732124916604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392656654","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016568188,0.012139936,0.0000012668409,0.0036774427,0.9656798,0.00090032653,0.0009033267,0.00004850125,0.0000812052],"genre_scores_gemma":[0.012574888,0.03247195,0.000017558074,0.001332291,0.9525981,0.000094592324,0.00074103766,0.000054816624,0.00011478449],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984753,0.00013935275,0.00036970247,0.00035823268,0.0003751483,0.00028227086],"domain_scores_gemma":[0.9988548,0.0006540212,0.00013666558,0.00014825775,0.00012530586,0.00008094035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021882905,0.00031829256,0.0004899661,0.00014003742,0.000099278936,0.000030187466,0.00014275928,0.0004922219,0.00006822709],"category_scores_gemma":[7.370838e-8,0.00022772713,0.000111774294,0.00015663246,0.00023270478,0.00010990049,0.000043452583,0.0010487357,0.0000033432866],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033329742,0.0006734555,0.0005745651,0.00053005666,0.108489364,0.00017865143,0.008342716,0.0000011572968,0.012183281,0.0000083242985,0.8647607,0.0009247659],"study_design_scores_gemma":[0.004326354,0.0006144418,0.00058979,0.00018743747,0.22503689,0.000025288438,0.00089577294,0.00005519811,0.0023479117,0.0000694887,0.7656019,0.00024957175],"about_ca_topic_score_codex":0.00012622958,"about_ca_topic_score_gemma":0.00002787657,"teacher_disagreement_score":0.116547525,"about_ca_system_score_codex":0.000116225114,"about_ca_system_score_gemma":0.00037020957,"threshold_uncertainty_score":0.92864424},"labels":[],"label_agreement":null},{"id":"W4392760712","doi":"10.1111/apt.17948","title":"Review article: Current indications and selection criteria for early liver transplantation in severe alcohol‐associated hepatitis","year":2024,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Fondo Nacional de Desarrollo Científico y Tecnológico","keywords":"Medicine; Liver transplantation; Abstinence; Transplantation; Alcoholic hepatitis; Liver disease; Alcoholic liver disease; Internal medicine; Referral; Hepatitis; Pediatrics; Intensive care medicine; Cirrhosis; Psychiatry; Family medicine","score_opus":0.11577830602977064,"score_gpt":0.45389306910651883,"score_spread":0.3381147630767482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392760712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9018086,0.087151885,0.0002048882,0.008288537,0.000528037,0.0018232428,0.0000752869,0.000098102035,0.000021419484],"genre_scores_gemma":[0.74271715,0.23333165,0.0001437619,0.023211569,0.00008471949,0.00028110435,0.00017899383,0.000018367136,0.000032692078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990313,0.00016788977,0.00027153856,0.00022910975,0.00008496848,0.00021517761],"domain_scores_gemma":[0.99958986,0.00018380779,0.00004881278,0.000041939227,0.000052274303,0.00008328717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030303228,0.00012180745,0.00019341419,0.00013069714,0.00009045785,0.000014177253,0.000031398595,0.000072577684,0.00033313586],"category_scores_gemma":[6.574566e-7,0.000120449455,0.00004535346,0.00023043736,0.00004985783,0.00012155631,0.0000071096338,0.00023510745,0.000025227375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023155152,0.0028447344,0.49477,0.037085984,0.010831963,0.00026148083,0.01058902,0.0000060801717,0.17868699,0.00054925674,0.031857606,0.23020136],"study_design_scores_gemma":[0.009674575,0.0014857396,0.8903559,0.005080817,0.026366385,0.00045363544,0.00003107,0.0154737495,0.007650978,0.00029958514,0.042584065,0.00054348964],"about_ca_topic_score_codex":0.000069422094,"about_ca_topic_score_gemma":0.00006926546,"teacher_disagreement_score":0.39558592,"about_ca_system_score_codex":0.00016004633,"about_ca_system_score_gemma":0.00009669432,"threshold_uncertainty_score":0.49117863},"labels":[],"label_agreement":null},{"id":"W4393146402","doi":"10.1111/apt.17972","title":"Review article: Recent advances in ascites and acute kidney injury management in cirrhosis","year":2024,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Hepatorenal syndrome; Medicine; Ascites; Cirrhosis; Terlipressin; Acute kidney injury; Intensive care medicine; Portal hypertension; Spontaneous bacterial peritonitis; Internal medicine; Gastroenterology; Kidney disease; Clinical trial","score_opus":0.01744957110093546,"score_gpt":0.365067743579804,"score_spread":0.3476181724788685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393146402","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4363365,0.5318183,0.000010597918,0.029110318,0.0006422709,0.001323586,0.00008969707,0.000076772456,0.00059203646],"genre_scores_gemma":[0.16270626,0.761393,0.00010736835,0.07554296,0.000034757642,0.00008323648,0.000090892354,0.000012358382,0.000029179808],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991076,0.00008519144,0.00024245013,0.00025715417,0.00010224138,0.00020534874],"domain_scores_gemma":[0.9997542,0.000035023415,0.000021052318,0.00008002326,0.000012264514,0.00009746721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015508637,0.00013147554,0.00018757016,0.00015510975,0.000021961725,0.0000092255395,0.00005029324,0.00003370018,0.00038986758],"category_scores_gemma":[3.1737855e-8,0.00011728155,0.00003206308,0.0003303554,0.000052856994,0.00020200726,0.000023336484,0.00015745289,0.000026496547],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046357345,0.0027565612,0.22999692,0.02045942,0.06616438,0.005849515,0.003686688,0.000008124238,0.11682,0.0006567901,0.010125608,0.53884023],"study_design_scores_gemma":[0.014456626,0.0014453727,0.09053144,0.01280716,0.19272906,0.0002557936,0.0004452244,0.0019073038,0.10173578,0.0022524807,0.5802607,0.0011730896],"about_ca_topic_score_codex":0.000007039852,"about_ca_topic_score_gemma":0.0000031094685,"teacher_disagreement_score":0.57013506,"about_ca_system_score_codex":0.00007977416,"about_ca_system_score_gemma":0.000036666628,"threshold_uncertainty_score":0.47826028},"labels":[],"label_agreement":null},{"id":"W4393944768","doi":"10.1111/apt.17944","title":"Quantitative <scp>MRCP</scp> and metrics of bile duct disease over time in patients with primary sclerosing cholangitis: A prospective study","year":2024,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"National Institute for Health and Care Research","keywords":"Medicine; Primary sclerosing cholangitis; Magnetic resonance cholangiopancreatography; Internal medicine; Gastroenterology; Magnetic resonance imaging; Prospective cohort study; Liver disease; Elastography; Radiology; Biliary disease; Quantitative assessment; Endoscopic retrograde cholangiopancreatography; Disease; Pancreatitis; Ultrasound","score_opus":0.02080001540561348,"score_gpt":0.3054893454552266,"score_spread":0.2846893300496131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393944768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909461,0.0068451236,0.0000038159096,0.00009941348,0.00017326922,0.0016646369,0.00015270262,0.000044509205,0.00007041368],"genre_scores_gemma":[0.99754477,0.00033201347,0.00011966475,0.0017138206,0.000035417917,0.000049418708,0.0000970791,0.000038000857,0.00006981291],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868727,0.00018952176,0.0002556583,0.0003388971,0.00027870343,0.00024997423],"domain_scores_gemma":[0.99923074,0.00030306878,0.00007616561,0.00015878357,0.00009611072,0.00013510764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016618776,0.000212623,0.0003354756,0.00029582094,0.00007317444,0.000023615115,0.000084858475,0.00003972535,0.00008038936],"category_scores_gemma":[0.0000014858336,0.00016889397,0.000057439072,0.0005830968,0.00020876058,0.00026328044,0.00010217031,0.0002695689,0.000008183407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012647075,0.003989743,0.9793165,0.00014957103,0.006442096,0.000086154236,0.0025183186,0.0000055391724,0.005723025,0.000009673832,0.00014734454,0.00034738283],"study_design_scores_gemma":[0.006156511,0.0033812558,0.97926635,0.00012831707,0.008680036,0.0000018774043,0.000688249,0.0004113844,0.0011072274,0.00003764816,0.000053898002,0.000087275774],"about_ca_topic_score_codex":0.00006601112,"about_ca_topic_score_gemma":0.000001345274,"teacher_disagreement_score":0.0065986565,"about_ca_system_score_codex":0.00018922257,"about_ca_system_score_gemma":0.00014893158,"threshold_uncertainty_score":0.68872964},"labels":[],"label_agreement":null},{"id":"W4394874261","doi":"10.1111/apt.17987","title":"Prospective evaluation of patients with non‐cirrhotic portal hypertension: A single centre study","year":2024,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Portal hypertension; Cirrhosis; Decompensation; Gastroenterology; Internal medicine; Prospective cohort study; Portal venous pressure; Liver disease; Varices; Esophageal varices; Portal hypertensive gastropathy; Liver biopsy; Biopsy","score_opus":0.03238391007832044,"score_gpt":0.31037361351143394,"score_spread":0.2779897034331135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394874261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99640226,0.0006717481,0.000006263876,0.0002872531,0.00042131357,0.0019097031,0.00003966512,0.00004082109,0.00022095194],"genre_scores_gemma":[0.99835515,0.000023427441,0.00003663127,0.0012176554,0.0000719455,0.000037089983,0.0001911878,0.000026967016,0.0000399672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882597,0.00010403612,0.00019611951,0.00026569102,0.00045876554,0.0001494189],"domain_scores_gemma":[0.99947685,0.000034956254,0.000049093404,0.000106542575,0.0002716481,0.0000608874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014062943,0.00014153493,0.00018508697,0.000086515734,0.000036220103,0.000007162002,0.000040180355,0.000035649813,0.0005891481],"category_scores_gemma":[3.084456e-8,0.0001074029,0.00004818186,0.0001560335,0.00006081664,0.000113592956,0.000010086904,0.00010719205,0.000029470999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030336217,0.008724518,0.9047935,0.00019765264,0.049138065,0.00041490755,0.007306618,0.000041440428,0.025212405,0.0000063678594,0.00012023052,0.0010106686],"study_design_scores_gemma":[0.014992797,0.0032472673,0.7384567,0.00012307141,0.21007831,0.000026036798,0.00184716,0.0015452108,0.02940162,0.000058255606,0.000023898057,0.00019961687],"about_ca_topic_score_codex":0.000012732471,"about_ca_topic_score_gemma":0.0000064779115,"teacher_disagreement_score":0.16633676,"about_ca_system_score_codex":0.000088963134,"about_ca_system_score_gemma":0.00012257336,"threshold_uncertainty_score":0.6450758},"labels":[],"label_agreement":null},{"id":"W4395030232","doi":"10.1111/apt.17973","title":"Editorial: Sequencing rescue therapy for acute severe ulcerative colitis—Ready for revision?","year":2024,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ulcerative colitis; Rescue therapy; Colitis; MEDLINE; Intensive care medicine; Internal medicine; Disease","score_opus":0.022827731381590423,"score_gpt":0.36107021497924874,"score_spread":0.3382424835976583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395030232","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035119,0.00287271,0.00014108163,0.00045271657,0.97802776,0.004409541,0.010427257,0.00009899885,0.000058021047],"genre_scores_gemma":[0.00020819443,0.008384051,0.0007304064,0.0057407953,0.9631983,0.0018088458,0.017487146,0.00035478335,0.0020875025],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961087,0.00038413735,0.000738069,0.0013737016,0.000495442,0.00089991104],"domain_scores_gemma":[0.99754524,0.00043871778,0.00030359632,0.00061580277,0.0008775103,0.00021915536],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00078144507,0.00089373376,0.0006905266,0.00012466146,0.00038163626,0.0001181826,0.0007574714,0.0017235457,0.00008264196],"category_scores_gemma":[0.000005605825,0.00088030385,0.0005664192,0.00008915124,0.00023715854,0.000020116297,0.00021838823,0.0007379105,0.000033830427],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010368693,0.00011936421,0.0000026778903,0.00021351365,0.024182979,0.0000429489,0.00015400746,0.00003277295,0.060966764,0.000018555917,0.90354323,0.0003545139],"study_design_scores_gemma":[0.005227666,0.0014333013,0.0000022743584,0.00006865508,0.012437234,0.0000065079985,0.000076628734,0.00008812095,0.025345542,0.00034199827,0.95407206,0.00089999835],"about_ca_topic_score_codex":0.000018705903,"about_ca_topic_score_gemma":0.000038647697,"teacher_disagreement_score":0.050528865,"about_ca_system_score_codex":0.00041782824,"about_ca_system_score_gemma":0.0018905385,"threshold_uncertainty_score":0.99957246},"labels":[],"label_agreement":null},{"id":"W4396813044","doi":"10.1111/apt.18027","title":"Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in <scp>IBD</scp>","year":2024,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University","funders":"","keywords":"Medicine; Gastroenterology; Intestinal permeability; Internal medicine","score_opus":0.031110155589788937,"score_gpt":0.31967245727206955,"score_spread":0.28856230168228064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396813044","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56960005,0.0018809949,0.00045914008,0.42089033,0.0030836696,0.003064363,0.000088961424,0.00044427716,0.0004882207],"genre_scores_gemma":[0.08742924,0.000051728817,0.008313414,0.8969136,0.0046342947,0.00040125212,0.001056675,0.00029053594,0.000909272],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944969,0.00035632597,0.0012675311,0.0015416138,0.00063650985,0.001701138],"domain_scores_gemma":[0.9959011,0.002810571,0.00037346868,0.00053862645,0.00016575244,0.0002104705],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00091108715,0.0010574185,0.001232785,0.00060002296,0.00024954416,0.00010354098,0.00054633804,0.0005319125,0.00014957713],"category_scores_gemma":[0.000046778954,0.0010533517,0.00077635364,0.00044275649,0.0003561008,0.00022007145,0.00028849873,0.0046071215,0.00006525964],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006593376,0.0012127147,0.2601326,0.005022698,0.0061131436,0.0062501687,0.0011066702,0.000055180157,0.0885986,0.0000039987303,0.6289186,0.0019263035],"study_design_scores_gemma":[0.020174878,0.009634543,0.017578544,0.01470304,0.056754146,0.0063491906,0.0014944712,0.013674565,0.013228585,0.0015254755,0.8434401,0.0014424538],"about_ca_topic_score_codex":0.000088741166,"about_ca_topic_score_gemma":0.000020479678,"teacher_disagreement_score":0.48217082,"about_ca_system_score_codex":0.00085316674,"about_ca_system_score_gemma":0.00052224024,"threshold_uncertainty_score":0.9991917},"labels":[],"label_agreement":null},{"id":"W4396944332","doi":"10.1111/apt.18029","title":"Meta‐analysis: Intestinal ultrasound to evaluate colonic contents and constipation","year":2024,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University; University of Calgary","funders":"","keywords":"Constipation; Medicine; Meta-analysis; Internal medicine; Echogenicity; MEDLINE; Functional constipation; Ultrasound; Gastroenterology; Radiology","score_opus":0.11862994104452422,"score_gpt":0.3872759009223741,"score_spread":0.26864595987784984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396944332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9686554,0.012142855,0.0009079354,0.016678061,0.00039995267,0.0008691793,0.00006314965,0.0001362423,0.00014722385],"genre_scores_gemma":[0.9631538,0.00012685687,0.0010053308,0.03517653,0.000046182347,0.00012610818,0.00008416161,0.00001836647,0.00026267287],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99853694,0.00022817242,0.00029424296,0.00041160802,0.00023469624,0.00029431348],"domain_scores_gemma":[0.9991292,0.00041677465,0.00004517966,0.00013195137,0.000097505326,0.00017941151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038211083,0.00021274219,0.00047028452,0.0002733683,0.00013146148,0.000031937685,0.00008743707,0.00003875037,0.0007654111],"category_scores_gemma":[0.000001132125,0.00018871612,0.00025664817,0.00050329557,0.0001951962,0.00006820088,0.000066049,0.00029879087,0.000055212968],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019287823,0.00065327086,0.034395367,0.00011293273,0.8140773,0.00021437321,0.001099282,0.0006963511,0.14519879,0.00009780429,0.00089211366,0.0006336354],"study_design_scores_gemma":[0.0014576417,0.002005998,0.009870248,0.00001552857,0.973171,0.0006244492,0.00042595968,0.005531183,0.0048671835,0.0002669482,0.0015785086,0.00018534146],"about_ca_topic_score_codex":0.00008451849,"about_ca_topic_score_gemma":0.00003428075,"teacher_disagreement_score":0.15909372,"about_ca_system_score_codex":0.000088832436,"about_ca_system_score_gemma":0.00009100576,"threshold_uncertainty_score":0.83807147},"labels":[],"label_agreement":null},{"id":"W4398218095","doi":"10.1111/apt.18032","title":"Editorial: Unravelling real‐world impact of second‐line therapies in primary biliary cholangitis— Time to change our targets?","year":2024,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Medicine; Gastroenterology; Internal medicine; Primary sclerosing cholangitis; Disease","score_opus":0.029535014582323594,"score_gpt":0.3575878439178748,"score_spread":0.3280528293355512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398218095","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03878486,0.016612845,5.064882e-7,0.0016792152,0.9370943,0.0020626606,0.0032781835,0.00014669458,0.00034076776],"genre_scores_gemma":[0.003455383,0.012980473,0.000097090575,0.004738537,0.9708733,0.00020171492,0.004394863,0.00024681148,0.0030118076],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963282,0.0003960605,0.0009409101,0.0007594159,0.00078725594,0.00078817137],"domain_scores_gemma":[0.9979565,0.0004986312,0.0003262449,0.0005808574,0.0003180462,0.00031968718],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000697932,0.0008040481,0.0014609352,0.000751786,0.00008281079,0.00003712928,0.0005284229,0.00075209985,0.002457877],"category_scores_gemma":[0.0000017577958,0.0006994486,0.000615943,0.0006818028,0.00011263448,0.00021806473,0.00033402132,0.0020386942,0.00032781172],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028285992,0.001010515,0.0010655845,0.00059087184,0.016382532,0.00011660642,0.0010354145,0.000008106544,0.03753159,2.427816e-7,0.9387595,0.0006704569],"study_design_scores_gemma":[0.0044045304,0.002879678,0.0039943904,0.0006153512,0.014859778,0.00000522072,0.00013160525,0.00006459074,0.0025759768,0.000051798073,0.9696496,0.00076748437],"about_ca_topic_score_codex":0.0013650366,"about_ca_topic_score_gemma":0.000050864008,"teacher_disagreement_score":0.03532948,"about_ca_system_score_codex":0.001236248,"about_ca_system_score_gemma":0.0010621367,"threshold_uncertainty_score":0.9995457},"labels":[],"label_agreement":null},{"id":"W4399125649","doi":"10.1111/apt.18095","title":"Socio‐economic association of alcohol use disorder and cardiovascular and alcohol‐associated liver disease from 2010 to 2019","year":2024,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Alcohol use disorder; Liver disease; Disease burden; Environmental health; Alcoholic liver disease; Alcohol; Population; Burden of disease; Internal medicine; Liver cancer; Cancer; Cirrhosis","score_opus":0.07201113220699239,"score_gpt":0.3657418253598722,"score_spread":0.2937306931528798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399125649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9594624,0.030184967,0.00001761065,0.007906479,0.0010643321,0.0009086435,0.00036659275,0.000075279706,0.000013715653],"genre_scores_gemma":[0.966177,0.015638385,0.00010226801,0.016884902,0.00019323286,0.00004983997,0.00020780426,0.00004309111,0.00070347235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985645,0.00024697694,0.00029541436,0.00040700397,0.00019021824,0.000295912],"domain_scores_gemma":[0.9989266,0.00049275544,0.00007754972,0.00017117972,0.000050626582,0.0002812829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040457884,0.00020564462,0.00042665156,0.0001290844,0.00009860956,0.000029095205,0.000056021305,0.00015923883,0.00044598596],"category_scores_gemma":[0.0000019236722,0.00020225943,0.0001541423,0.00007892723,0.000095125215,0.00015735898,0.00007570556,0.00026645514,0.000090649555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091863825,0.00035146347,0.9066874,0.00022778059,0.04561485,0.000111990754,0.0015342142,0.000054920754,0.021643523,0.00003685473,0.016692715,0.00612567],"study_design_scores_gemma":[0.0057704686,0.00028807254,0.91750425,0.00011294009,0.02993534,0.000008091643,0.000080367834,0.004111432,0.0013357046,0.00006661312,0.040452596,0.00033412044],"about_ca_topic_score_codex":0.0009256804,"about_ca_topic_score_gemma":0.00004890991,"teacher_disagreement_score":0.023759881,"about_ca_system_score_codex":0.00028794204,"about_ca_system_score_gemma":0.00013506717,"threshold_uncertainty_score":0.82479},"labels":[],"label_agreement":null},{"id":"W4399301472","doi":"10.1111/apt.18101","title":"Global epidemiology of alcohol‐associated liver disease in adolescents and young adults","year":2024,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"National Institute on Alcohol Abuse and Alcoholism","keywords":"Medicine; Young adult; Demography; Epidemiology; Incidence (geometry); Public health; Mortality rate; Alcoholic liver disease; Disease burden; Burden of disease; Gerontology; Environmental health; Pediatrics; Population; Surgery; Internal medicine","score_opus":0.09919701954204511,"score_gpt":0.42772313359556563,"score_spread":0.3285261140535205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399301472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.958981,0.03559894,0.000011833862,0.0035696784,0.0009882363,0.00068074325,0.00005981987,0.0000661228,0.000043670723],"genre_scores_gemma":[0.96812665,0.0058459523,0.000046072415,0.025756922,0.00008353417,0.000029882885,0.000053608266,0.000016710195,0.000040654213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983678,0.00039918182,0.00041592747,0.00033371022,0.000110146364,0.00037327126],"domain_scores_gemma":[0.9993631,0.00017282809,0.000080036145,0.00010972058,0.000040105464,0.00023416497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043584369,0.00017719922,0.0003869426,0.000118898206,0.000040607443,0.0000022864479,0.00006727286,0.00013127449,0.00015199554],"category_scores_gemma":[0.0000024802794,0.00016363594,0.00007597352,0.00021290686,0.000219973,0.00006022426,0.00005595461,0.00025700207,0.000025748968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015770684,0.00042583776,0.9921371,0.0005830602,0.0014551881,0.0002727203,0.00026164105,0.0000042826964,0.00077492814,0.00008250166,0.00026648823,0.0021591927],"study_design_scores_gemma":[0.0037396292,0.00029534448,0.9837359,0.00057474023,0.0032281377,0.000034710505,0.000026270647,0.007568977,0.000119058626,0.00012185747,0.00043194756,0.00012340801],"about_ca_topic_score_codex":0.00033514012,"about_ca_topic_score_gemma":0.00010623683,"teacher_disagreement_score":0.02975299,"about_ca_system_score_codex":0.00022774556,"about_ca_system_score_gemma":0.00013934867,"threshold_uncertainty_score":0.66728795},"labels":[],"label_agreement":null},{"id":"W4399322652","doi":"10.1111/apt.18103","title":"The aging gastrointestinal tract: Epidemiology and clinical significance of disorders of gut‐brain interaction in the older general population","year":2024,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Medicine; Epidemiology; Depression (economics); Constipation; Anxiety; Irritable bowel syndrome; Quality of life (healthcare); Population; Internal medicine; Disease; Demography; Psychiatry","score_opus":0.05861712725841623,"score_gpt":0.4173625259748676,"score_spread":0.3587453987164514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399322652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9565106,0.0016181333,0.000342012,0.040616915,0.00035703718,0.00047779497,0.0000060167285,0.000015973164,0.000055490033],"genre_scores_gemma":[0.9922568,0.00060938677,0.00075325265,0.0062024803,0.000102690465,0.000018257148,0.000021571252,0.000011941777,0.000023609597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978995,0.00081040064,0.0006979507,0.0002417834,0.000105255545,0.00024510824],"domain_scores_gemma":[0.99573594,0.0038887393,0.00016713972,0.0001375708,0.000029902541,0.00004069482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017231285,0.00013727136,0.00028336854,0.00007773582,0.00006631106,0.000005979196,0.000118210686,0.000046024943,0.000040912826],"category_scores_gemma":[0.000016152428,0.00008850677,0.0001170152,0.00015579442,0.00048246945,0.000076691445,0.000029031715,0.0004909843,0.0000011761799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006659719,0.00053251174,0.9733241,0.000105163665,0.00045642743,0.000013816142,0.0005221199,0.00017928149,0.008677727,0.00026505574,0.00026507778,0.014992726],"study_design_scores_gemma":[0.0012809833,0.0013067125,0.9762744,0.0001521215,0.0013623303,0.00028686822,0.0013225537,0.015647179,0.00019843855,0.0013182409,0.0007734998,0.00007668432],"about_ca_topic_score_codex":0.00031434346,"about_ca_topic_score_gemma":0.00012240457,"teacher_disagreement_score":0.035746183,"about_ca_system_score_codex":0.000034447377,"about_ca_system_score_gemma":0.000044914083,"threshold_uncertainty_score":0.36092013},"labels":[],"label_agreement":null},{"id":"W4399434812","doi":"10.1111/apt.18109","title":"Editorial: Sonographic assessment of colonic content—A new tool for constipation? Authors' reply","year":2024,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University; University of Calgary","funders":"","keywords":"Medicine; Constipation; Content (measure theory); Gastroenterology; General surgery; Internal medicine","score_opus":0.045723664309850205,"score_gpt":0.38911243462230216,"score_spread":0.34338877031245196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399434812","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033090194,0.0020372383,0.0004111678,0.006751021,0.9836598,0.0027443643,0.00084477867,0.00016537115,0.000077234225],"genre_scores_gemma":[0.0027907754,0.001124501,0.0035572809,0.005174642,0.9830588,0.0003227641,0.002534576,0.00013590946,0.0013007435],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99643886,0.00021241207,0.0011150553,0.0008065919,0.00082381855,0.0006032499],"domain_scores_gemma":[0.9962238,0.0018099846,0.0005341001,0.00043789405,0.00074855704,0.00024568432],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008538135,0.0005923416,0.0011031658,0.00033904522,0.00012722572,0.000038107202,0.00033477912,0.00077979465,0.00030020424],"category_scores_gemma":[0.000016650198,0.00057837914,0.0005890547,0.00029260007,0.00045250994,0.00009726741,0.00011838469,0.001569998,0.000014964487],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024251596,0.0007164349,0.0015972761,0.0007210629,0.012567106,0.000014168657,0.000120766716,0.000009085426,0.0070125987,0.00004922256,0.9745239,0.00024324202],"study_design_scores_gemma":[0.007488197,0.004810122,0.00018108825,0.00032059007,0.039003547,0.0000126784325,0.0001205049,0.00022943344,0.00087476417,0.00053217507,0.94607157,0.00035535745],"about_ca_topic_score_codex":0.00020017159,"about_ca_topic_score_gemma":0.000029458397,"teacher_disagreement_score":0.028452337,"about_ca_system_score_codex":0.00031350565,"about_ca_system_score_gemma":0.0030694103,"threshold_uncertainty_score":0.99966675},"labels":[],"label_agreement":null},{"id":"W4399788231","doi":"10.1111/apt.18040","title":"Systematic review: Patient‐related, microbial, surgical, and histopathological risk factors for endoscopic post‐operative recurrence in patients with Crohn's disease","year":2024,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital","funders":"Pfizer","keywords":"Medicine; Crohn's disease; Cohort study; Cohort; Disease; Internal medicine; Cochrane Library; Interquartile range; Surgery; Meta-analysis","score_opus":0.013408980077432379,"score_gpt":0.3086061791850553,"score_spread":0.29519719910762293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399788231","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09319914,0.8973698,0.0000010107889,0.000032520842,0.0005522981,0.006835802,0.001983234,0.000022711856,0.0000034769039],"genre_scores_gemma":[0.0018829454,0.99274766,0.000037482412,0.0011714626,0.000052574323,0.0012256629,0.0027202214,0.00009831761,0.00006364334],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9960624,0.0012537071,0.0010353554,0.0009928389,0.00017428855,0.00048141018],"domain_scores_gemma":[0.99852675,0.00014923568,0.00055352395,0.00041559341,0.00013170148,0.0002231703],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025735472,0.000808169,0.0014756132,0.00013723115,0.00014399193,0.00003493563,0.0003425819,0.00032779117,0.00004322352],"category_scores_gemma":[0.000006801994,0.0005483546,0.00039522437,0.00014902004,0.00031209574,0.000014381256,0.00021576152,0.0004857465,0.000017116261],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019038084,0.002447668,0.0055517894,0.9519332,0.025787702,0.0030311982,0.00050279114,0.000007736829,0.000054781467,0.000026298494,0.0019234107,0.006829637],"study_design_scores_gemma":[0.009987667,0.004913827,0.0029113428,0.29066956,0.41289595,0.00010523841,0.00014524609,0.000023134378,0.0000717676,0.000036421527,0.27370238,0.0045374488],"about_ca_topic_score_codex":0.0000036172273,"about_ca_topic_score_gemma":0.0000032937246,"teacher_disagreement_score":0.6612636,"about_ca_system_score_codex":0.00015734573,"about_ca_system_score_gemma":0.0002723383,"threshold_uncertainty_score":0.9996968},"labels":[],"label_agreement":null},{"id":"W4400010932","doi":"10.1111/apt.18134","title":"The overlap with metabolic dysfunction‐associated steatotic liver disease negatively affects outcomes of primary biliary cholangitis","year":2024,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Steatosis; Gastroenterology; Fatty liver; Steatohepatitis; Ursodeoxycholic acid; Cohort; Metabolic syndrome; Disease; Obesity","score_opus":0.022753199103145914,"score_gpt":0.28646520993365965,"score_spread":0.2637120108305137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400010932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9568734,0.037480123,0.000011823006,0.0034128523,0.00086807925,0.00085635216,0.00016847698,0.00012938079,0.00019947554],"genre_scores_gemma":[0.9809691,0.005981482,0.00003345156,0.0117174955,0.000105043684,0.00006322424,0.00014754426,0.0000494392,0.00093323726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984495,0.0003358068,0.0002442117,0.00028274025,0.00033926516,0.00034848705],"domain_scores_gemma":[0.9986914,0.0006422839,0.00010210962,0.0002855428,0.00009259889,0.0001860921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021631666,0.00027099546,0.00040309087,0.00010116981,0.00023620356,0.000032216136,0.00017270155,0.00006226245,0.00028143422],"category_scores_gemma":[0.0000011262863,0.00016377059,0.00021886796,0.00032778928,0.0003805603,0.00021054441,0.00009103466,0.00035133783,0.000029663459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042825085,0.0025561105,0.8566227,0.00044993497,0.0935151,0.0006274623,0.001086046,0.00003225677,0.028276969,0.0003165384,0.0032122815,0.009022069],"study_design_scores_gemma":[0.0028475788,0.00063931185,0.94929385,0.000089283676,0.03611499,0.000019271882,0.0001965358,0.00054725405,0.004187487,0.00006303333,0.00579958,0.00020183701],"about_ca_topic_score_codex":0.00011564466,"about_ca_topic_score_gemma":0.000006907555,"teacher_disagreement_score":0.09267111,"about_ca_system_score_codex":0.00016778435,"about_ca_system_score_gemma":0.0003394505,"threshold_uncertainty_score":0.6678371},"labels":[],"label_agreement":null},{"id":"W4400260520","doi":"10.1111/apt.18139","title":"Incidence and predictors of major gastrointestinal bleeding in patients on aspirin, low‐dose rivaroxaban, or the combination: Secondary analysis of the <scp>COMPASS</scp> randomised controlled trial","year":2024,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute; University of Ottawa; University of Calgary","funders":"Regeneron Pharmaceuticals; Medicines Company; Boston Scientific Corporation; Sanofi; St. Jude Medical; Servier; Pfizer; AstraZeneca; Daiichi Sankyo Europe; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Rivaroxaban; Gastrointestinal bleeding; Aspirin; Incidence (geometry); Randomized controlled trial; Gastroenterology; Internal medicine; Warfarin; Surgery; Atrial fibrillation","score_opus":0.01906603185302129,"score_gpt":0.2991254895289618,"score_spread":0.2800594576759405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400260520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942019,0.0003718343,0.000005542821,0.0015638102,0.00063514226,0.0030589334,0.000041274245,0.00002375261,0.00009780483],"genre_scores_gemma":[0.99765635,0.000093315575,0.00007746291,0.00173415,0.00008340125,0.00022872517,0.000034614022,0.000020756584,0.00007120324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978789,0.00032400023,0.00077493873,0.00032654923,0.00041325597,0.00028234223],"domain_scores_gemma":[0.99608445,0.003161171,0.0003287648,0.00020432161,0.00014148379,0.00007978118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006321102,0.00027213528,0.00080322305,0.00034044604,0.00009535714,0.000019769526,0.0002068471,0.000053678417,0.00011412553],"category_scores_gemma":[0.000018768058,0.00013482028,0.00032145358,0.00071093923,0.00036875802,0.00007406461,0.00009692456,0.0004185727,0.0000016301385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09535052,0.0042477585,0.86280084,0.00013280976,0.027412478,0.00006393692,0.000870374,0.00021284827,0.008047702,0.000055382832,0.000435739,0.00036959155],"study_design_scores_gemma":[0.45357713,0.0064756325,0.4813274,0.00051074947,0.046014592,0.000034839402,0.00023857398,0.004216138,0.007466528,0.000035227105,0.000041958418,0.000061222534],"about_ca_topic_score_codex":0.00004226019,"about_ca_topic_score_gemma":0.000014500044,"teacher_disagreement_score":0.38147345,"about_ca_system_score_codex":0.00013660727,"about_ca_system_score_gemma":0.00016114955,"threshold_uncertainty_score":0.54978114},"labels":[],"label_agreement":null},{"id":"W4400695496","doi":"10.1111/apt.18159","title":"Outcomes of patients with alcohol‐associated hepatitis and acute kidney injury – Results from the HRS Harmony Consortium","year":2024,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre; University Health Network","funders":"Roche; National Center for Advancing Translational Sciences; Liver Center, University of California, San Francisco; National Institute of Diabetes and Digestive and Kidney Diseases; Gilead Sciences; National Institutes of Health; American Association for the Study of Liver Diseases; GlaxoSmithKline; Merck; University of California, San Francisco; National Institute on Alcohol Abuse and Alcoholism; Bristol-Myers Squibb","keywords":"Medicine; Hepatorenal syndrome; Acute kidney injury; Internal medicine; Gastroenterology; Cirrhosis; Alcoholic hepatitis; Hemodialysis; Cohort; Retrospective cohort study; Renal replacement therapy; Alcoholic liver disease; Kidney disease; Incidence (geometry); Liver injury","score_opus":0.049030979086567304,"score_gpt":0.371147552954188,"score_spread":0.3221165738676207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400695496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96620595,0.0007830246,0.0000028729798,0.0285001,0.00076204067,0.0009125491,0.002643661,0.0000928628,0.0000969066],"genre_scores_gemma":[0.8829949,0.0027490424,0.0000921831,0.11272225,0.00006280058,0.000035372675,0.00091239606,0.00003382576,0.0003972396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984614,0.00022505685,0.0004217274,0.00033523975,0.00026388347,0.00029269324],"domain_scores_gemma":[0.9988365,0.0005376943,0.00013393348,0.00020188132,0.00010037125,0.0001895949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024692988,0.0002288726,0.0003894487,0.00006189086,0.00013066902,0.000016715168,0.00010591809,0.00011454066,0.0007771066],"category_scores_gemma":[0.0000019778251,0.00014565887,0.00006928891,0.00016233588,0.00034046048,0.00008522052,0.000048553797,0.00035802467,0.000040922452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027235334,0.00037158033,0.94306827,0.000043290827,0.022550933,0.000050592684,0.001076176,3.045344e-7,0.004791119,0.000011516961,0.022376265,0.002936425],"study_design_scores_gemma":[0.008013628,0.0008234764,0.9470243,0.0001015767,0.015458005,0.000004268115,0.000024546793,0.00026011936,0.0041385414,0.00002257679,0.023954205,0.00017475012],"about_ca_topic_score_codex":0.0003891689,"about_ca_topic_score_gemma":0.000017596478,"teacher_disagreement_score":0.084222145,"about_ca_system_score_codex":0.00009286477,"about_ca_system_score_gemma":0.00017282619,"threshold_uncertainty_score":0.8508772},"labels":[],"label_agreement":null},{"id":"W4401040001","doi":"10.1111/apt.18184","title":"Efficacy and safety of risankizumab by baseline corticosteroid use and achievement of corticosteroid‐free clinical and endoscopic outcomes in patients with moderately to severely active Crohn's disease","year":2024,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Corticosteroid; Crohn's disease; Internal medicine; Crohn disease; Disease; Gastroenterology","score_opus":0.01752045709135874,"score_gpt":0.3008436742415589,"score_spread":0.28332321715020015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401040001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968368,0.0008039823,0.000060837592,0.00039623733,0.00013366893,0.00097544095,0.0007832493,0.0000080332975,0.0000017510346],"genre_scores_gemma":[0.99582124,0.0006664104,0.0001851692,0.0030788945,0.000017913993,0.00002942316,0.00015480639,0.000029085715,0.000017083172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842733,0.0002601467,0.00050052325,0.00044888034,0.00014092914,0.00022221245],"domain_scores_gemma":[0.9992528,0.00014040647,0.00010761924,0.00023340833,0.00005980118,0.00020597127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014729181,0.00023883629,0.00030095218,0.00006597046,0.000039538798,0.000018900048,0.000110189874,0.00008072462,0.000013100139],"category_scores_gemma":[0.0000039051433,0.00020567384,0.00003636481,0.000052149106,0.00030960882,0.000026454694,0.00023957397,0.00013050219,4.2289196e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04602895,0.0012114781,0.9250223,0.00011971499,0.0035604776,0.00008227435,0.00020414375,0.000041211235,0.020831054,0.0000048885795,0.00010536257,0.0027881612],"study_design_scores_gemma":[0.008299705,0.0009867048,0.9782411,0.000040396808,0.0015708212,9.937082e-7,0.000023842002,0.00019733212,0.01025747,0.000009554109,0.00019445628,0.0001776411],"about_ca_topic_score_codex":0.000016183352,"about_ca_topic_score_gemma":0.000019391333,"teacher_disagreement_score":0.053218797,"about_ca_system_score_codex":0.000020742908,"about_ca_system_score_gemma":0.000074032425,"threshold_uncertainty_score":0.8387136},"labels":[],"label_agreement":null},{"id":"W4401136557","doi":"10.1111/apt.18194","title":"Systematic review: Methotrexate—A poorly understood and underused medication in inflammatory bowel disease","year":2024,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Methotrexate; Inflammatory bowel disease; Ulcerative colitis; Internal medicine; Adverse effect; Infliximab; Thiopurine methyltransferase; Adalimumab; Crohn's disease; Gastroenterology; Observational study; Dosing; Incidence (geometry); Azathioprine; Disease; Surgery","score_opus":0.028179103213653696,"score_gpt":0.35220388964045013,"score_spread":0.32402478642679644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401136557","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022952571,0.9946466,0.000015358519,0.0005329975,0.0007094181,0.0036406787,0.00013975624,0.000051599316,0.000034048575],"genre_scores_gemma":[0.00009735689,0.986352,0.00003953958,0.010894216,0.0002615347,0.001037319,0.0009540801,0.00015046881,0.00021344685],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99551725,0.0015655597,0.0012511947,0.0009071513,0.0002829298,0.0004759092],"domain_scores_gemma":[0.99836427,0.000103330094,0.0005000268,0.0006761104,0.000046244626,0.00031001144],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008847606,0.0007680514,0.0012486998,0.00026502786,0.00008452974,0.000042139716,0.00053255,0.0003998428,0.000059350223],"category_scores_gemma":[0.000003688097,0.000657236,0.00043168684,0.00017176216,0.0002651744,0.00001453922,0.00029151575,0.00051006075,0.00010116514],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103014114,0.00020053032,0.000046518224,0.97938174,0.0147974985,0.00070236844,0.0000679779,0.0000025057411,0.00020712645,0.00005660398,0.002560488,0.0018736043],"study_design_scores_gemma":[0.0021432997,0.0002072501,0.00010637087,0.3013071,0.37691295,0.00016095326,0.00011832437,0.00015092017,0.00006722188,0.00025098302,0.31620196,0.0023726416],"about_ca_topic_score_codex":0.0000033514416,"about_ca_topic_score_gemma":0.0000112396265,"teacher_disagreement_score":0.67807466,"about_ca_system_score_codex":0.00021441183,"about_ca_system_score_gemma":0.00069632934,"threshold_uncertainty_score":0.9995879},"labels":[],"label_agreement":null},{"id":"W4401213085","doi":"10.1111/apt.18158","title":"Long‐term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow‐up in the SELECTION open‐label long‐term extension study","year":2024,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Western University","funders":"Janssen Biotech; Gilead Sciences; AstraZeneca; Galápagos; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Ulcerative colitis; Open label; Janus kinase inhibitor; Interim analysis; Colitis; Interim; Internal medicine; Surgery; Gastroenterology; Clinical trial; Janus kinase","score_opus":0.05138483360915472,"score_gpt":0.382088891262624,"score_spread":0.33070405765346933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401213085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953565,0.00042386455,0.0004211139,0.00019528074,0.0002653601,0.0027984271,0.0005309136,0.0000044364892,0.000004108953],"genre_scores_gemma":[0.9980436,0.00037664888,0.00007167929,0.00097525184,0.000053465814,0.00022247627,0.00017786477,0.00002048138,0.00005855189],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985501,0.00037910775,0.00037828676,0.00039616035,0.000116090734,0.00018022684],"domain_scores_gemma":[0.9992535,0.00023276672,0.00011491771,0.00024166217,0.00010582206,0.00005131146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022913296,0.00019320886,0.00032162166,0.00010547632,0.0000702584,0.000022805394,0.00027619407,0.000070220514,0.000039506394],"category_scores_gemma":[0.0000012312339,0.00014259134,0.00011314612,0.00024739737,0.00008735455,0.000013877901,0.00011861848,0.00006580633,8.1535944e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20797883,0.0067724274,0.04970275,0.00008082,0.09271248,0.00010331702,0.05695224,0.0028514343,0.54002756,0.000017423252,0.0002022208,0.042598505],"study_design_scores_gemma":[0.00476172,0.003132012,0.8628423,0.000018384399,0.008483503,0.0000018729656,0.00083815143,0.0006090495,0.11910505,0.0000070765996,0.00006881455,0.00013203516],"about_ca_topic_score_codex":0.00018123863,"about_ca_topic_score_gemma":0.0011418007,"teacher_disagreement_score":0.81313956,"about_ca_system_score_codex":0.000071239796,"about_ca_system_score_gemma":0.00009091604,"threshold_uncertainty_score":0.5814706},"labels":[],"label_agreement":null},{"id":"W4401388801","doi":"10.1111/apt.18201","title":"Editorial: The future of managing drug induced liver injury","year":2024,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. John’s Health Sciences Centre","funders":"","keywords":"Medicine; Drug; Liver injury; MEDLINE; Intensive care medicine; Pharmacology; Law","score_opus":0.05222711963505704,"score_gpt":0.40435892234955617,"score_spread":0.3521318027144991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401388801","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007254688,0.011079129,0.0000040534374,0.005333477,0.97218263,0.0019359213,0.0010545838,0.00033013677,0.0008253607],"genre_scores_gemma":[0.00904879,0.023483982,0.000028349084,0.008696623,0.9562145,0.00040461836,0.00046047376,0.00023850691,0.0014241751],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927833,0.0026399153,0.0012368718,0.0011077058,0.0010961001,0.0011360869],"domain_scores_gemma":[0.9955609,0.0022131456,0.00082941813,0.0006761576,0.0004540489,0.0002663586],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0027709054,0.001127188,0.0010754194,0.00047079314,0.000774758,0.000082599625,0.0017257163,0.0035386109,0.0013453424],"category_scores_gemma":[0.000002640489,0.0009327102,0.0005853443,0.00073681487,0.0006542729,0.0002760238,0.0006456619,0.010655983,0.0005303084],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012439671,0.00046054245,0.00001628832,0.00045416638,0.012678299,0.000054344513,0.0019423038,0.000026190935,0.039893754,0.000074547745,0.9300879,0.013067683],"study_design_scores_gemma":[0.0014198789,0.00035275836,0.0000022016623,0.00008045572,0.015921488,0.000009268269,0.00035715746,0.00029588828,0.06350272,0.00090894836,0.91637725,0.00077197875],"about_ca_topic_score_codex":0.00031382588,"about_ca_topic_score_gemma":0.00011027496,"teacher_disagreement_score":0.023608968,"about_ca_system_score_codex":0.0005547327,"about_ca_system_score_gemma":0.0007725622,"threshold_uncertainty_score":0.99956757},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4401463336","doi":"10.1111/apt.18153","title":"Editorial: Tracking the course of Wilson's disease","year":2024,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Trace Elements in Health","field":"Nursing","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa","funders":"","keywords":"Medicine; Course (navigation); MEDLINE; Biology; Astronomy","score_opus":0.0242208137829856,"score_gpt":0.3844802904453739,"score_spread":0.36025947666238833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401463336","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010445258,0.018376313,0.0000031620607,0.012832643,0.9642458,0.0013297079,0.0018962572,0.00022888363,0.00004270341],"genre_scores_gemma":[0.0039097317,0.0024363752,0.000049791448,0.006413402,0.9858109,0.00015596727,0.0006923157,0.00027936508,0.00025219028],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949248,0.00084847887,0.0010121742,0.0008494694,0.0014196243,0.00094546884],"domain_scores_gemma":[0.9950429,0.0029555256,0.00065661495,0.00077550136,0.00032779333,0.00024163871],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0011899997,0.00076609507,0.00076365843,0.00016594594,0.00034921308,0.00008343935,0.0013106768,0.00082896964,0.0002893024],"category_scores_gemma":[0.0000033705905,0.00059700507,0.00036833383,0.00032471534,0.000634198,0.00018363925,0.00024481845,0.0030791492,0.00007487289],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001407445,0.0005591245,0.00010054857,0.000464892,0.00860111,0.000022966482,0.00092978467,0.000031993288,0.0019755946,0.0000065230697,0.9837437,0.0021562933],"study_design_scores_gemma":[0.0013262054,0.00044728548,0.000022981278,0.00018662754,0.033193048,0.0000013368572,0.00019321553,0.00008908839,0.0031647577,0.00035706244,0.96055883,0.00045958246],"about_ca_topic_score_codex":0.00013626504,"about_ca_topic_score_gemma":0.000034250803,"teacher_disagreement_score":0.024591936,"about_ca_system_score_codex":0.0005706549,"about_ca_system_score_gemma":0.00079880544,"threshold_uncertainty_score":0.99964815},"labels":[],"label_agreement":null},{"id":"W4401524049","doi":"10.1111/apt.18210","title":"Performance of bowel preparation quality scales in patients with Crohn's disease","year":2024,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia; Western University","funders":"Leona M. and Harry B. Helmsley Charitable Trust","keywords":"Intraclass correlation; Medicine; Visual analogue scale; Colonoscopy; Food and drug administration; Scale (ratio); Reliability (semiconductor); Crohn's disease; Quality of life (healthcare); Correlation; Internal medicine; Disease; Gastroenterology; Surgery; Psychometrics; Pharmacology; Colorectal cancer","score_opus":0.022340066189645843,"score_gpt":0.34066087186543154,"score_spread":0.3183208056757857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401524049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977037,0.0008184842,0.000017908405,0.00046813968,0.00034673855,0.00043469944,0.000017220294,0.00005629801,0.00013682702],"genre_scores_gemma":[0.99818075,0.00019040283,0.00008336394,0.0013191137,0.00006471943,0.000038911563,0.000055511227,0.000013792776,0.000053459014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919033,0.00007123701,0.00021714398,0.00020205716,0.00017873025,0.00014050909],"domain_scores_gemma":[0.99969786,0.000045998182,0.000046609897,0.00010156426,0.00004858101,0.00005940272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012926159,0.00010702718,0.00014849266,0.000103589584,0.000033651893,0.000005942345,0.000041594947,0.000038912618,0.00006735179],"category_scores_gemma":[1.2696555e-7,0.00008752535,0.00003936827,0.00019098067,0.00009077061,0.00011807299,0.000017495695,0.00014225539,0.000005349045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043243393,0.000523529,0.9440986,0.00024498306,0.0013258564,0.000021693311,0.00035231723,0.00023561627,0.004609754,0.000007747635,0.000055170938,0.0052813445],"study_design_scores_gemma":[0.0019426098,0.0024455627,0.9736571,0.000076678625,0.0014320881,0.0000017373626,0.000020536878,0.0056448453,0.014376034,0.000007895162,0.00029855335,0.00009636126],"about_ca_topic_score_codex":0.000041947354,"about_ca_topic_score_gemma":0.000024193305,"teacher_disagreement_score":0.041300785,"about_ca_system_score_codex":0.00011710897,"about_ca_system_score_gemma":0.000080193466,"threshold_uncertainty_score":0.356918},"labels":[],"label_agreement":null},{"id":"W4402097272","doi":"10.1111/apt.18212","title":"Letter: Resmetirom for treatment of <scp>MASH</scp> with children and adolescents","year":2024,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"Novo Nordisk; AstraZeneca","keywords":"Medicine; Pediatrics","score_opus":0.026085020695671077,"score_gpt":0.3073774636038779,"score_spread":0.2812924429082068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402097272","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5433908,0.028162286,0.000004097666,0.41952232,0.0010124512,0.0051916596,0.0025300535,0.00011042229,0.000075891985],"genre_scores_gemma":[0.039202575,0.011253278,0.00032553554,0.940488,0.0031495045,0.00071894063,0.0038405338,0.00019772993,0.0008239103],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979865,0.00009980718,0.00038087933,0.00072875334,0.00028818552,0.00051588],"domain_scores_gemma":[0.9990247,0.00024037468,0.00019532144,0.00033358045,0.00006975193,0.00013628018],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00004728672,0.00063199113,0.0008813546,0.00021346308,0.00008154786,0.000025479556,0.00012660185,0.0003699694,0.000047786834],"category_scores_gemma":[8.3047325e-8,0.00044973876,0.00029675773,0.000102543294,0.00027293837,0.000042516225,0.000049727674,0.00030689818,0.000019335848],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005124747,0.0024902532,0.0763779,0.0007020848,0.096235156,0.0010094275,0.00049313356,0.0000010859196,0.0013121354,0.0000027953072,0.81926066,0.0016028896],"study_design_scores_gemma":[0.014358591,0.0075348956,0.02064695,0.0004973321,0.1845144,0.00016320818,0.000029988745,0.000018787632,0.027818069,0.000045961722,0.744114,0.00025785607],"about_ca_topic_score_codex":0.000065048385,"about_ca_topic_score_gemma":0.0000026145783,"teacher_disagreement_score":0.5209657,"about_ca_system_score_codex":0.0002515677,"about_ca_system_score_gemma":0.00013853278,"threshold_uncertainty_score":0.99979544},"labels":[],"label_agreement":null},{"id":"W4402202468","doi":"10.1111/apt.18246","title":"Letter: Potential impact of<i>Helicobacter pylori</i>infection on oesophageal disorders in chronic liver disease—Authors' reply","year":2024,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Helicobacter pylori; Gastroenterology; Disease; Helicobacter Infections; Internal medicine; Helicobacter pylori infection","score_opus":0.019905411849694472,"score_gpt":0.3140177218890897,"score_spread":0.29411231003939525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402202468","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4145589,0.005123197,0.000012323098,0.57093656,0.0066817547,0.0019291484,0.0004559726,0.00022297919,0.00007918207],"genre_scores_gemma":[0.26551846,0.0072331456,0.00001962584,0.71810347,0.0067962143,0.00022296858,0.0013167632,0.00024281544,0.0005465061],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949461,0.0007137517,0.0011205956,0.0013033343,0.0005889846,0.0013272142],"domain_scores_gemma":[0.99837536,0.00018159937,0.0004076196,0.00069822697,0.00011648497,0.0002206863],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0003051852,0.001139502,0.0012968224,0.0010279674,0.00012452416,0.00002922574,0.0003411201,0.00095650187,0.0007335271],"category_scores_gemma":[9.784881e-7,0.0010017301,0.0009908582,0.0004855175,0.0006453931,0.00016199236,0.00025406503,0.0051530246,0.0002946776],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038548766,0.0009577071,0.07446859,0.0007500773,0.06577241,0.005234301,0.00043332513,0.0003948119,0.008198717,8.008477e-7,0.8382832,0.0016512272],"study_design_scores_gemma":[0.0106268,0.010118863,0.23727867,0.0008013326,0.07102333,0.00028871253,0.000009408121,0.0012288826,0.0019731098,0.00008281007,0.6651908,0.0013772403],"about_ca_topic_score_codex":0.000711971,"about_ca_topic_score_gemma":0.00007267585,"teacher_disagreement_score":0.17309232,"about_ca_system_score_codex":0.002278623,"about_ca_system_score_gemma":0.000454351,"threshold_uncertainty_score":0.9992433},"labels":[],"label_agreement":null},{"id":"W4402380876","doi":"10.1111/apt.18252","title":"Letter: Social work and clinical synergy—Optimizing health interventions for elderly <scp>DGBI</scp> populations: Authors' reply","year":2024,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Health disparities and outcomes","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Medicine; Psychological intervention; Gerontology; MEDLINE; Intensive care medicine; Nursing","score_opus":0.17921343081106578,"score_gpt":0.48356096183792235,"score_spread":0.3043475310268566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402380876","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024089338,0.011849824,0.00027263697,0.9680956,0.015062108,0.0015887754,0.00031066712,0.00024180043,0.00016967556],"genre_scores_gemma":[0.0007088022,0.004545039,0.0018136904,0.97051954,0.014584956,0.00027425357,0.0005804009,0.00011309812,0.006860236],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99412274,0.0018061114,0.0014774299,0.0008207125,0.00040533498,0.0013676427],"domain_scores_gemma":[0.99663943,0.002182117,0.0005987266,0.00021548975,0.00010009652,0.00026413094],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0024539856,0.0004548749,0.00095266046,0.00024744356,0.0024381783,0.00023602876,0.0004934329,0.00096536364,0.00016875728],"category_scores_gemma":[0.000007870256,0.00047886593,0.0008051469,0.0003645902,0.0006487232,0.00018852408,0.00016662804,0.0022944259,0.000027611033],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001494529,0.00010292149,0.0011764459,0.0006014726,0.0034035495,0.000030722687,0.0030829832,0.0000016743974,4.96802e-7,0.00073119137,0.9865668,0.0042868336],"study_design_scores_gemma":[0.0006301046,0.00025153902,0.0006603837,0.0002414398,0.004403526,0.000002594235,0.0008245885,0.000023552184,0.0000013957679,0.0013445095,0.99141574,0.00020062446],"about_ca_topic_score_codex":0.0011496665,"about_ca_topic_score_gemma":0.0004678917,"teacher_disagreement_score":0.007304786,"about_ca_system_score_codex":0.0005147171,"about_ca_system_score_gemma":0.0005779315,"threshold_uncertainty_score":0.9997663},"labels":[],"label_agreement":null},{"id":"W4402650594","doi":"10.1111/apt.18288","title":"Editorial: Advancing care in Crohn's disease—Time to standardise bowel preparation scales. Authors' reply","year":2024,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University","funders":"","keywords":"Medicine; Crohn's disease; Crohn disease; Inflammatory bowel disease; Intensive care medicine; Gastroenterology; Disease; Internal medicine","score_opus":0.004481428005697611,"score_gpt":0.3055616031220515,"score_spread":0.3010801751163539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402650594","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022341074,0.005977929,0.000014142571,0.00051846536,0.96583873,0.0018480297,0.003155542,0.00011900143,0.00018706746],"genre_scores_gemma":[0.0027148505,0.0009929048,0.000124413,0.0041331593,0.9826164,0.0005516269,0.0070655826,0.000266534,0.001534499],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99553216,0.0005243074,0.0007739297,0.0014767613,0.00083617645,0.00085665606],"domain_scores_gemma":[0.9979583,0.000095622694,0.0002247896,0.0007764393,0.00041378813,0.0005310632],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058302603,0.00078698073,0.0005053065,0.00026356915,0.00017488458,0.00010659954,0.0006589272,0.0009437564,0.00022148371],"category_scores_gemma":[0.000010501187,0.0008806785,0.00032063143,0.00018971895,0.00016535832,0.00002494069,0.00050925626,0.0009056247,0.0003449304],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074856984,0.00015325533,0.00010729474,0.00028743796,0.0022064142,0.00058308727,0.00031882475,0.0006828498,0.021273764,4.7565132e-7,0.9666461,0.0002548139],"study_design_scores_gemma":[0.0016703176,0.0003906831,0.0002511363,0.00013244007,0.004147993,0.0000010860512,0.00007218818,0.00006570945,0.002906793,0.000027509253,0.9894776,0.0008565504],"about_ca_topic_score_codex":0.00002415523,"about_ca_topic_score_gemma":0.00012014507,"teacher_disagreement_score":0.02283151,"about_ca_system_score_codex":0.00073939183,"about_ca_system_score_gemma":0.0015869905,"threshold_uncertainty_score":0.9993644},"labels":[],"label_agreement":null},{"id":"W4402650807","doi":"10.1111/apt.18269","title":"Editorial: Advancing care in Crohn's disease—Time to standardise bowel preparation scales","year":2024,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Crohn's disease; Crohn disease; Inflammatory bowel disease; Intensive care medicine; MEDLINE; Gastroenterology; Disease; Internal medicine","score_opus":0.004244819493587047,"score_gpt":0.30372763235821854,"score_spread":0.29948281286463146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402650807","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03454078,0.006931906,0.000010226854,0.00027423492,0.9532841,0.0015511743,0.003138761,0.00008986423,0.00017898189],"genre_scores_gemma":[0.0037064091,0.0012321029,0.00009363668,0.0022258023,0.9845003,0.00048137785,0.0066655814,0.00022037645,0.00087441335],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963616,0.00038669075,0.000638155,0.001170995,0.00070555496,0.0007370058],"domain_scores_gemma":[0.9984305,0.00008757885,0.00017313677,0.0005719608,0.00033473407,0.00040207457],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003809945,0.00068863283,0.00042836918,0.00022454129,0.00014477353,0.00008799512,0.0005698841,0.000844671,0.0002007354],"category_scores_gemma":[0.000005883282,0.00076197885,0.00028400563,0.00014737855,0.00014232409,0.00002044183,0.0004315924,0.00067171006,0.000355946],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006427329,0.00013893555,0.000113489616,0.0002796279,0.0021122599,0.00044135968,0.00024081404,0.000755437,0.026481563,4.0777212e-7,0.9627722,0.00023660366],"study_design_scores_gemma":[0.0015460696,0.00033900896,0.00026336827,0.000118266595,0.0038136444,7.1616734e-7,0.0000721787,0.00005104596,0.003077218,0.000023625542,0.9899389,0.0007559292],"about_ca_topic_score_codex":0.000015326554,"about_ca_topic_score_gemma":0.00015683811,"teacher_disagreement_score":0.031216228,"about_ca_system_score_codex":0.00056630914,"about_ca_system_score_gemma":0.0012785677,"threshold_uncertainty_score":0.9994831},"labels":[],"label_agreement":null},{"id":"W4402726217","doi":"10.1111/apt.18211","title":"Editorial: Defining corticosteroid use in clinical trials","year":2024,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Adrenal Hormones and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Corticosteroid; Clinical trial; MEDLINE; Intensive care medicine; Medical physics; Internal medicine","score_opus":0.11716099015029488,"score_gpt":0.46950637617214397,"score_spread":0.35234538602184906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402726217","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007235961,0.012754743,0.0000062075405,0.0014674105,0.9766206,0.0012485951,0.00039719982,0.00015317048,0.000116101866],"genre_scores_gemma":[0.0007936957,0.017066048,0.0001390338,0.010067209,0.96908003,0.0001223842,0.001842946,0.00019829298,0.0006903651],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930675,0.001558469,0.0027287393,0.0009908745,0.0009119048,0.00074252184],"domain_scores_gemma":[0.9897809,0.00861871,0.00064201717,0.0004409218,0.00020649546,0.00031097283],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0043337047,0.0006995506,0.0022630515,0.0003664335,0.00007427139,0.00008299811,0.00031582674,0.002082818,0.00038036943],"category_scores_gemma":[0.00005533233,0.000600347,0.0007789589,0.00030142677,0.00029565702,0.00015610344,0.00025277928,0.0038210591,0.00036764392],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004244493,0.00075821875,0.0010106581,0.00012851333,0.012765491,0.00037044345,0.0001452664,0.0000037516822,0.0007976474,0.0000046956848,0.97801733,0.001753489],"study_design_scores_gemma":[0.008296099,0.0014030439,0.000083041385,0.00021518685,0.037534323,0.0000123443715,0.00011078633,0.000096805736,0.00013374454,0.00010732949,0.9515338,0.00047352383],"about_ca_topic_score_codex":0.00021631614,"about_ca_topic_score_gemma":0.000080634236,"teacher_disagreement_score":0.026483558,"about_ca_system_score_codex":0.00032161656,"about_ca_system_score_gemma":0.0010228608,"threshold_uncertainty_score":0.9996448},"labels":[],"label_agreement":null},{"id":"W4402917665","doi":"10.1111/apt.18278","title":"Eight‐year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials","year":2024,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Gilead Sciences","keywords":"Tenofovir alafenamide; Medicine; Internal medicine; Gastroenterology; Renal function; HBeAg; Hepatitis B virus; Hepatitis B; Creatinine; Immunology; HBsAg; Viral load; Virus","score_opus":0.0980559863978301,"score_gpt":0.41642528874091866,"score_spread":0.3183693023430886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402917665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9705769,0.019162973,0.00029484226,0.0020892543,0.0011845459,0.0031942462,0.0033613967,0.000062912884,0.000072962226],"genre_scores_gemma":[0.89695334,0.09973973,0.0006942457,0.0007688554,0.000882932,0.00020040374,0.0005811542,0.000044880457,0.00013444552],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975914,0.00038401777,0.0011398757,0.00041736654,0.00017798158,0.00028937112],"domain_scores_gemma":[0.99628973,0.0030298405,0.0002831508,0.00020688854,0.0000952561,0.00009510794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057562994,0.000304085,0.0012086347,0.00015856263,0.00010967015,0.00000878426,0.00006048256,0.00010170062,0.00037757793],"category_scores_gemma":[0.0000071121335,0.00023889552,0.0002940729,0.00015173513,0.00030845223,0.00007273017,0.000035500365,0.0000963989,0.000008777463],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13643533,0.0032592881,0.010121533,0.00027245088,0.06275371,0.000112206806,0.002775865,0.00007081131,0.700705,0.00004924981,0.0012295782,0.082214996],"study_design_scores_gemma":[0.3159131,0.0109689515,0.0048073423,0.00021500241,0.03992429,0.00001980331,0.000016570704,0.0028786475,0.57656825,0.00014953478,0.04826545,0.00027304218],"about_ca_topic_score_codex":0.0057179276,"about_ca_topic_score_gemma":0.0011477106,"teacher_disagreement_score":0.17947778,"about_ca_system_score_codex":0.00034078956,"about_ca_system_score_gemma":0.000280466,"threshold_uncertainty_score":0.9741877},"labels":[],"label_agreement":null},{"id":"W4403156830","doi":"10.1111/apt.18315","title":"Network Meta‐Analysis: Histologic and Histo‐Endoscopic Improvement and Remission With Advanced Therapy in Ulcerative Colitis","year":2024,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Internal medicine; Confidence interval; Subgroup analysis; Randomized controlled trial; Gastroenterology; Relative risk; Ulcerative colitis; Meta-analysis; Surgery","score_opus":0.052423939024589014,"score_gpt":0.35233026530255557,"score_spread":0.29990632627796654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403156830","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0067212232,0.9910775,0.0000092741375,0.00016183205,0.00026306722,0.0016028259,0.00009564231,0.000023916811,0.0000447538],"genre_scores_gemma":[0.0019450936,0.99182284,0.0002577688,0.0042942525,0.00014497458,0.0007701222,0.00040923193,0.00007363214,0.0002821104],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99730945,0.00060033373,0.000539366,0.0009532161,0.00013451069,0.00046310044],"domain_scores_gemma":[0.9991598,0.000050781986,0.0002824221,0.0003238359,0.00004095309,0.00014219111],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002796161,0.00068775035,0.0015207543,0.00018031058,0.00011838866,0.000028470255,0.00021147069,0.0003216685,0.00009792969],"category_scores_gemma":[1.6575319e-7,0.0004925262,0.00036723097,0.00026594257,0.00027574506,0.000009579664,0.00018388181,0.0003819897,0.0000030275066],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019291955,0.0003511714,0.00025395514,0.0031989082,0.84763676,0.0008887682,0.00023827104,0.00008946389,0.0015277923,0.00003911087,0.0008308991,0.14301573],"study_design_scores_gemma":[0.0013764934,0.0009507737,0.000109306675,0.0001661915,0.5305622,0.000026618778,0.00003162583,0.00002034402,0.0001474373,0.00005019038,0.4659934,0.00056539633],"about_ca_topic_score_codex":0.000014125425,"about_ca_topic_score_gemma":0.00011603452,"teacher_disagreement_score":0.46516252,"about_ca_system_score_codex":0.00013549485,"about_ca_system_score_gemma":0.00023298006,"threshold_uncertainty_score":0.99975264},"labels":[],"label_agreement":null},{"id":"W4403435524","doi":"10.1111/apt.18228","title":"Review article: Optimisation of biologic (monoclonal antibody) therapeutic response in inflammatory bowel disease","year":2024,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Dosing; Immunogenicity; Therapeutic drug monitoring; Inflammatory bowel disease; Monoclonal antibody; Vedolizumab; Drug; Immunology; Concomitant; Disease; Adalimumab; Antibody; Intensive care medicine; Pharmacology; Internal medicine; Tumor necrosis factor alpha","score_opus":0.036643735642195974,"score_gpt":0.37844909950759414,"score_spread":0.34180536386539817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403435524","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023625402,0.97303516,0.000006595961,0.00026574332,0.0007269722,0.00199107,0.00029263538,0.000040464394,0.000015972526],"genre_scores_gemma":[0.0017434919,0.98860717,0.00005414825,0.0075300625,0.00025077077,0.00040471586,0.001191599,0.00012501699,0.00009301197],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951933,0.0019248723,0.0012756113,0.00085032184,0.0002063358,0.0005495734],"domain_scores_gemma":[0.9983991,0.000119240765,0.00050989207,0.00067677506,0.0000851022,0.0002099101],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001071537,0.0007533989,0.00096949906,0.00028959572,0.00006298469,0.000020512527,0.00064153346,0.00043816923,0.00019624871],"category_scores_gemma":[0.0000031276534,0.0006486211,0.0006886035,0.0002814493,0.0003747154,0.0000145413815,0.0003007521,0.00051797414,0.00010848219],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030203097,0.0054833763,0.011991645,0.34524366,0.09597985,0.0063109626,0.00041134405,0.00045226022,0.20340672,0.0002748394,0.011418161,0.28882408],"study_design_scores_gemma":[0.0012720274,0.00045845463,0.0018814219,0.012725708,0.050043467,0.000059664093,0.000017182694,0.00009443376,0.00084627664,0.00007373087,0.9312485,0.0012791619],"about_ca_topic_score_codex":0.000002722058,"about_ca_topic_score_gemma":0.000002564716,"teacher_disagreement_score":0.9198303,"about_ca_system_score_codex":0.00016144077,"about_ca_system_score_gemma":0.0010401667,"threshold_uncertainty_score":0.9995965},"labels":[],"label_agreement":null},{"id":"W4403435556","doi":"10.1111/apt.18231","title":"Review article: Measuring disease severity in inflammatory bowel disease – Beyond treat to target","year":2024,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Disease; Inflammatory bowel disease; Ulcerative colitis; Psychosocial; Severity of illness; Crohn's disease; MEDLINE; Quality of life (healthcare); Intensive care medicine; Natural history; Immunology; Internal medicine; Psychiatry","score_opus":0.030953815907064537,"score_gpt":0.3408289420853725,"score_spread":0.309875126178308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403435556","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003718546,0.99045724,0.00000429905,0.0006968838,0.0010756584,0.0031156603,0.0007630002,0.00008021829,0.000088512534],"genre_scores_gemma":[0.0002127496,0.9681849,0.00006243122,0.027811918,0.00069275865,0.0012693062,0.0011482987,0.0002184249,0.0003992228],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99547833,0.0009190398,0.0010862026,0.0013060862,0.00033151815,0.0008788191],"domain_scores_gemma":[0.99766505,0.00003841325,0.00023873475,0.0009486106,0.000078912846,0.0010302702],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005493437,0.0010417766,0.0010260635,0.00025914423,0.00012355721,0.00005486579,0.0007919258,0.00029507297,0.00029216876],"category_scores_gemma":[0.0000034825991,0.0009800622,0.00078386854,0.00030341724,0.00017897027,0.000021170763,0.00062313577,0.00061403075,0.0004914459],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056435247,0.004590739,0.00914255,0.4777595,0.05204502,0.03957771,0.00037821187,0.00036841017,0.0043854313,0.00010666332,0.14645986,0.25954238],"study_design_scores_gemma":[0.00058404874,0.000052258925,0.0005572821,0.00779601,0.036011837,0.00002742109,0.0000055529313,0.000031631826,0.0000912442,0.000059000075,0.95371735,0.0010663797],"about_ca_topic_score_codex":0.0000041809226,"about_ca_topic_score_gemma":0.000009539908,"teacher_disagreement_score":0.8072575,"about_ca_system_score_codex":0.00033713417,"about_ca_system_score_gemma":0.0011147037,"threshold_uncertainty_score":0.99926496},"labels":[],"label_agreement":null},{"id":"W4403436316","doi":"10.1111/apt.18326","title":"Clinical Trial Design Considerations for Hospitalised Patients With Ulcerative Colitis Flares and Application to Study Hyperbaric Oxygen Therapy in the <scp>NIDDK HBOT</scp>‐<scp>UC</scp> Consortium","year":2024,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Lawson Health Research Institute; McMaster University; Population Health Research Institute","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Clinical trial; Population; Ulcerative colitis; Clinical study design; Randomized controlled trial; Psychological intervention; Intensive care medicine; Inclusion and exclusion criteria; Internal medicine; Disease; Alternative medicine; Pathology","score_opus":0.06685441823281675,"score_gpt":0.3843310534955598,"score_spread":0.31747663526274306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403436316","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5193604,0.44180226,0.00037521604,0.00015898458,0.0011020744,0.036042117,0.0010713949,0.000055192,0.000032351367],"genre_scores_gemma":[0.04513606,0.91100985,0.0011544364,0.018659217,0.0013450152,0.020041078,0.0022079283,0.0002930097,0.00015337713],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99460584,0.0024086933,0.0010890738,0.0010969093,0.00027086266,0.0005286347],"domain_scores_gemma":[0.9969119,0.0017304333,0.0004198152,0.00053656206,0.00022188097,0.00017941478],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011198337,0.0007165453,0.00096887635,0.00014912357,0.00030772446,0.00012349337,0.00045633607,0.00042789837,0.000010016225],"category_scores_gemma":[0.00001913782,0.00051200914,0.00029578735,0.00022525954,0.00029986675,0.000017308288,0.00014498434,0.00044936832,0.000018037237],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046928268,0.0561144,0.03365183,0.006487777,0.3031206,0.0014147665,0.034424152,0.0005062715,0.002283692,0.00042945423,0.18715891,0.32747987],"study_design_scores_gemma":[0.07382426,0.022226516,0.011636841,0.00027810418,0.04978972,0.000035046323,0.0024081478,0.000107913016,0.00032127285,0.00030585637,0.8383711,0.000695241],"about_ca_topic_score_codex":0.000007222665,"about_ca_topic_score_gemma":0.00004083373,"teacher_disagreement_score":0.65121216,"about_ca_system_score_codex":0.00007617896,"about_ca_system_score_gemma":0.00056458823,"threshold_uncertainty_score":0.99973315},"labels":[],"label_agreement":null},{"id":"W4404327100","doi":"10.1111/apt.18394","title":"Letter: Bowel Preparation Quality in Patients With Crohn's Disease—Authors' Reply","year":2024,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Crohn's disease; Crohn disease; Gastroenterology; Internal medicine; Disease; Dermatology","score_opus":0.01396159435843026,"score_gpt":0.30275986836825514,"score_spread":0.2887982740098249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404327100","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7738944,0.0010975552,0.000014367597,0.21948366,0.0025316642,0.0019049306,0.00083959306,0.00008536953,0.00014844828],"genre_scores_gemma":[0.06309555,0.00012856888,0.00006721794,0.9238523,0.0030101174,0.00030418095,0.0080778655,0.00016634112,0.001297862],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99634737,0.0007424269,0.00064533326,0.0011573912,0.0004428909,0.0006645747],"domain_scores_gemma":[0.99867594,0.000032530446,0.0002806032,0.00075062277,0.00011660773,0.0001437216],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028732134,0.00064898457,0.000354333,0.00016733391,0.00010503194,0.000060438935,0.00047189055,0.00058298267,0.00016942174],"category_scores_gemma":[5.933422e-7,0.000616502,0.00020461962,0.000116487965,0.0002647856,0.000018232897,0.00021436888,0.0010975754,0.00008924226],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051845964,0.0003851211,0.047784735,0.00029845422,0.0056860414,0.002179839,0.000103599734,0.000081545106,0.0018747422,0.0000022939203,0.9363405,0.00007851292],"study_design_scores_gemma":[0.0025233433,0.00031019346,0.17079416,0.000053404437,0.004695127,0.0000025092172,0.0000058798805,0.00003619659,0.0014264603,0.000052077983,0.8192157,0.0008849608],"about_ca_topic_score_codex":0.000023250783,"about_ca_topic_score_gemma":0.000020645479,"teacher_disagreement_score":0.71079886,"about_ca_system_score_codex":0.00017883182,"about_ca_system_score_gemma":0.00029172385,"threshold_uncertainty_score":0.9996286},"labels":[],"label_agreement":null},{"id":"W4404389092","doi":"10.1111/apt.18382","title":"Meta‐Analysis: Evaluating Placebo Rates Across Outcomes in Eosinophilic Oesophagitis Randomised Controlled Trials","year":2024,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University; University of Calgary","funders":"","keywords":"Medicine; Placebo; Internal medicine; Meta-analysis; Eosinophilic esophagitis; Randomized controlled trial; Eosinophil; Clinical trial; Eosinophilic; Gastroenterology; Asthma; Pathology; Disease","score_opus":0.3491004654995002,"score_gpt":0.5409696077187488,"score_spread":0.1918691422192486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404389092","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00091928826,0.9754519,0.0000044163558,0.0025593385,0.0021456932,0.017653152,0.00087948074,0.00027897948,0.00010775939],"genre_scores_gemma":[0.0010632785,0.97391325,0.000285104,0.012323801,0.0007484435,0.00832445,0.0010792172,0.0003390485,0.0019234195],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97914547,0.009715322,0.0065609054,0.0019196138,0.0011196218,0.0015390932],"domain_scores_gemma":[0.9809217,0.015027642,0.0023540005,0.0010651877,0.00023711119,0.00039436546],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.013564259,0.0022850754,0.0354888,0.001818091,0.0002378392,0.00017502684,0.0008128182,0.0010980916,0.0037551986],"category_scores_gemma":[0.00003804295,0.0014719943,0.016215442,0.0022257324,0.0004781138,0.00019326333,0.00035695822,0.0023270862,0.00036962706],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005433796,0.000771613,0.000073602605,0.0038198018,0.96718377,0.0010608066,0.0004720486,0.00001798617,0.00012459766,0.0000055195615,0.00017708502,0.020859372],"study_design_scores_gemma":[0.099834464,0.0005007944,0.000009305175,0.000714294,0.8812569,0.00017169872,0.00007604961,0.0002728803,0.00015299261,0.000072218405,0.016095497,0.0008429097],"about_ca_topic_score_codex":0.00010882763,"about_ca_topic_score_gemma":0.00004060985,"teacher_disagreement_score":0.09440067,"about_ca_system_score_codex":0.0007716989,"about_ca_system_score_gemma":0.0009990355,"threshold_uncertainty_score":0.9999746},"labels":[],"label_agreement":null},{"id":"W4404971110","doi":"10.1111/apt.18416","title":"Early <scp>HBcrAg</scp> and Anti‐<scp>HBc</scp> Levels Identify Patients at High Risk for Severe Flares After Nucleos(t)ide Analogue Cessation—A Pooled Analysis of Two Clinical Trials","year":2024,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"Stichting voor Lever- en Maag-Darm Onderzoek","keywords":"Medicine; Internal medicine; Coronavirus disease 2019 (COVID-19); Adverse effect; Logistic regression; Clinical trial; Prospective cohort study; Flare; Gastroenterology; Disease","score_opus":0.0658515124310486,"score_gpt":0.41025378124588596,"score_spread":0.3444022688148374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404971110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898597,0.0029478457,0.00030045255,0.000272067,0.0010809923,0.0014047644,0.004029498,0.00008183845,0.000022811731],"genre_scores_gemma":[0.9892659,0.0035486263,0.00024514322,0.0041054212,0.0003536496,0.00011432773,0.0021069204,0.000057939655,0.0002020514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960036,0.0010865614,0.0013520872,0.0006985467,0.00042134558,0.00043784926],"domain_scores_gemma":[0.9940204,0.0047405935,0.00046938233,0.00026459334,0.000247686,0.000257341],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014767413,0.0003749351,0.0011359211,0.00053321454,0.00017956656,0.000056363762,0.00016729947,0.00024293552,0.00026508613],"category_scores_gemma":[0.000009307644,0.00032455445,0.0006633248,0.0005659046,0.00025018957,0.00031625645,0.00007408473,0.0003121423,0.000027280415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056161225,0.00061005086,0.81726104,0.00024801714,0.16433161,0.00007908117,0.0021971765,0.00007679924,0.012877674,0.00001853474,0.00058604043,0.0011523678],"study_design_scores_gemma":[0.0077600866,0.00044951495,0.6891996,0.00005325433,0.28702056,0.000004317447,0.00017676044,0.0011052797,0.013440782,0.00025521187,0.00045779216,0.00007681725],"about_ca_topic_score_codex":0.00022155051,"about_ca_topic_score_gemma":0.000060815513,"teacher_disagreement_score":0.12806143,"about_ca_system_score_codex":0.00009706955,"about_ca_system_score_gemma":0.000112731606,"threshold_uncertainty_score":0.99992067},"labels":[],"label_agreement":null},{"id":"W4405110103","doi":"10.1111/apt.18408","title":"Editorial: Mesenchymal Stem Cell Therapy for Perianal Fistulising Crohn's Disease—Effective or Hype?","year":2024,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Diverticular Disease and Complications","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Mesenchymal stem cell; Crohn's disease; Stem cell; Stem-cell therapy; Disease; Cancer research; Internal medicine; Pathology","score_opus":0.025439515800692418,"score_gpt":0.34911827365670894,"score_spread":0.3236787578560165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405110103","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003446706,0.014223089,0.00006593385,0.0021881736,0.97281414,0.004365836,0.0024508224,0.00025681593,0.00018850765],"genre_scores_gemma":[0.0023155066,0.004189388,0.00011389072,0.0064415447,0.977867,0.002089682,0.0029682117,0.00024167351,0.0037731167],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965086,0.00025931385,0.0005618936,0.0010782088,0.00087854627,0.00071341806],"domain_scores_gemma":[0.9970251,0.0011903915,0.00022355226,0.00056167954,0.00051474734,0.0004845327],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028049838,0.00075525907,0.0008447679,0.00022356791,0.00036230494,0.00013305257,0.00046765487,0.00064445497,0.00053401454],"category_scores_gemma":[0.0000014958586,0.00061427115,0.000681047,0.00027325694,0.00024309676,0.00012734643,0.00016152648,0.0010061347,0.00015153781],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00952305,0.0012991126,0.00003183819,0.000465384,0.01686253,0.00024918685,0.00029855294,0.0000060495663,0.0049097007,0.000005810009,0.963963,0.0023857877],"study_design_scores_gemma":[0.0054263994,0.0010948782,0.000115155846,0.00013665791,0.045525476,0.0000045863812,0.00014058572,0.00019886048,0.0021195621,0.00010655979,0.9445557,0.00057557534],"about_ca_topic_score_codex":0.00002185931,"about_ca_topic_score_gemma":0.0000032041808,"teacher_disagreement_score":0.028662944,"about_ca_system_score_codex":0.0004995699,"about_ca_system_score_gemma":0.0016402834,"threshold_uncertainty_score":0.99963087},"labels":[],"label_agreement":null},{"id":"W4405115290","doi":"10.1111/apt.18426","title":"Mortality of Acute Kidney Injury in Cirrhosis: A Systematic Review and Meta‐Analysis of Over 5 Million Patients Across Different Clinical Settings","year":2024,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Acute kidney injury; Cirrhosis; Confidence interval; Meta-analysis; Internal medicine; Intensive care unit; Mortality rate; Kidney disease; Intensive care medicine","score_opus":0.09233206592109197,"score_gpt":0.47974540389600506,"score_spread":0.38741333797491306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405115290","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016194452,0.9741842,7.039588e-7,0.00014363724,0.00019054046,0.0032739867,0.0059955744,0.000014690709,0.0000021979915],"genre_scores_gemma":[0.0039790883,0.98388547,0.0000073104698,0.009368674,0.000018294893,0.00030710836,0.0023833294,0.000036243582,0.000014474711],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9957421,0.00096489745,0.0022335183,0.00049939076,0.00031961268,0.00024047717],"domain_scores_gemma":[0.99829316,0.00019624343,0.0009197967,0.00034164393,0.000084221014,0.00016493276],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006665101,0.00047132646,0.006833852,0.0003120061,0.000022523995,0.000005900852,0.00016805454,0.00024026728,0.0001514332],"category_scores_gemma":[3.6342453e-7,0.0003059917,0.0020116377,0.00066381786,0.00015776632,0.000059568072,0.00008593166,0.00041303516,0.0000035580513],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043356562,0.00042341795,0.0019408298,0.43373355,0.563594,0.000014375145,0.00011230371,9.355448e-9,0.0000036796882,5.8522113e-7,0.000041406343,0.00009248512],"study_design_scores_gemma":[0.0007064371,0.00023203054,0.0012845953,0.033900034,0.96331406,0.0000033286267,0.000006427596,0.000009407983,0.000027602759,0.0000032083585,0.00032398367,0.00018887312],"about_ca_topic_score_codex":0.000034873687,"about_ca_topic_score_gemma":0.000002230707,"teacher_disagreement_score":0.39983353,"about_ca_system_score_codex":0.00007296012,"about_ca_system_score_gemma":0.000111534755,"threshold_uncertainty_score":0.9999392},"labels":[],"label_agreement":null},{"id":"W4405477412","doi":"10.1111/apt.18435","title":"Risk‐Adapted Starting Ages of Colorectal Cancer Screening for People With Diabetes or Metabolic Syndrome","year":2024,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Bundesministerium für Bildung und Forschung","keywords":"Medicine; Metabolic syndrome; Diabetes mellitus; Confidence interval; Population; Demography; Colorectal cancer; Risk assessment; Gerontology; Environmental health; Internal medicine; Cancer; Endocrinology","score_opus":0.020830516407344284,"score_gpt":0.31010694639037323,"score_spread":0.28927642998302894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405477412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75763315,0.24046722,0.0002442951,0.0001428,0.00059265405,0.00046416128,0.00041628844,0.0000313429,0.000008082277],"genre_scores_gemma":[0.95000064,0.04423811,0.0016189105,0.0029916526,0.00032784021,0.00044282904,0.00020469488,0.00007733452,0.00009799343],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99846697,0.00014098221,0.00031453618,0.0004455097,0.00014930044,0.0004826833],"domain_scores_gemma":[0.9993955,0.00011811982,0.00015745188,0.00015149829,0.00009454767,0.00008288305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002785582,0.00027797068,0.00042093566,0.00008362364,0.00013123498,0.000023264183,0.00022011386,0.00012372244,0.00028653842],"category_scores_gemma":[8.0411957e-7,0.00021501725,0.0001371413,0.00022104793,0.00014915918,0.000015884403,0.00007212516,0.00015862692,0.0000017802429],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012595876,0.00017049426,0.023122182,0.00018334987,0.023873512,0.000009272274,0.0004898695,0.0006929102,0.90994674,0.000016951246,0.0010399661,0.03919514],"study_design_scores_gemma":[0.0017553732,0.001037926,0.0034216437,0.00004779962,0.00877869,0.0000061814408,0.00018775511,0.0019436737,0.89921975,0.000029927654,0.08321196,0.00035933236],"about_ca_topic_score_codex":0.00007525764,"about_ca_topic_score_gemma":0.00018170397,"teacher_disagreement_score":0.19622912,"about_ca_system_score_codex":0.000017831004,"about_ca_system_score_gemma":0.00015101499,"threshold_uncertainty_score":0.8768149},"labels":[],"label_agreement":null},{"id":"W4405891320","doi":"10.1111/apt.18420","title":"Management of Patients With Refractory Reflux‐Like Symptoms Despite Proton Pump Inhibitor Therapy: Evidence‐Based Consensus Statements","year":2024,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; McMaster University; Population Health Research Institute","funders":"Ethicon Endo-Surgery; National Institute of Diabetes and Digestive and Kidney Diseases; Samsung; Ironwood Pharmaceuticals, Incorporated; Dr. Falk Pharma; Intuitive Surgical; Boston Scientific Corporation; Sanofi","keywords":"Medicine; Proton-pump inhibitor; Reflux; Refractory (planetary science); GERD; Gastroenterology; Disease; Internal medicine; Esophageal disease; Intensive care medicine; Esophagus","score_opus":0.04920407407808237,"score_gpt":0.3735430577292261,"score_spread":0.3243389836511437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405891320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912868,0.0032269042,0.00002186679,0.0006241476,0.00082530855,0.003670765,0.00010089683,0.00014316918,0.00010015591],"genre_scores_gemma":[0.99129343,0.001162818,0.000810224,0.0055085067,0.00007711023,0.0004210424,0.0002360399,0.000087982226,0.0004028247],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974842,0.00019721517,0.00055523764,0.00059403625,0.0006429801,0.0005262945],"domain_scores_gemma":[0.99895364,0.00014104991,0.00018735843,0.0003658886,0.00016470917,0.00018737269],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022445306,0.0004421365,0.00044032614,0.00023557257,0.0001002513,0.000024565128,0.00016638527,0.000106016436,0.000537741],"category_scores_gemma":[1.2293566e-7,0.00032024298,0.0001382488,0.00032309757,0.00026576067,0.00021075309,0.0000640722,0.0002973714,0.000056478297],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0148681225,0.009330937,0.8220797,0.002064421,0.071843505,0.0047665616,0.00065525784,0.000061471954,0.03173862,0.000023442311,0.00052116305,0.042046767],"study_design_scores_gemma":[0.05512596,0.036507223,0.35834458,0.0034111617,0.049721945,0.000043147,0.000204533,0.00075808365,0.46195197,0.00008969586,0.032833625,0.0010080747],"about_ca_topic_score_codex":0.000010329507,"about_ca_topic_score_gemma":3.2254167e-7,"teacher_disagreement_score":0.46373513,"about_ca_system_score_codex":0.00033831416,"about_ca_system_score_gemma":0.00016403725,"threshold_uncertainty_score":0.99992496},"labels":[],"label_agreement":null},{"id":"W4405996267","doi":"10.1111/apt.18478","title":"Lubiprostone Reduces Fat Content on <scp>MRI</scp>‐<scp>PDFF</scp> in Patients With <scp>MASLD</scp>: A 48‐Week Randomised Controlled Trial","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Lubiprostone; Medicine; Laxative; Gastroenterology; Intestinal permeability; Pharmacology; Internal medicine; Constipation","score_opus":0.026125245665402495,"score_gpt":0.29569313569475164,"score_spread":0.26956789002934917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405996267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732397,0.004037739,0.0000058350474,0.0016468727,0.0027748854,0.015493659,0.00019598,0.0001574939,0.002447828],"genre_scores_gemma":[0.9556807,0.0017377504,0.00010826595,0.03254747,0.0004446179,0.0039724377,0.0006750321,0.00011797928,0.004715738],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99465555,0.0007851093,0.0012880869,0.0011682542,0.0008495872,0.0012534084],"domain_scores_gemma":[0.99351126,0.0044966377,0.0005876719,0.00057317974,0.0003384264,0.0004928362],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005201461,0.0010018545,0.0020324318,0.00059693085,0.00032668977,0.00007295898,0.0004213865,0.00034725748,0.000100412464],"category_scores_gemma":[0.000033016444,0.0007533114,0.0005984104,0.0005888215,0.0004221554,0.00021734087,0.00012202927,0.00071178994,0.00011967876],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44664976,0.07983392,0.24584395,0.00027640295,0.11756404,0.0010256084,0.005945109,0.00020753447,0.025924278,0.00015561153,0.07421119,0.0023626059],"study_design_scores_gemma":[0.85554785,0.0073313136,0.029817672,0.00023649952,0.028688641,0.0000044036497,0.0017671805,0.00014214044,0.06592758,0.000049524282,0.0103645,0.00012271346],"about_ca_topic_score_codex":0.00013026169,"about_ca_topic_score_gemma":0.000021625863,"teacher_disagreement_score":0.4088981,"about_ca_system_score_codex":0.00068406056,"about_ca_system_score_gemma":0.0004282912,"threshold_uncertainty_score":0.9994918},"labels":[],"label_agreement":null},{"id":"W4406111053","doi":"10.1111/apt.18479","title":"Editorial: Heads or Tails in the Treatment of Functional Dyspepsia—Does the Side of the Coin Matter? Authors' Reply","year":2025,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Guideline; Irritable bowel syndrome; Distress; Postprandial; Clinical trial; Internal medicine; Intensive care medicine; Psychiatry; Clinical psychology; Pathology","score_opus":0.025264237072495522,"score_gpt":0.3364157913802173,"score_spread":0.3111515543077218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406111053","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018953597,0.0011500634,0.000006747234,0.0320393,0.9452775,0.0019575004,0.00038758494,0.000021623011,0.00020609671],"genre_scores_gemma":[0.019158378,0.0022796006,0.000086305576,0.01942698,0.95492685,0.0003673,0.0004721261,0.000065892185,0.0032165854],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99643177,0.0009623809,0.0008761776,0.0004502624,0.0008733925,0.0004060006],"domain_scores_gemma":[0.9949693,0.003525058,0.00047881997,0.00072940066,0.00024491412,0.000052487223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072348816,0.0004593466,0.0007512751,0.00012513196,0.00017105739,0.000014207512,0.0006056358,0.0003818425,0.0005261197],"category_scores_gemma":[0.00001301205,0.00019504402,0.00037781513,0.00037900603,0.0007428657,0.000043383476,0.00009306001,0.0009970518,0.000007874814],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057047936,0.0021936232,0.0057031405,0.00016859194,0.0041499985,0.000013154891,0.0010795128,0.00003761389,0.0025730098,0.000006451959,0.97803867,0.00033145316],"study_design_scores_gemma":[0.0050526266,0.0027167534,0.0034451832,0.00018263879,0.012418783,0.00001875611,0.0011873454,0.000024479461,0.0028797062,0.00021120202,0.97170705,0.00015550658],"about_ca_topic_score_codex":0.0007600379,"about_ca_topic_score_gemma":0.00040896144,"teacher_disagreement_score":0.012612321,"about_ca_system_score_codex":0.000282629,"about_ca_system_score_gemma":0.0009968671,"threshold_uncertainty_score":0.79536647},"labels":[],"label_agreement":null},{"id":"W4406112209","doi":"10.1111/apt.18466","title":"Management of Perianal Fistulizing Crohn's Disease According to Principles of Wound Repair","year":2025,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Anorectal Disease Treatments and Outcomes","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Crohn's disease; Crohn disease; MEDLINE; Surgery; Disease; Dermatology; Internal medicine","score_opus":0.08189396083718846,"score_gpt":0.41820034189578015,"score_spread":0.3363063810585917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406112209","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030352755,0.9919162,0.00001084453,0.00025777885,0.0005940352,0.0026613132,0.0003039306,0.00006720546,0.0011534467],"genre_scores_gemma":[0.0010773824,0.9922131,0.0009949501,0.0026433433,0.000096008356,0.0002271091,0.0002997937,0.000053985343,0.0023943847],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99782586,0.00015878344,0.00087506004,0.00050221925,0.00027905594,0.0003590424],"domain_scores_gemma":[0.99871695,0.0001689169,0.00036076276,0.0004338101,0.00006502809,0.00025454382],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012952888,0.00050284585,0.0017283363,0.00031974915,0.00008529591,0.000006570191,0.00027166784,0.00011828039,0.00036874774],"category_scores_gemma":[4.131128e-7,0.0004014241,0.0009906963,0.00037788035,0.00013498771,0.000042302956,0.000321271,0.00018943466,0.000012686979],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029153444,0.0037732117,0.011260137,0.14825006,0.24072534,0.0041571874,0.0002868075,0.00001610264,0.000067260706,0.0006923227,0.00066571706,0.5871905],"study_design_scores_gemma":[0.0018095693,0.00032981802,0.0045358785,0.013833135,0.27026457,0.000011903551,0.0002875947,0.000012307846,0.00008084423,0.000011517214,0.7084037,0.0004191209],"about_ca_topic_score_codex":0.000015905483,"about_ca_topic_score_gemma":8.4959476e-7,"teacher_disagreement_score":0.70773804,"about_ca_system_score_codex":0.0002765891,"about_ca_system_score_gemma":0.0003530447,"threshold_uncertainty_score":0.9998438},"labels":[],"label_agreement":null},{"id":"W4406130697","doi":"10.1111/apt.18446","title":"Editorial: Hepatitis D Screening—<scp>DAS</scp> (Delta Virus Awareness and Screening) Approach in Primary Care","year":2025,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital","funders":"","keywords":"Medicine; Hepatitis D; HBsAg; Hepatocellular carcinoma; Hepatitis D virus; Liver disease; Hepatitis B virus; Hepatitis B; Internal medicine; Vaccination; Cirrhosis; Disease; Immunology; Virology; Virus","score_opus":0.02438191713381358,"score_gpt":0.333643554253644,"score_spread":0.3092616371198304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406130697","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012556445,0.026620757,0.00018327427,0.00032097465,0.9533634,0.0024534848,0.002839434,0.000276916,0.0013852881],"genre_scores_gemma":[0.0013759506,0.04585153,0.0029640591,0.007699741,0.93015194,0.00069101417,0.0101750605,0.00026317645,0.0008275308],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936619,0.0007173102,0.0012270386,0.0016151092,0.0014916214,0.0012870646],"domain_scores_gemma":[0.99556667,0.002250809,0.0004906792,0.0006751477,0.0006923015,0.00032436955],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0006739709,0.0012681478,0.0022321688,0.0007562442,0.0004956897,0.00007577588,0.0006449988,0.0020326253,0.000037066497],"category_scores_gemma":[0.000015994532,0.0013363668,0.00029695634,0.0006146425,0.0006468056,0.00022480839,0.000911509,0.0030957789,0.000011944436],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004891055,0.0005323469,0.071461074,0.0013697578,0.0116887605,0.00019319628,0.0017103165,0.000015590023,0.0013344035,0.0000016677576,0.90868163,0.002522155],"study_design_scores_gemma":[0.008236515,0.0007338668,0.0050010807,0.0006111162,0.016833253,0.000011964855,0.00037246477,0.00012958155,0.0016734278,0.0000103609555,0.9658871,0.00049921084],"about_ca_topic_score_codex":0.010535804,"about_ca_topic_score_gemma":0.0012194123,"teacher_disagreement_score":0.06646,"about_ca_system_score_codex":0.0007636216,"about_ca_system_score_gemma":0.0014284332,"threshold_uncertainty_score":0.9992629},"labels":[],"label_agreement":null},{"id":"W4406573929","doi":"10.1111/apt.18500","title":"Network Meta‐Analysis: Comparison of Endoscopic Dysplasia Detection Technologies in Inflammatory Bowel Disease","year":2025,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Alberta; University of Ottawa","funders":"","keywords":"Medicine; Dysplasia; Chromoendoscopy; Inflammatory bowel disease; Internal medicine; Colonoscopy; Gastroenterology; Ulcerative colitis; Randomized controlled trial; Colorectal cancer; Disease; Cancer","score_opus":0.04501953635661763,"score_gpt":0.36169325151099285,"score_spread":0.3166737151543752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406573929","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013785305,0.9960301,0.000084009545,0.00006084583,0.0006008163,0.0014641815,0.00028178096,0.000070776,0.00002896615],"genre_scores_gemma":[0.013146493,0.9840916,0.000121719946,0.000544534,0.00014589717,0.0006097082,0.0012124589,0.00005683635,0.00007077578],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9961678,0.0009385597,0.0012081467,0.00093281205,0.00021145883,0.0005412429],"domain_scores_gemma":[0.99772763,0.00014536423,0.00073218887,0.0012339178,0.00006868363,0.00009223394],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040952422,0.00069388305,0.0020191907,0.00054042065,0.00010348904,0.00001775021,0.0012360971,0.00062114204,0.000060866256],"category_scores_gemma":[0.0000018479755,0.00065474305,0.0010710802,0.0006238219,0.00030640303,0.000012614065,0.0007576601,0.0005246795,0.000007996823],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006206012,0.000756795,0.009359237,0.011267833,0.9434523,0.00019200864,0.000036190064,0.0024347343,0.00056528114,0.000019624598,0.0004470861,0.030848335],"study_design_scores_gemma":[0.000586939,0.00008849361,0.00030102985,0.00025014157,0.8631921,0.00000146681,0.000048205908,0.00023489077,0.00077513256,0.00003880846,0.13397817,0.0005046402],"about_ca_topic_score_codex":0.0000067808637,"about_ca_topic_score_gemma":0.00011334354,"teacher_disagreement_score":0.1335311,"about_ca_system_score_codex":0.00008824615,"about_ca_system_score_gemma":0.0005747757,"threshold_uncertainty_score":0.9995904},"labels":[],"label_agreement":null},{"id":"W4406815848","doi":"10.1111/apt.18496","title":"The Impact of Postoperative Prophylactic Medication on Long‐Term Surgical, Severe Endoscopic and Endoscopic or Radiologic Recurrence Following Primary Ileocecal Resection in Patients With Crohn's Disease","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Crohn's disease; Surgery; Hazard ratio; Retrospective cohort study; Proportional hazards model; Confounding; Cohort; Disease; Internal medicine; Confidence interval","score_opus":0.010105873039879351,"score_gpt":0.30856194480199634,"score_spread":0.29845607176211697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406815848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974063,0.001008374,0.0000062133386,0.00024178221,0.0002729026,0.0009733936,0.00003094347,0.000007745392,0.000052326952],"genre_scores_gemma":[0.9981907,0.00054045615,0.000017850392,0.00087896385,0.000033255,0.0001072499,0.00016732064,0.00001226018,0.00005196172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985785,0.00044054457,0.0002510492,0.00034120725,0.00013773175,0.00025098462],"domain_scores_gemma":[0.99940723,0.00011356327,0.00012010558,0.00021866802,0.000059699807,0.000080728256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016511834,0.0002058505,0.00017173206,0.00007055845,0.00019196396,0.000015569985,0.00017432946,0.000087575034,0.000020575793],"category_scores_gemma":[0.0000031059208,0.0001265465,0.00006362458,0.00012062809,0.0002625754,0.000017365355,0.0000754543,0.0001782534,8.2192656e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017645184,0.0005132436,0.97143143,0.000049341405,0.0015687078,0.00015923489,0.00007223331,0.00008958491,0.006915976,0.0000055067476,0.000052238796,0.0014972945],"study_design_scores_gemma":[0.0047541982,0.0014320232,0.98941755,0.000050284245,0.0005375154,0.0000017741668,0.000017483228,0.00003190399,0.0035862022,0.00001385088,0.000042289463,0.00011490816],"about_ca_topic_score_codex":0.0000101176465,"about_ca_topic_score_gemma":0.000018410105,"teacher_disagreement_score":0.017986113,"about_ca_system_score_codex":0.00012899862,"about_ca_system_score_gemma":0.0003371073,"threshold_uncertainty_score":0.51604164},"labels":[],"label_agreement":null},{"id":"W4407558684","doi":"10.1111/apt.70025","title":"Letter: Clinical Trial: Treatment of Functional Dyspepsia According to Subtype Compared With Empirical Proton Pump Inhibitor: Authors' Reply","year":2025,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Proton-pump inhibitor; Internal medicine; Clinical trial; Gastroenterology; Empirical treatment; Biochemistry; Chemistry","score_opus":0.16823071098132825,"score_gpt":0.4248693887312367,"score_spread":0.25663867774990845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407558684","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30484048,0.00017535345,0.00011358938,0.6862937,0.002683218,0.005515905,0.00008052137,0.00012026364,0.00017697086],"genre_scores_gemma":[0.031040257,0.000109535664,0.0010437589,0.9602234,0.004769149,0.000610853,0.0009958418,0.000083084524,0.0011241509],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956806,0.00072482025,0.0013325397,0.0010304542,0.00056840415,0.0006631819],"domain_scores_gemma":[0.99768704,0.00078116416,0.00047220162,0.0005998867,0.000237057,0.00022264563],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040596284,0.0006840467,0.0015162157,0.00035592265,0.00013360023,0.000021501419,0.00024870547,0.0005389157,0.0003970817],"category_scores_gemma":[0.0000033322435,0.00055012514,0.0004721036,0.0003694341,0.00042005,0.00006253958,0.0001000782,0.0015206706,0.000038348626],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16770291,0.0047999993,0.09074715,0.00034060283,0.016838368,0.000627009,0.00021459746,0.000040512103,0.0012953366,7.199844e-7,0.7165414,0.00085140584],"study_design_scores_gemma":[0.05813749,0.0284993,0.0024620106,0.00023552125,0.020998849,0.00013592222,0.000109378576,0.00008425069,0.0031901984,0.000019235802,0.88572013,0.00040773881],"about_ca_topic_score_codex":0.00008664574,"about_ca_topic_score_gemma":0.00000982579,"teacher_disagreement_score":0.2739297,"about_ca_system_score_codex":0.00042925787,"about_ca_system_score_gemma":0.0007522568,"threshold_uncertainty_score":0.999695},"labels":[],"label_agreement":null},{"id":"W4407676836","doi":"10.1111/apt.70048","title":"Letter: Lubiprostone—A Novel Therapeutic Avenue for Gastrointestinal Complications in <scp>MASLD</scp>. Authors' Reply","year":2025,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Lubiprostone; Medicine; Gastroenterology; Internal medicine; Constipation","score_opus":0.04994515309479444,"score_gpt":0.3491100140670978,"score_spread":0.2991648609723033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407676836","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019434372,0.0018163152,0.0014058962,0.96530324,0.0028846555,0.0065286923,0.0015924536,0.00029068653,0.00074370945],"genre_scores_gemma":[0.015384999,0.000104458384,0.005279604,0.9649844,0.0022581962,0.001340773,0.004111757,0.00016604667,0.006369724],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960997,0.00016375602,0.0009081503,0.0011319349,0.00041761127,0.0012788253],"domain_scores_gemma":[0.99737304,0.001081144,0.00042895996,0.0007441556,0.00020465767,0.0001680166],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00028457906,0.00087100326,0.0010400054,0.0005603023,0.00026450318,0.00004243666,0.00052503083,0.00051320303,0.00008041924],"category_scores_gemma":[0.0000030453577,0.0008530881,0.00044905496,0.00037255016,0.00033952636,0.000090767346,0.0001105741,0.002424488,0.000069394686],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023860851,0.002060247,0.031578656,0.0005126857,0.012155866,0.001667824,0.0003533866,0.000020087591,0.02263847,0.000026447628,0.92787164,0.00087607314],"study_design_scores_gemma":[0.009734445,0.0015431859,0.01455823,0.00031249312,0.018583724,0.0007073759,0.000038956157,0.00039263177,0.0051847696,0.00023236962,0.9484909,0.0002208735],"about_ca_topic_score_codex":0.00003664455,"about_ca_topic_score_gemma":0.0000041312937,"teacher_disagreement_score":0.020619296,"about_ca_system_score_codex":0.00062165165,"about_ca_system_score_gemma":0.00041801922,"threshold_uncertainty_score":0.999877},"labels":[],"label_agreement":null},{"id":"W4407696899","doi":"10.1111/apt.70024","title":"Comparison Between Dynamic Models for Predicting Response to Corticosteroids in Alcohol‐Associated Hepatitis: A Global Cohort Study","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; London Health Sciences Centre; Western University","funders":"Fondo Nacional de Desarrollo Científico y Tecnológico","keywords":"Medicine; Cohort; Corticosteroid; Cohort study; Internal medicine; Alcoholic hepatitis; Hepatitis; Neutrophil to lymphocyte ratio; Lymphocyte; Bilirubin; Immunology","score_opus":0.04756264544594332,"score_gpt":0.4196206402011086,"score_spread":0.3720579947551653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407696899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889134,0.00071012584,0.0001773213,0.003411158,0.00042791027,0.005782952,0.00043064976,0.000085305706,0.00006115976],"genre_scores_gemma":[0.9873519,0.00009502887,0.00016156225,0.011108921,0.0000326077,0.00087493175,0.00029874773,0.000020467975,0.000055820674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978057,0.00040089453,0.0005983825,0.0005012408,0.00023287545,0.00046090636],"domain_scores_gemma":[0.99891406,0.00047444063,0.00011413618,0.00022768762,0.00010369421,0.00016598395],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004696757,0.00027540533,0.000651714,0.00016564305,0.00012685759,0.00001990257,0.00015579112,0.00010215459,0.000036055455],"category_scores_gemma":[0.000001773352,0.0002751488,0.00011867222,0.00038758363,0.000048072845,0.000078107856,0.000085889034,0.00015894751,0.0000066866824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041607292,0.0043935333,0.96899027,0.000018444614,0.019210683,0.000058372294,0.000550299,0.0005213599,0.00062422967,0.0000022082882,0.00016497383,0.0013048813],"study_design_scores_gemma":[0.011929862,0.0023030723,0.94493324,0.00007810935,0.023500908,0.0000012453066,0.00041347736,0.01584884,0.00067246245,0.00009623294,0.000054512642,0.00016804125],"about_ca_topic_score_codex":0.0005430634,"about_ca_topic_score_gemma":0.00042870254,"teacher_disagreement_score":0.02405705,"about_ca_system_score_codex":0.0011384062,"about_ca_system_score_gemma":0.00019144258,"threshold_uncertainty_score":0.9999701},"labels":[],"label_agreement":null},{"id":"W4407945377","doi":"10.1111/apt.70057","title":"Editorial: Surveillance Colonoscopy for Detection of Neoplasia in Inflammatory Bowel Disease—Is Dye‐Based Chromoendoscopy Always the Final Answer? Authors' Reply","year":2025,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Chromoendoscopy; Medicine; Inflammatory bowel disease; Colonoscopy; Gastroenterology; Inflammatory Bowel Diseases; Internal medicine; General surgery; Colorectal cancer; Disease; Cancer","score_opus":0.010114274670957463,"score_gpt":0.30103794940690276,"score_spread":0.29092367473594527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407945377","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0721433,0.0018249684,0.00017424727,0.0009552711,0.9194429,0.0024417054,0.0029537845,0.00004854728,0.000015270893],"genre_scores_gemma":[0.03358909,0.0014913196,0.000151623,0.00781393,0.95106924,0.0015712241,0.0037611355,0.00018605948,0.00036638917],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958718,0.00080782187,0.0009819114,0.0010363958,0.0005798246,0.0007222792],"domain_scores_gemma":[0.99707204,0.0006479828,0.0007041466,0.0008867476,0.0005054179,0.00018367266],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009832755,0.0007216834,0.0005558598,0.00021026004,0.00026692578,0.00004320145,0.00095749256,0.0010288642,0.000043118904],"category_scores_gemma":[0.000023399565,0.0007039237,0.00042208625,0.00018082376,0.00046281898,0.000016362806,0.00020744963,0.0008304141,0.000004890822],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016663788,0.0003116447,0.0028976111,0.00046923183,0.0028292558,0.00002892721,0.000064903856,0.0002749988,0.1140096,0.0000017603539,0.8623762,0.00007206971],"study_design_scores_gemma":[0.0050855465,0.0006958335,0.0015042764,0.00007896931,0.0027607095,5.483044e-7,0.000026470125,0.00058975274,0.1092179,0.000042776872,0.8794291,0.0005681289],"about_ca_topic_score_codex":0.00005522162,"about_ca_topic_score_gemma":0.00014229213,"teacher_disagreement_score":0.038554214,"about_ca_system_score_codex":0.00027240254,"about_ca_system_score_gemma":0.002492595,"threshold_uncertainty_score":0.99954116},"labels":[],"label_agreement":null},{"id":"W4408418475","doi":"10.1111/apt.70076","title":"Editorial: Upadacitinib—A Promising Induction Agent for Paediatric Crohn's Disease?","year":2025,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Crohn disease; Crohn's disease; MEDLINE; Intensive care medicine; Disease; Internal medicine","score_opus":0.012801103936274401,"score_gpt":0.3099830048250564,"score_spread":0.297181900888782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408418475","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008225288,0.0027844177,0.00012886309,0.0003946282,0.98375785,0.0022306216,0.002342862,0.00007984244,0.000055625907],"genre_scores_gemma":[0.0005796507,0.0027398318,0.00020838654,0.0033586214,0.97974896,0.0009208915,0.010713539,0.00015076136,0.0015793288],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965625,0.00037993438,0.000647878,0.0011122351,0.0005499905,0.00074747787],"domain_scores_gemma":[0.99802005,0.00021463932,0.00043294663,0.0005774855,0.0005131775,0.00024169433],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00048349414,0.0007199412,0.00044374165,0.0001973221,0.00036938055,0.00007318867,0.0006552747,0.0013272291,0.00007387897],"category_scores_gemma":[0.000011136068,0.00079686556,0.00045723937,0.00013555231,0.00019789317,0.000015886138,0.0003025591,0.0006754541,0.000015872041],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003991307,0.00031648777,0.00008533228,0.00033206126,0.006156935,0.00005587358,0.000028130054,0.00005572285,0.019728769,0.0000023547266,0.96871114,0.000535895],"study_design_scores_gemma":[0.003214555,0.00020879431,0.000188446,0.000037516504,0.013679243,6.5476337e-7,0.00002370426,0.000033438206,0.005534356,0.00008391049,0.9762867,0.00070868025],"about_ca_topic_score_codex":0.000009813616,"about_ca_topic_score_gemma":0.0000068415543,"teacher_disagreement_score":0.014194413,"about_ca_system_score_codex":0.0002566664,"about_ca_system_score_gemma":0.0018530798,"threshold_uncertainty_score":0.99996924},"labels":[],"label_agreement":null},{"id":"W4408580650","doi":"10.1111/apt.70081","title":"The Impact of Setons on Perianal Fistula Outcomes in Patients With Crohn's Disease Treated With Anti‐<scp>TNF</scp> Therapy: A Multicentre Study","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of British Columbia Hospital; McGill University Health Centre; McGill University; Ottawa Hospital; University of Ottawa","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Propensity score matching; Fistula; Internal medicine; Crohn's disease; Surgery; Concomitant; Gastroenterology; Disease","score_opus":0.008047224777989422,"score_gpt":0.29315269245757386,"score_spread":0.28510546767958445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408580650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975147,0.00021995157,0.0000018555348,0.00013163315,0.00009353512,0.001775088,0.0001902385,0.000015799227,0.000057166533],"genre_scores_gemma":[0.9976721,0.000102292935,0.000009509855,0.0016878642,0.000023176786,0.00012259792,0.00016368616,0.000036357545,0.00018242831],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982603,0.00040163758,0.00030162293,0.0004141299,0.00019962378,0.00042263774],"domain_scores_gemma":[0.99903435,0.000111673304,0.00015691551,0.00045501313,0.00012243769,0.000119625525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012241212,0.00036904062,0.0002782029,0.00009943508,0.00019886228,0.00002393022,0.00033866157,0.000072252435,0.000019834659],"category_scores_gemma":[0.0000014096119,0.0002162898,0.00012995463,0.00018107898,0.00026028353,0.00001007492,0.00007794909,0.0001634725,0.00000233495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007146324,0.004171163,0.97242296,0.0000072131957,0.010617264,0.00013190407,0.00024381683,0.00083249935,0.004058089,0.000002171584,0.00017242559,0.0001941919],"study_design_scores_gemma":[0.01177562,0.0015517258,0.980916,0.000012418748,0.0015382675,3.1482577e-7,0.0004005813,0.00008935236,0.0034216784,0.0000034427446,0.00016782623,0.0001227385],"about_ca_topic_score_codex":0.00006695837,"about_ca_topic_score_gemma":0.00007912708,"teacher_disagreement_score":0.009078996,"about_ca_system_score_codex":0.00008339719,"about_ca_system_score_gemma":0.00025251496,"threshold_uncertainty_score":0.8820042},"labels":[],"label_agreement":null},{"id":"W4408677215","doi":"10.1111/apt.70095","title":"<scp>Letter</scp>: <scp>Predictors of Corticosteroid Response in Alcohol</scp>‐<scp>Related Hepatitis</scp>—Authors' Reply","year":2025,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Immunology; Corticosteroid; Alcohol; Internal medicine; Biochemistry; Biology","score_opus":0.02355464289666823,"score_gpt":0.3037121649947198,"score_spread":0.28015752209805156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408677215","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86919075,0.010944953,0.0000037808709,0.10666314,0.0062522246,0.0036462657,0.0018078865,0.00028082688,0.0012101497],"genre_scores_gemma":[0.10199107,0.009510728,0.0001386672,0.872128,0.0018338664,0.00067753147,0.0052707396,0.00029156602,0.008157847],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9900931,0.0023862103,0.0023906806,0.0019268736,0.0012703883,0.0019327577],"domain_scores_gemma":[0.98671657,0.0096818395,0.0012822747,0.001437951,0.00035176147,0.0005295807],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0009218868,0.0016531595,0.0024322767,0.0014326782,0.00024322236,0.000073202515,0.0009297161,0.0018045093,0.0002728544],"category_scores_gemma":[0.00005975744,0.0016219973,0.0009669311,0.0010735062,0.0007496744,0.00026111223,0.00041238838,0.0036210332,0.00018937408],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023624375,0.0020912006,0.23829319,0.00042129814,0.034097016,0.0073034824,0.0018511562,0.00003626579,0.005425382,0.0000020883729,0.71009046,0.00015219676],"study_design_scores_gemma":[0.013596142,0.0028309166,0.14879766,0.0008218755,0.051374257,0.00016856648,0.00045208703,0.00018371463,0.032927807,0.00009620222,0.74852175,0.0002290096],"about_ca_topic_score_codex":0.0005244306,"about_ca_topic_score_gemma":0.000019583804,"teacher_disagreement_score":0.7671997,"about_ca_system_score_codex":0.0010269872,"about_ca_system_score_gemma":0.0009117764,"threshold_uncertainty_score":0.99962157},"labels":[],"label_agreement":null},{"id":"W4409148907","doi":"10.1111/apt.70120","title":"Longitudinal Relationship Between Elevated Liver Biochemical Tests and Negative Clinical Outcomes in Primary Biliary Cholangitis: A Population‐Based Study","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"Intercept Pharmaceuticals","keywords":"Medicine; Internal medicine; Hazard ratio; Gastroenterology; Liver transplantation; Proportional hazards model; Alkaline phosphatase; Liver function tests; Population; Bilirubin; Clinical endpoint; Primary biliary cirrhosis; Alanine transaminase; Confidence interval; Transplantation; Clinical trial","score_opus":0.09479233927317886,"score_gpt":0.418933294399615,"score_spread":0.32414095512643615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409148907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956865,0.00073474395,0.00000707585,0.0020383683,0.00019844399,0.0011947481,0.00004689241,0.000057215075,0.000036035886],"genre_scores_gemma":[0.98853236,0.00006885771,0.00026478883,0.010650933,0.00006679645,0.000048801456,0.00027089252,0.000016405851,0.00008015139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981353,0.0005351613,0.0005547722,0.00037015454,0.00015909261,0.00024550923],"domain_scores_gemma":[0.99775934,0.001736117,0.000101783226,0.00022903124,0.000062358304,0.000111344576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036956277,0.00021390367,0.0004720748,0.00022947123,0.00012559214,0.000013346549,0.00012059355,0.00014402848,0.000084221036],"category_scores_gemma":[0.0000075006074,0.00019218952,0.00010470891,0.00036190572,0.00014800225,0.00011816575,0.00012019104,0.000567417,0.0000074597756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000668899,0.0023917546,0.9923189,0.000039671777,0.0034737901,0.00004672295,0.0001204428,0.0000013491344,0.00053504325,0.0000036407384,0.000104214894,0.00029553793],"study_design_scores_gemma":[0.008044692,0.000547307,0.98210496,0.000041656596,0.008410572,0.000002272086,0.0001327692,0.000091037546,0.0003514034,0.00010367708,0.000018034225,0.00015161096],"about_ca_topic_score_codex":0.00034496584,"about_ca_topic_score_gemma":0.000013751487,"teacher_disagreement_score":0.010213966,"about_ca_system_score_codex":0.00019932062,"about_ca_system_score_gemma":0.00015797997,"threshold_uncertainty_score":0.7837261},"labels":[],"label_agreement":null},{"id":"W4409175552","doi":"10.1111/apt.70132","title":"Letter: Lubiprostone Treatment for <scp>MASLD</scp>—Gender Imbalance and Blinding Considerations. Authors' Reply","year":2025,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Lubiprostone; Blinding; Medicine; Food science; Internal medicine; Clinical trial; Chemistry","score_opus":0.0764472983053039,"score_gpt":0.3626413704806529,"score_spread":0.28619407217534903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409175552","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.070204034,0.011253419,0.000106873864,0.90254295,0.008526687,0.0056720525,0.0007344692,0.00023824206,0.0007212934],"genre_scores_gemma":[0.014020298,0.0021124415,0.0035872809,0.9665399,0.0045186784,0.0011961614,0.0010444801,0.00013769665,0.0068430575],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99666154,0.00023154578,0.0007208095,0.00112617,0.00035384027,0.0009061063],"domain_scores_gemma":[0.99696827,0.001822463,0.00033576073,0.00052846293,0.00019500624,0.00015003986],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025804873,0.0008119822,0.0010294856,0.0003514209,0.00038149153,0.000060274728,0.00017810245,0.00086930714,0.00028317163],"category_scores_gemma":[0.0000043002965,0.00076183234,0.00028711677,0.00017734506,0.00041215596,0.000065508706,0.0000945183,0.0012572658,0.000014578087],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001829191,0.00020937448,0.0030522274,0.000323093,0.015510226,0.00026806176,0.0009100606,0.000009088782,0.029583978,0.0000065513354,0.9495242,0.00042020186],"study_design_scores_gemma":[0.005158673,0.001334515,0.00033822702,0.00007060567,0.021544363,0.000207876,0.000064575455,0.00015605219,0.085894756,0.0002579713,0.8847098,0.00026258876],"about_ca_topic_score_codex":0.000046350488,"about_ca_topic_score_gemma":0.000006389743,"teacher_disagreement_score":0.064814426,"about_ca_system_score_codex":0.00083358586,"about_ca_system_score_gemma":0.00057320937,"threshold_uncertainty_score":0.9994833},"labels":[],"label_agreement":null},{"id":"W4409182920","doi":"10.1111/apt.70109","title":"Clinical Trial: Dose‐Finding Study of Linaprazan Glurate, A Novel Potassium‐Competitive Acid Blocker, Versus Lansoprazole for the Treatment of Erosive Oesophagitis","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Lansoprazole; Medicine; Proton-pump inhibitor; Internal medicine; Dosing; Gastroenterology; Randomized controlled trial; Omeprazole","score_opus":0.13076475827712342,"score_gpt":0.45647648728026985,"score_spread":0.32571172900314643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409182920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892468,0.001727183,0.000050725634,0.0008731512,0.0025716678,0.00515474,0.0002106822,0.000031328385,0.00013371694],"genre_scores_gemma":[0.9956631,0.0011984536,0.0005886549,0.0013148447,0.00023662938,0.000554657,0.00009674194,0.00003233181,0.00031458307],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99786276,0.00020526492,0.00088034564,0.00043955722,0.00022877472,0.0003832923],"domain_scores_gemma":[0.99748385,0.0014590381,0.00039784,0.0003683623,0.00019546061,0.00009542263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026948572,0.0003467599,0.00085150544,0.00014615427,0.00018003129,0.000008797132,0.00022032815,0.00013784098,0.00008389643],"category_scores_gemma":[0.0000020457558,0.00023656583,0.00036674482,0.00026259996,0.00028889338,0.00004899041,0.000060274648,0.00019165645,0.0000040587342],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3377576,0.11025095,0.21920392,0.00014064716,0.22613285,0.00032919287,0.005458143,0.000051592066,0.0763607,0.00029993182,0.0003024649,0.023712013],"study_design_scores_gemma":[0.5611126,0.09033772,0.060822234,0.000050386545,0.077588044,0.00001135247,0.0031489958,0.00023554474,0.20376615,0.000027860697,0.0027120474,0.00018708303],"about_ca_topic_score_codex":0.000058307443,"about_ca_topic_score_gemma":0.000024947296,"teacher_disagreement_score":0.22335498,"about_ca_system_score_codex":0.00018941406,"about_ca_system_score_gemma":0.00019983212,"threshold_uncertainty_score":0.96468747},"labels":[],"label_agreement":null},{"id":"W4409818223","doi":"10.1111/apt.70153","title":"Letter: Re‐Examining Seton Efficacy in Perianal Crohn's Disease—Critical Considerations for Outcome Measurement and Clinical Interpretation. Authors' Reply","year":2025,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Anorectal Disease Treatments and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University Health Centre; Ottawa Hospital; University of British Columbia Hospital; University of Ottawa","funders":"","keywords":"Medicine; Interpretation (philosophy); Outcome (game theory); Crohn's disease; Dermatology; Disease; Medical physics; Surgery; Intensive care medicine; Internal medicine; Computer science","score_opus":0.1633479898128966,"score_gpt":0.44080306257459245,"score_spread":0.27745507276169584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409818223","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02105946,0.002288993,0.0001655848,0.97033554,0.0028225349,0.0026369398,0.0004681225,0.00010038521,0.00012241205],"genre_scores_gemma":[0.13179813,0.000277508,0.0010066819,0.8638889,0.0014799933,0.0002883019,0.00066705304,0.000063452564,0.0005299762],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962567,0.00059938995,0.0012288574,0.0009119822,0.00041673356,0.0005863451],"domain_scores_gemma":[0.9965222,0.0024758994,0.00019164906,0.00035782045,0.00019283612,0.00025960183],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056251045,0.0005572745,0.0010086994,0.00029362095,0.0002339639,0.00006412726,0.00013322351,0.000425395,0.00049325346],"category_scores_gemma":[0.000039373193,0.0005003234,0.000378321,0.00010285511,0.00045444528,0.00009910757,0.00010287127,0.0012776318,0.000008826693],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035174973,0.0019444939,0.124238044,0.0008117612,0.02251367,0.0046847626,0.0004950721,0.000006808155,0.00017751034,0.000046167876,0.8394858,0.0020783856],"study_design_scores_gemma":[0.02157692,0.0018683136,0.37240726,0.0008843296,0.119943604,0.000066655,0.00018029938,0.0020914066,0.00016558975,0.00067416433,0.47875902,0.0013824548],"about_ca_topic_score_codex":0.00002627928,"about_ca_topic_score_gemma":0.000015086238,"teacher_disagreement_score":0.3607268,"about_ca_system_score_codex":0.0004330553,"about_ca_system_score_gemma":0.0004761823,"threshold_uncertainty_score":0.99974483},"labels":[],"label_agreement":null},{"id":"W4409858961","doi":"10.1111/apt.70170","title":"Editorial: Seton Use in Perianal Fistulising Crohn's Disease. Authors' Reply","year":2025,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Anorectal Disease Treatments and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University Health Centre; University of British Columbia Hospital; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Crohn's disease; Crohn disease; Dermatology; MEDLINE; General surgery; Disease; Internal medicine","score_opus":0.022518316778471083,"score_gpt":0.3531456690333535,"score_spread":0.3306273522548824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409858961","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010107939,0.0028298828,0.0000029944365,0.0030857057,0.9809965,0.0013226118,0.0013186259,0.00016414908,0.00017160909],"genre_scores_gemma":[0.0015240995,0.0032717204,0.00012347325,0.017945563,0.96396405,0.00017061915,0.005391516,0.0001331604,0.007475825],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99600756,0.0004010169,0.00080532534,0.0010576204,0.0009228201,0.0008056708],"domain_scores_gemma":[0.99745655,0.0009691542,0.00028093098,0.0005821803,0.00023474023,0.00047641885],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002788868,0.00083220965,0.0011310953,0.0004257331,0.00021793037,0.000095363066,0.00034181654,0.00081626436,0.0007009335],"category_scores_gemma":[0.000010428403,0.00075663155,0.00047364848,0.00033817792,0.00025130424,0.00022877699,0.00021775089,0.0015244999,0.000039801525],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005722121,0.0010876864,0.0116507225,0.00022072933,0.010642992,0.0016358144,0.00017900008,0.000007006799,0.00025395764,0.0000033348379,0.9683,0.0002966626],"study_design_scores_gemma":[0.0059293844,0.0002474192,0.010277277,0.0002907375,0.03336324,0.000002285321,0.000057735284,0.000051796236,0.00012063243,0.000044490946,0.9490809,0.00053414016],"about_ca_topic_score_codex":0.0006395793,"about_ca_topic_score_gemma":0.000054531803,"teacher_disagreement_score":0.022720251,"about_ca_system_score_codex":0.0010655917,"about_ca_system_score_gemma":0.0015881956,"threshold_uncertainty_score":0.9994885},"labels":[],"label_agreement":null},{"id":"W4410137337","doi":"10.1111/apt.70181","title":"The Effectiveness of Medical Therapies for Joint, Skin and Eye Extraintestinal Manifestations in IBD—An Umbrella Review","year":2025,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Ustekinumab; Vedolizumab; Psoriatic arthritis; Dermatology; Psoriasis; Inflammatory bowel disease; Adalimumab; Tofacitinib; Surgery; Internal medicine; Disease; Rheumatoid arthritis","score_opus":0.0882969606328234,"score_gpt":0.4568709974585391,"score_spread":0.3685740368257157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410137337","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027065913,0.9935404,0.000013214748,0.0015165627,0.00042597234,0.003998255,0.00012795415,0.000016892409,0.00009006602],"genre_scores_gemma":[0.00009929641,0.9954139,0.00016280866,0.0026046217,0.00008188571,0.0012595446,0.00025757306,0.000037679212,0.00008270596],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972487,0.0010322025,0.00073203037,0.00039604676,0.00025896635,0.00033202767],"domain_scores_gemma":[0.9962715,0.0030707011,0.00023954493,0.0002376048,0.00008978787,0.00009088536],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014287161,0.00039510135,0.0014717705,0.00012217685,0.00018410925,0.000008443177,0.00021516172,0.0001837965,0.00008309512],"category_scores_gemma":[0.0000060984066,0.00025792464,0.00029840137,0.00020048958,0.00038758622,0.000030098401,0.00009844785,0.00036302142,0.0000018963472],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003580946,0.0008588392,0.00043012816,0.0749573,0.015614664,0.00017754147,0.000112205795,6.126931e-8,0.00002192966,0.00030977756,0.00022718408,0.9069323],"study_design_scores_gemma":[0.007974712,0.001992298,0.0012329131,0.13206759,0.07576048,0.00062736246,0.00019898171,0.00001866371,0.000061037856,0.00034122015,0.7792703,0.0004544655],"about_ca_topic_score_codex":0.000049489387,"about_ca_topic_score_gemma":0.000050465147,"teacher_disagreement_score":0.9064778,"about_ca_system_score_codex":0.00011724032,"about_ca_system_score_gemma":0.00041653417,"threshold_uncertainty_score":0.9999873},"labels":[],"label_agreement":null},{"id":"W4410820620","doi":"10.1111/apt.70189","title":"Functional Dyspepsia and Its Subgroups: Prevalence and Impact in the Rome IV Global Epidemiology Study","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Cyclic vomiting syndrome; Quality of life (healthcare); Epidemiology; Anxiety; Distress; Nausea; Vomiting; Depression (economics); Migraine; Population; Internal medicine; Psychiatry; Environmental health; Clinical psychology","score_opus":0.06276461201338668,"score_gpt":0.3970931187072454,"score_spread":0.3343285066938587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410820620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772303,0.007175711,0.000019920944,0.014293198,0.00019277753,0.0009167934,0.000016829557,0.00002090879,0.000133545],"genre_scores_gemma":[0.9681013,0.00053237623,0.0000558178,0.031162694,0.00004020537,0.000042397463,0.0000124904345,0.0000049993655,0.000047720805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998358,0.0006051236,0.0002961923,0.0003322616,0.00009626046,0.0003121282],"domain_scores_gemma":[0.9990587,0.00065159437,0.000056565586,0.0001298112,0.000034386543,0.000068901616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000765416,0.00018592068,0.00029653078,0.000070562935,0.00010387575,0.0000068597205,0.00010805497,0.00006315528,0.00016933569],"category_scores_gemma":[0.000004713482,0.00013185902,0.000045256114,0.00022238118,0.00021571887,0.00007124216,0.00007782979,0.00029913653,0.0000051007737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016096318,0.0009369474,0.99365413,0.000051835133,0.0014279068,0.000034170713,0.00030000915,0.00001833799,0.0011358208,0.00013043646,0.00023421718,0.00046652518],"study_design_scores_gemma":[0.0036031683,0.0022232742,0.9884199,0.00002186714,0.0030357426,0.00022575624,0.0008544766,0.0006205616,0.000029063107,0.0007991033,0.000093292736,0.00007381573],"about_ca_topic_score_codex":0.0001080475,"about_ca_topic_score_gemma":0.00006381487,"teacher_disagreement_score":0.016869497,"about_ca_system_score_codex":0.000089935755,"about_ca_system_score_gemma":0.000072388444,"threshold_uncertainty_score":0.5377055},"labels":[],"label_agreement":null},{"id":"W4410924331","doi":"10.1111/apt.70183","title":"Underdiagnosis of Alpha‐1 Antitrypsin Deficiency in Cirrhotic Liver Transplant Candidates: Findings From a Multicenter Retrospective Study","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Alpha 1-antitrypsin deficiency; Multicenter study; Liver transplantation; Retrospective cohort study; Gastroenterology; Alpha (finance); Internal medicine; Intensive care medicine; Transplantation; Surgery; Randomized controlled trial; Patient satisfaction","score_opus":0.01262278330861907,"score_gpt":0.2878660941596159,"score_spread":0.27524331085099685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410924331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99496776,0.0030927723,0.00017468176,0.00022034232,0.0005040319,0.0007957856,0.00013091379,0.00001078575,0.00010291583],"genre_scores_gemma":[0.99455583,0.0011013907,0.00011986238,0.0039426866,0.00004464286,0.00007314127,0.00009799972,0.000017203973,0.000047215846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986004,0.00019690799,0.0003390372,0.00044769087,0.000121156154,0.00029480678],"domain_scores_gemma":[0.99959296,0.000033933487,0.0000759558,0.00021360109,0.00004314411,0.000040400042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015585822,0.00021483656,0.00026442265,0.00012464705,0.00007043598,0.000008883758,0.00026019753,0.00013483987,0.00013133224],"category_scores_gemma":[4.2409692e-7,0.00021475033,0.000086820575,0.00018509866,0.000098353594,0.000010285898,0.00009490102,0.00016819462,0.0000059163717],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045306855,0.0013886824,0.2598982,0.00001212775,0.0015938047,0.000026876589,0.000579363,0.000008028023,0.7357396,0.000012254922,0.0002294845,0.000058549896],"study_design_scores_gemma":[0.0037582468,0.0008263793,0.040770434,0.000039530703,0.0019541145,0.0000015663516,0.00044599373,0.0002658319,0.9514286,0.00011898739,0.00018935946,0.00020096866],"about_ca_topic_score_codex":0.0005547144,"about_ca_topic_score_gemma":0.00034630037,"teacher_disagreement_score":0.21912774,"about_ca_system_score_codex":0.00007578302,"about_ca_system_score_gemma":0.00007874993,"threshold_uncertainty_score":0.8757264},"labels":[],"label_agreement":null},{"id":"W4411452318","doi":"10.1111/apt.70187","title":"Systematic Review: Variability in Definitions of Fibrostenosis in Eosinophilic Oesophagitis","year":2025,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Eosinophilic esophagitis; MEDLINE; Eosinophilic; Endoscopy; Internal medicine; Gastroenterology; Pathology; Radiology; Disease","score_opus":0.05572019628442505,"score_gpt":0.383886275645094,"score_spread":0.32816607936066894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411452318","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005442976,0.9877105,0.0000020920916,0.0012840988,0.00057759025,0.009277897,0.00051913835,0.000057167315,0.0005170967],"genre_scores_gemma":[0.00024607612,0.981913,0.00020157828,0.014731065,0.00007292675,0.0019806926,0.00067963474,0.00008633052,0.00008873868],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9915527,0.0029445272,0.003504592,0.0009115406,0.00041830912,0.0006683166],"domain_scores_gemma":[0.994324,0.0033601471,0.00093895075,0.001079691,0.00015247261,0.00014473381],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017613693,0.0008607164,0.006723304,0.001067684,0.00005220975,0.00000869799,0.00059911027,0.00061695924,0.0005110051],"category_scores_gemma":[0.000021356096,0.0007856208,0.00088219123,0.0019420779,0.0003499873,0.00010456171,0.00024659123,0.001241689,0.000049218597],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000315708,0.0013944177,0.00023021367,0.9849879,0.0075891824,0.00029163866,0.00009699302,4.0482823e-7,0.000032243366,0.00007839541,0.00026393635,0.0050030793],"study_design_scores_gemma":[0.0020477616,0.00035864837,0.00007267487,0.8353254,0.15494488,0.00033054323,0.000021204458,0.000008005277,0.00013176362,0.00033271842,0.00585728,0.0005690822],"about_ca_topic_score_codex":0.00008792377,"about_ca_topic_score_gemma":0.00001766374,"teacher_disagreement_score":0.1496625,"about_ca_system_score_codex":0.0009986951,"about_ca_system_score_gemma":0.001037003,"threshold_uncertainty_score":0.99945945},"labels":[],"label_agreement":null},{"id":"W4411702401","doi":"10.1111/apt.70250","title":"Expert Position Statement: Defining the Role of Intestinal Ultrasound in Assessing Constipation and Faecal Loading","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; South Health Campus; University of Calgary; London Health Sciences Centre","funders":"National Health and Medical Research Council; University of Queensland; Samsung; University of Adelaide; Gastroenterological Society of Australia; Celltrion; Mater Foundation; Gilead Sciences; Sanofi; Mylan; GlaxoSmithKline; Hospital Research Foundation; Tillotts Pharma; Amgen; Dr. Falk Pharma; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Constipation; Ultrasound; Echogenicity; Internal medicine; Radiology","score_opus":0.018628686472521194,"score_gpt":0.34711238367762054,"score_spread":0.32848369720509935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411702401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917841,0.0030497266,0.0005871947,0.0034387326,0.00011551584,0.00028438776,0.0000037367674,0.000017552155,0.0007190554],"genre_scores_gemma":[0.99063313,0.00018550489,0.0014224276,0.0076844264,0.00001367506,0.000015968502,0.000032675063,0.0000060321754,0.0000061473756],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991544,0.0001394287,0.00029070376,0.00015633837,0.0000878783,0.0001712749],"domain_scores_gemma":[0.9992197,0.0005545241,0.00008241668,0.00006946771,0.000044874192,0.000029003986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025245213,0.000107196225,0.00015541827,0.0001019451,0.00009356726,0.000013745149,0.000052560892,0.000035519002,0.00005596769],"category_scores_gemma":[0.0000030373603,0.000090343165,0.00002744682,0.00015160543,0.0002494609,0.000099832134,0.000032175307,0.00020198253,9.96175e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051416236,0.00032134092,0.48866025,0.00003393937,0.00054885435,0.000008229092,0.0009783944,0.000040894505,0.500957,0.0005006301,0.00002741304,0.0074088797],"study_design_scores_gemma":[0.010067419,0.0015759288,0.40985143,0.0009133685,0.0060955095,0.00046961152,0.025531936,0.01310721,0.52488583,0.0057808645,0.0013836146,0.00033729448],"about_ca_topic_score_codex":0.00013253672,"about_ca_topic_score_gemma":0.000018101622,"teacher_disagreement_score":0.078808814,"about_ca_system_score_codex":0.000082338534,"about_ca_system_score_gemma":0.00008348151,"threshold_uncertainty_score":0.36840874},"labels":[],"label_agreement":null},{"id":"W4411965250","doi":"10.1111/apt.70247","title":"Pain and Sedative Medication Use Among Individuals With Inflammatory Bowel Disease: A Nationwide Population‐Based Cohort Study","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"School for Public Health Research; National Institute for Health and Care Research; Imperial College Healthcare NHS Trust; University College London; Imperial College London; Department of Health and Social Care; London School of Hygiene and Tropical Medicine","keywords":"Medicine; Sedative; Fibromyalgia; Medical prescription; Inflammatory bowel disease; Depression (economics); Population; Discontinuation; Chronic pain; Irritable bowel syndrome; Internal medicine; Mood disorders; Pregabalin; Anxiety; Psychiatry; Disease","score_opus":0.009104662822267644,"score_gpt":0.2844027455799575,"score_spread":0.27529808275768985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411965250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968608,0.00020566926,0.0003725351,0.0005623927,0.00015902285,0.0017107573,0.00006703382,0.000040583735,0.000021203216],"genre_scores_gemma":[0.9861703,0.00005299279,0.00017623822,0.0120125,0.00007065572,0.0004378365,0.00090188603,0.000028038732,0.00014953865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979714,0.00077779015,0.00030380185,0.0004715514,0.00023996823,0.000235444],"domain_scores_gemma":[0.99916476,0.000106980515,0.00016669503,0.00030711942,0.00011418741,0.00014026689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006414364,0.0002482626,0.00014669361,0.00014336854,0.00022433192,0.000038409173,0.00018188522,0.00009806852,0.00005159794],"category_scores_gemma":[0.00000391663,0.00023848655,0.00004060902,0.00010872459,0.00020942219,0.000031885662,0.00009285717,0.00012973788,0.0000019962174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005413832,0.00034278078,0.99098134,0.000026812682,0.004060104,0.000030426687,0.000097490025,0.00034936244,0.0031402435,0.000013764936,0.00031469515,0.000101581885],"study_design_scores_gemma":[0.0023098006,0.0001636664,0.9908009,0.000017540471,0.0032856234,5.33297e-7,0.00014036862,0.0009664906,0.0012282669,0.000030108746,0.00082217075,0.00023453741],"about_ca_topic_score_codex":0.000035258567,"about_ca_topic_score_gemma":0.00012535392,"teacher_disagreement_score":0.011450107,"about_ca_system_score_codex":0.000058036327,"about_ca_system_score_gemma":0.00022067038,"threshold_uncertainty_score":0.97251993},"labels":[],"label_agreement":null},{"id":"W4412487185","doi":"10.1111/apt.70264","title":"Clinical Trial: Association Between Early Disease Clearance and Long‐Term Outcomes—4‐Year Results From the Phase 3 <scp>UNIFI</scp> Study of Ustekinumab in Ulcerative Colitis","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Johnson and Johnson","keywords":"Ustekinumab; Medicine; Maintenance therapy; Placebo; Internal medicine; Gastroenterology; Ulcerative colitis; Inflammatory bowel disease; Randomization; Randomized controlled trial; Surgery; Disease; Chemotherapy; Infliximab; Pathology","score_opus":0.04368964154569343,"score_gpt":0.388983153546386,"score_spread":0.3452935120006926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412487185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99605036,0.00020722894,0.000008148505,0.00055142725,0.00059946865,0.0017727662,0.0007534921,0.0000130255485,0.00004408916],"genre_scores_gemma":[0.9951108,0.00033509923,0.000014713035,0.0036496355,0.00025348077,0.00008600522,0.0002753938,0.00002143315,0.00025341727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966332,0.0015614496,0.0008104202,0.00050810515,0.00019031526,0.00029655607],"domain_scores_gemma":[0.9982153,0.00081398746,0.0003787749,0.00038351453,0.000097297474,0.0001111038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008790554,0.00023372003,0.00036476867,0.000053606676,0.00011960603,0.00002682117,0.00032373937,0.00018092954,0.000009401099],"category_scores_gemma":[0.000022623426,0.00020611651,0.00011974308,0.00011623185,0.00017614216,0.000015789508,0.00018703088,0.0002907317,0.0000038932926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028251592,0.0017156996,0.9611811,0.0000080490545,0.006168109,0.00004647554,0.00070681144,0.000009745078,0.0008445342,0.0000041566577,0.00042827227,0.0006354454],"study_design_scores_gemma":[0.08439986,0.0008363299,0.90970653,0.000012986892,0.003197003,8.2141064e-8,0.00034623436,0.000019734915,0.0009027116,0.000042404117,0.0004504295,0.00008569354],"about_ca_topic_score_codex":0.00008692974,"about_ca_topic_score_gemma":0.00026203098,"teacher_disagreement_score":0.056148265,"about_ca_system_score_codex":0.00007497684,"about_ca_system_score_gemma":0.00016652637,"threshold_uncertainty_score":0.8405188},"labels":[],"label_agreement":null},{"id":"W4412638950","doi":"10.1111/apt.70297","title":"Bradycardia and Other Arrhythmias in Patients With Hepatorenal Syndrome‐Acute Kidney Injury Following Terlipressin Treatment: A Pooled Analysis of Three North American Phase <scp>III</scp> Clinical Studies","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Mallinckrodt Pharmaceuticals","keywords":"Terlipressin; Medicine; Bradycardia; Hepatorenal syndrome; Placebo; Anesthesia; Internal medicine; Acute kidney injury; Adverse effect; Cirrhosis; Heart rate; Blood pressure; Pathology","score_opus":0.02691369401906443,"score_gpt":0.3729745917855129,"score_spread":0.3460608977664485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412638950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99753994,0.0007976682,0.000022446955,0.00020422075,0.00019407204,0.0006891601,0.00050676794,0.000026592252,0.000019114445],"genre_scores_gemma":[0.9899916,0.0008388509,0.00011294987,0.008565152,0.00002885225,0.000056963363,0.0003672178,0.000019990064,0.00001842877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984302,0.00020926607,0.00050843495,0.00039149128,0.00019035676,0.00027026268],"domain_scores_gemma":[0.9991642,0.00024874133,0.00019456909,0.00018673087,0.00005423499,0.00015152193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011571552,0.00026877635,0.000949398,0.00043806137,0.00006757826,0.0000074622903,0.000070423586,0.0000524146,0.000007482709],"category_scores_gemma":[3.0325256e-7,0.00020633129,0.00023609163,0.0007970012,0.00031806034,0.00009754701,0.00002689752,0.0001458011,0.000001007196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018893629,0.0011741047,0.7308042,0.00002517429,0.26318768,0.00018159131,0.0007583445,0.000003775903,0.00031974673,0.0000010010142,0.000017284612,0.0016377124],"study_design_scores_gemma":[0.015496612,0.0020461262,0.70553637,0.00005399353,0.27433193,0.0000026922319,0.00013421445,0.00020738629,0.0020490221,0.0000046080145,0.00006514635,0.000071932154],"about_ca_topic_score_codex":0.00017541017,"about_ca_topic_score_gemma":0.00010944929,"teacher_disagreement_score":0.025267879,"about_ca_system_score_codex":0.000096222044,"about_ca_system_score_gemma":0.00013849381,"threshold_uncertainty_score":0.8413946},"labels":[],"label_agreement":null},{"id":"W4412687296","doi":"10.1111/apt.70295","title":"Network Meta‐Analysis: Comparative Efficacy of Biologics and Small Molecules in the Induction and Maintenance of Remission in Crohn's Disease","year":2025,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Calgary; McGill University Health Centre","funders":"","keywords":"Medicine; Crohn's disease; Disease; Meta-analysis; Crohn disease; Maintenance therapy; MEDLINE; Internal medicine; Gastroenterology; Chemotherapy","score_opus":0.10338185777660835,"score_gpt":0.37940187422081945,"score_spread":0.2760200164442111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412687296","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.050247595,0.94848245,0.000020115822,0.000090803645,0.000072777555,0.0009608413,0.000103419414,0.0000027821143,0.000019210947],"genre_scores_gemma":[0.029459741,0.96884143,0.00015679665,0.0010606173,0.000042049825,0.00011740366,0.0002966879,0.000011137489,0.000014152033],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9974031,0.0013111298,0.00057768275,0.00041640864,0.00007360916,0.0002180574],"domain_scores_gemma":[0.99904805,0.0002044857,0.00038797138,0.00026703358,0.000042411808,0.000050047518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000460852,0.00031969004,0.0011321582,0.00016881876,0.00003944469,0.0000056697163,0.0002663963,0.00021068765,0.000010336816],"category_scores_gemma":[0.0000015620035,0.00021892082,0.00033679133,0.0003706465,0.0003287517,0.0000039086744,0.00016550129,0.00023315873,1.3567706e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00804944,0.0036149914,0.014225527,0.020571638,0.87620676,0.0009368738,0.0017099171,0.005950718,0.0044131936,0.00050936564,0.00063739414,0.06317417],"study_design_scores_gemma":[0.00241117,0.00026835443,0.037432287,0.0008043312,0.9168462,0.000011000372,0.00030653275,0.00020013767,0.00041548713,0.0002714277,0.04025932,0.0007737277],"about_ca_topic_score_codex":0.000014839589,"about_ca_topic_score_gemma":0.000035079513,"teacher_disagreement_score":0.062400445,"about_ca_system_score_codex":0.000018232571,"about_ca_system_score_gemma":0.0001514518,"threshold_uncertainty_score":0.8927332},"labels":[],"label_agreement":null},{"id":"W4413108968","doi":"10.1111/apt.70327","title":"Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Toronto Liver Centre; University of Toronto","funders":"Gilead Sciences","keywords":"Tenofovir alafenamide; Tenofovir; Medicine; Hepatitis B; Internal medicine; Emtricitabine; Chronic hepatitis; Virology; Human immunodeficiency virus (HIV); Pharmacology; Lamivudine; Viral load; Virus; Antiretroviral therapy","score_opus":0.011533508807962407,"score_gpt":0.294771667927084,"score_spread":0.2832381591191216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413108968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931426,0.0035255386,0.000010530043,0.0015104394,0.00017299563,0.0013197403,0.00011228908,0.000015925527,0.00018994536],"genre_scores_gemma":[0.99414575,0.004248222,0.0002857252,0.00049242895,0.000011928026,0.00005121156,0.00019414588,0.000025331003,0.00054525124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823624,0.0001754349,0.0007000305,0.00037107067,0.00018895089,0.00032824877],"domain_scores_gemma":[0.9993021,0.000136603,0.00023004126,0.00019420333,0.00004527607,0.000091797905],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017073572,0.00029845198,0.00077506626,0.00023575418,0.00005833952,0.0000035648573,0.000096595024,0.00012518697,0.000048472295],"category_scores_gemma":[0.0000010307282,0.00026834733,0.000120780045,0.00029687068,0.00026431362,0.00007657846,0.000097198215,0.00014003864,0.0000013458675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020326462,0.002500337,0.7994163,0.00016509106,0.011883024,0.00003805003,0.0027277514,0.000010212126,0.14071456,0.00001514727,0.00014032338,0.040356558],"study_design_scores_gemma":[0.05474421,0.003846077,0.77172625,0.00048658563,0.01306167,0.000005564977,0.00040322245,0.0004235072,0.15193294,0.00005524739,0.0028849058,0.0004298054],"about_ca_topic_score_codex":0.00041627808,"about_ca_topic_score_gemma":0.00017971307,"teacher_disagreement_score":0.05271156,"about_ca_system_score_codex":0.00052620686,"about_ca_system_score_gemma":0.0002758815,"threshold_uncertainty_score":0.9999769},"labels":[],"label_agreement":null},{"id":"W4413138644","doi":"10.1111/apt.70338","title":"Editorial: Intestinal Ultrasound for the Assessment of Constipation—Out of the Shadows? Authors' Reply","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; South Health Campus; University of Calgary","funders":"","keywords":"Medicine; Constipation; Ultrasound; General surgery; Gastroenterology; Radiology","score_opus":0.031786616262632454,"score_gpt":0.3799668082037449,"score_spread":0.34818019194111244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413138644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64882237,0.001895871,0.022698196,0.13355216,0.18040676,0.008895081,0.00031226588,0.00014864358,0.0032686533],"genre_scores_gemma":[0.9796842,0.00007594371,0.0023566424,0.015641661,0.0018653012,0.00009825203,0.00002405291,0.000012709671,0.00024126195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987724,0.00015784556,0.0004532357,0.0001962626,0.00022028449,0.00019997016],"domain_scores_gemma":[0.9971893,0.0019408112,0.00023442309,0.00029842733,0.00030017443,0.00003690986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000533808,0.00014820509,0.00026079238,0.000051979136,0.00015199385,0.0000059949393,0.00026986518,0.00006043652,0.00012006353],"category_scores_gemma":[0.000016649738,0.000093873365,0.00017127446,0.00018036837,0.0006517619,0.00003544586,0.0000689704,0.0003022175,7.182196e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024615026,0.0019689398,0.46430862,0.00037242597,0.0096016,0.0000013361308,0.0009183863,0.00031931401,0.4176419,0.0019327275,0.098977745,0.0014954896],"study_design_scores_gemma":[0.02155177,0.005538158,0.35488772,0.000726038,0.06806303,0.000089455934,0.0052646445,0.006237458,0.2327815,0.0074207583,0.2969246,0.00051485735],"about_ca_topic_score_codex":0.000059431415,"about_ca_topic_score_gemma":0.000017151175,"teacher_disagreement_score":0.3308618,"about_ca_system_score_codex":0.00007009829,"about_ca_system_score_gemma":0.00040090928,"threshold_uncertainty_score":0.38280445},"labels":[],"label_agreement":null},{"id":"W4413356799","doi":"10.1111/apt.70325","title":"<scp>Editorial: PSC</scp> as an Independent Risk Factor for <scp>CRC</scp> Without <scp>IBD</scp> : Can Observed Epidemiological Trends Help Uncover Biological Mechanisms and Guide Surveillance Strategies?","year":2025,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Queen's University; University Health Network","funders":"","keywords":"Medicine; Epidemiology; Risk factor; Bioinformatics; Computational biology; Internal medicine; Biology","score_opus":0.04996894752268923,"score_gpt":0.3588862917596399,"score_spread":0.30891734423695066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413356799","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4054036,0.0050275377,0.0002046429,0.00033958085,0.57194215,0.0027127792,0.013532289,0.00048002924,0.00035738264],"genre_scores_gemma":[0.083393894,0.03357298,0.0018017234,0.014039307,0.8393204,0.0012447999,0.018687781,0.00049255503,0.0074465363],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9880236,0.0035450382,0.0020697499,0.0025982638,0.0014210144,0.0023423692],"domain_scores_gemma":[0.9777344,0.017125327,0.0016046542,0.0012757276,0.0010008779,0.0012590346],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0027015072,0.002166119,0.003430971,0.00048514112,0.00087146147,0.00024021901,0.0015552429,0.0041340766,0.00018723588],"category_scores_gemma":[0.000515881,0.0017629258,0.0010043007,0.0005865054,0.0009303977,0.0004197237,0.0008607674,0.0040717693,0.000024145935],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007549392,0.0022171983,0.029946728,0.000369379,0.023508357,0.00014618397,0.0008966357,0.000045857178,0.014604535,0.000109652996,0.9264591,0.00094146124],"study_design_scores_gemma":[0.013944499,0.009121741,0.023711888,0.00011986766,0.016954752,0.0000289367,0.0030472935,0.00026450906,0.004084935,0.0022841967,0.92604715,0.00039025952],"about_ca_topic_score_codex":0.0016141852,"about_ca_topic_score_gemma":0.0003221093,"teacher_disagreement_score":0.3220097,"about_ca_system_score_codex":0.0009580986,"about_ca_system_score_gemma":0.0023057621,"threshold_uncertainty_score":0.99910796},"labels":[],"label_agreement":null},{"id":"W4413775104","doi":"10.1111/apt.70290","title":"Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Inflammatory bowel disease; Statement (logic); Pregnancy; Inflammatory Bowel Diseases; Crohn disease; MEDLINE; Intensive care medicine; Disease management; Consensus conference; Disease; Internal medicine","score_opus":0.029200623685359948,"score_gpt":0.36260420010016303,"score_spread":0.33340357641480306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413775104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9385754,0.009219498,0.0000413933,0.044054788,0.000978373,0.0020083338,0.00007265211,0.000044090495,0.005005482],"genre_scores_gemma":[0.9653204,0.0034297702,0.00008182496,0.03041124,0.000019431442,0.0001584424,0.000020197018,0.000007830882,0.0005508527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987972,0.00014902129,0.00039724653,0.00020442194,0.0002005584,0.00025160325],"domain_scores_gemma":[0.9993748,0.000099923855,0.000108447624,0.00029411848,0.000030655105,0.000092044844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020647218,0.00015057922,0.00016204492,0.00007598852,0.000052095715,0.0000033474425,0.00015990947,0.00004124837,0.00024020301],"category_scores_gemma":[3.2032264e-7,0.00011055485,0.00006432942,0.00018431497,0.00020260797,0.00002035844,0.00006457916,0.00013719748,0.000011350868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013477114,0.009901194,0.7737028,0.0034114823,0.064591825,0.0019362239,0.001706433,0.0007136339,0.016312663,0.041198924,0.02207458,0.050973143],"study_design_scores_gemma":[0.023100685,0.00085424614,0.8681138,0.007479977,0.02279104,0.00001028929,0.0016846189,0.0011965354,0.03944692,0.00420622,0.030637048,0.00047862146],"about_ca_topic_score_codex":0.000007767028,"about_ca_topic_score_gemma":0.0000019334516,"teacher_disagreement_score":0.09441102,"about_ca_system_score_codex":0.00022730583,"about_ca_system_score_gemma":0.00019385426,"threshold_uncertainty_score":0.4508296},"labels":[],"label_agreement":null},{"id":"W4414032672","doi":"10.1111/apt.70342","title":"Editorial: The Devil Is in the Detail—Interpreting the Findings of Network Meta‐Analyses. Authors' Reply","year":2025,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Epistemology; Cognitive science; Psychology; Philosophy","score_opus":0.03361278433150953,"score_gpt":0.36820096194434326,"score_spread":0.3345881776128337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414032672","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004476754,0.011093914,0.000024623889,0.0056250743,0.9769046,0.0012554924,0.00031850973,0.000019028936,0.0002820171],"genre_scores_gemma":[0.009155228,0.0033078059,0.000051300012,0.04405588,0.94186527,0.0003598661,0.00055685564,0.00008512872,0.0005626536],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944749,0.0024449523,0.00095477735,0.00071678625,0.0007362398,0.0006723271],"domain_scores_gemma":[0.99639744,0.0015314468,0.00058772764,0.00114084,0.00028364715,0.000058922244],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032933806,0.0006345582,0.0006533136,0.00007705821,0.00038155663,0.0000681841,0.0024072693,0.0008122806,0.00016442419],"category_scores_gemma":[0.000019645966,0.00034908674,0.00076950423,0.00032368704,0.00054735626,0.000009776307,0.0005796731,0.0015467841,0.000008993264],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006730312,0.00009343288,0.000249907,0.00004951966,0.036295496,0.000017333654,0.00043426425,0.00021585917,0.00473934,0.000007276651,0.957185,0.00003955235],"study_design_scores_gemma":[0.0007302018,0.000118750555,0.000067351844,0.000032055974,0.049638867,0.0000019870477,0.00019263737,0.000061007857,0.0066333255,0.00010782741,0.9421073,0.00030869344],"about_ca_topic_score_codex":0.00013696123,"about_ca_topic_score_gemma":0.00010984712,"teacher_disagreement_score":0.038430806,"about_ca_system_score_codex":0.00007648824,"about_ca_system_score_gemma":0.0007021709,"threshold_uncertainty_score":0.9998961},"labels":[],"label_agreement":null},{"id":"W4414081254","doi":"10.1111/apt.70360","title":"Prediction of Hepatocellular Carcinoma and Other Liver‐Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction‐Associated Steatotic Liver Disease","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"Stichting voor Lever- en Maag-Darm Onderzoek; Gilead Sciences","keywords":"Hepatocellular carcinoma; Cirrhosis; Incidence (geometry); Chronic hepatitis; Liver dysfunction; Risk factor; Chronic liver disease; Metabolic syndrome","score_opus":0.02039867330445939,"score_gpt":0.255730190843956,"score_spread":0.2353315175394966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414081254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977651,0.019369328,0.000012657037,0.00023022215,0.00044839105,0.0019140703,0.000297773,0.000054097643,0.00002243678],"genre_scores_gemma":[0.99000335,0.0064705103,0.000017373231,0.002521501,0.000041891715,0.0002525571,0.00043981042,0.000040270257,0.00021273177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980991,0.00033092735,0.000467156,0.0004621371,0.0002977668,0.00034294615],"domain_scores_gemma":[0.99914736,0.00010487425,0.00020439454,0.00022582077,0.00014173568,0.00017584853],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012648084,0.0003382409,0.0005372305,0.0003281167,0.00011723725,0.000006677544,0.00007983969,0.00012589397,0.00055497244],"category_scores_gemma":[0.0000010098668,0.0002648423,0.000111832655,0.00049932196,0.0001453777,0.00016591355,0.000057235644,0.00020010049,0.000009675332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024426277,0.0032752072,0.9782501,0.00012938995,0.013623433,0.00007625649,0.0002431763,0.000045887675,0.00064099615,0.000037371457,0.000051950108,0.0011836078],"study_design_scores_gemma":[0.016751194,0.0010034507,0.93805563,0.00015557185,0.03427033,0.0000032668456,0.000028984658,0.0057012937,0.0032914528,0.000022418597,0.0005495331,0.00016687965],"about_ca_topic_score_codex":0.0012557704,"about_ca_topic_score_gemma":0.0001533131,"teacher_disagreement_score":0.040194474,"about_ca_system_score_codex":0.00044613512,"about_ca_system_score_gemma":0.00033476567,"threshold_uncertainty_score":0.9999804},"labels":[],"label_agreement":null},{"id":"W4414305229","doi":"10.1111/apt.70377","title":"<scp>IL23</scp> Receptor Polymorphism Is a Predictor of Anti‐Tumour Necrosis Factor‐α‐Induced Paradoxical Psoriasis in Inflammatory Bowel Disease","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Academic Medical Organization of Southwestern Ontario","keywords":"Inflammatory bowel disease; Psoriasis; Ulcerative colitis; Crohn's disease; Necrosis; Disease; Inflammatory Bowel Diseases; Risk stratification; Receptor","score_opus":0.022700917845449923,"score_gpt":0.28127084809036224,"score_spread":0.2585699302449123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414305229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98311925,0.009454581,0.0000069939138,0.0016413266,0.003961252,0.00082246755,0.000751288,0.000109879715,0.00013297211],"genre_scores_gemma":[0.9897004,0.0023092614,0.00004732736,0.006050215,0.00011263705,0.0001838163,0.0002734046,0.000046760204,0.0012761749],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99685603,0.0007059335,0.0008328778,0.000691456,0.00011150099,0.00080220844],"domain_scores_gemma":[0.99848163,0.0006116289,0.00029382991,0.00042544096,0.00007551869,0.00011197293],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022387672,0.0005528943,0.000686133,0.00046445307,0.00021057557,0.000016505985,0.00056293583,0.00051729666,0.0009282488],"category_scores_gemma":[0.000003042929,0.0005314988,0.0003291056,0.0003957732,0.0003665293,0.00016915858,0.00019047513,0.00045328232,0.00017748552],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065800693,0.0011898632,0.2087427,0.00005087137,0.0088391295,0.000029028095,0.0011667563,0.0000039139136,0.77377224,0.00006184947,0.0039260066,0.0015596221],"study_design_scores_gemma":[0.007098765,0.00026743163,0.24217013,0.000061028684,0.005199704,0.0000050495005,0.0002652002,0.000019502499,0.7330478,0.00015350436,0.011500072,0.00021183332],"about_ca_topic_score_codex":0.000099943376,"about_ca_topic_score_gemma":0.000009127821,"teacher_disagreement_score":0.04072447,"about_ca_system_score_codex":0.00018530358,"about_ca_system_score_gemma":0.00031327602,"threshold_uncertainty_score":0.99998504},"labels":[],"label_agreement":null},{"id":"W4414373613","doi":"10.1111/apt.70383","title":"Meta‐Analysis: Mortality Trends and Risk Factors in Severe Alcohol‐Associated Hepatitis","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Saskatchewan","funders":"","keywords":"Hepatitis; Selection (genetic algorithm); MEDLINE; Mortality rate; Hepatitis a virus; Epidemiology","score_opus":0.16129909913338067,"score_gpt":0.4375749117504698,"score_spread":0.2762758126170891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414373613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98840547,0.006383925,0.000011207403,0.003949687,0.00029244734,0.0004023318,0.000111094116,0.000076047414,0.00036780618],"genre_scores_gemma":[0.9645401,0.008000718,0.000044897435,0.026468989,0.00002015692,0.00006338243,0.00018416943,0.000014058733,0.000663501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804986,0.000591218,0.00042738303,0.00038834737,0.00017086806,0.00037234224],"domain_scores_gemma":[0.99911976,0.0003357557,0.00015789486,0.00019923876,0.000049584058,0.00013779166],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048802223,0.0002559429,0.00089090795,0.0006039936,0.00015015152,0.000011137419,0.00008671516,0.00017811338,0.0014947613],"category_scores_gemma":[6.229493e-7,0.00022226671,0.00032460346,0.0009841995,0.00014221518,0.00007301312,0.000055222452,0.00045647105,0.000006449804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008966324,0.0002499531,0.64771277,0.00002055472,0.35085076,0.00001982981,0.00022938708,0.000019914629,0.00046571525,0.000010543556,0.00011361647,0.00021727728],"study_design_scores_gemma":[0.0018637816,0.00008803726,0.5688952,0.0000035741848,0.42711303,0.0000016069241,0.000036958816,0.00066931546,0.00079757214,0.00003409943,0.0003986872,0.000098084856],"about_ca_topic_score_codex":0.003262693,"about_ca_topic_score_gemma":0.0020675568,"teacher_disagreement_score":0.07881754,"about_ca_system_score_codex":0.00018214172,"about_ca_system_score_gemma":0.00008756267,"threshold_uncertainty_score":0.999418},"labels":[],"label_agreement":null},{"id":"W4414382923","doi":"10.1111/apt.70378","title":"Non‐Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta Hospital; University of Alberta; Institute of Infection and Immunity","funders":"Dr. Falk Pharma; National Institute for Health and Care Research; Intercept Pharmaceuticals","keywords":"Obeticholic acid; Discontinuation; Clinical trial; Primary biliary cirrhosis; Ursodeoxycholic acid; Biliary tract","score_opus":0.07602182644909838,"score_gpt":0.414160776554416,"score_spread":0.33813895010531764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414382923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924221,0.0008538481,0.000037811777,0.005205833,0.00038903742,0.0008752065,0.000058282443,0.00003105581,0.00012684571],"genre_scores_gemma":[0.9085366,0.00070915103,0.0004417341,0.08993787,0.000034210832,0.000044208376,0.000086914566,0.000022819147,0.00018646132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979453,0.0005474169,0.00060875114,0.0003317684,0.00020934887,0.00035743258],"domain_scores_gemma":[0.99890894,0.0003872553,0.00014427688,0.0002858138,0.00014402506,0.00012970708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073507003,0.00022186853,0.00054839614,0.00025925704,0.000075453274,0.000004485109,0.00023741239,0.00015872637,0.00016841527],"category_scores_gemma":[0.000003015775,0.00019299178,0.0001254227,0.00056803774,0.00014257996,0.00009085395,0.00016743112,0.00039826037,0.000014281503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010857977,0.0014851737,0.92729217,0.000050903644,0.008016707,0.000056496185,0.00037692394,0.0000046028863,0.04980537,0.0000011431093,0.00028039684,0.0017721407],"study_design_scores_gemma":[0.008790293,0.00090561784,0.92974436,0.00025886556,0.0041088196,0.0000056574404,0.0000727839,0.000057068704,0.055062443,0.000030329345,0.0007940884,0.00016964768],"about_ca_topic_score_codex":0.00010063427,"about_ca_topic_score_gemma":0.0000068254117,"teacher_disagreement_score":0.08473204,"about_ca_system_score_codex":0.00034828574,"about_ca_system_score_gemma":0.00059172895,"threshold_uncertainty_score":0.7869976},"labels":[],"label_agreement":null},{"id":"W4414420165","doi":"10.1111/apt.70385","title":"Systematic Review: Ultrasound Goes Echo—Decarbonising Inflammatory Bowel Disease Care Through Intestinal Ultrasound","year":2025,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Climate Change and Health Impacts","field":"Environmental Science","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Inflammatory bowel disease; Ultrasound; MEDLINE; Prospective cohort study; Crohn disease; Crohn's disease; Standard of care","score_opus":0.04914682573072579,"score_gpt":0.38440919322196254,"score_spread":0.3352623674912367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414420165","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008214103,0.99083185,0.000008608093,0.00038115715,0.001447131,0.005827782,0.00036989828,0.00016404285,0.00088740105],"genre_scores_gemma":[0.000037201004,0.96011645,0.00011970488,0.03732688,0.00028766258,0.0008599738,0.00084548903,0.00011542987,0.00029118868],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.994186,0.0012497504,0.0017859021,0.0010280308,0.0005958869,0.0011544233],"domain_scores_gemma":[0.9952309,0.0023094714,0.0010473925,0.00090485177,0.0000423124,0.0004650515],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005936767,0.0011563624,0.0025249966,0.00012711766,0.00053834845,0.000081876286,0.0011491282,0.00033676153,0.0022099933],"category_scores_gemma":[0.000014130262,0.00096426066,0.0006831643,0.000514556,0.00048378817,0.00033687014,0.00043101617,0.000979609,0.00063115393],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003175057,0.00022214044,0.0003252487,0.9856446,0.003143631,0.00020181178,0.0010092927,0.000007774748,0.00006113743,0.0000039758197,0.0060706064,0.0032780694],"study_design_scores_gemma":[0.00064361637,0.0001735654,0.00003268902,0.5561356,0.15006442,0.00030341346,0.00043476303,0.0000049336186,0.000047308386,0.00011754343,0.29054517,0.0014969711],"about_ca_topic_score_codex":0.00006792977,"about_ca_topic_score_gemma":0.000029811217,"teacher_disagreement_score":0.42950895,"about_ca_system_score_codex":0.0018450044,"about_ca_system_score_gemma":0.00035354076,"threshold_uncertainty_score":0.9992808},"labels":[],"label_agreement":null},{"id":"W4415099255","doi":"10.1111/apt.70403","title":"Meta‐Analysis: Utilisation of Hepatocellular Carcinoma Surveillance","year":2025,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital","funders":"National Medical Research Council","keywords":"Hepatocellular carcinoma; Health care; MEDLINE; Ultrasound; Carcinoma; Patient care","score_opus":0.23578646460547834,"score_gpt":0.37684904805760383,"score_spread":0.1410625834521255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415099255","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00130019,0.99475116,0.000030808555,0.00031907373,0.00040757534,0.0025088275,0.00035550448,0.000071757706,0.00025510433],"genre_scores_gemma":[0.02508478,0.96940005,0.00020811948,0.0014646425,0.0001239808,0.0005093685,0.002487232,0.00006494192,0.0006568625],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99617416,0.0010158822,0.0012191021,0.00074804114,0.00036953326,0.0004732573],"domain_scores_gemma":[0.9977394,0.00060598424,0.0006496628,0.00068669533,0.00016636973,0.00015188765],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00050196826,0.0008031446,0.0055136746,0.0009028615,0.000096064825,0.0000119051165,0.00033534077,0.00049785775,0.0015587066],"category_scores_gemma":[2.6252562e-7,0.00063672743,0.0046238597,0.0015624424,0.00019054044,0.000055903758,0.00011938246,0.00046867097,0.000033481883],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083297586,0.0005431179,0.040760484,0.008744136,0.93138516,0.000168482,0.00007501956,4.5728436e-7,0.000043181644,0.000009789709,0.00009791695,0.018088935],"study_design_scores_gemma":[0.00064283976,0.00022231018,0.000045641726,0.0001511584,0.7845162,0.000019587787,0.000011440142,0.00023437198,0.001107701,0.0000058468304,0.21274635,0.0002965085],"about_ca_topic_score_codex":0.00011000997,"about_ca_topic_score_gemma":0.0000052704854,"teacher_disagreement_score":0.21264844,"about_ca_system_score_codex":0.00019095448,"about_ca_system_score_gemma":0.0005957138,"threshold_uncertainty_score":0.9996084},"labels":[],"label_agreement":null},{"id":"W4415268272","doi":"10.1111/apt.70418","title":"Overall and Comparative Risk of Shingles With Advanced Therapies in Patients With Inflammatory Bowel Diseases","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Calgary; London Health Sciences Centre","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Shingles; Inflammatory Bowel Diseases; Inflammatory bowel disease; Ruxolitinib; MEDLINE; Risk assessment","score_opus":0.006913212178577727,"score_gpt":0.25547593789943046,"score_spread":0.24856272572085272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415268272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969672,0.0020993736,0.000014909381,0.00007869592,0.000077722914,0.000553159,0.0001257709,0.000011740302,0.00007145666],"genre_scores_gemma":[0.9970363,0.00053258863,0.00021102911,0.0019844368,0.00001651188,0.00005549991,0.00011879111,0.000015153709,0.000029681674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896204,0.0002027598,0.00021607506,0.00029756833,0.00010783781,0.00021370844],"domain_scores_gemma":[0.9994863,0.00004071631,0.00014985596,0.00018573321,0.00008337512,0.00005396784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000062906416,0.0002236531,0.00020144091,0.000079972095,0.000074577765,0.000008594952,0.00014328718,0.00006491321,0.000017067188],"category_scores_gemma":[2.5197892e-7,0.00017846652,0.00003304717,0.000062623934,0.00036063403,0.000018012788,0.000075430245,0.00011262501,6.610832e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007362685,0.00041546667,0.9727506,0.000040628944,0.0040731733,0.000010178383,0.00031410105,0.0005933979,0.014077906,0.00005730575,0.000057853827,0.00024672816],"study_design_scores_gemma":[0.006520581,0.0005718756,0.97238636,0.00003343663,0.001460168,3.8328758e-7,0.00022582174,0.000053764543,0.01785108,0.0000555494,0.0006314478,0.00020954903],"about_ca_topic_score_codex":0.0000074759673,"about_ca_topic_score_gemma":0.000056070894,"teacher_disagreement_score":0.003773176,"about_ca_system_score_codex":0.000025577576,"about_ca_system_score_gemma":0.00010104698,"threshold_uncertainty_score":0.7277654},"labels":[],"label_agreement":null},{"id":"W4415497331","doi":"10.1111/apt.70429","title":"High Risk of Colorectal Cancer After High‐Grade Dysplasia in Inflammatory Bowel Disease Patients","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Inflammatory bowel disease; Dysplasia; Colorectal cancer; Colonoscopy; Ulcerative colitis; Disease; Endoscopy","score_opus":0.0046259185881577175,"score_gpt":0.25956515514766954,"score_spread":0.25493923655951184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415497331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99591297,0.0012537874,0.0000070748038,0.0003064621,0.0012551338,0.0006829917,0.00054093474,0.000017839579,0.000022783675],"genre_scores_gemma":[0.99255425,0.001187892,0.00008272857,0.005308557,0.00011047274,0.0003684299,0.00026145656,0.000035522076,0.000090719885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818105,0.0003460635,0.00045768803,0.00044775716,0.00016470754,0.0004027261],"domain_scores_gemma":[0.9992732,0.00003305437,0.00018972949,0.00027280406,0.0000963181,0.00013490437],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013706213,0.00030335813,0.00021488681,0.00014541617,0.00007206746,0.00000954436,0.00030430415,0.00017501172,0.0002176838],"category_scores_gemma":[9.882182e-7,0.00031737483,0.00012564173,0.000116186406,0.00027451362,0.000013378955,0.00019689658,0.00021196045,0.000008868694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048419484,0.0006479301,0.9197293,0.00006957541,0.0030798214,0.00007255092,0.00006877137,0.000723271,0.07002953,0.000027673239,0.0005028352,0.00020678615],"study_design_scores_gemma":[0.004128151,0.000112584734,0.8937083,0.000024339322,0.002516223,2.5466187e-7,0.000019845802,0.00012403031,0.09797554,0.00012386907,0.001010531,0.0002563298],"about_ca_topic_score_codex":0.000118883734,"about_ca_topic_score_gemma":0.00016858013,"teacher_disagreement_score":0.027946016,"about_ca_system_score_codex":0.00010933588,"about_ca_system_score_gemma":0.00027770636,"threshold_uncertainty_score":0.9999278},"labels":[],"label_agreement":null},{"id":"W4415620362","doi":"10.1111/apt.70433","title":"Inherited Genetic Risk of Liver Fibrosis in Lean Versus Nonlean Metabolic Dysfunction–Associated Steatotic Liver Disease ( <scp>MASLD</scp> )","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"Overweight; Liver fibrosis; Fibrosis; Liver disease; Metabolic syndrome; Obesity; Fatty liver","score_opus":0.024146034112414488,"score_gpt":0.2944919407155134,"score_spread":0.2703459066030989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415620362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9716599,0.025447452,0.000009063147,0.0003714336,0.00081575604,0.0011958145,0.00025344425,0.00007746573,0.00016964656],"genre_scores_gemma":[0.97656184,0.017498521,0.00013993101,0.0048787743,0.00008854382,0.0001703019,0.00026414683,0.00004525246,0.00035269983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770653,0.0003951905,0.0005554367,0.00052423374,0.00030619293,0.0005123869],"domain_scores_gemma":[0.9982846,0.0007074238,0.00023743646,0.00035737996,0.00014340862,0.00026976192],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016533124,0.00039674377,0.0006144746,0.0003808983,0.00013693477,0.000013317404,0.0001888065,0.00014981533,0.00047918217],"category_scores_gemma":[0.0000050093954,0.0003756031,0.00030161862,0.00067877735,0.00022771244,0.00010002547,0.000119230965,0.0003200878,0.000049809438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020748961,0.0068145604,0.9409446,0.00015384542,0.037053354,0.00037310354,0.00081302004,0.00023456383,0.0056909756,0.000036782043,0.0017316953,0.0040785866],"study_design_scores_gemma":[0.014652693,0.0006623649,0.9037102,0.0001061465,0.06159477,0.0000018184932,0.00027975393,0.0029943094,0.013931,0.000045122815,0.0018873785,0.00013448257],"about_ca_topic_score_codex":0.00090234587,"about_ca_topic_score_gemma":0.00018109131,"teacher_disagreement_score":0.037234455,"about_ca_system_score_codex":0.0003518795,"about_ca_system_score_gemma":0.0002723051,"threshold_uncertainty_score":0.9998696},"labels":[],"label_agreement":null},{"id":"W4415848750","doi":"10.1111/apt.70446","title":"Meta‐Analysis: Improvement of Bowel Urgency With Advanced Therapies for Inflammatory Bowel Disease","year":2025,"lang":"en","type":"review","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University; London Health Sciences Centre; McMaster University; University Health Network; University of Toronto","funders":"","keywords":"Inflammatory bowel disease; Inflammatory Bowel Diseases; Ulcerative colitis; Crohn disease; Disease","score_opus":0.03403192709735031,"score_gpt":0.34042792436129427,"score_spread":0.30639599726394395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415848750","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011575654,0.9924988,0.0002490896,0.00011041507,0.00043455212,0.003883929,0.001592226,0.000036033376,0.000037356927],"genre_scores_gemma":[0.0004805666,0.9894068,0.00047196695,0.0030365195,0.000187199,0.003501342,0.0021093534,0.00011773125,0.00068847166],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9967082,0.00035989337,0.0010615004,0.0009886321,0.00027496772,0.00060679077],"domain_scores_gemma":[0.9975919,0.00012740104,0.00086712406,0.00093631353,0.00023754602,0.0002396795],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033685972,0.0009540113,0.0018722684,0.00035737202,0.00016333567,0.000017779505,0.00077399524,0.00032833178,0.00021915569],"category_scores_gemma":[6.2624036e-7,0.0007556428,0.0027154067,0.00027587631,0.00030625274,0.000014701235,0.00022876766,0.00023414171,0.0000037595253],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016101935,0.00053025904,0.00013068186,0.011257961,0.96851623,0.000049845614,0.000049154045,0.00021284801,0.001984771,0.00003267318,0.00022626566,0.015399089],"study_design_scores_gemma":[0.0010418734,0.00032530935,0.00004419726,0.00014114064,0.71235746,0.0000011441932,0.000030246047,0.000013058038,0.0014962634,0.000018997162,0.28394088,0.00058941037],"about_ca_topic_score_codex":0.0000029702603,"about_ca_topic_score_gemma":0.000011997854,"teacher_disagreement_score":0.28371462,"about_ca_system_score_codex":0.000071697665,"about_ca_system_score_gemma":0.0011091405,"threshold_uncertainty_score":0.9994895},"labels":[],"label_agreement":null},{"id":"W4415990911","doi":"10.1111/apt.70455","title":"Letter: Refining Mortality Estimates in Severe Alcohol–Associated Hepatitis—Addressing Heterogeneity and Prognostic Assessment. Authors' Reply","year":2025,"lang":"en","type":"letter","venue":"Alimentary Pharmacology & Therapeutics","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"MEDLINE; Mortality rate; Liver disease; Disease; Hepatitis; Corticosteroid","score_opus":0.16530085493614805,"score_gpt":0.4577627479649725,"score_spread":0.29246189302882447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415990911","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51115906,0.0021277387,0.000014475657,0.48279122,0.0017875265,0.0014597799,0.00017199389,0.00022709693,0.00026108546],"genre_scores_gemma":[0.079662226,0.0014898721,0.0007560713,0.91462904,0.0007910305,0.00027569922,0.0019852188,0.00009007459,0.00032077488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99535435,0.0011018362,0.000997086,0.0010454379,0.0004998929,0.0010013627],"domain_scores_gemma":[0.99762046,0.0010980488,0.0005343785,0.0004377091,0.00012933745,0.00018005734],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0009621963,0.00071369443,0.0012437698,0.00043527636,0.00034244958,0.000070080794,0.00022772556,0.0010188275,0.00023094036],"category_scores_gemma":[0.0000064236183,0.0007384993,0.00017200047,0.00032010072,0.00033539106,0.00014632547,0.00021926472,0.0037173561,0.000012122588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012214818,0.00029559238,0.80062723,0.0011105618,0.008023281,0.0018174837,0.000128682,0.0000054651505,0.0023898378,0.0000016777849,0.1846709,0.00080714276],"study_design_scores_gemma":[0.009017524,0.0007342817,0.7612489,0.0021757504,0.030961685,0.00028258484,0.00001777777,0.0028065727,0.0015265871,0.00008040787,0.1899667,0.00118125],"about_ca_topic_score_codex":0.00066356274,"about_ca_topic_score_gemma":0.00016900859,"teacher_disagreement_score":0.43183783,"about_ca_system_score_codex":0.00079551985,"about_ca_system_score_gemma":0.00056133076,"threshold_uncertainty_score":0.9995066},"labels":[],"label_agreement":null},{"id":"W4416134576","doi":"10.1111/apt.70439","title":"A Population‐Based Matched Cohort Study of Extra‐Digestive Cancer Incidence and Mortality in Individuals With and Without Inflammatory Bowel Disease","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children’s Health Research Institute; SickKids Foundation; Research Manitoba; Queen's University; Mount Sinai Hospital; Institute for Work & Health; University of Calgary; University of Ottawa; Institute for Clinical Evaluative Sciences; Western University; University of Toronto; Ottawa Public Health; Ottawa Hospital; University Health Network; University of Manitoba; Manitoba Health","funders":"Ministry of Long-Term Care; Canadian Institutes of Health Research; University of Toronto; University of Manitoba; Ministry of Health; Crohn's and Colitis Canada; Hospital for Sick Children; University of Ottawa","keywords":"Inflammatory bowel disease; Incidence (geometry); Colorectal cancer; Cohort study; Ulcerative colitis; Cancer; Inflammatory Bowel Diseases; Cancer incidence; Cohort","score_opus":0.013159128004395742,"score_gpt":0.32250280159429257,"score_spread":0.30934367358989684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416134576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99739516,0.0009705431,0.00001258309,0.00013638541,0.0000815492,0.0013189288,0.00006233639,0.000011625292,0.000010897557],"genre_scores_gemma":[0.9968585,0.00021069871,0.00007065312,0.0024232662,0.000023607066,0.00031338484,0.00006125637,0.000017822469,0.000020819709],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863183,0.0002766725,0.00031138345,0.00041933288,0.00015408288,0.00020670793],"domain_scores_gemma":[0.9994333,0.00002670249,0.0001468734,0.00022886193,0.00006361674,0.00010064165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002511156,0.0002185611,0.00022705209,0.00010562021,0.00007603563,0.000011164233,0.00013131808,0.000078142235,0.000019460242],"category_scores_gemma":[7.834998e-7,0.00020914372,0.00002284982,0.00009421845,0.00021166081,0.000015822716,0.00011328968,0.000115590105,1.8857126e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009690341,0.000408249,0.9813932,0.00007149749,0.0024770969,0.000028279743,0.00022910762,0.000722645,0.013635117,0.0000048984425,0.0000073523875,0.000053492782],"study_design_scores_gemma":[0.003373796,0.00014020668,0.98888385,0.000035826793,0.002918231,8.749017e-7,0.00021222708,0.00045647967,0.0037393486,0.000030547126,0.0000147274795,0.00019390167],"about_ca_topic_score_codex":0.0002881541,"about_ca_topic_score_gemma":0.0006539533,"teacher_disagreement_score":0.009895768,"about_ca_system_score_codex":0.000043500113,"about_ca_system_score_gemma":0.00022841114,"threshold_uncertainty_score":0.8528634},"labels":[],"label_agreement":null},{"id":"W4416145492","doi":"10.1111/apt.70459","title":"Letter: From Descriptive Epidemiology to Clinical Imperative—Challenging the Paradigm of Pain and Sedative Use in Inflammatory Bowel Disease. Authors' Reply","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Sedative; Chronic pain; Anxiety; Depression (economics); Inflammatory bowel disease; Medical prescription; Adverse effect; Comorbidity; Fibromyalgia","score_opus":0.04404759933984602,"score_gpt":0.35118196262655316,"score_spread":0.3071343632867071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416145492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831904,0.0022707996,0.000938565,0.0119294785,0.0006783718,0.0008286451,0.000134686,0.000015405501,0.000013634318],"genre_scores_gemma":[0.86846435,0.00083796907,0.00034320727,0.12979206,0.00024263335,0.00013497741,0.000104459854,0.00002415554,0.000056169836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994526,0.0035680123,0.0007846219,0.00063594175,0.000083932995,0.00040146383],"domain_scores_gemma":[0.9980535,0.0010665335,0.00019976069,0.0004411396,0.00006190445,0.0001771561],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018807517,0.0002914202,0.00034116316,0.00010151903,0.00013194248,0.000013254602,0.00033268315,0.00017452502,0.00002729563],"category_scores_gemma":[0.000034781646,0.00024982725,0.00013364885,0.00009007607,0.0005633254,0.000019428098,0.00030468902,0.00034041036,0.000003411608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033079458,0.00026423202,0.94173545,0.00003027817,0.0045075105,0.00009787548,0.0009930222,0.00056111824,0.04192496,0.00041253207,0.0052797324,0.0008853768],"study_design_scores_gemma":[0.002356564,0.00032231628,0.95963323,0.00006492815,0.0015144139,0.0000013288796,0.0005541526,0.0020797388,0.008108529,0.001081304,0.02390343,0.0003800442],"about_ca_topic_score_codex":0.00007668071,"about_ca_topic_score_gemma":0.000093173076,"teacher_disagreement_score":0.11786259,"about_ca_system_score_codex":0.000057420602,"about_ca_system_score_gemma":0.0001724662,"threshold_uncertainty_score":0.9999954},"labels":[],"label_agreement":null},{"id":"W4416227806","doi":"10.1111/apt.70449","title":"Review Article: Extending the Frontiers of Intestinal Ultrasound Knowledge, Performance and Expansion","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Mylan; Celltrion; Sanofi; Pfizer; Samsung; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Ultrasound; MEDLINE; Ultrasonography; Clinical Practice","score_opus":0.024699583076087637,"score_gpt":0.3411573818564672,"score_spread":0.31645779878037955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416227806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8585675,0.133946,0.000043656433,0.006205298,0.00038651557,0.00050415983,0.0000025368533,0.000023474611,0.00032090035],"genre_scores_gemma":[0.8905788,0.09306998,0.0010990201,0.0150161395,0.00004118094,0.000048200072,0.000007885881,0.000009808751,0.00012896299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991829,0.00007592669,0.00027327117,0.00018754817,0.00007883261,0.0002015407],"domain_scores_gemma":[0.9992845,0.00035961266,0.00008497942,0.0001390841,0.00007914455,0.000052670493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024091583,0.00015024403,0.00026874556,0.00006242478,0.00012386529,0.00000550973,0.00008923769,0.000026366972,0.000061609324],"category_scores_gemma":[0.0000020437244,0.00009990372,0.00005850219,0.00020258714,0.0002447327,0.000046746518,0.00005458422,0.00017489237,0.0000047351864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035493862,0.0011179065,0.8103576,0.0010350071,0.004543099,0.000014979362,0.00024337412,0.0000049410833,0.12683363,0.00005773977,0.02840361,0.027033178],"study_design_scores_gemma":[0.0070562544,0.003415488,0.5391378,0.009316854,0.060127646,0.0010551402,0.0007693617,0.001719648,0.34670186,0.00016091781,0.03013988,0.0003991949],"about_ca_topic_score_codex":0.000008952018,"about_ca_topic_score_gemma":0.0000012592042,"teacher_disagreement_score":0.27121982,"about_ca_system_score_codex":0.0000659153,"about_ca_system_score_gemma":0.00007111369,"threshold_uncertainty_score":0.40739554},"labels":[],"label_agreement":null},{"id":"W4416671669","doi":"10.1111/apt.70387","title":"Letter: Affirming Cardiac Safety While Highlighting Areas for Further Research","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bradycardia; Adverse effect; Cohort; Retrospective cohort study; Patient safety; Randomized controlled trial; MEDLINE; Clinical trial","score_opus":0.06499201441577279,"score_gpt":0.39816169876280244,"score_spread":0.33316968434702965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416671669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90345025,0.0060383873,0.0006508121,0.07946791,0.0029126867,0.002929666,0.00022501501,0.00018668492,0.004138576],"genre_scores_gemma":[0.9474029,0.0015369155,0.00043466125,0.048366733,0.0007479071,0.00016335612,0.00035437086,0.000034373847,0.0009588024],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985096,0.00023324342,0.0002597646,0.0003337375,0.00021345331,0.00045020983],"domain_scores_gemma":[0.999055,0.0004855925,0.00004133041,0.00017977176,0.00015012737,0.00008815718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049739704,0.0001628995,0.00025533032,0.00019403717,0.0003079094,0.000015350732,0.00012579348,0.00009830701,0.00020796494],"category_scores_gemma":[9.873649e-8,0.00015276956,0.00014244532,0.00024333867,0.00012352211,0.00008984988,0.00003769407,0.0002656932,0.000032571894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01083964,0.0013284436,0.0665923,0.00085066597,0.09191072,0.00016100322,0.0064805374,0.000050418446,0.785093,0.0011804015,0.026577877,0.008934993],"study_design_scores_gemma":[0.010600201,0.0006174842,0.016124146,0.00023520499,0.059172302,0.000012157677,0.0013934402,0.0006422693,0.555884,0.00051175785,0.3543888,0.00041821477],"about_ca_topic_score_codex":0.00003796715,"about_ca_topic_score_gemma":0.00000373266,"teacher_disagreement_score":0.3278109,"about_ca_system_score_codex":0.00015861412,"about_ca_system_score_gemma":0.00015330281,"threshold_uncertainty_score":0.6229761},"labels":[],"label_agreement":null},{"id":"W4416678098","doi":"10.1111/apt.70473","title":"Editorial: High‐Grade Dysplasia in Colonic Inflammatory Bowel Disease Is Associated With a High Risk of Synchronous or Metachronous Colorectal Cancer—Authors' Reply","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Dysplasia; Inflammatory bowel disease; Colorectal cancer; Comorbidity; Cohort; Disease; Colonoscopy; Confounding","score_opus":0.006702927641555581,"score_gpt":0.27446671114253685,"score_spread":0.2677637835009813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416678098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847199,0.0014447155,0.000012905422,0.0008778395,0.010958193,0.0011787859,0.0007427177,0.000051487896,0.000013456823],"genre_scores_gemma":[0.988344,0.0017837284,0.00007238006,0.0064094975,0.0023231562,0.00048452007,0.00033270277,0.00007230085,0.00017772552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99690294,0.0007471292,0.0006595309,0.000734854,0.0003133371,0.00064222544],"domain_scores_gemma":[0.9985272,0.00014003176,0.00048614727,0.0004357465,0.00019681931,0.00021403063],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042931663,0.00048418308,0.0004750106,0.0001876662,0.00018172429,0.000020278248,0.00049397524,0.00033317524,0.00019314671],"category_scores_gemma":[0.000006613359,0.00044147688,0.00015477536,0.00029640054,0.00048354303,0.000022330834,0.00019606334,0.00043025304,0.0000059628615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03832842,0.003104585,0.54231197,0.0002931695,0.044501573,0.00088059535,0.0006856563,0.0041210065,0.31820476,0.000056019737,0.047242634,0.00026960418],"study_design_scores_gemma":[0.019845404,0.0020127997,0.61595815,0.00019504705,0.024211299,0.000008267065,0.00019326482,0.0009120105,0.3187175,0.00020213386,0.016469216,0.0012749025],"about_ca_topic_score_codex":0.00045008777,"about_ca_topic_score_gemma":0.0008569057,"teacher_disagreement_score":0.07364617,"about_ca_system_score_codex":0.00039435638,"about_ca_system_score_gemma":0.0017129274,"threshold_uncertainty_score":0.9998037},"labels":[],"label_agreement":null},{"id":"W4416738224","doi":"10.1111/apt.70474","title":"Review article: Seeing Is Believing–The Eosinophilic Oesophagitis Endoscopic Reference Score Can Serve as a Valuable Clinical Trial Endpoint in Eosinophilic Oesophagitis","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Eosinophilic esophagitis; Clinical trial; Clinical endpoint; Disease; Clinical disease; Esophageal disease","score_opus":0.0982860007103061,"score_gpt":0.4339852748359141,"score_spread":0.33569927412560796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416738224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75634,0.16188747,0.0000048144198,0.07252257,0.0025317003,0.0053159404,0.00011942377,0.00020920053,0.001068883],"genre_scores_gemma":[0.64728814,0.061710015,0.00018805133,0.28852636,0.0006465116,0.00055695797,0.00013315825,0.000091915375,0.0008589094],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9917371,0.0016640094,0.002671847,0.0016197106,0.00079605135,0.0015112726],"domain_scores_gemma":[0.99581695,0.001278048,0.00059288787,0.0015338727,0.000336684,0.00044156914],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022554023,0.0009282052,0.0018611193,0.00044439477,0.00048533038,0.000082691244,0.0010726928,0.0005290433,0.0027229392],"category_scores_gemma":[0.000029695595,0.00081133324,0.0005352127,0.0016526736,0.0009770409,0.0002860119,0.0005739714,0.0023050744,0.00025734215],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05398675,0.020691046,0.5595954,0.009466256,0.05912619,0.009467349,0.0055933916,0.000054499757,0.05692895,0.0025678345,0.086358264,0.13616407],"study_design_scores_gemma":[0.3173215,0.016389491,0.24070641,0.017334683,0.088726975,0.0018626535,0.00075315445,0.0012257763,0.17326905,0.01050914,0.12808828,0.003812872],"about_ca_topic_score_codex":0.0008428438,"about_ca_topic_score_gemma":0.00017213258,"teacher_disagreement_score":0.318889,"about_ca_system_score_codex":0.00078149495,"about_ca_system_score_gemma":0.0013398665,"threshold_uncertainty_score":0.99999666},"labels":[],"label_agreement":null},{"id":"W4416809671","doi":"10.1111/apt.70453","title":"Diabetes Mellitus is a Risk Factor for Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Transjugular intrahepatic portosystemic shunt; Risk factor; Hepatic encephalopathy; Cirrhosis; Diabetes mellitus; Incidence (geometry); Portal hypertension","score_opus":0.015168304225937462,"score_gpt":0.30513791517437633,"score_spread":0.28996961094843887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416809671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847333,0.008360604,0.0011767871,0.0016819393,0.001391039,0.0018697258,0.000635313,0.00010421163,0.000047083387],"genre_scores_gemma":[0.97447556,0.0035468268,0.0003521428,0.020983964,0.000120596465,0.00025071276,0.00015945105,0.000034795212,0.000075952375],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982652,0.00016626048,0.00048705575,0.00041471457,0.00020811168,0.00045864566],"domain_scores_gemma":[0.9991568,0.0003171958,0.00011695095,0.00021349396,0.00006302989,0.00013255091],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018934975,0.00029881077,0.00047697837,0.00018068415,0.00019989985,0.000016936025,0.00015420285,0.00012854449,0.00038177316],"category_scores_gemma":[1.6436044e-7,0.00027574407,0.00035585725,0.00021266052,0.00007065894,0.00013180396,0.00001319734,0.00020786248,0.00001666274],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015546958,0.0010079258,0.53099304,0.0016352525,0.08919754,0.00012415445,0.00819202,0.000016666792,0.352411,0.00003242276,0.00011326619,0.014721983],"study_design_scores_gemma":[0.015107331,0.0012410834,0.06549802,0.00049413025,0.25939733,0.000010464583,0.0006917933,0.0075707873,0.64670336,0.00097655226,0.0016561492,0.00065298576],"about_ca_topic_score_codex":0.000035808866,"about_ca_topic_score_gemma":0.000006306501,"teacher_disagreement_score":0.46549505,"about_ca_system_score_codex":0.00013851222,"about_ca_system_score_gemma":0.00017731391,"threshold_uncertainty_score":0.9999695},"labels":[],"label_agreement":null},{"id":"W4416827849","doi":"10.1111/apt.70485","title":"Systematic Review: Efficacy, Safety and Metabolic Outcomes of GLP‐1 Receptor Agonists in Inflammatory Bowel Disease","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"South Health Campus; University of Calgary","funders":"","keywords":"Inflammatory bowel disease; Observational study; Receptor; Inflammatory Bowel Diseases; Disease; MEDLINE; Inflammation","score_opus":0.011087597979531362,"score_gpt":0.3123107193256974,"score_spread":0.301223121346166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416827849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7072164,0.26816073,0.000007923877,0.017492022,0.0007575891,0.0057261144,0.000041209096,0.00007832144,0.0005196967],"genre_scores_gemma":[0.64733773,0.22556378,0.000295317,0.12224264,0.00005516136,0.0005532552,0.0002232188,0.00005726622,0.0036716557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843246,0.000223094,0.00067524315,0.0002570915,0.00016094228,0.00025118497],"domain_scores_gemma":[0.9992038,0.00019870092,0.00016884251,0.00028936449,0.00003730138,0.00010197175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034466595,0.00023918271,0.000854107,0.00019254995,0.00004497904,0.000006378458,0.00012884755,0.000046589914,0.00012476499],"category_scores_gemma":[0.0000018886202,0.00018916323,0.00013268566,0.00017473851,0.00013585834,0.00006122724,0.000108455286,0.000119724566,0.000014747051],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002602791,0.004693424,0.6561212,0.21876605,0.09834539,0.00017070385,0.00062996557,0.000016307895,0.01147201,0.001931591,0.0031754025,0.0020751378],"study_design_scores_gemma":[0.026160168,0.0005454483,0.6426437,0.0347788,0.25491598,0.000004432209,0.0002734382,0.00030781594,0.014383683,0.00014806347,0.02507651,0.0007620001],"about_ca_topic_score_codex":0.000008873349,"about_ca_topic_score_gemma":0.0000024880849,"teacher_disagreement_score":0.18398724,"about_ca_system_score_codex":0.00009055531,"about_ca_system_score_gemma":0.00007068962,"threshold_uncertainty_score":0.77138525},"labels":[],"label_agreement":null},{"id":"W4416907352","doi":"10.1111/apt.70484","title":"Editorial for ‘Review Article: Extending the Frontiers of Intestinal Ultrasound Knowledge, Performance, and Expansion’","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Modalities; Inflammatory bowel disease; Disease; Ultrasound; Magnetic resonance imaging; Clinical Practice; Modality (human–computer interaction); MEDLINE","score_opus":0.010367440291899278,"score_gpt":0.308499942486655,"score_spread":0.29813250219475573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416907352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9443433,0.03412214,0.00033203035,0.00053070456,0.019621195,0.0008505674,0.000027721944,0.000012462389,0.00015986187],"genre_scores_gemma":[0.9399735,0.039038107,0.0007191552,0.012140645,0.007353868,0.00028130642,0.000095910655,0.000031549753,0.00036598413],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991645,0.000114117465,0.00024209383,0.00020804413,0.00006619403,0.00020504798],"domain_scores_gemma":[0.9994917,0.00010417856,0.000083601524,0.00016776826,0.0001110671,0.00004171877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030770348,0.00014331327,0.00014337592,0.000032728833,0.00015480591,0.00000705036,0.00019547108,0.00007034361,0.000017453818],"category_scores_gemma":[0.0000029748915,0.00011400492,0.00006990134,0.000074158954,0.00025041547,0.0000074739087,0.00008474758,0.00009368778,0.0000012994774],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010011381,0.00020977439,0.02026442,0.0004566526,0.002696852,0.0000012391795,0.00007950278,0.000014501476,0.6173065,0.0000389427,0.35349223,0.0044382536],"study_design_scores_gemma":[0.0043624546,0.0005898232,0.02080572,0.0002689482,0.009986873,0.000019086145,0.00024918106,0.00061785884,0.42649043,0.00017565348,0.53599757,0.00043640778],"about_ca_topic_score_codex":0.0000011237952,"about_ca_topic_score_gemma":0.000002351585,"teacher_disagreement_score":0.19081607,"about_ca_system_score_codex":0.0000182041,"about_ca_system_score_gemma":0.0001473092,"threshold_uncertainty_score":0.46489856},"labels":[],"label_agreement":null},{"id":"W4417102121","doi":"10.1111/apt.70488","title":"Letter on ‘Meta‐Analysis: Mortality Trends and Risk Factors in Severe Alcohol‐Associated Hepatitis’—Authors' Reply","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Mortality rate; MEDLINE; Risk of mortality; Statement (logic); Risk assessment; Randomized controlled trial","score_opus":0.13120394859156023,"score_gpt":0.4313408188394181,"score_spread":0.30013687024785785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417102121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97895217,0.0019410219,0.000007916092,0.017499795,0.00049667736,0.00049035717,0.000104951054,0.00008793306,0.00041920762],"genre_scores_gemma":[0.8280349,0.0023491017,0.000027642734,0.16848724,0.00004659347,0.0000660974,0.00017284112,0.000017138538,0.00079849316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751145,0.0008050334,0.0005016805,0.00052477565,0.00022499541,0.0004320482],"domain_scores_gemma":[0.9988856,0.00042418405,0.00019559334,0.00029054118,0.000048496735,0.00015559251],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00064114545,0.00031372704,0.00090387656,0.00071306655,0.00017636883,0.000014661266,0.000101118094,0.00020083133,0.0012359093],"category_scores_gemma":[0.000001417679,0.0002682258,0.00034334342,0.0008920867,0.00014986821,0.00006874832,0.000052659198,0.0006986712,0.0000122945185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024208114,0.00040163047,0.74881387,0.000025716607,0.24767698,0.000042072825,0.00027129133,0.000036245692,0.00053731276,0.000014321856,0.0016684046,0.00027004795],"study_design_scores_gemma":[0.0024295507,0.00021192661,0.66903704,0.000009068197,0.3231398,0.0000018565324,0.000022331815,0.0005414402,0.0012429107,0.0000342353,0.0031810936,0.00014875786],"about_ca_topic_score_codex":0.0019702895,"about_ca_topic_score_gemma":0.0007210682,"teacher_disagreement_score":0.15098743,"about_ca_system_score_codex":0.00021980554,"about_ca_system_score_gemma":0.00006853323,"threshold_uncertainty_score":0.999977},"labels":[],"label_agreement":null},{"id":"W4417313574","doi":"10.1111/apt.70494","title":"Editorial: Targeting Urgency in <scp>IBD</scp> —A Historical Divide. Authors' Reply","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Clinical trial; Inflammatory Bowel Diseases; Inflammatory bowel disease; Quality of life (healthcare); MEDLINE; Disease; Value (mathematics); Clinical endpoint","score_opus":0.011261357778575651,"score_gpt":0.29073328487286937,"score_spread":0.2794719270942937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417313574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88805217,0.005061682,0.00017051492,0.0024980016,0.10243498,0.00073839864,0.00003118846,0.00008645143,0.00092661893],"genre_scores_gemma":[0.89605236,0.0018262133,0.00057787506,0.049914822,0.045118757,0.00038176248,0.00046166682,0.0001343886,0.0055321427],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975344,0.000435728,0.0005664407,0.00063207344,0.00021463484,0.0006167221],"domain_scores_gemma":[0.9991072,0.00012318479,0.00014925821,0.0003598744,0.0001061988,0.00015429183],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005909931,0.00032898868,0.00026143075,0.00015544507,0.00017051169,0.000019265202,0.00045328238,0.00032238374,0.00006707395],"category_scores_gemma":[0.000010811021,0.00036140482,0.00016235777,0.00022062018,0.00011045671,0.000014050613,0.00027583668,0.0003917963,0.000028307491],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019492726,0.00035627748,0.033223286,0.000029223409,0.0015208301,0.00007027441,0.00016851423,0.000085179185,0.39836934,0.0000335109,0.5656306,0.0003180391],"study_design_scores_gemma":[0.0016454363,0.00011895874,0.005075173,0.00001061852,0.0011176621,0.000002327729,0.000104865394,0.00007788038,0.084363975,0.00029197137,0.90702295,0.00016818567],"about_ca_topic_score_codex":0.000049047387,"about_ca_topic_score_gemma":0.000018376939,"teacher_disagreement_score":0.34139234,"about_ca_system_score_codex":0.00033403558,"about_ca_system_score_gemma":0.00028871445,"threshold_uncertainty_score":0.9998838},"labels":[],"label_agreement":null},{"id":"W7117388694","doi":"10.1111/apt.70492","title":"Meta‐Analysis: Prevalence of Eating Disorders in Inflammatory Bowel Disease","year":2025,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Inflammatory bowel disease; Eating disorders; Inflammatory Bowel Diseases; Ulcerative colitis; Disease; Crohn disease; MEDLINE","score_opus":0.017213628704758736,"score_gpt":0.3035461547495535,"score_spread":0.28633252604479476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117388694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98857105,0.009867983,0.00012120285,0.00037327796,0.00020330743,0.0005119212,0.00007963006,0.000017302635,0.00025433395],"genre_scores_gemma":[0.99299246,0.0014714221,0.0001242586,0.004762848,0.00003588227,0.00016267048,0.00006984339,0.00001830965,0.00036232846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983477,0.00035281072,0.00044329138,0.00041565372,0.00013351113,0.0003070587],"domain_scores_gemma":[0.99928766,0.000043969692,0.00015187869,0.00037871528,0.000049020946,0.000088780165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027711215,0.00023801555,0.00028078,0.00023231017,0.00006615059,0.000007973497,0.00036315058,0.000098265766,0.0002264616],"category_scores_gemma":[6.097921e-7,0.0002444946,0.0004418426,0.00024598493,0.00021970247,0.000011028298,0.00017091766,0.00012864065,0.0000034908842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072644424,0.00031177336,0.70332414,0.00024721285,0.21920149,0.00002037371,0.00008565985,0.0045142057,0.07139708,0.00005755497,0.00005824336,0.00005584264],"study_design_scores_gemma":[0.0014497185,0.00006685007,0.53974026,0.000011327645,0.43475398,3.3636493e-7,0.00008862978,0.0014347471,0.021171208,0.00021629207,0.00073776033,0.00032888664],"about_ca_topic_score_codex":0.000013937889,"about_ca_topic_score_gemma":0.000073484036,"teacher_disagreement_score":0.21555251,"about_ca_system_score_codex":0.000028764673,"about_ca_system_score_gemma":0.00017507629,"threshold_uncertainty_score":0.99702},"labels":[],"label_agreement":null}]}